,id,date,news,label,pct_change,text_length,textlemma,textlengthforlemma,word_count,topic,topic_name,Entities,IsEntity
104,nifty_2,2010-01-11,Research and Markets: Epilepsy - Drug Pipeline Analysis and Market Forecasts to 2015 Report,Fall,-0.0093,91,research and market epilepsy drug pipeline analysis and market forecast report,78,11,0,pharmacy,"['research', 'and', 'market', 'e', '##pile', '##psy', 'drug', 'pipeline', 'analysis', 'and', 'market', 'forecast', 'report']",1
127,nifty_2,2010-01-11," Weird Science?  Big Pharma's Top Three M&A; Deals in 2009 Nears $160 Billion, an Industrial Info News Alert",Fall,-0.0093,108,weird science big pharma top three deal nears billion industrial info news alert,80,13,0,pharmacy,"['weird', 'science', 'big', 'p', '##har', '##ma', 'top', 'three', 'deal', 'near', '##s', 'billion', 'industrial', 'info', 'news', 'alert']",1
186,nifty_2,2010-01-11,Research and Markets: Booming Hospital Services Market in India,Fall,-0.0093,63,research and market booming hospital service market india,57,8,0,pharmacy,"['research', 'and', 'market', 'boom', '##ing', 'hospital', 'service', 'market', 'in', '##dia']",1
222,nifty_2,2010-01-11, BioCentury Publishes Investor Picks for New Biotech Bellwethers in 2010,Fall,-0.0093,72,biocentury publishes investor pick for new biotech bellwether,61,8,0,pharmacy,"['bio', '##cent', '##ury', 'publishes', 'investor', 'pick', 'for', 'new', 'bio', '##tech', 'bell', '##we', '##ther']",1
396,nifty_2,2010-01-11,Research and Markets: Vertex Pharmaceuticals - SWOT Framework Analysis,Fall,-0.0093,70,research and market vertex pharmaceutical swot framework analysis,65,8,0,pharmacy,"['research', 'and', 'market', 'vertex', 'pharmaceutical', 's', '##wo', '##t', 'framework', 'analysis']",1
404,nifty_2,2010-01-11,Elite Pharma Insiders to Reveal Key Survival Strategies for Pharmaceutical Industry in 2010,Fall,-0.0093,91,elite pharma insider reveal key survival strategy for pharmaceutical industry,77,10,0,pharmacy,"['elite', 'p', '##har', '##ma', 'inside', '##r', 'reveal', 'key', 'survival', 'strategy', 'for', 'pharmaceutical', 'industry']",1
492,nifty_2,2010-01-11,Resverlogix Presenting at Biotech Showcase,Fall,-0.0093,42,resverlogix presenting biotech showcase,39,4,0,pharmacy,"['re', '##s', '##ver', '##log', '##ix', 'presenting', 'bio', '##tech', 'showcase']",1
493,nifty_2,2010-01-11,"Renewed Brand: First Report - Managed Care Focuses on Urgent Reporting of Healthcare, Pharmaceuticals and Managed Markets",Fall,-0.0093,121,renewed brand first report managed care focus urgent reporting healthcare pharmaceutical and managed market,107,14,0,pharmacy,"['renewed', 'brand', 'first', 'report', 'managed', 'care', 'focus', 'urgent', 'reporting', 'healthcare', 'pharmaceutical', 'and', 'managed', 'market']",1
516,nifty_2,2010-01-11,AMAG shares rise on strong revenue outlook for anemia drug,Fall,-0.0093,58,amag share rise strong revenue outlook for anemia drug,54,9,0,pharmacy,"['am', '##ag', 'share', 'rise', 'strong', 'revenue', 'outlook', 'for', 'an', '##emia', 'drug']",1
661,nifty_2,2010-01-11,Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco,Fall,-0.0093,99,spherix present annual onemedplace finance forum and ebd biotech showcase san francisco,87,12,0,pharmacy,"['s', '##pher', '##ix', 'present', 'annual', 'one', '##med', '##place', 'finance', 'forum', 'and', 'e', '##b', '##d', 'bio', '##tech', 'showcase', 'sa', '##n', 'f', '##ran', '##cis', '##co']",1
681,nifty_2,2010-01-11,Mexx Worldwide Strengthens Product Team,Fall,-0.0093,39,mexx worldwide strengthens product team,39,5,0,pharmacy,"['me', '##x', '##x', 'worldwide', 'strengthen', '##s', 'product', 'team']",1
734,nifty_2,2010-01-11,FDA Unveils First Phase of Transparency Initiative,Fall,-0.0093,50,fda unveils first phase transparency initiative,47,6,0,pharmacy,"['f', '##da', 'un', '##ve', '##ils', 'first', 'phase', 'transparency', 'initiative']",1
764,nifty_2,2010-01-11,"UPDATE 1-Molecular Insight cuts job, shares fall",Fall,-0.0093,48,update molecular insight cut job share fall,43,7,0,pharmacy,"['update', 'molecular', 'insight', 'cut', 'job', 'share', 'fall']",1
771,nifty_2,2010-01-11,New GAO Study: Lack of Competition Helping Drive `Extraordinary` Brand-Name Drug Price Increases,Fall,-0.0093,96,new gao study lack competition helping drive extraordinary brand name drug price increase,89,13,0,pharmacy,"['new', 'g', '##ao', 'study', 'lack', 'competition', 'helping', 'drive', 'extraordinary', 'brand', 'name', 'drug', 'price', 'increase']",1
778,nifty_2,2010-01-11,"US GAO finds ""extraordinary"" increases in drug prices",Fall,-0.0093,53,gao find extraordinary increase drug price,42,6,0,pharmacy,"['g', '##ao', 'find', 'extraordinary', 'increase', 'drug', 'price']",1
792,nifty_2,2010-01-11,AHF Blasts Merck on AIDS Drug Pricing During Investor Conference Protest in S.F.,Fall,-0.0093,80,ahf blast merck aid drug pricing during investor conference protest,67,10,0,pharmacy,"['ah', '##f', 'blast', 'me', '##rc', '##k', 'aid', 'drug', 'pricing', 'during', 'investor', 'conference', 'protest']",1
827,nifty_2,2010-01-11,Research and Markets: New Report: OTC Healthcare in China to 2013,Fall,-0.0093,65,research and market new report otc healthcare china,51,8,0,pharmacy,"['research', 'and', 'market', 'new', 'report', 'o', '##t', '##c', 'healthcare', 'chin', '##a']",1
973,nifty_3,2010-01-12,Research and Markets: Pharma Bio World: Annual Subscription for Senior Professionals in the Pharmaceutical and Biotechnology Sectors,Rise,0.0084,132,research and market pharma bio world annual subscription for senior professional the pharmaceutical and biotechnology sector,124,16,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', 'bio', 'world', 'annual', 'subscription', 'for', 'senior', 'professional', 'the', 'pharmaceutical', 'and', 'bio', '##tech', '##nology', 'sector']",1
1028,nifty_3,2010-01-12,AHF Blasts Merck on AIDS Drug Pricing During Investor Conference Protest in S.F.,Rise,0.0084,80,ahf blast merck aid drug pricing during investor conference protest,67,10,0,pharmacy,"['ah', '##f', 'blast', 'me', '##rc', '##k', 'aid', 'drug', 'pricing', 'during', 'investor', 'conference', 'protest']",1
1065,nifty_3,2010-01-12, Medical Care Technologies Inc. Completes International Secure Practice Management Suite for Testing in China,Rise,0.0084,109,medical care technology inc completes international secure practice management suite for testing china,102,13,0,pharmacy,"['medical', 'care', 'technology', 'in', '##c', 'complete', '##s', 'international', 'secure', 'practice', 'management', 'suite', 'for', 'testing', 'chin', '##a']",1
1077,nifty_3,2010-01-12,Molecular Biometrics Closes $12.5 Million Series B Equity Funding,Rise,0.0084,65,molecular biometrics close million series equity funding,56,7,0,pharmacy,"['molecular', 'bio', '##metric', '##s', 'close', 'million', 'series', 'equity', 'funding']",1
1117,nifty_3,2010-01-12,Gaco Western`s WallFoam 184 BIO Offers Green Upside in Down Market,Rise,0.0084,66,gaco western wallfoam bio offer green upside down market,56,9,0,pharmacy,"['g', '##aco', 'western', 'wall', '##fo', '##am', 'bio', 'offer', 'green', 'upside', 'down', 'market']",1
1156,nifty_3,2010-01-12," Allocade Featured in Spinoff, NASA's Annual Premier Publication Highlighting Successfully Commercialized Technology",Rise,0.0084,116,allocade featured spinoff nasa annual premier publication highlighting successfully commercialized technology,109,11,0,pharmacy,"['all', '##oc', '##ade', 'featured', 'spin', '##off', 'na', '##sa', 'annual', 'premier', 'publication', 'highlighting', 'successfully', 'commercial', '##ized', 'technology']",1
1166,nifty_3,2010-01-12,Biogen Idec to Provide Business Update at Investor Meeting,Rise,0.0084,58,biogen idec provide business update investor meeting,52,7,0,pharmacy,"['bio', '##gen', 'id', '##ec', 'provide', 'business', 'update', 'investor', 'meeting']",1
1231,nifty_3,2010-01-12,"BioLeap, Inc. Secures $5M Series A Financing from Adams Capital Management and Quaker BioVentures",Rise,0.0084,97,bioleap inc secures series financing from adam capital management and quaker bioventures,88,12,0,pharmacy,"['bio', '##lea', '##p', 'in', '##c', 'secure', '##s', 'series', 'financing', 'from', 'ad', '##am', 'capital', 'management', 'and', 'q', '##ua', '##ker', 'bio', '##vent', '##ures']",1
1267,nifty_3,2010-01-12,FDA Unveils First Phase of Transparency Initiative,Rise,0.0084,50,fda unveils first phase transparency initiative,47,6,0,pharmacy,"['f', '##da', 'un', '##ve', '##ils', 'first', 'phase', 'transparency', 'initiative']",1
1454,nifty_3,2010-01-12,"""Extraordinary"" increases in drug prices: report",Rise,0.0084,48,extraordinary increase drug price report,40,5,0,pharmacy,"['extraordinary', 'increase', 'drug', 'price', 'report']",1
1801,nifty_3,2010-01-12,Health Mailbox: Columnist Melinda Beck Answers Readers' Questions,Rise,0.0084,65,health mailbox columnist melinda beck answer reader question,60,8,0,pharmacy,"['health', 'mail', '##box', 'columnist', 'me', '##lind', '##a', 'be', '##ck', 'answer', 'reader', 'question']",1
1966,nifty_5,2010-01-14,BioInvent Announces a Directed New Share Issue of SEK 150 Million,Fall,-0.0112,65,bioinvent announces directed new share issue sek million,56,8,0,pharmacy,"['bio', '##in', '##vent', 'announces', 'directed', 'new', 'share', 'issue', 'se', '##k', 'million']",1
1974,nifty_5,2010-01-14,"Research and Markets: The Future of Metabolic Disorder Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis",Fall,-0.0112,157,research and market the future metabolic disorder therapeutic market forecast competitive benchmarking product pipeline and deal analysis,137,17,0,pharmacy,"['research', 'and', 'market', 'the', 'future', 'metabolic', 'disorder', 'therapeutic', 'market', 'forecast', 'competitive', 'bench', '##mark', '##ing', 'product', 'pipeline', 'and', 'deal', 'analysis']",1
2002,nifty_5,2010-01-14,Research and Markets: 2010 Report Forecasts the Market Size of the Medical Devices Market in Europe for 2008-2012,Fall,-0.0112,113,research and market report forecast the market size the medical device market europe for,88,14,0,pharmacy,"['research', 'and', 'market', 'report', 'forecast', 'the', 'market', 'size', 'the', 'medical', 'device', 'market', 'euro', '##pe', 'for']",1
2023,nifty_5,2010-01-14,"Research and Markets: The Global Pharmaceutical Packaging Market is Forecast to Grow at a CAGR of 6.9% between 2008 and 2015, Reaching a Value of $68 Billion by 2015",Fall,-0.0112,165,research and market the global pharmaceutical packaging market forecast grow cagr between and reaching value billion,116,16,0,pharmacy,"['research', 'and', 'market', 'the', 'global', 'pharmaceutical', 'packaging', 'market', 'forecast', 'grow', 'ca', '##g', '##r', 'between', 'and', 'reaching', 'value', 'billion']",1
2282,nifty_5,2010-01-14," RemoteMDx, Inc. Announces $21.8M Recapitalization and Equity Raise",Fall,-0.0112,67,remotemdx inc announces recapitalization and equity raise,57,7,0,pharmacy,"['remote', '##m', '##d', '##x', 'in', '##c', 'announces', 're', '##cap', '##ital', '##ization', 'and', 'equity', 'raise']",1
2374,nifty_5,2010-01-14,AREVA: Bioenergies: Contracts Worth 260 Million Euros,Fall,-0.0112,53,areva bioenergies contract worth million euro,45,6,0,pharmacy,"['are', '##va', 'bio', '##ener', '##gies', 'contract', 'worth', 'million', 'euro']",1
2386,nifty_5,2010-01-14,Risk still a red flag for biotech deals,Fall,-0.0112,39,risk still red flag for biotech deal,36,7,0,pharmacy,"['risk', 'still', 'red', 'flag', 'for', 'bio', '##tech', 'deal']",1
2547,nifty_5,2010-01-14, Medical Care Technologies Inc. Launches Secure Care-Giving Technology to Promote Independent Living,Fall,-0.0112,100,medical care technology inc launch secure care giving technology promote independent living,91,12,0,pharmacy,"['medical', 'care', 'technology', 'in', '##c', 'launch', 'secure', 'care', 'giving', 'technology', 'promote', 'independent', 'living']",1
2887,nifty_7,2010-01-20,Research and Markets: Brain Tumor - Drug Pipeline Analysis and Market Forecasts to 2016,Fall,-0.0192,87,research and market brain tumor drug pipeline analysis and market forecast,74,11,0,pharmacy,"['research', 'and', 'market', 'brain', 'tumor', 'drug', 'pipeline', 'analysis', 'and', 'market', 'forecast']",1
2952,nifty_7,2010-01-20,"Medical Connections, Inc. Provides Corporate Update to the Financial Community",Fall,-0.0192,78,medical connection inc provides corporate update the financial community,72,9,0,pharmacy,"['medical', 'connection', 'in', '##c', 'provides', 'corporate', 'update', 'the', 'financial', 'community']",1
2973,nifty_7,2010-01-20,"Research and Markets: Innovations in Epigenetics: Advances in Technologies, Diagnostics & Therapeutics",Fall,-0.0192,102,research and market innovation epigenetics advance technology diagnostics therapeutic,85,9,0,pharmacy,"['research', 'and', 'market', 'innovation', 'e', '##pi', '##gene', '##tics', 'advance', 'technology', 'diagnostic', '##s', 'therapeutic']",1
2989,nifty_7,2010-01-20,Research and Markets: Migraine - Drug Pipeline Analysis and Market Forecasts to 2016,Fall,-0.0192,84,research and market migraine drug pipeline analysis and market forecast,71,10,0,pharmacy,"['research', 'and', 'market', 'mi', '##gra', '##ine', 'drug', 'pipeline', 'analysis', 'and', 'market', 'forecast']",1
3010,nifty_7,2010-01-20,"Research and Markets: The Cancer Market Outlook to 2014: Competitive Landscape, Market Size, Pipeline Analysis and Growth Opportunities",Fall,-0.0192,135,research and market the cancer market outlook competitive landscape market size pipeline analysis and growth opportunity,120,16,0,pharmacy,"['research', 'and', 'market', 'the', 'cancer', 'market', 'outlook', 'competitive', 'landscape', 'market', 'size', 'pipeline', 'analysis', 'and', 'growth', 'opportunity']",1
3021,nifty_7,2010-01-20,"ANALYSIS-""Silent pandemic"" will force drug price rethink",Fall,-0.0192,56,analysis silent pandemic will force drug price rethink,54,8,0,pharmacy,"['analysis', 'silent', 'pan', '##de', '##mic', 'will', 'force', 'drug', 'price', 're', '##thin', '##k']",1
3023,nifty_7,2010-01-20,"""Silent pandemic"" will force drug price rethink",Fall,-0.0192,47,silent pandemic will force drug price rethink,45,7,0,pharmacy,"['silent', 'pan', '##de', '##mic', 'will', 'force', 'drug', 'price', 're', '##thin', '##k']",1
3214,nifty_7,2010-01-20,"A Recovery Act Success Story:  NIH Funding of Biomedical Innovation Is Creating Jobs, Fueling Industry Growth, and Helping Reduce Long-term Health Care Costs",Fall,-0.0192,157,recovery act success story nih funding biomedical innovation creating job fueling industry growth and helping reduce long term health care cost,143,21,0,pharmacy,"['recovery', 'act', 'success', 'story', 'ni', '##h', 'funding', 'bio', '##medical', 'innovation', 'creating', 'job', 'fuel', '##ing', 'industry', 'growth', 'and', 'helping', 'reduce', 'long', 'term', 'health', 'care', 'cost']",1
3265,nifty_7,2010-01-20,"A Recovery Act Success Story: NIH Funding of Biomedical Innovation is Creating Jobs,  Fueling Industry Growth, and Helping Reduce Long-term Health Care Costs",Fall,-0.0192,157,recovery act success story nih funding biomedical innovation creating job fueling industry growth and helping reduce long term health care cost,143,21,0,pharmacy,"['recovery', 'act', 'success', 'story', 'ni', '##h', 'funding', 'bio', '##medical', 'innovation', 'creating', 'job', 'fuel', '##ing', 'industry', 'growth', 'and', 'helping', 'reduce', 'long', 'term', 'health', 'care', 'cost']",1
3300,nifty_7,2010-01-20,"Research and Markets: Toxicology and Pharmacology Report: Outsourcing, History, Process and Regulation; Technical, Political and Economic Challenges",Fall,-0.0192,148,research and market toxicology and pharmacology report outsourcing history process and regulation technical political and economic challenge,140,17,0,pharmacy,"['research', 'and', 'market', 'toxic', '##ology', 'and', 'p', '##har', '##ma', '##cology', 'report', 'outs', '##our', '##cing', 'history', 'process', 'and', 'regulation', 'technical', 'political', 'and', 'economic', 'challenge']",1
3407,nifty_7,2010-01-20,Amylin Pharmaceuticals to Webcast Year-End Financial Results,Fall,-0.0192,60,amylin pharmaceutical webcast year end financial result,55,7,0,pharmacy,"['am', '##yl', '##in', 'pharmaceutical', 'web', '##cast', 'year', 'end', 'financial', 'result']",1
3590,nifty_7,2010-01-20,"For Severely Ill Kids, a Dearth of Doctors",Fall,-0.0192,42,for severely ill kid dearth doctor,34,6,0,pharmacy,"['for', 'severely', 'ill', 'kid', 'dear', '##th', 'doctor']",1
3765,nifty_11,2010-01-27,Research and Markets: Japan Pharmaceuticals and Healthcare Report Q1 2010,Fall,-0.0115,73,research and market japan pharmaceutical and healthcare report,62,8,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##n', 'pharmaceutical', 'and', 'healthcare', 'report']",1
3779,nifty_11,2010-01-27,Research and Markets: Colombia Pharmaceuticals and Healthcare Report Q1 2010,Fall,-0.0115,76,research and market colombia pharmaceutical and healthcare report,65,8,0,pharmacy,"['research', 'and', 'market', 'co', '##lo', '##mb', '##ia', 'pharmaceutical', 'and', 'healthcare', 'report']",1
3877,nifty_11,2010-01-27,International Stem Cell Corporation joins Information Portal StockProfile.com,Fall,-0.0115,77,international stem cell corporation join information portal stockprofile com,76,9,0,pharmacy,"['international', 'stem', 'cell', 'corporation', 'join', 'information', 'portal', 'stock', '##p', '##ro', '##fi', '##le', 'com']",1
3946,nifty_11,2010-01-27,Somaxon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference,Fall,-0.0115,83,somaxon pharmaceutical present the annual bio ceo investor conference,69,9,0,pharmacy,"['so', '##max', '##on', 'pharmaceutical', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
4004,nifty_11,2010-01-27,China Biologic Products Responds to Allegations on Financial Websites,Fall,-0.0115,69,china biologic product responds allegation financial website,60,7,0,pharmacy,"['chin', '##a', 'bio', '##log', '##ic', 'product', 'responds', 'all', '##egation', 'financial', 'website']",1
4125,nifty_11,2010-01-27,"Research and Markets: According to Market Analytical Studies, the Therapeutic Lung Cancer Drug Market Is Predicted to Exceed $4 Billion between 2010 and 2015",Fall,-0.0115,157,research and market according market analytical study the therapeutic lung cancer drug market predicted exceed billion between and,130,18,0,pharmacy,"['research', 'and', 'market', 'according', 'market', 'analytical', 'study', 'the', 'therapeutic', 'lung', 'cancer', 'drug', 'market', 'predicted', 'exceed', 'billion', 'between', 'and']",1
4166,nifty_11,2010-01-27,International Decision Systems(R) Announces ProFinia(R) Release 4.2,Fall,-0.0115,67,international decision system announces profinia release,56,6,0,pharmacy,"['international', 'decision', 'system', 'announces', 'pro', '##fin', '##ia', 'release']",1
4308,nifty_11,2010-01-27,Valuations and Exit Strategies for Medtech Companies in the New Economy Analyzed in Online Industry Presentation by Medical Capital Advisors Chairman & CEO Christopher J.P. Velis,Fall,-0.0115,178,valuation and exit strategy for medtech company the new economy analyzed online industry presentation medical capital advisor chairman ceo christopher velis,156,21,0,pharmacy,"['v', '##al', '##uation', 'and', 'exit', 'strategy', 'for', 'me', '##dt', '##ech', 'company', 'the', 'new', 'economy', 'analyzed', 'online', 'industry', 'presentation', 'medical', 'capital', 'advisor', 'chairman', 'c', '##eo', 'ch', '##risto', '##pher', 've', '##lis']",1
4349,nifty_11,2010-01-27,Synygy and Health Market Science Form Strategic Partnership,Fall,-0.0115,59,synygy and health market science form strategic partnership,59,8,0,pharmacy,"['s', '##yn', '##y', '##gy', 'and', 'health', 'market', 'science', 'form', 'strategic', 'partnership']",1
4423,nifty_11,2010-01-27, Molecular Insight Announces Updates to Board of Directors,Fall,-0.0115,58,molecular insight announces update board director,49,6,0,pharmacy,"['molecular', 'insight', 'announces', 'update', 'board', 'director']",1
4799,nifty_13,2010-02-01,SuperGen to Present at BIO CEO & Investor Conference on February 8th,Rise,0.0121,68,supergen present bio ceo investor conference february,53,7,0,pharmacy,"['super', '##gen', 'present', 'bio', 'c', '##eo', 'investor', 'conference', 'f', '##eb', '##ru', '##ary']",1
4845,nifty_13,2010-02-01,Cyclacel Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference,Rise,0.0121,84,cyclacel pharmaceutical present the annual bio ceo investor conference,70,9,0,pharmacy,"['c', '##y', '##c', '##lace', '##l', 'pharmaceutical', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
4873,nifty_13,2010-02-01,GenVec to Present at the 12th Annual BIO CEO & Investor Conference,Rise,0.0121,66,genvec present the annual bio ceo investor conference,53,8,0,pharmacy,"['g', '##en', '##ve', '##c', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
4912,nifty_13,2010-02-01,Affymax to Present at the 12th Annual BIO CEO & Investor Conference,Rise,0.0121,67,affymax present the annual bio ceo investor conference,54,8,0,pharmacy,"['a', '##ffy', '##max', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
4921,nifty_13,2010-02-01,Response Biomedical Announces Additional Chinese Partnership,Rise,0.0121,60,response biomedical announces additional chinese partnership,60,6,0,pharmacy,"['response', 'bio', '##medical', 'announces', 'additional', 'chin', '##ese', 'partnership']",1
4928,nifty_13,2010-02-01,Research and Markets: 2010 Trends to Watch: Pharmaceutical Technology,Rise,0.0121,69,research and market trend watch pharmaceutical technology,57,7,0,pharmacy,"['research', 'and', 'market', 'trend', 'watch', 'pharmaceutical', 'technology']",1
4952,nifty_13,2010-02-01,Research and Markets: 2010 Trends to Watch: Healthcare Technology,Rise,0.0121,65,research and market trend watch healthcare technology,53,7,0,pharmacy,"['research', 'and', 'market', 'trend', 'watch', 'healthcare', 'technology']",1
4953,nifty_13,2010-02-01,RXi Pharmaceuticals to Webcast Presentation at the 12th Annual BIO CEO & Investor Conference,Rise,0.0121,92,rxi pharmaceutical webcast presentation the annual bio ceo investor conference,78,10,0,pharmacy,"['r', '##xi', 'pharmaceutical', 'web', '##cast', 'presentation', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
4971,nifty_13,2010-02-01,CytRx to Present at the 12th Annual BIO CEO & Investor Conference,Rise,0.0121,65,cytrx present the annual bio ceo investor conference,52,8,0,pharmacy,"['c', '##yt', '##r', '##x', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
5021,nifty_13,2010-02-01," MDRNA, Inc. to Present at the 12th Annual BIO CEO & Investor Conference",Rise,0.0121,72,mdrna inc present the annual bio ceo investor conference,56,9,0,pharmacy,"['m', '##dr', '##na', 'in', '##c', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
5026,nifty_13,2010-02-01,"BioSpec Global Solutions Inc, takes delivery of new TOG's 3000 Home edition for the U.S. and international markets",Rise,0.0121,114,biospec global solution inc take delivery new tog home edition for the and international market,95,15,0,pharmacy,"['bio', '##sp', '##ec', 'global', 'solution', 'in', '##c', 'take', 'delivery', 'new', 'to', '##g', 'home', 'edition', 'for', 'the', 'and', 'international', 'market']",1
5027,nifty_13,2010-02-01," Multinational Medtech Companies and Savvy Medtech Investors Will Reveal Investment, M&A; and Partnering Preferences at",Rise,0.0121,119,multinational medtech company and savvy medtech investor will reveal investment and partnering preference,105,13,0,pharmacy,"['multinational', 'me', '##dt', '##ech', 'company', 'and', 'sa', '##v', '##vy', 'me', '##dt', '##ech', 'investor', 'will', 'reveal', 'investment', 'and', 'partner', '##ing', 'preference']",1
5029,nifty_13,2010-02-01,Infinitus Clinical Research Consolidates- Sino-Indian CRO Enhances Core Capabilities,Rise,0.0121,84,infinitus clinical research consolidates sino indian cro enhances core capability,81,10,0,pharmacy,"['in', '##fin', '##it', '##us', 'clinical', 'research', 'con', '##solidate', '##s', 'sin', '##o', 'in', '##dian', 'c', '##ro', 'enhance', '##s', 'core', 'capability']",1
5127,nifty_13,2010-02-01,Research and Markets: The Bioeconomy to 2030: Designing a Policy Agenda,Rise,0.0121,71,research and market the bioeconomy designing policy agenda,58,8,0,pharmacy,"['research', 'and', 'market', 'the', 'bio', '##ec', '##onomy', 'designing', 'policy', 'agenda']",1
5151,nifty_13,2010-02-01, New Report Analyzes the U.S. Diagnostic and Medical Labs Industry,Rise,0.0121,66,new report analyzes the diagnostic and medical lab industry,59,9,0,pharmacy,"['new', 'report', 'analyze', '##s', 'the', 'diagnostic', 'and', 'medical', 'lab', 'industry']",1
5360,nifty_13,2010-02-01,Research and Markets: Zimbabwe Pharmaceuticals and Healthcare Report Q1 2010,Rise,0.0121,76,research and market zimbabwe pharmaceutical and healthcare report,65,8,0,pharmacy,"['research', 'and', 'market', 'z', '##im', '##ba', '##b', '##we', 'pharmaceutical', 'and', 'healthcare', 'report']",1
5362,nifty_13,2010-02-01,Array BioPharma to Present at the 12th Annual BIO CEO & Investor Conference,Rise,0.0121,75,array biopharma present the annual bio ceo investor conference,62,9,0,pharmacy,"['array', 'bio', '##pha', '##rma', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
5457,nifty_13,2010-02-01, Cytokinetics to Present at BIO CEO and Investor Conference,Rise,0.0121,59,cytokinetics present bio ceo and investor conference,52,7,0,pharmacy,"['c', '##yt', '##oki', '##net', '##ics', 'present', 'bio', 'c', '##eo', 'and', 'investor', 'conference']",1
5476,nifty_13,2010-02-01,Idenix Pharmaceuticals To Present at 12th Annual BIO CEO & Investor Conference,Rise,0.0121,78,idenix pharmaceutical present annual bio ceo investor conference,64,8,0,pharmacy,"['id', '##eni', '##x', 'pharmaceutical', 'present', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
5487,nifty_13,2010-02-01,Curis to Present at the 12th Annual BIO CEO & Investor Conference,Rise,0.0121,65,curis present the annual bio ceo investor conference,52,8,0,pharmacy,"['cu', '##ris', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
5602,nifty_13,2010-02-01,BNA Books' New 2009 Cumulative Supplement to 'E-Health Business and Transactional Law' Provides Vital Information for an Industry Increasingly Reliant on Information Technology,Rise,0.0121,176,bna book new cumulative supplement health business and transactional law provides vital information for industry increasingly reliant information technology,156,19,0,pharmacy,"['b', '##na', 'book', 'new', 'cumulative', 'supplement', 'health', 'business', 'and', 'transaction', '##al', 'law', 'provides', 'vital', 'information', 'for', 'industry', 'increasingly', 're', '##lian', '##t', 'information', 'technology']",1
5882,nifty_22,2010-02-17,Aspirin Found to Aid Cancer Patients,Rise,0.0059,36,aspirin found aid cancer patient,32,5,0,pharmacy,"['as', '##pi', '##rin', 'found', 'aid', 'cancer', 'patient']",1
5958,nifty_25,2010-02-23,Don't Expect Miracles From Health Confab,Rise,0.0092,40,don expect miracle from health confab,37,6,0,pharmacy,"['don', 'expect', 'miracle', 'from', 'health', 'con', '##fa', '##b']",1
6048,nifty_29,2010-03-02,Drug to Help Transplants Wins Support,Neutral,0.0009,37,drug help transplant win support,32,5,0,pharmacy,"['drug', 'help', 'transplant', 'win', 'support']",1
6107,nifty_30,2010-03-03,China Medical Technologies Reports Third Fiscal Quarter Financial Results,Neutral,0.003,73,china medical technology report third fiscal quarter financial result,69,9,0,pharmacy,"['chin', '##a', 'medical', 'technology', 'report', 'third', 'fiscal', 'quarter', 'financial', 'result']",1
6140,nifty_30,2010-03-03,"Research and Markets: Pharmaceuticals Manufacturing Analysis: Approx 1,500 Companies with Combined Annual Revenue of $200+ Billion",Neutral,0.003,130,research and market pharmaceutical manufacturing analysis approx company with combined annual revenue billion,109,13,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'manufacturing', 'analysis', 'approx', 'company', 'with', 'combined', 'annual', 'revenue', 'billion']",1
6288,nifty_30,2010-03-03,"Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing",Neutral,0.003,115,biostar pharmaceutical inc present the rodman renshaw annual china investment conference beijing,96,12,0,pharmacy,"['bio', '##star', 'pharmaceutical', 'in', '##c', 'present', 'the', 'rod', '##man', 're', '##ns', '##haw', 'annual', 'chin', '##a', 'investment', 'conference', 'be', '##iji', '##ng']",1
6306,nifty_30,2010-03-03,BSD Medical Retains Financial Profiles for Investor Relations,Neutral,0.003,61,bsd medical retains financial profile for investor relation,59,8,0,pharmacy,"['b', '##s', '##d', 'medical', 'retains', 'financial', 'profile', 'for', 'investor', 'relation']",1
6385,nifty_30,2010-03-03,China Sky One Medical to Attend Rodman & Renshaw Annual China Investment Conference,Neutral,0.003,83,china sky one medical attend rodman renshaw annual china investment conference,78,11,0,pharmacy,"['chin', '##a', 'sky', 'one', 'medical', 'attend', 'rod', '##man', 're', '##ns', '##haw', 'annual', 'chin', '##a', 'investment', 'conference']",1
6425,nifty_30,2010-03-03,China Kangtai Cactus Biotech Announces Preliminary FY 2009 Results and Forecasts FY 2010 Guidance,Neutral,0.003,97,china kangtai cactus biotech announces preliminary result and forecast guidance,79,10,0,pharmacy,"['chin', '##a', 'ka', '##ng', '##tai', 'ca', '##ctus', 'bio', '##tech', 'announces', 'preliminary', 'result', 'and', 'forecast', 'guidance']",1
6539,nifty_30,2010-03-03,Research and Markets: Emerging Medical Technologies (EMT) Database - Includes Over 1081 Companies,Neutral,0.003,97,research and market emerging medical technology emt database includes over company,82,11,0,pharmacy,"['research', 'and', 'market', 'emerging', 'medical', 'technology', 'em', '##t', 'database', 'includes', 'over', 'company']",1
6597,nifty_30,2010-03-03,Psychiatric Solutions to Present atthe Raymond James 31st Annual Institutional Investors Conference,Neutral,0.003,99,psychiatric solution present atthe raymond james annual institutional investor conference,89,10,0,pharmacy,"['psychiatric', 'solution', 'present', 'at', '##the', 'ray', '##mond', 'jam', '##es', 'annual', 'institutional', 'investor', 'conference']",1
6622,nifty_30,2010-03-03,Research and Markets: U.S. Generic Drugs Market Trends,Neutral,0.003,54,research and market generic drug market trend,45,7,0,pharmacy,"['research', 'and', 'market', 'generic', 'drug', 'market', 'trend']",1
7218,nifty_31,2010-03-04,Celldex Reports Fourth Quarter and Fiscal 2009 Financial Results,Rise,0.0143,64,celldex report fourth quarter and fiscal financial result,57,8,0,pharmacy,"['cell', '##de', '##x', 'report', 'fourth', 'quarter', 'and', 'fiscal', 'financial', 'result']",1
7237,nifty_31,2010-03-04,Bristol-Myers Squibb to Highlight Strong Pipeline and Execution of BioPharma Strategy in Meeting with Investment Community,Rise,0.0143,122,bristol myers squibb highlight strong pipeline and execution biopharma strategy meeting with investment community,113,14,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'highlight', 'strong', 'pipeline', 'and', 'execution', 'bio', '##pha', '##rma', 'strategy', 'meeting', 'with', 'investment', 'community']",1
7310,nifty_31,2010-03-04,Research and Markets: Opportunities in Orphan Drugs: Strategies for Developing Maximum Returns from Niche Indications,Rise,0.0143,117,research and market opportunity orphan drug strategy for developing maximum return from niche indication,104,14,0,pharmacy,"['research', 'and', 'market', 'opportunity', 'orphan', 'drug', 'strategy', 'for', 'developing', 'maximum', 'return', 'from', 'niche', 'indication']",1
7311,nifty_31,2010-03-04,Research and Markets: China Healthcare Sector Analysis,Rise,0.0143,54,research and market china healthcare sector analysis,52,7,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'healthcare', 'sector', 'analysis']",1
7360,nifty_31,2010-03-04," Nova Energy, Inc. PPS Increase Potential From Upcoming Milestone Events Featured in Not-For-Profit Small Equity",Rise,0.0143,112,nova energy inc pps increase potential from upcoming milestone event featured not for profit small equity,105,16,0,pharmacy,"['no', '##va', 'energy', 'in', '##c', 'pp', '##s', 'increase', 'potential', 'from', 'upcoming', 'milestone', 'event', 'featured', 'not', 'for', 'profit', 'small', 'equity']",1
7429,nifty_31,2010-03-04,Research and Markets: Pulmonary Arterial Hypertension (PAH) - Drug Pipeline Analysis and Market Forecasts to 2016,Rise,0.0143,113,research and market pulmonary arterial hypertension pah drug pipeline analysis and market forecast,98,13,0,pharmacy,"['research', 'and', 'market', 'pulmonary', 'art', '##erial', 'h', '##yper', '##tens', '##ion', 'p', '##ah', 'drug', 'pipeline', 'analysis', 'and', 'market', 'forecast']",1
7595,nifty_31,2010-03-04,"Professional and Patient Web Innovators, Pharma, Insurance and Government Converge to Speak at First Health 2.0 Europe Conference in Paris April 6-7, 2010",Rise,0.0143,154,professional and patient web innovator pharma insurance and government converge speak first health europe conference paris april,128,17,0,pharmacy,"['professional', 'and', 'patient', 'web', 'inn', '##ova', '##tor', 'p', '##har', '##ma', 'insurance', 'and', 'government', 'con', '##ver', '##ge', 'speak', 'first', 'health', 'euro', '##pe', 'conference', 'par', '##is', 'a', '##p', '##ril']",1
7639,nifty_31,2010-03-04,Research and Markets: The Dyslipidemia Market Is Forecast To Decline At A CAGR Of -4.6% From $34.4 Billion In 2009 To $24.7 Billion By 2016,Rise,0.0143,139,research and market the dyslipidemia market forecast decline cagr from billion billion,86,12,0,pharmacy,"['research', 'and', 'market', 'the', 'd', '##ys', '##lip', '##ide', '##mia', 'market', 'forecast', 'decline', 'ca', '##g', '##r', 'from', 'billion', 'billion']",1
7643,nifty_31,2010-03-04,Veteran Health Plan Exec Highlights Opportunities to Capitalize on ICD-10 Transition at Healthcare Education Associates Conference,Rise,0.0143,130,veteran health plan exec highlight opportunity capitalize icd transition healthcare education associate conference,114,13,0,pharmacy,"['veteran', 'health', 'plan', 'ex', '##ec', 'highlight', 'opportunity', 'capital', '##ize', 'i', '##c', '##d', 'transition', 'healthcare', 'education', 'associate', 'conference']",1
7652,nifty_31,2010-03-04,Research and Markets: Investments in Medical Equipment Industry Remained Steady at $18.07 Billion in Q4 2009,Rise,0.0143,108,research and market investment medical equipment industry remained steady billion,81,10,0,pharmacy,"['research', 'and', 'market', 'investment', 'medical', 'equipment', 'industry', 'remained', 'steady', 'billion']",1
7708,nifty_31,2010-03-04," Computerworld Launches Vertical Sites Targeting Health Care, Financial and Government Markets",Rise,0.0143,94,computerworld launch vertical site targeting health care financial and government market,88,11,0,pharmacy,"['computer', '##world', 'launch', 'vertical', 'site', 'targeting', 'health', 'care', 'financial', 'and', 'government', 'market']",1
7834,nifty_31,2010-03-04,Research and Markets: China Biological & Biochemical Product Manufacturing Industry Report 2010,Rise,0.0143,95,research and market china biological biochemical product manufacturing industry report,86,10,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'biological', 'bio', '##chemical', 'product', 'manufacturing', 'industry', 'report']",1
7918,nifty_32,2010-03-08,bioMÃ©rieux - 2009 Financial Results,Neutral,0.0017,36,biomã rieux financial result,28,4,0,pharmacy,"['bio', '##m', '##ã', 'r', '##ieu', '##x', 'financial', 'result']",1
7979,nifty_32,2010-03-08,BUY OR SELL-Lundbeck investors torn between patents & pipeline,Neutral,0.0017,62,buy sell lundbeck investor torn between patent pipeline,55,8,0,pharmacy,"['buy', 'sell', 'l', '##und', '##beck', 'investor', 'torn', 'between', 'patent', 'pipeline']",1
8160,nifty_32,2010-03-08,"Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Friday, March 12, 2010",Neutral,0.0017,113,arena pharmaceutical host business and financial update conference call and webcast friday march,96,13,0,pharmacy,"['arena', 'pharmaceutical', 'host', 'business', 'and', 'financial', 'update', 'conference', 'call', 'and', 'web', '##cast', 'f', '##rida', '##y', 'march']",1
8328,nifty_32,2010-03-08,Industrial Biotechnology: the Best Kept Secret in Green Jobs,Neutral,0.0017,60,industrial biotechnology the best kept secret green job,55,8,0,pharmacy,"['industrial', 'bio', '##tech', '##nology', 'the', 'best', 'kept', 'secret', 'green', 'job']",1
8514,nifty_32,2010-03-08,Research and Markets: An Essential Report on the Global Generic Pharmaceuticals Industry,Neutral,0.0017,88,research and market essential report the global generic pharmaceutical industry,79,10,0,pharmacy,"['research', 'and', 'market', 'essential', 'report', 'the', 'global', 'generic', 'pharmaceutical', 'industry']",1
8524,nifty_32,2010-03-08,Research and Markets: An Essential Report on the Global Biotechnology (Pharmaceuticals),Neutral,0.0017,87,research and market essential report the global biotechnology pharmaceutical,76,9,0,pharmacy,"['research', 'and', 'market', 'essential', 'report', 'the', 'global', 'bio', '##tech', '##nology', 'pharmaceutical']",1
8528,nifty_32,2010-03-08,"European shares ease; drugmakers, chemicals fall",Neutral,0.0017,48,european share ease drugmakers chemical fall,44,6,0,pharmacy,"['euro', '##pe', '##an', 'share', 'ease', 'drug', '##makers', 'chemical', 'fall']",1
8554,nifty_32,2010-03-08,Research and Markets: An Essential Report on the Biotechnology Sector,Neutral,0.0017,69,research and market essential report the biotechnology sector,61,8,0,pharmacy,"['research', 'and', 'market', 'essential', 'report', 'the', 'bio', '##tech', '##nology', 'sector']",1
8746,nifty_32,2010-03-08,Research and Markets: 2010 Social and Infrastructure Analysis for the Chinese Healthcare Industry,Neutral,0.0017,97,research and market social and infrastructure analysis for the chinese healthcare industry,90,12,0,pharmacy,"['research', 'and', 'market', 'social', 'and', 'infrastructure', 'analysis', 'for', 'the', 'chin', '##ese', 'healthcare', 'industry']",1
9149,nifty_37,2010-03-16,IMS Announces 17 Countries Now Rank as High-Growth `Pharmerging` Markets; Forecast to Contribute Nearly Half of Industry Growth by 2013,Rise,0.0059,135,ims announces country now rank high growth pharmerging market forecast contribute nearly half industry growth,109,15,0,pharmacy,"['im', '##s', 'announces', 'country', 'now', 'rank', 'high', 'growth', 'p', '##har', '##mer', '##ging', 'market', 'forecast', 'contribute', 'nearly', 'half', 'industry', 'growth']",1
9204,nifty_37,2010-03-16,"PDL BioPharma To Hold Annual Meeting of Stockholders on June 9, 2010",Rise,0.0059,68,pdl biopharma hold annual meeting stockholder june,50,7,0,pharmacy,"['p', '##dl', 'bio', '##pha', '##rma', 'hold', 'annual', 'meeting', 'stock', '##holder', 'j', '##une']",1
9251,nifty_37,2010-03-16,"Everything Channel Releases IPED's Health of the Channel eBook, Provides Technology Vendors with a Detailed Analysis of the Financial Conditions and Concerns of Solution Providers",Rise,0.0059,179,everything channel release iped health the channel ebook provides technology vendor with detailed analysis the financial condition and concern solution provider,160,21,0,pharmacy,"['everything', 'channel', 'release', 'i', '##ped', 'health', 'the', 'channel', 'e', '##book', 'provides', 'technology', 'vendor', 'with', 'detailed', 'analysis', 'the', 'financial', 'condition', 'and', 'concern', 'solution', 'provider']",1
9270,nifty_37,2010-03-16,R&D; Investment by U.S. Biopharmaceutical Companies Remains Strong Despite Ongoing Economic Challenges,Rise,0.0059,102,investment biopharmaceutical company remains strong despite ongoing economic challenge,86,9,0,pharmacy,"['investment', 'bio', '##pha', '##rma', '##ce', '##utical', 'company', 'remains', 'strong', 'despite', 'ongoing', 'economic', 'challenge']",1
9400,nifty_37,2010-03-16, AXcess News: Dual Stem Cell Market Approach Benefits Investors,Rise,0.0059,63,axcess news dual stem cell market approach benefit investor,59,9,0,pharmacy,"['a', '##x', '##cess', 'news', 'dual', 'stem', 'cell', 'market', 'approach', 'benefit', 'investor']",1
9466,nifty_37,2010-03-16,"Research and Markets: Cold, Cough, and Sore Throat Remedies - Global Strategic Business Report",Rise,0.0059,94,research and market cold cough and sore throat remedy global strategic business report,86,13,0,pharmacy,"['research', 'and', 'market', 'cold', 'cough', 'and', 'sore', 'throat', 'remedy', 'global', 'strategic', 'business', 'report']",1
9471,nifty_37,2010-03-16,Research and Markets: America's 100 Biggest Acute Hospitals - Get Detailed Information on Particular Organisations,Rise,0.0059,114,research and market america biggest acute hospital get detailed information particular organisation,99,12,0,pharmacy,"['research', 'and', 'market', 'am', '##eric', '##a', 'biggest', 'acute', 'hospital', 'get', 'detailed', 'information', 'particular', 'organisation']",1
9496,nifty_37,2010-03-16,"Research and Markets: The German Pharmaceuticals Market Generated Total Revenues of $37,139.2 Million In 2009",Rise,0.0059,109,research and market the german pharmaceutical market generated total revenue million,84,11,0,pharmacy,"['research', 'and', 'market', 'the', 'g', '##erman', 'pharmaceutical', 'market', 'generated', 'total', 'revenue', 'million']",1
9507,nifty_37,2010-03-16," Molecular Insight Pharmaceuticals, Inc. to Report Fourth Quarter and Year-End 2009 Financial and Operational Results",Rise,0.0059,117,molecular insight pharmaceutical inc report fourth quarter and year end financial and operational result,104,14,0,pharmacy,"['molecular', 'insight', 'pharmaceutical', 'in', '##c', 'report', 'fourth', 'quarter', 'and', 'year', 'end', 'financial', 'and', 'operational', 'result']",1
9528,nifty_37,2010-03-16,"R&D; Investment by U.S. Biopharmaceutical Companies Increases to Record $65.3 Billion, Study Finds",Rise,0.0059,98,investment biopharmaceutical company increase record billion study find,71,8,0,pharmacy,"['investment', 'bio', '##pha', '##rma', '##ce', '##utical', 'company', 'increase', 'record', 'billion', 'study', 'find']",1
9566,nifty_37,2010-03-16,Research and Markets: OTC Pharmaceuticals Market Report 2010,Rise,0.0059,60,research and market otc pharmaceutical market report,52,7,0,pharmacy,"['research', 'and', 'market', 'o', '##t', '##c', 'pharmaceutical', 'market', 'report']",1
9695,nifty_37,2010-03-16, Molecular Insight Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial and Operational Results,Rise,0.0059,109,molecular insight pharmaceutical report fourth quarter and year end financial and operational result,100,13,0,pharmacy,"['molecular', 'insight', 'pharmaceutical', 'report', 'fourth', 'quarter', 'and', 'year', 'end', 'financial', 'and', 'operational', 'result']",1
9720,nifty_37,2010-03-16,StockCross Trades for a Cure: Seventh Annual Trading for a Cure Day Set,Rise,0.0059,71,stockcross trade for cure seventh annual trading for cure day set,65,11,0,pharmacy,"['stock', '##cross', 'trade', 'for', 'cure', 'seventh', 'annual', 'trading', 'for', 'cure', 'day', 'set']",1
9727,nifty_37,2010-03-16,Research and Markets: Self Diagnostics in the United States 2010,Rise,0.0059,64,research and market self diagnostics the united state,53,8,0,pharmacy,"['research', 'and', 'market', 'self', 'diagnostic', '##s', 'the', 'united', 'state']",1
9792,nifty_37,2010-03-16,UPDATE 1-Molecular Insight says gets going concern warning,Rise,0.0059,58,update molecular insight say get going concern warning,54,8,0,pharmacy,"['update', 'molecular', 'insight', 'say', 'get', 'going', 'concern', 'warning']",1
9827,nifty_37,2010-03-16, Paladin Makes First Step Into Emerging Markets Through Strategic Investment in Pharmaplan,Rise,0.0059,90,paladin make first step into emerging market through strategic investment pharmaplan,84,11,0,pharmacy,"['p', '##ala', '##din', 'make', 'first', 'step', 'into', 'emerging', 'market', 'through', 'strategic', 'investment', 'p', '##har', '##ma', '##p', '##lan']",1
10182,nifty_41,2010-03-23,"TVM Capital Portfolio Company, Evotec AG, Named M&A; Advisor Global Healthcare Turnaround...",Neutral,-0.0049,92,tvm capital portfolio company evotec named advisor global healthcare turnaround,79,10,0,pharmacy,"['t', '##v', '##m', 'capital', 'portfolio', 'company', 'e', '##vo', '##tec', 'named', 'advisor', 'global', 'healthcare', 'turn', '##around']",1
10259,nifty_41,2010-03-23,Research and Markets: 2010 Analysis on Healthcare Consultants - A Comprehensive Profile of 232 Companies Operating in the UK Market,Neutral,-0.0049,131,research and market analysis healthcare consultant comprehensive profile company operating the market,101,12,0,pharmacy,"['research', 'and', 'market', 'analysis', 'healthcare', 'consultant', 'comprehensive', 'profile', 'company', 'operating', 'the', 'market']",1
10310,nifty_41,2010-03-23,Sinovac to Present at Inaugural China Healthcare Investment Conference,Neutral,-0.0049,70,sinovac present inaugural china healthcare investment conference,64,7,0,pharmacy,"['sin', '##ova', '##c', 'present', 'inaugural', 'chin', '##a', 'healthcare', 'investment', 'conference']",1
10346,nifty_41,2010-03-23,Research and Markets: Netherlands Pharmaceuticals and Healthcare Report Q2 2010 Reveals Drug Sales will Reach EUR6.11bn (US$8.85bn) in the End of 2010,Neutral,-0.0049,150,research and market netherlands pharmaceutical and healthcare report reveals drug sale will reach eur the end,109,16,0,pharmacy,"['research', 'and', 'market', 'net', '##her', '##lands', 'pharmaceutical', 'and', 'healthcare', 'report', 'reveals', 'drug', 'sale', 'will', 'reach', 'e', '##ur', 'the', 'end']",1
10401,nifty_41,2010-03-23,Genstar Capital Names Veteran Technology Executives Steve Mankoff and David Wroe to Strategic Advisory Board,Neutral,-0.0049,108,genstar capital name veteran technology executive steve mankoff and david wroe strategic advisory board,103,14,0,pharmacy,"['g', '##ens', '##tar', 'capital', 'name', 'veteran', 'technology', 'executive', 's', '##te', '##ve', 'man', '##ko', '##ff', 'and', 'da', '##vid', 'w', '##ro', '##e', 'strategic', 'advisory', 'board']",1
10426,nifty_41,2010-03-23,Solix Technologies Incorporates SAND/DNA Software for Enterprise Application Retirement,Neutral,-0.0049,87,solix technology incorporates sand dna software for enterprise application retirement,85,10,0,pharmacy,"['so', '##lix', 'technology', 'incorporates', 'sand', 'd', '##na', 'software', 'for', 'enterprise', 'application', 'retirement']",1
10452,nifty_41,2010-03-23, Healthcare IT Market Poised for Strong Growth,Neutral,-0.0049,46,healthcare market poised for strong growth,42,6,0,pharmacy,"['healthcare', 'market', 'poised', 'for', 'strong', 'growth']",1
10570,nifty_41,2010-03-23,Research and Markets: The Future of Market Research: Challenges and Changes In a Core Pharmaceutical Function,Neutral,-0.0049,109,research and market the future market research challenge and change core pharmaceutical function,96,13,0,pharmacy,"['research', 'and', 'market', 'the', 'future', 'market', 'research', 'challenge', 'and', 'change', 'core', 'pharmaceutical', 'function']",1
10630,nifty_41,2010-03-23,Who Is The Next-Generation Pharmacist(TM)?,Neutral,-0.0049,42,who the next generation pharmacist,34,5,0,pharmacy,"['who', 'the', 'next', 'generation', 'p', '##har', '##ma', '##cist']",1
10718,nifty_41,2010-03-23,"Cornerstone Pharmaceuticals Enters into a Collaboration Agreement with the U.S. National Cancer Institute to Evaluate Cornerstone's Highly Selective Cancer Cell Targeting Nanotechnology, Emulsiphan, in Combination with Innov",Neutral,-0.0049,224,cornerstone pharmaceutical enters into collaboration agreement with the national cancer institute evaluate cornerstone highly selective cancer cell targeting nanotechnology emulsiphan combination with innov,206,23,0,pharmacy,"['corners', '##tone', 'pharmaceutical', 'enters', 'into', 'collaboration', 'agreement', 'with', 'the', 'national', 'cancer', 'institute', 'evaluate', 'corners', '##tone', 'highly', 'selective', 'cancer', 'cell', 'targeting', 'na', '##note', '##ch', '##nology', 'em', '##ul', '##si', '##pha', '##n', 'combination', 'with', 'inn', '##ov']",1
10730,nifty_41,2010-03-23,Advocates see growth for health savings accounts,Neutral,-0.0049,48,advocate see growth for health saving account,45,7,0,pharmacy,"['advocate', 'see', 'growth', 'for', 'health', 'saving', 'account']",1
10755,nifty_41,2010-03-23," Sapient Financial Group Advisors Present $1,000 to American Cancer Society",Neutral,-0.0049,75,sapient financial group advisor present american cancer society,63,8,0,pharmacy,"['sa', '##pie', '##nt', 'financial', 'group', 'advisor', 'present', 'am', '##eric', '##an', 'cancer', 'society']",1
10805,nifty_41,2010-03-23,PharmAthene Reports Year-End 2009 Financial and Operational Results and Provides Update On Ongoing Litigation With SIGA Technologies,Neutral,-0.0049,132,pharmathene report year end financial and operational result and provides update ongoing litigation with siga technology,120,16,0,pharmacy,"['p', '##har', '##mat', '##hen', '##e', 'report', 'year', 'end', 'financial', 'and', 'operational', 'result', 'and', 'provides', 'update', 'ongoing', 'litigation', 'with', 'si', '##ga', 'technology']",1
10831,nifty_41,2010-03-23,Miami Protest: AHF to Blast Merck on AIDS Drug Pricing During Barclays Investor Conference,Neutral,-0.0049,90,miami protest ahf blast merck aid drug pricing during barclays investor conference,82,12,0,pharmacy,"['mi', '##ami', 'protest', 'ah', '##f', 'blast', 'me', '##rc', '##k', 'aid', 'drug', 'pricing', 'during', 'bar', '##c', '##lay', '##s', 'investor', 'conference']",1
10835,nifty_41,2010-03-23,Medco Chief Medical Officer to Host Warfarin Effectiveness Study Webinar for Investment Community,Neutral,-0.0049,97,medco chief medical officer host warfarin effectiveness study webinar for investment community,94,12,0,pharmacy,"['me', '##d', '##co', 'chief', 'medical', 'officer', 'host', 'war', '##fari', '##n', 'effectiveness', 'study', 'web', '##ina', '##r', 'for', 'investment', 'community']",1
11296,nifty_45,2010-03-30,MedeAnalytics Details Financial Downside Risk of Meaningful Use,Neutral,-0.0034,63,medeanalytics detail financial downside risk meaningful use,59,7,0,pharmacy,"['me', '##dea', '##nal', '##ytic', '##s', 'detail', 'financial', 'down', '##side', 'risk', 'meaningful', 'use']",1
11330,nifty_45,2010-03-30,"NovaBay Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2009 Financial...",Neutral,-0.0034,84,novabay pharmaceutical inc report fourth quarter and full year financial,72,10,0,pharmacy,"['no', '##va', '##bay', 'pharmaceutical', 'in', '##c', 'report', 'fourth', 'quarter', 'and', 'full', 'year', 'financial']",1
11584,nifty_45,2010-03-30,"Research and Markets: Barr Pharmaceuticals - a View of the Company's Major Products & Services, Locations & Subsidiaries and Financial Profile",Neutral,-0.0034,142,research and market barr pharmaceutical view the company major product service location subsidiary and financial profile,120,16,0,pharmacy,"['research', 'and', 'market', 'bar', '##r', 'pharmaceutical', 'view', 'the', 'company', 'major', 'product', 'service', 'location', 'subsidiary', 'and', 'financial', 'profile']",1
11607,nifty_45,2010-03-30,"Research and Markets: Lexington, KY Market Overview 2010 Is The Only Healthcare Dynamics Analysis That Examines All Healthcare Market Drivers",Neutral,-0.0034,141,research and market lexington market overview the only healthcare dynamic analysis that examines all healthcare market driver,125,17,0,pharmacy,"['research', 'and', 'market', 'le', '##xing', '##ton', 'market', 'overview', 'the', 'only', 'healthcare', 'dynamic', 'analysis', 'that', 'examines', 'all', 'healthcare', 'market', 'driver']",1
12072,nifty_46,2010-03-31,Sanofi to invest $200 mln in French biotech plants,Rise,0.0068,50,sanofi invest mln french biotech plant,38,6,0,pharmacy,"['sa', '##no', '##fi', 'invest', 'm', '##ln', 'f', '##rench', 'bio', '##tech', 'plant']",1
12139,nifty_46,2010-03-31,RXi Pharmaceuticals Reports Fourth Quarter and 2009 Financial Results,Rise,0.0068,69,rxi pharmaceutical report fourth quarter and financial result,61,8,0,pharmacy,"['r', '##xi', 'pharmaceutical', 'report', 'fourth', 'quarter', 'and', 'financial', 'result']",1
12179,nifty_46,2010-03-31,Diamyd Medical: Fund Invests 35 MSEK in Diamyd,Rise,0.0068,46,diamyd medical fund invests msek diamyd,39,6,0,pharmacy,"['di', '##am', '##yd', 'medical', 'fund', 'invest', '##s', 'm', '##se', '##k', 'di', '##am', '##yd']",1
12222,nifty_46,2010-03-31," Elsevier's 'IN3 Europe' Investor Conference in Paris, April 29-30, 2010, to Include ""State of the Medical Device",Rise,0.0068,113,elsevier europe investor conference paris april include state the medical device,80,11,0,pharmacy,"['else', '##vier', 'euro', '##pe', 'investor', 'conference', 'par', '##is', 'a', '##p', '##ril', 'include', 'state', 'the', 'medical', 'device']",1
12319,nifty_46,2010-03-31,Research and Markets: A Comprehensive Report on Health & Medical Insurance in the US,Rise,0.0068,84,research and market comprehensive report health medical insurance the,69,9,0,pharmacy,"['research', 'and', 'market', 'comprehensive', 'report', 'health', 'medical', 'insurance', 'the']",1
12423,nifty_46,2010-03-31,Research and Markets: Financial Analysis - Kindred Healthcare,Rise,0.0068,61,research and market financial analysis kindred healthcare,57,7,0,pharmacy,"['research', 'and', 'market', 'financial', 'analysis', 'kind', '##red', 'healthcare']",1
12466,nifty_46,2010-03-31,Research and Markets: Dual Diagnosis: Practice in Context,Rise,0.0068,57,research and market dual diagnosis practice context,51,7,0,pharmacy,"['research', 'and', 'market', 'dual', 'diagnosis', 'practice', 'context']",1
12573,nifty_46,2010-03-31,Amyris Biotechnologies Secures Investment from Temasek Holdings,Rise,0.0068,63,amyris biotechnology secures investment from temasek holding,60,7,0,pharmacy,"['am', '##yr', '##is', 'bio', '##tech', '##nology', 'secure', '##s', 'investment', 'from', 'te', '##mas', '##ek', 'holding']",1
12574,nifty_46,2010-03-31,Research and Markets: Adult Stem Cells and iPSCs 2010 Market Report,Rise,0.0068,67,research and market adult stem cell and ipscs market report,59,10,0,pharmacy,"['research', 'and', 'market', 'adult', 'stem', 'cell', 'and', 'i', '##ps', '##cs', 'market', 'report']",1
12578,nifty_46,2010-03-31, VIA Pharmaceuticals Announces Strategic Restructuring and Financing,Rise,0.0068,68,via pharmaceutical announces strategic restructuring and financing,66,7,0,pharmacy,"['via', 'pharmaceutical', 'announces', 'strategic', 'restructuring', 'and', 'financing']",1
12678,nifty_46,2010-03-31,Depomed to Present at the BioCentury and Thomson Reuters Future Leaders In The Biotech Industry Conference,Rise,0.0068,106,depomed present the biocentury and thomson reuters future leader the biotech industry conference,96,13,0,pharmacy,"['de', '##po', '##med', 'present', 'the', 'bio', '##cent', '##ury', 'and', 'th', '##oms', '##on', 're', '##uters', 'future', 'leader', 'the', 'bio', '##tech', 'industry', 'conference']",1
12703,nifty_46,2010-03-31," Forbes Medi-Tech Announces Financial Results for the Year Ended December 31, 2009",Rise,0.0068,82,forbes medi tech announces financial result for the year ended december,71,11,0,pharmacy,"['for', '##bes', 'me', '##di', 'tech', 'announces', 'financial', 'result', 'for', 'the', 'year', 'ended', 'de', '##ce', '##mber']",1
12785,nifty_47,2010-04-05,A Note of Caution on Biotech Strategy,Neutral,0.0024,37,note caution biotech strategy,29,4,0,pharmacy,"['note', 'caution', 'bio', '##tech', 'strategy']",1
13181,nifty_53,2010-04-14,Research and Markets: an Essential Report on the OTC Pharmaceuticals in the United States,Neutral,0.0008,89,research and market essential report the otc pharmaceutical the united state,76,11,0,pharmacy,"['research', 'and', 'market', 'essential', 'report', 'the', 'o', '##t', '##c', 'pharmaceutical', 'the', 'united', 'state']",1
13227,nifty_53,2010-04-14," Biotech Distributor BDI Pharma, Inc. Announces Record Revenue Pace",Neutral,0.0008,67,biotech distributor bdi pharma inc announces record revenue pace,64,9,0,pharmacy,"['bio', '##tech', 'distributor', 'b', '##di', 'p', '##har', '##ma', 'in', '##c', 'announces', 'record', 'revenue', 'pace']",1
13252,nifty_53,2010-04-14,Research and Markets: Urinary Incontinence (UI) - Drug Pipeline Analysis and Market Forecasts Through to 2016,Neutral,0.0008,109,research and market urinary incontinence drug pipeline analysis and market forecast through,91,12,0,pharmacy,"['research', 'and', 'market', 'u', '##rina', '##ry', 'in', '##con', '##tine', '##nce', 'drug', 'pipeline', 'analysis', 'and', 'market', 'forecast', 'through']",1
13308,nifty_53,2010-04-14,"Arkayne Inc., Announces Powerful New Content Analysis Software; Arkayne Diagnostics",Neutral,0.0008,83,arkayne inc announces powerful new content analysis software arkayne diagnostics,80,10,0,pharmacy,"['a', '##rka', '##yne', 'in', '##c', 'announces', 'powerful', 'new', 'content', 'analysis', 'software', 'a', '##rka', '##yne', 'diagnostic', '##s']",1
13342,nifty_53,2010-04-14,Research and Markets: Booming Biotech Market in India,Neutral,0.0008,53,research and market booming biotech market india,48,7,0,pharmacy,"['research', 'and', 'market', 'boom', '##ing', 'bio', '##tech', 'market', 'in', '##dia']",1
13427,nifty_53,2010-04-14,Research and Markets: Women's Infertility - Drug Pipeline Analysis and Market Forecasts Through to 2016,Neutral,0.0008,103,research and market woman infertility drug pipeline analysis and market forecast through,88,12,0,pharmacy,"['research', 'and', 'market', 'woman', 'in', '##fer', '##tility', 'drug', 'pipeline', 'analysis', 'and', 'market', 'forecast', 'through']",1
13428,nifty_53,2010-04-14,Research and Markets: the Medical Device Market in Germany Estimated at US$19.0 Billion in 2009,Neutral,0.0008,95,research and market the medical device market germany estimated billion,71,10,0,pharmacy,"['research', 'and', 'market', 'the', 'medical', 'device', 'market', 'g', '##erman', '##y', 'estimated', 'billion']",1
13430,nifty_53,2010-04-14,Research and Markets: Renal Cell Carcinoma Drug Discoveries - What the Future Holds,Neutral,0.0008,83,research and market renal cell carcinoma drug discovery what the future hold,76,12,0,pharmacy,"['research', 'and', 'market', 're', '##nal', 'cell', 'car', '##cin', '##oma', 'drug', 'discovery', 'what', 'the', 'future', 'hold']",1
13432,nifty_53,2010-04-14,Research and Markets: Benign Prostatic Hyperplasia - Drug Pipeline Analysis and Market Forecasts to 2016,Neutral,0.0008,104,research and market benign prostatic hyperplasia drug pipeline analysis and market forecast,91,12,0,pharmacy,"['research', 'and', 'market', 'ben', '##ign', 'pro', '##static', 'h', '##yper', '##p', '##lasia', 'drug', 'pipeline', 'analysis', 'and', 'market', 'forecast']",1
13474,nifty_53,2010-04-14," Innovative Health Sciences, Inc. to Announce New Product Launches",Neutral,0.0008,66,innovative health science inc announce new product launch,57,8,0,pharmacy,"['innovative', 'health', 'science', 'in', '##c', 'announce', 'new', 'product', 'launch']",1
13534,nifty_53,2010-04-14,EBD Group and MassBio Forge Alliance to Change the Face of Biotech Partnering in North America,Neutral,0.0008,94,ebd group and massbio forge alliance change the face biotech partnering north america,85,13,0,pharmacy,"['e', '##b', '##d', 'group', 'and', 'mass', '##bio', 'forge', 'alliance', 'change', 'the', 'face', 'bio', '##tech', 'partner', '##ing', 'north', 'am', '##eric', '##a']",1
13985,nifty_54,2010-04-15,Research and Markets: By 2012 The Clinical Trials Industry in India Is Expected To Reach US$630 Million,Fall,-0.0159,103,research and market the clinical trial industry india expected reach million,76,11,0,pharmacy,"['research', 'and', 'market', 'the', 'clinical', 'trial', 'industry', 'in', '##dia', 'expected', 'reach', 'million']",1
13994,nifty_54,2010-04-15," Pharmaceutical-Biotech Capital Construction Investment Snapshot: Top 10 Projects Near $3 Billion for 2010, an",Fall,-0.0159,110,pharmaceutical biotech capital construction investment snapshot top project near billion for,92,11,0,pharmacy,"['pharmaceutical', 'bio', '##tech', 'capital', 'construction', 'investment', 'snaps', '##hot', 'top', 'project', 'near', 'billion', 'for']",1
14035,nifty_54,2010-04-15,UnitedHealth Group to Release New Report Identifying Billions of Dollars in Potential Savings For States Facing Unprecedented Medicaid Expansion,Fall,-0.0159,144,unitedhealth group release new report identifying billion dollar potential saving for state facing unprecedented medicaid expansion,131,16,0,pharmacy,"['united', '##hea', '##lt', '##h', 'group', 'release', 'new', 'report', 'identifying', 'billion', 'dollar', 'potential', 'saving', 'for', 'state', 'facing', 'unprecedented', 'me', '##dic', '##aid', 'expansion']",1
14084,nifty_54,2010-04-15," ""Future Leaders in the Biotech Industry"" Attracts Standing Room Only Audience",Fall,-0.0159,78,future leader the biotech industry attracts standing room only audience,71,10,0,pharmacy,"['future', 'leader', 'the', 'bio', '##tech', 'industry', 'attracts', 'standing', 'room', 'only', 'audience']",1
14085,nifty_54,2010-04-15,Research and Markets: The In-Vitro Diagnostics (IVD) Market in BRIC is Expected to Grow from $2.9 Billion 2009 to $7.2 Billion - $7.5 Billion in 2014,Fall,-0.0159,149,research and market the vitro diagnostics ivd market bric expected grow from billion billion billion,100,15,0,pharmacy,"['research', 'and', 'market', 'the', 'v', '##it', '##ro', 'diagnostic', '##s', 'i', '##v', '##d', 'market', 'br', '##ic', 'expected', 'grow', 'from', 'billion', 'billion', 'billion']",1
14091,nifty_54,2010-04-15,UnitedHealth Group Identifies $366 Billion in Potential Federal and State Savings by Modernizing Medicaid As It Faces Unprecedented Expansion,Fall,-0.0159,141,unitedhealth group identifies billion potential federal and state saving modernizing medicaid face unprecedented expansion,122,14,0,pharmacy,"['united', '##hea', '##lt', '##h', 'group', 'identifies', 'billion', 'potential', 'federal', 'and', 'state', 'saving', 'modern', '##izing', 'me', '##dic', '##aid', 'face', 'unprecedented', 'expansion']",1
14110,nifty_54,2010-04-15,Research and Markets: Uzbekistan Pharmaceuticals and Healthcare Report Q2 2010,Fall,-0.0159,78,research and market uzbekistan pharmaceutical and healthcare report,67,8,0,pharmacy,"['research', 'and', 'market', 'u', '##z', '##bek', '##istan', 'pharmaceutical', 'and', 'healthcare', 'report']",1
14239,nifty_54,2010-04-15,Medtech Companies Aim to Take Strategic Leap Forward at EuroMedtech 2010,Fall,-0.0159,72,medtech company aim take strategic leap forward euromedtech,59,8,0,pharmacy,"['me', '##dt', '##ech', 'company', 'aim', 'take', 'strategic', 'leap', 'forward', 'euro', '##med', '##tech']",1
14276,nifty_54,2010-04-15,Research and Markets: Disease and Therapy Review: Schizophrenia,Fall,-0.0159,63,research and market disease and therapy review schizophrenia,60,8,0,pharmacy,"['research', 'and', 'market', 'disease', 'and', 'therapy', 'review', 's', '##chi', '##zophrenia']",1
14290,nifty_54,2010-04-15,China Kangtai Cactus Biotech 2009 Revenue Up 31% to $26.5M; Reports Strong Cash Generation From Operations,Fall,-0.0159,106,china kangtai cactus biotech revenue report strong cash generation from operation,81,11,0,pharmacy,"['chin', '##a', 'ka', '##ng', '##tai', 'ca', '##ctus', 'bio', '##tech', 'revenue', 'report', 'strong', 'cash', 'generation', 'from', 'operation']",1
14293,nifty_54,2010-04-15,Research and Markets: Medical Imaging Markets - A Comprehensive Look at Various Platform Technologies for Medical Imaging Markets,Fall,-0.0159,129,research and market medical imaging market comprehensive look various platform technology for medical imaging market,116,15,0,pharmacy,"['research', 'and', 'market', 'medical', 'imaging', 'market', 'comprehensive', 'look', 'various', 'platform', 'technology', 'for', 'medical', 'imaging', 'market']",1
14350,nifty_54,2010-04-15,Research and Markets: Biotech 2010 Life Sciences: Adapting for Success,Fall,-0.0159,70,research and market biotech life science adapting for success,61,9,0,pharmacy,"['research', 'and', 'market', 'bio', '##tech', 'life', 'science', 'adapt', '##ing', 'for', 'success']",1
14480,nifty_54,2010-04-15,Research and Markets: Portfolio Analytics in the Pancreatic Cancer Pipeline and Portfolio Planning - High Unmet Medical Need but Where to Target?,Fall,-0.0159,145,research and market portfolio analytics the pancreatic cancer pipeline and portfolio planning high unmet medical need but where target,134,19,0,pharmacy,"['research', 'and', 'market', 'portfolio', 'anal', '##ytic', '##s', 'the', 'pan', '##cre', '##atic', 'cancer', 'pipeline', 'and', 'portfolio', 'planning', 'high', 'un', '##met', 'medical', 'need', 'but', 'where', 'target']",1
15595,nifty_65,2010-05-05,Inovio Biomedical to Present at Investor Conferences,Fall,-0.0332,52,inovio biomedical present investor conference,45,5,0,pharmacy,"['in', '##ov', '##io', 'bio', '##medical', 'present', 'investor', 'conference']",1
15605,nifty_65,2010-05-05,"Sanofi-aventis, Massachusetts Life Sciences Center to Announce New Investment Partnership at BIO 2010",Fall,-0.0332,101,sanofi aventis massachusetts life science center announce new investment partnership bio,88,11,0,pharmacy,"['sa', '##no', '##fi', 'a', '##vent', '##is', 'mass', '##ach', '##use', '##tts', 'life', 'science', 'center', 'announce', 'new', 'investment', 'partnership', 'bio']",1
15617,nifty_65,2010-05-05, King Pharmaceuticals Reports First-Quarter 2010 Financial Results,Fall,-0.0332,66,king pharmaceutical report first quarter financial result,57,7,0,pharmacy,"['king', 'pharmaceutical', 'report', 'first', 'quarter', 'financial', 'result']",1
15653,nifty_65,2010-05-05,Research and Markets: an Essential Overview of Iran's Healthcare and Pharmaceuticals Industry,Fall,-0.0332,93,research and market essential overview iran healthcare and pharmaceutical industry,82,10,0,pharmacy,"['research', 'and', 'market', 'essential', 'overview', 'i', '##ran', 'healthcare', 'and', 'pharmaceutical', 'industry']",1
15669,nifty_65,2010-05-05,CPEX Pharmaceuticals Reports First-Quarter 2010 Financial Results,Fall,-0.0332,65,cpex pharmaceutical report first quarter financial result,57,7,0,pharmacy,"['c', '##pe', '##x', 'pharmaceutical', 'report', 'first', 'quarter', 'financial', 'result']",1
15689,nifty_65,2010-05-05,Research and Markets: Disease and Therapy Review: Myocardial Infarction,Fall,-0.0332,71,research and market disease and therapy review myocardial infarction,68,9,0,pharmacy,"['research', 'and', 'market', 'disease', 'and', 'therapy', 'review', 'my', '##oc', '##ard', '##ial', 'in', '##far', '##ction']",1
15736,nifty_65,2010-05-05,BioTime Announces First Quarter 2010 Financial Results and Recent Corporate Developments,Fall,-0.0332,88,biotime announces first quarter financial result and recent corporate development,81,10,0,pharmacy,"['bio', '##time', 'announces', 'first', 'quarter', 'financial', 'result', 'and', 'recent', 'corporate', 'development']",1
15886,nifty_65,2010-05-05,"Research and Markets: Morningstar Healthcare Observer Journal: Delivering a Comprehensive, Unbiased View on the Healthcare Industry Every month",Fall,-0.0332,143,research and market morningstar healthcare observer journal delivering comprehensive unbiased view the healthcare industry every month,134,16,0,pharmacy,"['research', 'and', 'market', 'mornings', '##tar', 'healthcare', 'observer', 'journal', 'delivering', 'comprehensive', 'un', '##bia', '##sed', 'view', 'the', 'healthcare', 'industry', 'every', 'month']",1
15907,nifty_65,2010-05-05,Research and Markets: The Global Biopharmaceuticals Industry Report,Fall,-0.0332,67,research and market the global biopharmaceuticals industry report,65,8,0,pharmacy,"['research', 'and', 'market', 'the', 'global', 'bio', '##pha', '##rma', '##ce', '##utical', '##s', 'industry', 'report']",1
15931,nifty_65,2010-05-05,Research and Markets: Financial Analysis - Health Management Associates,Fall,-0.0332,71,research and market financial analysis health management associate,66,8,0,pharmacy,"['research', 'and', 'market', 'financial', 'analysis', 'health', 'management', 'associate']",1
16235,nifty_65,2010-05-05,BIO and Campbell Alliance Release Two New Industry Reports on Deal-Making Trendsat the 2010 BIO International Convention,Fall,-0.0332,120,bio and campbell alliance release two new industry report deal making trendsat the bio international convention,111,16,0,pharmacy,"['bio', 'and', 'camp', '##bell', 'alliance', 'release', 'two', 'new', 'industry', 'report', 'deal', 'making', 'trends', '##at', 'the', 'bio', 'international', 'convention']",1
16303,nifty_65,2010-05-05,"ESCO Technologies, American Medical Systems Holdings: Biggest Price Gainers (ESE, AMMD)",Fall,-0.0332,87,esco technology american medical system holding biggest price gainer ese ammd,77,11,0,pharmacy,"['es', '##co', 'technology', 'am', '##eric', '##an', 'medical', 'system', 'holding', 'biggest', 'price', 'gain', '##er', 'es', '##e', 'am', '##m', '##d']",1
16355,nifty_65,2010-05-05,Stomach-Cancer Rate Puzzles Scientists,Fall,-0.0332,38,stomach cancer rate puzzle scientist,36,5,0,pharmacy,"['stomach', 'cancer', 'rate', 'puzzle', 'scientist']",1
16949,nifty_75,2010-05-24,Posen Warns of More U.K. Pain,Neutral,0.001,29,posen warns more pain,21,4,0,pharmacy,"['pose', '##n', 'warns', 'more', 'pain']",1
17553,nifty_79,2010-06-01,Research and Markets: Global In Vitro Diagnostics Sector: Prospects in Emerging Markets,Rise,0.026,87,research and market global vitro diagnostics sector prospect emerging market,76,10,0,pharmacy,"['research', 'and', 'market', 'global', 'v', '##it', '##ro', 'diagnostic', '##s', 'sector', 'prospect', 'emerging', 'market']",1
17622,nifty_79,2010-06-01,Research and Markets: Telmisartan - Pipeline Developer: Used by the Worlds Leading Generic Pharmaceutical Companies & Legal Teams,Rise,0.026,129,research and market telmisartan pipeline developer used the world leading generic pharmaceutical company legal team,115,15,0,pharmacy,"['research', 'and', 'market', 'te', '##lm', '##isa', '##rta', '##n', 'pipeline', 'developer', 'used', 'the', 'world', 'leading', 'generic', 'pharmaceutical', 'company', 'legal', 'team']",1
17630,nifty_79,2010-06-01,"Research and Markets: Posaconazole - Pipeline Developer: Your own Team of Pharmaceutical Patent Experts, at a Fraction of the Cost & Without the Wait!",Rise,0.026,150,research and market posaconazole pipeline developer your own team pharmaceutical patent expert fraction the cost without the wait,129,18,0,pharmacy,"['research', 'and', 'market', 'p', '##osa', '##cona', '##zo', '##le', 'pipeline', 'developer', 'your', 'own', 'team', 'pharmaceutical', 'patent', 'expert', 'fraction', 'the', 'cost', 'without', 'the', 'wait']",1
17657,nifty_79,2010-06-01,Research and Markets: Ezetimibe - Pipeline Developer: Eliminate Unnecessary Risk with the Industry Benchmark in Comprehensive Patent Information,Rise,0.026,144,research and market ezetimibe pipeline developer eliminate unnecessary risk with the industry benchmark comprehensive patent information,136,16,0,pharmacy,"['research', 'and', 'market', 'e', '##ze', '##ti', '##mi', '##be', 'pipeline', 'developer', 'eliminate', 'unnecessary', 'risk', 'with', 'the', 'industry', 'bench', '##mark', 'comprehensive', 'patent', 'information']",1
17840,nifty_79,2010-06-01,Research and Markets: Neutropenia - Drug Pipeline Analysis and Market Forecasts to 2016,Rise,0.026,87,research and market neutropenia drug pipeline analysis and market forecast,74,10,0,pharmacy,"['research', 'and', 'market', 'ne', '##ut', '##rop', '##enia', 'drug', 'pipeline', 'analysis', 'and', 'market', 'forecast']",1
17844,nifty_79,2010-06-01,Research and Markets: Growth Hormone Deficiency (GHD) - Pipeline Analysis and Market Forecasts to 2016,Rise,0.026,102,research and market growth hormone deficiency ghd pipeline analysis and market forecast,87,12,0,pharmacy,"['research', 'and', 'market', 'growth', 'hormone', 'deficiency', 'g', '##h', '##d', 'pipeline', 'analysis', 'and', 'market', 'forecast']",1
17850,nifty_79,2010-06-01,"Research and Markets: Poland Pharmaceuticals and Healthcare Report Q3 2010 Report Forecasts Sales to Grow By 6.4% in 2010, To a Value of PLN32.2bn (US$11.6bn)",Rise,0.026,158,research and market poland pharmaceutical and healthcare report report forecast sale grow value pln,99,14,0,pharmacy,"['research', 'and', 'market', 'p', '##ola', '##nd', 'pharmaceutical', 'and', 'healthcare', 'report', 'report', 'forecast', 'sale', 'grow', 'value', 'p', '##ln']",1
17883,nifty_79,2010-06-01,Research and Markets: Pancreatic Cancer - Drug Pipeline Analysis and Market Forecasts to 2016,Rise,0.026,93,research and market pancreatic cancer drug pipeline analysis and market forecast,80,11,0,pharmacy,"['research', 'and', 'market', 'pan', '##cre', '##atic', 'cancer', 'drug', 'pipeline', 'analysis', 'and', 'market', 'forecast']",1
17913,nifty_79,2010-06-01,NPS Pharmaceuticals to Present at Upcoming Conferences,Rise,0.026,54,np pharmaceutical present upcoming conference,45,5,0,pharmacy,"['n', '##p', 'pharmaceutical', 'present', 'upcoming', 'conference']",1
17919,nifty_79,2010-06-01,Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences,Rise,0.026,90,vertex pharmaceutical announces webcasts it presentation two investor conference,80,9,0,pharmacy,"['vertex', 'pharmaceutical', 'announces', 'web', '##cast', '##s', 'it', 'presentation', 'two', 'investor', 'conference']",1
17924,nifty_79,2010-06-01,Research and Markets: Argentina Diabetes Care Devices Market Outlook to 2016,Rise,0.026,76,research and market argentina diabetes care device market outlook,65,9,0,pharmacy,"['research', 'and', 'market', 'a', '##rgent', '##ina', 'diabetes', 'care', 'device', 'market', 'outlook']",1
18241,nifty_82,2010-06-07,"Hellenic Telecommunications Organization, Celldex Therapeutics: Biggest Price Decliners (OTE, CLDX)",Rise,0.0107,99,hellenic telecommunication organization celldex therapeutic biggest price decliners ote cldx,92,10,0,pharmacy,"['hell', '##eni', '##c', 'te', '##le', '##com', '##munication', 'organization', 'cell', '##de', '##x', 'therapeutic', 'biggest', 'price', 'decline', '##rs', 'o', '##te', 'c', '##ld', '##x']",1
18650,nifty_89,2010-06-17,FDA Questions Safety of 'Female Viagra',Neutral,-0.0037,39,fda question safety female viagra,33,5,0,pharmacy,"['f', '##da', 'question', 'safety', 'female', 'via', '##gra']",1
18947,nifty_91,2010-06-22,Research and Markets: Spain Diagnostic Imaging Market Outlook to 2016,Neutral,-0.0031,69,research and market spain diagnostic imaging market outlook,59,8,0,pharmacy,"['research', 'and', 'market', 'spa', '##in', 'diagnostic', 'imaging', 'market', 'outlook']",1
19049,nifty_91,2010-06-22, Radient Pharmaceuticals Schedules Investor Call to Discuss Onko-Sure Commercialization Developments,Neutral,-0.0031,100,radient pharmaceutical schedule investor call discus onko sure commercialization development,92,10,0,pharmacy,"['r', '##adi', '##ent', 'pharmaceutical', 'schedule', 'investor', 'call', 'disc', '##us', 'on', '##ko', 'sure', 'commercial', '##ization', 'development']",1
19100,nifty_91,2010-06-22,Research and Markets: Japan Diagnostic Imaging Market Outlook to 2016,Neutral,-0.0031,69,research and market japan diagnostic imaging market outlook,59,8,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##n', 'diagnostic', 'imaging', 'market', 'outlook']",1
19108,nifty_91,2010-06-22,Research and Markets: Germany Diagnostic Imaging Market Outlook to 2016,Neutral,-0.0031,71,research and market germany diagnostic imaging market outlook,61,8,0,pharmacy,"['research', 'and', 'market', 'g', '##erman', '##y', 'diagnostic', 'imaging', 'market', 'outlook']",1
19150,nifty_91,2010-06-22,Research and Markets: Australia Diagnostic Imaging Market Outlook to 2016,Neutral,-0.0031,73,research and market australia diagnostic imaging market outlook,63,8,0,pharmacy,"['research', 'and', 'market', 'au', '##stra', '##lia', 'diagnostic', 'imaging', 'market', 'outlook']",1
19161,nifty_91,2010-06-22,"Research and Markets: Future Oncology: A Comprehensive, Up-To-Date Analysis Of Scientific, Technological, Clinical And Commercial Developments In Oncology",Neutral,-0.0031,154,research and market future oncology comprehensive date analysis scientific technological clinical and commercial development oncology,133,15,0,pharmacy,"['research', 'and', 'market', 'future', 'on', '##cology', 'comprehensive', 'date', 'analysis', 'scientific', 'technological', 'clinical', 'and', 'commercial', 'development', 'on', '##cology']",1
19224,nifty_91,2010-06-22,"Research and Markets: AntiCancer, Inc Company Report - An Up-to-Date Insight into the Structure & Operations of the Company",Neutral,-0.0031,123,research and market anticancer inc company report date insight into the structure operation the company,103,15,0,pharmacy,"['research', 'and', 'market', 'anti', '##can', '##cer', 'in', '##c', 'company', 'report', 'date', 'insight', 'into', 'the', 'structure', 'operation', 'the', 'company']",1
19232,nifty_91,2010-06-22,Research and Markets: Economic Benefits and the Drive for Going Green Bolstering Medical Device Reprocessing,Neutral,-0.0031,108,research and market economic benefit and the drive for going green bolstering medical device reprocessing,105,15,0,pharmacy,"['research', 'and', 'market', 'economic', 'benefit', 'and', 'the', 'drive', 'for', 'going', 'green', 'b', '##ols', '##tering', 'medical', 'device', 're', '##p', '##ro', '##cess', '##ing']",1
19235,nifty_91,2010-06-22,"Research and Markets: Astellas Pharma Canada, Inc. Company Report - Up to Date Insight into the Structure & Operations of the Company",Neutral,-0.0031,133,research and market astellas pharma canada inc company report date insight into the structure operation the company,115,17,0,pharmacy,"['research', 'and', 'market', 'as', '##tel', '##las', 'p', '##har', '##ma', 'can', '##ada', 'in', '##c', 'company', 'report', 'date', 'insight', 'into', 'the', 'structure', 'operation', 'the', 'company']",1
19237,nifty_91,2010-06-22,Research and Markets: Advanced Cancer Therapeutics Company Report - An Up-to-Date Insight into the Structure & Operations of the Company,Neutral,-0.0031,136,research and market advanced cancer therapeutic company report date insight into the structure operation the company,116,16,0,pharmacy,"['research', 'and', 'market', 'advanced', 'cancer', 'therapeutic', 'company', 'report', 'date', 'insight', 'into', 'the', 'structure', 'operation', 'the', 'company']",1
19268,nifty_91,2010-06-22,Shareholders of Penwest Pharmaceuticals Co. Elect Tang Capital and Perceptive Nominees to the Board,Neutral,-0.0031,99,shareholder penwest pharmaceutical elect tang capital and perceptive nominee the board,86,11,0,pharmacy,"['shareholder', 'pen', '##wes', '##t', 'pharmaceutical', 'elect', 'tan', '##g', 'capital', 'and', 'per', '##ceptive', 'nominee', 'the', 'board']",1
19786,nifty_95,2010-06-29,Sawai: to mull capital tie-up with bigger drugmaker,Fall,-0.0095,51,sawai mull capital tie with bigger drugmaker,44,7,0,pharmacy,"['saw', '##ai', 'm', '##ull', 'capital', 'tie', 'with', 'bigger', 'drug', '##maker']",1
19788,nifty_95,2010-06-29,UPDATE 1-Sawai: to mull capital tie-up with bigger drugmaker,Fall,-0.0095,60,update sawai mull capital tie with bigger drugmaker,51,8,0,pharmacy,"['update', 'saw', '##ai', 'm', '##ull', 'capital', 'tie', 'with', 'bigger', 'drug', '##maker']",1
19874,nifty_95,2010-06-29,"Advanced Technologies Present Growth Opportunities for Current Immunoassay Players and New Entrants, Scientia Advisors Finds",Fall,-0.0095,124,advanced technology present growth opportunity for current immunoassay player and new entrant scientia advisor find,115,15,0,pharmacy,"['advanced', 'technology', 'present', 'growth', 'opportunity', 'for', 'current', 'im', '##mu', '##no', '##ass', '##ay', 'player', 'and', 'new', 'en', '##tra', '##nt', 's', '##cie', '##nti', '##a', 'advisor', 'find']",1
19882,nifty_95,2010-06-29,Research and Markets: Singapore Pharmaceuticals and Healthcare Report - Q3 2010,Fall,-0.0095,79,research and market singapore pharmaceutical and healthcare report,66,8,0,pharmacy,"['research', 'and', 'market', 'sing', '##ap', '##ore', 'pharmaceutical', 'and', 'healthcare', 'report']",1
19893,nifty_95,2010-06-29,Industrial Biotech Companies to Showcase Biobased Products at World Congress on Industrial Biotechnology & Bioprocessing,Fall,-0.0095,120,industrial biotech company showcase biobased product world congress industrial biotechnology bioprocessing,106,11,0,pharmacy,"['industrial', 'bio', '##tech', 'company', 'showcase', 'bio', '##base', '##d', 'product', 'world', 'congress', 'industrial', 'bio', '##tech', '##nology', 'bio', '##p', '##ro', '##cess', '##ing']",1
19911,nifty_95,2010-06-29,BIND Biosciences Secures $12.4 Million Financing,Fall,-0.0095,48,bind bioscience secures million financing,41,5,0,pharmacy,"['bind', 'bio', '##science', 'secure', '##s', 'million', 'financing']",1
20022,nifty_95,2010-06-29,Research and Markets: Biogen Idec - SWOT Framework Analysis,Fall,-0.0095,59,research and market biogen idec swot framework analysis,55,8,0,pharmacy,"['research', 'and', 'market', 'bio', '##gen', 'id', '##ec', 's', '##wo', '##t', 'framework', 'analysis']",1
20027,nifty_95,2010-06-29,Research and Markets: Bristol Myers Squibb - SWOT Framework Analysis,Fall,-0.0095,68,research and market bristol myers squibb swot framework analysis,64,9,0,pharmacy,"['research', 'and', 'market', 'br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 's', '##wo', '##t', 'framework', 'analysis']",1
20201,nifty_95,2010-06-29,Research and Markets: Bipolar Disorder - A Comprehensive Global Strategic Business Report,Fall,-0.0095,89,research and market bipolar disorder comprehensive global strategic business report,83,10,0,pharmacy,"['research', 'and', 'market', 'bi', '##pol', '##ar', 'disorder', 'comprehensive', 'global', 'strategic', 'business', 'report']",1
20203,nifty_95,2010-06-29,Research and Markets: Colombia Pharmaceuticals and Healthcare Report Q3 2010 Reveals Pharmaceutical Sales Reached a Value of US$2.24bn in 2009,Fall,-0.0095,142,research and market colombia pharmaceutical and healthcare report reveals pharmaceutical sale reached value,107,13,0,pharmacy,"['research', 'and', 'market', 'co', '##lo', '##mb', '##ia', 'pharmaceutical', 'and', 'healthcare', 'report', 'reveals', 'pharmaceutical', 'sale', 'reached', 'value']",1
20228,nifty_95,2010-06-29,Research and Markets: Dyslipidemia Pipeline Assessment and Market Forecasts to 2016,Fall,-0.0095,83,research and market dyslipidemia pipeline assessment and market forecast,72,9,0,pharmacy,"['research', 'and', 'market', 'd', '##ys', '##lip', '##ide', '##mia', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
20282,nifty_95,2010-06-29,Research and Markets: Type 1 Diabetes - Drug Pipeline Assessment and Market Forecasts to 2017,Fall,-0.0095,93,research and market type diabetes drug pipeline assessment and market forecast,78,11,0,pharmacy,"['research', 'and', 'market', 'type', 'diabetes', 'drug', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
20334,nifty_95,2010-06-29,"Leading Pharmaceutical, Biotech, and BioBanking Companies Including UK BioBank, PrecisionMed, Sanofi-Aventis and Merck to Address the Challenges Facing Today's BioBanks",Fall,-0.0095,168,leading pharmaceutical biotech and biobanking company including biobank precisionmed sanofi aventis and merck address the challenge facing today biobanks,153,19,0,pharmacy,"['leading', 'pharmaceutical', 'bio', '##tech', 'and', 'bio', '##bank', '##ing', 'company', 'including', 'bio', '##bank', 'precision', '##med', 'sa', '##no', '##fi', 'a', '##vent', '##is', 'and', 'me', '##rc', '##k', 'address', 'the', 'challenge', 'facing', 'today', 'bio', '##bank', '##s']",1
20351,nifty_95,2010-06-29, Global Immune Technologies Announces It Is Progressing With Its Business Development,Fall,-0.0095,85,global immune technology announces progressing with it business development,75,9,0,pharmacy,"['global', 'immune', 'technology', 'announces', 'progress', '##ing', 'with', 'it', 'business', 'development']",1
20358,nifty_95,2010-06-29,Wall Street Media Presents Potential VVUS Options Trades Ahead of the FDA Panel,Fall,-0.0095,79,wall street medium present potential vvus option trade ahead the fda panel,74,12,0,pharmacy,"['wall', 'street', 'medium', 'present', 'potential', 'v', '##vu', '##s', 'option', 'trade', 'ahead', 'the', 'f', '##da', 'panel']",1
20372,nifty_95,2010-06-29,"CORRECTING and REPLACING Advanced Technologies Present Growth Opportunities for Current Immunoassay Players and New Entrants, Scientia Advisors Finds",Fall,-0.0095,149,correcting and replacing advanced technology present growth opportunity for current immunoassay player and new entrant scientia advisor find,140,18,0,pharmacy,"['correct', '##ing', 'and', 'replacing', 'advanced', 'technology', 'present', 'growth', 'opportunity', 'for', 'current', 'im', '##mu', '##no', '##ass', '##ay', 'player', 'and', 'new', 'en', '##tra', '##nt', 's', '##cie', '##nti', '##a', 'advisor', 'find']",1
20596,nifty_95,2010-06-29,The Next Step: Treatment,Fall,-0.0095,24,the next step treatment,23,4,0,pharmacy,"['the', 'next', 'step', 'treatment']",1
20956,nifty_98,2010-07-06, MMRGlobal's China Joint Venture Plans for Electronic Health Record Project in Henan Province,Rise,0.0315,93,mmrglobal china joint venture plan for electronic health record project henan province,86,12,0,pharmacy,"['mm', '##rg', '##lo', '##bal', 'chin', '##a', 'joint', 'venture', 'plan', 'for', 'electronic', 'health', 'record', 'project', 'he', '##nan', 'province']",1
20963,nifty_98,2010-07-06,"Research and Markets: Clinical Chemistry and Immunodiagnostics Markets Product Development Opportunities, Market Penetration Strategies, Entry Barriers and Risks",Rise,0.0315,161,research and market clinical chemistry and immunodiagnostics market product development opportunity market penetration strategy entry barrier and risk,150,18,0,pharmacy,"['research', 'and', 'market', 'clinical', 'chemistry', 'and', 'im', '##mu', '##no', '##dia', '##gno', '##stics', 'market', 'product', 'development', 'opportunity', 'market', 'penetration', 'strategy', 'entry', 'barrier', 'and', 'risk']",1
20997,nifty_98,2010-07-06,Research and Markets: Leading Clinical Chemistry and Immunodiagnostics Market Players Strategic Assessments of 25 Major Suppliers and Emerging Market Entrants,Rise,0.0315,158,research and market leading clinical chemistry and immunodiagnostics market player strategic assessment major supplier and emerging market entrant,146,18,0,pharmacy,"['research', 'and', 'market', 'leading', 'clinical', 'chemistry', 'and', 'im', '##mu', '##no', '##dia', '##gno', '##stics', 'market', 'player', 'strategic', 'assessment', 'major', 'supplier', 'and', 'emerging', 'market', 'en', '##tra', '##nt']",1
21030,nifty_98,2010-07-06,Research and Markets: Analyzing the Major Pharmaceutical Markets 2010 - a Comprehensive Update on Pharma Markets Worldwide,Rise,0.0315,122,research and market analyzing the major pharmaceutical market comprehensive update pharma market worldwide,106,13,0,pharmacy,"['research', 'and', 'market', 'analyzing', 'the', 'major', 'pharmaceutical', 'market', 'comprehensive', 'update', 'p', '##har', '##ma', 'market', 'worldwide']",1
21067,nifty_98,2010-07-06, Applied DNA Sciences and H.W. Sands Corp. Sign Agreement to Jointly Market Security Technologies,Rise,0.0315,97,applied dna science and sand corp sign agreement jointly market security technology,83,12,0,pharmacy,"['applied', 'd', '##na', 'science', 'and', 'sand', 'co', '##rp', 'sign', 'agreement', 'jointly', 'market', 'security', 'technology']",1
21076,nifty_98,2010-07-06,"Research and Markets: Proteomics - Technologies, Markets and Companies",Rise,0.0315,70,research and market proteomics technology market and company,60,8,0,pharmacy,"['research', 'and', 'market', 'pro', '##te', '##omi', '##cs', 'technology', 'market', 'and', 'company']",1
21083,nifty_98,2010-07-06,"Research and Markets: Transdermal Drug Delivery - Technologies, Markets, and Companies",Rise,0.0315,86,research and market transdermal drug delivery technology market and company,75,10,0,pharmacy,"['research', 'and', 'market', 'trans', '##der', '##mal', 'drug', 'delivery', 'technology', 'market', 'and', 'company']",1
21193,nifty_98,2010-07-06, New Report Analyzes $138.3 Billion U.S. Medical Device Market,Rise,0.0315,62,new report analyzes billion medical device market,49,7,0,pharmacy,"['new', 'report', 'analyze', '##s', 'billion', 'medical', 'device', 'market']",1
21262,nifty_98,2010-07-06,"Research and Markets: DNA Sequencing - Technologies, Markets and Companies: Profiles of 54 Companies Involved in Sequencing and their 50 Collaborations",Rise,0.0315,151,research and market dna sequencing technology market and company profile company involved sequencing and their collaboration,124,16,0,pharmacy,"['research', 'and', 'market', 'd', '##na', 'se', '##quencing', 'technology', 'market', 'and', 'company', 'profile', 'company', 'involved', 'se', '##quencing', 'and', 'their', 'collaboration']",1
21269,nifty_98,2010-07-06,"Research and Markets: Lundbeck, a Research-Based Pharmaceutical Company: Pipeline, Products, Performance and Potential",Rise,0.0315,118,research and market lundbeck research based pharmaceutical company pipeline product performance and potential,109,13,0,pharmacy,"['research', 'and', 'market', 'l', '##und', '##beck', 'research', 'based', 'pharmaceutical', 'company', 'pipeline', 'product', 'performance', 'and', 'potential']",1
21271,nifty_98,2010-07-06,Research and Markets: Point of Care Diagnostic Testing World Markets,Rise,0.0315,68,research and market point care diagnostic testing world market,62,9,0,pharmacy,"['research', 'and', 'market', 'point', 'care', 'diagnostic', 'testing', 'world', 'market']",1
21288,nifty_98,2010-07-06,"UPDATE1-Medical Staffing Network bankrupt, lenders to buy co",Rise,0.0315,60,update medical staffing network bankrupt lender buy,51,7,0,pharmacy,"['update', 'medical', 'staff', '##ing', 'network', 'bankrupt', 'lend', '##er', 'buy']",1
21409,nifty_98,2010-07-06,"Research and Markets: Nitric Oxide - Therapeutics, Markets and Companies - Competely Updated with 500 NO Selected References",Rise,0.0315,124,research and market nitric oxide therapeutic market and company competely updated with selected reference,105,14,0,pharmacy,"['research', 'and', 'market', 'ni', '##tric', 'oxide', 'therapeutic', 'market', 'and', 'company', 'compete', '##ly', 'updated', 'with', 'selected', 'reference']",1
21562,nifty_98,2010-07-06,Bionovo Announces a $15 Million At-The-Market Firm Commitment Financing Agreement,Rise,0.0315,81,bionovo announces million the market firm commitment financing agreement,72,9,0,pharmacy,"['bio', '##nov', '##o', 'announces', 'million', 'the', 'market', 'firm', 'commitment', 'financing', 'agreement']",1
21577,nifty_98,2010-07-06,Research and Markets: Indian Biotechnology Sector Industry Profile - Discussing the Significant Developments in the Industry & Analysing the Key Trends & Issues,Rise,0.0315,160,research and market indian biotechnology sector industry profile discussing the significant development the industry analysing the key trend issue,146,19,0,pharmacy,"['research', 'and', 'market', 'in', '##dian', 'bio', '##tech', '##nology', 'sector', 'industry', 'profile', 'discussing', 'the', 'significant', 'development', 'the', 'industry', 'anal', '##ys', '##ing', 'the', 'key', 'trend', 'issue']",1
21578,nifty_98,2010-07-06,Research and Markets: Chinese Biotechnology Sector Industry Profile - Discusses the Significant Developments in the Industry & Analyses the Key Trends & Issues,Rise,0.0315,159,research and market chinese biotechnology sector industry profile discusses the significant development the industry analysis the key trend issue,145,19,0,pharmacy,"['research', 'and', 'market', 'chin', '##ese', 'bio', '##tech', '##nology', 'sector', 'industry', 'profile', 'discusses', 'the', 'significant', 'development', 'the', 'industry', 'analysis', 'the', 'key', 'trend', 'issue']",1
21579,nifty_98,2010-07-06,Research and Markets: Japanese Biotechnology Sector Industry Profile - a Comprehensive Analysis of the Industry and Its Market Segment,Rise,0.0315,134,research and market japanese biotechnology sector industry profile comprehensive analysis the industry and it market segment,124,16,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##nese', 'bio', '##tech', '##nology', 'sector', 'industry', 'profile', 'comprehensive', 'analysis', 'the', 'industry', 'and', 'it', 'market', 'segment']",1
21943,nifty_99,2010-07-07,"Research and Markets: the Clinical Chemistry Market: US, Europe, Japan - Now Available",Rise,0.0099,86,research and market the clinical chemistry market europe japan now available,76,11,0,pharmacy,"['research', 'and', 'market', 'the', 'clinical', 'chemistry', 'market', 'euro', '##pe', 'j', '##apa', '##n', 'now', 'available']",1
22089,nifty_99,2010-07-07, New Report Details Rapid Innovation and Growth in Biopharma,Rise,0.0099,60,new report detail rapid innovation and growth biopharma,55,8,0,pharmacy,"['new', 'report', 'detail', 'rapid', 'innovation', 'and', 'growth', 'bio', '##pha', '##rma']",1
22282,nifty_99,2010-07-07,Research and Markets: Outlook for Pharmaceuticals Worldwide to 2015 - Comprehensive & Compelling Analysis of Current & Future Opportunities in over 60 Countries Worldwide,Rise,0.0099,170,research and market outlook for pharmaceutical worldwide comprehensive compelling analysis current future opportunity over country worldwide,140,16,0,pharmacy,"['research', 'and', 'market', 'outlook', 'for', 'pharmaceutical', 'worldwide', 'comprehensive', 'compelling', 'analysis', 'current', 'future', 'opportunity', 'over', 'country', 'worldwide']",1
22285,nifty_99,2010-07-07,Research and Markets: Disease and Therapy Review: Chronic Obstructive Pulmonary Disease (COPD),Rise,0.0099,94,research and market disease and therapy review chronic obstructive pulmonary disease copd,89,12,0,pharmacy,"['research', 'and', 'market', 'disease', 'and', 'therapy', 'review', 'chronic', 'o', '##bs', '##truct', '##ive', 'pulmonary', 'disease', 'cop', '##d']",1
22428,nifty_99,2010-07-07,"Research and Markets: Western USA Biotechnology Companies Subscription: Annual Subscription Including Unlimited Searching and Viewing and up to 7,000 Downloads",Rise,0.0099,159,research and market western usa biotechnology company subscription annual subscription including unlimited searching and viewing and downloads,142,17,0,pharmacy,"['research', 'and', 'market', 'western', 'us', '##a', 'bio', '##tech', '##nology', 'company', 'subscription', 'annual', 'subscription', 'including', 'unlimited', 'searching', 'and', 'viewing', 'and', 'downloads']",1
22444,nifty_99,2010-07-07,"Research and Markets: Triple Analysis: Colorectal Cancer, Lymphoma and Melanoma 2010 - Out Today",Rise,0.0099,96,research and market triple analysis colorectal cancer lymphoma and melanoma out today,85,12,0,pharmacy,"['research', 'and', 'market', 'triple', 'analysis', 'color', '##ec', '##tal', 'cancer', 'l', '##ymph', '##oma', 'and', 'me', '##lan', '##oma', 'out', 'today']",1
22445,nifty_99,2010-07-07,"Research and Markets: Triple Analysis: Breast Cancer, Colorectal Cancer and Lymphoma - 2010 Out Today",Rise,0.0099,101,research and market triple analysis breast cancer colorectal cancer and lymphoma out today,90,13,0,pharmacy,"['research', 'and', 'market', 'triple', 'analysis', 'breast', 'cancer', 'color', '##ec', '##tal', 'cancer', 'and', 'l', '##ymph', '##oma', 'out', 'today']",1
22449,nifty_99,2010-07-07,"Research and Markets: Triple Analysis: Breast Cancer, Lung Cancer and Lymphoma - 2010 Out Now",Rise,0.0099,93,research and market triple analysis breast cancer lung cancer and lymphoma out now,82,13,0,pharmacy,"['research', 'and', 'market', 'triple', 'analysis', 'breast', 'cancer', 'lung', 'cancer', 'and', 'l', '##ymph', '##oma', 'out', 'now']",1
22450,nifty_99,2010-07-07,"Research and Markets: Triple Analysis: Breast Cancer, Prostate Cancer and Protein Kinase Inhibitors 2010 - Out Today",Rise,0.0099,116,research and market triple analysis breast cancer prostate cancer and protein kinase inhibitor out today,104,15,0,pharmacy,"['research', 'and', 'market', 'triple', 'analysis', 'breast', 'cancer', 'pro', '##state', 'cancer', 'and', 'protein', 'kinase', 'inhibitor', 'out', 'today']",1
22451,nifty_99,2010-07-07,"Research and Markets: Triple Analysis: Breast Cancer, Colorectal Cancer and Pancreatic Cancer 2010",Rise,0.0099,98,research and market triple analysis breast cancer colorectal cancer and pancreatic cancer,89,12,0,pharmacy,"['research', 'and', 'market', 'triple', 'analysis', 'breast', 'cancer', 'color', '##ec', '##tal', 'cancer', 'and', 'pan', '##cre', '##atic', 'cancer']",1
22460,nifty_99,2010-07-07,Research and Markets: US Pharmaceutical Sector: Industry Profile,Rise,0.0099,64,research and market pharmaceutical sector industry profile,58,7,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'sector', 'industry', 'profile']",1
22462,nifty_99,2010-07-07,"Research and Markets: Triple Analysis: Breast Cancer, Lung Cancer and Melanoma 2010 Defines Development Strategies for 124 Melanoma Drugs",Rise,0.0099,137,research and market triple analysis breast cancer lung cancer and melanoma defines development strategy for melanoma drug,121,17,0,pharmacy,"['research', 'and', 'market', 'triple', 'analysis', 'breast', 'cancer', 'lung', 'cancer', 'and', 'me', '##lan', '##oma', 'defines', 'development', 'strategy', 'for', 'me', '##lan', '##oma', 'drug']",1
22472,nifty_99,2010-07-07,"Research and Markets: Triple Analysis: Breast Cancer, Colorectal Cancer and Protein Kinase Inhibitors - 2010",Rise,0.0099,108,research and market triple analysis breast cancer colorectal cancer and protein kinase inhibitor,96,13,0,pharmacy,"['research', 'and', 'market', 'triple', 'analysis', 'breast', 'cancer', 'color', '##ec', '##tal', 'cancer', 'and', 'protein', 'kinase', 'inhibitor']",1
22570,nifty_99,2010-07-07,"Zacks Analyst Blog Highlights:Accenture plc, Statoil ASA, Procter & Gamble,Sara Lee and Cell Therapeutics",Rise,0.0099,105,zacks analyst blog highlight accenture plc statoil asa procter gamble sara lee and cell therapeutic,99,15,0,pharmacy,"['z', '##ack', '##s', 'analyst', 'blog', 'highlight', 'accent', '##ure', 'plc', 's', '##tat', '##oil', 'as', '##a', 'pro', '##cter', 'g', '##amble', 'sa', '##ra', 'le', '##e', 'and', 'cell', 'therapeutic']",1
22630,nifty_99,2010-07-07,Research and Markets: Chinese Pharmaceutical Sector: Industry Profile,Rise,0.0099,69,research and market chinese pharmaceutical sector industry profile,66,8,0,pharmacy,"['research', 'and', 'market', 'chin', '##ese', 'pharmaceutical', 'sector', 'industry', 'profile']",1
22650,nifty_99,2010-07-07,Research and Markets: Japanese Pharmaceutical Sector: Industry Profile,Rise,0.0099,70,research and market japanese pharmaceutical sector industry profile,67,8,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##nese', 'pharmaceutical', 'sector', 'industry', 'profile']",1
22698,nifty_99,2010-07-07,Colon Cancer Screening Rates Improve,Rise,0.0099,36,colon cancer screening rate improve,35,5,0,pharmacy,"['co', '##lon', 'cancer', 'screening', 'rate', 'improve']",1
23067,nifty_103,2010-07-14,"Research and Markets: Breast Cancer, Melanoma and Protein Kinase Inhibitors - Triple Analysis Focus on Cancer Drug Development Strategies",Neutral,0.0003,137,research and market breast cancer melanoma and protein kinase inhibitor triple analysis focus cancer drug development strategy,126,17,0,pharmacy,"['research', 'and', 'market', 'breast', 'cancer', 'me', '##lan', '##oma', 'and', 'protein', 'kinase', 'inhibitor', 'triple', 'analysis', 'focus', 'cancer', 'drug', 'development', 'strategy']",1
23142,nifty_103,2010-07-14,Pacific Biosciences Announces $109 Million Financing,Neutral,0.0003,52,pacific bioscience announces million financing,46,5,0,pharmacy,"['p', '##ac', '##ific', 'bio', '##science', 'announces', 'million', 'financing']",1
23157,nifty_103,2010-07-14,Research and Markets: Bristol Myers Squibb Co.: Corporate Analysis on the Strategic Positioning of the Company,Neutral,0.0003,110,research and market bristol myers squibb corporate analysis the strategic positioning the company,97,13,0,pharmacy,"['research', 'and', 'market', 'br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'corporate', 'analysis', 'the', 'strategic', 'positioning', 'the', 'company']",1
23413,nifty_103,2010-07-14,"Research and Markets: Triple Analysis: a Comprehensive Analysis, Focusing on Cancer Drug Development Strategies Colorectal Cancer, Lymphoma and Apoptosis",Neutral,0.0003,153,research and market triple analysis comprehensive analysis focusing cancer drug development strategy colorectal cancer lymphoma and apoptosis,141,17,0,pharmacy,"['research', 'and', 'market', 'triple', 'analysis', 'comprehensive', 'analysis', 'focusing', 'cancer', 'drug', 'development', 'strategy', 'color', '##ec', '##tal', 'cancer', 'l', '##ymph', '##oma', 'and', 'a', '##pop', '##tosis']",1
23415,nifty_103,2010-07-14,Research and Markets: Biotech Investment and Business Trends: Weathering the Economic Storm,Neutral,0.0003,91,research and market biotech investment and business trend weathering the economic storm,87,12,0,pharmacy,"['research', 'and', 'market', 'bio', '##tech', 'investment', 'and', 'business', 'trend', 'weather', '##ing', 'the', 'economic', 'storm']",1
23416,nifty_103,2010-07-14,"Research and Markets: USA Bioscience Data Subscription - Includes Every Company in Life Sciences, Biotechnology, Pharmaceutical & Medical Device Supply in the US",Neutral,0.0003,161,research and market usa bioscience data subscription includes every company life science biotechnology pharmaceutical medical device supply the,143,18,0,pharmacy,"['research', 'and', 'market', 'us', '##a', 'bio', '##science', 'data', 'subscription', 'includes', 'every', 'company', 'life', 'science', 'bio', '##tech', '##nology', 'pharmaceutical', 'medical', 'device', 'supply', 'the']",1
23532,nifty_103,2010-07-14,"Research and Markets: Mergers, Acquisitions and Partnerships in the Medical Devices Industry - Inorganic Growth Driven by the Strategic Need to Hold a Diversified Portfolio",Neutral,0.0003,172,research and market merger acquisition and partnership the medical device industry inorganic growth driven the strategic need hold diversified portfolio,152,20,0,pharmacy,"['research', 'and', 'market', 'merger', 'acquisition', 'and', 'partnership', 'the', 'medical', 'device', 'industry', 'in', '##or', '##gan', '##ic', 'growth', 'driven', 'the', 'strategic', 'need', 'hold', 'divers', '##ified', 'portfolio']",1
23591,nifty_103,2010-07-14,"Webcast Alert: ADVENTRX Pharmaceuticals, Inc. Announces LHA Life Sciences & Med Tech Day 2010 Presentation",Neutral,0.0003,106,webcast alert adventrx pharmaceutical inc announces lha life science med tech day presentation,94,13,0,pharmacy,"['web', '##cast', 'alert', 'advent', '##r', '##x', 'pharmaceutical', 'in', '##c', 'announces', 'l', '##ha', 'life', 'science', 'me', '##d', 'tech', 'day', 'presentation']",1
23786,nifty_103,2010-07-14,"BioMimetic Therapeutics, Inc. Prices Public Offering of Common Stock",Neutral,0.0003,68,biomimetic therapeutic inc price public offering common stock,61,8,0,pharmacy,"['bio', '##mi', '##met', '##ic', 'therapeutic', 'in', '##c', 'price', 'public', 'offering', 'common', 'stock']",1
24020,nifty_106,2010-07-20,Biogen Net Soars on Higher Sales,Fall,-0.013,32,biogen net soar higher sale,27,5,0,pharmacy,"['bio', '##gen', 'net', 'so', '##ar', 'higher', 'sale']",1
24430,nifty_110,2010-07-27,Global Cancer Drugs Market 2009-2013 and Other New Market Reports on Healthcare Equipment & Services Recently Added by MarketPublishers.com,Fall,-0.0065,139,global cancer drug market and other new market report healthcare equipment service recently added marketpublishers com,118,16,0,pharmacy,"['global', 'cancer', 'drug', 'market', 'and', 'other', 'new', 'market', 'report', 'healthcare', 'equipment', 'service', 'recently', 'added', 'market', '##pu', '##b', '##lish', '##ers', 'com']",1
24634,nifty_110,2010-07-27,"iBio Taps Pharmaceutical and Biotech Research Leader Terence E. Ryan, PhD to Drive New Business Development",Fall,-0.0065,107,ibio tap pharmaceutical and biotech research leader terence ryan phd drive new business development,99,14,0,pharmacy,"['i', '##bio', 'tap', 'pharmaceutical', 'and', 'bio', '##tech', 'research', 'leader', 'te', '##ren', '##ce', 'r', '##yan', 'p', '##h', '##d', 'drive', 'new', 'business', 'development']",1
24660,nifty_110,2010-07-27,"Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 3",Fall,-0.0065,108,arena pharmaceutical host business and financial update conference call and webcast tuesday august,98,13,0,pharmacy,"['arena', 'pharmaceutical', 'host', 'business', 'and', 'financial', 'update', 'conference', 'call', 'and', 'web', '##cast', 't', '##ues', '##day', 'au', '##gus', '##t']",1
24726,nifty_110,2010-07-27,Research and Markets: UK Pharmaceutical Market Overview - Pricing and Reimbursement Challenges Dampen Future Growth,Fall,-0.0065,115,research and market pharmaceutical market overview pricing and reimbursement challenge dampen future growth,107,13,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'market', 'overview', 'pricing', 'and', 're', '##im', '##bur', '##se', '##ment', 'challenge', 'damp', '##en', 'future', 'growth']",1
24801,nifty_110,2010-07-27,Entest BioMedical Retains Crescendo Communications as Investor Relations and Corporate...,Fall,-0.0065,89,entest biomedical retains crescendo communication investor relation and corporate,81,9,0,pharmacy,"['en', '##test', 'bio', '##medical', 'retains', 'c', '##res', '##cend', '##o', 'communication', 'investor', 'relation', 'and', 'corporate']",1
24930,nifty_110,2010-07-27,Research and Markets: Mexico In Vitro Diagnostics Market Outlook to 2016,Fall,-0.0065,72,research and market mexico vitro diagnostics market outlook,59,8,0,pharmacy,"['research', 'and', 'market', 'me', '##xi', '##co', 'v', '##it', '##ro', 'diagnostic', '##s', 'market', 'outlook']",1
24973,nifty_110,2010-07-27,Research and Markets: South Africa In Vitro Diagnostics Market Outlook to 2016,Fall,-0.0065,78,research and market south africa vitro diagnostics market outlook,65,9,0,pharmacy,"['research', 'and', 'market', 'south', 'a', '##f', '##rica', 'v', '##it', '##ro', 'diagnostic', '##s', 'market', 'outlook']",1
25041,nifty_110,2010-07-27,"Research and Markets: Taisho Pharmaceutical Co Ltd - Detailed Analysis on the Company, Examining its Performance in the Consumer Health Industry",Fall,-0.0065,144,research and market taisho pharmaceutical ltd detailed analysis the company examining it performance the consumer health industry,129,17,0,pharmacy,"['research', 'and', 'market', 'ta', '##ish', '##o', 'pharmaceutical', 'l', '##t', '##d', 'detailed', 'analysis', 'the', 'company', 'examining', 'it', 'performance', 'the', 'consumer', 'health', 'industry']",1
25158,nifty_110,2010-07-27,Foundation Venture Capital Group Sells Interest in Longevica Pharmaceuticals,Fall,-0.0065,76,foundation venture capital group sell interest longevica pharmaceutical,71,8,0,pharmacy,"['foundation', 'venture', 'capital', 'group', 'sell', 'interest', 'long', '##ev', '##ica', 'pharmaceutical']",1
25198,nifty_110,2010-07-27, Neuro-Biotech Corp. - Update to Shareholders,Fall,-0.0065,45,neuro biotech corp update shareholder,37,5,0,pharmacy,"['ne', '##uro', 'bio', '##tech', 'co', '##rp', 'update', 'shareholder']",1
25254,nifty_110,2010-07-27,Cadence Pharmaceuticals to Present at Three Investment Conferences During the Month of August 2010,Fall,-0.0065,98,cadence pharmaceutical present three investment conference during the month august,82,10,0,pharmacy,"['ca', '##dence', 'pharmaceutical', 'present', 'three', 'investment', 'conference', 'during', 'the', 'month', 'au', '##gus', '##t']",1
25289,nifty_110,2010-07-27,Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences,Fall,-0.0065,70,idenix pharmaceutical present two upcoming investor conference,62,7,0,pharmacy,"['id', '##eni', '##x', 'pharmaceutical', 'present', 'two', 'upcoming', 'investor', 'conference']",1
25316,nifty_110,2010-07-27,"Cell Therapeutics, Inc. Announces the Successful Closing of a Private Offering of $4.06 Million of Securities",Fall,-0.0065,109,cell therapeutic inc announces the successful closing private offering million security,87,11,0,pharmacy,"['cell', 'therapeutic', 'in', '##c', 'announces', 'the', 'successful', 'closing', 'private', 'offering', 'million', 'security']",1
25641,nifty_112,2010-07-29,"BB BIOTECH AG: Interim Report of BB BIOTECH AG as of June 30, 2010",Neutral,-0.0002,66,biotech interim report biotech june,35,5,0,pharmacy,"['bio', '##tech', 'interim', 'report', 'bio', '##tech', 'j', '##une']",1
25716,nifty_112,2010-07-29, CEGEDIM ACQUIRES SWISS CRM AND DIRECT MARKETING BUSINESS FROM IMS HEALTH,Neutral,-0.0002,73,cegedim acquires swiss crm and direct marketing business from ims health,72,11,0,pharmacy,"['c', '##ege', '##di', '##m', 'acquire', '##s', 's', '##wi', '##ss', 'c', '##rm', 'and', 'direct', 'marketing', 'business', 'from', 'im', '##s', 'health']",1
25877,nifty_112,2010-07-29,Aptuit and Siena Biotech Announce Strategic Relationship in Italy,Neutral,-0.0002,65,aptuit and siena biotech announce strategic relationship italy,62,8,0,pharmacy,"['a', '##pt', '##uit', 'and', 'si', '##ena', 'bio', '##tech', 'announce', 'strategic', 'relationship', 'it', '##aly']",1
26081,nifty_112,2010-07-29,"Celldex Therapeutics to Report Second Quarter 2010 Financial Results on August 4, 2010",Neutral,-0.0002,86,celldex therapeutic report second quarter financial result august,65,8,0,pharmacy,"['cell', '##de', '##x', 'therapeutic', 'report', 'second', 'quarter', 'financial', 'result', 'au', '##gus', '##t']",1
26113,nifty_112,2010-07-29,Research and Markets: Global Pharma-Biotech Alliance Analysis Report: Pharmaceutical Companies Burdened with High Drug Development Costs Seek Opportunities in Lucrative Emerging Markets,Neutral,-0.0002,185,research and market global pharma biotech alliance analysis report pharmaceutical company burdened with high drug development cost seek opportunity lucrative emerging market,173,22,0,pharmacy,"['research', 'and', 'market', 'global', 'p', '##har', '##ma', 'bio', '##tech', 'alliance', 'analysis', 'report', 'pharmaceutical', 'company', 'burden', '##ed', 'with', 'high', 'drug', 'development', 'cost', 'seek', 'opportunity', 'lucrative', 'emerging', 'market']",1
26127,nifty_112,2010-07-29,AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call,Neutral,-0.0002,85,avanir pharmaceutical invite investor fiscal third quarter conference call,74,9,0,pharmacy,"['a', '##vani', '##r', 'pharmaceutical', 'invite', 'investor', 'fiscal', 'third', 'quarter', 'conference', 'call']",1
26129,nifty_112,2010-07-29, Eurand to Present at Bank of America Merrill Lynch Specialty Pharmaceuticals Conference,Neutral,-0.0002,88,eurand present bank america merrill lynch specialty pharmaceutical conference,77,9,0,pharmacy,"['e', '##ura', '##nd', 'present', 'bank', 'am', '##eric', '##a', 'me', '##rri', '##ll', 'l', '##ync', '##h', 'specialty', 'pharmaceutical', 'conference']",1
26139,nifty_112,2010-07-29,Access Pharmaceuticals to Host North American MuGard Commercialization Update Conference Call for Investors,Neutral,-0.0002,107,access pharmaceutical host north american mugard commercialization update conference call for investor,102,12,0,pharmacy,"['access', 'pharmaceutical', 'host', 'north', 'am', '##eric', '##an', 'mug', '##ard', 'commercial', '##ization', 'update', 'conference', 'call', 'for', 'investor']",1
26171,nifty_112,2010-07-29," Marina Biotech, Inc. Announces Upcoming Investor Conference Presentations",Neutral,-0.0002,74,marina biotech inc announces upcoming investor conference presentation,70,8,0,pharmacy,"['ma', '##rina', 'bio', '##tech', 'in', '##c', 'announces', 'upcoming', 'investor', 'conference', 'presentation']",1
26465,nifty_112,2010-07-29,Research and Markets: The Future of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities in Personalized Medicine,Neutral,-0.0002,136,research and market the future molecular diagnostics innovative technology driving market opportunity personalized medicine,123,14,0,pharmacy,"['research', 'and', 'market', 'the', 'future', 'molecular', 'diagnostic', '##s', 'innovative', 'technology', 'driving', 'market', 'opportunity', 'personal', '##ized', 'medicine']",1
26468,nifty_112,2010-07-29, AVI BioPharma to Present at BMO Capital Markets Focus on Healthcare Conference,Neutral,-0.0002,79,avi biopharma present bmo capital market focus healthcare conference,68,9,0,pharmacy,"['a', '##vi', 'bio', '##pha', '##rma', 'present', 'b', '##mo', 'capital', 'market', 'focus', 'healthcare', 'conference']",1
26488,nifty_112,2010-07-29,Health Market Science Announces Immediate Availability of Email MasterFile for the Healthcare Industry,Neutral,-0.0002,102,health market science announces immediate availability email masterfile for the healthcare industry,99,12,0,pharmacy,"['health', 'market', 'science', 'announces', 'immediate', 'availability', 'email', 'master', '##fi', '##le', 'for', 'the', 'healthcare', 'industry']",1
26659,nifty_112,2010-07-29,NPS Pharmaceuticals to Present at Upcoming Conferences,Neutral,-0.0002,54,np pharmaceutical present upcoming conference,45,5,0,pharmacy,"['n', '##p', 'pharmaceutical', 'present', 'upcoming', 'conference']",1
26939,nifty_112,2010-07-29,Drug Firms Feel Pinch,Neutral,-0.0002,21,drug firm feel pinch,20,4,0,pharmacy,"['drug', 'firm', 'feel', 'pinch']",1
27319,nifty_113,2010-08-02, Molecular Diagnostics Market Expected to Grow at a Double-Digit Pace Through 2015,Neutral,-0.0048,82,molecular diagnostics market expected grow double digit pace through,68,9,0,pharmacy,"['molecular', 'diagnostic', '##s', 'market', 'expected', 'grow', 'double', 'digit', 'pace', 'through']",1
27527,nifty_113,2010-08-02,"No Economy Will Ever Be Able to Afford Healthcare without Reengineering, Warn Jim Champy, Bestselling Author of REENGINEERING THE CORPORATION, and Leading Physician Harry Greenspun in REENGINEERING HEALTH CARE",Neutral,-0.0048,209,economy will ever able afford healthcare without reengineering warn jim champy bestselling author reengineering the corporation and leading physician harry greenspun reengineering health care,191,24,0,pharmacy,"['economy', 'will', 'ever', 'able', 'afford', 'healthcare', 'without', 're', '##eng', '##ine', '##ering', 'warn', 'ji', '##m', 'ch', '##amp', '##y', 'best', '##sel', '##ling', 'author', 're', '##eng', '##ine', '##ering', 'the', 'corporation', 'and', 'leading', 'physician', 'ha', '##rry', 'green', '##sp', '##un', 're', '##eng', '##ine', '##ering', 'health', 'care']",1
27540,nifty_113,2010-08-02,Cross Atlantic Capital Partners Leads Series B Funding for Health Market Science,Neutral,-0.0048,80,cross atlantic capital partner lead series funding for health market science,76,11,0,pharmacy,"['cross', 'at', '##lant', '##ic', 'capital', 'partner', 'lead', 'series', 'funding', 'for', 'health', 'market', 'science']",1
27564,nifty_113,2010-08-02,TRADE NEWS: Agilent Technologies Introduces Compact Scanning Electron Microscope for Wide Use in Research,Neutral,-0.0048,105,trade news agilent technology introduces compact scanning electron microscope for wide use research,99,13,0,pharmacy,"['trade', 'news', 'a', '##gi', '##lent', 'technology', 'introduces', 'compact', 'scanning', 'electron', 'micro', '##scope', 'for', 'wide', 'use', 'research']",1
27589,nifty_113,2010-08-02,Media Registration for 9th Annual BIO Investor Forum Now Available Online,Neutral,-0.0048,73,medium registration for annual bio investor forum now available online,70,10,0,pharmacy,"['medium', 'registration', 'for', 'annual', 'bio', 'investor', 'forum', 'now', 'available', 'online']",1
27679,nifty_113,2010-08-02,"Cumberland Pharmaceuticals to Present at the Bank of America Merrill Lynch Specialty Pharmaceuticals Conference in Southampton, New York on August 13, 2010",Neutral,-0.0048,155,cumberland pharmaceutical present the bank america merrill lynch specialty pharmaceutical conference southampton new york august,128,15,0,pharmacy,"['cum', '##ber', '##land', 'pharmaceutical', 'present', 'the', 'bank', 'am', '##eric', '##a', 'me', '##rri', '##ll', 'l', '##ync', '##h', 'specialty', 'pharmaceutical', 'conference', 'south', '##amp', '##ton', 'new', 'yo', '##rk', 'au', '##gus', '##t']",1
28368,nifty_119,2010-08-11,Active Biotech: Active Biotech AB Interim report January - June 2010,Fall,-0.0061,68,active biotech active biotech interim report january june,57,8,0,pharmacy,"['active', 'bio', '##tech', 'active', 'bio', '##tech', 'interim', 'report', 'j', '##anu', '##ary', 'j', '##une']",1
28504,nifty_119,2010-08-11,Research and Markets: Updates on Vietnam's Medical Device Market,Fall,-0.0061,64,research and market update vietnam medical device market,56,8,0,pharmacy,"['research', 'and', 'market', 'update', 'v', '##iet', '##nam', 'medical', 'device', 'market']",1
28507,nifty_119,2010-08-11,"Research and Markets: Advances in Imaging Biomarkers: Innovative Technologies, Applications in R&D; and Clinical Practice, and Informatics and Regulatory Requirements",Fall,-0.0061,166,research and market advance imaging biomarkers innovative technology application and clinical practice and informatics and regulatory requirement,145,17,0,pharmacy,"['research', 'and', 'market', 'advance', 'imaging', 'bio', '##mark', '##ers', 'innovative', 'technology', 'application', 'and', 'clinical', 'practice', 'and', 'inform', '##atic', '##s', 'and', 'regulatory', 'requirement']",1
28532,nifty_119,2010-08-11,Research and Markets: Stakeholder Opinions: Ophthalmology - Leading Brands under Threat,Fall,-0.0061,87,research and market stakeholder opinion ophthalmology leading brand under threat,80,10,0,pharmacy,"['research', 'and', 'market', 'stake', '##holder', 'opinion', 'op', '##ht', '##hal', '##mology', 'leading', 'brand', 'under', 'threat']",1
28569,nifty_119,2010-08-11,Research and Markets: 2010 Guide to the Life Sciences Industry for Technology Providers: Overview of the Pharmaceutical and Biotechnology Sectors,Fall,-0.0061,145,research and market guide the life science industry for technology provider overview the pharmaceutical and biotechnology sector,128,17,0,pharmacy,"['research', 'and', 'market', 'guide', 'the', 'life', 'science', 'industry', 'for', 'technology', 'provider', 'overview', 'the', 'pharmaceutical', 'and', 'bio', '##tech', '##nology', 'sector']",1
28576,nifty_119,2010-08-11,RXi Pharmaceuticals Reports Financial Results for the Second Quarter of 2010,Fall,-0.0061,76,rxi pharmaceutical report financial result for the second quarter,65,9,0,pharmacy,"['r', '##xi', 'pharmaceutical', 'report', 'financial', 'result', 'for', 'the', 'second', 'quarter']",1
28588,nifty_119,2010-08-11, Stellar Pharmaceuticals Inc. to Present at Global Hunter Investor Conference,Fall,-0.0061,77,stellar pharmaceutical inc present global hunter investor conference,68,8,0,pharmacy,"['stellar', 'pharmaceutical', 'in', '##c', 'present', 'global', 'hunter', 'investor', 'conference']",1
28624,nifty_119,2010-08-11,"Owing to Generic Erosion of Key Agents Such as Effexor XR, Cymbalta/Xeristar, Cipralex/Seroplex and Lexapro, the Unipolar Depression Drug Market Will Decrease by Nearly 10 Percent in 2019",Fall,-0.0061,187,owing generic erosion key agent such effexor cymbalta xeristar cipralex seroplex and lexapro the unipolar depression drug market will decrease nearly percent,157,22,0,pharmacy,"['owing', 'generic', 'erosion', 'key', 'agent', 'such', 'e', '##ffe', '##x', '##or', 'c', '##ym', '##balt', '##a', 'x', '##eri', '##star', 'c', '##ip', '##ral', '##ex', 'se', '##rop', '##lex', 'and', 'le', '##xa', '##p', '##ro', 'the', 'un', '##ip', '##olar', 'depression', 'drug', 'market', 'will', 'decrease', 'nearly', 'percent']",1
28625,nifty_119,2010-08-11,UnitedHealth Group Poised to Capture New Covered Lives Resulting From Healthcare Reform by Focusing on Potential Acquisitions and Growth in Capacity,Fall,-0.0061,148,unitedhealth group poised capture new covered life resulting from healthcare reform focusing potential acquisition and growth capacity,134,17,0,pharmacy,"['united', '##hea', '##lt', '##h', 'group', 'poised', 'capture', 'new', 'covered', 'life', 'resulting', 'from', 'healthcare', 'reform', 'focusing', 'potential', 'acquisition', 'and', 'growth', 'capacity']",1
28639,nifty_119,2010-08-11, GeneNews Reports Second Quarter 2010 Financial Results,Fall,-0.0061,55,genenews report second quarter financial result,47,6,0,pharmacy,"['gene', '##ne', '##ws', 'report', 'second', 'quarter', 'financial', 'result']",1
28699,nifty_119,2010-08-11,Syndax Pharmaceuticals Raises $6 Million in Securities Offering,Fall,-0.0061,63,syndax pharmaceutical raise million security offering,53,6,0,pharmacy,"['s', '##yn', '##da', '##x', 'pharmaceutical', 'raise', 'million', 'security', 'offering']",1
28950,nifty_119,2010-08-11,"Research and Markets: Pharmaceutical Key Trends 2010 - Key Drivers and Resistors Facing Pharma, Biotech and Generics Players to 2014",Fall,-0.0061,132,research and market pharmaceutical key trend key driver and resistor facing pharma biotech and generic player,109,16,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'key', 'trend', 'key', 'driver', 'and', 'resist', '##or', 'facing', 'p', '##har', '##ma', 'bio', '##tech', 'and', 'generic', 'player']",1
28964,nifty_119,2010-08-11,Research and Markets: Top 500 Prescription Medicines 2010,Fall,-0.0061,57,research and market top prescription medicine,45,6,0,pharmacy,"['research', 'and', 'market', 'top', 'prescription', 'medicine']",1
29099,nifty_119,2010-08-11,"Research and Markets: Hip and Knee Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016",Fall,-0.0061,123,research and market hip and knee implant global pipeline analysis opportunity assessment and market forecast,108,15,0,pharmacy,"['research', 'and', 'market', 'hip', 'and', 'knee', 'imp', '##lant', 'global', 'pipeline', 'analysis', 'opportunity', 'assessment', 'and', 'market', 'forecast']",1
29103,nifty_119,2010-08-11,"Research and Markets: Insulin Pumps - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016",Fall,-0.0061,115,research and market insulin pump global pipeline analysis opportunity assessment and market forecast,100,13,0,pharmacy,"['research', 'and', 'market', 'insulin', 'pump', 'global', 'pipeline', 'analysis', 'opportunity', 'assessment', 'and', 'market', 'forecast']",1
29141,nifty_119,2010-08-11,'Inventing the Future' Will Explore Innovation in Healthcare,Fall,-0.0061,60,inventing the future will explore innovation healthcare,55,7,0,pharmacy,"['in', '##venting', 'the', 'future', 'will', 'explore', 'innovation', 'healthcare']",1
29224,nifty_119,2010-08-11,Swift Biosciences Announces $3 Million Series A Financing,Fall,-0.0061,57,swift bioscience announces million series financing,51,6,0,pharmacy,"['swift', 'bio', '##science', 'announces', 'million', 'series', 'financing']",1
29334,nifty_119,2010-08-11,Shengtai Pharmaceutical Retains DME Capital LLC to Implement Global Investor Relations Program,Fall,-0.0061,94,shengtai pharmaceutical retains dme capital llc implement global investor relation program,90,11,0,pharmacy,"['she', '##ng', '##tai', 'pharmaceutical', 'retains', 'd', '##me', 'capital', 'll', '##c', 'implement', 'global', 'investor', 'relation', 'program']",1
29560,nifty_121,2010-08-16,China Medical Technologies Reports First Fiscal Quarter Financial Results,Rise,0.0123,73,china medical technology report first fiscal quarter financial result,69,9,0,pharmacy,"['chin', '##a', 'medical', 'technology', 'report', 'first', 'fiscal', 'quarter', 'financial', 'result']",1
29564,nifty_121,2010-08-16,HID Global Targets North American RFID Market with Expanded Presence and Portfolio,Rise,0.0123,82,hid global target north american rfid market with expanded presence and portfolio,81,12,0,pharmacy,"['hid', 'global', 'target', 'north', 'am', '##eric', '##an', 'r', '##fi', '##d', 'market', 'with', 'expanded', 'presence', 'and', 'portfolio']",1
29819,nifty_121,2010-08-16,Lotus Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results,Rise,0.0123,74,lotus pharmaceutical report strong second quarter financial result,66,8,0,pharmacy,"['lot', '##us', 'pharmaceutical', 'report', 'strong', 'second', 'quarter', 'financial', 'result']",1
29826,nifty_121,2010-08-16,Cryo-Cell International to Explore Strategic Acquisition Opportunities,Rise,0.0123,70,cryo cell international explore strategic acquisition opportunity,65,7,0,pharmacy,"['cry', '##o', 'cell', 'international', 'explore', 'strategic', 'acquisition', 'opportunity']",1
29858,nifty_121,2010-08-16,Research and Markets: Medical Equipment Quarterly Deals Analysis: M&A; and Investments Trends - Q2 2010,Rise,0.0123,103,research and market medical equipment quarterly deal analysis and investment trend,82,11,0,pharmacy,"['research', 'and', 'market', 'medical', 'equipment', 'quarterly', 'deal', 'analysis', 'and', 'investment', 'trend']",1
29912,nifty_121,2010-08-16," Forbes Medi-Tech Provides Further Update on Revised Offer From Pharmachem Laboratories, Inc. and Announces Intention to",Rise,0.0123,120,forbes medi tech provides further update revised offer from pharmachem laboratory inc and announces intention,109,15,0,pharmacy,"['for', '##bes', 'me', '##di', 'tech', 'provides', 'further', 'update', 'revised', 'offer', 'from', 'p', '##har', '##ma', '##che', '##m', 'laboratory', 'in', '##c', 'and', 'announces', 'intention']",1
29914,nifty_121,2010-08-16,China Kangtai Cactus Biotech Q2 Revenue Up 34% to $8.7M; Net Income up 989% to $3M; First Half Year Revenue Up 45% to 14.3M; Net Income up 765% to $5.4M,Rise,0.0123,152,china kangtai cactus biotech revenue net income first half year revenue net income,82,13,0,pharmacy,"['chin', '##a', 'ka', '##ng', '##tai', 'ca', '##ctus', 'bio', '##tech', 'revenue', 'net', 'income', 'first', 'half', 'year', 'revenue', 'net', 'income']",1
29925,nifty_121,2010-08-16,Weikang Bio-Technology Reports Second Quarter 2010 Financial Results,Rise,0.0123,68,weikang bio technology report second quarter financial result,61,8,0,pharmacy,"['we', '##ika', '##ng', 'bio', 'technology', 'report', 'second', 'quarter', 'financial', 'result']",1
29949,nifty_121,2010-08-16, Global Bioinformatics Market Expected to Reach $8.3 Billion by 2014,Rise,0.0123,68,global bioinformatics market expected reach billion,51,6,0,pharmacy,"['global', 'bio', '##in', '##formatics', 'market', 'expected', 'reach', 'billion']",1
30003,nifty_121,2010-08-16,Research and Markets: Pipeline Insight: Inflammatory Bowel Disease - Varied Drug Targets to Broaden Future Therapy Options,Rise,0.0123,122,research and market pipeline insight inflammatory bowel disease varied drug target broaden future therapy option,112,15,0,pharmacy,"['research', 'and', 'market', 'pipeline', 'insight', 'inflammatory', 'bow', '##el', 'disease', 'varied', 'drug', 'target', 'broad', '##en', 'future', 'therapy', 'option']",1
30081,nifty_121,2010-08-16,Research and Markets: United Kingdom In Vitro Diagnostics Market Outlook to 2016,Rise,0.0123,80,research and market united kingdom vitro diagnostics market outlook,67,9,0,pharmacy,"['research', 'and', 'market', 'united', 'kingdom', 'v', '##it', '##ro', 'diagnostic', '##s', 'market', 'outlook']",1
30261,nifty_121,2010-08-16,Healthcare and Financial Leaders Collaborate on Industry White Paper,Rise,0.0123,68,healthcare and financial leader collaborate industry white paper,64,8,0,pharmacy,"['healthcare', 'and', 'financial', 'leader', 'collaborate', 'industry', 'white', 'paper']",1
30345,nifty_121,2010-08-16,BestWeek Asia/Pacific: Insurance a Key Player in China`s Health Care Reform,Rise,0.0123,75,bestweek asia pacific insurance key player china health care reform,67,10,0,pharmacy,"['best', '##week', 'as', '##ia', 'p', '##ac', '##ific', 'insurance', 'key', 'player', 'chin', '##a', 'health', 'care', 'reform']",1
30385,nifty_121,2010-08-16,BioTime Announces Second Quarter 2010 Financial Results and Recent Corporate Developments,Rise,0.0123,89,biotime announces second quarter financial result and recent corporate development,82,10,0,pharmacy,"['bio', '##time', 'announces', 'second', 'quarter', 'financial', 'result', 'and', 'recent', 'corporate', 'development']",1
30754,nifty_122,2010-08-17,Research and Markets: Pipeline and Commercial Insight: Insomnia - Future of Innovative Orexin Drug Class in Doubt,Neutral,0.0018,113,research and market pipeline and commercial insight insomnia future innovative orexin drug class doubt,102,14,0,pharmacy,"['research', 'and', 'market', 'pipeline', 'and', 'commercial', 'insight', 'ins', '##om', '##nia', 'future', 'innovative', 'ore', '##xin', 'drug', 'class', 'doubt']",1
30796,nifty_122,2010-08-17,Research and Markets: Healthcare Providers Guide to Telehealth (Best Practice Insights),Neutral,0.0018,87,research and market healthcare provider guide telehealth best practice insight,78,10,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'provider', 'guide', 'te', '##le', '##hea', '##lt', '##h', 'best', 'practice', 'insight']",1
30807,nifty_122,2010-08-17,"Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal...",Neutral,0.0018,88,elite pharmaceutical inc report financial result for the first quarter fiscal,77,11,0,pharmacy,"['elite', 'pharmaceutical', 'in', '##c', 'report', 'financial', 'result', 'for', 'the', 'first', 'quarter', 'fiscal']",1
30844,nifty_122,2010-08-17,"Decision Resources' Competitive Landscape Seminar Series: Biologics and Biosimilars on September 14, 2010 Will Help Pharmaceutical Companies Understand Market Opportunities for Biologics and Biosimilars",Neutral,0.0018,202,decision resource competitive landscape seminar series biologics and biosimilars september will help pharmaceutical company understand market opportunity for biologics and biosimilars,183,21,0,pharmacy,"['decision', 'resource', 'competitive', 'landscape', 'seminar', 'series', 'bio', '##log', '##ics', 'and', 'bio', '##si', '##mi', '##lars', 'se', '##pt', '##em', '##ber', 'will', 'help', 'pharmaceutical', 'company', 'understand', 'market', 'opportunity', 'for', 'bio', '##log', '##ics', 'and', 'bio', '##si', '##mi', '##lars']",1
30865,nifty_122,2010-08-17,Research and Markets: This Market Analysis Gives a Clear Overview of the Actual Situation and Future Outlook of the Medical Device Market in Malaysia,Neutral,0.0018,149,research and market this market analysis give clear overview the actual situation and future outlook the medical device market malaysia,135,20,0,pharmacy,"['research', 'and', 'market', 'this', 'market', 'analysis', 'give', 'clear', 'overview', 'the', 'actual', 'situation', 'and', 'future', 'outlook', 'the', 'medical', 'device', 'market', 'ma', '##lay', '##sia']",1
30867,nifty_122,2010-08-17,Research and Markets: This Market Analysis Gives a Clear Overview of the Actual Situation and Future Outlook of the Medical Device Market in Pakistan,Neutral,0.0018,149,research and market this market analysis give clear overview the actual situation and future outlook the medical device market pakistan,135,20,0,pharmacy,"['research', 'and', 'market', 'this', 'market', 'analysis', 'give', 'clear', 'overview', 'the', 'actual', 'situation', 'and', 'future', 'outlook', 'the', 'medical', 'device', 'market', 'p', '##aki', '##stan']",1
30994,nifty_122,2010-08-17,Research and Markets: Bristol-Myers Squibb Co.: PharmaVitae Profile,Neutral,0.0018,67,research and market bristol myers squibb pharmavitae profile,60,8,0,pharmacy,"['research', 'and', 'market', 'br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'p', '##har', '##ma', '##vi', '##ta', '##e', 'profile']",1
31115,nifty_122,2010-08-17,"Research and Markets: Meaningful Use of EHRs: The Good, the Bad and the Ugly (Analyst Insight)",Neutral,0.0018,94,research and market meaningful use ehrs the good the bad and the ugly analyst insight,85,15,0,pharmacy,"['research', 'and', 'market', 'meaningful', 'use', 'eh', '##rs', 'the', 'good', 'the', 'bad', 'and', 'the', 'ugly', 'analyst', 'insight']",1
31242,nifty_122,2010-08-17,Bio-Path Holdings Reports Fiscal 2010 Second Quarter Financial Results,Neutral,0.0018,70,bio path holding report fiscal second quarter financial result,62,9,0,pharmacy,"['bio', 'path', 'holding', 'report', 'fiscal', 'second', 'quarter', 'financial', 'result']",1
31313,nifty_122,2010-08-17,"Research and Markets: Every Other Month, Microbial Update International Gives You Eight Pages That Describe Approximately 10 Technologies under Development",Neutral,0.0018,155,research and market every other month microbial update international give you eight page that describe approximately technology under development,145,19,0,pharmacy,"['research', 'and', 'market', 'every', 'other', 'month', 'micro', '##bial', 'update', 'international', 'give', 'you', 'eight', 'page', 'that', 'describe', 'approximately', 'technology', 'under', 'development']",1
31407,nifty_122,2010-08-17,"Zacks Analyst Blog Highlights: Elan, Transition Therapeutics, Pfizer, Novartis AG, Johnson & Johnson and Forest Laboratories",Neutral,0.0018,124,zacks analyst blog highlight elan transition therapeutic pfizer novartis johnson johnson and forest laboratory,110,14,0,pharmacy,"['z', '##ack', '##s', 'analyst', 'blog', 'highlight', 'el', '##an', 'transition', 'therapeutic', 'p', '##fi', '##zer', 'no', '##var', '##tis', 'j', '##oh', '##nson', 'j', '##oh', '##nson', 'and', 'forest', 'laboratory']",1
31479,nifty_122,2010-08-17,Research and Markets: Medical Devices in Japan - A Clear Overview of the Actual Situation & Future Outlook of the Medical Device Market,Neutral,0.0018,135,research and market medical device japan clear overview the actual situation future outlook the medical device market,117,17,0,pharmacy,"['research', 'and', 'market', 'medical', 'device', 'j', '##apa', '##n', 'clear', 'overview', 'the', 'actual', 'situation', 'future', 'outlook', 'the', 'medical', 'device', 'market']",1
31490,nifty_122,2010-08-17,Research and Markets: Australia Pharmaceuticals and Healthcare Report Q3 2010,Neutral,0.0018,77,research and market australia pharmaceutical and healthcare report,66,8,0,pharmacy,"['research', 'and', 'market', 'au', '##stra', '##lia', 'pharmaceutical', 'and', 'healthcare', 'report']",1
31562,nifty_122,2010-08-17,Medco to Buy Drug Researcher,Neutral,0.0018,28,medco buy drug researcher,25,4,0,pharmacy,"['me', '##d', '##co', 'buy', 'drug', 'researcher']",1
31698,nifty_125,2010-08-23,"Gabelli Utility Trust, Jazz Pharmaceuticals: Biggest Price Decliners (GUT, JAZZ)",Fall,-0.0148,80,gabelli utility trust jazz pharmaceutical biggest price decliners gut jazz,74,10,0,pharmacy,"['g', '##abe', '##lli', 'utility', 'trust', 'jazz', 'pharmaceutical', 'biggest', 'price', 'decline', '##rs', 'gut', 'jazz']",1
31975,nifty_128,2010-08-26,"Research and Markets: Italian Pharmaceutical Market Analysis, 2010-2014",Rise,0.0155,71,research and market italian pharmaceutical market analysis,58,7,0,pharmacy,"['research', 'and', 'market', 'it', '##alia', '##n', 'pharmaceutical', 'market', 'analysis']",1
32006,nifty_128,2010-08-26,"Research and Markets: Examine the United Kingdom Pharmaceutical Market with This Essential Analysis and Forecast to 2014 As the Market Generated Total Revenues of $25,681.9 Million In 2009",Rise,0.0155,188,research and market examine the united kingdom pharmaceutical market with this essential analysis and forecast the market generated total revenue million,153,21,0,pharmacy,"['research', 'and', 'market', 'examine', 'the', 'united', 'kingdom', 'pharmaceutical', 'market', 'with', 'this', 'essential', 'analysis', 'and', 'forecast', 'the', 'market', 'generated', 'total', 'revenue', 'million']",1
32213,nifty_128,2010-08-26,"Research and Markets: Examine the US Pharmaceutical Market with This Essential Analysis and Forecast to 2014 As the Market Generated Total Revenues of $276,681.9 Million In 2009",Rise,0.0155,177,research and market examine the pharmaceutical market with this essential analysis and forecast the market generated total revenue million,138,19,0,pharmacy,"['research', 'and', 'market', 'examine', 'the', 'pharmaceutical', 'market', 'with', 'this', 'essential', 'analysis', 'and', 'forecast', 'the', 'market', 'generated', 'total', 'revenue', 'million']",1
32221,nifty_128,2010-08-26,Research and Markets: This Essential World Pharmaceutical Market Analysis Digest Guide with Forecasts Predicts the Market Will Stabilize the Years Up To 2014,Rise,0.0155,157,research and market this essential world pharmaceutical market analysis digest guide with forecast predicts the market will stabilize the year,142,20,0,pharmacy,"['research', 'and', 'market', 'this', 'essential', 'world', 'pharmaceutical', 'market', 'analysis', 'dig', '##est', 'guide', 'with', 'forecast', 'predict', '##s', 'the', 'market', 'will', 'stab', '##ilize', 'the', 'year']",1
32245,nifty_128,2010-08-26,Research and Markets: Examine the Europe Pharmaceutical Market with This Essential Analysis as the Market is Expected to Decelerate Followed by a Slow and Graduate Increase over the Years up to 2014 to Fluctuate over the Yea,Rise,0.0155,224,research and market examine the europe pharmaceutical market with this essential analysis the market expected decelerate followed slow and graduate increase over the year fluctuate over the yea,193,28,0,pharmacy,"['research', 'and', 'market', 'examine', 'the', 'euro', '##pe', 'pharmaceutical', 'market', 'with', 'this', 'essential', 'analysis', 'the', 'market', 'expected', 'de', '##cel', '##era', '##te', 'followed', 'slow', 'and', 'graduate', 'increase', 'over', 'the', 'year', 'flu', '##ct', '##uate', 'over', 'the', 'ye', '##a']",1
32275,nifty_128,2010-08-26,Research and Markets: This Comprehensive Global Biotechnology Industry Profile is an Essential Resource for Top-Level Data and Analysis,Rise,0.0155,135,research and market this comprehensive global biotechnology industry profile essential resource for top level data and analysis,127,17,0,pharmacy,"['research', 'and', 'market', 'this', 'comprehensive', 'global', 'bio', '##tech', '##nology', 'industry', 'profile', 'essential', 'resource', 'for', 'top', 'level', 'data', 'and', 'analysis']",1
32474,nifty_128,2010-08-26,Novartis to push ahead with disputed Alcon buyout,Rise,0.0155,49,novartis push ahead with disputed alcon buyout,46,7,0,pharmacy,"['no', '##var', '##tis', 'push', 'ahead', 'with', 'disputed', 'al', '##con', 'buy', '##out']",1
32489,nifty_128,2010-08-26,Research and Markets: Biomarkers: Applications and Trends - The Biomarker Discovery Segment is the Largest Revenue Generator,Rise,0.0155,124,research and market biomarkers application and trend the biomarker discovery segment the largest revenue generator,114,15,0,pharmacy,"['research', 'and', 'market', 'bio', '##mark', '##ers', 'application', 'and', 'trend', 'the', 'bio', '##mark', '##er', 'discovery', 'segment', 'the', 'largest', 'revenue', 'generator']",1
32490,nifty_128,2010-08-26,Research and Markets: Online Healthcare Empowers Consumers - Healthcare Providers are Beginning to Offer Their Services Online,Rise,0.0155,126,research and market online healthcare empowers consumer healthcare provider are beginning offer their service online,116,15,0,pharmacy,"['research', 'and', 'market', 'online', 'healthcare', 'em', '##power', '##s', 'consumer', 'healthcare', 'provider', 'are', 'beginning', 'offer', 'their', 'service', 'online']",1
32510,nifty_128,2010-08-26,Research and Markets: Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 2017,Rise,0.0155,93,research and market erectile dysfunction pipeline assessment and market forecast,80,10,0,pharmacy,"['research', 'and', 'market', 'erect', '##ile', 'd', '##ys', '##function', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
32520,nifty_128,2010-08-26,Research and Markets: Women's Infertility - Pipeline Assessment and Market Forecasts to 2017,Rise,0.0155,92,research and market woman infertility pipeline assessment and market forecast,77,10,0,pharmacy,"['research', 'and', 'market', 'woman', 'in', '##fer', '##tility', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
32543,nifty_128,2010-08-26,Research and Markets: France Opthalmic Devices Market Outlook to 2016,Rise,0.0155,69,research and market france opthalmic device market outlook,58,8,0,pharmacy,"['research', 'and', 'market', 'f', '##rance', 'op', '##thal', '##mic', 'device', 'market', 'outlook']",1
32555,nifty_128,2010-08-26,Research and Markets: Medical Equipment Monthly Deals Analysis: M&A; and Investments Trends 2010,Rise,0.0155,96,research and market medical equipment monthly deal analysis and investment trend,80,11,0,pharmacy,"['research', 'and', 'market', 'medical', 'equipment', 'monthly', 'deal', 'analysis', 'and', 'investment', 'trend']",1
32595,nifty_128,2010-08-26, Pharma Industry Ups Digital Ad Spending,Rise,0.0155,40,pharma industry ups digital spending,36,5,0,pharmacy,"['p', '##har', '##ma', 'industry', 'ups', 'digital', 'spending']",1
32638,nifty_128,2010-08-26,Luminex Announces Commercial Launch of New Cystic Fibrosis Test,Rise,0.0155,63,luminex announces commercial launch new cystic fibrosis test,60,8,0,pharmacy,"['l', '##umi', '##nex', 'announces', 'commercial', 'launch', 'new', 'c', '##ys', '##tic', 'fi', '##bro', '##sis', 'test']",1
32677,nifty_128,2010-08-26,Research and Markets: Bayer Ag-Detailed Product Pipeline 2010 Includes Detail on A Company's Deals And Alliances,Rise,0.0155,112,research and market bayer detailed product pipeline includes detail company deal and alliance,93,13,0,pharmacy,"['research', 'and', 'market', 'bay', '##er', 'detailed', 'product', 'pipeline', 'includes', 'detail', 'company', 'deal', 'and', 'alliance']",1
33409,nifty_134,2010-09-08,Research and Markets: Czech Republic Pharmaceuticals and Healthcare Q3 2010 - Independent Forecasts & Competitive Intelligence on the Industry,Neutral,0.0046,142,research and market czech republic pharmaceutical and healthcare independent forecast competitive intelligence the industry,123,14,0,pharmacy,"['research', 'and', 'market', 'c', '##ze', '##ch', 'republic', 'pharmaceutical', 'and', 'healthcare', 'independent', 'forecast', 'competitive', 'intelligence', 'the', 'industry']",1
33418,nifty_134,2010-09-08,"Kugman Partners Acts as Financial Advisor to Allan Holdings, LLC/Pharma Pac and Pro Derma, LLC",Neutral,0.0046,94,kugman partner act financial advisor allan holding llc pharma pac and pro derma llc,83,14,0,pharmacy,"['k', '##ug', '##man', 'partner', 'act', 'financial', 'advisor', 'all', '##an', 'holding', 'll', '##c', 'p', '##har', '##ma', 'p', '##ac', 'and', 'pro', 'der', '##ma', 'll', '##c']",1
33499,nifty_134,2010-09-08,PDL BioPharma to Present at Upcoming Investor Conferences,Neutral,0.0046,57,pdl biopharma present upcoming investor conference,50,6,0,pharmacy,"['p', '##dl', 'bio', '##pha', '##rma', 'present', 'upcoming', 'investor', 'conference']",1
33503,nifty_134,2010-09-08,"Cardiogenesis Executive Chairman Paul J. McCormick Updates Commercial and Regulatory Progress in Interview With Wall Street Reporter, Available Online",Neutral,0.0046,150,cardiogenesis executive chairman paul mccormick update commercial and regulatory progress interview with wall street reporter available online,142,17,0,pharmacy,"['card', '##io', '##genesis', 'executive', 'chairman', 'p', '##aul', 'm', '##cco', '##rm', '##ick', 'update', 'commercial', 'and', 'regulatory', 'progress', 'interview', 'with', 'wall', 'street', 'reporter', 'available', 'online']",1
33512,nifty_134,2010-09-08,"BioDelivery Sciences to Present at Rodman & Renshaw, Baird, and Stifel Nicolaus Investor Conferences",Neutral,0.0046,100,biodelivery science present rodman renshaw baird and stifel nicolaus investor conference,88,11,0,pharmacy,"['bio', '##del', '##iver', '##y', 'science', 'present', 'rod', '##man', 're', '##ns', '##haw', 'b', '##air', '##d', 'and', 's', '##ti', '##fe', '##l', 'ni', '##cola', '##us', 'investor', 'conference']",1
33552,nifty_134,2010-09-08,Celgene Corporation to Present at Four Upcoming Investor Conferences,Neutral,0.0046,68,celgene corporation present four upcoming investor conference,61,7,0,pharmacy,"['c', '##el', '##gene', 'corporation', 'present', 'four', 'upcoming', 'investor', 'conference']",1
33687,nifty_134,2010-09-08,Access Pharmaceuticals to Present At Rodman & Renshaw Annual Global Investment Conference in New York City,Neutral,0.0046,106,access pharmaceutical present rodman renshaw annual global investment conference new york city,94,12,0,pharmacy,"['access', 'pharmaceutical', 'present', 'rod', '##man', 're', '##ns', '##haw', 'annual', 'global', 'investment', 'conference', 'new', 'yo', '##rk', 'city']",1
33702,nifty_134,2010-09-08, Mediware Delivers Record Revenue and Doubles Earnings in FY 2010,Neutral,0.0046,65,mediware delivers record revenue and double earnings,52,7,0,pharmacy,"['me', '##di', '##ware', 'delivers', 'record', 'revenue', 'and', 'double', 'earnings']",1
33730,nifty_134,2010-09-08,Research and Markets: Cell Culture Life Science Dashboard Series 3 - Examining the Characteristics & Dynamics of the Market for Cell Culture Products,Neutral,0.0046,149,research and market cell culture life science dashboard series examining the characteristic dynamic the market for cell culture product,135,19,0,pharmacy,"['research', 'and', 'market', 'cell', 'culture', 'life', 'science', 'dash', '##board', 'series', 'examining', 'the', 'characteristic', 'dynamic', 'the', 'market', 'for', 'cell', 'culture', 'product']",1
33805,nifty_134,2010-09-08,Dyadic International and EnGen Bio to Present at Rodman & Renshaw Annual Global Investment Conference,Neutral,0.0046,101,dyadic international and engen bio present rodman renshaw annual global investment conference,93,12,0,pharmacy,"['d', '##ya', '##dic', 'international', 'and', 'en', '##gen', 'bio', 'present', 'rod', '##man', 're', '##ns', '##haw', 'annual', 'global', 'investment', 'conference']",1
33809,nifty_134,2010-09-08,"Pharmaceutical Industry Insiders, VIPs All Coming Together for Future of Pharma Market, Pharmaceutical Competitive Intelligence",Neutral,0.0046,127,pharmaceutical industry insider vip all coming together for future pharma market pharmaceutical competitive intelligence,120,14,0,pharmacy,"['pharmaceutical', 'industry', 'inside', '##r', 'v', '##ip', 'all', 'coming', 'together', 'for', 'future', 'p', '##har', '##ma', 'market', 'pharmaceutical', 'competitive', 'intelligence']",1
33818,nifty_134,2010-09-08,BioNeutral Group Inc. to Present at the Rodman & Renshaw 12th Annual Global Investment...,Neutral,0.0046,89,bioneutral group inc present the rodman renshaw annual global investment,72,10,0,pharmacy,"['bio', '##ne', '##ut', '##ral', 'group', 'in', '##c', 'present', 'the', 'rod', '##man', 're', '##ns', '##haw', 'annual', 'global', 'investment']",1
33849,nifty_134,2010-09-08,Research and Markets: Japanese Drug Sector: Sector Report,Neutral,0.0046,57,research and market japanese drug sector sector report,54,8,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##nese', 'drug', 'sector', 'sector', 'report']",1
33885,nifty_134,2010-09-08," Healthcare Growth in Emerging Markets Driven by Awareness, Affordability and Access",Neutral,0.0046,84,healthcare growth emerging market driven awareness affordability and access,75,9,0,pharmacy,"['healthcare', 'growth', 'emerging', 'market', 'driven', 'awareness', 'afford', '##ability', 'and', 'access']",1
33952,nifty_134,2010-09-08, Pacific Biomarkers Featured in September 1 Issue of Genetic Engineering & Biotechnology News,Neutral,0.0046,93,pacific biomarkers featured september issue genetic engineering biotechnology news,82,9,0,pharmacy,"['p', '##ac', '##ific', 'bio', '##mark', '##ers', 'featured', 'se', '##pt', '##em', '##ber', 'issue', 'genetic', 'engineering', 'bio', '##tech', '##nology', 'news']",1
33976,nifty_134,2010-09-08, Hospital Information Systems (HIS) Market to Reach $18 Billion in 2016,Neutral,0.0046,71,hospital information system his market reach billion,52,7,0,pharmacy,"['hospital', 'information', 'system', 'his', 'market', 'reach', 'billion']",1
34000,nifty_134,2010-09-08,Research and Markets: The CenterWatch Monthly Subscription - Authoritative Business Coverage for the Clinical Trials Community,Neutral,0.0046,126,research and market the centerwatch monthly subscription authoritative business coverage for the clinical trial community,121,15,0,pharmacy,"['research', 'and', 'market', 'the', 'center', '##watch', 'monthly', 'subscription', 'authoritative', 'business', 'coverage', 'for', 'the', 'clinical', 'trial', 'community']",1
34144,nifty_134,2010-09-08,Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts,Neutral,0.0046,109,lotus pharmaceutical announces engagement redchip company lead public and investor relation effort,98,12,0,pharmacy,"['lot', '##us', 'pharmaceutical', 'announces', 'engagement', 'red', '##chi', '##p', 'company', 'lead', 'public', 'and', 'investor', 'relation', 'effort']",1
34273,nifty_134,2010-09-08,Idera Pharmaceuticals to Present at Upcoming Investor Conferences,Neutral,0.0046,65,idera pharmaceutical present upcoming investor conference,57,6,0,pharmacy,"['id', '##era', 'pharmaceutical', 'present', 'upcoming', 'investor', 'conference']",1
34296,nifty_134,2010-09-08,Gilead Sciences to Present at Two Upcoming Investor Conferences,Neutral,0.0046,63,gilead science present two upcoming investor conference,55,7,0,pharmacy,"['g', '##ile', '##ad', 'science', 'present', 'two', 'upcoming', 'investor', 'conference']",1
34299,nifty_134,2010-09-08,Infinity Pharmaceuticals to Present at Two Upcoming Conferences,Neutral,0.0046,63,infinity pharmaceutical present two upcoming conference,55,6,0,pharmacy,"['in', '##finity', 'pharmaceutical', 'present', 'two', 'upcoming', 'conference']",1
34673,nifty_138,2010-09-15,Pronova BioPharma ASA: Marketing authorization in Mexico increases Pronova BioPharma's growth potential,Neutral,-0.0003,103,pronova biopharma asa marketing authorization mexico increase pronova biopharma growth potential,96,11,0,pharmacy,"['pro', '##nova', 'bio', '##pha', '##rma', 'as', '##a', 'marketing', 'authorization', 'me', '##xi', '##co', 'increase', 'pro', '##nova', 'bio', '##pha', '##rma', 'growth', 'potential']",1
34687,nifty_138,2010-09-15,Addex Pharmaceuticals: Addex Pharmaceuticals Raises CHF20 Million from Biotechnology Value Fund,Neutral,-0.0003,95,addex pharmaceutical addex pharmaceutical raise chf million from biotechnology value fund,89,11,0,pharmacy,"['add', '##ex', 'pharmaceutical', 'add', '##ex', 'pharmaceutical', 'raise', 'ch', '##f', 'million', 'from', 'bio', '##tech', '##nology', 'value', 'fund']",1
34690,nifty_138,2010-09-15, Addex Pharmaceuticals Raises CHF20 Million from Biotechnology Value Fund,Neutral,-0.0003,73,addex pharmaceutical raise chf million from biotechnology value fund,68,9,0,pharmacy,"['add', '##ex', 'pharmaceutical', 'raise', 'ch', '##f', 'million', 'from', 'bio', '##tech', '##nology', 'value', 'fund']",1
34976,nifty_138,2010-09-15,Research and Markets: This Special Focus Issue of the Journal Regenerative Medicine Aims to Shed Light on the Real Potential of iPS Cells as an Alternative to Embryonic Stem Cells,Neutral,-0.0003,179,research and market this special focus issue the journal regenerative medicine aim shed light the real potential ip cell alternative embryonic stem cell,152,23,0,pharmacy,"['research', 'and', 'market', 'this', 'special', 'focus', 'issue', 'the', 'journal', 're', '##gene', '##rative', 'medicine', 'aim', 'shed', 'light', 'the', 'real', 'potential', 'i', '##p', 'cell', 'alternative', 'em', '##b', '##ryo', '##nic', 'stem', 'cell']",1
34988,nifty_138,2010-09-15,PDL BioPharma to Present at Upcoming Investor Conferences,Neutral,-0.0003,57,pdl biopharma present upcoming investor conference,50,6,0,pharmacy,"['p', '##dl', 'bio', '##pha', '##rma', 'present', 'upcoming', 'investor', 'conference']",1
35209,nifty_138,2010-09-15,Polydex Pharmaceuticals Issues Second Quarter Financial Results,Neutral,-0.0003,63,polydex pharmaceutical issue second quarter financial result,60,7,0,pharmacy,"['p', '##oly', '##de', '##x', 'pharmaceutical', 'issue', 'second', 'quarter', 'financial', 'result']",1
35351,nifty_138,2010-09-15,"Research and Markets: Rochester, NY Market Overview 2010 Answers Very Important Questions in the Healthcare Field",Neutral,-0.0003,113,research and market rochester market overview answer very important question the healthcare field,97,13,0,pharmacy,"['research', 'and', 'market', 'r', '##och', '##ester', 'market', 'overview', 'answer', 'very', 'important', 'question', 'the', 'healthcare', 'field']",1
35467,nifty_138,2010-09-15,Research and Markets: Australian Drug Sector: Sector Report,Neutral,-0.0003,59,research and market australian drug sector sector report,56,8,0,pharmacy,"['research', 'and', 'market', 'au', '##stra', '##lian', 'drug', 'sector', 'sector', 'report']",1
35475,nifty_138,2010-09-15,Research and Markets: 2010 IT Spending Predictor for the Top 10 Companies in the US Healthcare Industry,Neutral,-0.0003,103,research and market spending predictor for the top company the healthcare industry,82,12,0,pharmacy,"['research', 'and', 'market', 'spending', 'predict', '##or', 'for', 'the', 'top', 'company', 'the', 'healthcare', 'industry']",1
35582,nifty_138,2010-09-15,Research and Markets: Knowledge-Based Bioinformatics: Fundamental Aspects from Analysis to Interpretation,Neutral,-0.0003,105,research and market knowledge based bioinformatics fundamental aspect from analysis interpretation,98,11,0,pharmacy,"['research', 'and', 'market', 'knowledge', 'based', 'bio', '##in', '##formatics', 'fundamental', 'aspect', 'from', 'analysis', 'interpretation']",1
35611,nifty_138,2010-09-15,Research and Markets: Chemokine Receptors as Drug Targets,Neutral,-0.0003,57,research and market chemokine receptor drug target,50,7,0,pharmacy,"['research', 'and', 'market', 'ch', '##em', '##oki', '##ne', 'receptor', 'drug', 'target']",1
35717,nifty_138,2010-09-15,BIO Announces Plenary Sessions and Business Roundtables Featured at 9th Annual BIO Investor Forum,Neutral,-0.0003,97,bio announces plenary session and business roundtable featured annual bio investor forum,88,12,0,pharmacy,"['bio', 'announces', 'p', '##lena', '##ry', 'session', 'and', 'business', 'round', '##table', 'featured', 'annual', 'bio', 'investor', 'forum']",1
35787,nifty_138,2010-09-15," The Drug-Resistant Medical Travel NDM-1 ""Superbug"" Is Growing, Says Online Medical Tourism Agency Health Options",Neutral,-0.0003,113,the drug resistant medical travel ndm superbug growing say online medical tourism agency health option,102,15,0,pharmacy,"['the', 'drug', 'resistant', 'medical', 'travel', 'n', '##d', '##m', 'superb', '##ug', 'growing', 'say', 'online', 'medical', 'tourism', 'agency', 'health', 'option']",1
35939,nifty_139,2010-09-16,New diet drug faces U.S. advisers amid risk debate,Neutral,-0.005,50,new diet drug face adviser amid risk debate,43,8,0,pharmacy,"['new', 'diet', 'drug', 'face', 'adviser', 'amid', 'risk', 'debate']",1
36165,nifty_139,2010-09-16," BioCentury Partners with CBS Affiliate in Washington. D.C.; Biotech Show Joins ""Sunday Power Block"" TV Lineup",Neutral,-0.005,110,biocentury partner with cbs affiliate washington biotech show join sunday power block lineup,92,13,0,pharmacy,"['bio', '##cent', '##ury', 'partner', 'with', 'c', '##bs', 'affiliate', 'washing', '##ton', 'bio', '##tech', 'show', 'join', 'sun', '##day', 'power', 'block', 'lineup']",1
36179,nifty_139,2010-09-16,New In-demand Healthcare Equipment & Services Market Reports Added by MarketPublishers.com,Neutral,-0.005,90,new demand healthcare equipment service market report added marketpublishers com,80,10,0,pharmacy,"['new', 'demand', 'healthcare', 'equipment', 'service', 'market', 'report', 'added', 'market', '##pu', '##b', '##lish', '##ers', 'com']",1
36609,nifty_139,2010-09-16,"Research and Markets: Nitric Oxide - Therapeutics, Markets and Companies",Neutral,-0.005,72,research and market nitric oxide therapeutic market and company,63,9,0,pharmacy,"['research', 'and', 'market', 'ni', '##tric', 'oxide', 'therapeutic', 'market', 'and', 'company']",1
36640,nifty_139,2010-09-16,"Research and Markets: Biomarkers - Technologies, Markets and Companies",Neutral,-0.005,70,research and market biomarkers technology market and company,60,8,0,pharmacy,"['research', 'and', 'market', 'bio', '##mark', '##ers', 'technology', 'market', 'and', 'company']",1
36653,nifty_139,2010-09-16,Research and Markets: Contemporary Clinical Psychology 3rd Edition - A Realistic & Contemporary Portrayal of the Dynamic Field of Clinical Psychology,Neutral,-0.005,149,research and market contemporary clinical psychology edition realistic contemporary portrayal the dynamic field clinical psychology,131,15,0,pharmacy,"['research', 'and', 'market', 'contemporary', 'clinical', 'psychology', 'edition', 'realistic', 'contemporary', 'portrayal', 'the', 'dynamic', 'field', 'clinical', 'psychology']",1
36655,nifty_139,2010-09-16,"Research and Markets: Biomarkers: In Medicine, Drug Discovery, and Environmental Health",Neutral,-0.005,87,research and market biomarkers medicine drug discovery and environmental health,79,10,0,pharmacy,"['research', 'and', 'market', 'bio', '##mark', '##ers', 'medicine', 'drug', 'discovery', 'and', 'environmental', 'health']",1
36701,nifty_139,2010-09-16,Research and Markets: Emerging Cancer Therapy: Microbial Approaches and Biotechnological Tools 2010 Edition Out Today,Neutral,-0.005,117,research and market emerging cancer therapy microbial approach and biotechnological tool edition out today,106,14,0,pharmacy,"['research', 'and', 'market', 'emerging', 'cancer', 'therapy', 'micro', '##bial', 'approach', 'and', 'bio', '##tech', '##nological', 'tool', 'edition', 'out', 'today']",1
36708,nifty_139,2010-09-16,Research and Markets: Bipolar Disorder: Clinical and Neurobiological Foundations,Neutral,-0.005,80,research and market bipolar disorder clinical and neurobiological foundation,76,9,0,pharmacy,"['research', 'and', 'market', 'bi', '##pol', '##ar', 'disorder', 'clinical', 'and', 'ne', '##uro', '##bio', '##logical', 'foundation']",1
36773,nifty_139,2010-09-16,"Research and Markets: Bulgaria Pharmaceuticals and Healthcare Report Q4 2010 - In June 2010, Major Pharmaceutical Companies in Bulgaria Registered A 14% Year-On-Year Increase",Neutral,-0.005,174,research and market bulgaria pharmaceutical and healthcare report june major pharmaceutical company bulgaria registered year year increase,138,17,0,pharmacy,"['research', 'and', 'market', 'b', '##ul', '##gar', '##ia', 'pharmaceutical', 'and', 'healthcare', 'report', 'j', '##une', 'major', 'pharmaceutical', 'company', 'b', '##ul', '##gar', '##ia', 'registered', 'year', 'year', 'increase']",1
36792,nifty_139,2010-09-16,Research and Markets: Telecom Industry Health Check (2Q10): Financial Deals Tracker Out Now,Neutral,-0.005,91,research and market telecom industry health check financial deal tracker out now,80,12,0,pharmacy,"['research', 'and', 'market', 'te', '##le', '##com', 'industry', 'health', 'check', 'financial', 'deal', 'track', '##er', 'out', 'now']",1
36877,nifty_139,2010-09-16,Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at UBS Healthcare Conference,Neutral,-0.005,105,human genome science invite investor listen webcast presentation ubs healthcare conference,90,11,0,pharmacy,"['human', 'genome', 'science', 'invite', 'investor', 'listen', 'web', '##cast', 'presentation', 'u', '##bs', 'healthcare', 'conference']",1
36930,nifty_139,2010-09-16,"Cell Therapeutics, Inc. Reports Outcome of Annual Meeting of Shareholders",Neutral,-0.005,73,cell therapeutic inc report outcome annual meeting shareholder,62,8,0,pharmacy,"['cell', 'therapeutic', 'in', '##c', 'report', 'outcome', 'annual', 'meeting', 'shareholder']",1
36994,nifty_139,2010-09-16,UPDATE 5-US advisers reject Arena diet drug; shares plunge,Neutral,-0.005,58,update adviser reject arena diet drug share plunge,50,8,0,pharmacy,"['update', 'adviser', 'reject', 'arena', 'diet', 'drug', 'share', 'p', '##lung', '##e']",1
36995,nifty_139,2010-09-16,U.S. advisers reject Arena diet drug; shares plunge,Neutral,-0.005,51,adviser reject arena diet drug share plunge,43,7,0,pharmacy,"['adviser', 'reject', 'arena', 'diet', 'drug', 'share', 'p', '##lung', '##e']",1
37355,nifty_141,2010-09-21,Research and Markets: Singapore Pharmaceutical Industry - 2H10 Report,Neutral,-0.0049,69,research and market singapore pharmaceutical industry report,60,7,0,pharmacy,"['research', 'and', 'market', 'sing', '##ap', '##ore', 'pharmaceutical', 'industry', 'report']",1
37396,nifty_141,2010-09-21,Pharmaceutical Markets Covered in New Research Reports Published at MarketPublishers.com,Neutral,-0.0049,88,pharmaceutical market covered new research report published marketpublishers com,80,9,0,pharmacy,"['pharmaceutical', 'market', 'covered', 'new', 'research', 'report', 'published', 'market', '##pu', '##b', '##lish', '##ers', 'com']",1
37417,nifty_141,2010-09-21,Research and Markets: Korea Diabetes Management Devices Market Assessment and Forecasts to 2015,Neutral,-0.0049,95,research and market korea diabetes management device market assessment and forecast,83,11,0,pharmacy,"['research', 'and', 'market', 'k', '##ore', '##a', 'diabetes', 'management', 'device', 'market', 'assessment', 'and', 'forecast']",1
37452,nifty_141,2010-09-21, Allied Healthcare International Inc. to Present at the Jefferies 2010 Global SpecPharma and European Healthcare,Neutral,-0.0049,112,allied healthcare international inc present the jefferies global specpharma and european healthcare,99,12,0,pharmacy,"['allied', 'healthcare', 'international', 'in', '##c', 'present', 'the', 'j', '##ef', '##fer', '##ies', 'global', 's', '##pec', '##pha', '##rma', 'and', 'euro', '##pe', '##an', 'healthcare']",1
37507,nifty_141,2010-09-21,Research and Markets: Biomarkers: Discovery Techniques and Applications - A Global Market Overview,Neutral,-0.0049,98,research and market biomarkers discovery technique and application global market overview,89,11,0,pharmacy,"['research', 'and', 'market', 'bio', '##mark', '##ers', 'discovery', 'technique', 'and', 'application', 'global', 'market', 'overview']",1
37620,nifty_141,2010-09-21,Research and Markets: This New 2010 Report Offers Complete Coverage of Tactical and Strategic Trends for the Global Industrial/Medical Electronics and Semiconductor Markets to 2015,Neutral,-0.0049,180,research and market this new report offer complete coverage tactical and strategic trend for the global industrial medical electronics and semiconductor market,159,22,0,pharmacy,"['research', 'and', 'market', 'this', 'new', 'report', 'offer', 'complete', 'coverage', 'tactical', 'and', 'strategic', 'trend', 'for', 'the', 'global', 'industrial', 'medical', 'electronics', 'and', 'semi', '##conductor', 'market']",1
37630,nifty_141,2010-09-21,Research and Markets: Tactical Analysis of the World Industrial/Medical Electronics Market & Supply Chain - 2010 Edition,Neutral,-0.0049,120,research and market tactical analysis the world industrial medical electronics market supply chain edition,106,14,0,pharmacy,"['research', 'and', 'market', 'tactical', 'analysis', 'the', 'world', 'industrial', 'medical', 'electronics', 'market', 'supply', 'chain', 'edition']",1
37655,nifty_141,2010-09-21,Intermountain Healthcare Selects CA Technologies as IT Management Partner to Support Enterprise IT Transformation Initiative Across its Healthcare System,Neutral,-0.0049,153,intermountain healthcare selects technology management partner support enterprise transformation initiative across it healthcare system,135,14,0,pharmacy,"['inter', '##mount', '##ain', 'healthcare', 'select', '##s', 'technology', 'management', 'partner', 'support', 'enterprise', 'transformation', 'initiative', 'across', 'it', 'healthcare', 'system']",1
37809,nifty_141,2010-09-21, Men's Heath Market to Reach $4 Billion by 2016,Neutral,-0.0049,47,men heath market reach billion,30,5,0,pharmacy,"['men', 'heat', '##h', 'market', 'reach', 'billion']",1
37884,nifty_141,2010-09-21,Research and Markets: Strategies for Building Biologics Capabilities and Franchises,Neutral,-0.0049,83,research and market strategy for building biologics capability and franchise,76,10,0,pharmacy,"['research', 'and', 'market', 'strategy', 'for', 'building', 'bio', '##log', '##ics', 'capability', 'and', 'franchise']",1
37886,nifty_141,2010-09-21,Research and Markets: MRSA Drug Futures - Three New Products Expected to Launch From 2011 Will Add US$1.1 Billion to the Sectors Value,Neutral,-0.0049,134,research and market mrsa drug future three new product expected launch from will add billion the sector value,109,18,0,pharmacy,"['research', 'and', 'market', 'm', '##rsa', 'drug', 'future', 'three', 'new', 'product', 'expected', 'launch', 'from', 'will', 'add', 'billion', 'the', 'sector', 'value']",1
37887,nifty_141,2010-09-21,Research and Markets: Healthcare IT Market Outlook in Canada to 2016 - Hospital Information Systems and Medical Imaging Information Systems,Neutral,-0.0049,139,research and market healthcare market outlook canada hospital information system and medical imaging information system,119,15,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'market', 'outlook', 'can', '##ada', 'hospital', 'information', 'system', 'and', 'medical', 'imaging', 'information', 'system']",1
37906,nifty_141,2010-09-21,MedExpress Urgent Care Welcomes Growth Capital Investment,Neutral,-0.0049,57,medexpress urgent care welcome growth capital investment,56,7,0,pharmacy,"['me', '##de', '##x', '##press', 'urgent', 'care', 'welcome', 'growth', 'capital', 'investment']",1
37932,nifty_141,2010-09-21,"Research and Markets: Pittsburgh, PA Market Overview - Which Suburb Will Be Home To A New $250 Million Acute-Care Facility In 2012?",Neutral,-0.0049,131,research and market pittsburgh market overview which suburb will home new million acute care facility,101,15,0,pharmacy,"['research', 'and', 'market', 'pit', '##ts', '##burgh', 'market', 'overview', 'which', 'suburb', 'will', 'home', 'new', 'million', 'acute', 'care', 'facility']",1
37969,nifty_141,2010-09-21,Research and Markets: Global In Vitro Diagnostics (IVD) Market Trends and Future Forecasts from 2009 Through to 2014,Neutral,-0.0049,116,research and market global vitro diagnostics ivd market trend and future forecast from through,94,14,0,pharmacy,"['research', 'and', 'market', 'global', 'v', '##it', '##ro', 'diagnostic', '##s', 'i', '##v', '##d', 'market', 'trend', 'and', 'future', 'forecast', 'from', 'through']",1
37992,nifty_141,2010-09-21,Research and Markets: The Impact of US Healthcare Reform on Pharma: Analyzing the Effects,Neutral,-0.0049,89,research and market the impact healthcare reform pharma analyzing the effect,76,11,0,pharmacy,"['research', 'and', 'market', 'the', 'impact', 'healthcare', 'reform', 'p', '##har', '##ma', 'analyzing', 'the', 'effect']",1
38274,nifty_141,2010-09-21,Research and Markets: Healthcare IT Market Outlook in New Zealand to 2016 - Hospital Information Systems and Medical Imaging Information Systems,Neutral,-0.0049,144,research and market healthcare market outlook new zealand hospital information system and medical imaging information system,124,16,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'market', 'outlook', 'new', 'z', '##eal', '##and', 'hospital', 'information', 'system', 'and', 'medical', 'imaging', 'information', 'system']",1
38549,nifty_142,2010-09-22,Inovio Pharmaceuticals to Present at Investor Conferences In New York and San Francisco,Fall,-0.0081,87,inovio pharmaceutical present investor conference new york and san francisco,76,10,0,pharmacy,"['in', '##ov', '##io', 'pharmaceutical', 'present', 'investor', 'conference', 'new', 'yo', '##rk', 'and', 'sa', '##n', 'f', '##ran', '##cis', '##co']",1
38671,nifty_142,2010-09-22,Research and Markets: Practical Gastroenterology and Hepatology: Small and Large Intestine and Pancreas,Fall,-0.0081,103,research and market practical gastroenterology and hepatology small and large intestine and pancreas,100,13,0,pharmacy,"['research', 'and', 'market', 'practical', 'gas', '##tro', '##enter', '##ology', 'and', 'he', '##pa', '##tology', 'small', 'and', 'large', 'in', '##test', '##ine', 'and', 'pan', '##cre', '##as']",1
38703,nifty_142,2010-09-22,Research and Markets: Practical Gastroenterology and Hepatology: Esophagus and Stomach,Fall,-0.0081,86,research and market practical gastroenterology and hepatology esophagus and stomach,83,10,0,pharmacy,"['research', 'and', 'market', 'practical', 'gas', '##tro', '##enter', '##ology', 'and', 'he', '##pa', '##tology', 'es', '##op', '##ha', '##gus', 'and', 'stomach']",1
38730,nifty_142,2010-09-22,Aeterna Zentaris to Present at Upcoming Sachs 10th Annual Biotech Europe Investment Forum on September 29,Fall,-0.0081,105,aeterna zentaris present upcoming sachs annual biotech europe investment forum september,88,11,0,pharmacy,"['a', '##eter', '##na', 'z', '##ent', '##aris', 'present', 'upcoming', 'sa', '##chs', 'annual', 'bio', '##tech', 'euro', '##pe', 'investment', 'forum', 'se', '##pt', '##em', '##ber']",1
38755,nifty_142,2010-09-22,Research and Markets: Clinician's Guide to Post-traumatic Stress Disorder,Fall,-0.0081,73,research and market clinician guide post traumatic stress disorder,66,9,0,pharmacy,"['research', 'and', 'market', 'clinic', '##ian', 'guide', 'post', 'traumatic', 'stress', 'disorder']",1
38765,nifty_142,2010-09-22,"STOCKS NEWS EUROPE-Merck KGaA down, Novartis drug approval",Fall,-0.0081,58,stock news europe merck kgaa down novartis drug approval,56,9,0,pharmacy,"['stock', 'news', 'euro', '##pe', 'me', '##rc', '##k', 'kg', '##aa', 'down', 'no', '##var', '##tis', 'drug', 'approval']",1
38799,nifty_142,2010-09-22,Research and Markets: Practical Gastroenterology and Hepatology: Liver and Biliary Disease,Fall,-0.0081,90,research and market practical gastroenterology and hepatology liver and biliary disease,87,11,0,pharmacy,"['research', 'and', 'market', 'practical', 'gas', '##tro', '##enter', '##ology', 'and', 'he', '##pa', '##tology', 'liver', 'and', 'bi', '##lia', '##ry', 'disease']",1
38850,nifty_142,2010-09-22,Syndax Pharmaceuticals to Present at Sachs Biotech in Europe Investor Forum,Fall,-0.0081,75,syndax pharmaceutical present sachs biotech europe investor forum,65,8,0,pharmacy,"['s', '##yn', '##da', '##x', 'pharmaceutical', 'present', 'sa', '##chs', 'bio', '##tech', 'euro', '##pe', 'investor', 'forum']",1
38872,nifty_142,2010-09-22,Cellectis Unveils Its New Corporate Website,Fall,-0.0081,43,cellectis unveils it new corporate website,42,6,0,pharmacy,"['cell', '##ec', '##tis', 'un', '##ve', '##ils', 'it', 'new', 'corporate', 'website']",1
38881,nifty_142,2010-09-22,"Research and Markets: Clinical Data Management 2010 Summit - 19 October, 2010, ITC Maratha, Mumbai, India - Register Now",Fall,-0.0081,120,research and market clinical data management summit october itc maratha mumbai india register now,97,14,0,pharmacy,"['research', 'and', 'market', 'clinical', 'data', 'management', 'summit', 'o', '##ct', '##obe', '##r', 'it', '##c', 'ma', '##rat', '##ha', 'mum', '##ba', '##i', 'in', '##dia', 'register', 'now']",1
39043,nifty_142,2010-09-22,Research and Markets: US Biotechnology Sector Report: 1500 Companies such as Amgen and Genzyme with Combined Annual Revenue of $90 Billion,Fall,-0.0081,138,research and market biotechnology sector report company such amgen and genzyme with combined annual revenue billion,115,16,0,pharmacy,"['research', 'and', 'market', 'bio', '##tech', '##nology', 'sector', 'report', 'company', 'such', 'am', '##gen', 'and', 'g', '##en', '##zy', '##me', 'with', 'combined', 'annual', 'revenue', 'billion']",1
39157,nifty_142,2010-09-22,TAXIS Pharmaceuticals Moves to High-Tech Business Incubator,Fall,-0.0081,59,taxi pharmaceutical move high tech business incubator,53,7,0,pharmacy,"['taxi', 'pharmaceutical', 'move', 'high', 'tech', 'business', 'in', '##cu', '##bat', '##or']",1
39166,nifty_142,2010-09-22,Biotrends Foundation: Innovation gets Innovative at CGI.,Fall,-0.0081,56,biotrends foundation innovation get innovative cgi,50,6,0,pharmacy,"['bio', '##tre', '##nds', 'foundation', 'innovation', 'get', 'innovative', 'c', '##gi']",1
39271,nifty_142,2010-09-22,"Owing to Generic Erosion of Key Agents, the Colorectal Cancer Drug Market Will Remain Relatively Flat Through 2019",Fall,-0.0081,114,owing generic erosion key agent the colorectal cancer drug market will remain relatively flat through,101,15,0,pharmacy,"['owing', 'generic', 'erosion', 'key', 'agent', 'the', 'color', '##ec', '##tal', 'cancer', 'drug', 'market', 'will', 'remain', 'relatively', 'flat', 'through']",1
39534,nifty_142,2010-09-22,S*BIO Announces US$5 Million Investment by Mitsui Ventures,Fall,-0.0081,58,bio announces million investment mitsui venture,47,6,0,pharmacy,"['bio', 'announces', 'million', 'investment', 'mit', '##sui', 'venture']",1
39627,nifty_142,2010-09-22,Clorox to Sell Auto-Care Operations,Fall,-0.0081,35,clorox sell auto care operation,31,5,0,pharmacy,"['c', '##lor', '##ox', 'sell', 'auto', 'care', 'operation']",1
39893,nifty_147,2010-09-30,"Cell Therapeutics, Inc. (CTI) to Present at 9th Annual BIO Investor Forum",Neutral,0.0042,73,cell therapeutic inc cti present annual bio investor forum,58,9,0,pharmacy,"['cell', 'therapeutic', 'in', '##c', 'c', '##ti', 'present', 'annual', 'bio', 'investor', 'forum']",1
39958,nifty_147,2010-09-30,Active Biotech: Number of shares and votes in Active Biotech,Neutral,0.0042,60,active biotech number share and vote active biotech,51,8,0,pharmacy,"['active', 'bio', '##tech', 'number', 'share', 'and', 'vote', 'active', 'bio', '##tech']",1
40218,nifty_147,2010-09-30,Research and Markets: This Report Provides Critical Market Data on the Medical Imaging Sector In Russia and Provides Forecasts To 2015,Neutral,0.0042,134,research and market this report provides critical market data the medical imaging sector russia and provides forecast,117,17,0,pharmacy,"['research', 'and', 'market', 'this', 'report', 'provides', 'critical', 'market', 'data', 'the', 'medical', 'imaging', 'sector', 'r', '##uss', '##ia', 'and', 'provides', 'forecast']",1
40219,nifty_147,2010-09-30,Research and Markets: This Report Provides Critical Market Data on the Patient Monitoring and Diagnostics Sector In Russia and Provides Forecasts To 2015,Neutral,0.0042,153,research and market this report provides critical market data the patient monitoring and diagnostics sector russia and provides forecast,136,19,0,pharmacy,"['research', 'and', 'market', 'this', 'report', 'provides', 'critical', 'market', 'data', 'the', 'patient', 'monitoring', 'and', 'diagnostic', '##s', 'sector', 'r', '##uss', '##ia', 'and', 'provides', 'forecast']",1
40262,nifty_147,2010-09-30," Ansell Healthcare Asks ""What Will You Promise to Do in the Next 69 Seconds to Make a Global Impact?""",Neutral,0.0042,101,ansell healthcare asks what will you promise the next second make global impact,79,13,0,pharmacy,"['an', '##sel', '##l', 'healthcare', 'asks', 'what', 'will', 'you', 'promise', 'the', 'next', 'second', 'make', 'global', 'impact']",1
40278,nifty_147,2010-09-30,BioSante Pharmaceuticals to Present at the Bio Investor Forum,Neutral,0.0042,61,biosante pharmaceutical present the bio investor forum,54,7,0,pharmacy,"['bio', '##san', '##te', 'pharmaceutical', 'present', 'the', 'bio', 'investor', 'forum']",1
40300,nifty_147,2010-09-30,Techcomp to Expand Market Presence in PRC Healthcare Laboratory Market,Neutral,0.0042,70,techcomp expand market presence prc healthcare laboratory market,64,8,0,pharmacy,"['tech', '##com', '##p', 'expand', 'market', 'presence', 'p', '##rc', 'healthcare', 'laboratory', 'market']",1
40319,nifty_147,2010-09-30,RXi Pharmaceuticals to Webcast Presentation at the 9th Annual BIO Investor Forum,Neutral,0.0042,80,rxi pharmaceutical webcast presentation the annual bio investor forum,69,9,0,pharmacy,"['r', '##xi', 'pharmaceutical', 'web', '##cast', 'presentation', 'the', 'annual', 'bio', 'investor', 'forum']",1
40446,nifty_147,2010-09-30,Sandata Technologies Launches Santrax Agency Management as Centerpiece of End-to-End Technology Solution for the Home Healthcare Industry,Neutral,0.0042,137,sandata technology launch santrax agency management centerpiece end end technology solution for the home healthcare industry,124,16,0,pharmacy,"['sand', '##ata', 'technology', 'launch', 'sa', '##nt', '##rax', 'agency', 'management', 'center', '##piece', 'end', 'end', 'technology', 'solution', 'for', 'the', 'home', 'healthcare', 'industry']",1
40574,nifty_147,2010-09-30,Research and Markets: The Hospital Market for Standard IV Administration Sets - Includes Trends in Market Size & Shares,Neutral,0.0042,119,research and market the hospital market for standard administration set includes trend market size share,104,15,0,pharmacy,"['research', 'and', 'market', 'the', 'hospital', 'market', 'for', 'standard', 'administration', 'set', 'includes', 'trend', 'market', 'size', 'share']",1
40616,nifty_147,2010-09-30,"Mercer Launches `Innovation Conversations` - Live Broadcast/Onsite Event Series on Current Issues of Health Care Reform, Talent Management and Retirement",Neutral,0.0042,153,mercer launch innovation conversation live broadcast onsite event series current issue health care reform talent management and retirement,138,18,0,pharmacy,"['me', '##rc', '##er', 'launch', 'innovation', 'conversation', 'live', 'broadcast', 'on', '##site', 'event', 'series', 'current', 'issue', 'health', 'care', 'reform', 'talent', 'management', 'and', 'retirement']",1
40634,nifty_147,2010-09-30,The Wall Street Journal`s 2010 Technology Innovation Awards Recognize Ingenix for Breakthrough Approach to Health Information Technology,Neutral,0.0042,136,the wall street journal technology innovation award recognize ingenix for breakthrough approach health information technology,125,15,0,pharmacy,"['the', 'wall', 'street', 'journal', 'technology', 'innovation', 'award', 'recognize', 'ing', '##eni', '##x', 'for', 'breakthrough', 'approach', 'health', 'information', 'technology']",1
40715,nifty_147,2010-09-30,Research and Markets: Top 50 Biotechnology Companies & Their Pipelines 2010,Neutral,0.0042,75,research and market top biotechnology company their pipeline,60,8,0,pharmacy,"['research', 'and', 'market', 'top', 'bio', '##tech', '##nology', 'company', 'their', 'pipeline']",1
40734,nifty_147,2010-09-30,Research and Markets: Protected Cell Companies - A Guide to Their Implementation and Use Contains Substantial Additions But With the Same Practical Emphasis of the Original Book,Neutral,0.0042,177,research and market protected cell company guide their implementation and use contains substantial addition but with the same practical emphasis the original book,162,23,0,pharmacy,"['research', 'and', 'market', 'protected', 'cell', 'company', 'guide', 'their', 'implementation', 'and', 'use', 'contains', 'substantial', 'addition', 'but', 'with', 'the', 'same', 'practical', 'emphasis', 'the', 'original', 'book']",1
40775,nifty_147,2010-09-30,The Number of Biotechnology Companies Has Only Decreased by 10% Despite the Crisis,Neutral,0.0042,82,the number biotechnology company ha only decreased despite the crisis,69,10,0,pharmacy,"['the', 'number', 'bio', '##tech', '##nology', 'company', 'ha', 'only', 'decreased', 'despite', 'the', 'crisis']",1
40823,nifty_147,2010-09-30,Alinean Launches 'Fight Frugalnomics' Resource Center,Neutral,0.0042,53,alinean launch fight frugalnomics resource center,49,6,0,pharmacy,"['al', '##ine', '##an', 'launch', 'fight', 'f', '##rug', '##al', '##no', '##mic', '##s', 'resource', 'center']",1
41080,nifty_147,2010-09-30,FDA Issues Warning on Infant Sleep Aids,Neutral,0.0042,39,fda issue warning infant sleep aid,34,6,0,pharmacy,"['f', '##da', 'issue', 'warning', 'infant', 'sleep', 'aid']",1
41481,nifty_150,2010-10-06,The Ultimate Experiment: Can Gaming Technology Resuscitate Medical Research?,Neutral,-0.0012,76,the ultimate experiment can gaming technology resuscitate medical research,74,9,0,pharmacy,"['the', 'ultimate', 'experiment', 'can', 'gaming', 'technology', 're', '##sus', '##ci', '##tate', 'medical', 'research']",1
41559,nifty_150,2010-10-06,Research and Markets: Belgium Medical Imaging Market Assessment and Forecasts to 2015,Neutral,-0.0012,85,research and market belgium medical imaging market assessment and forecast,74,10,0,pharmacy,"['research', 'and', 'market', 'be', '##l', '##gi', '##um', 'medical', 'imaging', 'market', 'assessment', 'and', 'forecast']",1
41560,nifty_150,2010-10-06,Research and Markets: France Patient Monitoring and Diagnostic Systems Market Assessment and Forecasts to 2015,Neutral,-0.0012,110,research and market france patient monitoring and diagnostic system market assessment and forecast,98,13,0,pharmacy,"['research', 'and', 'market', 'f', '##rance', 'patient', 'monitoring', 'and', 'diagnostic', 'system', 'market', 'assessment', 'and', 'forecast']",1
41634,nifty_150,2010-10-06,"Research and Markets: Cell Therapy - Technologies, Markets and Companies: Includes Profiles of 68 Academic Institutions in the US Involved in Cell Therapy",Neutral,-0.0012,154,research and market cell therapy technology market and company includes profile academic institution the involved cell therapy,126,17,0,pharmacy,"['research', 'and', 'market', 'cell', 'therapy', 'technology', 'market', 'and', 'company', 'includes', 'profile', 'academic', 'institution', 'the', 'involved', 'cell', 'therapy']",1
41641,nifty_150,2010-10-06,"Research and Markets: Proteomics - Technologies, Markets and Companies: Includes Profiles of 218 Companies Involved in Proteomics",Neutral,-0.0012,129,research and market proteomics technology market and company includes profile company involved proteomics,105,13,0,pharmacy,"['research', 'and', 'market', 'pro', '##te', '##omi', '##cs', 'technology', 'market', 'and', 'company', 'includes', 'profile', 'company', 'involved', 'pro', '##te', '##omi', '##cs']",1
41673,nifty_150,2010-10-06,Iroko Pharmaceuticals Announces Financial Investment in New Product Development,Neutral,-0.0012,79,iroko pharmaceutical announces financial investment new product development,75,8,0,pharmacy,"['i', '##rok', '##o', 'pharmaceutical', 'announces', 'financial', 'investment', 'new', 'product', 'development']",1
41687,nifty_150,2010-10-06,"Research and Markets: Gene Therapy - Technologies, Markets and Companies",Neutral,-0.0012,72,research and market gene therapy technology market and company,62,9,0,pharmacy,"['research', 'and', 'market', 'gene', 'therapy', 'technology', 'market', 'and', 'company']",1
41802,nifty_150,2010-10-06,"Research and Markets: Triple Analysis on Lung Cancer, Angiogenesis and Cancer Vaccines - A Focus on Cancer Drug Development Strategies in Lung Cancer",Neutral,-0.0012,149,research and market triple analysis lung cancer angiogenesis and cancer vaccine focus cancer drug development strategy lung cancer,130,18,0,pharmacy,"['research', 'and', 'market', 'triple', 'analysis', 'lung', 'cancer', 'an', '##gio', '##genesis', 'and', 'cancer', 'vaccine', 'focus', 'cancer', 'drug', 'development', 'strategy', 'lung', 'cancer']",1
41848,nifty_150,2010-10-06, Therapeutics for Anxiety Reviewed by NeuroInvestment,Neutral,-0.0012,53,therapeutic for anxiety reviewed neuroinvestment,48,5,0,pharmacy,"['therapeutic', 'for', 'anxiety', 'reviewed', 'ne', '##uro', '##in', '##ves', '##tment']",1
41923,nifty_150,2010-10-06,"Research and Markets: Molecular Diagnostics - Technologies, Markets and Companies: 295 Companies are Profiled in the Report",Neutral,-0.0012,123,research and market molecular diagnostics technology market and company company are profiled the report,103,14,0,pharmacy,"['research', 'and', 'market', 'molecular', 'diagnostic', '##s', 'technology', 'market', 'and', 'company', 'company', 'are', 'profile', '##d', 'the', 'report']",1
41940,nifty_150,2010-10-06,"Research and Markets: Pain Therapeutics - Drugs, Markets and Companies: Includes a Mix of 303 Pharmaceutical and Biotechnology Companies",Neutral,-0.0012,136,research and market pain therapeutic drug market and company includes mix pharmaceutical and biotechnology company,114,15,0,pharmacy,"['research', 'and', 'market', 'pain', 'therapeutic', 'drug', 'market', 'and', 'company', 'includes', 'mix', 'pharmaceutical', 'and', 'bio', '##tech', '##nology', 'company']",1
42008,nifty_150,2010-10-06,MedTech Companies & Coulter Foundation Translational Research Partnership Universities Present Life Changing Medical Devices/Technologies and Company Profiles to Industry Leaders and Investors at AdvaMed 2010,Neutral,-0.0012,208,medtech company coulter foundation translational research partnership university present life changing medical device technology and company profile industry leader and investor advamed,185,22,0,pharmacy,"['me', '##dt', '##ech', 'company', 'co', '##ulter', 'foundation', 'translation', '##al', 'research', 'partnership', 'university', 'present', 'life', 'changing', 'medical', 'device', 'technology', 'and', 'company', 'profile', 'industry', 'leader', 'and', 'investor', 'ad', '##va', '##med']",1
42037,nifty_150,2010-10-06,U.S. FDA to push for more investment in science,Neutral,-0.0012,47,fda push for more investment science,36,6,0,pharmacy,"['f', '##da', 'push', 'for', 'more', 'investment', 'science']",1
42039,nifty_150,2010-10-06,Research and Markets: 2011 US Health & Medical Insurance Carriers Industry Report,Neutral,-0.0012,81,research and market health medical insurance carrier industry report,68,9,0,pharmacy,"['research', 'and', 'market', 'health', 'medical', 'insurance', 'carrier', 'industry', 'report']",1
42040,nifty_150,2010-10-06,Research and Markets: Personalized Medicine - Scientific and Commercial Aspects: Includes Profiles of 231 Companies Involved In Developing Technologies for Personalized Medicines,Neutral,-0.0012,178,research and market personalized medicine scientific and commercial aspect includes profile company involved developing technology for personalized medicine,156,18,0,pharmacy,"['research', 'and', 'market', 'personal', '##ized', 'medicine', 'scientific', 'and', 'commercial', 'aspect', 'includes', 'profile', 'company', 'involved', 'developing', 'technology', 'for', 'personal', '##ized', 'medicine']",1
42066,nifty_150,2010-10-06,FDA to push for more investment in science,Neutral,-0.0012,42,fda push for more investment science,36,6,0,pharmacy,"['f', '##da', 'push', 'for', 'more', 'investment', 'science']",1
42329,nifty_150,2010-10-06,"IMS Health Forecasts Global Pharmaceutical Market Growth of 5-7 Percent in 2011, Reaching $880 Billion",Neutral,-0.0012,102,ims health forecast global pharmaceutical market growth percent reaching billion,80,10,0,pharmacy,"['im', '##s', 'health', 'forecast', 'global', 'pharmaceutical', 'market', 'growth', 'percent', 'reaching', 'billion']",1
42369,nifty_150,2010-10-06,Robbins & Myers to Buy T-3,Neutral,-0.0012,26,robbins myers buy,17,3,0,pharmacy,"['r', '##ob', '##bin', '##s', 'my', '##ers', 'buy']",1
42715,nifty_152,2010-10-11,"Genesis Biopharma to Present at the Informed Investors Forum Biotech, Healthcare & Pharma Virtual Conference on October 13",Neutral,0.0031,122,genesis biopharma present the informed investor forum biotech healthcare pharma virtual conference october,106,13,0,pharmacy,"['genes', '##is', 'bio', '##pha', '##rma', 'present', 'the', 'informed', 'investor', 'forum', 'bio', '##tech', 'healthcare', 'p', '##har', '##ma', 'virtual', 'conference', 'o', '##ct', '##obe', '##r']",1
42866,nifty_152,2010-10-11,Allscripts Acute Care Users Conference Explores Industry Changes in CPOE and Electronic Health Records,Neutral,0.0031,102,allscripts acute care user conference explores industry change cpoe and electronic health record,96,13,0,pharmacy,"['all', '##s', '##cripts', 'acute', 'care', 'user', 'conference', 'explores', 'industry', 'change', 'c', '##po', '##e', 'and', 'electronic', 'health', 'record']",1
42911,nifty_152,2010-10-11,Research and Markets: Healthcare IT Market Outlook in India to 2016 - Hospital Information Systems and Medical Imaging Information Systems,Neutral,0.0031,138,research and market healthcare market outlook india hospital information system and medical imaging information system,118,15,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'market', 'outlook', 'in', '##dia', 'hospital', 'information', 'system', 'and', 'medical', 'imaging', 'information', 'system']",1
42924,nifty_152,2010-10-11,Pivotal Study and New Product Announcement,Neutral,0.0031,42,pivotal study and new product announcement,42,6,0,pharmacy,"['pivotal', 'study', 'and', 'new', 'product', 'announcement']",1
42928,nifty_152,2010-10-11,"Manhattan Pharmaceuticals to Present at Precision IR Biotech, Healthcare & Pharmaceutical...",Neutral,0.0031,92,manhattan pharmaceutical present precision biotech healthcare pharmaceutical,76,7,0,pharmacy,"['man', '##hat', '##tan', 'pharmaceutical', 'present', 'precision', 'bio', '##tech', 'healthcare', 'pharmaceutical']",1
42955,nifty_152,2010-10-11,Research and Markets: Practical Guide to Finding Partners in Pharma and Biotech - The Updated 2010 4th Edition,Neutral,0.0031,110,research and market practical guide finding partner pharma and biotech the updated edition,90,13,0,pharmacy,"['research', 'and', 'market', 'practical', 'guide', 'finding', 'partner', 'p', '##har', '##ma', 'and', 'bio', '##tech', 'the', 'updated', 'edition']",1
42971,nifty_152,2010-10-11,2010 NaviNet Healthcare Forum: Nation`s Leading Health Plans to Discuss Industry Trends and How to Leverage Technology to Succeed in a Time of Change,Neutral,0.0031,149,navinet healthcare forum nation leading health plan discus industry trend and how leverage technology succeed time change,121,17,0,pharmacy,"['na', '##vin', '##et', 'healthcare', 'forum', 'nation', 'leading', 'health', 'plan', 'disc', '##us', 'industry', 'trend', 'and', 'how', 'leverage', 'technology', 'succeed', 'time', 'change']",1
43158,nifty_152,2010-10-11,"Medical Technology, Funding & Government Experts Address Business, Investment, Reimbursement, Compliance, Innovation, Regulatory and Legal Issues at AdvaMed 2010",Neutral,0.0031,161,medical technology funding government expert address business investment reimbursement compliance innovation regulatory and legal issue advamed,143,16,0,pharmacy,"['medical', 'technology', 'funding', 'government', 'expert', 'address', 'business', 'investment', 're', '##im', '##bur', '##se', '##ment', 'compliance', 'innovation', 'regulatory', 'and', 'legal', 'issue', 'ad', '##va', '##med']",1
43181,nifty_152,2010-10-11,"Webcast Alert: CEL-SCI Corp. (CVM) Announces the Biotech, Healthcare and Pharma Virtual Conference",Neutral,0.0031,98,webcast alert cel sci corp cvm announces the biotech healthcare and pharma virtual conference,93,14,0,pharmacy,"['web', '##cast', 'alert', 'c', '##el', 's', '##ci', 'co', '##rp', 'c', '##v', '##m', 'announces', 'the', 'bio', '##tech', 'healthcare', 'and', 'p', '##har', '##ma', 'virtual', 'conference']",1
43188,nifty_152,2010-10-11,Research and Markets: US Pharmaceutical Market Overview: Once Recession-Proof Industry Feeling Impact of Economic Downturn,Neutral,0.0031,122,research and market pharmaceutical market overview once recession proof industry feeling impact economic downturn,113,14,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'market', 'overview', 'once', 'recession', 'proof', 'industry', 'feeling', 'impact', 'economic', 'down', '##turn']",1
43315,nifty_152,2010-10-11,Johnson & Johnson to Host Analyst Meeting to Discuss Third-Quarter Financial Results and Review Pharmaceutical Business,Neutral,0.0031,119,johnson johnson host analyst meeting discus third quarter financial result and review pharmaceutical business,109,14,0,pharmacy,"['j', '##oh', '##nson', 'j', '##oh', '##nson', 'host', 'analyst', 'meeting', 'disc', '##us', 'third', 'quarter', 'financial', 'result', 'and', 'review', 'pharmaceutical', 'business']",1
43841,nifty_154,2010-10-13,Research and Markets: Zollinger-Ellison Syndrome Therapy Area Pipeline Report,Neutral,-0.0039,77,research and market zollinger ellison syndrome therapy area pipeline report,75,10,0,pharmacy,"['research', 'and', 'market', 'z', '##oll', '##inger', 'el', '##lis', '##on', 'syndrome', 'therapy', 'area', 'pipeline', 'report']",1
44102,nifty_154,2010-10-13,Q-Cells SE: Q-Cells SE announces results of capital increase,Neutral,-0.0039,60,cell cell announces result capital increase,43,6,0,pharmacy,"['cell', 'cell', 'announces', 'result', 'capital', 'increase']",1
44195,nifty_154,2010-10-13,"Research and Markets: The Genitourinary Market Outlook to 2015: Competitive Landscape, Global Market Analysis and Pipeline Analysis",Neutral,-0.0039,131,research and market the genitourinary market outlook competitive landscape global market analysis and pipeline analysis,119,15,0,pharmacy,"['research', 'and', 'market', 'the', 'g', '##eni', '##tour', '##ina', '##ry', 'market', 'outlook', 'competitive', 'landscape', 'global', 'market', 'analysis', 'and', 'pipeline', 'analysis']",1
44306,nifty_154,2010-10-13,Research and Markets: Examine the Global Medical Equipment and Devices Industry with this Comprehensive Report,Neutral,-0.0039,110,research and market examine the global medical equipment and device industry with this comprehensive report,107,15,0,pharmacy,"['research', 'and', 'market', 'examine', 'the', 'global', 'medical', 'equipment', 'and', 'device', 'industry', 'with', 'this', 'comprehensive', 'report']",1
44403,nifty_154,2010-10-13,"Research and Markets: Managed Healthcare in the US: Includes About 1,000 Companies, Including Blue Cross, Aetna and Humana, with Combined Annual Revenue of About $500 Billion",Neutral,-0.0039,174,research and market managed healthcare the includes about company including blue cross aetna and humana with combined annual revenue about billion,146,21,0,pharmacy,"['research', 'and', 'market', 'managed', 'healthcare', 'the', 'includes', 'about', 'company', 'including', 'blue', 'cross', 'a', '##et', '##na', 'and', 'human', '##a', 'with', 'combined', 'annual', 'revenue', 'about', 'billion']",1
44418,nifty_154,2010-10-13,Research and Markets: Global Optical Coherence Tomography: This Market Potential Analysis Shows that the Market is Continuing to Grow at a Fast Pace,Neutral,-0.0039,148,research and market global optical coherence tomography this market potential analysis show that the market continuing grow fast pace,133,19,0,pharmacy,"['research', 'and', 'market', 'global', 'optical', 'co', '##herence', 'to', '##mo', '##graphy', 'this', 'market', 'potential', 'analysis', 'show', 'that', 'the', 'market', 'continuing', 'grow', 'fast', 'pace']",1
44454,nifty_154,2010-10-13,Research and Markets: Bioinformatics in Drug Discovery,Neutral,-0.0039,54,research and market bioinformatics drug discovery,49,6,0,pharmacy,"['research', 'and', 'market', 'bio', '##in', '##formatics', 'drug', 'discovery']",1
44567,nifty_154,2010-10-13,U.S. to pay SIGA up to $2.8 billion in biodefense deal,Neutral,-0.0039,54,pay siga billion biodefense deal,32,5,0,pharmacy,"['pay', 'si', '##ga', 'billion', 'bio', '##de', '##fen', '##se', 'deal']",1
45036,nifty_159,2010-10-21,Novartis's Net Profit Jumps 10%,Neutral,0.0019,31,novartis net profit jump,24,4,0,pharmacy,"['no', '##var', '##tis', 'net', 'profit', 'jump']",1
45177,nifty_161,2010-10-26,Bristol-Myers Profit Slips,Neutral,-0.0029,26,bristol myers profit slip,25,4,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'profit', 'slip']",1
45225,nifty_161,2010-10-26,Long Odds Seen For Diet Drugs,Neutral,-0.0029,29,long odds seen for diet drug,28,6,0,pharmacy,"['long', 'odds', 'seen', 'for', 'diet', 'drug']",1
45339,nifty_162,2010-10-27,Active Biotech: Active Biotech AB Interim Report January - September 2010,Neutral,0.0002,73,active biotech active biotech interim report january september,62,8,0,pharmacy,"['active', 'bio', '##tech', 'active', 'bio', '##tech', 'interim', 'report', 'j', '##anu', '##ary', 'se', '##pt', '##em', '##ber']",1
45487,nifty_162,2010-10-27,Research and Markets: The Indian Bulk Drug Industry is to Grow To US$ 17 Billion By 2014 According to this Latest Report,Neutral,0.0002,120,research and market the indian bulk drug industry grow billion according this latest report,91,14,0,pharmacy,"['research', 'and', 'market', 'the', 'in', '##dian', 'bulk', 'drug', 'industry', 'grow', 'billion', 'according', 'this', 'latest', 'report']",1
45504,nifty_162,2010-10-27,Research and Markets: This U.S. Market for Medical Imaging Equipment 2010 Forecasts the Market to Slowly Recover Following its 14.6% Decrease in Value in 2009,Neutral,0.0002,158,research and market this market for medical imaging equipment forecast the market slowly recover following it decrease value,124,18,0,pharmacy,"['research', 'and', 'market', 'this', 'market', 'for', 'medical', 'imaging', 'equipment', 'forecast', 'the', 'market', 'slowly', 'recover', 'following', 'it', 'decrease', 'value']",1
45519,nifty_162,2010-10-27,Cancer Drug Futures Analysed in New In-demand Market Reports Available at MarketPublishers.com,Neutral,0.0002,94,cancer drug future analysed new demand market report available marketpublishers com,83,11,0,pharmacy,"['cancer', 'drug', 'future', 'anal', '##ys', '##ed', 'new', 'demand', 'market', 'report', 'available', 'market', '##pu', '##b', '##lish', '##ers', 'com']",1
45654,nifty_162,2010-10-27,Research and Markets: Japan Pharmaceuticals and Healthcare Report Q4 2010,Neutral,0.0002,73,research and market japan pharmaceutical and healthcare report,62,8,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##n', 'pharmaceutical', 'and', 'healthcare', 'report']",1
45737,nifty_162,2010-10-27,"Research and Markets: Pharmacies, Drug Stores & Health & Beauty Stores in Bulgaria - with Reliable Historical Data & Full Five Year Forecasting",Neutral,0.0002,143,research and market pharmacy drug store health beauty store bulgaria with reliable historical data full five year forecasting,125,18,0,pharmacy,"['research', 'and', 'market', 'pharmacy', 'drug', 'store', 'health', 'beauty', 'store', 'b', '##ul', '##gar', '##ia', 'with', 'reliable', 'historical', 'data', 'full', 'five', 'year', 'forecast', '##ing']",1
45739,nifty_162,2010-10-27,Research and Markets: Forecast Insight: Asthma/COPD - Pipeline Potential Outweighs Downward Pressure From Generics,Neutral,0.0002,114,research and market forecast insight asthma copd pipeline potential outweighs downward pressure from generic,108,14,0,pharmacy,"['research', 'and', 'market', 'forecast', 'insight', 'as', '##th', '##ma', 'cop', '##d', 'pipeline', 'potential', 'out', '##wei', '##gh', '##s', 'downward', 'pressure', 'from', 'generic']",1
45745,nifty_162,2010-10-27,Research and Markets: Colorectal Cancer - Pipeline Assessment and Market Forecasts to 2020,Neutral,0.0002,90,research and market colorectal cancer pipeline assessment and market forecast,77,10,0,pharmacy,"['research', 'and', 'market', 'color', '##ec', '##tal', 'cancer', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
45843,nifty_162,2010-10-27,Business Wire: Second Parliamentary Debate on Biotechnologies,Neutral,0.0002,61,business wire second parliamentary debate biotechnology,55,6,0,pharmacy,"['business', 'wire', 'second', 'parliamentary', 'debate', 'bio', '##tech', '##nology']",1
45994,nifty_162,2010-10-27,"Zacks Bull and Bear of the Day Highlights: Gilead Sciences, Linear Technology, Biogen Idec, Elan and Novartis",Neutral,0.0002,109,zacks bull and bear the day highlight gilead science linear technology biogen idec elan and novartis,100,16,0,pharmacy,"['z', '##ack', '##s', 'bull', 'and', 'bear', 'the', 'day', 'highlight', 'g', '##ile', '##ad', 'science', 'linear', 'technology', 'bio', '##gen', 'id', '##ec', 'el', '##an', 'and', 'no', '##var', '##tis']",1
46062,nifty_162,2010-10-27," Pacific Biomarkers, Inc. Among Deloitte's 2010 Technology Fast 500(TM)",Neutral,0.0002,71,pacific biomarkers inc among deloitte technology fast,53,7,0,pharmacy,"['p', '##ac', '##ific', 'bio', '##mark', '##ers', 'in', '##c', 'among', 'del', '##oit', '##te', 'technology', 'fast']",1
46096,nifty_162,2010-10-27,Research and Markets: Genomic Technologies: Market Insights for Life Science Suppliers,Neutral,0.0002,86,research and market genomic technology market insight for life science supplier,79,11,0,pharmacy,"['research', 'and', 'market', 'g', '##eno', '##mic', 'technology', 'market', 'insight', 'for', 'life', 'science', 'supplier']",1
46100,nifty_162,2010-10-27,Research and Markets: Bayer Healthcare Pharmaceuticals - a Detailed Product Pipeline Report on the Company,Neutral,0.0002,106,research and market bayer healthcare pharmaceutical detailed product pipeline report the company,96,12,0,pharmacy,"['research', 'and', 'market', 'bay', '##er', 'healthcare', 'pharmaceutical', 'detailed', 'product', 'pipeline', 'report', 'the', 'company']",1
46104,nifty_162,2010-10-27,Research and Markets: Actavis - a Detailed Product Pipeline on the Company,Neutral,0.0002,74,research and market actavis detailed product pipeline the company,65,9,0,pharmacy,"['research', 'and', 'market', 'act', '##avi', '##s', 'detailed', 'product', 'pipeline', 'the', 'company']",1
46149,nifty_162,2010-10-27,GE and UPMC Unveil Breakthrough Digital Pathology Technology,Neutral,0.0002,60,and upmc unveil breakthrough digital pathology technology,57,7,0,pharmacy,"['and', 'up', '##m', '##c', 'un', '##ve', '##il', 'breakthrough', 'digital', 'path', '##ology', 'technology']",1
46230,nifty_162,2010-10-27,Research and Markets: Intravenous (IV) Iron Drugs - Global Strategic Business Report with Profiles of the Key and Niche Players,Neutral,0.0002,127,research and market intravenous iron drug global strategic business report with profile the key and niche player,112,17,0,pharmacy,"['research', 'and', 'market', 'in', '##tra', '##ven', '##ous', 'iron', 'drug', 'global', 'strategic', 'business', 'report', 'with', 'profile', 'the', 'key', 'and', 'niche', 'player']",1
46416,nifty_162,2010-10-27,Human Genome Sciences Announces Third Quarter 2010 Financial Results and Key Developments,Neutral,0.0002,89,human genome science announces third quarter financial result and key development,81,11,0,pharmacy,"['human', 'genome', 'science', 'announces', 'third', 'quarter', 'financial', 'result', 'and', 'key', 'development']",1
46420,nifty_162,2010-10-27,"Idenix Pharmaceuticals to Hold an Investor/Analyst Day Event on October 30, 2010",Neutral,0.0002,80,idenix pharmaceutical hold investor analyst day event october,61,8,0,pharmacy,"['id', '##eni', '##x', 'pharmaceutical', 'hold', 'investor', 'analyst', 'day', 'event', 'o', '##ct', '##obe', '##r']",1
46442,nifty_162,2010-10-27,UPDATE 2-Pacific Biosciences shares rise in debut,Neutral,0.0002,49,update pacific bioscience share rise debut,42,6,0,pharmacy,"['update', 'p', '##ac', '##ific', 'bio', '##science', 'share', 'rise', 'debut']",1
46446,nifty_162,2010-10-27,Pacific Biosciences shares rise in debut,Neutral,0.0002,40,pacific bioscience share rise debut,35,5,0,pharmacy,"['p', '##ac', '##ific', 'bio', '##science', 'share', 'rise', 'debut']",1
46447,nifty_162,2010-10-27,Research and Markets: 2010 Commercializing Cancer Drugs Affecting Angiogenesis: A Decision Support Tool for Optimizing the Pipeline Out Now,Neutral,0.0002,139,research and market commercializing cancer drug affecting angiogenesis decision support tool for optimizing the pipeline out now,128,17,0,pharmacy,"['research', 'and', 'market', 'commercial', '##izing', 'cancer', 'drug', 'affecting', 'an', '##gio', '##genesis', 'decision', 'support', 'tool', 'for', 'op', '##ti', '##mizing', 'the', 'pipeline', 'out', 'now']",1
46604,nifty_162,2010-10-27,"Research and Markets: Updated Molecular Diagnostics Report : Market Segmentation and Opportunities - Market Size, Growth, Segments and Trends to 2013",Neutral,0.0002,149,research and market updated molecular diagnostics report market segmentation and opportunity market size growth segment and trend,129,17,0,pharmacy,"['research', 'and', 'market', 'updated', 'molecular', 'diagnostic', '##s', 'report', 'market', 'segment', '##ation', 'and', 'opportunity', 'market', 'size', 'growth', 'segment', 'and', 'trend']",1
46728,nifty_162,2010-10-27,Diabetes Drugs Aid Nordisk Profit,Neutral,0.0002,33,diabetes drug aid nordisk profit,32,5,0,pharmacy,"['diabetes', 'drug', 'aid', 'nor', '##dis', '##k', 'profit']",1
47207,nifty_165,2010-11-02,China Medical Technologies to Participate in Investor Conferences in November 2010,Neutral,0.004,82,china medical technology participate investor conference november,65,7,0,pharmacy,"['chin', '##a', 'medical', 'technology', 'participate', 'investor', 'conference', 'no', '##ve', '##mber']",1
47210,nifty_165,2010-11-02,"PDL BioPharma to Announce Third Quarter 2010 Financial Results on November 10, 2010",Neutral,0.004,83,pdl biopharma announce third quarter financial result november,62,8,0,pharmacy,"['p', '##dl', 'bio', '##pha', '##rma', 'announce', 'third', 'quarter', 'financial', 'result', 'no', '##ve', '##mber']",1
47324,nifty_165,2010-11-02,Celldex Reports Third Quarter 2010 Financial Results,Neutral,0.004,52,celldex report third quarter financial result,45,6,0,pharmacy,"['cell', '##de', '##x', 'report', 'third', 'quarter', 'financial', 'result']",1
47352,nifty_165,2010-11-02,DC to VC Summit Outlines the Future of Health Information Technology,Neutral,0.004,68,summit outline the future health information technology,55,7,0,pharmacy,"['summit', 'outline', 'the', 'future', 'health', 'information', 'technology']",1
47358,nifty_165,2010-11-02,NPS Pharmaceuticals Reports Third Quarter 2010 Financial Results and Two Phase 3 Development Programs on Track with Stated Timelines,Neutral,0.004,132,np pharmaceutical report third quarter financial result and two phase development program track with stated timeline,116,16,0,pharmacy,"['n', '##p', 'pharmaceutical', 'report', 'third', 'quarter', 'financial', 'result', 'and', 'two', 'phase', 'development', 'program', 'track', 'with', 'stated', 'timeline']",1
47375,nifty_165,2010-11-02,Analysis: Cheaper biotech drugs in U.S. still years away,Neutral,0.004,56,analysis cheaper biotech drug still year away,45,7,0,pharmacy,"['analysis', 'cheaper', 'bio', '##tech', 'drug', 'still', 'year', 'away']",1
47405,nifty_165,2010-11-02,Dicerna Pharmaceuticals to Present at Upcoming Conferences in November,Neutral,0.004,70,dicerna pharmaceutical present upcoming conference november,59,6,0,pharmacy,"['dice', '##rna', 'pharmaceutical', 'present', 'upcoming', 'conference', 'no', '##ve', '##mber']",1
47512,nifty_165,2010-11-02,XIFIN Continues Leadership Position in Molecular Diagnostics Market,Neutral,0.004,67,xifin continues leadership position molecular diagnostics market,64,7,0,pharmacy,"['x', '##if', '##in', 'continues', 'leadership', 'position', 'molecular', 'diagnostic', '##s', 'market']",1
47534,nifty_165,2010-11-02, Kane Biotech Appoints Board Advisor and Announces Private Placement Offering,Neutral,0.004,77,kane biotech appoints board advisor and announces private placement offering,76,10,0,pharmacy,"['ka', '##ne', 'bio', '##tech', 'appoint', '##s', 'board', 'advisor', 'and', 'announces', 'private', 'placement', 'offering']",1
47665,nifty_165,2010-11-02,Research and Markets: Ischemic Stroke: An Atlas of Investigation and Treatment,Neutral,0.004,78,research and market ischemic stroke atlas investigation and treatment,69,9,0,pharmacy,"['research', 'and', 'market', 'is', '##che', '##mic', 'stroke', 'at', '##las', 'investigation', 'and', 'treatment']",1
47669,nifty_165,2010-11-02,"Research and Markets: Strategic Analysis of the Global In Vitro Diagnostics Market - Market Drivers, Restraints, Industry Trends & Competitive Environment",Neutral,0.004,154,research and market strategic analysis the global vitro diagnostics market market driver restraint industry trend competitive environment,137,17,0,pharmacy,"['research', 'and', 'market', 'strategic', 'analysis', 'the', 'global', 'v', '##it', '##ro', 'diagnostic', '##s', 'market', 'market', 'driver', 'restraint', 'industry', 'trend', 'competitive', 'environment']",1
47735,nifty_165,2010-11-02,Research and Markets: This Report Provides Insight into the Pipeline Status of Constipation Drugs by Company and By Stage As Well As a Summary of the Latest News and Developments,Neutral,0.004,178,research and market this report provides insight into the pipeline status constipation drug company and stage well summary the latest news and development,154,23,0,pharmacy,"['research', 'and', 'market', 'this', 'report', 'provides', 'insight', 'into', 'the', 'pipeline', 'status', 'con', '##st', '##ip', '##ation', 'drug', 'company', 'and', 'stage', 'well', 'summary', 'the', 'latest', 'news', 'and', 'development']",1
47777,nifty_165,2010-11-02,Research and Markets: This Report Provides Insight into the Pipeline Status of Chronic Obstructive Pulmonary Drugs by Company and By Stage As Well As the Latest News and Developments,Neutral,0.004,182,research and market this report provides insight into the pipeline status chronic obstructive pulmonary drug company and stage well the latest news and development,163,24,0,pharmacy,"['research', 'and', 'market', 'this', 'report', 'provides', 'insight', 'into', 'the', 'pipeline', 'status', 'chronic', 'o', '##bs', '##truct', '##ive', 'pulmonary', 'drug', 'company', 'and', 'stage', 'well', 'the', 'latest', 'news', 'and', 'development']",1
47793,nifty_165,2010-11-02,"UPDATE 1-Canada's Med BioGene explores sale, shares sink",Neutral,0.004,56,update canada med biogene explores sale share sink,50,8,0,pharmacy,"['update', 'can', '##ada', 'me', '##d', 'bio', '##gene', 'explores', 'sale', 'share', 'sink']",1
47795,nifty_165,2010-11-02,Research and Markets: Therapeutic Strategies in Schizophrenia,Neutral,0.004,61,research and market therapeutic strategy schizophrenia,54,6,0,pharmacy,"['research', 'and', 'market', 'therapeutic', 'strategy', 's', '##chi', '##zophrenia']",1
47852,nifty_165,2010-11-02,Research and Markets: Pfizer Inc - Detailed Product Pipeline 2010 Features the Pfizer's Deals and Alliances and Recent Corporate News,Neutral,0.004,133,research and market pfizer inc detailed product pipeline feature the pfizer deal and alliance and recent corporate news,119,18,0,pharmacy,"['research', 'and', 'market', 'p', '##fi', '##zer', 'in', '##c', 'detailed', 'product', 'pipeline', 'feature', 'the', 'p', '##fi', '##zer', 'deal', 'and', 'alliance', 'and', 'recent', 'corporate', 'news']",1
47892,nifty_165,2010-11-02,"Macrowikinomics: Rebooting Business and the World co-authored by Don Tapscott and Anthony D. Williams discusses the five principles of wikinomics; collaboration, openness, sharing, interdependence and integrity and how they ",Neutral,0.004,224,macrowikinomics rebooting business and the world authored don tapscott and anthony williams discusses the five principle wikinomics collaboration openness sharing interdependence and integrity and how they,205,26,0,pharmacy,"['mac', '##row', '##iki', '##no', '##mic', '##s', 're', '##boo', '##ting', 'business', 'and', 'the', 'world', 'authored', 'don', 'tap', '##sco', '##tt', 'and', 'ant', '##hon', '##y', 'will', '##iam', '##s', 'discusses', 'the', 'five', 'principle', 'w', '##iki', '##no', '##mic', '##s', 'collaboration', 'open', '##ness', 'sharing', 'inter', '##de', '##pen', '##dence', 'and', 'integrity', 'and', 'how', 'they']",1
47939,nifty_165,2010-11-02,Research and Markets: Inspire Pharmaceuticals Inc-Detailed Product Pipeline Includes Detail on A Company's Deals And Alliances,Neutral,0.004,126,research and market inspire pharmaceutical inc detailed product pipeline includes detail company deal and alliance,114,15,0,pharmacy,"['research', 'and', 'market', 'inspire', 'pharmaceutical', 'in', '##c', 'detailed', 'product', 'pipeline', 'includes', 'detail', 'company', 'deal', 'and', 'alliance']",1
47987,nifty_165,2010-11-02,Research and Markets: Colgate-Palmolive Co. Detailed Product Pipeline for 2010 Provides The User With Real Detail On A Company's Pipeline,Neutral,0.004,137,research and market colgate palmolive detailed product pipeline for provides the user with real detail company pipeline,119,17,0,pharmacy,"['research', 'and', 'market', 'co', '##l', '##gate', 'palm', '##oli', '##ve', 'detailed', 'product', 'pipeline', 'for', 'provides', 'the', 'user', 'with', 'real', 'detail', 'company', 'pipeline']",1
47993,nifty_165,2010-11-02,ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results,Neutral,0.004,65,ista pharmaceutical report third quarter financial result,57,7,0,pharmacy,"['is', '##ta', 'pharmaceutical', 'report', 'third', 'quarter', 'financial', 'result']",1
48045,nifty_165,2010-11-02, Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of More Than 5 Percent,Neutral,0.004,85,bio rad report third quarter currency neutral revenue growth more than percent,78,12,0,pharmacy,"['bio', 'r', '##ad', 'report', 'third', 'quarter', 'currency', 'neutral', 'revenue', 'growth', 'more', 'than', 'percent']",1
48156,nifty_165,2010-11-02,Drug research heads to Asia as local markets boom,Neutral,0.004,49,drug research head asia local market boom,41,7,0,pharmacy,"['drug', 'research', 'head', 'as', '##ia', 'local', 'market', 'boom']",1
48170,nifty_165,2010-11-02,"Research and Markets: Healthcare Information Technology Market in India - Market Trends, Drivers, Restraints, Technology Trends & Much More",Neutral,0.004,139,research and market healthcare information technology market india market trend driver restraint technology trend much more,123,16,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'information', 'technology', 'market', 'in', '##dia', 'market', 'trend', 'driver', 'restraint', 'technology', 'trend', 'much', 'more']",1
48276,nifty_166,2010-11-03,"Asia Pacific Pharma Companies Turning to High-Risk, High-Reward Drug Development, According to New Report from Thomson Reuters",Rise,0.0193,126,asia pacific pharma company turning high risk high reward drug development according new report from thomson reuters,116,17,0,pharmacy,"['as', '##ia', 'p', '##ac', '##ific', 'p', '##har', '##ma', 'company', 'turning', 'high', 'risk', 'high', 'reward', 'drug', 'development', 'according', 'new', 'report', 'from', 'th', '##oms', '##on', 're', '##uters']",1
48563,nifty_166,2010-11-03,"Research and Markets: Biochips - Technologies, Markets and Companies Report - Analysis of Biochip/Microarray Markets Based on Technologies and Applications",Rise,0.0193,155,research and market biochip technology market and company report analysis biochip microarray market based technology and application,132,17,0,pharmacy,"['research', 'and', 'market', 'bio', '##chi', '##p', 'technology', 'market', 'and', 'company', 'report', 'analysis', 'bio', '##chi', '##p', 'micro', '##arra', '##y', 'market', 'based', 'technology', 'and', 'application']",1
48636,nifty_166,2010-11-03,MAP Pharmaceuticals to Present at Upcoming Investor Conferences,Rise,0.0193,63,map pharmaceutical present upcoming investor conference,55,6,0,pharmacy,"['map', 'pharmaceutical', 'present', 'upcoming', 'investor', 'conference']",1
48646,nifty_166,2010-11-03,Research and Markets: the New Pharmaceutical Sales Force - Key Trends Shaping Future Sales Strategies,Rise,0.0193,101,research and market the new pharmaceutical sale force key trend shaping future sale strategy,92,14,0,pharmacy,"['research', 'and', 'market', 'the', 'new', 'pharmaceutical', 'sale', 'force', 'key', 'trend', 'shaping', 'future', 'sale', 'strategy']",1
48653,nifty_166,2010-11-03,BRIEF-Zealand Pharma says no use for new funds till 2014,Rise,0.0193,56,brief zealand pharma say use for new fund till,46,9,0,pharmacy,"['brief', 'z', '##eal', '##and', 'p', '##har', '##ma', 'say', 'use', 'for', 'new', 'fund', 'till']",1
48868,nifty_166,2010-11-03,Research and Markets: This Report Provides Insight into the Pipeline Status of Congestive Heart Failure Drugs by Company and By Stage As Well As a Summary of the Latest News and Developments,Rise,0.0193,190,research and market this report provides insight into the pipeline status congestive heart failure drug company and stage well summary the latest news and development,166,25,0,pharmacy,"['research', 'and', 'market', 'this', 'report', 'provides', 'insight', 'into', 'the', 'pipeline', 'status', 'con', '##ges', '##tive', 'heart', 'failure', 'drug', 'company', 'and', 'stage', 'well', 'summary', 'the', 'latest', 'news', 'and', 'development']",1
48915,nifty_166,2010-11-03,Research and Markets: Clinical Diagnostics Industry in East Africa,Rise,0.0193,66,research and market clinical diagnostics industry east africa,61,8,0,pharmacy,"['research', 'and', 'market', 'clinical', 'diagnostic', '##s', 'industry', 'east', 'a', '##f', '##rica']",1
48923,nifty_166,2010-11-03,TRADE NEWS: Agilent Technologies Expands Gene Expression Analysis Offerings With Microarrays Providing Exon-Level Insight,Rise,0.0193,121,trade news agilent technology expands gene expression analysis offering with microarrays providing exon level insight,117,15,0,pharmacy,"['trade', 'news', 'a', '##gi', '##lent', 'technology', 'expands', 'gene', 'expression', 'analysis', 'offering', 'with', 'micro', '##arra', '##ys', 'providing', 'ex', '##on', 'level', 'insight']",1
48950,nifty_166,2010-11-03,Cypin Production Announces Launch of U.S./China BioPharma Conference:,Rise,0.0193,69,cypin production announces launch china biopharma conference,60,7,0,pharmacy,"['c', '##y', '##pin', 'production', 'announces', 'launch', 'chin', '##a', 'bio', '##pha', '##rma', 'conference']",1
48981,nifty_166,2010-11-03,Research and Markets: the Obama Administration and the Pharmaceutical Industry - Overview of the 2009 Recovery Act and the 2010 Federal Budget,Rise,0.0193,142,research and market the obama administration and the pharmaceutical industry overview the recovery act and the federal budget,125,18,0,pharmacy,"['research', 'and', 'market', 'the', 'o', '##ba', '##ma', 'administration', 'and', 'the', 'pharmaceutical', 'industry', 'overview', 'the', 'recovery', 'act', 'and', 'the', 'federal', 'budget']",1
49058,nifty_166,2010-11-03,Research and Markets: Examine the Healthcare Information Technology Market in South Korea as the Country Rapidly Emerges as a Medical Hotspot,Rise,0.0193,141,research and market examine the healthcare information technology market south korea the country rapidly emerges medical hotspot,128,17,0,pharmacy,"['research', 'and', 'market', 'examine', 'the', 'healthcare', 'information', 'technology', 'market', 'south', 'k', '##ore', '##a', 'the', 'country', 'rapidly', 'emerges', 'medical', 'hot', '##sp', '##ot']",1
49066,nifty_166,2010-11-03,Research and Markets: Anemia - Pipeline Assessment and Market Forecasts to 2017,Rise,0.0193,79,research and market anemia pipeline assessment and market forecast,66,9,0,pharmacy,"['research', 'and', 'market', 'an', '##emia', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
49119,nifty_166,2010-11-03,"Final Biosimilars Pathway Must Make Patient Safety and Incentives for Continued Innovation Top Priorities, Says BIO",Rise,0.0193,115,final biosimilars pathway must make patient safety and incentive for continued innovation top priority say bio,110,16,0,pharmacy,"['final', 'bio', '##si', '##mi', '##lars', 'pathway', 'must', 'make', 'patient', 'safety', 'and', 'incentive', 'for', 'continued', 'innovation', 'top', 'priority', 'say', 'bio']",1
49145,nifty_166,2010-11-03,Research and Markets: A Greater Prevalence of Diabetes Patients Drives the Taiwanese SMBG Devices and Strips Market,Rise,0.0193,115,research and market greater prevalence diabetes patient drive the taiwanese smbg device and strip market,104,15,0,pharmacy,"['research', 'and', 'market', 'greater', 'prevalence', 'diabetes', 'patient', 'drive', 'the', 'ta', '##i', '##wan', '##ese', 's', '##mb', '##g', 'device', 'and', 'strip', 'market']",1
49244,nifty_166,2010-11-03,"Research and Markets: Eli Lilly Executive Report - a Publicly Traded Global Pharmaceutical Company Based in Indiana, US",Rise,0.0193,119,research and market eli lilly executive report publicly traded global pharmaceutical company based indiana,106,14,0,pharmacy,"['research', 'and', 'market', 'el', '##i', 'l', '##ill', '##y', 'executive', 'report', 'publicly', 'traded', 'global', 'pharmaceutical', 'company', 'based', 'in', '##dian', '##a']",1
49297,nifty_166,2010-11-03,Research and Markets: Key Trends Shaping Future Marketing Strategies in the Pharmaceutical Industry - Optimizing Your Online Channels,Rise,0.0193,133,research and market key trend shaping future marketing strategy the pharmaceutical industry optimizing your online channel,122,16,0,pharmacy,"['research', 'and', 'market', 'key', 'trend', 'shaping', 'future', 'marketing', 'strategy', 'the', 'pharmaceutical', 'industry', 'op', '##ti', '##mizing', 'your', 'online', 'channel']",1
49337,nifty_166,2010-11-03,Research and Markets: Immunoassay Systems - Global Strategic Business Report 2010 Features a Six-Year Historic Analysis for the Market and Estimates Up To 2015,Rise,0.0193,159,research and market immunoassay system global strategic business report feature six year historic analysis for the market and estimate,134,19,0,pharmacy,"['research', 'and', 'market', 'im', '##mu', '##no', '##ass', '##ay', 'system', 'global', 'strategic', 'business', 'report', 'feature', 'six', 'year', 'historic', 'analysis', 'for', 'the', 'market', 'and', 'estimate']",1
49401,nifty_166,2010-11-03,"BIO Urges Renewal of Therapeutic Discovery Project To Accelerate Research for New Therapies, Create Jobs And Maintain US Competitiveness",Rise,0.0193,136,bio urge renewal therapeutic discovery project accelerate research for new therapy create job and maintain competitiveness,122,16,0,pharmacy,"['bio', 'urge', 'renewal', 'therapeutic', 'discovery', 'project', 'accelerate', 'research', 'for', 'new', 'therapy', 'create', 'job', 'and', 'maintain', 'competitive', '##ness']",1
49441,nifty_166,2010-11-03,UPDATE 1-U.S. awards $1 billion to small biotechs,Rise,0.0193,49,update award billion small biotech,34,5,0,pharmacy,"['update', 'award', 'billion', 'small', 'bio', '##tech']",1
50406,nifty_170,2010-11-10,Research and Markets: Therapeutic Strategies in Diabetes,Neutral,-0.0038,56,research and market therapeutic strategy diabetes,49,6,0,pharmacy,"['research', 'and', 'market', 'therapeutic', 'strategy', 'diabetes']",1
50621,nifty_170,2010-11-10,"Driven by the Uptake of Several Emerging Agents, the MRSA Drug Market Will Increase From $631 Million in 2009 to $752 Million in 2019",Neutral,-0.0038,133,driven the uptake several emerging agent the mrsa drug market will increase from million million,96,15,0,pharmacy,"['driven', 'the', 'up', '##take', 'several', 'emerging', 'agent', 'the', 'm', '##rsa', 'drug', 'market', 'will', 'increase', 'from', 'million', 'million']",1
50623,nifty_170,2010-11-10,RXi Pharmaceuticals to Webcast Presentation at the Lazard Capital Markets Annual Healthcare Conference,Neutral,-0.0038,102,rxi pharmaceutical webcast presentation the lazard capital market annual healthcare conference,94,11,0,pharmacy,"['r', '##xi', 'pharmaceutical', 'web', '##cast', 'presentation', 'the', 'la', '##zard', 'capital', 'market', 'annual', 'healthcare', 'conference']",1
50645,nifty_170,2010-11-10,"Research and Markets: Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis 2010 Edition Makes It Easy To Find and Compare Analysis Between Different Areas",Neutral,-0.0038,157,research and market triple analysis lung cancer lymphoma and angiogenesis edition make easy find and compare analysis between different area,140,20,0,pharmacy,"['research', 'and', 'market', 'triple', 'analysis', 'lung', 'cancer', 'l', '##ymph', '##oma', 'and', 'an', '##gio', '##genesis', 'edition', 'make', 'easy', 'find', 'and', 'compare', 'analysis', 'between', 'different', 'area']",1
50695,nifty_170,2010-11-10,Research and Markets: Argentina Patient Monitoring and Diagnostic Systems Market Assessment and Forecasts to 2015,Neutral,-0.0038,113,research and market argentina patient monitoring and diagnostic system market assessment and forecast,101,13,0,pharmacy,"['research', 'and', 'market', 'a', '##rgent', '##ina', 'patient', 'monitoring', 'and', 'diagnostic', 'system', 'market', 'assessment', 'and', 'forecast']",1
50713,nifty_170,2010-11-10,"Zacks Industry Outlook Highlights: Bayer, Sanofi-Aventis, Alcon, Gilead Sciencesand Biogen Idec",Neutral,-0.0038,95,zacks industry outlook highlight bayer sanofi aventis alcon gilead sciencesand biogen idec,90,12,0,pharmacy,"['z', '##ack', '##s', 'industry', 'outlook', 'highlight', 'bay', '##er', 'sa', '##no', '##fi', 'a', '##vent', '##is', 'al', '##con', 'g', '##ile', '##ad', 'sciences', '##and', 'bio', '##gen', 'id', '##ec']",1
50771,nifty_170,2010-11-10,Research and Markets: Venezuela Pharmaceuticals and Healthcare Report Q4 2010,Neutral,-0.0038,77,research and market venezuela pharmaceutical and healthcare report,66,8,0,pharmacy,"['research', 'and', 'market', 've', '##ne', '##zu', '##ela', 'pharmaceutical', 'and', 'healthcare', 'report']",1
50836,nifty_170,2010-11-10,Research and Markets: Therapeutic Proteins to 2014,Neutral,-0.0038,50,research and market therapeutic protein,39,5,0,pharmacy,"['research', 'and', 'market', 'therapeutic', 'protein']",1
50843,nifty_170,2010-11-10,Research and Markets: Drug Self-Administration Markets to 2014,Neutral,-0.0038,62,research and market drug self administration market,51,7,0,pharmacy,"['research', 'and', 'market', 'drug', 'self', 'administration', 'market']",1
50845,nifty_170,2010-11-10,"Research and Markets: the Past Decade Has Seen a Dramatic Shift in Terms of the Types of Approved Injectable Drugs, the Diseases They Target, and the Devices Used to Deliver Them",Neutral,-0.0038,178,research and market the past decade ha seen dramatic shift term the type approved injectable drug the disease they target and the device used deliver them,154,26,0,pharmacy,"['research', 'and', 'market', 'the', 'past', 'decade', 'ha', 'seen', 'dramatic', 'shift', 'term', 'the', 'type', 'approved', 'in', '##ject', '##able', 'drug', 'the', 'disease', 'they', 'target', 'and', 'the', 'device', 'used', 'deliver', 'them']",1
50848,nifty_170,2010-11-10,Research and Markets: Biosimilars - The Future Transformation of Product Exclusivity in the Biotechnology Arena,Neutral,-0.0038,111,research and market biosimilars the future transformation product exclusivity the biotechnology arena,101,12,0,pharmacy,"['research', 'and', 'market', 'bio', '##si', '##mi', '##lars', 'the', 'future', 'transformation', 'product', 'ex', '##c', '##lus', '##ivity', 'the', 'bio', '##tech', '##nology', 'arena']",1
51049,nifty_170,2010-11-10,Tetraphase Announces Presentation at Lazard Capital Markets and Piper Jaffray & Co. Healthcare Conferences,Neutral,-0.0038,106,tetraphase announces presentation lazard capital market and piper jaffray healthcare conference,95,11,0,pharmacy,"['te', '##tra', '##pha', '##se', 'announces', 'presentation', 'la', '##zard', 'capital', 'market', 'and', 'pipe', '##r', 'j', '##af', '##fra', '##y', 'healthcare', 'conference']",1
51162,nifty_170,2010-11-10,China Medicine Reports Third Quarter 2010 Financial Results,Neutral,-0.0038,59,china medicine report third quarter financial result,52,7,0,pharmacy,"['chin', '##a', 'medicine', 'report', 'third', 'quarter', 'financial', 'result']",1
51173,nifty_170,2010-11-10," Marina Biotech, Inc. Announces Third Quarter 2010 Financial Results",Neutral,-0.0038,68,marina biotech inc announces third quarter financial result,59,8,0,pharmacy,"['ma', '##rina', 'bio', '##tech', 'in', '##c', 'announces', 'third', 'quarter', 'financial', 'result']",1
51180,nifty_170,2010-11-10, SciClone Pharmaceuticals to Present at Two Investor Conferences in November,Neutral,-0.0038,76,sciclone pharmaceutical present two investor conference november,64,7,0,pharmacy,"['s', '##ci', '##c', '##lone', 'pharmaceutical', 'present', 'two', 'investor', 'conference', 'no', '##ve', '##mber']",1
52309,nifty_181,2010-12-02,Research and Markets: Asia Pacific Diabetes Care Devices Market Outlook to 2016 Features Profiles of Key Companies Operating Within the Asia Pacific Surgical Equipment,Neutral,0.0027,167,research and market asia pacific diabetes care device market outlook feature profile key company operating within the asia pacific surgical equipment,149,21,0,pharmacy,"['research', 'and', 'market', 'as', '##ia', 'p', '##ac', '##ific', 'diabetes', 'care', 'device', 'market', 'outlook', 'feature', 'profile', 'key', 'company', 'operating', 'within', 'the', 'as', '##ia', 'p', '##ac', '##ific', 'surgical', 'equipment']",1
52342,nifty_181,2010-12-02,Research and Markets: Singapore Retail Report Q1 2011 Forecasts the Over-The-Counter (OTC) Pharmaceutical Sector to Be Worth US$0.13bn In 2011,Neutral,0.0027,142,research and market singapore retail report forecast the over the counter otc pharmaceutical sector worth,105,15,0,pharmacy,"['research', 'and', 'market', 'sing', '##ap', '##ore', 'retail', 'report', 'forecast', 'the', 'over', 'the', 'counter', 'o', '##t', '##c', 'pharmaceutical', 'sector', 'worth']",1
52442,nifty_181,2010-12-02, Barbados Government Launches Bold Initiatives to Attract Biotech Companies,Neutral,0.0027,75,barbados government launch bold initiative attract biotech company,66,8,0,pharmacy,"['bar', '##bad', '##os', 'government', 'launch', 'bold', 'initiative', 'attract', 'bio', '##tech', 'company']",1
52478,nifty_181,2010-12-02,Arteriocyte Announces the Launch of NANEXâ¢ Stem Cell Expansion System at the Upcoming American Society of Cell Biology Meeting,Neutral,0.0027,128,arteriocyte announces the launch nanexâ stem cell expansion system the upcoming american society cell biology meeting,117,16,0,pharmacy,"['art', '##eri', '##oc', '##yte', 'announces', 'the', 'launch', 'na', '##nex', '##â', 'stem', 'cell', 'expansion', 'system', 'the', 'upcoming', 'am', '##eric', '##an', 'society', 'cell', 'biology', 'meeting']",1
52558,nifty_181,2010-12-02,Advanced Cell Technology Strengthens Balance Sheet,Neutral,0.0027,50,advanced cell technology strengthens balance sheet,50,6,0,pharmacy,"['advanced', 'cell', 'technology', 'strengthen', '##s', 'balance', 'sheet']",1
52700,nifty_181,2010-12-02, Invitation-Immunovaccine Inc. Investor Reception,Neutral,0.0027,49,invitation immunovaccine inc investor reception,47,5,0,pharmacy,"['invitation', 'im', '##mu', '##nova', '##cci', '##ne', 'in', '##c', 'investor', 'reception']",1
52722,nifty_181,2010-12-02, Premier Diagnostic Health Services Inc. (CNSX: PDH) Announces Its CEO-China Operations Is Travelling to China to,Neutral,0.0027,113,premier diagnostic health service inc cnsx pdh announces it ceo china operation travelling china,96,14,0,pharmacy,"['premier', 'diagnostic', 'health', 'service', 'in', '##c', 'c', '##ns', '##x', 'p', '##dh', 'announces', 'it', 'c', '##eo', 'chin', '##a', 'operation', 'travelling', 'chin', '##a']",1
52762,nifty_181,2010-12-02, 'IN3 West' Will Offer Partnering Opportunities for Medtech Companies With Top Investors and Corporate Acquirers in Las,Neutral,0.0027,119,west will offer partnering opportunity for medtech company with top investor and corporate acquirer la,102,15,0,pharmacy,"['west', 'will', 'offer', 'partner', '##ing', 'opportunity', 'for', 'me', '##dt', '##ech', 'company', 'with', 'top', 'investor', 'and', 'corporate', 'acquire', '##r', 'la']",1
53138,nifty_181,2010-12-02,International SOS to Host Webinar on Managing Healthcare Needs of a Global Workforce in China,Neutral,0.0027,93,international so host webinar managing healthcare need global workforce china,77,10,0,pharmacy,"['international', 'so', 'host', 'web', '##ina', '##r', 'managing', 'healthcare', 'need', 'global', 'workforce', 'chin', '##a']",1
53908,nifty_184,2010-12-08,"Government Regulation of Drug Prices will Increase in Both Mature and Emerging Markets, Including Markets that Traditionally Play a Limited Role in Pharmaceutical Pricing",Neutral,0.0039,170,government regulation drug price will increase both mature and emerging market including market that traditionally play limited role pharmaceutical pricing,155,20,0,pharmacy,"['government', 'regulation', 'drug', 'price', 'will', 'increase', 'both', 'mature', 'and', 'emerging', 'market', 'including', 'market', 'that', 'traditionally', 'play', 'limited', 'role', 'pharmaceutical', 'pricing']",1
53955,nifty_184,2010-12-08,Catabasis Pharmaceuticals Secures $14.5 Million Second Tranche in Series A Financing,Neutral,0.0039,84,catabasis pharmaceutical secures million second tranche series financing,72,8,0,pharmacy,"['cat', '##aba', '##sis', 'pharmaceutical', 'secure', '##s', 'million', 'second', 't', '##ran', '##che', 'series', 'financing']",1
53992,nifty_184,2010-12-08,"Research and Markets: European Cancer Support Therapies Market - Analysing Market Drivers, Restraints & Challenges Faced by Industry Participants",Neutral,0.0039,145,research and market european cancer support therapy market analysing market driver restraint challenge faced industry participant,129,16,0,pharmacy,"['research', 'and', 'market', 'euro', '##pe', '##an', 'cancer', 'support', 'therapy', 'market', 'anal', '##ys', '##ing', 'market', 'driver', 'restraint', 'challenge', 'faced', 'industry', 'participant']",1
54193,nifty_184,2010-12-08,Research and Markets: Iran Pharmaceuticals and Healthcare Report Q1 2011,Neutral,0.0039,72,research and market iran pharmaceutical and healthcare report,61,8,0,pharmacy,"['research', 'and', 'market', 'i', '##ran', 'pharmaceutical', 'and', 'healthcare', 'report']",1
54220,nifty_184,2010-12-08, International Drug & Explosives Detection Company IDenta Corp Updates Shareholders,Neutral,0.0039,83,international drug explosive detection company identa corp update shareholder,77,9,0,pharmacy,"['international', 'drug', 'explosive', 'detection', 'company', 'id', '##ent', '##a', 'co', '##rp', 'update', 'shareholder']",1
54450,nifty_184,2010-12-08,"Global Growth in Healthcare Spending Creates Multi-Trillion Dollar Market Opportunity for Private Capital and Innovation, Says PwC",Neutral,0.0039,130,global growth healthcare spending creates multi trillion dollar market opportunity for private capital and innovation say pwc,125,17,0,pharmacy,"['global', 'growth', 'healthcare', 'spending', 'creates', 'multi', 'trillion', 'dollar', 'market', 'opportunity', 'for', 'private', 'capital', 'and', 'innovation', 'say', 'p', '##w', '##c']",1
54572,nifty_184,2010-12-08,Targeted Genetics Corporation Updates Investors on Annual Meeting Matters,Neutral,0.0039,73,targeted genetics corporation update investor annual meeting matter,67,8,0,pharmacy,"['targeted', 'genetics', 'corporation', 'update', 'investor', 'annual', 'meeting', 'matter']",1
54644,nifty_184,2010-12-08,Research and Markets: Southeast Asian Pharmaceuticals Industry: Generic Drug Market Picks up Traction in the Southeast Asian Pharmaceuticals Industry,Neutral,0.0039,149,research and market southeast asian pharmaceutical industry generic drug market pick traction the southeast asian pharmaceutical industry,137,17,0,pharmacy,"['research', 'and', 'market', 'southeast', 'as', '##ian', 'pharmaceutical', 'industry', 'generic', 'drug', 'market', 'pick', 'traction', 'the', 'southeast', 'as', '##ian', 'pharmaceutical', 'industry']",1
55167,nifty_185,2010-12-09, Advanced Cell Technology's CEO Says Markets Are Just Starting to Appreciate the Significance of Their Stem Cell Derived,Rise,0.0058,120,advanced cell technology ceo say market are just starting appreciate the significance their stem cell derived,109,16,0,pharmacy,"['advanced', 'cell', 'technology', 'c', '##eo', 'say', 'market', 'are', 'just', 'starting', 'appreciate', 'the', 'significance', 'their', 'stem', 'cell', 'derived']",1
55338,nifty_185,2010-12-09,Neoprobe Granted Pre-IND Meeting with FDA to Review RIGS Technology,Rise,0.0058,67,neoprobe granted pre ind meeting with fda review rig technology,63,10,0,pharmacy,"['neo', '##p', '##robe', 'granted', 'pre', 'in', '##d', 'meeting', 'with', 'f', '##da', 'review', 'rig', 'technology']",1
55345,nifty_185,2010-12-09,OpSec Security Identifies Latest Market Trends in the Online Sales of Prescription Drugs by Internet Pharmacies and B2B Trade Boards,Rise,0.0058,132,opsec security identifies latest market trend the online sale prescription drug internet pharmacy and trade board,113,16,0,pharmacy,"['op', '##se', '##c', 'security', 'identifies', 'latest', 'market', 'trend', 'the', 'online', 'sale', 'prescription', 'drug', 'internet', 'pharmacy', 'and', 'trade', 'board']",1
55350,nifty_185,2010-12-09,"Zacks Analyst Blog Highlights: Orexigen Therapeutics, Arena Pharmaceuticals, Vivus, MoneyGram Internationaland Western Union",Rise,0.0058,124,zacks analyst blog highlight orexigen therapeutic arena pharmaceutical vivus moneygram internationaland western union,117,13,0,pharmacy,"['z', '##ack', '##s', 'analyst', 'blog', 'highlight', 'ore', '##xi', '##gen', 'therapeutic', 'arena', 'pharmaceutical', 'v', '##iv', '##us', 'money', '##gram', 'international', '##and', 'western', 'union']",1
55447,nifty_185,2010-12-09, Reinstatement-Global Biotech Corp (GBQ),Rise,0.0058,40,reinstatement global biotech corp gbq,37,5,0,pharmacy,"['reins', '##tate', '##ment', 'global', 'bio', '##tech', 'co', '##rp', 'g', '##b', '##q']",1
55533,nifty_185,2010-12-09,"2nd Season of ""Wide World of Stocks"" Launches with Viral Genetics CEO Haig Keledjian",Rise,0.0058,84,season wide world stock launch with viral genetics ceo haig keledjian,69,11,0,pharmacy,"['season', 'wide', 'world', 'stock', 'launch', 'with', 'viral', 'genetics', 'c', '##eo', 'ha', '##ig', 'k', '##ele', '##d', '##ji', '##an']",1
55589,nifty_185,2010-12-09,Research and Markets: Pakistan Pharmaceuticals and Healthcare Report Q1 2011,Rise,0.0058,76,research and market pakistan pharmaceutical and healthcare report,65,8,0,pharmacy,"['research', 'and', 'market', 'p', '##aki', '##stan', 'pharmaceutical', 'and', 'healthcare', 'report']",1
55641,nifty_185,2010-12-09,"By 2019, the Acute Gout Drug Market Will Triple in Size While the Chronic Gout Drug Market Will Reach $1.83 Billion",Rise,0.0058,115,the acute gout drug market will triple size while the chronic gout drug market will reach billion,97,17,0,pharmacy,"['the', 'acute', 'go', '##ut', 'drug', 'market', 'will', 'triple', 'size', 'while', 'the', 'chronic', 'go', '##ut', 'drug', 'market', 'will', 'reach', 'billion']",1
55642,nifty_185,2010-12-09,"Medical Electronic Device Conference & Expo (MEDCon) Addresses Low-Power Design, Innovation and Regulatory Challenges for Medical Device Engineers and Designers",Rise,0.0058,160,medical electronic device conference expo medcon address low power design innovation and regulatory challenge for medical device engineer and designer,150,20,0,pharmacy,"['medical', 'electronic', 'device', 'conference', 'ex', '##po', 'me', '##d', '##con', 'address', 'low', 'power', 'design', 'innovation', 'and', 'regulatory', 'challenge', 'for', 'medical', 'device', 'engineer', 'and', 'designer']",1
55907,nifty_185,2010-12-09," Molecular Insight Announces $45-Million Financing Commitment, Chapter 11 Filing, Corporate Restructuring and Management",Rise,0.0058,120,molecular insight announces million financing commitment chapter filing corporate restructuring and management,110,12,0,pharmacy,"['molecular', 'insight', 'announces', 'million', 'financing', 'commitment', 'chapter', 'filing', 'corporate', 'restructuring', 'and', 'management']",1
56131,nifty_187,2010-12-14,UPDATE 1-UK's OFT to probe private healthcare market,Neutral,-0.0046,52,update oft probe private healthcare market,42,6,0,pharmacy,"['update', 'of', '##t', 'probe', 'private', 'healthcare', 'market']",1
56333,nifty_187,2010-12-14,Research and Markets: UK Hospital Treatment Plans Market Report - New Products and Products with Potential in the UK Financial Services Sector,Neutral,-0.0046,142,research and market hospital treatment plan market report new product and product with potential the financial service sector,125,18,0,pharmacy,"['research', 'and', 'market', 'hospital', 'treatment', 'plan', 'market', 'report', 'new', 'product', 'and', 'product', 'with', 'potential', 'the', 'financial', 'service', 'sector']",1
56424,nifty_187,2010-12-14,Research and Markets: Europe Drug Delivery Devices Market Outlook to 2016 Provides Company Shares and Distribution Shares Data,Neutral,-0.0046,126,research and market europe drug delivery device market outlook provides company share and distribution share data,113,16,0,pharmacy,"['research', 'and', 'market', 'euro', '##pe', 'drug', 'delivery', 'device', 'market', 'outlook', 'provides', 'company', 'share', 'and', 'distribution', 'share', 'data']",1
56652,nifty_187,2010-12-14, Closer Look: Advanced Cell Technology Among Stem Cell Sector Stocks That Have Recently Set Themselves Apart From the,Neutral,-0.0046,117,closer look advanced cell technology among stem cell sector stock that have recently set themselves apart from the,114,18,0,pharmacy,"['closer', 'look', 'advanced', 'cell', 'technology', 'among', 'stem', 'cell', 'sector', 'stock', 'that', 'have', 'recently', 'set', 'themselves', 'apart', 'from', 'the']",1
56685,nifty_187,2010-12-14,Research and Markets: Baxter International Inc-Deals & Alliances Report 2010,Neutral,-0.0046,76,research and market baxter international inc deal alliance report,65,9,0,pharmacy,"['research', 'and', 'market', 'b', '##ax', '##ter', 'international', 'in', '##c', 'deal', 'alliance', 'report']",1
56715,nifty_187,2010-12-14,Research and Markets: Cell Therapeutics Inc-Deals & Alliances Report 2010,Neutral,-0.0046,73,research and market cell therapeutic inc deal alliance report,61,9,0,pharmacy,"['research', 'and', 'market', 'cell', 'therapeutic', 'in', '##c', 'deal', 'alliance', 'report']",1
56752,nifty_187,2010-12-14,Research and Markets: Australia Pharmaceuticals and Healthcare Report Q1 2011,Neutral,-0.0046,77,research and market australia pharmaceutical and healthcare report,66,8,0,pharmacy,"['research', 'and', 'market', 'au', '##stra', '##lia', 'pharmaceutical', 'and', 'healthcare', 'report']",1
56834,nifty_187,2010-12-14,Research and Markets: Biobetters - Major Players and Market Prospects,Neutral,-0.0046,69,research and market biobetters major player and market prospect,63,9,0,pharmacy,"['research', 'and', 'market', 'bio', '##bet', '##ters', 'major', 'player', 'and', 'market', 'prospect']",1
56878,nifty_187,2010-12-14,Research and Markets: Examine the 2011 U.S. Market for Patient Monitoring Devices is it was Valued at $3 Billion in 2010,Neutral,-0.0046,120,research and market examine the market for patient monitoring device wa valued billion,86,13,0,pharmacy,"['research', 'and', 'market', 'examine', 'the', 'market', 'for', 'patient', 'monitoring', 'device', 'wa', 'valued', 'billion']",1
56880,nifty_187,2010-12-14,Research and Markets: This Report Forecasts the US Healthcare Sector to Grow at a CAGR of 5% during 2010-2013,Neutral,-0.0046,109,research and market this report forecast the healthcare sector grow cagr during,79,12,0,pharmacy,"['research', 'and', 'market', 'this', 'report', 'forecast', 'the', 'healthcare', 'sector', 'grow', 'ca', '##g', '##r', 'during']",1
56913,nifty_187,2010-12-14,Research and Markets: Pharma Market Insights: Generics,Neutral,-0.0046,54,research and market pharma market insight generic,49,7,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', 'market', 'insight', 'generic']",1
56916,nifty_187,2010-12-14,Research and Markets: Blood Glucose Meters and Strips - Global Strategic Business Report,Neutral,-0.0046,88,research and market blood glucose meter and strip global strategic business report,82,12,0,pharmacy,"['research', 'and', 'market', 'blood', 'glucose', 'meter', 'and', 'strip', 'global', 'strategic', 'business', 'report']",1
56945,nifty_187,2010-12-14,Research and Markets: Kenya Pharmaceuticals and Healthcare Report Q1 2011,Neutral,-0.0046,73,research and market kenya pharmaceutical and healthcare report,62,8,0,pharmacy,"['research', 'and', 'market', 'k', '##en', '##ya', 'pharmaceutical', 'and', 'healthcare', 'report']",1
57007,nifty_187,2010-12-14,"Research and Markets: Pro-Pharmaceuticals, Inc is Now Delivered as a Company Profile for all your Requirements on the Treatment of Cancer and Fibrosis",Neutral,-0.0046,150,research and market pro pharmaceutical inc now delivered company profile for all your requirement the treatment cancer and fibrosis,131,19,0,pharmacy,"['research', 'and', 'market', 'pro', 'pharmaceutical', 'in', '##c', 'now', 'delivered', 'company', 'profile', 'for', 'all', 'your', 'requirement', 'the', 'treatment', 'cancer', 'and', 'fi', '##bro', '##sis']",1
57091,nifty_187,2010-12-14,SurModics to Explore Strategic Alternatives for Its SurModics Pharmaceuticals Business,Neutral,-0.0046,86,surmodics explore strategic alternative for it surmodics pharmaceutical business,80,9,0,pharmacy,"['sur', '##mo', '##dic', '##s', 'explore', 'strategic', 'alternative', 'for', 'it', 'sur', '##mo', '##dic', '##s', 'pharmaceutical', 'business']",1
57113,nifty_187,2010-12-14,Bristol-Myers Squibb Announces Dividend Increase,Neutral,-0.0046,48,bristol myers squibb announces dividend increase,48,6,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'announces', 'divide', '##nd', 'increase']",1
57400,nifty_189,2010-12-16,Research and Markets: Prostate Cancer - Japan Drug Forecasts and Treatment Analysis to 2020,Neutral,-0.0042,91,research and market prostate cancer japan drug forecast and treatment analysis,78,11,0,pharmacy,"['research', 'and', 'market', 'pro', '##state', 'cancer', 'j', '##apa', '##n', 'drug', 'forecast', 'and', 'treatment', 'analysis']",1
57764,nifty_189,2010-12-16,"US Hoards $48B in Unobligated Health Funds as AIDS Drug Crisis Threatens Lives of Over 4,500 Americans, Says AHF",Neutral,-0.0042,112,hoard unobligated health fund aid drug crisis threatens life over american say ahf,82,13,0,pharmacy,"['ho', '##ard', 'un', '##ob', '##liga', '##ted', 'health', 'fund', 'aid', 'drug', 'crisis', 'threatens', 'life', 'over', 'am', '##eric', '##an', 'say', 'ah', '##f']",1
57923,nifty_189,2010-12-16,Water Street Healthcare Partners Announces Investment in New Century Health,Neutral,-0.0042,75,water street healthcare partner announces investment new century health,71,9,0,pharmacy,"['water', 'street', 'healthcare', 'partner', 'announces', 'investment', 'new', 'century', 'health']",1
57946,nifty_189,2010-12-16,Research and Markets: Europe Hospital Supplies Market Outlook to 2016,Neutral,-0.0042,69,research and market europe hospital supply market outlook,57,8,0,pharmacy,"['research', 'and', 'market', 'euro', '##pe', 'hospital', 'supply', 'market', 'outlook']",1
57951,nifty_189,2010-12-16,Research and Markets: Diabetes Market to 2016 - Biguanides and Insulin Analogs will be the Largest Selling Anti-Diabetic Drugs,Neutral,-0.0042,126,research and market diabetes market biguanides and insulin analog will the largest selling anti diabetic drug,109,16,0,pharmacy,"['research', 'and', 'market', 'diabetes', 'market', 'big', '##uan', '##ides', 'and', 'insulin', 'analog', 'will', 'the', 'largest', 'selling', 'anti', 'di', '##abe', '##tic', 'drug']",1
57983,nifty_189,2010-12-16,"Research and Markets: More Than 200 Million mHealth Applications Are in Use Today, And That Number Is Expected to Increase Threefold By 2012",Neutral,-0.0042,140,research and market more than million mhealth application are use today and that number expected increase threefold,115,17,0,pharmacy,"['research', 'and', 'market', 'more', 'than', 'million', 'm', '##hea', '##lt', '##h', 'application', 'are', 'use', 'today', 'and', 'that', 'number', 'expected', 'increase', 'three', '##fold']",1
58085,nifty_189,2010-12-16,Research and Markets: Healthcare Trends & Forecasts in 2011: Performance Expectations for the Healthcare Industry,Neutral,-0.0042,113,research and market healthcare trend forecast performance expectation for the healthcare industry,97,12,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'trend', 'forecast', 'performance', 'expectation', 'for', 'the', 'healthcare', 'industry']",1
58115,nifty_189,2010-12-16,Research and Markets: North America Drug Delivery Devices Market Outlook to 2016,Neutral,-0.0042,80,research and market north america drug delivery device market outlook,69,10,0,pharmacy,"['research', 'and', 'market', 'north', 'am', '##eric', '##a', 'drug', 'delivery', 'device', 'market', 'outlook']",1
58169,nifty_189,2010-12-16,Research and Markets: Examine the US Biotech Market with this Essential Analysis as the Industry is Expected to Reach US$ 95 Billion by 2013,Neutral,-0.0042,140,research and market examine the biotech market with this essential analysis the industry expected reach billion,111,16,0,pharmacy,"['research', 'and', 'market', 'examine', 'the', 'bio', '##tech', 'market', 'with', 'this', 'essential', 'analysis', 'the', 'industry', 'expected', 'reach', 'billion']",1
58171,nifty_189,2010-12-16,Research and Markets: Candidiasis Therapeutics Market - Pipeline Assessment and Market Forecasts to 2017,Neutral,-0.0042,104,research and market candidiasis therapeutic market pipeline assessment and market forecast,90,11,0,pharmacy,"['research', 'and', 'market', 'can', '##di', '##dia', '##sis', 'therapeutic', 'market', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
58214,nifty_189,2010-12-16,Research and Markets: Europe Patient Monitoring Market Outlook to 2016,Neutral,-0.0042,70,research and market europe patient monitoring market outlook,60,8,0,pharmacy,"['research', 'and', 'market', 'euro', '##pe', 'patient', 'monitoring', 'market', 'outlook']",1
58231,nifty_189,2010-12-16,Research and Markets: Ulcerative Colitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017,Neutral,-0.0042,104,research and market ulcerative colitis therapeutic pipeline assessment and market forecast,90,11,0,pharmacy,"['research', 'and', 'market', 'ul', '##cer', '##ative', 'co', '##lit', '##is', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
58295,nifty_189,2010-12-16,Research and Markets: The Pharmaceutical Market: USA,Neutral,-0.0042,52,research and market the pharmaceutical market usa,49,7,0,pharmacy,"['research', 'and', 'market', 'the', 'pharmaceutical', 'market', 'us', '##a']",1
58305,nifty_189,2010-12-16,Research and Markets: King Pharmaceuticals Inc.: PharmaVitae Profile 2010 Gives a Strategic Insight into the Prospects for King Pharmaceuticals Inc over The Next Six Years,Neutral,-0.0042,171,research and market king pharmaceutical inc pharmavitae profile give strategic insight into the prospect for king pharmaceutical inc over the next six year,155,23,0,pharmacy,"['research', 'and', 'market', 'king', 'pharmaceutical', 'in', '##c', 'p', '##har', '##ma', '##vi', '##ta', '##e', 'profile', 'give', 'strategic', 'insight', 'into', 'the', 'prospect', 'for', 'king', 'pharmaceutical', 'in', '##c', 'over', 'the', 'next', 'six', 'year']",1
58450,nifty_189,2010-12-16,"BioMimetic Therapeutics, Inc. Continues to Enhance Patent Portfolio",Neutral,-0.0042,67,biomimetic therapeutic inc continues enhance patent portfolio,61,7,0,pharmacy,"['bio', '##mi', '##met', '##ic', 'therapeutic', 'in', '##c', 'continues', 'enhance', 'patent', 'portfolio']",1
58548,nifty_189,2010-12-16,Research and Markets: Asia-Pacific Patient Monitoring Market Outlook to 2016,Neutral,-0.0042,76,research and market asia pacific patient monitoring market outlook,66,9,0,pharmacy,"['research', 'and', 'market', 'as', '##ia', 'p', '##ac', '##ific', 'patient', 'monitoring', 'market', 'outlook']",1
58966,nifty_192,2010-12-22,"Research and Markets: China Pharmaceutical Chain Industry Report, 2010",Neutral,-0.0014,70,research and market china pharmaceutical chain industry report,62,8,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'pharmaceutical', 'chain', 'industry', 'report']",1
59143,nifty_192,2010-12-22,Research and Markets: the Pharmaceutical Market - Singapore,Neutral,-0.0014,59,research and market the pharmaceutical market singapore,55,7,0,pharmacy,"['research', 'and', 'market', 'the', 'pharmaceutical', 'market', 'sing', '##ap', '##ore']",1
59144,nifty_192,2010-12-22,Research and Markets: Pipeline and Commercial Insight: Schizophrenia - Opportunity remains beyond positive symptoms,Neutral,-0.0014,115,research and market pipeline and commercial insight schizophrenia opportunity remains beyond positive symptom,109,13,0,pharmacy,"['research', 'and', 'market', 'pipeline', 'and', 'commercial', 'insight', 's', '##chi', '##zophrenia', 'opportunity', 'remains', 'beyond', 'positive', 's', '##ym', '##pt', '##om']",1
59148,nifty_192,2010-12-22,Research and Markets: the Pharmaceutical Market: Bulgaria Review,Neutral,-0.0014,64,research and market the pharmaceutical market bulgaria review,61,8,0,pharmacy,"['research', 'and', 'market', 'the', 'pharmaceutical', 'market', 'b', '##ul', '##gar', '##ia', 'review']",1
59179,nifty_192,2010-12-22, Healthnostics Addresses Stock Price,Neutral,-0.0014,36,healthnostics address stock price,33,4,0,pharmacy,"['health', '##nos', '##tics', 'address', 'stock', 'price']",1
59189,nifty_192,2010-12-22,Research and Markets: The Pharmaceutical Market: Colombian Review,Neutral,-0.0014,65,research and market the pharmaceutical market colombian review,62,8,0,pharmacy,"['research', 'and', 'market', 'the', 'pharmaceutical', 'market', 'co', '##lo', '##mb', '##ian', 'review']",1
59227,nifty_192,2010-12-22,Research and Markets: The Pharmaceutical Market: Denmark Review,Neutral,-0.0014,63,research and market the pharmaceutical market denmark review,60,8,0,pharmacy,"['research', 'and', 'market', 'the', 'pharmaceutical', 'market', 'den', '##mark', 'review']",1
59248,nifty_192,2010-12-22,Research and Markets: The Pharmaceutical Market: Cuban Review,Neutral,-0.0014,61,research and market the pharmaceutical market cuban review,58,8,0,pharmacy,"['research', 'and', 'market', 'the', 'pharmaceutical', 'market', 'cu', '##ban', 'review']",1
59363,nifty_192,2010-12-22," PennyKings.Com Mid-Day Report: Neurokine Pharmaceuticals, Corcept Therapeutics, Pfizer, Martek Biosciences, Sunesis",Neutral,-0.0014,116,pennykings com mid day report neurokine pharmaceutical corcept therapeutic pfizer martek bioscience sunesis,107,13,0,pharmacy,"['penny', '##king', '##s', 'com', 'mid', 'day', 'report', 'ne', '##uro', '##kin', '##e', 'pharmaceutical', 'co', '##rc', '##ept', 'therapeutic', 'p', '##fi', '##zer', 'ma', '##rte', '##k', 'bio', '##science', 'sun', '##esis']",1
59365,nifty_192,2010-12-22,Research and Markets: The Pharmaceutical Market - South Korea: South Korean Biologics Sector Experiencing Rapid Growth,Neutral,-0.0014,118,research and market the pharmaceutical market south korea south korean biologics sector experiencing rapid growth,113,15,0,pharmacy,"['research', 'and', 'market', 'the', 'pharmaceutical', 'market', 'south', 'k', '##ore', '##a', 'south', 'k', '##ore', '##an', 'bio', '##log', '##ics', 'sector', 'experiencing', 'rapid', 'growth']",1
59425,nifty_192,2010-12-22,Research and Markets: Proteomics - Global Strategic Business Report Reveals Vital Forecasts up to 2015 and Profiles of 168 Companies,Neutral,-0.0014,132,research and market proteomics global strategic business report reveals vital forecast and profile company,106,14,0,pharmacy,"['research', 'and', 'market', 'pro', '##te', '##omi', '##cs', 'global', 'strategic', 'business', 'report', 'reveals', 'vital', 'forecast', 'and', 'profile', 'company']",1
59811,nifty_193,2010-12-27, Interview With the CEO of Radient Pharmaceuticals Provides Perspective as Company Shares See Increased Volume and,Neutral,0.0014,114,interview with the ceo radient pharmaceutical provides perspective company share see increased volume and,105,14,0,pharmacy,"['interview', 'with', 'the', 'c', '##eo', 'r', '##adi', '##ent', 'pharmaceutical', 'provides', 'perspective', 'company', 'share', 'see', 'increased', 'volume', 'and']",1
59864,nifty_193,2010-12-27," PennyKings.com Morning Report: Neurokine Pharmaceuticals, Repros Therapeutics Inc., Pfizer, Xoma Ltd., Biosante",Neutral,0.0014,112,pennykings com morning report neurokine pharmaceutical repros therapeutic inc pfizer xoma ltd biosante,102,13,0,pharmacy,"['penny', '##king', '##s', 'com', 'morning', 'report', 'ne', '##uro', '##kin', '##e', 'pharmaceutical', 're', '##p', '##ros', 'therapeutic', 'in', '##c', 'p', '##fi', '##zer', 'x', '##oma', 'l', '##t', '##d', 'bio', '##san', '##te']",1
60473,nifty_195,2010-12-29,"DARA BioSciences, Inc. Prices Registered Securities Offering",Neutral,-0.0016,60,dara bioscience inc price registered security offering,54,7,0,pharmacy,"['da', '##ra', 'bio', '##science', 'in', '##c', 'price', 'registered', 'security', 'offering']",1
60500,nifty_195,2010-12-29, Wall Street Analyst Bogner Publishes Speculative Buy Recommendation on Radient Pharmaceuticals; Sets 6-12 Month Price,Neutral,-0.0016,118,wall street analyst bogner publishes speculative buy recommendation radient pharmaceutical set month price,106,13,0,pharmacy,"['wall', 'street', 'analyst', 'b', '##og', '##ner', 'publishes', 's', '##peculative', 'buy', 'recommendation', 'r', '##adi', '##ent', 'pharmaceutical', 'set', 'month', 'price']",1
60678,nifty_195,2010-12-29,Get Ready for Drug Bust Flurry at 2012 London Olympics Say Ex-White House Drug Spokesman Robert Weiner and Analyst Caitlin Harrison,Neutral,-0.0016,131,get ready for drug bust flurry london olympics say white house drug spokesman robert weiner and analyst caitlin harrison,120,19,0,pharmacy,"['get', 'ready', 'for', 'drug', 'bust', 'flu', '##rry', 'lo', '##ndon', 'o', '##ly', '##mp', '##ics', 'say', 'white', 'house', 'drug', 'spokesman', 'robe', '##rt', 'we', '##iner', 'and', 'analyst', 'ca', '##it', '##lin', 'ha', '##rri', '##son']",1
61328,nifty_202,2011-01-11,"Research and Markets: Emerging Markets Clinical Development Series: Brazil, Russia, India and China (BRIC)",Rise,0.009,106,research and market emerging market clinical development series brazil russia india and china bric,98,14,0,pharmacy,"['research', 'and', 'market', 'emerging', 'market', 'clinical', 'development', 'series', 'bra', '##zi', '##l', 'r', '##uss', '##ia', 'in', '##dia', 'and', 'chin', '##a', 'br', '##ic']",1
61375,nifty_202,2011-01-11,"Research and Markets: Estonia Pharmaceuticals and Healthcare Report Q1 2011 - By 2014, the Value of the Estonian Market for Medical Devices Is Expected To Rise to EEK1.47bn (US$118mn)",Rise,0.009,183,research and market estonia pharmaceutical and healthcare report the value the estonian market for medical device expected rise eek,131,19,0,pharmacy,"['research', 'and', 'market', 'est', '##onia', 'pharmaceutical', 'and', 'healthcare', 'report', 'the', 'value', 'the', 'est', '##onia', '##n', 'market', 'for', 'medical', 'device', 'expected', 'rise', 'e', '##ek']",1
61502,nifty_202,2011-01-11,Research and Markets: 2011 Worldwide Offices of Physicians Industry Report with 2012 Forecasts,Rise,0.009,94,research and market worldwide office physician industry report with forecast,76,10,0,pharmacy,"['research', 'and', 'market', 'worldwide', 'office', 'physician', 'industry', 'report', 'with', 'forecast']",1
61570,nifty_202,2011-01-11,Research and Markets: South Korea Pharmaceuticals and Healthcare Report Q1 2011,Rise,0.009,79,research and market south korea pharmaceutical and healthcare report,68,9,0,pharmacy,"['research', 'and', 'market', 'south', 'k', '##ore', '##a', 'pharmaceutical', 'and', 'healthcare', 'report']",1
61598,nifty_202,2011-01-11,CareFirst Expands Technology Offering To Consumer Market With BENEFITFOCUS eBilling,Rise,0.009,83,carefirst expands technology offering consumer market with benefitfocus ebilling,80,9,0,pharmacy,"['care', '##fi', '##rst', 'expands', 'technology', 'offering', 'consumer', 'market', 'with', 'benefit', '##fo', '##cus', 'e', '##bill', '##ing']",1
61754,nifty_202,2011-01-11,Research and Markets: Multiparameter Patient Monitoring Market to 2016 - Increasing Demand from Emerging Markets to Upset Global Market Maturity,Rise,0.009,144,research and market multiparameter patient monitoring market increasing demand from emerging market upset global market maturity,128,16,0,pharmacy,"['research', 'and', 'market', 'multi', '##par', '##ame', '##ter', 'patient', 'monitoring', 'market', 'increasing', 'demand', 'from', 'emerging', 'market', 'upset', 'global', 'market', 'maturity']",1
61779,nifty_202,2011-01-11,"Research and Markets: Heart Failure - Pipeline Review, Q4 2010",Rise,0.009,62,research and market heart failure pipeline review,49,7,0,pharmacy,"['research', 'and', 'market', 'heart', 'failure', 'pipeline', 'review']",1
61792,nifty_202,2011-01-11,"Research and Markets: Wounds - Pipeline Review, Q4 2010",Rise,0.009,55,research and market wound pipeline review,41,6,0,pharmacy,"['research', 'and', 'market', 'wound', 'pipeline', 'review']",1
61799,nifty_202,2011-01-11,Research and Markets: Guide to U.S. Specialty Pharmaceutical Market: 90+ Companies Marketing More than 550 Prescription Pharmaceutical Products,Rise,0.009,143,research and market guide specialty pharmaceutical market company marketing more than prescription pharmaceutical product,121,14,0,pharmacy,"['research', 'and', 'market', 'guide', 'specialty', 'pharmaceutical', 'market', 'company', 'marketing', 'more', 'than', 'prescription', 'pharmaceutical', 'product']",1
61823,nifty_202,2011-01-11,"Research and Markets: Burns - Pipeline Review, Q4 2010",Rise,0.009,54,research and market burn pipeline review,40,6,0,pharmacy,"['research', 'and', 'market', 'burn', 'pipeline', 'review']",1
61866,nifty_202,2011-01-11,Research and Markets: Medical Equipment Monthly Deals Analysis: M&A; and Investment Trends - Q4 2010,Rise,0.009,100,research and market medical equipment monthly deal analysis and investment trend,80,11,0,pharmacy,"['research', 'and', 'market', 'medical', 'equipment', 'monthly', 'deal', 'analysis', 'and', 'investment', 'trend']",1
61967,nifty_202,2011-01-11,Research and Markets: Enzon Pharmaceuticals Inc-Detailed Product Pipeline,Rise,0.009,73,research and market enzon pharmaceutical inc detailed product pipeline,70,9,0,pharmacy,"['research', 'and', 'market', 'en', '##zon', 'pharmaceutical', 'in', '##c', 'detailed', 'product', 'pipeline']",1
61973,nifty_202,2011-01-11,Research and Markets: Ligand Pharmaceuticals Inc-Detailed Product Pipeline,Rise,0.009,74,research and market ligand pharmaceutical inc detailed product pipeline,71,9,0,pharmacy,"['research', 'and', 'market', 'l', '##igan', '##d', 'pharmaceutical', 'in', '##c', 'detailed', 'product', 'pipeline']",1
62002,nifty_202,2011-01-11,Research and Markets: ISTA Pharmaceuticals Inc-Detailed Product Pipeline,Rise,0.009,72,research and market ista pharmaceutical inc detailed product pipeline,69,9,0,pharmacy,"['research', 'and', 'market', 'is', '##ta', 'pharmaceutical', 'in', '##c', 'detailed', 'product', 'pipeline']",1
62020,nifty_202,2011-01-11,Research and Markets: Penwest Pharmaceuticals Co-Detailed Product Pipeline,Rise,0.009,74,research and market penwest pharmaceutical detailed product pipeline,68,8,0,pharmacy,"['research', 'and', 'market', 'pen', '##wes', '##t', 'pharmaceutical', 'detailed', 'product', 'pipeline']",1
62034,nifty_202,2011-01-11,TOMORROW: U.S. CTO Aneesh Chopra and CNN`s Fareed Zakaria to Headline National Medical Innovation Forum,Rise,0.009,103,tomorrow cto aneesh chopra and cnn fareed zakaria headline national medical innovation forum,92,13,0,pharmacy,"['tomorrow', 'c', '##to', 'an', '##ees', '##h', 'ch', '##op', '##ra', 'and', 'c', '##nn', 'fare', '##ed', 'z', '##aka', '##ria', 'headline', 'national', 'medical', 'innovation', 'forum']",1
62145,nifty_202,2011-01-11,Biogen Idec Provides Business Update at Investor Meeting,Rise,0.009,56,biogen idec provides business update investor meeting,53,7,0,pharmacy,"['bio', '##gen', 'id', '##ec', 'provides', 'business', 'update', 'investor', 'meeting']",1
62303,nifty_202,2011-01-11,Research and Markets: Emerging Markets Clinical Development Series in Asia - Addresses Challenges & Answer Key Questions About Conducting Clinical Trials in Asia,Rise,0.009,161,research and market emerging market clinical development series asia address challenge answer key question about conducting clinical trial asia,143,19,0,pharmacy,"['research', 'and', 'market', 'emerging', 'market', 'clinical', 'development', 'series', 'as', '##ia', 'address', 'challenge', 'answer', 'key', 'question', 'about', 'conducting', 'clinical', 'trial', 'as', '##ia']",1
62319,nifty_202,2011-01-11,Research and Markets: Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market,Rise,0.009,168,research and market oncology market china better access cancer therapy for the rising cancer population through healthcare reform drive the market,146,21,0,pharmacy,"['research', 'and', 'market', 'on', '##cology', 'market', 'chin', '##a', 'better', 'access', 'cancer', 'therapy', 'for', 'the', 'rising', 'cancer', 'population', 'through', 'healthcare', 'reform', 'drive', 'the', 'market']",1
62408,nifty_203,2011-01-12,St. Jude Estimates Strong Revenue,Neutral,-0.0016,33,jude estimate strong revenue,28,4,0,pharmacy,"['j', '##ude', 'estimate', 'strong', 'revenue']",1
63003,nifty_207,2011-01-20,Research and Markets: Brain Tumor - Pipeline Assessment and Market Forecasts to 2017,Neutral,0.0023,84,research and market brain tumor pipeline assessment and market forecast,71,10,0,pharmacy,"['research', 'and', 'market', 'brain', 'tumor', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
63093,nifty_207,2011-01-20,PwC and BIOTECanada: Life Sciences Survey Shows Industry Wants Government to Step up Its Support,Neutral,0.0023,96,pwc and biotecanada life science survey show industry want government step it support,85,13,0,pharmacy,"['p', '##w', '##c', 'and', 'bio', '##teca', '##na', '##da', 'life', 'science', 'survey', 'show', 'industry', 'want', 'government', 'step', 'it', 'support']",1
63122,nifty_207,2011-01-20,Money meets innovation at Biotech Showcase 2011,Neutral,0.0023,47,money meet innovation biotech showcase,38,5,0,pharmacy,"['money', 'meet', 'innovation', 'bio', '##tech', 'showcase']",1
63168,nifty_207,2011-01-20, Radient Pharmaceuticals Receives Updated European Union Certification for Onko-Sure(R); CE Mark Opens Large Market for,Neutral,0.0023,119,radient pharmaceutical receives updated european union certification for onko sure mark open large market for,109,15,0,pharmacy,"['r', '##adi', '##ent', 'pharmaceutical', 'receives', 'updated', 'euro', '##pe', '##an', 'union', 'certification', 'for', 'on', '##ko', 'sure', 'mark', 'open', 'large', 'market', 'for']",1
63221,nifty_207,2011-01-20,"Griffin Securities, Inc. Announces Investment Opinion on ZIOPHARM Oncology, Inc.",Neutral,0.0023,80,griffin security inc announces investment opinion ziopharm oncology inc,71,9,0,pharmacy,"['g', '##riff', '##in', 'security', 'in', '##c', 'announces', 'investment', 'opinion', 'z', '##io', '##pha', '##rm', 'on', '##cology', 'in', '##c']",1
63315,nifty_207,2011-01-20,Research and Markets: Bronchitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017,Neutral,0.0023,96,research and market bronchitis therapeutic pipeline assessment and market forecast,82,10,0,pharmacy,"['research', 'and', 'market', 'br', '##on', '##chi', '##tis', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
63388,nifty_207,2011-01-20,"Research and Markets: Depression - Pipeline Review, Q4 2010",Neutral,0.0023,59,research and market depression pipeline review,46,6,0,pharmacy,"['research', 'and', 'market', 'depression', 'pipeline', 'review']",1
63402,nifty_207,2011-01-20,SCHEDULE CHANGE: Roundtable for Reporters: Industrial Biotech Companies Discuss USDA BioPreferredSM Certified Biobased Product Label,Neutral,0.0023,132,schedule change roundtable for reporter industrial biotech company discus usda biopreferredsm certified biobased product label,126,15,0,pharmacy,"['schedule', 'change', 'round', '##table', 'for', 'reporter', 'industrial', 'bio', '##tech', 'company', 'disc', '##us', 'us', '##da', 'bio', '##p', '##re', '##ferred', '##sm', 'certified', 'bio', '##base', '##d', 'product', 'label']",1
63475,nifty_207,2011-01-20,"Research and Markets: Fatigue - Pipeline Review, Q4 2010",Neutral,0.0023,56,research and market fatigue pipeline review,43,6,0,pharmacy,"['research', 'and', 'market', 'fatigue', 'pipeline', 'review']",1
63581,nifty_207,2011-01-20,"Research and Markets: Forecast Insight: Depression - High Rewards for Novel and Adjunctive Therapies in Treatment-Resistant Depression, Says 2011 Study",Neutral,0.0023,151,research and market forecast insight depression high reward for novel and adjunctive therapy treatment resistant depression say study,133,18,0,pharmacy,"['research', 'and', 'market', 'forecast', 'insight', 'depression', 'high', 'reward', 'for', 'novel', 'and', 'ad', '##junct', '##ive', 'therapy', 'treatment', 'resistant', 'depression', 'say', 'study']",1
63592,nifty_207,2011-01-20,Research and Markets: Sanofi-Aventis: PharmaVitae Profile 2011 Benchmarks Sanofi-Aventis's performance against key rivals,Neutral,0.0023,121,research and market sanofi aventis pharmavitae profile benchmark sanofi aventis performance against key rival,109,14,0,pharmacy,"['research', 'and', 'market', 'sa', '##no', '##fi', 'a', '##vent', '##is', 'p', '##har', '##ma', '##vi', '##ta', '##e', 'profile', 'bench', '##mark', 'sa', '##no', '##fi', 'a', '##vent', '##is', 'performance', 'against', 'key', 'rival']",1
63601,nifty_207,2011-01-20,"Research and Markets: Case or Care Management, 3rd Edition (2011 Update)",Neutral,0.0023,72,research and market case care management edition update,55,8,0,pharmacy,"['research', 'and', 'market', 'case', 'care', 'management', 'edition', 'update']",1
63608,nifty_207,2011-01-20,Research and Markets: Stakeholder Insight: Epilepsy - Neurologists Remain Loyal to Brands in Genericized Market States 2011 Study,Neutral,0.0023,129,research and market stakeholder insight epilepsy neurologist remain loyal brand genericized market state study,110,14,0,pharmacy,"['research', 'and', 'market', 'stake', '##holder', 'insight', 'e', '##pile', '##psy', 'ne', '##uro', '##logist', 'remain', 'loyal', 'brand', 'generic', '##ized', 'market', 'state', 'study']",1
63646,nifty_207,2011-01-20,"Research and Markets: U.S. Market for Magnetic Resonance, Computed Tomography and Nuclear Medicine 2010",Neutral,0.0023,103,research and market market for magnetic resonance computed tomography and nuclear medicine,90,12,0,pharmacy,"['research', 'and', 'market', 'market', 'for', 'magnetic', 'resonance', 'com', '##puted', 'to', '##mo', '##graphy', 'and', 'nuclear', 'medicine']",1
63665,nifty_207,2011-01-20,"Delisting of Securities of Molecular Insight Pharmaceuticals, Inc., Helicos BioSciences...",Neutral,0.0023,90,delisting security molecular insight pharmaceutical inc helicos bioscience,74,8,0,pharmacy,"['del', '##ist', '##ing', 'security', 'molecular', 'insight', 'pharmaceutical', 'in', '##c', 'he', '##lic', '##os', 'bio', '##science']",1
63711,nifty_207,2011-01-20,"Research and Markets: Drug Solubility Technology and Platforms: Evolving Strategies, Emerging Opportunities",Neutral,0.0023,107,research and market drug solubility technology and platform evolving strategy emerging opportunity,98,12,0,pharmacy,"['research', 'and', 'market', 'drug', 'so', '##lub', '##ility', 'technology', 'and', 'platform', 'evolving', 'strategy', 'emerging', 'opportunity']",1
64080,nifty_210,2011-01-26,St. Jude Profit Rises 8.9%,Neutral,0.0025,26,jude profit rise,16,3,0,pharmacy,"['j', '##ude', 'profit', 'rise']",1
64162,nifty_211,2011-01-27,Drug Makers Expect Tough 2011,Fall,-0.0175,29,drug maker expect tough,23,4,0,pharmacy,"['drug', 'maker', 'expect', 'tough']",1
64213,nifty_211,2011-01-27,Decline Found in Freshmen's Mental Health,Fall,-0.0175,41,decline found freshman mental health,36,5,0,pharmacy,"['decline', 'found', 'freshman', 'mental', 'health']",1
64809,nifty_214,2011-02-02,"BioClinica, Inc. to Participate in Upcoming Industry Events and Demonstrate Global Technology-Enhanced Capabilities",Neutral,0.0022,115,bioclinica inc participate upcoming industry event and demonstrate global technology enhanced capability,104,12,0,pharmacy,"['bio', '##c', '##lini', '##ca', 'in', '##c', 'participate', 'upcoming', 'industry', 'event', 'and', 'demonstrate', 'global', 'technology', 'enhanced', 'capability']",1
64831,nifty_214,2011-02-02,RCS - Trinity Biotech PLC - Trinity Biotech Acquires Phoenix Biotech,Neutral,0.0022,68,rcs trinity biotech plc trinity biotech acquires phoenix biotech,64,9,0,pharmacy,"['r', '##cs', 't', '##rini', '##ty', 'bio', '##tech', 'plc', 't', '##rini', '##ty', 'bio', '##tech', 'acquire', '##s', 'p', '##hoe', '##ni', '##x', 'bio', '##tech']",1
64884,nifty_214,2011-02-02,"Research and Markets: Modern Pharmaceutics, Fifth Edition (2 Vol Set) Helps You Stay Current with the Basic Sciences, Systems, Applications and Advances in Drug Development",Neutral,0.0022,172,research and market modern pharmaceutic fifth edition vol set help you stay current with the basic science system application and advance drug development,154,23,0,pharmacy,"['research', 'and', 'market', 'modern', 'p', '##har', '##ma', '##ce', '##uti', '##c', 'fifth', 'edition', 'vol', 'set', 'help', 'you', 'stay', 'current', 'with', 'the', 'basic', 'science', 'system', 'application', 'and', 'advance', 'drug', 'development']",1
64973,nifty_214,2011-02-02,Research and Markets: Ghana Pharmaceuticals and Healthcare Report Q1 2011,Neutral,0.0022,73,research and market ghana pharmaceutical and healthcare report,62,8,0,pharmacy,"['research', 'and', 'market', 'g', '##hana', 'pharmaceutical', 'and', 'healthcare', 'report']",1
65007,nifty_214,2011-02-02,"Pharmaceutical Industry Bracing for Record Patent Expiries, EvaluatePharma Data Reveals",Neutral,0.0022,87,pharmaceutical industry bracing for record patent expiry evaluatepharma data reveals,84,10,0,pharmacy,"['pharmaceutical', 'industry', 'bra', '##cing', 'for', 'record', 'patent', 'ex', '##pi', '##ry', 'evaluate', '##pha', '##rma', 'data', 'reveals']",1
65017,nifty_214,2011-02-02,Research and Markets: Gastroesophageal Reflux Disease (GERD) Therapeutics - Pipeline Assessment and Market Forecasts to 2017,Neutral,0.0022,124,research and market gastroesophageal reflux disease gerd therapeutic pipeline assessment and market forecast,108,13,0,pharmacy,"['research', 'and', 'market', 'gas', '##tro', '##es', '##op', '##hage', '##al', 're', '##f', '##lux', 'disease', 'g', '##erd', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
65039,nifty_214,2011-02-02,AstraZeneca and HealthCore Announce Real-World Evidence Data Collaboration in the U.S.,Neutral,0.0022,86,astrazeneca and healthcore announce real world evidence data collaboration the,78,10,0,pharmacy,"['as', '##tra', '##zen', '##eca', 'and', 'health', '##core', 'announce', 'real', 'world', 'evidence', 'data', 'collaboration', 'the']",1
65044,nifty_214,2011-02-02,Research and Markets: Medical Equipment Quarterly Deals Analysis: M&A; and Investment Trends - Q3 2010,Neutral,0.0022,102,research and market medical equipment quarterly deal analysis and investment trend,82,11,0,pharmacy,"['research', 'and', 'market', 'medical', 'equipment', 'quarterly', 'deal', 'analysis', 'and', 'investment', 'trend']",1
65068,nifty_214,2011-02-02,Elixir Bio-Tech Inc. Elected One of Top 50 Emerging Companies by 100 Venture Capital Funds & Angel Investors,Neutral,0.0022,108,elixir bio tech inc elected one top emerging company venture capital fund angel investor,88,14,0,pharmacy,"['el', '##ix', '##ir', 'bio', 'tech', 'in', '##c', 'elected', 'one', 'top', 'emerging', 'company', 'venture', 'capital', 'fund', 'angel', 'investor']",1
65071,nifty_214,2011-02-02,"TRADE NEWS: Agilent Technologies Debuts RNA Target Enrichment, Streamlining Transcriptome Profiling Studies to Advance Cancer and Stem Cell Research",Neutral,0.0022,148,trade news agilent technology debut rna target enrichment streamlining transcriptome profiling study advance cancer and stem cell research,138,18,0,pharmacy,"['trade', 'news', 'a', '##gi', '##lent', 'technology', 'debut', 'r', '##na', 'target', 'en', '##rich', '##ment', 'stream', '##lining', 'trans', '##cript', '##ome', 'pro', '##fi', '##ling', 'study', 'advance', 'cancer', 'and', 'stem', 'cell', 'research']",1
65072,nifty_214,2011-02-02,Sanderson Farms to Participate in Goldman Sachs Agricultural Biotech Forum,Neutral,0.0022,74,sanderson farm participate goldman sachs agricultural biotech forum,67,8,0,pharmacy,"['sand', '##erson', 'farm', 'participate', 'gold', '##man', 'sa', '##chs', 'agricultural', 'bio', '##tech', 'forum']",1
65186,nifty_214,2011-02-02,"Biotech Begins Year on a Quiet, but Optimistic Note",Neutral,0.0022,51,biotech begin year quiet but optimistic note,44,7,0,pharmacy,"['bio', '##tech', 'begin', 'year', 'quiet', 'but', 'optimistic', 'note']",1
65272,nifty_214,2011-02-02,BIO Announces Business Roundtables Featured at Thirteenth Annual BIO CEO & Investor Conference,Neutral,0.0022,94,bio announces business roundtable featured thirteenth annual bio ceo investor conference,88,11,0,pharmacy,"['bio', 'announces', 'business', 'round', '##table', 'featured', 'thirteenth', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
65353,nifty_214,2011-02-02,Research and Markets: The 2011 Global Diagnostic Imaging Market Dynamics and Trends,Neutral,0.0022,83,research and market the global diagnostic imaging market dynamic and trend,74,11,0,pharmacy,"['research', 'and', 'market', 'the', 'global', 'diagnostic', 'imaging', 'market', 'dynamic', 'and', 'trend']",1
65452,nifty_214,2011-02-02,Research and Markets: Epidemiology: Dyslipidemia - Gain Insight to Market Potential with a Robust 10-Year Epidemiology Forecast of Total Prevalent Cases of Dyslipidemia,Neutral,0.0022,168,research and market epidemiology dyslipidemia gain insight market potential with robust year epidemiology forecast total prevalent case dyslipidemia,148,18,0,pharmacy,"['research', 'and', 'market', 'e', '##pid', '##em', '##iology', 'd', '##ys', '##lip', '##ide', '##mia', 'gain', 'insight', 'market', 'potential', 'with', 'robust', 'year', 'e', '##pid', '##em', '##iology', 'forecast', 'total', 'prevalent', 'case', 'd', '##ys', '##lip', '##ide', '##mia']",1
65469,nifty_214,2011-02-02,"Zacks Analyst Blog Highlights: Biogen Idec, Elan Corp, Novartis, Roche and Teva",Neutral,0.0022,79,zacks analyst blog highlight biogen idec elan corp novartis roche and teva,74,12,0,pharmacy,"['z', '##ack', '##s', 'analyst', 'blog', 'highlight', 'bio', '##gen', 'id', '##ec', 'el', '##an', 'co', '##rp', 'no', '##var', '##tis', 'r', '##och', '##e', 'and', 'te', '##va']",1
65947,nifty_216,2011-02-07,Repligen to Present at the BIO CEO & Investor Conference,Neutral,0.0045,56,repligen present the bio ceo investor conference,48,7,0,pharmacy,"['re', '##p', '##li', '##gen', 'present', 'the', 'bio', 'c', '##eo', 'investor', 'conference']",1
65988,nifty_216,2011-02-07,ARIAD to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,0.0045,65,ariad present the annual bio ceo investor conference,52,8,0,pharmacy,"['a', '##riad', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
66050,nifty_216,2011-02-07,Idera Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,0.0045,81,idera pharmaceutical present the annual bio ceo investor conference,67,9,0,pharmacy,"['id', '##era', 'pharmaceutical', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
66065,nifty_216,2011-02-07,Zalicus to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,0.0045,67,zalicus present the annual bio ceo investor conference,54,8,0,pharmacy,"['z', '##ali', '##cus', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
66112,nifty_216,2011-02-07,CytRx to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,0.0045,65,cytrx present the annual bio ceo investor conference,52,8,0,pharmacy,"['c', '##yt', '##r', '##x', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
66117,nifty_216,2011-02-07,NOVARESE's Earnings Grow to New Record Highs in FY12/10,Neutral,0.0045,55,novarese earnings grow new record high,38,6,0,pharmacy,"['no', '##var', '##ese', 'earnings', 'grow', 'new', 'record', 'high']",1
66120,nifty_216,2011-02-07,Cerus to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,0.0045,65,cerus present the annual bio ceo investor conference,52,8,0,pharmacy,"['c', '##erus', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
66122,nifty_216,2011-02-07,InSite Vision to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,0.0045,73,insite vision present the annual bio ceo investor conference,60,9,0,pharmacy,"['ins', '##ite', 'vision', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
66182,nifty_216,2011-02-07,Curis to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,0.0045,65,curis present the annual bio ceo investor conference,52,8,0,pharmacy,"['cu', '##ris', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
66298,nifty_216,2011-02-07,"Research and Markets: Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors",Neutral,0.0045,104,research and market competitor analysis therapeutic protein biosimilars biobetters biosuperiors,95,10,0,pharmacy,"['research', 'and', 'market', 'competitor', 'analysis', 'therapeutic', 'protein', 'bio', '##si', '##mi', '##lars', 'bio', '##bet', '##ters', 'bio', '##su', '##per', '##ior', '##s']",1
66328,nifty_216,2011-02-07,Presentazione della Synergy Pharmaceuticals alla 13a Conferenza annuale BIO CEO & Investor,Neutral,0.0045,90,presentazione della synergy pharmaceutical alla conferenza annuale bio ceo investor,83,10,0,pharmacy,"['present', '##azi', '##one', 'della', 's', '##yne', '##rgy', 'pharmaceutical', 'all', '##a', 'con', '##fer', '##en', '##za', 'annual', '##e', 'bio', 'c', '##eo', 'investor']",1
66346,nifty_216,2011-02-07,Research and Markets: The Drug Discovery Outsourcing Market,Neutral,0.0045,59,research and market the drug discovery outsourcing market,57,8,0,pharmacy,"['research', 'and', 'market', 'the', 'drug', 'discovery', 'outs', '##our', '##cing', 'market']",1
66374,nifty_216,2011-02-07,Research and Markets: Innovations in the Delivery of Cancer Therapies,Neutral,0.0045,69,research and market innovation the delivery cancer therapy,58,8,0,pharmacy,"['research', 'and', 'market', 'innovation', 'the', 'delivery', 'cancer', 'therapy']",1
66385,nifty_216,2011-02-07,Intellipharmaceutics Expands Drug Commercialization Expertise,Neutral,0.0045,61,intellipharmaceutics expands drug commercialization expertise,61,5,0,pharmacy,"['in', '##tel', '##lip', '##har', '##ma', '##ce', '##uti', '##cs', 'expands', 'drug', 'commercial', '##ization', 'expertise']",1
66409,nifty_216,2011-02-07,Changes in Biotie's Financial Information in 2011,Neutral,0.0045,49,change biotie financial information,35,4,0,pharmacy,"['change', 'bio', '##tie', 'financial', 'information']",1
66615,nifty_216,2011-02-07,Somaxon Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,0.0045,83,somaxon pharmaceutical present the annual bio ceo investor conference,69,9,0,pharmacy,"['so', '##max', '##on', 'pharmaceutical', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
66616,nifty_216,2011-02-07,Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences,Neutral,0.0045,70,idenix pharmaceutical present two upcoming investor conference,62,7,0,pharmacy,"['id', '##eni', '##x', 'pharmaceutical', 'present', 'two', 'upcoming', 'investor', 'conference']",1
66634,nifty_216,2011-02-07,Ventrus to Present at 2011 BIO CEO & Investor Conference,Neutral,0.0045,56,ventrus present bio ceo investor conference,43,6,0,pharmacy,"['vent', '##rus', 'present', 'bio', 'c', '##eo', 'investor', 'conference']",1
66686,nifty_216,2011-02-07,DURECT to Present at the BIO CEO & Investor Conference,Neutral,0.0045,54,durect present the bio ceo investor conference,46,7,0,pharmacy,"['du', '##re', '##ct', 'present', 'the', 'bio', 'c', '##eo', 'investor', 'conference']",1
66802,nifty_216,2011-02-07,"Uralkali, Silvinit Deal Approved",Neutral,0.0045,32,uralkali silvinit deal approved,31,4,0,pharmacy,"['u', '##ral', '##kal', '##i', 'si', '##lvin', '##it', 'deal', 'approved']",1
66840,nifty_217,2011-02-08,"Cell Therapeutics, Inc. (CTI) to Present at 13th Annual BIO CEO & Investor Conference",Neutral,-0.0023,85,cell therapeutic inc cti present annual bio ceo investor conference,67,10,0,pharmacy,"['cell', 'therapeutic', 'in', '##c', 'c', '##ti', 'present', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
66940,nifty_217,2011-02-08, Media Alert: App-DNA Unveils 3 Major Announcements,Neutral,-0.0023,51,medium alert app dna unveils major announcement,47,7,0,pharmacy,"['medium', 'alert', 'app', 'd', '##na', 'un', '##ve', '##ils', 'major', 'announcement']",1
66978,nifty_217,2011-02-08,Santarus to Present at the 13th Annual Bio CEO & Investor Conference,Neutral,-0.0023,68,santarus present the annual bio ceo investor conference,55,8,0,pharmacy,"['sa', '##nta', '##rus', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
67066,nifty_217,2011-02-08,Lexicon Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,-0.0023,83,lexicon pharmaceutical present the annual bio ceo investor conference,69,9,0,pharmacy,"['le', '##xi', '##con', 'pharmaceutical', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
67072,nifty_217,2011-02-08,SuperGen to Present at BIO CEO & Investor Conference on February 15th,Neutral,-0.0023,69,supergen present bio ceo investor conference february,53,7,0,pharmacy,"['super', '##gen', 'present', 'bio', 'c', '##eo', 'investor', 'conference', 'f', '##eb', '##ru', '##ary']",1
67074,nifty_217,2011-02-08,OncoGenex Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,-0.0023,85,oncogenex pharmaceutical present the annual bio ceo investor conference,71,9,0,pharmacy,"['on', '##co', '##gene', '##x', 'pharmaceutical', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
67093,nifty_217,2011-02-08,Alimera Sciences to Present at BIO CEO & Investor Conference,Neutral,-0.0023,60,alimera science present bio ceo investor conference,51,7,0,pharmacy,"['al', '##ime', '##ra', 'science', 'present', 'bio', 'c', '##eo', 'investor', 'conference']",1
67095,nifty_217,2011-02-08,ZIOPHARM to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,-0.0023,68,ziopharm present the annual bio ceo investor conference,55,8,0,pharmacy,"['z', '##io', '##pha', '##rm', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
67107,nifty_217,2011-02-08,"Research and Markets: Biochips - Products, Applications, Technologies and End-Use Markets Growth Analysis, 2009-2015",Neutral,-0.0023,116,research and market biochip product application technology and end use market growth analysis,93,13,0,pharmacy,"['research', 'and', 'market', 'bio', '##chi', '##p', 'product', 'application', 'technology', 'and', 'end', 'use', 'market', 'growth', 'analysis']",1
67112,nifty_217,2011-02-08, SciClone Pharmaceuticals to Present at BIO CEO & Investor Conference,Neutral,-0.0023,69,sciclone pharmaceutical present bio ceo investor conference,59,7,0,pharmacy,"['s', '##ci', '##c', '##lone', 'pharmaceutical', 'present', 'bio', 'c', '##eo', 'investor', 'conference']",1
67116,nifty_217,2011-02-08,Sunesis to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,-0.0023,67,sunesis present the annual bio ceo investor conference,54,8,0,pharmacy,"['sun', '##esis', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
67117,nifty_217,2011-02-08,PDL BioPharma to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,-0.0023,73,pdl biopharma present the annual bio ceo investor conference,60,9,0,pharmacy,"['p', '##dl', 'bio', '##pha', '##rma', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
67118,nifty_217,2011-02-08,Spectrum Pharmaceuticals to Present at the BIO CEO Investor Conference,Neutral,-0.0023,70,spectrum pharmaceutical present the bio ceo investor conference,63,8,0,pharmacy,"['spectrum', 'pharmaceutical', 'present', 'the', 'bio', 'c', '##eo', 'investor', 'conference']",1
67120,nifty_217,2011-02-08,BioDelivery Sciences to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,-0.0023,80,biodelivery science present the annual bio ceo investor conference,66,9,0,pharmacy,"['bio', '##del', '##iver', '##y', 'science', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
67160,nifty_217,2011-02-08,Aeterna Zentaris to Present at Upcoming Bio CEO & Investor Conference in New York,Neutral,-0.0023,81,aeterna zentaris present upcoming bio ceo investor conference new york,70,10,0,pharmacy,"['a', '##eter', '##na', 'z', '##ent', '##aris', 'present', 'upcoming', 'bio', 'c', '##eo', 'investor', 'conference', 'new', 'yo', '##rk']",1
67164,nifty_217,2011-02-08,CorMedix to Present at 13th Annual BIO CEO and Investor Conference,Neutral,-0.0023,66,cormedix present annual bio ceo and investor conference,55,8,0,pharmacy,"['co', '##rmed', '##ix', 'present', 'annual', 'bio', 'c', '##eo', 'and', 'investor', 'conference']",1
67165,nifty_217,2011-02-08,Pro-Pharmaceuticals to Present Corporate Update at Bio CEO & Investor Conference,Neutral,-0.0023,80,pro pharmaceutical present corporate update bio ceo investor conference,71,9,0,pharmacy,"['pro', 'pharmaceutical', 'present', 'corporate', 'update', 'bio', 'c', '##eo', 'investor', 'conference']",1
67219,nifty_217,2011-02-08,GenVec to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,-0.0023,66,genvec present the annual bio ceo investor conference,53,8,0,pharmacy,"['g', '##en', '##ve', '##c', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
67228,nifty_217,2011-02-08,Depomed to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,-0.0023,67,depomed present the annual bio ceo investor conference,54,8,0,pharmacy,"['de', '##po', '##med', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
67230,nifty_217,2011-02-08, Depomed to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,-0.0023,68,depomed present the annual bio ceo investor conference,54,8,0,pharmacy,"['de', '##po', '##med', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
67245,nifty_217,2011-02-08,Affymax to Present at BIO CEO & Investor Conference,Neutral,-0.0023,51,affymax present bio ceo investor conference,43,6,0,pharmacy,"['a', '##ffy', '##max', 'present', 'bio', 'c', '##eo', 'investor', 'conference']",1
67268,nifty_217,2011-02-08,NovaBay Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,-0.0023,83,novabay pharmaceutical present the annual bio ceo investor conference,69,9,0,pharmacy,"['no', '##va', '##bay', 'pharmaceutical', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
67269,nifty_217,2011-02-08,Elite Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference...,Neutral,-0.0023,84,elite pharmaceutical present the annual bio ceo investor conference,67,9,0,pharmacy,"['elite', 'pharmaceutical', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
67306,nifty_217,2011-02-08,"""The Drug Discovery Outsourcing Market"" and Other New Market Reports by Business Insights Available at MarketPublishers.com",Neutral,-0.0023,123,the drug discovery outsourcing market and other new market report business insight available marketpublishers com,113,15,0,pharmacy,"['the', 'drug', 'discovery', 'outs', '##our', '##cing', 'market', 'and', 'other', 'new', 'market', 'report', 'business', 'insight', 'available', 'market', '##pu', '##b', '##lish', '##ers', 'com']",1
67323,nifty_217,2011-02-08,RXi Pharmaceuticals to Webcast Presentation at the 13th Annual BIO CEO & Investor Conference,Neutral,-0.0023,92,rxi pharmaceutical webcast presentation the annual bio ceo investor conference,78,10,0,pharmacy,"['r', '##xi', 'pharmaceutical', 'web', '##cast', 'presentation', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
67365,nifty_217,2011-02-08,Targacept to Present at 13th Annual BIO CEO & Investor Conference,Neutral,-0.0023,65,targacept present annual bio ceo investor conference,52,7,0,pharmacy,"['ta', '##rga', '##ce', '##pt', 'present', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
67370,nifty_217,2011-02-08,GHX to Sponsor Feb. 16 HFMA Webinar on Transforming the Healthcare Supply Chain Into a Strategic Asset,Neutral,-0.0023,102,ghx sponsor feb hfma webinar transforming the healthcare supply chain into strategic asset,90,13,0,pharmacy,"['g', '##h', '##x', 'sponsor', 'f', '##eb', 'h', '##f', '##ma', 'web', '##ina', '##r', 'transforming', 'the', 'healthcare', 'supply', 'chain', 'into', 'strategic', 'asset']",1
67392,nifty_217,2011-02-08," Marina Biotech, Inc. to Present at The 13th Annual BIO CEO & Investor Conference",Neutral,-0.0023,81,marina biotech inc present the annual bio ceo investor conference,65,10,0,pharmacy,"['ma', '##rina', 'bio', '##tech', 'in', '##c', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
67404,nifty_217,2011-02-08,"StemCells, Inc. to Present at BIO CEO & Investor Conference",Neutral,-0.0023,59,stemcells inc present bio ceo investor conference,49,7,0,pharmacy,"['stem', '##cell', '##s', 'in', '##c', 'present', 'bio', 'c', '##eo', 'investor', 'conference']",1
67466,nifty_217,2011-02-08,Exact Sciences to Present at BIO CEO & Investor Conference,Neutral,-0.0023,58,exact science present bio ceo investor conference,49,7,0,pharmacy,"['exact', 'science', 'present', 'bio', 'c', '##eo', 'investor', 'conference']",1
67596,nifty_217,2011-02-08,Research and Markets: Global Injectable Drug Delivery Market (2010 - 2015),Neutral,-0.0023,74,research and market global injectable drug delivery market,58,8,0,pharmacy,"['research', 'and', 'market', 'global', 'in', '##ject', '##able', 'drug', 'delivery', 'market']",1
67620,nifty_217,2011-02-08,"Kindred buys RehabCare, eyeing growth, health reform",Neutral,-0.0023,52,kindred buy rehabcare eyeing growth health reform,49,7,0,pharmacy,"['kind', '##red', 'buy', 're', '##hab', '##care', 'eyeing', 'growth', 'health', 'reform']",1
67652,nifty_217,2011-02-08,"Research and Markets: Metabolic Risk for Cardiovascular Disease - Related Mostly to the Increasing Prevalence of Obesity, Metabolic Syndrome and Type 2 Diabetes",Neutral,-0.0023,160,research and market metabolic risk for cardiovascular disease related mostly the increasing prevalence obesity metabolic syndrome and type diabetes,147,19,0,pharmacy,"['research', 'and', 'market', 'metabolic', 'risk', 'for', 'card', '##iovascular', 'disease', 'related', 'mostly', 'the', 'increasing', 'prevalence', 'o', '##besity', 'metabolic', 'syndrome', 'and', 'type', 'diabetes']",1
67828,nifty_217,2011-02-08, 'FutureMed' at Singularity University to Focus on Impact of Exponential Technologies on the Future of Medicine &,Neutral,-0.0023,113,futuremed singularity university focus impact exponential technology the future medicine,88,10,0,pharmacy,"['future', '##med', 'singular', '##ity', 'university', 'focus', 'impact', 'ex', '##po', '##nent', '##ial', 'technology', 'the', 'future', 'medicine']",1
67833,nifty_217,2011-02-08,Spherix to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,-0.0023,67,spherix present the annual bio ceo investor conference,54,8,0,pharmacy,"['s', '##pher', '##ix', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
67847,nifty_217,2011-02-08,Research and Markets: Acute Coronary Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017,Neutral,-0.0023,109,research and market acute coronary syndrome therapeutic pipeline assessment and market forecast,95,12,0,pharmacy,"['research', 'and', 'market', 'acute', 'co', '##rona', '##ry', 'syndrome', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
67864,nifty_217,2011-02-08,"Genomic Health Announces Year-End 2010 Financial Results, Provides 2011 Financial Outlook",Neutral,-0.0023,89,genomic health announces year end financial result provides financial outlook,77,10,0,pharmacy,"['g', '##eno', '##mic', 'health', 'announces', 'year', 'end', 'financial', 'result', 'provides', 'financial', 'outlook']",1
67866,nifty_217,2011-02-08,Cadence Pharmaceuticals to Present at Two Investment Conferences in February 2011,Neutral,-0.0023,81,cadence pharmaceutical present two investment conference february,65,7,0,pharmacy,"['ca', '##dence', 'pharmaceutical', 'present', 'two', 'investment', 'conference', 'f', '##eb', '##ru', '##ary']",1
67878,nifty_217,2011-02-08,"Transcept Pharmaceuticals to Present at BIO CEO & Investor Conference on February 15, 2011",Neutral,-0.0023,90,transcept pharmaceutical present bio ceo investor conference february,69,8,0,pharmacy,"['trans', '##ce', '##pt', 'pharmaceutical', 'present', 'bio', 'c', '##eo', 'investor', 'conference', 'f', '##eb', '##ru', '##ary']",1
67942,nifty_217,2011-02-08,MannKind to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,-0.0023,68,mannkind present the annual bio ceo investor conference,55,8,0,pharmacy,"['man', '##nk', '##ind', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
68393,nifty_218,2011-02-09,"Research and Markets: Patient Monitoring: Emerging Countries Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016",Neutral,0.0004,135,research and market patient monitoring emerging country opportunity assessment competitive landscape and market forecast,120,14,0,pharmacy,"['research', 'and', 'market', 'patient', 'monitoring', 'emerging', 'country', 'opportunity', 'assessment', 'competitive', 'landscape', 'and', 'market', 'forecast']",1
68459,nifty_218,2011-02-09,"Research and Markets: Remote Patient Monitoring: Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016",Neutral,0.0004,126,research and market remote patient monitoring global pipeline analysis opportunity assessment and market forecast,113,14,0,pharmacy,"['research', 'and', 'market', 'remote', 'patient', 'monitoring', 'global', 'pipeline', 'analysis', 'opportunity', 'assessment', 'and', 'market', 'forecast']",1
68491,nifty_218,2011-02-09,Arrowhead Research to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,0.0004,78,arrowhead research present the annual bio ceo investor conference,65,9,0,pharmacy,"['arrow', '##head', 'research', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
68492,nifty_218,2011-02-09,"Research and Markets: Advanced Oral & Parenteral Drug Delivery Technologies: Players, Products & Prospects to 2015",Neutral,0.0004,114,research and market advanced oral parenteral drug delivery technology player product prospect,93,12,0,pharmacy,"['research', 'and', 'market', 'advanced', 'oral', 'parent', '##eral', 'drug', 'delivery', 'technology', 'player', 'product', 'prospect']",1
68511,nifty_218,2011-02-09,Cempra Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,0.0004,82,cempra pharmaceutical present the annual bio ceo investor conference,68,9,0,pharmacy,"['c', '##em', '##pra', 'pharmaceutical', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
68603,nifty_218,2011-02-09,Arena Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,0.0004,81,arena pharmaceutical present the annual bio ceo investor conference,67,9,0,pharmacy,"['arena', 'pharmaceutical', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
68605,nifty_218,2011-02-09,Access Pharmaceuticals Receives Early MuGard Prescriber Anecdotal Feedback Validating Larger Target Market Potential,Neutral,0.0004,116,access pharmaceutical receives early mugard prescriber anecdotal feedback validating larger target market potential,115,13,0,pharmacy,"['access', 'pharmaceutical', 'receives', 'early', 'mug', '##ard', 'pre', '##s', '##cribe', '##r', 'an', '##ec', '##do', '##tal', 'feedback', 'valid', '##ating', 'larger', 'target', 'market', 'potential']",1
68615,nifty_218,2011-02-09,Soligenix to Present at 13th Annual BIO CEO & Investor Conference,Neutral,0.0004,65,soligenix present annual bio ceo investor conference,52,7,0,pharmacy,"['so', '##li', '##gen', '##ix', 'present', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
68641,nifty_218,2011-02-09,Research and Markets: the Drug Delivery Device Market Outlook to 2015,Neutral,0.0004,69,research and market the drug delivery device market outlook,59,9,0,pharmacy,"['research', 'and', 'market', 'the', 'drug', 'delivery', 'device', 'market', 'outlook']",1
68650,nifty_218,2011-02-09,Research and Markets: the Future of In Vitro and In Vivo Diagnostic Integration,Neutral,0.0004,79,research and market the future vitro and vivo diagnostic integration,68,10,0,pharmacy,"['research', 'and', 'market', 'the', 'future', 'v', '##it', '##ro', 'and', 'v', '##ivo', 'diagnostic', 'integration']",1
68661,nifty_218,2011-02-09,"CEA-Leti Reports Progress in Computing, Medical Electronics, Communications, and Other Fields at ISSCC 2011",Neutral,0.0004,107,cea leti report progress computing medical electronics communication and other field isscc,90,12,0,pharmacy,"['c', '##ea', 'let', '##i', 'report', 'progress', 'computing', 'medical', 'electronics', 'communication', 'and', 'other', 'field', 'is', '##s', '##cc']",1
68673,nifty_218,2011-02-09,Senesco Technologies to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,0.0004,80,senesco technology present the annual bio ceo investor conference,65,9,0,pharmacy,"['se', '##nes', '##co', 'technology', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
68680,nifty_218,2011-02-09,Momenta Pharmaceuticals to Present at the 13th Annual BIO CEO Investor Conference,Neutral,0.0004,81,momentum pharmaceutical present the annual bio ceo investor conference,70,9,0,pharmacy,"['momentum', 'pharmaceutical', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
68855,nifty_218,2011-02-09,"Agilent Technologies, GE Healthcare and Life Technologies Join the WIN Consortium",Neutral,0.0004,81,agilent technology healthcare and life technology join the win consortium,73,10,0,pharmacy,"['a', '##gi', '##lent', 'technology', 'healthcare', 'and', 'life', 'technology', 'join', 'the', 'win', 'consortium']",1
68885,nifty_218,2011-02-09,Research and Markets: This 2011 Report on the U.S. Market for Interventional Ophthalmic Devices Forecasts the Market to Reach $2 billion by 2017,Neutral,0.0004,144,research and market this report the market for interventional ophthalmic device forecast the market reach billion,113,16,0,pharmacy,"['research', 'and', 'market', 'this', 'report', 'the', 'market', 'for', 'intervention', '##al', 'op', '##ht', '##hal', '##mic', 'device', 'forecast', 'the', 'market', 'reach', 'billion']",1
68974,nifty_218,2011-02-09,Biovest to Exhibit at World Money Show Investor Conference,Neutral,0.0004,58,biovest exhibit world money show investor conference,52,7,0,pharmacy,"['bio', '##ves', '##t', 'exhibit', 'world', 'money', 'show', 'investor', 'conference']",1
68984,nifty_218,2011-02-09,"Research and Markets: Partnerships, Licensing, Investments and M&A; Deals and Trends in Pharmaceuticals",Neutral,0.0004,103,research and market partnership licensing investment and deal and trend pharmaceutical,86,11,0,pharmacy,"['research', 'and', 'market', 'partnership', 'licensing', 'investment', 'and', 'deal', 'and', 'trend', 'pharmaceutical']",1
69028,nifty_218,2011-02-09,"Research and Markets: Schizophrenia Global Clinical Trials Review, Q1, 2011",Neutral,0.0004,75,research and market schizophrenia global clinical trial review,62,8,0,pharmacy,"['research', 'and', 'market', 's', '##chi', '##zophrenia', 'global', 'clinical', 'trial', 'review']",1
69043,nifty_218,2011-02-09,"Treatment for Prescription Drug Addiction and Painkiller Abuse has Risen Sharply Since Onset of Financial Crisis, Reflecting Uncertainty About Economy",Neutral,0.0004,150,treatment for prescription drug addiction and painkiller abuse ha risen sharply since onset financial crisis reflecting uncertainty about economy,145,19,0,pharmacy,"['treatment', 'for', 'prescription', 'drug', 'addiction', 'and', 'pain', '##kill', '##er', 'abuse', 'ha', 'risen', 'sharply', 'since', 'onset', 'financial', 'crisis', 'reflecting', 'uncertainty', 'about', 'economy']",1
69071,nifty_218,2011-02-09,Research and Markets: MarketWatch - Personal Care 2010,Neutral,0.0004,54,research and market marketwatch personal care,45,6,0,pharmacy,"['research', 'and', 'market', 'market', '##watch', 'personal', 'care']",1
69219,nifty_218,2011-02-09,NPS Pharmaceuticals to Report 2010 Financial Results,Neutral,0.0004,52,np pharmaceutical report financial result,41,5,0,pharmacy,"['n', '##p', 'pharmaceutical', 'report', 'financial', 'result']",1
69251,nifty_218,2011-02-09,EpiCept to Present at the 13th Annual BIO CEO & Investor Conference,Neutral,0.0004,67,epicept present the annual bio ceo investor conference,54,8,0,pharmacy,"['epic', '##ept', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
69391,nifty_218,2011-02-09,"Research and Markets: China Medical Diagnosis, Monitoring and Treatment Equipment Manufacturing Industry 2011",Neutral,0.0004,109,research and market china medical diagnosis monitoring and treatment equipment manufacturing industry,101,12,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'medical', 'diagnosis', 'monitoring', 'and', 'treatment', 'equipment', 'manufacturing', 'industry']",1
69898,nifty_219,2011-02-10,"Five Prime Therapeutics, Inc. to Present at the 13th Annual BIO CEO & Investor Conference",Rise,0.006,89,five prime therapeutic inc present the annual bio ceo investor conference,73,11,0,pharmacy,"['five', 'prime', 'therapeutic', 'in', '##c', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
69975,nifty_219,2011-02-10,ADVENTRX Pharmaceuticals to Present at the 13th Annual BIOCEO & Investor Conference on February 15,Rise,0.006,98,adventrx pharmaceutical present the annual bioceo investor conference february,78,9,0,pharmacy,"['advent', '##r', '##x', 'pharmaceutical', 'present', 'the', 'annual', 'bio', '##ce', '##o', 'investor', 'conference', 'f', '##eb', '##ru', '##ary']",1
69978,nifty_219,2011-02-10, AVI BioPharma to Present Company Overview at the 13th Annual BIO CEO & Investor Conference,Rise,0.006,91,avi biopharma present company overview the annual bio ceo investor conference,77,11,0,pharmacy,"['a', '##vi', 'bio', '##pha', '##rma', 'present', 'company', 'overview', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
69987,nifty_219,2011-02-10,NOVAVAX to Present at 13th Annual BIO CEO & Investor Conference,Rise,0.006,63,novavax present annual bio ceo investor conference,50,7,0,pharmacy,"['no', '##va', '##va', '##x', 'present', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
70003,nifty_219,2011-02-10,"Elite Pharmaceuticals, Inc. to Discuss Third Quarter Results of Operations on Monday,...",Rise,0.006,88,elite pharmaceutical inc discus third quarter result operation monday,69,9,0,pharmacy,"['elite', 'pharmaceutical', 'in', '##c', 'disc', '##us', 'third', 'quarter', 'result', 'operation', 'mon', '##day']",1
70026,nifty_219,2011-02-10, Bradmer Pharmaceuticals Inc. Announces Proposed Reverse Take-Over Transaction with P1 Energy Corp.,Rise,0.006,99,bradmer pharmaceutical inc announces proposed reverse take over transaction with energy corp,92,12,0,pharmacy,"['bra', '##d', '##mer', 'pharmaceutical', 'in', '##c', 'announces', 'proposed', 'reverse', 'take', 'over', 'transaction', 'with', 'energy', 'co', '##rp']",1
70096,nifty_219,2011-02-10,NeoStem to Present at 13th Annual BIO CEO & Investor Conference,Rise,0.006,63,neostem present annual bio ceo investor conference,50,7,0,pharmacy,"['neo', '##ste', '##m', 'present', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
70175,nifty_219,2011-02-10,"Don't expect genome breakthroughs yet, expert says",Rise,0.006,50,don expect genome breakthrough yet expert say,45,7,0,pharmacy,"['don', 'expect', 'genome', 'breakthrough', 'yet', 'expert', 'say']",1
70178,nifty_219,2011-02-10,Research and Markets: Country Report - United Kingdom Hospital & Healthcare System,Rise,0.006,82,research and market country report united kingdom hospital healthcare system,76,10,0,pharmacy,"['research', 'and', 'market', 'country', 'report', 'united', 'kingdom', 'hospital', 'healthcare', 'system']",1
70196,nifty_219,2011-02-10,Research and Markets: Country Report - Netherlands Hospital & Healthcare System,Rise,0.006,79,research and market country report netherlands hospital healthcare system,73,9,0,pharmacy,"['research', 'and', 'market', 'country', 'report', 'net', '##her', '##lands', 'hospital', 'healthcare', 'system']",1
70331,nifty_219,2011-02-10,Research and Markets: OTC Pharmaceuticals Market Report 2011,Rise,0.006,60,research and market otc pharmaceutical market report,52,7,0,pharmacy,"['research', 'and', 'market', 'o', '##t', '##c', 'pharmaceutical', 'market', 'report']",1
70381,nifty_219,2011-02-10,Research and Markets: Global Pharmaceutical Market Forecast to 2012,Rise,0.006,67,research and market global pharmaceutical market forecast,57,7,0,pharmacy,"['research', 'and', 'market', 'global', 'pharmaceutical', 'market', 'forecast']",1
70396,nifty_219,2011-02-10,Research and Markets: China Pharmaceutical Industry 1H11,Rise,0.006,56,research and market china pharmaceutical industry,49,6,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'pharmaceutical', 'industry']",1
70499,nifty_219,2011-02-10,Research and Markets: Atherosclerosis or Coronary Artery Disease (CAD) - Pipeline Assessment and Market Forecasts to 2017,Rise,0.006,121,research and market atherosclerosis coronary artery disease cad pipeline assessment and market forecast,103,13,0,pharmacy,"['research', 'and', 'market', 'at', '##her', '##os', '##cle', '##rosis', 'co', '##rona', '##ry', 'artery', 'disease', 'ca', '##d', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
70597,nifty_219,2011-02-10,Research and Markets: The Proton-Deuterium Swap - Will the Heavy Strategy Work?,Rise,0.006,79,research and market the proton deuterium swap will the heavy strategy work,74,12,0,pharmacy,"['research', 'and', 'market', 'the', 'pro', '##ton', 'de', '##uter', '##ium', 'swap', 'will', 'the', 'heavy', 'strategy', 'work']",1
70606,nifty_219,2011-02-10,MEDIA ADVISORY - Oncolytics BiotechÂ® Inc. to Present at 13th Annual BIO CEO & Investor Conference,Rise,0.006,98,medium advisory oncolytics biotechâ inc present annual bio ceo investor conference,82,11,0,pharmacy,"['medium', 'advisory', 'on', '##co', '##ly', '##tics', 'bio', '##tech', '##â', 'in', '##c', 'present', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
70608,nifty_219,2011-02-10,Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at ISI Annual Conference,Rise,0.006,101,human genome science invite investor listen webcast presentation isi annual conference,86,11,0,pharmacy,"['human', 'genome', 'science', 'invite', 'investor', 'listen', 'web', '##cast', 'presentation', 'is', '##i', 'annual', 'conference']",1
70615,nifty_219,2011-02-10,"Research and Markets: Wound Closure Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts",Rise,0.006,115,research and market wound closure device global pipeline analysis opportunity assessment and market forecast,108,14,0,pharmacy,"['research', 'and', 'market', 'wound', 'closure', 'device', 'global', 'pipeline', 'analysis', 'opportunity', 'assessment', 'and', 'market', 'forecast']",1
70621,nifty_219,2011-02-10,Research and Markets: Clinical Challenges in Heart Failure Is Designed For the Busy Clinical Practitioner Who Is In Search Of Authoritative Discussion,Rise,0.006,150,research and market clinical challenge heart failure designed for the busy clinical practitioner who search authoritative discussion,132,17,0,pharmacy,"['research', 'and', 'market', 'clinical', 'challenge', 'heart', 'failure', 'designed', 'for', 'the', 'busy', 'clinical', 'practitioner', 'who', 'search', 'authoritative', 'discussion']",1
70690,nifty_219,2011-02-10,Arena Pharmaceuticals Announces Upcoming Departure of Chief Financial Officer,Rise,0.006,77,arena pharmaceutical announces upcoming departure chief financial officer,73,8,0,pharmacy,"['arena', 'pharmaceutical', 'announces', 'upcoming', 'departure', 'chief', 'financial', 'officer']",1
71116,nifty_222,2011-02-16,Double-breasted everywhere,Neutral,0.003,26,double breasted everywhere,26,3,0,pharmacy,"['double', 'breast', '##ed', 'everywhere']",1
71453,nifty_227,2011-02-28,"Novartis to commence subsequent offering period for Genoptix, Inc.",Fall,-0.0167,66,novartis commence subsequent offering period for genoptix inc,61,8,0,pharmacy,"['no', '##var', '##tis', 'commence', 'subsequent', 'offering', 'period', 'for', 'g', '##eno', '##pt', '##ix', 'in', '##c']",1
71634,nifty_227,2011-02-28,"ShangPharma to Present at the Citibank Global Health Care Conference from March 1 - 3, 2011",Fall,-0.0167,91,shangpharma present the citibank global health care conference from march,73,10,0,pharmacy,"['s', '##hang', '##pha', '##rma', 'present', 'the', 'c', '##iti', '##bank', 'global', 'health', 'care', 'conference', 'from', 'march']",1
71675,nifty_227,2011-02-28,New Research Reports on Medical Device Markets Published by MarketPublishers.com,Fall,-0.0167,80,new research report medical device market published marketpublishers com,72,9,0,pharmacy,"['new', 'research', 'report', 'medical', 'device', 'market', 'published', 'market', '##pu', '##b', '##lish', '##ers', 'com']",1
71676,nifty_227,2011-02-28,Global Medical Devices Markets Analysed in Reports Published by MarketPublishers.com,Fall,-0.0167,84,global medical device market analysed report published marketpublishers com,75,9,0,pharmacy,"['global', 'medical', 'device', 'market', 'anal', '##ys', '##ed', 'report', 'published', 'market', '##pu', '##b', '##lish', '##ers', 'com']",1
71694,nifty_227,2011-02-28,Universal Bioenergy Announces Major Financial Restructuring Plan to Increase Profits...,Fall,-0.0167,87,universal bioenergy announces major financial restructuring plan increase profit,80,9,0,pharmacy,"['universal', 'bio', '##ener', '##gy', 'announces', 'major', 'financial', 'restructuring', 'plan', 'increase', 'profit']",1
71740,nifty_227,2011-02-28,BioCryst to Present at Two Upcoming Investor Conferences,Fall,-0.0167,56,biocryst present two upcoming investor conference,49,6,0,pharmacy,"['bio', '##c', '##ry', '##st', 'present', 'two', 'upcoming', 'investor', 'conference']",1
71928,nifty_227,2011-02-28,Infinity Pharmaceuticals to Present at Two Upcoming Conferences,Fall,-0.0167,63,infinity pharmaceutical present two upcoming conference,55,6,0,pharmacy,"['in', '##finity', 'pharmaceutical', 'present', 'two', 'upcoming', 'conference']",1
72083,nifty_227,2011-02-28,Cryo-Cell Reports Financial Results for Fiscal Year 2010,Fall,-0.0167,56,cryo cell report financial result for fiscal year,49,8,0,pharmacy,"['cry', '##o', 'cell', 'report', 'financial', 'result', 'for', 'fiscal', 'year']",1
72084,nifty_227,2011-02-28,BrainStorm Cell Therapeutics Raises $3.6 Million from Institutional and Private Investors in Equity Financing,Fall,-0.0167,109,brainstorm cell therapeutic raise million from institutional and private investor equity financing,98,12,0,pharmacy,"['brains', '##tor', '##m', 'cell', 'therapeutic', 'raise', 'million', 'from', 'institutional', 'and', 'private', 'investor', 'equity', 'financing']",1
72087,nifty_227,2011-02-28,"Oramed Pharmaceuticals Sells its Stake in Entera Bio for $1.15 Million; Buyer Also to Invest $250,000 in Oramed",Fall,-0.0167,111,oramed pharmaceutical sell it stake enteron bio for million buyer also invest oramed,84,13,0,pharmacy,"['or', '##amed', 'pharmaceutical', 'sell', 'it', 'stake', 'enter', '##on', 'bio', 'for', 'million', 'buyer', 'also', 'invest', 'or', '##amed']",1
72098,nifty_227,2011-02-28,Thomson Reuters and CQ Roll Call Team Up for Healthcare News and Analysis,Fall,-0.0167,73,thomson reuters and roll call team for healthcare news and analysis,67,11,0,pharmacy,"['th', '##oms', '##on', 're', '##uters', 'and', 'roll', 'call', 'team', 'for', 'healthcare', 'news', 'and', 'analysis']",1
72164,nifty_227,2011-02-28,Research and Markets: Acute Ischemic Stroke Global Clinical Trials Review Q1 2011,Fall,-0.0167,81,research and market acute ischemic stroke global clinical trial review,70,10,0,pharmacy,"['research', 'and', 'market', 'acute', 'is', '##che', '##mic', 'stroke', 'global', 'clinical', 'trial', 'review']",1
72211,nifty_227,2011-02-28,Research and Markets: Gene Therapy - Global Strategic Business Report,Fall,-0.0167,69,research and market gene therapy global strategic business report,65,9,0,pharmacy,"['research', 'and', 'market', 'gene', 'therapy', 'global', 'strategic', 'business', 'report']",1
72219,nifty_227,2011-02-28,Emergent Health Corp. Updates Shareholders,Fall,-0.0167,42,emergent health corp update shareholder,39,5,0,pharmacy,"['emerge', '##nt', 'health', 'co', '##rp', 'update', 'shareholder']",1
72279,nifty_227,2011-02-28," EMR Market Grew in 2010, Despite Confusion Over Meaningful Use",Fall,-0.0167,63,emr market grew despite confusion over meaningful use,53,8,0,pharmacy,"['em', '##r', 'market', 'grew', 'despite', 'confusion', 'over', 'meaningful', 'use']",1
72377,nifty_227,2011-02-28,Research and Markets: Advanced Biomedical Image Analysis,Fall,-0.0167,56,research and market advanced biomedical image analysis,54,7,0,pharmacy,"['research', 'and', 'market', 'advanced', 'bio', '##medical', 'image', 'analysis']",1
72420,nifty_227,2011-02-28,Lighthouse1 Continues Leadership in a Rapidly-Growing Healthcare Market,Fall,-0.0167,71,lighthouse continues leadership rapidly growing healthcare market,65,7,0,pharmacy,"['lighthouse', 'continues', 'leadership', 'rapidly', 'growing', 'healthcare', 'market']",1
72482,nifty_227,2011-02-28,Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Citi Conference,Fall,-0.0167,95,human genome science invite investor listen webcast presentation citi conference,80,10,0,pharmacy,"['human', 'genome', 'science', 'invite', 'investor', 'listen', 'web', '##cast', 'presentation', 'c', '##iti', 'conference']",1
72497,nifty_227,2011-02-28,Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2010 Financial Results,Fall,-0.0167,81,idenix pharmaceutical report fourth quarter and year end financial result,73,10,0,pharmacy,"['id', '##eni', '##x', 'pharmaceutical', 'report', 'fourth', 'quarter', 'and', 'year', 'end', 'financial', 'result']",1
72498,nifty_227,2011-02-28,Somaxon Pharmaceuticals to Present at Upcoming Investor Conferences,Fall,-0.0167,67,somaxon pharmaceutical present upcoming investor conference,59,6,0,pharmacy,"['so', '##max', '##on', 'pharmaceutical', 'present', 'upcoming', 'investor', 'conference']",1
72499,nifty_227,2011-02-28,Sucampo Pharmaceuticals Invites Investors to Listen to Webcast of Presentation at Cowen Conference,Fall,-0.0167,98,sucampo pharmaceutical invite investor listen webcast presentation cowen conference,83,9,0,pharmacy,"['su', '##cam', '##po', 'pharmaceutical', 'invite', 'investor', 'listen', 'web', '##cast', 'presentation', 'cow', '##en', 'conference']",1
72636,nifty_227,2011-02-28,The Ensign Group to Present at the 2011 RBC Capital Markets' Healthcare Conference,Fall,-0.0167,82,the ensign group present the rbc capital market healthcare conference,69,10,0,pharmacy,"['the', 'en', '##sign', 'group', 'present', 'the', 'r', '##b', '##c', 'capital', 'market', 'healthcare', 'conference']",1
73155,nifty_232,2011-03-08,Cancer in the Economy,Neutral,-0.0014,21,cancer the economy,18,3,0,pharmacy,"['cancer', 'the', 'economy']",1
73291,nifty_234,2011-03-10,RCS - EiRx Therapeutic PLC - Proposed Fundraising,Rise,0.0069,49,rcs eirx therapeutic plc proposed fundraising,45,6,0,pharmacy,"['r', '##cs', 'e', '##ir', '##x', 'therapeutic', 'plc', 'proposed', 'fundraising']",1
73525,nifty_234,2011-03-10,Research and Markets: Benelux Healthcare & Hospitals IT Costs 2011 - Large Healthcare Companies Budgets & Forecasts,Rise,0.0069,115,research and market benelux healthcare hospital cost large healthcare company budget forecast,93,12,0,pharmacy,"['research', 'and', 'market', 'ben', '##el', '##ux', 'healthcare', 'hospital', 'cost', 'large', 'healthcare', 'company', 'budget', 'forecast']",1
73535,nifty_234,2011-03-10,Research and Markets: Drug Patent Challenge Report 2011 Profiles More than 80 Drugs and 60 Companies,Rise,0.0069,100,research and market drug patent challenge report profile more than drug and company,83,13,0,pharmacy,"['research', 'and', 'market', 'drug', 'patent', 'challenge', 'report', 'profile', 'more', 'than', 'drug', 'and', 'company']",1
73709,nifty_234,2011-03-10," eHealth, Inc. Scheduled to Speak at Upcoming Conferences on State Health Insurance Exchanges",Rise,0.0069,93,ehealth inc scheduled speak upcoming conference state health insurance exchange,79,10,0,pharmacy,"['eh', '##eal', '##th', 'in', '##c', 'scheduled', 'speak', 'upcoming', 'conference', 'state', 'health', 'insurance', 'exchange']",1
73751,nifty_234,2011-03-10,Nimbus Discovery Unveils First Of Its Kind Drug Discovery Paradigm; Announces Seed Round Co-Led By Bill Gates,Rise,0.0069,109,nimbus discovery unveils first it kind drug discovery paradigm announces seed round led bill gate,97,15,0,pharmacy,"['ni', '##mb', '##us', 'discovery', 'un', '##ve', '##ils', 'first', 'it', 'kind', 'drug', 'discovery', 'paradigm', 'announces', 'seed', 'round', 'led', 'bill', 'gate']",1
73752,nifty_234,2011-03-10,Research and Markets: Switzerland Drug Patent Inventor Report - 2011,Rise,0.0069,68,research and market switzerland drug patent inventor report,59,8,0,pharmacy,"['research', 'and', 'market', 's', '##witz', '##erland', 'drug', 'patent', 'inventor', 'report']",1
73766,nifty_234,2011-03-10,NPS Pharmaceuticals to Present at Barclays Capital Global Healthcare Conference,Rise,0.0069,79,np pharmaceutical present barclays capital global healthcare conference,71,8,0,pharmacy,"['n', '##p', 'pharmaceutical', 'present', 'bar', '##c', '##lay', '##s', 'capital', 'global', 'healthcare', 'conference']",1
73773,nifty_234,2011-03-10,NovaBay Pharmaceuticals Provides Fourth Quarter and Full Year 2010 Financial Results...,Rise,0.0069,87,novabay pharmaceutical provides fourth quarter and full year financial result,77,10,0,pharmacy,"['no', '##va', '##bay', 'pharmaceutical', 'provides', 'fourth', 'quarter', 'and', 'full', 'year', 'financial', 'result']",1
73782,nifty_234,2011-03-10,A Brighter Decade Ahead for Biotech - In-Depth Research Featuring Biodel Inc. and MannKind Corporation,Rise,0.0069,102,brighter decade ahead for biotech depth research featuring biodel inc and mannkind corporation,94,13,0,pharmacy,"['brighter', 'decade', 'ahead', 'for', 'bio', '##tech', 'depth', 'research', 'featuring', 'bio', '##del', 'in', '##c', 'and', 'man', '##nk', '##ind', 'corporation']",1
73846,nifty_234,2011-03-10,"Research and Markets: Evaluate the Global Pharmaceutical Fine Chemicals Market in terms of Regulatory Environment, Market Size and Structure",Rise,0.0069,140,research and market evaluate the global pharmaceutical fine chemical market term regulatory environment market size and structure,129,17,0,pharmacy,"['research', 'and', 'market', 'evaluate', 'the', 'global', 'pharmaceutical', 'fine', 'chemical', 'market', 'term', 'regulatory', 'environment', 'market', 'size', 'and', 'structure']",1
73874,nifty_234,2011-03-10,No proof of drug industry sway on WHO in pandemic-report,Rise,0.0069,56,proof drug industry sway who pandemic report,44,7,0,pharmacy,"['proof', 'drug', 'industry', 'sway', 'who', 'pan', '##de', '##mic', 'report']",1
73913,nifty_234,2011-03-10,New Pharmaceuticals and Healthcare Reports Recently Published by MarketPublishers.com,Rise,0.0069,85,new pharmaceutical and healthcare report recently published marketpublishers com,80,9,0,pharmacy,"['new', 'pharmaceutical', 'and', 'healthcare', 'report', 'recently', 'published', 'market', '##pu', '##b', '##lish', '##ers', 'com']",1
73926,nifty_234,2011-03-10,No proof of drug industry sway on WHO in pandemic: report,Rise,0.0069,57,proof drug industry sway who pandemic report,44,7,0,pharmacy,"['proof', 'drug', 'industry', 'sway', 'who', 'pan', '##de', '##mic', 'report']",1
73948,nifty_234,2011-03-10,Research and Markets: Global In Vitro Diagnostic Market Analysis - This Comprehensive Report Forecasts the Industry to Grow to US$ 52 Billion by 2013,Rise,0.0069,149,research and market global vitro diagnostic market analysis this comprehensive report forecast the industry grow billion,120,16,0,pharmacy,"['research', 'and', 'market', 'global', 'v', '##it', '##ro', 'diagnostic', 'market', 'analysis', 'this', 'comprehensive', 'report', 'forecast', 'the', 'industry', 'grow', 'billion']",1
74000,nifty_234,2011-03-10,"OncoVista Innovative Therapies Outlines Business Strategy; ""Company Is Moving Full-Speed Ahead,"" Says CEO",Rise,0.0069,105,oncovista innovative therapy outline business strategy company moving full speed ahead say ceo,94,13,0,pharmacy,"['on', '##co', '##vist', '##a', 'innovative', 'therapy', 'outline', 'business', 'strategy', 'company', 'moving', 'full', 'speed', 'ahead', 'say', 'c', '##eo']",1
74027,nifty_234,2011-03-10,Research and Markets: An Essential Report on the Russian Pharma Sector with Forecasts to 2013,Rise,0.0069,93,research and market essential report the russian pharma sector with forecast,76,11,0,pharmacy,"['research', 'and', 'market', 'essential', 'report', 'the', 'r', '##uss', '##ian', 'p', '##har', '##ma', 'sector', 'with', 'forecast']",1
74192,nifty_234,2011-03-10,Research and Markets: China Pharma Outsourcing Annual Review - Latest Development Trends,Rise,0.0069,88,research and market china pharma outsourcing annual review latest development trend,83,11,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'p', '##har', '##ma', 'outs', '##our', '##cing', 'annual', 'review', 'latest', 'development', 'trend']",1
74289,nifty_234,2011-03-10,Endocyte Reports 2010 Financial Results,Rise,0.0069,39,endocyte report financial result,32,4,0,pharmacy,"['end', '##oc', '##yte', 'report', 'financial', 'result']",1
74309,nifty_234,2011-03-10,BioSpecifics Technologies Corp. to Present at the Roth Capital Partners 23rd Annual OC Growth Stock Conference,Rise,0.0069,110,biospecifics technology corp present the roth capital partner annual growth stock conference,92,12,0,pharmacy,"['bio', '##sp', '##ec', '##ific', '##s', 'technology', 'co', '##rp', 'present', 'the', 'rot', '##h', 'capital', 'partner', 'annual', 'growth', 'stock', 'conference']",1
74320,nifty_234,2011-03-10, E-Commerce Health Up 6% in February,Rise,0.0069,36,commerce health february,24,3,0,pharmacy,"['commerce', 'health', 'f', '##eb', '##ru', '##ary']",1
74322,nifty_234,2011-03-10,Tatum Experts Available to Comment on Future of Hospital Financing Trends,Rise,0.0069,73,tatum expert available comment future hospital financing trend,62,8,0,pharmacy,"['ta', '##tum', 'expert', 'available', 'comment', 'future', 'hospital', 'financing', 'trend']",1
75017,nifty_237,2011-03-16,China Medical Technologies to Meet Investors,Rise,0.0132,44,china medical technology meet investor,38,5,0,pharmacy,"['chin', '##a', 'medical', 'technology', 'meet', 'investor']",1
75032,nifty_237,2011-03-16,Research and Markets: Pharmaceuticals in Japan - 2011 Report,Rise,0.0132,60,research and market pharmaceutical japan report,47,6,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'j', '##apa', '##n', 'report']",1
75101,nifty_237,2011-03-16,USOC concerned about drug war ahead of Pan Am Games,Rise,0.0132,51,usoc concerned about drug war ahead pan game,44,8,0,pharmacy,"['us', '##oc', 'concerned', 'about', 'drug', 'war', 'ahead', 'pan', 'game']",1
75188,nifty_237,2011-03-16, National Pharmaceuticals Corp. Appoints Chief Scientific Advisor,Rise,0.0132,65,national pharmaceutical corp appoints chief scientific advisor,62,7,0,pharmacy,"['national', 'pharmaceutical', 'co', '##rp', 'appoint', '##s', 'chief', 'scientific', 'advisor']",1
75232,nifty_237,2011-03-16,Research and Markets: The Medical Device Market: Japan - 2011 Report,Rise,0.0132,68,research and market the medical device market japan report,58,9,0,pharmacy,"['research', 'and', 'market', 'the', 'medical', 'device', 'market', 'j', '##apa', '##n', 'report']",1
75481,nifty_237,2011-03-16,Research and Markets: Gamma/Scintillation Cameras - Global Strategic Business Report - 2011 Concentrates on Nuclear Medicine Imaging Procedures and SPECT & PET Comparative Analysis,Rise,0.0132,180,research and market gamma scintillation camera global strategic business report concentrate nuclear medicine imaging procedure and spect pet comparative analysis,161,20,0,pharmacy,"['research', 'and', 'market', 'gamma', 's', '##cin', '##til', '##lation', 'camera', 'global', 'strategic', 'business', 'report', 'concentrate', 'nuclear', 'medicine', 'imaging', 'procedure', 'and', 's', '##pect', 'pet', 'comparative', 'analysis']",1
75619,nifty_237,2011-03-16,Research and Markets: Regulated Bioanalytical Laboratories: Technical and Regulatory Aspects from Global Perspectives,Rise,0.0132,117,research and market regulated bioanalytical laboratory technical and regulatory aspect from global perspective,110,13,0,pharmacy,"['research', 'and', 'market', 'regulated', 'bio', '##ana', '##ly', '##tical', 'laboratory', 'technical', 'and', 'regulatory', 'aspect', 'from', 'global', 'perspective']",1
75628,nifty_237,2011-03-16,CAGW`s Spending Cut Alert: National Drug Intelligence Center,Rise,0.0132,60,cagw spending cut alert national drug intelligence center,57,8,0,pharmacy,"['ca', '##g', '##w', 'spending', 'cut', 'alert', 'national', 'drug', 'intelligence', 'center']",1
75633,nifty_237,2011-03-16, Hail First Pharma Hires Investor Relations Firm DGR Advisors LLC,Rise,0.0132,65,hail first pharma hire investor relation firm dgr advisor llc,61,10,0,pharmacy,"['hail', 'first', 'p', '##har', '##ma', 'hire', 'investor', 'relation', 'firm', 'd', '##g', '##r', 'advisor', 'll', '##c']",1
75672,nifty_237,2011-03-16,Research and Markets: Top 20 Company Pipelines 2010,Rise,0.0132,51,research and market top company pipeline,40,6,0,pharmacy,"['research', 'and', 'market', 'top', 'company', 'pipeline']",1
75673,nifty_237,2011-03-16,Research and Markets: Personalized Medicine Market Analysis,Rise,0.0132,59,research and market personalized medicine market analysis,57,7,0,pharmacy,"['research', 'and', 'market', 'personal', '##ized', 'medicine', 'market', 'analysis']",1
75690,nifty_237,2011-03-16,Research and Markets: Top 15 Therapeutic Areas 2010,Rise,0.0132,51,research and market top therapeutic area,40,6,0,pharmacy,"['research', 'and', 'market', 'top', 'therapeutic', 'area']",1
75734,nifty_237,2011-03-16,Research and Markets: Gout Therapeutics - Pipeline Assessment and Market Forecasts to 2017,Rise,0.0132,90,research and market gout therapeutic pipeline assessment and market forecast,76,10,0,pharmacy,"['research', 'and', 'market', 'go', '##ut', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
75784,nifty_237,2011-03-16,BioSante Pharmaceuticals Reports Financial Results for 2010 and Clinical Development and Business Highlights,Rise,0.0132,108,biosante pharmaceutical report financial result for and clinical development and business highlight,99,12,0,pharmacy,"['bio', '##san', '##te', 'pharmaceutical', 'report', 'financial', 'result', 'for', 'and', 'clinical', 'development', 'and', 'business', 'highlight']",1
75919,nifty_237,2011-03-16,Mesirow Financial says CEO dies of cancer,Rise,0.0132,41,mesirow financial say ceo dy cancer,35,6,0,pharmacy,"['me', '##sir', '##ow', 'financial', 'say', 'c', '##eo', 'd', '##y', 'cancer']",1
76776,nifty_243,2011-03-28,Biosimilars seen as a $3.7bln drug market by 2015,Rise,0.0067,49,biosimilars seen bln drug market,32,5,0,pharmacy,"['bio', '##si', '##mi', '##lars', 'seen', 'b', '##ln', 'drug', 'market']",1
77118,nifty_243,2011-03-28,Research and Markets: Bioinformatics - A Global Market Overview Projects the Industry to Reach $7.6 Billion by 2017,Rise,0.0067,115,research and market bioinformatics global market overview project the industry reach billion,92,12,0,pharmacy,"['research', 'and', 'market', 'bio', '##in', '##formatics', 'global', 'market', 'overview', 'project', 'the', 'industry', 'reach', 'billion']",1
77226,nifty_243,2011-03-28,Epilepsy Advocates Undeterred by Struggling Economy and Cold Temps,Rise,0.0067,66,epilepsy advocate undeterred struggling economy and cold temp,61,8,0,pharmacy,"['e', '##pile', '##psy', 'advocate', 'und', '##eter', '##red', 'struggling', 'economy', 'and', 'cold', 'te', '##mp']",1
77246,nifty_243,2011-03-28,NovaBay Pharmaceuticals Releases CEO Webcast on Business and Clinical Developments...,Rise,0.0067,85,novabay pharmaceutical release ceo webcast business and clinical development,76,9,0,pharmacy,"['no', '##va', '##bay', 'pharmaceutical', 'release', 'c', '##eo', 'web', '##cast', 'business', 'and', 'clinical', 'development']",1
77384,nifty_243,2011-03-28,"Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited",Rise,0.0067,118,cephalon launch recommended takeover bid for australian biopharmaceutical company chemgenex pharmaceutical limited,114,12,0,pharmacy,"['c', '##ep', '##hal', '##on', 'launch', 'recommended', 'takeover', 'bid', 'for', 'au', '##stra', '##lian', 'bio', '##pha', '##rma', '##ce', '##utical', 'company', 'ch', '##em', '##gene', '##x', 'pharmaceutical', 'limited']",1
77812,nifty_244,2011-03-29,Northwest Biotherapeutics Launches Public Information Campaign in Collaboration with the Money Channel,Rise,0.0069,102,northwest biotherapeutics launch public information campaign collaboration with the money channel,97,11,0,pharmacy,"['northwest', 'bio', '##ther', '##ap', '##eu', '##tics', 'launch', 'public', 'information', 'campaign', 'collaboration', 'with', 'the', 'money', 'channel']",1
77876,nifty_244,2011-03-29,Institut Pasteur Shanghai Announces the Creation of its Global Biotech Accelerator Advance BioChina,Rise,0.0069,99,institut pasteur shanghai announces the creation it global biotech accelerator advance biochina,95,12,0,pharmacy,"['ins', '##ti', '##tu', '##t', 'paste', '##ur', 's', '##hang', '##hai', 'announces', 'the', 'creation', 'it', 'global', 'bio', '##tech', 'a', '##ccelerator', 'advance', 'bio', '##china']",1
78055,nifty_244,2011-03-29,Research and Markets: Glomerulonephritis Therapeutics - Pipeline Assessment and Market Forecasts to 2017,Rise,0.0069,104,research and market glomerulonephritis therapeutic pipeline assessment and market forecast,90,10,0,pharmacy,"['research', 'and', 'market', 'g', '##lo', '##mer', '##ulon', '##ep', '##hr', '##itis', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
78339,nifty_244,2011-03-29,"Research and Markets: Tetanus - Pipeline Review, Q4 2010",Rise,0.0069,56,research and market tetanus pipeline review,43,6,0,pharmacy,"['research', 'and', 'market', 'te', '##tan', '##us', 'pipeline', 'review']",1
78344,nifty_244,2011-03-29,"Research and Markets: Diarrhea - Pipeline Review, Q4 2010",Rise,0.0069,57,research and market diarrhea pipeline review,44,6,0,pharmacy,"['research', 'and', 'market', 'di', '##ar', '##r', '##hea', 'pipeline', 'review']",1
78379,nifty_244,2011-03-29, FDA and FTC Censorship Fails to Prop Up Collapsing Pharmaceutical Industry,Rise,0.0069,75,fda and ftc censorship fails prop collapsing pharmaceutical industry,68,9,0,pharmacy,"['f', '##da', 'and', 'ft', '##c', 'censorship', 'fails', 'prop', 'collapsing', 'pharmaceutical', 'industry']",1
78382,nifty_244,2011-03-29,"Research and Markets: Bioplastics Magazine - A Continuous Medium That Keeps You Updated About New Developments, Applications, Political Framework Conditions, Market Development, Etc.",Rise,0.0069,182,research and market bioplastics magazine continuous medium that keep you updated about new development application political framework condition market development etc,167,21,0,pharmacy,"['research', 'and', 'market', 'bio', '##p', '##lastic', '##s', 'magazine', 'continuous', 'medium', 'that', 'keep', 'you', 'updated', 'about', 'new', 'development', 'application', 'political', 'framework', 'condition', 'market', 'development', 'etc']",1
78389,nifty_244,2011-03-29,Research and Markets: Italy Pharmaceuticals and Healthcare Report Q1 2011,Rise,0.0069,73,research and market italy pharmaceutical and healthcare report,62,8,0,pharmacy,"['research', 'and', 'market', 'it', '##aly', 'pharmaceutical', 'and', 'healthcare', 'report']",1
78413,nifty_244,2011-03-29,Research and Markets: Top 1000 Medical Devices Manufacturers - 2011 Global Report,Rise,0.0069,81,research and market top medical device manufacturer global report,65,9,0,pharmacy,"['research', 'and', 'market', 'top', 'medical', 'device', 'manufacturer', 'global', 'report']",1
78415,nifty_244,2011-03-29,Research and Markets: Strategic Analysis of the U.S. Next Generation Sequencing Markets,Rise,0.0069,87,research and market strategic analysis the next generation sequencing market,76,10,0,pharmacy,"['research', 'and', 'market', 'strategic', 'analysis', 'the', 'next', 'generation', 'se', '##quencing', 'market']",1
78500,nifty_244,2011-03-29,Commonwealth Biotechnologies 2011 Annual Shareholder Vote & Meeting Update Information,Rise,0.0069,86,commonwealth biotechnology annual shareholder vote meeting update information,77,8,0,pharmacy,"['common', '##we', '##al', '##th', 'bio', '##tech', '##nology', 'annual', 'shareholder', 'vote', 'meeting', 'update', 'information']",1
78520,nifty_244,2011-03-29,"Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash",Rise,0.0069,84,valeant pharmaceutical proposes acquire cephalon inc for per share cash,71,10,0,pharmacy,"['v', '##ale', '##ant', 'pharmaceutical', 'proposes', 'acquire', 'c', '##ep', '##hal', '##on', 'in', '##c', 'for', 'per', 'share', 'cash']",1
78743,nifty_245,2011-03-30,Versace Sees Return to Health,Neutral,-0.0014,29,versace see return health,25,4,0,pharmacy,"['versa', '##ce', 'see', 'return', 'health']",1
78998,nifty_248,2011-04-05,Cancer Clues in Breast Milk,Neutral,0.0032,27,cancer clue breast milk,23,4,0,pharmacy,"['cancer', 'clue', 'breast', 'milk']",1
79044,nifty_249,2011-04-06,Talwalkars Aims for 60-65 New Health Clubs,Neutral,-0.0025,42,talwalkars aim for new health club,34,6,0,pharmacy,"['ta', '##l', '##walk', '##ars', 'aim', 'for', 'new', 'health', 'club']",1
79114,nifty_250,2011-04-07,"Strawberries Show Promise in Fighting Cancer, Study Shows",Neutral,-0.0035,57,strawberry show promise fighting cancer study show,50,7,0,pharmacy,"['straw', '##berry', 'show', 'promise', 'fighting', 'cancer', 'study', 'show']",1
79671,nifty_252,2011-04-12,Research and Markets: Middle East and Africa Pharma Sector Forecast to 2012,Neutral,-0.0001,75,research and market middle east and africa pharma sector forecast,65,10,0,pharmacy,"['research', 'and', 'market', 'middle', 'east', 'and', 'a', '##f', '##rica', 'p', '##har', '##ma', 'sector', 'forecast']",1
79850,nifty_252,2011-04-12,Research and Markets: UAE Healthcare Sector Forecast to 2012,Neutral,-0.0001,60,research and market uae healthcare sector forecast,50,7,0,pharmacy,"['research', 'and', 'market', 'u', '##ae', 'healthcare', 'sector', 'forecast']",1
79882,nifty_252,2011-04-12,"Research and Markets: Partnerships, Licensing, Investments and M&A; Deals and Trends in Pharmaceuticals - Q4 2010",Neutral,-0.0001,113,research and market partnership licensing investment and deal and trend pharmaceutical,86,11,0,pharmacy,"['research', 'and', 'market', 'partnership', 'licensing', 'investment', 'and', 'deal', 'and', 'trend', 'pharmaceutical']",1
79963,nifty_252,2011-04-12, Genmed Holding Corp. CEO Featured in Business Focused Publications,Neutral,-0.0001,67,genmed holding corp ceo featured business focused publication,61,8,0,pharmacy,"['g', '##en', '##med', 'holding', 'co', '##rp', 'c', '##eo', 'featured', 'business', 'focused', 'publication']",1
80002,nifty_252,2011-04-12,EuroMedtech 2011 to Make Turin the Medtech Funding Hotspot,Neutral,-0.0001,58,euromedtech make turin the medtech funding hotspot,50,7,0,pharmacy,"['euro', '##med', '##tech', 'make', 't', '##uri', '##n', 'the', 'me', '##dt', '##ech', 'funding', 'hot', '##sp', '##ot']",1
80017,nifty_252,2011-04-12,"UPDATE 1-Skilled Healthcare says may sell itself, shares up",Neutral,-0.0001,59,update skilled healthcare say may sell itself share,51,8,0,pharmacy,"['update', 'skilled', 'healthcare', 'say', 'may', 'sell', 'itself', 'share']",1
80114,nifty_252,2011-04-12,"Decision Resources, Inc.`s Competitive Landscape Seminar Series: Immune and Inflammatory Diseases on April 14, 2011 Will Address Current and Future Trends in the Immune and Inflammation Drug Markets",Neutral,-0.0001,198,decision resource inc competitive landscape seminar series immune and inflammatory disease april will address current and future trend the immune and inflammation drug market,174,24,0,pharmacy,"['decision', 'resource', 'in', '##c', 'competitive', 'landscape', 'seminar', 'series', 'immune', 'and', 'inflammatory', 'disease', 'a', '##p', '##ril', 'will', 'address', 'current', 'and', 'future', 'trend', 'the', 'immune', 'and', 'inflammation', 'drug', 'market']",1
80217,nifty_252,2011-04-12,Research and Markets: Chronic Pain Therapeutics Market Is Forecast To Show Slow Growth until 2017 When It Will Reach $24.9 Billion,Neutral,-0.0001,130,research and market chronic pain therapeutic market forecast show slow growth until when will reach billion,107,16,0,pharmacy,"['research', 'and', 'market', 'chronic', 'pain', 'therapeutic', 'market', 'forecast', 'show', 'slow', 'growth', 'until', 'when', 'will', 'reach', 'billion']",1
80372,nifty_252,2011-04-12,Research and Markets: Drug Stores and Health and Beauty Stores in China: Market Snapshot to 2015,Neutral,-0.0001,96,research and market drug store and health and beauty store china market snapshot,80,13,0,pharmacy,"['research', 'and', 'market', 'drug', 'store', 'and', 'health', 'and', 'beauty', 'store', 'chin', '##a', 'market', 'snaps', '##hot']",1
80446,nifty_252,2011-04-12,Doctors Heal Themselves Differently,Neutral,-0.0001,35,doctor heal themselves differently,34,4,0,pharmacy,"['doctor', 'heal', 'themselves', 'differently']",1
80613,nifty_255,2011-04-18,FDA Chemist's Hearing Canceled,Rise,0.0057,30,fda chemist hearing canceled,28,4,0,pharmacy,"['f', '##da', 'chemist', 'hearing', 'canceled']",1
81250,nifty_259,2011-04-26,Research and Markets: Endometrial Cancer Therapeutics - Market is Forecast to Show Moderate Growth,Rise,0.0065,98,research and market endometrial cancer therapeutic market forecast show moderate growth,87,11,0,pharmacy,"['research', 'and', 'market', 'end', '##ome', '##tri', '##al', 'cancer', 'therapeutic', 'market', 'forecast', 'show', 'moderate', 'growth']",1
81320,nifty_259,2011-04-26,Aegerion Pharmaceuticals to Present at the Deutsche Bank Securities 36th Annual Healthcare...,Rise,0.0065,93,aegerion pharmaceutical present the deutsche bank security annual healthcare,76,9,0,pharmacy,"['a', '##ege', '##rion', 'pharmaceutical', 'present', 'the', 'de', '##uts', '##che', 'bank', 'security', 'annual', 'healthcare']",1
81321,nifty_259,2011-04-26,Emergent Health Corp. Reports First Quarter 2011 Financial and Business Progress,Rise,0.0065,80,emergent health corp report first quarter financial and business progress,73,10,0,pharmacy,"['emerge', '##nt', 'health', 'co', '##rp', 'report', 'first', 'quarter', 'financial', 'and', 'business', 'progress']",1
81356,nifty_259,2011-04-26,"Medical Care Technologies Inc. Selects Virmmac, LLC for U.S. Marketing and Investor Relations",Rise,0.0065,93,medical care technology inc selects virmmac llc for marketing and investor relation,83,12,0,pharmacy,"['medical', 'care', 'technology', 'in', '##c', 'select', '##s', 'v', '##ir', '##mma', '##c', 'll', '##c', 'for', 'marketing', 'and', 'investor', 'relation']",1
81455,nifty_259,2011-04-26, Wall Street Journal Radio Interviews Eric Roberts About Genmed Holding Corp.,Rise,0.0065,77,wall street journal radio interview eric robert about genmed holding corp,73,11,0,pharmacy,"['wall', 'street', 'journal', 'radio', 'interview', 'er', '##ic', 'robe', '##rt', 'about', 'g', '##en', '##med', 'holding', 'co', '##rp']",1
81596,nifty_259,2011-04-26,Research and Markets: Global RFID Market Report - Market Booms as Solutions Add Efficiency and Intelligence to Drive Business,Rise,0.0065,125,research and market global rfid market report market boom solution add efficiency and intelligence drive business,113,16,0,pharmacy,"['research', 'and', 'market', 'global', 'r', '##fi', '##d', 'market', 'report', 'market', 'boom', 'solution', 'add', 'efficiency', 'and', 'intelligence', 'drive', 'business']",1
81600,nifty_259,2011-04-26,"Griffin Securities, Inc. Announces Investment Opinion on ZIOPHARM Oncology, Inc.",Rise,0.0065,80,griffin security inc announces investment opinion ziopharm oncology inc,71,9,0,pharmacy,"['g', '##riff', '##in', 'security', 'in', '##c', 'announces', 'investment', 'opinion', 'z', '##io', '##pha', '##rm', 'on', '##cology', 'in', '##c']",1
81661,nifty_259,2011-04-26,"Research and Markets: Pharmaceutical Key Trends 2011 - Pharmaceutical Industry Infrastructure Overview: Pharma Innovates, Diversifies and Contains Cost In Order To Grow Profits",Rise,0.0065,176,research and market pharmaceutical key trend pharmaceutical industry infrastructure overview pharma innovates diversifies and contains cost order grow profit,157,19,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'key', 'trend', 'pharmaceutical', 'industry', 'infrastructure', 'overview', 'p', '##har', '##ma', 'inn', '##ova', '##tes', 'divers', '##ifies', 'and', 'contains', 'cost', 'order', 'grow', 'profit']",1
81686,nifty_259,2011-04-26," DIAGNOS Announces Proposed Financing of up to $3,190,000",Rise,0.0065,57,diagnos announces proposed financing,36,4,0,pharmacy,"['di', '##ag', '##nos', 'announces', 'proposed', 'financing']",1
81712,nifty_259,2011-04-26,Research and Markets: DePuy Medical Device Company Intelligence Report 2011,Rise,0.0065,75,research and market depuy medical device company intelligence report,68,9,0,pharmacy,"['research', 'and', 'market', 'de', '##pu', '##y', 'medical', 'device', 'company', 'intelligence', 'report']",1
81734,nifty_259,2011-04-26,Research and Markets: Ethicon Medical Device Company Intelligence Report 2011,Rise,0.0065,77,research and market ethicon medical device company intelligence report,70,9,0,pharmacy,"['research', 'and', 'market', 'et', '##hic', '##on', 'medical', 'device', 'company', 'intelligence', 'report']",1
81987,nifty_259,2011-04-26,USC and Coulter Foundation Partner to Invest $5M in Breakthrough Innovation in Biomedical Engineering,Rise,0.0065,101,usc and coulter foundation partner invest breakthrough innovation biomedical engineering,88,10,0,pharmacy,"['us', '##c', 'and', 'co', '##ulter', 'foundation', 'partner', 'invest', 'breakthrough', 'innovation', 'bio', '##medical', 'engineering']",1
82236,nifty_259,2011-04-26,"Study: Aspirin, Prozac Can Mix Badly",Rise,0.0065,36,study aspirin prozac can mix badly,34,6,0,pharmacy,"['study', 'as', '##pi', '##rin', 'pro', '##zac', 'can', 'mix', 'badly']",1
82346,nifty_261,2011-04-28,Bristol-Myers Profit Rises 33%,Neutral,0.0024,30,bristol myers profit rise,25,4,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'profit', 'rise']",1
82584,nifty_264,2011-05-04,IMG's Forstmann Treated for Cancer,Fall,-0.009,34,img forstmann treated for cancer,32,5,0,pharmacy,"['im', '##g', 'for', '##st', '##mann', 'treated', 'for', 'cancer']",1
82653,nifty_265,2011-05-05,REG - Biome Technologies - Trading Update,Neutral,0.0044,41,reg biome technology trading update,35,5,0,pharmacy,"['re', '##g', 'bio', '##me', 'technology', 'trading', 'update']",1
83008,nifty_265,2011-05-05,Oncolytics BiotechÂ® Inc. Announces Details of 2011 Annual Shareholder Meeting,Neutral,0.0044,78,oncolytics biotechâ inc announces detail annual shareholder meeting,67,8,0,pharmacy,"['on', '##co', '##ly', '##tics', 'bio', '##tech', '##â', 'in', '##c', 'announces', 'detail', 'annual', 'shareholder', 'meeting']",1
83077,nifty_265,2011-05-05,Global Pharmaceutical Market Remains in Declining Growth Trend,Neutral,0.0044,62,global pharmaceutical market remains declining growth trend,59,7,0,pharmacy,"['global', 'pharmaceutical', 'market', 'remains', 'declining', 'growth', 'trend']",1
83366,nifty_265,2011-05-05, Biosimilar Market to Reach $3.7 Billion by 2015,Neutral,0.0044,48,biosimilar market reach billion,31,4,0,pharmacy,"['bio', '##si', '##mi', '##lar', 'market', 'reach', 'billion']",1
83444,nifty_265,2011-05-05,"Research and Markets: Psychogenic Movement Disorders Global Clinical Trials Review, Q1, 2011",Neutral,0.0044,92,research and market psychogenic movement disorder global clinical trial review,78,10,0,pharmacy,"['research', 'and', 'market', 'ps', '##ych', '##ogenic', 'movement', 'disorder', 'global', 'clinical', 'trial', 'review']",1
83458,nifty_265,2011-05-05,Research and Markets: Novel Antibodies & Therapeutic Proteins: Technological Challenges & Future Prospects,Neutral,0.0044,106,research and market novel antibody therapeutic protein technological challenge future prospect,94,11,0,pharmacy,"['research', 'and', 'market', 'novel', 'anti', '##body', 'therapeutic', 'protein', 'technological', 'challenge', 'future', 'prospect']",1
83472,nifty_265,2011-05-05,Research and Markets: Multiplexed Diagnostics 2010 Market Report - Market Is Expected To Tip In Favour Of Continued Rapid Growth,Neutral,0.0044,128,research and market multiplexed diagnostics market report market expected tip favour continued rapid growth,107,14,0,pharmacy,"['research', 'and', 'market', 'multiple', '##xed', 'diagnostic', '##s', 'market', 'report', 'market', 'expected', 'tip', 'favour', 'continued', 'rapid', 'growth']",1
83478,nifty_265,2011-05-05,Opportunities Abound for Investors: Wireless and Mobile Healthcare Innovators To Be Showcased At WLSA Convergence Summit 2011,Neutral,0.0044,125,opportunity abound for investor wireless and mobile healthcare innovator showcased wlsa convergence summit,106,13,0,pharmacy,"['opportunity', 'a', '##bound', 'for', 'investor', 'wireless', 'and', 'mobile', 'healthcare', 'inn', '##ova', '##tor', 'showcased', 'w', '##ls', '##a', 'convergence', 'summit']",1
83565,nifty_265,2011-05-05,Analogic to Present at Bank of America Merrill Lynch 2011 Health Care Investor Conference,Neutral,0.0044,89,analogic present bank america merrill lynch health care investor conference,75,10,0,pharmacy,"['analog', '##ic', 'present', 'bank', 'am', '##eric', '##a', 'me', '##rri', '##ll', 'l', '##ync', '##h', 'health', 'care', 'investor', 'conference']",1
83645,nifty_265,2011-05-05,Research and Markets: eHealthcare Strategy & Trends - Gain an e-healthcare Advantage with the Leading Internet Resource,Neutral,0.0044,119,research and market ehealthcare strategy trend gain healthcare advantage with the leading internet resource,107,14,0,pharmacy,"['research', 'and', 'market', 'eh', '##eal', '##th', '##care', 'strategy', 'trend', 'gain', 'healthcare', 'advantage', 'with', 'the', 'leading', 'internet', 'resource']",1
83802,nifty_265,2011-05-05,BioScrip to Present at Upcoming Investor Conferences,Neutral,0.0044,52,bioscrip present upcoming investor conference,45,5,0,pharmacy,"['bio', '##s', '##c', '##rip', 'present', 'upcoming', 'investor', 'conference']",1
83819,nifty_265,2011-05-05,BioTime Announces First Quarter 2011 Financial Results and Corporate Developments,Neutral,0.0044,81,biotime announces first quarter financial result and corporate development,74,9,0,pharmacy,"['bio', '##time', 'announces', 'first', 'quarter', 'financial', 'result', 'and', 'corporate', 'development']",1
84568,nifty_268,2011-05-11,Dealtalk: No biotech too large to buy?,Neutral,0.0048,38,dealtalk biotech too large buy,30,5,0,pharmacy,"['dealt', '##alk', 'bio', '##tech', 'too', 'large', 'buy']",1
84750,nifty_268,2011-05-11,Healthcare Equipment and Services Markets Analyzed in New Research Reports Published by MarketPublishers.com,Neutral,0.0048,108,healthcare equipment and service market analyzed new research report published marketpublishers com,99,12,0,pharmacy,"['healthcare', 'equipment', 'and', 'service', 'market', 'analyzed', 'new', 'research', 'report', 'published', 'market', '##pu', '##b', '##lish', '##ers', 'com']",1
84778,nifty_268,2011-05-11,Seventh Sense Biosystems Secures $4.5 Million of Two-Tranche $10 Million Extension of its Series A Financing,Neutral,0.0048,108,seventh sense biosystems secures million two tranche million extension it series financing,90,12,0,pharmacy,"['seventh', 'sense', 'bio', '##sy', '##ste', '##ms', 'secure', '##s', 'million', 'two', 't', '##ran', '##che', 'million', 'extension', 'it', 'series', 'financing']",1
84830,nifty_268,2011-05-11,"Pharma Elite to Unveil Latest Industry News/Program Agenda with 70+ Expert Speakers at Exclusive Event: Pharma CI Conference, September 13-14, 2011 in New Jersey",Neutral,0.0048,161,pharma elite unveil latest industry news program agenda with expert speaker exclusive event pharma conference september new jersey,130,18,0,pharmacy,"['p', '##har', '##ma', 'elite', 'un', '##ve', '##il', 'latest', 'industry', 'news', 'program', 'agenda', 'with', 'expert', 'speaker', 'exclusive', 'event', 'p', '##har', '##ma', 'conference', 'se', '##pt', '##em', '##ber', 'new', 'jersey']",1
84852,nifty_268,2011-05-11,Ligand to Webcast Analyst and Investor Day on June 23 in New York City,Neutral,0.0048,70,ligand webcast analyst and investor day june new york city,58,10,0,pharmacy,"['l', '##igan', '##d', 'web', '##cast', 'analyst', 'and', 'investor', 'day', 'j', '##une', 'new', 'yo', '##rk', 'city']",1
84864,nifty_268,2011-05-11,IncellDx CEO Unveils Revolutionary New Tool In The Fight Against Cancer,Neutral,0.0048,71,incelldx ceo unveils revolutionary new tool the fight against cancer,68,10,0,pharmacy,"['in', '##cell', '##d', '##x', 'c', '##eo', 'un', '##ve', '##ils', 'revolutionary', 'new', 'tool', 'the', 'fight', 'against', 'cancer']",1
84948,nifty_268,2011-05-11,Research and Markets: Report on Emerging Medtech Companies in Q1 2011 - Details on 140 Emerging Medical Technology Companies!,Neutral,0.0048,125,research and market report emerging medtech company detail emerging medical technology company,94,12,0,pharmacy,"['research', 'and', 'market', 'report', 'emerging', 'me', '##dt', '##ech', 'company', 'detail', 'emerging', 'medical', 'technology', 'company']",1
85051,nifty_268,2011-05-11,Aileron Therapeutics Appoints Veterans of Life Sciences Industry and Wall Street to its BOD; Nobel Laureate and Venerated Drug Developers Join Company`s SAB,Neutral,0.0048,156,aileron therapeutic appoints veteran life science industry and wall street it bod nobel laureate and venerated drug developer join company sab,142,21,0,pharmacy,"['a', '##iler', '##on', 'therapeutic', 'appoint', '##s', 'veteran', 'life', 'science', 'industry', 'and', 'wall', 'street', 'it', 'b', '##od', 'no', '##bel', 'la', '##ure', '##ate', 'and', 've', '##ner', '##ated', 'drug', 'developer', 'join', 'company', 'sa', '##b']",1
85060,nifty_268,2011-05-11,Product Commercialization Comes Into Focus at Emerging Leaders Workshop at 2011 BIO International Convention,Neutral,0.0048,108,product commercialization come into focus emerging leader workshop bio international convention,95,11,0,pharmacy,"['product', 'commercial', '##ization', 'come', 'into', 'focus', 'emerging', 'leader', 'workshop', 'bio', 'international', 'convention']",1
85113,nifty_268,2011-05-11, Physicians' Push to Secure EHR Incentive Funds Drives Significant Growth for Doctors Administrative Solutions,Neutral,0.0048,110,physician push secure ehr incentive fund drive significant growth for doctor administrative solution,100,13,0,pharmacy,"['physician', 'push', 'secure', 'eh', '##r', 'incentive', 'fund', 'drive', 'significant', 'growth', 'for', 'doctor', 'administrative', 'solution']",1
85242,nifty_268,2011-05-11,Research and Markets: 2011 R&D; Trends: Depression - Pipeline Characterized by its Depth and Diversity,Neutral,0.0048,102,research and market trend depression pipeline characterized it depth and diversity,82,11,0,pharmacy,"['research', 'and', 'market', 'trend', 'depression', 'pipeline', 'characterized', 'it', 'depth', 'and', 'diversity']",1
85254,nifty_268,2011-05-11,Research and Markets: Pharmaceutical Key Trends 2011 - Rising Healthcare Costs Coupled With the Economic Downturn Continue To Shape the Healthcare Landscape,Neutral,0.0048,156,research and market pharmaceutical key trend rising healthcare cost coupled with the economic downturn continue shape the healthcare landscape,142,19,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'key', 'trend', 'rising', 'healthcare', 'cost', 'coupled', 'with', 'the', 'economic', 'down', '##turn', 'continue', 'shape', 'the', 'healthcare', 'landscape']",1
85273,nifty_268,2011-05-11,Research and Markets: FDA Changes Suggested in 510(k) Process - Impact and Opportunities in 2011,Neutral,0.0048,96,research and market fda change suggested process impact and opportunity,71,10,0,pharmacy,"['research', 'and', 'market', 'f', '##da', 'change', 'suggested', 'process', 'impact', 'and', 'opportunity']",1
85280,nifty_268,2011-05-11,Research and Markets: R&D; Trends: Sepsis - Improvements in Clinical Trial Design and Advances in Biomarker Research Hold the Key to a Tailored Approach to Sepsis Therapy,Neutral,0.0048,170,research and market trend sepsis improvement clinical trial design and advance biomarker research hold the key tailored approach sepsis therapy,143,20,0,pharmacy,"['research', 'and', 'market', 'trend', 'se', '##psis', 'improvement', 'clinical', 'trial', 'design', 'and', 'advance', 'bio', '##mark', '##er', 'research', 'hold', 'the', 'key', 'tailored', 'approach', 'se', '##psis', 'therapy']",1
85292,nifty_268,2011-05-11,Research and Markets: 2011 Case Study: Autism Spectrum Disorders - Public Awareness and Physician Detailing Will Drive Market Growth,Neutral,0.0048,132,research and market case study autism spectrum disorder public awareness and physician detailing will drive market growth,121,17,0,pharmacy,"['research', 'and', 'market', 'case', 'study', 'autism', 'spectrum', 'disorder', 'public', 'awareness', 'and', 'physician', 'detailing', 'will', 'drive', 'market', 'growth']",1
85411,nifty_268,2011-05-11,Cumberland Pharmaceuticals to Present at the 2011 UBS Global Specialty Pharmaceuticals Conference in London,Neutral,0.0048,107,cumberland pharmaceutical present the ubs global specialty pharmaceutical conference london,91,10,0,pharmacy,"['cum', '##ber', '##land', 'pharmaceutical', 'present', 'the', 'u', '##bs', 'global', 'specialty', 'pharmaceutical', 'conference', 'lo', '##ndon']",1
85455,nifty_268,2011-05-11,"BioSpecifics Technologies Corp. to Present at SEVEN, Noble Financial Capital Markets' Seventh Annual Equity Conference",Neutral,0.0048,118,biospecifics technology corp present seven noble financial capital market seventh annual equity conference,106,13,0,pharmacy,"['bio', '##sp', '##ec', '##ific', '##s', 'technology', 'co', '##rp', 'present', 'seven', 'noble', 'financial', 'capital', 'market', 'seventh', 'annual', 'equity', 'conference']",1
85884,nifty_272,2011-05-18,IMS Institute Forecasts Global Spending on Medicines to Reach Nearly $1.1 Trillion by 2015,Neutral,0.0024,90,ims institute forecast global spending medicine reach nearly trillion,69,9,0,pharmacy,"['im', '##s', 'institute', 'forecast', 'global', 'spending', 'medicine', 'reach', 'nearly', 'trillion']",1
86322,nifty_272,2011-05-18,"BioSante Pharmaceuticals, Inc. To Present at Two Upcoming Investor Conferences",Neutral,0.0024,78,biosante pharmaceutical inc present two upcoming investor conference,68,8,0,pharmacy,"['bio', '##san', '##te', 'pharmaceutical', 'in', '##c', 'present', 'two', 'upcoming', 'investor', 'conference']",1
86408,nifty_272,2011-05-18,ADFLOW Health Networks Announces Strategic Investment from Fortune 100 Healthcare Company,Neutral,0.0024,89,adflow health network announces strategic investment from fortune healthcare company,84,10,0,pharmacy,"['ad', '##flow', 'health', 'network', 'announces', 'strategic', 'investment', 'from', 'fortune', 'healthcare', 'company']",1
86409,nifty_272,2011-05-18,Cempra Pharmaceuticals to Present at Two Investor Conferences in Paris,Neutral,0.0024,70,cempra pharmaceutical present two investor conference paris,59,7,0,pharmacy,"['c', '##em', '##pra', 'pharmaceutical', 'present', 'two', 'investor', 'conference', 'par', '##is']",1
86433,nifty_272,2011-05-18, Healthnostics Addresses Unusual Trading,Neutral,0.0024,40,healthnostics address unusual trading,37,4,0,pharmacy,"['health', '##nos', '##tics', 'address', 'unusual', 'trading']",1
86472,nifty_272,2011-05-18,Celldex Prices Public Offering of Common Stock,Neutral,0.0024,46,celldex price public offering common stock,42,6,0,pharmacy,"['cell', '##de', '##x', 'price', 'public', 'offering', 'common', 'stock']",1
86478,nifty_272,2011-05-18," Biotech Approaching Inflection Point - Equity Research on Marina Biotech, Inc. and Arrowhead Research Corporation",Neutral,0.0024,114,biotech approaching inflection point equity research marina biotech inc and arrowhead research corporation,106,13,0,pharmacy,"['bio', '##tech', 'approaching', 'in', '##fle', '##ction', 'point', 'equity', 'research', 'ma', '##rina', 'bio', '##tech', 'in', '##c', 'and', 'arrow', '##head', 'research', 'corporation']",1
86633,nifty_272,2011-05-18,Research and Markets: Bone Metastases Therapeutics - Strong Pipeline is Likely to Result in Steep Growth for the Market,Neutral,0.0024,119,research and market bone metastasis therapeutic strong pipeline likely result steep growth for the market,105,15,0,pharmacy,"['research', 'and', 'market', 'bone', 'meta', '##sta', '##sis', 'therapeutic', 'strong', 'pipeline', 'likely', 'result', 'steep', 'growth', 'for', 'the', 'market']",1
86665,nifty_272,2011-05-18,Research and Markets: Demonstrating the Value of Healthcare: A Beginner's Guide,Neutral,0.0024,79,research and market demonstrating the value healthcare beginner guide,69,9,0,pharmacy,"['research', 'and', 'market', 'demonstrating', 'the', 'value', 'healthcare', 'begin', '##ner', 'guide']",1
86667,nifty_272,2011-05-18,Research and Markets: Pharmaceutical Key Trends 2011 - Healthcare System & Drug Regulatory Overview,Neutral,0.0024,99,research and market pharmaceutical key trend healthcare system drug regulatory overview,87,11,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'key', 'trend', 'healthcare', 'system', 'drug', 'regulatory', 'overview']",1
86784,nifty_272,2011-05-18,Genesis Biopharma Forms Scientific and Medical Advisory Board,Neutral,0.0024,61,genesis biopharma form scientific and medical advisory board,60,8,0,pharmacy,"['genes', '##is', 'bio', '##pha', '##rma', 'form', 'scientific', 'and', 'medical', 'advisory', 'board']",1
86801,nifty_272,2011-05-18,Research and Markets: Exploring New Opportunities in the Expanding Diabetes Market: Novel Targets and Strategies,Neutral,0.0024,112,research and market exploring new opportunity the expanding diabetes market novel target and strategy,101,14,0,pharmacy,"['research', 'and', 'market', 'exploring', 'new', 'opportunity', 'the', 'expanding', 'diabetes', 'market', 'novel', 'target', 'and', 'strategy']",1
86802,nifty_272,2011-05-18,"Research and Markets: Elsevier Science and Technology Notes Report - Comprehensive Biotechnology, 2nd edition. Edition No. 2",Neutral,0.0024,124,research and market elsevier science and technology note report comprehensive biotechnology edition edition,107,13,0,pharmacy,"['research', 'and', 'market', 'else', '##vier', 'science', 'and', 'technology', 'note', 'report', 'comprehensive', 'bio', '##tech', '##nology', 'edition', 'edition']",1
86937,nifty_272,2011-05-18, GeneNews Reports First Quarter 2011 Financial Results,Neutral,0.0024,54,genenews report first quarter financial result,46,6,0,pharmacy,"['gene', '##ne', '##ws', 'report', 'first', 'quarter', 'financial', 'result']",1
86950,nifty_272,2011-05-18,"Ads in medical journals lack backing, experts find",Neutral,0.0024,50,ad medical journal lack backing expert find,43,7,0,pharmacy,"['ad', 'medical', 'journal', 'lack', 'backing', 'expert', 'find']",1
87424,nifty_273,2011-05-19,Research and Markets: Handbook of Epigenetics: The New Molecular and Medical Genetics,Fall,-0.0079,85,research and market handbook epigenetics the new molecular and medical genetics,79,11,0,pharmacy,"['research', 'and', 'market', 'hand', '##book', 'e', '##pi', '##gene', '##tics', 'the', 'new', 'molecular', 'and', 'medical', 'genetics']",1
87477,nifty_273,2011-05-19,Research and Markets: Pharmaceutical Opportunities in Emerging Markets - Newly Industrialized Asia,Fall,-0.0079,98,research and market pharmaceutical opportunity emerging market newly industrialized asia,88,10,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'opportunity', 'emerging', 'market', 'newly', 'industrial', '##ized', 'as', '##ia']",1
87632,nifty_273,2011-05-19,Genesis Biopharma Retains Leading Strategic Consultancy The Emmes Group,Fall,-0.0079,71,genesis biopharma retains leading strategic consultancy the emmes group,71,9,0,pharmacy,"['genes', '##is', 'bio', '##pha', '##rma', 'retains', 'leading', 'strategic', 'consult', '##ancy', 'the', 'em', '##mes', 'group']",1
87683,nifty_273,2011-05-19,Research and Markets: Elsevier Science and Technology Notes - MRI Atlas of Human White Matter. Edition No. 2,Fall,-0.0079,108,research and market elsevier science and technology note mri atlas human white matter edition,93,14,0,pharmacy,"['research', 'and', 'market', 'else', '##vier', 'science', 'and', 'technology', 'note', 'm', '##ri', 'at', '##las', 'human', 'white', 'matter', 'edition']",1
87777,nifty_273,2011-05-19,"Griffin Securities, Inc. Announces Investment Opinion on ZIOPHARM Oncology, Inc.",Fall,-0.0079,80,griffin security inc announces investment opinion ziopharm oncology inc,71,9,0,pharmacy,"['g', '##riff', '##in', 'security', 'in', '##c', 'announces', 'investment', 'opinion', 'z', '##io', '##pha', '##rm', 'on', '##cology', 'in', '##c']",1
87807,nifty_273,2011-05-19,Research and Markets: Biotechgate Company Database Gives Access to 14'725 Global Company Profiles,Fall,-0.0079,97,research and market biotechgate company database give access global company profile,83,11,0,pharmacy,"['research', 'and', 'market', 'bio', '##tech', '##gate', 'company', 'database', 'give', 'access', 'global', 'company', 'profile']",1
87916,nifty_273,2011-05-19,New Medical Devices and Hospital Supplies Markets Reports Published at MarketPublishers.com,Fall,-0.0079,91,new medical device and hospital supply market report published marketpublishers com,83,11,0,pharmacy,"['new', 'medical', 'device', 'and', 'hospital', 'supply', 'market', 'report', 'published', 'market', '##pu', '##b', '##lish', '##ers', 'com']",1
87932,nifty_273,2011-05-19,"DNA Dynamics, Inc. Announces Current Information on OTC Markets",Fall,-0.0079,63,dna dynamic inc announces current information otc market,56,8,0,pharmacy,"['d', '##na', 'dynamic', 'in', '##c', 'announces', 'current', 'information', 'o', '##t', '##c', 'market']",1
87975,nifty_273,2011-05-19,Research and Markets: Elsevier Science and Technology Notes - Handbook of Modern Pharmaceutical Analysis Edition No. 2,Fall,-0.0079,118,research and market elsevier science and technology note handbook modern pharmaceutical analysis edition,104,13,0,pharmacy,"['research', 'and', 'market', 'else', '##vier', 'science', 'and', 'technology', 'note', 'hand', '##book', 'modern', 'pharmaceutical', 'analysis', 'edition']",1
87979,nifty_273,2011-05-19,Research and Markets: Global DNA & Gene Chip (Microarray) Market (2010 - 2015),Fall,-0.0079,78,research and market global dna gene chip microarray market,58,9,0,pharmacy,"['research', 'and', 'market', 'global', 'd', '##na', 'gene', 'chip', 'micro', '##arra', '##y', 'market']",1
88072,nifty_273,2011-05-19,Research and Markets: State of the Pharmaceutical Industry 2011 - Industry Remodeling Activities,Fall,-0.0079,96,research and market state the pharmaceutical industry industry remodeling activity,82,10,0,pharmacy,"['research', 'and', 'market', 'state', 'the', 'pharmaceutical', 'industry', 'industry', 're', '##mo', '##del', '##ing', 'activity']",1
88122,nifty_273,2011-05-19,Unilife to Present at the 2011 UBS Global Specialty Pharmaceuticals Conference in London,Fall,-0.0079,88,unilife present the ubs global specialty pharmaceutical conference london,73,9,0,pharmacy,"['un', '##ili', '##fe', 'present', 'the', 'u', '##bs', 'global', 'specialty', 'pharmaceutical', 'conference', 'lo', '##ndon']",1
88286,nifty_273,2011-05-19,EpiCept to Present at the 18th Annual Euro-Biotech Forum,Fall,-0.0079,56,epicept present the annual euro biotech forum,45,7,0,pharmacy,"['epic', '##ept', 'present', 'the', 'annual', 'euro', 'bio', '##tech', 'forum']",1
88303,nifty_273,2011-05-19,IVAX Diagnostics Postpones Its Annual Meeting of Stockholders,Fall,-0.0079,61,ivax diagnostics postpones it annual meeting stockholder,56,7,0,pharmacy,"['i', '##va', '##x', 'diagnostic', '##s', 'post', '##po', '##nes', 'it', 'annual', 'meeting', 'stock', '##holder']",1
88310,nifty_273,2011-05-19,"Healthcare Liaison, Inc. Featured In MarketWatch / Wall Street Journal Digital Network Story On Growing Healthcare Advocacy Profession",Fall,-0.0079,134,healthcare liaison inc featured marketwatch wall street journal digital network story growing healthcare advocacy profession,124,15,0,pharmacy,"['healthcare', 'liaison', 'in', '##c', 'featured', 'market', '##watch', 'wall', 'street', 'journal', 'digital', 'network', 'story', 'growing', 'healthcare', 'advocacy', 'profession']",1
88386,nifty_273,2011-05-19,Research and Markets: Japan: Pharmaceuticals Industry Guide 2011,Fall,-0.0079,64,research and market japan pharmaceutical industry guide,55,7,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##n', 'pharmaceutical', 'industry', 'guide']",1
88790,nifty_275,2011-05-24,"Edmond de Rothschild Investment Partners leads the â¬ 14.5 M capital increase of GenKyoTex to develop NOX enzyme inhibitors, as the company appoints new management team",Neutral,0.0033,169,edmond rothschild investment partner lead the capital increase genkyotex develop nox enzyme inhibitor the company appoints new management team,142,19,0,pharmacy,"['ed', '##mond', 'rot', '##hs', '##child', 'investment', 'partner', 'lead', 'the', 'capital', 'increase', 'g', '##en', '##ky', '##ote', '##x', 'develop', 'no', '##x', 'enzyme', 'inhibitor', 'the', 'company', 'appoint', '##s', 'new', 'management', 'team']",1
88970,nifty_275,2011-05-24,Cryo-Cell International Shares Recognized in the Health Care Services Industry for...,Neutral,0.0033,85,cryo cell international share recognized the health care service industry for,77,11,0,pharmacy,"['cry', '##o', 'cell', 'international', 'share', 'recognized', 'the', 'health', 'care', 'service', 'industry', 'for']",1
88995,nifty_275,2011-05-24,"Quintiles` New Health Report 2011 Finds Patients, Physicians, Biopharma and Payers Are Optimistic About the Future of Drug Development, Yet Differ Widely on Defining Value",Neutral,0.0033,171,quintiles new health report find patient physician biopharma and payer are optimistic about the future drug development yet differ widely defining value,152,22,0,pharmacy,"['q', '##uin', '##tile', '##s', 'new', 'health', 'report', 'find', 'patient', 'physician', 'bio', '##pha', '##rma', 'and', 'pay', '##er', 'are', 'optimistic', 'about', 'the', 'future', 'drug', 'development', 'yet', 'differ', 'widely', 'defining', 'value']",1
88999,nifty_275,2011-05-24,Visual Healthcare ADE Platform Attracts Positive Market Response,Neutral,0.0033,64,visual healthcare ade platform attracts positive market response,64,8,0,pharmacy,"['visual', 'healthcare', 'ad', '##e', 'platform', 'attracts', 'positive', 'market', 'response']",1
89103,nifty_275,2011-05-24, First China Pharma Invests in Updates to Proprietary Order Fulfillment and Supply Chain Management Systems,Neutral,0.0033,107,first china pharma invests update proprietary order fulfillment and supply chain management system,98,13,0,pharmacy,"['first', 'chin', '##a', 'p', '##har', '##ma', 'invest', '##s', 'update', 'proprietary', 'order', 'fulfill', '##ment', 'and', 'supply', 'chain', 'management', 'system']",1
89220,nifty_275,2011-05-24,"Congressional and Corporate Leaders to Address Legal Reform, International Trade, Health Care and Other Issues Impacting Small and Medium-Sized Businesses",Neutral,0.0033,154,congressional and corporate leader address legal reform international trade health care and other issue impacting small and medium sized business,145,20,0,pharmacy,"['congressional', 'and', 'corporate', 'leader', 'address', 'legal', 'reform', 'international', 'trade', 'health', 'care', 'and', 'other', 'issue', 'impact', '##ing', 'small', 'and', 'medium', 'sized', 'business']",1
89352,nifty_275,2011-05-24,Research and Markets: Financial Health of Companies in the 'Other Healthcare Services',Neutral,0.0033,86,research and market financial health company the other healthcare service,73,10,0,pharmacy,"['research', 'and', 'market', 'financial', 'health', 'company', 'the', 'other', 'healthcare', 'service']",1
89370,nifty_275,2011-05-24,Research and Markets: Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues,Neutral,0.0033,133,research and market generic growth strategy manufacturer increase focus super generic and biosimilars drive revenue,115,15,0,pharmacy,"['research', 'and', 'market', 'generic', 'growth', 'strategy', 'manufacturer', 'increase', 'focus', 'super', 'generic', 'and', 'bio', '##si', '##mi', '##lars', 'drive', 'revenue']",1
89396,nifty_275,2011-05-24,Research and Markets: Biotech M&A; and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines,Neutral,0.0033,152,research and market biotech and licensing strategy development agreement are poised increase the future counter drying pipeline,127,17,0,pharmacy,"['research', 'and', 'market', 'bio', '##tech', 'and', 'licensing', 'strategy', 'development', 'agreement', 'are', 'poised', 'increase', 'the', 'future', 'counter', 'drying', 'pipeline']",1
89435,nifty_275,2011-05-24, Biotonix: Annual and Special Meeting of Shareholders,Neutral,0.0033,53,biotonix annual and special meeting shareholder,47,6,0,pharmacy,"['bio', '##ton', '##ix', 'annual', 'and', 'special', 'meeting', 'shareholder']",1
89457,nifty_275,2011-05-24,Research and Markets: Lifestyle Disorders Market to 2016 - Limited Pipeline Products and Slow Progress in R&D; are Major Concerns,Neutral,0.0033,129,research and market lifestyle disorder market limited pipeline product and slow progress are major concern,106,15,0,pharmacy,"['research', 'and', 'market', 'lifestyle', 'disorder', 'market', 'limited', 'pipeline', 'product', 'and', 'slow', 'progress', 'are', 'major', 'concern']",1
89587,nifty_275,2011-05-24,Abbott Receives U.S. FDA Approval for XIENCE nanoâ¢ to Treat Coronary Artery Disease in Small Vessels,Neutral,0.0033,102,abbott receives fda approval for xience nanoâ treat coronary artery disease small vessel,88,13,0,pharmacy,"['abbot', '##t', 'receives', 'f', '##da', 'approval', 'for', 'x', '##ience', 'na', '##no', '##â', 'treat', 'co', '##rona', '##ry', 'artery', 'disease', 'small', 'vessel']",1
90130,nifty_276,2011-05-25,Research and Markets: The Year in Diabetes and Obesity,Neutral,0.0046,54,research and market the year diabetes and obesity,49,8,0,pharmacy,"['research', 'and', 'market', 'the', 'year', 'diabetes', 'and', 'o', '##besity']",1
90195,nifty_276,2011-05-25,Liaison Technologies CTO Bruce Chen to Guide Company`s Further Expansion into Healthcare Informatics,Neutral,0.0046,100,liaison technology cto bruce chen guide company further expansion into healthcare informatics,93,12,0,pharmacy,"['liaison', 'technology', 'c', '##to', 'br', '##uce', 'ch', '##en', 'guide', 'company', 'further', 'expansion', 'into', 'healthcare', 'inform', '##atic', '##s']",1
90203,nifty_276,2011-05-25,Cryo-Cell International Shares Potentially Undervalued in Terms of Earnings Yield,Neutral,0.0046,81,cryo cell international share potentially undervalued term earnings yield,73,9,0,pharmacy,"['cry', '##o', 'cell', 'international', 'share', 'potentially', 'under', '##val', '##ued', 'term', 'earnings', 'yield']",1
90210,nifty_276,2011-05-25, Report: What You Need to Know About Radient Pharmaceuticals' Late Filing and Pending News,Neutral,0.0046,90,report what you need know about radient pharmaceutical late filing and pending news,83,13,0,pharmacy,"['report', 'what', 'you', 'need', 'know', 'about', 'r', '##adi', '##ent', 'pharmaceutical', 'late', 'filing', 'and', 'pending', 'news']",1
90338,nifty_276,2011-05-25, Molecular Diagnostics Market Reached $4.8 Billion in 2010,Neutral,0.0046,58,molecular diagnostics market reached billion,44,5,0,pharmacy,"['molecular', 'diagnostic', '##s', 'market', 'reached', 'billion']",1
90570,nifty_276,2011-05-25,Research and Markets: Drug Delivery Devices Market Outlook in China to 2017 - Company Shares and Distribution Shares Data for Each of the Market Categories,Neutral,0.0046,155,research and market drug delivery device market outlook china company share and distribution share data for each the market category,132,20,0,pharmacy,"['research', 'and', 'market', 'drug', 'delivery', 'device', 'market', 'outlook', 'chin', '##a', 'company', 'share', 'and', 'distribution', 'share', 'data', 'for', 'each', 'the', 'market', 'category']",1
90585,nifty_276,2011-05-25,Research and Markets: The 2011 Tsunami and Earthquake in Japan - Explore Possible Repercussions on Medical Devices Market Dynamics,Neutral,0.0046,130,research and market the tsunami and earthquake japan explore possible repercussion medical device market dynamic,112,15,0,pharmacy,"['research', 'and', 'market', 'the', 'tsunami', 'and', 'earthquake', 'j', '##apa', '##n', 'explore', 'possible', 're', '##per', '##cus', '##sion', 'medical', 'device', 'market', 'dynamic']",1
90759,nifty_276,2011-05-25,Science Center CEO Highlights Life Sciences as an Economic Driver During Testimony Before U.S. Congress Joint Economic Committee,Neutral,0.0046,128,science center ceo highlight life science economic driver during testimony before congress joint economic committee,115,15,0,pharmacy,"['science', 'center', 'c', '##eo', 'highlight', 'life', 'science', 'economic', 'driver', 'during', 'testimony', 'before', 'congress', 'joint', 'economic', 'committee']",1
90799,nifty_276,2011-05-25,Research and Markets: Top 10 Healthcare Trends in 2011,Neutral,0.0046,54,research and market top healthcare trend,40,6,0,pharmacy,"['research', 'and', 'market', 'top', 'healthcare', 'trend']",1
90889,nifty_276,2011-05-25,Annual Shareholders' Meeting of InNexus Biotechnology: Shareholders Approve All Resolutions,Neutral,0.0046,91,annual shareholder meeting innexus biotechnology shareholder approve all resolution,83,9,0,pharmacy,"['annual', 'shareholder', 'meeting', 'inn', '##ex', '##us', 'bio', '##tech', '##nology', 'shareholder', 'approve', 'all', 'resolution']",1
90998,nifty_276,2011-05-25,Research and Markets: The Outlook for Medical Devices in South East Asia to 2015 - Complete Quarterly-Updated Analysis to Keep you Informed,Neutral,0.0046,139,research and market the outlook for medical device south east asia complete quarterly updated analysis keep you informed,120,18,0,pharmacy,"['research', 'and', 'market', 'the', 'outlook', 'for', 'medical', 'device', 'south', 'east', 'as', '##ia', 'complete', 'quarterly', 'updated', 'analysis', 'keep', 'you', 'informed']",1
91390,nifty_282,2011-06-07,Lorillard Taps Ex-FDA Official for Post,Neutral,-0.0042,39,lorillard tap fda official for post,35,6,0,pharmacy,"['lo', '##rilla', '##rd', 'tap', 'f', '##da', 'official', 'for', 'post']",1
91840,nifty_283,2011-06-08,"Research and Markets: Transdermal CNS Therapeutics: Products, Pipeline Candidates, Markets, Forecasts",Rise,0.0076,101,research and market transdermal cns therapeutic product pipeline candidate market forecast,90,11,0,pharmacy,"['research', 'and', 'market', 'trans', '##der', '##mal', 'c', '##ns', 'therapeutic', 'product', 'pipeline', 'candidate', 'market', 'forecast']",1
91894,nifty_283,2011-06-08,Assured Pharmacy Engages The Investor Relations Group,Rise,0.0076,53,assured pharmacy engages the investor relation group,52,7,0,pharmacy,"['assured', 'pharmacy', 'engages', 'the', 'investor', 'relation', 'group']",1
91911,nifty_283,2011-06-08, Expert Briefing: What Investors Should Know About Tight Glycemic Control and Its Future,Rise,0.0076,88,expert briefing what investor should know about tight glycemic control and it future,84,13,0,pharmacy,"['expert', 'brief', '##ing', 'what', 'investor', 'should', 'know', 'about', 'tight', 'g', '##ly', '##ce', '##mic', 'control', 'and', 'it', 'future']",1
91943,nifty_283,2011-06-08,BIO-key International(R) Releases Survey Results and Comments on Continued Security...,Rise,0.0076,86,bio key international release survey result and comment continued security,74,10,0,pharmacy,"['bio', 'key', 'international', 'release', 'survey', 'result', 'and', 'comment', 'continued', 'security']",1
91962,nifty_283,2011-06-08,"Sandbox Industries Announces Healthbox, a Business Accelerator for Healthcare Startups",Rise,0.0076,86,sandbox industry announces healthbox business accelerator for healthcare startup,80,9,0,pharmacy,"['sand', '##box', 'industry', 'announces', 'health', '##box', 'business', 'a', '##ccelerator', 'for', 'healthcare', 'start', '##up']",1
91966,nifty_283,2011-06-08,Research and Markets: Essential Biochemistry for Medicine,Rise,0.0076,57,research and market essential biochemistry for medicine,55,7,0,pharmacy,"['research', 'and', 'market', 'essential', 'bio', '##chemistry', 'for', 'medicine']",1
91967,nifty_283,2011-06-08,"Research and Markets: ABC of COPD, 2nd Edition",Rise,0.0076,46,research and market abc copd edition,36,6,0,pharmacy,"['research', 'and', 'market', 'a', '##b', '##c', 'cop', '##d', 'edition']",1
91984,nifty_283,2011-06-08, Stellar Pharmaceuticals Engages Advisory Consultant for Its Products in the United States Market,Rise,0.0076,97,stellar pharmaceutical engages advisory consultant for it product the united state market,89,12,0,pharmacy,"['stellar', 'pharmaceutical', 'engages', 'advisory', 'consultant', 'for', 'it', 'product', 'the', 'united', 'state', 'market']",1
92014,nifty_283,2011-06-08," Hope of a Healthy Sector to Drive Pharmaceuticals -- Research Report on Orexigen Therapeutics, Inc. and VIVUS, Inc.",Rise,0.0076,116,hope healthy sector drive pharmaceutical research report orexigen therapeutic inc and vivus inc,95,13,0,pharmacy,"['hope', 'healthy', 'sector', 'drive', 'pharmaceutical', 'research', 'report', 'ore', '##xi', '##gen', 'therapeutic', 'in', '##c', 'and', 'v', '##iv', '##us', 'in', '##c']",1
92061,nifty_283,2011-06-08,"Booming Health Economy is Driving New Gold Rush for Innovators and Job Seekers, Says PwC",Rise,0.0076,88,booming health economy driving new gold rush for innovator and job seeker say pwc,81,14,0,pharmacy,"['boom', '##ing', 'health', 'economy', 'driving', 'new', 'gold', 'rush', 'for', 'inn', '##ova', '##tor', 'and', 'job', 'seek', '##er', 'say', 'p', '##w', '##c']",1
92246,nifty_283,2011-06-08,Leading Biotechnology Entrepreneur and Investor Isaac Blech Joins Medgenics Board of Directors,Rise,0.0076,94,leading biotechnology entrepreneur and investor isaac blech join medgenics board director,89,11,0,pharmacy,"['leading', 'bio', '##tech', '##nology', 'entrepreneur', 'and', 'investor', 'is', '##aa', '##c', 'b', '##le', '##ch', 'join', 'me', '##dge', '##nics', 'board', 'director']",1
92280,nifty_283,2011-06-08,"Research and Markets: A Brain Metastasis Global Clinical Trials Review for Q4, 2010: Examine In Depth Clinical Trial Data",Rise,0.0076,121,research and market brain metastasis global clinical trial review for examine depth clinical trial data,103,15,0,pharmacy,"['research', 'and', 'market', 'brain', 'meta', '##sta', '##sis', 'global', 'clinical', 'trial', 'review', 'for', 'examine', 'depth', 'clinical', 'trial', 'data']",1
92287,nifty_283,2011-06-08,Thomson Reuters Trademark Report Reveals New Challenges and Opportunities for Pharmaceutical Brands,Rise,0.0076,99,thomson reuters trademark report reveals new challenge and opportunity for pharmaceutical brand,95,12,0,pharmacy,"['th', '##oms', '##on', 're', '##uters', 'trademark', 'report', 'reveals', 'new', 'challenge', 'and', 'opportunity', 'for', 'pharmaceutical', 'brand']",1
92352,nifty_283,2011-06-08,Research and Markets: An Apoptosis Market Report: An Analysis of 370 Apoptosis from 233 Originating Companies,Rise,0.0076,109,research and market apoptosis market report analysis apoptosis from originating company,87,11,0,pharmacy,"['research', 'and', 'market', 'a', '##pop', '##tosis', 'market', 'report', 'analysis', 'a', '##pop', '##tosis', 'from', 'originating', 'company']",1
92355,nifty_283,2011-06-08,HHS and The Office of the National Coordinator for Health Information Technology introduce new Investing in Innovations (i2) Initiative,Rise,0.0076,135,hhs and the office the national coordinator for health information technology introduce new investing innovation initiative,123,16,0,pharmacy,"['h', '##hs', 'and', 'the', 'office', 'the', 'national', 'coordinator', 'for', 'health', 'information', 'technology', 'introduce', 'new', 'investing', 'innovation', 'initiative']",1
92368,nifty_283,2011-06-08,"Research and Markets: Inflammatory Bowel Disease - Pipeline Review, Q2 2011",Rise,0.0076,75,research and market inflammatory bowel disease pipeline review,62,8,0,pharmacy,"['research', 'and', 'market', 'inflammatory', 'bow', '##el', 'disease', 'pipeline', 'review']",1
92414,nifty_283,2011-06-08,Financial transparency skin-deep at medical journals,Rise,0.0076,52,financial transparency skin deep medical journal,48,6,0,pharmacy,"['financial', 'transparency', 'skin', 'deep', 'medical', 'journal']",1
92446,nifty_283,2011-06-08,Research and Markets: The Private Health Insurance Market in India - Identify Key Health Insurance Competitors,Rise,0.0076,110,research and market the private health insurance market india identify key health insurance competitor,102,14,0,pharmacy,"['research', 'and', 'market', 'the', 'private', 'health', 'insurance', 'market', 'in', '##dia', 'identify', 'key', 'health', 'insurance', 'competitor']",1
92448,nifty_283,2011-06-08,Research and Markets: Advances in Drug-Diagnostic Co-Development - Report Available Now!,Rise,0.0076,88,research and market advance drug diagnostic development report available now,76,10,0,pharmacy,"['research', 'and', 'market', 'advance', 'drug', 'diagnostic', 'development', 'report', 'available', 'now']",1
93121,nifty_288,2011-06-16,"ClinTec International Expands into China, Singapore and Thailand, Increasing Its Presence in the Emerging Markets for Clinical Research",Neutral,-0.002,135,clintec international expands into china singapore and thailand increasing it presence the emerging market for clinical research,128,17,0,pharmacy,"['c', '##lint', '##ec', 'international', 'expands', 'into', 'chin', '##a', 'sing', '##ap', '##ore', 'and', 'th', '##ail', '##and', 'increasing', 'it', 'presence', 'the', 'emerging', 'market', 'for', 'clinical', 'research']",1
93179,nifty_288,2011-06-16,Research and Markets: Chemotherapy Clinic Market in India Is Forecast To Reach A Value of $76.9 Bn by 2013 Representing A CAGR of 5.1percent (2007-13),Neutral,-0.002,150,research and market chemotherapy clinic market india forecast reach value representing cagr percent,99,13,0,pharmacy,"['research', 'and', 'market', 'ch', '##em', '##otherapy', 'clinic', 'market', 'in', '##dia', 'forecast', 'reach', 'value', 'representing', 'ca', '##g', '##r', 'percent']",1
93220,nifty_288,2011-06-16,Research and Markets: Exploiting Information Technology Tools to Advance Personalized Medicine,Neutral,-0.002,94,research and market exploiting information technology tool advance personalized medicine,88,10,0,pharmacy,"['research', 'and', 'market', 'exploit', '##ing', 'information', 'technology', 'tool', 'advance', 'personal', '##ized', 'medicine']",1
93322,nifty_288,2011-06-16,Aegerion Pharmaceuticals Holds Pre-NDA Meeting With FDA for Investigational Lomitapide...,Neutral,-0.002,89,aegerion pharmaceutical hold pre nda meeting with fda for investigational lomitapide,84,11,0,pharmacy,"['a', '##ege', '##rion', 'pharmaceutical', 'hold', 'pre', 'n', '##da', 'meeting', 'with', 'f', '##da', 'for', 'investigation', '##al', 'lo', '##mit', '##ap', '##ide']",1
93327,nifty_288,2011-06-16,Research and Markets: Pharma Blogging: Speaking out - Required Reading for All Those Interested in What's Next in Contemporary Healthcare Communications,Neutral,-0.002,152,research and market pharma blogging speaking out required reading for all those interested what next contemporary healthcare communication,138,18,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', 'blog', '##ging', 'speaking', 'out', 'required', 'reading', 'for', 'all', 'those', 'interested', 'what', 'next', 'contemporary', 'healthcare', 'communication']",1
93333,nifty_288,2011-06-16,Sinobiomed (d/b/a Sitoa Global) Announces Strategic Partnership With Solana HK Limited...,Neutral,-0.002,89,sinobiomed sitoa global announces strategic partnership with solana limited,75,9,0,pharmacy,"['sin', '##ob', '##io', '##med', 'sit', '##oa', 'global', 'announces', 'strategic', 'partnership', 'with', 'so', '##lana', 'limited']",1
93337,nifty_288,2011-06-16, Small Biotech Company With Significant Potential Now Has FDA Trade Catalyst in Play,Neutral,-0.002,84,small biotech company with significant potential now ha fda trade catalyst play,79,12,0,pharmacy,"['small', 'bio', '##tech', 'company', 'with', 'significant', 'potential', 'now', 'ha', 'f', '##da', 'trade', 'catalyst', 'play']",1
93347,nifty_288,2011-06-16,Research and Markets: Global Obesity Drug Market Analysis - Provides an extensive research into the recent trends of the market,Neutral,-0.002,127,research and market global obesity drug market analysis provides extensive research into the recent trend the market,116,17,0,pharmacy,"['research', 'and', 'market', 'global', 'o', '##besity', 'drug', 'market', 'analysis', 'provides', 'extensive', 'research', 'into', 'the', 'recent', 'trend', 'the', 'market']",1
93397,nifty_288,2011-06-16,"Research and Markets: Pharmaceutical Pricing, Reimbursement, and Market Access News in the First Quarter of 2011",Neutral,-0.002,112,research and market pharmaceutical pricing reimbursement and market access news the first quarter,97,13,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'pricing', 're', '##im', '##bur', '##se', '##ment', 'and', 'market', 'access', 'news', 'the', 'first', 'quarter']",1
93407,nifty_288,2011-06-16,ADVENTRX Pharmaceuticals to Present at the OneMedForum Business Development and Investment Conference on June 23,Neutral,-0.002,112,adventrx pharmaceutical present the onemedforum business development and investment conference june,99,11,0,pharmacy,"['advent', '##r', '##x', 'pharmaceutical', 'present', 'the', 'one', '##med', '##fo', '##rum', 'business', 'development', 'and', 'investment', 'conference', 'j', '##une']",1
93412,nifty_288,2011-06-16,iCAD to Participate in the Lazard Capital Markets Medical Technology and Healthcare Services Conference,Neutral,-0.002,103,icad participate the lazard capital market medical technology and healthcare service conference,95,12,0,pharmacy,"['i', '##ca', '##d', 'participate', 'the', 'la', '##zard', 'capital', 'market', 'medical', 'technology', 'and', 'healthcare', 'service', 'conference']",1
93580,nifty_288,2011-06-16,Navigators Launches Life Sciences Products Addressing Emerging Risks,Neutral,-0.002,68,navigator launch life science product addressing emerging risk,62,8,0,pharmacy,"['na', '##vigator', 'launch', 'life', 'science', 'product', 'addressing', 'emerging', 'risk']",1
93740,nifty_288,2011-06-16,Research and Markets: Analyze the Global Schizophrenia Therapeutics Market as it Will Increase at a CAGR of 7.5% Between 2010 and 2018: Including Forecasts & a Pipeline Analysis,Neutral,-0.002,177,research and market analyze the global schizophrenia therapeutic market will increase cagr between and including forecast pipeline analysis,139,18,0,pharmacy,"['research', 'and', 'market', 'analyze', 'the', 'global', 's', '##chi', '##zophrenia', 'therapeutic', 'market', 'will', 'increase', 'ca', '##g', '##r', 'between', 'and', 'including', 'forecast', 'pipeline', 'analysis']",1
93751,nifty_288,2011-06-16,Research and Markets: Immunochemicals - Global Strategic Business Report 2011,Neutral,-0.002,77,research and market immunochemicals global strategic business report,68,8,0,pharmacy,"['research', 'and', 'market', 'im', '##mu', '##no', '##chemical', '##s', 'global', 'strategic', 'business', 'report']",1
93847,nifty_288,2011-06-16,Research and Markets: Clinical Diagnostics Automation - Global Strategic Business Report 2011,Neutral,-0.002,93,research and market clinical diagnostics automation global strategic business report,84,10,0,pharmacy,"['research', 'and', 'market', 'clinical', 'diagnostic', '##s', 'automation', 'global', 'strategic', 'business', 'report']",1
93870,nifty_288,2011-06-16,Kendle Experts to Address Key Industry Issues at Drug Information Association 47th Annual Meeting,Neutral,-0.002,97,kendle expert address key industry issue drug information association annual meeting,84,11,0,pharmacy,"['k', '##end', '##le', 'expert', 'address', 'key', 'industry', 'issue', 'drug', 'information', 'association', 'annual', 'meeting']",1
93913,nifty_288,2011-06-16,Shenzhen Wuzhou Changlian International Trading Co. Establishes Relationship with Hospital in Africa,Neutral,-0.002,100,shenzhen wuzhou changlian international trading establishes relationship with hospital africa,93,10,0,pharmacy,"['she', '##nz', '##hen', 'w', '##uz', '##hou', 'ch', '##ang', '##lian', 'international', 'trading', 'establishes', 'relationship', 'with', 'hospital', 'a', '##f', '##rica']",1
93965,nifty_288,2011-06-16, First TASER X2 ECDs Ship for Revenue,Neutral,-0.002,37,first taser ecds ship for revenue,33,6,0,pharmacy,"['first', 'ta', '##ser', 'e', '##c', '##ds', 'ship', 'for', 'revenue']",1
94086,nifty_288,2011-06-16,SuperGen Stockholders Approve Stock Issuance In Connection with the Proposed Acquisition of Astex Therapeutics Limited,Neutral,-0.002,118,supergen stockholder approve stock issuance connection with the proposed acquisition astex therapeutic limited,110,13,0,pharmacy,"['super', '##gen', 'stock', '##holder', 'approve', 'stock', 'is', '##su', '##ance', 'connection', 'with', 'the', 'proposed', 'acquisition', 'as', '##te', '##x', 'therapeutic', 'limited']",1
94116,nifty_288,2011-06-16,"Foresight to Exhibit at the 47th Drug Information Association Annual Meeting - June 19, 2011 in Chicago, IL",Neutral,-0.002,107,foresight exhibit the drug information association annual meeting june chicago,78,10,0,pharmacy,"['fore', '##sight', 'exhibit', 'the', 'drug', 'information', 'association', 'annual', 'meeting', 'j', '##une', 'ch', '##ica', '##go']",1
94455,nifty_291,2011-06-22,Pharma Firm Injects Life,Neutral,-0.0029,24,pharma firm injects life,24,4,0,pharmacy,"['p', '##har', '##ma', 'firm', 'in', '##jects', 'life']",1
94969,nifty_300,2011-07-11,Imtech: impact of technology in care & cure market increases,Neutral,-0.0043,60,imtech impact technology care cure market increase,50,7,0,pharmacy,"['im', '##tech', 'impact', 'technology', 'care', 'cure', 'market', 'increase']",1
95194,nifty_300,2011-07-11,"Research and Markets: Ukraine Pharmaceuticals and Healthcare Report Q3 2011 - In 2011, the Country's Pharmaceutical Market Will Surpass Its Previous Peak In 2008",Neutral,-0.0043,161,research and market ukraine pharmaceutical and healthcare report the country pharmaceutical market will surpass it previous peak,128,17,0,pharmacy,"['research', 'and', 'market', 'uk', '##rain', '##e', 'pharmaceutical', 'and', 'healthcare', 'report', 'the', 'country', 'pharmaceutical', 'market', 'will', 'sur', '##pass', 'it', 'previous', 'peak']",1
95317,nifty_300,2011-07-11,NovaBay Pharmaceuticals Provides Business Update,Neutral,-0.0043,48,novabay pharmaceutical provides business update,47,5,0,pharmacy,"['no', '##va', '##bay', 'pharmaceutical', 'provides', 'business', 'update']",1
95318,nifty_300,2011-07-11,Sinobiomed (d/b/a Sitoa Global) Announces Strategic Partnership With Soconison Technology...,Neutral,-0.0043,92,sinobiomed sitoa global announces strategic partnership with soconison technology,81,9,0,pharmacy,"['sin', '##ob', '##io', '##med', 'sit', '##oa', 'global', 'announces', 'strategic', 'partnership', 'with', 'so', '##con', '##ison', 'technology']",1
95426,nifty_300,2011-07-11,Medical Care Technologies Inc. Advances Discussions to Expand Pediatric Healthcare Operations in Beijing,Neutral,-0.0043,104,medical care technology inc advance discussion expand pediatric healthcare operation beijing,92,11,0,pharmacy,"['medical', 'care', 'technology', 'in', '##c', 'advance', 'discussion', 'expand', 'p', '##ediatric', 'healthcare', 'operation', 'be', '##iji', '##ng']",1
95432,nifty_300,2011-07-11,Sagent Pharmaceuticals and Chongqing Lummy Pharmaceutical Company Announce Development...,Neutral,-0.0043,89,sagent pharmaceutical and chongqing lummy pharmaceutical company announce development,85,9,0,pharmacy,"['sage', '##nt', 'pharmaceutical', 'and', 'ch', '##ong', '##qing', 'l', '##um', '##my', 'pharmaceutical', 'company', 'announce', 'development']",1
95440,nifty_300,2011-07-11,Novartis could be ready to go for buys soon-paper,Neutral,-0.0043,49,novartis could ready for buy soon paper,39,7,0,pharmacy,"['no', '##var', '##tis', 'could', 'ready', 'for', 'buy', 'soon', 'paper']",1
95583,nifty_300,2011-07-11,"Research and Markets: 'Nausea And Vomiting: Pipeline Review, Q2 2011' - A Snapshot of the Global Therapeutic Scenario",Neutral,-0.0043,117,research and market nausea and vomiting pipeline review snapshot the global therapeutic scenario,96,13,0,pharmacy,"['research', 'and', 'market', 'nausea', 'and', 'vomit', '##ing', 'pipeline', 'review', 'snaps', '##hot', 'the', 'global', 'therapeutic', 'scenario']",1
95605,nifty_300,2011-07-11,"Research and Markets: 'Fistula: Pipeline Review, Q2 2011' - Latest news and deals relating to the products.",Neutral,-0.0043,107,research and market fistula pipeline review latest news and deal relating the product,85,13,0,pharmacy,"['research', 'and', 'market', 'fist', '##ula', 'pipeline', 'review', 'latest', 'news', 'and', 'deal', 'relating', 'the', 'product']",1
95607,nifty_300,2011-07-11,BRICS Healthcare Equipment & Services Markets Outlooks Recently Published by MarketPublishers.com,Neutral,-0.0043,97,brics healthcare equipment service market outlook recently published marketpublishers com,89,10,0,pharmacy,"['br', '##ics', 'healthcare', 'equipment', 'service', 'market', 'outlook', 'recently', 'published', 'market', '##pu', '##b', '##lish', '##ers', 'com']",1
95609,nifty_300,2011-07-11,"Research and Markets: Generalized Seizures - Pipeline Review, Q2 2011",Neutral,-0.0043,69,research and market generalized seizure pipeline review,55,7,0,pharmacy,"['research', 'and', 'market', 'generalized', 'seizure', 'pipeline', 'review']",1
95653,nifty_300,2011-07-11,Research and Markets: 'Advancing Molecular Diagnostics to Personalize Cancer Therapy' report analyzes current and potential world markets,Neutral,-0.0043,137,research and market advancing molecular diagnostics personalize cancer therapy report analyzes current and potential world market,129,16,0,pharmacy,"['research', 'and', 'market', 'advancing', 'molecular', 'diagnostic', '##s', 'personal', '##ize', 'cancer', 'therapy', 'report', 'analyze', '##s', 'current', 'and', 'potential', 'world', 'market']",1
95674,nifty_300,2011-07-11,"Research and Markets: 'Amnesia - Pipeline Review, Q2 2011' - A Snapshot of the Global Therapeutic Scenario",Neutral,-0.0043,106,research and market amnesia pipeline review snapshot the global therapeutic scenario,84,11,0,pharmacy,"['research', 'and', 'market', 'am', '##nesia', 'pipeline', 'review', 'snaps', '##hot', 'the', 'global', 'therapeutic', 'scenario']",1
96040,nifty_300,2011-07-11,"U.S. healthcare, financials primed for growth, says PE firm",Neutral,-0.0043,59,healthcare financials primed for growth say firm,48,7,0,pharmacy,"['healthcare', 'financial', '##s', 'prime', '##d', 'for', 'growth', 'say', 'firm']",1
96174,nifty_301,2011-07-12,Neutralizing Salt's Heart Impact,Neutral,0.0033,32,neutralizing salt heart impact,30,4,0,pharmacy,"['neutral', '##izing', 'salt', 'heart', 'impact']",1
96482,nifty_303,2011-07-14,Research and Markets: IMS Pharmaceutical Pricing & Reimbursement Concise Guide 2011: South Korea Provide Industry Players and Decision Makers with a Thorough Understanding,Rise,0.0058,171,research and market ims pharmaceutical pricing reimbursement concise guide south korea provide industry player and decision maker with thorough understanding,157,20,0,pharmacy,"['research', 'and', 'market', 'im', '##s', 'pharmaceutical', 'pricing', 're', '##im', '##bur', '##se', '##ment', 'con', '##cise', 'guide', 'south', 'k', '##ore', '##a', 'provide', 'industry', 'player', 'and', 'decision', 'maker', 'with', 'thorough', 'understanding']",1
96595,nifty_303,2011-07-14,Groundbreaking Report Details the New $80 Billion Accountable-Care Market,Rise,0.0058,73,groundbreaking report detail the new billion accountable care market,68,9,0,pharmacy,"['groundbreaking', 'report', 'detail', 'the', 'new', 'billion', 'account', '##able', 'care', 'market']",1
96689,nifty_303,2011-07-14," Despite Recession, Medical Device Development Group Continues to Thrive",Rise,0.0058,72,despite recession medical device development group continues thrive,67,8,0,pharmacy,"['despite', 'recession', 'medical', 'device', 'development', 'group', 'continues', 'th', '##rive']",1
96766,nifty_303,2011-07-14,"Summer Street Research Announces Expansion of Research Team with the Addition of Ling Wang, CFA, Senior Biotechnology Analyst",Rise,0.0058,125,summer street research announces expansion research team with the addition ling wang cfa senior biotechnology analyst,117,16,0,pharmacy,"['summer', 'street', 'research', 'announces', 'expansion', 'research', 'team', 'with', 'the', 'addition', 'l', '##ing', 'wa', '##ng', 'c', '##fa', 'senior', 'bio', '##tech', '##nology', 'analyst']",1
96804,nifty_303,2011-07-14,"Health Discovery Corporation Sees Consumer ""App"" Market as Viable Channel to Leverage Its Intellectual Property Portfolio",Rise,0.0058,121,health discovery corporation see consumer app market viable channel leverage it intellectual property portfolio,111,14,0,pharmacy,"['health', 'discovery', 'corporation', 'see', 'consumer', 'app', 'market', 'viable', 'channel', 'leverage', 'it', 'intellectual', 'property', 'portfolio']",1
96892,nifty_303,2011-07-14,Various Biotechnology Companies Product Pipeline Reviews Published by MarketPublishers.com,Rise,0.0058,90,various biotechnology company product pipeline review published marketpublishers com,84,9,0,pharmacy,"['various', 'bio', '##tech', '##nology', 'company', 'product', 'pipeline', 'review', 'published', 'market', '##pu', '##b', '##lish', '##ers', 'com']",1
96954,nifty_303,2011-07-14,"Research and Markets: 'Scar: Pipeline Review, Q2 2011' - Key discontinued pipeline projects",Rise,0.0058,91,research and market scar pipeline review key discontinued pipeline project,74,10,0,pharmacy,"['research', 'and', 'market', 'scar', 'pipeline', 'review', 'key', 'discontinued', 'pipeline', 'project']",1
97015,nifty_303,2011-07-14,Research and Markets: Top R&D; Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure,Rise,0.0058,150,research and market top drug failure toxicity and serious adverse event late stage drug development are the major cause drug failure,132,21,0,pharmacy,"['research', 'and', 'market', 'top', 'drug', 'failure', 'toxicity', 'and', 'serious', 'adverse', 'event', 'late', 'stage', 'drug', 'development', 'are', 'the', 'major', 'cause', 'drug', 'failure']",1
97017,nifty_303,2011-07-14, Emerging Markets Clinical Trials Help Development Teams Meet Patient Enrollment Challenges,Rise,0.0058,91,emerging market clinical trial help development team meet patient enrollment challenge,86,11,0,pharmacy,"['emerging', 'market', 'clinical', 'trial', 'help', 'development', 'team', 'meet', 'patient', 'enrollment', 'challenge']",1
97075,nifty_303,2011-07-14,Cegedim Relationship Management Offers Biotech Companies a Comprehensive Approach to Their Transparency Needs,Rise,0.0058,109,cegedim relationship management offer biotech company comprehensive approach their transparency need,100,11,0,pharmacy,"['c', '##ege', '##di', '##m', 'relationship', 'management', 'offer', 'bio', '##tech', 'company', 'comprehensive', 'approach', 'their', 'transparency', 'need']",1
97120,nifty_303,2011-07-14,QuantRx Biomedical Corporation Provides Corporate Update,Rise,0.0058,56,quantrx biomedical corporation provides corporate update,56,6,0,pharmacy,"['q', '##uant', '##r', '##x', 'bio', '##medical', 'corporation', 'provides', 'corporate', 'update']",1
97130,nifty_303,2011-07-14,Research and Markets: An Epidemiology Report on Sepsis - The Number of Incident Cases of Severe Sepsis in the 7 Major Markets Will Increase by 1.7% Between 2010 and 2020,Rise,0.0058,169,research and market epidemiology report sepsis the number incident case severe sepsis the major market will increase between and,128,19,0,pharmacy,"['research', 'and', 'market', 'e', '##pid', '##em', '##iology', 'report', 'se', '##psis', 'the', 'number', 'incident', 'case', 'severe', 'se', '##psis', 'the', 'major', 'market', 'will', 'increase', 'between', 'and']",1
97217,nifty_303,2011-07-14,Webinar: Public Health Experts Provide Update on Current Infectious Diseases Threats,Rise,0.0058,84,webinar public health expert provide update current infectious disease threat,77,10,0,pharmacy,"['web', '##ina', '##r', 'public', 'health', 'expert', 'provide', 'update', 'current', 'infectious', 'disease', 'threat']",1
97240,nifty_303,2011-07-14,Research and Markets: An Ewing's Sarcoma Therapeutics Pipeline Assessment and Market Forecasts to 2017 Report - Ewing's Sarcoma Therapeutics Market Forecast to Show Slow Growth,Rise,0.0058,176,research and market ewing sarcoma therapeutic pipeline assessment and market forecast report ewing sarcoma therapeutic market forecast show slow growth,151,20,0,pharmacy,"['research', 'and', 'market', 'e', '##wing', 'sa', '##rc', '##oma', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast', 'report', 'e', '##wing', 'sa', '##rc', '##oma', 'therapeutic', 'market', 'forecast', 'show', 'slow', 'growth']",1
97295,nifty_303,2011-07-14,InformationWeek's Healthcare IT Leadership Forum Highlights Key Business Technology Trends and Innovations in the Healthcare Sector,Rise,0.0058,131,informationweek healthcare leadership forum highlight key business technology trend and innovation the healthcare sector,120,14,0,pharmacy,"['information', '##week', 'healthcare', 'leadership', 'forum', 'highlight', 'key', 'business', 'technology', 'trend', 'and', 'innovation', 'the', 'healthcare', 'sector']",1
97297,nifty_303,2011-07-14,Research and Markets: A 2011 Global Migraine Therapeutics Market Report: The US Will Remain the Largest Migraine Therapeutics Market in 2018 with a 79% Market Share,Rise,0.0058,164,research and market global migraine therapeutic market report the will remain the largest migraine therapeutic market with market share,135,19,0,pharmacy,"['research', 'and', 'market', 'global', 'mi', '##gra', '##ine', 'therapeutic', 'market', 'report', 'the', 'will', 'remain', 'the', 'largest', 'mi', '##gra', '##ine', 'therapeutic', 'market', 'with', 'market', 'share']",1
97313,nifty_303,2011-07-14,Research and Markets: A Sepsis Therapeutics Pipeline Assessment & Market Forecasts Report to 2017: The Sepsis Therapeutics Market is Forecast to Show High Growth Until 2017,Rise,0.0058,172,research and market sepsis therapeutic pipeline assessment market forecast report the sepsis therapeutic market forecast show high growth until,143,19,0,pharmacy,"['research', 'and', 'market', 'se', '##psis', 'therapeutic', 'pipeline', 'assessment', 'market', 'forecast', 'report', 'the', 'se', '##psis', 'therapeutic', 'market', 'forecast', 'show', 'high', 'growth', 'until']",1
97324,nifty_303,2011-07-14,Research and Markets: A 2011 Migraine Therapeutics Market in the US Report: The US Market is Expected to Increase at a Rate of 3.2% Between 2010-2018,Rise,0.0058,149,research and market migraine therapeutic market the report the market expected increase rate between,100,14,0,pharmacy,"['research', 'and', 'market', 'mi', '##gra', '##ine', 'therapeutic', 'market', 'the', 'report', 'the', 'market', 'expected', 'increase', 'rate', 'between']",1
97512,nifty_304,2011-07-18,Novartis Is Expected to Outpace Peers,Rise,0.0162,37,novartis expected outpace peer,30,4,0,pharmacy,"['no', '##var', '##tis', 'expected', 'out', '##pace', 'peer']",1
97624,nifty_306,2011-07-20,FDA Approves Astra's Anticlotting Drug,Rise,0.0139,38,fda approves astra anticlotting drug,36,5,0,pharmacy,"['f', '##da', 'approve', '##s', 'as', '##tra', 'anti', '##c', '##lot', '##ting', 'drug']",1
97755,nifty_307,2011-07-21,Biocon Net Profit Falls 8.7%,Neutral,0.0007,28,biocon net profit fall,22,4,0,pharmacy,"['bio', '##con', 'net', 'profit', 'fall']",1
97815,nifty_308,2011-07-25,Nespresso Rival Removes Capsules From Sale,Neutral,-0.0037,42,nespresso rival remove capsule from sale,40,6,0,pharmacy,"['ne', '##sp', '##ress', '##o', 'rival', 'remove', 'capsule', 'from', 'sale']",1
97866,nifty_309,2011-07-26,"Cell Therapeutics, Inc. (CTI) to Report Second Quarter Financial Results on July 28",Fall,-0.0205,83,cell therapeutic inc cti report second quarter financial result july,68,10,0,pharmacy,"['cell', 'therapeutic', 'in', '##c', 'c', '##ti', 'report', 'second', 'quarter', 'financial', 'result', 'j', '##ul', '##y']",1
98000,nifty_309,2011-07-26,Research and Markets: Morocco Pharmaceuticals and Healthcare Report Q3 2011,Fall,-0.0205,75,research and market morocco pharmaceutical and healthcare report,64,8,0,pharmacy,"['research', 'and', 'market', 'm', '##oro', '##cco', 'pharmaceutical', 'and', 'healthcare', 'report']",1
98099,nifty_309,2011-07-26,Research and Markets: Slovenia Pharmaceuticals and Healthcare Report Q3 2011,Fall,-0.0205,76,research and market slovenia pharmaceutical and healthcare report,65,8,0,pharmacy,"['research', 'and', 'market', 's', '##love', '##nia', 'pharmaceutical', 'and', 'healthcare', 'report']",1
98295,nifty_309,2011-07-26,"Telemedicine Technology is Ready but Deployments Need a Boost to Meet Exploding Demand for Healthcare Access Around the World, Say IEEE Experts",Fall,-0.0205,143,telemedicine technology ready but deployment need boost meet exploding demand for healthcare access around the world say ieee expert,132,19,0,pharmacy,"['te', '##lem', '##edic', '##ine', 'technology', 'ready', 'but', 'deployment', 'need', 'boost', 'meet', 'exploding', 'demand', 'for', 'healthcare', 'access', 'around', 'the', 'world', 'say', 'i', '##ee', '##e', 'expert']",1
98397,nifty_309,2011-07-26,Research and Markets: eDetailing: A Strategic Analysis of Implementation and ROI - Pharmaceutical Detailing Using the Internet,Fall,-0.0205,126,research and market edetailing strategic analysis implementation and roi pharmaceutical detailing using the internet,116,14,0,pharmacy,"['research', 'and', 'market', 'ed', '##eta', '##iling', 'strategic', 'analysis', 'implementation', 'and', 'r', '##oi', 'pharmaceutical', 'detailing', 'using', 'the', 'internet']",1
98410,nifty_309,2011-07-26,"Top 5 Ways to Get Insider Track on Healthcare, Pharma & Biotech Discoveries & Latest News",Fall,-0.0205,89,top way get insider track healthcare pharma biotech discovery latest news,73,11,0,pharmacy,"['top', 'way', 'get', 'inside', '##r', 'track', 'healthcare', 'p', '##har', '##ma', 'bio', '##tech', 'discovery', 'latest', 'news']",1
98585,nifty_309,2011-07-26, Healthscreen Announces Board of Director Changes and QHR Acquires Healthscreen's Secured Debt,Fall,-0.0205,94,healthscreen announces board director change and qhr acquires healthscreen secured debt,87,11,0,pharmacy,"['health', '##screen', 'announces', 'board', 'director', 'change', 'and', 'q', '##hr', 'acquire', '##s', 'health', '##screen', 'secured', 'debt']",1
98730,nifty_309,2011-07-26,Mentor Capital Seeks Partners as Neutron Cancer Therapy Investee Accelerates Path to Treatment and Increased Valuation,Fall,-0.0205,118,mentor capital seek partner neutron cancer therapy investee accelerates path treatment and increased valuation,110,14,0,pharmacy,"['mentor', 'capital', 'seek', 'partner', 'neutron', 'cancer', 'therapy', 'invest', '##ee', 'accelerate', '##s', 'path', 'treatment', 'and', 'increased', 'v', '##al', '##uation']",1
99008,nifty_309,2011-07-26,"Research and Markets: North American Market for Computer-Aided Detection and Diagnosis - Forecast Market Metrics, Market Drivers and Segmentation",Fall,-0.0205,145,research and market north american market for computer aided detection and diagnosis forecast market metric market driver and segmentation,138,19,0,pharmacy,"['research', 'and', 'market', 'north', 'am', '##eric', '##an', 'market', 'for', 'computer', 'aided', 'detection', 'and', 'diagnosis', 'forecast', 'market', 'metric', 'market', 'driver', 'and', 'segment', '##ation']",1
99009,nifty_309,2011-07-26,Research and Markets: The RFID Market in the Healthcare Industry to Grow At A CAGR Of 29 Percent over the Period of 2010-2014,Fall,-0.0205,125,research and market the rfid market the healthcare industry grow cagr percent over the period,93,15,0,pharmacy,"['research', 'and', 'market', 'the', 'r', '##fi', '##d', 'market', 'the', 'healthcare', 'industry', 'grow', 'ca', '##g', '##r', 'percent', 'over', 'the', 'period']",1
99397,nifty_311,2011-07-28,"Bristol-Myers Net Falls, but Plavix Sales Are Up",Fall,-0.0068,48,bristol myers net fall but plavix sale are,42,8,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'net', 'fall', 'but', 'p', '##lav', '##ix', 'sale', 'are']",1
99783,nifty_315,2011-08-04,Report Rips Chemical Testing Program,Neutral,-0.0015,36,report rip chemical testing program,35,5,0,pharmacy,"['report', 'rip', 'chemical', 'testing', 'program']",1
99985,nifty_318,2011-08-10,Thomson Reuters Identifies Most- and Least-Expensive Healthcare Markets in U.S.,Rise,0.0449,79,thomson reuters identifies most and least expensive healthcare market,69,9,0,pharmacy,"['th', '##oms', '##on', 're', '##uters', 'identifies', 'most', 'and', 'least', 'expensive', 'healthcare', 'market']",1
100365,nifty_318,2011-08-10, GeneNews Reports Second Quarter 2011 Financial Results,Rise,0.0449,55,genenews report second quarter financial result,47,6,0,pharmacy,"['gene', '##ne', '##ws', 'report', 'second', 'quarter', 'financial', 'result']",1
100373,nifty_318,2011-08-10,Research and Markets: The Age of Responsibility: CSR 2.0 and the New DNA of Business,Rise,0.0449,84,research and market the age responsibility csr and the new dna business,71,12,0,pharmacy,"['research', 'and', 'market', 'the', 'age', 'responsibility', 'c', '##s', '##r', 'and', 'the', 'new', 'd', '##na', 'business']",1
100415,nifty_318,2011-08-10,SANUWAVE Health Reports Second Quarter Financial Results and Provides Business Update,Rise,0.0449,85,sanuwave health report second quarter financial result and provides business update,83,11,0,pharmacy,"['sa', '##nu', '##wave', 'health', 'report', 'second', 'quarter', 'financial', 'result', 'and', 'provides', 'business', 'update']",1
100442,nifty_318,2011-08-10,NovaBay Pharmaceuticals Reports Second Quarter Financial Results,Rise,0.0449,64,novabay pharmaceutical report second quarter financial result,61,7,0,pharmacy,"['no', '##va', '##bay', 'pharmaceutical', 'report', 'second', 'quarter', 'financial', 'result']",1
100482,nifty_318,2011-08-10,NWBT Highlights Cost Effectiveness of DCVax in View of Recent Immunotherapy Pricing Concerns,Rise,0.0449,92,nwbt highlight cost effectiveness dcvax view recent immunotherapy pricing concern,81,10,0,pharmacy,"['n', '##w', '##bt', 'highlight', 'cost', 'effectiveness', 'd', '##c', '##va', '##x', 'view', 'recent', 'im', '##mu', '##not', '##her', '##ap', '##y', 'pricing', 'concern']",1
100576,nifty_318,2011-08-10," Healthnostics, Inc. Records Near $1 Million Gain for HNS Fund Co.",Rise,0.0449,66,healthnostics inc record near million gain for hn fund,54,9,0,pharmacy,"['health', '##nos', '##tics', 'in', '##c', 'record', 'near', 'million', 'gain', 'for', 'h', '##n', 'fund']",1
100598,nifty_318,2011-08-10,Nuuko and CSI Announce Plans to Launch New Internet-Based Diagnostic Tool,Rise,0.0449,73,nuuko and csi announce plan launch new internet based diagnostic tool,69,11,0,pharmacy,"['n', '##u', '##uk', '##o', 'and', 'c', '##si', 'announce', 'plan', 'launch', 'new', 'internet', 'based', 'diagnostic', 'tool']",1
101664,nifty_320,2011-08-15,Pulmatrix Secures a $14 million Financing to Advance Clinical Programs in COPD and Cystic Fibrosis,Fall,-0.0085,98,pulmatrix secures million financing advance clinical program copd and cystic fibrosis,85,11,0,pharmacy,"['pu', '##lma', '##tri', '##x', 'secure', '##s', 'million', 'financing', 'advance', 'clinical', 'program', 'cop', '##d', 'and', 'c', '##ys', '##tic', 'fi', '##bro', '##sis']",1
101790,nifty_320,2011-08-15,BIO-key International Inc.(R) Reports 2011 Second Quarter Financial Results,Fall,-0.0085,75,bio key international inc report second quarter financial result,64,9,0,pharmacy,"['bio', 'key', 'international', 'in', '##c', 'report', 'second', 'quarter', 'financial', 'result']",1
101853,nifty_320,2011-08-15,"Amid Health Care Reform and a Slow Economy, Benefits Brokers and Consultants Optimistic about Own Future but Concerned about Industry, According to MetLife Study",Fall,-0.0085,161,amid health care reform and slow economy benefit broker and consultant optimistic about own future but concerned about industry according metlife study,151,22,0,pharmacy,"['amid', 'health', 'care', 'reform', 'and', 'slow', 'economy', 'benefit', 'broker', 'and', 'consultant', 'optimistic', 'about', 'own', 'future', 'but', 'concerned', 'about', 'industry', 'according', 'met', '##life', 'study']",1
101859,nifty_320,2011-08-15,China Kangtai Cactus Biotech Q2 Revenue Up 9% to $9.5M; Q2 Operating Income Up 68% to $3.85M; EPS $0.13; YTD Revenue Up 12% to $15.96M; Operating Income Up 69% to $5.88M,Fall,-0.0085,169,china kangtai cactus biotech revenue operating income eps ytd revenue operating income,86,12,0,pharmacy,"['chin', '##a', 'ka', '##ng', '##tai', 'ca', '##ctus', 'bio', '##tech', 'revenue', 'operating', 'income', 'e', '##ps', 'y', '##t', '##d', 'revenue', 'operating', 'income']",1
101908,nifty_320,2011-08-15,"Deloitte Stakes Claim in Drug Safety & Regulatory Consulting Market With Acquisition of Intrasphere Technologies, Inc. Assets",Fall,-0.0085,125,deloitte stake claim drug safety regulatory consulting market with acquisition intrasphere technology inc asset,111,14,0,pharmacy,"['del', '##oit', '##te', 'stake', 'claim', 'drug', 'safety', 'regulatory', 'consulting', 'market', 'with', 'acquisition', 'in', '##tras', '##phere', 'technology', 'in', '##c', 'asset']",1
101958,nifty_320,2011-08-15,Bio-Path Holdings Reports Second Quarter 2011 Financial Results,Fall,-0.0085,63,bio path holding report second quarter financial result,55,8,0,pharmacy,"['bio', 'path', 'holding', 'report', 'second', 'quarter', 'financial', 'result']",1
102030,nifty_320,2011-08-15,"Research and Markets: Wireless Healthcare 2nd Edition - A Growing Interest From Care Providers, Insurers & Technology Developers is Driving the Industry's Expansion",Fall,-0.0085,164,research and market wireless healthcare edition growing interest from care provider insurer technology developer driving the industry expansion,143,18,0,pharmacy,"['research', 'and', 'market', 'wireless', 'healthcare', 'edition', 'growing', 'interest', 'from', 'care', 'provider', 'ins', '##urer', 'technology', 'developer', 'driving', 'the', 'industry', 'expansion']",1
102031,nifty_320,2011-08-15,Research and Markets: The World Medical Markets Fact Book 2011,Fall,-0.0085,62,research and market the world medical market fact book,54,9,0,pharmacy,"['research', 'and', 'market', 'the', 'world', 'medical', 'market', 'fact', 'book']",1
102041,nifty_320,2011-08-15,Research and Markets: The World Pharmaceutical Markets Fact Book 2011,Fall,-0.0085,69,research and market the world pharmaceutical market fact book,61,9,0,pharmacy,"['research', 'and', 'market', 'the', 'world', 'pharmaceutical', 'market', 'fact', 'book']",1
102221,nifty_320,2011-08-15,"Research and Markets: Stroke - Pipeline Review, Q3 2011",Fall,-0.0085,55,research and market stroke pipeline review,42,6,0,pharmacy,"['research', 'and', 'market', 'stroke', 'pipeline', 'review']",1
102631,nifty_322,2011-08-17,China opens its healthcare sector,Fall,-0.0431,33,china open it healthcare sector,31,5,0,pharmacy,"['chin', '##a', 'open', 'it', 'healthcare', 'sector']",1
103014,nifty_322,2011-08-17,"Research and Markets: Hepatic Encephalopathy Pipeline Review, Q2 2011 - Gain an Insight into the Global Therapeutic Scenario for Hepatic Encephalopathy",Fall,-0.0431,151,research and market hepatic encephalopathy pipeline review gain insight into the global therapeutic scenario for hepatic encephalopathy,135,17,0,pharmacy,"['research', 'and', 'market', 'he', '##pa', '##tic', 'en', '##ce', '##pha', '##lop', '##athy', 'pipeline', 'review', 'gain', 'insight', 'into', 'the', 'global', 'therapeutic', 'scenario', 'for', 'he', '##pa', '##tic', 'en', '##ce', '##pha', '##lop', '##athy']",1
103052,nifty_322,2011-08-17,International Stem Cell Corporation Announces Second Quarter 2011 Financial Results and Corporate Events,Fall,-0.0431,104,international stem cell corporation announces second quarter financial result and corporate event,97,12,0,pharmacy,"['international', 'stem', 'cell', 'corporation', 'announces', 'second', 'quarter', 'financial', 'result', 'and', 'corporate', 'event']",1
103090,nifty_322,2011-08-17,Research and Markets: Oropharyngeal Cancer Therapeutics Pipeline & Market Forecasts to 2017 Report - Oropharyngeal Cancer Market Forecast to Show Moderate Growth Until 2017,Fall,-0.0431,172,research and market oropharyngeal cancer therapeutic pipeline market forecast report oropharyngeal cancer market forecast show moderate growth until,148,18,0,pharmacy,"['research', 'and', 'market', 'or', '##op', '##har', '##yn', '##ge', '##al', 'cancer', 'therapeutic', 'pipeline', 'market', 'forecast', 'report', 'or', '##op', '##har', '##yn', '##ge', '##al', 'cancer', 'market', 'forecast', 'show', 'moderate', 'growth', 'until']",1
103267,nifty_322,2011-08-17,Clinical Developments at Enlivex Therapeutics - a Hadasit Bio-Holdings Portfolio Company,Fall,-0.0431,88,clinical development enlivex therapeutic hadasit bio holding portfolio company,78,9,0,pharmacy,"['clinical', 'development', 'en', '##li', '##ve', '##x', 'therapeutic', 'had', '##asi', '##t', 'bio', 'holding', 'portfolio', 'company']",1
103363,nifty_322,2011-08-17,Research and Markets: Global Radiopharmaceuticals Market (PET/SPECT Imaging & Therapy) - Current Trends & Forecasts (2010 - 2015),Fall,-0.0431,129,research and market global radiopharmaceutical market pet spect imaging therapy current trend forecast,102,13,0,pharmacy,"['research', 'and', 'market', 'global', 'radio', '##pha', '##rma', '##ce', '##utical', 'market', 'pet', 's', '##pect', 'imaging', 'therapy', 'current', 'trend', 'forecast']",1
103443,nifty_322,2011-08-17,Research and Markets: World Healthcare IT Market: Trends & Forecast (2010 - 2015),Fall,-0.0431,81,research and market world healthcare market trend forecast,58,8,0,pharmacy,"['research', 'and', 'market', 'world', 'healthcare', 'market', 'trend', 'forecast']",1
103445,nifty_322,2011-08-17,Research and Markets: Hot Topics: Obesity - The US FDA and Cardiovascular Risk Analysis: The AdComm Cometh,Fall,-0.0431,106,research and market hot topic obesity the fda and cardiovascular risk analysis the adcomm cometh,96,15,0,pharmacy,"['research', 'and', 'market', 'hot', 'topic', 'o', '##besity', 'the', 'f', '##da', 'and', 'card', '##iovascular', 'risk', 'analysis', 'the', 'ad', '##com', '##m', 'comet', '##h']",1
103462,nifty_322,2011-08-17,Healthcare IT market to grow to USD 162.2 billion in 2015: companiesandmarkets.com,Fall,-0.0431,82,healthcare market grow usd billion companiesandmarkets com,58,7,0,pharmacy,"['healthcare', 'market', 'grow', 'us', '##d', 'billion', 'companies', '##and', '##market', '##s', 'com']",1
103470,nifty_322,2011-08-17,FDA: Regulatory Science Plan Positions Agency to Foster Innovation Through Better Science,Fall,-0.0431,89,fda regulatory science plan position agency foster innovation through better science,84,11,0,pharmacy,"['f', '##da', 'regulatory', 'science', 'plan', 'position', 'agency', 'foster', 'innovation', 'through', 'better', 'science']",1
103504,nifty_322,2011-08-17,Research and Markets: The Global Disposable Hospital Supplies Market is Forecast to Exceed $14 billion by 2017,Fall,-0.0431,110,research and market the global disposable hospital supply market forecast exceed billion,88,12,0,pharmacy,"['research', 'and', 'market', 'the', 'global', 'di', '##sp', '##osa', '##ble', 'hospital', 'supply', 'market', 'forecast', 'exceed', 'billion']",1
103517,nifty_322,2011-08-17,FDA Consumer Health Information - FDA Modernizing Regulatory Science,Fall,-0.0431,68,fda consumer health information fda modernizing regulatory science,66,8,0,pharmacy,"['f', '##da', 'consumer', 'health', 'information', 'f', '##da', 'modern', '##izing', 'regulatory', 'science']",1
103982,nifty_326,2011-08-24,Sanofi Unit to Buy India Nutrition Pharma Business,Fall,-0.0152,50,sanofi unit buy india nutrition pharma business,47,7,0,pharmacy,"['sa', '##no', '##fi', 'unit', 'buy', 'in', '##dia', 'nutrition', 'p', '##har', '##ma', 'business']",1
105168,nifty_332,2011-09-06,BioCryst to Present at Three Upcoming Investor Conferences,Rise,0.0282,58,biocryst present three upcoming investor conference,51,6,0,pharmacy,"['bio', '##c', '##ry', '##st', 'present', 'three', 'upcoming', 'investor', 'conference']",1
105227,nifty_332,2011-09-06, Pharmaceutical Sector Jobs: Pharmajob.ca Gets a New Look,Rise,0.0282,57,pharmaceutical sector job pharmajob get new look,48,7,0,pharmacy,"['pharmaceutical', 'sector', 'job', 'p', '##har', '##ma', '##jo', '##b', 'get', 'new', 'look']",1
105261,nifty_332,2011-09-06,ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference on September 12,Rise,0.0282,111,adventrx pharmaceutical present the rodman renshaw annual global investment conference september,96,11,0,pharmacy,"['advent', '##r', '##x', 'pharmaceutical', 'present', 'the', 'rod', '##man', 're', '##ns', '##haw', 'annual', 'global', 'investment', 'conference', 'se', '##pt', '##em', '##ber']",1
105345,nifty_332,2011-09-06,"Research and Markets: Auto Inflammatory Disease - Pipeline Review, Q2 2011",Rise,0.0282,74,research and market auto inflammatory disease pipeline review,61,8,0,pharmacy,"['research', 'and', 'market', 'auto', 'inflammatory', 'disease', 'pipeline', 'review']",1
105373,nifty_332,2011-09-06," Analyst View, Current Global Forecast - Equity Research on Quality Systems, Inc. and Allscripts Healthcare Solutions",Rise,0.0282,117,analyst view current global forecast equity research quality system inc and allscripts healthcare solution,106,14,0,pharmacy,"['analyst', 'view', 'current', 'global', 'forecast', 'equity', 'research', 'quality', 'system', 'in', '##c', 'and', 'all', '##s', '##cripts', 'healthcare', 'solution']",1
105510,nifty_332,2011-09-06,Bio-Path Holdings to Present at the Rodman & Renshaw Annual Global Investment Conference,Rise,0.0282,88,bio path holding present the rodman renshaw annual global investment conference,79,11,0,pharmacy,"['bio', 'path', 'holding', 'present', 'the', 'rod', '##man', 're', '##ns', '##haw', 'annual', 'global', 'investment', 'conference']",1
105526,nifty_332,2011-09-06, Genetic Testing Sector to Reach $4 Billion by 2015,Rise,0.0282,51,genetic testing sector reach billion,36,5,0,pharmacy,"['genetic', 'testing', 'sector', 'reach', 'billion']",1
105574,nifty_332,2011-09-06,TRADE NEWS: Agilent Technologies` Revolutionary Atomic Spectroscopy Instrument Runs Entirely on Air,Rise,0.0282,99,trade news agilent technology revolutionary atomic spectroscopy instrument run entirely air,91,11,0,pharmacy,"['trade', 'news', 'a', '##gi', '##lent', 'technology', 'revolutionary', 'atomic', 's', '##pect', '##ros', '##copy', 'instrument', 'run', 'entirely', 'air']",1
105615,nifty_332,2011-09-06,"Therapeutic Proteins Market Dominated by Roche, Amgen and Novo Nordisk: companiesandmarkets.com",Rise,0.0282,95,therapeutic protein market dominated roche amgen and novo nordisk companiesandmarkets com,89,11,0,pharmacy,"['therapeutic', 'protein', 'market', 'dominated', 'r', '##och', '##e', 'am', '##gen', 'and', 'no', '##vo', 'nor', '##dis', '##k', 'companies', '##and', '##market', '##s', 'com']",1
105622,nifty_332,2011-09-06,"Pharmaceutical Licensing Market Led By AstraZeneca, GSK Merck, Novartis, Pfizer and Roche: companiesandmarkets.com",Rise,0.0282,114,pharmaceutical licensing market led astrazeneca gsk merck novartis pfizer and roche companiesandmarkets com,107,13,0,pharmacy,"['pharmaceutical', 'licensing', 'market', 'led', 'as', '##tra', '##zen', '##eca', 'g', '##sk', 'me', '##rc', '##k', 'no', '##var', '##tis', 'p', '##fi', '##zer', 'and', 'r', '##och', '##e', 'companies', '##and', '##market', '##s', 'com']",1
105648,nifty_332,2011-09-06,Cellectis to Present at Two Upcoming International Investor Conferences,Rise,0.0282,71,cellectis present two upcoming international investor conference,64,7,0,pharmacy,"['cell', '##ec', '##tis', 'present', 'two', 'upcoming', 'international', 'investor', 'conference']",1
105790,nifty_332,2011-09-06,BIO Announces Presenting Companies for 10th Annual BIO Investor Forum,Rise,0.0282,69,bio announces presenting company for annual bio investor forum,62,9,0,pharmacy,"['bio', 'announces', 'presenting', 'company', 'for', 'annual', 'bio', 'investor', 'forum']",1
105844,nifty_332,2011-09-06,Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences,Rise,0.0282,70,idenix pharmaceutical present two upcoming investor conference,62,7,0,pharmacy,"['id', '##eni', '##x', 'pharmaceutical', 'present', 'two', 'upcoming', 'investor', 'conference']",1
105854,nifty_332,2011-09-06,NPS Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference,Rise,0.0282,77,np pharmaceutical present morgan stanley global healthcare conference,69,8,0,pharmacy,"['n', '##p', 'pharmaceutical', 'present', 'm', '##or', '##gan', 's', '##tan', '##ley', 'global', 'healthcare', 'conference']",1
105963,nifty_332,2011-09-06,MAP Pharmaceuticals to Present at Upcoming Investor Conferences,Rise,0.0282,63,map pharmaceutical present upcoming investor conference,55,6,0,pharmacy,"['map', 'pharmaceutical', 'present', 'upcoming', 'investor', 'conference']",1
106405,nifty_333,2011-09-07,Tranzyme Pharma to Present at Upcoming Investor Conferences,Fall,-0.0104,59,tranzyme pharma present upcoming investor conference,52,6,0,pharmacy,"['t', '##ran', '##zy', '##me', 'p', '##har', '##ma', 'present', 'upcoming', 'investor', 'conference']",1
106565,nifty_333,2011-09-07,Neovasc to Present at Rodman and Renshaw Annual Global Investment Conference and UBS Global Healthcare Conference,Fall,-0.0104,113,neovasc present rodman and renshaw annual global investment conference and ubs global healthcare conference,107,14,0,pharmacy,"['neo', '##vas', '##c', 'present', 'rod', '##man', 'and', 're', '##ns', '##haw', 'annual', 'global', 'investment', 'conference', 'and', 'u', '##bs', 'global', 'healthcare', 'conference']",1
106654,nifty_333,2011-09-07,Access Pharmaceuticals and CuraScript Team Up to Further Expand MuGard Market Access and Distribution,Fall,-0.0104,101,access pharmaceutical and curascript team further expand mugard market access and distribution,94,12,0,pharmacy,"['access', 'pharmaceutical', 'and', 'cu', '##ras', '##cript', 'team', 'further', 'expand', 'mug', '##ard', 'market', 'access', 'and', 'distribution']",1
106656,nifty_333,2011-09-07, Trimel Pharmaceuticals Corporation to Present at Upcoming Scientific and Investor Conferences,Fall,-0.0104,94,trimel pharmaceutical corporation present upcoming scientific and investor conference,85,9,0,pharmacy,"['trim', '##el', 'pharmaceutical', 'corporation', 'present', 'upcoming', 'scientific', 'and', 'investor', 'conference']",1
106665,nifty_333,2011-09-07,SeraCare Life Sciences Continues to Expand Product Portfolio,Fall,-0.0104,60,seracare life science continues expand product portfolio,56,7,0,pharmacy,"['se', '##rac', '##are', 'life', 'science', 'continues', 'expand', 'product', 'portfolio']",1
106719,nifty_333,2011-09-07, Mediware Again Delivers Record Revenue,Fall,-0.0104,39,mediware again delivers record revenue,38,5,0,pharmacy,"['me', '##di', '##ware', 'again', 'delivers', 'record', 'revenue']",1
106819,nifty_333,2011-09-07,"Microsoft Releases National Survey Findings on How to Inspire the Next Generation of Doctors, Scientists, Software Developers and Engineers",Fall,-0.0104,139,microsoft release national survey finding how inspire the next generation doctor scientist software developer and engineer,122,16,0,pharmacy,"['micro', '##so', '##ft', 'release', 'national', 'survey', 'finding', 'how', 'inspire', 'the', 'next', 'generation', 'doctor', 'scientist', 'software', 'developer', 'and', 'engineer']",1
106910,nifty_333,2011-09-07,Research and Markets: Chemical Synthetic Biology,Fall,-0.0104,48,research and market chemical synthetic biology,46,6,0,pharmacy,"['research', 'and', 'market', 'chemical', 'synthetic', 'biology']",1
107024,nifty_333,2011-09-07,New Digital MedTech Physician Study Finds Significant Opportunities for Device Marketers to Reach Physicians through Video and Online Promotional Programs,Fall,-0.0104,154,new digital medtech physician study find significant opportunity for device marketer reach physician through video and online promotional program,145,19,0,pharmacy,"['new', 'digital', 'me', '##dt', '##ech', 'physician', 'study', 'find', 'significant', 'opportunity', 'for', 'device', 'market', '##er', 'reach', 'physician', 'through', 'video', 'and', 'online', 'promotional', 'program']",1
107039,nifty_333,2011-09-07,Millennium HealthCare Inc. Engages Scarsdale Equities LLC,Fall,-0.0104,57,millennium healthcare inc engages scarsdale equity llc,54,7,0,pharmacy,"['millennium', 'healthcare', 'in', '##c', 'engages', 'scars', '##dale', 'equity', 'll', '##c']",1
107135,nifty_333,2011-09-07,"Lourie Zak, Former Amgen Finance Executive, Joins PBS Biotech, Inc. as Chief Financial Officer",Fall,-0.0104,94,lourie zak former amgen finance executive join pb biotech inc chief financial officer,85,13,0,pharmacy,"['lo', '##uri', '##e', 'z', '##ak', 'former', 'am', '##gen', 'finance', 'executive', 'join', 'p', '##b', 'bio', '##tech', 'in', '##c', 'chief', 'financial', 'officer']",1
107204,nifty_333,2011-09-07,"Research and Markets: The World's Top 100 Pharmaceutical Companies - Key Contact Information - Address, Telephone and Fax Numbers, Email and Website Addresses",Fall,-0.0104,158,research and market the world top pharmaceutical company key contact information address telephone and fax number email and website address,139,20,0,pharmacy,"['research', 'and', 'market', 'the', 'world', 'top', 'pharmaceutical', 'company', 'key', 'contact', 'information', 'address', 'telephone', 'and', 'f', '##ax', 'number', 'email', 'and', 'website', 'address']",1
107322,nifty_333,2011-09-07,Research and Markets: Bangladesh Pharmaceuticals and Healthcare Report Q3 2011,Fall,-0.0104,78,research and market bangladesh pharmaceutical and healthcare report,67,8,0,pharmacy,"['research', 'and', 'market', 'bang', '##lades', '##h', 'pharmaceutical', 'and', 'healthcare', 'report']",1
107326,nifty_333,2011-09-07,Research and Markets: Colombia Pharmaceuticals and Healthcare Report Q3 2011,Fall,-0.0104,76,research and market colombia pharmaceutical and healthcare report,65,8,0,pharmacy,"['research', 'and', 'market', 'co', '##lo', '##mb', '##ia', 'pharmaceutical', 'and', 'healthcare', 'report']",1
107422,nifty_333,2011-09-07,"Research and Markets: Glioma - Pipeline Review, Q3 2011",Fall,-0.0104,55,research and market glioma pipeline review,42,6,0,pharmacy,"['research', 'and', 'market', 'g', '##lio', '##ma', 'pipeline', 'review']",1
107926,nifty_335,2011-09-12,Research and Markets: Future of Window Coverings/Treatment Products in UK to 2015: Market Profile,Rise,0.0092,97,research and market future window covering treatment product market profile,75,10,0,pharmacy,"['research', 'and', 'market', 'future', 'window', 'covering', 'treatment', 'product', 'market', 'profile']",1
108050,nifty_335,2011-09-12," IntelliCell BioSciences, Inc. Announces It Will Present at the Rodman & Renshaw Annual Global Investment Summit in New",Rise,0.0092,119,intellicell bioscience inc announces will present the rodman renshaw annual global investment summit new,104,14,0,pharmacy,"['in', '##tel', '##lice', '##ll', 'bio', '##science', 'in', '##c', 'announces', 'will', 'present', 'the', 'rod', '##man', 're', '##ns', '##haw', 'annual', 'global', 'investment', 'summit', 'new']",1
108132,nifty_335,2011-09-12,Infinity Pharmaceuticals to Present at UBS Conference,Rise,0.0092,53,infinity pharmaceutical present ubs conference,46,5,0,pharmacy,"['in', '##finity', 'pharmaceutical', 'present', 'u', '##bs', 'conference']",1
108284,nifty_335,2011-09-12,Polydex Reports Growing Sales and Cost Management Initiatives Result in Profitable...,Rise,0.0092,85,polydex report growing sale and cost management initiative result profitable,76,10,0,pharmacy,"['p', '##oly', '##de', '##x', 'report', 'growing', 'sale', 'and', 'cost', 'management', 'initiative', 'result', 'profitable']",1
108447,nifty_335,2011-09-12,Research and Markets: Argentina Pharmaceuticals and Healthcare Report Q4 2011,Rise,0.0092,77,research and market argentina pharmaceutical and healthcare report,66,8,0,pharmacy,"['research', 'and', 'market', 'a', '##rgent', '##ina', 'pharmaceutical', 'and', 'healthcare', 'report']",1
108476,nifty_335,2011-09-12," Medical Device, Technology & Equipment Market to Reach $348 Billion by 2016",Rise,0.0092,76,medical device technology equipment market reach billion,56,7,0,pharmacy,"['medical', 'device', 'technology', 'equipment', 'market', 'reach', 'billion']",1
108485,nifty_335,2011-09-12,"AMAG Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences",Rise,0.0092,70,amag pharmaceutical inc present upcoming investor conference,60,7,0,pharmacy,"['am', '##ag', 'pharmaceutical', 'in', '##c', 'present', 'upcoming', 'investor', 'conference']",1
108594,nifty_335,2011-09-12,Research and Markets: Emerging Medtech Companies in Q2 2011,Rise,0.0092,59,research and market emerging medtech company,44,6,0,pharmacy,"['research', 'and', 'market', 'emerging', 'me', '##dt', '##ech', 'company']",1
108653,nifty_335,2011-09-12,"Research and Markets: Cost-Contained Regulatory Compliance: For the Pharmaceutical, Biologics, and Medical Device Industries",Rise,0.0092,124,research and market cost contained regulatory compliance for the pharmaceutical biologics and medical device industry,117,15,0,pharmacy,"['research', 'and', 'market', 'cost', 'contained', 'regulatory', 'compliance', 'for', 'the', 'pharmaceutical', 'bio', '##log', '##ics', 'and', 'medical', 'device', 'industry']",1
109214,nifty_338,2011-09-15,EvaluatePharma Japan KK - Now Open for Business in Tokyo,Neutral,0.0007,56,evaluatepharma japan now open for business tokyo,48,7,0,pharmacy,"['evaluate', '##pha', '##rma', 'j', '##apa', '##n', 'now', 'open', 'for', 'business', 'to', '##ky', '##o']",1
109284,nifty_338,2011-09-15,Research and Markets: Future of Window Coverings/Treatment Products in Germany to 2015: Market Profile,Neutral,0.0007,102,research and market future window covering treatment product germany market profile,83,11,0,pharmacy,"['research', 'and', 'market', 'future', 'window', 'covering', 'treatment', 'product', 'g', '##erman', '##y', 'market', 'profile']",1
109507,nifty_338,2011-09-15,HealthTech Capital Announces Two New Investments in the Emerging HealthTech Market,Neutral,0.0007,82,healthtech capital announces two new investment the emerging healthtech market,78,10,0,pharmacy,"['health', '##tech', 'capital', 'announces', 'two', 'new', 'investment', 'the', 'emerging', 'health', '##tech', 'market']",1
109716,nifty_338,2011-09-15,GE Healthcare to Invest $1 Billion in New Oncology Solutions,Neutral,0.0007,60,healthcare invest billion new oncology solution,47,6,0,pharmacy,"['healthcare', 'invest', 'billion', 'new', 'on', '##cology', 'solution']",1
109768,nifty_338,2011-09-15,Research and Markets: Women's Infertility Therapeutics - Pipeline Assessment and Market Forecasts to 2018 - Identify Emerging Players with Potentially Strong Product Portfolios,Neutral,0.0007,176,research and market woman infertility therapeutic pipeline assessment and market forecast identify emerging player with potentially strong product portfolio,156,19,0,pharmacy,"['research', 'and', 'market', 'woman', 'in', '##fer', '##tility', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast', 'identify', 'emerging', 'player', 'with', 'potentially', 'strong', 'product', 'portfolio']",1
109769,nifty_338,2011-09-15,San Francisco Healthcare Market Leads the Way in Innovation,Neutral,0.0007,59,san francisco healthcare market lead the way innovation,55,8,0,pharmacy,"['sa', '##n', 'f', '##ran', '##cis', '##co', 'healthcare', 'market', 'lead', 'the', 'way', 'innovation']",1
109811,nifty_338,2011-09-15,Research and Markets: Belgium Pharmaceuticals and Healthcare Report Q4 2011,Neutral,0.0007,75,research and market belgium pharmaceutical and healthcare report,64,8,0,pharmacy,"['research', 'and', 'market', 'be', '##l', '##gi', '##um', 'pharmaceutical', 'and', 'healthcare', 'report']",1
109890,nifty_338,2011-09-15,Research and Markets: Acne Therapeutics - Pipeline Assessment and Market Forecasts to 2018,Neutral,0.0007,90,research and market acne therapeutic pipeline assessment and market forecast,76,10,0,pharmacy,"['research', 'and', 'market', 'a', '##c', '##ne', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
109892,nifty_338,2011-09-15,Research and Markets: Gastrointestinal Disorder Therapeutics Market to 2017 - Crohn's Disease and Irritable Bowel Syndrome Markets Show Strongest Growth,Neutral,0.0007,152,research and market gastrointestinal disorder therapeutic market crohn disease and irritable bowel syndrome market show strongest growth,136,17,0,pharmacy,"['research', 'and', 'market', 'gas', '##tro', '##int', '##est', '##inal', 'disorder', 'therapeutic', 'market', 'c', '##ro', '##hn', 'disease', 'and', 'i', '##rri', '##table', 'bow', '##el', 'syndrome', 'market', 'show', 'strongest', 'growth']",1
109893,nifty_338,2011-09-15,Research and Markets: Chronic Obstructive Pulmonary Disease (COPD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018,Neutral,0.0007,130,research and market chronic obstructive pulmonary disease copd therapeutic pipeline assessment and market forecast,114,14,0,pharmacy,"['research', 'and', 'market', 'chronic', 'o', '##bs', '##truct', '##ive', 'pulmonary', 'disease', 'cop', '##d', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
109896,nifty_338,2011-09-15,Research and Markets: Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2018,Neutral,0.0007,92,research and market anemia therapeutic pipeline assessment and market forecast,78,10,0,pharmacy,"['research', 'and', 'market', 'an', '##emia', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
109898,nifty_338,2011-09-15,Research and Markets: Respiratory Disorders Therapeutics Market to 2017 - Novel Pipeline Molecules such as VX-770 and pirfenidone May Offset Negative Effect of Patent Expiries,Neutral,0.0007,175,research and market respiratory disorder therapeutic market novel pipeline molecule such and pirfenidone may offset negative effect patent expiry,145,19,0,pharmacy,"['research', 'and', 'market', 'respiratory', 'disorder', 'therapeutic', 'market', 'novel', 'pipeline', 'molecule', 'such', 'and', 'p', '##ir', '##fen', '##ido', '##ne', 'may', 'offset', 'negative', 'effect', 'patent', 'ex', '##pi', '##ry']",1
110048,nifty_338,2011-09-15,"Research and Markets: Kidney Cancer Drugs - 2011 Report on the Multi-Million Dollar Industry Featuring Giants such as Bayer, Onyx, GSK and Pfizer",Neutral,0.0007,145,research and market kidney cancer drug report the multi million dollar industry featuring giant such bayer onyx gsk and pfizer,126,20,0,pharmacy,"['research', 'and', 'market', 'kidney', 'cancer', 'drug', 'report', 'the', 'multi', 'million', 'dollar', 'industry', 'featuring', 'giant', 'such', 'bay', '##er', 'on', '##yx', 'g', '##sk', 'and', 'p', '##fi', '##zer']",1
110067,nifty_338,2011-09-15,"AHF Requests $50M Help from Global Fund, Warren Buffett to End AIDS Drug Crisis in US",Neutral,0.0007,85,ahf request help from global fund warren buffett end aid drug crisis,68,12,0,pharmacy,"['ah', '##f', 'request', 'help', 'from', 'global', 'fund', 'war', '##ren', 'b', '##uff', '##ett', 'end', 'aid', 'drug', 'crisis']",1
110072,nifty_338,2011-09-15,Research and Markets: ADME-Toxicology Testing - 2011 Global Strategic Business Report,Neutral,0.0007,85,research and market adme toxicology testing global strategic business report,76,10,0,pharmacy,"['research', 'and', 'market', 'ad', '##me', 'toxic', '##ology', 'testing', 'global', 'strategic', 'business', 'report']",1
110134,nifty_338,2011-09-15,Avanir Pharmaceuticals to Participate in Two Investor Conferences,Neutral,0.0007,65,avanir pharmaceutical participate two investor conference,57,6,0,pharmacy,"['a', '##vani', '##r', 'pharmaceutical', 'participate', 'two', 'investor', 'conference']",1
110146,nifty_338,2011-09-15,Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences,Neutral,0.0007,70,anadys pharmaceutical present two upcoming investor conference,62,7,0,pharmacy,"['an', '##ady', '##s', 'pharmaceutical', 'present', 'two', 'upcoming', 'investor', 'conference']",1
110612,nifty_341,2011-09-21,Home Forecast Calls for Pain,Fall,-0.0323,28,home forecast call for pain,27,5,0,pharmacy,"['home', 'forecast', 'call', 'for', 'pain']",1
110686,nifty_343,2011-09-26,Astex Pharmaceuticals to Present at Jefferies Global Healthcare Conferenceon September 27th,Rise,0.0112,91,astex pharmaceutical present jefferies global healthcare conferenceon september,79,8,0,pharmacy,"['as', '##te', '##x', 'pharmaceutical', 'present', 'j', '##ef', '##fer', '##ies', 'global', 'healthcare', 'conference', '##on', 'se', '##pt', '##em', '##ber']",1
110885,nifty_343,2011-09-26, Bristol-Myers CEO: 2012 sales drop 'very manageable',Rise,0.0112,53,bristol myers ceo sale drop very manageable,43,7,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'c', '##eo', 'sale', 'drop', 'very', 'manage', '##able']",1
110914,nifty_343,2011-09-26,"Research and Markets: Orthobiologics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017",Rise,0.0112,115,research and market orthobiologics global pipeline analysis competitive landscape and market forecast,101,12,0,pharmacy,"['research', 'and', 'market', 'or', '##th', '##ob', '##iol', '##og', '##ics', 'global', 'pipeline', 'analysis', 'competitive', 'landscape', 'and', 'market', 'forecast']",1
110915,nifty_343,2011-09-26,"Research and Markets: Arthroscopy Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecast to 2017",Rise,0.0112,120,research and market arthroscopy device global pipeline analysis opportunity assessment and market forecast,106,13,0,pharmacy,"['research', 'and', 'market', 'art', '##hr', '##os', '##copy', 'device', 'global', 'pipeline', 'analysis', 'opportunity', 'assessment', 'and', 'market', 'forecast']",1
110941,nifty_343,2011-09-26,UPDATE 1-Bristol-Myers CEO: 2012 sales drop 'very manageable',Rise,0.0112,61,update bristol myers ceo sale drop very manageable,50,8,0,pharmacy,"['update', 'br', '##ist', '##ol', 'my', '##ers', 'c', '##eo', 'sale', 'drop', 'very', 'manage', '##able']",1
110942,nifty_343,2011-09-26, Frost & Sullivan Award Highlights Sartorius Stedim's Technology Innovation in Biotechnology Industry,Rise,0.0112,101,frost sullivan award highlight sartorius stedim technology innovation biotechnology industry,92,10,0,pharmacy,"['frost', 'su', '##lli', '##van', 'award', 'highlight', 'sa', '##rt', '##ori', '##us', 's', '##ted', '##im', 'technology', 'innovation', 'bio', '##tech', '##nology', 'industry']",1
111026,nifty_343,2011-09-26,RXi Pharmaceuticals(R) to Strengthen Strategic Focus by Separating Into Two Publicly...,Rise,0.0112,87,rxi pharmaceutical strengthen strategic focus separating into two publicly,74,9,0,pharmacy,"['r', '##xi', 'pharmaceutical', 'strengthen', 'strategic', 'focus', 'separating', 'into', 'two', 'publicly']",1
111049,nifty_343,2011-09-26,Research and Markets: Post-Menopausal Hormone Replacement Therapy (HRT) - Pipeline Assessment and Market Forecasts to 2018,Rise,0.0112,122,research and market post menopausal hormone replacement therapy hrt pipeline assessment and market forecast,107,14,0,pharmacy,"['research', 'and', 'market', 'post', 'men', '##op', '##aus', '##al', 'hormone', 'replacement', 'therapy', 'h', '##rt', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
111125,nifty_343,2011-09-26, Biochips Market to Reach $9.6 Billion by 2016,Rise,0.0112,46,biochip market reach billion,28,4,0,pharmacy,"['bio', '##chi', '##p', 'market', 'reach', 'billion']",1
111155,nifty_343,2011-09-26,AMAG Pharmaceuticals Urges Stockholders to Postpone Making Any Decision Regarding the MSMB Capital Preliminary Consent Solicitation,Rise,0.0112,131,amag pharmaceutical urge stockholder postpone making any decision regarding the msmb capital preliminary consent solicitation,125,15,0,pharmacy,"['am', '##ag', 'pharmaceutical', 'urge', 'stock', '##holder', 'post', '##po', '##ne', 'making', 'any', 'decision', 'regarding', 'the', 'm', '##sm', '##b', 'capital', 'preliminary', 'consent', 'so', '##licit', '##ation']",1
111200,nifty_343,2011-09-26,"The Obesity Drug Market Will Increase More Than Six-Fold over the Next Decade, Increasing to $2.6 Billion in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan",Rise,0.0112,195,the obesity drug market will increase more than six fold over the next decade increasing billion the united state france germany italy spain the united kingdom and japan,169,28,0,pharmacy,"['the', 'o', '##besity', 'drug', 'market', 'will', 'increase', 'more', 'than', 'six', 'fold', 'over', 'the', 'next', 'decade', 'increasing', 'billion', 'the', 'united', 'state', 'f', '##rance', 'g', '##erman', '##y', 'it', '##aly', 'spa', '##in', 'the', 'united', 'kingdom', 'and', 'j', '##apa', '##n']",1
111244,nifty_343,2011-09-26,"AdvaMed2011: The MedTech Conference Opens with Dialogues on Finance, Competitiveness, Harmonization, Entrepreneurship, Compliance and Health Reform One Year Later",Rise,0.0112,162,advamed the medtech conference open with dialogue finance competitiveness harmonization entrepreneurship compliance and health reform one year later,148,18,0,pharmacy,"['ad', '##va', '##med', 'the', 'me', '##dt', '##ech', 'conference', 'open', 'with', 'dialogue', 'finance', 'competitive', '##ness', 'harm', '##oni', '##zation', 'entrepreneurs', '##hip', 'compliance', 'and', 'health', 'reform', 'one', 'year', 'later']",1
111281,nifty_343,2011-09-26,Research and Markets: Puerto Rico Pharmaceuticals and Healthcare Report Q4 2011 - Significant Opportunities for Drugmakers,Rise,0.0112,122,research and market puerto rico pharmaceutical and healthcare report significant opportunity for drugmakers,107,13,0,pharmacy,"['research', 'and', 'market', 'pu', '##ert', '##o', 'r', '##ico', 'pharmaceutical', 'and', 'healthcare', 'report', 'significant', 'opportunity', 'for', 'drug', '##makers']",1
111305,nifty_343,2011-09-26,Research and Markets: Romania Pharmaceuticals and Healthcare Report Q4 2011 - Return to High Single-Digit Growth in 2011 and 2012,Rise,0.0112,129,research and market romania pharmaceutical and healthcare report return high single digit growth and,100,14,0,pharmacy,"['research', 'and', 'market', 'r', '##oman', '##ia', 'pharmaceutical', 'and', 'healthcare', 'report', 'return', 'high', 'single', 'digit', 'growth', 'and']",1
112742,nifty_352,2011-10-11,MonoSol Rx Strengthens Canadian Patent Portfolio for PharmFilm(R),Rise,0.0088,65,monosol strengthens canadian patent portfolio for pharmfilm,59,7,0,pharmacy,"['mon', '##oso', '##l', 'strengthen', '##s', 'can', '##adia', '##n', 'patent', 'portfolio', 'for', 'p', '##har', '##m', '##film']",1
112930,nifty_352,2011-10-11,"Research and Markets: Disorders of Personality: Introducing a DSM/ICD Spectrum from Normal to Abnormal, 3rd Edition",Rise,0.0088,115,research and market disorder personality introducing dsm icd spectrum from normal abnormal edition,98,13,0,pharmacy,"['research', 'and', 'market', 'disorder', 'personality', 'introducing', 'd', '##sm', 'i', '##c', '##d', 'spectrum', 'from', 'normal', 'abnormal', 'edition']",1
112989,nifty_352,2011-10-11,"New White Paper Highlights Need for Civic Innovation, Attention to Community Concerns to Build a Healthy Information Environment",Rise,0.0088,128,new white paper highlight need for civic innovation attention community concern build healthy information environment,117,15,0,pharmacy,"['new', 'white', 'paper', 'highlight', 'need', 'for', 'civic', 'innovation', 'attention', 'community', 'concern', 'build', 'healthy', 'information', 'environment']",1
113013,nifty_352,2011-10-11,10th Annual BIO Investor ForumBusiness Roundtables Highlight Innovative Strategies in Deal-Making and Investments,Rise,0.0088,113,annual bio investor forumbusiness roundtable highlight innovative strategy deal making and investment,101,12,0,pharmacy,"['annual', 'bio', 'investor', 'forum', '##bus', '##iness', 'round', '##table', 'highlight', 'innovative', 'strategy', 'deal', 'making', 'and', 'investment']",1
113039,nifty_352,2011-10-11,"Research and Markets: Alopecia Therapeutics - Market Expected to Show High Grow Until 2017, New Report Says",Rise,0.0088,107,research and market alopecia therapeutic market expected show high grow until new report say,92,14,0,pharmacy,"['research', 'and', 'market', 'al', '##ope', '##cia', 'therapeutic', 'market', 'expected', 'show', 'high', 'grow', 'until', 'new', 'report', 'say']",1
113077,nifty_352,2011-10-11,"Research and Markets: The Handbook of Narcissism and Narcissistic Personality Disorder: Theoretical Approaches, Empirical Findings, and Treatments",Rise,0.0088,146,research and market the handbook narcissism and narcissistic personality disorder theoretical approach empirical finding and treatment,134,16,0,pharmacy,"['research', 'and', 'market', 'the', 'hand', '##book', 'na', '##rc', '##iss', '##ism', 'and', 'na', '##rc', '##iss', '##istic', 'personality', 'disorder', 'theoretical', 'approach', 'empirical', 'finding', 'and', 'treatment']",1
113124,nifty_352,2011-10-11,"MicroPhage Partners with Cardinal Health on Funding, Marketing First One-Day Susceptibility Test",Rise,0.0088,96,microphage partner with cardinal health funding marketing first one day susceptibility test,91,12,0,pharmacy,"['micro', '##pha', '##ge', 'partner', 'with', 'cardinal', 'health', 'funding', 'marketing', 'first', 'one', 'day', 'su', '##s', '##ce', '##pt', '##ibility', 'test']",1
113126,nifty_352,2011-10-11,Research and Markets: The World Biotech Flavors Market - 2011 Report on the $19 Billion Industry,Rise,0.0088,96,research and market the world biotech flavor market report the billion industry,79,12,0,pharmacy,"['research', 'and', 'market', 'the', 'world', 'bio', '##tech', 'flavor', 'market', 'report', 'the', 'billion', 'industry']",1
113232,nifty_352,2011-10-11,Research and Markets: Acute Ischemic Stroke (AIS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018,Rise,0.0088,113,research and market acute ischemic stroke ai therapeutic pipeline assessment and market forecast,96,13,0,pharmacy,"['research', 'and', 'market', 'acute', 'is', '##che', '##mic', 'stroke', 'a', '##i', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
113263,nifty_352,2011-10-11,Research and Markets: Chronic Kidney Disease (CKD) Therapeutics - Unmet Need Continues to Challenge the Pipeline Drugs,Rise,0.0088,118,research and market chronic kidney disease ckd therapeutic unmet need continues challenge the pipeline drug,107,15,0,pharmacy,"['research', 'and', 'market', 'chronic', 'kidney', 'disease', 'c', '##k', '##d', 'therapeutic', 'un', '##met', 'need', 'continues', 'challenge', 'the', 'pipeline', 'drug']",1
113264,nifty_352,2011-10-11,Research and Markets: North America Ophthalmic Devices Market Outlook to 2017,Rise,0.0088,77,research and market north america ophthalmic device market outlook,66,9,0,pharmacy,"['research', 'and', 'market', 'north', 'am', '##eric', '##a', 'op', '##ht', '##hal', '##mic', 'device', 'market', 'outlook']",1
113275,nifty_352,2011-10-11,Research and Markets: Biotechnology in Asia-Pacific - Descriptions of the leading players including,Rise,0.0088,99,research and market biotechnology asia pacific description the leading player including,87,11,0,pharmacy,"['research', 'and', 'market', 'bio', '##tech', '##nology', 'as', '##ia', 'p', '##ac', '##ific', 'description', 'the', 'leading', 'player', 'including']",1
113887,nifty_353,2011-10-12, Infocast's Investing in Brazilian Healthcare Premieres,Neutral,-0.002,55,infocast investing brazilian healthcare premiere,48,5,0,pharmacy,"['info', '##cast', 'investing', 'bra', '##zi', '##lian', 'healthcare', 'premiere']",1
113915,nifty_353,2011-10-12,Companies & Markets: Biochip Market to Reach Nearly $10bn,Neutral,-0.002,57,company market biochip market reach nearly,42,6,0,pharmacy,"['company', 'market', 'bio', '##chi', '##p', 'market', 'reach', 'nearly']",1
113922,nifty_353,2011-10-12,Research and Markets: Endometriosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018,Neutral,-0.002,99,research and market endometriosis therapeutic pipeline assessment and market forecast,85,10,0,pharmacy,"['research', 'and', 'market', 'end', '##ome', '##tri', '##osis', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
113956,nifty_353,2011-10-12,DNAnexus Secures $15 Million Funding Led by Google Ventures and TPG Biotech,Neutral,-0.002,75,dnanexus secures million funding led google venture and tpg biotech,67,10,0,pharmacy,"['d', '##nan', '##ex', '##us', 'secure', '##s', 'million', 'funding', 'led', 'go', '##og', '##le', 'venture', 'and', 't', '##p', '##g', 'bio', '##tech']",1
113959,nifty_353,2011-10-12,Infinity Pharmaceuticals to Present at BioCentury NewsMakers Conference,Neutral,-0.002,71,infinity pharmaceutical present biocentury newsmakers conference,64,6,0,pharmacy,"['in', '##finity', 'pharmaceutical', 'present', 'bio', '##cent', '##ury', 'news', '##makers', 'conference']",1
113971,nifty_353,2011-10-12,"Research and Markets: Dyslipidemia Therapeutics - Market is Competitive and Expected to Decline Due to Patent Expiries, New Report Says",Neutral,-0.002,135,research and market dyslipidemia therapeutic market competitive and expected decline due patent expiry new report say,117,16,0,pharmacy,"['research', 'and', 'market', 'd', '##ys', '##lip', '##ide', '##mia', 'therapeutic', 'market', 'competitive', 'and', 'expected', 'decline', 'due', 'patent', 'ex', '##pi', '##ry', 'new', 'report', 'say']",1
114029,nifty_353,2011-10-12,Research and Markets: Biotechnology in Germany - Market is Forecast to Accelerate,Neutral,-0.002,81,research and market biotechnology germany market forecast accelerate,68,8,0,pharmacy,"['research', 'and', 'market', 'bio', '##tech', '##nology', 'g', '##erman', '##y', 'market', 'forecast', 'accelerate']",1
114166,nifty_353,2011-10-12,"Research and Markets: Hospital Information Systems (HIS) - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017",Neutral,-0.002,140,research and market hospital information system his global opportunity assessment competitive landscape and market forecast,123,15,0,pharmacy,"['research', 'and', 'market', 'hospital', 'information', 'system', 'his', 'global', 'opportunity', 'assessment', 'competitive', 'landscape', 'and', 'market', 'forecast']",1
114327,nifty_353,2011-10-12,Research and Markets: Pharma Marketing Excellence: Lessons from Experience,Neutral,-0.002,74,research and market pharma marketing excellence lesson from experience,70,9,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', 'marketing', 'excellence', 'lesson', 'from', 'experience']",1
114334,nifty_353,2011-10-12,"TRADE NEWS: Agilent Technologies Supports Research at the Broad Institute, Developing Proteomics Technology to Detect Disease Biomarkers",Neutral,-0.002,136,trade news agilent technology support research the broad institute developing proteomics technology detect disease biomarkers,125,15,0,pharmacy,"['trade', 'news', 'a', '##gi', '##lent', 'technology', 'support', 'research', 'the', 'broad', 'institute', 'developing', 'pro', '##te', '##omi', '##cs', 'technology', 'detect', 'disease', 'bio', '##mark', '##ers']",1
114372,nifty_353,2011-10-12,"Research and Markets: 2011 Chinese Patent Drug Processing Industry - Investment, Import/Export, Competition, and More...",Neutral,-0.002,120,research and market chinese patent drug processing industry investment import export competition and more,105,14,0,pharmacy,"['research', 'and', 'market', 'chin', '##ese', 'patent', 'drug', 'processing', 'industry', 'investment', 'import', 'export', 'competition', 'and', 'more']",1
114456,nifty_353,2011-10-12, Biomaterials Market to Grow 14% Annually Through 2017,Neutral,-0.002,54,biomaterials market grow annually through,41,5,0,pharmacy,"['bio', '##mate', '##rial', '##s', 'market', 'grow', 'annually', 'through']",1
114457,nifty_353,2011-10-12, Bioinformatics Market to Grow 18% Annually Through 2017,Neutral,-0.002,56,bioinformatics market grow annually through,43,5,0,pharmacy,"['bio', '##in', '##formatics', 'market', 'grow', 'annually', 'through']",1
114460,nifty_353,2011-10-12,Research and Markets: 2011 Trendology: U.S. Health & Medical Insurance Carriers Features Forecasts Readily Available for 2012,Neutral,-0.002,125,research and market trendology health medical insurance carrier feature forecast readily available for,102,13,0,pharmacy,"['research', 'and', 'market', 'trend', '##ology', 'health', 'medical', 'insurance', 'carrier', 'feature', 'forecast', 'readily', 'available', 'for']",1
114522,nifty_353,2011-10-12,"China Drives Manufacturing Past Healthcare as Largest Vertical in $5 Billion Enterprise Mobile App Market, Says ABI Research",Neutral,-0.002,124,china drive manufacturing past healthcare largest vertical billion enterprise mobile app market say abi research,112,15,0,pharmacy,"['chin', '##a', 'drive', 'manufacturing', 'past', 'healthcare', 'largest', 'vertical', 'billion', 'enterprise', 'mobile', 'app', 'market', 'say', 'a', '##bi', 'research']",1
114669,nifty_353,2011-10-12,Cumberland Pharmaceuticals Appoints Rick S. Greene Chief Financial Officer,Neutral,-0.002,74,cumberland pharmaceutical appoints rick greene chief financial officer,70,8,0,pharmacy,"['cum', '##ber', '##land', 'pharmaceutical', 'appoint', '##s', 'r', '##ick', 'green', '##e', 'chief', 'financial', 'officer']",1
114729,nifty_353,2011-10-12, Doctor Reveals Massive Cost Savings Hidden In Electronic Medical Records,Neutral,-0.002,73,doctor reveals massive cost saving hidden electronic medical record,67,9,0,pharmacy,"['doctor', 'reveals', 'massive', 'cost', 'saving', 'hidden', 'electronic', 'medical', 'record']",1
115143,nifty_355,2011-10-17,China Medical Technologies Announces the Approval of the Renewed High and New Technology Enterprise Status for a Major Subsidiary in China,Rise,0.0195,138,china medical technology announces the approval the renewed high and new technology enterprise status for major subsidiary china,128,18,0,pharmacy,"['chin', '##a', 'medical', 'technology', 'announces', 'the', 'approval', 'the', 'renewed', 'high', 'and', 'new', 'technology', 'enterprise', 'status', 'for', 'major', 'subsidiary', 'chin', '##a']",1
115271,nifty_355,2011-10-17,"Research and Markets: China Ophthalmic Devices Market Outlook to 2017 - Value, Volume, Key Players, Forecasts, and More...",Rise,0.0195,122,research and market china ophthalmic device market outlook value volume key player forecast and more,100,15,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'op', '##ht', '##hal', '##mic', 'device', 'market', 'outlook', 'value', 'volume', 'key', 'player', 'forecast', 'and', 'more']",1
115278,nifty_355,2011-10-17,"BioSante Pharmaceuticals, Inc. To Present at BioCentury and BIO Healthcare Conferences",Rise,0.0195,86,biosante pharmaceutical inc present biocentury and bio healthcare conference,76,9,0,pharmacy,"['bio', '##san', '##te', 'pharmaceutical', 'in', '##c', 'present', 'bio', '##cent', '##ury', 'and', 'bio', 'healthcare', 'conference']",1
115354,nifty_355,2011-10-17,Research and Markets: Biotechnology: Global Industry Guide. An Essential Market Information Resource Out Now,Rise,0.0195,108,research and market biotechnology global industry guide essential market information resource out now,101,13,0,pharmacy,"['research', 'and', 'market', 'bio', '##tech', '##nology', 'global', 'industry', 'guide', 'essential', 'market', 'information', 'resource', 'out', 'now']",1
115399,nifty_355,2011-10-17, Pharmakon Advisors Seeks to Invest an Additional $363 Million in Debt Securities Backed by Royalties on,Rise,0.0195,104,pharmakon advisor seek invest additional million debt security backed royalty,77,10,0,pharmacy,"['p', '##har', '##ma', '##kon', 'advisor', 'seek', 'invest', 'additional', 'million', 'debt', 'security', 'backed', 'royalty']",1
115431,nifty_355,2011-10-17,The Uptake of Oral Agents with Novel Modes of Action Such as Brilinta/Brilique Will Drive Sales in the 12-Month Post-Hospital Acute Coronary Syndrome Drug Market to Reach Approximately $2.8 Billion in 2020,Rise,0.0195,205,the uptake oral agent with novel mode action such brilinta brilique will drive sale the month post hospital acute coronary syndrome drug market reach approximately billion,171,26,0,pharmacy,"['the', 'up', '##take', 'oral', 'agent', 'with', 'novel', 'mode', 'action', 'such', 'br', '##ili', '##nta', 'br', '##ili', '##que', 'will', 'drive', 'sale', 'the', 'month', 'post', 'hospital', 'acute', 'co', '##rona', '##ry', 'syndrome', 'drug', 'market', 'reach', 'approximately', 'billion']",1
115438,nifty_355,2011-10-17,New XIFIN White Paper Highlights Next Generation Revenue Cycle Management Systems Needed for Diagnostic Healthcare Providers to Survive,Rise,0.0195,135,new xifin white paper highlight next generation revenue cycle management system needed for diagnostic healthcare provider survive,129,17,0,pharmacy,"['new', 'x', '##if', '##in', 'white', 'paper', 'highlight', 'next', 'generation', 'revenue', 'cycle', 'management', 'system', 'needed', 'for', 'diagnostic', 'healthcare', 'provider', 'survive']",1
115458,nifty_355,2011-10-17,"Gold Standard Diagnostics Extends Relationship with Fujirebio Diagnostics, Inc. and Signs an Exclusive US Distribution Agreement for Cyfra 21-1 EIA",Rise,0.0195,147,gold standard diagnostics extends relationship with fujirebio diagnostics inc and sign exclusive distribution agreement for cyfra eia,133,17,0,pharmacy,"['gold', 'standard', 'diagnostic', '##s', 'extends', 'relationship', 'with', 'f', '##u', '##ji', '##re', '##bio', 'diagnostic', '##s', 'in', '##c', 'and', 'sign', 'exclusive', 'distribution', 'agreement', 'for', 'c', '##y', '##fra', 'e', '##ia']",1
115586,nifty_355,2011-10-17,Advaxis to Present at the 2011 10th Annual BIO Investor Forum on October 25th,Rise,0.0195,77,advaxis present the annual bio investor forum october,53,8,0,pharmacy,"['ad', '##va', '##xi', '##s', 'present', 'the', 'annual', 'bio', 'investor', 'forum', 'o', '##ct', '##obe', '##r']",1
115704,nifty_355,2011-10-17, Digital X-Ray Systems Market to Grow 5% Through 2014,Rise,0.0195,53,digital ray system market grow through,38,6,0,pharmacy,"['digital', 'ray', 'system', 'market', 'grow', 'through']",1
115745,nifty_355,2011-10-17,"Research and Markets: Insulin - Asia. Actual situation, Trends and Future Outlook of the Insulin Markets in 19 Countries",Rise,0.0195,120,research and market insulin asia actual situation trend and future outlook the insulin market country,101,15,0,pharmacy,"['research', 'and', 'market', 'insulin', 'as', '##ia', 'actual', 'situation', 'trend', 'and', 'future', 'outlook', 'the', 'insulin', 'market', 'country']",1
115760,nifty_355,2011-10-17,Hemispherx Biopharma Reports on Annual Stockholder Meeting,Rise,0.0195,58,hemispherx biopharma report annual stockholder meeting,54,6,0,pharmacy,"['hem', '##is', '##pher', '##x', 'bio', '##pha', '##rma', 'report', 'annual', 'stock', '##holder', 'meeting']",1
115876,nifty_355,2011-10-17,"Research and Markets: SOURCE Select - China's Premier Pharma and Biotech Newswire Is an Ideal News and Research Tool for Managers, Executives and Analysts",Rise,0.0195,154,research and market source select china premier pharma and biotech newswire ideal news and research tool for manager executive and analyst,138,21,0,pharmacy,"['research', 'and', 'market', 'source', 'select', 'chin', '##a', 'premier', 'p', '##har', '##ma', 'and', 'bio', '##tech', 'news', '##wire', 'ideal', 'news', 'and', 'research', 'tool', 'for', 'manager', 'executive', 'and', 'analyst']",1
115901,nifty_355,2011-10-17,Inc. 500|5000 Marks Continued Growth for Healthcare Company,Rise,0.0195,59,inc mark continued growth for healthcare company,48,7,0,pharmacy,"['in', '##c', 'mark', 'continued', 'growth', 'for', 'healthcare', 'company']",1
115967,nifty_355,2011-10-17,Sucampo Pharmaceuticals Invites Investors to Listen to Webcast of Presentation from BioCentury Conference,Rise,0.0195,105,sucampo pharmaceutical invite investor listen webcast presentation from biocentury conference,93,10,0,pharmacy,"['su', '##cam', '##po', 'pharmaceutical', 'invite', 'investor', 'listen', 'web', '##cast', 'presentation', 'from', 'bio', '##cent', '##ury', 'conference']",1
116359,nifty_358,2011-10-20,BB Biotech AG continues to maintain a deliberate investment strategy,Rise,0.019,68,biotech continues maintain deliberate investment strategy,57,6,0,pharmacy,"['bio', '##tech', 'continues', 'maintain', 'deliberate', 'investment', 'strategy']",1
116360,nifty_358,2011-10-20,"Cell Therapeutics, Inc. (CTI) to Report Third Quarter 2011 Financial Results on October 25",Rise,0.019,90,cell therapeutic inc cti report third quarter financial result october,70,10,0,pharmacy,"['cell', 'therapeutic', 'in', '##c', 'c', '##ti', 'report', 'third', 'quarter', 'financial', 'result', 'o', '##ct', '##obe', '##r']",1
116615,nifty_358,2011-10-20,Research and Markets: Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value,Rise,0.019,153,research and market metabolic disorder therapeutic market patent expiry lipitor will negatively impact dyslipidemia market value,128,16,0,pharmacy,"['research', 'and', 'market', 'metabolic', 'disorder', 'therapeutic', 'market', 'patent', 'ex', '##pi', '##ry', 'lip', '##itor', 'will', 'negatively', 'impact', 'd', '##ys', '##lip', '##ide', '##mia', 'market', 'value']",1
116642,nifty_358,2011-10-20,RBCC Forms New Division to Enter $84.6 Billion Biotechnology Sector,Rise,0.019,67,rbcc form new division enter billion biotechnology sector,57,8,0,pharmacy,"['r', '##b', '##cc', 'form', 'new', 'division', 'enter', 'billion', 'bio', '##tech', '##nology', 'sector']",1
116678,nifty_358,2011-10-20,Companies & Markets: Topcon Corp Leads the Global Ophthalmic Diagnostic Equipment Market,Rise,0.019,88,company market topcon corp lead the global ophthalmic diagnostic equipment market,81,11,0,pharmacy,"['company', 'market', 'top', '##con', 'co', '##rp', 'lead', 'the', 'global', 'op', '##ht', '##hal', '##mic', 'diagnostic', 'equipment', 'market']",1
116706,nifty_358,2011-10-20,Companiesandmarkets.com: Depression Therapeutics Market To See Patent Expiries,Rise,0.019,78,companiesandmarkets com depression therapeutic market see patent expiry,71,8,0,pharmacy,"['companies', '##and', '##market', '##s', 'com', 'depression', 'therapeutic', 'market', 'see', 'patent', 'ex', '##pi', '##ry']",1
116713,nifty_358,2011-10-20,Companies & Markets: Glioblastoma Multiforme (GBM) Therapeutics - Pipeline Assessment and Market Forecasts to 2018,Rise,0.019,114,company market glioblastoma multiforme gbm therapeutic pipeline assessment and market forecast,94,11,0,pharmacy,"['company', 'market', 'g', '##lio', '##blast', '##oma', 'multi', '##form', '##e', 'g', '##b', '##m', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
116744,nifty_358,2011-10-20,Companiesandmarkets.com: Cancer Diagnostic Testing World Markets,Rise,0.019,64,companiesandmarkets com cancer diagnostic testing world market,62,7,0,pharmacy,"['companies', '##and', '##market', '##s', 'com', 'cancer', 'diagnostic', 'testing', 'world', 'market']",1
116745,nifty_358,2011-10-20,Companies & Markets: Women`s Health Diagnostic Testing - Market Research Published,Rise,0.019,82,company market woman health diagnostic testing market research published,72,9,0,pharmacy,"['company', 'market', 'woman', 'health', 'diagnostic', 'testing', 'market', 'research', 'published']",1
116747,nifty_358,2011-10-20,Companies & Markets: Cancer Therapeutics Markets,Rise,0.019,48,company market cancer therapeutic market,40,5,0,pharmacy,"['company', 'market', 'cancer', 'therapeutic', 'market']",1
116751,nifty_358,2011-10-20,Companies & Markets: Over-the-Counter Diagnostic Products World Markets - Market Research Published,Rise,0.019,99,company market over the counter diagnostic product world market market research published,89,12,0,pharmacy,"['company', 'market', 'over', 'the', 'counter', 'diagnostic', 'product', 'world', 'market', 'market', 'research', 'published']",1
116850,nifty_358,2011-10-20,"Unigene to Present at the 10th Annual BIO Investor Forum on October 25, 2011",Rise,0.019,76,unigene present the annual bio investor forum october,53,8,0,pharmacy,"['un', '##ige', '##ne', 'present', 'the', 'annual', 'bio', 'investor', 'forum', 'o', '##ct', '##obe', '##r']",1
116862,nifty_358,2011-10-20,Research and Markets: US Medical Imaging Devices Market,Rise,0.019,55,research and market medical imaging device market,49,7,0,pharmacy,"['research', 'and', 'market', 'medical', 'imaging', 'device', 'market']",1
116916,nifty_358,2011-10-20,Senesco Technologies to Present at BIO Investor Forum Conference,Rise,0.019,64,senesco technology present bio investor forum conference,56,7,0,pharmacy,"['se', '##nes', '##co', 'technology', 'present', 'bio', 'investor', 'forum', 'conference']",1
116937,nifty_358,2011-10-20, What's Ahead: Today's Economic Outlook - Equity Research on Human Genome Sciences and Pharmaceutical Product,Rise,0.019,109,what ahead today economic outlook equity research human genome science and pharmaceutical product,97,13,0,pharmacy,"['what', 'ahead', 'today', 'economic', 'outlook', 'equity', 'research', 'human', 'genome', 'science', 'and', 'pharmaceutical', 'product']",1
117014,nifty_358,2011-10-20,"Amid Continued Clinical Trial Failures, No Novel Acute Ischemic Stroke Drug Therapies Are Forecasted to Launch Through 2020",Rise,0.019,123,amid continued clinical trial failure novel acute ischemic stroke drug therapy are forecasted launch through,108,15,0,pharmacy,"['amid', 'continued', 'clinical', 'trial', 'failure', 'novel', 'acute', 'is', '##che', '##mic', 'stroke', 'drug', 'therapy', 'are', 'forecast', '##ed', 'launch', 'through']",1
117018,nifty_358,2011-10-20,Companies & Markets: Indian In-vitro Diagnostics Market expanding by 18% CAGR between 2009-16,Rise,0.019,93,company market indian vitro diagnostics market expanding cagr between,69,9,0,pharmacy,"['company', 'market', 'in', '##dian', 'v', '##it', '##ro', 'diagnostic', '##s', 'market', 'expanding', 'ca', '##g', '##r', 'between']",1
117088,nifty_358,2011-10-20,Global Bio-Pharma Clinical Leaders Call for Industry Transformation at 21st Annual Partnerships in Clinical Trials,Rise,0.019,114,global bio pharma clinical leader call for industry transformation annual partnership clinical trial,100,13,0,pharmacy,"['global', 'bio', 'p', '##har', '##ma', 'clinical', 'leader', 'call', 'for', 'industry', 'transformation', 'annual', 'partnership', 'clinical', 'trial']",1
117229,nifty_358,2011-10-20,"Zack`s Investment Research Initiates Coverage on Corgenix Medical Corporation with ""Outperform"" Rating",Rise,0.019,102,zack investment research initiate coverage corgenix medical corporation with outperform rating,94,11,0,pharmacy,"['z', '##ack', 'investment', 'research', 'initiate', 'coverage', 'co', '##rgen', '##ix', 'medical', 'corporation', 'with', 'out', '##per', '##form', 'rating']",1
117275,nifty_358,2011-10-20,"bioMÃ©rieux: Business Review for the Nine Months Ended September 30, 2011",Rise,0.019,73,biomã rieux business review for the nine month ended september,62,10,0,pharmacy,"['bio', '##m', '##ã', 'r', '##ieu', '##x', 'business', 'review', 'for', 'the', 'nine', 'month', 'ended', 'se', '##pt', '##em', '##ber']",1
117295,nifty_358,2011-10-20,"Pharmaceutical Market Access Teams Gaining Independence, Cutting Edge Information Finds",Rise,0.019,87,pharmaceutical market access team gaining independence cutting edge information find,84,10,0,pharmacy,"['pharmaceutical', 'market', 'access', 'team', 'gaining', 'independence', 'cutting', 'edge', 'information', 'find']",1
117308,nifty_358,2011-10-20,Research and Markets: The Global Laparotomy Sponge Market to Grow At A CAGR of 11.9 over the Period of 2010-2014,Rise,0.019,112,research and market the global laparotomy sponge market grow cagr over the period,81,13,0,pharmacy,"['research', 'and', 'market', 'the', 'global', 'lap', '##aro', '##tom', '##y', 's', '##po', '##nge', 'market', 'grow', 'ca', '##g', '##r', 'over', 'the', 'period']",1
117336,nifty_358,2011-10-20,Genprex Presenting at 10th Annual BIO Investor Forum,Rise,0.019,52,genprex presenting annual bio investor forum,44,6,0,pharmacy,"['g', '##en', '##p', '##re', '##x', 'presenting', 'annual', 'bio', 'investor', 'forum']",1
117713,nifty_358,2011-10-20,Biocon Profit Slips 3.9%,Rise,0.019,24,biocon profit slip,18,3,0,pharmacy,"['bio', '##con', 'profit', 'slip']",1
117830,nifty_360,2011-10-25,"Cell Therapeutics, Inc. (CTI) Reports Third Quarter Financial Results and Milestones",Rise,0.0102,84,cell therapeutic inc cti report third quarter financial result and milestone,76,11,0,pharmacy,"['cell', 'therapeutic', 'in', '##c', 'c', '##ti', 'report', 'third', 'quarter', 'financial', 'result', 'and', 'milestone']",1
117929,nifty_360,2011-10-25,Novartis achieves strong third quarter financial performance and pipeline progress,Rise,0.0102,82,novartis achieves strong third quarter financial performance and pipeline progress,82,10,0,pharmacy,"['no', '##var', '##tis', 'achieve', '##s', 'strong', 'third', 'quarter', 'financial', 'performance', 'and', 'pipeline', 'progress']",1
118131,nifty_360,2011-10-25,PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value,Rise,0.0102,120,parexel expands commercialization capability with dedicated team help biopharma company demonstrate product value,113,13,0,pharmacy,"['par', '##ex', '##el', 'expands', 'commercial', '##ization', 'capability', 'with', 'dedicated', 'team', 'help', 'bio', '##pha', '##rma', 'company', 'demonstrate', 'product', 'value']",1
118220,nifty_360,2011-10-25,Webcast Alert: Isis Pharmaceuticals' Third Quarter 2011 Financial Results Conference Call,Rise,0.0102,89,webcast alert isi pharmaceutical third quarter financial result conference call,79,10,0,pharmacy,"['web', '##cast', 'alert', 'is', '##i', 'pharmaceutical', 'third', 'quarter', 'financial', 'result', 'conference', 'call']",1
118277,nifty_360,2011-10-25,Research and Markets: 2012 U.S. Pharmacies & Drug Stores Industry-Industry & Market Report,Rise,0.0102,90,research and market pharmacy drug store industry industry market report,71,10,0,pharmacy,"['research', 'and', 'market', 'pharmacy', 'drug', 'store', 'industry', 'industry', 'market', 'report']",1
118402,nifty_360,2011-10-25,Research and Markets: Glioblastoma Multiforme Therapeutics - Pipeline Assessment and Market Forecasts to 2018. Current Treatment Options are Moderately Successful in Meeting Market Demand,Rise,0.0102,187,research and market glioblastoma multiforme therapeutic pipeline assessment and market forecast current treatment option are moderately successful meeting market demand,168,20,0,pharmacy,"['research', 'and', 'market', 'g', '##lio', '##blast', '##oma', 'multi', '##form', '##e', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast', 'current', 'treatment', 'option', 'are', 'moderately', 'successful', 'meeting', 'market', 'demand']",1
118411,nifty_360,2011-10-25, Allon's CEO Presenting at BIO Investor Forum,Rise,0.0102,45,allon ceo presenting bio investor forum,39,6,0,pharmacy,"['all', '##on', 'c', '##eo', 'presenting', 'bio', 'investor', 'forum']",1
118428,nifty_360,2011-10-25,"Research and Markets: Medical Equipment Monthly Deals Analysis - M&A; and Investment Trends, Q4 2011",Rise,0.0102,100,research and market medical equipment monthly deal analysis and investment trend,80,11,0,pharmacy,"['research', 'and', 'market', 'medical', 'equipment', 'monthly', 'deal', 'analysis', 'and', 'investment', 'trend']",1
118501,nifty_360,2011-10-25,"The Breast Cancer Drug Market Will Increase Marginally over the Next Decade, Despite Generic and Biosimilar Erosion of Key Agents",Rise,0.0102,129,the breast cancer drug market will increase marginally over the next decade despite generic and biosimilar erosion key agent,124,19,0,pharmacy,"['the', 'breast', 'cancer', 'drug', 'market', 'will', 'increase', 'marginal', '##ly', 'over', 'the', 'next', 'decade', 'despite', 'generic', 'and', 'bio', '##si', '##mi', '##lar', 'erosion', 'key', 'agent']",1
118662,nifty_360,2011-10-25,Unprecedented Transparency Taking Root in Healthcare Industry,Rise,0.0102,61,unprecedented transparency taking root healthcare industry,58,6,0,pharmacy,"['unprecedented', 'transparency', 'taking', 'root', 'healthcare', 'industry']",1
118703,nifty_360,2011-10-25,Research and Markets: U.S. Hospital EHR Market 2009-2016. Exceptionally Dynamic Market Ensures Niche Opportunities for New Vendors,Rise,0.0102,130,research and market hospital ehr market exceptionally dynamic market ensures niche opportunity for new vendor,109,15,0,pharmacy,"['research', 'and', 'market', 'hospital', 'eh', '##r', 'market', 'exceptionally', 'dynamic', 'market', 'ensures', 'niche', 'opportunity', 'for', 'new', 'vendor']",1
118731,nifty_360,2011-10-25,"Research and Markets: Nitric Oxide (NO) Therapeutics, Markets, Forecasts and Companies: an Updated Report",Rise,0.0102,105,research and market nitric oxide therapeutic market forecast and company updated report,87,12,0,pharmacy,"['research', 'and', 'market', 'ni', '##tric', 'oxide', 'therapeutic', 'market', 'forecast', 'and', 'company', 'updated', 'report']",1
118845,nifty_360,2011-10-25,"Research and Markets: Post Traumatic Stress Disorder: Diagnosis, Management and Treatment - Updated Second Edition",Rise,0.0102,114,research and market post traumatic stress disorder diagnosis management and treatment updated second edition,108,14,0,pharmacy,"['research', 'and', 'market', 'post', 'traumatic', 'stress', 'disorder', 'diagnosis', 'management', 'and', 'treatment', 'updated', 'second', 'edition']",1
118951,nifty_360,2011-10-25,Research and Markets: The BioTech Stock Report 2011 Is the Only Biotech Newsletter That Explains Recent Developments In Light Of Underlying Technology,Rise,0.0102,150,research and market the biotech stock report the only biotech newsletter that explains recent development light underlying technology,133,18,0,pharmacy,"['research', 'and', 'market', 'the', 'bio', '##tech', 'stock', 'report', 'the', 'only', 'bio', '##tech', 'newsletter', 'that', 'explains', 'recent', 'development', 'light', 'underlying', 'technology']",1
119015,nifty_360,2011-10-25,Human Genome Sciences Announces Third Quarter 2011 Financial Results and Key Developments,Rise,0.0102,89,human genome science announces third quarter financial result and key development,81,11,0,pharmacy,"['human', 'genome', 'science', 'announces', 'third', 'quarter', 'financial', 'result', 'and', 'key', 'development']",1
119835,nifty_361,2011-10-26,Infinity Pharmaceuticals Announces Its Participation at Two Investor Conferences,Rise,0.0348,80,infinity pharmaceutical announces it participation two investor conference,74,8,0,pharmacy,"['in', '##finity', 'pharmaceutical', 'announces', 'it', 'participation', 'two', 'investor', 'conference']",1
119931,nifty_361,2011-10-26,"Research and Markets: Rising Tendencies Towards Self-Treatment Drives the Indian Otc Drug Market, Finds Netscribes",Rise,0.0348,114,research and market rising tendency towards self treatment drive the indian otc drug market find netscribes,107,16,0,pharmacy,"['research', 'and', 'market', 'rising', 'tendency', 'towards', 'self', 'treatment', 'drive', 'the', 'in', '##dian', 'o', '##t', '##c', 'drug', 'market', 'find', 'nets', '##cribe', '##s']",1
119985,nifty_361,2011-10-26,"Pharmaceutical Industry Leaders to Tackle Groundbreaking Challenges, Opportunities for Pharma & Biotech at Elite Event",Rise,0.0348,118,pharmaceutical industry leader tackle groundbreaking challenge opportunity for pharma biotech elite event,105,12,0,pharmacy,"['pharmaceutical', 'industry', 'leader', 'tackle', 'groundbreaking', 'challenge', 'opportunity', 'for', 'p', '##har', '##ma', 'bio', '##tech', 'elite', 'event']",1
120087,nifty_361,2011-10-26,FDA Invests $2 Million in Partnerships Through Centers of Excellence in Regulatory Science and Innovation,Rise,0.0348,105,fda invests million partnership through center excellence regulatory science and innovation,91,11,0,pharmacy,"['f', '##da', 'invest', '##s', 'million', 'partnership', 'through', 'center', 'excellence', 'regulatory', 'science', 'and', 'innovation']",1
120091,nifty_361,2011-10-26,RWJF and Ashoka Changemakers Announce Global Competition to Find Cutting-Edge Health Care Solutions,Rise,0.0348,99,rwjf and ashoka changemakers announce global competition find cutting edge health care solution,95,13,0,pharmacy,"['r', '##w', '##j', '##f', 'and', 'ash', '##oka', 'change', '##makers', 'announce', 'global', 'competition', 'find', 'cutting', 'edge', 'health', 'care', 'solution']",1
120344,nifty_361,2011-10-26,Research and Markets: Biosimilar/Follow-on Biologics Market Report & Forecast: A Focus on the US (2011-2020),Rise,0.0348,108,research and market biosimilar follow biologics market report forecast focus the,80,11,0,pharmacy,"['research', 'and', 'market', 'bio', '##si', '##mi', '##lar', 'follow', 'bio', '##log', '##ics', 'market', 'report', 'forecast', 'focus', 'the']",1
120532,nifty_361,2011-10-26,"Research and Markets: Clinical Diagnostic Market in India - Competition Analysis, Future Opportunities, Major Players and More...",Rise,0.0348,129,research and market clinical diagnostic market india competition analysis future opportunity major player and more,114,15,0,pharmacy,"['research', 'and', 'market', 'clinical', 'diagnostic', 'market', 'in', '##dia', 'competition', 'analysis', 'future', 'opportunity', 'major', 'player', 'and', 'more']",1
120771,nifty_362,2011-10-27,Thomson Reuters Launches New Competitive Intelligence Solution for the Pharmaceutical Industry,Neutral,-0.0002,94,thomson reuters launch new competitive intelligence solution for the pharmaceutical industry,92,11,0,pharmacy,"['th', '##oms', '##on', 're', '##uters', 'launch', 'new', 'competitive', 'intelligence', 'solution', 'for', 'the', 'pharmaceutical', 'industry']",1
121311,nifty_362,2011-10-27,"Bristol-Myers Squibb Delivers Strong Third Quarter with Important Clinical Data, Solid Operating Results and Continued Focus on Business Development",Neutral,-0.0002,148,bristol myers squibb delivers strong third quarter with important clinical data solid operating result and continued focus business development,143,19,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'delivers', 'strong', 'third', 'quarter', 'with', 'important', 'clinical', 'data', 'solid', 'operating', 'result', 'and', 'continued', 'focus', 'business', 'development']",1
121313,nifty_362,2011-10-27,Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance,Neutral,-0.0002,105,endo pharmaceutical report strong third quarter financial result and reaffirms financial guidance,97,12,0,pharmacy,"['end', '##o', 'pharmaceutical', 'report', 'strong', 'third', 'quarter', 'financial', 'result', 'and', 're', '##af', '##fi', '##rms', 'financial', 'guidance']",1
121573,nifty_362,2011-10-27,"Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Adamis Pharmaceuticals Corp.",Neutral,-0.0002,110,crystal research associate llc issue executive informational overview eio adamis pharmaceutical corp,100,12,0,pharmacy,"['crystal', 'research', 'associate', 'll', '##c', 'issue', 'executive', 'information', '##al', 'overview', 'e', '##io', 'ad', '##ami', '##s', 'pharmaceutical', 'co', '##rp']",1
121608,nifty_362,2011-10-27,Research and Markets: Pharmaceutical Distribution in the US: Current and Future Perspectives - Wholesale Sector Consolidation Boosts Power of 'Big Three',Neutral,-0.0002,153,research and market pharmaceutical distribution the current and future perspective wholesale sector consolidation boost power big three,135,17,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'distribution', 'the', 'current', 'and', 'future', 'perspective', 'wholesale', 'sector', 'consolidation', 'boost', 'power', 'big', 'three']",1
121645,nifty_362,2011-10-27,Research and Markets: The Latin American Pharmaceutical Market Is Now Worth $45bn and Multinational Companies Consider Success in Brazil and Mexico as Essential,Neutral,-0.0002,160,research and market the latin american pharmaceutical market now worth and multinational company consider success brazil and mexico essential,141,19,0,pharmacy,"['research', 'and', 'market', 'the', 'la', '##tin', 'am', '##eric', '##an', 'pharmaceutical', 'market', 'now', 'worth', 'and', 'multinational', 'company', 'consider', 'success', 'bra', '##zi', '##l', 'and', 'me', '##xi', '##co', 'essential']",1
121695,nifty_362,2011-10-27,Research and Markets: The Future of European Pharmaceutical Distribution: - In 2010 There Was No Sign That DTP Was Being Explored In France and Germany,Neutral,-0.0002,151,research and market the future european pharmaceutical distribution there wa sign that dtp wa being explored france and germany,127,19,0,pharmacy,"['research', 'and', 'market', 'the', 'future', 'euro', '##pe', '##an', 'pharmaceutical', 'distribution', 'there', 'wa', 'sign', 'that', 'd', '##t', '##p', 'wa', 'being', 'explored', 'f', '##rance', 'and', 'g', '##erman', '##y']",1
121724,nifty_362,2011-10-27,"Research and Markets: Major Pharmaceutical Markets of the Middle East 2nd Edition: An Overview of Egypt, Israel, Jordan, Lebanon, Saudi Arabia & UAE",Neutral,-0.0002,148,research and market major pharmaceutical market the middle east edition overview egypt israel jordan lebanon saudi arabia uae,125,18,0,pharmacy,"['research', 'and', 'market', 'major', 'pharmaceutical', 'market', 'the', 'middle', 'east', 'edition', 'overview', 'e', '##gy', '##pt', 'is', '##rae', '##l', 'j', '##ord', '##an', 'le', '##ban', '##on', 'sa', '##udi', 'a', '##rab', '##ia', 'u', '##ae']",1
121744,nifty_362,2011-10-27,"SCAN Health Plan Exhibits ""Trading Ages"" at Capitol Hill Health Expo",Neutral,-0.0002,68,scan health plan exhibit trading age capitol hill health expo,61,10,0,pharmacy,"['scan', 'health', 'plan', 'exhibit', 'trading', 'age', 'cap', '##ito', '##l', 'hill', 'health', 'ex', '##po']",1
121816,nifty_362,2011-10-27,"Research and Markets: Pharmaceutical Pricing, Reimbursement, and Market Access News in the Second Quarter of 2011",Neutral,-0.0002,113,research and market pharmaceutical pricing reimbursement and market access news the second quarter,98,13,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'pricing', 're', '##im', '##bur', '##se', '##ment', 'and', 'market', 'access', 'news', 'the', 'second', 'quarter']",1
121818,nifty_362,2011-10-27,Research and Markets: The Global Market for New Cancer Patients is Set to Increase from 4.0 Million Cases in the Major Cancer Markets in 2007 to 4.2 Million in 2012,Neutral,-0.0002,164,research and market the global market for new cancer patient set increase from million case the major cancer market million,123,20,0,pharmacy,"['research', 'and', 'market', 'the', 'global', 'market', 'for', 'new', 'cancer', 'patient', 'set', 'increase', 'from', 'million', 'case', 'the', 'major', 'cancer', 'market', 'million']",1
121821,nifty_362,2011-10-27,"Research and Markets: The Global Pharmaceutical Market is Forecast to Grow to $1,033 Billion in 2014, an Equivalent CAGR of 5.0% over the Next Five Years",Neutral,-0.0002,153,research and market the global pharmaceutical market forecast grow billion equivalent cagr over the next five year,114,17,0,pharmacy,"['research', 'and', 'market', 'the', 'global', 'pharmaceutical', 'market', 'forecast', 'grow', 'billion', 'equivalent', 'ca', '##g', '##r', 'over', 'the', 'next', 'five', 'year']",1
121852,nifty_362,2011-10-27,Research and Markets: The Pharma Contract Research Annual Review 2010 Provides an In-Depth Analysis of the CRO Market,Neutral,-0.0002,117,research and market the pharma contract research annual review provides depth analysis the cro market,101,15,0,pharmacy,"['research', 'and', 'market', 'the', 'p', '##har', '##ma', 'contract', 'research', 'annual', 'review', 'provides', 'depth', 'analysis', 'the', 'c', '##ro', 'market']",1
121907,nifty_362,2011-10-27,"Research and Markets: Toxicology and Pharmacology: Outsourcing, History, Process and Regulation; Technical, Political and Economic Challenges",Neutral,-0.0002,141,research and market toxicology and pharmacology outsourcing history process and regulation technical political and economic challenge,133,16,0,pharmacy,"['research', 'and', 'market', 'toxic', '##ology', 'and', 'p', '##har', '##ma', '##cology', 'outs', '##our', '##cing', 'history', 'process', 'and', 'regulation', 'technical', 'political', 'and', 'economic', 'challenge']",1
121941,nifty_362,2011-10-27,"Research and Markets: Mergers and Acquisitions in the Pharmaceuticals Sector, 2009: Critical Success Factors for Competing in a Consolidating Market",Neutral,-0.0002,148,research and market merger and acquisition the pharmaceutical sector critical success factor for competing consolidating market,127,16,0,pharmacy,"['research', 'and', 'market', 'merger', 'and', 'acquisition', 'the', 'pharmaceutical', 'sector', 'critical', 'success', 'factor', 'for', 'competing', 'con', '##sol', '##ida', '##ting', 'market']",1
121959,nifty_362,2011-10-27,"Research and Markets: Manufacturing in the Global Pharmaceuticals Industry: Key Drivers, Company Strategies and Regulations 3rd Edition",Neutral,-0.0002,135,research and market manufacturing the global pharmaceutical industry key driver company strategy and regulation edition,119,15,0,pharmacy,"['research', 'and', 'market', 'manufacturing', 'the', 'global', 'pharmaceutical', 'industry', 'key', 'driver', 'company', 'strategy', 'and', 'regulation', 'edition']",1
121980,nifty_362,2011-10-27,NOVAVAX CEO Addresses U.S. Patent and Trademark Office (USPTO) on Behalf of the Biotechnology...,Neutral,-0.0002,96,novavax ceo address patent and trademark office uspto behalf the biotechnology,78,11,0,pharmacy,"['no', '##va', '##va', '##x', 'c', '##eo', 'address', 'patent', 'and', 'trademark', 'office', 'us', '##pt', '##o', 'behalf', 'the', 'bio', '##tech', '##nology']",1
121987,nifty_362,2011-10-27,"Research and Markets: Virtual Pharma: The Radical Route to Success Provides Information and Data of the Highest Quality, Taken Directly From the EvaluatePharma Database",Neutral,-0.0002,168,research and market virtual pharma the radical route success provides information and data the highest quality taken directly from the evaluatepharma database,158,22,0,pharmacy,"['research', 'and', 'market', 'virtual', 'p', '##har', '##ma', 'the', 'radical', 'route', 'success', 'provides', 'information', 'and', 'data', 'the', 'highest', 'quality', 'taken', 'directly', 'from', 'the', 'evaluate', '##pha', '##rma', 'database']",1
122003,nifty_362,2011-10-27,"HealthTech Holdings Inc. Names Industry Veterans to New CTO, CIO Posts",Neutral,-0.0002,70,healthtech holding inc name industry veteran new cto cio post,61,10,0,pharmacy,"['health', '##tech', 'holding', 'in', '##c', 'name', 'industry', 'veteran', 'new', 'c', '##to', 'c', '##io', 'post']",1
122031,nifty_362,2011-10-27,"Research and Markets: DNA Sequencing - Technologies, Markets and Companies: an Updated Report",Neutral,-0.0002,93,research and market dna sequencing technology market and company updated report,79,11,0,pharmacy,"['research', 'and', 'market', 'd', '##na', 'se', '##quencing', 'technology', 'market', 'and', 'company', 'updated', 'report']",1
122107,nifty_362,2011-10-27, GeneNews Reports Third Quarter 2011 Financial Results,Neutral,-0.0002,54,genenews report third quarter financial result,46,6,0,pharmacy,"['gene', '##ne', '##ws', 'report', 'third', 'quarter', 'financial', 'result']",1
122681,nifty_364,2011-11-01,Cutting-Edge India Diagnostic Imaging Market Research Report Now Available at MarketPublishers.com,Rise,0.0163,98,cutting edge india diagnostic imaging market research report now available marketpublishers com,95,12,0,pharmacy,"['cutting', 'edge', 'in', '##dia', 'diagnostic', 'imaging', 'market', 'research', 'report', 'now', 'available', 'market', '##pu', '##b', '##lish', '##ers', 'com']",1
122743,nifty_364,2011-11-01, Ongoing Market Volatility Dampens Public Financings for Biotech,Rise,0.0163,64,ongoing market volatility dampens public financing for biotech,62,8,0,pharmacy,"['ongoing', 'market', 'vol', '##ati', '##lity', 'damp', '##ens', 'public', 'financing', 'for', 'bio', '##tech']",1
122769,nifty_364,2011-11-01,Teleflex to Present at theLazard Capital Markets 8th Annual Healthcare Conference,Rise,0.0163,81,teleflex present thelazard capital market annual healthcare conference,70,8,0,pharmacy,"['te', '##le', '##fle', '##x', 'present', 'the', '##la', '##zard', 'capital', 'market', 'annual', 'healthcare', 'conference']",1
122947,nifty_364,2011-11-01,Research and Markets: the Medical Device Market: Ireland - the Republic of Ireland Represents a Small but Advanced Market for Medical Equipment,Rise,0.0163,143,research and market the medical device market ireland the republic ireland represents small but advanced market for medical equipment,133,19,0,pharmacy,"['research', 'and', 'market', 'the', 'medical', 'device', 'market', 'i', '##rel', '##and', 'the', 'republic', 'i', '##rel', '##and', 'represents', 'small', 'but', 'advanced', 'market', 'for', 'medical', 'equipment']",1
123051,nifty_364,2011-11-01,"COPD Foundation Leads Campaign During November COPD Awareness Month: Accelerate Research, Improve Diagnosis and Therapies, Raise Funding",Rise,0.0163,136,copd foundation lead campaign during november copd awareness month accelerate research improve diagnosis and therapy raise funding,130,17,0,pharmacy,"['cop', '##d', 'foundation', 'lead', 'campaign', 'during', 'no', '##ve', '##mber', 'cop', '##d', 'awareness', 'month', 'accelerate', 'research', 'improve', 'diagnosis', 'and', 'therapy', 'raise', 'funding']",1
123111,nifty_364,2011-11-01,"The Zacks Analyst Blog Highlights: Laboratory Corporation of America Holdings, Humana, WellPoint, Cigna and Quest Diagnostics",Rise,0.0163,125,the zacks analyst blog highlight laboratory corporation america holding humana wellpoint cigna and quest diagnostics,116,15,0,pharmacy,"['the', 'z', '##ack', '##s', 'analyst', 'blog', 'highlight', 'laboratory', 'corporation', 'am', '##eric', '##a', 'holding', 'human', '##a', 'well', '##point', 'c', '##ign', '##a', 'and', 'quest', 'diagnostic', '##s']",1
123194,nifty_364,2011-11-01,Research and Markets: Malaysia Pharmaceuticals and Healthcare Report Q4 2011,Rise,0.0163,76,research and market malaysia pharmaceutical and healthcare report,65,8,0,pharmacy,"['research', 'and', 'market', 'ma', '##lay', '##sia', 'pharmaceutical', 'and', 'healthcare', 'report']",1
123207,nifty_364,2011-11-01,Northwest Bio Announces Interview of CEO Linda Powers in Today's CEO/CFO Publication,Rise,0.0163,84,northwest bio announces interview ceo linda power today ceo cfo publication,75,11,0,pharmacy,"['northwest', 'bio', 'announces', 'interview', 'c', '##eo', 'l', '##inda', 'power', 'today', 'c', '##eo', 'c', '##fo', 'publication']",1
123250,nifty_364,2011-11-01,"Research and Markets: Dysmenorrhea - Pipeline Review, H2 2011",Rise,0.0163,61,research and market dysmenorrhea pipeline review,48,6,0,pharmacy,"['research', 'and', 'market', 'd', '##ys', '##men', '##or', '##r', '##hea', 'pipeline', 'review']",1
123358,nifty_364,2011-11-01,Research and Markets: MicroRNA Market Trends 2011,Rise,0.0163,49,research and market microrna market trend,41,6,0,pharmacy,"['research', 'and', 'market', 'micro', '##rna', 'market', 'trend']",1
123426,nifty_364,2011-11-01,"Research and Markets: Autism - Pipeline Review, H2 2011",Rise,0.0163,55,research and market autism pipeline review,42,6,0,pharmacy,"['research', 'and', 'market', 'autism', 'pipeline', 'review']",1
123470,nifty_364,2011-11-01,"Back-Up Compounds and S1P1 Lead Compounds, Assets Generated by Epix Pharmaceuticals, Inc. and Amgen, Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale",Rise,0.0163,163,back compound and lead compound asset generated epix pharmaceutical inc and amgen will offered for sale december sealed bid sale,128,20,0,pharmacy,"['back', 'compound', 'and', 'lead', 'compound', 'asset', 'generated', 'e', '##pi', '##x', 'pharmaceutical', 'in', '##c', 'and', 'am', '##gen', 'will', 'offered', 'for', 'sale', 'de', '##ce', '##mber', 'sealed', 'bid', 'sale']",1
123503,nifty_364,2011-11-01, ISTA Pharmaceuticals Reports Third Quarter 2011 Financial Results,Rise,0.0163,66,ista pharmaceutical report third quarter financial result,57,7,0,pharmacy,"['is', '##ta', 'pharmaceutical', 'report', 'third', 'quarter', 'financial', 'result']",1
123518,nifty_364,2011-11-01,Nature's Bioceuticals Tears Into the Multi-Billion Dollar Chronic Kidney Disease Market,Rise,0.0163,87,nature bioceuticals tear into the multi billion dollar chronic kidney disease market,84,12,0,pharmacy,"['nature', 'bio', '##ce', '##utical', '##s', 'tear', 'into', 'the', 'multi', 'billion', 'dollar', 'chronic', 'kidney', 'disease', 'market']",1
123747,nifty_364,2011-11-01,SurModics Announces Agreement to Sell Pharmaceutical AssetsMacau Gambling Revenue Hits High,Rise,0.0163,91,surmodics announces agreement sell pharmaceutical assetsmacau gambling revenue hit high,87,10,0,pharmacy,"['sur', '##mo', '##dic', '##s', 'announces', 'agreement', 'sell', 'pharmaceutical', 'assets', '##ma', '##ca', '##u', 'gambling', 'revenue', 'hit', 'high']",1
124074,nifty_367,2011-11-07,"Research and Markets: Indonesia's Pharmaceutical Market Projected to Grow at a Compound Annual Growth Rate Of 11.3%, reaching a Value of USD 11.08 Billion By 2015",Rise,0.0128,162,research and market indonesia pharmaceutical market projected grow compound annual growth rate reaching value usd billion,121,16,0,pharmacy,"['research', 'and', 'market', 'in', '##don', '##esi', '##a', 'pharmaceutical', 'market', 'projected', 'grow', 'compound', 'annual', 'growth', 'rate', 'reaching', 'value', 'us', '##d', 'billion']",1
124192,nifty_367,2011-11-07,Research and Markets: The Pharmaceutical Market: Austria,Rise,0.0128,56,research and market the pharmaceutical market austria,53,7,0,pharmacy,"['research', 'and', 'market', 'the', 'pharmaceutical', 'market', 'au', '##st', '##ria']",1
124462,nifty_367,2011-11-07,NovaBay Pharmaceuticals Reports Third Quarter Financial Results,Rise,0.0128,63,novabay pharmaceutical report third quarter financial result,60,7,0,pharmacy,"['no', '##va', '##bay', 'pharmaceutical', 'report', 'third', 'quarter', 'financial', 'result']",1
124482,nifty_367,2011-11-07, Exclusive: President and CEO of IntelGenX Discusses the Firm's Pending FDA Decision,Rise,0.0128,84,exclusive president and ceo intelgenx discusses the firm pending fda decision,77,11,0,pharmacy,"['exclusive', 'president', 'and', 'c', '##eo', 'in', '##tel', '##gen', '##x', 'discusses', 'the', 'firm', 'pending', 'f', '##da', 'decision']",1
124539,nifty_367,2011-11-07,"Driven by the Launches of Promising Emerging Therapies, the Prostate Cancer Drug Market Will Experience Robust Growth over the Next Decade, Increasing from $3.6 Billion in 2010 to $10.1 Billion in 2020",Rise,0.0128,201,driven the launch promising emerging therapy the prostate cancer drug market will experience robust growth over the next decade increasing from billion billion,159,23,0,pharmacy,"['driven', 'the', 'launch', 'promising', 'emerging', 'therapy', 'the', 'pro', '##state', 'cancer', 'drug', 'market', 'will', 'experience', 'robust', 'growth', 'over', 'the', 'next', 'decade', 'increasing', 'from', 'billion', 'billion']",1
124590,nifty_367,2011-11-07, Biotechnology Market to Reach $398 Billion by 2015,Rise,0.0128,51,biotechnology market reach billion,34,4,0,pharmacy,"['bio', '##tech', '##nology', 'market', 'reach', 'billion']",1
124649,nifty_367,2011-11-07,Research and Markets: Bahrain Retail Report Q4 2011 - Consumer Electronics and OTC Pharmaceuticals to Rise by 26% and 39% Respectively,Rise,0.0128,134,research and market bahrain retail report consumer electronics and otc pharmaceutical rise and respectively,107,14,0,pharmacy,"['research', 'and', 'market', 'b', '##ah', '##rain', 'retail', 'report', 'consumer', 'electronics', 'and', 'o', '##t', '##c', 'pharmaceutical', 'rise', 'and', 'respectively']",1
124771,nifty_367,2011-11-07,Research and Markets: GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing,Rise,0.0128,105,research and market gpcrs drug discovery effort orphanize novel gpcr target are increasing,90,13,0,pharmacy,"['research', 'and', 'market', 'g', '##p', '##c', '##rs', 'drug', 'discovery', 'effort', 'orphan', '##ize', 'novel', 'g', '##p', '##c', '##r', 'target', 'are', 'increasing']",1
125000,nifty_367,2011-11-07,OCTANe Announces Its 6th Annual Medical Device & Investor Forum,Rise,0.0128,63,octane announces it annual medical device investor forum,56,8,0,pharmacy,"['o', '##ct', '##ane', 'announces', 'it', 'annual', 'medical', 'device', 'investor', 'forum']",1
125048,nifty_367,2011-11-07,Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Credit Suisse Conference,Rise,0.0128,104,human genome science invite investor listen webcast presentation credit suisse conference,89,11,0,pharmacy,"['human', 'genome', 'science', 'invite', 'investor', 'listen', 'web', '##cast', 'presentation', 'credit', 'su', '##isse', 'conference']",1
126093,nifty_376,2011-11-22,China Health Resource Announces Record Breaking 3rd Quarter 2011 Financial Results,Fall,-0.0221,82,china health resource announces record breaking quarter financial result,72,9,0,pharmacy,"['chin', '##a', 'health', 'resource', 'announces', 'record', 'breaking', 'quarter', 'financial', 'result']",1
126184,nifty_376,2011-11-22,Research and Markets: Diabetic Emergencies: Diagnosis and Clinical Management,Fall,-0.0221,77,research and market diabetic emergency diagnosis and clinical management,72,9,0,pharmacy,"['research', 'and', 'market', 'di', '##abe', '##tic', 'emergency', 'diagnosis', 'and', 'clinical', 'management']",1
126270,nifty_376,2011-11-22,Catabasis Pharmaceuticals to Present at Upcoming Industry and Investment Conferences,Fall,-0.0221,84,catabasis pharmaceutical present upcoming industry and investment conference,76,8,0,pharmacy,"['cat', '##aba', '##sis', 'pharmaceutical', 'present', 'upcoming', 'industry', 'and', 'investment', 'conference']",1
126452,nifty_376,2011-11-22,"The Zacks Analyst Blog Highlights: Gilead Sciences, Pharmasset, Nasdaq Biotechnology ETF, InterMune and Dendreon",Fall,-0.0221,112,the zacks analyst blog highlight gilead science pharmasset nasdaq biotechnology etf intermune and dendreon,106,14,0,pharmacy,"['the', 'z', '##ack', '##s', 'analyst', 'blog', 'highlight', 'g', '##ile', '##ad', 'science', 'p', '##har', '##mass', '##et', 'na', '##s', '##da', '##q', 'bio', '##tech', '##nology', 'et', '##f', 'inter', '##mu', '##ne', 'and', 'den', '##dre', '##on']",1
126503,nifty_376,2011-11-22,Research and Markets: BioImaging Technologies - Global Strategic Business Report,Fall,-0.0221,80,research and market bioimaging technology global strategic business report,74,9,0,pharmacy,"['research', 'and', 'market', 'bio', '##ima', '##ging', 'technology', 'global', 'strategic', 'business', 'report']",1
126518,nifty_376,2011-11-22,"Research and Markets: Coagulation Factors 2011 - Who does meet the market needs? A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis",Fall,-0.0221,150,research and market coagulation factor who doe meet the market need pipeline assessment market survey and corporate benchmark analysis,134,19,0,pharmacy,"['research', 'and', 'market', 'co', '##agu', '##lation', 'factor', 'who', 'do', '##e', 'meet', 'the', 'market', 'need', 'pipeline', 'assessment', 'market', 'survey', 'and', 'corporate', 'bench', '##mark', 'analysis']",1
126602,nifty_376,2011-11-22,Research and Markets: Healthcare IT Market Outlook in Israel to 2017 - Hospital Information Systems and Medical Imaging Information Systems,Fall,-0.0221,139,research and market healthcare market outlook israel hospital information system and medical imaging information system,119,15,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'market', 'outlook', 'is', '##rae', '##l', 'hospital', 'information', 'system', 'and', 'medical', 'imaging', 'information', 'system']",1
126603,nifty_376,2011-11-22,"Research and Markets: Netherlands Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others",Fall,-0.0221,214,research and market netherlands diagnostic imaging market outlook ultrasound system mri system computed tomography system nuclear imaging equipment ray system mammography equipment and others,191,24,0,pharmacy,"['research', 'and', 'market', 'net', '##her', '##lands', 'diagnostic', 'imaging', 'market', 'outlook', 'ultra', '##sound', 'system', 'm', '##ri', 'system', 'com', '##puted', 'to', '##mo', '##graphy', 'system', 'nuclear', 'imaging', 'equipment', 'ray', 'system', 'ma', '##mm', '##ography', 'equipment', 'and', 'others']",1
126729,nifty_376,2011-11-22,"Research and Markets: X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017",Fall,-0.0221,114,research and market ray system global pipeline analysis competitive landscape and market forecast,97,13,0,pharmacy,"['research', 'and', 'market', 'ray', 'system', 'global', 'pipeline', 'analysis', 'competitive', 'landscape', 'and', 'market', 'forecast']",1
126730,nifty_376,2011-11-22,Research and Markets: Bipolar Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2018,Fall,-0.0221,102,research and market bipolar disorder therapeutic pipeline assessment and market forecast,88,11,0,pharmacy,"['research', 'and', 'market', 'bi', '##pol', '##ar', 'disorder', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
126738,nifty_376,2011-11-22,"'The Global Leaders' Seek Solutions to Healthcare Crisis by Bringing Together Investors With CEOs in Healthcare, Biotech and Pharma",Fall,-0.0221,131,the global leader seek solution healthcare crisis bringing together investor with ceo healthcare biotech and pharma,115,16,0,pharmacy,"['the', 'global', 'leader', 'seek', 'solution', 'healthcare', 'crisis', 'bringing', 'together', 'investor', 'with', 'c', '##eo', 'healthcare', 'bio', '##tech', 'and', 'p', '##har', '##ma']",1
126742,nifty_376,2011-11-22,Research and Markets: Europe Diagnostic Imaging Market Outlook to 2017,Fall,-0.0221,70,research and market europe diagnostic imaging market outlook,60,8,0,pharmacy,"['research', 'and', 'market', 'euro', '##pe', 'diagnostic', 'imaging', 'market', 'outlook']",1
126754,nifty_376,2011-11-22,Research and Markets: Medical Technology Report 2011: International Investment Strategies and Location Benchmarking Study,Fall,-0.0221,121,research and market medical technology report international investment strategy and location benchmarking study,111,13,0,pharmacy,"['research', 'and', 'market', 'medical', 'technology', 'report', 'international', 'investment', 'strategy', 'and', 'location', 'bench', '##mark', '##ing', 'study']",1
126767,nifty_376,2011-11-22,"Research and Markets: Comprehensive Biomaterials - Analyzing Strengths, Weaknesses, Performance as Well as Future Prospects",Fall,-0.0221,123,research and market comprehensive biomaterials analyzing strength weakness performance well future prospect,107,12,0,pharmacy,"['research', 'and', 'market', 'comprehensive', 'bio', '##mate', '##rial', '##s', 'analyzing', 'strength', 'weakness', 'performance', 'well', 'future', 'prospect']",1
126770,nifty_376,2011-11-22,BIO Announces Presenting Companies for 14th Annual BIO CEO & Investor Conference,Fall,-0.0221,80,bio announces presenting company for annual bio ceo investor conference,71,10,0,pharmacy,"['bio', 'announces', 'presenting', 'company', 'for', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
126816,nifty_376,2011-11-22,Research and Markets: United States and Canada Healthcare IT Market Outlook to 2017,Fall,-0.0221,83,research and market united state and canada healthcare market outlook,69,10,0,pharmacy,"['research', 'and', 'market', 'united', 'state', 'and', 'can', '##ada', 'healthcare', 'market', 'outlook']",1
126829,nifty_376,2011-11-22,Research and Markets: Polycystic Ovarian Syndrome (PCOS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018,Fall,-0.0221,120,research and market polycystic ovarian syndrome pcos therapeutic pipeline assessment and market forecast,104,13,0,pharmacy,"['research', 'and', 'market', 'p', '##oly', '##cy', '##stic', 'o', '##var', '##ian', 'syndrome', 'p', '##cos', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
126847,nifty_376,2011-11-22,Research and Markets: Pneumonia Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Featuring Basilea Pharmaceutica Ltd. and Pfizer Inc.,Fall,-0.0221,148,research and market pneumonia therapeutic pipeline assessment and market forecast featuring basilea pharmaceutica ltd and pfizer inc,132,17,0,pharmacy,"['research', 'and', 'market', 'pneumonia', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast', 'featuring', 'b', '##asi', '##lea', 'p', '##har', '##ma', '##ce', '##uti', '##ca', 'l', '##t', '##d', 'and', 'p', '##fi', '##zer', 'in', '##c']",1
126855,nifty_376,2011-11-22,Research and Markets: Canada Nuclear Imaging - Market Trend Till 2016 and Contains Market Share of Companies Provided For 2010,Fall,-0.0221,126,research and market canada nuclear imaging market trend till and contains market share company provided for,107,16,0,pharmacy,"['research', 'and', 'market', 'can', '##ada', 'nuclear', 'imaging', 'market', 'trend', 'till', 'and', 'contains', 'market', 'share', 'company', 'provided', 'for']",1
127617,nifty_381,2011-12-05,"Research and Markets: Triple Analysis: Breast Cancer, Lung Cancer and Protein Kinase Inhibitors",Neutral,0.0003,95,research and market triple analysis breast cancer lung cancer and protein kinase inhibitor,90,13,0,pharmacy,"['research', 'and', 'market', 'triple', 'analysis', 'breast', 'cancer', 'lung', 'cancer', 'and', 'protein', 'kinase', 'inhibitor']",1
127630,nifty_381,2011-12-05,"Research and Markets: Triple Analysis: Breast Cancer, Lymphoma and Prostate Cancer",Neutral,0.0003,82,research and market triple analysis breast cancer lymphoma and prostate cancer,78,11,0,pharmacy,"['research', 'and', 'market', 'triple', 'analysis', 'breast', 'cancer', 'l', '##ymph', '##oma', 'and', 'pro', '##state', 'cancer']",1
127651,nifty_381,2011-12-05,"Research and Markets: Biorepositories: Technologies & Ownership - A Global Market Watch, 2009-2015",Neutral,0.0003,98,research and market biorepositories technology ownership global market watch,76,9,0,pharmacy,"['research', 'and', 'market', 'bio', '##re', '##po', '##si', '##tor', '##ies', 'technology', 'ownership', 'global', 'market', 'watch']",1
127868,nifty_381,2011-12-05,"Express Scripts and Medco Save Americans Tens of Billions in Healthcare Costs, New Economic Report Shows",Neutral,0.0003,104,express script and medco save american ten billion healthcare cost new economic report show,91,14,0,pharmacy,"['express', 'script', 'and', 'me', '##d', '##co', 'save', 'am', '##eric', '##an', 'ten', 'billion', 'healthcare', 'cost', 'new', 'economic', 'report', 'show']",1
127871,nifty_381,2011-12-05,Research and Markets: What does Today's Data Say about Tomorrow's Weight Management Market?,Neutral,0.0003,91,research and market what doe today data say about tomorrow weight management market,83,13,0,pharmacy,"['research', 'and', 'market', 'what', 'do', '##e', 'today', 'data', 'say', 'about', 'tomorrow', 'weight', 'management', 'market']",1
127961,nifty_381,2011-12-05,Leading Indian CRO 'Max Neeman International' Expands in Response to Positive Biosimilars Market in India,Neutral,0.0003,105,leading indian cro max neeman international expands response positive biosimilars market india,94,12,0,pharmacy,"['leading', 'in', '##dian', 'c', '##ro', 'ma', '##x', 'ne', '##eman', 'international', 'expands', 'response', 'positive', 'bio', '##si', '##mi', '##lars', 'market', 'in', '##dia']",1
127978,nifty_381,2011-12-05,FDA sees huge opportunities in opening up drug data,Neutral,0.0003,51,fda see huge opportunity opening drug data,42,7,0,pharmacy,"['f', '##da', 'see', 'huge', 'opportunity', 'opening', 'drug', 'data']",1
128019,nifty_381,2011-12-05,"Despite the Generic Erosion of Key Agents, the Non-Small-Cell Lung Cancer Drug Market Will Increase 2.5 Percent Annually Between 2010 and 2020",Neutral,0.0003,142,despite the generic erosion key agent the non small cell lung cancer drug market will increase percent annually between and,123,20,0,pharmacy,"['despite', 'the', 'generic', 'erosion', 'key', 'agent', 'the', 'non', 'small', 'cell', 'lung', 'cancer', 'drug', 'market', 'will', 'increase', 'percent', 'annually', 'between', 'and']",1
128069,nifty_381,2011-12-05,"Research and Markets: ABC of Intensive Care, 2nd Edition",Neutral,0.0003,56,research and market abc intensive care edition,46,7,0,pharmacy,"['research', 'and', 'market', 'a', '##b', '##c', 'intensive', 'care', 'edition']",1
128107,nifty_381,2011-12-05,"Research and Markets: Psychological Recovery: Beyond Mental Illness. A Consumer-oriented, Stage-based Model",Neutral,0.0003,107,research and market psychological recovery beyond mental illness consumer oriented stage based model,100,13,0,pharmacy,"['research', 'and', 'market', 'psychological', 'recovery', 'beyond', 'mental', 'illness', 'consumer', 'oriented', 'stage', 'based', 'model']",1
128128,nifty_381,2011-12-05,"BSI Healthcare Services Leverages Expertise, Creates New Focused Organization",Neutral,0.0003,77,bsi healthcare service leverage expertise creates new focused organization,74,9,0,pharmacy,"['b', '##si', 'healthcare', 'service', 'leverage', 'expertise', 'creates', 'new', 'focused', 'organization']",1
128170,nifty_381,2011-12-05,Research and Markets: Epistemology of the Cell: A Systems Perspective on Biological Knowledge,Neutral,0.0003,93,research and market epistemology the cell system perspective biological knowledge,81,10,0,pharmacy,"['research', 'and', 'market', 'e', '##pis', '##tem', '##ology', 'the', 'cell', 'system', 'perspective', 'biological', 'knowledge']",1
128181,nifty_381,2011-12-05,"Research and Markets: Increasing Healthcare Infrastructure to Fuel Growth in the Medical Device Market, Finds Netscribes",Neutral,0.0003,120,research and market increasing healthcare infrastructure fuel growth the medical device market find netscribes,110,14,0,pharmacy,"['research', 'and', 'market', 'increasing', 'healthcare', 'infrastructure', 'fuel', 'growth', 'the', 'medical', 'device', 'market', 'find', 'nets', '##cribe', '##s']",1
128223,nifty_381,2011-12-05,Research and Markets: Medistat Interactive Market Evaluator Additional License - Analyse Medical Technology Markets Worldwide with a Discount Subscription,Neutral,0.0003,154,research and market medistat interactive market evaluator additional license analyse medical technology market worldwide with discount subscription,147,17,0,pharmacy,"['research', 'and', 'market', 'me', '##dis', '##tat', 'interactive', 'market', 'e', '##val', '##ua', '##tor', 'additional', 'license', 'anal', '##ys', '##e', 'medical', 'technology', 'market', 'worldwide', 'with', 'discount', 'subscription']",1
128527,nifty_384,2011-12-08,"GE, Microsoft in healthcare software joint venture",Rise,0.0169,50,microsoft healthcare software joint venture,43,5,0,pharmacy,"['micro', '##so', '##ft', 'healthcare', 'software', 'joint', 'venture']",1
128528,nifty_384,2011-12-08,"GE, Microsoft to Launch Joint Venture Aimed at Global Healthcare System Transformation",Rise,0.0169,86,microsoft launch joint venture aimed global healthcare system transformation,76,9,0,pharmacy,"['micro', '##so', '##ft', 'launch', 'joint', 'venture', 'aimed', 'global', 'healthcare', 'system', 'transformation']",1
128658,nifty_384,2011-12-08,UPDATE 1-Britain set to investigate private healthcare market,Rise,0.0169,61,update britain set investigate private healthcare market,56,7,0,pharmacy,"['update', 'br', '##ita', '##in', 'set', 'investigate', 'private', 'healthcare', 'market']",1
128721,nifty_384,2011-12-08,"Research and Markets: Triple Analysis: Lung Cancer, Pancreatic Cancer and Prostate Cancer",Rise,0.0169,89,research and market triple analysis lung cancer pancreatic cancer and prostate cancer,85,12,0,pharmacy,"['research', 'and', 'market', 'triple', 'analysis', 'lung', 'cancer', 'pan', '##cre', '##atic', 'cancer', 'and', 'pro', '##state', 'cancer']",1
128731,nifty_384,2011-12-08,"Research and Markets: Triple Analysis: Colorectal Cancer, Prostate Cancer and Peptides",Rise,0.0169,86,research and market triple analysis colorectal cancer prostate cancer and peptide,81,11,0,pharmacy,"['research', 'and', 'market', 'triple', 'analysis', 'color', '##ec', '##tal', 'cancer', 'pro', '##state', 'cancer', 'and', 'p', '##eptide']",1
128866,nifty_384,2011-12-08,Research and Markets: Medistat Interactive Market Evaluator Middle East/Africa. Taking Medical Market Analysis to a New Level,Rise,0.0169,125,research and market medistat interactive market evaluator middle east africa taking medical market analysis new level,117,16,0,pharmacy,"['research', 'and', 'market', 'me', '##dis', '##tat', 'interactive', 'market', 'e', '##val', '##ua', '##tor', 'middle', 'east', 'a', '##f', '##rica', 'taking', 'medical', 'market', 'analysis', 'new', 'level']",1
128961,nifty_384,2011-12-08,"IGI Laboratories, Inc. and Medimetriks Pharmaceuticals, Inc. Enter Long Term Strategic Partnership",Rise,0.0169,98,igi laboratory inc and medimetriks pharmaceutical inc enter long term strategic partnership,91,12,0,pharmacy,"['i', '##gi', 'laboratory', 'in', '##c', 'and', 'me', '##di', '##met', '##rik', '##s', 'pharmaceutical', 'in', '##c', 'enter', 'long', 'term', 'strategic', 'partnership']",1
129045,nifty_384,2011-12-08,"Research and Markets: Future Cell Surface Markers: US, Europe, Japan - lab practices, forecasts, leading suppliers, market strategies and more...",Rise,0.0169,145,research and market future cell surface marker europe japan lab practice forecast leading supplier market strategy and more,123,18,0,pharmacy,"['research', 'and', 'market', 'future', 'cell', 'surface', 'marker', 'euro', '##pe', 'j', '##apa', '##n', 'lab', 'practice', 'forecast', 'leading', 'supplier', 'market', 'strategy', 'and', 'more']",1
129084,nifty_384,2011-12-08,Genesis Biopharma to Host Investor Meetings in San Francisco in January 2012,Rise,0.0169,76,genesis biopharma host investor meeting san francisco january,61,8,0,pharmacy,"['genes', '##is', 'bio', '##pha', '##rma', 'host', 'investor', 'meeting', 'sa', '##n', 'f', '##ran', '##cis', '##co', 'j', '##anu', '##ary']",1
129150,nifty_384,2011-12-08,Drug Development Outsourcing Reviewed in New Market Research Report Published at MarketPublishers.com,Rise,0.0169,101,drug development outsourcing reviewed new market research report published marketpublishers com,95,11,0,pharmacy,"['drug', 'development', 'outs', '##our', '##cing', 'reviewed', 'new', 'market', 'research', 'report', 'published', 'market', '##pu', '##b', '##lish', '##ers', 'com']",1
129215,nifty_384,2011-12-08,UPDATE 1-Bio-Reference Labs Q4 beats market estimates,Rise,0.0169,53,update bio reference lab beat market estimate,45,7,0,pharmacy,"['update', 'bio', 'reference', 'lab', 'beat', 'market', 'estimate']",1
129229,nifty_384,2011-12-08,Research and Markets: Top 50 Pharmaceutical Companies & Their Pipelines 2011,Rise,0.0169,76,research and market top pharmaceutical company their pipeline,61,8,0,pharmacy,"['research', 'and', 'market', 'top', 'pharmaceutical', 'company', 'their', 'pipeline']",1
129235,nifty_384,2011-12-08,Research and Markets: Emerging Cancer Diagnostic Tests and Companies Developing New Technologies - 2011 Report Presents an Overview of the Clinical Significance and Market Needs,Rise,0.0169,177,research and market emerging cancer diagnostic test and company developing new technology report present overview the clinical significance and market need,155,21,0,pharmacy,"['research', 'and', 'market', 'emerging', 'cancer', 'diagnostic', 'test', 'and', 'company', 'developing', 'new', 'technology', 'report', 'present', 'overview', 'the', 'clinical', 'significance', 'and', 'market', 'need']",1
129256,nifty_384,2011-12-08,Research and Markets: Eircom Group plc - Company Capsule - 2011 Is a Crucial Resource for Industry Executives and Anyone Looking To Access Key Information about Eircom Group Plc,Rise,0.0169,177,research and market eircom group plc company capsule crucial resource for industry executive and anyone looking access key information about eircom group plc,157,23,0,pharmacy,"['research', 'and', 'market', 'e', '##ir', '##com', 'group', 'plc', 'company', 'capsule', 'crucial', 'resource', 'for', 'industry', 'executive', 'and', 'anyone', 'looking', 'access', 'key', 'information', 'about', 'e', '##ir', '##com', 'group', 'plc']",1
129260,nifty_384,2011-12-08,"Research and Markets: Global Diagnostic Imaging Companies: M&As;, Joint Ventures, R&D; Pipeline, and Strategies",Rise,0.0169,111,research and market global diagnostic imaging company joint venture pipeline and strategy,89,12,0,pharmacy,"['research', 'and', 'market', 'global', 'diagnostic', 'imaging', 'company', 'joint', 'venture', 'pipeline', 'and', 'strategy']",1
129262,nifty_384,2011-12-08,The Renal Cell Carcinoma Drug Market Will Experience Robust 3.7 Percent Annual Growth from 2010 to 2020,Rise,0.0169,103,the renal cell carcinoma drug market will experience robust percent annual growth from,86,13,0,pharmacy,"['the', 're', '##nal', 'cell', 'car', '##cin', '##oma', 'drug', 'market', 'will', 'experience', 'robust', 'percent', 'annual', 'growth', 'from']",1
129362,nifty_384,2011-12-08,Research and Markets: Comprehensive Biotechnology,Rise,0.0169,49,research and market comprehensive biotechnology,47,5,0,pharmacy,"['research', 'and', 'market', 'comprehensive', 'bio', '##tech', '##nology']",1
130033,nifty_388,2011-12-15,"Research and Markets: Panic Disorders - Pipeline Review, H2 2011 - A snapshot of the global therapeutic scenario for Panic Disorders",Neutral,-0.0048,132,research and market panic disorder pipeline review snapshot the global therapeutic scenario for panic disorder,110,15,0,pharmacy,"['research', 'and', 'market', 'panic', 'disorder', 'pipeline', 'review', 'snaps', '##hot', 'the', 'global', 'therapeutic', 'scenario', 'for', 'panic', 'disorder']",1
130037,nifty_388,2011-12-15,"Research and Markets: Cellulite - Pipeline Review, H2 2011 - A snapshot of the global therapeutic scenario for Cellulite",Neutral,-0.0048,120,research and market cellulite pipeline review snapshot the global therapeutic scenario for cellulite,100,13,0,pharmacy,"['research', 'and', 'market', 'cell', '##uli', '##te', 'pipeline', 'review', 'snaps', '##hot', 'the', 'global', 'therapeutic', 'scenario', 'for', 'cell', '##uli', '##te']",1
130046,nifty_388,2011-12-15,"Research and Markets: Biobanking Global Market Report (2009-2015): public, private, academic, disease-based and more",Neutral,-0.0048,116,research and market biobanking global market report public private academic disease based and more,98,14,0,pharmacy,"['research', 'and', 'market', 'bio', '##bank', '##ing', 'global', 'market', 'report', 'public', 'private', 'academic', 'disease', 'based', 'and', 'more']",1
130049,nifty_388,2011-12-15,"Research and Markets: Biobanking End-Users Global Market Report (2009-2015): pharmaceuticals, biotechnology, personal care, petrochemicals and more",Neutral,-0.0048,147,research and market biobanking end user global market report pharmaceutical biotechnology personal care petrochemical and more,126,16,0,pharmacy,"['research', 'and', 'market', 'bio', '##bank', '##ing', 'end', 'user', 'global', 'market', 'report', 'pharmaceutical', 'bio', '##tech', '##nology', 'personal', 'care', 'pet', '##ro', '##chemical', 'and', 'more']",1
130144,nifty_388,2011-12-15,Covidien Plans Spin-Off of Pharmaceuticals Business,Neutral,-0.0048,51,covidien plan spin off pharmaceutical business,46,6,0,pharmacy,"['co', '##vid', '##ien', 'plan', 'spin', 'off', 'pharmaceutical', 'business']",1
130288,nifty_388,2011-12-15,"Research and Markets: Auto Inflammatory Disease - Pipeline Review, H2 2011 - A snapshot of the global therapeutic scenario for Auto Inflammatory Disease",Neutral,-0.0048,152,research and market auto inflammatory disease pipeline review snapshot the global therapeutic scenario for auto inflammatory disease,132,17,0,pharmacy,"['research', 'and', 'market', 'auto', 'inflammatory', 'disease', 'pipeline', 'review', 'snaps', '##hot', 'the', 'global', 'therapeutic', 'scenario', 'for', 'auto', 'inflammatory', 'disease']",1
130311,nifty_388,2011-12-15,"Research and Markets: Cardiogenic Shock - Pipeline Review, H2 2011 - A snapshot of the global therapeutic scenario for Cardiogenic Shock",Neutral,-0.0048,136,research and market cardiogenic shock pipeline review snapshot the global therapeutic scenario for cardiogenic shock,116,15,0,pharmacy,"['research', 'and', 'market', 'card', '##io', '##genic', 'shock', 'pipeline', 'review', 'snaps', '##hot', 'the', 'global', 'therapeutic', 'scenario', 'for', 'card', '##io', '##genic', 'shock']",1
130319,nifty_388,2011-12-15,Atlas Venture and Shire Enter Alliance to Invest in Innovative Early-Stage Rare Disease Therapies,Neutral,-0.0048,97,atlas venture and shire enter alliance invest innovative early stage rare disease therapy,89,13,0,pharmacy,"['at', '##las', 'venture', 'and', 's', '##hire', 'enter', 'alliance', 'invest', 'innovative', 'early', 'stage', 'rare', 'disease', 'therapy']",1
130426,nifty_388,2011-12-15,Research and Markets: Stem Cells in Regenerative Medicine: Benchmarking Analysis of Big Companies Entering the Market,Neutral,-0.0048,117,research and market stem cell regenerative medicine benchmarking analysis big company entering the market,105,14,0,pharmacy,"['research', 'and', 'market', 'stem', 'cell', 're', '##gene', '##rative', 'medicine', 'bench', '##mark', '##ing', 'analysis', 'big', 'company', 'entering', 'the', 'market']",1
130567,nifty_388,2011-12-15,Research and Markets: Botulinum Toxin - Global Strategic Business Report with 19 Company Profiles Including Many Key Players,Neutral,-0.0048,124,research and market botulinum toxin global strategic business report with company profile including many key player,115,16,0,pharmacy,"['research', 'and', 'market', 'b', '##ot', '##ulin', '##um', 'to', '##xin', 'global', 'strategic', 'business', 'report', 'with', 'company', 'profile', 'including', 'many', 'key', 'player']",1
130628,nifty_388,2011-12-15,"Covidien to spin off pharma business, shares jump",Neutral,-0.0048,49,covidien spin off pharma business share jump,44,7,0,pharmacy,"['co', '##vid', '##ien', 'spin', 'off', 'p', '##har', '##ma', 'business', 'share', 'jump']",1
131206,nifty_391,2011-12-21,"Research and Markets: Pharmaceutical Digital Marketing and Social Media: Managing Growth, Mitigating Risk and Mastering Strategy",Rise,0.0089,128,research and market pharmaceutical digital marketing and social medium managing growth mitigating risk and mastering strategy,125,16,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'digital', 'marketing', 'and', 'social', 'medium', 'managing', 'growth', 'mit', '##iga', '##ting', 'risk', 'and', 'mastering', 'strategy']",1
131220,nifty_391,2011-12-21,"Research and Markets: Diastolic Heart Failure Global Clinical Trials Review, H2, 2011",Rise,0.0089,85,research and market diastolic heart failure global clinical trial review,72,10,0,pharmacy,"['research', 'and', 'market', 'di', '##ast', '##olic', 'heart', 'failure', 'global', 'clinical', 'trial', 'review']",1
131249,nifty_391,2011-12-21,Research and Markets: Company Scan: Alembic Pharmaceuticals Ltd,Rise,0.0089,63,research and market company scan alembic pharmaceutical ltd,59,8,0,pharmacy,"['research', 'and', 'market', 'company', 'scan', 'ale', '##mb', '##ic', 'pharmaceutical', 'l', '##t', '##d']",1
131390,nifty_391,2011-12-21,Allos Therapeutics Invites Investors to Listen to Webcast of Presentation at J.P. Morgan Healthcare Conference,Rise,0.0089,110,allos therapeutic invite investor listen webcast presentation morgan healthcare conference,90,10,0,pharmacy,"['all', '##os', 'therapeutic', 'invite', 'investor', 'listen', 'web', '##cast', 'presentation', 'm', '##or', '##gan', 'healthcare', 'conference']",1
131398,nifty_391,2011-12-21,Research and Markets: Zicronapine - Analysis and Forecasts from 2014 to 2020,Rise,0.0089,76,research and market zicronapine analysis and forecast from,58,8,0,pharmacy,"['research', 'and', 'market', 'z', '##ic', '##rona', '##pine', 'analysis', 'and', 'forecast', 'from']",1
131438,nifty_391,2011-12-21,Cardium and SourceOne Global Partners Enter Into Cross-Strategic Equity Investment with Plans to Jointly Develop Nutritional Supplements and Medical Foods,Rise,0.0089,154,cardium and sourceone global partner enter into cross strategic equity investment with plan jointly develop nutritional supplement and medical food,147,20,0,pharmacy,"['card', '##ium', 'and', 'source', '##one', 'global', 'partner', 'enter', 'into', 'cross', 'strategic', 'equity', 'investment', 'with', 'plan', 'jointly', 'develop', 'nutrition', '##al', 'supplement', 'and', 'medical', 'food']",1
131450,nifty_391,2011-12-21,Five Hospital Business Development Trends to Watch in 2012,Rise,0.0089,58,five hospital business development trend watch,46,6,0,pharmacy,"['five', 'hospital', 'business', 'development', 'trend', 'watch']",1
131535,nifty_391,2011-12-21,"Research and Markets: Fragile X Syndrome - Pipeline Review, H2 2011",Rise,0.0089,67,research and market fragile syndrome pipeline review,52,7,0,pharmacy,"['research', 'and', 'market', 'fragile', 'syndrome', 'pipeline', 'review']",1
131547,nifty_391,2011-12-21,"Research and Markets: Paralysis Global Clinical Trials Review, H2, 2011",Rise,0.0089,71,research and market paralysis global clinical trial review,58,8,0,pharmacy,"['research', 'and', 'market', 'para', '##lysis', 'global', 'clinical', 'trial', 'review']",1
131560,nifty_391,2011-12-21,"Research and Markets: Anal Fissure Global Clinical Trials Review, H2, 2011",Rise,0.0089,74,research and market anal fissure global clinical trial review,61,9,0,pharmacy,"['research', 'and', 'market', 'anal', 'fi', '##ss', '##ure', 'global', 'clinical', 'trial', 'review']",1
131656,nifty_391,2011-12-21,"Healthcare, Biotech and Pharmaceutical Leaders to Meet With Investors in Search of Breakthrough Business Solutions at 'The Global Leaders Healthcare Forum' in San Francisco January 10",Rise,0.0089,183,healthcare biotech and pharmaceutical leader meet with investor search breakthrough business solution the global leader healthcare forum san francisco january,158,20,0,pharmacy,"['healthcare', 'bio', '##tech', 'and', 'pharmaceutical', 'leader', 'meet', 'with', 'investor', 'search', 'breakthrough', 'business', 'solution', 'the', 'global', 'leader', 'healthcare', 'forum', 'sa', '##n', 'f', '##ran', '##cis', '##co', 'j', '##anu', '##ary']",1
131657,nifty_391,2011-12-21,Research and Markets: Global Regenerative Medicine Market,Rise,0.0089,57,research and market global regenerative medicine market,55,7,0,pharmacy,"['research', 'and', 'market', 'global', 're', '##gene', '##rative', 'medicine', 'market']",1
131770,nifty_391,2011-12-21,Research and Markets: Turkey Pharmaceuticals and Healthcare Report Q1 2012,Rise,0.0089,74,research and market turkey pharmaceutical and healthcare report,63,8,0,pharmacy,"['research', 'and', 'market', 'turkey', 'pharmaceutical', 'and', 'healthcare', 'report']",1
131799,nifty_391,2011-12-21,"Emergent BioSolutions Announces Fuad El-Hibri to Retire as CEO, Remain as Executive Chairman of the Board of Directors Focused on Corporate Strategy and M&A; Opportunities",Rise,0.0089,171,emergent biosolutions announces fuad hibri retire ceo remain executive chairman the board director focused corporate strategy and opportunity,141,18,0,pharmacy,"['emerge', '##nt', 'bio', '##sol', '##ution', '##s', 'announces', 'f', '##uad', 'hi', '##bri', 'retire', 'c', '##eo', 'remain', 'executive', 'chairman', 'the', 'board', 'director', 'focused', 'corporate', 'strategy', 'and', 'opportunity']",1
132539,nifty_394,2011-12-28,Celgene Corporation to Present at Two Upcoming Investor Conferences,Rise,0.0103,67,celgene corporation present two upcoming investor conference,60,7,0,pharmacy,"['c', '##el', '##gene', 'corporation', 'present', 'two', 'upcoming', 'investor', 'conference']",1
132774,nifty_394,2011-12-28,Epicore BioNetworks Inc. Strong Start to Fiscal Year 2012,Rise,0.0103,57,epicore bionetworks inc strong start fiscal year,48,7,0,pharmacy,"['epic', '##ore', 'bio', '##net', '##works', 'in', '##c', 'strong', 'start', 'fiscal', 'year']",1
133336,nifty_399,2012-01-09,SK Capital and IBA Join to Accelerate Growth of IBA Molecular Imaging,Rise,0.0087,69,capital and iba join accelerate growth iba molecular imaging,60,9,0,pharmacy,"['capital', 'and', 'i', '##ba', 'join', 'accelerate', 'growth', 'i', '##ba', 'molecular', 'imaging']",1
133395,nifty_399,2012-01-09,Amicus Therapeutics Provides Full-Year 2012 Strategic Outlook and Financial Guidance,Rise,0.0087,84,amicus therapeutic provides full year strategic outlook and financial guidance,78,10,0,pharmacy,"['am', '##icus', 'therapeutic', 'provides', 'full', 'year', 'strategic', 'outlook', 'and', 'financial', 'guidance']",1
133401,nifty_399,2012-01-09,AMAG Pharmaceuticals Provides Business Update,Rise,0.0087,45,amag pharmaceutical provides business update,44,5,0,pharmacy,"['am', '##ag', 'pharmaceutical', 'provides', 'business', 'update']",1
133444,nifty_399,2012-01-09,Next IT Expands Bench of Pharmaceutical Industry Expertise,Rise,0.0087,58,next expands bench pharmaceutical industry expertise,52,6,0,pharmacy,"['next', 'expands', 'bench', 'pharmaceutical', 'industry', 'expertise']",1
133445,nifty_399,2012-01-09,ManTech Enters the Healthcare IT Market with Acquisition of Evolvent Technologies,Rise,0.0087,81,mantech enters the healthcare market with acquisition evolvent technology,73,9,0,pharmacy,"['man', '##tech', 'enters', 'the', 'healthcare', 'market', 'with', 'acquisition', 'evolve', '##nt', 'technology']",1
133456,nifty_399,2012-01-09,Unprecedented Technology Reads & Reacts to Brainwaves Through the Extremities of the Body,Rise,0.0087,89,unprecedented technology read reacts brainwave through the extremity the body,77,10,0,pharmacy,"['unprecedented', 'technology', 'read', 'react', '##s', 'brain', '##wave', 'through', 'the', 'ex', '##tre', '##mity', 'the', 'body']",1
133460,nifty_399,2012-01-09,Research and Markets: Healthcare IT Market Outlook in New Zealand to 2017 - Hospital Information Systems and Medical Imaging Information Systems,Rise,0.0087,144,research and market healthcare market outlook new zealand hospital information system and medical imaging information system,124,16,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'market', 'outlook', 'new', 'z', '##eal', '##and', 'hospital', 'information', 'system', 'and', 'medical', 'imaging', 'information', 'system']",1
133507,nifty_399,2012-01-09,Research and Markets: India Patient Monitoring Market Outlook to 2017,Rise,0.0087,69,research and market india patient monitoring market outlook,59,8,0,pharmacy,"['research', 'and', 'market', 'in', '##dia', 'patient', 'monitoring', 'market', 'outlook']",1
133509,nifty_399,2012-01-09,Open Solutions` Revolutionary DNAappstore Propels Sales of DNA Core Banking Platform,Rise,0.0087,84,open solution revolutionary dnaappstore propels sale dna core banking platform,78,10,0,pharmacy,"['open', 'solution', 'revolutionary', 'd', '##na', '##ap', '##ps', '##tore', 'prop', '##els', 'sale', 'd', '##na', 'core', 'banking', 'platform']",1
133510,nifty_399,2012-01-09,AsepticSure Patent Protection Program Expanded -- Superbugs In Five Countries Get Nervous,Rise,0.0087,89,asepticsure patent protection program expanded superbug five country get nervous,80,10,0,pharmacy,"['as', '##ept', '##ics', '##ure', 'patent', 'protection', 'program', 'expanded', 'superb', '##ug', 'five', 'country', 'get', 'nervous']",1
133542,nifty_399,2012-01-09,e-Therapeutics Outlines Goals for 2012 and Announces Presentation at Biotech Showcase Conference,Rise,0.0087,96,therapeutic outline goal for and announces presentation biotech showcase conference,83,10,0,pharmacy,"['therapeutic', 'outline', 'goal', 'for', 'and', 'announces', 'presentation', 'bio', '##tech', 'showcase', 'conference']",1
133552,nifty_399,2012-01-09,"WuXi PharmaTech Provides Update of 2011 Financial Guidance, to Present at J.P. Morgan Healthcare Conference",Rise,0.0087,107,wuxi pharmatech provides update financial guidance present morgan healthcare conference,87,10,0,pharmacy,"['w', '##ux', '##i', 'p', '##har', '##mate', '##ch', 'provides', 'update', 'financial', 'guidance', 'present', 'm', '##or', '##gan', 'healthcare', 'conference']",1
133588,nifty_399,2012-01-09,Merit Medical to Present at Noble Financial Capital Markets' Equity Conference,Rise,0.0087,78,merit medical present noble financial capital market equity conference,70,9,0,pharmacy,"['merit', 'medical', 'present', 'noble', 'financial', 'capital', 'market', 'equity', 'conference']",1
133611,nifty_399,2012-01-09,Research and Markets: Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years,Rise,0.0087,176,research and market private equity and venture capital activity medical device number investment smaller company ha increased over the past four year,149,22,0,pharmacy,"['research', 'and', 'market', 'private', 'equity', 'and', 'venture', 'capital', 'activity', 'medical', 'device', 'number', 'investment', 'smaller', 'company', 'ha', 'increased', 'over', 'the', 'past', 'four', 'year']",1
133612,nifty_399,2012-01-09,"Research and Markets: Critical Care Market to 2017 - Shift of Focus towards PCC, Factor Concentrates and Antithrombins due to Better Safety and Efficacy Profiles",Rise,0.0087,161,research and market critical care market shift focus towards pcc factor concentrate and antithrombins due better safety and efficacy profile,140,20,0,pharmacy,"['research', 'and', 'market', 'critical', 'care', 'market', 'shift', 'focus', 'towards', 'p', '##cc', 'factor', 'concentrate', 'and', 'anti', '##th', '##rom', '##bin', '##s', 'due', 'better', 'safety', 'and', 'efficacy', 'profile']",1
133629,nifty_399,2012-01-09,Research and Markets: Drug Discovery and Preclinical Molecules by Therapy Area - Innovation Focuses on Stem Cell Therapies and Gene Therapies,Rise,0.0087,141,research and market drug discovery and preclinical molecule therapy area innovation focus stem cell therapy and gene therapy,124,18,0,pharmacy,"['research', 'and', 'market', 'drug', 'discovery', 'and', 'pre', '##c', '##lini', '##cal', 'molecule', 'therapy', 'area', 'innovation', 'focus', 'stem', 'cell', 'therapy', 'and', 'gene', 'therapy']",1
133668,nifty_399,2012-01-09,"Research and Markets: Mexico Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others",Rise,0.0087,209,research and market mexico diagnostic imaging market outlook ultrasound system mri system computed tomography system nuclear imaging equipment ray system mammography equipment and others,186,24,0,pharmacy,"['research', 'and', 'market', 'me', '##xi', '##co', 'diagnostic', 'imaging', 'market', 'outlook', 'ultra', '##sound', 'system', 'm', '##ri', 'system', 'com', '##puted', 'to', '##mo', '##graphy', 'system', 'nuclear', 'imaging', 'equipment', 'ray', 'system', 'ma', '##mm', '##ography', 'equipment', 'and', 'others']",1
133685,nifty_399,2012-01-09,Research and Markets: Strategic Development of Neural Stem & Progenitor Cell Products (Updated),Rise,0.0087,95,research and market strategic development neural stem progenitor cell product updated,85,11,0,pharmacy,"['research', 'and', 'market', 'strategic', 'development', 'neural', 'stem', 'pro', '##gen', '##itor', 'cell', 'product', 'updated']",1
133739,nifty_399,2012-01-09,Celgene Corporation Announces 2012 Financial Outlook and Reviews 2011 Achievements,Rise,0.0087,82,celgene corporation announces financial outlook and review achievement,70,8,0,pharmacy,"['c', '##el', '##gene', 'corporation', 'announces', 'financial', 'outlook', 'and', 'review', 'achievement']",1
133792,nifty_399,2012-01-09,Research and Markets: mHealth and Home Monitoring - 4th Edition - These Devices Are Projected To Grow At A CAGR Of 34.6 Percent to 2.47 Million In 2016,Rise,0.0087,151,research and market mhealth and home monitoring edition these device are projected grow cagr percent million,108,16,0,pharmacy,"['research', 'and', 'market', 'm', '##hea', '##lt', '##h', 'and', 'home', 'monitoring', 'edition', 'these', 'device', 'are', 'projected', 'grow', 'ca', '##g', '##r', 'percent', 'million']",1
133872,nifty_399,2012-01-09,FEI Buys ASPEX Corporation,Rise,0.0087,26,fei buy aspex corporation,25,4,0,pharmacy,"['f', '##ei', 'buy', 'as', '##pe', '##x', 'corporation']",1
134083,nifty_399,2012-01-09,Bristol-Myers to Acquire Inhibitex,Rise,0.0087,34,bristol myers acquire inhibitex,31,4,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'acquire', 'in', '##hibit', '##ex']",1
134403,nifty_404,2012-01-18,"UPDATE 1-Novartis wins backing in China for Lucentis, Galvus",Rise,0.0053,60,update novartis win backing china for lucentis galvus,53,8,0,pharmacy,"['update', 'no', '##var', '##tis', 'win', 'backing', 'chin', '##a', 'for', 'l', '##uce', '##nti', '##s', 'gal', '##vu', '##s']",1
134474,nifty_404,2012-01-18,Research and Markets: The Medical Device Market: Taiwan 2012 Edition - Taiwan Remains a Lucrative Market,Rise,0.0053,104,research and market the medical device market taiwan edition taiwan remains lucrative market,92,13,0,pharmacy,"['research', 'and', 'market', 'the', 'medical', 'device', 'market', 'ta', '##i', '##wan', 'edition', 'ta', '##i', '##wan', 'remains', 'lucrative', 'market']",1
134475,nifty_404,2012-01-18,"Research and Markets: The Medical Device Market: Malaysia - Current Growth in the Market to Be A Strong 9.1% per Year, Reaching US$1.9 Billion, or US$61 Per Capita, By 2016",Rise,0.0053,172,research and market the medical device market malaysia current growth the market strong per year reaching billion per caput,123,19,0,pharmacy,"['research', 'and', 'market', 'the', 'medical', 'device', 'market', 'ma', '##lay', '##sia', 'current', 'growth', 'the', 'market', 'strong', 'per', 'year', 'reaching', 'billion', 'per', 'cap', '##ut']",1
134536,nifty_404,2012-01-18,"UPDATE 2-Novartis wins backing in China for Lucentis, Galvus",Rise,0.0053,60,update novartis win backing china for lucentis galvus,53,8,0,pharmacy,"['update', 'no', '##var', '##tis', 'win', 'backing', 'chin', '##a', 'for', 'l', '##uce', '##nti', '##s', 'gal', '##vu', '##s']",1
134585,nifty_404,2012-01-18,Research and Markets: Assessment of the fast growing Indian Biotech Market,Rise,0.0053,74,research and market assessment the fast growing indian biotech market,69,10,0,pharmacy,"['research', 'and', 'market', 'assessment', 'the', 'fast', 'growing', 'in', '##dian', 'bio', '##tech', 'market']",1
134713,nifty_404,2012-01-18,Research and Markets: the Medical Device Market: South Africa is Expected to Grow at a CAGR of 1.3% from 2011-2016,Rise,0.0053,114,research and market the medical device market south africa expected grow cagr from,82,13,0,pharmacy,"['research', 'and', 'market', 'the', 'medical', 'device', 'market', 'south', 'a', '##f', '##rica', 'expected', 'grow', 'ca', '##g', '##r', 'from']",1
134790,nifty_404,2012-01-18,Research and Markets: NovoLog (Type 2 Diabetes) - Analysis and Forecasts to 2020,Rise,0.0053,80,research and market novolog type diabetes analysis and forecast,63,9,0,pharmacy,"['research', 'and', 'market', 'no', '##vo', '##log', 'type', 'diabetes', 'analysis', 'and', 'forecast']",1
134845,nifty_404,2012-01-18,"Research and Markets: China Pharmaceutical Equipment Industry Report, 2011-2012",Rise,0.0053,79,research and market china pharmaceutical equipment industry report,66,8,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'pharmaceutical', 'equipment', 'industry', 'report']",1
134892,nifty_404,2012-01-18,"New Book, 'The Creative Destruction of Medicine,' Describes How Digital Revolution Will Create Better Health Care",Rise,0.0053,113,new book the creative destruction medicine describes how digital revolution will create better health care,106,15,0,pharmacy,"['new', 'book', 'the', 'creative', 'destruction', 'medicine', 'describes', 'how', 'digital', 'revolution', 'will', 'create', 'better', 'health', 'care']",1
134984,nifty_404,2012-01-18, Stellar Biotechnologies Announces Investor Relations Agreement,Rise,0.0053,63,stellar biotechnology announces investor relation agreement,59,6,0,pharmacy,"['stellar', 'bio', '##tech', '##nology', 'announces', 'investor', 'relation', 'agreement']",1
135036,nifty_404,2012-01-18,Research and Markets: Depression - Agomelatine Failure Creates US Market Opportunity,Rise,0.0053,84,research and market depression agomelatine failure creates market opportunity,77,9,0,pharmacy,"['research', 'and', 'market', 'depression', 'ago', '##mel', '##ati', '##ne', 'failure', 'creates', 'market', 'opportunity']",1
135062,nifty_404,2012-01-18,Research and Markets: Strategies for Effective Partnerships Between Pharmaceutical and Diagnostic Companies: a Business Insights Report,Rise,0.0053,135,research and market strategy for effective partnership between pharmaceutical and diagnostic company business insight report,124,15,0,pharmacy,"['research', 'and', 'market', 'strategy', 'for', 'effective', 'partnership', 'between', 'pharmaceutical', 'and', 'diagnostic', 'company', 'business', 'insight', 'report']",1
135116,nifty_404,2012-01-18,Research and Markets: Big Pharma Cuts Down on Early-Stage Research into Neuropathic Pain,Rise,0.0053,88,research and market big pharma cut down early stage research into neuropathic pain,82,13,0,pharmacy,"['research', 'and', 'market', 'big', 'p', '##har', '##ma', 'cut', 'down', 'early', 'stage', 'research', 'into', 'ne', '##uro', '##pathic', 'pain']",1
135118,nifty_404,2012-01-18,Research and Markets: Benchmark the Competitive Landscape within the Stem Cell Sector,Rise,0.0053,85,research and market benchmark the competitive landscape within the stem cell sector,83,12,0,pharmacy,"['research', 'and', 'market', 'bench', '##mark', 'the', 'competitive', 'landscape', 'within', 'the', 'stem', 'cell', 'sector']",1
135284,nifty_404,2012-01-18,"Research and Markets: Hungary Diagnostic Imaging Investment Opportunities, Analysis and Forecasts to 2017",Rise,0.0053,105,research and market hungary diagnostic imaging investment opportunity analysis and forecast,91,11,0,pharmacy,"['research', 'and', 'market', 'hung', '##ary', 'diagnostic', 'imaging', 'investment', 'opportunity', 'analysis', 'and', 'forecast']",1
135753,nifty_408,2012-01-25,Novartis's Profit Drops,Fall,-0.0051,23,novartis profit drop,20,3,0,pharmacy,"['no', '##var', '##tis', 'profit', 'drop']",1
135819,nifty_409,2012-01-26,Bristol-Myers Net Rises,Neutral,-0.0005,23,bristol myers net rise,22,4,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'net', 'rise']",1
135858,nifty_409,2012-01-26,Gas Titan's Blueprint Rests on Deals,Neutral,-0.0005,36,gas titan blueprint rest deal,29,5,0,pharmacy,"['gas', 't', '##ita', '##n', 'blue', '##print', 'rest', 'deal']",1
135926,nifty_411,2012-01-31,Biogen's Net Rises 25%,Rise,0.0088,22,biogen net rise,15,3,0,pharmacy,"['bio', '##gen', 'net', 'rise']",1
136253,nifty_412,2012-02-01,Research and Markets: Clinical Trials in CIS countries 2012 - Development Forecasts for 2012-2014,Neutral,0.0016,97,research and market clinical trial ci country development forecast for,70,10,0,pharmacy,"['research', 'and', 'market', 'clinical', 'trial', 'c', '##i', 'country', 'development', 'forecast', 'for']",1
136503,nifty_412,2012-02-01,Research and Markets: International Directory of Pharmaceutical Companies 2012: Your Connection to Key Decision-Makers around the World,Neutral,0.0016,135,research and market international directory pharmaceutical company your connection key decision maker around the world,118,15,0,pharmacy,"['research', 'and', 'market', 'international', 'directory', 'pharmaceutical', 'company', 'your', 'connection', 'key', 'decision', 'maker', 'around', 'the', 'world']",1
136549,nifty_412,2012-02-01,Irish Medical Device Association: Vibrant Med Tech Sector in Ireland Identifies Continued Evolution & Convergence in 4 Year Plan,Neutral,0.0016,128,irish medical device association vibrant med tech sector ireland identifies continued evolution convergence year plan,117,15,0,pharmacy,"['i', '##ris', '##h', 'medical', 'device', 'association', 'vibrant', 'me', '##d', 'tech', 'sector', 'i', '##rel', '##and', 'identifies', 'continued', 'evolution', 'convergence', 'year', 'plan']",1
136608,nifty_412,2012-02-01, Biotech Dealmaking Gets Off to a Strong Start in 2012,Neutral,0.0016,54,biotech dealmaking get off strong start,39,6,0,pharmacy,"['bio', '##tech', 'deal', '##making', 'get', 'off', 'strong', 'start']",1
136676,nifty_412,2012-02-01,"World's Leading Pharmaceutical Executives All Converging in Zurich, Switzerland on February 21-22, 2012 for Breakthrough Event",Neutral,0.0016,126,world leading pharmaceutical executive all converging zurich switzerland february for breakthrough event,104,12,0,pharmacy,"['world', 'leading', 'pharmaceutical', 'executive', 'all', 'con', '##ver', '##ging', 'zur', '##ich', 's', '##witz', '##erland', 'f', '##eb', '##ru', '##ary', 'for', 'breakthrough', 'event']",1
136689,nifty_412,2012-02-01,"Psychiatric Medication Spending Growth Slows, According to New Thomson Reuters Research",Neutral,0.0016,87,psychiatric medication spending growth slows according new thomson reuters research,83,10,0,pharmacy,"['psychiatric', 'medication', 'spending', 'growth', 'slow', '##s', 'according', 'new', 'th', '##oms', '##on', 're', '##uters', 'research']",1
136734,nifty_412,2012-02-01,"The Zacks Analyst Blog Highlights: Pfizer, Biogen Idec, Elan, Novartis and Roche",Neutral,0.0016,80,the zacks analyst blog highlight pfizer biogen idec elan novartis and roche,75,12,0,pharmacy,"['the', 'z', '##ack', '##s', 'analyst', 'blog', 'highlight', 'p', '##fi', '##zer', 'bio', '##gen', 'id', '##ec', 'el', '##an', 'no', '##var', '##tis', 'and', 'r', '##och', '##e']",1
136832,nifty_412,2012-02-01,Global Weight Management Market Analysis and Forecast Now Available at MarketPublishers.com,Neutral,0.0016,91,global weight management market analysis and forecast now available marketpublishers com,88,11,0,pharmacy,"['global', 'weight', 'management', 'market', 'analysis', 'and', 'forecast', 'now', 'available', 'market', '##pu', '##b', '##lish', '##ers', 'com']",1
136841,nifty_412,2012-02-01,REG - Merrion Pharm Plc - Further re Equity Funding Proposal,Neutral,0.0016,60,reg merrion pharm plc further equity funding proposal,53,8,0,pharmacy,"['re', '##g', 'me', '##rri', '##on', 'p', '##har', '##m', 'plc', 'further', 'equity', 'funding', 'proposal']",1
136908,nifty_412,2012-02-01,Research and Markets: Medical Device Companies Analysis - 50+ Major Companies and Subsidiaries,Neutral,0.0016,94,research and market medical device company analysis major company and subsidiary,80,11,0,pharmacy,"['research', 'and', 'market', 'medical', 'device', 'company', 'analysis', 'major', 'company', 'and', 'subsidiary']",1
136932,nifty_412,2012-02-01,"Horizon Healthcare Innovations, Duke, Rutgers Launch Nurse Training Collaborative",Neutral,0.0016,81,horizon healthcare innovation duke rutgers launch nurse training collaborative,78,9,0,pharmacy,"['horizon', 'healthcare', 'innovation', 'duke', 'r', '##ut', '##gers', 'launch', 'nurse', 'training', 'collaborative']",1
137908,nifty_417,2012-02-09,Research and Markets: Future German Cancer Diagnostics Market: Growth Opportunities and Business Expansion Strategies,Fall,-0.0074,117,research and market future german cancer diagnostics market growth opportunity and business expansion strategy,110,14,0,pharmacy,"['research', 'and', 'market', 'future', 'g', '##erman', 'cancer', 'diagnostic', '##s', 'market', 'growth', 'opportunity', 'and', 'business', 'expansion', 'strategy']",1
137979,nifty_417,2012-02-09,Delcath to Present at the 14th Annual BIO CEO & Investor Conference on February 14,Fall,-0.0074,82,delcath present the annual bio ceo investor conference february,63,9,0,pharmacy,"['del', '##cat', '##h', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference', 'f', '##eb', '##ru', '##ary']",1
138026,nifty_417,2012-02-09,Sucampo Announces Webcast of Its Presentation at the 14th Annual BIO CEO + Investor Conference,Fall,-0.0074,94,sucampo announces webcast it presentation the annual bio ceo investor conference,80,11,0,pharmacy,"['su', '##cam', '##po', 'announces', 'web', '##cast', 'it', 'presentation', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
138129,nifty_417,2012-02-09,Ambit Biosciences to Present at Two Upcoming Investor Conferences,Fall,-0.0074,65,ambit bioscience present two upcoming investor conference,57,7,0,pharmacy,"['am', '##bit', 'bio', '##science', 'present', 'two', 'upcoming', 'investor', 'conference']",1
138137,nifty_417,2012-02-09,Veloxis Pharmaceuticals to Present at 14th Annual BIO CEO & Investor Conference,Fall,-0.0074,79,veloxis pharmaceutical present annual bio ceo investor conference,65,8,0,pharmacy,"['ve', '##lo', '##xi', '##s', 'pharmaceutical', 'present', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
138141,nifty_417,2012-02-09,Aegerion Pharmaceuticals Announces Webcast of Investor Presentations at Upcoming Conferences,Fall,-0.0074,92,aegerion pharmaceutical announces webcast investor presentation upcoming conference,83,8,0,pharmacy,"['a', '##ege', '##rion', 'pharmaceutical', 'announces', 'web', '##cast', 'investor', 'presentation', 'upcoming', 'conference']",1
138146,nifty_417,2012-02-09,NovaBay Pharmaceuticals Provides Business Update and 2012 Outlook,Fall,-0.0074,65,novabay pharmaceutical provides business update and outlook,59,7,0,pharmacy,"['no', '##va', '##bay', 'pharmaceutical', 'provides', 'business', 'update', 'and', 'outlook']",1
138153,nifty_417,2012-02-09,Synergy Pharmaceuticals verzorgt presentatie tijdens 14e jaarlijkse BIO CEO & Investor Conference,Fall,-0.0074,97,synergy pharmaceutical verzorgt presentatie tijdens jaarlijkse bio ceo investor conference,90,10,0,pharmacy,"['s', '##yne', '##rgy', 'pharmaceutical', 've', '##rz', '##or', '##gt', 'present', '##ati', '##e', 't', '##i', '##j', '##den', '##s', 'j', '##aar', '##li', '##jk', '##se', 'bio', 'c', '##eo', 'investor', 'conference']",1
138278,nifty_417,2012-02-09,Celldex Therapeutics to Participate on Therapeutic Workshop Panel at the BIO CEO & Investor Conference,Fall,-0.0074,102,celldex therapeutic participate therapeutic workshop panel the bio ceo investor conference,90,11,0,pharmacy,"['cell', '##de', '##x', 'therapeutic', 'participate', 'therapeutic', 'workshop', 'panel', 'the', 'bio', 'c', '##eo', 'investor', 'conference']",1
138281,nifty_417,2012-02-09,Advaxis to Present at the 14th Annual BIO CEO & Investor Conference,Fall,-0.0074,67,advaxis present the annual bio ceo investor conference,54,8,0,pharmacy,"['ad', '##va', '##xi', '##s', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
138384,nifty_417,2012-02-09,Research and Markets: Generic Pharmaceuticals Market - A Global Analysis,Fall,-0.0074,72,research and market generic pharmaceutical market global analysis,65,8,0,pharmacy,"['research', 'and', 'market', 'generic', 'pharmaceutical', 'market', 'global', 'analysis']",1
138492,nifty_417,2012-02-09,Research and Markets: SThree Plc - Company Capsule - 2012,Fall,-0.0074,57,research and market sthree plc company capsule,46,7,0,pharmacy,"['research', 'and', 'market', 's', '##th', '##ree', 'plc', 'company', 'capsule']",1
138623,nifty_417,2012-02-09,Ligand to Present at the BIO CEO and Investor Conference on February 13,Fall,-0.0074,71,ligand present the bio ceo and investor conference february,59,9,0,pharmacy,"['l', '##igan', '##d', 'present', 'the', 'bio', 'c', '##eo', 'and', 'investor', 'conference', 'f', '##eb', '##ru', '##ary']",1
138654,nifty_417,2012-02-09,Research and Markets: Sotheby's - Company Capsule - A Crucial Resource - 2012,Fall,-0.0074,77,research and market sotheby company capsule crucial resource,60,8,0,pharmacy,"['research', 'and', 'market', 'so', '##the', '##by', 'company', 'capsule', 'crucial', 'resource']",1
138796,nifty_417,2012-02-09,Gilead Sciences to Present at Two Upcoming Investor Conferences,Fall,-0.0074,63,gilead science present two upcoming investor conference,55,7,0,pharmacy,"['g', '##ile', '##ad', 'science', 'present', 'two', 'upcoming', 'investor', 'conference']",1
139444,nifty_420,2012-02-15," Pharmaceutical-Bio Industry Closes the Door on 2011 With More Than $12 billion in North American Project Starts, an",Rise,0.0111,116,pharmaceutical bio industry close the door with more than billion north american project start,94,14,0,pharmacy,"['pharmaceutical', 'bio', 'industry', 'close', 'the', 'door', 'with', 'more', 'than', 'billion', 'north', 'am', '##eric', '##an', 'project', 'start']",1
139481,nifty_420,2012-02-15,Global Imaging Systems Expands Business in Iowa and Illinois with RK Dixon Acquisition,Rise,0.0111,86,global imaging system expands business iowa and illinois with dixon acquisition,79,11,0,pharmacy,"['global', 'imaging', 'system', 'expands', 'business', 'i', '##owa', 'and', 'ill', '##ino', '##is', 'with', 'di', '##xon', 'acquisition']",1
139530,nifty_420,2012-02-15, Medicity Reports Health Information Exchange Market Accelerated in 2011 as Organizations Prepare for Payment Reform and,Rise,0.0111,120,medicity report health information exchange market accelerated organization prepare for payment reform and,106,13,0,pharmacy,"['me', '##dic', '##ity', 'report', 'health', 'information', 'exchange', 'market', 'accelerated', 'organization', 'prepare', 'for', 'payment', 'reform', 'and']",1
139547,nifty_420,2012-02-15,"Research and Markets: Future Therapeutic Drug Monitoring Market: US, Europe, Japan",Rise,0.0111,82,research and market future therapeutic drug monitoring market europe japan,74,10,0,pharmacy,"['research', 'and', 'market', 'future', 'therapeutic', 'drug', 'monitoring', 'market', 'euro', '##pe', 'j', '##apa', '##n']",1
139606,nifty_420,2012-02-15,Research and Markets: Australia Diabetes Care Devices Market Outlook to 2017 - Glucose Monitoring and Insulin Delivery,Rise,0.0111,118,research and market australia diabetes care device market outlook glucose monitoring and insulin delivery,105,14,0,pharmacy,"['research', 'and', 'market', 'au', '##stra', '##lia', 'diabetes', 'care', 'device', 'market', 'outlook', 'glucose', 'monitoring', 'and', 'insulin', 'delivery']",1
139621,nifty_420,2012-02-15,Research and Markets: Future Japanese Cancer Diagnostics Market: Growth Opportunities and Business Expansion Strategies,Rise,0.0111,119,research and market future japanese cancer diagnostics market growth opportunity and business expansion strategy,112,14,0,pharmacy,"['research', 'and', 'market', 'future', 'j', '##apa', '##nese', 'cancer', 'diagnostic', '##s', 'market', 'growth', 'opportunity', 'and', 'business', 'expansion', 'strategy']",1
139852,nifty_420,2012-02-15,"Research and Markets: 2012 Report on the $85 Billion US Medical Equipment & Supplies Manufacturing Industry Featuring Baxter Intl, Boston Scientific, J&J; and Medtronic",Rise,0.0111,168,research and market report the billion medical equipment supply manufacturing industry featuring baxter intl boston scientific and medtronic,140,18,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'billion', 'medical', 'equipment', 'supply', 'manufacturing', 'industry', 'featuring', 'b', '##ax', '##ter', 'in', '##tl', 'b', '##ost', '##on', 'scientific', 'and', 'me', '##dt', '##ronic']",1
139898,nifty_420,2012-02-15,"Acella Pharmaceuticals, LLC Names Allen Fields as New VP, Head of R&D;",Rise,0.0111,70,acella pharmaceutical llc name allen field new head,51,8,0,pharmacy,"['ace', '##lla', 'pharmaceutical', 'll', '##c', 'name', 'all', '##en', 'field', 'new', 'head']",1
139906,nifty_420,2012-02-15,Analysis: Drugmakers relegate Europe as crisis saps returns,Rise,0.0111,59,analysis drugmakers relegate europe crisis sap return,53,7,0,pharmacy,"['analysis', 'drug', '##makers', 're', '##leg', '##ate', 'euro', '##pe', 'crisis', 'sa', '##p', 'return']",1
139908,nifty_420,2012-02-15,Research and Markets: Insulin Delivery Systems Market Forecast to 2014,Rise,0.0111,70,research and market insulin delivery system market forecast,59,8,0,pharmacy,"['research', 'and', 'market', 'insulin', 'delivery', 'system', 'market', 'forecast']",1
139926,nifty_420,2012-02-15,"Research and Markets: Infertility Drugs And Devices Market - Global And China Forecast, Market Share, Size, Growth And Industry Analysis (2010-2017)",Rise,0.0111,148,research and market infertility drug and device market global and china forecast market share size growth and industry analysis,127,19,0,pharmacy,"['research', 'and', 'market', 'in', '##fer', '##tility', 'drug', 'and', 'device', 'market', 'global', 'and', 'chin', '##a', 'forecast', 'market', 'share', 'size', 'growth', 'and', 'industry', 'analysis']",1
139996,nifty_420,2012-02-15,Research and Markets: Sick on the Job? - Myths and Realities about Mental Health and Work,Rise,0.0111,89,research and market sick the job myth and reality about mental health and work,78,14,0,pharmacy,"['research', 'and', 'market', 'sick', 'the', 'job', 'myth', 'and', 'reality', 'about', 'mental', 'health', 'and', 'work']",1
140045,nifty_420,2012-02-15,Research and Markets: 2012 Report on the $45 Billion US Medical & Diagnostic Laboratories Featuring Major Companies like Quest Diagnostics and Laboratory Corporation of America,Rise,0.0111,176,research and market report the billion medical diagnostic laboratory featuring major company like quest diagnostics and laboratory corporation america,150,19,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'billion', 'medical', 'diagnostic', 'laboratory', 'featuring', 'major', 'company', 'like', 'quest', 'diagnostic', '##s', 'and', 'laboratory', 'corporation', 'am', '##eric', '##a']",1
140087,nifty_420,2012-02-15,WellNow Urgent Care Launching with $35 Million of Committed Capital,Rise,0.0111,67,wellnow urgent care launching with million committed capital,60,8,0,pharmacy,"['well', '##no', '##w', 'urgent', 'care', 'launching', 'with', 'million', 'committed', 'capital']",1
140098,nifty_420,2012-02-15, Point of Care Diagnostic Testing World Market to Jump to $15.9 Billion by 2018,Rise,0.0111,79,point care diagnostic testing world market jump billion,55,8,0,pharmacy,"['point', 'care', 'diagnostic', 'testing', 'world', 'market', 'jump', 'billion']",1
140112,nifty_420,2012-02-15,"CIVCO Promotes Robin Therme to Senior VP of Sales & Marketing, Multi-Modality Imaging",Rise,0.0111,85,civco promotes robin therme senior sale marketing multi modality imaging,72,10,0,pharmacy,"['c', '##iv', '##co', 'promotes', 'robin', 'the', '##rm', '##e', 'senior', 'sale', 'marketing', 'multi', 'm', '##oda', '##lity', 'imaging']",1
140115,nifty_420,2012-02-15,BIO Industry Analysis Investor Survey:FDA Approvals Expected to Increase and Majority of Investors Believe Now Is a Good Time to Invest in Biotech,Rise,0.0111,146,bio industry analysis investor survey fda approval expected increase and majority investor believe now good time invest biotech,127,18,0,pharmacy,"['bio', 'industry', 'analysis', 'investor', 'survey', 'f', '##da', 'approval', 'expected', 'increase', 'and', 'majority', 'investor', 'believe', 'now', 'good', 'time', 'invest', 'bio', '##tech']",1
140161,nifty_420,2012-02-15,"Research and Markets: Biosimilars Market - Global And China Forecast, Market Share, Size, Growth And Industry Analysis (2010-2017)",Rise,0.0111,130,research and market biosimilars market global and china forecast market share size growth and industry analysis,111,16,0,pharmacy,"['research', 'and', 'market', 'bio', '##si', '##mi', '##lars', 'market', 'global', 'and', 'chin', '##a', 'forecast', 'market', 'share', 'size', 'growth', 'and', 'industry', 'analysis']",1
140168,nifty_420,2012-02-15,"""Fast Company"" Names Heritage Provider Network One of the Global 10 Most Innovative Companies in Health Care for 2012",Rise,0.0111,117,fast company name heritage provider network one the global most innovative company health care for,98,15,0,pharmacy,"['fast', 'company', 'name', 'heritage', 'provider', 'network', 'one', 'the', 'global', 'most', 'innovative', 'company', 'health', 'care', 'for']",1
140189,nifty_420,2012-02-15,Anacor Pharmaceuticals to Present at Upcoming Investor Conferences,Rise,0.0111,66,anacor pharmaceutical present upcoming investor conference,58,6,0,pharmacy,"['an', '##aco', '##r', 'pharmaceutical', 'present', 'upcoming', 'investor', 'conference']",1
140220,nifty_420,2012-02-15,Protalix BioTherapeutics Announces Proposed Public Offering of Common Stock,Rise,0.0111,75,protalix biotherapeutics announces proposed public offering common stock,72,8,0,pharmacy,"['pro', '##tal', '##ix', 'bio', '##ther', '##ap', '##eu', '##tics', 'announces', 'proposed', 'public', 'offering', 'common', 'stock']",1
140236,nifty_420,2012-02-15,NPS Pharmaceuticals Reports 2011 Year-End Financial Results and 2012 Cash Burn Guidance,Rise,0.0111,87,np pharmaceutical report year end financial result and cash burn guidance,73,11,0,pharmacy,"['n', '##p', 'pharmaceutical', 'report', 'year', 'end', 'financial', 'result', 'and', 'cash', 'burn', 'guidance']",1
140326,nifty_420,2012-02-15,FDA Consumer Health Information - FDA's MedWatch Safety Alerts: January 2012,Rise,0.0111,76,fda consumer health information fda medwatch safety alert january,65,9,0,pharmacy,"['f', '##da', 'consumer', 'health', 'information', 'f', '##da', 'me', '##d', '##watch', 'safety', 'alert', 'j', '##anu', '##ary']",1
140612,nifty_422,2012-02-21,Defining Debate on Contraception,Neutral,-0.0032,32,defining debate contraception,29,3,0,pharmacy,"['defining', 'debate', 'con', '##tra', '##ception']",1
140854,nifty_426,2012-02-28,Dendreon Drug Facing Hurdles,Neutral,-0.0039,28,dendreon drug facing hurdle,27,4,0,pharmacy,"['den', '##dre', '##on', 'drug', 'facing', 'h', '##ur', '##dle']",1
140988,nifty_427,2012-02-29,"Celerion and Ricerca Biosciences Announce ""The Biosimilars Alliance"" to Offer Clients a More Effective Development Path for Biosimilars",Rise,0.0052,135,celerion and ricerca bioscience announce the biosimilars alliance offer client more effective development path for biosimilars,126,16,0,pharmacy,"['c', '##ele', '##rion', 'and', 'rice', '##rca', 'bio', '##science', 'announce', 'the', 'bio', '##si', '##mi', '##lars', 'alliance', 'offer', 'client', 'more', 'effective', 'development', 'path', 'for', 'bio', '##si', '##mi', '##lars']",1
141088,nifty_427,2012-02-29,UK Pharmaceutical & Medical Devices Market Discussed in New Study Now Available at MarketPublishers.com,Rise,0.0052,103,pharmaceutical medical device market discussed new study now available marketpublishers com,91,11,0,pharmacy,"['pharmaceutical', 'medical', 'device', 'market', 'discussed', 'new', 'study', 'now', 'available', 'market', '##pu', '##b', '##lish', '##ers', 'com']",1
141181,nifty_427,2012-02-29,Research and Markets: Introduction to Pharmaceutical Chemical Analysis,Rise,0.0052,70,research and market introduction pharmaceutical chemical analysis,65,7,0,pharmacy,"['research', 'and', 'market', 'introduction', 'pharmaceutical', 'chemical', 'analysis']",1
141251,nifty_427,2012-02-29," Pharma-Biotech Capital Construction Investment Snapshot: 2012 North American Project Starts Top $16 Billion, an",Rise,0.0052,112,pharma biotech capital construction investment snapshot north american project start top billion,96,12,0,pharmacy,"['p', '##har', '##ma', 'bio', '##tech', 'capital', 'construction', 'investment', 'snaps', '##hot', 'north', 'am', '##eric', '##an', 'project', 'start', 'top', 'billion']",1
141276,nifty_427,2012-02-29, Media Advisory/REMINDER: Minister Paradis Helps Unveil Advanced Medical Technology,Rise,0.0052,83,medium advisory reminder minister paradis help unveil advanced medical technology,81,10,0,pharmacy,"['medium', 'advisory', 'reminder', 'minister', 'para', '##dis', 'help', 'un', '##ve', '##il', 'advanced', 'medical', 'technology']",1
141289,nifty_427,2012-02-29," Pharmspective, a Specialty Therapeutics Market Research Firm, Announces Launch of Syndicated Research Offering and",Rise,0.0052,115,pharmspective specialty therapeutic market research firm announces launch syndicated research offering and,106,12,0,pharmacy,"['p', '##har', '##ms', '##pect', '##ive', 'specialty', 'therapeutic', 'market', 'research', 'firm', 'announces', 'launch', 'syndicated', 'research', 'offering', 'and']",1
141341,nifty_427,2012-02-29,BioSpecifics Technologies Corp. Announces Presentations at Two Upcoming Investor Conferences in March,Rise,0.0052,101,biospecifics technology corp announces presentation two upcoming investor conference march,90,10,0,pharmacy,"['bio', '##sp', '##ec', '##ific', '##s', 'technology', 'co', '##rp', 'announces', 'presentation', 'two', 'upcoming', 'investor', 'conference', 'march']",1
141368,nifty_427,2012-02-29,Transcept Pharmaceuticals to Present at Two Upcoming Investor Conferences,Rise,0.0052,73,transcept pharmaceutical present two upcoming investor conference,65,7,0,pharmacy,"['trans', '##ce', '##pt', 'pharmaceutical', 'present', 'two', 'upcoming', 'investor', 'conference']",1
141394,nifty_427,2012-02-29,Catabasis Pharmaceuticals to Present at Upcoming Investor and Industry Conferences,Rise,0.0052,82,catabasis pharmaceutical present upcoming investor and industry conference,74,8,0,pharmacy,"['cat', '##aba', '##sis', 'pharmaceutical', 'present', 'upcoming', 'investor', 'and', 'industry', 'conference']",1
141461,nifty_427,2012-02-29,ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences,Rise,0.0052,66,acadia pharmaceutical present upcoming investor conference,58,6,0,pharmacy,"['a', '##ca', '##dia', 'pharmaceutical', 'present', 'upcoming', 'investor', 'conference']",1
141493,nifty_427,2012-02-29,"Decade in Review: Medical Devices M&A; Dollar Volume Increasing, According to Deal Search Online",Rise,0.0052,96,decade review medical device dollar volume increasing according deal search online,82,11,0,pharmacy,"['decade', 'review', 'medical', 'device', 'dollar', 'volume', 'increasing', 'according', 'deal', 'search', 'online']",1
141505,nifty_427,2012-02-29,"Research and Markets: Molecular Analysis and Genome Discovery, 2nd Edition is an Indispensable Resource for Those Working in the Biotechnology and Pharmaceutical Industries",Rise,0.0052,172,research and market molecular analysis and genome discovery edition indispensable resource for those working the biotechnology and pharmaceutical industry,154,19,0,pharmacy,"['research', 'and', 'market', 'molecular', 'analysis', 'and', 'genome', 'discovery', 'edition', 'in', '##dis', '##pen', '##sable', 'resource', 'for', 'those', 'working', 'the', 'bio', '##tech', '##nology', 'and', 'pharmaceutical', 'industry']",1
141624,nifty_427,2012-02-29,Nuvilex Reveals Goldman Small Cap Research Cites Groundbreaking Cancer Therapy in Updating Buy Recommendation,Rise,0.0052,109,nuvilex reveals goldman small cap research cite groundbreaking cancer therapy updating buy recommendation,105,13,0,pharmacy,"['n', '##u', '##vil', '##ex', 'reveals', 'gold', '##man', 'small', 'cap', 'research', 'c', '##ite', 'groundbreaking', 'cancer', 'therapy', 'up', '##dating', 'buy', 'recommendation']",1
141692,nifty_427,2012-02-29," AMI Research Initiates Analyst Coverage on Pressure BioSciences, Inc.; BUY",Rise,0.0052,75,ami research initiate analyst coverage pressure bioscience inc buy,66,9,0,pharmacy,"['am', '##i', 'research', 'initiate', 'analyst', 'coverage', 'pressure', 'bio', '##science', 'in', '##c', 'buy']",1
141695,nifty_427,2012-02-29,bswift Publishes White Paper Explaining Emerging Health Insurance Exchange Models & Market Forces Behind Them,Rise,0.0052,109,bswift publishes white paper explaining emerging health insurance exchange model market force behind them,105,14,0,pharmacy,"['b', '##s', '##wi', '##ft', 'publishes', 'white', 'paper', 'explaining', 'emerging', 'health', 'insurance', 'exchange', 'model', 'market', 'force', 'behind', 'them']",1
141707,nifty_427,2012-02-29,Research and Markets: Indian Healthcare Sector - Performance & Ranking Review,Rise,0.0052,77,research and market indian healthcare sector performance ranking review,71,9,0,pharmacy,"['research', 'and', 'market', 'in', '##dian', 'healthcare', 'sector', 'performance', 'ranking', 'review']",1
141909,nifty_427,2012-02-29,Cryo-Cell Reports Financial Results for Fiscal 2011,Rise,0.0052,51,cryo cell report financial result for fiscal,44,7,0,pharmacy,"['cry', '##o', 'cell', 'report', 'financial', 'result', 'for', 'fiscal']",1
141915,nifty_427,2012-02-29,Research and Markets: China's Guidebook for Pharmaceutical Patent Protection: An Essential Resource for Overseas and Multinational Pharmaceutical Companies,Rise,0.0052,155,research and market china guidebook for pharmaceutical patent protection essential resource for overseas and multinational pharmaceutical company,145,17,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'guide', '##book', 'for', 'pharmaceutical', 'patent', 'protection', 'essential', 'resource', 'for', 'overseas', 'and', 'multinational', 'pharmaceutical', 'company']",1
141968,nifty_427,2012-02-29,Celldex Therapeutics to Host Corporate 2011 Year-End and 2012 Objectives Update Call,Rise,0.0052,84,celldex therapeutic host corporate year end and objective update call,69,10,0,pharmacy,"['cell', '##de', '##x', 'therapeutic', 'host', 'corporate', 'year', 'end', 'and', 'objective', 'update', 'call']",1
141997,nifty_427,2012-02-29,Research and Markets: Global Epilepsy Market 2010-2014 - The Global Epilepsy Market to Reach US$8.1 Billion By 2014,Rise,0.0052,115,research and market global epilepsy market the global epilepsy market reach billion,83,12,0,pharmacy,"['research', 'and', 'market', 'global', 'e', '##pile', '##psy', 'market', 'the', 'global', 'e', '##pile', '##psy', 'market', 'reach', 'billion']",1
142019,nifty_427,2012-02-29,Cumberland Pharmaceuticals Reports 2011 Annual Financial Results,Rise,0.0052,64,cumberland pharmaceutical report annual financial result,56,6,0,pharmacy,"['cum', '##ber', '##land', 'pharmaceutical', 'report', 'annual', 'financial', 'result']",1
142022,nifty_427,2012-02-29,Idenix Pharmaceuticals to Present at Three Upcoming Investor Conferences,Rise,0.0052,72,idenix pharmaceutical present three upcoming investor conference,64,7,0,pharmacy,"['id', '##eni', '##x', 'pharmaceutical', 'present', 'three', 'upcoming', 'investor', 'conference']",1
142085,nifty_427,2012-02-29, BioExx Obtains Preliminary Third Party Technology Confirmation,Rise,0.0052,63,bioexx obtains preliminary third party technology confirmation,62,7,0,pharmacy,"['bio', '##ex', '##x', 'obtain', '##s', 'preliminary', 'third', 'party', 'technology', 'confirmation']",1
142434,nifty_430,2012-03-06,Long Wait for Cancer Drug Trial Results,Rise,0.007,39,long wait for cancer drug trial result,38,7,0,pharmacy,"['long', 'wait', 'for', 'cancer', 'drug', 'trial', 'result']",1
143049,nifty_438,2012-03-20,Reuters Today: More M&A; in pipeline but markets wilt,Neutral,-0.0016,53,reuters today more pipeline but market wilt,43,7,0,pharmacy,"['re', '##uters', 'today', 'more', 'pipeline', 'but', 'market', 'w', '##ilt']",1
143323,nifty_438,2012-03-20,US BioDesign Begins Building Partner Network with Global Medical Device Companies,Neutral,-0.0016,81,biodesign begin building partner network with global medical device company,75,10,0,pharmacy,"['bio', '##des', '##ign', 'begin', 'building', 'partner', 'network', 'with', 'global', 'medical', 'device', 'company']",1
143377,nifty_438,2012-03-20,BG Medical Technologies Issues Shareholder Update,Neutral,-0.0016,49,medical technology issue shareholder update,43,5,0,pharmacy,"['medical', 'technology', 'issue', 'shareholder', 'update']",1
143404,nifty_438,2012-03-20,Research and Markets: Sarcoidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019,Neutral,-0.0016,97,research and market sarcoidosis therapeutic pipeline assessment and market forecast,83,10,0,pharmacy,"['research', 'and', 'market', 'sa', '##rc', '##oid', '##osis', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
143435,nifty_438,2012-03-20,HawkPartners/ ICARE Global Patient Pulse Reveals Health Warnings for Some Institutions,Neutral,-0.0016,86,hawkpartners icare global patient pulse reveals health warning for some institution,83,11,0,pharmacy,"['hawk', '##par', '##t', '##ners', 'i', '##care', 'global', 'patient', 'pulse', 'reveals', 'health', 'warning', 'for', 'some', 'institution']",1
143699,nifty_438,2012-03-20,Research and Markets: China Benign Prostate Hyperplasia Prescription Drug Sales Data 2006-2010,Neutral,-0.0016,94,research and market china benign prostate hyperplasia prescription drug sale data,81,11,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'ben', '##ign', 'pro', '##state', 'h', '##yper', '##p', '##lasia', 'prescription', 'drug', 'sale', 'data']",1
144399,nifty_443,2012-03-28,Generic Seroquel Set for U.S. Launch,Neutral,-0.0017,36,generic seroquel set for launch,31,5,0,pharmacy,"['generic', 'se', '##ro', '##quel', 'set', 'for', 'launch']",1
144668,nifty_444,2012-03-29,Research and Markets: US Patient Monitoring and Diagnostic Systems Market Outlook and Opportunities,Neutral,0.0041,99,research and market patient monitoring and diagnostic system market outlook and opportunity,91,12,0,pharmacy,"['research', 'and', 'market', 'patient', 'monitoring', 'and', 'diagnostic', 'system', 'market', 'outlook', 'and', 'opportunity']",1
144732,nifty_444,2012-03-29,"Research and Markets: Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry",Neutral,0.0041,151,research and market global pharmaceutical survey market trend marketing spend and sale strategy the global pharmaceutical industry,130,17,0,pharmacy,"['research', 'and', 'market', 'global', 'pharmaceutical', 'survey', 'market', 'trend', 'marketing', 'spend', 'and', 'sale', 'strategy', 'the', 'global', 'pharmaceutical', 'industry']",1
144880,nifty_444,2012-03-29,Research and Markets: Prostate Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010,Neutral,0.0041,102,research and market prostate cancer global drug forecast and treatment analysis,79,11,0,pharmacy,"['research', 'and', 'market', 'pro', '##state', 'cancer', 'global', 'drug', 'forecast', 'and', 'treatment', 'analysis']",1
144901,nifty_444,2012-03-29,"Research and Markets: Blood Glucose Monitoring Devices (Meters, Test Strips, Lancets) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017",Neutral,0.0041,164,research and market blood glucose monitoring device meter test strip lancet global pipeline analysis competitive landscape and market forecast,142,19,0,pharmacy,"['research', 'and', 'market', 'blood', 'glucose', 'monitoring', 'device', 'meter', 'test', 'strip', 'lance', '##t', 'global', 'pipeline', 'analysis', 'competitive', 'landscape', 'and', 'market', 'forecast']",1
144930,nifty_444,2012-03-29,ICSE Pharma Outsourcing Event Announces Conference Agenda for US Debut in May,Neutral,0.0041,77,icse pharma outsourcing event announces conference agenda for debut may,71,10,0,pharmacy,"['i', '##cs', '##e', 'p', '##har', '##ma', 'outs', '##our', '##cing', 'event', 'announces', 'conference', 'agenda', 'for', 'debut', 'may']",1
144957,nifty_444,2012-03-29,Research and Markets: US MRI Systems Market - Present and Future Trends - Forecasts to 2016,Neutral,0.0041,91,research and market mri system market present and future trend forecast,71,11,0,pharmacy,"['research', 'and', 'market', 'm', '##ri', 'system', 'market', 'present', 'and', 'future', 'trend', 'forecast']",1
144958,nifty_444,2012-03-29,Research and Markets: US Nuclear Imaging Market - Present and Future Trends - Forecasts to 2016,Neutral,0.0041,95,research and market nuclear imaging market present and future trend forecast,76,11,0,pharmacy,"['research', 'and', 'market', 'nuclear', 'imaging', 'market', 'present', 'and', 'future', 'trend', 'forecast']",1
144975,nifty_444,2012-03-29,Syndax Pharmaceuticals to Present at Upcoming Conferences,Neutral,0.0041,57,syndax pharmaceutical present upcoming conference,49,5,0,pharmacy,"['s', '##yn', '##da', '##x', 'pharmaceutical', 'present', 'upcoming', 'conference']",1
144993,nifty_444,2012-03-29,Research and Markets: Dyslipidemia - Undertreated and Underdiagnosed Pandemic,Neutral,0.0041,77,research and market dyslipidemia undertreated and underdiagnosed pandemic,73,8,0,pharmacy,"['research', 'and', 'market', 'd', '##ys', '##lip', '##ide', '##mia', 'under', '##tre', '##ated', 'and', 'under', '##dia', '##gno', '##sed', 'pan', '##de', '##mic']",1
144994,nifty_444,2012-03-29,Covis' ZantacÂ® Injection Returns to the Market,Neutral,0.0041,47,covis zantacâ injection return the market,41,6,0,pharmacy,"['co', '##vis', 'z', '##ant', '##ac', '##â', 'injection', 'return', 'the', 'market']",1
145048,nifty_444,2012-03-29,Research and Markets: Depression - A Significant Economic Burden on Society and the Individual,Neutral,0.0041,94,research and market depression significant economic burden society and the individual,85,11,0,pharmacy,"['research', 'and', 'market', 'depression', 'significant', 'economic', 'burden', 'society', 'and', 'the', 'individual']",1
145194,nifty_444,2012-03-29,"Research and Markets: Hospitalists: Policies, Procedures, Resources 2012",Neutral,0.0041,72,research and market hospitalists policy procedure resource,58,7,0,pharmacy,"['research', 'and', 'market', 'hospital', '##ists', 'policy', 'procedure', 'resource']",1
145348,nifty_444,2012-03-29, Stellar Pharmaceuticals Inc.: Shareholder Early Warning News Release,Neutral,0.0041,69,stellar pharmaceutical inc shareholder early warning news release,65,8,0,pharmacy,"['stellar', 'pharmaceutical', 'in', '##c', 'shareholder', 'early', 'warning', 'news', 'release']",1
145453,nifty_444,2012-03-29,Bio-Path Holdings Engages PondelWilkinson for Retail Investor Relations Program,Neutral,0.0041,79,bio path holding engages pondelwilkinson for retail investor relation program,77,10,0,pharmacy,"['bio', 'path', 'holding', 'engages', 'pond', '##el', '##wi', '##lk', '##ins', '##on', 'for', 'retail', 'investor', 'relation', 'program']",1
145480,nifty_444,2012-03-29, Enterey Consultant Saves Biotech Millions in Two Ways,Neutral,0.0041,54,enterey consultant save biotech million two way,47,7,0,pharmacy,"['enter', '##ey', 'consultant', 'save', 'bio', '##tech', 'million', 'two', 'way']",1
145609,nifty_444,2012-03-29,Progenics Pharmaceuticals to Participate in Investor Conferences,Neutral,0.0041,64,progenics pharmaceutical participate investor conference,56,5,0,pharmacy,"['pro', '##genic', '##s', 'pharmaceutical', 'participate', 'investor', 'conference']",1
146129,nifty_450,2012-04-11,Active Biotech: Notice of Annual General Meeting of Shareholders,Rise,0.0131,64,active biotech notice annual general meeting shareholder,56,7,0,pharmacy,"['active', 'bio', '##tech', 'notice', 'annual', 'general', 'meeting', 'shareholder']",1
146132,nifty_450,2012-04-11, Active Biotech: Notice of Annual General Meeting of Shareholders,Rise,0.0131,65,active biotech notice annual general meeting shareholder,56,7,0,pharmacy,"['active', 'bio', '##tech', 'notice', 'annual', 'general', 'meeting', 'shareholder']",1
146228,nifty_450,2012-04-11,Research and Markets: Pharmaceuticals - Global Group of Eight (G8) Industry Guide,Rise,0.0131,81,research and market pharmaceutical global group eight industry guide,68,9,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'global', 'group', 'eight', 'industry', 'guide']",1
146236,nifty_450,2012-04-11,Research and Markets: Australia In Vitro Diagnostics Market Outlook to 2017,Rise,0.0131,75,research and market australia vitro diagnostics market outlook,62,8,0,pharmacy,"['research', 'and', 'market', 'au', '##stra', '##lia', 'v', '##it', '##ro', 'diagnostic', '##s', 'market', 'outlook']",1
146246,nifty_450,2012-04-11,Research and Markets: Indian Hospital Services Market Outlook,Rise,0.0131,61,research and market indian hospital service market outlook,58,8,0,pharmacy,"['research', 'and', 'market', 'in', '##dian', 'hospital', 'service', 'market', 'outlook']",1
146284,nifty_450,2012-04-11, New Market Research Forecasts the Next Generation Sequencing (NGS) Market,Rise,0.0131,74,new market research forecast the next generation sequencing ng market,69,10,0,pharmacy,"['new', 'market', 'research', 'forecast', 'the', 'next', 'generation', 'se', '##quencing', 'ng', 'market']",1
146364,nifty_450,2012-04-11,"Research and Markets: Cough - Pipeline Review, H1 2012",Rise,0.0131,54,research and market cough pipeline review,41,6,0,pharmacy,"['research', 'and', 'market', 'cough', 'pipeline', 'review']",1
146392,nifty_450,2012-04-11,"Research and Markets: Premature Ejaculation - Pipeline Review, H1 2012",Rise,0.0131,70,research and market premature ejaculation pipeline review,57,7,0,pharmacy,"['research', 'and', 'market', 'premature', 'e', '##ja', '##cula', '##tion', 'pipeline', 'review']",1
146471,nifty_450,2012-04-11,Research and Markets: UAE Healthcare Sector Forecast to 2014,Rise,0.0131,60,research and market uae healthcare sector forecast,50,7,0,pharmacy,"['research', 'and', 'market', 'u', '##ae', 'healthcare', 'sector', 'forecast']",1
146483,nifty_450,2012-04-11,"Research and Markets: Healthcare, Regulatory and Reimbursement Landscape - China 2012",Rise,0.0131,85,research and market healthcare regulatory and reimbursement landscape china,75,9,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'regulatory', 'and', 're', '##im', '##bur', '##se', '##ment', 'landscape', 'chin', '##a']",1
146664,nifty_450,2012-04-11,Research and Markets: GE Healthcare Medical Device Company Intelligence Report,Rise,0.0131,78,research and market healthcare medical device company intelligence report,73,9,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'medical', 'device', 'company', 'intelligence', 'report']",1
146679,nifty_450,2012-04-11,Research and Markets: Understanding Regional Chinese Health Markets. Critical Information and Statistics on National and Regional Health Infrastructure and Provision,Rise,0.0131,165,research and market understanding regional chinese health market critical information and statistic national and regional health infrastructure and provision,157,19,0,pharmacy,"['research', 'and', 'market', 'understanding', 'regional', 'chin', '##ese', 'health', 'market', 'critical', 'information', 'and', 's', '##tat', '##istic', 'national', 'and', 'regional', 'health', 'infrastructure', 'and', 'provision']",1
146944,nifty_450,2012-04-11,"Global Bioenergies: Half-Year Financial Results as of December 31st, 2011",Rise,0.0131,73,global bioenergies half year financial result december,54,7,0,pharmacy,"['global', 'bio', '##ener', '##gies', 'half', 'year', 'financial', 'result', 'de', '##ce', '##mber']",1
148195,nifty_456,2012-04-23,"Japan Signs $22.4 Million Dollar Order For Advanced Chemical, Biological, And Radiological Detection And Early Warning Systems From Lockheed Martin",Neutral,0.0038,147,japan sign million dollar order for advanced chemical biological and radiological detection and early warning system from lockheed martin,137,19,0,pharmacy,"['j', '##apa', '##n', 'sign', 'million', 'dollar', 'order', 'for', 'advanced', 'chemical', 'biological', 'and', 'radio', '##logical', 'detection', 'and', 'early', 'warning', 'system', 'from', 'lock', '##hee', '##d', 'ma', '##rt', '##in']",1
148218,nifty_456,2012-04-23,SD Biotech Association Expands Event for Researchers,Neutral,0.0038,52,biotech association expands event for researcher,48,6,0,pharmacy,"['bio', '##tech', 'association', 'expands', 'event', 'for', 'researcher']",1
148219,nifty_456,2012-04-23,KonLin Letter Cites Clinical Trials and Future Partnerships as Rationale for its Projection of Strong Future Revenue,Neutral,0.0038,116,konlin letter cite clinical trial and future partnership rationale for it projection strong future revenue,106,15,0,pharmacy,"['k', '##on', '##lin', 'letter', 'c', '##ite', 'clinical', 'trial', 'and', 'future', 'partnership', 'rational', '##e', 'for', 'it', 'projection', 'strong', 'future', 'revenue']",1
148254,nifty_456,2012-04-23,Thomson Reuters Launches Life Sciences Partner Ecosystem to Drive Collaborative R&D; Drug Processes,Neutral,0.0038,99,thomson reuters launch life science partner ecosystem drive collaborative drug process,86,11,0,pharmacy,"['th', '##oms', '##on', 're', '##uters', 'launch', 'life', 'science', 'partner', 'ecosystem', 'drive', 'collaborative', 'drug', 'process']",1
148530,nifty_456,2012-04-23,Research and Markets: OTC Pharmaceuticals Market in the United States Is Expected To Increase to a Value of $32.6 Billion by the End of 2015,Neutral,0.0038,140,research and market otc pharmaceutical market the united state expected increase value billion the end,102,15,0,pharmacy,"['research', 'and', 'market', 'o', '##t', '##c', 'pharmaceutical', 'market', 'the', 'united', 'state', 'expected', 'increase', 'value', 'billion', 'the', 'end']",1
148537,nifty_456,2012-04-23,NanoMarkets Says that Dye Sensitized Cell (DSC) PV Market Poised to Expand Greatly in the Next Several Years,Neutral,0.0038,108,nanomarkets say that dye sensitized cell dsc market poised expand greatly the next several year,95,15,0,pharmacy,"['na', '##no', '##market', '##s', 'say', 'that', 'dye', 'se', '##ns', '##iti', '##zed', 'cell', 'd', '##s', '##c', 'market', 'poised', 'expand', 'greatly', 'the', 'next', 'several', 'year']",1
148538,nifty_456,2012-04-23,Research and Markets: OTC Pharmaceuticals Industry in the United Kingdom Expected To Increase To a Value of $5.1 Billion by the End Of 2015,Neutral,0.0038,139,research and market otc pharmaceutical industry the united kingdom expected increase value billion the end,106,15,0,pharmacy,"['research', 'and', 'market', 'o', '##t', '##c', 'pharmaceutical', 'industry', 'the', 'united', 'kingdom', 'expected', 'increase', 'value', 'billion', 'the', 'end']",1
149037,nifty_457,2012-04-24,Novartis Profit Hit by Diovan,Rise,0.0137,29,novartis profit hit diovan,26,4,0,pharmacy,"['no', '##var', '##tis', 'profit', 'hit', 'di', '##ova', '##n']",1
149147,nifty_459,2012-04-26,Bristol-Myers Net Rises 12% on High Cancer Drug Sales,Neutral,0.0016,53,bristol myers net rise high cancer drug sale,44,8,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'net', 'rise', 'high', 'cancer', 'drug', 'sale']",1
150035,nifty_469,2012-05-15, Market Research Forecasts Patient Monitoring Devices Market at $19 Billion by 2016,Neutral,-0.0038,83,market research forecast patient monitoring device market billion,65,8,0,pharmacy,"['market', 'research', 'forecast', 'patient', 'monitoring', 'device', 'market', 'billion']",1
150073,nifty_469,2012-05-15,Acclaimed Innovation Book Macrowikinomics to be Released as a Revised Paperback May 29,Neutral,-0.0038,86,acclaimed innovation book macrowikinomics released revised paperback may,72,8,0,pharmacy,"['acclaimed', 'innovation', 'book', 'mac', '##row', '##iki', '##no', '##mic', '##s', 'released', 'revised', 'paperback', 'may']",1
150092,nifty_469,2012-05-15,"Research and Markets: Partnerships, Licensing, Investments and M&A; Deals and Trends for Q1 2012 in Pharmaceuticals",Neutral,-0.0038,115,research and market partnership licensing investment and deal and trend for pharmaceutical,90,12,0,pharmacy,"['research', 'and', 'market', 'partnership', 'licensing', 'investment', 'and', 'deal', 'and', 'trend', 'for', 'pharmaceutical']",1
150100,nifty_469,2012-05-15,Research and Markets: Tensions Rising between Branded Drugmakers and Health Plans - The Co-Pay Coupon Lawsuit and the Implications,Neutral,-0.0038,130,research and market tension rising between branded drugmakers and health plan the pay coupon lawsuit and the implication,120,18,0,pharmacy,"['research', 'and', 'market', 'tension', 'rising', 'between', 'branded', 'drug', '##makers', 'and', 'health', 'plan', 'the', 'pay', 'coup', '##on', 'lawsuit', 'and', 'the', 'imp', '##lication']",1
150213,nifty_469,2012-05-15,Research and Markets: Gabon Pharmaceuticals and Healthcare Report Q2 2012,Neutral,-0.0038,73,research and market gabon pharmaceutical and healthcare report,62,8,0,pharmacy,"['research', 'and', 'market', 'g', '##ab', '##on', 'pharmaceutical', 'and', 'healthcare', 'report']",1
150220,nifty_469,2012-05-15, Stellar Pharmaceuticals Reports First Quarter 2012 Financial Results,Neutral,-0.0038,69,stellar pharmaceutical report first quarter financial result,60,7,0,pharmacy,"['stellar', 'pharmaceutical', 'report', 'first', 'quarter', 'financial', 'result']",1
150370,nifty_469,2012-05-15,"Research and Markets: Pruritus - Pipeline Review, H1 2012",Neutral,-0.0038,57,research and market pruritus pipeline review,44,6,0,pharmacy,"['research', 'and', 'market', 'p', '##ru', '##rit', '##us', 'pipeline', 'review']",1
150569,nifty_469,2012-05-15,Bristol-Myers Squibb Foundation Announces $15 Million Expansionof Together on DiabetesÂ® to China and India,Neutral,-0.0038,107,bristol myers squibb foundation announces million expansionof together diabetesâ china and india,96,12,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'foundation', 'announces', 'million', 'expansion', '##of', 'together', 'diabetes', '##â', 'chin', '##a', 'and', 'in', '##dia']",1
150615,nifty_469,2012-05-15,"Research and Markets: Clinical Chemistry - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018",Neutral,-0.0038,119,research and market clinical chemistry global pipeline analysis competitive landscape and market forecast,105,13,0,pharmacy,"['research', 'and', 'market', 'clinical', 'chemistry', 'global', 'pipeline', 'analysis', 'competitive', 'landscape', 'and', 'market', 'forecast']",1
150625,nifty_469,2012-05-15,"Research and Markets: Nausea - Pipeline Review, H1 2012 - A Snapshot of the Global Therapeutic Scenario for Nausea",Neutral,-0.0038,114,research and market nausea pipeline review snapshot the global therapeutic scenario for nausea,94,13,0,pharmacy,"['research', 'and', 'market', 'nausea', 'pipeline', 'review', 'snaps', '##hot', 'the', 'global', 'therapeutic', 'scenario', 'for', 'nausea']",1
150627,nifty_469,2012-05-15,"Research and Markets: Patch Pump Drug Delivery Systems. Devices, Markets, Players and Prospects",Neutral,-0.0038,95,research and market patch pump drug delivery system device market player and prospect,85,13,0,pharmacy,"['research', 'and', 'market', 'patch', 'pump', 'drug', 'delivery', 'system', 'device', 'market', 'player', 'and', 'prospect']",1
150768,nifty_469,2012-05-15,Research and Markets: The Global Botox Market Is Forecast To Reach $2.9 Billion by 2018 at A CAGR Of 14% Says New Report,Neutral,-0.0038,120,research and market the global botox market forecast reach billion cagr say new report,86,14,0,pharmacy,"['research', 'and', 'market', 'the', 'global', 'b', '##oto', '##x', 'market', 'forecast', 'reach', 'billion', 'ca', '##g', '##r', 'say', 'new', 'report']",1
150842,nifty_469,2012-05-15,"Research and Markets: the Global Biopsy Devices Market Was Valued at $970M in 2011, and is Forecast to Grow at a CAGR of 5% to Reach $1.4 Billion by 2018",Neutral,-0.0038,153,research and market the global biopsy device market wa valued and forecast grow cagr reach billion,98,16,0,pharmacy,"['research', 'and', 'market', 'the', 'global', 'bio', '##psy', 'device', 'market', 'wa', 'valued', 'and', 'forecast', 'grow', 'ca', '##g', '##r', 'reach', 'billion']",1
150935,nifty_469,2012-05-15,Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock,Neutral,-0.0038,72,arena pharmaceutical announces proposed public offering common stock,68,8,0,pharmacy,"['arena', 'pharmaceutical', 'announces', 'proposed', 'public', 'offering', 'common', 'stock']",1
151076,nifty_469,2012-05-15,"bswift Summit 2012 Focuses on Exchanges, Wellness and Consumerism to Prepare Employers for the Future of Health Care",Neutral,-0.0038,116,bswift summit focus exchange wellness and consumerism prepare employer for the future health care,97,14,0,pharmacy,"['b', '##s', '##wi', '##ft', 'summit', 'focus', 'exchange', 'well', '##ness', 'and', 'consumer', '##ism', 'prepare', 'employer', 'for', 'the', 'future', 'health', 'care']",1
151256,nifty_469,2012-05-15,U.K. Warns on Drug Exports,Neutral,-0.0038,26,warns drug export,17,3,0,pharmacy,"['warns', 'drug', 'export']",1
151313,nifty_470,2012-05-16,RCS - NextGen Group PLC - New Generation Biomarker Products for CSF,Fall,-0.0148,67,rcs nextgen group plc new generation biomarker product for csf,62,10,0,pharmacy,"['r', '##cs', 'next', '##gen', 'group', 'plc', 'new', 'generation', 'bio', '##mark', '##er', 'product', 'for', 'c', '##s', '##f']",1
151517,nifty_470,2012-05-16,"Research and Markets: Surgical Sutures Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018",Fall,-0.0148,115,research and market surgical suture market outlook brics brazil russia india china south africa,95,14,0,pharmacy,"['research', 'and', 'market', 'surgical', 'su', '##ture', 'market', 'outlook', 'br', '##ics', 'bra', '##zi', '##l', 'r', '##uss', '##ia', 'in', '##dia', 'chin', '##a', 'south', 'a', '##f', '##rica']",1
151772,nifty_470,2012-05-16,International Stem Cell Corp Announces First Quarter 2012 Financial Results and Business Highlights,Fall,-0.0148,99,international stem cell corp announces first quarter financial result and business highlight,92,12,0,pharmacy,"['international', 'stem', 'cell', 'co', '##rp', 'announces', 'first', 'quarter', 'financial', 'result', 'and', 'business', 'highlight']",1
151846,nifty_470,2012-05-16,Arena Pharmaceuticals Prices Public Offering of Common Stock,Fall,-0.0148,60,arena pharmaceutical price public offering common stock,55,7,0,pharmacy,"['arena', 'pharmaceutical', 'price', 'public', 'offering', 'common', 'stock']",1
151969,nifty_470,2012-05-16,"Research and Markets: Scar - Pipeline Review, H1 2012",Fall,-0.0148,53,research and market scar pipeline review,40,6,0,pharmacy,"['research', 'and', 'market', 'scar', 'pipeline', 'review']",1
152025,nifty_470,2012-05-16,"Viropro, Inc. to Unlock Value from its Biosimilars Portfolio",Fall,-0.0148,60,viropro inc unlock value from it biosimilars portfolio,54,8,0,pharmacy,"['v', '##iro', '##p', '##ro', 'in', '##c', 'unlock', 'value', 'from', 'it', 'bio', '##si', '##mi', '##lars', 'portfolio']",1
152230,nifty_470,2012-05-16,Scientia Advisors` Patrick Terry to be featured speaker at the Genome-wide Partnering and Deal-making Conference,Fall,-0.0148,112,scientia advisor patrick terry featured speaker the genome wide partnering and deal making conference,101,14,0,pharmacy,"['s', '##cie', '##nti', '##a', 'advisor', 'pat', '##rick', 'te', '##rry', 'featured', 'speaker', 'the', 'genome', 'wide', 'partner', '##ing', 'and', 'deal', 'making', 'conference']",1
152271,nifty_470,2012-05-16, Patient Investing by Developer Allows Seaside to Thrive as New Urban Icon Celebrates 30th Year,Fall,-0.0148,95,patient investing developer allows seaside thrive new urban icon celebrates year,80,11,0,pharmacy,"['patient', 'investing', 'developer', 'allows', 'seas', '##ide', 'th', '##rive', 'new', 'urban', 'icon', 'celebrates', 'year']",1
152455,nifty_470,2012-05-16,Panel of Top Industry Executives to Discuss Biotech and Big Pharma - What`s Next? - 2012 BIO International Convention Keynote,Fall,-0.0148,125,panel top industry executive discus biotech and big pharma what next bio international convention keynote,105,15,0,pharmacy,"['panel', 'top', 'industry', 'executive', 'disc', '##us', 'bio', '##tech', 'and', 'big', 'p', '##har', '##ma', 'what', 'next', 'bio', 'international', 'convention', 'key', '##note']",1
152910,nifty_473,2012-05-22,Timing Good for NCKU to Get into Medical Technology: Academician,Neutral,0.0005,64,timing good for ncku get into medical technology academician,60,9,0,pharmacy,"['timing', 'good', 'for', 'n', '##ck', '##u', 'get', 'into', 'medical', 'technology', 'academic', '##ian']",1
152918,nifty_473,2012-05-22, Market Research Forecasts Oncology Orphan Disease Market at $6.4 Billion by 2018,Neutral,0.0005,81,market research forecast oncology orphan disease market billion,63,8,0,pharmacy,"['market', 'research', 'forecast', 'on', '##cology', 'orphan', 'disease', 'market', 'billion']",1
153027,nifty_473,2012-05-22,US-Based Everist Genomics Bucks the Outsourcing Trend and Accelerates Growth Through India,Neutral,0.0005,90,based everist genomics buck the outsourcing trend and accelerates growth through india,86,12,0,pharmacy,"['based', 'ever', '##ist', 'g', '##eno', '##mic', '##s', 'b', '##uck', 'the', 'outs', '##our', '##cing', 'trend', 'and', 'accelerate', '##s', 'growth', 'through', 'in', '##dia']",1
153030,nifty_473,2012-05-22,BioCryst to Present at Two Upcoming Investor Conferences,Neutral,0.0005,56,biocryst present two upcoming investor conference,49,6,0,pharmacy,"['bio', '##c', '##ry', '##st', 'present', 'two', 'upcoming', 'investor', 'conference']",1
153065,nifty_473,2012-05-22,"Research and Markets: Oligodendroglioma - Pipeline Review, H1 2012",Neutral,0.0005,66,research and market oligodendroglioma pipeline review,53,6,0,pharmacy,"['research', 'and', 'market', 'o', '##li', '##go', '##den', '##dr', '##og', '##lio', '##ma', 'pipeline', 'review']",1
153229,nifty_473,2012-05-22," Biopharmaceutical Companies That Attract Corporate Venture Investment More Likely to Be Acquired, Go Public, Analysis",Neutral,0.0005,118,biopharmaceutical company that attract corporate venture investment more likely acquired public analysis,104,12,0,pharmacy,"['bio', '##pha', '##rma', '##ce', '##utical', 'company', 'that', 'attract', 'corporate', 'venture', 'investment', 'more', 'likely', 'acquired', 'public', 'analysis']",1
153327,nifty_473,2012-05-22,"Research and Markets: China Aged Care Service Industry Report, 2011-2012",Neutral,0.0005,72,research and market china aged care service industry report,59,9,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'aged', 'care', 'service', 'industry', 'report']",1
153676,nifty_473,2012-05-22,Research and Markets: Orphan Disease Therapeutics Market to 2018 - Big Pharma to Target Orphan Diseases,Neutral,0.0005,103,research and market orphan disease therapeutic market big pharma target orphan disease,86,12,0,pharmacy,"['research', 'and', 'market', 'orphan', 'disease', 'therapeutic', 'market', 'big', 'p', '##har', '##ma', 'target', 'orphan', 'disease']",1
153719,nifty_473,2012-05-22,"Research and Markets: The US Is Expected To Lead the OTC Pharmaceuticals Industry in the G8 Nations with a Value of $32,613.4 Million in 2016 Says Latest Report",Neutral,0.0005,160,research and market the expected lead the otc pharmaceutical industry the nation with value million say latest report,117,18,0,pharmacy,"['research', 'and', 'market', 'the', 'expected', 'lead', 'the', 'o', '##t', '##c', 'pharmaceutical', 'industry', 'the', 'nation', 'with', 'value', 'million', 'say', 'latest', 'report']",1
153729,nifty_473,2012-05-22,"Research and Markets: Healthcare Providers: Global Industry Guide - The Global Healthcare Providers Sector Grew By 5.4% in 2011 to Reach a Value of $6,333.1 Billion",Neutral,0.0005,164,research and market healthcare provider global industry guide the global healthcare provider sector grew reach value billion,124,17,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'provider', 'global', 'industry', 'guide', 'the', 'global', 'healthcare', 'provider', 'sector', 'grew', 'reach', 'value', 'billion']",1
153789,nifty_473,2012-05-22,Myriad Genetics to Present at Upcoming Investor Conferences in June,Neutral,0.0005,67,myriad genetics present upcoming investor conference june,57,7,0,pharmacy,"['my', '##riad', 'genetics', 'present', 'upcoming', 'investor', 'conference', 'j', '##une']",1
153810,nifty_473,2012-05-22,ETEX Corporation to present at the 9th World Biomaterial Congress,Neutral,0.0005,65,etex corporation present the world biomaterial congress,55,7,0,pharmacy,"['et', '##ex', 'corporation', 'present', 'the', 'world', 'bio', '##mate', '##rial', 'congress']",1
154395,nifty_474,2012-05-23,Research and Markets: Livestock Epigenetics: Information on this Rapidly Expanding Field of Research from a Global Team of Experts,Neutral,0.002,130,research and market livestock epigenetics information this rapidly expanding field research from global team expert,115,15,0,pharmacy,"['research', 'and', 'market', 'livestock', 'e', '##pi', '##gene', '##tics', 'information', 'this', 'rapidly', 'expanding', 'field', 'research', 'from', 'global', 'team', 'expert']",1
154412,nifty_474,2012-05-23,"Research and Markets: Injectable Antibodies. Products, Markets, Players and Forecasts",Neutral,0.002,85,research and market injectable antibody product market player and forecast,74,10,0,pharmacy,"['research', 'and', 'market', 'in', '##ject', '##able', 'anti', '##body', 'product', 'market', 'player', 'and', 'forecast']",1
154423,nifty_474,2012-05-23,"Research and Markets: Non-Insulin Diabetes. Management Products, Players, Markets, and Forecasts",Neutral,0.002,96,research and market non insulin diabetes management product player market and forecast,86,12,0,pharmacy,"['research', 'and', 'market', 'non', 'insulin', 'diabetes', 'management', 'product', 'player', 'market', 'and', 'forecast']",1
154424,nifty_474,2012-05-23,"Research and Markets: Cushing's Syndrome - Pipeline Review, H1 2012",Neutral,0.002,67,research and market cushing syndrome pipeline review,52,7,0,pharmacy,"['research', 'and', 'market', 'cu', '##shing', 'syndrome', 'pipeline', 'review']",1
154455,nifty_474,2012-05-23,Research and Markets: Oral Drug Delivery Market to 2017 - Patients to See Innovations in the Market,Neutral,0.002,99,research and market oral drug delivery market patient see innovation the market,79,12,0,pharmacy,"['research', 'and', 'market', 'oral', 'drug', 'delivery', 'market', 'patient', 'see', 'innovation', 'the', 'market']",1
154612,nifty_474,2012-05-23,"Research and Markets: Restenosis - Pipeline Review, H1 2012",Neutral,0.002,59,research and market restenosis pipeline review,46,6,0,pharmacy,"['research', 'and', 'market', 'rest', '##eno', '##sis', 'pipeline', 'review']",1
154768,nifty_474,2012-05-23,IMMUNE Pharmaceuticals Announces Strategic Partnership With the World-Renowned Weizmann Institute,Neutral,0.002,97,immune pharmaceutical announces strategic partnership with the world renowned weizmann institute,96,11,0,pharmacy,"['immune', 'pharmaceutical', 'announces', 'strategic', 'partnership', 'with', 'the', 'world', 'renowned', 'we', '##iz', '##mann', 'institute']",1
155632,nifty_476,2012-05-29,Zealand Pharma to Present at Upcoming Global Healthcare Investor Conferences in the US,Fall,-0.0145,86,zealand pharma present upcoming global healthcare investor conference the,73,9,0,pharmacy,"['z', '##eal', '##and', 'p', '##har', '##ma', 'present', 'upcoming', 'global', 'healthcare', 'investor', 'conference', 'the']",1
155654,nifty_476,2012-05-29,Research and Markets: How to Reap Big Health Care Savings Through a Dependent Audit,Fall,-0.0145,83,research and market how reap big health care saving through dependent audit,75,12,0,pharmacy,"['research', 'and', 'market', 'how', 're', '##ap', 'big', 'health', 'care', 'saving', 'through', 'dependent', 'audit']",1
155884,nifty_476,2012-05-29,Genomic Health to Present at Two Upcoming Investor Conferences,Fall,-0.0145,62,genomic health present two upcoming investor conference,55,7,0,pharmacy,"['g', '##eno', '##mic', 'health', 'present', 'two', 'upcoming', 'investor', 'conference']",1
155900,nifty_476,2012-05-29,Bristol-Myers Squibb Announces Global Collaboration with Leading Academic Institutions to Advance Science of Immuno-Oncology,Fall,-0.0145,124,bristol myers squibb announces global collaboration with leading academic institution advance science immuno oncology,117,14,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'announces', 'global', 'collaboration', 'with', 'leading', 'academic', 'institution', 'advance', 'science', 'im', '##mu', '##no', 'on', '##cology']",1
155921,nifty_476,2012-05-29,Research and Markets: Understanding Medical Research: The Studies That Shaped Medicine,Fall,-0.0145,86,research and market understanding medical research the study that shaped medicine,81,11,0,pharmacy,"['research', 'and', 'market', 'understanding', 'medical', 'research', 'the', 'study', 'that', 'shaped', 'medicine']",1
155922,nifty_476,2012-05-29,"Research and Markets: Pharmacoepidemiology, 5th Edition",Fall,-0.0145,55,research and market pharmacoepidemiology edition,48,5,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##coe', '##pid', '##em', '##iology', 'edition']",1
155932,nifty_476,2012-05-29,GeneNews to Present at BioFinance 2012,Fall,-0.0145,38,genenews present biofinance,27,3,0,pharmacy,"['gene', '##ne', '##ws', 'present', 'bio', '##fin', '##ance']",1
155956,nifty_476,2012-05-29,Research and Markets: The Year in Immunology: Immunoregulatory Mechanisms,Fall,-0.0145,73,research and market the year immunology immunoregulatory mechanism,66,8,0,pharmacy,"['research', 'and', 'market', 'the', 'year', 'im', '##mu', '##nology', 'im', '##mu', '##nor', '##eg', '##ulatory', 'mechanism']",1
155988,nifty_476,2012-05-29," Upcoming Economic Outlook - Report Highlights Genetic Technologies Limited (ADR) and Complete Genomics, Inc.",Fall,-0.0145,109,upcoming economic outlook report highlight genetic technology limited adr and complete genomics inc,99,13,0,pharmacy,"['upcoming', 'economic', 'outlook', 'report', 'highlight', 'genetic', 'technology', 'limited', 'ad', '##r', 'and', 'complete', 'g', '##eno', '##mic', '##s', 'in', '##c']",1
156231,nifty_476,2012-05-29,Research and Markets: EPO Biosimilars Market Forecast to 2015,Fall,-0.0145,61,research and market epo biosimilars market forecast,51,7,0,pharmacy,"['research', 'and', 'market', 'e', '##po', 'bio', '##si', '##mi', '##lars', 'market', 'forecast']",1
156241,nifty_476,2012-05-29,Webinar: Health Experts Provide Update on Current Infectious Disease Threats,Fall,-0.0145,76,webinar health expert provide update current infectious disease threat,70,9,0,pharmacy,"['web', '##ina', '##r', 'health', 'expert', 'provide', 'update', 'current', 'infectious', 'disease', 'threat']",1
156286,nifty_476,2012-05-29,"Digital Marketing Plays Key Role in Global Pharmaceutical Launches, Finds Cutting Edge Information",Fall,-0.0145,98,digital marketing play key role global pharmaceutical launch find cutting edge information,90,12,0,pharmacy,"['digital', 'marketing', 'play', 'key', 'role', 'global', 'pharmaceutical', 'launch', 'find', 'cutting', 'edge', 'information']",1
156410,nifty_476,2012-05-29,Research and Markets: Biomedical Engineering. Bridging Medicine and Technology,Fall,-0.0145,78,research and market biomedical engineering bridging medicine and technology,75,9,0,pharmacy,"['research', 'and', 'market', 'bio', '##medical', 'engineering', 'br', '##id', '##ging', 'medicine', 'and', 'technology']",1
156446,nifty_476,2012-05-29,Onyx Pharmaceuticals to Present at Upcoming Investor Conferences,Fall,-0.0145,64,onyx pharmaceutical present upcoming investor conference,56,6,0,pharmacy,"['on', '##yx', 'pharmaceutical', 'present', 'upcoming', 'investor', 'conference']",1
156475,nifty_476,2012-05-29,NPS Pharmaceuticals to Present at Jefferies Global Healthcare Conference,Fall,-0.0145,72,np pharmaceutical present jefferies global healthcare conference,64,7,0,pharmacy,"['n', '##p', 'pharmaceutical', 'present', 'j', '##ef', '##fer', '##ies', 'global', 'healthcare', 'conference']",1
156493,nifty_476,2012-05-29,Gilead Sciences to Present at Two Upcoming Investor Conferences,Fall,-0.0145,63,gilead science present two upcoming investor conference,55,7,0,pharmacy,"['g', '##ile', '##ad', 'science', 'present', 'two', 'upcoming', 'investor', 'conference']",1
156529,nifty_476,2012-05-29,"AMAG Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences",Fall,-0.0145,70,amag pharmaceutical inc present upcoming investor conference,60,7,0,pharmacy,"['am', '##ag', 'pharmaceutical', 'in', '##c', 'present', 'upcoming', 'investor', 'conference']",1
156733,nifty_478,2012-05-31, Prima BioMed to Host Shareholder Briefing,Fall,-0.0252,42,prima biomed host shareholder briefing,38,5,0,pharmacy,"['p', '##rima', 'bio', '##med', 'host', 'shareholder', 'brief', '##ing']",1
156762,nifty_478,2012-05-31,REG - Biome Technologies - Trading Update,Fall,-0.0252,41,reg biome technology trading update,35,5,0,pharmacy,"['re', '##g', 'bio', '##me', 'technology', 'trading', 'update']",1
156860,nifty_478,2012-05-31," CSD reports continued growth in pharmaceutical marketing investments in Brazil and China, whereas Russia declines",Fall,-0.0252,114,csd report continued growth pharmaceutical marketing investment brazil and china whereas russia decline,103,13,0,pharmacy,"['c', '##s', '##d', 'report', 'continued', 'growth', 'pharmaceutical', 'marketing', 'investment', 'bra', '##zi', '##l', 'and', 'chin', '##a', 'whereas', 'r', '##uss', '##ia', 'decline']",1
156972,nifty_478,2012-05-31,Research and Markets: HGH Biosimilars Market Forecast to 2015,Fall,-0.0252,61,research and market hgh biosimilars market forecast,51,7,0,pharmacy,"['research', 'and', 'market', 'h', '##gh', 'bio', '##si', '##mi', '##lars', 'market', 'forecast']",1
156974,nifty_478,2012-05-31,Research and Markets: Obsessive Compulsive Disorder (OCD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019,Fall,-0.0252,121,research and market obsessive compulsive disorder ocd therapeutic pipeline assessment and market forecast,105,13,0,pharmacy,"['research', 'and', 'market', 'o', '##bs', '##ess', '##ive', 'com', '##pu', '##lsive', 'disorder', 'o', '##c', '##d', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
157087,nifty_478,2012-05-31,Research and Markets: Healthcare Providers - Top 5 Emerging Markets Industry Guide,Fall,-0.0252,82,research and market healthcare provider top emerging market industry guide,74,10,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'provider', 'top', 'emerging', 'market', 'industry', 'guide']",1
157251,nifty_478,2012-05-31,"Research and Markets: Triple Analysis: Pancreatic Cancer, Cancer Vaccines and Protein Kinase Inhibitors",Fall,-0.0252,103,research and market triple analysis pancreatic cancer cancer vaccine and protein kinase inhibitor,97,13,0,pharmacy,"['research', 'and', 'market', 'triple', 'analysis', 'pan', '##cre', '##atic', 'cancer', 'cancer', 'vaccine', 'and', 'protein', 'kinase', 'inhibitor']",1
157254,nifty_478,2012-05-31,"Research and Markets: Triple Analysis: Pancreatic Cancer, Protein Kinase Inhibitors and Peptides",Fall,-0.0252,96,research and market triple analysis pancreatic cancer protein kinase inhibitor and peptide,90,12,0,pharmacy,"['research', 'and', 'market', 'triple', 'analysis', 'pan', '##cre', '##atic', 'cancer', 'protein', 'kinase', 'inhibitor', 'and', 'p', '##eptide']",1
157292,nifty_478,2012-05-31,Celldex Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference,Fall,-0.0252,82,celldex therapeutic present the jefferies global healthcare conference,70,8,0,pharmacy,"['cell', '##de', '##x', 'therapeutic', 'present', 'the', 'j', '##ef', '##fer', '##ies', 'global', 'healthcare', 'conference']",1
157346,nifty_478,2012-05-31,EHNAC to Host Industry Forum for Financial Institutions on Protected Health Information (PHI),Fall,-0.0252,93,ehnac host industry forum for financial institution protected health information phi,84,11,0,pharmacy,"['eh', '##nac', 'host', 'industry', 'forum', 'for', 'financial', 'institution', 'protected', 'health', 'information', 'p', '##hi']",1
157424,nifty_478,2012-05-31,BioCurex Announces Investment Into the Company by Paulson Investment Company,Fall,-0.0252,76,biocurex announces investment into the company paulson investment company,73,9,0,pharmacy,"['bio', '##cure', '##x', 'announces', 'investment', 'into', 'the', 'company', 'p', '##aul', '##son', 'investment', 'company']",1
157793,nifty_478,2012-05-31,The Advisory Board Company to Highlight New Technology Capabilities that Support Accountable Care,Fall,-0.0252,97,the advisory board company highlight new technology capability that support accountable care,92,12,0,pharmacy,"['the', 'advisory', 'board', 'company', 'highlight', 'new', 'technology', 'capability', 'that', 'support', 'account', '##able', 'care']",1
157855,nifty_478,2012-05-31,Health Management to Present at Investor Conferences in June,Fall,-0.0252,60,health management present investor conference june,50,6,0,pharmacy,"['health', 'management', 'present', 'investor', 'conference', 'j', '##une']",1
158598,nifty_485,2012-06-13, Market Research Forecasts the Asian Medical Devices Market at $71 Billion by 2015,Rise,0.0106,82,market research forecast the asian medical device market billion,64,9,0,pharmacy,"['market', 'research', 'forecast', 'the', 'as', '##ian', 'medical', 'device', 'market', 'billion']",1
158701,nifty_485,2012-06-13,Research and Markets: The Pharmaceutical Market: USA. Enhanced Strategic Intelligence In A User-friendly Format,Rise,0.0106,111,research and market the pharmaceutical market usa enhanced strategic intelligence user friendly format,102,13,0,pharmacy,"['research', 'and', 'market', 'the', 'pharmaceutical', 'market', 'us', '##a', 'enhanced', 'strategic', 'intelligence', 'user', 'friendly', 'format']",1
158862,nifty_485,2012-06-13,Seventh Sense Biosystems Appoints President and CEO and Closes $10 Million Series-A Financing,Rise,0.0106,93,seventh sense biosystems appoints president and ceo and close million series financing,86,12,0,pharmacy,"['seventh', 'sense', 'bio', '##sy', '##ste', '##ms', 'appoint', '##s', 'president', 'and', 'c', '##eo', 'and', 'close', 'million', 'series', 'financing']",1
158928,nifty_485,2012-06-13, Today's Market Driven by Key Factors - Featured Research on Quest Diagnostics Inc and Lions Gate Entertainment Corp.,Rise,0.0106,117,today market driven key factor featured research quest diagnostics inc and lion gate entertainment corp,103,15,0,pharmacy,"['today', 'market', 'driven', 'key', 'factor', 'featured', 'research', 'quest', 'diagnostic', '##s', 'in', '##c', 'and', 'lion', 'gate', 'entertainment', 'co', '##rp']",1
159035,nifty_485,2012-06-13,Research and Markets: The Pharmaceutical Market: Switzerland,Rise,0.0106,60,research and market the pharmaceutical market switzerland,57,7,0,pharmacy,"['research', 'and', 'market', 'the', 'pharmaceutical', 'market', 's', '##witz', '##erland']",1
159122,nifty_485,2012-06-13,Healthways to Present at the INVEST Tennessee Equity Conference,Rise,0.0106,63,healthways present the invest tennessee equity conference,57,7,0,pharmacy,"['health', '##ways', 'present', 'the', 'invest', 'ten', '##ness', '##ee', 'equity', 'conference']",1
159337,nifty_485,2012-06-13,Prime Therapeutics reports one of the industry's lowest drug trends in its annual Drug Trend Insights report,Rise,0.0106,108,prime therapeutic report one the industry lowest drug trend it annual drug trend insight report,95,15,0,pharmacy,"['prime', 'therapeutic', 'report', 'one', 'the', 'industry', 'lowest', 'drug', 'trend', 'it', 'annual', 'drug', 'trend', 'insight', 'report']",1
159388,nifty_485,2012-06-13,Aegerion Pharmaceuticals Announces Proposed Public Offering of Common Stock,Rise,0.0106,75,aegerion pharmaceutical announces proposed public offering common stock,71,8,0,pharmacy,"['a', '##ege', '##rion', 'pharmaceutical', 'announces', 'proposed', 'public', 'offering', 'common', 'stock']",1
159878,nifty_486,2012-06-14,Research and Markets: China Healthcare Market Analysis,Rise,0.005,54,research and market china healthcare market analysis,52,7,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'healthcare', 'market', 'analysis']",1
159903,nifty_486,2012-06-14,Research and Markets: The Pharmaceutical Market: Israel. Enhanced Strategic Intelligence In A User-Friendly Format,Rise,0.005,114,research and market the pharmaceutical market israel enhanced strategic intelligence user friendly format,105,13,0,pharmacy,"['research', 'and', 'market', 'the', 'pharmaceutical', 'market', 'is', '##rae', '##l', 'enhanced', 'strategic', 'intelligence', 'user', 'friendly', 'format']",1
159951,nifty_486,2012-06-14,Research and Markets: The Pharmaceutical Market: South Korea,Rise,0.005,60,research and market the pharmaceutical market south korea,57,8,0,pharmacy,"['research', 'and', 'market', 'the', 'pharmaceutical', 'market', 'south', 'k', '##ore', '##a']",1
159993,nifty_486,2012-06-14,The 2nd Pharma Logistics China 2012 is Upcoming,Rise,0.005,47,the pharma logistics china upcoming,35,5,0,pharmacy,"['the', 'p', '##har', '##ma', 'logistics', 'chin', '##a', 'upcoming']",1
160148,nifty_486,2012-06-14," Calendar of Events - Report Highlights Arena Pharmaceuticals, Inc. and VIVUS, Inc.",Rise,0.005,83,calendar event report highlight arena pharmaceutical inc and vivus inc,70,10,0,pharmacy,"['calendar', 'event', 'report', 'highlight', 'arena', 'pharmaceutical', 'in', '##c', 'and', 'v', '##iv', '##us', 'in', '##c']",1
160190,nifty_486,2012-06-14,Aegerion Pharmaceuticals Prices Public Offering of Common Stock,Rise,0.005,63,aegerion pharmaceutical price public offering common stock,58,7,0,pharmacy,"['a', '##ege', '##rion', 'pharmaceutical', 'price', 'public', 'offering', 'common', 'stock']",1
160272,nifty_486,2012-06-14,Senate Majority Leaders Daschle and Frist Headline Conference on the Role of Technology Innovation in Health Care Delivery,Rise,0.005,122,senate majority leader daschle and frist headline conference the role technology innovation health care delivery,112,15,0,pharmacy,"['senate', 'majority', 'leader', 'das', '##ch', '##le', 'and', 'f', '##rist', 'headline', 'conference', 'the', 'role', 'technology', 'innovation', 'health', 'care', 'delivery']",1
160368,nifty_486,2012-06-14,Research and Markets: Japan Pharmaceuticals and Healthcare Report Q3 2012,Rise,0.005,73,research and market japan pharmaceutical and healthcare report,62,8,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##n', 'pharmaceutical', 'and', 'healthcare', 'report']",1
160380,nifty_486,2012-06-14,Research and Markets: Healthcare Providers in the United States,Rise,0.005,63,research and market healthcare provider the united state,56,8,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'provider', 'the', 'united', 'state']",1
160491,nifty_486,2012-06-14,Sanovas Secures First U.S. Patent for Microinvasive Lung Cancer Technology,Rise,0.005,74,sanovas secures first patent for microinvasive lung cancer technology,69,9,0,pharmacy,"['sa', '##nova', '##s', 'secure', '##s', 'first', 'patent', 'for', 'micro', '##in', '##vasive', 'lung', 'cancer', 'technology']",1
160523,nifty_486,2012-06-14, ChinaBio(R) and BioCentury Boost News Flow From China's Life Science Industry,Rise,0.005,78,chinabio and biocentury boost news flow from china life science industry,72,11,0,pharmacy,"['chin', '##abi', '##o', 'and', 'bio', '##cent', '##ury', 'boost', 'news', 'flow', 'from', 'chin', '##a', 'life', 'science', 'industry']",1
161332,nifty_493,2012-06-27,Research and Markets: Psychobiological Approaches for Anxiety Disorders: Treatment Combination Strategies,Neutral,-0.0029,105,research and market psychobiological approach for anxiety disorder treatment combination strategy,97,11,0,pharmacy,"['research', 'and', 'market', 'ps', '##ych', '##ob', '##iol', '##ogical', 'approach', 'for', 'anxiety', 'disorder', 'treatment', 'combination', 'strategy']",1
161344,nifty_493,2012-06-27,Research and Markets: Molecular Cancer Therapeutics: Strategies for Drug Discovery and Development,Neutral,-0.0029,98,research and market molecular cancer therapeutic strategy for drug discovery and development,92,12,0,pharmacy,"['research', 'and', 'market', 'molecular', 'cancer', 'therapeutic', 'strategy', 'for', 'drug', 'discovery', 'and', 'development']",1
161352,nifty_493,2012-06-27,Research and Markets: Collaborative / Therapeutic Assessment: A Casebook and Guide,Neutral,-0.0029,82,research and market collaborative therapeutic assessment casebook and guide,75,9,0,pharmacy,"['research', 'and', 'market', 'collaborative', 'therapeutic', 'assessment', 'case', '##book', 'and', 'guide']",1
161408,nifty_493,2012-06-27,"Research and Markets: Health Psychology, 2nd Edition",Neutral,-0.0029,52,research and market health psychology edition,45,6,0,pharmacy,"['research', 'and', 'market', 'health', 'psychology', 'edition']",1
161449,nifty_493,2012-06-27,"Armed with Impressive Partnerships, Can This Emerging Innovator Become 2012's Most Successful Medical Device IPO?",Neutral,-0.0029,113,armed with impressive partnership can this emerging innovator become most successful medical device ipo,103,14,0,pharmacy,"['armed', 'with', 'impressive', 'partnership', 'can', 'this', 'emerging', 'inn', '##ova', '##tor', 'become', 'most', 'successful', 'medical', 'device', 'i', '##po']",1
161453,nifty_493,2012-06-27,Research and Markets: Basen (Type 2 Diabetes) - Analysis and Forecasts to 2020,Neutral,-0.0029,78,research and market basen type diabetes analysis and forecast,61,9,0,pharmacy,"['research', 'and', 'market', 'base', '##n', 'type', 'diabetes', 'analysis', 'and', 'forecast']",1
161480,nifty_493,2012-06-27,Research and Markets: 3M Medical Device Company Intelligence Report,Neutral,-0.0029,67,research and market medical device company intelligence report,62,8,0,pharmacy,"['research', 'and', 'market', 'medical', 'device', 'company', 'intelligence', 'report']",1
161541,nifty_493,2012-06-27,Fund View: T Rowe health fund finds value in biotechs,Neutral,-0.0029,53,fund view rowe health fund find value biotech,45,8,0,pharmacy,"['fund', 'view', 'row', '##e', 'health', 'fund', 'find', 'value', 'bio', '##tech']",1
161555,nifty_493,2012-06-27,Research and Markets: ASP1941 (Type 2 Diabetes) - Analysis and Forecasts to 2020,Neutral,-0.0029,80,research and market asp type diabetes analysis and forecast,59,9,0,pharmacy,"['research', 'and', 'market', 'as', '##p', 'type', 'diabetes', 'analysis', 'and', 'forecast']",1
161559,nifty_493,2012-06-27,"Elite Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year Ending March 31st, 2012 Investor Conference Call on Tuesday, July 3, 2012",Neutral,-0.0029,142,elite pharmaceutical inc announces fourth quarter and fiscal year ending march investor conference call tuesday july,116,16,0,pharmacy,"['elite', 'pharmaceutical', 'in', '##c', 'announces', 'fourth', 'quarter', 'and', 'fiscal', 'year', 'ending', 'march', 'investor', 'conference', 'call', 't', '##ues', '##day', 'j', '##ul', '##y']",1
161612,nifty_493,2012-06-27,Research and Markets: Acute Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019,Neutral,-0.0029,96,research and market acute pain therapeutic pipeline assessment and market forecast,82,11,0,pharmacy,"['research', 'and', 'market', 'acute', 'pain', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
161660,nifty_493,2012-06-27,Equity Briefing : Cel-Sci's CEO Kersten sounds bullish on MultikineR  Phase III trial progress,Neutral,-0.0029,94,equity briefing cel sci ceo kersten sound bullish multikiner phase iii trial progress,85,13,0,pharmacy,"['equity', 'brief', '##ing', 'c', '##el', 's', '##ci', 'c', '##eo', 'k', '##ers', '##ten', 'sound', 'bull', '##ish', 'multi', '##kin', '##er', 'phase', 'ii', '##i', 'trial', 'progress']",1
161667,nifty_493,2012-06-27,Research and Markets: OTC Pharmaceuticals in Germany,Neutral,-0.0029,52,research and market otc pharmaceutical germany,46,6,0,pharmacy,"['research', 'and', 'market', 'o', '##t', '##c', 'pharmaceutical', 'g', '##erman', '##y']",1
161713,nifty_493,2012-06-27,"Research and Markets: Re-evaluating Pharmaceutical Pipelines - Emerging Markets, Biologics and Orphan Drugs to Shape Future Decision Making",Neutral,-0.0029,139,research and market evaluating pharmaceutical pipeline emerging market biologics and orphan drug shape future decision making,125,16,0,pharmacy,"['research', 'and', 'market', 'evaluating', 'pharmaceutical', 'pipeline', 'emerging', 'market', 'bio', '##log', '##ics', 'and', 'orphan', 'drug', 'shape', 'future', 'decision', 'making']",1
161816,nifty_493,2012-06-27,"Novosit Inks $7.5 Million Deal to Host, Distribute Brainware Distiller",Neutral,-0.0029,70,novosit ink million deal host distribute brainware distiller,60,8,0,pharmacy,"['no', '##vos', '##it', 'ink', 'million', 'deal', 'host', 'distribute', 'brain', '##ware', 'di', '##st', '##ille', '##r']",1
161973,nifty_493,2012-06-27,Research and Markets: Acute Respiratory Distress Syndrome (ARDS) Therapeutics - Pipeline Assessment and Market Forecasts to 2019,Neutral,-0.0029,128,research and market acute respiratory distress syndrome ards therapeutic pipeline assessment and market forecast,112,14,0,pharmacy,"['research', 'and', 'market', 'acute', 'respiratory', 'distress', 'syndrome', 'a', '##rds', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
162062,nifty_493,2012-06-27,"Research and Markets: China pharmaceutical manufacturing industry, 2012 study provides in-depth analysis and detailed insight into the pharmaceutical manufacturing industry",Neutral,-0.0029,172,research and market china pharmaceutical manufacturing industry study provides depth analysis and detailed insight into the pharmaceutical manufacturing industry,161,19,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'pharmaceutical', 'manufacturing', 'industry', 'study', 'provides', 'depth', 'analysis', 'and', 'detailed', 'insight', 'into', 'the', 'pharmaceutical', 'manufacturing', 'industry']",1
162104,nifty_493,2012-06-27,Alliance Yields New Analytic Capabilities and Insights to Healthcare Market Research,Neutral,-0.0029,84,alliance yield new analytic capability and insight healthcare market research,77,10,0,pharmacy,"['alliance', 'yield', 'new', 'anal', '##ytic', 'capability', 'and', 'insight', 'healthcare', 'market', 'research']",1
162654,nifty_496,2012-07-05,Research and Markets: Biological Strategies in the Emerging Markets - BRIC Countries Will Underpin Future Pharma Growth,Fall,-0.0095,119,research and market biological strategy the emerging market bric country will underpin future pharma growth,107,15,0,pharmacy,"['research', 'and', 'market', 'biological', 'strategy', 'the', 'emerging', 'market', 'br', '##ic', 'country', 'will', 'under', '##pin', 'future', 'p', '##har', '##ma', 'growth']",1
162786,nifty_496,2012-07-05,Research and Markets: Rare and Niche Diseases Catalyst Monitor - Key Event Analysis H1 2012,Fall,-0.0095,91,research and market rare and niche disease catalyst monitor key event analysis,78,12,0,pharmacy,"['research', 'and', 'market', 'rare', 'and', 'niche', 'disease', 'catalyst', 'monitor', 'key', 'event', 'analysis']",1
162852,nifty_496,2012-07-05,Research and Markets: Smiths Medical Medical Device Company Intelligence Report,Fall,-0.0095,79,research and market smith medical medical device company intelligence report,76,10,0,pharmacy,"['research', 'and', 'market', 's', '##mith', 'medical', 'medical', 'device', 'company', 'intelligence', 'report']",1
162898,nifty_496,2012-07-05,"Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs",Fall,-0.0095,141,arena pharmaceutical promotes craig audet executive officer senior vice president operation and head global regulatory affair,125,16,0,pharmacy,"['arena', 'pharmaceutical', 'promotes', 'c', '##rai', '##g', 'au', '##det', 'executive', 'officer', 'senior', 'vice', 'president', 'operation', 'and', 'head', 'global', 'regulatory', 'affair']",1
163031,nifty_496,2012-07-05,Research and Markets: Epilepsy Partnering 2007-2012,Fall,-0.0095,51,research and market epilepsy partnering,39,5,0,pharmacy,"['research', 'and', 'market', 'e', '##pile', '##psy', 'partner', '##ing']",1
163388,nifty_496,2012-07-05,"Equity Briefing: Healthcare Review; ARNA, OSUR and GERN Move",Fall,-0.0095,60,equity briefing healthcare review arna osur and gern move,57,9,0,pharmacy,"['equity', 'brief', '##ing', 'healthcare', 'review', 'a', '##rna', 'o', '##su', '##r', 'and', 'g', '##ern', 'move']",1
163393,nifty_496,2012-07-05,"Equity Briefing: Healthcare Review; SXCI, CYTR and MDGN Move",Fall,-0.0095,60,equity briefing healthcare review sxci cytr and mdgn move,57,9,0,pharmacy,"['equity', 'brief', '##ing', 'healthcare', 'review', 's', '##x', '##ci', 'c', '##yt', '##r', 'and', 'm', '##d', '##gn', 'move']",1
164010,nifty_498,2012-07-10,Research and Markets: Competitor Analysis: B7 - CD28/CTLA-4 Pathway,Neutral,0.0001,67,research and market competitor analysis ctla pathway,52,7,0,pharmacy,"['research', 'and', 'market', 'competitor', 'analysis', 'c', '##tl', '##a', 'pathway']",1
164183,nifty_498,2012-07-10,Research and Markets: Emerging Pharmaceutical Market in Argentina - Domestic Pharmaceutical Companies Dominate the Market with More Than 55% of the Industry Revenue,Neutral,0.0001,164,research and market emerging pharmaceutical market argentina domestic pharmaceutical company dominate the market with more than the industry revenue,148,19,0,pharmacy,"['research', 'and', 'market', 'emerging', 'pharmaceutical', 'market', 'a', '##rgent', '##ina', 'domestic', 'pharmaceutical', 'company', 'dominate', 'the', 'market', 'with', 'more', 'than', 'the', 'industry', 'revenue']",1
164223,nifty_498,2012-07-10,"Research and Markets: General Anxiety Disorder - Pipeline Review, H1 2012",Neutral,0.0001,73,research and market general anxiety disorder pipeline review,60,8,0,pharmacy,"['research', 'and', 'market', 'general', 'anxiety', 'disorder', 'pipeline', 'review']",1
164228,nifty_498,2012-07-10," Huge News Just Released: Centaurus Diamond Technologies (CTDT), Preventia (PVTA), Oncosec Medical (ONCS), B2Gold Corp (BGLPF), Nov",Neutral,0.0001,131,huge news just released centaurus diamond technology ctdt preventia pvta oncosec medical oncs bgold corp bglpf nov,114,17,0,pharmacy,"['huge', 'news', 'just', 'released', 'cent', '##aurus', 'diamond', 'technology', 'c', '##t', '##dt', 'prevent', '##ia', 'p', '##v', '##ta', 'on', '##cos', '##ec', 'medical', 'on', '##cs', 'b', '##gold', 'co', '##rp', 'b', '##g', '##l', '##pf', 'no', '##v']",1
164244,nifty_498,2012-07-10,"A Top Five Pharmaceutical Company Upgrades to the Revitas Flex Platform, Capitalizes on Enterprise Revenue Dynamics",Neutral,0.0001,115,top five pharmaceutical company upgrade the revitas flex platform capitalizes enterprise revenue dynamic,104,13,0,pharmacy,"['top', 'five', 'pharmaceutical', 'company', 'upgrade', 'the', 're', '##vi', '##tas', 'fl', '##ex', 'platform', 'capital', '##izes', 'enterprise', 'revenue', 'dynamic']",1
164257,nifty_498,2012-07-10,Practice Fusion Drives Innovation as Health Tech Incubator,Neutral,0.0001,58,practice fusion drive innovation health tech incubator,54,7,0,pharmacy,"['practice', 'fusion', 'drive', 'innovation', 'health', 'tech', 'in', '##cu', '##bat', '##or']",1
164264,nifty_498,2012-07-10,Thomson Reuters Welcomes Inova Software to Its Partner Ecosystem for Life Sciences,Neutral,0.0001,82,thomson reuters welcome inova software it partner ecosystem for life science,76,11,0,pharmacy,"['th', '##oms', '##on', 're', '##uters', 'welcome', 'in', '##ova', 'software', 'it', 'partner', 'ecosystem', 'for', 'life', 'science']",1
164306,nifty_498,2012-07-10,"The Zacks Analyst Blog Highlights: Qiagen, Bristol-Myers Squibb, Eli Lilly, Quest Diagnostics and Myriad Genetics",Neutral,0.0001,113,the zacks analyst blog highlight qiagen bristol myers squibb eli lilly quest diagnostics and myriad genetics,108,16,0,pharmacy,"['the', 'z', '##ack', '##s', 'analyst', 'blog', 'highlight', 'q', '##ia', '##gen', 'br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'el', '##i', 'l', '##ill', '##y', 'quest', 'diagnostic', '##s', 'and', 'my', '##riad', 'genetics']",1
164343,nifty_498,2012-07-10," Latest News Just Released: PVTA (Preventia), CTDT (Centaurus Diamond Tech), ONVO (Organovo Holdings), DYNIQ (Dynergy), BGLPF (B2Go",Neutral,0.0001,131,latest news just released pvta preventia ctdt centaurus diamond tech onvo organovo holding dyniq dynergy bglpf bgo,114,17,0,pharmacy,"['latest', 'news', 'just', 'released', 'p', '##v', '##ta', 'prevent', '##ia', 'c', '##t', '##dt', 'cent', '##aurus', 'diamond', 'tech', 'on', '##vo', 'organ', '##ovo', 'holding', 'd', '##yn', '##iq', 'd', '##yne', '##rgy', 'b', '##g', '##l', '##pf', 'b', '##go']",1
165014,nifty_499,2012-07-11,REG - Ultrasis PLC - China Hospital Partnership,Neutral,-0.0048,47,reg ultrasis plc china hospital partnership,43,6,0,pharmacy,"['re', '##g', 'ultra', '##sis', 'plc', 'chin', '##a', 'hospital', 'partnership']",1
165025,nifty_499,2012-07-11,"Equity Briefing: Healthcare Review - KERX, MAKO, OMPI, CHTP, IART and OSUR Move",Neutral,-0.0048,79,equity briefing healthcare review kerx mako ompi chtp iart and osur move,72,12,0,pharmacy,"['equity', 'brief', '##ing', 'healthcare', 'review', 'k', '##er', '##x', 'ma', '##ko', 'o', '##mp', '##i', 'ch', '##t', '##p', 'i', '##art', 'and', 'o', '##su', '##r', 'move']",1
165207,nifty_499,2012-07-11, Market Research Forecasts Radiotherapy Devices Market at $5.8 Billion by 2016,Neutral,-0.0048,78,market research forecast radiotherapy device market billion,59,7,0,pharmacy,"['market', 'research', 'forecast', 'radio', '##ther', '##ap', '##y', 'device', 'market', 'billion']",1
165348,nifty_499,2012-07-11,"Research and Markets: Wrinkles - Pipeline Review, H1 2012",Neutral,-0.0048,57,research and market wrinkle pipeline review,43,6,0,pharmacy,"['research', 'and', 'market', 'w', '##rin', '##kle', 'pipeline', 'review']",1
165355,nifty_499,2012-07-11,Research and Markets: Herceptin (Breast Cancer) - Analysis and Forecasts to 2020,Neutral,-0.0048,80,research and market herceptin breast cancer analysis and forecast,65,9,0,pharmacy,"['research', 'and', 'market', 'her', '##ce', '##pt', '##in', 'breast', 'cancer', 'analysis', 'and', 'forecast']",1
165390,nifty_499,2012-07-11,"Research and Markets: Narcolepsy - Pipeline Review, H1 2012",Neutral,-0.0048,59,research and market narcolepsy pipeline review,46,6,0,pharmacy,"['research', 'and', 'market', 'na', '##rc', '##ole', '##psy', 'pipeline', 'review']",1
165492,nifty_499,2012-07-11,"Interview with Array BioPharma CEO: Vast Pipeline, Robust Partnerships, and 2012 Catalysts",Neutral,-0.0048,90,interview with array biopharma ceo vast pipeline robust partnership and catalyst,80,11,0,pharmacy,"['interview', 'with', 'array', 'bio', '##pha', '##rma', 'c', '##eo', 'vast', 'pipeline', 'robust', 'partnership', 'and', 'catalyst']",1
165702,nifty_499,2012-07-11,BioPharm America 2012 Program to Feature First SciBX: Science-Business eXchange Innovation in BioPharma Summit,Neutral,-0.0048,110,biopharm america program feature first scibx science business exchange innovation biopharma summit,98,12,0,pharmacy,"['bio', '##pha', '##rm', 'am', '##eric', '##a', 'program', 'feature', 'first', 's', '##ci', '##b', '##x', 'science', 'business', 'exchange', 'innovation', 'bio', '##pha', '##rma', 'summit']",1
165741,nifty_499,2012-07-11,Research and Markets: Stem Cell Research in India 2012,Neutral,-0.0048,54,research and market stem cell research india,44,7,0,pharmacy,"['research', 'and', 'market', 'stem', 'cell', 'research', 'in', '##dia']",1
165826,nifty_499,2012-07-11,"Research and Markets: Neurofibromatoses - Pipeline Review, H1 2012",Neutral,-0.0048,66,research and market neurofibromatoses pipeline review,53,6,0,pharmacy,"['research', 'and', 'market', 'ne', '##uro', '##fi', '##bro', '##mat', '##ose', '##s', 'pipeline', 'review']",1
165856,nifty_499,2012-07-11,Research and Markets: Diabetic Foot Ulcer Therapeutics - Pipeline Assessment and Market Forecasts to 2019,Neutral,-0.0048,105,research and market diabetic foot ulcer therapeutic pipeline assessment and market forecast,91,12,0,pharmacy,"['research', 'and', 'market', 'di', '##abe', '##tic', 'foot', 'ul', '##cer', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
165858,nifty_499,2012-07-11,"Research and Markets: Partnerships, Licensing, Investments and M&A; Deals and Trends for Q2 2012 in Pharmaceuticals",Neutral,-0.0048,115,research and market partnership licensing investment and deal and trend for pharmaceutical,90,12,0,pharmacy,"['research', 'and', 'market', 'partnership', 'licensing', 'investment', 'and', 'deal', 'and', 'trend', 'for', 'pharmaceutical']",1
165930,nifty_499,2012-07-11,Research and Markets: Medical Market Tracker,Neutral,-0.0048,44,research and market medical market tracker,42,6,0,pharmacy,"['research', 'and', 'market', 'medical', 'market', 'track', '##er']",1
165937,nifty_499,2012-07-11,"Research and Markets: U.S. Market Report for Diabetes Monitoring, Treatment and Drug Delivery - Expected to exceed $17.87 billion by 2018",Neutral,-0.0048,137,research and market market report for diabetes monitoring treatment and drug delivery expected exceed billion,109,15,0,pharmacy,"['research', 'and', 'market', 'market', 'report', 'for', 'diabetes', 'monitoring', 'treatment', 'and', 'drug', 'delivery', 'expected', 'exceed', 'billion']",1
166436,nifty_500,2012-07-12,BioElectronics Corporation Announces Initiative for UK and German Markets,Rise,0.0168,73,bioelectronics corporation announces initiative for and german market,69,8,0,pharmacy,"['bio', '##ele', '##ct', '##ronic', '##s', 'corporation', 'announces', 'initiative', 'for', 'and', 'g', '##erman', 'market']",1
166549,nifty_500,2012-07-12,"BioClinica, Inc. to Participate in Upcoming Industry Events and Demonstrate Global Technology-Enhanced Capabilities",Rise,0.0168,115,bioclinica inc participate upcoming industry event and demonstrate global technology enhanced capability,104,12,0,pharmacy,"['bio', '##c', '##lini', '##ca', 'in', '##c', 'participate', 'upcoming', 'industry', 'event', 'and', 'demonstrate', 'global', 'technology', 'enhanced', 'capability']",1
166624,nifty_500,2012-07-12,"IMS Study Forecasts Rebound in Global Spending on Medicines, Reaching Nearly $1.2 Trillion By 2016",Rise,0.0168,98,ims study forecast rebound global spending medicine reaching nearly trillion,76,10,0,pharmacy,"['im', '##s', 'study', 'forecast', 're', '##bound', 'global', 'spending', 'medicine', 'reaching', 'nearly', 'trillion']",1
166627,nifty_500,2012-07-12,Abaxis: Cash Resources Will Allow Us To Scale Our Medical Business,Rise,0.0168,66,abaxis cash resource will allow scale our medical business,58,9,0,pharmacy,"['a', '##ba', '##xi', '##s', 'cash', 'resource', 'will', 'allow', 'scale', 'our', 'medical', 'business']",1
166635,nifty_500,2012-07-12,Research and Markets: 2012 U.S. Market for Gastro Intestinal Devices - Executive Summary,Rise,0.0168,88,research and market market for gastro intestinal device executive summary,73,10,0,pharmacy,"['research', 'and', 'market', 'market', 'for', 'gas', '##tro', 'in', '##test', '##inal', 'device', 'executive', 'summary']",1
166770,nifty_500,2012-07-12,Research and Markets: Pancreatitis Therapeutics - The Pancreatitis Therapeutics Market is Forecast to Decline until 2019,Rise,0.0168,120,research and market pancreatitis therapeutic the pancreatitis therapeutic market forecast decline until,103,12,0,pharmacy,"['research', 'and', 'market', 'pan', '##cre', '##ati', '##tis', 'therapeutic', 'the', 'pan', '##cre', '##ati', '##tis', 'therapeutic', 'market', 'forecast', 'decline', 'until']",1
166806,nifty_500,2012-07-12,Complete Genomics shares rise on new technology,Rise,0.0168,47,complete genomics share rise new technology,43,6,0,pharmacy,"['complete', 'g', '##eno', '##mic', '##s', 'share', 'rise', 'new', 'technology']",1
166807,nifty_500,2012-07-12,"ImmunoGen, Inc. Prices Public Offering of Common Stock",Rise,0.0168,54,immunogen inc price public offering common stock,48,7,0,pharmacy,"['im', '##mu', '##no', '##gen', 'in', '##c', 'price', 'public', 'offering', 'common', 'stock']",1
166810,nifty_500,2012-07-12,"Research and Markets: Bariatric Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018",Rise,0.0168,126,research and market bariatric surgery device global pipeline analysis competitive landscape and market forecast,111,14,0,pharmacy,"['research', 'and', 'market', 'bar', '##ia', '##tric', 'surgery', 'device', 'global', 'pipeline', 'analysis', 'competitive', 'landscape', 'and', 'market', 'forecast']",1
166956,nifty_500,2012-07-12,Research and Markets: End-stage Renal Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2019,Rise,0.0168,109,research and market end stage renal disease therapeutic pipeline assessment and market forecast,95,13,0,pharmacy,"['research', 'and', 'market', 'end', 'stage', 're', '##nal', 'disease', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
167042,nifty_500,2012-07-12,"Research and Markets: Panic Disorders - Pipeline Review, H1 2012",Rise,0.0168,64,research and market panic disorder pipeline review,50,7,0,pharmacy,"['research', 'and', 'market', 'panic', 'disorder', 'pipeline', 'review']",1
167140,nifty_500,2012-07-12,"Equity Briefing : GNOM, AFFY and MRK are Notable Gainers in Healthcare",Rise,0.0168,70,equity briefing gnom affy and mrk are notable gainer healthcare,63,10,0,pharmacy,"['equity', 'brief', '##ing', 'g', '##no', '##m', 'a', '##ffy', 'and', 'm', '##rk', 'are', 'notable', 'gain', '##er', 'healthcare']",1
167613,nifty_501,2012-07-16,"Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China",Rise,0.0069,161,ampio advance nce cancer drug into preclinical development following successful recent financing and the granting patent usa canada europe and china,148,21,0,pharmacy,"['am', '##pio', 'advance', 'n', '##ce', 'cancer', 'drug', 'into', 'pre', '##c', '##lini', '##cal', 'development', 'following', 'successful', 'recent', 'financing', 'and', 'the', 'granting', 'patent', 'us', '##a', 'can', '##ada', 'euro', '##pe', 'and', 'chin', '##a']",1
167680,nifty_501,2012-07-16,Research and Markets: 2012 Healthcare Benchmarks: Embedded Case Management,Rise,0.0069,74,research and market healthcare benchmark embedded case management,65,8,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'bench', '##mark', 'embedded', 'case', 'management']",1
167804,nifty_501,2012-07-16,Research and Markets: Comprehensive Biophysics,Rise,0.0069,46,research and market comprehensive biophysics,44,5,0,pharmacy,"['research', 'and', 'market', 'comprehensive', 'bio', '##physics']",1
167904,nifty_501,2012-07-16,Research and Markets: 2012 Outsourcing Guide for the Drugs & Biotechnology Industry,Rise,0.0069,83,research and market outsourcing guide for the drug biotechnology industry,73,10,0,pharmacy,"['research', 'and', 'market', 'outs', '##our', '##cing', 'guide', 'for', 'the', 'drug', 'bio', '##tech', '##nology', 'industry']",1
167958,nifty_501,2012-07-16,Research and Markets: The Top 25 Global Healthcare Buildings Projects: Project Guide,Rise,0.0069,84,research and market the top global healthcare building project project guide,76,11,0,pharmacy,"['research', 'and', 'market', 'the', 'top', 'global', 'healthcare', 'building', 'project', 'project', 'guide']",1
167959,nifty_501,2012-07-16,BioTime CEO Dr. Michael West to Present at the 2012 Agora Financial Investment Symposium,Rise,0.0069,88,biotime ceo michael west present the agora financial investment symposium,73,10,0,pharmacy,"['bio', '##time', 'c', '##eo', 'mi', '##cha', '##el', 'west', 'present', 'the', 'ago', '##ra', 'financial', 'investment', 's', '##ym', '##po', '##sium']",1
168109,nifty_501,2012-07-16," Must See Trades: Centaurus Diamond Technologies (CTDT), Sky Power Solutions (SPOW), Patriot Coal (PCSCQ), Life Design Station (LDS",Rise,0.0069,131,must see trade centaurus diamond technology ctdt sky power solution spow patriot coal pcscq life design station lds,115,18,0,pharmacy,"['must', 'see', 'trade', 'cent', '##aurus', 'diamond', 'technology', 'c', '##t', '##dt', 'sky', 'power', 'solution', 's', '##po', '##w', 'pat', '##riot', 'coal', 'p', '##cs', '##c', '##q', 'life', 'design', 'station', 'l', '##ds']",1
168241,nifty_501,2012-07-16,Research and Markets: The Home Healthcare Device Market Expected To Reach an Estimated US $29 Billion in 2017 with A CAGR Of 3.4% over the Next Five Years,Rise,0.0069,154,research and market the home healthcare device market expected reach estimated billion with cagr over the next five year,120,19,0,pharmacy,"['research', 'and', 'market', 'the', 'home', 'healthcare', 'device', 'market', 'expected', 'reach', 'estimated', 'billion', 'with', 'ca', '##g', '##r', 'over', 'the', 'next', 'five', 'year']",1
168253,nifty_501,2012-07-16,"Research and Markets: Global Medical Device Industry 2012-2017: Trends, Profits and Forecast Analysis - APAC is projected to lead the market and grow at the highest CAGR during the forecast period",Rise,0.0069,196,research and market global medical device industry trend profit and forecast analysis apac projected lead the market and grow the highest cagr during the forecast period,169,26,0,pharmacy,"['research', 'and', 'market', 'global', 'medical', 'device', 'industry', 'trend', 'profit', 'and', 'forecast', 'analysis', 'a', '##pa', '##c', 'projected', 'lead', 'the', 'market', 'and', 'grow', 'the', 'highest', 'ca', '##g', '##r', 'during', 'the', 'forecast', 'period']",1
168285,nifty_501,2012-07-16,AIBioTech Purchases Mitotyping Technologies,Rise,0.0069,43,aibiotech purchase mitotyping technology,40,4,0,pharmacy,"['a', '##ibi', '##ote', '##ch', 'purchase', 'mit', '##ot', '##y', '##ping', 'technology']",1
168503,nifty_501,2012-07-16,Fight against obesity is major investment trend - BofA,Rise,0.0069,54,fight against obesity major investment trend bofa,49,7,0,pharmacy,"['fight', 'against', 'o', '##besity', 'major', 'investment', 'trend', 'b', '##of', '##a']",1
168504,nifty_501,2012-07-16,Fight against obesity is major investment trend: BofA,Rise,0.0069,53,fight against obesity major investment trend bofa,49,7,0,pharmacy,"['fight', 'against', 'o', '##besity', 'major', 'investment', 'trend', 'b', '##of', '##a']",1
168884,nifty_502,2012-07-17,Research and Markets: Bladder Pathology,Rise,0.0074,39,research and market bladder pathology,37,5,0,pharmacy,"['research', 'and', 'market', 'bladder', 'path', '##ology']",1
168914,nifty_502,2012-07-17,Bionexo Announces Partnership with Insight Venture Partners,Rise,0.0074,59,bionexo announces partnership with insight venture partner,58,7,0,pharmacy,"['bio', '##nex', '##o', 'announces', 'partnership', 'with', 'insight', 'venture', 'partner']",1
168964,nifty_502,2012-07-17,Research and Markets: International IT Regulations and Compliance. Quality Standards in the Pharmaceutical and Regulated Industries,Rise,0.0074,131,research and market international regulation and compliance quality standard the pharmaceutical and regulated industry,118,14,0,pharmacy,"['research', 'and', 'market', 'international', 'regulation', 'and', 'compliance', 'quality', 'standard', 'the', 'pharmaceutical', 'and', 'regulated', 'industry']",1
169008,nifty_502,2012-07-17,Rising Medical Solutions Deploys Advanced Technology Responding to Marketplace Demand,Rise,0.0074,85,rising medical solution deploys advanced technology responding marketplace demand,81,9,0,pharmacy,"['rising', 'medical', 'solution', 'deploy', '##s', 'advanced', 'technology', 'responding', 'marketplace', 'demand']",1
169068,nifty_502,2012-07-17,Research and Markets: Pharmaceutical Lifecycle Management. Making the Most of Each and Every Brand,Rise,0.0074,98,research and market pharmaceutical lifecycle management making the most each and every brand,92,13,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'life', '##cycle', 'management', 'making', 'the', 'most', 'each', 'and', 'every', 'brand']",1
169406,nifty_502,2012-07-17,"Human Genome Sciences Shareholder Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate Sale of Human Genome Sciences to GlaxoSmithKline plc",Rise,0.0074,149,human genome science shareholder alert the briscoe law firm and power taylor llp investigate sale human genome science glaxosmithkline plc,138,20,0,pharmacy,"['human', 'genome', 'science', 'shareholder', 'alert', 'the', 'br', '##isco', '##e', 'law', 'firm', 'and', 'power', 'ta', '##yl', '##or', 'll', '##p', 'investigate', 'sale', 'human', 'genome', 'science', 'g', '##lax', '##os', '##mith', '##k', '##line', 'plc']",1
169433,nifty_502,2012-07-17,UPDATE 1-BrainStorm to sell shares to fund clinical trials,Rise,0.0074,58,update brainstorm sell share fund clinical trial,48,7,0,pharmacy,"['update', 'brains', '##tor', '##m', 'sell', 'share', 'fund', 'clinical', 'trial']",1
169434,nifty_502,2012-07-17,"Government, Healthcare & Citizen ID Market Worth in Excess of $86 Billion over the Next Five Years, Says ABI Research",Rise,0.0074,117,government healthcare citizen market worth excess billion over the next five year say abi research,98,15,0,pharmacy,"['government', 'healthcare', 'citizen', 'market', 'worth', 'excess', 'billion', 'over', 'the', 'next', 'five', 'year', 'say', 'a', '##bi', 'research']",1
169478,nifty_502,2012-07-17,The Biomedical Device Industry in America: Challenges at Home and Abroad,Rise,0.0074,72,the biomedical device industry america challenge home and abroad,64,9,0,pharmacy,"['the', 'bio', '##medical', 'device', 'industry', 'am', '##eric', '##a', 'challenge', 'home', 'and', 'abroad']",1
169615,nifty_502,2012-07-17," EncounterCare Forms New Subsidiary Cyber Fuels, Inc. and Partners for Addiction Recovery Treatment",Rise,0.0074,99,encountercare form new subsidiary cyber fuel inc and partner for addiction recovery treatment,93,13,0,pharmacy,"['encounter', '##care', 'form', 'new', 'subsidiary', 'c', '##y', '##ber', 'fuel', 'in', '##c', 'and', 'partner', 'for', 'addiction', 'recovery', 'treatment']",1
169727,nifty_502,2012-07-17,Research and Markets: 2012 Healthcare Benchmarks: Accountable Care Organizations,Rise,0.0074,80,research and market healthcare benchmark accountable care organization,70,8,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'bench', '##mark', 'account', '##able', 'care', 'organization']",1
169878,nifty_502,2012-07-17," Biomni Establishes Business Presence in Singapore, China, and Japan",Rise,0.0074,68,biomni establishes business presence singapore china and japan,62,8,0,pharmacy,"['bio', '##m', '##ni', 'establishes', 'business', 'presence', 'sing', '##ap', '##ore', 'chin', '##a', 'and', 'j', '##apa', '##n']",1
170085,nifty_504,2012-07-19,Problems Hit Novartis,Fall,-0.0091,21,problem hit novartis,20,3,0,pharmacy,"['problem', 'hit', 'no', '##var', '##tis']",1
170463,nifty_505,2012-07-23,Research and Markets: Japanese Biotechnology Sector: Industry Profile,Fall,-0.0086,69,research and market japanese biotechnology sector industry profile,66,8,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##nese', 'bio', '##tech', '##nology', 'sector', 'industry', 'profile']",1
170516,nifty_505,2012-07-23,"Research and Markets: Eye Care in the United Kingdom: Market Sizes, Forecasts, and Company Shares",Fall,-0.0086,97,research and market eye care the united kingdom market size forecast and company share,86,14,0,pharmacy,"['research', 'and', 'market', 'eye', 'care', 'the', 'united', 'kingdom', 'market', 'size', 'forecast', 'and', 'company', 'share']",1
170586,nifty_505,2012-07-23,"New Study Reveals Digital Differences between PAs, APRNs and RNs and Physicians and Key Opportunities for Marketers",Fall,-0.0086,115,new study reveals digital difference between pa aprns and rn and physician and key opportunity for marketer,107,17,0,pharmacy,"['new', 'study', 'reveals', 'digital', 'difference', 'between', 'p', '##a', 'a', '##p', '##rns', 'and', 'r', '##n', 'and', 'physician', 'and', 'key', 'opportunity', 'for', 'market', '##er']",1
170691,nifty_505,2012-07-23,Research and Markets: European Directory of Biotechnology Companies 2012-2013,Fall,-0.0086,77,research and market european directory biotechnology company,60,7,0,pharmacy,"['research', 'and', 'market', 'euro', '##pe', '##an', 'directory', 'bio', '##tech', '##nology', 'company']",1
170786,nifty_505,2012-07-23,"Leading India-USA based CRO Announces Data Management/EDC, Medical Writing Milestone",Fall,-0.0086,84,leading india usa based cro announces data management edc medical writing milestone,83,12,0,pharmacy,"['leading', 'in', '##dia', 'us', '##a', 'based', 'c', '##ro', 'announces', 'data', 'management', 'ed', '##c', 'medical', 'writing', 'milestone']",1
170806,nifty_505,2012-07-23,"Research and Markets: Cardiogenic Shock - Pipeline Review, H1 2012",Fall,-0.0086,66,research and market cardiogenic shock pipeline review,53,7,0,pharmacy,"['research', 'and', 'market', 'card', '##io', '##genic', 'shock', 'pipeline', 'review']",1
170911,nifty_505,2012-07-23,Research and Markets: Biobanks - 2012 Year Book,Fall,-0.0086,47,research and market biobanks year book,38,6,0,pharmacy,"['research', 'and', 'market', 'bio', '##bank', '##s', 'year', 'book']",1
170989,nifty_505,2012-07-23,"Economy 2012: PWC Chairman says healthcare, tech lead growth",Fall,-0.0086,60,economy pwc chairman say healthcare tech lead growth,52,8,0,pharmacy,"['economy', 'p', '##w', '##c', 'chairman', 'say', 'healthcare', 'tech', 'lead', 'growth']",1
171082,nifty_505,2012-07-23,Bioniche Life Sciences Inc. Moves Closer to Market Launch of Immunocidinâ¢,Fall,-0.0086,75,bioniche life science inc move closer market launch immunocidinâ,64,9,0,pharmacy,"['bio', '##nic', '##he', 'life', 'science', 'in', '##c', 'move', 'closer', 'market', 'launch', 'im', '##mu', '##no', '##cid', '##in', '##â']",1
171290,nifty_505,2012-07-23," International Biotech Gurus, Renowned Consultants, Venture Capitalists and Industry Participants Assemble for Bio Business ASIA 2012",Fall,-0.0086,133,international biotech guru renowned consultant venture capitalist and industry participant assemble for bio business asia,121,15,0,pharmacy,"['international', 'bio', '##tech', 'g', '##uru', 'renowned', 'consultant', 'venture', 'capitalist', 'and', 'industry', 'participant', 'assemble', 'for', 'bio', 'business', 'as', '##ia']",1
171494,nifty_507,2012-07-25,Patent Expirations Hurt Bristol-Myers,Rise,0.0165,37,patent expiration hurt bristol myers,36,5,0,pharmacy,"['patent', 'ex', '##piration', 'hurt', 'br', '##ist', '##ol', 'my', '##ers']",1
171549,nifty_508,2012-07-26,Europe Drug Makers Face Patent Woes,Rise,0.0184,35,europe drug maker face patent woe,33,6,0,pharmacy,"['euro', '##pe', 'drug', 'maker', 'face', 'patent', 'w', '##oe']",1
171726,nifty_511,2012-08-01,Pharming secures EUR10 million working capital facility from existing investors,Fall,-0.0069,79,pharming secures eur million working capital facility from existing investor,76,10,0,pharmacy,"['p', '##har', '##ming', 'secure', '##s', 'e', '##ur', 'million', 'working', 'capital', 'facility', 'from', 'existing', 'investor']",1
171728,nifty_511,2012-08-01, Pharming Secures EUR10 Million Working Capital Facility From Existing Investors,Fall,-0.0069,80,pharming secures eur million working capital facility from existing investor,76,10,0,pharmacy,"['p', '##har', '##ming', 'secure', '##s', 'e', '##ur', 'million', 'working', 'capital', 'facility', 'from', 'existing', 'investor']",1
171971,nifty_511,2012-08-01,Genetic Engineering Drug Sector Globally & in China Examined in New Report Published at MarketPublishers.com,Fall,-0.0069,108,genetic engineering drug sector globally china examined new report published marketpublishers com,97,12,0,pharmacy,"['genetic', 'engineering', 'drug', 'sector', 'globally', 'chin', '##a', 'examined', 'new', 'report', 'published', 'market', '##pu', '##b', '##lish', '##ers', 'com']",1
172084,nifty_511,2012-08-01,Synageva BioPharma to Present at Upcoming Investor Conferences,Fall,-0.0069,62,synageva biopharma present upcoming investor conference,55,6,0,pharmacy,"['s', '##yna', '##ge', '##va', 'bio', '##pha', '##rma', 'present', 'upcoming', 'investor', 'conference']",1
172097,nifty_511,2012-08-01,Research and Markets: Analysis of the Video Telemedicine Market: Sifting Through the Real and Imagined Value for Healthcare,Fall,-0.0069,123,research and market analysis the video telemedicine market sifting through the real and imagined value for healthcare,117,17,0,pharmacy,"['research', 'and', 'market', 'analysis', 'the', 'video', 'te', '##lem', '##edic', '##ine', 'market', 'si', '##fting', 'through', 'the', 'real', 'and', 'imagined', 'value', 'for', 'healthcare']",1
172292,nifty_511,2012-08-01,"Former Chairman and CEO of Celgene Believes His New Firm Can Become ""A Substantial Player"" in Biotech",Fall,-0.0069,101,former chairman and ceo celgene belief his new firm can become substantial player biotech,89,14,0,pharmacy,"['former', 'chairman', 'and', 'c', '##eo', 'c', '##el', '##gene', 'belief', 'his', 'new', 'firm', 'can', 'become', 'substantial', 'player', 'bio', '##tech']",1
172361,nifty_511,2012-08-01,"Medgenic's New Chairman Bullish on Platform Technology, Medical Economics, and Expanded Applications",Fall,-0.0069,100,medgenic new chairman bullish platform technology medical economics and expanded application,92,11,0,pharmacy,"['me', '##dge', '##nic', 'new', 'chairman', 'bull', '##ish', 'platform', 'technology', 'medical', 'economics', 'and', 'expanded', 'application']",1
172459,nifty_511,2012-08-01,"Research and Markets: Research Report on Chinese Medicine Intermediate Industry, 2012",Fall,-0.0069,85,research and market research report chinese medicine intermediate industry,74,9,0,pharmacy,"['research', 'and', 'market', 'research', 'report', 'chin', '##ese', 'medicine', 'intermediate', 'industry']",1
172529,nifty_511,2012-08-01," Pharma Partnering Dollars Continue to Decline for Biotech, Burrill & Company Reports",Fall,-0.0069,85,pharma partnering dollar continue decline for biotech burrill company report,76,10,0,pharmacy,"['p', '##har', '##ma', 'partner', '##ing', 'dollar', 'continue', 'decline', 'for', 'bio', '##tech', 'b', '##ur', '##rill', 'company', 'report']",1
172590,nifty_511,2012-08-01,Research and Markets: Future Molecular Diagnostics and NAT Market: Sales Forecasts and Key Supplier Shares (DataPack),Fall,-0.0069,117,research and market future molecular diagnostics and nat market sale forecast and key supplier share datapack,109,16,0,pharmacy,"['research', 'and', 'market', 'future', 'molecular', 'diagnostic', '##s', 'and', 'na', '##t', 'market', 'sale', 'forecast', 'and', 'key', 'supplier', 'share', 'data', '##pack']",1
172605,nifty_511,2012-08-01,Research and Markets: Top 200 Biopharmaceutical Companies (Global),Fall,-0.0069,66,research and market top biopharmaceutical company global,56,7,0,pharmacy,"['research', 'and', 'market', 'top', 'bio', '##pha', '##rma', '##ce', '##utical', 'company', 'global']",1
172676,nifty_511,2012-08-01,Research and Markets: U.S. Market for Patient Monitoring Equipment - Market Expected to Exceed $4 billion by 2018,Fall,-0.0069,113,research and market market for patient monitoring equipment market expected exceed billion,90,12,0,pharmacy,"['research', 'and', 'market', 'market', 'for', 'patient', 'monitoring', 'equipment', 'market', 'expected', 'exceed', 'billion']",1
172731,nifty_511,2012-08-01,"Healthcare Review: Genworth & Laboratory Corp. Soars, Array Biopharma Slumps On News",Fall,-0.0069,84,healthcare review genworth laboratory corp soar array biopharma slump news,74,10,0,pharmacy,"['healthcare', 'review', 'g', '##en', '##worth', 'laboratory', 'co', '##rp', 'so', '##ar', 'array', 'bio', '##pha', '##rma', 's', '##lump', 'news']",1
172821,nifty_511,2012-08-01,NPS Pharmaceuticals Reports Second Quarter 2012 Financial Results,Fall,-0.0069,65,np pharmaceutical report second quarter financial result,56,7,0,pharmacy,"['n', '##p', 'pharmaceutical', 'report', 'second', 'quarter', 'financial', 'result']",1
172859,nifty_511,2012-08-01,BioSante Pharmaceuticals Reports Second Quarter Financial Results and Pipeline Update,Fall,-0.0069,85,biosante pharmaceutical report second quarter financial result and pipeline update,82,10,0,pharmacy,"['bio', '##san', '##te', 'pharmaceutical', 'report', 'second', 'quarter', 'financial', 'result', 'and', 'pipeline', 'update']",1
173223,nifty_512,2012-08-02,Silence Therapeutics - Admission of Shares and Board Update,Rise,0.0198,59,silence therapeutic admission share and board update,52,7,0,pharmacy,"['silence', 'therapeutic', 'admission', 'share', 'and', 'board', 'update']",1
173327,nifty_512,2012-08-02,"Research and Markets: Japanese Encephalitis - Pipeline Review, H1 2012",Rise,0.0198,70,research and market japanese encephalitis pipeline review,57,7,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##nese', 'en', '##ce', '##pha', '##lit', '##is', 'pipeline', 'review']",1
173329,nifty_512,2012-08-02,Research and Markets: The US Molecular Diagnostics and NAT Market: Sales Forecasts and Key Supplier Shares (DataPack),Rise,0.0198,117,research and market the molecular diagnostics and nat market sale forecast and key supplier share datapack,106,16,0,pharmacy,"['research', 'and', 'market', 'the', 'molecular', 'diagnostic', '##s', 'and', 'na', '##t', 'market', 'sale', 'forecast', 'and', 'key', 'supplier', 'share', 'data', '##pack']",1
173331,nifty_512,2012-08-02,Research and Markets: US Biotechnology Sector: Industry Profile,Rise,0.0198,63,research and market biotechnology sector industry profile,57,7,0,pharmacy,"['research', 'and', 'market', 'bio', '##tech', '##nology', 'sector', 'industry', 'profile']",1
173380,nifty_512,2012-08-02,BioCryst Provides Corporate Update and Reports Second Quarter 2012 Financial Results,Rise,0.0198,84,biocryst provides corporate update and report second quarter financial result,77,10,0,pharmacy,"['bio', '##c', '##ry', '##st', 'provides', 'corporate', 'update', 'and', 'report', 'second', 'quarter', 'financial', 'result']",1
173475,nifty_512,2012-08-02," Bioheart Receives $ 2 Million Term Sheet Investment Offer From Vitalmex, a Global Leader in Healthcare in Latin America and Europe",Rise,0.0198,131,bioheart receives million term sheet investment offer from vitalmex global leader healthcare latin america and europe,117,16,0,pharmacy,"['bio', '##heart', 'receives', 'million', 'term', 'sheet', 'investment', 'offer', 'from', 'vital', '##me', '##x', 'global', 'leader', 'healthcare', 'la', '##tin', 'am', '##eric', '##a', 'and', 'euro', '##pe']",1
173542,nifty_512,2012-08-02,Research and Markets: Israel Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery,Rise,0.0198,114,research and market israel diabetes care device market outlook glucose monitoring and insulin delivery,102,14,0,pharmacy,"['research', 'and', 'market', 'is', '##rae', '##l', 'diabetes', 'care', 'device', 'market', 'outlook', 'glucose', 'monitoring', 'and', 'insulin', 'delivery']",1
173560,nifty_512,2012-08-02,Amicus Therapeutics: Strong Catalyst Trade With GlaxoSmithKline And Heavy Insider Buying,Rise,0.0198,88,amicus therapeutic strong catalyst trade with glaxosmithkline and heavy insider buying,86,11,0,pharmacy,"['am', '##icus', 'therapeutic', 'strong', 'catalyst', 'trade', 'with', 'g', '##lax', '##os', '##mith', '##k', '##line', 'and', 'heavy', 'inside', '##r', 'buying']",1
173653,nifty_512,2012-08-02,Celldex Therapeutics to Report Second Quarter 2012 Financial Results and Host Corporate 2012 Objectives Update Call,Rise,0.0198,115,celldex therapeutic report second quarter financial result and host corporate objective update call,99,13,0,pharmacy,"['cell', '##de', '##x', 'therapeutic', 'report', 'second', 'quarter', 'financial', 'result', 'and', 'host', 'corporate', 'objective', 'update', 'call']",1
173769,nifty_512,2012-08-02,"Bion Announces Initial Success of Advanced Separation Technology Pilot -- Enables Improved Asset Recovery, Further Reductions of N & P, Increased Sustainability at Lower Cost",Rise,0.0198,174,bion announces initial success advanced separation technology pilot enables improved asset recovery further reduction increased sustainability lower cost,153,18,0,pharmacy,"['bio', '##n', 'announces', 'initial', 'success', 'advanced', 'separation', 'technology', 'pilot', 'enables', 'improved', 'asset', 'recovery', 'further', 'reduction', 'increased', 'sustainability', 'lower', 'cost']",1
173770,nifty_512,2012-08-02,"Research and Markets: The UK AIDS Testing Market (DataPack) - 2012 Report Features Companies such as Roche, Novartis Diagnostics and Abbott",Rise,0.0198,139,research and market the aid testing market datapack report feature company such roche novartis diagnostics and abbott,117,17,0,pharmacy,"['research', 'and', 'market', 'the', 'aid', 'testing', 'market', 'data', '##pack', 'report', 'feature', 'company', 'such', 'r', '##och', '##e', 'no', '##var', '##tis', 'diagnostic', '##s', 'and', 'abbot', '##t']",1
173801,nifty_512,2012-08-02,Idenix Pharmaceuticals Prices Public Offering of Common Stock,Rise,0.0198,61,idenix pharmaceutical price public offering common stock,56,7,0,pharmacy,"['id', '##eni', '##x', 'pharmaceutical', 'price', 'public', 'offering', 'common', 'stock']",1
173875,nifty_512,2012-08-02,Health IT Booming Due to Affordable Care Act and Electronic Health Records,Rise,0.0198,74,health booming due affordable care act and electronic health record,67,10,0,pharmacy,"['health', 'boom', '##ing', 'due', 'affordable', 'care', 'act', 'and', 'electronic', 'health', 'record']",1
173991,nifty_512,2012-08-02,"Accounting for Nearly 90 Percent of Major-Market Sales in 2011, the United States Dominates the Bipolar Disorder Drug Market",Rise,0.0198,124,accounting for nearly percent major market sale the united state dominates the bipolar disorder drug market,107,16,0,pharmacy,"['accounting', 'for', 'nearly', 'percent', 'major', 'market', 'sale', 'the', 'united', 'state', 'dominate', '##s', 'the', 'bi', '##pol', '##ar', 'disorder', 'drug', 'market']",1
173992,nifty_512,2012-08-02,Research and Markets: Strategic Trends and Insights in Health and Wellness,Rise,0.0198,74,research and market strategic trend and insight health and wellness,67,10,0,pharmacy,"['research', 'and', 'market', 'strategic', 'trend', 'and', 'insight', 'health', 'and', 'well', '##ness']",1
174155,nifty_512,2012-08-02,Biotech M&A; at 4-year high as pharma faces expiring patents,Rise,0.0198,60,biotech year high pharma face expiring patent,45,7,0,pharmacy,"['bio', '##tech', 'year', 'high', 'p', '##har', '##ma', 'face', 'ex', '##pi', '##ring', 'patent']",1
174207,nifty_512,2012-08-02,Endocyte Reports Second Quarter 2012 Financial Results and Business Update,Rise,0.0198,74,endocyte report second quarter financial result and business update,67,9,0,pharmacy,"['end', '##oc', '##yte', 'report', 'second', 'quarter', 'financial', 'result', 'and', 'business', 'update']",1
174240,nifty_512,2012-08-02,"Furiex Pharmaceuticals Amends Current Loan and Security Agreement, Adding an Additional $30.0 Million",Rise,0.0198,101,furiex pharmaceutical amends current loan and security agreement adding additional million,90,11,0,pharmacy,"['fur', '##ie', '##x', 'pharmaceutical', 'am', '##ends', 'current', 'loan', 'and', 'security', 'agreement', 'adding', 'additional', 'million']",1
174247,nifty_512,2012-08-02,Cumberland Pharmaceuticals Reports Second Quarter 2012 Financial Results,Rise,0.0198,72,cumberland pharmaceutical report second quarter financial result,64,7,0,pharmacy,"['cum', '##ber', '##land', 'pharmaceutical', 'report', 'second', 'quarter', 'financial', 'result']",1
174664,nifty_516,2012-08-09,"New Study Fine-Tunes Diabetes, Statin Link",Neutral,0.0016,42,new study fine tune diabetes statin link,40,7,0,pharmacy,"['new', 'study', 'fine', 'tune', 'diabetes', 's', '##tat', '##in', 'link']",1
174911,nifty_521,2012-08-20,Addex Therapeutics First Half 2012 Financial Results Next Wednesday,Neutral,-0.003,67,addex therapeutic first half financial result next wednesday,60,8,0,pharmacy,"['add', '##ex', 'therapeutic', 'first', 'half', 'financial', 'result', 'next', 'wed', '##nes', '##day']",1
174914,nifty_521,2012-08-20, Addex Therapeutics First Half 2012 Financial Results Next Wednesday,Neutral,-0.003,68,addex therapeutic first half financial result next wednesday,60,8,0,pharmacy,"['add', '##ex', 'therapeutic', 'first', 'half', 'financial', 'result', 'next', 'wed', '##nes', '##day']",1
175150,nifty_521,2012-08-20,Research and Markets: Global Health Care Equipment & Supplies,Neutral,-0.003,61,research and market global health care equipment supply,55,8,0,pharmacy,"['research', 'and', 'market', 'global', 'health', 'care', 'equipment', 'supply']",1
175218,nifty_521,2012-08-20,The 2nd Pharma Logistics China 2012 will be Held in October,Neutral,-0.003,59,the pharma logistics china will held october,44,7,0,pharmacy,"['the', 'p', '##har', '##ma', 'logistics', 'chin', '##a', 'will', 'held', 'o', '##ct', '##obe', '##r']",1
175321,nifty_521,2012-08-20,Research and Markets: Schizophrenia. Current Science and Clinical Practice,Neutral,-0.003,74,research and market schizophrenia current science and clinical practice,71,9,0,pharmacy,"['research', 'and', 'market', 's', '##chi', '##zophrenia', 'current', 'science', 'and', 'clinical', 'practice']",1
175365,nifty_521,2012-08-20,Research and Markets: Medical Market Tracker,Neutral,-0.003,44,research and market medical market tracker,42,6,0,pharmacy,"['research', 'and', 'market', 'medical', 'market', 'track', '##er']",1
175446,nifty_521,2012-08-20,NovaBay Pharmaceuticals to Present at Southern California Investor Conference,Neutral,-0.003,77,novabay pharmaceutical present southern california investor conference,70,7,0,pharmacy,"['no', '##va', '##bay', 'pharmaceutical', 'present', 'southern', 'ca', '##li', '##fo', '##rn', '##ia', 'investor', 'conference']",1
175454,nifty_521,2012-08-20,Research and Markets: Epidemiology: Social Anxiety Disorder - Highly co-morbid anxiety disorder will continue to remain a significant public health burden,Neutral,-0.003,154,research and market epidemiology social anxiety disorder highly morbid anxiety disorder will continue remain significant public health burden,141,18,0,pharmacy,"['research', 'and', 'market', 'e', '##pid', '##em', '##iology', 'social', 'anxiety', 'disorder', 'highly', 'm', '##or', '##bid', 'anxiety', 'disorder', 'will', 'continue', 'remain', 'significant', 'public', 'health', 'burden']",1
175457,nifty_521,2012-08-20,Research and Markets: Emerging Pharmaceutical Markets in the Middle East to 2017,Neutral,-0.003,80,research and market emerging pharmaceutical market the middle east,66,9,0,pharmacy,"['research', 'and', 'market', 'emerging', 'pharmaceutical', 'market', 'the', 'middle', 'east']",1
175477,nifty_521,2012-08-20,Research and Markets: Pharmaceutical Diversification Trends 2012,Neutral,-0.003,64,research and market pharmaceutical diversification trend,56,6,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'divers', '##ification', 'trend']",1
175614,nifty_521,2012-08-20,HealthSouth To Present At Investor Conferences In September,Neutral,-0.003,59,healthsouth present investor conference september,49,5,0,pharmacy,"['health', '##so', '##uth', 'present', 'investor', 'conference', 'se', '##pt', '##em', '##ber']",1
175633,nifty_521,2012-08-20,"Research and Markets: Tardive Dyskinesia - Pipeline Review, H2 2012",Neutral,-0.003,67,research and market tardive dyskinesia pipeline review,54,7,0,pharmacy,"['research', 'and', 'market', 'ta', '##rdi', '##ve', 'd', '##ys', '##kin', '##esi', '##a', 'pipeline', 'review']",1
175710,nifty_521,2012-08-20,Research and Markets: Global Biobanking Market 2011-2015: The Global Biobanking market to grow at a CAGR of 5.5 percent over the period 2011-2015,Neutral,-0.003,145,research and market global biobanking market the global biobanking market grow cagr percent over the period,107,16,0,pharmacy,"['research', 'and', 'market', 'global', 'bio', '##bank', '##ing', 'market', 'the', 'global', 'bio', '##bank', '##ing', 'market', 'grow', 'ca', '##g', '##r', 'percent', 'over', 'the', 'period']",1
175712,nifty_521,2012-08-20,Research and Markets: Human Insulin Market in China 2011-2015: The Human Insulin Market in China to Grow at a CAGR of 19.2 Percent over the Period 2011-2015,Neutral,-0.003,156,research and market human insulin market china the human insulin market china grow cagr percent over the period,111,18,0,pharmacy,"['research', 'and', 'market', 'human', 'insulin', 'market', 'chin', '##a', 'the', 'human', 'insulin', 'market', 'chin', '##a', 'grow', 'ca', '##g', '##r', 'percent', 'over', 'the', 'period']",1
175718,nifty_521,2012-08-20,"Research and Markets: United Arab Emirates Pharmaceutical and Healthcare Report Q3 2012: Prices for Tests Such as Blood Tests, X-Rays, MRI Scans and CAT Scans Will Decrease by 24%",Neutral,-0.003,179,research and market united arab emirate pharmaceutical and healthcare report price for test such blood test ray mri scan and cat scan will decrease,147,24,0,pharmacy,"['research', 'and', 'market', 'united', 'a', '##rab', 'em', '##ira', '##te', 'pharmaceutical', 'and', 'healthcare', 'report', 'price', 'for', 'test', 'such', 'blood', 'test', 'ray', 'm', '##ri', 'scan', 'and', 'cat', 'scan', 'will', 'decrease']",1
176132,nifty_525,2012-08-27,"Inovio Pharmaceuticals to Present at Liolios, Stifel, and Rodman & Renshaw Investor Conferences",Neutral,-0.001,95,inovio pharmaceutical present liolios stifel and rodman renshaw investor conference,83,10,0,pharmacy,"['in', '##ov', '##io', 'pharmaceutical', 'present', 'l', '##iol', '##ios', 's', '##ti', '##fe', '##l', 'and', 'rod', '##man', 're', '##ns', '##haw', 'investor', 'conference']",1
176194,nifty_525,2012-08-27,"Research and Markets: Exanthema - Pipeline Review, H1 2012",Neutral,-0.001,58,research and market exanthema pipeline review,45,6,0,pharmacy,"['research', 'and', 'market', 'ex', '##ant', '##hem', '##a', 'pipeline', 'review']",1
176196,nifty_525,2012-08-27,"Research and Markets: Emesis (Vomiting) - Pipeline Review, H1 2012",Neutral,-0.001,66,research and market emesis vomiting pipeline review,51,7,0,pharmacy,"['research', 'and', 'market', 'em', '##esis', 'vomit', '##ing', 'pipeline', 'review']",1
176219,nifty_525,2012-08-27,"Pharmaceuticals, Medical Technology Are Among Attractive Investments in Emerging Markets, According to The Boston Company Asset Management",Neutral,-0.001,138,pharmaceutical medical technology are among attractive investment emerging market according the boston company asset management,127,15,0,pharmacy,"['pharmaceutical', 'medical', 'technology', 'are', 'among', 'attractive', 'investment', 'emerging', 'market', 'according', 'the', 'b', '##ost', '##on', 'company', 'asset', 'management']",1
176262,nifty_525,2012-08-27,Research and Markets: Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities 2012 - Edition 7,Neutral,-0.001,129,research and market emerging medical technology spotlight report investment partnering opportunity edition,106,12,0,pharmacy,"['research', 'and', 'market', 'emerging', 'medical', 'technology', 'spotlight', 'report', 'investment', 'partner', '##ing', 'opportunity', 'edition']",1
176326,nifty_525,2012-08-27,Celgene Corporation to Present at Investor Conferences in September,Neutral,-0.001,67,celgene corporation present investor conference september,57,6,0,pharmacy,"['c', '##el', '##gene', 'corporation', 'present', 'investor', 'conference', 'se', '##pt', '##em', '##ber']",1
176353,nifty_525,2012-08-27,"Professor Gordon Liu, Key Figure in Chinese Health Care Reform Efforts, Joins Analysis Group as Academic Affiliate",Neutral,-0.001,114,professor gordon liu key figure chinese health care reform effort join analysis group academic affiliate,104,15,0,pharmacy,"['professor', 'go', '##rdon', 'l', '##iu', 'key', 'figure', 'chin', '##ese', 'health', 'care', 'reform', 'effort', 'join', 'analysis', 'group', 'academic', 'affiliate']",1
176643,nifty_525,2012-08-27,Medtronic Establishes Shanghai Innovation Center,Neutral,-0.001,48,medtronic establishes shanghai innovation center,48,5,0,pharmacy,"['me', '##dt', '##ronic', 'establishes', 's', '##hang', '##hai', 'innovation', 'center']",1
177114,nifty_529,2012-09-04,Research and Markets: Stem Cells - Current Topics in Molecular Cell Biology and Molecular Medicine Series,Neutral,-0.0009,105,research and market stem cell current topic molecular cell biology and molecular medicine series,96,14,0,pharmacy,"['research', 'and', 'market', 'stem', 'cell', 'current', 'topic', 'molecular', 'cell', 'biology', 'and', 'molecular', 'medicine', 'series']",1
177117,nifty_529,2012-09-04,Research and Markets: Biochemical Pathways. An Atlas of Biochemistry and Molecular Biology,Neutral,-0.0009,90,research and market biochemical pathway atlas biochemistry and molecular biology,80,10,0,pharmacy,"['research', 'and', 'market', 'bio', '##chemical', 'pathway', 'at', '##las', 'bio', '##chemistry', 'and', 'molecular', 'biology']",1
177278,nifty_529,2012-09-04,Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences,Neutral,-0.0009,78,orexigen therapeutic announces presentation upcoming investor conference,72,7,0,pharmacy,"['ore', '##xi', '##gen', 'therapeutic', 'announces', 'presentation', 'upcoming', 'investor', 'conference']",1
177312,nifty_529,2012-09-04,BioSpecifics Technologies Corp. to Present at Two Upcoming Investor Conferences in September,Neutral,-0.0009,92,biospecifics technology corp present two upcoming investor conference september,79,9,0,pharmacy,"['bio', '##sp', '##ec', '##ific', '##s', 'technology', 'co', '##rp', 'present', 'two', 'upcoming', 'investor', 'conference', 'se', '##pt', '##em', '##ber']",1
177313,nifty_529,2012-09-04, FluoroPharma to Present at the Rodman & Renshaw Annual Global Investment Conference,Neutral,-0.0009,84,fluoropharma present the rodman renshaw annual global investment conference,75,9,0,pharmacy,"['flu', '##oro', '##pha', '##rma', 'present', 'the', 'rod', '##man', 're', '##ns', '##haw', 'annual', 'global', 'investment', 'conference']",1
177416,nifty_529,2012-09-04, BioCentury and Thomson Reuters to Convene the 19th Annual NewsMakers in the Biotech Industry in New York,Neutral,-0.0009,105,biocentury and thomson reuters convene the annual newsmakers the biotech industry new york,90,13,0,pharmacy,"['bio', '##cent', '##ury', 'and', 'th', '##oms', '##on', 're', '##uters', 'con', '##ven', '##e', 'the', 'annual', 'news', '##makers', 'the', 'bio', '##tech', 'industry', 'new', 'yo', '##rk']",1
177423,nifty_529,2012-09-04,Aegerion Pharmaceuticals Announces Participation at Morgan Stanley and Think Equity Healthcare Conferences,Neutral,-0.0009,106,aegerion pharmaceutical announces participation morgan stanley and think equity healthcare conference,101,11,0,pharmacy,"['a', '##ege', '##rion', 'pharmaceutical', 'announces', 'participation', 'm', '##or', '##gan', 's', '##tan', '##ley', 'and', 'think', 'equity', 'healthcare', 'conference']",1
177660,nifty_529,2012-09-04,"Research and Markets: Biomet Profile (Biomaterials): Global Market Share Analysis by Region, SWOT, Product Pipeline & Financials",Neutral,-0.0009,128,research and market biomet profile biomaterials global market share analysis region swot product pipeline financials,116,15,0,pharmacy,"['research', 'and', 'market', 'bio', '##met', 'profile', 'bio', '##mate', '##rial', '##s', 'global', 'market', 'share', 'analysis', 'region', 's', '##wo', '##t', 'product', 'pipeline', 'financial', '##s']",1
177679,nifty_529,2012-09-04,"Cegedim Relationship Management`s Latest Thought Leadership Report on Russia`s Life Sciences Industry Reveals Sustained Market Expansion and New, More Targeted Pharma Regulations",Neutral,-0.0009,178,cegedim relationship management latest thought leadership report russia life science industry reveals sustained market expansion and new more targeted pharma regulation,168,21,0,pharmacy,"['c', '##ege', '##di', '##m', 'relationship', 'management', 'latest', 'thought', 'leadership', 'report', 'r', '##uss', '##ia', 'life', 'science', 'industry', 'reveals', 'sustained', 'market', 'expansion', 'and', 'new', 'more', 'targeted', 'p', '##har', '##ma', 'regulation']",1
177718,nifty_529,2012-09-04,Bio-Path Holdings to Present at the Rodman & Renshaw Annual Global Investment Conference,Neutral,-0.0009,88,bio path holding present the rodman renshaw annual global investment conference,79,11,0,pharmacy,"['bio', 'path', 'holding', 'present', 'the', 'rod', '##man', 're', '##ns', '##haw', 'annual', 'global', 'investment', 'conference']",1
177827,nifty_529,2012-09-04,Research and Markets: The Global Patient Monitoring Systems Market to Grow At A CAGR Of 6.04 Percent over the Period 2011-2015,Neutral,-0.0009,126,research and market the global patient monitoring system market grow cagr percent over the period,97,15,0,pharmacy,"['research', 'and', 'market', 'the', 'global', 'patient', 'monitoring', 'system', 'market', 'grow', 'ca', '##g', '##r', 'percent', 'over', 'the', 'period']",1
177847,nifty_529,2012-09-04,Onyx Pharmaceuticals To Present At Upcoming Investor Conferences,Neutral,-0.0009,64,onyx pharmaceutical present upcoming investor conference,56,6,0,pharmacy,"['on', '##yx', 'pharmaceutical', 'present', 'upcoming', 'investor', 'conference']",1
177858,nifty_529,2012-09-04,Transcept Pharmaceuticals to Present at the Rodman & Renshaw Global Investment Conference,Neutral,-0.0009,89,transcept pharmaceutical present the rodman renshaw global investment conference,80,9,0,pharmacy,"['trans', '##ce', '##pt', 'pharmaceutical', 'present', 'the', 'rod', '##man', 're', '##ns', '##haw', 'global', 'investment', 'conference']",1
177938,nifty_529,2012-09-04, Sarepta Therapeutics Announces At-the-Market Equity Offering,Neutral,-0.0009,61,sarepta therapeutic announces the market equity offering,56,7,0,pharmacy,"['sa', '##re', '##pta', 'therapeutic', 'announces', 'the', 'market', 'equity', 'offering']",1
178225,nifty_532,2012-09-10,China Economy Shows Frailty,Neutral,0.0028,27,china economy show frailty,26,4,0,pharmacy,"['chin', '##a', 'economy', 'show', 'f', '##rail', '##ty']",1
178645,nifty_534,2012-09-12,Research and Markets: Iran Pharmaceuticals and Healthcare Report Q3 2012,Rise,0.0152,72,research and market iran pharmaceutical and healthcare report,61,8,0,pharmacy,"['research', 'and', 'market', 'i', '##ran', 'pharmaceutical', 'and', 'healthcare', 'report']",1
178712,nifty_534,2012-09-12,Research and Markets: Portugal Pharmaceuticals and Healthcare Report Q3 2012,Rise,0.0152,76,research and market portugal pharmaceutical and healthcare report,65,8,0,pharmacy,"['research', 'and', 'market', 'port', '##uga', '##l', 'pharmaceutical', 'and', 'healthcare', 'report']",1
178863,nifty_534,2012-09-12,Small Biotech and Pharma Companies Struggling with Regulatory Submission Timeline,Rise,0.0152,81,small biotech and pharma company struggling with regulatory submission timeline,79,10,0,pharmacy,"['small', 'bio', '##tech', 'and', 'p', '##har', '##ma', 'company', 'struggling', 'with', 'regulatory', 'submission', 'timeline']",1
179106,nifty_534,2012-09-12,Licensing Executives Society Annual Meeting Keynote Speaker Eric Topol Says High Tech Medical and Digital Innovations Are Revolutionizing Health Care,Rise,0.0152,149,licensing executive society annual meeting keynote speaker eric topol say high tech medical and digital innovation are revolutionizing health care,146,20,0,pharmacy,"['licensing', 'executive', 'society', 'annual', 'meeting', 'key', '##note', 'speaker', 'er', '##ic', 'top', '##ol', 'say', 'high', 'tech', 'medical', 'and', 'digital', 'innovation', 'are', 'revolution', '##izing', 'health', 'care']",1
179172,nifty_534,2012-09-12,"Research and Markets: Injectable Drug Delivery to 2016 - Drugs, Devices, Targets, Therapeutics and Forecasts",Rise,0.0152,108,research and market injectable drug delivery drug device target therapeutic and forecast,88,12,0,pharmacy,"['research', 'and', 'market', 'in', '##ject', '##able', 'drug', 'delivery', 'drug', 'device', 'target', 'therapeutic', 'and', 'forecast']",1
179219,nifty_534,2012-09-12,"Research and Markets: Microneedle Drug Delivery Patches, Syringes & Systems - Devices, Players, Markets and Forecasts",Rise,0.0152,117,research and market microneedle drug delivery patch syrinx system device player market and forecast,99,14,0,pharmacy,"['research', 'and', 'market', 'micro', '##nee', '##dle', 'drug', 'delivery', 'patch', 's', '##yr', '##in', '##x', 'system', 'device', 'player', 'market', 'and', 'forecast']",1
179284,nifty_534,2012-09-12,Research and Markets: Future Horizons in the Global Tumor Marker Testing Market 2012: Supplier Shares and Sales Forecasts for 40 Cancer Assays by Country,Rise,0.0152,153,research and market future horizon the global tumor marker testing market supplier share and sale forecast for cancer assay country,131,20,0,pharmacy,"['research', 'and', 'market', 'future', 'horizon', 'the', 'global', 'tumor', 'marker', 'testing', 'market', 'supplier', 'share', 'and', 'sale', 'forecast', 'for', 'cancer', 'ass', '##ay', 'country']",1
179341,nifty_534,2012-09-12,Research and Markets: Future Horizons in the US Cancer Diagnostics Market 2012: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Market Segment,Rise,0.0152,154,research and market future horizon the cancer diagnostics market supplier share and sale forecast for tumor marker market segment,129,19,0,pharmacy,"['research', 'and', 'market', 'future', 'horizon', 'the', 'cancer', 'diagnostic', '##s', 'market', 'supplier', 'share', 'and', 'sale', 'forecast', 'for', 'tumor', 'marker', 'market', 'segment']",1
180210,nifty_540,2012-09-24,Research and Markets: Polymerase Chain Reaction (PCR) 2012: A Focus on Sales Growth - Market Expected to Grow to Over $38 Billion by 2015,Fall,-0.0106,137,research and market polymerase chain reaction pcr focus sale growth market expected grow over billion,101,15,0,pharmacy,"['research', 'and', 'market', 'polymer', '##ase', 'chain', 'reaction', 'p', '##c', '##r', 'focus', 'sale', 'growth', 'market', 'expected', 'grow', 'over', 'billion']",1
180312,nifty_540,2012-09-24,BRIEF-Questcor pharma drops in premarket on U.S. government investigation,Fall,-0.0106,73,brief questcor pharma drop premarket government investigation,61,7,0,pharmacy,"['brief', 'quest', '##cor', 'p', '##har', '##ma', 'drop', 'pre', '##market', 'government', 'investigation']",1
180318,nifty_540,2012-09-24,"EP Global Communications, Inc. Lands One of the World's Leading Biomedical Engineers",Fall,-0.0106,84,global communication inc land one the world leading biomedical engineer,71,10,0,pharmacy,"['global', 'communication', 'in', '##c', 'land', 'one', 'the', 'world', 'leading', 'bio', '##medical', 'engineer']",1
180324,nifty_540,2012-09-24,Research and Markets: Reliance Pharmaceuticals: Biosimilars Company Analysis,Fall,-0.0106,76,research and market reliance pharmaceutical biosimilars company analysis,72,8,0,pharmacy,"['research', 'and', 'market', 'reliance', 'pharmaceutical', 'bio', '##si', '##mi', '##lars', 'company', 'analysis']",1
180510,nifty_540,2012-09-24,"The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, GlaxoSmithKline, AstraZeneca, Merck and Pfizer",Fall,-0.0106,107,the zacks analyst blog highlight reddy laboratory glaxosmithkline astrazeneca merck and pfizer,94,12,0,pharmacy,"['the', 'z', '##ack', '##s', 'analyst', 'blog', 'highlight', 'red', '##dy', 'laboratory', 'g', '##lax', '##os', '##mith', '##k', '##line', 'as', '##tra', '##zen', '##eca', 'me', '##rc', '##k', 'and', 'p', '##fi', '##zer']",1
180761,nifty_540,2012-09-24,"Doctors', Patients' Organizations Bring NIH Experts to Patients via Webinar about Future of Deadly Lung Disease Research",Fall,-0.0106,120,doctor patient organization bring nih expert patient via webinar about future deadly lung disease research,106,15,0,pharmacy,"['doctor', 'patient', 'organization', 'bring', 'ni', '##h', 'expert', 'patient', 'via', 'web', '##ina', '##r', 'about', 'future', 'deadly', 'lung', 'disease', 'research']",1
180774,nifty_540,2012-09-24,"Research and Markets: Fragile X Syndrome Global Clinical Trials Review, H2, 2012",Fall,-0.0106,80,research and market fragile syndrome global clinical trial review,65,9,0,pharmacy,"['research', 'and', 'market', 'fragile', 'syndrome', 'global', 'clinical', 'trial', 'review']",1
181172,nifty_542,2012-09-26,	Want Health-Conscious Consumers Back,Rise,0.0094,37,want health conscious consumer back,35,5,0,pharmacy,"['want', 'health', 'conscious', 'consumer', 'back']",1
181370,nifty_544,2012-10-01,Research and Markets: Dyslipidemia (Event Driven),Neutral,0.001,49,research and market dyslipidemia event driven,45,6,0,pharmacy,"['research', 'and', 'market', 'd', '##ys', '##lip', '##ide', '##mia', 'event', 'driven']",1
181404,nifty_544,2012-10-01,Research and Markets: Diabetes Care Devices Market to 2018 - Integrated Insulin Pumps with Continuous Glucose Monitoring Technology to Add a New Dimension to Diabetes Management,Neutral,0.001,177,research and market diabetes care device market integrated insulin pump with continuous glucose monitoring technology add new dimension diabetes management,155,20,0,pharmacy,"['research', 'and', 'market', 'diabetes', 'care', 'device', 'market', 'integrated', 'insulin', 'pump', 'with', 'continuous', 'glucose', 'monitoring', 'technology', 'add', 'new', 'dimension', 'diabetes', 'management']",1
181410,nifty_544,2012-10-01,Horizon Pharma Announces Completion of Sales Force Expansion,Neutral,0.001,60,horizon pharma announces completion sale force expansion,56,7,0,pharmacy,"['horizon', 'p', '##har', '##ma', 'announces', 'completion', 'sale', 'force', 'expansion']",1
181469,nifty_544,2012-10-01,"Research and Markets: Future Horizons in the US In Vitro Diagnostics Market: Strategic Implications of Emerging Reimbursement, Technological and Market Trends",Neutral,0.001,158,research and market future horizon the vitro diagnostics market strategic implication emerging reimbursement technological and market trend,139,17,0,pharmacy,"['research', 'and', 'market', 'future', 'horizon', 'the', 'v', '##it', '##ro', 'diagnostic', '##s', 'market', 'strategic', 'imp', '##lication', 'emerging', 're', '##im', '##bur', '##se', '##ment', 'technological', 'and', 'market', 'trend']",1
181518,nifty_544,2012-10-01,Worldwide IR ImagingMarket Dynamics Examined in New In-Demand Study Published at MarketPublishers.com,Neutral,0.001,101,worldwide imagingmarket dynamic examined new demand study published marketpublishers com,88,10,0,pharmacy,"['worldwide', 'imaging', '##market', 'dynamic', 'examined', 'new', 'demand', 'study', 'published', 'market', '##pu', '##b', '##lish', '##ers', 'com']",1
181767,nifty_544,2012-10-01,Research and Markets: 2012 Analysis of the World Cancer Diagnostics Market: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers,Neutral,0.001,146,research and market analysis the world cancer diagnostics market sale forecast country and strategic profile leading supplier,125,17,0,pharmacy,"['research', 'and', 'market', 'analysis', 'the', 'world', 'cancer', 'diagnostic', '##s', 'market', 'sale', 'forecast', 'country', 'and', 'strategic', 'profile', 'leading', 'supplier']",1
181768,nifty_544,2012-10-01,Research and Markets: Trinity College Dublin - 2012 Product Pipeline Analysis Provides Detailed Analysis on Each Pipeline Product,Neutral,0.001,129,research and market trinity college dublin product pipeline analysis provides detailed analysis each pipeline product,117,15,0,pharmacy,"['research', 'and', 'market', 't', '##rini', '##ty', 'college', 'dub', '##lin', 'product', 'pipeline', 'analysis', 'provides', 'detailed', 'analysis', 'each', 'pipeline', 'product']",1
181954,nifty_544,2012-10-01,"U.S. Leveraged Finance Spotlight Series - Community Health Systems, Inc.",Neutral,0.001,72,leveraged finance spotlight series community health system inc,62,8,0,pharmacy,"['leverage', '##d', 'finance', 'spotlight', 'series', 'community', 'health', 'system', 'in', '##c']",1
182134,nifty_545,2012-10-02,Global medtech industry delivering strong returns despite economic conditions,Neutral,0.0041,77,global medtech industry delivering strong return despite economic condition,75,9,0,pharmacy,"['global', 'me', '##dt', '##ech', 'industry', 'delivering', 'strong', 'return', 'despite', 'economic', 'condition']",1
182135,nifty_545,2012-10-02,Venture capital for medical technology harder to come by-report,Neutral,0.0041,63,venture capital for medical technology harder come report,57,8,0,pharmacy,"['venture', 'capital', 'for', 'medical', 'technology', 'harder', 'come', 'report']",1
182162,nifty_545,2012-10-02,Venture capital for medical technology harder to come by: report,Neutral,0.0041,64,venture capital for medical technology harder come report,57,8,0,pharmacy,"['venture', 'capital', 'for', 'medical', 'technology', 'harder', 'come', 'report']",1
182242,nifty_545,2012-10-02,"Lando & Anastasi, LLP Expands Litigation, Chemical/Materials, Biotechnology/Pharmaceutical, and Electrical/Computer Depth",Neutral,0.0041,121,lando anastasi llp expands litigation chemical material biotechnology pharmaceutical and electrical computer depth,114,13,0,pharmacy,"['land', '##o', 'an', '##ast', '##asi', 'll', '##p', 'expands', 'litigation', 'chemical', 'material', 'bio', '##tech', '##nology', 'pharmaceutical', 'and', 'electrical', 'computer', 'depth']",1
182252,nifty_545,2012-10-02,Research and Markets: DRG Insight: Colorectal Cancer (G7),Neutral,0.0041,57,research and market drg insight colorectal cancer,49,7,0,pharmacy,"['research', 'and', 'market', 'd', '##rg', 'insight', 'color', '##ec', '##tal', 'cancer']",1
182254,nifty_545,2012-10-02,"Research and Markets: Onyx Pharmaceuticals, Inc. - Product Pipeline Review - 2012",Neutral,0.0041,81,research and market onyx pharmaceutical inc product pipeline review,67,9,0,pharmacy,"['research', 'and', 'market', 'on', '##yx', 'pharmaceutical', 'in', '##c', 'product', 'pipeline', 'review']",1
182266,nifty_545,2012-10-02,Astex Pharmaceuticals to Present at BIO Investor Forum,Neutral,0.0041,54,astex pharmaceutical present bio investor forum,47,6,0,pharmacy,"['as', '##te', '##x', 'pharmaceutical', 'present', 'bio', 'investor', 'forum']",1
182299,nifty_545,2012-10-02,World-Class Business and Academic Leaders Advise AdvaMed 2012 Audience on How to Strengthen Medical Technology Industry,Neutral,0.0041,119,world class business and academic leader advise advamed audience how strengthen medical technology industry,107,14,0,pharmacy,"['world', 'class', 'business', 'and', 'academic', 'leader', 'advise', 'ad', '##va', '##med', 'audience', 'how', 'strengthen', 'medical', 'technology', 'industry']",1
182302,nifty_545,2012-10-02,Spectrum Pharmaceuticals to Present Corporate Update at the 11th Annual BIO Investor Forum in San Francisco on October 9th,Neutral,0.0041,122,spectrum pharmaceutical present corporate update the annual bio investor forum san francisco october,100,13,0,pharmacy,"['spectrum', 'pharmaceutical', 'present', 'corporate', 'update', 'the', 'annual', 'bio', 'investor', 'forum', 'sa', '##n', 'f', '##ran', '##cis', '##co', 'o', '##ct', '##obe', '##r']",1
182306,nifty_545,2012-10-02,Research and Markets: The Financial Professional's Guide to Healthcare Reform. Wiley Finance,Neutral,0.0041,92,research and market the financial professional guide healthcare reform wiley finance,84,11,0,pharmacy,"['research', 'and', 'market', 'the', 'financial', 'professional', 'guide', 'healthcare', 'reform', 'w', '##ile', '##y', 'finance']",1
182307,nifty_545,2012-10-02,RXi Pharmaceuticals to Present at 11th Annual BIO Investor Forum,Neutral,0.0041,64,rxi pharmaceutical present annual bio investor forum,52,7,0,pharmacy,"['r', '##xi', 'pharmaceutical', 'present', 'annual', 'bio', 'investor', 'forum']",1
182379,nifty_545,2012-10-02,"Research and Markets: Celtic Biotech, Ltd. - Product Pipeline Review - 2012",Neutral,0.0041,75,research and market celtic biotech ltd product pipeline review,62,9,0,pharmacy,"['research', 'and', 'market', 'c', '##el', '##tic', 'bio', '##tech', 'l', '##t', '##d', 'product', 'pipeline', 'review']",1
182389,nifty_545,2012-10-02,"Research and Markets: Cell Therapeutics, Inc. - Product Pipeline Review - 2012",Neutral,0.0041,78,research and market cell therapeutic inc product pipeline review,64,9,0,pharmacy,"['research', 'and', 'market', 'cell', 'therapeutic', 'in', '##c', 'product', 'pipeline', 'review']",1
182430,nifty_545,2012-10-02,Organovo To Present At 2012 Bio Investor Forum,Neutral,0.0041,46,organovo present bio investor forum,35,5,0,pharmacy,"['organ', '##ovo', 'present', 'bio', 'investor', 'forum']",1
182471,nifty_545,2012-10-02," Unsustainable Commercial Costs, Outdated Commercial Model Threaten Medtech",Neutral,0.0041,75,unsustainable commercial cost outdated commercial model threaten medtech,72,8,0,pharmacy,"['un', '##sus', '##tain', '##able', 'commercial', 'cost', 'out', '##dated', 'commercial', 'model', 'threaten', 'me', '##dt', '##ech']",1
182487,nifty_545,2012-10-02,Chinese Medical Imaging Equipment Market Report Bundle Now Available at MarketPublishers.com,Neutral,0.0041,92,chinese medical imaging equipment market report bundle now available marketpublishers com,89,11,0,pharmacy,"['chin', '##ese', 'medical', 'imaging', 'equipment', 'market', 'report', 'bundle', 'now', 'available', 'market', '##pu', '##b', '##lish', '##ers', 'com']",1
182494,nifty_545,2012-10-02,Medtech Market to Achieve Global Sales of $440 Billion by 2018,Neutral,0.0041,62,medtech market achieve global sale billion,42,6,0,pharmacy,"['me', '##dt', '##ech', 'market', 'achieve', 'global', 'sale', 'billion']",1
182587,nifty_545,2012-10-02,"Research and Markets: Advances in Molecular Toxicology, Vol 5",Neutral,0.0041,61,research and market advance molecular toxicology vol,52,7,0,pharmacy,"['research', 'and', 'market', 'advance', 'molecular', 'toxic', '##ology', 'vol']",1
182592,nifty_545,2012-10-02,Healthcare Market Success: Cave Consulting Group (CCGroup) Affirms Continued Downloads of Free CaveGrouper-Lite,Neutral,0.0041,111,healthcare market success cave consulting group ccgroup affirms continued downloads free cavegrouper lite,105,13,0,pharmacy,"['healthcare', 'market', 'success', 'cave', 'consulting', 'group', 'cc', '##group', 'a', '##ff', '##ir', '##ms', 'continued', 'downloads', 'free', 'cave', '##group', '##er', 'lit', '##e']",1
182600,nifty_545,2012-10-02,"Research and Markets: Royalty Rates for Pharmaceuticals & Biotechnology, 8th Edition",Neutral,0.0041,84,research and market royalty rate for pharmaceutical biotechnology edition,73,9,0,pharmacy,"['research', 'and', 'market', 'royalty', 'rate', 'for', 'pharmaceutical', 'bio', '##tech', '##nology', 'edition']",1
182678,nifty_545,2012-10-02,Health 2.0 Advisors Announce 10 Industry Leaders Seeking Health Care Innovation Partnerships,Neutral,0.0041,92,health advisor announce industry leader seeking health care innovation partnership,82,10,0,pharmacy,"['health', 'advisor', 'announce', 'industry', 'leader', 'seeking', 'health', 'care', 'innovation', 'partnership']",1
183288,nifty_549,2012-10-09,Research and Markets: Synthesis of Essential Drugs,Fall,-0.0064,50,research and market synthesis essential drug,44,6,0,pharmacy,"['research', 'and', 'market', 'synthesis', 'essential', 'drug']",1
183290,nifty_549,2012-10-09,Research and Markets: In-Depth Financial Evaluation of the Top 50 Contraception Manufacturers (Global) - 2012 Report,Fall,-0.0064,116,research and market depth financial evaluation the top contraception manufacturer global report,95,12,0,pharmacy,"['research', 'and', 'market', 'depth', 'financial', 'evaluation', 'the', 'top', 'con', '##tra', '##ception', 'manufacturer', 'global', 'report']",1
183294,nifty_549,2012-10-09,"Research and Markets: Molecular Imaging Agents: Targets, Technology, Markets, and Commercial Opportunities",Fall,-0.0064,106,research and market molecular imaging agent target technology market and commercial opportunity,95,12,0,pharmacy,"['research', 'and', 'market', 'molecular', 'imaging', 'agent', 'target', 'technology', 'market', 'and', 'commercial', 'opportunity']",1
183297,nifty_549,2012-10-09,Research and Markets: In-Depth Financial Evaluation of the Top 60 Diagnostic Substances Companies - 2012 Global Report,Fall,-0.0064,118,research and market depth financial evaluation the top diagnostic substance company global report,97,13,0,pharmacy,"['research', 'and', 'market', 'depth', 'financial', 'evaluation', 'the', 'top', 'diagnostic', 'substance', 'company', 'global', 'report']",1
183322,nifty_549,2012-10-09,Matthew Kirk of Access Financial Markets: Healthcare Reform's Effects Already Felt,Fall,-0.0064,82,matthew kirk access financial market healthcare reform effect already felt,74,10,0,pharmacy,"['mat', '##the', '##w', 'k', '##irk', 'access', 'financial', 'market', 'healthcare', 'reform', 'effect', 'already', 'felt']",1
183389,nifty_549,2012-10-09,Research and Markets: Singapore Pharmaceutical Industry: The Pharmaceutical Hub of Southeast Asia,Fall,-0.0064,97,research and market singapore pharmaceutical industry the pharmaceutical hub southeast asia,91,11,0,pharmacy,"['research', 'and', 'market', 'sing', '##ap', '##ore', 'pharmaceutical', 'industry', 'the', 'pharmaceutical', 'hub', 'southeast', 'as', '##ia']",1
183431,nifty_549,2012-10-09,Growing Chinese Medical Device Market Has Many Pitfalls for Those Attempting to Enter,Fall,-0.0064,85,growing chinese medical device market ha many pitfall for those attempting enter,80,12,0,pharmacy,"['growing', 'chin', '##ese', 'medical', 'device', 'market', 'ha', 'many', 'pit', '##fall', 'for', 'those', 'attempting', 'enter']",1
183569,nifty_549,2012-10-09,"The Zacks Analyst Blog Highlights: GlaxoSmithKline, Pfizer, Theravance, Amicus Therapeutics and Parker-Hannifin",Fall,-0.0064,111,the zacks analyst blog highlight glaxosmithkline pfizer theravance amicus therapeutic and parker hannifin,105,13,0,pharmacy,"['the', 'z', '##ack', '##s', 'analyst', 'blog', 'highlight', 'g', '##lax', '##os', '##mith', '##k', '##line', 'p', '##fi', '##zer', 'the', '##ra', '##vance', 'am', '##icus', 'therapeutic', 'and', 'park', '##er', 'ha', '##nn', '##if', '##in']",1
183597,nifty_549,2012-10-09,Research and Markets: Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans,Fall,-0.0064,134,research and market biodefense industry market benefit from federal funding such the bio edep fund support security plan,120,18,0,pharmacy,"['research', 'and', 'market', 'bio', '##de', '##fen', '##se', 'industry', 'market', 'benefit', 'from', 'federal', 'funding', 'such', 'the', 'bio', 'ed', '##ep', 'fund', 'support', 'security', 'plan']",1
183607,nifty_549,2012-10-09,Research and Markets: CONRAD - Product Pipeline Review - 2012,Fall,-0.0064,61,research and market conrad product pipeline review,50,7,0,pharmacy,"['research', 'and', 'market', 'con', '##rad', 'product', 'pipeline', 'review']",1
183821,nifty_549,2012-10-09, Aidarex Pharmaceuticals Takes Business to the Next Level With Jeeves Universal,Fall,-0.0064,79,aidarex pharmaceutical take business the next level with jeeves universal,73,10,0,pharmacy,"['aid', '##are', '##x', 'pharmaceutical', 'take', 'business', 'the', 'next', 'level', 'with', 'j', '##ee', '##ves', 'universal']",1
183829,nifty_549,2012-10-09, U.S. Over-the-Counter Diagnostic Testing Market to Catapult to $10.19 Billion by 2018,Fall,-0.0064,86,over the counter diagnostic testing market catapult billion,59,8,0,pharmacy,"['over', 'the', 'counter', 'diagnostic', 'testing', 'market', 'cat', '##ap', '##ult', 'billion']",1
183849,nifty_549,2012-10-09,"DuPont Chief Innovation Officer Thomas Connelly, Jr., to Keynote SCD-iBIO's BioTech Forum",Fall,-0.0064,89,dupont chief innovation officer thomas connelly keynote scd ibio biotech forum,78,11,0,pharmacy,"['du', '##pont', 'chief', 'innovation', 'officer', 'th', '##oma', '##s', 'con', '##nell', '##y', 'key', '##note', 's', '##c', '##d', 'i', '##bio', 'bio', '##tech', 'forum']",1
183894,nifty_549,2012-10-09,"AxoGen, Inc. Completes $20.8 Million Financing with PDL BioPharma, Inc.",Fall,-0.0064,71,axogen inc completes million financing with pdl biopharma inc,61,9,0,pharmacy,"['a', '##x', '##ogen', 'in', '##c', 'complete', '##s', 'million', 'financing', 'with', 'p', '##dl', 'bio', '##pha', '##rma', 'in', '##c']",1
184455,nifty_553,2012-10-16, Matthew Kirk of Access Financial Markets Responds to Report on Healthcare Waste,Neutral,0.0045,80,matthew kirk access financial market responds report healthcare waste,69,9,0,pharmacy,"['mat', '##the', '##w', 'k', '##irk', 'access', 'financial', 'market', 'responds', 'report', 'healthcare', 'waste']",1
184523,nifty_553,2012-10-16,NPS Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Review Gattex New Drug Application for the Treatment of Adults with Short Bowel Syndrome,Neutral,0.0045,162,np pharmaceutical stock trading halted today fda advisory committee review gattex new drug application for the treatment adult with short bowel syndrome,152,22,0,pharmacy,"['n', '##p', 'pharmaceutical', 'stock', 'trading', 'halted', 'today', 'f', '##da', 'advisory', 'committee', 'review', 'g', '##att', '##ex', 'new', 'drug', 'application', 'for', 'the', 'treatment', 'adult', 'with', 'short', 'bow', '##el', 'syndrome']",1
184582,nifty_553,2012-10-16,Research and Markets: Nigeria Pharmaceuticals and Healthcare Report Q4 2012,Neutral,0.0045,75,research and market nigeria pharmaceutical and healthcare report,64,8,0,pharmacy,"['research', 'and', 'market', 'ni', '##ger', '##ia', 'pharmaceutical', 'and', 'healthcare', 'report']",1
184610,nifty_553,2012-10-16,Confidential Pricing Agreements Mitigate the Risks of Low Drug Prices in Key Markets,Neutral,0.0045,84,confidential pricing agreement mitigate the risk low drug price key market,74,11,0,pharmacy,"['confidential', 'pricing', 'agreement', 'mit', '##igate', 'the', 'risk', 'low', 'drug', 'price', 'key', 'market']",1
184695,nifty_553,2012-10-16, Infor Healthcare Applications to Unify Financials at the Institute for Transfusion Medicine,Neutral,0.0045,92,infor healthcare application unify financials the institute for transfusion medicine,84,10,0,pharmacy,"['info', '##r', 'healthcare', 'application', 'un', '##ify', 'financial', '##s', 'the', 'institute', 'for', 'trans', '##fusion', 'medicine']",1
184696,nifty_553,2012-10-16,Research and Markets: Adamis Pharmaceuticals Corporation - Product Pipeline Review - 2012,Neutral,0.0045,89,research and market adamis pharmaceutical corporation product pipeline review,77,9,0,pharmacy,"['research', 'and', 'market', 'ad', '##ami', '##s', 'pharmaceutical', 'corporation', 'product', 'pipeline', 'review']",1
184698,nifty_553,2012-10-16,"Research and Markets: AVEO Pharmaceuticals, Inc. - Product Pipeline Review - 2012",Neutral,0.0045,81,research and market aveo pharmaceutical inc product pipeline review,67,9,0,pharmacy,"['research', 'and', 'market', 'a', '##ve', '##o', 'pharmaceutical', 'in', '##c', 'product', 'pipeline', 'review']",1
184704,nifty_553,2012-10-16,Research and Markets: Cyclacel Pharmaceuticals Inc. - Product Pipeline Review - 2012,Neutral,0.0045,84,research and market cyclacel pharmaceutical inc product pipeline review,71,9,0,pharmacy,"['research', 'and', 'market', 'c', '##y', '##c', '##lace', '##l', 'pharmaceutical', 'in', '##c', 'product', 'pipeline', 'review']",1
184803,nifty_553,2012-10-16,Research and Markets: Genomics World Markets - Transforming the Pharmaceutical Industry,Neutral,0.0045,87,research and market genomics world market transforming the pharmaceutical industry,82,10,0,pharmacy,"['research', 'and', 'market', 'g', '##eno', '##mic', '##s', 'world', 'market', 'transforming', 'the', 'pharmaceutical', 'industry']",1
184876,nifty_553,2012-10-16,"Research and Markets: Partnerships, Licensing, Investments and M&A; Deals and Trends for Q4 2012 in Pharmaceuticals Gives Analysis of the Market Trends for the Pharmaceutical Industry in the Global Arena",Neutral,0.0045,203,research and market partnership licensing investment and deal and trend for pharmaceutical give analysis the market trend for the pharmaceutical industry the global arena,170,24,0,pharmacy,"['research', 'and', 'market', 'partnership', 'licensing', 'investment', 'and', 'deal', 'and', 'trend', 'for', 'pharmaceutical', 'give', 'analysis', 'the', 'market', 'trend', 'for', 'the', 'pharmaceutical', 'industry', 'the', 'global', 'arena']",1
184932,nifty_553,2012-10-16,"Research and Markets: Cachexia - Pipeline Review, H2 2012",Neutral,0.0045,57,research and market cachexia pipeline review,44,6,0,pharmacy,"['research', 'and', 'market', 'cache', '##xia', 'pipeline', 'review']",1
184968,nifty_553,2012-10-16,Cryo-Cell Reports Fiscal Third Quarter Financial Results,Neutral,0.0045,56,cryo cell report fiscal third quarter financial result,54,8,0,pharmacy,"['cry', '##o', 'cell', 'report', 'fiscal', 'third', 'quarter', 'financial', 'result']",1
184971,nifty_553,2012-10-16,Research and Markets: Diagnoptics Technologies B.V. - Product Pipeline Analysis,Neutral,0.0045,79,research and market diagnoptics technology product pipeline analysis,68,8,0,pharmacy,"['research', 'and', 'market', 'di', '##ag', '##no', '##ptic', '##s', 'technology', 'product', 'pipeline', 'analysis']",1
185053,nifty_553,2012-10-16," Onyx Pharmaceuticals to Report Third Quarter 2012 Financial Results After Market on October 30, 2012",Neutral,0.0045,101,onyx pharmaceutical report third quarter financial result after market october,78,10,0,pharmacy,"['on', '##yx', 'pharmaceutical', 'report', 'third', 'quarter', 'financial', 'result', 'after', 'market', 'o', '##ct', '##obe', '##r']",1
185128,nifty_553,2012-10-16,MonoSol Rx Defeats BioDelivery Sciences International's Reexamination Challenges to MonoSol Rx's PharmFilm(R) Patents,Neutral,0.0045,117,monosol defeat biodelivery science international reexamination challenge monosol pharmfilm patent,97,10,0,pharmacy,"['mon', '##oso', '##l', 'defeat', 'bio', '##del', '##iver', '##y', 'science', 'international', 're', '##ex', '##ami', '##nation', 'challenge', 'mon', '##oso', '##l', 'p', '##har', '##m', '##film', 'patent']",1
185431,nifty_554,2012-10-17," Industry Without Borders: Pharmaceutical-Biotech Capital Investment Leaps Around the Globe, an Industrial Info News Alert",Neutral,-0.0026,122,industry without border pharmaceutical biotech capital investment leap around the globe industrial info news alert,114,15,0,pharmacy,"['industry', 'without', 'border', 'pharmaceutical', 'bio', '##tech', 'capital', 'investment', 'leap', 'around', 'the', 'globe', 'industrial', 'info', 'news', 'alert']",1
185435,nifty_554,2012-10-17,Research and Markets: Clinical Imaging Market Dynamics and Service Provider Performance,Neutral,-0.0026,87,research and market clinical imaging market dynamic and service provider performance,84,11,0,pharmacy,"['research', 'and', 'market', 'clinical', 'imaging', 'market', 'dynamic', 'and', 'service', 'provider', 'performance']",1
185463,nifty_554,2012-10-17,SV Life Sciences and Third Rock Ventures Launch Transformative Medical Device Company Cibiem with $10 Million Series A,Neutral,-0.0026,118,life science and third rock venture launch transformative medical device company cibiem with million series,107,15,0,pharmacy,"['life', 'science', 'and', 'third', 'rock', 'venture', 'launch', 'transform', '##ative', 'medical', 'device', 'company', 'c', '##ibi', '##em', 'with', 'million', 'series']",1
185500,nifty_554,2012-10-17,Hard Metrics for Tracking Digital Marketing ROI Prove Challenging for Drug Companies,Neutral,-0.0026,84,hard metric for tracking digital marketing roi prove challenging for drug company,81,12,0,pharmacy,"['hard', 'metric', 'for', 'tracking', 'digital', 'marketing', 'r', '##oi', 'prove', 'challenging', 'for', 'drug', 'company']",1
185505,nifty_554,2012-10-17,Research and Markets: Oman Pharmaceuticals and Healthcare Report Q4 2012,Neutral,-0.0026,72,research and market oman pharmaceutical and healthcare report,61,8,0,pharmacy,"['research', 'and', 'market', 'o', '##man', 'pharmaceutical', 'and', 'healthcare', 'report']",1
185509,nifty_554,2012-10-17,"St. Jude posts weaker quarterly earnings, but beats Street view",Neutral,-0.0026,63,jude post weaker quarterly earnings but beat street view,56,9,0,pharmacy,"['j', '##ude', 'post', 'weaker', 'quarterly', 'earnings', 'but', 'beat', 'street', 'view']",1
185608,nifty_554,2012-10-17,"Ascendiant Capital Markets Initiates Research Coverage of StemCells, Inc. With Buy Recommendation",Neutral,-0.0026,97,ascendiant capital market initiate research coverage stemcells inc with buy recommendation,90,11,0,pharmacy,"['as', '##cend', '##iant', 'capital', 'market', 'initiate', 'research', 'coverage', 'stem', '##cell', '##s', 'in', '##c', 'with', 'buy', 'recommendation']",1
185735,nifty_554,2012-10-17,Research and Markets: The Pharmaceutical Market: Germany - The Market is Predicted to increase at a low CAGR between 2012 and 2017,Neutral,-0.0026,130,research and market the pharmaceutical market germany the market predicted increase low cagr between and,104,15,0,pharmacy,"['research', 'and', 'market', 'the', 'pharmaceutical', 'market', 'g', '##erman', '##y', 'the', 'market', 'predicted', 'increase', 'low', 'ca', '##g', '##r', 'between', 'and']",1
185839,nifty_554,2012-10-17,PropThink: Potential FDA Warning and Earnings Overshadow STJ Share Repurchase Program,Neutral,-0.0026,85,propthink potential fda warning and earnings overshadow stj share repurchase program,84,11,0,pharmacy,"['prop', '##thin', '##k', 'potential', 'f', '##da', 'warning', 'and', 'earnings', 'overs', '##had', '##ow', 's', '##t', '##j', 'share', 're', '##pur', '##chase', 'program']",1
185885,nifty_554,2012-10-17,Research and Markets: Acute Myeloid Leukemia (AML) Therapeutics - Pipeline Assessment and Market Forecasts to 2017,Neutral,-0.0026,114,research and market acute myeloid leukemia aml therapeutic pipeline assessment and market forecast,98,13,0,pharmacy,"['research', 'and', 'market', 'acute', 'my', '##elo', '##id', 'le', '##uke', '##mia', 'am', '##l', 'therapeutic', 'pipeline', 'assessment', 'and', 'market', 'forecast']",1
186057,nifty_554,2012-10-17,Given Imaging says looking at strategic options for the co,Neutral,-0.0026,58,given imaging say looking strategic option for the,50,8,0,pharmacy,"['given', 'imaging', 'say', 'looking', 'strategic', 'option', 'for', 'the']",1
186066,nifty_554,2012-10-17,Given Imaging says looking at strategic options for the company,Neutral,-0.0026,63,given imaging say looking strategic option for the company,58,9,0,pharmacy,"['given', 'imaging', 'say', 'looking', 'strategic', 'option', 'for', 'the', 'company']",1
186229,nifty_554,2012-10-17,"St. Jude Reports Lower Earnings, FDA Probe of Facility",Neutral,-0.0026,54,jude report lower earnings fda probe facility,45,7,0,pharmacy,"['j', '##ude', 'report', 'lower', 'earnings', 'f', '##da', 'probe', 'facility']",1
186267,nifty_555,2012-10-18,Abbott Says Study of Kidney Drug Is Halted,Fall,-0.0167,42,abbott say study kidney drug halted,35,6,0,pharmacy,"['abbot', '##t', 'say', 'study', 'kidney', 'drug', 'halted']",1
186494,nifty_557,2012-10-23,"Research and Markets: Other Toxic Disorders - Pipeline Review, H2 2012",Neutral,-0.0028,70,research and market other toxic disorder pipeline review,56,8,0,pharmacy,"['research', 'and', 'market', 'other', 'toxic', 'disorder', 'pipeline', 'review']",1
186529,nifty_557,2012-10-23,"Astex Pharmaceuticals to Announce 2012 Third Quarter Financial Results on October 30, 2012",Neutral,-0.0028,90,astex pharmaceutical announce third quarter financial result october,68,8,0,pharmacy,"['as', '##te', '##x', 'pharmaceutical', 'announce', 'third', 'quarter', 'financial', 'result', 'o', '##ct', '##obe', '##r']",1
186546,nifty_557,2012-10-23,"Research and Markets: Antidepressants Market to 2018 - Despite Safety Concerns, Selective Serotonin Re-uptake Inhibitors (SSRIs) Continue to Dominate in the Absence of Effective Therapeutic Alternatives",Neutral,-0.0028,202,research and market antidepressant market despite safety concern selective serotonin uptake inhibitor ssri continue dominate the absence effective therapeutic alternative,170,20,0,pharmacy,"['research', 'and', 'market', 'anti', '##de', '##press', '##ant', 'market', 'despite', 'safety', 'concern', 'selective', 'se', '##rot', '##oni', '##n', 'up', '##take', 'inhibitor', 's', '##s', '##ri', 'continue', 'dominate', 'the', 'absence', 'effective', 'therapeutic', 'alternative']",1
186547,nifty_557,2012-10-23,Research and Markets: Europe Healthcare IT Market Outlook to 2018 - Clinical IT Systems and Medical Imaging Information Systems,Neutral,-0.0028,127,research and market europe healthcare market outlook clinical system and medical imaging information system,107,14,0,pharmacy,"['research', 'and', 'market', 'euro', '##pe', 'healthcare', 'market', 'outlook', 'clinical', 'system', 'and', 'medical', 'imaging', 'information', 'system']",1
186560,nifty_557,2012-10-23,Research and Markets: Global Tuberculosis Drug Pipeline Capsule - 2012 Update,Neutral,-0.0028,77,research and market global tuberculosis drug pipeline capsule update,68,9,0,pharmacy,"['research', 'and', 'market', 'global', 'tuberculosis', 'drug', 'pipeline', 'capsule', 'update']",1
186585,nifty_557,2012-10-23, Stellar Biotechnologies Engages MZ Group as Its Investor Relations Firm,Neutral,-0.0028,72,stellar biotechnology engages group it investor relation firm,61,8,0,pharmacy,"['stellar', 'bio', '##tech', '##nology', 'engages', 'group', 'it', 'investor', 'relation', 'firm']",1
186605,nifty_557,2012-10-23,Research and Markets: United States Healthcare IT Market Outlook to 2018 - Clinical IT Systems and Medical Imaging Information Systems,Neutral,-0.0028,134,research and market united state healthcare market outlook clinical system and medical imaging information system,113,15,0,pharmacy,"['research', 'and', 'market', 'united', 'state', 'healthcare', 'market', 'outlook', 'clinical', 'system', 'and', 'medical', 'imaging', 'information', 'system']",1
186631,nifty_557,2012-10-23,"Research and Markets: Medtronic, Inc.: the Journey from Electrical Repair Shop to Global Medical Technology Giant",Neutral,-0.0028,113,research and market medtronic inc the journey from electrical repair shop global medical technology giant,105,15,0,pharmacy,"['research', 'and', 'market', 'me', '##dt', '##ronic', 'in', '##c', 'the', 'journey', 'from', 'electrical', 'repair', 'shop', 'global', 'medical', 'technology', 'giant']",1
186705,nifty_557,2012-10-23,"New LowestMed Corporate Rx Program Drives Significant Cost Savings, Offers More Choice on Prescription Drugs",Neutral,-0.0028,108,new lowestmed corporate program drive significant cost saving offer more choice prescription drug,97,13,0,pharmacy,"['new', 'lowest', '##med', 'corporate', 'program', 'drive', 'significant', 'cost', 'saving', 'offer', 'more', 'choice', 'prescription', 'drug']",1
186716,nifty_557,2012-10-23,"Wall Street Resources, Inc. Releases an Analytical Profile on BioPower Operations Corporation",Neutral,-0.0028,93,wall street resource inc release analytical profile biopower operation corporation,82,10,0,pharmacy,"['wall', 'street', 'resource', 'in', '##c', 'release', 'analytical', 'profile', 'bio', '##power', 'operation', 'corporation']",1
186726,nifty_557,2012-10-23,Research and Markets: United States Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery,Neutral,-0.0028,121,research and market united state diabetes care device market outlook glucose monitoring and insulin delivery,108,15,0,pharmacy,"['research', 'and', 'market', 'united', 'state', 'diabetes', 'care', 'device', 'market', 'outlook', 'glucose', 'monitoring', 'and', 'insulin', 'delivery']",1
186732,nifty_557,2012-10-23,Research and Markets: North America Healthcare IT Market Outlook to 2018 - Clinical IT Systems and Medical Imaging Information Systems,Neutral,-0.0028,134,research and market north america healthcare market outlook clinical system and medical imaging information system,114,15,0,pharmacy,"['research', 'and', 'market', 'north', 'am', '##eric', '##a', 'healthcare', 'market', 'outlook', 'clinical', 'system', 'and', 'medical', 'imaging', 'information', 'system']",1
186745,nifty_557,2012-10-23,"Research and Markets: U.S. Enterprise Medical Image Archiving Market: Evaluating Trends in Image Data Volumes, Enterprise PACS Archives, and Vendor-neutral Archives",Neutral,-0.0028,164,research and market enterprise medical image archiving market evaluating trend image data volume enterprise pac archive and vendor neutral archive,146,20,0,pharmacy,"['research', 'and', 'market', 'enterprise', 'medical', 'image', 'arch', '##iving', 'market', 'evaluating', 'trend', 'image', 'data', 'volume', 'enterprise', 'p', '##ac', 'archive', 'and', 'vendor', 'neutral', 'archive']",1
186759,nifty_557,2012-10-23,Thomson Reuters Corporation : Thomson Reuters Helps Pharmaceutical Executives Identify Drugs with Repositioning Potential,Neutral,-0.0028,121,thomson reuters corporation thomson reuters help pharmaceutical executive identify drug with repositioning potential,116,13,0,pharmacy,"['th', '##oms', '##on', 're', '##uters', 'corporation', 'th', '##oms', '##on', 're', '##uters', 'help', 'pharmaceutical', 'executive', 'identify', 'drug', 'with', 're', '##position', '##ing', 'potential']",1
186856,nifty_557,2012-10-23, Compass Biotechnologies to Change Its Name to 1WorldDirect Holdings Inc. and Release an Online Video of Its Business Advantage,Neutral,-0.0028,127,compass biotechnology change it name worlddirect holding inc and release online video it business advantage,107,15,0,pharmacy,"['compass', 'bio', '##tech', '##nology', 'change', 'it', 'name', 'world', '##dir', '##ec', '##t', 'holding', 'in', '##c', 'and', 'release', 'online', 'video', 'it', 'business', 'advantage']",1
186872,nifty_557,2012-10-23,Ernst & Young report: risk-informed investment strategy critical to addressing aging pipelines and other critical assets,Neutral,-0.0028,120,ernst young report risk informed investment strategy critical addressing aging pipeline and other critical asset,112,15,0,pharmacy,"['er', '##nst', 'young', 'report', 'risk', 'informed', 'investment', 'strategy', 'critical', 'addressing', 'aging', 'pipeline', 'and', 'other', 'critical', 'asset']",1
186982,nifty_557,2012-10-23,"bioMÃ©rieux: Business Review for the nine months ended September 30, 2012",Neutral,-0.0028,73,biomã rieux business review for the nine month ended september,62,10,0,pharmacy,"['bio', '##m', '##ã', 'r', '##ieu', '##x', 'business', 'review', 'for', 'the', 'nine', 'month', 'ended', 'se', '##pt', '##em', '##ber']",1
187044,nifty_557,2012-10-23,"Research and Markets: Central Nervous System (CNS) Cancer - Pipeline Review, H2 2012 Features Companies such as Merck & Co., Inc. and Teva Pharmaceutical Industries Limited",Neutral,-0.0028,172,research and market central nervous system cns cancer pipeline review feature company such merck inc and teva pharmaceutical industry limited,141,20,0,pharmacy,"['research', 'and', 'market', 'central', 'nervous', 'system', 'c', '##ns', 'cancer', 'pipeline', 'review', 'feature', 'company', 'such', 'me', '##rc', '##k', 'in', '##c', 'and', 'te', '##va', 'pharmaceutical', 'industry', 'limited']",1
187628,nifty_558,2012-10-24,Research and Markets: Global Biosimulation Technology Market (For Drug Discovery & Development) (2012 - 2017),Neutral,0.0029,109,research and market global biosimulation technology market for drug discovery development,89,11,0,pharmacy,"['research', 'and', 'market', 'global', 'bio', '##si', '##mu', '##lation', 'technology', 'market', 'for', 'drug', 'discovery', 'development']",1
187643,nifty_558,2012-10-24,Bristol-Myers Squibb Reports Third Quarter 2012 Financial Results,Neutral,0.0029,65,bristol myers squibb report third quarter financial result,58,8,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'report', 'third', 'quarter', 'financial', 'result']",1
187644,nifty_558,2012-10-24,Health Essentials Receives Investment in Post-Acute Care Companies to Drive Future Growth,Neutral,0.0029,89,health essential receives investment post acute care company drive future growth,80,11,0,pharmacy,"['health', 'essential', 'receives', 'investment', 'post', 'acute', 'care', 'company', 'drive', 'future', 'growth']",1
187790,nifty_558,2012-10-24, Where We Are Headed -- New Outlook on Bristol-Myers Squibb Company and AstraZeneca Plc,Neutral,0.0029,87,where are headed new outlook bristol myers squibb company and astrazeneca plc,77,12,0,pharmacy,"['where', 'are', 'headed', 'new', 'outlook', 'br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'company', 'and', 'as', '##tra', '##zen', '##eca', 'plc']",1
187821,nifty_558,2012-10-24,Mirna Therapeutics Secures $34.5 Million Series C Financing to Advance Oncology microRNA Pipeline into the Clinic,Neutral,0.0029,113,mirna therapeutic secures million series financing advance oncology microrna pipeline into the clinic,101,13,0,pharmacy,"['mi', '##rna', 'therapeutic', 'secure', '##s', 'million', 'series', 'financing', 'advance', 'on', '##cology', 'micro', '##rna', 'pipeline', 'into', 'the', 'clinic']",1
187843,nifty_558,2012-10-24,MicuRx and Shanghai Zhangjiang Biomedical Industry Venture Capital  Partner to Develop Next-generation Antibiotic MRX-I for Chinese Market,Neutral,0.0029,138,micurx and shanghai zhangjiang biomedical industry venture capital partner develop next generation antibiotic mrx for chinese market,132,17,0,pharmacy,"['mi', '##cu', '##r', '##x', 'and', 's', '##hang', '##hai', 'z', '##hang', '##jiang', 'bio', '##medical', 'industry', 'venture', 'capital', 'partner', 'develop', 'next', 'generation', 'anti', '##biotic', 'm', '##r', '##x', 'for', 'chin', '##ese', 'market']",1
187901,nifty_558,2012-10-24,eHealth Global Technologies Announces Rebrand,Neutral,0.0029,45,ehealth global technology announces rebrand,43,5,0,pharmacy,"['eh', '##eal', '##th', 'global', 'technology', 'announces', 're', '##brand']",1
187910,nifty_558,2012-10-24,Research and Markets: Brazil Healthcare IT Market Outlook to 2018 - Clinical IT Systems and Medical Imaging Information Systems,Neutral,0.0029,127,research and market brazil healthcare market outlook clinical system and medical imaging information system,107,14,0,pharmacy,"['research', 'and', 'market', 'bra', '##zi', '##l', 'healthcare', 'market', 'outlook', 'clinical', 'system', 'and', 'medical', 'imaging', 'information', 'system']",1
187922,nifty_558,2012-10-24,Research and Markets: North America Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery,Neutral,0.0029,122,research and market north america diabetes care device market outlook glucose monitoring and insulin delivery,109,15,0,pharmacy,"['research', 'and', 'market', 'north', 'am', '##eric', '##a', 'diabetes', 'care', 'device', 'market', 'outlook', 'glucose', 'monitoring', 'and', 'insulin', 'delivery']",1
188174,nifty_558,2012-10-24,"Healthcare Wednesday: Amarin, Gilead, XOMA, NuVasive, United Therapeutics, Discovery Laboratories Are Market Movers",Neutral,0.0029,115,healthcare wednesday amarin gilead xoma nuvasive united therapeutic discovery laboratory are market mover,105,13,0,pharmacy,"['healthcare', 'wed', '##nes', '##day', 'am', '##ari', '##n', 'g', '##ile', '##ad', 'x', '##oma', 'n', '##u', '##vasive', 'united', 'therapeutic', 'discovery', 'laboratory', 'are', 'market', 'move', '##r']",1
188236,nifty_558,2012-10-24," Q Therapeutics, Inc. Selects Hanover|Elite as New Investor and Public Relations Counsel of Record",Neutral,0.0029,98,therapeutic inc selects hanover elite new investor and public relation counsel record,85,12,0,pharmacy,"['therapeutic', 'in', '##c', 'select', '##s', 'ha', '##nov', '##er', 'elite', 'new', 'investor', 'and', 'public', 'relation', 'counsel', 'record']",1
188550,nifty_559,2012-10-25,'Patent Cliff' Hits Drug Makers,Neutral,-0.0006,31,patent cliff hit drug maker,27,5,0,pharmacy,"['patent', 'cliff', 'hit', 'drug', 'maker']",1
188682,nifty_562,2012-11-05,Humana Brings Doctors In-House,Rise,0.0078,30,humana brings doctor house,26,4,0,pharmacy,"['human', '##a', 'brings', 'doctor', 'house']",1
188706,nifty_562,2012-11-05,Keeping Autistic Child on Medicaid,Rise,0.0078,34,keeping autistic child medicaid,31,4,0,pharmacy,"['keeping', 'au', '##tist', '##ic', 'child', 'me', '##dic', '##aid']",1
188818,nifty_563,2012-11-06,Research and Markets: Cellular Imaging Techniques for Neuroscience and Beyond,Fall,-0.0227,77,research and market cellular imaging technique for neuroscience and beyond,74,10,0,pharmacy,"['research', 'and', 'market', 'cellular', 'imaging', 'technique', 'for', 'ne', '##uro', '##science', 'and', 'beyond']",1
188932,nifty_563,2012-11-06, Financial Review on Healthcare Stocks Baxter Intl. Inc. and Thermo Fisher Scientific Inc. - Medical Instrument Makers Looking to Grow,Fall,-0.0227,134,financial review healthcare stock baxter intl inc and thermo fisher scientific inc medical instrument maker looking grow,120,17,0,pharmacy,"['financial', 'review', 'healthcare', 'stock', 'b', '##ax', '##ter', 'in', '##tl', 'in', '##c', 'and', 'the', '##rm', '##o', 'fish', '##er', 'scientific', 'in', '##c', 'medical', 'instrument', 'maker', 'looking', 'grow']",1
188939,nifty_563,2012-11-06, Financial Review on Healthcare Stocks CareFusion Corp. and PerkinElmer Inc. - Medical Instrument Makers Looking to Grow,Fall,-0.0227,120,financial review healthcare stock carefusion corp and perkinelmer inc medical instrument maker looking grow,107,14,0,pharmacy,"['financial', 'review', 'healthcare', 'stock', 'care', '##fusion', 'co', '##rp', 'and', 'per', '##kin', '##el', '##mer', 'in', '##c', 'medical', 'instrument', 'maker', 'looking', 'grow']",1
188954,nifty_563,2012-11-06,US Diagnostic Imaging Market to Grow Slowly to $4.5 Billion by 2017,Fall,-0.0227,67,diagnostic imaging market grow slowly billion,45,6,0,pharmacy,"['diagnostic', 'imaging', 'market', 'grow', 'slowly', 'billion']",1
189184,nifty_563,2012-11-06,Research and Markets: Global Wireless Medical Technologies Market 2011-2015 Report Discusses That One of the Major Challenges Is the Lack of Basic IT Infrastructure,Fall,-0.0227,164,research and market global wireless medical technology market report discusses that one the major challenge the lack basic infrastructure,137,19,0,pharmacy,"['research', 'and', 'market', 'global', 'wireless', 'medical', 'technology', 'market', 'report', 'discusses', 'that', 'one', 'the', 'major', 'challenge', 'the', 'lack', 'basic', 'infrastructure']",1
189274,nifty_563,2012-11-06,"Lab Liquidation Auction:Geron, ACADIA Pharmaceuticals and More",Fall,-0.0227,62,lab liquidation auction geron acadia pharmaceutical and more,60,8,0,pharmacy,"['lab', 'liquid', '##ation', 'auction', 'g', '##eron', 'a', '##ca', '##dia', 'pharmaceutical', 'and', 'more']",1
189297,nifty_563,2012-11-06,Research and Markets: Global Bipolar Depression Epidemiology and Patient Flow Analysis - 2012,Fall,-0.0227,93,research and market global bipolar depression epidemiology and patient flow analysis,84,11,0,pharmacy,"['research', 'and', 'market', 'global', 'bi', '##pol', '##ar', 'depression', 'e', '##pid', '##em', '##iology', 'and', 'patient', 'flow', 'analysis']",1
189388,nifty_563,2012-11-06,"Research and Markets: Smart Pills Technologies Market (2012-2017) (Diagnostic Imaging, Patient Monitoring, Drug Delivery)",Fall,-0.0227,121,research and market smart pill technology market diagnostic imaging patient monitoring drug delivery,100,13,0,pharmacy,"['research', 'and', 'market', 'smart', 'pill', 'technology', 'market', 'diagnostic', 'imaging', 'patient', 'monitoring', 'drug', 'delivery']",1
189389,nifty_563,2012-11-06,Research and Markets: Molecular Diagnostics Market - Global Forecast to 2017,Fall,-0.0227,76,research and market molecular diagnostics market global forecast,64,8,0,pharmacy,"['research', 'and', 'market', 'molecular', 'diagnostic', '##s', 'market', 'global', 'forecast']",1
189397,nifty_563,2012-11-06,"Research and Markets: Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012-2017) (Neurodegenerative, cardiovascular, cancer & autoimmune, skin and infectious diseases)",Fall,-0.0227,182,research and market autologous stem cell and non stem cell based therapy market neurodegenerative cardiovascular cancer autoimmune skin and infectious disease,158,21,0,pharmacy,"['research', 'and', 'market', 'auto', '##log', '##ous', 'stem', 'cell', 'and', 'non', 'stem', 'cell', 'based', 'therapy', 'market', 'ne', '##uro', '##de', '##gene', '##rative', 'card', '##iovascular', 'cancer', 'auto', '##im', '##mu', '##ne', 'skin', 'and', 'infectious', 'disease']",1
189400,nifty_563,2012-11-06,"Research and Markets: China Medical Diagnosis, Monitoring & Treatment Equipment Market Report",Fall,-0.0227,93,research and market china medical diagnosis monitoring treatment equipment market report,88,11,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'medical', 'diagnosis', 'monitoring', 'treatment', 'equipment', 'market', 'report']",1
189436,nifty_563,2012-11-06,Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2012 Financial Results,Fall,-0.0227,96,arena pharmaceutical provides corporate update and report third quarter financial result,88,11,0,pharmacy,"['arena', 'pharmaceutical', 'provides', 'corporate', 'update', 'and', 'report', 'third', 'quarter', 'financial', 'result']",1
189501,nifty_563,2012-11-06, Onyx Pharmaceuticals to Present at Upcoming Investor Conferences,Fall,-0.0227,65,onyx pharmaceutical present upcoming investor conference,56,6,0,pharmacy,"['on', '##yx', 'pharmaceutical', 'present', 'upcoming', 'investor', 'conference']",1
189503,nifty_563,2012-11-06,Kindred Healthcare to Present at Investor Conferences,Fall,-0.0227,53,kindred healthcare present investor conference,46,5,0,pharmacy,"['kind', '##red', 'healthcare', 'present', 'investor', 'conference']",1
189632,nifty_563,2012-11-06,Novartis Heart Drug Shows Mixed Results,Fall,-0.0227,39,novartis heart drug show mixed result,37,6,0,pharmacy,"['no', '##var', '##tis', 'heart', 'drug', 'show', 'mixed', 'result']",1
189756,nifty_565,2012-11-08,"Novartis future growth prospects secured by industry-leading pipeline, with more than 139 projects with 73 new compounds",Neutral,0.0009,120,novartis future growth prospect secured industry leading pipeline with more than project with new compound,106,15,0,pharmacy,"['no', '##var', '##tis', 'future', 'growth', 'prospect', 'secured', 'industry', 'leading', 'pipeline', 'with', 'more', 'than', 'project', 'with', 'new', 'compound']",1
189766,nifty_565,2012-11-08,Novartis says expects to have 14 new blockbusters by 2017,Neutral,0.0009,57,novartis say expects have new blockbuster,41,6,0,pharmacy,"['no', '##var', '##tis', 'say', 'expects', 'have', 'new', 'block', '##buster']",1
189869,nifty_565,2012-11-08,"Research and Markets: China Medical Professional Engineering Industry Report, 2012-2014",Neutral,0.0009,87,research and market china medical professional engineering industry report,74,9,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'medical', 'professional', 'engineering', 'industry', 'report']",1
189926,nifty_565,2012-11-08,BioCryst Provides Corporate Update and Reports Third Quarter 2012 Financial Results,Neutral,0.0009,83,biocryst provides corporate update and report third quarter financial result,76,10,0,pharmacy,"['bio', '##c', '##ry', '##st', 'provides', 'corporate', 'update', 'and', 'report', 'third', 'quarter', 'financial', 'result']",1
189964,nifty_565,2012-11-08,Spectrum Pharmaceuticals to Present Corporate Update at Credit Suisse 2012 Healthcare Conference in Phoenix on November 15th,Neutral,0.0009,124,spectrum pharmaceutical present corporate update credit suisse healthcare conference phoenix november,101,11,0,pharmacy,"['spectrum', 'pharmaceutical', 'present', 'corporate', 'update', 'credit', 'su', '##isse', 'healthcare', 'conference', 'p', '##hoe', '##ni', '##x', 'no', '##ve', '##mber']",1
190095,nifty_565,2012-11-08,Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences,Neutral,0.0009,69,arena pharmaceutical present two upcoming investor conference,61,7,0,pharmacy,"['arena', 'pharmaceutical', 'present', 'two', 'upcoming', 'investor', 'conference']",1
190141,nifty_565,2012-11-08,Novartis says may have 14 new blockbuster drugs by 2017,Neutral,0.0009,55,novartis say may have new blockbuster drug,42,7,0,pharmacy,"['no', '##var', '##tis', 'say', 'may', 'have', 'new', 'block', '##buster', 'drug']",1
190144,nifty_565,2012-11-08," ""Patient Portal Technology Is the New Wave of the Future"" Reports Pittsburgh Business Times",Neutral,0.0009,92,patient portal technology the new wave the future report pittsburgh business time,81,12,0,pharmacy,"['patient', 'portal', 'technology', 'the', 'new', 'wave', 'the', 'future', 'report', 'pit', '##ts', '##burgh', 'business', 'time']",1
190210,nifty_565,2012-11-08,Pharmaceutical Innovation Spotlighted at ISPE Annual Meeting,Neutral,0.0009,60,pharmaceutical innovation spotlighted ispe annual meeting,57,6,0,pharmacy,"['pharmaceutical', 'innovation', 'spotlight', '##ed', 'is', '##pe', 'annual', 'meeting']",1
190285,nifty_565,2012-11-08, New Online Publication Transformative Health Provides Industry Expert Perspectives on the Intersection of Patient Engagement and Technology,Neutral,0.0009,140,new online publication transformative health provides industry expert perspective the intersection patient engagement and technology,132,15,0,pharmacy,"['new', 'online', 'publication', 'transform', '##ative', 'health', 'provides', 'industry', 'expert', 'perspective', 'the', 'intersection', 'patient', 'engagement', 'and', 'technology']",1
190597,nifty_565,2012-11-08,BioSpecifics Technologies Corp. Reports Third Quarter 2012 Financial Results,Neutral,0.0009,76,biospecifics technology corp report third quarter financial result,66,8,0,pharmacy,"['bio', '##sp', '##ec', '##ific', '##s', 'technology', 'co', '##rp', 'report', 'third', 'quarter', 'financial', 'result']",1
190604,nifty_565,2012-11-08,Trius Therapeutics to Host Analyst and Investor Update Call,Neutral,0.0009,59,trius therapeutic host analyst and investor update call,55,8,0,pharmacy,"['t', '##rius', 'therapeutic', 'host', 'analyst', 'and', 'investor', 'update', 'call']",1
190645,nifty_565,2012-11-08,BioSante Pharmaceuticals Reports Third Quarter Financial Results and Merger Update,Neutral,0.0009,82,biosante pharmaceutical report third quarter financial result and merger update,79,10,0,pharmacy,"['bio', '##san', '##te', 'pharmaceutical', 'report', 'third', 'quarter', 'financial', 'result', 'and', 'merger', 'update']",1
190674,nifty_565,2012-11-08,Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences,Neutral,0.0009,85,momentum pharmaceutical webcast presentation two upcoming investor conference,77,8,0,pharmacy,"['momentum', 'pharmaceutical', 'web', '##cast', 'presentation', 'two', 'upcoming', 'investor', 'conference']",1
190676,nifty_565,2012-11-08,China Biologic Reports Financial Results for the Third Quarter and First Nine Months of 2012,Neutral,0.0009,92,china biologic report financial result for the third quarter and first nine month,81,13,0,pharmacy,"['chin', '##a', 'bio', '##log', '##ic', 'report', 'financial', 'result', 'for', 'the', 'third', 'quarter', 'and', 'first', 'nine', 'month']",1
190677,nifty_565,2012-11-08,MAP Pharmaceuticals to Present at Upcoming Investor Conferences,Neutral,0.0009,63,map pharmaceutical present upcoming investor conference,55,6,0,pharmacy,"['map', 'pharmaceutical', 'present', 'upcoming', 'investor', 'conference']",1
190712,nifty_565,2012-11-08,Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences,Neutral,0.0009,78,orexigen therapeutic announces presentation upcoming investor conference,72,7,0,pharmacy,"['ore', '##xi', '##gen', 'therapeutic', 'announces', 'presentation', 'upcoming', 'investor', 'conference']",1
191040,nifty_567,2012-11-13,Merck Stops Development of Diabetes-Cholesterol Pill,Fall,-0.0135,52,merck stop development diabetes cholesterol pill,48,6,0,pharmacy,"['me', '##rc', '##k', 'stop', 'development', 'diabetes', 'ch', '##ole', '##ster', '##ol', 'pill']",1
191135,nifty_569,2012-11-15,Biotech Intarcia Raises $210 Million,Neutral,0.0049,36,biotech intarcia raise million,30,4,0,pharmacy,"['bio', '##tech', 'in', '##tar', '##cia', 'raise', 'million']",1
191193,nifty_571,2012-11-20,Doctor Highlights Ties Between Investors and Medical Field,Neutral,0.0019,58,doctor highlight tie between investor and medical field,55,8,0,pharmacy,"['doctor', 'highlight', 'tie', 'between', 'investor', 'and', 'medical', 'field']",1
191283,nifty_572,2012-11-26,FDA Says TB Drug Appears Safe,Fall,-0.0051,29,fda say drug appears safe,25,5,0,pharmacy,"['f', '##da', 'say', 'drug', 'appears', 'safe']",1
191342,nifty_573,2012-11-27, ARKADIN Acquires Novasight With the Support of AXA Private Equity,Rise,0.0081,66,arkadin acquires novasight with the support axa private equity,62,9,0,pharmacy,"['a', '##rka', '##din', 'acquire', '##s', 'no', '##vas', '##ight', 'with', 'the', 'support', 'a', '##xa', 'private', 'equity']",1
191378,nifty_573,2012-11-27,Research and Markets: Denmark Healthcare IT Market Outlook to 2018 - Clinical IT Systems and Medical Imaging Information Systems,Rise,0.0081,128,research and market denmark healthcare market outlook clinical system and medical imaging information system,108,14,0,pharmacy,"['research', 'and', 'market', 'den', '##mark', 'healthcare', 'market', 'outlook', 'clinical', 'system', 'and', 'medical', 'imaging', 'information', 'system']",1
191414,nifty_573,2012-11-27,"Research and Markets: Inflammation Global Clinical Trials Review, H2, 2012",Rise,0.0081,74,research and market inflammation global clinical trial review,61,8,0,pharmacy,"['research', 'and', 'market', 'inflammation', 'global', 'clinical', 'trial', 'review']",1
191440,nifty_573,2012-11-27,Research and Markets: Global Insomnia Drug Pipeline Capsule - 2012 Update,Rise,0.0081,73,research and market global insomnia drug pipeline capsule update,64,9,0,pharmacy,"['research', 'and', 'market', 'global', 'ins', '##om', '##nia', 'drug', 'pipeline', 'capsule', 'update']",1
191451,nifty_573,2012-11-27,ChemoCentryx Expands CCR2 Inhibitor Franchise with CCX872,Rise,0.0081,57,chemocentryx expands ccr inhibitor franchise with ccx,53,7,0,pharmacy,"['ch', '##em', '##oc', '##entry', '##x', 'expands', 'cc', '##r', 'inhibitor', 'franchise', 'with', 'cc', '##x']",1
191491,nifty_573,2012-11-27,Research and Markets: Global Infertility Drug Pipeline Capsule - 2012 Update,Rise,0.0081,76,research and market global infertility drug pipeline capsule update,67,9,0,pharmacy,"['research', 'and', 'market', 'global', 'in', '##fer', '##tility', 'drug', 'pipeline', 'capsule', 'update']",1
191515,nifty_573,2012-11-27," eHealth, Inc. Reaches New Leadership Milestone as It Insures Over 3 Million Consumers",Rise,0.0081,86,ehealth inc reach new leadership milestone insures over million consumer,72,10,0,pharmacy,"['eh', '##eal', '##th', 'in', '##c', 'reach', 'new', 'leadership', 'milestone', 'ins', '##ures', 'over', 'million', 'consumer']",1
191531,nifty_573,2012-11-27,"Griffin Securities, Inc. Announces Investment Opinion on Oragenics, Inc.",Rise,0.0081,72,griffin security inc announces investment opinion oragenics inc,63,8,0,pharmacy,"['g', '##riff', '##in', 'security', 'in', '##c', 'announces', 'investment', 'opinion', 'or', '##age', '##nics', 'in', '##c']",1
191553,nifty_573,2012-11-27,"AdCare Health Systems, Inc. to Present at Upcoming Investor Conferences",Rise,0.0081,71,adcare health system inc present upcoming investor conference,61,8,0,pharmacy,"['ad', '##care', 'health', 'system', 'in', '##c', 'present', 'upcoming', 'investor', 'conference']",1
191619,nifty_573,2012-11-27,Reminder: Ligand to Host Analyst Day on December 4th in New York City,Rise,0.0081,69,reminder ligand host analyst day december new york city,55,9,0,pharmacy,"['reminder', 'l', '##igan', '##d', 'host', 'analyst', 'day', 'de', '##ce', '##mber', 'new', 'yo', '##rk', 'city']",1
191662,nifty_573,2012-11-27,KPMG's Paul Hencoski Available For Commentary On Health Insurance Exchanges,Rise,0.0081,75,kpmg paul hencoski available for commentary health insurance exchange,69,9,0,pharmacy,"['k', '##pm', '##g', 'p', '##aul', 'he', '##nco', '##ski', 'available', 'for', 'commentary', 'health', 'insurance', 'exchange']",1
191760,nifty_573,2012-11-27,Community Health Systems to Participate in The Bank of America Merrill Lynch 2012 Leveraged Finance Conference,Rise,0.0081,110,community health system participate the bank america merrill lynch leveraged finance conference,95,12,0,pharmacy,"['community', 'health', 'system', 'participate', 'the', 'bank', 'am', '##eric', '##a', 'me', '##rri', '##ll', 'l', '##ync', '##h', 'leverage', '##d', 'finance', 'conference']",1
191785,nifty_573,2012-11-27,"Affluence, an Aging Population, and Anticipated Rx-to-OTC Switches Boost a Healthy $32 Billion OTC Market in China, According to Kline",Rise,0.0081,134,affluence aging population and anticipated otc switch boost healthy billion otc market china according kline,108,15,0,pharmacy,"['a', '##ff', '##lue', '##nce', 'aging', 'population', 'and', 'anticipated', 'o', '##t', '##c', 'switch', 'boost', 'healthy', 'billion', 'o', '##t', '##c', 'market', 'chin', '##a', 'according', 'k', '##line']",1
191804,nifty_573,2012-11-27,"Research and Markets: Medical Device Market Opportunities In Germany, 2012",Rise,0.0081,74,research and market medical device market opportunity germany,61,8,0,pharmacy,"['research', 'and', 'market', 'medical', 'device', 'market', 'opportunity', 'g', '##erman', '##y']",1
191813,nifty_573,2012-11-27,Hot Biopharma Stocks on the Move Tuesday,Rise,0.0081,40,hot biopharma stock the move tuesday,36,6,0,pharmacy,"['hot', 'bio', '##pha', '##rma', 'stock', 'the', 'move', 't', '##ues', '##day']",1
191817,nifty_573,2012-11-27,15th Annual BIO CEO & Investor Conference to Highlight Drivers of Biotech Momentum,Rise,0.0081,82,annual bio ceo investor conference highlight driver biotech momentum,68,9,0,pharmacy,"['annual', 'bio', 'c', '##eo', 'investor', 'conference', 'highlight', 'driver', 'bio', '##tech', 'momentum']",1
191873,nifty_573,2012-11-27,"Research and Markets: Greece Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018",Rise,0.0081,107,research and market greece diabetes care device investment opportunity analysis and forecast,92,12,0,pharmacy,"['research', 'and', 'market', 'g', '##ree', '##ce', 'diabetes', 'care', 'device', 'investment', 'opportunity', 'analysis', 'and', 'forecast']",1
191917,nifty_573,2012-11-27,"Research Down Syndrome Holds Annual ""Empower the Extraordinary"" Event",Rise,0.0081,69,research down syndrome hold annual empower the extraordinary event,66,9,0,pharmacy,"['research', 'down', 'syndrome', 'hold', 'annual', 'em', '##power', 'the', 'extraordinary', 'event']",1
192165,nifty_573,2012-11-27,Acadia Drug Shows Promise,Rise,0.0081,25,acadia drug show promise,24,4,0,pharmacy,"['a', '##ca', '##dia', 'drug', 'show', 'promise']",1
192197,nifty_574,2012-11-28,Erectile Drug Shows Promise in Rare Muscle Disease,Neutral,0.0047,50,erectile drug show promise rare muscle disease,46,7,0,pharmacy,"['erect', '##ile', 'drug', 'show', 'promise', 'rare', 'muscle', 'disease']",1
192198,nifty_574,2012-11-28,"Brand-Name Drug Prices Rise, But Generics Get Cheaper",Neutral,0.0047,53,brand name drug price rise but generic get cheaper,50,9,0,pharmacy,"['brand', 'name', 'drug', 'price', 'rise', 'but', 'generic', 'get', 'cheaper']",1
192455,nifty_578,2012-12-05,Pronova BioPharma ASA : Offer Document from BASF Approved by the Oslo Stock Exchange,Neutral,0.0034,84,pronova biopharma asa offer document from basf approved the oslo stock exchange,79,12,0,pharmacy,"['pro', '##nova', 'bio', '##pha', '##rma', 'as', '##a', 'offer', 'document', 'from', 'b', '##as', '##f', 'approved', 'the', 'o', '##s', '##lo', 'stock', 'exchange']",1
192492,nifty_578,2012-12-05,"Research and Markets: Mycoses - Pipeline Review, H2 2012",Neutral,0.0034,56,research and market mycoses pipeline review,43,6,0,pharmacy,"['research', 'and', 'market', 'my', '##cos', '##es', 'pipeline', 'review']",1
192506,nifty_578,2012-12-05,"Research and Markets: Brain Cancer - Pipeline Review, H2 2012",Neutral,0.0034,61,research and market brain cancer pipeline review,48,7,0,pharmacy,"['research', 'and', 'market', 'brain', 'cancer', 'pipeline', 'review']",1
192522,nifty_578,2012-12-05,Research and Markets: Stem Cell & Regenerative Medicine,Neutral,0.0034,55,research and market stem cell regenerative medicine,51,7,0,pharmacy,"['research', 'and', 'market', 'stem', 'cell', 're', '##gene', '##rative', 'medicine']",1
192530,nifty_578,2012-12-05,Research and Markets: Diagnostic Technologies in Ophthalmology,Neutral,0.0034,62,research and market diagnostic technology ophthalmology,55,6,0,pharmacy,"['research', 'and', 'market', 'diagnostic', 'technology', 'op', '##ht', '##hal', '##mology']",1
192538,nifty_578,2012-12-05," Pharma-Bio Industry Expects to Wrap Up $12.6 Billion in 2012 North American Capital/MRO Investments, an Industrial Info News Alert",Neutral,0.0034,131,pharma bio industry expects wrap billion north american capital mro investment industrial info news alert,105,15,0,pharmacy,"['p', '##har', '##ma', 'bio', 'industry', 'expects', 'wrap', 'billion', 'north', 'am', '##eric', '##an', 'capital', 'm', '##ro', 'investment', 'industrial', 'info', 'news', 'alert']",1
192547,nifty_578,2012-12-05,Research and Markets: X-Ray Systems Market to 2016 - The Digital X-Ray Systems Segment to be the Growth Driver,Neutral,0.0034,110,research and market ray system market the digital ray system segment the growth driver,86,14,0,pharmacy,"['research', 'and', 'market', 'ray', 'system', 'market', 'the', 'digital', 'ray', 'system', 'segment', 'the', 'growth', 'driver']",1
192607,nifty_578,2012-12-05,"Day of Pharma Blockbusters Are Over as Industry Reboots for Agile, Open Innovation",Neutral,0.0034,82,day pharma blockbuster are over industry reboots for agile open innovation,74,11,0,pharmacy,"['day', 'p', '##har', '##ma', 'block', '##buster', 'are', 'over', 'industry', 're', '##boo', '##ts', 'for', 'a', '##gi', '##le', 'open', 'innovation']",1
192623,nifty_578,2012-12-05,"Thomson Reuters Corporation: Thomson Reuters Empowers Drug Development and Clinical Professionals to Develop Better, Faster Clinical Trials with Best-in-Class Intelligence Solution",Neutral,0.0034,180,thomson reuters corporation thomson reuters empowers drug development and clinical professional develop better faster clinical trial with best class intelligence solution,170,21,0,pharmacy,"['th', '##oms', '##on', 're', '##uters', 'corporation', 'th', '##oms', '##on', 're', '##uters', 'em', '##power', '##s', 'drug', 'development', 'and', 'clinical', 'professional', 'develop', 'better', 'faster', 'clinical', 'trial', 'with', 'best', 'class', 'intelligence', 'solution']",1
192684,nifty_578,2012-12-05,"MedCAREERS Group, Inc. Secures Financing",Neutral,0.0034,40,medcareers group inc secures financing,38,5,0,pharmacy,"['me', '##d', '##care', '##ers', 'group', 'in', '##c', 'secure', '##s', 'financing']",1
192923,nifty_578,2012-12-05,"BIO CEO & Investor Conference 2013 to be held Feb. 11 - 12, 2013, in New York, NY, US",Neutral,0.0034,85,bio ceo investor conference held feb new york,45,8,0,pharmacy,"['bio', 'c', '##eo', 'investor', 'conference', 'held', 'f', '##eb', 'new', 'yo', '##rk']",1
192987,nifty_578,2012-12-05,"Pressure BioSciences, Inc. Appoints Conrad F. Mir as Chief Financial Officer",Neutral,0.0034,76,pressure bioscience inc appoints conrad mir chief financial officer,67,9,0,pharmacy,"['pressure', 'bio', '##science', 'in', '##c', 'appoint', '##s', 'con', '##rad', 'mi', '##r', 'chief', 'financial', 'officer']",1
193035,nifty_578,2012-12-05,National Community Pharmacists Association and Purdue Pharma Urge Americans to Safeguard Rx Medicines This Holiday Season,Neutral,0.0034,121,national community pharmacist association and purdue pharma urge american safeguard medicine this holiday season,112,14,0,pharmacy,"['national', 'community', 'p', '##har', '##ma', '##cist', 'association', 'and', 'pu', '##rd', '##ue', 'p', '##har', '##ma', 'urge', 'am', '##eric', '##an', 'safe', '##guard', 'medicine', 'this', 'holiday', 'season']",1
193060,nifty_578,2012-12-05,Modernizing Medicine gets $12M to push physicians into the digital age,Neutral,0.0034,70,modernizing medicine get push physician into the digital age,60,9,0,pharmacy,"['modern', '##izing', 'medicine', 'get', 'push', 'physician', 'into', 'the', 'digital', 'age']",1
193298,nifty_578,2012-12-05,FDA Drug Approvals Increase,Neutral,0.0034,27,fda drug approval increase,26,4,0,pharmacy,"['f', '##da', 'drug', 'approval', 'increase']",1
193311,nifty_578,2012-12-05,"Drug Firms, Universities Team Up on Stem Cells",Neutral,0.0034,46,drug firm university team stem cell,35,6,0,pharmacy,"['drug', 'firm', 'university', 'team', 'stem', 'cell']",1
193410,nifty_580,2012-12-10,Amgen to Buy DeCODE Genetics,Rise,0.0068,28,amgen buy decode genetics,25,4,0,pharmacy,"['am', '##gen', 'buy', 'de', '##code', 'genetics']",1
193493,nifty_581,2012-12-11,Solvay invests in Sofinnova Green Seed Fund to support innovation in industrial biotechnologies,Neutral,0.0005,95,solvay invests sofinnova green seed fund support innovation industrial biotechnology,84,10,0,pharmacy,"['so', '##l', '##va', '##y', 'invest', '##s', 'so', '##fin', '##nova', 'green', 'seed', 'fund', 'support', 'innovation', 'industrial', 'bio', '##tech', '##nology']",1
193589,nifty_581,2012-12-11,Research and Markets: Global Cardiovascular Disorders Drug Pipeline Capsule - 2012,Neutral,0.0005,82,research and market global cardiovascular disorder drug pipeline capsule,72,9,0,pharmacy,"['research', 'and', 'market', 'global', 'card', '##iovascular', 'disorder', 'drug', 'pipeline', 'capsule']",1
193592,nifty_581,2012-12-11,Research and Markets: Global CNS Disorders Drug Pipeline Capsule - 2012,Neutral,0.0005,71,research and market global cns disorder drug pipeline capsule,61,9,0,pharmacy,"['research', 'and', 'market', 'global', 'c', '##ns', 'disorder', 'drug', 'pipeline', 'capsule']",1
193606,nifty_581,2012-12-11,Research and Markets: Global Infectious Diseases Drug Pipeline Capsule - 2012,Neutral,0.0005,77,research and market global infectious disease drug pipeline capsule,67,9,0,pharmacy,"['research', 'and', 'market', 'global', 'infectious', 'disease', 'drug', 'pipeline', 'capsule']",1
193616,nifty_581,2012-12-11,Research and Markets: Global Oncology Drug Pipeline Capsule - 2012,Neutral,0.0005,66,research and market global oncology drug pipeline capsule,57,8,0,pharmacy,"['research', 'and', 'market', 'global', 'on', '##cology', 'drug', 'pipeline', 'capsule']",1
193620,nifty_581,2012-12-11,Research and Markets: Global Ophthalmology Drug Pipeline Capsule - 2012,Neutral,0.0005,71,research and market global ophthalmology drug pipeline capsule,62,8,0,pharmacy,"['research', 'and', 'market', 'global', 'op', '##ht', '##hal', '##mology', 'drug', 'pipeline', 'capsule']",1
193708,nifty_581,2012-12-11,Research and Markets: Key Pharma Industry Trends through 2014,Neutral,0.0005,61,research and market key pharma industry trend through,53,8,0,pharmacy,"['research', 'and', 'market', 'key', 'p', '##har', '##ma', 'industry', 'trend', 'through']",1
193715,nifty_581,2012-12-11,"Research and Markets: Sezary Syndrome - Pipeline Review, H2 2012",Neutral,0.0005,64,research and market sezary syndrome pipeline review,51,7,0,pharmacy,"['research', 'and', 'market', 'se', '##zar', '##y', 'syndrome', 'pipeline', 'review']",1
193740,nifty_581,2012-12-11,"The Epilepsy Drug Market Will Increase $800 Million by 2016, Primarily Due to Uptake of Premium-Priced Third-Generation Antiepileptic Drugs (AEDs), Before Leveling Off Through 2021",Neutral,0.0005,180,the epilepsy drug market will increase million primarily due uptake premium priced third generation antiepileptic drug aeds before leveling off through,151,21,0,pharmacy,"['the', 'e', '##pile', '##psy', 'drug', 'market', 'will', 'increase', 'million', 'primarily', 'due', 'up', '##take', 'premium', 'priced', 'third', 'generation', 'anti', '##ep', '##ile', '##ptic', 'drug', 'a', '##eds', 'before', 'level', '##ing', 'off', 'through']",1
193824,nifty_581,2012-12-11,Research and Markets: US OTC Pharmaceutical Market Guide,Neutral,0.0005,56,research and market otc pharmaceutical market guide,51,7,0,pharmacy,"['research', 'and', 'market', 'o', '##t', '##c', 'pharmaceutical', 'market', 'guide']",1
193830,nifty_581,2012-12-11,Centralized Portfolio Management Teams Guide Decisions Amid Pharmaceutical Patent Expirations,Neutral,0.0005,93,centralized portfolio management team guide decision amid pharmaceutical patent expiration,90,10,0,pharmacy,"['centralized', 'portfolio', 'management', 'team', 'guide', 'decision', 'amid', 'pharmaceutical', 'patent', 'ex', '##piration']",1
193835,nifty_581,2012-12-11,Navidea Biopharmaceuticals Provides Financing Update,Neutral,0.0005,52,navidea biopharmaceuticals provides financing update,52,5,0,pharmacy,"['na', '##vide', '##a', 'bio', '##pha', '##rma', '##ce', '##utical', '##s', 'provides', 'financing', 'update']",1
193870,nifty_581,2012-12-11,Research and Markets: The U.S. Health Information Exchange Market,Neutral,0.0005,65,research and market the health information exchange market,58,8,0,pharmacy,"['research', 'and', 'market', 'the', 'health', 'information', 'exchange', 'market']",1
194040,nifty_581,2012-12-11,"Research and Markets: Depression - Pipeline Review, H2 2012 Gives an Accurate Account of the Market Today",Neutral,0.0005,105,research and market depression pipeline review give accurate account the market today,85,12,0,pharmacy,"['research', 'and', 'market', 'depression', 'pipeline', 'review', 'give', 'accurate', 'account', 'the', 'market', 'today']",1
194424,nifty_583,2012-12-13,Invest In Tissue World - Barcelona 2013,Neutral,-0.0037,39,invest tissue world barcelona,29,4,0,pharmacy,"['invest', 'tissue', 'world', 'bar', '##cel', '##ona']",1
194565,nifty_583,2012-12-13,"Research and Markets: Future Horizons in the European Cancer Diagnostics Market - France, Germany, Italy, Spain and UK: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Country",Neutral,-0.0037,187,research and market future horizon the european cancer diagnostics market france germany italy spain and supplier share and sale forecast for tumor marker country,162,24,0,pharmacy,"['research', 'and', 'market', 'future', 'horizon', 'the', 'euro', '##pe', '##an', 'cancer', 'diagnostic', '##s', 'market', 'f', '##rance', 'g', '##erman', '##y', 'it', '##aly', 'spa', '##in', 'and', 'supplier', 'share', 'and', 'sale', 'forecast', 'for', 'tumor', 'marker', 'country']",1
194580,nifty_583,2012-12-13,Research and Markets: Future Horizons in the $4.5 Billion European Molecular Diagnostics Market - Supplier Shares and Sales Forecasts for 35 Tests and Applications by Country,Neutral,-0.0037,174,research and market future horizon the billion european molecular diagnostics market supplier share and sale forecast for test and application country,150,21,0,pharmacy,"['research', 'and', 'market', 'future', 'horizon', 'the', 'billion', 'euro', '##pe', '##an', 'molecular', 'diagnostic', '##s', 'market', 'supplier', 'share', 'and', 'sale', 'forecast', 'for', 'test', 'and', 'application', 'country']",1
194627,nifty_583,2012-12-13,NovaBay Pharmaceuticals Provides Business Update and 2013 Outlook,Neutral,-0.0037,65,novabay pharmaceutical provides business update and outlook,59,7,0,pharmacy,"['no', '##va', '##bay', 'pharmaceutical', 'provides', 'business', 'update', 'and', 'outlook']",1
194652,nifty_583,2012-12-13,Thomson Reuters Spotlights the Impact of Personalized Medicine on Pharmaceutical R&D;,Neutral,-0.0037,85,thomson reuters spotlight the impact personalized medicine pharmaceutical,73,8,0,pharmacy,"['th', '##oms', '##on', 're', '##uters', 'spotlight', 'the', 'impact', 'personal', '##ized', 'medicine', 'pharmaceutical']",1
194819,nifty_583,2012-12-13,"Research and Markets: Louisville, KY Healthcare Market Overview",Neutral,-0.0037,63,research and market louisville healthcare market overview,57,7,0,pharmacy,"['research', 'and', 'market', 'lo', '##ui', '##sville', 'healthcare', 'market', 'overview']",1
194847,nifty_583,2012-12-13,Pharmaceutical Companies Underpay Some Managed Markets Executives,Neutral,-0.0037,65,pharmaceutical company underpay some managed market executive,61,7,0,pharmacy,"['pharmaceutical', 'company', 'under', '##pa', '##y', 'some', 'managed', 'market', 'executive']",1
194953,nifty_583,2012-12-13,Research and Markets: 2012 China New Medical Reform Policy Specific Analysis and the Influence on Medical Industry,Neutral,-0.0037,114,research and market china new medical reform policy specific analysis and the influence medical industry,104,15,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'new', 'medical', 'reform', 'policy', 'specific', 'analysis', 'and', 'the', 'influence', 'medical', 'industry']",1
195023,nifty_583,2012-12-13,The Market for Pain Therapies Will Grow at an Annual Rate of 1.8 Percent Over the Next 15 Years,Neutral,-0.0037,95,the market for pain therapy will grow annual rate percent over the next year,76,14,0,pharmacy,"['the', 'market', 'for', 'pain', 'therapy', 'will', 'grow', 'annual', 'rate', 'percent', 'over', 'the', 'next', 'year']",1
195291,nifty_583,2012-12-13,Making Stem Cells From Adult Cells,Neutral,-0.0037,34,making stem cell from adult cell,32,6,0,pharmacy,"['making', 'stem', 'cell', 'from', 'adult', 'cell']",1
195414,nifty_585,2012-12-18,FDA Questions Hemispherx's Fatigue Drug,Fall,-0.0074,39,fda question hemispherx fatigue drug,36,5,0,pharmacy,"['f', '##da', 'question', 'hem', '##is', '##pher', '##x', 'fatigue', 'drug']",1
195419,nifty_585,2012-12-18,Amgen Pleads Guilty on Promotion of Anemia Drug,Fall,-0.0074,47,amgen pleads guilty promotion anemia drug,41,6,0,pharmacy,"['am', '##gen', 'plea', '##ds', 'guilty', 'promotion', 'an', '##emia', 'drug']",1
195529,nifty_587,2012-12-20,Panel Rejects Drug for Chronic Fatigue Syndrome,Fall,-0.0161,47,panel reject drug for chronic fatigue syndrome,46,7,0,pharmacy,"['panel', 'reject', 'drug', 'for', 'chronic', 'fatigue', 'syndrome']",1
195630,nifty_588,2012-12-26,"AMAG Pharmaceuticals, Inc. to Present at the 31st Annual J.P. Morgan Healthcare Conference",Neutral,-0.0013,90,amag pharmaceutical inc present the annual morgan healthcare conference,71,9,0,pharmacy,"['am', '##ag', 'pharmaceutical', 'in', '##c', 'present', 'the', 'annual', 'm', '##or', '##gan', 'healthcare', 'conference']",1
195868,nifty_590,2013-01-02,Drug Maker AbbVie Begins Life Without Abbott,Neutral,-0.0023,44,drug maker abbvie begin life without abbott,43,7,0,pharmacy,"['drug', 'maker', 'a', '##bb', '##vie', 'begin', 'life', 'without', 'abbot', '##t']",1
195894,nifty_590,2013-01-02,J&J's TB Treatment Gains Approval,Neutral,-0.0023,33,treatment gain approval,23,3,0,pharmacy,"['treatment', 'gain', 'approval']",1
195915,nifty_591,2013-01-03,Biogen Ends Development of ALS Drug,Neutral,0.0044,35,biogen end development al drug,30,5,0,pharmacy,"['bio', '##gen', 'end', 'development', 'al', 'drug']",1
195940,nifty_592,2013-01-07,"Big pharma will increasingly tap M&A; to close $100 billion growth gap, but path to deals grows more complex",Neutral,-0.0029,108,big pharma will increasingly tap close billion growth gap but path deal grows more complex,90,15,0,pharmacy,"['big', 'p', '##har', '##ma', 'will', 'increasingly', 'tap', 'close', 'billion', 'growth', 'gap', 'but', 'path', 'deal', 'grows', 'more', 'complex']",1
196041,nifty_592,2013-01-07,BioMed Innovation Summit 2013 Will Launch in China,Neutral,-0.0029,50,biomed innovation summit will launch china,42,6,0,pharmacy,"['bio', '##med', 'innovation', 'summit', 'will', 'launch', 'chin', '##a']",1
196108,nifty_592,2013-01-07,Global Publishing Market for General Medicine Education is Expected to Reach USD 3.6 Billion by 2018: Transparency Market Research,Neutral,-0.0029,130,global publishing market for general medicine education expected reach usd billion transparency market research,111,14,0,pharmacy,"['global', 'publishing', 'market', 'for', 'general', 'medicine', 'education', 'expected', 'reach', 'us', '##d', 'billion', 'transparency', 'market', 'research']",1
196117,nifty_592,2013-01-07,"Research and Markets: Point-of-Delivery Drug, Reconstitution Systems Markets, Strategies and Prospects",Neutral,-0.0029,102,research and market point delivery drug reconstitution system market strategy and prospect,90,12,0,pharmacy,"['research', 'and', 'market', 'point', 'delivery', 'drug', 're', '##con', '##st', '##itution', 'system', 'market', 'strategy', 'and', 'prospect']",1
196143,nifty_592,2013-01-07,Research and Markets: Competitor Analysis: EGF-R Antibodies - Biosimilars and Biosuperiors,Neutral,-0.0029,90,research and market competitor analysis egf antibody biosimilars and biosuperiors,81,10,0,pharmacy,"['research', 'and', 'market', 'competitor', 'analysis', 'e', '##g', '##f', 'anti', '##body', 'bio', '##si', '##mi', '##lars', 'and', 'bio', '##su', '##per', '##ior', '##s']",1
196153,nifty_592,2013-01-07,Aegerion Pharmaceuticals Announces Key Business and Financial Objectives for 2013 as the Company Prepares for U.S. Launch of JUXTAPID(TM) (lomitapide) Capsules,Neutral,-0.0029,159,aegerion pharmaceutical announces key business and financial objective for the company prepares for launch juxtapid lomitapide capsule,134,17,0,pharmacy,"['a', '##ege', '##rion', 'pharmaceutical', 'announces', 'key', 'business', 'and', 'financial', 'objective', 'for', 'the', 'company', 'prepares', 'for', 'launch', 'j', '##ux', '##ta', '##pid', 'lo', '##mit', '##ap', '##ide', 'capsule']",1
196154,nifty_592,2013-01-07,EntreMed Files New Drug Clinical Trial Application For ENMD-2076 With China SFDA To Advance Global Development Strategy,Neutral,-0.0029,119,entremed file new drug clinical trial application for enmd with china sfda advance global development strategy,110,16,0,pharmacy,"['en', '##tre', '##med', 'file', 'new', 'drug', 'clinical', 'trial', 'application', 'for', 'en', '##m', '##d', 'with', 'chin', '##a', 's', '##f', '##da', 'advance', 'global', 'development', 'strategy']",1
196183,nifty_592,2013-01-07,Amicus Therapeutics Provides Full-Year 2013 Financial Guidance and Strategic Outlook,Neutral,-0.0029,84,amicus therapeutic provides full year financial guidance and strategic outlook,78,10,0,pharmacy,"['am', '##icus', 'therapeutic', 'provides', 'full', 'year', 'financial', 'guidance', 'and', 'strategic', 'outlook']",1
196185,nifty_592,2013-01-07,Halozyme Therapeutics Issues Financial Guidance For 2013,Neutral,-0.0029,56,halozyme therapeutic issue financial guidance for,49,6,0,pharmacy,"['ha', '##lo', '##zy', '##me', 'therapeutic', 'issue', 'financial', 'guidance', 'for']",1
196208,nifty_592,2013-01-07,"Echo Therapeutics, Inc. (Nasdaq: ECTE) Provides an Update to Shareholders",Neutral,-0.0029,73,echo therapeutic inc nasdaq ecte provides update shareholder,60,8,0,pharmacy,"['echo', 'therapeutic', 'in', '##c', 'na', '##s', '##da', '##q', 'e', '##ct', '##e', 'provides', 'update', 'shareholder']",1
196214,nifty_592,2013-01-07,Research and Markets: Rencarex (Renal Cell Carcinoma)- Analysis and Forecasts to 2022,Neutral,-0.0029,85,research and market rencarex renal cell carcinoma analysis and forecast,71,10,0,pharmacy,"['research', 'and', 'market', 're', '##nc', '##are', '##x', 're', '##nal', 'cell', 'car', '##cin', '##oma', 'analysis', 'and', 'forecast']",1
196220,nifty_592,2013-01-07,"WuXi PharmaTech Provides Update of 2012 Financial Guidance, to Present at J.P. Morgan Healthcare Conference",Neutral,-0.0029,107,wuxi pharmatech provides update financial guidance present morgan healthcare conference,87,10,0,pharmacy,"['w', '##ux', '##i', 'p', '##har', '##mate', '##ch', 'provides', 'update', 'financial', 'guidance', 'present', 'm', '##or', '##gan', 'healthcare', 'conference']",1
196289,nifty_592,2013-01-07,Research and Markets: OTC Pharmaceuticals and Self-medication in Seven Emerging Markets,Neutral,-0.0029,87,research and market otc pharmaceutical and self medication seven emerging market,80,11,0,pharmacy,"['research', 'and', 'market', 'o', '##t', '##c', 'pharmaceutical', 'and', 'self', 'medication', 'seven', 'emerging', 'market']",1
196292,nifty_592,2013-01-07,Safecode Drug Technologies Receives Investment From Biomedix Ltd,Neutral,-0.0029,64,safecode drug technology receives investment from biomedix ltd,62,8,0,pharmacy,"['safe', '##code', 'drug', 'technology', 'receives', 'investment', 'from', 'bio', '##med', '##ix', 'l', '##t', '##d']",1
196480,nifty_592,2013-01-07,"MEDIA ADVISORY -- Sharecare to Launch ""HealthMakers 250: Conversations on the Leading Edge"" at 4th Annual Digital Health Summit at the 2013 International CES",Neutral,-0.0029,157,medium advisory sharecare launch healthmakers conversation the leading edge annual digital health summit the international ce,125,16,0,pharmacy,"['medium', 'advisory', 'share', '##care', 'launch', 'health', '##makers', 'conversation', 'the', 'leading', 'edge', 'annual', 'digital', 'health', 'summit', 'the', 'international', 'c', '##e']",1
196503,nifty_592,2013-01-07,Research and Markets: Global Pharmaceutical & Biotechnology Outlook 2013: Global Pharma,Neutral,-0.0029,87,research and market global pharmaceutical biotechnology outlook global pharma,77,9,0,pharmacy,"['research', 'and', 'market', 'global', 'pharmaceutical', 'bio', '##tech', '##nology', 'outlook', 'global', 'p', '##har', '##ma']",1
196549,nifty_592,2013-01-07,"Research and Markets: Future Horizons in the Italian Immunodiagnostics Market: Supplier Shares and Sales Forecasts for 100 Chemistry, TDM, Endocrine, Cancer, Immunoprotein and Abused Drug Tests by Market Segment",Neutral,-0.0029,211,research and market future horizon the italian immunodiagnostics market supplier share and sale forecast for chemistry tdm endocrine cancer immunoprotein and abused drug test market segment,189,26,0,pharmacy,"['research', 'and', 'market', 'future', 'horizon', 'the', 'it', '##alia', '##n', 'im', '##mu', '##no', '##dia', '##gno', '##stics', 'market', 'supplier', 'share', 'and', 'sale', 'forecast', 'for', 'chemistry', 't', '##d', '##m', 'end', '##oc', '##rine', 'cancer', 'im', '##mu', '##no', '##p', '##rote', '##in', 'and', 'abused', 'drug', 'test', 'market', 'segment']",1
196552,nifty_592,2013-01-07,Research and Markets: Future Horizons in the French Cancer Diagnostics Market: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Market Segment,Neutral,-0.0029,153,research and market future horizon the french cancer diagnostics market supplier share and sale forecast for tumor marker market segment,136,20,0,pharmacy,"['research', 'and', 'market', 'future', 'horizon', 'the', 'f', '##rench', 'cancer', 'diagnostic', '##s', 'market', 'supplier', 'share', 'and', 'sale', 'forecast', 'for', 'tumor', 'marker', 'market', 'segment']",1
196569,nifty_592,2013-01-07,Research and Markets: The Top 100 Drug Delivery Technology Companies Worldwide (2013),Neutral,-0.0029,85,research and market the top drug delivery technology company worldwide,70,10,0,pharmacy,"['research', 'and', 'market', 'the', 'top', 'drug', 'delivery', 'technology', 'company', 'worldwide']",1
196610,nifty_592,2013-01-07,"Research and Markets: Metastatic Lung Cancer - Pipeline Review, H2 2012",Neutral,-0.0029,71,research and market metastatic lung cancer pipeline review,58,8,0,pharmacy,"['research', 'and', 'market', 'meta', '##static', 'lung', 'cancer', 'pipeline', 'review']",1
196618,nifty_592,2013-01-07,Celgene Corporation Announces Financial Outlook and Preliminary 2012 Results,Neutral,-0.0029,76,celgene corporation announces financial outlook and preliminary result,70,8,0,pharmacy,"['c', '##el', '##gene', 'corporation', 'announces', 'financial', 'outlook', 'and', 'preliminary', 'result']",1
196632,nifty_592,2013-01-07,"Research and Markets: Research Report on China's Diabetes Drug Market, 2013-2017",Neutral,-0.0029,80,research and market research report china diabetes drug market,62,9,0,pharmacy,"['research', 'and', 'market', 'research', 'report', 'chin', '##a', 'diabetes', 'drug', 'market']",1
196645,nifty_592,2013-01-07,"Research and Markets: Research Report on China's Antidepressant Market, 2013-2017",Neutral,-0.0029,81,research and market research report china antidepressant market,63,8,0,pharmacy,"['research', 'and', 'market', 'research', 'report', 'chin', '##a', 'anti', '##de', '##press', '##ant', 'market']",1
196677,nifty_592,2013-01-07,Research and Markets: Nuclear Medicine - Global Strategic Business Report 2012-2018,Neutral,-0.0029,83,research and market nuclear medicine global strategic business report,69,9,0,pharmacy,"['research', 'and', 'market', 'nuclear', 'medicine', 'global', 'strategic', 'business', 'report']",1
196755,nifty_592,2013-01-07,Research and Markets: Trends Shaping U.S. Medical Devices Industry Strategies,Neutral,-0.0029,77,research and market trend shaping medical device industry strategy,66,9,0,pharmacy,"['research', 'and', 'market', 'trend', 'shaping', 'medical', 'device', 'industry', 'strategy']",1
196789,nifty_592,2013-01-07,Research and Markets: Frontiers in Anti-infective Drug Discovery Volume 1,Neutral,-0.0029,73,research and market frontier anti infective drug discovery volume,65,9,0,pharmacy,"['research', 'and', 'market', 'frontier', 'anti', 'in', '##fect', '##ive', 'drug', 'discovery', 'volume']",1
197087,nifty_593,2013-01-08,FDA: J&J Diabetes Drug Effective,Neutral,0.0025,32,fda diabetes drug effective,27,4,0,pharmacy,"['f', '##da', 'diabetes', 'drug', 'effective']",1
197313,nifty_595,2013-01-10,"Research and Markets: Closed Drug Transfer Systems. Therapeutic Markets, Strategies and Outlook",Neutral,-0.0001,95,research and market closed drug transfer system therapeutic market strategy and outlook,87,12,0,pharmacy,"['research', 'and', 'market', 'closed', 'drug', 'transfer', 'system', 'therapeutic', 'market', 'strategy', 'and', 'outlook']",1
197377,nifty_595,2013-01-10,Marken and BioStorage Technologies Forge New Strategic Partnership in Singapore,Neutral,-0.0001,79,marken and biostorage technology forge new strategic partnership singapore,74,9,0,pharmacy,"['mark', '##en', 'and', 'bio', '##sto', '##rage', 'technology', 'forge', 'new', 'strategic', 'partnership', 'sing', '##ap', '##ore']",1
197392,nifty_595,2013-01-10,"Research and Markets: Biochips and Microarrays - Technologies, Markets and Companies - Updated 2013 Report",Neutral,-0.0001,106,research and market biochip and microarrays technology market and company updated report,88,12,0,pharmacy,"['research', 'and', 'market', 'bio', '##chi', '##p', 'and', 'micro', '##arra', '##ys', 'technology', 'market', 'and', 'company', 'updated', 'report']",1
197427,nifty_595,2013-01-10,"Research and Markets: Des Moines, IA Healthcare Market Overview",Neutral,-0.0001,63,research and market de moines healthcare market overview,56,8,0,pharmacy,"['research', 'and', 'market', 'de', 'm', '##oi', '##nes', 'healthcare', 'market', 'overview']",1
197448,nifty_595,2013-01-10,Research and Markets: Biotechnology Partnering Yearbook 2013,Neutral,-0.0001,60,research and market biotechnology partnering yearbook,53,6,0,pharmacy,"['research', 'and', 'market', 'bio', '##tech', '##nology', 'partner', '##ing', 'year', '##book']",1
197470,nifty_595,2013-01-10,Absolute Software Wins Multi Million Dollar Deal in the Healthcare Industry,Neutral,-0.0001,75,absolute software win multi million dollar deal the healthcare industry,71,10,0,pharmacy,"['absolute', 'software', 'win', 'multi', 'million', 'dollar', 'deal', 'the', 'healthcare', 'industry']",1
197508,nifty_595,2013-01-10,American Diversified Holdings Corporation (ADHC) to Focus on Medical Wireless Device Application Market for 2013,Neutral,-0.0001,112,american diversified holding corporation adhc focus medical wireless device application market for,98,12,0,pharmacy,"['am', '##eric', '##an', 'divers', '##ified', 'holding', 'corporation', 'ad', '##h', '##c', 'focus', 'medical', 'wireless', 'device', 'application', 'market', 'for']",1
197524,nifty_595,2013-01-10,Research and Markets: Neuropathic Pain Report - Analysis of the $5.7 Billion Market,Neutral,-0.0001,83,research and market neuropathic pain report analysis the billion market,71,10,0,pharmacy,"['research', 'and', 'market', 'ne', '##uro', '##pathic', 'pain', 'report', 'analysis', 'the', 'billion', 'market']",1
197546,nifty_595,2013-01-10,Research and Markets: Opthalmics Partnering Terms & Agreements: Key Analysis of how and why Companies Enter Opthalmics Partnering Deals,Neutral,-0.0001,135,research and market opthalmics partnering term agreement key analysis how and why company enter opthalmics partnering deal,122,17,0,pharmacy,"['research', 'and', 'market', 'op', '##thal', '##mic', '##s', 'partner', '##ing', 'term', 'agreement', 'key', 'analysis', 'how', 'and', 'why', 'company', 'enter', 'op', '##thal', '##mic', '##s', 'partner', '##ing', 'deal']",1
197567,nifty_595,2013-01-10,Applied DNA Sciences Closes on $5.5 Million of Financing,Neutral,-0.0001,56,applied dna science close million financing,43,6,0,pharmacy,"['applied', 'd', '##na', 'science', 'close', 'million', 'financing']",1
197778,nifty_595,2013-01-10,AdCare Health Systems to Present at the Noble Financial Capital Markets' Ninth Annual Equity Conference,Neutral,-0.0001,103,adcare health system present the noble financial capital market ninth annual equity conference,94,13,0,pharmacy,"['ad', '##care', 'health', 'system', 'present', 'the', 'noble', 'financial', 'capital', 'market', 'ninth', 'annual', 'equity', 'conference']",1
197781,nifty_595,2013-01-10,"Research and Markets: India In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture",Neutral,-0.0001,211,research and market india vitro diagnostics market outlook clinical chemistry genetic testing haematology histology and cytology immuno chemistry infectious immunology and microbiology culture,192,23,0,pharmacy,"['research', 'and', 'market', 'in', '##dia', 'v', '##it', '##ro', 'diagnostic', '##s', 'market', 'outlook', 'clinical', 'chemistry', 'genetic', 'testing', 'ha', '##ema', '##tology', 'his', '##tology', 'and', 'c', '##yt', '##ology', 'im', '##mu', '##no', 'chemistry', 'infectious', 'im', '##mu', '##nology', 'and', 'micro', '##biology', 'culture']",1
197809,nifty_595,2013-01-10,Research and Markets: Taiwan In Vitro Diagnostics Market Outlook to 2018,Neutral,-0.0001,72,research and market taiwan vitro diagnostics market outlook,59,8,0,pharmacy,"['research', 'and', 'market', 'ta', '##i', '##wan', 'v', '##it', '##ro', 'diagnostic', '##s', 'market', 'outlook']",1
197824,nifty_595,2013-01-10,Research and Markets: Non-Small-Cell Lung Cancer (Event Driven) - Drug Development Moving Towards a Personalised Medicine Approach,Neutral,-0.0001,130,research and market non small cell lung cancer event driven drug development moving towards personalised medicine approach,122,17,0,pharmacy,"['research', 'and', 'market', 'non', 'small', 'cell', 'lung', 'cancer', 'event', 'driven', 'drug', 'development', 'moving', 'towards', 'personal', '##ised', 'medicine', 'approach']",1
197849,nifty_595,2013-01-10,Research and Markets: Acute Ischemic Stroke (Event Driven) - A Leading Cause of Death and Neurological Disability Worldwide,Neutral,-0.0001,123,research and market acute ischemic stroke event driven leading cause death and neurological disability worldwide,112,15,0,pharmacy,"['research', 'and', 'market', 'acute', 'is', '##che', '##mic', 'stroke', 'event', 'driven', 'leading', 'cause', 'death', 'and', 'ne', '##uro', '##logical', 'disability', 'worldwide']",1
197910,nifty_595,2013-01-10,Research and Markets: Diagnostics Partnering Yearbook 2013,Neutral,-0.0001,58,research and market diagnostics partnering yearbook,51,6,0,pharmacy,"['research', 'and', 'market', 'diagnostic', '##s', 'partner', '##ing', 'year', '##book']",1
197963,nifty_595,2013-01-10,Aegerion Pharmaceuticals Announces Proposed Public Offering of Common Stock,Neutral,-0.0001,75,aegerion pharmaceutical announces proposed public offering common stock,71,8,0,pharmacy,"['a', '##ege', '##rion', 'pharmaceutical', 'announces', 'proposed', 'public', 'offering', 'common', 'stock']",1
198104,nifty_595,2013-01-10,Benefits to BIOX Corporation (TSX:BX) from Passage of Recent Fiscal Cliff Legislation Discussed in Video on Investmentpitch.com,Neutral,-0.0001,127,benefit biox corporation tsx from passage recent fiscal cliff legislation discussed video investmentpitch com,109,14,0,pharmacy,"['benefit', 'bio', '##x', 'corporation', 't', '##s', '##x', 'from', 'passage', 'recent', 'fiscal', 'cliff', 'legislation', 'discussed', 'video', 'investment', '##pit', '##ch', 'com']",1
198186,nifty_595,2013-01-10,FDA Panel Backs J&J Diabetes Drug,Neutral,-0.0001,33,fda panel back diabetes drug,28,5,0,pharmacy,"['f', '##da', 'panel', 'back', 'diabetes', 'drug']",1
198238,nifty_596,2013-01-14,St. Jude Gets FDA Warning Letter,Neutral,0.0007,32,jude get fda warning letter,27,5,0,pharmacy,"['j', '##ude', 'get', 'f', '##da', 'warning', 'letter']",1
198580,nifty_602,2013-01-24,Biotech sector still attractively valued despite its rally,Rise,0.0056,58,biotech sector still attractively valued despite it rally,57,8,0,pharmacy,"['bio', '##tech', 'sector', 'still', 'attractive', '##ly', 'valued', 'despite', 'it', 'rally']",1
198598,nifty_602,2013-01-24,Ipsen and Inspiration Biopharmaceuticals Enter into an Asset Purchase Agreement with Baxter International on OBI-1,Rise,0.0056,114,ipsen and inspiration biopharmaceuticals enter into asset purchase agreement with baxter international obi,106,13,0,pharmacy,"['i', '##pse', '##n', 'and', 'inspiration', 'bio', '##pha', '##rma', '##ce', '##utical', '##s', 'enter', 'into', 'asset', 'purchase', 'agreement', 'with', 'b', '##ax', '##ter', 'international', 'o', '##bi']",1
198825,nifty_602,2013-01-24,"Research and Markets: United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018",Rise,0.0056,120,research and market united arab emirate vitro diagnostics investment opportunity analysis and forecast,102,13,0,pharmacy,"['research', 'and', 'market', 'united', 'a', '##rab', 'em', '##ira', '##te', 'v', '##it', '##ro', 'diagnostic', '##s', 'investment', 'opportunity', 'analysis', 'and', 'forecast']",1
198881,nifty_602,2013-01-24,Bregal Sagemount Invests $20 Million in Recondo Technology,Rise,0.0056,58,bregal sagemount invests million recondo technology,51,6,0,pharmacy,"['br', '##eg', '##al', 'sage', '##mount', 'invest', '##s', 'million', 're', '##con', '##do', 'technology']",1
198917,nifty_602,2013-01-24,Celgene Reports Strong Fourth Quarter and Full Year 2012 Operating and Financial Results,Rise,0.0056,88,celgene report strong fourth quarter and full year operating and financial result,81,12,0,pharmacy,"['c', '##el', '##gene', 'report', 'strong', 'fourth', 'quarter', 'and', 'full', 'year', 'operating', 'and', 'financial', 'result']",1
198919,nifty_602,2013-01-24,Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2012 Financial Results,Rise,0.0056,80,bristol myers squibb report fourth quarter and full year financial result,73,11,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'report', 'fourth', 'quarter', 'and', 'full', 'year', 'financial', 'result']",1
198937,nifty_602,2013-01-24,Medical Devices 2013: A Frost & Sullivan Executive MindXchange- Sustaining the Vitality of the Industry and Your Company,Rise,0.0056,120,medical device frost sullivan executive mindxchange sustaining the vitality the industry and your company,105,14,0,pharmacy,"['medical', 'device', 'frost', 'su', '##lli', '##van', 'executive', 'mind', '##x', '##chang', '##e', 'sustaining', 'the', 'vital', '##ity', 'the', 'industry', 'and', 'your', 'company']",1
199084,nifty_602,2013-01-24,"Research and Markets: Denmark Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others",Rise,0.0056,210,research and market denmark diagnostic imaging market outlook ultrasound system mri system computed tomography system nuclear imaging equipment ray system mammography equipment and others,187,24,0,pharmacy,"['research', 'and', 'market', 'den', '##mark', 'diagnostic', 'imaging', 'market', 'outlook', 'ultra', '##sound', 'system', 'm', '##ri', 'system', 'com', '##puted', 'to', '##mo', '##graphy', 'system', 'nuclear', 'imaging', 'equipment', 'ray', 'system', 'ma', '##mm', '##ography', 'equipment', 'and', 'others']",1
199099,nifty_602,2013-01-24,"Ontario Centres of Excellence Invests $250,000 in ScarX Therapeutics' Revolutionary Anti-Scarring Medication",Rise,0.0056,108,ontario centre excellence invests scarx therapeutic revolutionary anti scarring medication,90,10,0,pharmacy,"['on', '##tar', '##io', 'centre', 'excellence', 'invest', '##s', 'scar', '##x', 'therapeutic', 'revolutionary', 'anti', 'scar', '##ring', 'medication']",1
199115,nifty_602,2013-01-24,Tsunami of Coming Biosimilars Set to Shake up Drug Development Game,Rise,0.0056,67,tsunami coming biosimilars set shake drug development game,58,8,0,pharmacy,"['tsunami', 'coming', 'bio', '##si', '##mi', '##lars', 'set', 'shake', 'drug', 'development', 'game']",1
199179,nifty_602,2013-01-24,"Research and Markets: Cellulitis - Pipeline Review, H2 2012 - Latest News and Deals",Rise,0.0056,83,research and market cellulitis pipeline review latest news and deal,67,10,0,pharmacy,"['research', 'and', 'market', 'cell', '##uli', '##tis', 'pipeline', 'review', 'latest', 'news', 'and', 'deal']",1
199191,nifty_602,2013-01-24,"Research and Markets: Pancreatitis - Pipeline Review, H2 2012",Rise,0.0056,61,research and market pancreatitis pipeline review,48,6,0,pharmacy,"['research', 'and', 'market', 'pan', '##cre', '##ati', '##tis', 'pipeline', 'review']",1
199204,nifty_602,2013-01-24,Novus Biologicals Hires David Eansor to Lead New Corporate-Development Effort,Rise,0.0056,77,novus biologicals hire david eansor lead new corporate development effort,73,10,0,pharmacy,"['no', '##vu', '##s', 'biological', '##s', 'hire', 'da', '##vid', 'e', '##ans', '##or', 'lead', 'new', 'corporate', 'development', 'effort']",1
199307,nifty_602,2013-01-24,Research and Markets: Analysis of the Expanding U.S. Market for Gastrointestinal Disorders Prescription Pharmaceuticals,Rise,0.0056,119,research and market analysis the expanding market for gastrointestinal disorder prescription pharmaceutical,107,12,0,pharmacy,"['research', 'and', 'market', 'analysis', 'the', 'expanding', 'market', 'for', 'gas', '##tro', '##int', '##est', '##inal', 'disorder', 'prescription', 'pharmaceutical']",1
199529,nifty_602,2013-01-24,CORRECTING and REPLACING 15th Annual BIO CEO & Investor Conference to Feature Fireside Chats Between Biopharma Executives and Analysts,Rise,0.0056,134,correcting and replacing annual bio ceo investor conference feature fireside chat between biopharma executive and analyst,121,16,0,pharmacy,"['correct', '##ing', 'and', 'replacing', 'annual', 'bio', 'c', '##eo', 'investor', 'conference', 'feature', 'fires', '##ide', 'chat', 'between', 'bio', '##pha', '##rma', 'executive', 'and', 'analyst']",1
199714,nifty_602,2013-01-24,Tax Benefit Boosts Bristol's Profit,Rise,0.0056,35,tax benefit boost bristol profit,32,5,0,pharmacy,"['tax', 'benefit', 'boost', 'br', '##ist', '##ol', 'profit']",1
199770,nifty_603,2013-01-28,Biogen's Net Slips on Higher Costs,Neutral,0.0039,34,biogen net slip higher cost,27,5,0,pharmacy,"['bio', '##gen', 'net', 'slip', 'higher', 'cost']",1
199847,nifty_605,2013-01-30,Adopting Orphan Drugs,Neutral,-0.0025,21,adopting orphan drug,20,3,0,pharmacy,"['adopting', 'orphan', 'drug']",1
199866,nifty_605,2013-01-30,Bayer Faces Halt to Acne-Drug Sales,Neutral,-0.0025,35,bayer face halt acne drug sale,30,6,0,pharmacy,"['bay', '##er', 'face', 'halt', 'a', '##c', '##ne', 'drug', 'sale']",1
199917,nifty_606,2013-01-31,"AstraZeneca, Bristol-Myers Deepen Diabetes Alliance",Rise,0.0103,51,astrazeneca bristol myers deepen diabetes alliance,50,6,0,pharmacy,"['as', '##tra', '##zen', '##eca', 'br', '##ist', '##ol', 'my', '##ers', 'deep', '##en', 'diabetes', 'alliance']",1
199973,nifty_606,2013-01-31,"J&J, Novartis Get Antitrust Complaint",Rise,0.0103,37,novartis get antitrust complaint,32,4,0,pharmacy,"['no', '##var', '##tis', 'get', 'anti', '##tr', '##ust', 'complaint']",1
200180,nifty_608,2013-02-05,Research and Markets: TrendSights: Disease Management Analysis 2012,Neutral,0.0007,67,research and market trendsights disease management analysis,59,7,0,pharmacy,"['research', 'and', 'market', 'trends', '##ight', '##s', 'disease', 'management', 'analysis']",1
200184,nifty_608,2013-02-05,Research and Markets: TrendSights: Guided Health Report - Products and Services that will Help People Reach their Health Goals,Neutral,0.0007,126,research and market trendsights guided health report product and service that will help people reach their health goal,118,18,0,pharmacy,"['research', 'and', 'market', 'trends', '##ight', '##s', 'guided', 'health', 'report', 'product', 'and', 'service', 'that', 'will', 'help', 'people', 'reach', 'their', 'health', 'goal']",1
200217,nifty_608,2013-02-05,Research and Markets: Cellular Therapy and Cord Blood 2013 Market Report,Neutral,0.0007,72,research and market cellular therapy and cord blood market report,65,10,0,pharmacy,"['research', 'and', 'market', 'cellular', 'therapy', 'and', 'cord', 'blood', 'market', 'report']",1
200265,nifty_608,2013-02-05,Astex Pharmaceuticals to Present at BIO CEO & Investor Conference,Neutral,0.0007,65,astex pharmaceutical present bio ceo investor conference,56,7,0,pharmacy,"['as', '##te', '##x', 'pharmaceutical', 'present', 'bio', 'c', '##eo', 'investor', 'conference']",1
200270,nifty_608,2013-02-05,Biodel to Present at 2013 BIO CEO and Investor Conference,Neutral,0.0007,57,biodel present bio ceo and investor conference,46,7,0,pharmacy,"['bio', '##del', 'present', 'bio', 'c', '##eo', 'and', 'investor', 'conference']",1
200434,nifty_608,2013-02-05,"Ferraris, Bentleys, Porsches and Corvettes Race to Raise Money for Research and Awareness of Type 1 Diabetes",Neutral,0.0007,108,ferraris bentleys porsches and corvette race raise money for research and awareness type diabetes,97,14,0,pharmacy,"['f', '##er', '##rar', '##is', 'bent', '##ley', '##s', 'p', '##ors', '##ches', 'and', 'co', '##rvette', 'race', 'raise', 'money', 'for', 'research', 'and', 'awareness', 'type', 'diabetes']",1
200438,nifty_608,2013-02-05,Grand & Toy Leverages GHX to Drive Greater Efficiency and Sustainability in the Healthcare Supply Chain,Neutral,0.0007,103,grand toy leverage ghx drive greater efficiency and sustainability the healthcare supply chain,94,13,0,pharmacy,"['grand', 'toy', 'leverage', 'g', '##h', '##x', 'drive', 'greater', 'efficiency', 'and', 'sustainability', 'the', 'healthcare', 'supply', 'chain']",1
200439,nifty_608,2013-02-05,Tengion to Present at the BIO CEO & Investor Conference,Neutral,0.0007,55,tengion present the bio ceo investor conference,47,7,0,pharmacy,"['ten', '##gion', 'present', 'the', 'bio', 'c', '##eo', 'investor', 'conference']",1
200443,nifty_608,2013-02-05,ADVENTRX To Present At The 15th Annual BIO CEO & Investor Conference On February 12,Neutral,0.0007,83,adventrx present the annual bio ceo investor conference february,64,9,0,pharmacy,"['advent', '##r', '##x', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference', 'f', '##eb', '##ru', '##ary']",1
200447,nifty_608,2013-02-05,Catalyst Pharmaceutical Partners to Present at 15th Annual BIO CEO & Investor Conference,Neutral,0.0007,88,catalyst pharmaceutical partner present annual bio ceo investor conference,74,9,0,pharmacy,"['catalyst', 'pharmaceutical', 'partner', 'present', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
200496,nifty_608,2013-02-05,DiaMedica to Present at 15th Annual BIO CEO & Investor Conference,Neutral,0.0007,65,diamedica present annual bio ceo investor conference,52,7,0,pharmacy,"['di', '##amed', '##ica', 'present', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
200504,nifty_608,2013-02-05,Zalicus to Present at the 2013 BIO CEO & Investor Conference,Neutral,0.0007,60,zalicus present the bio ceo investor conference,47,7,0,pharmacy,"['z', '##ali', '##cus', 'present', 'the', 'bio', 'c', '##eo', 'investor', 'conference']",1
200527,nifty_608,2013-02-05,Research and Markets: Analysis of Teva Pharmaceutical Industries,Neutral,0.0007,64,research and market analysis teva pharmaceutical industry,57,7,0,pharmacy,"['research', 'and', 'market', 'analysis', 'te', '##va', 'pharmaceutical', 'industry']",1
200633,nifty_608,2013-02-05,Research and Markets: Diabetes Diagnostics - Global Strategic Business Report,Neutral,0.0007,77,research and market diabetes diagnostics global strategic business report,73,9,0,pharmacy,"['research', 'and', 'market', 'diabetes', 'diagnostic', '##s', 'global', 'strategic', 'business', 'report']",1
200643,nifty_608,2013-02-05,Research and Markets: Biopesticides - Global Strategic Business Report,Neutral,0.0007,70,research and market biopesticides global strategic business report,66,8,0,pharmacy,"['research', 'and', 'market', 'bio', '##pes', '##tic', '##ides', 'global', 'strategic', 'business', 'report']",1
200703,nifty_608,2013-02-05,"Griffin Securities, Inc. Announces Investment Opinion on Synthetic Biologics, Inc.",Neutral,0.0007,82,griffin security inc announces investment opinion synthetic biologics inc,73,9,0,pharmacy,"['g', '##riff', '##in', 'security', 'in', '##c', 'announces', 'investment', 'opinion', 'synthetic', 'bio', '##log', '##ics', 'in', '##c']",1
200837,nifty_608,2013-02-05,Research and Markets: The 2012 Molecular Diagnostics Market: DNA Probes and Biochips - New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers,Neutral,0.0007,195,research and market the molecular diagnostics market dna probe and biochip new product development opportunity and business expansion strategy for instrument and reagent supplier,178,24,0,pharmacy,"['research', 'and', 'market', 'the', 'molecular', 'diagnostic', '##s', 'market', 'd', '##na', 'probe', 'and', 'bio', '##chi', '##p', 'new', 'product', 'development', 'opportunity', 'and', 'business', 'expansion', 'strategy', 'for', 'instrument', 'and', 're', '##age', '##nt', 'supplier']",1
200925,nifty_608,2013-02-05,"NeoGenomics Schedules its Q4 and Full Year 2012 Earnings Release for February 14, 2013",Neutral,0.0007,86,neogenomics schedule it and full year earnings release for february,67,10,0,pharmacy,"['neo', '##gen', '##omi', '##cs', 'schedule', 'it', 'and', 'full', 'year', 'earnings', 'release', 'for', 'f', '##eb', '##ru', '##ary']",1
200974,nifty_608,2013-02-05,Pacific Biosciences Completes $20.5 Million Debt Financing,Neutral,0.0007,58,pacific bioscience completes million debt financing,51,6,0,pharmacy,"['p', '##ac', '##ific', 'bio', '##science', 'complete', '##s', 'million', 'debt', 'financing']",1
200979,nifty_608,2013-02-05,Onyx Pharmaceuticals to Present at Upcoming Investor Conferences,Neutral,0.0007,64,onyx pharmaceutical present upcoming investor conference,56,6,0,pharmacy,"['on', '##yx', 'pharmaceutical', 'present', 'upcoming', 'investor', 'conference']",1
200983,nifty_608,2013-02-05,OncoGenex Pharmaceuticals to Present at Upcoming Investor Conferences,Neutral,0.0007,69,oncogenex pharmaceutical present upcoming investor conference,61,6,0,pharmacy,"['on', '##co', '##gene', '##x', 'pharmaceutical', 'present', 'upcoming', 'investor', 'conference']",1
200990,nifty_608,2013-02-05,Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences,Neutral,0.0007,70,idenix pharmaceutical present two upcoming investor conference,62,7,0,pharmacy,"['id', '##eni', '##x', 'pharmaceutical', 'present', 'two', 'upcoming', 'investor', 'conference']",1
200993,nifty_608,2013-02-05,"Cempra, Inc. to Present at BIO CEO & Investor Conference and Leerink Swann Global Healthcare Conference",Neutral,0.0007,103,cempra inc present bio ceo investor conference and leerink swann global healthcare conference,93,13,0,pharmacy,"['c', '##em', '##pra', 'in', '##c', 'present', 'bio', 'c', '##eo', 'investor', 'conference', 'and', 'le', '##eri', '##nk', 's', '##wan', '##n', 'global', 'healthcare', 'conference']",1
201004,nifty_608,2013-02-05,Raptor Pharmaceutical Corp. to Present at Upcoming Investor Conferences,Neutral,0.0007,71,raptor pharmaceutical corp present upcoming investor conference,63,7,0,pharmacy,"['rap', '##tor', 'pharmaceutical', 'co', '##rp', 'present', 'upcoming', 'investor', 'conference']",1
201012,nifty_608,2013-02-05,NPS Pharmaceuticals to Present at Upcoming Conferences,Neutral,0.0007,54,np pharmaceutical present upcoming conference,45,5,0,pharmacy,"['n', '##p', 'pharmaceutical', 'present', 'upcoming', 'conference']",1
201018,nifty_608,2013-02-05,Briefing: Leading Pharma Companies to Watch in Today's Market Session,Neutral,0.0007,69,briefing leading pharma company watch today market session,58,8,0,pharmacy,"['brief', '##ing', 'leading', 'p', '##har', '##ma', 'company', 'watch', 'today', 'market', 'session']",1
201027,nifty_608,2013-02-05,Immunovaccine Announces a Proposed Equity Offering,Neutral,0.0007,50,immunovaccine announces proposed equity offering,48,5,0,pharmacy,"['im', '##mu', '##nova', '##cci', '##ne', 'announces', 'proposed', 'equity', 'offering']",1
201133,nifty_608,2013-02-05,"Mir Imran, Prominent Healthcare Investor and Entrepreneur, to Speak at SEMDA 2013 Conference",Neutral,0.0007,92,mir imran prominent healthcare investor and entrepreneur speak semda conference,79,10,0,pharmacy,"['mi', '##r', 'im', '##ran', 'prominent', 'healthcare', 'investor', 'and', 'entrepreneur', 'speak', 'se', '##m', '##da', 'conference']",1
201148,nifty_608,2013-02-05,Transcept Pharmaceuticals to Present at Two Upcoming Investor Conferences,Neutral,0.0007,73,transcept pharmaceutical present two upcoming investor conference,65,7,0,pharmacy,"['trans', '##ce', '##pt', 'pharmaceutical', 'present', 'two', 'upcoming', 'investor', 'conference']",1
201161,nifty_608,2013-02-05,Celldex Announces Pricing of $90 Million Public Offering of Common Stock,Neutral,0.0007,72,celldex announces pricing million public offering common stock,62,8,0,pharmacy,"['cell', '##de', '##x', 'announces', 'pricing', 'million', 'public', 'offering', 'common', 'stock']",1
201301,nifty_609,2013-02-06,Ipsen and Inspiration Biopharmaceuticals enter into an Asset Purchase Agreement with Cangene Corporation on IB1001,Neutral,-0.0013,114,ipsen and inspiration biopharmaceuticals enter into asset purchase agreement with cangene corporation,101,12,0,pharmacy,"['i', '##pse', '##n', 'and', 'inspiration', 'bio', '##pha', '##rma', '##ce', '##utical', '##s', 'enter', 'into', 'asset', 'purchase', 'agreement', 'with', 'can', '##gene', 'corporation']",1
201454,nifty_609,2013-02-06,Lexicon To Present At The BIO CEO & Investor Conference,Neutral,-0.0013,55,lexicon present the bio ceo investor conference,47,7,0,pharmacy,"['le', '##xi', '##con', 'present', 'the', 'bio', 'c', '##eo', 'investor', 'conference']",1
201456,nifty_609,2013-02-06,Insception Biosciences Inc. Offers New Expertise to CCRM's Industry Consortium,Neutral,-0.0013,78,insception bioscience inc offer new expertise ccrm industry consortium,70,9,0,pharmacy,"['ins', '##ception', 'bio', '##science', 'in', '##c', 'offer', 'new', 'expertise', 'cc', '##rm', 'industry', 'consortium']",1
201513,nifty_609,2013-02-06,Sucampo Pharmaceuticals to Present at Investment Conferences,Neutral,-0.0013,60,sucampo pharmaceutical present investment conference,52,5,0,pharmacy,"['su', '##cam', '##po', 'pharmaceutical', 'present', 'investment', 'conference']",1
201601,nifty_609,2013-02-06,Three Upcoming Biopharma Catalyst Trades to Consider,Neutral,-0.0013,52,three upcoming biopharma catalyst trade consider,48,6,0,pharmacy,"['three', 'upcoming', 'bio', '##pha', '##rma', 'catalyst', 'trade', 'consider']",1
201611,nifty_609,2013-02-06,Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences,Neutral,-0.0013,69,arena pharmaceutical present two upcoming investor conference,61,7,0,pharmacy,"['arena', 'pharmaceutical', 'present', 'two', 'upcoming', 'investor', 'conference']",1
201619,nifty_609,2013-02-06,Insmed to Present at Two Upcoming Healthcare Investor Conferences,Neutral,-0.0013,65,insmed present two upcoming healthcare investor conference,58,7,0,pharmacy,"['ins', '##med', 'present', 'two', 'upcoming', 'healthcare', 'investor', 'conference']",1
201660,nifty_609,2013-02-06,ChemoCentryx to Present at 15th Annual BIO CEO & Investor Conference,Neutral,-0.0013,68,chemocentryx present annual bio ceo investor conference,55,7,0,pharmacy,"['ch', '##em', '##oc', '##entry', '##x', 'present', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
201699,nifty_609,2013-02-06,BioMarin to Present at the BIO CEO & Investor Conference,Neutral,-0.0013,56,biomarin present the bio ceo investor conference,48,7,0,pharmacy,"['bio', '##mar', '##in', 'present', 'the', 'bio', 'c', '##eo', 'investor', 'conference']",1
201700,nifty_609,2013-02-06,"StemCells, Inc. to Present at 2013 BIO CEO & Investor Conference",Neutral,-0.0013,64,stemcells inc present bio ceo investor conference,49,7,0,pharmacy,"['stem', '##cell', '##s', 'in', '##c', 'present', 'bio', 'c', '##eo', 'investor', 'conference']",1
201731,nifty_609,2013-02-06,Amgen and Peregrine Under StockCall Scrutiny: Pharma Stocks Deal with Drug Developments and Patents,Neutral,-0.0013,99,amgen and peregrine under stockcall scrutiny pharma stock deal with drug development and patent,95,14,0,pharmacy,"['am', '##gen', 'and', 'per', '##eg', '##rine', 'under', 'stock', '##cal', '##l', 'scrutiny', 'p', '##har', '##ma', 'stock', 'deal', 'with', 'drug', 'development', 'and', 'patent']",1
201790,nifty_609,2013-02-06,Research and Markets: New Zealand Diagnostic Imaging Market Outlook to 2018,Neutral,-0.0013,75,research and market new zealand diagnostic imaging market outlook,65,9,0,pharmacy,"['research', 'and', 'market', 'new', 'z', '##eal', '##and', 'diagnostic', 'imaging', 'market', 'outlook']",1
201805,nifty_609,2013-02-06,BioLineRx Announces Offering of American Depositary Shares,Neutral,-0.0013,58,biolinerx announces offering american depositary share,54,6,0,pharmacy,"['bio', '##liner', '##x', 'announces', 'offering', 'am', '##eric', '##an', 'deposit', '##ary', 'share']",1
201806,nifty_609,2013-02-06,"Research and Markets: Medical Device Market Opportunities In The U.K., 2012",Neutral,-0.0013,75,research and market medical device market opportunity the,57,8,0,pharmacy,"['research', 'and', 'market', 'medical', 'device', 'market', 'opportunity', 'the']",1
201859,nifty_609,2013-02-06,Nymox to Present at the 15th Annual BIO CEO & Investor Conference,Neutral,-0.0013,65,nymox present the annual bio ceo investor conference,52,8,0,pharmacy,"['n', '##ym', '##ox', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
201875,nifty_609,2013-02-06,eClinicalWorks Invests $25 Million in Patient Engagement,Neutral,-0.0013,56,eclinicalworks invests million patient engagement,49,5,0,pharmacy,"['e', '##c', '##lini', '##cal', '##works', 'invest', '##s', 'million', 'patient', 'engagement']",1
201894,nifty_609,2013-02-06,Research and Markets: Tropical Disease Partnering 2007-2012,Neutral,-0.0013,59,research and market tropical disease partnering,47,6,0,pharmacy,"['research', 'and', 'market', 'tropical', 'disease', 'partner', '##ing']",1
201940,nifty_609,2013-02-06,Diaxonhit is informed by Allergan that Bristol-Myers Squibb has decided to stop development of EHT/AGN 0001,Neutral,-0.0013,107,diaxonhit informed allergan that bristol myers squibb ha decided stop development eht agn,89,13,0,pharmacy,"['di', '##ax', '##on', '##hit', 'informed', 'all', '##er', '##gan', 'that', 'br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'ha', 'decided', 'stop', 'development', 'eh', '##t', 'a', '##gn']",1
202112,nifty_609,2013-02-06,Affymax to Present at the BIO CEO & Investor Conference,Neutral,-0.0013,55,affymax present the bio ceo investor conference,47,7,0,pharmacy,"['a', '##ffy', '##max', 'present', 'the', 'bio', 'c', '##eo', 'investor', 'conference']",1
202118,nifty_609,2013-02-06,"Genomic Health Announces Year-End 2012 Financial Results, Provides 2013 Financial Outlook",Neutral,-0.0013,89,genomic health announces year end financial result provides financial outlook,77,10,0,pharmacy,"['g', '##eno', '##mic', 'health', 'announces', 'year', 'end', 'financial', 'result', 'provides', 'financial', 'outlook']",1
202269,nifty_609,2013-02-06,EpiCept Corporation to Present at the 15th BIO CEO & Investor Conference,Neutral,-0.0013,72,epicept corporation present the bio ceo investor conference,59,8,0,pharmacy,"['epic', '##ept', 'corporation', 'present', 'the', 'bio', 'c', '##eo', 'investor', 'conference']",1
202284,nifty_609,2013-02-06,Korea Hot Stocks- Stem cell drugmaker surges on China nod,Neutral,-0.0013,57,korea hot stock stem cell drugmaker surge china nod,51,9,0,pharmacy,"['k', '##ore', '##a', 'hot', 'stock', 'stem', 'cell', 'drug', '##maker', 'surge', 'chin', '##a', 'nod']",1
202330,nifty_609,2013-02-06,Biogen to Buy Control of MS Drug,Neutral,-0.0013,32,biogen buy control drug,23,4,0,pharmacy,"['bio', '##gen', 'buy', 'control', 'drug']",1
202373,nifty_609,2013-02-06,FDA Warns of New Batch of Fake Cancer Drug,Neutral,-0.0013,42,fda warns new batch fake cancer drug,36,7,0,pharmacy,"['f', '##da', 'warns', 'new', 'batch', 'fake', 'cancer', 'drug']",1
202401,nifty_610,2013-02-07,Avastin Found to Improve Survival in Cervical Cancer,Rise,0.0056,52,avastin found improve survival cervical cancer,46,6,0,pharmacy,"['a', '##vas', '##tin', 'found', 'improve', 'survival', 'c', '##er', '##vic', '##al', 'cancer']",1
202407,nifty_610,2013-02-07,Pain-Pill Labeling Is Debated,Rise,0.0056,29,pain pill labeling debated,26,4,0,pharmacy,"['pain', 'pill', 'label', '##ing', 'debated']",1
202435,nifty_610,2013-02-07,Drug Firms Seek Targeted Approach,Rise,0.0056,33,drug firm seek targeted approach,32,5,0,pharmacy,"['drug', 'firm', 'seek', 'targeted', 'approach']",1
202513,nifty_612,2013-02-12,TiGenix: Presenting at 15th Annual BIO CEO & Investor Conference,Neutral,0.0009,64,tigenix presenting annual bio ceo investor conference,53,7,0,pharmacy,"['t', '##ige', '##ni', '##x', 'presenting', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
202667,nifty_612,2013-02-12,CLC bio Continues Success with a 30 Percent Growth in Software Sales and over 500 New Organizations as Customers in 2012,Neutral,0.0009,120,clc bio continues success with percent growth software sale and over new organization customer,94,14,0,pharmacy,"['c', '##l', '##c', 'bio', 'continues', 'success', 'with', 'percent', 'growth', 'software', 'sale', 'and', 'over', 'new', 'organization', 'customer']",1
202672,nifty_612,2013-02-12,Research and Markets: Gambro Medical Device Company Intelligence Report,Neutral,0.0009,71,research and market gambro medical device company intelligence report,69,9,0,pharmacy,"['research', 'and', 'market', 'g', '##am', '##bro', 'medical', 'device', 'company', 'intelligence', 'report']",1
202694,nifty_612,2013-02-12,"Boardwalk Pipeline Reaps Rewards From Acquisitions in 2012, Keeps Growth Projects on Front Burner, an Industrial Info News Alert",Neutral,0.0009,128,boardwalk pipeline reaps reward from acquisition keep growth project front burner industrial info news alert,108,15,0,pharmacy,"['board', '##walk', 'pipeline', 're', '##ap', '##s', 'reward', 'from', 'acquisition', 'keep', 'growth', 'project', 'front', 'burn', '##er', 'industrial', 'info', 'news', 'alert']",1
202708,nifty_612,2013-02-12,"Intraocular Lens (IOL): Market Shares, Strategies, and Forecasts, Worldwide, Nanotechnology, 2013 to 2018 :  MarketResearchReports.Biz",Neutral,0.0009,134,intraocular lens iol market share strategy and forecast worldwide nanotechnology marketresearchreports biz,106,12,0,pharmacy,"['in', '##tra', '##oc', '##ular', 'lens', 'i', '##ol', 'market', 'share', 'strategy', 'and', 'forecast', 'worldwide', 'na', '##note', '##ch', '##nology', 'market', '##res', '##ear', '##ch', '##re', '##ports', 'bi', '##z']",1
202736,nifty_612,2013-02-12,Biota Pharmaceuticals Reports Second Quarter Financial Results and Corporate Update,Neutral,0.0009,83,biota pharmaceutical report second quarter financial result and corporate update,80,10,0,pharmacy,"['bio', '##ta', 'pharmaceutical', 'report', 'second', 'quarter', 'financial', 'result', 'and', 'corporate', 'update']",1
202773,nifty_612,2013-02-12,New Product Launch: Are your Strategies for Emerging Healthcare and Life Sciences Markets Innovative and Structured?,Neutral,0.0009,116,new product launch are your strategy for emerging healthcare and life science market innovative and structured,110,16,0,pharmacy,"['new', 'product', 'launch', 'are', 'your', 'strategy', 'for', 'emerging', 'healthcare', 'and', 'life', 'science', 'market', 'innovative', 'and', 'structured']",1
202818,nifty_612,2013-02-12,Research and Markets: Canada & USA Drug Development & Outsourcing Guide 2013,Neutral,0.0009,76,research and market canada usa drug development outsourcing guide,65,9,0,pharmacy,"['research', 'and', 'market', 'can', '##ada', 'us', '##a', 'drug', 'development', 'outs', '##our', '##cing', 'guide']",1
202824,nifty_612,2013-02-12,Research and Markets: Canadian Medical Technologies Products & Industry Guide 2013,Neutral,0.0009,82,research and market canadian medical technology product industry guide,70,9,0,pharmacy,"['research', 'and', 'market', 'can', '##adia', '##n', 'medical', 'technology', 'product', 'industry', 'guide']",1
202852,nifty_612,2013-02-12,"Electronic Records Increasingly Sought by Medical Professionals, Says Atlanta's Business Computer Applications",Neutral,0.0009,110,electronic record increasingly sought medical professional say atlanta business computer application,100,11,0,pharmacy,"['electronic', 'record', 'increasingly', 'sought', 'medical', 'professional', 'say', 'at', '##lant', '##a', 'business', 'computer', 'application']",1
203006,nifty_612,2013-02-12,"Research and Markets: Switzerland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018",Neutral,0.0009,111,research and market switzerland vitro diagnostics investment opportunity analysis and forecast,94,11,0,pharmacy,"['research', 'and', 'market', 's', '##witz', '##erland', 'v', '##it', '##ro', 'diagnostic', '##s', 'investment', 'opportunity', 'analysis', 'and', 'forecast']",1
203012,nifty_612,2013-02-12,"Research and Markets: Ireland Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2018",Neutral,0.0009,105,research and market ireland ophthalmic device investment opportunity analysis and forecast,90,11,0,pharmacy,"['research', 'and', 'market', 'i', '##rel', '##and', 'op', '##ht', '##hal', '##mic', 'device', 'investment', 'opportunity', 'analysis', 'and', 'forecast']",1
203152,nifty_612,2013-02-12,Research and Markets: The Medical Device Market: France 2013,Neutral,0.0009,60,research and market the medical device market france,52,8,0,pharmacy,"['research', 'and', 'market', 'the', 'medical', 'device', 'market', 'f', '##rance']",1
203170,nifty_612,2013-02-12,Research and Markets: The Medical Device Market: New Zealand 2013,Neutral,0.0009,65,research and market the medical device market new zealand,57,9,0,pharmacy,"['research', 'and', 'market', 'the', 'medical', 'device', 'market', 'new', 'z', '##eal', '##and']",1
203183,nifty_612,2013-02-12,Research and Markets: The Medical Device Market: Russia 2013,Neutral,0.0009,60,research and market the medical device market russia,52,8,0,pharmacy,"['research', 'and', 'market', 'the', 'medical', 'device', 'market', 'r', '##uss', '##ia']",1
203186,nifty_612,2013-02-12,Research and Markets: The Medical Device Market: USA 2013,Neutral,0.0009,57,research and market the medical device market usa,49,8,0,pharmacy,"['research', 'and', 'market', 'the', 'medical', 'device', 'market', 'us', '##a']",1
203187,nifty_612,2013-02-12,Research and Markets: The Medical Device Market: India 2013,Neutral,0.0009,59,research and market the medical device market india,51,8,0,pharmacy,"['research', 'and', 'market', 'the', 'medical', 'device', 'market', 'in', '##dia']",1
203315,nifty_612,2013-02-12,"ICU Medical, Inc. to Present at the 2013 RBC Capital Markets Global Healthcare Conference",Neutral,0.0009,89,icu medical inc present the rbc capital market global healthcare conference,75,11,0,pharmacy,"['i', '##cu', 'medical', 'in', '##c', 'present', 'the', 'r', '##b', '##c', 'capital', 'market', 'global', 'healthcare', 'conference']",1
203567,nifty_613,2013-02-13,Sanofi to Refocus Drug R&D on Disease Biology,Neutral,0.0009,45,sanofi refocus drug disease biology,35,5,0,pharmacy,"['sa', '##no', '##fi', 're', '##fo', '##cus', 'drug', 'disease', 'biology']",1
203671,nifty_614,2013-02-14,Active Biotech AB Year-end report January - December 2012,Neutral,-0.0012,57,active biotech year end report january december,47,7,0,pharmacy,"['active', 'bio', '##tech', 'year', 'end', 'report', 'j', '##anu', '##ary', 'de', '##ce', '##mber']",1
203842,nifty_614,2013-02-14,Research and Markets: Illinois Health Market Review 2012,Neutral,-0.0012,56,research and market illinois health market review,49,7,0,pharmacy,"['research', 'and', 'market', 'ill', '##ino', '##is', 'health', 'market', 'review']",1
203864,nifty_614,2013-02-14,"Research and Markets: Turkey Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2018",Neutral,-0.0012,104,research and market turkey ophthalmic device investment opportunity analysis and forecast,89,11,0,pharmacy,"['research', 'and', 'market', 'turkey', 'op', '##ht', '##hal', '##mic', 'device', 'investment', 'opportunity', 'analysis', 'and', 'forecast']",1
203935,nifty_614,2013-02-14,NeoGenomics Reports 181% Increase in Adjusted EBITDA on 38% Revenue Growth and Achieves Profitability in 2012,Neutral,-0.0012,109,neogenomics report increase adjusted ebitda revenue growth and achieves profitability,85,10,0,pharmacy,"['neo', '##gen', '##omi', '##cs', 'report', 'increase', 'adjusted', 'e', '##bit', '##da', 'revenue', 'growth', 'and', 'achieve', '##s', 'profit', '##ability']",1
204038,nifty_614,2013-02-14,European Diagnostic Imaging System Market Will Grow Modestly To Almost $2.2 Billion In 2017,Neutral,-0.0012,91,european diagnostic imaging system market will grow modestly almost billion,75,10,0,pharmacy,"['euro', '##pe', '##an', 'diagnostic', 'imaging', 'system', 'market', 'will', 'grow', 'modest', '##ly', 'almost', 'billion']",1
204045,nifty_614,2013-02-14,Today's Technical View on Cardinal Health and McKesson: Emerging Markets to Drive Growth for Drugs Wholesalers,Neutral,-0.0012,110,today technical view cardinal health and mckesson emerging market drive growth for drug wholesaler,98,14,0,pharmacy,"['today', 'technical', 'view', 'cardinal', 'health', 'and', 'm', '##cke', '##sson', 'emerging', 'market', 'drive', 'growth', 'for', 'drug', 'wholesale', '##r']",1
204054,nifty_614,2013-02-14,Frost & Sullivan: Clinical Trial-based Evidence Vital to Obtain Venture Capital Funding for Wireless Patient Monitoring Technologies,Neutral,-0.0012,132,frost sullivan clinical trial based evidence vital obtain venture capital funding for wireless patient monitoring technology,124,16,0,pharmacy,"['frost', 'su', '##lli', '##van', 'clinical', 'trial', 'based', 'evidence', 'vital', 'obtain', 'venture', 'capital', 'funding', 'for', 'wireless', 'patient', 'monitoring', 'technology']",1
204064,nifty_614,2013-02-14,Former FDA Official Joins 3D Communications' Scientific and Regulatory Advisory Board,Neutral,-0.0012,85,former fda official join communication scientific and regulatory advisory board,79,10,0,pharmacy,"['former', 'f', '##da', 'official', 'join', 'communication', 'scientific', 'and', 'regulatory', 'advisory', 'board']",1
204145,nifty_614,2013-02-14,"Research and Markets: Global and Chinese Monoclonal Antibody Industry Report, 2013",Neutral,-0.0012,82,research and market global and chinese monoclonal antibody industry report,74,10,0,pharmacy,"['research', 'and', 'market', 'global', 'and', 'chin', '##ese', 'mon', '##oc', '##lon', '##al', 'anti', '##body', 'industry', 'report']",1
204194,nifty_614,2013-02-14,Research and Markets: The Medical Device Market: Belgium 2013,Neutral,-0.0012,61,research and market the medical device market belgium,53,8,0,pharmacy,"['research', 'and', 'market', 'the', 'medical', 'device', 'market', 'be', '##l', '##gi', '##um']",1
204199,nifty_614,2013-02-14,High Profile HealthCare Companies: Leading Pharma Company Secures New Patents,Neutral,-0.0012,77,high profile healthcare company leading pharma company secures new patent,73,10,0,pharmacy,"['high', 'profile', 'healthcare', 'company', 'leading', 'p', '##har', '##ma', 'company', 'secure', '##s', 'new', 'patent']",1
204201,nifty_614,2013-02-14,Research and Markets: Biosensors in Medical Diagnostics - Global Strategic Business Report 2012,Neutral,-0.0012,95,research and market biosensors medical diagnostics global strategic business report,83,10,0,pharmacy,"['research', 'and', 'market', 'bio', '##sen', '##sors', 'medical', 'diagnostic', '##s', 'global', 'strategic', 'business', 'report']",1
204206,nifty_614,2013-02-14,"HealthLeaders Media and Bank of America Merrill Lynch Begin Yearlong ""Executive Insight"" Project",Neutral,-0.0012,96,healthleaders medium and bank america merrill lynch begin yearlong executive insight project,92,12,0,pharmacy,"['health', '##leader', '##s', 'medium', 'and', 'bank', 'am', '##eric', '##a', 'me', '##rri', '##ll', 'l', '##ync', '##h', 'begin', 'year', '##long', 'executive', 'insight', 'project']",1
204209,nifty_614,2013-02-14,Research and Markets: The Medical Device Market: Colombia 2013,Neutral,-0.0012,62,research and market the medical device market colombia,54,8,0,pharmacy,"['research', 'and', 'market', 'the', 'medical', 'device', 'market', 'co', '##lo', '##mb', '##ia']",1
204222,nifty_614,2013-02-14,"Research and Markets: 2013 Research Report on the Medical Device Market in Italy, the Fourth Largest Medical Device Market in Europe",Neutral,-0.0012,132,research and market research report the medical device market italy the fourth largest medical device market europe,115,17,0,pharmacy,"['research', 'and', 'market', 'research', 'report', 'the', 'medical', 'device', 'market', 'it', '##aly', 'the', 'fourth', 'largest', 'medical', 'device', 'market', 'euro', '##pe']",1
204235,nifty_614,2013-02-14,Research and Markets: The Medical Device Market: Mexico 2013,Neutral,-0.0012,60,research and market the medical device market mexico,52,8,0,pharmacy,"['research', 'and', 'market', 'the', 'medical', 'device', 'market', 'me', '##xi', '##co']",1
204305,nifty_614,2013-02-14,Research and Markets: Competitor Analysis: Enzyme Replacement Therapies,Neutral,-0.0012,71,research and market competitor analysis enzyme replacement therapy,66,8,0,pharmacy,"['research', 'and', 'market', 'competitor', 'analysis', 'enzyme', 'replacement', 'therapy']",1
204386,nifty_614,2013-02-14,"Plastic Surgery Foundation Launches ""Shark Tank"" Technology Innovation Challenge for Healthcare Professionals, Entrepreneurs",Neutral,-0.0012,124,plastic surgery foundation launch shark tank technology innovation challenge for healthcare professional entrepreneur,117,13,0,pharmacy,"['plastic', 'surgery', 'foundation', 'launch', 'shark', 'tank', 'technology', 'innovation', 'challenge', 'for', 'healthcare', 'professional', 'entrepreneur']",1
204397,nifty_614,2013-02-14,Biosimilars Market Expected to Soar,Neutral,-0.0012,35,biosimilars market expected soar,32,4,0,pharmacy,"['bio', '##si', '##mi', '##lars', 'market', 'expected', 'so', '##ar']",1
204487,nifty_614,2013-02-14,Leading Pharmaceutical Companies Mid-day Trading with Mixed Results and also New Patent News Announced for Crown Marketing,Neutral,-0.0012,122,leading pharmaceutical company mid day trading with mixed result and also new patent news announced for crown marketing,119,18,0,pharmacy,"['leading', 'pharmaceutical', 'company', 'mid', 'day', 'trading', 'with', 'mixed', 'result', 'and', 'also', 'new', 'patent', 'news', 'announced', 'for', 'crown', 'marketing']",1
204593,nifty_614,2013-02-14,"Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal 2013",Neutral,-0.0012,90,elite pharmaceutical inc report financial result for the third quarter fiscal,77,11,0,pharmacy,"['elite', 'pharmaceutical', 'in', '##c', 'report', 'financial', 'result', 'for', 'the', 'third', 'quarter', 'fiscal']",1
204604,nifty_614,2013-02-14,"Cumberland Pharmaceuticals To Announce 2012 Year End Financial Results On February 28, 2013",Neutral,-0.0012,91,cumberland pharmaceutical announce year end financial result february,69,8,0,pharmacy,"['cum', '##ber', '##land', 'pharmaceutical', 'announce', 'year', 'end', 'financial', 'result', 'f', '##eb', '##ru', '##ary']",1
204989,nifty_616,2013-02-20,Novartis Axes Chairman's Exit Pay,Fall,-0.0061,33,novartis ax chairman exit pay,29,5,0,pharmacy,"['no', '##var', '##tis', 'a', '##x', 'chairman', 'exit', 'pay']",1
205054,nifty_618,2013-02-25,Affymax Shares Plunge on Drug's Recall,Rise,0.0068,38,affymax share plunge drug recall,32,5,0,pharmacy,"['a', '##ffy', '##max', 'share', 'p', '##lung', '##e', 'drug', 'recall']",1
205113,nifty_619,2013-02-26,"Cell Therapeutics to Report Fourth Quarter and Full Year 2012 Financial Results After Market on February 28, 2013",Rise,0.0126,113,cell therapeutic report fourth quarter and full year financial result after market february,91,13,0,pharmacy,"['cell', 'therapeutic', 'report', 'fourth', 'quarter', 'and', 'full', 'year', 'financial', 'result', 'after', 'market', 'f', '##eb', '##ru', '##ary']",1
205128,nifty_619,2013-02-26,BRIEF-Dechra Pharmaceuticals profit rises,Rise,0.0126,41,brief dechra pharmaceutical profit rise,39,5,0,pharmacy,"['brief', 'de', '##ch', '##ra', 'pharmaceutical', 'profit', 'rise']",1
205220,nifty_619,2013-02-26,Antisense Pharma unveils its corporate strategy for 2013,Rise,0.0126,56,antisense pharma unveils it corporate strategy for,50,7,0,pharmacy,"['anti', '##sen', '##se', 'p', '##har', '##ma', 'un', '##ve', '##ils', 'it', 'corporate', 'strategy', 'for']",1
205245,nifty_619,2013-02-26,"Research and Markets: United Arab Emirates Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2018",Rise,0.0126,118,research and market united arab emirate ophthalmic device investment opportunity analysis and forecast,102,13,0,pharmacy,"['research', 'and', 'market', 'united', 'a', '##rab', 'em', '##ira', '##te', 'op', '##ht', '##hal', '##mic', 'device', 'investment', 'opportunity', 'analysis', 'and', 'forecast']",1
205331,nifty_619,2013-02-26,"Research and Markets: Atlanta, GA Healthcare Market Overview",Rise,0.0126,60,research and market atlanta healthcare market overview,54,7,0,pharmacy,"['research', 'and', 'market', 'at', '##lant', '##a', 'healthcare', 'market', 'overview']",1
205364,nifty_619,2013-02-26,"ResearchMoz: Global MRI Systems Market to 2018 - Technological Advancements, Increasing Number of Applications and Advent of MRI Compatible Pacemakers to Drive Future Growth - Market Research Reports",Rise,0.0126,199,researchmoz global mri system market technological advancement increasing number application and advent mri compatible pacemaker drive future growth market research report,171,21,0,pharmacy,"['research', '##mo', '##z', 'global', 'm', '##ri', 'system', 'market', 'technological', 'advancement', 'increasing', 'number', 'application', 'and', 'advent', 'm', '##ri', 'compatible', 'pace', '##maker', 'drive', 'future', 'growth', 'market', 'research', 'report']",1
205382,nifty_619,2013-02-26,DecImmune Therapeutics Secures $2.25 Million in Development Funding,Rise,0.0126,67,decimmune therapeutic secures million development funding,57,6,0,pharmacy,"['de', '##ci', '##mm', '##une', 'therapeutic', 'secure', '##s', 'million', 'development', 'funding']",1
205391,nifty_619,2013-02-26,Research and Markets: UK Healthcare Market Profile to 2016-2017,Rise,0.0126,63,research and market healthcare market profile,45,6,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'market', 'profile']",1
205410,nifty_619,2013-02-26,"Americaâs lobbying abroad, and following a wonder drugâs money trail",Rise,0.0126,72,americaâ lobbying abroad and following wonder drugâ money trail,63,9,0,pharmacy,"['am', '##eric', '##a', '##â', 'lobbying', 'abroad', 'and', 'following', 'wonder', 'drug', '##â', 'money', 'trail']",1
205670,nifty_619,2013-02-26,Quotient Biodiagnostics Raises Further $5.0 Million of Growth Finance Led by Paul Cowan and Galen Partners,Rise,0.0126,106,quotient biodiagnostics raise further million growth finance led paul cowan and galen partner,93,13,0,pharmacy,"['q', '##uo', '##tien', '##t', 'bio', '##dia', '##gno', '##stics', 'raise', 'further', 'million', 'growth', 'finance', 'led', 'p', '##aul', 'cow', '##an', 'and', 'gal', '##en', 'partner']",1
205703,nifty_619,2013-02-26,"Investment-In-Innovation (IN3) Medical Device 360 Dublin to Feature 30+ Start-Ups Seeking Partnership, and Top-Tier Investors and Industry Leaders",Rise,0.0126,146,investment innovation medical device dublin feature start ups seeking partnership and top tier investor and industry leader,123,17,0,pharmacy,"['investment', 'innovation', 'medical', 'device', 'dub', '##lin', 'feature', 'start', 'ups', 'seeking', 'partnership', 'and', 'top', 'tier', 'investor', 'and', 'industry', 'leader']",1
205717,nifty_619,2013-02-26,"Research and Markets: Global Pharmaceutical Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry",Rise,0.0126,154,research and market global pharmaceutical survey market trend buyer spend and procurement strategy the global pharmaceutical industry,133,17,0,pharmacy,"['research', 'and', 'market', 'global', 'pharmaceutical', 'survey', 'market', 'trend', 'buyer', 'spend', 'and', 'pro', '##curement', 'strategy', 'the', 'global', 'pharmaceutical', 'industry']",1
205750,nifty_619,2013-02-26,COLUMN-Stories I'd like to see: America's lobbying and following a wonder drug's money trail,Rise,0.0126,92,column story like see america lobbying and following wonder drug money trail,76,12,0,pharmacy,"['column', 'story', 'like', 'see', 'am', '##eric', '##a', 'lobbying', 'and', 'following', 'wonder', 'drug', 'money', 'trail']",1
205808,nifty_619,2013-02-26,LifePoint Hospitals to Participate in the Raymond James Institutional Investors Conference,Rise,0.0126,90,lifepoint hospital participate the raymond james institutional investor conference,82,9,0,pharmacy,"['life', '##point', 'hospital', 'participate', 'the', 'ray', '##mond', 'jam', '##es', 'institutional', 'investor', 'conference']",1
205909,nifty_619,2013-02-26,Research and Markets: Future Horizons in the German Nucleic Acid Testing Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Market Segment,Rise,0.0126,164,research and market future horizon the german nucleic acid testing market supplier share and sale forecast for test and application market segment,146,22,0,pharmacy,"['research', 'and', 'market', 'future', 'horizon', 'the', 'g', '##erman', 'nuclei', '##c', 'acid', 'testing', 'market', 'supplier', 'share', 'and', 'sale', 'forecast', 'for', 'test', 'and', 'application', 'market', 'segment']",1
205964,nifty_619,2013-02-26,"PuraMed BioScienceInc., Manufacturers of LipiGesic M, Engaged FOCUS LLC, an Investment Banking Firm, to Explore Strategic Alternatives",Rise,0.0126,134,puramed bioscienceinc manufacturer lipigesic engaged focus llc investment banking firm explore strategic alternative,116,13,0,pharmacy,"['pu', '##ram', '##ed', 'bio', '##science', '##in', '##c', 'manufacturer', 'lip', '##ige', '##si', '##c', 'engaged', 'focus', 'll', '##c', 'investment', 'banking', 'firm', 'explore', 'strategic', 'alternative']",1
206003,nifty_619,2013-02-26,Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences,Rise,0.0126,70,idenix pharmaceutical present two upcoming investor conference,62,7,0,pharmacy,"['id', '##eni', '##x', 'pharmaceutical', 'present', 'two', 'upcoming', 'investor', 'conference']",1
206191,nifty_619,2013-02-26,Copies of Biotech Drugs Face Delays,Rise,0.0126,35,copy biotech drug face delay,28,5,0,pharmacy,"['copy', 'bio', '##tech', 'drug', 'face', 'delay']",1
206219,nifty_619,2013-02-26,Nestlé Health Science Ventures Into Depression Market,Rise,0.0126,53,nestlé health science venture into depression market,52,7,0,pharmacy,"['nest', '##lé', 'health', 'science', 'venture', 'into', 'depression', 'market']",1
206260,nifty_620,2013-02-27,Mylan to Buy Injectable-Products Maker for $1.6 Billion,Neutral,-0.002,55,mylan buy injectable product maker for billion,46,7,0,pharmacy,"['my', '##lan', 'buy', 'in', '##ject', '##able', 'product', 'maker', 'for', 'billion']",1
206279,nifty_620,2013-02-27,Novartis Exit Pay Galvanizes Swiss,Neutral,-0.002,34,novartis exit pay galvanizes swiss,34,5,0,pharmacy,"['no', '##var', '##tis', 'exit', 'pay', 'gal', '##vani', '##zes', 's', '##wi', '##ss']",1
206324,nifty_621,2013-02-28,Pharmacy Chains Push Into Health Care,Neutral,0.0033,37,pharmacy chain push into health care,36,6,0,pharmacy,"['pharmacy', 'chain', 'push', 'into', 'health', 'care']",1
206345,nifty_621,2013-02-28,Iraq Begins Design of Pipeline to Jordan,Neutral,0.0033,40,iraq begin design pipeline jordan,33,5,0,pharmacy,"['i', '##ra', '##q', 'begin', 'design', 'pipeline', 'j', '##ord', '##an']",1
206381,nifty_622,2013-03-04,FDA Panel Rejects Two Proposed Menopause Drugs,Rise,0.009,46,fda panel reject two proposed menopause drug,44,7,0,pharmacy,"['f', '##da', 'panel', 'reject', 'two', 'proposed', 'men', '##op', '##aus', '##e', 'drug']",1
206648,nifty_627,2013-03-12,Panel Clears Merck's Vytorin Trial to Continue,Neutral,0.0014,46,panel clear merck vytorin trial continue,40,6,0,pharmacy,"['panel', 'clear', 'me', '##rc', '##k', 'v', '##yt', '##ori', '##n', 'trial', 'continue']",1
206884,nifty_632,2013-03-20,FDA Panel Votes 5-3 on Abbott Device,Fall,-0.0085,36,fda panel vote abbott device,28,5,0,pharmacy,"['f', '##da', 'panel', 'vote', 'abbot', '##t', 'device']",1
206910,nifty_632,2013-03-20,Deal Transforms Pill Pipeline,Fall,-0.0085,29,deal transforms pill pipeline,29,4,0,pharmacy,"['deal', 'transforms', 'pill', 'pipeline']",1
206961,nifty_633,2013-03-21,Ipsen and Inspiration Biopharmaceuticals announce closing of the sale of OBI-1 to Baxter International,Rise,0.008,102,ipsen and inspiration biopharmaceuticals announce closing the sale obi baxter international,91,11,0,pharmacy,"['i', '##pse', '##n', 'and', 'inspiration', 'bio', '##pha', '##rma', '##ce', '##utical', '##s', 'announce', 'closing', 'the', 'sale', 'o', '##bi', 'b', '##ax', '##ter', 'international']",1
207055,nifty_633,2013-03-21,Micro Focus Strengthens IBM zEnterprise Strategy Through IT-oLogy Partnership,Rise,0.008,77,micro focus strengthens ibm zenterprise strategy through ology partnership,74,9,0,pharmacy,"['micro', 'focus', 'strengthen', '##s', 'i', '##b', '##m', 'z', '##enter', '##prise', 'strategy', 'through', 'o', '##logy', 'partnership']",1
207120,nifty_633,2013-03-21,Research and Markets: Taiwan Ophthalmic Devices Market Outlook to 2018,Rise,0.008,70,research and market taiwan ophthalmic device market outlook,59,8,0,pharmacy,"['research', 'and', 'market', 'ta', '##i', '##wan', 'op', '##ht', '##hal', '##mic', 'device', 'market', 'outlook']",1
207141,nifty_633,2013-03-21,Research and Markets: Analyzing the Indian Pharmaceutical Industry 2013,Rise,0.008,71,research and market analyzing the indian pharmaceutical industry,64,8,0,pharmacy,"['research', 'and', 'market', 'analyzing', 'the', 'in', '##dian', 'pharmaceutical', 'industry']",1
207160,nifty_633,2013-03-21,"Research and Markets: Premature Ejaculation - Pipeline Review, H1 2013",Rise,0.008,70,research and market premature ejaculation pipeline review,57,7,0,pharmacy,"['research', 'and', 'market', 'premature', 'e', '##ja', '##cula', '##tion', 'pipeline', 'review']",1
207201,nifty_633,2013-03-21,"Research and Markets: Brain Tumor - Pipeline Review, H1 2013",Rise,0.008,60,research and market brain tumor pipeline review,47,7,0,pharmacy,"['research', 'and', 'market', 'brain', 'tumor', 'pipeline', 'review']",1
207220,nifty_633,2013-03-21,BRIEF-Astra CEO says no plans to sell off anti-infectives or neuroscience,Rise,0.008,73,brief astra ceo say plan sell off anti infectives neuroscience,62,10,0,pharmacy,"['brief', 'as', '##tra', 'c', '##eo', 'say', 'plan', 'sell', 'off', 'anti', 'in', '##fect', '##ives', 'ne', '##uro', '##science']",1
207221,nifty_633,2013-03-21,"Research and Markets: Stroke - Pipeline Review, H1 2013",Rise,0.008,55,research and market stroke pipeline review,42,6,0,pharmacy,"['research', 'and', 'market', 'stroke', 'pipeline', 'review']",1
207276,nifty_633,2013-03-21,"PharmaVigilant Releases I-Vault (eTMF), Version 2.7",Rise,0.008,51,pharmavigilant release vault etmf version,41,5,0,pharmacy,"['p', '##har', '##ma', '##vi', '##gi', '##lant', 'release', 'vault', 'et', '##m', '##f', 'version']",1
207292,nifty_633,2013-03-21,Bioheart Secures Investment and Announces Immediate Launching of ANGEL Trial,Rise,0.008,76,bioheart secures investment and announces immediate launching angel trial,73,9,0,pharmacy,"['bio', '##heart', 'secure', '##s', 'investment', 'and', 'announces', 'immediate', 'launching', 'angel', 'trial']",1
207321,nifty_633,2013-03-21,"Timing Is Right for Big Pharma to Add Nuvilex, Inc. Technology to Its Pipeline",Rise,0.008,78,timing right for big pharma add nuvilex inc technology it pipeline,66,11,0,pharmacy,"['timing', 'right', 'for', 'big', 'p', '##har', '##ma', 'add', 'n', '##u', '##vil', '##ex', 'in', '##c', 'technology', 'it', 'pipeline']",1
207432,nifty_633,2013-03-21,"Research and Markets: China Pharmaceutical Equipment Industry Report, 2012-2015",Rise,0.008,79,research and market china pharmaceutical equipment industry report,66,8,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'pharmaceutical', 'equipment', 'industry', 'report']",1
207511,nifty_633,2013-03-21,"Research and Markets: Global Kidney Cancer Drugs Market 2012-2016: AVEO Pharmaceuticals Inc., Bayer AG, GlaxoSmithKline plc, Hoffmann-La Roche Ltd., Novartis AG, and Pfizer Inc. Dominate the Market",Rise,0.008,197,research and market global kidney cancer drug market aveo pharmaceutical inc bayer glaxosmithkline plc hoffmann roche ltd novartis and pfizer inc dominate the market,165,24,0,pharmacy,"['research', 'and', 'market', 'global', 'kidney', 'cancer', 'drug', 'market', 'a', '##ve', '##o', 'pharmaceutical', 'in', '##c', 'bay', '##er', 'g', '##lax', '##os', '##mith', '##k', '##line', 'plc', 'ho', '##ff', '##mann', 'r', '##och', '##e', 'l', '##t', '##d', 'no', '##var', '##tis', 'and', 'p', '##fi', '##zer', 'in', '##c', 'dominate', 'the', 'market']",1
207647,nifty_633,2013-03-21,"Research and Markets: Pharmacy Automation Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018",Rise,0.008,138,research and market pharmacy automation system market global industry analysis size share growth trend and forecast,115,16,0,pharmacy,"['research', 'and', 'market', 'pharmacy', 'automation', 'system', 'market', 'global', 'industry', 'analysis', 'size', 'share', 'growth', 'trend', 'and', 'forecast']",1
207651,nifty_633,2013-03-21,AstraZeneca CEO says exploring biosimilars market,Rise,0.008,49,astrazeneca ceo say exploring biosimilars market,48,6,0,pharmacy,"['as', '##tra', '##zen', '##eca', 'c', '##eo', 'say', 'exploring', 'bio', '##si', '##mi', '##lars', 'market']",1
207685,nifty_633,2013-03-21,"Research and Markets: Medical Gases and Equipment Market - Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018",Rise,0.008,130,research and market medical gas and equipment market global industry analysis size share growth and forecast,108,16,0,pharmacy,"['research', 'and', 'market', 'medical', 'gas', 'and', 'equipment', 'market', 'global', 'industry', 'analysis', 'size', 'share', 'growth', 'and', 'forecast']",1
207716,nifty_633,2013-03-21,Research and Markets: Medical Equipment Annual Deals Analysis: M&A; and Investments Trends - 2012,Rise,0.008,97,research and market medical equipment annual deal analysis and investment trend,79,11,0,pharmacy,"['research', 'and', 'market', 'medical', 'equipment', 'annual', 'deal', 'analysis', 'and', 'investment', 'trend']",1
208087,nifty_635,2013-03-26,Drug Firms Make More Injectables,Neutral,0.0,32,drug firm make more injectables,31,5,0,pharmacy,"['drug', 'firm', 'make', 'more', 'in', '##ject', '##ables']",1
208126,nifty_636,2013-03-27,Drugstores Press for Pricing Data,Neutral,0.0031,33,drugstore press for pricing data,32,5,0,pharmacy,"['drugs', '##tore', 'press', 'for', 'pricing', 'data']",1
208166,nifty_637,2013-04-01,"MARKET EYE-Natco, Cipla up; India's top court dismisses Novartis petition",Neutral,0.0049,73,market eye natco cipla india top court dismisses novartis petition,66,10,0,pharmacy,"['market', 'eye', 'na', '##t', '##co', 'c', '##ip', '##la', 'in', '##dia', 'top', 'court', 'dismiss', '##es', 'no', '##var', '##tis', 'petition']",1
208181,nifty_637,2013-04-01,"MedCAREERS GROUP, Inc. Provides Updates Regarding Recent Funding, Recent Events and Plans Moving Forward",Neutral,0.0049,104,medcareers group inc provides update regarding recent funding recent event and plan moving forward,98,14,0,pharmacy,"['me', '##d', '##care', '##ers', 'group', 'in', '##c', 'provides', 'update', 'regarding', 'recent', 'funding', 'recent', 'event', 'and', 'plan', 'moving', 'forward']",1
208207,nifty_637,2013-04-01,Wealth Strategies: Biotech stocks at an inflection point,Neutral,0.0049,56,wealth strategy biotech stock inflection point,46,6,0,pharmacy,"['wealth', 'strategy', 'bio', '##tech', 'stock', 'in', '##fle', '##ction', 'point']",1
208215,nifty_637,2013-04-01,Global Nuclear Medicine / Radiopharmaceuticals Market worth $5.55 Billion by 2017,Neutral,0.0049,81,global nuclear medicine radiopharmaceutical market worth billion,64,7,0,pharmacy,"['global', 'nuclear', 'medicine', 'radio', '##pha', '##rma', '##ce', '##utical', 'market', 'worth', 'billion']",1
208228,nifty_637,2013-04-01,Derma Sciences Expands TCC-EZÂ® Market Reach with Long-Term Exclusive Global Rights Agreement,Neutral,0.0049,93,derma science expands tcc ezâ market reach with long term exclusive global right agreement,90,14,0,pharmacy,"['der', '##ma', 'science', 'expands', 't', '##cc', 'e', '##z', '##â', 'market', 'reach', 'with', 'long', 'term', 'exclusive', 'global', 'right', 'agreement']",1
208245,nifty_637,2013-04-01,Two New Strategic Reports Expand Coverage Of BioTrend's Biosimilars Advisory Service,Neutral,0.0049,84,two new strategic report expand coverage biotrend biosimilars advisory service,78,10,0,pharmacy,"['two', 'new', 'strategic', 'report', 'expand', 'coverage', 'bio', '##tre', '##nd', 'bio', '##si', '##mi', '##lars', 'advisory', 'service']",1
208270,nifty_637,2013-04-01,BUYINS.NET Issues Provectus Pharmaceuticals SqueezeTrigger Report,Neutral,0.0049,65,buyins net issue provectus pharmaceutical squeezetrigger report,63,7,0,pharmacy,"['buy', '##ins', 'net', 'issue', 'prove', '##ctus', 'pharmaceutical', 'squeeze', '##tri', '##gger', 'report']",1
208314,nifty_637,2013-04-01,Arch Biopartners Announces Shareholder Approval to Allow Listing to Move to New Exchange,Neutral,0.0049,88,arch biopartners announces shareholder approval allow listing move new exchange,79,10,0,pharmacy,"['arch', 'bio', '##par', '##t', '##ners', 'announces', 'shareholder', 'approval', 'allow', 'listing', 'move', 'new', 'exchange']",1
208407,nifty_637,2013-04-01,World Cell Assays Market Prospects Analysed in In-Demand Visiongain Report Now Available at MarketPublishers.com,Neutral,0.0049,112,world cell assay market prospect analysed demand visiongain report now available marketpublishers com,101,13,0,pharmacy,"['world', 'cell', 'ass', '##ay', 'market', 'prospect', 'anal', '##ys', '##ed', 'demand', 'vision', '##gai', '##n', 'report', 'now', 'available', 'market', '##pu', '##b', '##lish', '##ers', 'com']",1
208543,nifty_637,2013-04-01,Pharma and Biotech Executives Lead Program at ChinaBioÂ® Partnering Forum 2013 in Beijing,Neutral,0.0049,89,pharma and biotech executive lead program chinabioâ partnering forum beijing,76,10,0,pharmacy,"['p', '##har', '##ma', 'and', 'bio', '##tech', 'executive', 'lead', 'program', 'chin', '##abi', '##o', '##â', 'partner', '##ing', 'forum', 'be', '##iji', '##ng']",1
208731,nifty_639,2013-04-03,Drug Firms Moving to Recoup Pay,Neutral,0.0041,31,drug firm moving recoup pay,27,5,0,pharmacy,"['drug', 'firm', 'moving', 're', '##co', '##up', 'pay']",1
208788,nifty_640,2013-04-04,St. Jude Hit by New Suits,Neutral,-0.0045,25,jude hit new suit,17,4,0,pharmacy,"['j', '##ude', 'hit', 'new', 'suit']",1
209179,nifty_644,2013-04-11,"Cydan, a New Orphan Drug Accelerator, Launches with $16 Million Financing from Leading Investors NEA, Pfizer Venture Investments and Alexandria Real Estate Equities",Neutral,-0.0024,164,cydan new orphan drug accelerator launch with million financing from leading investor nea pfizer venture investment and alexandria real estate equity,149,21,0,pharmacy,"['c', '##yd', '##an', 'new', 'orphan', 'drug', 'a', '##ccelerator', 'launch', 'with', 'million', 'financing', 'from', 'leading', 'investor', 'ne', '##a', 'p', '##fi', '##zer', 'venture', 'investment', 'and', 'ale', '##xa', '##nd', '##ria', 'real', 'estate', 'equity']",1
209311,nifty_644,2013-04-11,Global Trends and Transitions Shaping the Future of Medical Imaging Equipment,Neutral,-0.0024,77,global trend and transition shaping the future medical imaging equipment,72,10,0,pharmacy,"['global', 'trend', 'and', 'transition', 'shaping', 'the', 'future', 'medical', 'imaging', 'equipment']",1
209319,nifty_644,2013-04-11,"StockCall Scrutinizes Warner Chilcott, Dynavax Technologies, Isis Pharma, and United Therapeutics",Neutral,-0.0024,97,stockcall scrutinizes warner chilcott dynavax technology isi pharma and united therapeutic,90,11,0,pharmacy,"['stock', '##cal', '##l', 's', '##c', '##ru', '##tin', '##izes', 'warn', '##er', 'ch', '##il', '##cott', 'd', '##yna', '##va', '##x', 'technology', 'is', '##i', 'p', '##har', '##ma', 'and', 'united', 'therapeutic']",1
209342,nifty_644,2013-04-11,"Tonix Pharmaceuticals to Hold Annual Shareholders' Meeting on April 19, 2013",Neutral,-0.0024,76,tonix pharmaceutical hold annual shareholder meeting april,58,7,0,pharmacy,"['ton', '##ix', 'pharmaceutical', 'hold', 'annual', 'shareholder', 'meeting', 'a', '##p', '##ril']",1
209431,nifty_644,2013-04-11,Heritage Financial Corporation Selects DNA Account Processing Platform from Fiserv to Accelerate Growth,Neutral,-0.0024,103,heritage financial corporation selects dna account processing platform from fiserv accelerate growth,100,12,0,pharmacy,"['heritage', 'financial', 'corporation', 'select', '##s', 'd', '##na', 'account', 'processing', 'platform', 'from', 'fi', '##ser', '##v', 'accelerate', 'growth']",1
209473,nifty_644,2013-04-11,"News Briefing for Health Care Sector Companies: Embark Holdings, Vitamin Shoppe, MusclePharm, Repros Therapeutics, Unilife and Pfizer",Neutral,-0.0024,133,news briefing for health care sector company embark holding vitamin shoppe musclepharm repros therapeutic unilife and pfizer,124,17,0,pharmacy,"['news', 'brief', '##ing', 'for', 'health', 'care', 'sector', 'company', 'em', '##bark', 'holding', 'vitamin', 'shop', '##pe', 'muscle', '##pha', '##rm', 're', '##p', '##ros', 'therapeutic', 'un', '##ili', '##fe', 'and', 'p', '##fi', '##zer']",1
209624,nifty_644,2013-04-11,America's Biopharmaceutical Companies' Commitment to Research Remains Strong Despite Challenges,Neutral,-0.0024,95,america biopharmaceutical company commitment research remains strong despite challenge,86,9,0,pharmacy,"['am', '##eric', '##a', 'bio', '##pha', '##rma', '##ce', '##utical', 'company', 'commitment', 'research', 'remains', 'strong', 'despite', 'challenge']",1
209660,nifty_644,2013-04-11,Research and Markets: Competing in the Global Molecular Diagnostics Market - 2013,Neutral,-0.0024,81,research and market competing the global molecular diagnostics market,69,9,0,pharmacy,"['research', 'and', 'market', 'competing', 'the', 'global', 'molecular', 'diagnostic', '##s', 'market']",1
209684,nifty_644,2013-04-11,Medtech Industry Executives to Reveal Strategies for Gaining a Competitive Edge in Keynote Panel at EuroMedtechâ¢ 2013,Neutral,-0.0024,119,medtech industry executive reveal strategy for gaining competitive edge keynote panel euromedtechâ,98,12,0,pharmacy,"['me', '##dt', '##ech', 'industry', 'executive', 'reveal', 'strategy', 'for', 'gaining', 'competitive', 'edge', 'key', '##note', 'panel', 'euro', '##med', '##tech', '##â']",1
209705,nifty_644,2013-04-11,"PharmaVentures acts as Exclusive Advisor on the Sale of a Majority Stake in Dogu Tip, a Turkish Diagnostic Imaging Services Company,to Techno Group Investment Holdings, a Gulf Capital Portfolio Company",Neutral,-0.0024,201,pharmaventures act exclusive advisor the sale majority stake dogu tip turkish diagnostic imaging service company techno group investment holding gulf capital portfolio company,175,23,0,pharmacy,"['p', '##har', '##ma', '##vent', '##ures', 'act', 'exclusive', 'advisor', 'the', 'sale', 'majority', 'stake', 'dog', '##u', 'tip', 't', '##ur', '##kis', '##h', 'diagnostic', 'imaging', 'service', 'company', 'tech', '##no', 'group', 'investment', 'holding', 'g', '##ulf', 'capital', 'portfolio', 'company']",1
209726,nifty_644,2013-04-11,"Research and Markets: Uveitis - Pipeline Review, H1 2013",Neutral,-0.0024,56,research and market uveitis pipeline review,43,6,0,pharmacy,"['research', 'and', 'market', 'u', '##ve', '##itis', 'pipeline', 'review']",1
209736,nifty_644,2013-04-11,"Research and Markets: Dysmenorrhea - Pipeline Review, H1 2013",Neutral,-0.0024,61,research and market dysmenorrhea pipeline review,48,6,0,pharmacy,"['research', 'and', 'market', 'd', '##ys', '##men', '##or', '##r', '##hea', 'pipeline', 'review']",1
209795,nifty_644,2013-04-11,Planet Organic Health Corp.: Corporate Update,Neutral,-0.0024,45,planet organic health corp corporate update,43,6,0,pharmacy,"['planet', 'organic', 'health', 'co', '##rp', 'corporate', 'update']",1
209988,nifty_644,2013-04-11,"Research and Markets: Editing Scientific Technical and Medical Texts (Seminar, London) - 13-14 June 2013 at The Rembrandt Hotel",Neutral,-0.0024,127,research and market editing scientific technical and medical text seminar london june the rembrandt hotel,105,15,0,pharmacy,"['research', 'and', 'market', 'editing', 'scientific', 'technical', 'and', 'medical', 'text', 'seminar', 'lo', '##ndon', 'j', '##une', 'the', 're', '##mb', '##rand', '##t', 'hotel']",1
209996,nifty_644,2013-04-11,"Research and Markets: Pharmaceutical Regulatory Affairs in Africa (Seminar, London) - 24-25th June 2013 at The Rembrandt Hotel",Neutral,-0.0024,126,research and market pharmaceutical regulatory affair africa seminar london june the rembrandt hotel,99,13,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'regulatory', 'affair', 'a', '##f', '##rica', 'seminar', 'lo', '##ndon', 'j', '##une', 'the', 're', '##mb', '##rand', '##t', 'hotel']",1
210004,nifty_644,2013-04-11,"Research and Markets: Pharmacovigilance For Support Staff - An introductory course aimed at Administrators, Secretaries, Personal Assistants and Support Staff working in the Pharmaceutical Industry (Seminar, London)",Neutral,-0.0024,215,research and market pharmacovigilance for support staff introductory course aimed administrator secretary personal assistant and support staff working the pharmaceutical industry seminar london,193,23,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##co', '##vi', '##gi', '##lance', 'for', 'support', 'staff', 'intro', '##ductory', 'course', 'aimed', 'administrator', 'secretary', 'personal', 'assistant', 'and', 'support', 'staff', 'working', 'the', 'pharmaceutical', 'industry', 'seminar', 'lo', '##ndon']",1
210019,nifty_644,2013-04-11,Research and Markets: The Role of Case Managers in Emerging Care Delivery Models,Neutral,-0.0024,80,research and market the role case manager emerging care delivery model,70,11,0,pharmacy,"['research', 'and', 'market', 'the', 'role', 'case', 'manager', 'emerging', 'care', 'delivery', 'model']",1
210275,nifty_645,2013-04-15,Breast Pumps Market Is Expected to Reach USD 1.03 Billion Globally in 2018: Transparency Market Research,Rise,0.0148,104,breast pump market expected reach usd billion globally transparency market research,83,11,0,pharmacy,"['breast', 'pump', 'market', 'expected', 'reach', 'us', '##d', 'billion', 'globally', 'transparency', 'market', 'research']",1
210278,nifty_645,2013-04-15,"Research and Markets: Process Validation for Pharmaceuticals and Medical Devices in the EU And USA - Balancing Science and Risk During the Product Lifecycle (Seminar, London)",Rise,0.0148,174,research and market process validation for pharmaceutical and medical device the and usa balancing science and risk during the product lifecycle seminar london,159,23,0,pharmacy,"['research', 'and', 'market', 'process', 'valid', '##ation', 'for', 'pharmaceutical', 'and', 'medical', 'device', 'the', 'and', 'us', '##a', 'balancing', 'science', 'and', 'risk', 'during', 'the', 'product', 'life', '##cycle', 'seminar', 'lo', '##ndon']",1
210446,nifty_645,2013-04-15,"Ambit Biosciences Appoints David Parkinson, M.D., to Board of Directors",Rise,0.0148,71,ambit bioscience appoints david parkinson board director,56,7,0,pharmacy,"['am', '##bit', 'bio', '##science', 'appoint', '##s', 'da', '##vid', 'park', '##ins', '##on', 'board', 'director']",1
210473,nifty_645,2013-04-15,"Research and Markets: Tetanus - Pipeline Review, H1 2013",Rise,0.0148,56,research and market tetanus pipeline review,43,6,0,pharmacy,"['research', 'and', 'market', 'te', '##tan', '##us', 'pipeline', 'review']",1
210666,nifty_645,2013-04-15,CPhI and PharmaEvolution.com to Analyze Pharma Industry in Monthly and Annual Reports,Rise,0.0148,85,cphi and pharmaevolution com analyze pharma industry monthly and annual report,78,11,0,pharmacy,"['c', '##phi', 'and', 'p', '##har', '##ma', '##evo', '##lution', 'com', 'analyze', 'p', '##har', '##ma', 'industry', 'monthly', 'and', 'annual', 'report']",1
210724,nifty_645,2013-04-15,North Shore-LIJ Investing $175M in Cancer Institute Expansion,Rise,0.0148,61,north shore lij investing cancer institute expansion,52,7,0,pharmacy,"['north', 'shore', 'l', '##i', '##j', 'investing', 'cancer', 'institute', 'expansion']",1
210775,nifty_645,2013-04-15,"Research and Markets: Breast Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018",Rise,0.0148,123,research and market breast pump market global industry analysis size share growth trend and forecast,100,15,0,pharmacy,"['research', 'and', 'market', 'breast', 'pump', 'market', 'global', 'industry', 'analysis', 'size', 'share', 'growth', 'trend', 'and', 'forecast']",1
210785,nifty_645,2013-04-15,G2 Intelligence Helps Labs Master Changing Market Dynamics in Working with Health Plans,Rise,0.0148,87,intelligence help lab master changing market dynamic working with health plan,77,11,0,pharmacy,"['intelligence', 'help', 'lab', 'master', 'changing', 'market', 'dynamic', 'working', 'with', 'health', 'plan']",1
210788,nifty_645,2013-04-15,Research and Markets: Fluorescent Imaging Life Science Dashboard Series 1 (NA & EU),Rise,0.0148,83,research and market fluorescent imaging life science dashboard series,69,9,0,pharmacy,"['research', 'and', 'market', 'fluorescent', 'imaging', 'life', 'science', 'dash', '##board', 'series']",1
210809,nifty_645,2013-04-15,Pre-Clinical Imaging (In vivo) Market - by Systems and Reagents - Competitive Analysis & Global Forecasts to 2017,Rise,0.0148,113,pre clinical imaging vivo market system and reagent competitive analysis global forecast,88,12,0,pharmacy,"['pre', 'clinical', 'imaging', 'v', '##ivo', 'market', 'system', 'and', 're', '##age', '##nt', 'competitive', 'analysis', 'global', 'forecast']",1
210850,nifty_645,2013-04-15,Health:Refactored Charts Course For Developers And Designers To Leap Into Trillion Dollar Health Care Market,Rise,0.0148,108,health refactored chart course for developer and designer leap into trillion dollar health care market,102,15,0,pharmacy,"['health', 're', '##fa', '##ctor', '##ed', 'chart', 'course', 'for', 'developer', 'and', 'designer', 'leap', 'into', 'trillion', 'dollar', 'health', 'care', 'market']",1
210953,nifty_645,2013-04-15,ChemoCentryx Announces Proposed Public Offering of Common Stock,Rise,0.0148,63,chemocentryx announces proposed public offering common stock,60,7,0,pharmacy,"['ch', '##em', '##oc', '##entry', '##x', 'announces', 'proposed', 'public', 'offering', 'common', 'stock']",1
211375,nifty_647,2013-04-17,"Research and Markets: Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2012",Fall,-0.0063,98,research and market transitional cell cancer urothelial cell cancer pipeline review,83,11,0,pharmacy,"['research', 'and', 'market', 'transitional', 'cell', 'cancer', 'u', '##roth', '##eli', '##al', 'cell', 'cancer', 'pipeline', 'review']",1
211508,nifty_647,2013-04-17,Research and Markets: Medical Devices Market in India 2013,Fall,-0.0063,58,research and market medical device market india,47,7,0,pharmacy,"['research', 'and', 'market', 'medical', 'device', 'market', 'in', '##dia']",1
211528,nifty_647,2013-04-17,Breakout Labs Funds Two Companies Creating Radically Distinct Interfaces Between Biology and Technology,Fall,-0.0063,103,breakout lab fund two company creating radically distinct interface between biology and technology,98,13,0,pharmacy,"['break', '##out', 'lab', 'fund', 'two', 'company', 'creating', 'radical', '##ly', 'distinct', 'interface', 'between', 'biology', 'and', 'technology']",1
211632,nifty_647,2013-04-17,"Tigerlabs Health IT Accelerator Adds Innovation Track, Placing Entrepreneurs In Residence At Pharmaceutical And Hospital Participants",Fall,-0.0063,133,tigerlabs health accelerator add innovation track placing entrepreneur residence pharmaceutical and hospital participant,120,13,0,pharmacy,"['tiger', '##la', '##bs', 'health', 'a', '##ccelerator', 'add', 'innovation', 'track', 'placing', 'entrepreneur', 'residence', 'pharmaceutical', 'and', 'hospital', 'participant']",1
211752,nifty_647,2013-04-17,Breast Cancer Pipeline Reviewed by Global Markets Direct in New Report Now Available at MarketPublishers.com,Fall,-0.0063,108,breast cancer pipeline reviewed global market direct new report now available marketpublishers com,98,13,0,pharmacy,"['breast', 'cancer', 'pipeline', 'reviewed', 'global', 'market', 'direct', 'new', 'report', 'now', 'available', 'market', '##pu', '##b', '##lish', '##ers', 'com']",1
211771,nifty_647,2013-04-17,"UPDATE 2-St. Jude Medical profit tops view, forex to hurt revs",Fall,-0.0063,62,update jude medical profit top view forex hurt rev,50,9,0,pharmacy,"['update', 'j', '##ude', 'medical', 'profit', 'top', 'view', 'fore', '##x', 'hurt', 're', '##v']",1
211772,nifty_647,2013-04-17,"St. Jude Medical profit tops view, forex to hurt revenue",Fall,-0.0063,56,jude medical profit top view forex hurt revenue,47,8,0,pharmacy,"['j', '##ude', 'medical', 'profit', 'top', 'view', 'fore', '##x', 'hurt', 'revenue']",1
211876,nifty_647,2013-04-17,Research and Markets: Wright Medical Group Inc: 2013 Company Profile Report - Medical Devices,Fall,-0.0063,93,research and market wright medical group inc company profile report medical device,82,12,0,pharmacy,"['research', 'and', 'market', 'w', '##right', 'medical', 'group', 'in', '##c', 'company', 'profile', 'report', 'medical', 'device']",1
211879,nifty_647,2013-04-17,Research and Markets: DePuy Synthes Inc. 2013 Company Fact Sheet - Medical Devices,Fall,-0.0063,82,research and market depuy synthes inc company fact sheet medical device,71,11,0,pharmacy,"['research', 'and', 'market', 'de', '##pu', '##y', 's', '##ynth', '##es', 'in', '##c', 'company', 'fact', 'sheet', 'medical', 'device']",1
212055,nifty_647,2013-04-17,Roper to Buy Managed Health Care for $1 Billion,Fall,-0.0063,47,roper buy managed health care for billion,41,7,0,pharmacy,"['rope', '##r', 'buy', 'managed', 'health', 'care', 'for', 'billion']",1
212202,nifty_649,2013-04-22,BIND Therapeutics and AstraZeneca Announce Worldwide Development and Commercialization Agreement for Cancer Nanomedicine,Rise,0.0103,120,bind therapeutic and astrazeneca announce worldwide development and commercialization agreement for cancer nanomedicine,119,13,0,pharmacy,"['bind', 'therapeutic', 'and', 'as', '##tra', '##zen', '##eca', 'announce', 'worldwide', 'development', 'and', 'commercial', '##ization', 'agreement', 'for', 'cancer', 'na', '##no', '##med', '##ici', '##ne']",1
212203,nifty_649,2013-04-22,AstraZeneca bets on nanotech with Bind Therapeutics deal,Rise,0.0103,56,astrazeneca bet nanotech with bind therapeutic deal,51,7,0,pharmacy,"['as', '##tra', '##zen', '##eca', 'bet', 'na', '##note', '##ch', 'with', 'bind', 'therapeutic', 'deal']",1
212274,nifty_649,2013-04-22,Astex Pharmaceuticals to Announce 2013 First Quarter Financial Results on April 29th,Rise,0.0103,84,astex pharmaceutical announce first quarter financial result april,66,8,0,pharmacy,"['as', '##te', '##x', 'pharmaceutical', 'announce', 'first', 'quarter', 'financial', 'result', 'a', '##p', '##ril']",1
212299,nifty_649,2013-04-22,"Research and Markets: China Aged Care Industry Report, 2012-2015",Rise,0.0103,64,research and market china aged care industry report,51,8,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'aged', 'care', 'industry', 'report']",1
212363,nifty_649,2013-04-22,"Elite Pharmaceuticals, Inc. Secures $10 Million Funding Commitment From Lincoln Park Capital Fund, LLC",Rise,0.0103,102,elite pharmaceutical inc secures million funding commitment from lincoln park capital fund llc,94,13,0,pharmacy,"['elite', 'pharmaceutical', 'in', '##c', 'secure', '##s', 'million', 'funding', 'commitment', 'from', 'l', '##in', '##co', '##ln', 'park', 'capital', 'fund', 'll', '##c']",1
212526,nifty_649,2013-04-22,"UPDATE 3-Philips sees tough European, U.S. healthcare markets",Rise,0.0103,61,update philip see tough european healthcare market,50,7,0,pharmacy,"['update', 'p', '##hil', '##ip', 'see', 'tough', 'euro', '##pe', '##an', 'healthcare', 'market']",1
212679,nifty_649,2013-04-22,Lung Cancer Therapeutic Pipeline Study by Global Markets Direct Recently Published at MarketPublishers.com,Rise,0.0103,106,lung cancer therapeutic pipeline study global market direct recently published marketpublishers com,99,12,0,pharmacy,"['lung', 'cancer', 'therapeutic', 'pipeline', 'study', 'global', 'market', 'direct', 'recently', 'published', 'market', '##pu', '##b', '##lish', '##ers', 'com']",1
212713,nifty_649,2013-04-22,Research and Markets: The Medical Device Market: Canada 2013,Rise,0.0103,60,research and market the medical device market canada,52,8,0,pharmacy,"['research', 'and', 'market', 'the', 'medical', 'device', 'market', 'can', '##ada']",1
212942,nifty_649,2013-04-22,Moody's sees pick-up in pharmaceutical industry M&A; in 2013,Rise,0.0103,60,moody see pick pharmaceutical industry,38,5,0,pharmacy,"['mood', '##y', 'see', 'pick', 'pharmaceutical', 'industry']",1
213092,nifty_650,2013-04-23,FDA Device Surveillance to Tap App,Neutral,0.0006,34,fda device surveillance tap app,31,5,0,pharmacy,"['f', '##da', 'device', 'surveillance', 'tap', 'app']",1
213124,nifty_651,2013-04-24,FDA to Test Detection Device for Fake Drugs,Neutral,0.0041,43,fda test detection device for fake drug,39,7,0,pharmacy,"['f', '##da', 'test', 'detection', 'device', 'for', 'fake', 'drug']",1
213309,nifty_652,2013-04-25,"Research and Markets: Fatigue - Pipeline Review, H1 2013",Neutral,-0.0018,56,research and market fatigue pipeline review,43,6,0,pharmacy,"['research', 'and', 'market', 'fatigue', 'pipeline', 'review']",1
213314,nifty_652,2013-04-25,"Research and Markets: Cachexia - Pipeline Review, H1 2013",Neutral,-0.0018,57,research and market cachexia pipeline review,44,6,0,pharmacy,"['research', 'and', 'market', 'cache', '##xia', 'pipeline', 'review']",1
213318,nifty_652,2013-04-25,Research and Markets: Pharmaceutical & Healthcare Annual Deals Analysis: M&A; and Investments Trends - 2012,Neutral,-0.0018,107,research and market pharmaceutical healthcare annual deal analysis and investment trend,87,11,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'healthcare', 'annual', 'deal', 'analysis', 'and', 'investment', 'trend']",1
213375,nifty_652,2013-04-25,"Research and Markets: RFID Forecasts, Players and Opportunities 2012-2022 Updated Report",Neutral,-0.0018,88,research and market rfid forecast player and opportunity updated report,71,10,0,pharmacy,"['research', 'and', 'market', 'r', '##fi', '##d', 'forecast', 'player', 'and', 'opportunity', 'updated', 'report']",1
213456,nifty_652,2013-04-25,Bristol-Myers Squibb Reports First Quarter 2013 Financial Results,Neutral,-0.0018,65,bristol myers squibb report first quarter financial result,58,8,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'report', 'first', 'quarter', 'financial', 'result']",1
213517,nifty_652,2013-04-25,"Research and Markets: Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech, 2013 Edition",Neutral,-0.0018,107,research and market preclinical stage partnering term and agreement pharma and biotech edition,94,13,0,pharmacy,"['research', 'and', 'market', 'pre', '##c', '##lini', '##cal', 'stage', 'partner', '##ing', 'term', 'and', 'agreement', 'p', '##har', '##ma', 'and', 'bio', '##tech', 'edition']",1
213549,nifty_652,2013-04-25,TNI BioTech Names Terry Lierman of Summit Global Ventures as a Strategic Advisor,Neutral,-0.0018,80,tni biotech name terry lierman summit global venture strategic advisor,70,10,0,pharmacy,"['t', '##ni', 'bio', '##tech', 'name', 'te', '##rry', 'lie', '##rman', 'summit', 'global', 'venture', 'strategic', 'advisor']",1
213719,nifty_652,2013-04-25,Britain's 3i in talks to sell pharma firm Xellia -sources,Neutral,-0.0018,57,britain talk sell pharma firm xellia source,43,7,0,pharmacy,"['br', '##ita', '##in', 'talk', 'sell', 'p', '##har', '##ma', 'firm', 'x', '##elli', '##a', 'source']",1
213722,nifty_652,2013-04-25,Digital is Top-of-Mind Channel for Physicians in Growth Markets,Neutral,-0.0018,63,digital top mind channel for physician growth market,52,8,0,pharmacy,"['digital', 'top', 'mind', 'channel', 'for', 'physician', 'growth', 'market']",1
213723,nifty_652,2013-04-25,Britain's 3i in talks to sell pharma firm Xellia: sources,Neutral,-0.0018,57,britain talk sell pharma firm xellia source,43,7,0,pharmacy,"['br', '##ita', '##in', 'talk', 'sell', 'p', '##har', '##ma', 'firm', 'x', '##elli', '##a', 'source']",1
213835,nifty_652,2013-04-25,"Research and Markets: Diarrhea Global Clinical Trials Review, H1, 2013",Neutral,-0.0018,70,research and market diarrhea global clinical trial review,57,8,0,pharmacy,"['research', 'and', 'market', 'di', '##ar', '##r', '##hea', 'global', 'clinical', 'trial', 'review']",1
213838,nifty_652,2013-04-25,"REFILE-UPDATE 3-Bristol-Myers Squibb sales disappoint, shares fall",Neutral,-0.0018,66,refile update bristol myers squibb sale disappoint share fall,61,9,0,pharmacy,"['re', '##fi', '##le', 'update', 'br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'sale', 'di', '##sa', '##pp', '##oint', 'share', 'fall']",1
213839,nifty_652,2013-04-25,"Bristol-Myers Squibb sales disappoint, shares fall",Neutral,-0.0018,50,bristol myers squibb sale disappoint share fall,47,7,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'sale', 'di', '##sa', '##pp', '##oint', 'share', 'fall']",1
213868,nifty_652,2013-04-25,Research and Markets: Drug Delivery Technologies Market - Global Forecasts To 2017,Neutral,-0.0018,82,research and market drug delivery technology market global forecast,67,9,0,pharmacy,"['research', 'and', 'market', 'drug', 'delivery', 'technology', 'market', 'global', 'forecast']",1
214212,nifty_652,2013-04-25,Bristol-Myers Profit Drops,Neutral,-0.0018,26,bristol myers profit drop,25,4,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'profit', 'drop']",1
214225,nifty_652,2013-04-25,Mixed Results for Drug Firms,Neutral,-0.0018,28,mixed result for drug firm,26,5,0,pharmacy,"['mixed', 'result', 'for', 'drug', 'firm']",1
214394,nifty_654,2013-04-30,Research and Markets: Drug Delivery: Surveying the Global Competitive Landscape,Fall,-0.0088,79,research and market drug delivery surveying the global competitive landscape,76,10,0,pharmacy,"['research', 'and', 'market', 'drug', 'delivery', 'surveying', 'the', 'global', 'competitive', 'landscape']",1
214417,nifty_654,2013-04-30,Ligand Acquires Financial Rights to More Than 15 Fully-Funded Development Programs from Selexis SA,Fall,-0.0088,98,ligand acquires financial right more than fully funded development program from selexis,87,12,0,pharmacy,"['l', '##igan', '##d', 'acquire', '##s', 'financial', 'right', 'more', 'than', 'fully', 'funded', 'development', 'program', 'from', 'se', '##lex', '##is']",1
214424,nifty_654,2013-04-30,"Tiangen, Qiagen and Life Technologies Emerge as Leading Suppliers in Chinese Nucleic Acid Purification Market According to Percepta",Fall,-0.0088,131,tiangen qiagen and life technology emerge leading supplier chinese nucleic acid purification market according percepta,118,15,0,pharmacy,"['t', '##ian', '##gen', 'q', '##ia', '##gen', 'and', 'life', 'technology', 'emerge', 'leading', 'supplier', 'chin', '##ese', 'nuclei', '##c', 'acid', 'pu', '##rification', 'market', 'according', 'per', '##ce', '##pta']",1
214433,nifty_654,2013-04-30,Research and Markets: Analogic Medical Device Company Intelligence Report,Fall,-0.0088,73,research and market analogic medical device company intelligence report,71,9,0,pharmacy,"['research', 'and', 'market', 'analog', '##ic', 'medical', 'device', 'company', 'intelligence', 'report']",1
214435,nifty_654,2013-04-30,Research and Markets: Early Stage Drug Delivery Technologies: 62 Profiles of Start-ups and Emerging Companies,Fall,-0.0088,109,research and market early stage drug delivery technology profile start ups and emerging company,95,14,0,pharmacy,"['research', 'and', 'market', 'early', 'stage', 'drug', 'delivery', 'technology', 'profile', 'start', 'ups', 'and', 'emerging', 'company']",1
214536,nifty_654,2013-04-30,Research and Markets: MediPoint: Predictive Breast Cancer Gene Testing - EU Analysis and Market Forecasts,Fall,-0.0088,105,research and market medipoint predictive breast cancer gene testing analysis and market forecast,96,13,0,pharmacy,"['research', 'and', 'market', 'me', '##di', '##point', 'predict', '##ive', 'breast', 'cancer', 'gene', 'testing', 'analysis', 'and', 'market', 'forecast']",1
214547,nifty_654,2013-04-30,"TNI BioTech, Inc. Appoints Industry Veteran, Dr. Joseph Fortunak, as a Strategic Consultant",Fall,-0.0088,91,tni biotech inc appoints industry veteran joseph fortunak strategic consultant,78,10,0,pharmacy,"['t', '##ni', 'bio', '##tech', 'in', '##c', 'appoint', '##s', 'industry', 'veteran', 'j', '##ose', '##ph', 'fort', '##una', '##k', 'strategic', 'consultant']",1
214689,nifty_654,2013-04-30,"Research and Markets: Delirium Global Clinical Trials Review, H1, 2013",Fall,-0.0088,70,research and market delirium global clinical trial review,57,8,0,pharmacy,"['research', 'and', 'market', 'del', '##iri', '##um', 'global', 'clinical', 'trial', 'review']",1
214705,nifty_654,2013-04-30,Research and Markets: Molecular Diagnostics in Cancer Testing Report: 2013 Edition,Fall,-0.0088,82,research and market molecular diagnostics cancer testing report edition,71,9,0,pharmacy,"['research', 'and', 'market', 'molecular', 'diagnostic', '##s', 'cancer', 'testing', 'report', 'edition']",1
214737,nifty_654,2013-04-30,CNBC and Fox Business News Segment: IPG Leads Charge in Transforming Healthcare through Cost Transparency,Fall,-0.0088,105,cnbc and fox business news segment ipg lead charge transforming healthcare through cost transparency,100,14,0,pharmacy,"['c', '##n', '##b', '##c', 'and', 'fox', 'business', 'news', 'segment', 'i', '##p', '##g', 'lead', 'charge', 'transforming', 'healthcare', 'through', 'cost', 'transparency']",1
214753,nifty_654,2013-04-30,Research and Markets: Chinese Markets for Colon Cancer Treatment Drugs: 2016-2021 Forecasts Out Now,Fall,-0.0088,99,research and market chinese market for colon cancer treatment drug forecast out now,83,13,0,pharmacy,"['research', 'and', 'market', 'chin', '##ese', 'market', 'for', 'co', '##lon', 'cancer', 'treatment', 'drug', 'forecast', 'out', 'now']",1
214871,nifty_654,2013-04-30,Research and Markets: The Medical Device Market: Brazil 2013,Fall,-0.0088,60,research and market the medical device market brazil,52,8,0,pharmacy,"['research', 'and', 'market', 'the', 'medical', 'device', 'market', 'bra', '##zi', '##l']",1
214873,nifty_654,2013-04-30,Research and Markets: The Medical Device Market: Chile 2013,Fall,-0.0088,59,research and market the medical device market chile,51,8,0,pharmacy,"['research', 'and', 'market', 'the', 'medical', 'device', 'market', 'ch', '##ile']",1
214884,nifty_654,2013-04-30,Psychiatric Disorders Therapeutic Development Reviewed by Global Markets Direct in Discounted Study Published at MarketPublishers.com,Fall,-0.0088,133,psychiatric disorder therapeutic development reviewed global market direct discounted study published marketpublishers com,122,13,0,pharmacy,"['psychiatric', 'disorder', 'therapeutic', 'development', 'reviewed', 'global', 'market', 'direct', 'discount', '##ed', 'study', 'published', 'market', '##pu', '##b', '##lish', '##ers', 'com']",1
214919,nifty_654,2013-04-30,Research and Markets: Cancer Diagnostic Testing World Markets 2013,Fall,-0.0088,66,research and market cancer diagnostic testing world market,58,8,0,pharmacy,"['research', 'and', 'market', 'cancer', 'diagnostic', 'testing', 'world', 'market']",1
214934,nifty_654,2013-04-30,Research and Markets: 2013 U.S. HMO Medical Centers Industry - Industry & Market Report - 2013,Fall,-0.0088,94,research and market hmo medical center industry industry market report,70,10,0,pharmacy,"['research', 'and', 'market', 'h', '##mo', 'medical', 'center', 'industry', 'industry', 'market', 'report']",1
214949,nifty_654,2013-04-30,"Research and Markets: Boston Scientific Corporation (BSX) - Product Pipeline Analysis, 2013 Update",Fall,-0.0088,98,research and market boston scientific corporation bsx product pipeline analysis update,86,11,0,pharmacy,"['research', 'and', 'market', 'b', '##ost', '##on', 'scientific', 'corporation', 'b', '##s', '##x', 'product', 'pipeline', 'analysis', 'update']",1
214953,nifty_654,2013-04-30,"Research and Markets: Covidien plc (COV) - Product Pipeline Analysis, 2013 Update Available Now for Analysis",Fall,-0.0088,108,research and market covidien plc cov product pipeline analysis update available now for analysis,96,14,0,pharmacy,"['research', 'and', 'market', 'co', '##vid', '##ien', 'plc', 'co', '##v', 'product', 'pipeline', 'analysis', 'update', 'available', 'now', 'for', 'analysis']",1
214962,nifty_654,2013-04-30,"Research and Markets: Biomet, Inc. - Product Pipeline Analysis, 2013 Update",Fall,-0.0088,75,research and market biomet inc product pipeline analysis update,63,9,0,pharmacy,"['research', 'and', 'market', 'bio', '##met', 'in', '##c', 'product', 'pipeline', 'analysis', 'update']",1
214963,nifty_654,2013-04-30,"Research and Markets: W. L. Gore & Associates, Inc. - Product Pipeline Analysis, 2013 Update",Fall,-0.0088,92,research and market gore associate inc product pipeline analysis update,71,10,0,pharmacy,"['research', 'and', 'market', 'go', '##re', 'associate', 'in', '##c', 'product', 'pipeline', 'analysis', 'update']",1
214969,nifty_654,2013-04-30,"Research and Markets: Stryker Corporation (SYK) - Product Pipeline Analysis, 2013 Update Out Now",Fall,-0.0088,96,research and market stryker corporation syk product pipeline analysis update out now,84,12,0,pharmacy,"['research', 'and', 'market', 's', '##try', '##ker', 'corporation', 's', '##yk', 'product', 'pipeline', 'analysis', 'update', 'out', 'now']",1
214974,nifty_654,2013-04-30,"Research and Markets: Thermo Fisher Scientific Inc. (TMO) - Product Pipeline Analysis, 2013 Update",Fall,-0.0088,98,research and market thermo fisher scientific inc tmo product pipeline analysis update,85,12,0,pharmacy,"['research', 'and', 'market', 'the', '##rm', '##o', 'fish', '##er', 'scientific', 'in', '##c', 't', '##mo', 'product', 'pipeline', 'analysis', 'update']",1
215018,nifty_654,2013-04-30,"Cytokinetics, Incorporated Reports First Quarter 2013 Financial Results",Fall,-0.0088,71,cytokinetics incorporated report first quarter financial result,63,7,0,pharmacy,"['c', '##yt', '##oki', '##net', '##ics', 'incorporated', 'report', 'first', 'quarter', 'financial', 'result']",1
215039,nifty_654,2013-04-30,PDL BioPharma Appoints Peter Garcia as Chief Financial Officer,Fall,-0.0088,62,pdl biopharma appoints peter garcia chief financial officer,59,8,0,pharmacy,"['p', '##dl', 'bio', '##pha', '##rma', 'appoint', '##s', 'pet', '##er', 'g', '##ar', '##cia', 'chief', 'financial', 'officer']",1
215046,nifty_654,2013-04-30,Idenix Pharmaceuticals Reports First Quarter 2013 Financial Results,Fall,-0.0088,67,idenix pharmaceutical report first quarter financial result,59,7,0,pharmacy,"['id', '##eni', '##x', 'pharmaceutical', 'report', 'first', 'quarter', 'financial', 'result']",1
215345,nifty_655,2013-05-01,"Research and Markets: China Hospital Industry, 2013-2017",Rise,0.0093,56,research and market china hospital industry,43,6,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'hospital', 'industry']",1
215401,nifty_655,2013-05-01,Research and Markets: Advances in Molecular Imaging: A Market Coming of Age,Rise,0.0093,75,research and market advance molecular imaging market coming age,63,9,0,pharmacy,"['research', 'and', 'market', 'advance', 'molecular', 'imaging', 'market', 'coming', 'age']",1
215403,nifty_655,2013-05-01,Research and Markets: Medtronic Medical Device Company Intelligence Report,Rise,0.0093,74,research and market medtronic medical device company intelligence report,72,9,0,pharmacy,"['research', 'and', 'market', 'me', '##dt', '##ronic', 'medical', 'device', 'company', 'intelligence', 'report']",1
215405,nifty_655,2013-05-01,Research and Markets: EpiCast Report: Non-Small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2022,Rise,0.0093,104,research and market epicast report non small cell lung cancer nsclc epidemiology forecast,89,13,0,pharmacy,"['research', 'and', 'market', 'epic', '##ast', 'report', 'non', 'small', 'cell', 'lung', 'cancer', 'n', '##s', '##c', '##l', '##c', 'e', '##pid', '##em', '##iology', 'forecast']",1
215410,nifty_655,2013-05-01,"Research and Markets: Burns - Pipeline Review, H1 2013",Rise,0.0093,54,research and market burn pipeline review,40,6,0,pharmacy,"['research', 'and', 'market', 'burn', 'pipeline', 'review']",1
215506,nifty_655,2013-05-01,"DW Healthcare Partners Invests in Med-Pharmex, Inc.",Rise,0.0093,51,healthcare partner invests med pharmex inc,42,6,0,pharmacy,"['healthcare', 'partner', 'invest', '##s', 'me', '##d', 'p', '##har', '##me', '##x', 'in', '##c']",1
215539,nifty_655,2013-05-01,Research and Markets: Japan Pharmaceutical Market Outlook,Rise,0.0093,57,research and market japan pharmaceutical market outlook,55,7,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##n', 'pharmaceutical', 'market', 'outlook']",1
215590,nifty_655,2013-05-01,DOTmed Business Newsâ Biomed Symposium,Rise,0.0093,40,dotmed business newsâ biomed symposium,38,5,0,pharmacy,"['dot', '##med', 'business', 'news', '##â', 'bio', '##med', 's', '##ym', '##po', '##sium']",1
215672,nifty_655,2013-05-01,"Research and Markets: Dyskinesia Global Clinical Trials Review, H1, 2013",Rise,0.0093,72,research and market dyskinesia global clinical trial review,59,8,0,pharmacy,"['research', 'and', 'market', 'd', '##ys', '##kin', '##esi', '##a', 'global', 'clinical', 'trial', 'review']",1
215784,nifty_655,2013-05-01,Olim Technologies Group Extends ECM Leadership in Financial Services and Healthcare,Rise,0.0093,83,olim technology group extends ecm leadership financial service and healthcare,77,10,0,pharmacy,"['o', '##lim', 'technology', 'group', 'extends', 'e', '##c', '##m', 'leadership', 'financial', 'service', 'and', 'healthcare']",1
216164,nifty_656,2013-05-02,EuropaBio and Smithers Rapra Unveil Highly-Anticipated Agenda for the European Forum for Industrial Biotechnology (EFIB) from 1-2 October 2013 Taking Place in the Heart of Brussels at SQUARE.,Rise,0.0101,191,europabio and smithers rapra unveil highly anticipated agenda for the european forum for industrial biotechnology efib from october taking place the heart brussels square,170,24,0,pharmacy,"['euro', '##pa', '##bio', 'and', 's', '##mith', '##ers', 'rap', '##ra', 'un', '##ve', '##il', 'highly', 'anticipated', 'agenda', 'for', 'the', 'euro', '##pe', '##an', 'forum', 'for', 'industrial', 'bio', '##tech', '##nology', 'e', '##fi', '##b', 'from', 'o', '##ct', '##obe', '##r', 'taking', 'place', 'the', 'heart', 'br', '##uss', '##els', 'square']",1
216180,nifty_656,2013-05-02,"Research and Markets: Healthcare, Regulatory and Reimbursement Landscape - Belgium",Rise,0.0101,82,research and market healthcare regulatory and reimbursement landscape belgium,77,9,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'regulatory', 'and', 're', '##im', '##bur', '##se', '##ment', 'landscape', 'be', '##l', '##gi', '##um']",1
216246,nifty_656,2013-05-02,"Research and Markets: Partial Seizure - Pipeline Review, H1 2013",Rise,0.0101,64,research and market partial seizure pipeline review,51,7,0,pharmacy,"['research', 'and', 'market', 'partial', 'seizure', 'pipeline', 'review']",1
216275,nifty_656,2013-05-02,"NanoMarkets Announces Release of Report, ""Radiation Detection Materials Markets 2013""",Rise,0.0101,85,nanomarkets announces release report radiation detection material market,72,8,0,pharmacy,"['na', '##no', '##market', '##s', 'announces', 'release', 'report', 'radiation', 'detection', 'material', 'market']",1
216310,nifty_656,2013-05-02,Celldex Reports First Quarter 2013 Financial Results,Rise,0.0101,52,celldex report first quarter financial result,45,6,0,pharmacy,"['cell', '##de', '##x', 'report', 'first', 'quarter', 'financial', 'result']",1
216320,nifty_656,2013-05-02,NovaBay Pharmaceuticals Reports First Quarter Financial Results and Clinical and Business Update,Rise,0.0101,96,novabay pharmaceutical report first quarter financial result and clinical and business update,93,12,0,pharmacy,"['no', '##va', '##bay', 'pharmaceutical', 'report', 'first', 'quarter', 'financial', 'result', 'and', 'clinical', 'and', 'business', 'update']",1
216345,nifty_656,2013-05-02,"Research and Markets: Diabetes Landscape: Market, Technology and Intellectual Property",Rise,0.0101,86,research and market diabetes landscape market technology and intellectual property,82,10,0,pharmacy,"['research', 'and', 'market', 'diabetes', 'landscape', 'market', 'technology', 'and', 'intellectual', 'property']",1
216414,nifty_656,2013-05-02,"The Zacks Analyst Blog Highlights: AT&T;, Optimer Pharmaceuticals, ViroPharma, Astellas Pharma and Incyte",Rise,0.0101,105,the zacks analyst blog highlight optimer pharmaceutical viropharma astellas pharma and incyte,93,12,0,pharmacy,"['the', 'z', '##ack', '##s', 'analyst', 'blog', 'highlight', 'op', '##time', '##r', 'pharmaceutical', 'v', '##iro', '##pha', '##rma', 'as', '##tel', '##las', 'p', '##har', '##ma', 'and', 'in', '##cy', '##te']",1
216443,nifty_656,2013-05-02,Research and Markets: Effect of Sequestration on Pha/Bio Industry,Rise,0.0101,65,research and market effect sequestration pha bio industry,57,8,0,pharmacy,"['research', 'and', 'market', 'effect', 'se', '##quest', '##ration', 'p', '##ha', 'bio', 'industry']",1
216473,nifty_656,2013-05-02,"Research and Markets: Hungary Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018",Rise,0.0101,108,research and market hungary drug delivery device investment opportunity analysis and forecast,93,12,0,pharmacy,"['research', 'and', 'market', 'hung', '##ary', 'drug', 'delivery', 'device', 'investment', 'opportunity', 'analysis', 'and', 'forecast']",1
216475,nifty_656,2013-05-02,"AltheRx Pharmaceuticals Raises $15 Million, Names Jim Bennethum Chief Executive Officer and Appoints a New Board of Directors",Rise,0.0101,125,altherx pharmaceutical raise million name jim bennethum chief executive officer and appoints new board director,111,15,0,pharmacy,"['al', '##ther', '##x', 'pharmaceutical', 'raise', 'million', 'name', 'ji', '##m', 'ben', '##net', '##hum', 'chief', 'executive', 'officer', 'and', 'appoint', '##s', 'new', 'board', 'director']",1
216485,nifty_656,2013-05-02,Exchanges bust trades in West Pharmaceuticals,Rise,0.0101,45,exchange bust trade west pharmaceutical,39,5,0,pharmacy,"['exchange', 'bust', 'trade', 'west', 'pharmaceutical']",1
216488,nifty_656,2013-05-02,REFILE-Exchanges bust trades in West Pharmaceuticals,Rise,0.0101,52,refile exchange bust trade west pharmaceutical,46,6,0,pharmacy,"['re', '##fi', '##le', 'exchange', 'bust', 'trade', 'west', 'pharmaceutical']",1
216491,nifty_656,2013-05-02,"Research and Markets: Depression - Pipeline Review, H1 2013 Report Features Players such as Elan, Pfizer and AstraZeneca",Rise,0.0101,120,research and market depression pipeline review report feature player such elan pfizer and astrazeneca,101,14,0,pharmacy,"['research', 'and', 'market', 'depression', 'pipeline', 'review', 'report', 'feature', 'player', 'such', 'el', '##an', 'p', '##fi', '##zer', 'and', 'as', '##tra', '##zen', '##eca']",1
216635,nifty_656,2013-05-02,"Research and Markets: Cell Therapy - Technologies, Markets and Companies - Updated 2013 with New Companies and Profiles",Rise,0.0101,119,research and market cell therapy technology market and company updated with new company and profile,99,15,0,pharmacy,"['research', 'and', 'market', 'cell', 'therapy', 'technology', 'market', 'and', 'company', 'updated', 'with', 'new', 'company', 'and', 'profile']",1
216691,nifty_656,2013-05-02,Cell Therapeutics Reports First Quarter 2013 Financial Results,Rise,0.0101,62,cell therapeutic report first quarter financial result,54,7,0,pharmacy,"['cell', 'therapeutic', 'report', 'first', 'quarter', 'financial', 'result']",1
216705,nifty_656,2013-05-02,Endocyte Reports First Quarter 2013 Financial Results and Business Update,Rise,0.0101,73,endocyte report first quarter financial result and business update,66,9,0,pharmacy,"['end', '##oc', '##yte', 'report', 'first', 'quarter', 'financial', 'result', 'and', 'business', 'update']",1
216714,nifty_656,2013-05-02,"Research and Markets: Biomarkers - Technologies, Markets and Companies - Updated 2013 Report with 290 Company Profiles",Rise,0.0101,118,research and market biomarkers technology market and company updated report with company profile,96,13,0,pharmacy,"['research', 'and', 'market', 'bio', '##mark', '##ers', 'technology', 'market', 'and', 'company', 'updated', 'report', 'with', 'company', 'profile']",1
216718,nifty_656,2013-05-02,Cumberland Pharmaceuticals Reports First Quarter Financial Results,Rise,0.0101,66,cumberland pharmaceutical report first quarter financial result,63,7,0,pharmacy,"['cum', '##ber', '##land', 'pharmaceutical', 'report', 'first', 'quarter', 'financial', 'result']",1
216720,nifty_656,2013-05-02,Myriad Genetics Announces 2013 Analyst and Investor Day,Rise,0.0101,55,myriad genetics announces analyst and investor day,50,7,0,pharmacy,"['my', '##riad', 'genetics', 'announces', 'analyst', 'and', 'investor', 'day']",1
216735,nifty_656,2013-05-02,HealthSouth To Present At Investor Conferences In May,Rise,0.0101,53,healthsouth present investor conference may,43,5,0,pharmacy,"['health', '##so', '##uth', 'present', 'investor', 'conference', 'may']",1
216831,nifty_656,2013-05-02,Research and Markets: The Complete Guide to Companion Diagnostics: Market Environment Products and Companies,Rise,0.0101,108,research and market the complete guide companion diagnostics market environment product and company,99,13,0,pharmacy,"['research', 'and', 'market', 'the', 'complete', 'guide', 'companion', 'diagnostic', '##s', 'market', 'environment', 'product', 'and', 'company']",1
216921,nifty_656,2013-05-02,Probe Into Medicare Tips Grows,Rise,0.0101,30,probe into medicare tip grows,29,5,0,pharmacy,"['probe', 'into', 'me', '##dic', '##are', 'tip', 'grows']",1
216983,nifty_657,2013-05-06,FDA Seeks Cancer Warning for Tanning Beds,Rise,0.0051,41,fda seek cancer warning for tanning bed,39,7,0,pharmacy,"['f', '##da', 'seek', 'cancer', 'warning', 'for', 'tan', '##ning', 'bed']",1
217115,nifty_659,2013-05-08,BRIEF-Dechra Pharmaceuticals says on track despite Q3 slowdown,Neutral,-0.0028,62,brief dechra pharmaceutical say track despite slowdown,54,7,0,pharmacy,"['brief', 'de', '##ch', '##ra', 'pharmaceutical', 'say', 'track', 'despite', 'slow', '##down']",1
217237,nifty_659,2013-05-08,"Research and Markets: Partnerships, Licensing, Investments and M&A; Deals and Trends for 03 - 2013 in Pharmaceuticals",Neutral,-0.0028,117,research and market partnership licensing investment and deal and trend for pharmaceutical,90,12,0,pharmacy,"['research', 'and', 'market', 'partnership', 'licensing', 'investment', 'and', 'deal', 'and', 'trend', 'for', 'pharmaceutical']",1
217241,nifty_659,2013-05-08,Research and Markets: Medical Equipment Monthly Deals Analysis: March 2013- M&A; and Investment Trends,Neutral,-0.0028,102,research and market medical equipment monthly deal analysis march and investment trend,86,12,0,pharmacy,"['research', 'and', 'market', 'medical', 'equipment', 'monthly', 'deal', 'analysis', 'march', 'and', 'investment', 'trend']",1
217248,nifty_659,2013-05-08,Research and Markets: Influenza Partnering 2007-2012 - Partnering Deals and Agreements by the World's Leading Healthcare Companies,Neutral,-0.0028,130,research and market influenza partnering partnering deal and agreement the world leading healthcare company,107,14,0,pharmacy,"['research', 'and', 'market', 'in', '##fluenza', 'partner', '##ing', 'partner', '##ing', 'deal', 'and', 'agreement', 'the', 'world', 'leading', 'healthcare', 'company']",1
217297,nifty_659,2013-05-08,"Research and Markets: Molecular Diagnostics - Technologies, Markets and Companies - Updated 2013 Report",Neutral,-0.0028,103,research and market molecular diagnostics technology market and company updated report,86,11,0,pharmacy,"['research', 'and', 'market', 'molecular', 'diagnostic', '##s', 'technology', 'market', 'and', 'company', 'updated', 'report']",1
217350,nifty_659,2013-05-08,Real Time Genomics Secures a $5 Million Round of Funding to Expand Commercial Operations,Neutral,-0.0028,88,real time genomics secures million round funding expand commercial operation,76,10,0,pharmacy,"['real', 'time', 'g', '##eno', '##mic', '##s', 'secure', '##s', 'million', 'round', 'funding', 'expand', 'commercial', 'operation']",1
217369,nifty_659,2013-05-08,Biotech firms evolve from targets to acquirers,Neutral,-0.0028,46,biotech firm evolve from target acquirer,40,6,0,pharmacy,"['bio', '##tech', 'firm', 'evolve', 'from', 'target', 'acquire', '##r']",1
217372,nifty_659,2013-05-08,Research and Markets: Digital Pathology Systems - Global Strategic Business Report - 2013-2018,Neutral,-0.0028,94,research and market digital pathology system global strategic business report,77,10,0,pharmacy,"['research', 'and', 'market', 'digital', 'path', '##ology', 'system', 'global', 'strategic', 'business', 'report']",1
217558,nifty_659,2013-05-08,Analogic to Present at Bank of America Merrill Lynch 2013 Health Care Investor Conference,Neutral,-0.0028,89,analogic present bank america merrill lynch health care investor conference,75,10,0,pharmacy,"['analog', '##ic', 'present', 'bank', 'am', '##eric', '##a', 'me', '##rri', '##ll', 'l', '##ync', '##h', 'health', 'care', 'investor', 'conference']",1
217617,nifty_659,2013-05-08,Research and Markets: Chinese Markets for Insulin 2013,Neutral,-0.0028,54,research and market chinese market for insulin,46,7,0,pharmacy,"['research', 'and', 'market', 'chin', '##ese', 'market', 'for', 'insulin']",1
217648,nifty_659,2013-05-08,Research and Markets: Nuclear Medicine/Radiopharmaceuticals Market - Global Trends & Forecast to 2017,Neutral,-0.0028,101,research and market nuclear medicine radiopharmaceutical market global trend forecast,85,10,0,pharmacy,"['research', 'and', 'market', 'nuclear', 'medicine', 'radio', '##pha', '##rma', '##ce', '##utical', 'market', 'global', 'trend', 'forecast']",1
217657,nifty_659,2013-05-08,"Research and Markets: Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017",Neutral,-0.0028,120,research and market injectable drug delivery market formulation device therapeutic global forecast,98,12,0,pharmacy,"['research', 'and', 'market', 'in', '##ject', '##able', 'drug', 'delivery', 'market', 'formulation', 'device', 'therapeutic', 'global', 'forecast']",1
217747,nifty_659,2013-05-08,Research and Markets: Companion Diagnostics Partnering Terms & Agreements - 2013,Neutral,-0.0028,80,research and market companion diagnostics partnering term agreement,67,8,0,pharmacy,"['research', 'and', 'market', 'companion', 'diagnostic', '##s', 'partner', '##ing', 'term', 'agreement']",1
217780,nifty_659,2013-05-08,Research and Markets: The Medical Device Market 2013: Japan,Neutral,-0.0028,59,research and market the medical device market japan,51,8,0,pharmacy,"['research', 'and', 'market', 'the', 'medical', 'device', 'market', 'j', '##apa', '##n']",1
217807,nifty_659,2013-05-08,Research and Markets: The Medical Device Market 2013: Switzerland,Neutral,-0.0028,65,research and market the medical device market switzerland,57,8,0,pharmacy,"['research', 'and', 'market', 'the', 'medical', 'device', 'market', 's', '##witz', '##erland']",1
217827,nifty_659,2013-05-08,Research and Markets: Renal Failure Partnering 2007-2013 Available Now for Analysis,Neutral,-0.0028,83,research and market renal failure partnering available now for analysis,71,10,0,pharmacy,"['research', 'and', 'market', 're', '##nal', 'failure', 'partner', '##ing', 'available', 'now', 'for', 'analysis']",1
217829,nifty_659,2013-05-08,Ligand Reports First Quarter Financial Results,Neutral,-0.0028,46,ligand report first quarter financial result,44,6,0,pharmacy,"['l', '##igan', '##d', 'report', 'first', 'quarter', 'financial', 'result']",1
217857,nifty_659,2013-05-08,Raptor Pharmaceutical Reports First Quarter Calendar Year 2013 Financial Results,Neutral,-0.0028,80,raptor pharmaceutical report first quarter calendar year financial result,73,9,0,pharmacy,"['rap', '##tor', 'pharmaceutical', 'report', 'first', 'quarter', 'calendar', 'year', 'financial', 'result']",1
217917,nifty_659,2013-05-08,China Biologic Reports Financial Results for the First Quarter of 2013,Neutral,-0.0028,70,china biologic report financial result for the first quarter,60,9,0,pharmacy,"['chin', '##a', 'bio', '##log', '##ic', 'report', 'financial', 'result', 'for', 'the', 'first', 'quarter']",1
218274,nifty_661,2013-05-13,"Research and Markets: Essential Pharmacovigilance - A 1 Day Concise Overview (Conference, London) - 4th July 2013",Rise,0.0103,113,research and market essential pharmacovigilance day concise overview conference london july,91,11,0,pharmacy,"['research', 'and', 'market', 'essential', 'p', '##har', '##ma', '##co', '##vi', '##gi', '##lance', 'day', 'con', '##cise', 'overview', 'conference', 'lo', '##ndon', 'j', '##ul', '##y']",1
218303,nifty_661,2013-05-13,Research and Markets: Pharmaceutical Market India: A Comprehensive Industry Analysis,Rise,0.0103,84,research and market pharmaceutical market india comprehensive industry analysis,79,9,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'market', 'in', '##dia', 'comprehensive', 'industry', 'analysis']",1
218330,nifty_661,2013-05-13,Research and Markets: China Oncology Prescription Drug Sales Data 2007-2011,Rise,0.0103,75,research and market china oncology prescription drug sale data,62,9,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'on', '##cology', 'prescription', 'drug', 'sale', 'data']",1
218652,nifty_661,2013-05-13,PMMI and ISPE Partner To Launch Pharma EXPO,Rise,0.0103,43,pmmi and ispe partner launch pharma expo,40,7,0,pharmacy,"['pm', '##mi', 'and', 'is', '##pe', 'partner', 'launch', 'p', '##har', '##ma', 'ex', '##po']",1
218678,nifty_661,2013-05-13,Research and Markets: Bristol-Myers Squibb Partnering 2005-2013,Rise,0.0103,63,research and market bristol myers squibb partnering,51,7,0,pharmacy,"['research', 'and', 'market', 'br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'partner', '##ing']",1
218712,nifty_661,2013-05-13,Research and Markets: Indian In Vitro Diagnostics Market Opportunity Analysis 2018,Rise,0.0103,82,research and market indian vitro diagnostics market opportunity analysis,72,9,0,pharmacy,"['research', 'and', 'market', 'in', '##dian', 'v', '##it', '##ro', 'diagnostic', '##s', 'market', 'opportunity', 'analysis']",1
218775,nifty_661,2013-05-13,Leveraged Finance Community Unites to Support Melanoma Research Alliance,Rise,0.0103,72,leveraged finance community unites support melanoma research alliance,69,8,0,pharmacy,"['leverage', '##d', 'finance', 'community', 'unite', '##s', 'support', 'me', '##lan', '##oma', 'research', 'alliance']",1
218803,nifty_661,2013-05-13,"Ipreo Debtdomain Supports ""Leveraged Finance Fights Melanoma""",Rise,0.0103,61,ipreo debtdomain support leveraged finance fight melanoma,57,7,0,pharmacy,"['i', '##p', '##re', '##o', 'debt', '##dom', '##ain', 'support', 'leverage', '##d', 'finance', 'fight', 'me', '##lan', '##oma']",1
218817,nifty_661,2013-05-13,Research and Markets: Bipolar Disorder Partnering 2007-2013 Contains Over 20 Links to Online Copies of Actual Bipolar Disorder Deals and Contract Documents,Rise,0.0103,155,research and market bipolar disorder partnering contains over link online copy actual bipolar disorder deal and contract document,129,18,0,pharmacy,"['research', 'and', 'market', 'bi', '##pol', '##ar', 'disorder', 'partner', '##ing', 'contains', 'over', 'link', 'online', 'copy', 'actual', 'bi', '##pol', '##ar', 'disorder', 'deal', 'and', 'contract', 'document']",1
218852,nifty_661,2013-05-13,"ChemoCentryx Announces Financial Results for the Quarter Ended March 31, 2013",Rise,0.0103,77,chemocentryx announces financial result for the quarter ended march,67,9,0,pharmacy,"['ch', '##em', '##oc', '##entry', '##x', 'announces', 'financial', 'result', 'for', 'the', 'quarter', 'ended', 'march']",1
218856,nifty_661,2013-05-13,"The Ensign Group to Present at the Bank of America Merrill Lynch 2013 Healthcare Conference on May 16, 2013",Rise,0.0103,107,the ensign group present the bank america merrill lynch healthcare conference may,81,12,0,pharmacy,"['the', 'en', '##sign', 'group', 'present', 'the', 'bank', 'am', '##eric', '##a', 'me', '##rri', '##ll', 'l', '##ync', '##h', 'healthcare', 'conference', 'may']",1
218877,nifty_661,2013-05-13,Research and Markets: Chronic Kidney Disease Partnering 2007-2013 Study Available Now for Analysis,Rise,0.0103,98,research and market chronic kidney disease partnering study available now for analysis,86,12,0,pharmacy,"['research', 'and', 'market', 'chronic', 'kidney', 'disease', 'partner', '##ing', 'study', 'available', 'now', 'for', 'analysis']",1
218989,nifty_661,2013-05-13,Jazz Pharmaceuticals Announces Participation In Upcoming Investor Events,Rise,0.0103,72,jazz pharmaceutical announces participation upcoming investor event,67,7,0,pharmacy,"['jazz', 'pharmaceutical', 'announces', 'participation', 'upcoming', 'investor', 'event']",1
219105,nifty_663,2013-05-15,Bayer Gets FDA Approval for Advanced Prostate Cancer Drug,Neutral,-0.0047,57,bayer get fda approval for advanced prostate cancer drug,56,9,0,pharmacy,"['bay', '##er', 'get', 'f', '##da', 'approval', 'for', 'advanced', 'pro', '##state', 'cancer', 'drug']",1
219143,nifty_663,2013-05-15,Cancer Drugs' New Weapon,Neutral,-0.0047,24,cancer drug new weapon,22,4,0,pharmacy,"['cancer', 'drug', 'new', 'weapon']",1
219176,nifty_664,2013-05-16,Drug Firms Stalk Actavis,Rise,0.0097,24,drug firm stalk actavis,23,4,0,pharmacy,"['drug', 'firm', 'stalk', 'act', '##avi', '##s']",1
219307,nifty_665,2013-05-20,Research and Markets: Menopause Partnering 2007-2013,Neutral,0.0014,52,research and market menopause partnering,40,5,0,pharmacy,"['research', 'and', 'market', 'men', '##op', '##aus', '##e', 'partner', '##ing']",1
219318,nifty_665,2013-05-20,"Research and Markets: Diagnostic Substances (Global) - Analysis Of The Top 60 Companies Including Roche Diagnostics, Berlin-Chemie/Menarini Pharma And Abbott Arzneimittel",Neutral,0.0014,170,research and market diagnostic substance global analysis the top company including roche diagnostics berlin chemie menarini pharma and abbott arzneimittel,154,20,0,pharmacy,"['research', 'and', 'market', 'diagnostic', 'substance', 'global', 'analysis', 'the', 'top', 'company', 'including', 'r', '##och', '##e', 'diagnostic', '##s', 'be', '##rlin', 'ch', '##em', '##ie', 'men', '##ari', '##ni', 'p', '##har', '##ma', 'and', 'abbot', '##t', 'a', '##rz', '##ne', '##im', '##itte', '##l']",1
219336,nifty_665,2013-05-20,RXi Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference,Neutral,0.0014,81,rxi pharmaceutical present the jefferies global healthcare conference,69,8,0,pharmacy,"['r', '##xi', 'pharmaceutical', 'present', 'the', 'j', '##ef', '##fer', '##ies', 'global', 'healthcare', 'conference']",1
219421,nifty_665,2013-05-20,Research and Markets: US Healthcare IT Market Outlook to 2017,Neutral,0.0014,61,research and market healthcare market outlook,45,6,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'market', 'outlook']",1
219422,nifty_665,2013-05-20,Research and Markets: South Korea Pharmaceutical Market Outlook 2013,Neutral,0.0014,68,research and market south korea pharmaceutical market outlook,61,8,0,pharmacy,"['research', 'and', 'market', 'south', 'k', '##ore', '##a', 'pharmaceutical', 'market', 'outlook']",1
219428,nifty_665,2013-05-20,Research and Markets: Immunoglobulins Market to 2019 Report,Neutral,0.0014,59,research and market immunoglobulin market report,48,6,0,pharmacy,"['research', 'and', 'market', 'im', '##mu', '##no', '##g', '##lo', '##bul', '##in', 'market', 'report']",1
219436,nifty_665,2013-05-20,Introducing MQ Doctor: the Best Prescription for Customers to Learn about Nastel's WebSphere MQ Management Products,Neutral,0.0014,115,introducing doctor the best prescription for customer learn about nastel websphere management product,101,13,0,pharmacy,"['introducing', 'doctor', 'the', 'best', 'prescription', 'for', 'customer', 'learn', 'about', 'na', '##ste', '##l', 'web', '##sp', '##here', 'management', 'product']",1
219465,nifty_665,2013-05-20,Research and Markets: Critical Care Market to 2019 Report,Neutral,0.0014,57,research and market critical care market report,47,7,0,pharmacy,"['research', 'and', 'market', 'critical', 'care', 'market', 'report']",1
219482,nifty_665,2013-05-20,Research and Markets: Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market,Neutral,0.0014,105,research and market changing regulatory and reimbursement scenario for medical device the market,96,13,0,pharmacy,"['research', 'and', 'market', 'changing', 'regulatory', 'and', 're', '##im', '##bur', '##se', '##ment', 'scenario', 'for', 'medical', 'device', 'the', 'market']",1
219486,nifty_665,2013-05-20,Research and Markets: Genetic Testing Market Outlook to 2017,Neutral,0.0014,60,research and market genetic testing market outlook,50,7,0,pharmacy,"['research', 'and', 'market', 'genetic', 'testing', 'market', 'outlook']",1
219654,nifty_665,2013-05-20,"CEOs of Leading Education Technology, Mobile, Health IT Companies to Headline Game Changers at Capital Connection 2013",Neutral,0.0014,118,ceo leading education technology mobile health company headline game changer capital connection,95,12,0,pharmacy,"['c', '##eo', 'leading', 'education', 'technology', 'mobile', 'health', 'company', 'headline', 'game', 'change', '##r', 'capital', 'connection']",1
219677,nifty_665,2013-05-20,"Research and Markets: Personalized Medicine - A Strategic Analysis of Industry Trends, Technologies, Participants and Environment - 2013",Neutral,0.0014,136,research and market personalized medicine strategic analysis industry trend technology participant and environment,114,13,0,pharmacy,"['research', 'and', 'market', 'personal', '##ized', 'medicine', 'strategic', 'analysis', 'industry', 'trend', 'technology', 'participant', 'and', 'environment']",1
219711,nifty_665,2013-05-20,GentivaÂ® Health Services To Present at Upcoming Investor Conferences,Neutral,0.0014,69,gentivaâ health service present upcoming investor conference,60,7,0,pharmacy,"['g', '##ent', '##iva', '##â', 'health', 'service', 'present', 'upcoming', 'investor', 'conference']",1
219759,nifty_665,2013-05-20,Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference,Neutral,0.0014,92,valeant pharmaceutical present annual goldman sachs global healthcare conference,80,9,0,pharmacy,"['v', '##ale', '##ant', 'pharmaceutical', 'present', 'annual', 'gold', '##man', 'sa', '##chs', 'global', 'healthcare', 'conference']",1
219770,nifty_665,2013-05-20,Research and Markets: GlaxoSmithKline Partnering 2005-2013 is Essential Reading for Dealmakers in the Field,Neutral,0.0014,107,research and market glaxosmithkline partnering essential reading for dealmakers the field,89,11,0,pharmacy,"['research', 'and', 'market', 'g', '##lax', '##os', '##mith', '##k', '##line', 'partner', '##ing', 'essential', 'reading', 'for', 'deal', '##makers', 'the', 'field']",1
219776,nifty_665,2013-05-20,Research and Markets: Genzyme Partnering 2005-2013 Available Now for Review,Neutral,0.0014,75,research and market genzyme partnering available now for review,63,9,0,pharmacy,"['research', 'and', 'market', 'g', '##en', '##zy', '##me', 'partner', '##ing', 'available', 'now', 'for', 'review']",1
219814,nifty_665,2013-05-20,Attention digital health startups: VCs say now is a âgreatâ time to raise money,Neutral,0.0014,83,attention digital health startup vcs say now greatâ time raise money,68,11,0,pharmacy,"['attention', 'digital', 'health', 'start', '##up', 'v', '##cs', 'say', 'now', 'great', '##â', 'time', 'raise', 'money']",1
219881,nifty_665,2013-05-20,FDA Staff: Merck Sleep Drug Effective but Some Dosage Concerns,Neutral,0.0014,62,fda staff merck sleep drug effective but some dosage concern,60,10,0,pharmacy,"['f', '##da', 'staff', 'me', '##rc', '##k', 'sleep', 'drug', 'effective', 'but', 'some', 'dos', '##age', 'concern']",1
219984,nifty_667,2013-05-22,FDA Panel Backs Merck Insomnia Drug,Neutral,-0.0029,35,fda panel back merck insomnia drug,34,6,0,pharmacy,"['f', '##da', 'panel', 'back', 'me', '##rc', '##k', 'ins', '##om', '##nia', 'drug']",1
220101,nifty_669,2013-05-28,AstraZeneca Broadens Heart-Drug Portfolio,Fall,-0.0065,41,astrazeneca broadens heart drug portfolio,41,5,0,pharmacy,"['as', '##tra', '##zen', '##eca', 'broad', '##ens', 'heart', 'drug', 'portfolio']",1
220116,nifty_669,2013-05-28,Astra Broadens Heart-Drug Portfolio,Fall,-0.0065,35,astra broadens heart drug portfolio,35,5,0,pharmacy,"['as', '##tra', 'broad', '##ens', 'heart', 'drug', 'portfolio']",1
220179,nifty_671,2013-05-30,Dispute Flares Inside FDA Over Safety of Blood-Pressure Drugs,Fall,-0.0144,61,dispute flare inside fda over safety blood pressure drug,56,9,0,pharmacy,"['dispute', 'flare', 'inside', 'f', '##da', 'over', 'safety', 'blood', 'pressure', 'drug']",1
220252,nifty_672,2013-06-03,FDA Reconsiders Curbs on Avandia,Neutral,-0.0048,32,fda reconsiders curb avandia,28,4,0,pharmacy,"['f', '##da', 're', '##con', '##side', '##rs', 'curb', 'a', '##van', '##dia']",1
220260,nifty_672,2013-06-03,What Makes a Breakthrough Cancer Drug?,Neutral,-0.0048,38,what make breakthrough cancer drug,34,5,0,pharmacy,"['what', 'make', 'breakthrough', 'cancer', 'drug']",1
220402,nifty_675,2013-06-06,Avandia Scores FDA Victory,Rise,0.0127,26,avandia score fda victory,25,4,0,pharmacy,"['a', '##van', '##dia', 'score', 'f', '##da', 'victory']",1
220496,nifty_677,2013-06-11,Amgen Drug Faces Challenge,Fall,-0.0083,26,amgen drug face challenge,25,4,0,pharmacy,"['am', '##gen', 'drug', 'face', 'challenge']",1
220740,nifty_680,2013-06-17,Research and Markets: Global Dyslipidemia Pipeline Capsule - 2013,Rise,0.0079,65,research and market global dyslipidemia pipeline capsule,56,7,0,pharmacy,"['research', 'and', 'market', 'global', 'd', '##ys', '##lip', '##ide', '##mia', 'pipeline', 'capsule']",1
220751,nifty_680,2013-06-17,Research and Markets: Global Epilepsy Pipeline Capsule - 2013,Rise,0.0079,61,research and market global epilepsy pipeline capsule,52,7,0,pharmacy,"['research', 'and', 'market', 'global', 'e', '##pile', '##psy', 'pipeline', 'capsule']",1
220775,nifty_680,2013-06-17,Intercept Pharmaceuticals Announces Proposed Public Offering of Common Stock,Rise,0.0079,76,intercept pharmaceutical announces proposed public offering common stock,72,8,0,pharmacy,"['intercept', 'pharmaceutical', 'announces', 'proposed', 'public', 'offering', 'common', 'stock']",1
220835,nifty_680,2013-06-17,Research and Markets: Healthcare/Medical Simulation Market Report - Trends & Global Forecasts To 2017,Rise,0.0079,101,research and market healthcare medical simulation market report trend global forecast,85,11,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'medical', 'simulation', 'market', 'report', 'trend', 'global', 'forecast']",1
220843,nifty_680,2013-06-17,"Research and Markets: The Clinical Overview And Clinical Summary (Conference, London)",Rise,0.0079,85,research and market the clinical overview and clinical summary conference london,80,11,0,pharmacy,"['research', 'and', 'market', 'the', 'clinical', 'overview', 'and', 'clinical', 'summary', 'conference', 'lo', '##ndon']",1
220851,nifty_680,2013-06-17,"Sustainable Solutions, New Licensing Contracts, Acquisitions, and Improved Segment Performances - Research Report on PPG, Sigma-Aldrich, Huntsman, Valspar, and Chemtura",Rise,0.0079,168,sustainable solution new licensing contract acquisition and improved segment performance research report ppg sigma aldrich huntsman valspar and chemtura,152,19,0,pharmacy,"['sustainable', 'solution', 'new', 'licensing', 'contract', 'acquisition', 'and', 'improved', 'segment', 'performance', 'research', 'report', 'pp', '##g', 'si', '##gma', 'al', '##dric', '##h', 'hunt', '##sman', 'v', '##als', '##par', 'and', 'ch', '##em', '##tura']",1
220873,nifty_680,2013-06-17,"Research and Markets: Advanced Pharmacovigilance (Course, London)",Rise,0.0079,65,research and market advanced pharmacovigilance course london,60,7,0,pharmacy,"['research', 'and', 'market', 'advanced', 'p', '##har', '##ma', '##co', '##vi', '##gi', '##lance', 'course', 'lo', '##ndon']",1
220880,nifty_680,2013-06-17,"Research and Markets: Medical Device Clinical Studies (Course, London)",Rise,0.0079,70,research and market medical device clinical study course london,63,9,0,pharmacy,"['research', 'and', 'market', 'medical', 'device', 'clinical', 'study', 'course', 'lo', '##ndon']",1
220885,nifty_680,2013-06-17,Research and Markets: Complete 2012-13 Induced Pluripotent Stem Cell Industry Report (Updated),Rise,0.0079,94,research and market complete induced pluripotent stem cell industry report updated,82,11,0,pharmacy,"['research', 'and', 'market', 'complete', 'induced', 'p', '##lu', '##rip', '##ote', '##nt', 'stem', 'cell', 'industry', 'report', 'updated']",1
220887,nifty_680,2013-06-17,"Research and Markets: Vitiligo - Pipeline Review, H1 2013",Rise,0.0079,57,research and market vitiligo pipeline review,44,6,0,pharmacy,"['research', 'and', 'market', 'v', '##iti', '##li', '##go', 'pipeline', 'review']",1
220892,nifty_680,2013-06-17,Research and Markets: Global Insulin Delivery Devices Market Forecast to 2017,Rise,0.0079,77,research and market global insulin delivery device market forecast,66,9,0,pharmacy,"['research', 'and', 'market', 'global', 'insulin', 'delivery', 'device', 'market', 'forecast']",1
220947,nifty_680,2013-06-17,Emergent BioSolutions EVP Corporate Affairs Allen Shofe Appointed to MdBio Foundation Board of Directors,Rise,0.0079,104,emergent biosolutions evp corporate affair allen shofe appointed mdbio foundation board director,96,12,0,pharmacy,"['emerge', '##nt', 'bio', '##sol', '##ution', '##s', 'e', '##v', '##p', 'corporate', 'affair', 'all', '##en', 's', '##hof', '##e', 'appointed', 'm', '##d', '##bio', 'foundation', 'board', 'director']",1
220973,nifty_680,2013-06-17,"Alliance Life Sciences Empowers Life Sciences Industry to Enhance Accrual Calculations, and as a Result, Expand Market Share and Drive Revenue",Rise,0.0079,142,alliance life science empowers life science industry enhance accrual calculation and result expand market share and drive revenue,129,18,0,pharmacy,"['alliance', 'life', 'science', 'em', '##power', '##s', 'life', 'science', 'industry', 'enhance', 'a', '##cc', '##ru', '##al', 'calculation', 'and', 'result', 'expand', 'market', 'share', 'and', 'drive', 'revenue']",1
221136,nifty_680,2013-06-17,"Research and Markets: Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Review Report, H1 2013 Edition",Rise,0.0079,113,research and market pituitary acth hypersecretion cushing disease pipeline review report edition,96,12,0,pharmacy,"['research', 'and', 'market', 'pit', '##uit', '##ary', 'act', '##h', 'h', '##yper', '##se', '##cre', '##tion', 'cu', '##shing', 'disease', 'pipeline', 'review', 'report', 'edition']",1
221172,nifty_680,2013-06-17,UPDATE 1-Niche drugmaker ViroPharma attracts takeover interest -sources,Rise,0.0079,71,update niche drugmaker viropharma attracts takeover interest source,67,8,0,pharmacy,"['update', 'niche', 'drug', '##maker', 'v', '##iro', '##pha', '##rma', 'attracts', 'takeover', 'interest', 'source']",1
221229,nifty_680,2013-06-17,Research and Markets: GE Healthcare Market Share Analysis - 2013 Provides GE Healthcare Market Share Information in Twenty Three Key Market Categories,Rise,0.0079,150,research and market healthcare market share analysis provides healthcare market share information twenty three key market category,130,17,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'market', 'share', 'analysis', 'provides', 'healthcare', 'market', 'share', 'information', 'twenty', 'three', 'key', 'market', 'category']",1
221230,nifty_680,2013-06-17,"Research and Markets: St. Jude Medical, Inc. 2013 Market Share Analysis Gives Comprehensive Coverage of the Latest Financial Deals Involving the Company and its Subsidiaries",Rise,0.0079,173,research and market jude medical inc market share analysis give comprehensive coverage the latest financial deal involving the company and it subsidiary,152,22,0,pharmacy,"['research', 'and', 'market', 'j', '##ude', 'medical', 'in', '##c', 'market', 'share', 'analysis', 'give', 'comprehensive', 'coverage', 'the', 'latest', 'financial', 'deal', 'involving', 'the', 'company', 'and', 'it', 'subsidiary']",1
221244,nifty_680,2013-06-17,"Research and Markets: Bio-Rad Laboratories, Inc. Market Share Analysis - 2013 Out Now",Rise,0.0079,85,research and market bio rad laboratory inc market share analysis out now,72,12,0,pharmacy,"['research', 'and', 'market', 'bio', 'r', '##ad', 'laboratory', 'in', '##c', 'market', 'share', 'analysis', 'out', 'now']",1
221267,nifty_680,2013-06-17,GenMark Diagnostics Updates Annual Revenue Guidance,Rise,0.0079,51,genmark diagnostics update annual revenue guidance,50,6,0,pharmacy,"['g', '##en', '##mark', 'diagnostic', '##s', 'update', 'annual', 'revenue', 'guidance']",1
221403,nifty_680,2013-06-17,J&J Buys Drug Developer Aragon,Rise,0.0079,30,buy drug developer aragon,25,4,0,pharmacy,"['buy', 'drug', 'developer', 'a', '##rag', '##on']",1
221417,nifty_681,2013-06-18,"At Biogen, It's Crunch Time for CEO",Fall,-0.0138,35,biogen crunch time for ceo,26,5,0,pharmacy,"['bio', '##gen', 'c', '##runch', 'time', 'for', 'c', '##eo']",1
221424,nifty_681,2013-06-18,Lilly's Zyprexa Under Scrutiny,Fall,-0.0138,30,lilly zyprexa under scrutiny,28,4,0,pharmacy,"['l', '##ill', '##y', 'z', '##y', '##p', '##re', '##xa', 'under', 'scrutiny']",1
221506,nifty_682,2013-06-19,EU Fines Drug Firm Lundbeck,Fall,-0.0248,27,fine drug firm lundbeck,23,4,0,pharmacy,"['fine', 'drug', 'firm', 'l', '##und', '##beck']",1
221697,nifty_684,2013-06-24,"Research and Markets: Cardiac Fibrosis - Pipeline Review, H1 2013",Rise,0.0096,65,research and market cardiac fibrosis pipeline review,52,7,0,pharmacy,"['research', 'and', 'market', 'cardiac', 'fi', '##bro', '##sis', 'pipeline', 'review']",1
221709,nifty_684,2013-06-24,Research and Markets: Regenerative Medicine Markets - 2013 Report,Rise,0.0096,65,research and market regenerative medicine market report,55,7,0,pharmacy,"['research', 'and', 'market', 're', '##gene', '##rative', 'medicine', 'market', 'report']",1
221717,nifty_684,2013-06-24,"Research and Markets: Disruptive Behavior Disorder - Pipeline Review, H1 2013",Rise,0.0096,77,research and market disruptive behavior disorder pipeline review,64,8,0,pharmacy,"['research', 'and', 'market', 'disrupt', '##ive', 'behavior', 'disorder', 'pipeline', 'review']",1
221793,nifty_684,2013-06-24,"AMAG Pharmaceuticals Appoints Steven Caffe, M.D. as Chief Development and Regulatory Officer",Rise,0.0096,92,amag pharmaceutical appoints steven caffe chief development and regulatory officer,82,10,0,pharmacy,"['am', '##ag', 'pharmaceutical', 'appoint', '##s', 's', '##te', '##ven', 'ca', '##ffe', 'chief', 'development', 'and', 'regulatory', 'officer']",1
221818,nifty_684,2013-06-24,IT-as-a-Service Models to Net $11 Billion in Health IT Savings Over Next Three Years,Rise,0.0096,84,service model net billion health saving over next three year,60,10,0,pharmacy,"['service', 'model', 'net', 'billion', 'health', 'saving', 'over', 'next', 'three', 'year']",1
221880,nifty_684,2013-06-24,EU's drug data stance threatens investment -Sanofi CEO,Rise,0.0096,54,drug data stance threatens investment sanofi ceo,48,7,0,pharmacy,"['drug', 'data', 'stance', 'threatens', 'investment', 'sa', '##no', '##fi', 'c', '##eo']",1
221885,nifty_684,2013-06-24,"Return to Growth for Pharmaceutical Sector: Surge in Drug Approvals, R&D; Productivity and Investor Confidence to Drive Expansion Through 2018",Rise,0.0096,142,return growth for pharmaceutical sector surge drug approval productivity and investor confidence drive expansion through,120,15,0,pharmacy,"['return', 'growth', 'for', 'pharmaceutical', 'sector', 'surge', 'drug', 'approval', 'productivity', 'and', 'investor', 'confidence', 'drive', 'expansion', 'through']",1
221945,nifty_684,2013-06-24,UPDATE 1-EU's drug data stance threatens investment -Sanofi CEO,Rise,0.0096,63,update drug data stance threatens investment sanofi ceo,55,8,0,pharmacy,"['update', 'drug', 'data', 'stance', 'threatens', 'investment', 'sa', '##no', '##fi', 'c', '##eo']",1
221948,nifty_684,2013-06-24,"Carnegie Mellon University, Highmark and Allegheny Health Network Announce Creation of New Dynamic Disruptive Health Technology Institute",Rise,0.0096,137,carnegie mellon university highmark and allegheny health network announce creation new dynamic disruptive health technology institute,133,16,0,pharmacy,"['car', '##ne', '##gie', 'me', '##llon', 'university', 'high', '##mark', 'and', 'all', '##eg', '##hen', '##y', 'health', 'network', 'announce', 'creation', 'new', 'dynamic', 'disrupt', '##ive', 'health', 'technology', 'institute']",1
221957,nifty_684,2013-06-24,EU's drug data stance threatens investment: Sanofi CEO,Rise,0.0096,54,drug data stance threatens investment sanofi ceo,48,7,0,pharmacy,"['drug', 'data', 'stance', 'threatens', 'investment', 'sa', '##no', '##fi', 'c', '##eo']",1
221965,nifty_684,2013-06-24,Premier healthcare alliance Names New Informatics & Technology Services COO,Rise,0.0096,75,premier healthcare alliance name new informatics technology service coo,71,9,0,pharmacy,"['premier', 'healthcare', 'alliance', 'name', 'new', 'inform', '##atic', '##s', 'technology', 'service', 'co', '##o']",1
221988,nifty_684,2013-06-24,Research and Markets: Point of Care Diagnostic Testing: World Markets Report 2013,Rise,0.0096,81,research and market point care diagnostic testing world market report,69,10,0,pharmacy,"['research', 'and', 'market', 'point', 'care', 'diagnostic', 'testing', 'world', 'market', 'report']",1
221998,nifty_684,2013-06-24,Research and Markets: India Pharmaceutical Industry Research and Forecast to 2016: Patented Drugs Account for 9.60% of the Total Demand Which is Expected to Reach 13.30% by 2014,Rise,0.0096,177,research and market india pharmaceutical industry research and forecast patented drug account for the total demand which expected reach,135,19,0,pharmacy,"['research', 'and', 'market', 'in', '##dia', 'pharmaceutical', 'industry', 'research', 'and', 'forecast', 'patented', 'drug', 'account', 'for', 'the', 'total', 'demand', 'which', 'expected', 'reach']",1
222009,nifty_684,2013-06-24,"MNX Adds New Board Member, Seeking to Accelerate Growth in Pharmaceutical and Clinical Trial Logistics",Rise,0.0096,102,mnx add new board member seeking accelerate growth pharmaceutical and clinical trial logistics,94,13,0,pharmacy,"['m', '##nx', 'add', 'new', 'board', 'member', 'seeking', 'accelerate', 'growth', 'pharmaceutical', 'and', 'clinical', 'trial', 'logistics']",1
222059,nifty_684,2013-06-24,"Research and Markets: Cardiovascular Risk Factors - Pipeline Review, H1 2013",Rise,0.0096,76,research and market cardiovascular risk factor pipeline review,62,8,0,pharmacy,"['research', 'and', 'market', 'card', '##iovascular', 'risk', 'factor', 'pipeline', 'review']",1
222113,nifty_684,2013-06-24,"Research and Markets: Global Dye Sensitized Solar Cells (DSSC/DSC) Report : Technologies, Markets, Players - 2013-2023",Rise,0.0096,118,research and market global dye sensitized solar cell dssc dsc report technology market player,93,14,0,pharmacy,"['research', 'and', 'market', 'global', 'dye', 'se', '##ns', '##iti', '##zed', 'solar', 'cell', 'd', '##ss', '##c', 'd', '##s', '##c', 'report', 'technology', 'market', 'player']",1
222417,nifty_685,2013-06-25,OMERS to Buy CML Healthcare,Rise,0.0099,27,omers buy cml healthcare,24,4,0,pharmacy,"['o', '##mers', 'buy', 'cm', '##l', 'healthcare']",1
222763,nifty_690,2013-07-08,Media Alert: Leading Local Biotech Firms to Host Aspiring Young Scientists Next Week,Rise,0.0072,84,medium alert leading local biotech firm host aspiring young scientist next week,79,12,0,pharmacy,"['medium', 'alert', 'leading', 'local', 'bio', '##tech', 'firm', 'host', 'aspiring', 'young', 'scientist', 'next', 'week']",1
222828,nifty_690,2013-07-08,"Research and Markets: Radiation Detection, Monitoring & Safety Market for Nuclear Power Plants, Homeland Security & Defense, Manufacturing Industry - Trends & Global Forecasts to 2017",Rise,0.0072,183,research and market radiation detection monitoring safety market for nuclear power plant homeland security defense manufacturing industry trend global forecast,159,20,0,pharmacy,"['research', 'and', 'market', 'radiation', 'detection', 'monitoring', 'safety', 'market', 'for', 'nuclear', 'power', 'plant', 'homeland', 'security', 'defense', 'manufacturing', 'industry', 'trend', 'global', 'forecast']",1
222850,nifty_690,2013-07-08,Research and Markets: PharmaPoint: Chronic Heart Failure - Global Drug Forecast and Market Analysis to 2022,Rise,0.0072,107,research and market pharmapoint chronic heart failure global drug forecast and market analysis,94,13,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##point', 'chronic', 'heart', 'failure', 'global', 'drug', 'forecast', 'and', 'market', 'analysis']",1
222871,nifty_690,2013-07-08,BioNano Genomics and New York Genome Center Enter Into a Strategic Collaboration,Rise,0.0072,80,bionano genomics and new york genome center enter into strategic collaboration,78,11,0,pharmacy,"['bio', '##nan', '##o', 'g', '##eno', '##mic', '##s', 'and', 'new', 'yo', '##rk', 'genome', 'center', 'enter', 'into', 'strategic', 'collaboration']",1
223054,nifty_690,2013-07-08,Research and Markets: Global Protein Therapeutics Market 2012-2016,Rise,0.0072,66,research and market global protein therapeutic market,53,7,0,pharmacy,"['research', 'and', 'market', 'global', 'protein', 'therapeutic', 'market']",1
223114,nifty_690,2013-07-08,"Research and Markets: Analysis of Global Biochips Industry, 2012-2018",Rise,0.0072,69,research and market analysis global biochip industry,52,7,0,pharmacy,"['research', 'and', 'market', 'analysis', 'global', 'bio', '##chi', '##p', 'industry']",1
223177,nifty_690,2013-07-08,Research and Markets: Markets for Radiation Detection Equipment Report 2013-2020,Rise,0.0072,80,research and market market for radiation detection equipment report,67,9,0,pharmacy,"['research', 'and', 'market', 'market', 'for', 'radiation', 'detection', 'equipment', 'report']",1
223181,nifty_690,2013-07-08,Research and Markets: European Injectable Drug Delivery Report 2013: Market Forecasts to 2017,Rise,0.0072,93,research and market european injectable drug delivery report market forecast,76,10,0,pharmacy,"['research', 'and', 'market', 'euro', '##pe', '##an', 'in', '##ject', '##able', 'drug', 'delivery', 'report', 'market', 'forecast']",1
223311,nifty_690,2013-07-08,Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences,Rise,0.0072,69,vanda pharmaceutical participate upcoming investor conference,61,6,0,pharmacy,"['van', '##da', 'pharmaceutical', 'participate', 'upcoming', 'investor', 'conference']",1
223489,nifty_691,2013-07-09,Research and Markets: Digital Doctors: Marketing to Online Networks (2nd Edition),Neutral,0.0004,81,research and market digital doctor marketing online network edition,67,9,0,pharmacy,"['research', 'and', 'market', 'digital', 'doctor', 'marketing', 'online', 'network', 'edition']",1
223503,nifty_691,2013-07-09,Research and Markets: Biosimilars in Emerging Markets,Neutral,0.0004,53,research and market biosimilars emerging market,47,6,0,pharmacy,"['research', 'and', 'market', 'bio', '##si', '##mi', '##lars', 'emerging', 'market']",1
223512,nifty_691,2013-07-09,"Research and Markets: Pharma sales force shape, size and structure: where next?",Neutral,0.0004,79,research and market pharma sale force shape size and structure where next,73,12,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', 'sale', 'force', 'shape', 'size', 'and', 'structure', 'where', 'next']",1
223613,nifty_691,2013-07-09,Research and Markets: Pharma and the mHealth Revolution - Engaging with mobile-enabled physicians and HCPs,Neutral,0.0004,106,research and market pharma and the mhealth revolution engaging with mobile enabled physician and hcps,101,15,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', 'and', 'the', 'm', '##hea', '##lt', '##h', 'revolution', 'engaging', 'with', 'mobile', 'enabled', 'physician', 'and', 'h', '##c', '##ps']",1
223752,nifty_691,2013-07-09,$7.8 Billion Molecular Diagnostics Market Positioned for Significant Growth,Neutral,0.0004,75,billion molecular diagnostics market positioned for significant growth,70,8,0,pharmacy,"['billion', 'molecular', 'diagnostic', '##s', 'market', 'positioned', 'for', 'significant', 'growth']",1
223861,nifty_691,2013-07-09,"Technical Scrutiny: Bristol-Myers Squibb, Eli Lilly & Co., Allergan, and Endo Pharma",Neutral,0.0004,84,technical scrutiny bristol myers squibb eli lilly allergan and endo pharma,74,11,0,pharmacy,"['technical', 'scrutiny', 'br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'el', '##i', 'l', '##ill', '##y', 'all', '##er', '##gan', 'and', 'end', '##o', 'p', '##har', '##ma']",1
223938,nifty_691,2013-07-09,Research and Markets: China Medical Display Industry Report 2013,Neutral,0.0004,64,research and market china medical display industry report,57,8,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'medical', 'display', 'industry', 'report']",1
224000,nifty_691,2013-07-09,"Research and Markets: CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany",Neutral,0.0004,96,research and market countryfocus healthcare regulatory and reimbursement landscape germany,90,10,0,pharmacy,"['research', 'and', 'market', 'country', '##fo', '##cus', 'healthcare', 'regulatory', 'and', 're', '##im', '##bur', '##se', '##ment', 'landscape', 'g', '##erman', '##y']",1
224013,nifty_691,2013-07-09,"Research and Markets: Switzerland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018",Neutral,0.0004,112,research and market switzerland diabetes care device investment opportunity analysis and forecast,97,12,0,pharmacy,"['research', 'and', 'market', 's', '##witz', '##erland', 'diabetes', 'care', 'device', 'investment', 'opportunity', 'analysis', 'and', 'forecast']",1
224019,nifty_691,2013-07-09,"Research and Markets: Global Biomarkers Report - Technologies, Markets and Companies 2013-2022",Neutral,0.0004,94,research and market global biomarkers report technology market and company,74,10,0,pharmacy,"['research', 'and', 'market', 'global', 'bio', '##mark', '##ers', 'report', 'technology', 'market', 'and', 'company']",1
224161,nifty_691,2013-07-09,Crippling cost of pharmaceuticals in the USA at global highs and still rising,Neutral,0.0004,77,crippling cost pharmaceutical the usa global high and still rising,66,10,0,pharmacy,"['c', '##rip', '##pling', 'cost', 'pharmaceutical', 'the', 'us', '##a', 'global', 'high', 'and', 'still', 'rising']",1
224187,nifty_691,2013-07-09,Mix-Up in Clinical Study Delayed Drug's Approval,Neutral,0.0004,48,mix clinical study delayed drug approval,40,6,0,pharmacy,"['mix', 'clinical', 'study', 'delayed', 'drug', 'approval']",1
224328,nifty_692,2013-07-10,Research and Markets: 2013 Global Medical Imaging Equipment Market Outlook - Positioning for the Future,Rise,0.0136,103,research and market global medical imaging equipment market outlook positioning for the future,94,13,0,pharmacy,"['research', 'and', 'market', 'global', 'medical', 'imaging', 'equipment', 'market', 'outlook', 'positioning', 'for', 'the', 'future']",1
224334,nifty_692,2013-07-10,Research and Markets: Breast Pumps - Global Strategic Business Report - 2013-2018,Rise,0.0136,81,research and market breast pump global strategic business report,64,9,0,pharmacy,"['research', 'and', 'market', 'breast', 'pump', 'global', 'strategic', 'business', 'report']",1
224354,nifty_692,2013-07-10,"Research and Markets: Global Menotropin Market 2013 Report Featuring Leading Players Ferring Pharmaceuticals, Merck Serono And Others",Rise,0.0136,133,research and market global menotropin market report featuring leading player ferring pharmaceutical merck serono and others,123,16,0,pharmacy,"['research', 'and', 'market', 'global', 'men', '##ot', '##rop', '##in', 'market', 'report', 'featuring', 'leading', 'player', 'f', '##er', '##ring', 'pharmaceutical', 'me', '##rc', '##k', 'se', '##ron', '##o', 'and', 'others']",1
224492,nifty_692,2013-07-10,"Quarterly Results and Earnings Call Schedules, New Product Features, and FDA Approvals - Research Report on Infosys, FEI, Garmin, Cognex, and Cepheid",Rise,0.0136,149,quarterly result and earnings call schedule new product feature and fda approval research report infosys fei garmin cognex and cepheid,134,20,0,pharmacy,"['quarterly', 'result', 'and', 'earnings', 'call', 'schedule', 'new', 'product', 'feature', 'and', 'f', '##da', 'approval', 'research', 'report', 'info', '##sy', '##s', 'f', '##ei', 'g', '##arm', '##in', 'co', '##gne', '##x', 'and', 'c', '##ep', '##he', '##id']",1
224518,nifty_692,2013-07-10,"Positive Data, Financial Strategies, Marketing Authorizations, and Collaborations Promote Growth in Biotech Companies - Research Report on Biogen Idec, MannKind, Aegerion, Ariad, and Seattle Genetics",Rise,0.0136,199,positive data financial strategy marketing authorization and collaboration promote growth biotech company research report biogen idec mannkind aegerion ariad and seattle genetics,178,22,0,pharmacy,"['positive', 'data', 'financial', 'strategy', 'marketing', 'authorization', 'and', 'collaboration', 'promote', 'growth', 'bio', '##tech', 'company', 'research', 'report', 'bio', '##gen', 'id', '##ec', 'man', '##nk', '##ind', 'a', '##ege', '##rion', 'a', '##riad', 'and', 'seat', '##tle', 'genetics']",1
224779,nifty_692,2013-07-10,"Healthcare Companies in the News for July 10 - Pharmacyclics, Celldex Therapeutics, Pfizer, Nu Skin",Rise,0.0136,99,healthcare company the news for july pharmacyclics celldex therapeutic pfizer skin,82,11,0,pharmacy,"['healthcare', 'company', 'the', 'news', 'for', 'j', '##ul', '##y', 'pharmacy', '##c', '##lic', '##s', 'cell', '##de', '##x', 'therapeutic', 'p', '##fi', '##zer', 'skin']",1
225108,nifty_693,2013-07-11,DNA May Close Boston Strangler Case,Neutral,0.0004,35,dna may close boston strangler case,35,6,0,pharmacy,"['d', '##na', 'may', 'close', 'b', '##ost', '##on', 's', '##tra', '##ngle', '##r', 'case']",1
225203,nifty_695,2013-07-16,New Drugs Lift J&J's Quarter,Neutral,0.0026,28,new drug lift quarter,21,4,0,pharmacy,"['new', 'drug', 'lift', 'quarter']",1
225208,nifty_695,2013-07-16,FDA Cancels Meeting on Merck's Sugammadex,Neutral,0.0026,41,fda cancel meeting merck sugammadex,35,5,0,pharmacy,"['f', '##da', 'cancel', 'meeting', 'me', '##rc', '##k', 'su', '##gam', '##made', '##x']",1
225213,nifty_695,2013-07-16,Handling Hot Biotech Stocks With Care,Neutral,0.0026,37,handling hot biotech stock with care,36,6,0,pharmacy,"['handling', 'hot', 'bio', '##tech', 'stock', 'with', 'care']",1
225223,nifty_695,2013-07-16,China Targets Big Pharma,Neutral,0.0026,24,china target big pharma,23,4,0,pharmacy,"['chin', '##a', 'target', 'big', 'p', '##har', '##ma']",1
225337,nifty_696,2013-07-17,"Research and Markets: Ischemic Cerebral Stroke - Pipeline Review, H1 2013",Rise,0.0055,73,research and market ischemic cerebral stroke pipeline review,60,8,0,pharmacy,"['research', 'and', 'market', 'is', '##che', '##mic', 'cerebral', 'stroke', 'pipeline', 'review']",1
225351,nifty_696,2013-07-17,Research and Markets: Gilead Sciences Partnering 2005-2013,Rise,0.0055,58,research and market gilead science partnering,45,6,0,pharmacy,"['research', 'and', 'market', 'g', '##ile', '##ad', 'science', 'partner', '##ing']",1
225356,nifty_696,2013-07-17,"Research and Markets: Mania - Pipeline Review, H1 2013",Rise,0.0055,54,research and market mania pipeline review,41,6,0,pharmacy,"['research', 'and', 'market', 'man', '##ia', 'pipeline', 'review']",1
225365,nifty_696,2013-07-17,Research and Markets: BioCryst Pharmaceuticals Partnering 2005-2013,Rise,0.0055,67,research and market biocryst pharmaceutical partnering,54,6,0,pharmacy,"['research', 'and', 'market', 'bio', '##c', '##ry', '##st', 'pharmaceutical', 'partner', '##ing']",1
225380,nifty_696,2013-07-17,UPDATE 2-China launches crackdown on pharmaceutical sector,Rise,0.0055,58,update china launch crackdown pharmaceutical sector,51,6,0,pharmacy,"['update', 'chin', '##a', 'launch', 'crack', '##down', 'pharmaceutical', 'sector']",1
225384,nifty_696,2013-07-17,China launches crackdown on pharmaceutical sector,Rise,0.0055,49,china launch crackdown pharmaceutical sector,44,5,0,pharmacy,"['chin', '##a', 'launch', 'crack', '##down', 'pharmaceutical', 'sector']",1
225402,nifty_696,2013-07-17,Research and Markets: Pharma and Payers - Building Better Relationships,Rise,0.0055,71,research and market pharma and payer building better relationship,65,9,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', 'and', 'pay', '##er', 'building', 'better', 'relationship']",1
225421,nifty_696,2013-07-17,Research and Markets: Alnylam Pharmaceuticals Partnering 2005-2013,Rise,0.0055,66,research and market alnylam pharmaceutical partnering,53,6,0,pharmacy,"['research', 'and', 'market', 'al', '##ny', '##lam', 'pharmaceutical', 'partner', '##ing']",1
225431,nifty_696,2013-07-17,"Research and Markets: Global Medical Devices Survey 2013-2014 - Market Trends, Marketing Spend and Sales Strategies",Rise,0.0055,115,research and market global medical device survey market trend marketing spend and sale strategy,95,14,0,pharmacy,"['research', 'and', 'market', 'global', 'medical', 'device', 'survey', 'market', 'trend', 'marketing', 'spend', 'and', 'sale', 'strategy']",1
225475,nifty_696,2013-07-17,"FDA Reviews and Approvals, Commercialization, Integrations, and Top-Line Results - Research Report on Bristol-Myers Squibb, Medtronic, Boston Scientific, Varian, and Rockwell Medical",Rise,0.0055,182,fda review and approval commercialization integration and top line result research report bristol myers squibb medtronic boston scientific varian and rockwell medical,166,22,0,pharmacy,"['f', '##da', 'review', 'and', 'approval', 'commercial', '##ization', 'integration', 'and', 'top', 'line', 'result', 'research', 'report', 'br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'me', '##dt', '##ronic', 'b', '##ost', '##on', 'scientific', 'var', '##ian', 'and', 'rock', '##well', 'medical']",1
225504,nifty_696,2013-07-17,ARCA biopharma Provides Business Update,Rise,0.0055,39,arca biopharma provides business update,39,5,0,pharmacy,"['arc', '##a', 'bio', '##pha', '##rma', 'provides', 'business', 'update']",1
225578,nifty_696,2013-07-17,Research and Markets: A U.S. and Worldwide Market Report on the Use of Molecular Diagnostics in Cancer Detection and Therapy: Key Players Covered,Rise,0.0055,145,research and market and worldwide market report the use molecular diagnostics cancer detection and therapy key player covered,125,18,0,pharmacy,"['research', 'and', 'market', 'and', 'worldwide', 'market', 'report', 'the', 'use', 'molecular', 'diagnostic', '##s', 'cancer', 'detection', 'and', 'therapy', 'key', 'player', 'covered']",1
225609,nifty_696,2013-07-17,Research and Markets: The World Market For Personalized Medicine: Key Competitors Covered and Forecasts Provided to 2016,Rise,0.0055,120,research and market the world market for personalized medicine key competitor covered and forecast provided,107,15,0,pharmacy,"['research', 'and', 'market', 'the', 'world', 'market', 'for', 'personal', '##ized', 'medicine', 'key', 'competitor', 'covered', 'and', 'forecast', 'provided']",1
225632,nifty_696,2013-07-17,Matrix-Bioâs CEO to Present at New Mexico Angelsâ July Investors Showcase,Rise,0.0055,77,matrix bioâ ceo present new mexico angelsâ july investor showcase,65,10,0,pharmacy,"['matrix', 'bio', '##â', 'c', '##eo', 'present', 'new', 'me', '##xi', '##co', 'angels', '##â', 'j', '##ul', '##y', 'investor', 'showcase']",1
225657,nifty_696,2013-07-17,Research and Markets: US Epilepsy Market Insights Capsule: 2013-2013 Gives a Detailed Account of Forecasts,Rise,0.0055,106,research and market epilepsy market insight capsule give detailed account forecast,82,11,0,pharmacy,"['research', 'and', 'market', 'e', '##pile', '##psy', 'market', 'insight', 'capsule', 'give', 'detailed', 'account', 'forecast']",1
225676,nifty_696,2013-07-17,Research and Markets: The State of Research and Development in the Biopharmaceutical Industry: Assess the Strategies Being Used to Strengthen R&D; Productivity - A 2013 Report,Rise,0.0055,175,research and market the state research and development the biopharmaceutical industry assess the strategy being used strengthen productivity report,147,19,0,pharmacy,"['research', 'and', 'market', 'the', 'state', 'research', 'and', 'development', 'the', 'bio', '##pha', '##rma', '##ce', '##utical', 'industry', 'assess', 'the', 'strategy', 'being', 'used', 'strengthen', 'productivity', 'report']",1
225687,nifty_696,2013-07-17,Research and Markets: A 2013 Report on Oncology Therapy Development Strategies: Opportunities and Threats in the Market,Rise,0.0055,119,research and market report oncology therapy development strategy opportunity and threat the market,98,13,0,pharmacy,"['research', 'and', 'market', 'report', 'on', '##cology', 'therapy', 'development', 'strategy', 'opportunity', 'and', 'threat', 'the', 'market']",1
225698,nifty_696,2013-07-17,Research and Markets: Medical Devices (Global) Report - Spot the Winners,Rise,0.0055,72,research and market medical device global report spot the winner,64,10,0,pharmacy,"['research', 'and', 'market', 'medical', 'device', 'global', 'report', 'spot', 'the', 'winner']",1
225719,nifty_696,2013-07-17,Research and Markets: US Depression Market Insights Capsule Report - 2013-2018,Rise,0.0055,78,research and market depression market insight capsule report,60,8,0,pharmacy,"['research', 'and', 'market', 'depression', 'market', 'insight', 'capsule', 'report']",1
225738,nifty_696,2013-07-17,Research and Markets: Panic Disorders - Latest Pipeline Review Report,Rise,0.0055,69,research and market panic disorder latest pipeline review report,64,9,0,pharmacy,"['research', 'and', 'market', 'panic', 'disorder', 'latest', 'pipeline', 'review', 'report']",1
225765,nifty_696,2013-07-17,Research and Markets: UK Epilepsy Market Insights Capsule - 2013 Report Includes UK Epilepsy Market Size Estimates for 2012 and Forecasts for Six Years To 2018,Rise,0.0055,159,research and market epilepsy market insight capsule report includes epilepsy market size estimate for and forecast for six year,127,19,0,pharmacy,"['research', 'and', 'market', 'e', '##pile', '##psy', 'market', 'insight', 'capsule', 'report', 'includes', 'e', '##pile', '##psy', 'market', 'size', 'estimate', 'for', 'and', 'forecast', 'for', 'six', 'year']",1
225774,nifty_696,2013-07-17,Research and Markets: US Migraine Market Insights Capsule - 2013 Presents Migraine Market Competitive Landscape and Migraine Drug Forecasts in the US,Rise,0.0055,149,research and market migraine market insight capsule present migraine market competitive landscape and migraine drug forecast the,128,17,0,pharmacy,"['research', 'and', 'market', 'mi', '##gra', '##ine', 'market', 'insight', 'capsule', 'present', 'mi', '##gra', '##ine', 'market', 'competitive', 'landscape', 'and', 'mi', '##gra', '##ine', 'drug', 'forecast', 'the']",1
226058,nifty_696,2013-07-17,Novartis Trims Vasella's Exit Pay,Rise,0.0055,33,novartis trim vasella exit pay,30,5,0,pharmacy,"['no', '##var', '##tis', 'trim', 'vase', '##lla', 'exit', 'pay']",1
226106,nifty_697,2013-07-18,Celgene Discontinues Cancer Drug Study,Neutral,0.0018,38,celgene discontinues cancer drug study,38,5,0,pharmacy,"['c', '##el', '##gene', 'disco', '##ntin', '##ues', 'cancer', 'drug', 'study']",1
226126,nifty_698,2013-07-22,Should Bosses Know Your Genetic-Test Results?,Neutral,-0.0021,45,should boss know your genetic test result,41,7,0,pharmacy,"['should', 'boss', 'know', 'your', 'genetic', 'test', 'result']",1
226382,nifty_701,2013-07-25,"Research and Markets: Leukocyte Disorders (White Blood Cell Disorders) - Pipeline Review, H2 2012",Neutral,0.0011,97,research and market leukocyte disorder white blood cell disorder pipeline review,80,11,0,pharmacy,"['research', 'and', 'market', 'le', '##uk', '##oc', '##yte', 'disorder', 'white', 'blood', 'cell', 'disorder', 'pipeline', 'review']",1
226392,nifty_701,2013-07-25,"Research and Markets: Hungary Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2018",Neutral,0.0011,105,research and market hungary patient monitoring investment opportunity analysis and forecast,91,11,0,pharmacy,"['research', 'and', 'market', 'hung', '##ary', 'patient', 'monitoring', 'investment', 'opportunity', 'analysis', 'and', 'forecast']",1
226401,nifty_701,2013-07-25,"Research and Markets: Turkey Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2018",Neutral,0.0011,104,research and market turkey patient monitoring investment opportunity analysis and forecast,90,11,0,pharmacy,"['research', 'and', 'market', 'turkey', 'patient', 'monitoring', 'investment', 'opportunity', 'analysis', 'and', 'forecast']",1
226437,nifty_701,2013-07-25,Research and Markets: TDT-067 (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022,Neutral,0.0011,98,research and market tdt dermatophytic onychomycosis forecast and market analysis,80,10,0,pharmacy,"['research', 'and', 'market', 't', '##dt', 'der', '##mat', '##op', '##hy', '##tic', 'on', '##ych', '##omy', '##cos', '##is', 'forecast', 'and', 'market', 'analysis']",1
226453,nifty_701,2013-07-25,Research and Markets: PharmaPoint: Psoriasis - UK Drug Forecast and Market Analysis to 2022,Neutral,0.0011,91,research and market pharmapoint psoriasis drug forecast and market analysis,75,10,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##point', 'ps', '##oria', '##sis', 'drug', 'forecast', 'and', 'market', 'analysis']",1
226467,nifty_701,2013-07-25,Stem Cell Therapeutics Provides Corporate Update,Neutral,0.0011,48,stem cell therapeutic provides corporate update,47,6,0,pharmacy,"['stem', 'cell', 'therapeutic', 'provides', 'corporate', 'update']",1
226537,nifty_701,2013-07-25,Bristol-Myers Squibb Reports Second Quarter 2013 Financial Results,Neutral,0.0011,66,bristol myers squibb report second quarter financial result,59,8,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'report', 'second', 'quarter', 'financial', 'result']",1
226605,nifty_701,2013-07-25,Ascendancy Healthcare Announces Multi-Year Clinical Development Collaboration in China with Quintiles,Neutral,0.0011,101,ascendancy healthcare announces multi year clinical development collaboration china with quintiles,98,11,0,pharmacy,"['as', '##cend', '##ancy', 'healthcare', 'announces', 'multi', 'year', 'clinical', 'development', 'collaboration', 'chin', '##a', 'with', 'q', '##uin', '##tile', '##s']",1
226625,nifty_701,2013-07-25,"Research and Markets: MarketWatch Personal Care - 06, 2013",Neutral,0.0011,58,research and market marketwatch personal care,45,6,0,pharmacy,"['research', 'and', 'market', 'market', '##watch', 'personal', 'care']",1
226646,nifty_701,2013-07-25,Biz-Dev Execs From GBS Consults LLCÂ Say Emerging Medtech Companies Can Get Strategicsâ Attention Before They Are âDe-Riskedâ,Neutral,0.0011,131,biz dev exec from gb consults llcâ say emerging medtech company can get strategicsâ attention before they are riskedâ,117,19,0,pharmacy,"['bi', '##z', 'de', '##v', 'ex', '##ec', 'from', 'g', '##b', 'consult', '##s', 'll', '##c', '##â', 'say', 'emerging', 'me', '##dt', '##ech', 'company', 'can', 'get', 'strategic', '##s', '##â', 'attention', 'before', 'they', 'are', 'risked', '##â']",1
226863,nifty_701,2013-07-25,Research and Markets: The Global Metabolomics Market 2013 Report: An In-Depth Analysis and Forecast of the Market Covering the Leading Competitors in Metabolomics,Neutral,0.0011,162,research and market the global metabolomics market report depth analysis and forecast the market covering the leading competitor metabolomics,141,19,0,pharmacy,"['research', 'and', 'market', 'the', 'global', 'meta', '##bol', '##omi', '##cs', 'market', 'report', 'depth', 'analysis', 'and', 'forecast', 'the', 'market', 'covering', 'the', 'leading', 'competitor', 'meta', '##bol', '##omi', '##cs']",1
226897,nifty_701,2013-07-25,Research and Markets: The Injectable Drugs Market Report: An Analysis on the Shifting Landscape for Injectable Drug Delivery and the Market Impact of New and Emerging Injectable Drug Products by Therapeutic Indication,Neutral,0.0011,217,research and market the injectable drug market report analysis the shifting landscape for injectable drug delivery and the market impact new and emerging injectable drug product therapeutic indication,200,28,0,pharmacy,"['research', 'and', 'market', 'the', 'in', '##ject', '##able', 'drug', 'market', 'report', 'analysis', 'the', 'shifting', 'landscape', 'for', 'in', '##ject', '##able', 'drug', 'delivery', 'and', 'the', 'market', 'impact', 'new', 'and', 'emerging', 'in', '##ject', '##able', 'drug', 'product', 'therapeutic', 'indication']",1
227261,nifty_701,2013-07-25,Bristol-Myers Profit Off 17% on Sales Pressure From Patent Losses,Neutral,0.0011,65,bristol myers profit off sale pressure from patent loss,55,9,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'profit', 'off', 'sale', 'pressure', 'from', 'patent', 'loss']",1
227309,nifty_702,2013-07-29,Health Management Weighs Bid,Neutral,0.0,28,health management weighs bid,28,4,0,pharmacy,"['health', 'management', 'weighs', 'bid']",1
227319,nifty_702,2013-07-29,FDA: Sanofi Allergy Spray 'Good Candidate' for Nonprescription Switch,Neutral,0.0,69,fda sanofi allergy spray good candidate for nonprescription switch,66,9,0,pharmacy,"['f', '##da', 'sa', '##no', '##fi', 'all', '##er', '##gy', 'spray', 'good', 'candidate', 'for', 'non', '##p', '##res', '##cription', 'switch']",1
227348,nifty_703,2013-07-30,Community Health to Buy HMA for $3.9 Billion,Neutral,0.0007,44,community health buy hma for billion,36,6,0,pharmacy,"['community', 'health', 'buy', 'h', '##ma', 'for', 'billion']",1
227451,nifty_704,2013-07-31,AstraZeneca to Collaborate on Anemia Drug,Rise,0.0116,41,astrazeneca collaborate anemia drug,35,4,0,pharmacy,"['as', '##tra', '##zen', '##eca', 'collaborate', 'an', '##emia', 'drug']",1
227714,nifty_708,2013-08-07,"Research and Markets: Primary Dysmenorrhea - Pipeline Review, H2 2013",Neutral,0.0037,69,research and market primary dysmenorrhea pipeline review,56,7,0,pharmacy,"['research', 'and', 'market', 'primary', 'd', '##ys', '##men', '##or', '##r', '##hea', 'pipeline', 'review']",1
227745,nifty_708,2013-08-07,"Research and Markets: Brain Metastasis - Pipeline Review, H2 2013",Neutral,0.0037,65,research and market brain metastasis pipeline review,52,7,0,pharmacy,"['research', 'and', 'market', 'brain', 'meta', '##sta', '##sis', 'pipeline', 'review']",1
227754,nifty_708,2013-08-07,OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference,Neutral,0.0037,68,oncogenex pharmaceutical present upcoming investor conference,61,6,0,pharmacy,"['on', '##co', '##gene', '##x', 'pharmaceutical', 'present', 'upcoming', 'investor', 'conference']",1
227758,nifty_708,2013-08-07,"Research and Markets: Neurofibromatoses Type II - Pipeline Review, H2 2013",Neutral,0.0037,74,research and market neurofibromatoses type pipeline review,58,7,0,pharmacy,"['research', 'and', 'market', 'ne', '##uro', '##fi', '##bro', '##mat', '##ose', '##s', 'type', 'pipeline', 'review']",1
227771,nifty_708,2013-08-07,Idenix Pharmaceuticals Reports Second Quarter and Six Month 2013 Financial Results,Neutral,0.0037,82,idenix pharmaceutical report second quarter and six month financial result,74,10,0,pharmacy,"['id', '##eni', '##x', 'pharmaceutical', 'report', 'second', 'quarter', 'and', 'six', 'month', 'financial', 'result']",1
227791,nifty_708,2013-08-07,Research and Markets: 2013 Worldwide Diagnostic Imaging Centers Industry-Industry & Market report,Neutral,0.0037,97,research and market worldwide diagnostic imaging center industry industry market report,87,11,0,pharmacy,"['research', 'and', 'market', 'worldwide', 'diagnostic', 'imaging', 'center', 'industry', 'industry', 'market', 'report']",1
227797,nifty_708,2013-08-07,Venture capital warms to European biotechs,Neutral,0.0037,42,venture capital warms european biotech,38,5,0,pharmacy,"['venture', 'capital', 'warm', '##s', 'euro', '##pe', '##an', 'bio', '##tech']",1
227827,nifty_708,2013-08-07,Research and Markets: Optimer Pharmaceuticals Partnering 2005-2013 Considers the Biopharma Top 50 and Dealmaking Activity,Neutral,0.0037,121,research and market optimer pharmaceutical partnering considers the biopharma top and dealmaking activity,105,13,0,pharmacy,"['research', 'and', 'market', 'op', '##time', '##r', 'pharmaceutical', 'partner', '##ing', 'considers', 'the', 'bio', '##pha', '##rma', 'top', 'and', 'deal', '##making', 'activity']",1
227836,nifty_708,2013-08-07,"Collaborations, Global Platforms, and Strong Sales Drive Revenue Growth - Research Report on Baxter, Mylan, ImmunoGen, Emeritus, and Synta",Neutral,0.0037,138,collaboration global platform and strong sale drive revenue growth research report baxter mylan immunogen emeritus and synta,124,17,0,pharmacy,"['collaboration', 'global', 'platform', 'and', 'strong', 'sale', 'drive', 'revenue', 'growth', 'research', 'report', 'b', '##ax', '##ter', 'my', '##lan', 'im', '##mu', '##no', '##gen', 'emeritus', 'and', 's', '##yn', '##ta']",1
227837,nifty_708,2013-08-07,"Pre-Market Analysis: Community Health Systems, Isis Pharmaceuticals, Quest Diagnostics, and Santarus Inc.",Neutral,0.0037,105,pre market analysis community health system isi pharmaceutical quest diagnostics and santarus inc,97,13,0,pharmacy,"['pre', 'market', 'analysis', 'community', 'health', 'system', 'is', '##i', 'pharmaceutical', 'quest', 'diagnostic', '##s', 'and', 'sa', '##nta', '##rus', 'in', '##c']",1
227930,nifty_708,2013-08-07,Vanda Pharmaceuticals Inc. Prices Public Offering of Common Stock,Neutral,0.0037,65,vanda pharmaceutical inc price public offering common stock,59,8,0,pharmacy,"['van', '##da', 'pharmaceutical', 'in', '##c', 'price', 'public', 'offering', 'common', 'stock']",1
227962,nifty_708,2013-08-07,Carmenta Bioscience Secures Over $2 Million in Oversubscribed Seed Financing,Neutral,0.0037,76,carmenta bioscience secures over million oversubscribed seed financing,70,8,0,pharmacy,"['car', '##ment', '##a', 'bio', '##science', 'secure', '##s', 'over', 'million', 'overs', '##ub', '##scribed', 'seed', 'financing']",1
227978,nifty_708,2013-08-07,Research and Markets: Galapagos Partnering 2005-2013 Provides an In-Depth Insight into the Partnering Interests and Activities of One of the Worlds Leading Biopharma Companies,Neutral,0.0037,175,research and market galapagos partnering provides depth insight into the partnering interest and activity one the world leading biopharma company,145,20,0,pharmacy,"['research', 'and', 'market', 'gal', '##apa', '##gos', 'partner', '##ing', 'provides', 'depth', 'insight', 'into', 'the', 'partner', '##ing', 'interest', 'and', 'activity', 'one', 'the', 'world', 'leading', 'bio', '##pha', '##rma', 'company']",1
227988,nifty_708,2013-08-07,"Research and Markets: Asia Pacific: Pharmahandbook - Key Analysis on the 8 Country, $300 Billion Industry",Neutral,0.0037,105,research and market asia pacific pharmahandbook key analysis the country billion industry,89,12,0,pharmacy,"['research', 'and', 'market', 'as', '##ia', 'p', '##ac', '##ific', 'p', '##har', '##mah', '##and', '##book', 'key', 'analysis', 'the', 'country', 'billion', 'industry']",1
228026,nifty_708,2013-08-07,Research and Markets: Outlook of China Biopharmaceutical Outsourcing Market Report 2013-2018 - Market to Reach $1.3 Billion,Neutral,0.0037,123,research and market outlook china biopharmaceutical outsourcing market report market reach billion,98,12,0,pharmacy,"['research', 'and', 'market', 'outlook', 'chin', '##a', 'bio', '##pha', '##rma', '##ce', '##utical', 'outs', '##our', '##cing', 'market', 'report', 'market', 'reach', 'billion']",1
228033,nifty_708,2013-08-07,"Research and Markets: In Vitro Diagnostic (IVD) Market, Technique & Applications - Forecast To 2017",Neutral,0.0037,99,research and market vitro diagnostic ivd market technique application forecast,78,10,0,pharmacy,"['research', 'and', 'market', 'v', '##it', '##ro', 'diagnostic', 'i', '##v', '##d', 'market', 'technique', 'application', 'forecast']",1
228082,nifty_708,2013-08-07,"Research and Markets: Research Report on Global and China's In-Vitro Diagnostic Reagent Industry, 2013-2017",Neutral,0.0037,107,research and market research report global and china vitro diagnostic reagent industry,86,12,0,pharmacy,"['research', 'and', 'market', 'research', 'report', 'global', 'and', 'chin', '##a', 'v', '##it', '##ro', 'diagnostic', 're', '##age', '##nt', 'industry']",1
228227,nifty_708,2013-08-07,Research and Markets: Global Tradeshow Update: BioFach 2013,Neutral,0.0037,59,research and market global tradeshow update biofach,51,7,0,pharmacy,"['research', 'and', 'market', 'global', 'trades', '##how', 'update', 'bio', '##fa', '##ch']",1
228293,nifty_708,2013-08-07,Transcept Pharmaceuticals Reports Second Quarter Financial Results,Neutral,0.0037,66,transcept pharmaceutical report second quarter financial result,63,7,0,pharmacy,"['trans', '##ce', '##pt', 'pharmaceutical', 'report', 'second', 'quarter', 'financial', 'result']",1
228657,nifty_709,2013-08-08,"Research and Markets: Malignant Neoplasms - Pipeline Review, H2 2013",Neutral,-0.0029,68,research and market malignant neoplasm pipeline review,54,7,0,pharmacy,"['research', 'and', 'market', 'ma', '##li', '##gnant', 'neo', '##p', '##las', '##m', 'pipeline', 'review']",1
228720,nifty_709,2013-08-08,BioCryst Provides Corporate Update and Reports Second Quarter 2013 Financial Results,Neutral,-0.0029,84,biocryst provides corporate update and report second quarter financial result,77,10,0,pharmacy,"['bio', '##c', '##ry', '##st', 'provides', 'corporate', 'update', 'and', 'report', 'second', 'quarter', 'financial', 'result']",1
228749,nifty_709,2013-08-08,Research and Markets: 2013 Update on Cell Therapy in the US: More funding for R&D; will help maintain strong revenue gains,Neutral,-0.0029,122,research and market update cell therapy the more funding for will help maintain strong revenue gain,99,16,0,pharmacy,"['research', 'and', 'market', 'update', 'cell', 'therapy', 'the', 'more', 'funding', 'for', 'will', 'help', 'maintain', 'strong', 'revenue', 'gain']",1
228828,nifty_709,2013-08-08,UPDATE 3-Top insulin maker Novo caught up in China's widening drug probes,Neutral,-0.0029,73,update top insulin maker novo caught china widening drug probe,62,10,0,pharmacy,"['update', 'top', 'insulin', 'maker', 'no', '##vo', 'caught', 'chin', '##a', 'widening', 'drug', 'probe']",1
228829,nifty_709,2013-08-08,Top insulin maker Novo caught up in China's widening drug probes,Neutral,-0.0029,64,top insulin maker novo caught china widening drug probe,55,9,0,pharmacy,"['top', 'insulin', 'maker', 'no', '##vo', 'caught', 'chin', '##a', 'widening', 'drug', 'probe']",1
228861,nifty_709,2013-08-08,China's Type 2 Diabetes Market Will Grow To $3.5 Billion In 2017,Neutral,-0.0029,64,china type diabetes market will grow billion,44,7,0,pharmacy,"['chin', '##a', 'type', 'diabetes', 'market', 'will', 'grow', 'billion']",1
228875,nifty_709,2013-08-08,"New Technologies and Product Launches Drive Strong Revenue Growth and Certifications - Research Report on Hologic, Edwards Lifesciences, Volcano, Opko Health, and Wright Medical Group",Neutral,-0.0029,183,new technology and product launch drive strong revenue growth and certification research report hologic edward lifesciences volcano opko health and wright medical group,168,23,0,pharmacy,"['new', 'technology', 'and', 'product', 'launch', 'drive', 'strong', 'revenue', 'growth', 'and', 'certification', 'research', 'report', 'ho', '##log', '##ic', 'ed', '##ward', 'life', '##science', '##s', 'volcano', 'op', '##ko', 'health', 'and', 'w', '##right', 'medical', 'group']",1
228881,nifty_709,2013-08-08,"Regulatory Approvals, Ongoing Clinical Trials, Divestures, New Borrowings and Regulatory Applications - Research Report on Zoetis, GSK, Actavis, Kindred Healthcare, TESARO",Neutral,-0.0029,171,regulatory approval ongoing clinical trial divestures new borrowing and regulatory application research report zoetis gsk actavis kindred healthcare tesaro,155,19,0,pharmacy,"['regulatory', 'approval', 'ongoing', 'clinical', 'trial', 'dive', '##st', '##ures', 'new', 'borrow', '##ing', 'and', 'regulatory', 'application', 'research', 'report', 'z', '##oe', '##tis', 'g', '##sk', 'act', '##avi', '##s', 'kind', '##red', 'healthcare', 'te', '##sar', '##o']",1
228934,nifty_709,2013-08-08,"Research and Markets: Global 1,3-PDO Market - 2013 Report Featuring Dupont Tate & Lyle Bioproducts Company And Metabolic Explorer",Neutral,-0.0029,129,research and market global pdo market report featuring dupont tate lyle bioproducts company and metabolic explorer,114,16,0,pharmacy,"['research', 'and', 'market', 'global', 'p', '##do', 'market', 'report', 'featuring', 'du', '##pont', 'ta', '##te', 'l', '##yle', 'bio', '##p', '##rod', '##uc', '##ts', 'company', 'and', 'metabolic', 'explorer']",1
228958,nifty_709,2013-08-08,"Earnings Transcripts of Sarepta Therapeutics, LINN Energy and Royal Gold, Inc. Now Available",Neutral,-0.0029,92,earnings transcript sarepta therapeutic linn energy and royal gold inc now available,84,12,0,pharmacy,"['earnings', 'trans', '##cript', 'sa', '##re', '##pta', 'therapeutic', 'l', '##inn', 'energy', 'and', 'royal', 'gold', 'in', '##c', 'now', 'available']",1
229048,nifty_709,2013-08-08,GSK plugs into bioelectronics with $50 million venture fund,Neutral,-0.0029,59,gsk plug into bioelectronics with million venture fund,54,8,0,pharmacy,"['g', '##sk', 'plug', 'into', 'bio', '##ele', '##ct', '##ronic', '##s', 'with', 'million', 'venture', 'fund']",1
229132,nifty_709,2013-08-08,Research and Markets: Nucleic Acid Purification Life Science Dashboard Series 1 - China,Neutral,-0.0029,87,research and market nucleic acid purification life science dashboard series china,81,11,0,pharmacy,"['research', 'and', 'market', 'nuclei', '##c', 'acid', 'pu', '##rification', 'life', 'science', 'dash', '##board', 'series', 'chin', '##a']",1
229142,nifty_709,2013-08-08,"Research and Markets: Global Molecular Diagnostics Report 2013 - Updated Detailed Analysis on Technologies, Markets and 336 Companies",Neutral,-0.0029,133,research and market global molecular diagnostics report updated detailed analysis technology market and company,111,14,0,pharmacy,"['research', 'and', 'market', 'global', 'molecular', 'diagnostic', '##s', 'report', 'updated', 'detailed', 'analysis', 'technology', 'market', 'and', 'company']",1
229147,nifty_709,2013-08-08,"Research and Markets: Global Transdermal Drug Delivery Report 2013-2022 - Technologies, Markets, and Companies with Updated Figures",Neutral,-0.0029,131,research and market global transdermal drug delivery report technology market and company with updated figure,109,15,0,pharmacy,"['research', 'and', 'market', 'global', 'trans', '##der', '##mal', 'drug', 'delivery', 'report', 'technology', 'market', 'and', 'company', 'with', 'updated', 'figure']",1
229152,nifty_709,2013-08-08,"Research and Markets: Global Drug Delivery in Cancer Report 2013-2022: Updated Analysis of Technologies, Markets and Now, 224 Companies",Neutral,-0.0029,135,research and market global drug delivery cancer report updated analysis technology market and now company,105,15,0,pharmacy,"['research', 'and', 'market', 'global', 'drug', 'delivery', 'cancer', 'report', 'updated', 'analysis', 'technology', 'market', 'and', 'now', 'company']",1
229213,nifty_709,2013-08-08,"Research and Markets: Women Infertility - Pipeline Review, H2 2013 Report Features Players such as Merck KGaA, EndoCeutics, Inc. and Quatrx Pharmaceutical Company",Neutral,-0.0029,162,research and market woman infertility pipeline review report feature player such merck kgaa endoceutics inc and quatrx pharmaceutical company,141,19,0,pharmacy,"['research', 'and', 'market', 'woman', 'in', '##fer', '##tility', 'pipeline', 'review', 'report', 'feature', 'player', 'such', 'me', '##rc', '##k', 'kg', '##aa', 'end', '##oc', '##eu', '##tics', 'in', '##c', 'and', 'q', '##ua', '##tr', '##x', 'pharmaceutical', 'company']",1
229319,nifty_709,2013-08-08,NPS Pharmaceuticals Reports Second Quarter 2013 Financial Results and Provides Business Update,Neutral,-0.0029,94,np pharmaceutical report second quarter financial result and provides business update,85,11,0,pharmacy,"['n', '##p', 'pharmaceutical', 'report', 'second', 'quarter', 'financial', 'result', 'and', 'provides', 'business', 'update']",1
229347,nifty_709,2013-08-08,Anacor Pharmaceuticals to Present at Upcoming Investor Conferences,Neutral,-0.0029,66,anacor pharmaceutical present upcoming investor conference,58,6,0,pharmacy,"['an', '##aco', '##r', 'pharmaceutical', 'present', 'upcoming', 'investor', 'conference']",1
229689,nifty_711,2013-08-13,Intercept Pharmaceuticals Reports Second Quarter 2013 Financial Results,Fall,-0.0051,71,intercept pharmaceutical report second quarter financial result,63,7,0,pharmacy,"['intercept', 'pharmaceutical', 'report', 'second', 'quarter', 'financial', 'result']",1
229728,nifty_711,2013-08-13,"Research and Markets: Brain Cancer - Pipeline Review, H2 2013 Report Gives a Snapshot of the Global Therapeutic Scenario for Brain Cancer",Fall,-0.0051,137,research and market brain cancer pipeline review report give snapshot the global therapeutic scenario for brain cancer,118,17,0,pharmacy,"['research', 'and', 'market', 'brain', 'cancer', 'pipeline', 'review', 'report', 'give', 'snaps', '##hot', 'the', 'global', 'therapeutic', 'scenario', 'for', 'brain', 'cancer']",1
230012,nifty_711,2013-08-13,Research and Markets: NPS Pharmaceuticals Partnering 2005-2013 Includes In-Depth Contact Information for Individuals within the Business Development Function,Fall,-0.0051,157,research and market np pharmaceutical partnering includes depth contact information for individual within the business development function,139,17,0,pharmacy,"['research', 'and', 'market', 'n', '##p', 'pharmaceutical', 'partner', '##ing', 'includes', 'depth', 'contact', 'information', 'for', 'individual', 'within', 'the', 'business', 'development', 'function']",1
230065,nifty_711,2013-08-13,Research and Markets: Global Pharmaceutical Review Report 2013: Essential Insights into Worldwide Sales in the Pharmaceutical Market,Fall,-0.0051,132,research and market global pharmaceutical review report essential insight into worldwide sale the pharmaceutical market,119,15,0,pharmacy,"['research', 'and', 'market', 'global', 'pharmaceutical', 'review', 'report', 'essential', 'insight', 'into', 'worldwide', 'sale', 'the', 'pharmaceutical', 'market']",1
230089,nifty_711,2013-08-13,"State Health Insurance Exchanges Will Have Vastly Varied Impacts On Pharma, Broader Healthcare Industry",Fall,-0.0051,103,state health insurance exchange will have vastly varied impact pharma broader healthcare industry,97,13,0,pharmacy,"['state', 'health', 'insurance', 'exchange', 'will', 'have', 'vast', '##ly', 'varied', 'impact', 'p', '##har', '##ma', 'broader', 'healthcare', 'industry']",1
230125,nifty_711,2013-08-13,"Research and Markets: RFID Blood Monitoring Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019",Fall,-0.0051,140,research and market rfid blood monitoring system market global industry analysis size share growth trend and forecast,117,17,0,pharmacy,"['research', 'and', 'market', 'r', '##fi', '##d', 'blood', 'monitoring', 'system', 'market', 'global', 'industry', 'analysis', 'size', 'share', 'growth', 'trend', 'and', 'forecast']",1
230134,nifty_711,2013-08-13,"Research and Markets: Global Pain Management Therapeutics Market Report 2012-2018 - Anticonvulsants, Antidepressants, Anesthetics, NSAIDs, Opioids, Other Non-Narcotic Analgesics And Anti-Migraine Agents",Fall,-0.0051,202,research and market global pain management therapeutic market report anticonvulsant antidepressant anesthetic nsaid opioids other non narcotic analgesic and anti migraine agent,176,22,0,pharmacy,"['research', 'and', 'market', 'global', 'pain', 'management', 'therapeutic', 'market', 'report', 'anti', '##con', '##vu', '##ls', '##ant', 'anti', '##de', '##press', '##ant', 'an', '##est', '##hetic', 'n', '##sai', '##d', 'op', '##io', '##ids', 'other', 'non', 'na', '##rc', '##otic', 'anal', '##ges', '##ic', 'and', 'anti', 'mi', '##gra', '##ine', 'agent']",1
230140,nifty_711,2013-08-13,Research and Markets: Molecular Diagnostics in Genetic Testing - 2013 Study Analyzes the Size and Growth of the Molecular Diagnostics in Genetic Testing Market,Fall,-0.0051,159,research and market molecular diagnostics genetic testing study analyzes the size and growth the molecular diagnostics genetic testing market,141,19,0,pharmacy,"['research', 'and', 'market', 'molecular', 'diagnostic', '##s', 'genetic', 'testing', 'study', 'analyze', '##s', 'the', 'size', 'and', 'growth', 'the', 'molecular', 'diagnostic', '##s', 'genetic', 'testing', 'market']",1
230381,nifty_712,2013-08-14,Lilly Lung-Cancer Treatment Meets Survival Goal,Fall,-0.014,47,lilly lung cancer treatment meet survival goal,46,7,0,pharmacy,"['l', '##ill', '##y', 'lung', 'cancer', 'treatment', 'meet', 'survival', 'goal']",1
230452,nifty_714,2013-08-19,"Japan's Eisai Sues DEA, Seeking Clearance of Epilepsy Drug",Neutral,0.0049,58,japan eisai sue dea seeking clearance epilepsy drug,51,8,0,pharmacy,"['j', '##apa', '##n', 'e', '##isa', '##i', 'sue', 'de', '##a', 'seeking', 'clearance', 'e', '##pile', '##psy', 'drug']",1
230509,nifty_715,2013-08-20,Belgium biotech group Tigenix looks for new funding sources,Fall,-0.0062,59,belgium biotech group tigenix look for new funding source,57,9,0,pharmacy,"['be', '##l', '##gi', '##um', 'bio', '##tech', 'group', 't', '##ige', '##ni', '##x', 'look', 'for', 'new', 'funding', 'source']",1
230512,nifty_715,2013-08-20,Belgian biotech firm Tigenix seeks new funding,Fall,-0.0062,46,belgian biotech firm tigenix seek new funding,45,7,0,pharmacy,"['be', '##l', '##gia', '##n', 'bio', '##tech', 'firm', 't', '##ige', '##ni', '##x', 'seek', 'new', 'funding']",1
230621,nifty_715,2013-08-20,GeneNews Announces Strategic Restructuring,Fall,-0.0062,42,genenews announces strategic restructuring,42,4,0,pharmacy,"['gene', '##ne', '##ws', 'announces', 'strategic', 'restructuring']",1
230733,nifty_715,2013-08-20,"Research and Markets: Latest Developments in Pharmacovigilance - Part of Management Forum's 30th Anniversary Congress (Course, London)",Fall,-0.0062,134,research and market latest development pharmacovigilance part management forum anniversary congress course london,113,13,0,pharmacy,"['research', 'and', 'market', 'latest', 'development', 'p', '##har', '##ma', '##co', '##vi', '##gi', '##lance', 'part', 'management', 'forum', 'anniversary', 'congress', 'course', 'lo', '##ndon']",1
230849,nifty_715,2013-08-20,FidelityÂ® Survey Finds Lack of Understanding on How Health Savings Accounts Work,Fall,-0.0062,81,fidelityâ survey find lack understanding how health saving account work,71,10,0,pharmacy,"['fi', '##delity', '##â', 'survey', 'find', 'lack', 'understanding', 'how', 'health', 'saving', 'account', 'work']",1
230936,nifty_715,2013-08-20,"The Dyslipidemia Market Will Grow to $31 Billion in 2022, Driven by the Launch of Novel Therapies",Fall,-0.0062,97,the dyslipidemia market will grow billion driven the launch novel therapy,73,11,0,pharmacy,"['the', 'd', '##ys', '##lip', '##ide', '##mia', 'market', 'will', 'grow', 'billion', 'driven', 'the', 'launch', 'novel', 'therapy']",1
230967,nifty_715,2013-08-20,"Research and Markets: Research on China's IVD Reagent (In Vitro Diagnostic Reagent) Industry, 2013-2017",Fall,-0.0062,103,research and market research china ivd reagent vitro diagnostic reagent industry,80,11,0,pharmacy,"['research', 'and', 'market', 'research', 'chin', '##a', 'i', '##v', '##d', 're', '##age', '##nt', 'v', '##it', '##ro', 'diagnostic', 're', '##age', '##nt', 'industry']",1
230988,nifty_715,2013-08-20,DelosÂ® Founder Discusses Wellness Real Estateâ¢ with Deepak Chopra at the Fourth Annual Sages and Scientists Symposium,Fall,-0.0062,120,delosâ founder discusses wellness real estateâ with deepak chopra the fourth annual sage and scientist symposium,112,16,0,pharmacy,"['del', '##os', '##â', 'founder', 'discusses', 'well', '##ness', 'real', 'estate', '##â', 'with', 'deep', '##ak', 'ch', '##op', '##ra', 'the', 'fourth', 'annual', 'sage', 'and', 'scientist', 's', '##ym', '##po', '##sium']",1
231066,nifty_715,2013-08-20,"Research and Markets: Pharmaceutical Manufacturing in China - 2013 Includes Five Year Industry Forecasts, Growth Rates and an Analysis of the Industry Key Players",Fall,-0.0062,162,research and market pharmaceutical manufacturing china includes five year industry forecast growth rate and analysis the industry key player,140,19,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'manufacturing', 'chin', '##a', 'includes', 'five', 'year', 'industry', 'forecast', 'growth', 'rate', 'and', 'analysis', 'the', 'industry', 'key', 'player']",1
231338,nifty_717,2013-08-22,Doctors Face Scrutiny Over Gifts,Neutral,0.0034,32,doctor face scrutiny over gift,30,5,0,pharmacy,"['doctor', 'face', 'scrutiny', 'over', 'gift']",1
231673,nifty_723,2013-09-04,Iraq Shortlists Candidates to Build Pipeline to Jordan,Neutral,0.0013,54,iraq shortlist candidate build pipeline jordan,46,6,0,pharmacy,"['i', '##ra', '##q', 'short', '##list', 'candidate', 'build', 'pipeline', 'j', '##ord', '##an']",1
231738,nifty_724,2013-09-05,Active Biotech to Present at the Rodman & Renshaw Annual Global Investment Conference,Neutral,0.0005,85,active biotech present the rodman renshaw annual global investment conference,77,10,0,pharmacy,"['active', 'bio', '##tech', 'present', 'the', 'rod', '##man', 're', '##ns', '##haw', 'annual', 'global', 'investment', 'conference']",1
231780,nifty_724,2013-09-05,"Research and Markets: Fibromyalgia - Pipeline Review, H2 2013",Neutral,0.0005,61,research and market fibromyalgia pipeline review,48,6,0,pharmacy,"['research', 'and', 'market', 'fi', '##bro', '##my', '##al', '##gia', 'pipeline', 'review']",1
231807,nifty_724,2013-09-05,Research and Markets: The Worldwide Pharmaceutical Market Forecast to 2018,Neutral,0.0005,74,research and market the worldwide pharmaceutical market forecast,64,8,0,pharmacy,"['research', 'and', 'market', 'the', 'worldwide', 'pharmaceutical', 'market', 'forecast']",1
231953,nifty_724,2013-09-05,Aegerion Pharmaceuticals Announces Presentation at the Morgan Stanley Global Healthcare Conference,Neutral,0.0005,98,aegerion pharmaceutical announces presentation the morgan stanley global healthcare conference,94,10,0,pharmacy,"['a', '##ege', '##rion', 'pharmaceutical', 'announces', 'presentation', 'the', 'm', '##or', '##gan', 's', '##tan', '##ley', 'global', 'healthcare', 'conference']",1
232134,nifty_724,2013-09-05,"Research and Markets: Growth Disorders - Pipeline Review, H2 2013 Features Players such as Ipsen S.A., Novo Nordisk A/S and Zosano Pharma, Inc.",Neutral,0.0005,143,research and market growth disorder pipeline review feature player such ipsen novo nordisk and zosano pharma inc,112,17,0,pharmacy,"['research', 'and', 'market', 'growth', 'disorder', 'pipeline', 'review', 'feature', 'player', 'such', 'i', '##pse', '##n', 'no', '##vo', 'nor', '##dis', '##k', 'and', 'z', '##osa', '##no', 'p', '##har', '##ma', 'in', '##c']",1
232238,nifty_724,2013-09-05,"Research and Markets: Kidney Disease - Pipeline Review, H2 2013",Neutral,0.0005,63,research and market kidney disease pipeline review,50,7,0,pharmacy,"['research', 'and', 'market', 'kidney', 'disease', 'pipeline', 'review']",1
232254,nifty_724,2013-09-05,Research and Markets: Global 3D Medical Imaging Market Report 2013-2018: Reimbursement Issues Threaten Future Growth,Neutral,0.0005,116,research and market global medical imaging market report reimbursement issue threaten future growth,99,13,0,pharmacy,"['research', 'and', 'market', 'global', 'medical', 'imaging', 'market', 'report', 're', '##im', '##bur', '##se', '##ment', 'issue', 'threaten', 'future', 'growth']",1
232269,nifty_724,2013-09-05,"COPD Foundation Empowers Healthcare Providers to More Efficiently Diagnose and Treat COPD, Launches COPD Pocket Consultant Guide iPhone App",Neutral,0.0005,139,copd foundation empowers healthcare provider more efficiently diagnose and treat copd launch copd pocket consultant guide iphone app,132,18,0,pharmacy,"['cop', '##d', 'foundation', 'em', '##power', '##s', 'healthcare', 'provider', 'more', 'efficiently', 'di', '##ag', '##nose', 'and', 'treat', 'cop', '##d', 'launch', 'cop', '##d', 'pocket', 'consultant', 'guide', 'i', '##phone', 'app']",1
232287,nifty_724,2013-09-05,Research and Markets: Global Next Generation Sequencing (NGS) Market Report 2013-2017,Neutral,0.0005,85,research and market global next generation sequencing ng market report,70,10,0,pharmacy,"['research', 'and', 'market', 'global', 'next', 'generation', 'se', '##quencing', 'ng', 'market', 'report']",1
232305,nifty_724,2013-09-05,Research and Markets: Lung Cancer Drug Pipeline Update 2013: Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC) Comprises Over 95% of all Lung Cancers,Neutral,0.0005,168,research and market lung cancer drug pipeline update non small cell lung cancer nsclc and small cell lung cancer sclc comprises over all lung cancer,148,25,0,pharmacy,"['research', 'and', 'market', 'lung', 'cancer', 'drug', 'pipeline', 'update', 'non', 'small', 'cell', 'lung', 'cancer', 'n', '##s', '##c', '##l', '##c', 'and', 'small', 'cell', 'lung', 'cancer', 's', '##c', '##l', '##c', 'comprises', 'over', 'all', 'lung', 'cancer']",1
232328,nifty_724,2013-09-05,"Research and Markets: Dystonia - Pipeline Review, H2 2013 Report Features Players such as Addex Pharmaceuticals and QRxPharma Limited",Neutral,0.0005,133,research and market dystonia pipeline review report feature player such addex pharmaceutical and qrxpharma limited,114,15,0,pharmacy,"['research', 'and', 'market', 'd', '##ys', '##ton', '##ia', 'pipeline', 'review', 'report', 'feature', 'player', 'such', 'add', '##ex', 'pharmaceutical', 'and', 'q', '##r', '##x', '##pha', '##rma', 'limited']",1
232356,nifty_724,2013-09-05,"Research and Markets: Schizophrenia - Pipeline Review, H2 2013",Neutral,0.0005,62,research and market schizophrenia pipeline review,49,6,0,pharmacy,"['research', 'and', 'market', 's', '##chi', '##zophrenia', 'pipeline', 'review']",1
232403,nifty_724,2013-09-05,Helix BioPharma Corp. to Present at Rodman & Renshaw Annual Global Investment Conference,Neutral,0.0005,88,helix biopharma corp present rodman renshaw annual global investment conference,79,10,0,pharmacy,"['he', '##lix', 'bio', '##pha', '##rma', 'co', '##rp', 'present', 'rod', '##man', 're', '##ns', '##haw', 'annual', 'global', 'investment', 'conference']",1
232563,nifty_724,2013-09-05,"Novartis, India Clash Over Patent Laws",Neutral,0.0005,38,novartis india clash over patent law,36,6,0,pharmacy,"['no', '##var', '##tis', 'in', '##dia', 'clash', 'over', 'patent', 'law']",1
232649,nifty_726,2013-09-10,European Commission Approves Biosimilar of J&J and Merck's Remicade,Neutral,0.0031,67,european commission approves biosimilar and merck remicade,58,7,0,pharmacy,"['euro', '##pe', '##an', 'commission', 'approve', '##s', 'bio', '##si', '##mi', '##lar', 'and', 'me', '##rc', '##k', 're', '##mic', '##ade']",1
232781,nifty_727,2013-09-11,"Research and Markets: Dual Chamber Syringes & Injectors. Devices, Therapeutics, Markets and Forecasts",Neutral,-0.0027,101,research and market dual chamber syrinx injector device therapeutic market and forecast,87,12,0,pharmacy,"['research', 'and', 'market', 'dual', 'chamber', 's', '##yr', '##in', '##x', 'in', '##ject', '##or', 'device', 'therapeutic', 'market', 'and', 'forecast']",1
232892,nifty_727,2013-09-11,Research and Markets: Biotech 2013 - Life Sciences: Capturing Value,Neutral,-0.0027,67,research and market biotech life science capturing value,56,8,0,pharmacy,"['research', 'and', 'market', 'bio', '##tech', 'life', 'science', 'capturing', 'value']",1
232893,nifty_727,2013-09-11,"Research and Markets: Scar - Pipeline Review, H2 2013",Neutral,-0.0027,53,research and market scar pipeline review,40,6,0,pharmacy,"['research', 'and', 'market', 'scar', 'pipeline', 'review']",1
232904,nifty_727,2013-09-11,"Acquisitions, Regulatory Filings, New Community Resource Centers and Successful Clinical Trials- Research Report on Baxter, Endo, HCA, Elan, and Theravance",Neutral,-0.0027,155,acquisition regulatory filing new community resource center and successful clinical trial research report baxter endo hca elan and theravance,141,19,0,pharmacy,"['acquisition', 'regulatory', 'filing', 'new', 'community', 'resource', 'center', 'and', 'successful', 'clinical', 'trial', 'research', 'report', 'b', '##ax', '##ter', 'end', '##o', 'h', '##ca', 'el', '##an', 'and', 'the', '##ra', '##vance']",1
233124,nifty_727,2013-09-11,Research and Markets: Global Portable Medical Devices Market by Equipment & Semiconductor Components 2013-2018,Neutral,-0.0027,110,research and market global portable medical device market equipment semiconductor component,91,11,0,pharmacy,"['research', 'and', 'market', 'global', 'portable', 'medical', 'device', 'market', 'equipment', 'semi', '##conductor', 'component']",1
233131,nifty_727,2013-09-11,"Research and Markets: Global Aptamers Market Technology Trend Analysis Market Report 2013-2018: Therapeutics, Diagnostics, Biosensors, Biomarker/Drug Discovery & Applications",Neutral,-0.0027,174,research and market global aptamers market technology trend analysis market report therapeutic diagnostics biosensors biomarker drug discovery application,154,18,0,pharmacy,"['research', 'and', 'market', 'global', 'a', '##pta', '##mers', 'market', 'technology', 'trend', 'analysis', 'market', 'report', 'therapeutic', 'diagnostic', '##s', 'bio', '##sen', '##sors', 'bio', '##mark', '##er', 'drug', 'discovery', 'application']",1
233152,nifty_727,2013-09-11,BIO Announces Presenting Companies for 12th Annual BIO Investor Forum,Neutral,-0.0027,69,bio announces presenting company for annual bio investor forum,62,9,0,pharmacy,"['bio', 'announces', 'presenting', 'company', 'for', 'annual', 'bio', 'investor', 'forum']",1
233300,nifty_727,2013-09-11,PDL BioPharma to Present at the 4th Annual Credit Suisse Small/Mid Cap Conference,Neutral,-0.0027,81,pdl biopharma present the annual credit suisse small mid cap conference,71,11,0,pharmacy,"['p', '##dl', 'bio', '##pha', '##rma', 'present', 'the', 'annual', 'credit', 'su', '##isse', 'small', 'mid', 'cap', 'conference']",1
233324,nifty_727,2013-09-11,BioScrip Announces 2013 Investor Day,Neutral,-0.0027,36,bioscrip announces investor day,31,4,0,pharmacy,"['bio', '##s', '##c', '##rip', 'announces', 'investor', 'day']",1
233555,nifty_729,2013-09-16,Patients Share DNA for Cures,Neutral,0.0045,28,patient share dna for cure,26,5,0,pharmacy,"['patient', 'share', 'd', '##na', 'for', 'cure']",1
233633,nifty_730,2013-09-17,Europe Approves Sanofi's MS Drug,Rise,0.0116,32,europe approves sanofi drug,27,4,0,pharmacy,"['euro', '##pe', 'approve', '##s', 'sa', '##no', '##fi', 'drug']",1
233941,nifty_733,2013-09-23,"KaloBios Pharmaceuticals, Inc. Proposes Public Offering of Common Stock",Neutral,-0.0024,71,kalobios pharmaceutical inc proposes public offering common stock,65,8,0,pharmacy,"['ka', '##lo', '##bio', '##s', 'pharmaceutical', 'in', '##c', 'proposes', 'public', 'offering', 'common', 'stock']",1
233995,nifty_733,2013-09-23,Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference,Neutral,-0.0024,85,arena pharmaceutical present the newsmakers the biotech industry conference,75,9,0,pharmacy,"['arena', 'pharmaceutical', 'present', 'the', 'news', '##makers', 'the', 'bio', '##tech', 'industry', 'conference']",1
234081,nifty_733,2013-09-23,Worldwide Medtech Sales Forecast to Reach $455 Billion by 2018,Neutral,-0.0024,62,worldwide medtech sale forecast reach billion,45,6,0,pharmacy,"['worldwide', 'me', '##dt', '##ech', 'sale', 'forecast', 'reach', 'billion']",1
234164,nifty_733,2013-09-23,Final Reminder For BioScrip 2013 Investor Day,Neutral,-0.0024,45,final reminder for bioscrip investor day,40,6,0,pharmacy,"['final', 'reminder', 'for', 'bio', '##s', '##c', '##rip', 'investor', 'day']",1
234165,nifty_733,2013-09-23,Research and Markets: Global Marine Biotech Market 2012-2016: Europe Making Significant Contributions to the Market,Neutral,-0.0024,115,research and market global marine biotech market europe making significant contribution the market,98,13,0,pharmacy,"['research', 'and', 'market', 'global', 'marine', 'bio', '##tech', 'market', 'euro', '##pe', 'making', 'significant', 'contribution', 'the', 'market']",1
234201,nifty_733,2013-09-23,Repros to Present at Biocentury's NewsMakers in the Biotech Industry Conference,Neutral,-0.0024,79,repros present biocentury newsmakers the biotech industry conference,68,8,0,pharmacy,"['re', '##p', '##ros', 'present', 'bio', '##cent', '##ury', 'news', '##makers', 'the', 'bio', '##tech', 'industry', 'conference']",1
234229,nifty_733,2013-09-23,"Research and Markets: Global Stem Cells Pipeline Capsule - 2013 Covers Active Stem Cells Pipeline Molecules in Various Stages of Clinical Trials, Preclinical Research and Drug Discovery",Neutral,-0.0024,185,research and market global stem cell pipeline capsule cover active stem cell pipeline molecule various stage clinical trial preclinical research and drug discovery,163,23,0,pharmacy,"['research', 'and', 'market', 'global', 'stem', 'cell', 'pipeline', 'capsule', 'cover', 'active', 'stem', 'cell', 'pipeline', 'molecule', 'various', 'stage', 'clinical', 'trial', 'pre', '##c', '##lini', '##cal', 'research', 'and', 'drug', 'discovery']",1
234267,nifty_733,2013-09-23,Research and Markets: Global Oncology Drug Pipeline Capsule - 2013 will Help Executives Track their Competitor's Pipeline Molecules,Neutral,-0.0024,131,research and market global oncology drug pipeline capsule will help executive track their competitor pipeline molecule,118,16,0,pharmacy,"['research', 'and', 'market', 'global', 'on', '##cology', 'drug', 'pipeline', 'capsule', 'will', 'help', 'executive', 'track', 'their', 'competitor', 'pipeline', 'molecule']",1
234289,nifty_733,2013-09-23,Research and Markets: Oncology Drug Funding 2013,Neutral,-0.0024,48,research and market oncology drug funding,41,6,0,pharmacy,"['research', 'and', 'market', 'on', '##cology', 'drug', 'funding']",1
234310,nifty_733,2013-09-23,Research and Markets: India Bioinformatics Industry Outlook to 2018 - Surging Government Initiatives to Foster Future Prospects,Neutral,-0.0024,127,research and market india bioinformatics industry outlook surging government initiative foster future prospect,110,13,0,pharmacy,"['research', 'and', 'market', 'in', '##dia', 'bio', '##in', '##formatics', 'industry', 'outlook', 'sur', '##ging', 'government', 'initiative', 'foster', 'future', 'prospect']",1
234334,nifty_733,2013-09-23,Research and Markets: The US Clinical Research Market Outlook to 2017 - Led by Aging Population and Rise of Chronic Diseases,Neutral,-0.0024,124,research and market the clinical research market outlook led aging population and rise chronic disease,102,15,0,pharmacy,"['research', 'and', 'market', 'the', 'clinical', 'research', 'market', 'outlook', 'led', 'aging', 'population', 'and', 'rise', 'chronic', 'disease']",1
234361,nifty_733,2013-09-23,2013 Neurotech Leaders Forum to Feature Promising New Startups,Neutral,-0.0024,62,neurotech leader forum feature promising new startup,52,7,0,pharmacy,"['ne', '##uro', '##tech', 'leader', 'forum', 'feature', 'promising', 'new', 'start', '##up']",1
234419,nifty_733,2013-09-23,ChemoCentryx to Present at BioCentury's NewsMakers in the Biotech Industry Conference,Neutral,-0.0024,85,chemocentryx present biocentury newsmakers the biotech industry conference,74,8,0,pharmacy,"['ch', '##em', '##oc', '##entry', '##x', 'present', 'bio', '##cent', '##ury', 'news', '##makers', 'the', 'bio', '##tech', 'industry', 'conference']",1
234575,nifty_733,2013-09-23,FDA Again Rejects Merck Surgery Drug,Neutral,-0.0024,36,fda again reject merck surgery drug,35,6,0,pharmacy,"['f', '##da', 'again', 'reject', 'me', '##rc', '##k', 'surgery', 'drug']",1
234746,nifty_736,2013-09-26,Lilly's Cancer Drug Misses Target,Neutral,-0.0046,33,lilly cancer drug miss target,29,5,0,pharmacy,"['l', '##ill', '##y', 'cancer', 'drug', 'miss', 'target']",1
234801,nifty_737,2013-09-30,GSK Sells Thrombosis Brands,Rise,0.0079,27,gsk sell thrombosis brand,25,4,0,pharmacy,"['g', '##sk', 'sell', 'th', '##rom', '##bos', '##is', 'brand']",1
234940,nifty_738,2013-10-01,"Research and Markets: Postherpetic Neuralgia - Pipeline Review, H2 2013",Neutral,-0.0009,71,research and market postherpetic neuralgia pipeline review,58,7,0,pharmacy,"['research', 'and', 'market', 'post', '##her', '##pet', '##ic', 'neural', '##gia', 'pipeline', 'review']",1
234942,nifty_738,2013-10-01,"Research and Markets: Polycystic Kidney Disease - Pipeline Review, H2 2013",Neutral,-0.0009,74,research and market polycystic kidney disease pipeline review,61,8,0,pharmacy,"['research', 'and', 'market', 'p', '##oly', '##cy', '##stic', 'kidney', 'disease', 'pipeline', 'review']",1
234956,nifty_738,2013-10-01,"Research and Markets: Global Cancer Diagnostics Market 2013 - France, Germany, Italy, Japan, Spain, UK, USA - Sales Forecasts, Supplier Shares, Competitive Strategies",Neutral,-0.0009,166,research and market global cancer diagnostics market france germany italy japan spain usa sale forecast supplier share competitive strategy,139,19,0,pharmacy,"['research', 'and', 'market', 'global', 'cancer', 'diagnostic', '##s', 'market', 'f', '##rance', 'g', '##erman', '##y', 'it', '##aly', 'j', '##apa', '##n', 'spa', '##in', 'us', '##a', 'sale', 'forecast', 'supplier', 'share', 'competitive', 'strategy']",1
234970,nifty_738,2013-10-01,Furiex Pharmaceuticals Enters into a Loan Agreement for $15 Million and Restructures Its Existing Secured Loan,Neutral,-0.0009,110,furiex pharmaceutical enters into loan agreement for million and restructures it existing secured loan,102,14,0,pharmacy,"['fur', '##ie', '##x', 'pharmaceutical', 'enters', 'into', 'loan', 'agreement', 'for', 'million', 'and', 'rest', '##ru', '##cture', '##s', 'it', 'existing', 'secured', 'loan']",1
234972,nifty_738,2013-10-01,"Research and Markets: European Cancer Diagnostics Market 2013 - France, Germany, Italy, Spain, UK - Sales Forecasts, Supplier Shares, Competitive Strategies",Neutral,-0.0009,156,research and market european cancer diagnostics market france germany italy spain sale forecast supplier share competitive strategy,131,17,0,pharmacy,"['research', 'and', 'market', 'euro', '##pe', '##an', 'cancer', 'diagnostic', '##s', 'market', 'f', '##rance', 'g', '##erman', '##y', 'it', '##aly', 'spa', '##in', 'sale', 'forecast', 'supplier', 'share', 'competitive', 'strategy']",1
234976,nifty_738,2013-10-01,"Research and Markets: US Cancer Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies",Neutral,-0.0009,114,research and market cancer diagnostics market sale forecast supplier share competitive strategy,95,12,0,pharmacy,"['research', 'and', 'market', 'cancer', 'diagnostic', '##s', 'market', 'sale', 'forecast', 'supplier', 'share', 'competitive', 'strategy']",1
234978,nifty_738,2013-10-01,"Research and Markets: Diarrhea - Pipeline Review, H2 2013",Neutral,-0.0009,57,research and market diarrhea pipeline review,44,6,0,pharmacy,"['research', 'and', 'market', 'di', '##ar', '##r', '##hea', 'pipeline', 'review']",1
234982,nifty_738,2013-10-01,Merck Announces Global Initiative to Sharpen Commercial and R&D; Focus,Neutral,-0.0009,70,merck announces global initiative sharpen commercial and focus,62,8,0,pharmacy,"['me', '##rc', '##k', 'announces', 'global', 'initiative', 'sharp', '##en', 'commercial', 'and', 'focus']",1
235110,nifty_738,2013-10-01,Smooth Transitions are Important between Pharma Companiesâ Early Commercialization Groups,Neutral,-0.0009,91,smooth transition are important between pharma companiesâ early commercialization group,87,10,0,pharmacy,"['smooth', 'transition', 'are', 'important', 'between', 'p', '##har', '##ma', 'companies', '##â', 'early', 'commercial', '##ization', 'group']",1
235223,nifty_738,2013-10-01,Research and Markets: In-Vitro Colorectal Cancer Screening Tests - EU Analysis and Market Forecasts: 2013-2019,Neutral,-0.0009,110,research and market vitro colorectal cancer screening test analysis and market forecast,87,12,0,pharmacy,"['research', 'and', 'market', 'v', '##it', '##ro', 'color', '##ec', '##tal', 'cancer', 'screening', 'test', 'analysis', 'and', 'market', 'forecast']",1
235224,nifty_738,2013-10-01,"Research and Markets: Scar Global Clinical Trials Review, H2, 2013",Neutral,-0.0009,66,research and market scar global clinical trial review,53,8,0,pharmacy,"['research', 'and', 'market', 'scar', 'global', 'clinical', 'trial', 'review']",1
235286,nifty_738,2013-10-01,Research and Markets: Biomaterials China News 1308,Neutral,-0.0009,50,research and market biomaterials china news,43,6,0,pharmacy,"['research', 'and', 'market', 'bio', '##mate', '##rial', '##s', 'chin', '##a', 'news']",1
235355,nifty_738,2013-10-01,Global Markets for Bioseparations for Biopharmaceutical Manufacturing to Jump to $6 Billion by 2018,Neutral,-0.0009,99,global market for bioseparations for biopharmaceutical manufacturing jump billion,81,9,0,pharmacy,"['global', 'market', 'for', 'bio', '##se', '##par', '##ations', 'for', 'bio', '##pha', '##rma', '##ce', '##utical', 'manufacturing', 'jump', 'billion']",1
235384,nifty_738,2013-10-01,Myriad Genetics' shares rise as reimbursement concerns ease,Neutral,-0.0009,59,myriad genetics share rise reimbursement concern ease,53,7,0,pharmacy,"['my', '##riad', 'genetics', 'share', 'rise', 're', '##im', '##bur', '##se', '##ment', 'concern', 'ease']",1
235408,nifty_738,2013-10-01,ProQuest Supports Burgeoning Indian Research Market,Neutral,-0.0009,51,proquest support burgeoning indian research market,50,6,0,pharmacy,"['pro', '##quest', 'support', 'b', '##urge', '##oning', 'in', '##dian', 'research', 'market']",1
235424,nifty_738,2013-10-01,Bio-Path Holdings to Present at the 12th Annual BIO Investor Forum,Neutral,-0.0009,66,bio path holding present the annual bio investor forum,54,9,0,pharmacy,"['bio', 'path', 'holding', 'present', 'the', 'annual', 'bio', 'investor', 'forum']",1
235483,nifty_738,2013-10-01,BioExx Specialty Proteins Announces CCAA Filing,Neutral,-0.0009,47,bioexx specialty protein announces ccaa filing,46,6,0,pharmacy,"['bio', '##ex', '##x', 'specialty', 'protein', 'announces', 'cc', '##aa', 'filing']",1
235526,nifty_738,2013-10-01,Research and Markets: Gene Therapy Drug Pipeline Analysis Report 2013,Neutral,-0.0009,69,research and market gene therapy drug pipeline analysis report,62,9,0,pharmacy,"['research', 'and', 'market', 'gene', 'therapy', 'drug', 'pipeline', 'analysis', 'report']",1
235543,nifty_738,2013-10-01,Research and Markets: Global Cell Therapy Pipeline Analysis Report 2013,Neutral,-0.0009,71,research and market global cell therapy pipeline analysis report,64,9,0,pharmacy,"['research', 'and', 'market', 'global', 'cell', 'therapy', 'pipeline', 'analysis', 'report']",1
235625,nifty_738,2013-10-01,"Research and Markets: Cancer/Tumor Profiling Market by Applications, Technologies & Segments 2013 - 2018",Neutral,-0.0009,104,research and market cancer tumor profiling market application technology segment,80,10,0,pharmacy,"['research', 'and', 'market', 'cancer', 'tumor', 'pro', '##fi', '##ling', 'market', 'application', 'technology', 'segment']",1
236001,nifty_739,2013-10-02,Research and Markets: Italy Cancer Diagnostics Market: Innovative Technologies and Emerging Business Opportunities,Fall,-0.0092,114,research and market italy cancer diagnostics market innovative technology and emerging business opportunity,107,13,0,pharmacy,"['research', 'and', 'market', 'it', '##aly', 'cancer', 'diagnostic', '##s', 'market', 'innovative', 'technology', 'and', 'emerging', 'business', 'opportunity']",1
236003,nifty_739,2013-10-02,"Research and Markets: France Cancer Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies",Fall,-0.0092,118,research and market france cancer diagnostics market sale forecast supplier share competitive strategy,102,13,0,pharmacy,"['research', 'and', 'market', 'f', '##rance', 'cancer', 'diagnostic', '##s', 'market', 'sale', 'forecast', 'supplier', 'share', 'competitive', 'strategy']",1
236007,nifty_739,2013-10-02,"Research and Markets: UK Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers",Fall,-0.0092,111,research and market cancer diagnostics market outlook innovation trend and opportunity for supplier,99,13,0,pharmacy,"['research', 'and', 'market', 'cancer', 'diagnostic', '##s', 'market', 'outlook', 'innovation', 'trend', 'and', 'opportunity', 'for', 'supplier']",1
236009,nifty_739,2013-10-02,"Research and Markets: Japan Cancer Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies",Fall,-0.0092,117,research and market japan cancer diagnostics market sale forecast supplier share competitive strategy,101,13,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##n', 'cancer', 'diagnostic', '##s', 'market', 'sale', 'forecast', 'supplier', 'share', 'competitive', 'strategy']",1
236018,nifty_739,2013-10-02,"Research and Markets: UK Cancer Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies",Fall,-0.0092,114,research and market cancer diagnostics market sale forecast supplier share competitive strategy,95,12,0,pharmacy,"['research', 'and', 'market', 'cancer', 'diagnostic', '##s', 'market', 'sale', 'forecast', 'supplier', 'share', 'competitive', 'strategy']",1
236056,nifty_739,2013-10-02,Innovus Pharmaceuticals to Present at the 12th Annual BIO Investor Forum in San Francisco,Fall,-0.0092,89,innovus pharmaceutical present the annual bio investor forum san francisco,74,10,0,pharmacy,"['inn', '##ov', '##us', 'pharmaceutical', 'present', 'the', 'annual', 'bio', 'investor', 'forum', 'sa', '##n', 'f', '##ran', '##cis', '##co']",1
236080,nifty_739,2013-10-02,Ambit Announces Participation At 12th Annual BIO Investor Forum,Fall,-0.0092,63,ambit announces participation annual bio investor forum,55,7,0,pharmacy,"['am', '##bit', 'announces', 'participation', 'annual', 'bio', 'investor', 'forum']",1
236154,nifty_739,2013-10-02,"Regulatory Approval, New Appointments, Stock Price Movements, and Other Announcements - Research Report on Pfizer, Warner Chilcott, Rockwell Medical, InterMune, and Ligand",Fall,-0.0092,171,regulatory approval new appointment stock price movement and other announcement research report pfizer warner chilcott rockwell medical intermune and ligand,156,20,0,pharmacy,"['regulatory', 'approval', 'new', 'appointment', 'stock', 'price', 'movement', 'and', 'other', 'announcement', 'research', 'report', 'p', '##fi', '##zer', 'warn', '##er', 'ch', '##il', '##cott', 'rock', '##well', 'medical', 'inter', '##mu', '##ne', 'and', 'l', '##igan', '##d']",1
236157,nifty_739,2013-10-02,"Dividend Increases, Research Nominations, New Treatment Options, and Clinical Trials - Research Report on Covidien, Ironwood, ICON, Novadaq, and Antares",Fall,-0.0092,152,dividend increase research nomination new treatment option and clinical trial research report covidien ironwood icon novadaq and antares,136,18,0,pharmacy,"['divide', '##nd', 'increase', 'research', 'nomination', 'new', 'treatment', 'option', 'and', 'clinical', 'trial', 'research', 'report', 'co', '##vid', '##ien', 'iron', '##wood', 'icon', 'no', '##va', '##da', '##q', 'and', 'ant', '##ares']",1
236160,nifty_739,2013-10-02,"Healthcare Focused Collaborations, Program Expansions, New e-training Courses, Results Schedules and Product Launches - Research Report on IBM, Xerox, Rackspace, Riverbed, and FIS",Fall,-0.0092,179,healthcare focused collaboration program expansion new training course result schedule and product launch research report ibm xerox rackspace riverbed and fis,158,21,0,pharmacy,"['healthcare', 'focused', 'collaboration', 'program', 'expansion', 'new', 'training', 'course', 'result', 'schedule', 'and', 'product', 'launch', 'research', 'report', 'i', '##b', '##m', 'x', '##ero', '##x', 'rack', '##space', 'river', '##bed', 'and', 'fi', '##s']",1
236162,nifty_739,2013-10-02,Innovative BioDefense and Golden State Medical Supply Will Joint Venture to Sell Zylastâ¢ to the Government,Fall,-0.0092,108,innovative biodefense and golden state medical supply will joint venture sell zylastâ the government,100,14,0,pharmacy,"['innovative', 'bio', '##de', '##fen', '##se', 'and', 'golden', 'state', 'medical', 'supply', 'will', 'joint', 'venture', 'sell', 'z', '##yla', '##st', '##â', 'the', 'government']",1
236174,nifty_739,2013-10-02,BioNano Genomics Raises $10 Million Financing To Advance Irys System For Human Genome Analysis,Fall,-0.0092,94,bionano genomics raise million financing advance irys system for human genome analysis,86,12,0,pharmacy,"['bio', '##nan', '##o', 'g', '##eno', '##mic', '##s', 'raise', 'million', 'financing', 'advance', 'i', '##ry', '##s', 'system', 'for', 'human', 'genome', 'analysis']",1
236178,nifty_739,2013-10-02,diaDexus to Present at the BIO Investor Forum,Fall,-0.0092,45,diadexus present the bio investor forum,39,6,0,pharmacy,"['di', '##ade', '##x', '##us', 'present', 'the', 'bio', 'investor', 'forum']",1
236285,nifty_739,2013-10-02,Cerecor to Present at 12th Annual BIO Investor Forum,Fall,-0.0092,52,cerecor present annual bio investor forum,41,6,0,pharmacy,"['c', '##ere', '##cor', 'present', 'annual', 'bio', 'investor', 'forum']",1
236358,nifty_739,2013-10-02,"Research and Markets: Partnerships, Licensing, Investments and M&A; Deals and Trends in Pharmaceuticals - Q2 2013",Fall,-0.0092,113,research and market partnership licensing investment and deal and trend pharmaceutical,86,11,0,pharmacy,"['research', 'and', 'market', 'partnership', 'licensing', 'investment', 'and', 'deal', 'and', 'trend', 'pharmaceutical']",1
236363,nifty_739,2013-10-02,"Tech Strategy Development The Focus Of OPEN MINDS' 2013 Technology & Informatics Institute - Analytics, Telehealth, & Treatment Technologies Frame The Two-Day Institute Agenda",Fall,-0.0092,175,tech strategy development the focus open mind technology informatics institute analytics telehealth treatment technology frame the two day institute agenda,155,20,0,pharmacy,"['tech', 'strategy', 'development', 'the', 'focus', 'open', 'mind', 'technology', 'inform', '##atic', '##s', 'institute', 'anal', '##ytic', '##s', 'te', '##le', '##hea', '##lt', '##h', 'treatment', 'technology', 'frame', 'the', 'two', 'day', 'institute', 'agenda']",1
236394,nifty_739,2013-10-02,Research and Markets: Disease and Therapy Review: Constipation,Fall,-0.0092,62,research and market disease and therapy review constipation,59,8,0,pharmacy,"['research', 'and', 'market', 'disease', 'and', 'therapy', 'review', 'con', '##st', '##ip', '##ation']",1
236396,nifty_739,2013-10-02,Research and Markets: US Medical Radiopharmaceuticals Market,Fall,-0.0092,60,research and market medical radiopharmaceutical market,54,6,0,pharmacy,"['research', 'and', 'market', 'medical', 'radio', '##pha', '##rma', '##ce', '##utical', 'market']",1
236458,nifty_739,2013-10-02,Research and Markets: Vital Signs - Health Insurance Exchanges: Real-Time Analyst Insights on HIX August 2013,Fall,-0.0092,109,research and market vital sign health insurance exchange real time analyst insight hix august,93,14,0,pharmacy,"['research', 'and', 'market', 'vital', 'sign', 'health', 'insurance', 'exchange', 'real', 'time', 'analyst', 'insight', 'hi', '##x', 'au', '##gus', '##t']",1
236481,nifty_739,2013-10-02,Research and Markets: Clinical Laboratory Testing Services Market Trends and Forecasts - The Americas Edition 2014-2018,Fall,-0.0092,119,research and market clinical laboratory testing service market trend and forecast the america edition,101,14,0,pharmacy,"['research', 'and', 'market', 'clinical', 'laboratory', 'testing', 'service', 'market', 'trend', 'and', 'forecast', 'the', 'am', '##eric', '##a', 'edition']",1
236484,nifty_739,2013-10-02,Research and Markets: Clinical Laboratory Testing Services Market Trends and Forecasts Asia Pacific 2014-2018,Fall,-0.0092,109,research and market clinical laboratory testing service market trend and forecast asia pacific,94,13,0,pharmacy,"['research', 'and', 'market', 'clinical', 'laboratory', 'testing', 'service', 'market', 'trend', 'and', 'forecast', 'as', '##ia', 'p', '##ac', '##ific']",1
236514,nifty_739,2013-10-02,"Research and Markets: Global RNAi Market Report 2013-2022: Updated Technologies, Markets and Companies Analysis",Fall,-0.0092,111,research and market global rnai market report updated technology market and company analysis,92,13,0,pharmacy,"['research', 'and', 'market', 'global', 'r', '##nai', 'market', 'report', 'updated', 'technology', 'market', 'and', 'company', 'analysis']",1
236535,nifty_739,2013-10-02,Research and Markets: Corporate Reputation of the Major Pharma Companies in Italy - from a Patient Perspective: 2013 Survey,Fall,-0.0092,123,research and market corporate reputation the major pharma company italy from patient perspective survey,103,14,0,pharmacy,"['research', 'and', 'market', 'corporate', 'reputation', 'the', 'major', 'p', '##har', '##ma', 'company', 'it', '##aly', 'from', 'patient', 'perspective', 'survey']",1
236564,nifty_739,2013-10-02,Research and Markets: Corporate Reputation of the Major Pharma Companies in Germany - 2013 Survey,Fall,-0.0092,97,research and market corporate reputation the major pharma company germany survey,80,11,0,pharmacy,"['research', 'and', 'market', 'corporate', 'reputation', 'the', 'major', 'p', '##har', '##ma', 'company', 'g', '##erman', '##y', 'survey']",1
236570,nifty_739,2013-10-02,Research and Markets: End Stage Renal Disease - Disease and Therapy Review: 2013 Out Now,Fall,-0.0092,88,research and market end stage renal disease disease and therapy review out now,78,13,0,pharmacy,"['research', 'and', 'market', 'end', 'stage', 're', '##nal', 'disease', 'disease', 'and', 'therapy', 'review', 'out', 'now']",1
236837,nifty_740,2013-10-03,IMMUNE Pharmaceuticals Inc. to Present at 12th Annual BIO Investor Forum,Rise,0.0076,72,immune pharmaceutical inc present annual bio investor forum,59,8,0,pharmacy,"['immune', 'pharmaceutical', 'in', '##c', 'present', 'annual', 'bio', 'investor', 'forum']",1
236943,nifty_740,2013-10-03,Research and Markets: Corporate Reputation of the Major Pharma Companies in the USA - from a Patient Perspective,Rise,0.0076,112,research and market corporate reputation the major pharma company the usa from patient perspective,98,14,0,pharmacy,"['research', 'and', 'market', 'corporate', 'reputation', 'the', 'major', 'p', '##har', '##ma', 'company', 'the', 'us', '##a', 'from', 'patient', 'perspective']",1
236944,nifty_740,2013-10-03,Research and Markets: Corporate Reputation of the Major Pharma Companies in the UK - From a Patient Perspective,Rise,0.0076,111,research and market corporate reputation the major pharma company the from patient perspective,94,13,0,pharmacy,"['research', 'and', 'market', 'corporate', 'reputation', 'the', 'major', 'p', '##har', '##ma', 'company', 'the', 'from', 'patient', 'perspective']",1
236948,nifty_740,2013-10-03,"Research and Markets: Metabolic Syndrome - Pipeline Review, H2 2013",Rise,0.0076,67,research and market metabolic syndrome pipeline review,54,7,0,pharmacy,"['research', 'and', 'market', 'metabolic', 'syndrome', 'pipeline', 'review']",1
236964,nifty_740,2013-10-03,"Research and Markets: Neutropenia - Pipeline Review, H2 2013",Rise,0.0076,60,research and market neutropenia pipeline review,47,6,0,pharmacy,"['research', 'and', 'market', 'ne', '##ut', '##rop', '##enia', 'pipeline', 'review']",1
236997,nifty_740,2013-10-03,Novartis sees limited impact from Japan Diovan scandal,Rise,0.0076,54,novartis see limited impact from japan diovan scandal,53,8,0,pharmacy,"['no', '##var', '##tis', 'see', 'limited', 'impact', 'from', 'j', '##apa', '##n', 'di', '##ova', '##n', 'scandal']",1
237025,nifty_740,2013-10-03,"Protein Bar Receives Significant Investment From Catterton Partners, The Leading Consumer-Focused Private Equity Firm",Rise,0.0076,117,protein bar receives significant investment from catterton partner the leading consumer focused private equity firm,115,15,0,pharmacy,"['protein', 'bar', 'receives', 'significant', 'investment', 'from', 'cat', '##ter', '##ton', 'partner', 'the', 'leading', 'consumer', 'focused', 'private', 'equity', 'firm']",1
237048,nifty_740,2013-10-03,Research and Markets: Disease and Therapy Review: Fibromyalgia,Rise,0.0076,62,research and market disease and therapy review fibromyalgia,59,8,0,pharmacy,"['research', 'and', 'market', 'disease', 'and', 'therapy', 'review', 'fi', '##bro', '##my', '##al', '##gia']",1
237209,nifty_740,2013-10-03,BioClinica Shapes Global Industry Discussion At Upcoming Events,Rise,0.0076,63,bioclinica shape global industry discussion upcoming event,58,7,0,pharmacy,"['bio', '##c', '##lini', '##ca', 'shape', 'global', 'industry', 'discussion', 'upcoming', 'event']",1
237246,nifty_740,2013-10-03,Critical Outcome Technologies to Present at the 12th Annual BIO Investor Forum,Rise,0.0076,78,critical outcome technology present the annual bio investor forum,65,9,0,pharmacy,"['critical', 'outcome', 'technology', 'present', 'the', 'annual', 'bio', 'investor', 'forum']",1
237286,nifty_740,2013-10-03,Global Healthcare IT Outsourcing Market Report 2013-2018,Rise,0.0076,56,global healthcare outsourcing market report,43,5,0,pharmacy,"['global', 'healthcare', 'outs', '##our', '##cing', 'market', 'report']",1
237287,nifty_740,2013-10-03,Research and Markets: A Benchmarking Strategy for Corporate Patient Centricity - 2013 Report Out Now for the Pharma Sector,Rise,0.0076,122,research and market benchmarking strategy for corporate patient centricity report out now for the pharma sector,111,16,0,pharmacy,"['research', 'and', 'market', 'bench', '##mark', '##ing', 'strategy', 'for', 'corporate', 'patient', 'cent', '##ric', '##ity', 'report', 'out', 'now', 'for', 'the', 'p', '##har', '##ma', 'sector']",1
237296,nifty_740,2013-10-03,"Research and Markets: Data Processing (European) - Analysis of The Top 400 Companies Unicredit Business Integrated Solutions Societa' Consortile Per Azioni, Toll Collect Gmbh and Compugroup Medical Ag",Rise,0.0076,200,research and market data processing european analysis the top company unicredit business integrated solution societa consortile per azioni toll collect gmbh and compugroup medical,179,24,0,pharmacy,"['research', 'and', 'market', 'data', 'processing', 'euro', '##pe', '##an', 'analysis', 'the', 'top', 'company', 'un', '##ic', '##red', '##it', 'business', 'integrated', 'solution', 'so', '##cie', '##ta', 'consort', '##ile', 'per', 'a', '##zio', '##ni', 'toll', 'collect', 'g', '##mb', '##h', 'and', 'com', '##pu', '##group', 'medical']",1
237380,nifty_740,2013-10-03,Research and Markets: Clinical Laboratory Testing Services Market Trends and Forecasts Africa & The Middle East 2014-2018 Africa & The Middle East,Rise,0.0076,146,research and market clinical laboratory testing service market trend and forecast africa the middle east africa the middle east,127,19,0,pharmacy,"['research', 'and', 'market', 'clinical', 'laboratory', 'testing', 'service', 'market', 'trend', 'and', 'forecast', 'a', '##f', '##rica', 'the', 'middle', 'east', 'a', '##f', '##rica', 'the', 'middle', 'east']",1
237385,nifty_740,2013-10-03,Hemispherx Biopharma's 2013 Stockholder Annual Meeting Proposal 4 Removed From Stockholder Consideration,Rise,0.0076,104,hemispherx biopharma stockholder annual meeting proposal removed from stockholder consideration,95,10,0,pharmacy,"['hem', '##is', '##pher', '##x', 'bio', '##pha', '##rma', 'stock', '##holder', 'annual', 'meeting', 'proposal', 'removed', 'from', 'stock', '##holder', 'consideration']",1
237493,nifty_740,2013-10-03,OncoMed Pharmaceuticals to Present at 12th Annual BIO Investor Forum,Rise,0.0076,68,oncomed pharmaceutical present annual bio investor forum,56,7,0,pharmacy,"['on', '##come', '##d', 'pharmaceutical', 'present', 'annual', 'bio', 'investor', 'forum']",1
237502,nifty_740,2013-10-03,Press Release Issued Under the Early Warning System/Sale of Shares of Nymox Pharmaceutical Corporation,Rise,0.0076,102,press release issued under the early warning system sale share nymox pharmaceutical corporation,95,13,0,pharmacy,"['press', 'release', 'issued', 'under', 'the', 'early', 'warning', 'system', 'sale', 'share', 'n', '##ym', '##ox', 'pharmaceutical', 'corporation']",1
237694,nifty_741,2013-10-07,Biogen Says Death of MS Patient Not Related to Drug,Fall,-0.0116,51,biogen say death patient not related drug,41,7,0,pharmacy,"['bio', '##gen', 'say', 'death', 'patient', 'not', 'related', 'drug']",1
237793,nifty_743,2013-10-09,Setback for Ariad's Leukemia Drug,Rise,0.0216,33,setback for ariad leukemia drug,31,5,0,pharmacy,"['set', '##back', 'for', 'a', '##riad', 'le', '##uke', '##mia', 'drug']",1
237877,nifty_745,2013-10-14,New Drugs Zap Tumors Via Immune System,Fall,-0.0073,38,new drug zap tumor via immune system,36,7,0,pharmacy,"['new', 'drug', 'z', '##ap', 'tumor', 'via', 'immune', 'system']",1
238045,nifty_746,2013-10-15,New CEO Tom Zajac to Lead Wellcentive through Explosive Growth in Population Health Market,Rise,0.014,90,new ceo tom zajac lead wellcentive through explosive growth population health market,84,12,0,pharmacy,"['new', 'c', '##eo', 'to', '##m', 'z', '##aja', '##c', 'lead', 'well', '##cent', '##ive', 'through', 'explosive', 'growth', 'population', 'health', 'market']",1
238121,nifty_746,2013-10-15,"Upcoming Earnings Release Schedules, Board Nominations, Strategic Investments and FDA Responses - Research Report on Zimmer, ResMed, Varian, Opko and EnteroMedics",Rise,0.014,162,upcoming earnings release schedule board nomination strategic investment and fda response research report zimmer resmed varian opko and enteromedics,148,19,0,pharmacy,"['upcoming', 'earnings', 'release', 'schedule', 'board', 'nomination', 'strategic', 'investment', 'and', 'f', '##da', 'response', 'research', 'report', 'z', '##immer', 're', '##sm', '##ed', 'var', '##ian', 'op', '##ko', 'and', 'enter', '##ome', '##dic', '##s']",1
238321,nifty_746,2013-10-15,"Research and Markets: Global Medical Imaging Reagents Market 2012-2016 with Bracco, Covidien, GE healthcare and Lantheus Medical Imaging Dominating",Rise,0.014,147,research and market global medical imaging reagent market with bracco covidien healthcare and lantheus medical imaging dominating,129,17,0,pharmacy,"['research', 'and', 'market', 'global', 'medical', 'imaging', 're', '##age', '##nt', 'market', 'with', 'bra', '##cco', 'co', '##vid', '##ien', 'healthcare', 'and', 'la', '##nt', '##heus', 'medical', 'imaging', 'dominating']",1
238405,nifty_746,2013-10-15,"Research and Markets: Encephalitis Global Clinical Trials Review, H2, 2013",Rise,0.014,74,research and market encephalitis global clinical trial review,61,8,0,pharmacy,"['research', 'and', 'market', 'en', '##ce', '##pha', '##lit', '##is', 'global', 'clinical', 'trial', 'review']",1
238445,nifty_746,2013-10-15,Research and Markets: Private Healthcare Market in CIS Countries 2013,Rise,0.014,69,research and market private healthcare market ci country,56,8,0,pharmacy,"['research', 'and', 'market', 'private', 'healthcare', 'market', 'c', '##i', 'country']",1
238509,nifty_746,2013-10-15,"Research and Markets: An Introduction to Post Marketing Surveillance and the European Medical Device Vigilance (Course, London)",Rise,0.014,127,research and market introduction post marketing surveillance and the european medical device vigilance course london,116,15,0,pharmacy,"['research', 'and', 'market', 'introduction', 'post', 'marketing', 'surveillance', 'and', 'the', 'euro', '##pe', '##an', 'medical', 'device', 'v', '##igi', '##lance', 'course', 'lo', '##ndon']",1
238605,nifty_746,2013-10-15,"QIAGEN Launches Empowered Genome Community, Invites Citizen Scientists and Researchers to Pool and Collaboratively Interpret Human Genomes",Rise,0.014,138,qiagen launch empowered genome community invite citizen scientist and researcher pool and collaboratively interpret human genome,128,16,0,pharmacy,"['q', '##ia', '##gen', 'launch', 'em', '##powered', 'genome', 'community', 'invite', 'citizen', 'scientist', 'and', 'researcher', 'pool', 'and', 'collaborative', '##ly', 'interpret', 'human', 'genome']",1
238844,nifty_746,2013-10-15,Quest Diagnostics Offers Cancer Screening Test,Rise,0.014,46,quest diagnostics offer cancer screening test,45,6,0,pharmacy,"['quest', 'diagnostic', '##s', 'offer', 'cancer', 'screening', 'test']",1
238898,nifty_747,2013-10-16,New Cholesterol Drug Shows Promise,Rise,0.0067,34,new cholesterol drug show promise,33,5,0,pharmacy,"['new', 'ch', '##ole', '##ster', '##ol', 'drug', 'show', 'promise']",1
238910,nifty_747,2013-10-16,St. Jude Medical Earnings Up 49%,Rise,0.0067,32,jude medical earnings,21,3,0,pharmacy,"['j', '##ude', 'medical', 'earnings']",1
238946,nifty_748,2013-10-17,BB Biotech continues its strong performance - third-quarter profit CHF 338.8 mn / share price up more than 50% since beginning of the year,Rise,0.0068,138,biotech continues it strong performance third quarter profit chf share price more than since beginning the year,111,17,0,pharmacy,"['bio', '##tech', 'continues', 'it', 'strong', 'performance', 'third', 'quarter', 'profit', 'ch', '##f', 'share', 'price', 'more', 'than', 'since', 'beginning', 'the', 'year']",1
239247,nifty_748,2013-10-17,"10X Fund Issues Statement on Sale of Shares, Bullish Outlook Regarding Galectin Therapeutics",Rise,0.0068,92,fund issue statement sale share bullish outlook regarding galectin therapeutic,78,10,0,pharmacy,"['fund', 'issue', 'statement', 'sale', 'share', 'bull', '##ish', 'outlook', 'regarding', 'gal', '##ec', '##tin', 'therapeutic']",1
239266,nifty_748,2013-10-17,Research and Markets: Market Research: September 2013 Emerging Medical Technologies Report,Rise,0.0068,90,research and market market research september emerging medical technology report,80,10,0,pharmacy,"['research', 'and', 'market', 'market', 'research', 'se', '##pt', '##em', '##ber', 'emerging', 'medical', 'technology', 'report']",1
239275,nifty_748,2013-10-17,Drupal's on Steroids and It's Disrupting the Enterprise,Rise,0.0068,55,drupal steroid and disrupting the enterprise,44,6,0,pharmacy,"['d', '##rup', '##al', 's', '##tero', '##id', 'and', 'disrupt', '##ing', 'the', 'enterprise']",1
239288,nifty_748,2013-10-17,"Premier Biopharmaceutical Publication Pharmaceutical Executive Delivers Annual Audit of Most Valuable Companies to Shareholders, Finding Common Thread of Success Amongst Mid-Level Companies, Not Too Small for Global Reach or",Rise,0.0068,224,premier biopharmaceutical publication pharmaceutical executive delivers annual audit most valuable company shareholder finding common thread success amongst mid level company not too small for global reach,205,26,0,pharmacy,"['premier', 'bio', '##pha', '##rma', '##ce', '##utical', 'publication', 'pharmaceutical', 'executive', 'delivers', 'annual', 'audit', 'most', 'valuable', 'company', 'shareholder', 'finding', 'common', 'thread', 'success', 'amongst', 'mid', 'level', 'company', 'not', 'too', 'small', 'for', 'global', 'reach']",1
239294,nifty_748,2013-10-17,Research and Markets: EpiCast Report: Gram-Negative Bacterial Pneumonia - Epidemiology Forecast to 2022,Rise,0.0068,103,research and market epicast report gram negative bacterial pneumonia epidemiology forecast,90,11,0,pharmacy,"['research', 'and', 'market', 'epic', '##ast', 'report', 'gram', 'negative', 'bacterial', 'pneumonia', 'e', '##pid', '##em', '##iology', 'forecast']",1
239311,nifty_748,2013-10-17,"Research and Markets: Market Research - Epilepsy Global Clinical Trials Review, H2, 2013",Rise,0.0068,88,research and market market research epilepsy global clinical trial review,73,10,0,pharmacy,"['research', 'and', 'market', 'market', 'research', 'e', '##pile', '##psy', 'global', 'clinical', 'trial', 'review']",1
239327,nifty_748,2013-10-17,"AMAG Pharmaceuticals, Inc. to Host Conference Call on October 23, 2013 at 8:00 a.m. ET to Discuss Financial Results for the Quarter Ended September 30, 2013",Rise,0.0068,156,amag pharmaceutical inc host conference call october discus financial result for the quarter ended september,108,15,0,pharmacy,"['am', '##ag', 'pharmaceutical', 'in', '##c', 'host', 'conference', 'call', 'o', '##ct', '##obe', '##r', 'disc', '##us', 'financial', 'result', 'for', 'the', 'quarter', 'ended', 'se', '##pt', '##em', '##ber']",1
239359,nifty_748,2013-10-17,"Trinity Biotech Announces Quarter 3 Financial Results, Acquisition of Blood Bank Screening Business and FDA Approval of HIV-2 Claim",Rise,0.0068,131,trinity biotech announces quarter financial result acquisition blood bank screening business and fda approval hiv claim,119,16,0,pharmacy,"['t', '##rini', '##ty', 'bio', '##tech', 'announces', 'quarter', 'financial', 'result', 'acquisition', 'blood', 'bank', 'screening', 'business', 'and', 'f', '##da', 'approval', 'hi', '##v', 'claim']",1
239411,nifty_748,2013-10-17,"Research and Markets: EC Medical Devices Vigilance System & Post Marketing Surveillance - Ensuring Patient Safety (Conference, London)",Rise,0.0068,134,research and market medical device vigilance system post marketing surveillance ensuring patient safety conference london,121,15,0,pharmacy,"['research', 'and', 'market', 'medical', 'device', 'v', '##igi', '##lance', 'system', 'post', 'marketing', 'surveillance', 'ensuring', 'patient', 'safety', 'conference', 'lo', '##ndon']",1
239431,nifty_748,2013-10-17,"Research and Markets: Global Stem Cells Market Report 2013-2018: Adult Stem Cells, Human Embryonic Stem Cells and Other Stem Cells",Rise,0.0068,130,research and market global stem cell market report adult stem cell human embryonic stem cell and other stem cell,112,19,0,pharmacy,"['research', 'and', 'market', 'global', 'stem', 'cell', 'market', 'report', 'adult', 'stem', 'cell', 'human', 'em', '##b', '##ryo', '##nic', 'stem', 'cell', 'and', 'other', 'stem', 'cell']",1
239548,nifty_748,2013-10-17,"Technical Study: Amgen Inc., Questcor Pharmaceuticals Inc., PDL BioPharma Inc., and BioCryst Pharma Inc.",Rise,0.0068,104,technical study amgen inc questcor pharmaceutical inc pdl biopharma inc and biocryst pharma inc,95,14,0,pharmacy,"['technical', 'study', 'am', '##gen', 'in', '##c', 'quest', '##cor', 'pharmaceutical', 'in', '##c', 'p', '##dl', 'bio', '##pha', '##rma', 'in', '##c', 'and', 'bio', '##c', '##ry', '##st', 'p', '##har', '##ma', 'in', '##c']",1
239560,nifty_748,2013-10-17,"Research and Markets: Global Radiation Detection, Monitoring & Safety Market Report 2013-2017: Geiger Counter, Scintillator, Dosimeter, Area Process, Survey Meter, Portal Monitors",Rise,0.0068,179,research and market global radiation detection monitoring safety market report geiger counter scintillator dosimeter area process survey meter portal monitor,157,20,0,pharmacy,"['research', 'and', 'market', 'global', 'radiation', 'detection', 'monitoring', 'safety', 'market', 'report', 'g', '##ei', '##ger', 'counter', 's', '##cin', '##til', '##lator', 'dos', '##imeter', 'area', 'process', 'survey', 'meter', 'portal', 'monitor']",1
239566,nifty_748,2013-10-17,"Technical Study: AstraZeneca PLC, GlaxoSmithKline PLC, Keryx Biopharma Inc., and Raptor Pharma Corp.",Rise,0.0068,100,technical study astrazeneca plc glaxosmithkline plc keryx biopharma inc and raptor pharma corp,94,13,0,pharmacy,"['technical', 'study', 'as', '##tra', '##zen', '##eca', 'plc', 'g', '##lax', '##os', '##mith', '##k', '##line', 'plc', 'k', '##ery', '##x', 'bio', '##pha', '##rma', 'in', '##c', 'and', 'rap', '##tor', 'p', '##har', '##ma', 'co', '##rp']",1
239761,nifty_748,2013-10-17,SAC's Cohen trying to unload stake in Kadmon Pharmaceuticals,Rise,0.0068,60,sac cohen trying unload stake kadmon pharmaceutical,51,7,0,pharmacy,"['sa', '##c', 'co', '##hen', 'trying', 'un', '##load', 'stake', 'ka', '##d', '##mon', 'pharmaceutical']",1
239891,nifty_748,2013-10-17,U.K. Recalls Wockhardt Drugs,Rise,0.0068,28,recall wockhardt drug,21,3,0,pharmacy,"['recall', 'w', '##ock', '##hardt', 'drug']",1
239893,nifty_748,2013-10-17,Amarin Shares Plummet on Cholesterol Drug Setback,Rise,0.0068,49,amarin share plummet cholesterol drug setback,45,6,0,pharmacy,"['am', '##ari', '##n', 'share', 'p', '##lum', '##met', 'ch', '##ole', '##ster', '##ol', 'drug', 'set', '##back']",1
239971,nifty_750,2013-10-22,Medical Devices Face Tighter EU Rules,Neutral,-0.0048,37,medical device face tighter rule,32,5,0,pharmacy,"['medical', 'device', 'face', 'tighter', 'rule']",1
240106,nifty_751,2013-10-23,Bristol-Myers Returns to Sales Growth,Neutral,0.0033,37,bristol myers return sale growth,32,5,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'return', 'sale', 'growth']",1
240129,nifty_752,2013-10-24,FDA Urges New Limits on Pain Drugs,Neutral,0.0046,34,fda urge new limit pain drug,28,6,0,pharmacy,"['f', '##da', 'urge', 'new', 'limit', 'pain', 'drug']",1
240326,nifty_753,2013-10-28,Wolters Kluwer Health Investor Seminar,Rise,0.0053,38,wolters kluwer health investor seminar,38,5,0,pharmacy,"['w', '##olt', '##ers', 'k', '##lu', '##wer', 'health', 'investor', 'seminar']",1
240348,nifty_753,2013-10-28,Research and Markets: Global RFID Blood Monitoring Systems Market - 2013 Report,Rise,0.0053,79,research and market global rfid blood monitoring system market report,69,10,0,pharmacy,"['research', 'and', 'market', 'global', 'r', '##fi', '##d', 'blood', 'monitoring', 'system', 'market', 'report']",1
240356,nifty_753,2013-10-28,Research and Markets: Clinical Revolution: Working with CCGs in the New Primary Care Landscape,Rise,0.0053,94,research and market clinical revolution working with ccgs the new primary care landscape,88,13,0,pharmacy,"['research', 'and', 'market', 'clinical', 'revolution', 'working', 'with', 'cc', '##gs', 'the', 'new', 'primary', 'care', 'landscape']",1
240378,nifty_753,2013-10-28,"PDL BioPharma to Announce Third Quarter 2013 Financial Results on November 6, 2013",Rise,0.0053,82,pdl biopharma announce third quarter financial result november,62,8,0,pharmacy,"['p', '##dl', 'bio', '##pha', '##rma', 'announce', 'third', 'quarter', 'financial', 'result', 'no', '##ve', '##mber']",1
240413,nifty_753,2013-10-28,"Biogen's new MS drug tops expectations, earnings rise",Rise,0.0053,53,biogen new drug top expectation earnings rise,45,7,0,pharmacy,"['bio', '##gen', 'new', 'drug', 'top', 'expectation', 'earnings', 'rise']",1
240485,nifty_753,2013-10-28,"BioTime, Inc. to Provide Company Updates During Investor Day, October 28, 2013",Rise,0.0053,78,biotime inc provide company update during investor day october,62,9,0,pharmacy,"['bio', '##time', 'in', '##c', 'provide', 'company', 'update', 'during', 'investor', 'day', 'o', '##ct', '##obe', '##r']",1
240513,nifty_753,2013-10-28,"Today's Research: Hologic Inc., St. Jude Medical Inc., Navidea Biopharma Inc, and ResMed Inc.",Rise,0.0053,93,today research hologic inc jude medical inc navidea biopharma inc and resmed inc,80,13,0,pharmacy,"['today', 'research', 'ho', '##log', '##ic', 'in', '##c', 'j', '##ude', 'medical', 'in', '##c', 'na', '##vide', '##a', 'bio', '##pha', '##rma', 'in', '##c', 'and', 're', '##sm', '##ed', 'in', '##c']",1
240518,nifty_753,2013-10-28,"Recognitions, Patent Issuance, Financial Results, Upcoming Investor Conferences and Update on ClinicalTrial - Research Report on Stereotaxis, Immunomedics, Novadaq, Avanir, and Raptor Pharmaceuticals",Rise,0.0053,199,recognition patent issuance financial result upcoming investor conference and update clinicaltrial research report stereotaxis immunomedics novadaq avanir and raptor pharmaceutical,180,20,0,pharmacy,"['recognition', 'patent', 'is', '##su', '##ance', 'financial', 'result', 'upcoming', 'investor', 'conference', 'and', 'update', 'clinical', '##tri', '##al', 'research', 'report', 'stereo', '##ta', '##xi', '##s', 'im', '##mu', '##no', '##med', '##ics', 'no', '##va', '##da', '##q', 'a', '##vani', '##r', 'and', 'rap', '##tor', 'pharmaceutical']",1
240525,nifty_753,2013-10-28,"Today's Research: Inovio Pharmaceuticals Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc.",Rise,0.0053,114,today research inovio pharmaceutical inc sequenom inc nektar therapeutic and discovery laboratory inc,101,13,0,pharmacy,"['today', 'research', 'in', '##ov', '##io', 'pharmaceutical', 'in', '##c', 'se', '##que', '##no', '##m', 'in', '##c', 'ne', '##kt', '##ar', 'therapeutic', 'and', 'discovery', 'laboratory', 'in', '##c']",1
240527,nifty_753,2013-10-28,"Quarterly Financial Reports and Upcoming Earnings and Conferences Call Schedules - Research Report on St. Jude Medical, Varian, Techne, DexCom, and Hill-Rom",Rise,0.0053,156,quarterly financial report and upcoming earnings and conference call schedule research report jude medical varian techne dexcom and hill rom,140,20,0,pharmacy,"['quarterly', 'financial', 'report', 'and', 'upcoming', 'earnings', 'and', 'conference', 'call', 'schedule', 'research', 'report', 'j', '##ude', 'medical', 'var', '##ian', 'tech', '##ne', 'de', '##x', '##com', 'and', 'hill', 'r', '##om']",1
240550,nifty_753,2013-10-28,Neodyne Biosciences Announces 94% Market Adoption and 91% Re-order Rate of embraceÂ® Advanced Scar Therapy among Plastic Surgeons in Las Vegas Test Market,Rise,0.0053,154,neodyne bioscience announces market adoption and order rate embraceâ advanced scar therapy among plastic surgeon la vega test market,132,19,0,pharmacy,"['neo', '##dy', '##ne', 'bio', '##science', 'announces', 'market', 'adoption', 'and', 'order', 'rate', 'embrace', '##â', 'advanced', 'scar', 'therapy', 'among', 'plastic', 'surgeon', 'la', 've', '##ga', 'test', 'market']",1
240645,nifty_753,2013-10-28,Research and Markets: Crisis Communications Strategy for Pharmaceuticals and Life Sciences (Masterclass),Rise,0.0053,104,research and market crisis communication strategy for pharmaceutical and life science masterclass,97,12,0,pharmacy,"['research', 'and', 'market', 'crisis', 'communication', 'strategy', 'for', 'pharmaceutical', 'and', 'life', 'science', 'master', '##c', '##lass']",1
240656,nifty_753,2013-10-28,Foundation Venture Capital Group Portfolio Company Identifies FRY Gene As Breast Cancer Susceptibility Suppressor,Rise,0.0053,113,foundation venture capital group portfolio company identifies fry gene breast cancer susceptibility suppressor,110,13,0,pharmacy,"['foundation', 'venture', 'capital', 'group', 'portfolio', 'company', 'identifies', 'f', '##ry', 'gene', 'breast', 'cancer', 'su', '##s', '##ce', '##pt', '##ibility', 'suppress', '##or']",1
240687,nifty_753,2013-10-28,Medical Economics examines the financial health of HIT companies in its top 100 EHR ranking,Rise,0.0053,91,medical economics examines the financial health hit company it top ehr ranking,78,12,0,pharmacy,"['medical', 'economics', 'examines', 'the', 'financial', 'health', 'hit', 'company', 'it', 'top', 'eh', '##r', 'ranking']",1
240781,nifty_753,2013-10-28,ROI From EHR Investments: Case Studies From The Drenk Center & Children's Crisis Treatment Center,Rise,0.0053,97,roi from ehr investment case study from the drenk center child crisis treatment center,86,14,0,pharmacy,"['r', '##oi', 'from', 'eh', '##r', 'investment', 'case', 'study', 'from', 'the', 'd', '##ren', '##k', 'center', 'child', 'crisis', 'treatment', 'center']",1
240919,nifty_753,2013-10-28,UH Law Center Professors Look to Future of 'Genetics Revolution' in Panel Discussion Oct. 29,Rise,0.0053,92,law center professor look future genetics revolution panel discussion oct,73,10,0,pharmacy,"['law', 'center', 'professor', 'look', 'future', 'genetics', 'revolution', 'panel', 'discussion', 'o', '##ct']",1
241037,nifty_753,2013-10-28,"Biogen Posts Higher Earnings, Outlook",Rise,0.0053,37,biogen post higher earnings outlook,35,5,0,pharmacy,"['bio', '##gen', 'post', 'higher', 'earnings', 'outlook']",1
241102,nifty_754,2013-10-29,Vertex Pharmaceuticals to Cut Workforce 15%,Neutral,-0.005,43,vertex pharmaceutical cut workforce,35,4,0,pharmacy,"['vertex', 'pharmaceutical', 'cut', 'workforce']",1
241219,nifty_756,2013-10-31,Leukemia Drug Pulled From Sale by FDA,Neutral,0.0024,37,leukemia drug pulled from sale fda,34,6,0,pharmacy,"['le', '##uke', '##mia', 'drug', 'pulled', 'from', 'sale', 'f', '##da']",1
241259,nifty_756,2013-10-31,Helping Small Businesses with New Health Plans,Neutral,0.0024,46,helping small business with new health plan,43,7,0,pharmacy,"['helping', 'small', 'business', 'with', 'new', 'health', 'plan']",1
241283,nifty_756,2013-10-31,FDA Sets Rules to Address Drug Shortages,Neutral,0.0024,40,fda set rule address drug shortage,34,6,0,pharmacy,"['f', '##da', 'set', 'rule', 'address', 'drug', 'shortage']",1
241441,nifty_758,2013-11-05,"Research and Markets: Global Cell Therapy Market Report 2013 - with Analysis of Technologies, Companies and Markets",Rise,0.0051,115,research and market global cell therapy market report with analysis technology company and market,97,14,0,pharmacy,"['research', 'and', 'market', 'global', 'cell', 'therapy', 'market', 'report', 'with', 'analysis', 'technology', 'company', 'and', 'market']",1
241442,nifty_758,2013-11-05,Research and Markets: Global Personalized Medicine Market Report 2013,Rise,0.0051,69,research and market global personalized medicine market report,62,8,0,pharmacy,"['research', 'and', 'market', 'global', 'personal', '##ized', 'medicine', 'market', 'report']",1
241450,nifty_758,2013-11-05,"Research and Markets: Global Gene Therapy Market Report - Analysis of Technologies, Markets and Companies",Rise,0.0051,105,research and market global gene therapy market report analysis technology market and company,92,13,0,pharmacy,"['research', 'and', 'market', 'global', 'gene', 'therapy', 'market', 'report', 'analysis', 'technology', 'market', 'and', 'company']",1
241460,nifty_758,2013-11-05,Research and Markets: 2013 Report on the Healthcare Contract Research Outsourcing Market - with Forecast to 2018,Rise,0.0051,112,research and market report the healthcare contract research outsourcing market with forecast,92,12,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'healthcare', 'contract', 'research', 'outs', '##our', '##cing', 'market', 'with', 'forecast']",1
241462,nifty_758,2013-11-05,Biocartis Poised for 2014 Commerical Launch with EUR 30 Million Series E Equity Fundraising,Rise,0.0051,91,biocartis poised for commerical launch with eur million series equity fundraising,81,11,0,pharmacy,"['bio', '##car', '##tis', 'poised', 'for', 'com', '##mer', '##ical', 'launch', 'with', 'e', '##ur', 'million', 'series', 'equity', 'fundraising']",1
241499,nifty_758,2013-11-05,BioCryst Provides Corporate Update and Reports Third Quarter 2013 Financial Results,Rise,0.0051,83,biocryst provides corporate update and report third quarter financial result,76,10,0,pharmacy,"['bio', '##c', '##ry', '##st', 'provides', 'corporate', 'update', 'and', 'report', 'third', 'quarter', 'financial', 'result']",1
241501,nifty_758,2013-11-05,"Research and Markets: Cardiomyopathy - Pipeline Review, H2 2013",Rise,0.0051,63,research and market cardiomyopathy pipeline review,50,6,0,pharmacy,"['research', 'and', 'market', 'card', '##io', '##my', '##op', '##athy', 'pipeline', 'review']",1
241521,nifty_758,2013-11-05,"Research and Markets: Pruritus - Pipeline Review, H2 2013",Rise,0.0051,57,research and market pruritus pipeline review,44,6,0,pharmacy,"['research', 'and', 'market', 'p', '##ru', '##rit', '##us', 'pipeline', 'review']",1
241560,nifty_758,2013-11-05,Research and Markets: Global Small Animal Imaging (In Vivo) Market Report - with Forecasts to 2017,Rise,0.0051,98,research and market global small animal imaging vivo market report with forecast,80,12,0,pharmacy,"['research', 'and', 'market', 'global', 'small', 'animal', 'imaging', 'v', '##ivo', 'market', 'report', 'with', 'forecast']",1
241563,nifty_758,2013-11-05,"Research and Markets: 2013 Report on the Worldwide Radiation Detection, Monitoring & Safety Market - with Forecasts to 2017",Rise,0.0051,123,research and market report the worldwide radiation detection monitoring safety market with forecast,99,13,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'worldwide', 'radiation', 'detection', 'monitoring', 'safety', 'market', 'with', 'forecast']",1
241584,nifty_758,2013-11-05,Research and Markets: Global Epigenetics Technology Market Report 2013 - 2017,Rise,0.0051,77,research and market global epigenetics technology market report,63,8,0,pharmacy,"['research', 'and', 'market', 'global', 'e', '##pi', '##gene', '##tics', 'technology', 'market', 'report']",1
241825,nifty_758,2013-11-05,Breast Imaging Technologies Market - Technology and Market Analysis & Global Forecasts to 2017,Rise,0.0051,94,breast imaging technology market technology and market analysis global forecast,79,10,0,pharmacy,"['breast', 'imaging', 'technology', 'market', 'technology', 'and', 'market', 'analysis', 'global', 'forecast']",1
241933,nifty_758,2013-11-05,Majority Of Business Owners Hesitant To Visit Healthcare Exchanges,Rise,0.0051,66,majority business owner hesitant visit healthcare exchange,58,7,0,pharmacy,"['majority', 'business', 'owner', 'hesitant', 'visit', 'healthcare', 'exchange']",1
242017,nifty_758,2013-11-05,The US Market For Laparoscopic Devices Will Reach A Value Of Nearly $4.5 Billion By 2022,Rise,0.0051,88,the market for laparoscopic device will reach value nearly billion,66,10,0,pharmacy,"['the', 'market', 'for', 'lap', '##aro', '##scopic', 'device', 'will', 'reach', 'value', 'nearly', 'billion']",1
242070,nifty_758,2013-11-05,"Research and Markets: Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Review, H2 2013",Rise,0.0051,98,research and market pituitary acth hypersecretion cushing disease pipeline review,81,10,0,pharmacy,"['research', 'and', 'market', 'pit', '##uit', '##ary', 'act', '##h', 'h', '##yper', '##se', '##cre', '##tion', 'cu', '##shing', 'disease', 'pipeline', 'review']",1
242075,nifty_758,2013-11-05,Research and Markets: Personalized Medicine and Companion Diagnostic Market Q3 2013 research Report,Rise,0.0051,99,research and market personalized medicine and companion diagnostic market research report,89,11,0,pharmacy,"['research', 'and', 'market', 'personal', '##ized', 'medicine', 'and', 'companion', 'diagnostic', 'market', 'research', 'report']",1
242101,nifty_758,2013-11-05,"Research and Markets: North America Medical Imaging Market Reports, 2005 - 2018: Forecasts and Market Growth Explained",Rise,0.0051,118,research and market north america medical imaging market report forecast and market growth explained,100,14,0,pharmacy,"['research', 'and', 'market', 'north', 'am', '##eric', '##a', 'medical', 'imaging', 'market', 'report', 'forecast', 'and', 'market', 'growth', 'explained']",1
242143,nifty_758,2013-11-05,Endocyte Reports Third Quarter 2013 Financial Results and Provides Business Update,Rise,0.0051,82,endocyte report third quarter financial result and provides business update,75,10,0,pharmacy,"['end', '##oc', '##yte', 'report', 'third', 'quarter', 'financial', 'result', 'and', 'provides', 'business', 'update']",1
242169,nifty_758,2013-11-05,Cumberland Pharmaceuticals Reports Third Quarter Financial Results,Rise,0.0051,66,cumberland pharmaceutical report third quarter financial result,63,7,0,pharmacy,"['cum', '##ber', '##land', 'pharmaceutical', 'report', 'third', 'quarter', 'financial', 'result']",1
242241,nifty_758,2013-11-05,China Biologic Reports Financial Results for the Third Quarter and First Nine Months of 2013,Rise,0.0051,92,china biologic report financial result for the third quarter and first nine month,81,13,0,pharmacy,"['chin', '##a', 'bio', '##log', '##ic', 'report', 'financial', 'result', 'for', 'the', 'third', 'quarter', 'and', 'first', 'nine', 'month']",1
242422,nifty_758,2013-11-05,Endo Health to Buy Paladin Labs for $1.6 Billion,Rise,0.0051,48,endo health buy paladin lab for billion,39,7,0,pharmacy,"['end', '##o', 'health', 'buy', 'p', '##ala', '##din', 'lab', 'for', 'billion']",1
242555,nifty_759,2013-11-06,"Research and Markets: Asia Pacific Diabetes Management Market Growth Trends, 2013",Fall,-0.0126,81,research and market asia pacific diabetes management market growth trend,72,10,0,pharmacy,"['research', 'and', 'market', 'as', '##ia', 'p', '##ac', '##ific', 'diabetes', 'management', 'market', 'growth', 'trend']",1
242570,nifty_759,2013-11-06,"Research and Markets: Asia Pacific Patient Monitoring and Diagnostic Systems Market Trends and Forecast, 2013",Fall,-0.0126,109,research and market asia pacific patient monitoring and diagnostic system market trend and forecast,99,14,0,pharmacy,"['research', 'and', 'market', 'as', '##ia', 'p', '##ac', '##ific', 'patient', 'monitoring', 'and', 'diagnostic', 'system', 'market', 'trend', 'and', 'forecast']",1
242574,nifty_759,2013-11-06,"Research and Markets: Europe Patient Monitoring and Diagnostic Systems Market Trends and Forecast, 2013",Fall,-0.0126,103,research and market europe patient monitoring and diagnostic system market trend and forecast,93,13,0,pharmacy,"['research', 'and', 'market', 'euro', '##pe', 'patient', 'monitoring', 'and', 'diagnostic', 'system', 'market', 'trend', 'and', 'forecast']",1
242589,nifty_759,2013-11-06,Research and Markets: Germany Medical Imaging Market Opportunity and Growth Trend Forecast Till 2018,Fall,-0.0126,100,research and market germany medical imaging market opportunity and growth trend forecast till,93,13,0,pharmacy,"['research', 'and', 'market', 'g', '##erman', '##y', 'medical', 'imaging', 'market', 'opportunity', 'and', 'growth', 'trend', 'forecast', 'till']",1
242594,nifty_759,2013-11-06,"Research and Markets: Metastatic Lung Cancer - Pipeline Review, H2 2013",Fall,-0.0126,71,research and market metastatic lung cancer pipeline review,58,8,0,pharmacy,"['research', 'and', 'market', 'meta', '##static', 'lung', 'cancer', 'pipeline', 'review']",1
242605,nifty_759,2013-11-06,"Research and Markets: Immunoassay Market by Technology, Analyzers & Reagents, Applications & End Users - Global Forecast to 2018",Fall,-0.0126,128,research and market immunoassay market technology analyzer reagent application end user global forecast,103,13,0,pharmacy,"['research', 'and', 'market', 'im', '##mu', '##no', '##ass', '##ay', 'market', 'technology', 'analyze', '##r', 're', '##age', '##nt', 'application', 'end', 'user', 'global', 'forecast']",1
242738,nifty_759,2013-11-06,"Research and Markets: UK Diabetes Management Devices Market, 2005 - 2018 Report Features Players such as Bayer HealthCare AG, Medtronic, Inc. and Sanofi-Aventis",Fall,-0.0126,160,research and market diabetes management device market report feature player such bayer healthcare medtronic inc and sanofi aventis,130,18,0,pharmacy,"['research', 'and', 'market', 'diabetes', 'management', 'device', 'market', 'report', 'feature', 'player', 'such', 'bay', '##er', 'healthcare', 'me', '##dt', '##ronic', 'in', '##c', 'and', 'sa', '##no', '##fi', 'a', '##vent', '##is']",1
242765,nifty_759,2013-11-06,"Research and Markets: Market Research: Bronchopulmonary Dysplasia - Pipeline Review, H2 2013",Fall,-0.0126,92,research and market market research bronchopulmonary dysplasia pipeline review,78,9,0,pharmacy,"['research', 'and', 'market', 'market', 'research', 'br', '##on', '##cho', '##pu', '##lm', '##ona', '##ry', 'd', '##ys', '##p', '##lasia', 'pipeline', 'review']",1
242780,nifty_759,2013-11-06,"Presentations, Executive Appointments, and Quarterly Financial Reports - Research Report on Jazz Pharmaceuticals, Insulet, The Cooper Companies, Anika Therapeutics, and Sangamo Biosciences",Fall,-0.0126,188,presentation executive appointment and quarterly financial report research report jazz pharmaceutical insulet the cooper company anika therapeutic and sangamo bioscience,169,20,0,pharmacy,"['presentation', 'executive', 'appointment', 'and', 'quarterly', 'financial', 'report', 'research', 'report', 'jazz', 'pharmaceutical', 'ins', '##ulet', 'the', 'co', '##oper', 'company', 'an', '##ika', 'therapeutic', 'and', 'sang', '##amo', 'bio', '##science']",1
242781,nifty_759,2013-11-06,"Quarterly Dividends, Financial Results, and FDA Guidance - Research Report on Techne, ImmunoGen, Repros, Halozyme, and Synageva",Fall,-0.0126,127,quarterly dividend financial result and fda guidance research report techne immunogen repros halozyme and synageva,114,15,0,pharmacy,"['quarterly', 'divide', '##nd', 'financial', 'result', 'and', 'f', '##da', 'guidance', 'research', 'report', 'tech', '##ne', 'im', '##mu', '##no', '##gen', 're', '##p', '##ros', 'ha', '##lo', '##zy', '##me', 'and', 's', '##yna', '##ge', '##va']",1
242783,nifty_759,2013-11-06,"Financial Results, Upcoming Presentations, and Stock Price Movements - Research Report on Valeant Pharmaceuticals, St. Jude Medical, AstraZeneca, Stryker, and Smith & Nephew",Fall,-0.0126,173,financial result upcoming presentation and stock price movement research report valeant pharmaceutical jude medical astrazeneca stryker and smith nephew,152,19,0,pharmacy,"['financial', 'result', 'upcoming', 'presentation', 'and', 'stock', 'price', 'movement', 'research', 'report', 'v', '##ale', '##ant', 'pharmaceutical', 'j', '##ude', 'medical', 'as', '##tra', '##zen', '##eca', 's', '##try', '##ker', 'and', 's', '##mith', 'nephew']",1
242798,nifty_759,2013-11-06,NPS Pharmaceuticals Reports Third Quarter 2013 Financial Results and Provides Business Update,Fall,-0.0126,93,np pharmaceutical report third quarter financial result and provides business update,84,11,0,pharmacy,"['n', '##p', 'pharmaceutical', 'report', 'third', 'quarter', 'financial', 'result', 'and', 'provides', 'business', 'update']",1
242822,nifty_759,2013-11-06,"Quarterly Financial Results and Stock Price Movements - Research Report on Quest Diagnostics, Zimmer, ResMed, Thoratec and CareFusion",Fall,-0.0126,133,quarterly financial result and stock price movement research report quest diagnostics zimmer resmed thoratec and carefusion,123,16,0,pharmacy,"['quarterly', 'financial', 'result', 'and', 'stock', 'price', 'movement', 'research', 'report', 'quest', 'diagnostic', '##s', 'z', '##immer', 're', '##sm', '##ed', 'th', '##ora', '##tec', 'and', 'care', '##fusion']",1
242823,nifty_759,2013-11-06,"Financial Results and Upcoming Conference Calls - Research Report on Ariad, Idenix, Osiris, InterMune, and Array BioPharma",Fall,-0.0126,122,financial result and upcoming conference call research report ariad idenix osiris intermune and array biopharma,111,15,0,pharmacy,"['financial', 'result', 'and', 'upcoming', 'conference', 'call', 'research', 'report', 'a', '##riad', 'id', '##eni', '##x', 'o', '##sir', '##is', 'inter', '##mu', '##ne', 'and', 'array', 'bio', '##pha', '##rma']",1
242889,nifty_759,2013-11-06,"MIT Technology Review's November/December Issue Hits Newsstands Today, Examines the High Cost of Prescription Drugs",Fall,-0.0126,115,mit technology review november december issue hit newsstand today examines the high cost prescription drug,106,15,0,pharmacy,"['mit', 'technology', 'review', 'no', '##ve', '##mber', 'de', '##ce', '##mber', 'issue', 'hit', 'news', '##stand', 'today', 'examines', 'the', 'high', 'cost', 'prescription', 'drug']",1
242985,nifty_759,2013-11-06,Research and Markets: Global Radiopharmaceuticals Market Report 2013 - 2018,Fall,-0.0126,75,research and market global radiopharmaceutical market report,60,7,0,pharmacy,"['research', 'and', 'market', 'global', 'radio', '##pha', '##rma', '##ce', '##utical', 'market', 'report']",1
243004,nifty_759,2013-11-06,"Research and Markets: Lung Cancer - Pipeline Review, H2 2013 Gives a Snapshot of the Global Therapeutic Scenario for Lung Cancer",Fall,-0.0126,128,research and market lung cancer pipeline review give snapshot the global therapeutic scenario for lung cancer,109,16,0,pharmacy,"['research', 'and', 'market', 'lung', 'cancer', 'pipeline', 'review', 'give', 'snaps', '##hot', 'the', 'global', 'therapeutic', 'scenario', 'for', 'lung', 'cancer']",1
243041,nifty_759,2013-11-06,"Research and Markets: UK Patient Monitoring and Diagnostic Systems Market Trends and Forecast, 2013 Out Now",Fall,-0.0126,107,research and market patient monitoring and diagnostic system market trend and forecast out now,94,14,0,pharmacy,"['research', 'and', 'market', 'patient', 'monitoring', 'and', 'diagnostic', 'system', 'market', 'trend', 'and', 'forecast', 'out', 'now']",1
243047,nifty_759,2013-11-06,Research and Markets: India Patient Monitoring and Diagnostic Systems Market Assessment and Forecast to 2018,Fall,-0.0126,108,research and market india patient monitoring and diagnostic system market assessment and forecast,97,13,0,pharmacy,"['research', 'and', 'market', 'in', '##dia', 'patient', 'monitoring', 'and', 'diagnostic', 'system', 'market', 'assessment', 'and', 'forecast']",1
243071,nifty_759,2013-11-06,"Prefilled Syringes to 2018 Devices, Drugs, Markets, Players and Prospects",Fall,-0.0126,73,prefilled syrinx device drug market player and prospect,55,8,0,pharmacy,"['pre', '##fill', '##ed', 's', '##yr', '##in', '##x', 'device', 'drug', 'market', 'player', 'and', 'prospect']",1
243155,nifty_759,2013-11-06,"Research and Markets: Global Healthcare IT Market to 2016: McKesson, Dell, CareFusion & Philips Healthcare Dominate the Industry",Fall,-0.0126,128,research and market global healthcare market mckesson dell carefusion philip healthcare dominate the industry,109,14,0,pharmacy,"['research', 'and', 'market', 'global', 'healthcare', 'market', 'm', '##cke', '##sson', 'dell', 'care', '##fusion', 'p', '##hil', '##ip', 'healthcare', 'dominate', 'the', 'industry']",1
243197,nifty_759,2013-11-06,"Research and Markets: Ischemic Stroke Drug Pipeline Report, H2 2013 Review",Fall,-0.0126,74,research and market ischemic stroke drug pipeline report review,63,9,0,pharmacy,"['research', 'and', 'market', 'is', '##che', '##mic', 'stroke', 'drug', 'pipeline', 'report', 'review']",1
243367,nifty_759,2013-11-06,Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences,Fall,-0.0126,85,momentum pharmaceutical webcast presentation two upcoming investor conference,77,8,0,pharmacy,"['momentum', 'pharmaceutical', 'web', '##cast', 'presentation', 'two', 'upcoming', 'investor', 'conference']",1
243413,nifty_759,2013-11-06,"Celator(R) Pharmaceuticals to Webcast Conference Call Discussing Third Quarter 2013 Financial Results on November 12, 2013",Fall,-0.0126,122,celator pharmaceutical webcast conference call discussing third quarter financial result november,97,11,0,pharmacy,"['c', '##ela', '##tor', 'pharmaceutical', 'web', '##cast', 'conference', 'call', 'discussing', 'third', 'quarter', 'financial', 'result', 'no', '##ve', '##mber']",1
243433,nifty_759,2013-11-06,EVENT ADVISORY: BioteQ to Host Conference Call Regarding Q3 2013 Operating and Financial Results,Fall,-0.0126,96,event advisory bioteq host conference call regarding operating and financial result,83,11,0,pharmacy,"['event', 'advisory', 'bio', '##te', '##q', 'host', 'conference', 'call', 'regarding', 'operating', 'and', 'financial', 'result']",1
243670,nifty_760,2013-11-07,Pharming Reports On Financial Results For The First Nine Months Of 2013,Rise,0.0135,71,pharming report financial result for the first nine month,57,9,0,pharmacy,"['p', '##har', '##ming', 'report', 'financial', 'result', 'for', 'the', 'first', 'nine', 'month']",1
243781,nifty_760,2013-11-07,"Research and Markets: Market Research: Ischemia Reperfusion Injury - Pipeline Review, H2 2013",Rise,0.0135,93,research and market market research ischemia reperfusion injury pipeline review,79,10,0,pharmacy,"['research', 'and', 'market', 'market', 'research', 'is', '##che', '##mia', 're', '##per', '##fusion', 'injury', 'pipeline', 'review']",1
243827,nifty_760,2013-11-07,Research and Markets: GxP Regulations Series - US & International Regulations Governing Biotechnology and Pharmaceutical Products,Rise,0.0135,129,research and market gxp regulation series international regulation governing biotechnology and pharmaceutical product,117,13,0,pharmacy,"['research', 'and', 'market', 'g', '##x', '##p', 'regulation', 'series', 'international', 'regulation', 'governing', 'bio', '##tech', '##nology', 'and', 'pharmaceutical', 'product']",1
243892,nifty_760,2013-11-07,Biota Pharmaceuticals Reports First Quarter Financial Results,Rise,0.0135,61,biota pharmaceutical report first quarter financial result,58,7,0,pharmacy,"['bio', '##ta', 'pharmaceutical', 'report', 'first', 'quarter', 'financial', 'result']",1
243897,nifty_760,2013-11-07,PDL BioPharma to Present at Upcoming Investor Conferences,Rise,0.0135,57,pdl biopharma present upcoming investor conference,50,6,0,pharmacy,"['p', '##dl', 'bio', '##pha', '##rma', 'present', 'upcoming', 'investor', 'conference']",1
243918,nifty_760,2013-11-07,Research and Markets: Networked Medical Devices: Innovations and Business Models 4Q 2013,Rise,0.0135,88,research and market networked medical device innovation and business model,74,10,0,pharmacy,"['research', 'and', 'market', 'network', '##ed', 'medical', 'device', 'innovation', 'and', 'business', 'model']",1
243928,nifty_760,2013-11-07,"Research and Markets: Cardiac Fibrosis - Pipeline Review, H2 2013",Rise,0.0135,65,research and market cardiac fibrosis pipeline review,52,7,0,pharmacy,"['research', 'and', 'market', 'cardiac', 'fi', '##bro', '##sis', 'pipeline', 'review']",1
243938,nifty_760,2013-11-07,"Proteomics Market - Instruments, Reagents and Services - Trends and Global Forecasts to 2017",Rise,0.0135,92,proteomics market instrument reagent and service trend and global forecast,74,10,0,pharmacy,"['pro', '##te', '##omi', '##cs', 'market', 'instrument', 're', '##age', '##nt', 'and', 'service', 'trend', 'and', 'global', 'forecast']",1
243975,nifty_760,2013-11-07,"Upcoming Earnings Schedules, Quarterly Financial Results, Clinical Trial Results and Updates - Research Report on INSYS, Acorda, Spectrum Pharmaceuticals, XOMA, and Cambrex",Rise,0.0135,172,upcoming earnings schedule quarterly financial result clinical trial result and update research report insys acorda spectrum pharmaceutical xoma and cambrex,156,20,0,pharmacy,"['upcoming', 'earnings', 'schedule', 'quarterly', 'financial', 'result', 'clinical', 'trial', 'result', 'and', 'update', 'research', 'report', 'ins', '##ys', 'a', '##cor', '##da', 'spectrum', 'pharmaceutical', 'x', '##oma', 'and', 'ca', '##mbre', '##x']",1
244014,nifty_760,2013-11-07,"FDA Approvals, Successful Product Launches, Upcoming Earnings Schedules and Quarterly Financial Results - Research Report on Pfizer, Mettler-Toledo, Arena, Wright Medical, and Ophthotech",Rise,0.0135,186,fda approval successful product launch upcoming earnings schedule and quarterly financial result research report pfizer mettler toledo arena wright medical and ophthotech,170,22,0,pharmacy,"['f', '##da', 'approval', 'successful', 'product', 'launch', 'upcoming', 'earnings', 'schedule', 'and', 'quarterly', 'financial', 'result', 'research', 'report', 'p', '##fi', '##zer', 'met', '##tler', 'to', '##led', '##o', 'arena', 'w', '##right', 'medical', 'and', 'op', '##ht', '##hot', '##ech']",1
244049,nifty_760,2013-11-07,Research and Markets: 2013 Report on the X-Ray Market - with Forecast to 2018,Rise,0.0135,77,research and market report the ray market with forecast,55,9,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'ray', 'market', 'with', 'forecast']",1
244090,nifty_760,2013-11-07,Research and Markets: Canada MRI Systems Market Trends Forecast Through 2018,Rise,0.0135,76,research and market canada mri system market trend forecast through,67,10,0,pharmacy,"['research', 'and', 'market', 'can', '##ada', 'm', '##ri', 'system', 'market', 'trend', 'forecast', 'through']",1
244093,nifty_760,2013-11-07,Medgenics Reports Third Quarter Financial Results,Rise,0.0135,49,medgenics report third quarter financial result,47,6,0,pharmacy,"['me', '##dge', '##nics', 'report', 'third', 'quarter', 'financial', 'result']",1
244140,nifty_760,2013-11-07,Research and Markets: Medical Imaging Market Outlook in US Through 2018,Rise,0.0135,71,research and market medical imaging market outlook through,58,8,0,pharmacy,"['research', 'and', 'market', 'medical', 'imaging', 'market', 'outlook', 'through']",1
244220,nifty_760,2013-11-07,Research and Markets: 2013 Study on High-Growth Diagnostic Testing Markets Provides an Overview of the Diagnostic Testing Market,Rise,0.0135,128,research and market study high growth diagnostic testing market provides overview the diagnostic testing market,111,15,0,pharmacy,"['research', 'and', 'market', 'study', 'high', 'growth', 'diagnostic', 'testing', 'market', 'provides', 'overview', 'the', 'diagnostic', 'testing', 'market']",1
244269,nifty_760,2013-11-07,"Exponential Growth Continues at Outpatient Specialty Care Software Leader, Net Health",Rise,0.0135,85,exponential growth continues outpatient specialty care software leader net health,81,10,0,pharmacy,"['ex', '##po', '##nent', '##ial', 'growth', 'continues', 'out', '##patient', 'specialty', 'care', 'software', 'leader', 'net', 'health']",1
244274,nifty_760,2013-11-07,"Research and Markets: US Diabetes Management Devices Market Growth Trends, 2013 Report Reveals Forecasts up to 2018",Rise,0.0135,115,research and market diabetes management device market growth trend report reveals forecast,90,12,0,pharmacy,"['research', 'and', 'market', 'diabetes', 'management', 'device', 'market', 'growth', 'trend', 'report', 'reveals', 'forecast']",1
244290,nifty_760,2013-11-07,"Research and Markets: Europe Medical Imaging Market Growth and Forecast to 2018 will Help Professionals in Mapping Market Size, Understanding Historic and Future Growth Trends",Rise,0.0135,175,research and market europe medical imaging market growth and forecast will help professional mapping market size understanding historic and future growth trend,159,22,0,pharmacy,"['research', 'and', 'market', 'euro', '##pe', 'medical', 'imaging', 'market', 'growth', 'and', 'forecast', 'will', 'help', 'professional', 'mapping', 'market', 'size', 'understanding', 'historic', 'and', 'future', 'growth', 'trend']",1
244292,nifty_760,2013-11-07,BIOQuebec and Rx&D; join forces to strengthen Canada's biotechnology sector,Rise,0.0135,75,bioquebec and join force strengthen canada biotechnology sector,63,8,0,pharmacy,"['bio', '##que', '##be', '##c', 'and', 'join', 'force', 'strengthen', 'can', '##ada', 'bio', '##tech', '##nology', 'sector']",1
244305,nifty_760,2013-11-07,Research and Markets: Pharmerging Markets 2012-2016: Pharmerging Markets Expected to Contribute 30% by 2016 of the Global Pharmaceutical Market Spending,Rise,0.0135,152,research and market pharmerging market pharmerging market expected contribute the global pharmaceutical market spending,119,14,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##mer', '##ging', 'market', 'p', '##har', '##mer', '##ging', 'market', 'expected', 'contribute', 'the', 'global', 'pharmaceutical', 'market', 'spending']",1
244342,nifty_760,2013-11-07,"Research and Markets: Global DNA Sequencing Equipment and Services Market to 2016: Roche, Agilent Tech & Illumina Dominate the Industry",Rise,0.0135,135,research and market global dna sequencing equipment and service market roche agilent tech illumina dominate the industry,120,17,0,pharmacy,"['research', 'and', 'market', 'global', 'd', '##na', 'se', '##quencing', 'equipment', 'and', 'service', 'market', 'r', '##och', '##e', 'a', '##gi', '##lent', 'tech', 'ill', '##umi', '##na', 'dominate', 'the', 'industry']",1
244390,nifty_760,2013-11-07,"Research and Markets: Liver Fibrosis Drug Pipeline Report, H2 2013 Review",Rise,0.0135,73,research and market liver fibrosis drug pipeline report review,62,9,0,pharmacy,"['research', 'and', 'market', 'liver', 'fi', '##bro', '##sis', 'drug', 'pipeline', 'report', 'review']",1
244392,nifty_760,2013-11-07,"Research and Markets: Global Personalized Medicine Market to 2016: Abbott, AstraZeneca, F. Hoffman-La Roche, Novaris, Pfizer & Sanofi Dominate the Industry",Rise,0.0135,155,research and market global personalized medicine market abbott astrazeneca hoffman roche novaris pfizer sanofi dominate the industry,132,17,0,pharmacy,"['research', 'and', 'market', 'global', 'personal', '##ized', 'medicine', 'market', 'abbot', '##t', 'as', '##tra', '##zen', '##eca', 'ho', '##ff', '##man', 'r', '##och', '##e', 'no', '##var', '##is', 'p', '##fi', '##zer', 'sa', '##no', '##fi', 'dominate', 'the', 'industry']",1
244402,nifty_760,2013-11-07,"Research and Markets: Global Capnography Market to 2016: Covidien, Philips healthcare, Smiths Medical & Welch Allyn Dominate the Industry",Rise,0.0135,137,research and market global capnography market covidien philip healthcare smith medical welch allyn dominate the industry,120,16,0,pharmacy,"['research', 'and', 'market', 'global', 'cap', '##no', '##graphy', 'market', 'co', '##vid', '##ien', 'p', '##hil', '##ip', 'healthcare', 's', '##mith', 'medical', 'we', '##l', '##ch', 'ally', '##n', 'dominate', 'the', 'industry']",1
244454,nifty_760,2013-11-07,"Research and Markets: Global Hospital-Based Electronic Medical Records (EMR) Market to 2016 - Cerner, Epic Systems, McKesson & Siemens Dominate the Industry",Rise,0.0135,156,research and market global hospital based electronic medical record emr market cerner epic system mckesson siemens dominate the industry,136,19,0,pharmacy,"['research', 'and', 'market', 'global', 'hospital', 'based', 'electronic', 'medical', 'record', 'em', '##r', 'market', 'c', '##erne', '##r', 'epic', 'system', 'm', '##cke', '##sson', 'si', '##em', '##ens', 'dominate', 'the', 'industry']",1
244521,nifty_760,2013-11-07,"Budget Is the Biggest Challenge for Continuous Diagnostics and Mitigation Programs, Federal IT Professionals Say",Rise,0.0135,112,budget the biggest challenge for continuous diagnostics and mitigation program federal professional say,103,13,0,pharmacy,"['budget', 'the', 'biggest', 'challenge', 'for', 'continuous', 'diagnostic', '##s', 'and', 'mit', '##iga', '##tion', 'program', 'federal', 'professional', 'say']",1
244552,nifty_760,2013-11-07,"OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Third Quarter 2013 and Addresses Key Questions from Investors on Quarterly Conference Call",Rise,0.0135,152,oncogenex pharmaceutical inc report financial result for third quarter and address key question from investor quarterly conference call,135,18,0,pharmacy,"['on', '##co', '##gene', '##x', 'pharmaceutical', 'in', '##c', 'report', 'financial', 'result', 'for', 'third', 'quarter', 'and', 'address', 'key', 'question', 'from', 'investor', 'quarterly', 'conference', 'call']",1
244563,nifty_760,2013-11-07,BioAmber Reports Third Quarter 2013 Financial Results,Rise,0.0135,53,bioamber report third quarter financial result,46,6,0,pharmacy,"['bio', '##am', '##ber', 'report', 'third', 'quarter', 'financial', 'result']",1
244579,nifty_760,2013-11-07,"ChemoCentryx Announces Financial Results for the Quarter Ended September 30, 2013",Rise,0.0135,81,chemocentryx announces financial result for the quarter ended september,71,9,0,pharmacy,"['ch', '##em', '##oc', '##entry', '##x', 'announces', 'financial', 'result', 'for', 'the', 'quarter', 'ended', 'se', '##pt', '##em', '##ber']",1
244623,nifty_760,2013-11-07,"BioAmber Inc. : Form 8-K for the period ended September 30, 2013",Rise,0.0135,64,bioamber inc form for the period ended september,48,8,0,pharmacy,"['bio', '##am', '##ber', 'in', '##c', 'form', 'for', 'the', 'period', 'ended', 'se', '##pt', '##em', '##ber']",1
244805,nifty_760,2013-11-07,Bristol-Myers to End Some Drug Discovery,Rise,0.0135,40,bristol myers end some drug discovery,37,6,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'end', 'some', 'drug', 'discovery']",1
244891,nifty_761,2013-11-11,Spanish Firm to Buy Novartis Unit,Neutral,-0.002,33,spanish firm buy novartis unit,30,5,0,pharmacy,"['span', '##ish', 'firm', 'buy', 'no', '##var', '##tis', 'unit']",1
244968,nifty_762,2013-11-12,GSK Heart Drug Disappoints,Rise,0.008,26,gsk heart drug disappoints,26,4,0,pharmacy,"['g', '##sk', 'heart', 'drug', 'di', '##sa', '##pp', '##oint', '##s']",1
245032,nifty_763,2013-11-13,Merck Enters into Further Global Co-Development and Commercialization Agreement for PARP Inhibitor with Chinese R&D; Company BeiGene,Neutral,0.005,132,merck enters into further global development and commercialization agreement for parp inhibitor with chinese company beigene,124,16,0,pharmacy,"['me', '##rc', '##k', 'enters', 'into', 'further', 'global', 'development', 'and', 'commercial', '##ization', 'agreement', 'for', 'par', '##p', 'inhibitor', 'with', 'chin', '##ese', 'company', 'be', '##ige', '##ne']",1
245106,nifty_763,2013-11-13,Research and Markets: Italy Market for X-Ray Systems Through 2018,Neutral,0.005,65,research and market italy market for ray system through,55,9,0,pharmacy,"['research', 'and', 'market', 'it', '##aly', 'market', 'for', 'ray', 'system', 'through']",1
245110,nifty_763,2013-11-13,"Research and Markets: France Diabetes Management Devices Market Growth Trends, 2013",Neutral,0.005,83,research and market france diabetes management device market growth trend,73,10,0,pharmacy,"['research', 'and', 'market', 'f', '##rance', 'diabetes', 'management', 'device', 'market', 'growth', 'trend']",1
245112,nifty_763,2013-11-13,Research and Markets: Germany Diabetes Management Devices Market Growth and Forecast To 2018,Neutral,0.005,92,research and market germany diabetes management device market growth and forecast,81,11,0,pharmacy,"['research', 'and', 'market', 'g', '##erman', '##y', 'diabetes', 'management', 'device', 'market', 'growth', 'and', 'forecast']",1
245175,nifty_763,2013-11-13,"Research and Markets: China Nuclear Imaging Market Forecast and Opportunity Assessment, 2005 - 2018",Neutral,0.005,99,research and market china nuclear imaging market forecast and opportunity assessment,84,11,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'nuclear', 'imaging', 'market', 'forecast', 'and', 'opportunity', 'assessment']",1
245233,nifty_763,2013-11-13,BCC Research Publishes A New Report on Global Markets for Biorefinery technologies,Neutral,0.005,82,bcc research publishes new report global market for biorefinery technology,74,10,0,pharmacy,"['b', '##cc', 'research', 'publishes', 'new', 'report', 'global', 'market', 'for', 'bio', '##re', '##finery', 'technology']",1
245242,nifty_763,2013-11-13,Research and Markets: 2013 Report on the Global Pharmacy Automation Market - with Forecast to 2016,Neutral,0.005,98,research and market report the global pharmacy automation market with forecast,78,11,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'global', 'pharmacy', 'automation', 'market', 'with', 'forecast']",1
245292,nifty_763,2013-11-13,"Healthcare Sector Announces Financial Results and Financial Restatements - Research Report on Merck, Health Management Associates, ZELTIQ, MAKO, and Amarin",Neutral,0.005,155,healthcare sector announces financial result and financial restatement research report merck health management associate zeltiq mako and amarin,143,18,0,pharmacy,"['healthcare', 'sector', 'announces', 'financial', 'result', 'and', 'financial', 'rest', '##ate', '##ment', 'research', 'report', 'me', '##rc', '##k', 'health', 'management', 'associate', 'z', '##el', '##ti', '##q', 'ma', '##ko', 'and', 'am', '##ari', '##n']",1
245326,nifty_763,2013-11-13,"Acquisitions, Quarterly Reports, and Stock Price Movements - Research Report on Santarus, Celgene, Pharmacyclics, Quest Diagnostics, and Stryker",Neutral,0.005,144,acquisition quarterly report and stock price movement research report santarus celgene pharmacyclics quest diagnostics and stryker,130,16,0,pharmacy,"['acquisition', 'quarterly', 'report', 'and', 'stock', 'price', 'movement', 'research', 'report', 'sa', '##nta', '##rus', 'c', '##el', '##gene', 'pharmacy', '##c', '##lic', '##s', 'quest', 'diagnostic', '##s', 'and', 's', '##try', '##ker']",1
245329,nifty_763,2013-11-13,"Financial Results, New Appointments, and Stock Price Movements - Research Report on Salix Pharmaceuticals, Cigna, St. Jude Medical, Zimmer, and CareFusion",Neutral,0.005,154,financial result new appointment and stock price movement research report salix pharmaceutical cigna jude medical zimmer and carefusion,135,18,0,pharmacy,"['financial', 'result', 'new', 'appointment', 'and', 'stock', 'price', 'movement', 'research', 'report', 'sa', '##lix', 'pharmaceutical', 'c', '##ign', '##a', 'j', '##ude', 'medical', 'z', '##immer', 'and', 'care', '##fusion']",1
245336,nifty_763,2013-11-13,"Research and Markets: Market Research: Diphtheria - Pipeline Review, H2 2013",Neutral,0.005,76,research and market market research diphtheria pipeline review,62,8,0,pharmacy,"['research', 'and', 'market', 'market', 'research', 'dip', '##ht', '##her', '##ia', 'pipeline', 'review']",1
245498,nifty_763,2013-11-13,"Research and Markets: China Diabetes Management Devices Market, 2005 - 2018",Neutral,0.005,75,research and market china diabetes management device market,59,8,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'diabetes', 'management', 'device', 'market']",1
245529,nifty_763,2013-11-13,Creganna-Tactx Medical Opens Office in China,Neutral,0.005,44,creganna tactx medical open office china,40,6,0,pharmacy,"['c', '##re', '##gan', '##na', 'ta', '##ct', '##x', 'medical', 'open', 'office', 'chin', '##a']",1
245628,nifty_763,2013-11-13,"Research and Markets: Global Microfluidic Applications Report 2018: Pharmaceutical, Life Sciences, In-Vitro Diagnostic and Medical Devices",Neutral,0.005,138,research and market global microfluidic application report pharmaceutical life science vitro diagnostic and medical device,122,15,0,pharmacy,"['research', 'and', 'market', 'global', 'micro', '##f', '##lu', '##id', '##ic', 'application', 'report', 'pharmaceutical', 'life', 'science', 'v', '##it', '##ro', 'diagnostic', 'and', 'medical', 'device']",1
245724,nifty_763,2013-11-13,Research and Markets: Molecular Diagnostics Market Report: 2013 Edition,Neutral,0.005,71,research and market molecular diagnostics market report edition,63,8,0,pharmacy,"['research', 'and', 'market', 'molecular', 'diagnostic', '##s', 'market', 'report', 'edition']",1
245728,nifty_763,2013-11-13,Research and Markets: Asia Pacific Medical Imaging Market Report 2013: Growth and Forecasts to 2018,Neutral,0.005,99,research and market asia pacific medical imaging market report growth and forecast,82,12,0,pharmacy,"['research', 'and', 'market', 'as', '##ia', 'p', '##ac', '##ific', 'medical', 'imaging', 'market', 'report', 'growth', 'and', 'forecast']",1
246025,nifty_763,2013-11-13,MARKET EYE-India's Natco Pharma surges on favourable U.S. court ruling,Neutral,0.005,70,market eye india natco pharma surge favourable court ruling,59,9,0,pharmacy,"['market', 'eye', 'in', '##dia', 'na', '##t', '##co', 'p', '##har', '##ma', 'surge', 'favourable', 'court', 'ruling']",1
246042,nifty_763,2013-11-13,FDA Approves Drug for Rare Blood Cancer,Neutral,0.005,39,fda approves drug for rare blood cancer,39,7,0,pharmacy,"['f', '##da', 'approve', '##s', 'drug', 'for', 'rare', 'blood', 'cancer']",1
246155,nifty_764,2013-11-14,Lilly Boosts Insulin Manufacturing Investment by $700 Million,Neutral,0.0044,61,lilly boost insulin manufacturing investment million,52,6,0,pharmacy,"['l', '##ill', '##y', 'boost', 'insulin', 'manufacturing', 'investment', 'million']",1
246206,nifty_765,2013-11-18,Gilead's Vitekta Gets Approval in European Union,Neutral,-0.0022,48,gilead vitekta get approval european union,42,6,0,pharmacy,"['g', '##ile', '##ad', 'v', '##ite', '##kt', '##a', 'get', 'approval', 'euro', '##pe', '##an', 'union']",1
246207,nifty_765,2013-11-18,India Weighs Curbs on Pharma Investments,Neutral,-0.0022,40,india weighs curb pharma investment,35,5,0,pharmacy,"['in', '##dia', 'weighs', 'curb', 'p', '##har', '##ma', 'investment']",1
246250,nifty_766,2013-11-19,Daiichi Sankyo's Blood Thinner Works as Well as Warfarin in Trial,Neutral,-0.0031,65,daiichi sankyo blood thinner work well warfarin trial,53,8,0,pharmacy,"['da', '##ii', '##chi', 'sank', '##yo', 'blood', 'thinner', 'work', 'well', 'war', '##fari', '##n', 'trial']",1
246297,nifty_767,2013-11-20,Immune Pharmaceuticals Reports Third Quarter 2013 Financial Results,Rise,0.0081,67,immune pharmaceutical report third quarter financial result,59,7,0,pharmacy,"['immune', 'pharmaceutical', 'report', 'third', 'quarter', 'financial', 'result']",1
246365,nifty_767,2013-11-20,INNATE PHARMA : raises EUR20.3 million in a private placement subscribed entirely by US-based specialist investors,Rise,0.0081,114,innate pharma raise eur million private placement subscribed entirely based specialist investor,95,12,0,pharmacy,"['inn', '##ate', 'p', '##har', '##ma', 'raise', 'e', '##ur', 'million', 'private', 'placement', 'sub', '##scribed', 'entirely', 'based', 'specialist', 'investor']",1
246377,nifty_767,2013-11-20,INNATE PHARMA : raises [Eur]20.3 million in a private placement subscribed entirely by US-based specialist investors,Rise,0.0081,116,innate pharma raise eur million private placement subscribed entirely based specialist investor,95,12,0,pharmacy,"['inn', '##ate', 'p', '##har', '##ma', 'raise', 'e', '##ur', 'million', 'private', 'placement', 'sub', '##scribed', 'entirely', 'based', 'specialist', 'investor']",1
246417,nifty_767,2013-11-20,"Research and Markets: Market Research: Peptic Ulcers - Pipeline Review, H2 2013",Rise,0.0081,79,research and market market research peptic ulcer pipeline review,64,9,0,pharmacy,"['research', 'and', 'market', 'market', 'research', 'p', '##ept', '##ic', 'ul', '##cer', 'pipeline', 'review']",1
246437,nifty_767,2013-11-20,"Research and Markets: Market Research: Lysosomal Storage Disorder - Pipeline Review, H2 2013",Rise,0.0081,92,research and market market research lysosomal storage disorder pipeline review,78,10,0,pharmacy,"['research', 'and', 'market', 'market', 'research', 'l', '##ys', '##oso', '##mal', 'storage', 'disorder', 'pipeline', 'review']",1
246477,nifty_767,2013-11-20,Research and Markets: Global Wounds - Pipeline Review H2 2013,Rise,0.0081,61,research and market global wound pipeline review,48,7,0,pharmacy,"['research', 'and', 'market', 'global', 'wound', 'pipeline', 'review']",1
246492,nifty_767,2013-11-20,Research and Markets: Research Report: China Diabetes Market Outlook 2018,Rise,0.0081,73,research and market research report china diabetes market outlook,65,9,0,pharmacy,"['research', 'and', 'market', 'research', 'report', 'chin', '##a', 'diabetes', 'market', 'outlook']",1
246534,nifty_767,2013-11-20,Healthcare Trends Institute releases the Guide to Health Insurance Exchanges,Rise,0.0081,76,healthcare trend institute release the guide health insurance exchange,70,9,0,pharmacy,"['healthcare', 'trend', 'institute', 'release', 'the', 'guide', 'health', 'insurance', 'exchange']",1
246653,nifty_767,2013-11-20,Research and Markets: 2013 Report on the Global Healthcare Analytics/Medical Analytics Market Report - with Forecast to 2017,Rise,0.0081,124,research and market report the global healthcare analytics medical analytics market report with forecast,104,14,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'global', 'healthcare', 'anal', '##ytic', '##s', 'medical', 'anal', '##ytic', '##s', 'market', 'report', 'with', 'forecast']",1
246699,nifty_767,2013-11-20,"Stock Price Movements, Share Repurchase Programs, and Financial Results - Research Report on Jazz Pharmaceuticals, Novo Nordisk, Teleflex, DENTSPLY International, and Fonar",Rise,0.0081,172,stock price movement share repurchase program and financial result research report jazz pharmaceutical novo nordisk teleflex dentsply international and fonar,157,20,0,pharmacy,"['stock', 'price', 'movement', 'share', 're', '##pur', '##chase', 'program', 'and', 'financial', 'result', 'research', 'report', 'jazz', 'pharmaceutical', 'no', '##vo', 'nor', '##dis', '##k', 'te', '##le', '##fle', '##x', 'den', '##ts', '##p', '##ly', 'international', 'and', 'f', '##ona', '##r']",1
246702,nifty_767,2013-11-20,"PharmaPros Completes Business Transition, Becomes eClinical Insights(R)",Rise,0.0081,71,pharmapros completes business transition becomes eclinical insight,66,7,0,pharmacy,"['p', '##har', '##ma', '##p', '##ros', 'complete', '##s', 'business', 'transition', 'becomes', 'e', '##c', '##lini', '##cal', 'insight']",1
246707,nifty_767,2013-11-20,"Turkish Diagnostic Imaging System Market Will Fluctuate, While Russian Market Will Grow Moderately Through 2022",Rise,0.0081,111,turkish diagnostic imaging system market will fluctuate while russian market will grow moderately through,105,14,0,pharmacy,"['t', '##ur', '##kis', '##h', 'diagnostic', 'imaging', 'system', 'market', 'will', 'flu', '##ct', '##uate', 'while', 'r', '##uss', '##ian', 'market', 'will', 'grow', 'moderately', 'through']",1
246737,nifty_767,2013-11-20,"Stock Price Movement, Grants for Projects, and Clinical Data Presentations - Research Report on Gilead, Bristol-Myers Squibb, HCA, Allergan, and Alexion",Rise,0.0081,152,stock price movement grant for project and clinical data presentation research report gilead bristol myers squibb hca allergan and alexion,138,20,0,pharmacy,"['stock', 'price', 'movement', 'grant', 'for', 'project', 'and', 'clinical', 'data', 'presentation', 'research', 'report', 'g', '##ile', '##ad', 'br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'h', '##ca', 'all', '##er', '##gan', 'and', 'ale', '##xi', '##on']",1
246789,nifty_767,2013-11-20,New CVS Caremark Report Projects Annual Specialty Drug Spending will Quadruple to $402 Billion by 2020,Rise,0.0081,102,new cv caremark report project annual specialty drug spending will quadruple billion,84,12,0,pharmacy,"['new', 'c', '##v', 'care', '##mark', 'report', 'project', 'annual', 'specialty', 'drug', 'spending', 'will', 'q', '##uad', '##rup', '##le', 'billion']",1
246790,nifty_767,2013-11-20,"Moderna Therapeutics Announces New Equity Financing, Raising $110M to Develop messenger RNA Therapeuticsâ¢",Rise,0.0081,107,moderna therapeutic announces new equity financing raising develop messenger rna therapeuticsâ,94,11,0,pharmacy,"['modern', '##a', 'therapeutic', 'announces', 'new', 'equity', 'financing', 'raising', 'develop', 'messenger', 'r', '##na', 'therapeutic', '##s', '##â']",1
246794,nifty_767,2013-11-20,Collaborative Medical Technology Corporation Secures Investments from Two Prominent Medical Specialists,Rise,0.0081,103,collaborative medical technology corporation secures investment from two prominent medical specialist,101,11,0,pharmacy,"['collaborative', 'medical', 'technology', 'corporation', 'secure', '##s', 'investment', 'from', 'two', 'prominent', 'medical', 'specialist']",1
246819,nifty_767,2013-11-20,"Bullish Stocks Commentary: Voxeljet AG, Organovo Holdings, Digital Ally, Federal Home Loan Mortgage, Synta Pharmaceuticals Corp",Rise,0.0081,127,bullish stock commentary voxeljet organovo holding digital ally federal home loan mortgage synta pharmaceutical corp,116,15,0,pharmacy,"['bull', '##ish', 'stock', 'commentary', 'v', '##ox', '##el', '##jet', 'organ', '##ovo', 'holding', 'digital', 'ally', 'federal', 'home', 'loan', 'mortgage', 's', '##yn', '##ta', 'pharmaceutical', 'co', '##rp']",1
246840,nifty_767,2013-11-20,Research and Markets: 2013 Report on the Global Next Generation Sequencing (NGS) Market - with Forecast to 2017,Rise,0.0081,111,research and market report the global next generation sequencing ng market with forecast,88,13,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'global', 'next', 'generation', 'se', '##quencing', 'ng', 'market', 'with', 'forecast']",1
246864,nifty_767,2013-11-20,RelayHealth Financial First to Market with ICD-10 Readiness and End-to-End Testing,Rise,0.0081,82,relayhealth financial first market with icd readiness and end end testing,73,11,0,pharmacy,"['relay', '##hea', '##lt', '##h', 'financial', 'first', 'market', 'with', 'i', '##c', '##d', 'readiness', 'and', 'end', 'end', 'testing']",1
246917,nifty_767,2013-11-20,Zacks Industry Rank Analysis Highlights: Enanta Pharmaceuticals and Sucampo Pharmaceuticals,Rise,0.0081,91,zacks industry rank analysis highlight enanta pharmaceutical and sucampo pharmaceutical,87,10,0,pharmacy,"['z', '##ack', '##s', 'industry', 'rank', 'analysis', 'highlight', 'en', '##ant', '##a', 'pharmaceutical', 'and', 'su', '##cam', '##po', 'pharmaceutical']",1
247077,nifty_767,2013-11-20,Global Bioenergies Secures a 5.7 Million Euro Grant to Proceed with Its Second Industrial Pilot in Germany,Rise,0.0081,106,global bioenergies secures million euro grant proceed with it second industrial pilot germany,93,13,0,pharmacy,"['global', 'bio', '##ener', '##gies', 'secure', '##s', 'million', 'euro', 'grant', 'proceed', 'with', 'it', 'second', 'industrial', 'pilot', 'g', '##erman', '##y']",1
247089,nifty_767,2013-11-20,Research and Markets: Type 2 Diabetes - UK Drug Forecast and Market Analysis to 2022: Featuring Actos and Byetta,Rise,0.0081,112,research and market type diabetes drug forecast and market analysis featuring actos and byetta,94,14,0,pharmacy,"['research', 'and', 'market', 'type', 'diabetes', 'drug', 'forecast', 'and', 'market', 'analysis', 'featuring', 'act', '##os', 'and', 'bye', '##tta']",1
247199,nifty_767,2013-11-20,Research and Markets: Type 2 Diabetes - US Drug Forecast and Market Analysis to 2022 Available Now for Pharma Field,Rise,0.0081,115,research and market type diabetes drug forecast and market analysis available now for pharma field,98,15,0,pharmacy,"['research', 'and', 'market', 'type', 'diabetes', 'drug', 'forecast', 'and', 'market', 'analysis', 'available', 'now', 'for', 'p', '##har', '##ma', 'field']",1
247270,nifty_767,2013-11-20,BioCryst to Present at Two Upcoming Investor Conferences,Rise,0.0081,56,biocryst present two upcoming investor conference,49,6,0,pharmacy,"['bio', '##c', '##ry', '##st', 'present', 'two', 'upcoming', 'investor', 'conference']",1
247305,nifty_767,2013-11-20,Gentris Corporation Opens New Genomic Biomarker Laboratory in China,Rise,0.0081,67,gentris corporation open new genomic biomarker laboratory china,63,8,0,pharmacy,"['g', '##ent', '##ris', 'corporation', 'open', 'new', 'g', '##eno', '##mic', 'bio', '##mark', '##er', 'laboratory', 'chin', '##a']",1
247567,nifty_767,2013-11-20,FDA Approves New Gene-Sequencing Devices,Rise,0.0081,40,fda approves new gene sequencing device,39,6,0,pharmacy,"['f', '##da', 'approve', '##s', 'new', 'gene', 'se', '##quencing', 'device']",1
247737,nifty_768,2013-11-21,Research and Markets: Market Research: Indian Diagnostic Market Outlook to 2017,Rise,0.005,79,research and market market research indian diagnostic market outlook,68,9,0,pharmacy,"['research', 'and', 'market', 'market', 'research', 'in', '##dian', 'diagnostic', 'market', 'outlook']",1
247775,nifty_768,2013-11-21,Research and Markets: Research Report: Saudi Arabia Medical Device Market Outlook 2018,Rise,0.005,86,research and market research report saudi arabia medical device market outlook,78,11,0,pharmacy,"['research', 'and', 'market', 'research', 'report', 'sa', '##udi', 'a', '##rab', '##ia', 'medical', 'device', 'market', 'outlook']",1
247820,nifty_768,2013-11-21,"Research and Markets: How to Prepare for an FDA Meeting: Making the Most of Pre-IND/IDE, pre-NDA and Other Critical Meetings",Rise,0.005,124,research and market how prepare for fda meeting making the most pre ind ide pre nda and other critical meeting,110,20,0,pharmacy,"['research', 'and', 'market', 'how', 'prepare', 'for', 'f', '##da', 'meeting', 'making', 'the', 'most', 'pre', 'in', '##d', 'id', '##e', 'pre', 'n', '##da', 'and', 'other', 'critical', 'meeting']",1
247833,nifty_768,2013-11-21,RESEARCH ALERT-Amicus Therapeutics: JP Morgan cuts to neutral,Rise,0.005,61,research alert amicus therapeutic morgan cut neutral,52,7,0,pharmacy,"['research', 'alert', 'am', '##icus', 'therapeutic', 'm', '##or', '##gan', 'cut', 'neutral']",1
247851,nifty_768,2013-11-21,Research and Markets: Japan Patient Monitoring and Diagnostic Systems Market Assessment and Forecast to 2018,Rise,0.005,108,research and market japan patient monitoring and diagnostic system market assessment and forecast,97,13,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##n', 'patient', 'monitoring', 'and', 'diagnostic', 'system', 'market', 'assessment', 'and', 'forecast']",1
247882,nifty_768,2013-11-21,Research and Markets: Healthcare RMI Market - UK 2009-2013,Rise,0.005,58,research and market healthcare rmi market,41,6,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'r', '##mi', 'market']",1
247946,nifty_768,2013-11-21,Research and Markets: PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market Analysis to 2022,Rise,0.005,101,research and market pharmapoint type diabetes brazil drug forecast and market analysis,86,12,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##point', 'type', 'diabetes', 'bra', '##zi', '##l', 'drug', 'forecast', 'and', 'market', 'analysis']",1
247982,nifty_768,2013-11-21,"FDA Approvals, Stock Price Movements, and Study Results - Research Report on Pfizer, Celgene, Merck, Quest Diagnostics, and Pharmacyclics",Rise,0.005,137,fda approval stock price movement and study result research report pfizer celgene merck quest diagnostics and pharmacyclics,123,17,0,pharmacy,"['f', '##da', 'approval', 'stock', 'price', 'movement', 'and', 'study', 'result', 'research', 'report', 'p', '##fi', '##zer', 'c', '##el', '##gene', 'me', '##rc', '##k', 'quest', 'diagnostic', '##s', 'and', 'pharmacy', '##c', '##lic', '##s']",1
248008,nifty_768,2013-11-21,"Court Orders, Stock Price Movements, FDA Approvals and Strategic Collaborations - Research Report on Johnson & Johnson, Santarus, Salix, St. Jude Medical, and Covance",Rise,0.005,166,court order stock price movement fda approval and strategic collaboration research report johnson johnson santarus salix jude medical and covance,145,20,0,pharmacy,"['court', 'order', 'stock', 'price', 'movement', 'f', '##da', 'approval', 'and', 'strategic', 'collaboration', 'research', 'report', 'j', '##oh', '##nson', 'j', '##oh', '##nson', 'sa', '##nta', '##rus', 'sa', '##lix', 'j', '##ude', 'medical', 'and', 'co', '##vance']",1
248010,nifty_768,2013-11-21,"Stock Price Update, Recognitions, and Grant of Stock Options - Research Report on Cyberonics, Hill-Rom Holdings, Bio-Reference Laboratories, Avanir Pharmaceuticals, and ImmunoGen",Rise,0.005,178,stock price update recognition and grant stock option research report cyberonics hill rom holding bio reference laboratory avanir pharmaceutical and immunogen,158,21,0,pharmacy,"['stock', 'price', 'update', 'recognition', 'and', 'grant', 'stock', 'option', 'research', 'report', 'c', '##y', '##ber', '##onic', '##s', 'hill', 'r', '##om', 'holding', 'bio', 'reference', 'laboratory', 'a', '##vani', '##r', 'pharmaceutical', 'and', 'im', '##mu', '##no', '##gen']",1
248014,nifty_768,2013-11-21,"Stock Price Update, Financial Results, and Media Coverage - Research Report on Health Management, Mednax, LifePoint, Acadia, and IPC",Rise,0.005,132,stock price update financial result and medium coverage research report health management mednax lifepoint acadia and ipc,121,17,0,pharmacy,"['stock', 'price', 'update', 'financial', 'result', 'and', 'medium', 'coverage', 'research', 'report', 'health', 'management', 'me', '##dn', '##ax', 'life', '##point', 'a', '##ca', '##dia', 'and', 'i', '##p', '##c']",1
248046,nifty_768,2013-11-21,"Pre-Market Review: Star Scientific Inc., Pharmacyclics Inc., United Therapeutics Corp., and Impax Laboratories Inc.",Rise,0.005,115,pre market review star scientific inc pharmacyclics inc united therapeutic corp and impax laboratory inc,104,15,0,pharmacy,"['pre', 'market', 'review', 'star', 'scientific', 'in', '##c', 'pharmacy', '##c', '##lic', '##s', 'in', '##c', 'united', 'therapeutic', 'co', '##rp', 'and', 'imp', '##ax', 'laboratory', 'in', '##c']",1
248064,nifty_768,2013-11-21,New Report Finds Mid-Sized Firmsâ Focus on Healthcare Delivery Solutions Could Save $200 Billion,Rise,0.005,98,new report find mid sized firmsâ focus healthcare delivery solution could save billion,86,13,0,pharmacy,"['new', 'report', 'find', 'mid', 'sized', 'firms', '##â', 'focus', 'healthcare', 'delivery', 'solution', 'could', 'save', 'billion']",1
248097,nifty_768,2013-11-21,Research and Markets: EpiCast Report: Schizophrenia - Epidemiology Forecast to 2022,Rise,0.005,83,research and market epicast report schizophrenia epidemiology forecast,70,8,0,pharmacy,"['research', 'and', 'market', 'epic', '##ast', 'report', 's', '##chi', '##zophrenia', 'e', '##pid', '##em', '##iology', 'forecast']",1
248134,nifty_768,2013-11-21,BRIEF-Iroko Pharmaceuticals secures $75 million in debt financing,Rise,0.005,65,brief iroko pharmaceutical secures million debt financing,57,7,0,pharmacy,"['brief', 'i', '##rok', '##o', 'pharmaceutical', 'secure', '##s', 'million', 'debt', 'financing']",1
248201,nifty_768,2013-11-21,Research and Markets: Apidra (Type 2 Diabetes) - Forecast and Market Analysis to 2022,Rise,0.005,85,research and market apidra type diabetes forecast and market analysis,69,10,0,pharmacy,"['research', 'and', 'market', 'a', '##pid', '##ra', 'type', 'diabetes', 'forecast', 'and', 'market', 'analysis']",1
248321,nifty_768,2013-11-21,Research and Markets: Type 2 Diabetes - France Drug Forecast and Market Analysis to 2022 Out Now,Rise,0.005,96,research and market type diabetes france drug forecast and market analysis out now,82,13,0,pharmacy,"['research', 'and', 'market', 'type', 'diabetes', 'f', '##rance', 'drug', 'forecast', 'and', 'market', 'analysis', 'out', 'now']",1
248331,nifty_768,2013-11-21,Research and Markets: Indian In Vitro Diagnostics Market Analysis 2018,Rise,0.005,70,research and market indian vitro diagnostics market analysis,60,8,0,pharmacy,"['research', 'and', 'market', 'in', '##dian', 'v', '##it', '##ro', 'diagnostic', '##s', 'market', 'analysis']",1
248353,nifty_768,2013-11-21,GentivaÂ® Health Services To Present at Upcoming Investor Conferences,Rise,0.005,69,gentivaâ health service present upcoming investor conference,60,7,0,pharmacy,"['g', '##ent', '##iva', '##â', 'health', 'service', 'present', 'upcoming', 'investor', 'conference']",1
248354,nifty_768,2013-11-21,Vitamin Blue Provides Shareholder Update,Rise,0.005,40,vitamin blue provides shareholder update,40,5,0,pharmacy,"['vitamin', 'blue', 'provides', 'shareholder', 'update']",1
248470,nifty_768,2013-11-21,"Research and Markets: Schizophrenia Global Clinical Trials Review, 2013 Contains Essential Data for those in the Psychiatry Field",Rise,0.005,129,research and market schizophrenia global clinical trial review contains essential data for those the psychiatry field,117,16,0,pharmacy,"['research', 'and', 'market', 's', '##chi', '##zophrenia', 'global', 'clinical', 'trial', 'review', 'contains', 'essential', 'data', 'for', 'those', 'the', 'ps', '##ych', '##ia', '##try', 'field']",1
248503,nifty_768,2013-11-21,Iroko Pharmaceuticals Secures $75 Million in Debt Financing to Support ZORVOLEXâ¢ (diclofenac) Commercialization,Rise,0.005,113,iroko pharmaceutical secures million debt financing support zorvolexâ diclofenac commercialization,98,10,0,pharmacy,"['i', '##rok', '##o', 'pharmaceutical', 'secure', '##s', 'million', 'debt', 'financing', 'support', 'z', '##or', '##vo', '##lex', '##â', 'di', '##c', '##lo', '##fen', '##ac', 'commercial', '##ization']",1
248631,nifty_768,2013-11-21,BRIEF-Bluemountain Capital Management and Iszo Capital file lawsuit against Taro Pharmaceutical Industries,Rise,0.005,106,brief bluemountain capital management and iszo capital file lawsuit against taro pharmaceutical industry,104,13,0,pharmacy,"['brief', 'blue', '##mount', '##ain', 'capital', 'management', 'and', 'is', '##zo', 'capital', 'file', 'lawsuit', 'against', 'ta', '##ro', 'pharmaceutical', 'industry']",1
248644,nifty_768,2013-11-21,BRIEF-Biota Pharmaceuticals says will immediately suspend investment in its preclinical antibiotic program - SEC filing,Rise,0.005,119,brief biota pharmaceutical say will immediately suspend investment it preclinical antibiotic program sec filing,111,14,0,pharmacy,"['brief', 'bio', '##ta', 'pharmaceutical', 'say', 'will', 'immediately', 'su', '##sp', '##end', 'investment', 'it', 'pre', '##c', '##lini', '##cal', 'anti', '##biotic', 'program', 'se', '##c', 'filing']",1
248684,nifty_768,2013-11-21,Sixth Annual Biotech Showcaseâ¢ Returns to San Francisco January 13â15,Rise,0.005,73,sixth annual biotech showcaseâ return san francisco january,59,8,0,pharmacy,"['sixth', 'annual', 'bio', '##tech', 'showcase', '##â', 'return', 'sa', '##n', 'f', '##ran', '##cis', '##co', 'j', '##anu', '##ary']",1
248708,nifty_768,2013-11-21,China's Shandong Weigao to sell entire stake in Biosensors for $312.3 mln,Rise,0.005,73,china shandong weigao sell entire stake biosensors for mln,58,9,0,pharmacy,"['chin', '##a', 's', '##hand', '##ong', 'we', '##iga', '##o', 'sell', 'entire', 'stake', 'bio', '##sen', '##sors', 'for', 'm', '##ln']",1
248709,nifty_768,2013-11-21,China's Shandong Weigao to sell entire stake in Biosensors for $312.3 million,Rise,0.005,77,china shandong weigao sell entire stake biosensors for million,62,9,0,pharmacy,"['chin', '##a', 's', '##hand', '##ong', 'we', '##iga', '##o', 'sell', 'entire', 'stake', 'bio', '##sen', '##sors', 'for', 'million']",1
248900,nifty_769,2013-11-25,"Research and Markets: Psychiatric Disorders - Pipeline Review, H2 2013",Neutral,0.0003,70,research and market psychiatric disorder pipeline review,56,7,0,pharmacy,"['research', 'and', 'market', 'psychiatric', 'disorder', 'pipeline', 'review']",1
249072,nifty_769,2013-11-25,Research and Markets: Global Epigenetics Drugs And Diagnostic Technologies Market Report 2013 - 2018,Neutral,0.0003,100,research and market global epigenetics drug and diagnostic technology market report,83,11,0,pharmacy,"['research', 'and', 'market', 'global', 'e', '##pi', '##gene', '##tics', 'drug', 'and', 'diagnostic', 'technology', 'market', 'report']",1
249092,nifty_769,2013-11-25,"Upcoming Webinars, FDA Clearances, Preclinical Data Presentations, Completed Acquisitions and Financial Results - Research Report on Teva, Boston Scientific, Alnylam, Wright Medical, and Onconova",Neutral,0.0003,195,upcoming webinars fda clearance preclinical data presentation completed acquisition and financial result research report teva boston scientific alnylam wright medical and onconova,179,22,0,pharmacy,"['upcoming', 'web', '##ina', '##rs', 'f', '##da', 'clearance', 'pre', '##c', '##lini', '##cal', 'data', 'presentation', 'completed', 'acquisition', 'and', 'financial', 'result', 'research', 'report', 'te', '##va', 'b', '##ost', '##on', 'scientific', 'al', '##ny', '##lam', 'w', '##right', 'medical', 'and', 'on', '##con', '##ova']",1
249096,nifty_769,2013-11-25,"FDA Approvals, Public Offerings and Stock Price Movements - Research Report on BioMarin, AEterna Zentaris, Charles River, Anika Therapeutics and Halozyme Therapeutics",Neutral,0.0003,166,fda approval public offering and stock price movement research report biomarin aeterna zentaris charles river anika therapeutic and halozyme therapeutic,152,20,0,pharmacy,"['f', '##da', 'approval', 'public', 'offering', 'and', 'stock', 'price', 'movement', 'research', 'report', 'bio', '##mar', '##in', 'a', '##eter', '##na', 'z', '##ent', '##aris', 'ch', '##ar', '##les', 'river', 'an', '##ika', 'therapeutic', 'and', 'ha', '##lo', '##zy', '##me', 'therapeutic']",1
249098,nifty_769,2013-11-25,"Settlement Agreement, Presentation of Trial Results, and Stock Price Update - Research Report on Johnson & Johnson, Mettler-Toledo, Galena Biopharma, Dendreon, and Amedisys",Neutral,0.0003,172,settlement agreement presentation trial result and stock price update research report johnson johnson mettler toledo galena biopharma dendreon and amedisys,155,20,0,pharmacy,"['settlement', 'agreement', 'presentation', 'trial', 'result', 'and', 'stock', 'price', 'update', 'research', 'report', 'j', '##oh', '##nson', 'j', '##oh', '##nson', 'met', '##tler', 'to', '##led', '##o', 'gal', '##ena', 'bio', '##pha', '##rma', 'den', '##dre', '##on', 'and', 'am', '##ed', '##is', '##ys']",1
249132,nifty_769,2013-11-25,"Upcoming Conference Schedules, Orphan Drug Designations and Stock Price Updates - Research Report on Pfizer, ICU Medical, CONMED, Gentium, and Repros Therapeutics",Neutral,0.0003,162,upcoming conference schedule orphan drug designation and stock price update research report pfizer icu medical conmed gentium and repros therapeutic,148,20,0,pharmacy,"['upcoming', 'conference', 'schedule', 'orphan', 'drug', 'designation', 'and', 'stock', 'price', 'update', 'research', 'report', 'p', '##fi', '##zer', 'i', '##cu', 'medical', 'con', '##med', 'g', '##ent', '##ium', 'and', 're', '##p', '##ros', 'therapeutic']",1
249139,nifty_769,2013-11-25,Research and Markets: Global Artificial Vital Organs And Medical Bionics Market 2013 - 2018,Neutral,0.0003,91,research and market global artificial vital organ and medical bionics market,76,11,0,pharmacy,"['research', 'and', 'market', 'global', 'artificial', 'vital', 'organ', 'and', 'medical', 'bio', '##nics', 'market']",1
249227,nifty_769,2013-11-25,Metabolix To Present At LD Micro Investor Conference,Neutral,0.0003,52,metabolix present micro investor conference,43,5,0,pharmacy,"['meta', '##bol', '##ix', 'present', 'micro', 'investor', 'conference']",1
249240,nifty_769,2013-11-25,Research and Markets: Global BRIC Diabetes Drugs Market Report - Includes Forecast to 2015,Neutral,0.0003,90,research and market global bric diabetes drug market report includes forecast,77,11,0,pharmacy,"['research', 'and', 'market', 'global', 'br', '##ic', 'diabetes', 'drug', 'market', 'report', 'includes', 'forecast']",1
249320,nifty_769,2013-11-25,Research and Markets: China's Demand for Medical Devices Will Continue to Grow at About 10% by 2022,Neutral,0.0003,99,research and market china demand for medical device will continue grow about,76,12,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'demand', 'for', 'medical', 'device', 'will', 'continue', 'grow', 'about']",1
249395,nifty_769,2013-11-25,Research and Markets: Biomarker Partnering Terms and Agreements: 2013 Report is Out Now for Review,Neutral,0.0003,98,research and market biomarker partnering term and agreement report out now for review,85,13,0,pharmacy,"['research', 'and', 'market', 'bio', '##mark', '##er', 'partner', '##ing', 'term', 'and', 'agreement', 'report', 'out', 'now', 'for', 'review']",1
249424,nifty_769,2013-11-25,BRIEF-Biotech Value Fund Partners expands Ablynx stake to 5.23 pct,Neutral,0.0003,66,brief biotech value fund partner expands ablynx stake pct,57,9,0,pharmacy,"['brief', 'bio', '##tech', 'value', 'fund', 'partner', 'expands', 'a', '##bly', '##nx', 'stake', 'p', '##ct']",1
249489,nifty_769,2013-11-25,"International Digital Holding, Inc. through its subsidiary Syndicare, Inc. acquires PH SQUARED LLC aka Pharm-Houseâ¢ Pharmacy",Neutral,0.0003,126,international digital holding inc through it subsidiary syndicare inc acquires squared llc aka pharm houseâ pharmacy,116,16,0,pharmacy,"['international', 'digital', 'holding', 'in', '##c', 'through', 'it', 'subsidiary', 's', '##yn', '##dic', '##are', 'in', '##c', 'acquire', '##s', 'squared', 'll', '##c', 'aka', 'p', '##har', '##m', 'house', '##â', 'pharmacy']",1
249689,nifty_769,2013-11-25,Genetic Test Service Hits FDA Roadblock,Neutral,0.0003,39,genetic test service hit fda roadblock,38,6,0,pharmacy,"['genetic', 'test', 'service', 'hit', 'f', '##da', 'road', '##block']",1
249695,nifty_769,2013-11-25,FDA Reviewing Efficacy of Plan B in Women Over 165 Pounds,Neutral,0.0003,57,fda reviewing efficacy plan woman over pound,44,7,0,pharmacy,"['f', '##da', 'reviewing', 'efficacy', 'plan', 'woman', 'over', 'pound']",1
249702,nifty_769,2013-11-25,FDA Removes Marketing Limits on Diabetes Drug Avandia,Neutral,0.0003,53,fda remove marketing limit diabetes drug avandia,48,7,0,pharmacy,"['f', '##da', 'remove', 'marketing', 'limit', 'diabetes', 'drug', 'a', '##van', '##dia']",1
249713,nifty_769,2013-11-25,Orexigen to Seek FDA Approval for Contrave,Neutral,0.0003,42,orexigen seek fda approval for contrave,39,6,0,pharmacy,"['ore', '##xi', '##gen', 'seek', 'f', '##da', 'approval', 'for', 'con', '##tra', '##ve']",1
249812,nifty_771,2013-12-02,23andMe Stops Genetic Test Marketing,Neutral,-0.0043,36,andme stop genetic test marketing,33,5,0,pharmacy,"['and', '##me', 'stop', 'genetic', 'test', 'marketing']",1
249913,nifty_772,2013-12-03,BRIEF-Shanghai Zhangjiang Hi-tech and partners to double registered capital of a biotech & pharma JV,Neutral,-0.0001,100,brief shanghai zhangjiang tech and partner double registered capital biotech pharma,83,11,0,pharmacy,"['brief', 's', '##hang', '##hai', 'z', '##hang', '##jiang', 'tech', 'and', 'partner', 'double', 'registered', 'capital', 'bio', '##tech', 'p', '##har', '##ma']",1
249969,nifty_772,2013-12-03,Research and Markets: 2013 Report on the International Portable Medical Devices Market - Includes Forecasts to 2018,Neutral,-0.0001,115,research and market report the international portable medical device market includes forecast,93,12,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'portable', 'medical', 'device', 'market', 'includes', 'forecast']",1
250011,nifty_772,2013-12-03,"Research and Markets: Triple Analysis: Breast Cancer, Melanoma and Peptides - 2013 Report",Neutral,-0.0001,89,research and market triple analysis breast cancer melanoma and peptide report,77,11,0,pharmacy,"['research', 'and', 'market', 'triple', 'analysis', 'breast', 'cancer', 'me', '##lan', '##oma', 'and', 'p', '##eptide', 'report']",1
250019,nifty_772,2013-12-03,UPDATE 1-Novo confident of strong drug pipeline and future growth- CEO,Neutral,-0.0001,70,update novo confident strong drug pipeline and future growth ceo,64,10,0,pharmacy,"['update', 'no', '##vo', 'confident', 'strong', 'drug', 'pipeline', 'and', 'future', 'growth', 'c', '##eo']",1
250024,nifty_772,2013-12-03,Novo confident of strong drug pipeline and future growth- CEO,Neutral,-0.0001,61,novo confident strong drug pipeline and future growth ceo,57,9,0,pharmacy,"['no', '##vo', 'confident', 'strong', 'drug', 'pipeline', 'and', 'future', 'growth', 'c', '##eo']",1
250049,nifty_772,2013-12-03,"Research and Markets: Hernia Repair Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019",Neutral,-0.0001,132,research and market hernia repair device market global industry analysis size share growth trend and forecast,109,16,0,pharmacy,"['research', 'and', 'market', 'her', '##nia', 'repair', 'device', 'market', 'global', 'industry', 'analysis', 'size', 'share', 'growth', 'trend', 'and', 'forecast']",1
250109,nifty_772,2013-12-03,"Research and Markets: Triple Analysis: Lymphoma, Melanoma and Angiogenesis",Neutral,-0.0001,74,research and market triple analysis lymphoma melanoma and angiogenesis,70,9,0,pharmacy,"['research', 'and', 'market', 'triple', 'analysis', 'l', '##ymph', '##oma', 'me', '##lan', '##oma', 'and', 'an', '##gio', '##genesis']",1
250160,nifty_772,2013-12-03,Capillary Technologies Names Silicon Valley Veteran Janet A. Jaiswal as Vice President of Marketing,Neutral,-0.0001,99,capillary technology name silicon valley veteran janet jaiswal vice president marketing,87,11,0,pharmacy,"['cap', '##illa', '##ry', 'technology', 'name', 'silicon', 'valley', 'veteran', 'j', '##ane', '##t', 'j', '##ais', '##wal', 'vice', 'president', 'marketing']",1
250171,nifty_772,2013-12-03,"Biotech Firms Participate in Upcoming Conferences; Sees Steady Numbers around Thanksgiving - Research Report on BioMarin, Halozyme, PDL BioPharma, Anika Therapeutics, and Exelis",Neutral,-0.0001,177,biotech firm participate upcoming conference see steady number around thanksgiving research report biomarin halozyme pdl biopharma anika therapeutic and exelis,159,20,0,pharmacy,"['bio', '##tech', 'firm', 'participate', 'upcoming', 'conference', 'see', 'steady', 'number', 'around', 'thanks', '##gi', '##ving', 'research', 'report', 'bio', '##mar', '##in', 'ha', '##lo', '##zy', '##me', 'p', '##dl', 'bio', '##pha', '##rma', 'an', '##ika', 'therapeutic', 'and', 'ex', '##eli', '##s']",1
250184,nifty_772,2013-12-03,"Healthcare Companies Report Appointments, Phase 1 Studies, and Corporate Growth - Research Report on HCA, Isis Pharmaceuticals, Oxygen Biotherapeutics, Insmed, and Zalicus",Neutral,-0.0001,171,healthcare company report appointment phase study and corporate growth research report hca isi pharmaceutical oxygen biotherapeutics insmed and zalicus,151,19,0,pharmacy,"['healthcare', 'company', 'report', 'appointment', 'phase', 'study', 'and', 'corporate', 'growth', 'research', 'report', 'h', '##ca', 'is', '##i', 'pharmaceutical', 'oxygen', 'bio', '##ther', '##ap', '##eu', '##tics', 'ins', '##med', 'and', 'z', '##ali', '##cus']",1
250186,nifty_772,2013-12-03,Emergent Health Corp. Updates Shareholders,Neutral,-0.0001,42,emergent health corp update shareholder,39,5,0,pharmacy,"['emerge', '##nt', 'health', 'co', '##rp', 'update', 'shareholder']",1
250268,nifty_772,2013-12-03,Columbus Nova Acquires Controlling Interest in CIFC,Neutral,-0.0001,51,columbus nova acquires controlling interest cifc,48,6,0,pharmacy,"['co', '##lum', '##bus', 'no', '##va', 'acquire', '##s', 'controlling', 'interest', 'c', '##if', '##c']",1
250342,nifty_772,2013-12-03,"The Zacks Analyst Blog Highlights:Pretium Resources, Cadence Pharmaceuticals, Ariad Pharmaceuticals, Ventas and Kindred Healthcare",Neutral,-0.0001,130,the zacks analyst blog highlight pretium resource cadence pharmaceutical ariad pharmaceutical ventas and kindred healthcare,123,15,0,pharmacy,"['the', 'z', '##ack', '##s', 'analyst', 'blog', 'highlight', 'pre', '##tium', 'resource', 'ca', '##dence', 'pharmaceutical', 'a', '##riad', 'pharmaceutical', 'vent', '##as', 'and', 'kind', '##red', 'healthcare']",1
250420,nifty_772,2013-12-03,"CDRD Ventures Inc. of Vancouver, Canada Launches New Spin-Off, Sitka Biopharma",Neutral,-0.0001,78,cdrd venture inc vancouver canada launch new spin off sitka biopharma,69,11,0,pharmacy,"['c', '##dr', '##d', 'venture', 'in', '##c', 'van', '##co', '##uve', '##r', 'can', '##ada', 'launch', 'new', 'spin', 'off', 'sit', '##ka', 'bio', '##pha', '##rma']",1
250441,nifty_772,2013-12-03,The U.S. Market for Predictive Personalized Drugs Will Double from 2013 until 2019,Neutral,-0.0001,82,the market for predictive personalized drug will double from until,66,10,0,pharmacy,"['the', 'market', 'for', 'predict', '##ive', 'personal', '##ized', 'drug', 'will', 'double', 'from', 'until']",1
250553,nifty_772,2013-12-03,Morgan Joseph TriArtisan Technology Group Advises Green Biologics on $25 Million Growth Equity Financing,Neutral,-0.0001,104,morgan joseph triartisan technology group advises green biologics million growth equity financing,97,12,0,pharmacy,"['m', '##or', '##gan', 'j', '##ose', '##ph', 't', '##ria', '##rt', '##isan', 'technology', 'group', 'advise', '##s', 'green', 'bio', '##log', '##ics', 'million', 'growth', 'equity', 'financing']",1
250637,nifty_772,2013-12-03,Celldex Therapeutics Announces Proposed Public Offering of Common Stock,Neutral,-0.0001,71,celldex therapeutic announces proposed public offering common stock,67,8,0,pharmacy,"['cell', '##de', '##x', 'therapeutic', 'announces', 'proposed', 'public', 'offering', 'common', 'stock']",1
250789,nifty_772,2013-12-03,"Cancer Centers, Longtime Rivals, Launch Company to Develop New Drug",Neutral,-0.0001,67,cancer center longtime rival launch company develop new drug,60,9,0,pharmacy,"['cancer', 'center', 'longtime', 'rival', 'launch', 'company', 'develop', 'new', 'drug']",1
250814,nifty_772,2013-12-03,Novo Nordisk Preps Obesity Drug,Neutral,-0.0001,31,novo nordisk prep obesity drug,30,5,0,pharmacy,"['no', '##vo', 'nor', '##dis', '##k', 'pre', '##p', 'o', '##besity', 'drug']",1
250934,nifty_773,2013-12-04,Ligand Raises Fourth Quarter and Full Year 2013 Financial Forecast,Neutral,-0.0044,66,ligand raise fourth quarter and full year financial forecast,60,9,0,pharmacy,"['l', '##igan', '##d', 'raise', 'fourth', 'quarter', 'and', 'full', 'year', 'financial', 'forecast']",1
250957,nifty_773,2013-12-04,"Research and Markets: Market Research: Gastrointestinal Bleeding Global Clinical Trials Review, H2, 2013",Neutral,-0.0044,104,research and market market research gastrointestinal bleeding global clinical trial review,90,11,0,pharmacy,"['research', 'and', 'market', 'market', 'research', 'gas', '##tro', '##int', '##est', '##inal', 'bleeding', 'global', 'clinical', 'trial', 'review']",1
250959,nifty_773,2013-12-04,"Research and Markets: Sarcopenia - Pipeline Review, H2 2013",Neutral,-0.0044,59,research and market sarcopenia pipeline review,46,6,0,pharmacy,"['research', 'and', 'market', 'sa', '##rc', '##ope', '##nia', 'pipeline', 'review']",1
250963,nifty_773,2013-12-04,Research and Markets: Onglyza (Type 2 Diabetes) - Forecast and Market Analysis to 2022,Neutral,-0.0044,86,research and market onglyza type diabetes forecast and market analysis,70,10,0,pharmacy,"['research', 'and', 'market', 'on', '##gly', '##za', 'type', 'diabetes', 'forecast', 'and', 'market', 'analysis']",1
251066,nifty_773,2013-12-04,ProPhotonix Limited Provides Trading Update and Announces Enhanced Financing Facility,Neutral,-0.0044,85,prophotonix limited provides trading update and announces enhanced financing facility,85,10,0,pharmacy,"['prop', '##hot', '##oni', '##x', 'limited', 'provides', 'trading', 'update', 'and', 'announces', 'enhanced', 'financing', 'facility']",1
251085,nifty_773,2013-12-04,Research and Markets: Global Cancer Profiling Market Report 2013 - 2018,Neutral,-0.0044,71,research and market global cancer profiling market report,57,8,0,pharmacy,"['research', 'and', 'market', 'global', 'cancer', 'pro', '##fi', '##ling', 'market', 'report']",1
251120,nifty_773,2013-12-04,"Germany, Japan and Russia Will be the First Markets to Experience Peak Cases in Several Commercially Significant Drug Markets",Neutral,-0.0044,125,germany japan and russia will the first market experience peak case several commercially significant drug market,112,16,0,pharmacy,"['g', '##erman', '##y', 'j', '##apa', '##n', 'and', 'r', '##uss', '##ia', 'will', 'the', 'first', 'market', 'experience', 'peak', 'case', 'several', 'commercially', 'significant', 'drug', 'market']",1
251136,nifty_773,2013-12-04,"Regulatory Approval, Requisite Consents and Expiration of Consent Solicitations, and Stock Price Movements - Research Report on Thermo Fisher, Endo, Perrigo, Keryx, and Waters",Neutral,-0.0044,175,regulatory approval requisite consent and expiration consent solicitation and stock price movement research report thermo fisher endo perrigo keryx and water,157,21,0,pharmacy,"['regulatory', 'approval', 're', '##quisite', 'consent', 'and', 'ex', '##piration', 'consent', 'so', '##licit', '##ation', 'and', 'stock', 'price', 'movement', 'research', 'report', 'the', '##rm', '##o', 'fish', '##er', 'end', '##o', 'per', '##rig', '##o', 'k', '##ery', '##x', 'and', 'water']",1
251148,nifty_773,2013-12-04,"Stock Price Updates, and Charitable Contributions - Research Report on BioMarin, Covidien, United Therapeutics, Brookdale, and Seattle Genetics",Neutral,-0.0044,143,stock price update and charitable contribution research report biomarin covidien united therapeutic brookdale and seattle genetics,130,16,0,pharmacy,"['stock', 'price', 'update', 'and', 'charitable', 'contribution', 'research', 'report', 'bio', '##mar', '##in', 'co', '##vid', '##ien', 'united', 'therapeutic', 'br', '##ook', '##dale', 'and', 'seat', '##tle', 'genetics']",1
251239,nifty_773,2013-12-04,"Biotech Briefing: Advancing Biotechs Forging Ahead With Breaking News Developments: Alliqua, OncoMed Pharmaceuticals, EnteroMedics, Unilife, Amarin",Neutral,-0.0044,147,biotech briefing advancing biotech forging ahead with breaking news development alliqua oncomed pharmaceutical enteromedics unilife amarin,138,16,0,pharmacy,"['bio', '##tech', 'brief', '##ing', 'advancing', 'bio', '##tech', 'for', '##ging', 'ahead', 'with', 'breaking', 'news', 'development', 'all', '##iq', '##ua', 'on', '##come', '##d', 'pharmaceutical', 'enter', '##ome', '##dic', '##s', 'un', '##ili', '##fe', 'am', '##ari', '##n']",1
251325,nifty_773,2013-12-04,Research and Markets: Global Stroke Pipeline Highlights - 2014 Gives a Detailed Account of Forecasts,Neutral,-0.0044,100,research and market global stroke pipeline highlight give detailed account forecast,83,11,0,pharmacy,"['research', 'and', 'market', 'global', 'stroke', 'pipeline', 'highlight', 'give', 'detailed', 'account', 'forecast']",1
251355,nifty_773,2013-12-04,Research and Markets: Global Diabetic Nephropathy Pipeline Highlights - 2014: Discover what Products will be Launched in the US and Ex-US till 2017,Neutral,-0.0044,147,research and market global diabetic nephropathy pipeline highlight discover what product will launched the and till,115,16,0,pharmacy,"['research', 'and', 'market', 'global', 'di', '##abe', '##tic', 'ne', '##ph', '##rop', '##athy', 'pipeline', 'highlight', 'discover', 'what', 'product', 'will', 'launched', 'the', 'and', 'till']",1
251455,nifty_773,2013-12-04,"Research and Markets: The Global Predictive Breast Cancer Gene Testing Market to Grow Significantly, From US$422m in 2011 to US$1 Billion by 2018 at a CAGR of 14%",Neutral,-0.0044,162,research and market the global predictive breast cancer gene testing market grow significantly from billion cagr,112,16,0,pharmacy,"['research', 'and', 'market', 'the', 'global', 'predict', '##ive', 'breast', 'cancer', 'gene', 'testing', 'market', 'grow', 'significantly', 'from', 'billion', 'ca', '##g', '##r']",1
251462,nifty_773,2013-12-04,Research and Markets: LY2605541 (Type 2 Diabetes) - Forecast and Market Analysis to 2022,Neutral,-0.0044,88,research and market type diabetes forecast and market analysis,62,9,0,pharmacy,"['research', 'and', 'market', 'type', 'diabetes', 'forecast', 'and', 'market', 'analysis']",1
251492,nifty_773,2013-12-04,GLOBAL BIOENERGIES Receives the EnterNext Prize at the Third French Stock Market Conference,Neutral,-0.0044,91,global bioenergies receives the enternext prize the third french stock market conference,88,12,0,pharmacy,"['global', 'bio', '##ener', '##gies', 'receives', 'the', 'enter', '##nex', '##t', 'prize', 'the', 'third', 'f', '##rench', 'stock', 'market', 'conference']",1
251606,nifty_773,2013-12-04,Cognoptix President and CEO Paul Hartung named âEmerging Medical Technologies Innovator of the Monthâ by Life Science IntelligenceÂ®,Neutral,-0.0044,136,cognoptix president and ceo paul hartung named emerging medical technology innovator the monthâ life science intelligenceâ,122,16,0,pharmacy,"['co', '##gno', '##pt', '##ix', 'president', 'and', 'c', '##eo', 'p', '##aul', 'ha', '##rt', '##ung', 'named', 'emerging', 'medical', 'technology', 'inn', '##ova', '##tor', 'the', 'month', '##â', 'life', 'science', 'intelligence', '##â']",1
251641,nifty_773,2013-12-04,Aerie Pharmaceuticals Reports Third Quarter 2013 Financial Results and Provides Business and Product Development Update,Neutral,-0.0044,119,aerie pharmaceutical report third quarter financial result and provides business and product development update,111,14,0,pharmacy,"['a', '##erie', 'pharmaceutical', 'report', 'third', 'quarter', 'financial', 'result', 'and', 'provides', 'business', 'and', 'product', 'development', 'update']",1
251645,nifty_773,2013-12-04,Taigle and SAFE-BioPharma Enter Strategic Relationship,Neutral,-0.0044,54,taigle and safe biopharma enter strategic relationship,54,7,0,pharmacy,"['ta', '##ig', '##le', 'and', 'safe', 'bio', '##pha', '##rma', 'enter', 'strategic', 'relationship']",1
251694,nifty_773,2013-12-04,Lorus Therapeutics to File Final Prospectus for Equity Offering and Provides Corporate Update,Neutral,-0.0044,93,lorus therapeutic file final prospectus for equity offering and provides corporate update,89,12,0,pharmacy,"['lo', '##rus', 'therapeutic', 'file', 'final', 'prospect', '##us', 'for', 'equity', 'offering', 'and', 'provides', 'corporate', 'update']",1
251752,nifty_773,2013-12-04,Celldex Therapeutics Prices Public Offering of Common Stock,Neutral,-0.0044,59,celldex therapeutic price public offering common stock,54,7,0,pharmacy,"['cell', '##de', '##x', 'therapeutic', 'price', 'public', 'offering', 'common', 'stock']",1
251765,nifty_773,2013-12-04,Transcept Pharmaceuticals Provides Update to Key Initiatives Being Undertaken to Increase Stockholder Value,Neutral,-0.0044,107,transcept pharmaceutical provides update key initiative being undertaken increase stockholder value,99,11,0,pharmacy,"['trans', '##ce', '##pt', 'pharmaceutical', 'provides', 'update', 'key', 'initiative', 'being', 'undertaken', 'increase', 'stock', '##holder', 'value']",1
251959,nifty_774,2013-12-05,Alvotech Invests $250 Million in Biopharmaceuticals,Rise,0.0112,51,alvotech invests million biopharmaceuticals,43,4,0,pharmacy,"['al', '##vo', '##tech', 'invest', '##s', 'million', 'bio', '##pha', '##rma', '##ce', '##utical', '##s']",1
251967,nifty_774,2013-12-05,Research and Markets: Research Report: Strategic Analysis of the Global Omega-3 Pharmaceutical Market,Rise,0.0112,101,research and market research report strategic analysis the global omega pharmaceutical market,93,12,0,pharmacy,"['research', 'and', 'market', 'research', 'report', 'strategic', 'analysis', 'the', 'global', 'o', '##me', '##ga', 'pharmaceutical', 'market']",1
251976,nifty_774,2013-12-05,Biotech China -- Your Gateway to No.1 Biotechnology Base in China,Rise,0.0112,65,biotech china your gateway biotechnology base china,51,7,0,pharmacy,"['bio', '##tech', 'chin', '##a', 'your', 'gateway', 'bio', '##tech', '##nology', 'base', 'chin', '##a']",1
252057,nifty_774,2013-12-05,Research and Markets: Global Lysosomal Storage Disorders Pipeline Highlights - 2014,Rise,0.0112,83,research and market global lysosomal storage disorder pipeline highlight,72,9,0,pharmacy,"['research', 'and', 'market', 'global', 'l', '##ys', '##oso', '##mal', 'storage', 'disorder', 'pipeline', 'highlight']",1
252080,nifty_774,2013-12-05,Research and Markets: Global Crohn's Disease Pipeline Highlights - 2014,Rise,0.0112,71,research and market global crohn disease pipeline highlight,59,8,0,pharmacy,"['research', 'and', 'market', 'global', 'c', '##ro', '##hn', 'disease', 'pipeline', 'highlight']",1
252081,nifty_774,2013-12-05,Research and Markets: Global Schizophrenia Pipeline Highlights - 2014,Rise,0.0112,69,research and market global schizophrenia pipeline highlight,59,7,0,pharmacy,"['research', 'and', 'market', 'global', 's', '##chi', '##zophrenia', 'pipeline', 'highlight']",1
252092,nifty_774,2013-12-05,"Divestitures, Event Participations, Patents, Clinical Studies and Trials - Research Report on Allergan, Zoetis, XOMA, Isis, and Arrowhead",Rise,0.0112,137,divestiture event participation patent clinical study and trial research report allergan zoetis xoma isi and arrowhead,118,16,0,pharmacy,"['dive', '##st', '##iture', 'event', 'participation', 'patent', 'clinical', 'study', 'and', 'trial', 'research', 'report', 'all', '##er', '##gan', 'z', '##oe', '##tis', 'x', '##oma', 'is', '##i', 'and', 'arrow', '##head']",1
252095,nifty_774,2013-12-05,"Stock Price Movements, Campaigns, New Clinical Studies, and Approvals- Research Report on Actavis, Ariad Pharmaceuticals, DaVita, Celldex, and WellCare",Rise,0.0112,151,stock price movement campaign new clinical study and approval research report actavis ariad pharmaceutical davita celldex and wellcare,134,18,0,pharmacy,"['stock', 'price', 'movement', 'campaign', 'new', 'clinical', 'study', 'and', 'approval', 'research', 'report', 'act', '##avi', '##s', 'a', '##riad', 'pharmaceutical', 'da', '##vi', '##ta', 'cell', '##de', '##x', 'and', 'well', '##care']",1
252103,nifty_774,2013-12-05,"Biologics License Applications, Event Participations, and Stock Movements - Research Report on Baxter, WellPoint, Questcor Pharmaceuticals, CareFusion, and Hologic",Rise,0.0112,163,biologics license application event participation and stock movement research report baxter wellpoint questcor pharmaceutical carefusion and hologic,148,17,0,pharmacy,"['bio', '##log', '##ics', 'license', 'application', 'event', 'participation', 'and', 'stock', 'movement', 'research', 'report', 'b', '##ax', '##ter', 'well', '##point', 'quest', '##cor', 'pharmaceutical', 'care', '##fusion', 'and', 'ho', '##log', '##ic']",1
252148,nifty_774,2013-12-05,"Research and Markets: 2013 Report on the European (Germany, France, United Kingdom, Spain, Italy, Russia and Rest of Europe) Drug Delivery Technologies Market",Rise,0.0112,158,research and market report the european germany france united kingdom spain italy russia and rest europe drug delivery technology market,136,20,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'euro', '##pe', '##an', 'g', '##erman', '##y', 'f', '##rance', 'united', 'kingdom', 'spa', '##in', 'it', '##aly', 'r', '##uss', '##ia', 'and', 'rest', 'euro', '##pe', 'drug', 'delivery', 'technology', 'market']",1
252179,nifty_774,2013-12-05,"Research and Markets: Esophageal Cancer Global Clinical Trials Review, H2, 2013 Profiles Players such as Novartis AG, Sanofi and Bristol-Myers Squibb Company",Rise,0.0112,157,research and market esophageal cancer global clinical trial review profile player such novartis sanofi and bristol myers squibb company,135,19,0,pharmacy,"['research', 'and', 'market', 'es', '##op', '##hage', '##al', 'cancer', 'global', 'clinical', 'trial', 'review', 'profile', 'player', 'such', 'no', '##var', '##tis', 'sa', '##no', '##fi', 'and', 'br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'company']",1
252203,nifty_774,2013-12-05,Medbox in One of the Fastest-Growing Markets in the United States According to a New Report,Rise,0.0112,91,medbox one the fastest growing market the united state according new report,75,12,0,pharmacy,"['me', '##d', '##box', 'one', 'the', 'fastest', 'growing', 'market', 'the', 'united', 'state', 'according', 'new', 'report']",1
252268,nifty_774,2013-12-05,"The Zacks Analyst Blog Highlights: Celgene, Biogen, Gilead, Orexigen and Cubist",Rise,0.0112,79,the zacks analyst blog highlight celgene biogen gilead orexigen and cubist,74,11,0,pharmacy,"['the', 'z', '##ack', '##s', 'analyst', 'blog', 'highlight', 'c', '##el', '##gene', 'bio', '##gen', 'g', '##ile', '##ad', 'ore', '##xi', '##gen', 'and', 'cu', '##bis', '##t']",1
252291,nifty_774,2013-12-05,"Research and Markets: 2014 Analysis of the US Home/Self Testing Market: Diabetes, Pregnancy, Ovulation and Occult Blood",Rise,0.0112,119,research and market analysis the home self testing market diabetes pregnancy ovulation and occult blood,103,15,0,pharmacy,"['research', 'and', 'market', 'analysis', 'the', 'home', 'self', 'testing', 'market', 'diabetes', 'pregnancy', 'o', '##vu', '##lation', 'and', 'o', '##cc', '##ult', 'blood']",1
252352,nifty_774,2013-12-05,Research and Markets: Global Thrombosis Pipeline Highlights - 2014 Gives a Detailed Account of Forecasts up to 2017,Rise,0.0112,115,research and market global thrombosis pipeline highlight give detailed account forecast,87,11,0,pharmacy,"['research', 'and', 'market', 'global', 'th', '##rom', '##bos', '##is', 'pipeline', 'highlight', 'give', 'detailed', 'account', 'forecast']",1
252368,nifty_774,2013-12-05,Research and Markets: 2013 Report on the International Medical Power Supply Market - Includes Forecasts to 2017,Rise,0.0112,111,research and market report the international medical power supply market includes forecast,90,12,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'medical', 'power', 'supply', 'market', 'includes', 'forecast']",1
252462,nifty_774,2013-12-05,Media Advisory: Rep. Scott Peters (D-CA) to Welcome Industrial Biotechnology Companies and Researchers to San Diego,Rise,0.0112,115,medium advisory rep scott peter welcome industrial biotechnology company and researcher san diego,97,13,0,pharmacy,"['medium', 'advisory', 're', '##p', 's', '##cott', 'pet', '##er', 'welcome', 'industrial', 'bio', '##tech', '##nology', 'company', 'and', 'researcher', 'sa', '##n', 'die', '##go']",1
252529,nifty_774,2013-12-05,Research and Markets: Global Multiple Myeloma Pipeline Highlights - 2014 Gives a Detailed Account of Forecasts,Rise,0.0112,110,research and market global multiple myeloma pipeline highlight give detailed account forecast,93,12,0,pharmacy,"['research', 'and', 'market', 'global', 'multiple', 'my', '##elo', '##ma', 'pipeline', 'highlight', 'give', 'detailed', 'account', 'forecast']",1
252557,nifty_774,2013-12-05,"Research and Markets: Acute Coronary Syndrome Global Clinical Trials Review, H2, 2013",Rise,0.0112,85,research and market acute coronary syndrome global clinical trial review,72,10,0,pharmacy,"['research', 'and', 'market', 'acute', 'co', '##rona', '##ry', 'syndrome', 'global', 'clinical', 'trial', 'review']",1
252640,nifty_774,2013-12-05,Myriad Genetics Announces Upcoming Investor Event,Rise,0.0112,49,myriad genetics announces upcoming investor event,49,6,0,pharmacy,"['my', '##riad', 'genetics', 'announces', 'upcoming', 'investor', 'event']",1
252897,nifty_774,2013-12-05,Lilly Halts Add-On Depression Treatment After Disappointing Studies,Rise,0.0112,67,lilly halt add depression treatment after disappointing study,61,8,0,pharmacy,"['l', '##ill', '##y', 'halt', 'add', 'depression', 'treatment', 'after', 'disappointing', 'study']",1
252990,nifty_775,2013-12-09,"Research and Markets: Drug-Eluting Balloon Revenue to More than Double by 2019, Following US and Japanese Debut",Neutral,-0.0036,111,research and market drug eluting balloon revenue more than double following and japanese debut,94,14,0,pharmacy,"['research', 'and', 'market', 'drug', 'el', '##uti', '##ng', 'balloon', 'revenue', 'more', 'than', 'double', 'following', 'and', 'j', '##apa', '##nese', 'debut']",1
252993,nifty_775,2013-12-09,Research and Markets: Diabetic Foot Ulcer Market in Rapid Race to Reach More than $1.5 Billion Value,Neutral,-0.0036,100,research and market diabetic foot ulcer market rapid race reach more than billion value,87,14,0,pharmacy,"['research', 'and', 'market', 'di', '##abe', '##tic', 'foot', 'ul', '##cer', 'market', 'rapid', 'race', 'reach', 'more', 'than', 'billion', 'value']",1
253013,nifty_775,2013-12-09,Research and Markets: EpiCast Report: Diabetic Nephropathy - Epidemiology Forecast to 2022,Neutral,-0.0036,90,research and market epicast report diabetic nephropathy epidemiology forecast,77,9,0,pharmacy,"['research', 'and', 'market', 'epic', '##ast', 'report', 'di', '##abe', '##tic', 'ne', '##ph', '##rop', '##athy', 'e', '##pid', '##em', '##iology', 'forecast']",1
253033,nifty_775,2013-12-09,Research and Markets: 2013 Report on the International Breast Pumps Market - Includes Forecast to 2016,Neutral,-0.0036,102,research and market report the international breast pump market includes forecast,81,11,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'breast', 'pump', 'market', 'includes', 'forecast']",1
253168,nifty_775,2013-12-09,"Stock Price Movements, Completed Acquisitions, and New Clinical Studies - Research Report on UnitedHealth Group, Mylan, St. Jude Medical, and Cigna",Neutral,-0.0036,147,stock price movement completed acquisition and new clinical study research report unitedhealth group mylan jude medical and cigna,129,18,0,pharmacy,"['stock', 'price', 'movement', 'completed', 'acquisition', 'and', 'new', 'clinical', 'study', 'research', 'report', 'united', '##hea', '##lt', '##h', 'group', 'my', '##lan', 'j', '##ude', 'medical', 'and', 'c', '##ign', '##a']",1
253170,nifty_775,2013-12-09,"Strategic Collaborations, Clinical Studies, Regulatory Update, and Other Corporate Announcements - Research Report on OncoMed, Auxilium Pharma, BioTelemetry, Progenics Pharma, and Ambit Biosciences",Neutral,-0.0036,197,strategic collaboration clinical study regulatory update and other corporate announcement research report oncomed auxilium pharma biotelemetry progenics pharma and ambit bioscience,180,21,0,pharmacy,"['strategic', 'collaboration', 'clinical', 'study', 'regulatory', 'update', 'and', 'other', 'corporate', 'announcement', 'research', 'report', 'on', '##come', '##d', 'aux', '##ili', '##um', 'p', '##har', '##ma', 'bio', '##tel', '##em', '##et', '##ry', 'pro', '##genic', '##s', 'p', '##har', '##ma', 'and', 'am', '##bit', 'bio', '##science']",1
253171,nifty_775,2013-12-09,"Stock Price Updates, Conferences Participations - Research Report on Quest Diagnostics, Pharmacyclics, Health Management Associates, Theravance, and Immunomedics",Neutral,-0.0036,161,stock price update conference participation research report quest diagnostics pharmacyclics health management associate theravance and immunomedics,147,16,0,pharmacy,"['stock', 'price', 'update', 'conference', 'participation', 'research', 'report', 'quest', 'diagnostic', '##s', 'pharmacy', '##c', '##lic', '##s', 'health', 'management', 'associate', 'the', '##ra', '##vance', 'and', 'im', '##mu', '##no', '##med', '##ics']",1
253172,nifty_775,2013-12-09,"Stock Price Updates, FDA 510(k) Clearances, Conference Presentation and Resignations - Research Report on Gilead, Oculus Innovative Sciences, ARCA biopharma, Arena Pharma, and Tonix Pharma",Neutral,-0.0036,188,stock price update fda clearance conference presentation and resignation research report gilead oculus innovative science arca biopharma arena pharma and tonix pharma,166,22,0,pharmacy,"['stock', 'price', 'update', 'f', '##da', 'clearance', 'conference', 'presentation', 'and', 'resignation', 'research', 'report', 'g', '##ile', '##ad', 'o', '##culus', 'innovative', 'science', 'arc', '##a', 'bio', '##pha', '##rma', 'arena', 'p', '##har', '##ma', 'and', 'ton', '##ix', 'p', '##har', '##ma']",1
253255,nifty_775,2013-12-09,International Stem Cell Corporation Announces Major Advance in Stem Cell Technology,Neutral,-0.0036,83,international stem cell corporation announces major advance stem cell technology,80,10,0,pharmacy,"['international', 'stem', 'cell', 'corporation', 'announces', 'major', 'advance', 'stem', 'cell', 'technology']",1
253268,nifty_775,2013-12-09,Business Bio Expert Nancy Juetten Reveals Five Tips to Help Aspiring Experts Fix Bio Blunders Just in Time to Provide Successful Growth in the New Year,Neutral,-0.0036,151,business bio expert nancy juetten reveals five tip help aspiring expert fix bio blunder just time provide successful growth the new year,136,22,0,pharmacy,"['business', 'bio', 'expert', 'na', '##ncy', 'j', '##ue', '##tten', 'reveals', 'five', 'tip', 'help', 'aspiring', 'expert', 'fix', 'bio', 'b', '##lund', '##er', 'just', 'time', 'provide', 'successful', 'growth', 'the', 'new', 'year']",1
253276,nifty_775,2013-12-09,"Bullish Trend Commentary: Barrick Gold Corporation, Google Inc, Nokia Corporation, Petroleo Brasileiro Petrobras, Questcor Pharmaceuticals",Neutral,-0.0036,138,bullish trend commentary barrick gold corporation google inc nokia corporation petroleo brasileiro petrobras questcor pharmaceutical,132,15,0,pharmacy,"['bull', '##ish', 'trend', 'commentary', 'bar', '##rick', 'gold', 'corporation', 'go', '##og', '##le', 'in', '##c', 'no', '##ki', '##a', 'corporation', 'petrol', '##eo', 'bra', '##si', '##le', '##iro', 'pet', '##ro', '##bra', '##s', 'quest', '##cor', 'pharmaceutical']",1
253449,nifty_775,2013-12-09,Research and Markets: Global Victoza (Type 2 Diabetes) Report 2013 - Forecast and Market Analysis to 2022,Neutral,-0.0036,105,research and market global victoza type diabetes report forecast and market analysis,84,12,0,pharmacy,"['research', 'and', 'market', 'global', 'v', '##ict', '##oz', '##a', 'type', 'diabetes', 'report', 'forecast', 'and', 'market', 'analysis']",1
253516,nifty_775,2013-12-09,Research and Markets: Trelagliptin (Type 2 Diabetes) - Forecast and Market Analysis to 2022,Neutral,-0.0036,91,research and market trelagliptin type diabetes forecast and market analysis,75,10,0,pharmacy,"['research', 'and', 'market', 't', '##rel', '##ag', '##lip', '##tin', 'type', 'diabetes', 'forecast', 'and', 'market', 'analysis']",1
253538,nifty_775,2013-12-09,Research and Markets: Global Forxiga (Type 2 Diabetes) Report 2013 - Forecast and Market Analysis to 2022,Neutral,-0.0036,105,research and market global forxiga type diabetes report forecast and market analysis,84,12,0,pharmacy,"['research', 'and', 'market', 'global', 'for', '##xi', '##ga', 'type', 'diabetes', 'report', 'forecast', 'and', 'market', 'analysis']",1
253559,nifty_775,2013-12-09,Research and Markets: Global Auto Inflammatory Disease Market Report 2013,Neutral,-0.0036,73,research and market global auto inflammatory disease market report,66,9,0,pharmacy,"['research', 'and', 'market', 'global', 'auto', 'inflammatory', 'disease', 'market', 'report']",1
253564,nifty_775,2013-12-09,IBEX Global Answers The Call On Healthcare Reform,Neutral,-0.0036,49,ibex global answer the call healthcare reform,45,7,0,pharmacy,"['i', '##be', '##x', 'global', 'answer', 'the', 'call', 'healthcare', 'reform']",1
253905,nifty_776,2013-12-10,Zogenix Gets Approval for Smaller Dose of Migraine Treatment,Fall,-0.0112,60,zogenix get approval for smaller dose migraine treatment,56,8,0,pharmacy,"['z', '##ogen', '##ix', 'get', 'approval', 'for', 'smaller', 'dose', 'mi', '##gra', '##ine', 'treatment']",1
253923,nifty_776,2013-12-10,Drug Agent Joins Budding Industry,Fall,-0.0112,33,drug agent join budding industry,32,5,0,pharmacy,"['drug', 'agent', 'join', 'b', '##uddin', '##g', 'industry']",1
254140,nifty_779,2013-12-16,Research and Markets: Market Research: MK-3102 (Type 2 Diabetes) - Forecast and Market Analysis to 2022,Neutral,-0.0032,103,research and market market research type diabetes forecast and market analysis,78,11,0,pharmacy,"['research', 'and', 'market', 'market', 'research', 'type', 'diabetes', 'forecast', 'and', 'market', 'analysis']",1
254143,nifty_779,2013-12-16,Research and Markets: Research Report: Tofogliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022,Neutral,-0.0032,109,research and market research report tofogliflozin type diabetes forecast and market analysis,92,12,0,pharmacy,"['research', 'and', 'market', 'research', 'report', 'to', '##fo', '##gli', '##f', '##lo', '##zin', 'type', 'diabetes', 'forecast', 'and', 'market', 'analysis']",1
254146,nifty_779,2013-12-16,Research and Markets: LY2409021 (Type 2 Diabetes) - Forecast and Market Analysis to 2022,Neutral,-0.0032,88,research and market type diabetes forecast and market analysis,62,9,0,pharmacy,"['research', 'and', 'market', 'type', 'diabetes', 'forecast', 'and', 'market', 'analysis']",1
254156,nifty_779,2013-12-16,Research and Markets: Global miRNA Market Outlook to 2018 Research Report,Neutral,-0.0032,73,research and market global mirna market outlook research report,63,9,0,pharmacy,"['research', 'and', 'market', 'global', 'mi', '##rna', 'market', 'outlook', 'research', 'report']",1
254164,nifty_779,2013-12-16,"Research and Markets: Research Report: Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2013",Neutral,-0.0032,108,research and market research report glioblastoma multiforme gbm global clinical trial review,92,12,0,pharmacy,"['research', 'and', 'market', 'research', 'report', 'g', '##lio', '##blast', '##oma', 'multi', '##form', '##e', 'g', '##b', '##m', 'global', 'clinical', 'trial', 'review']",1
254256,nifty_779,2013-12-16,"Research and Markets: Global Intravenous Solutions Market 2014-2018: As of 2012, Nearly 100 Million Americans are Affected by Gastrointestinal Disorders Each Year, and More than 350 Million People Globally",Neutral,-0.0032,205,research and market global intravenous solution market nearly million american are affected gastrointestinal disorder each year and more than million people globally,165,22,0,pharmacy,"['research', 'and', 'market', 'global', 'in', '##tra', '##ven', '##ous', 'solution', 'market', 'nearly', 'million', 'am', '##eric', '##an', 'are', 'affected', 'gas', '##tro', '##int', '##est', '##inal', 'disorder', 'each', 'year', 'and', 'more', 'than', 'million', 'people', 'globally']",1
254259,nifty_779,2013-12-16,"Research and Markets: 2014 Analysis of the Global Endocrine Function Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan",Neutral,-0.0032,138,research and market analysis the global endocrine function testing market europe france germany italy spain japan,113,16,0,pharmacy,"['research', 'and', 'market', 'analysis', 'the', 'global', 'end', '##oc', '##rine', 'function', 'testing', 'market', 'euro', '##pe', 'f', '##rance', 'g', '##erman', '##y', 'it', '##aly', 'spa', '##in', 'j', '##apa', '##n']",1
254265,nifty_779,2013-12-16,"Research and Markets: Global and Chinese Insulin Industry Report, 2013-2017",Neutral,-0.0032,75,research and market global and chinese insulin industry report,62,9,0,pharmacy,"['research', 'and', 'market', 'global', 'and', 'chin', '##ese', 'insulin', 'industry', 'report']",1
254271,nifty_779,2013-12-16,Research and Markets: 2014 Analysis of Beta-2 Microglobulin Testing Technologies and Emerging Markets,Neutral,-0.0032,101,research and market analysis beta microglobulin testing technology and emerging market,86,11,0,pharmacy,"['research', 'and', 'market', 'analysis', 'beta', 'micro', '##g', '##lo', '##bul', '##in', 'testing', 'technology', 'and', 'emerging', 'market']",1
254276,nifty_779,2013-12-16,"FDA Reviews, Trial Initiation, New Innovations, and Multi-year Commercial Agreement - Research Report on Sanofi, Medivation, Align Technology, WuXi PharmaTech, and Insulet",Neutral,-0.0032,171,fda review trial initiation new innovation and multi year commercial agreement research report sanofi medivation align technology wuxi pharmatech and insulet,157,21,0,pharmacy,"['f', '##da', 'review', 'trial', 'initiation', 'new', 'innovation', 'and', 'multi', 'year', 'commercial', 'agreement', 'research', 'report', 'sa', '##no', '##fi', 'me', '##di', '##vation', 'al', '##ign', 'technology', 'w', '##ux', '##i', 'p', '##har', '##mate', '##ch', 'and', 'ins', '##ulet']",1
254281,nifty_779,2013-12-16,"Clinical Studies Updates, and Stock Price Movements - Research Report on Merck, Select Medical Holdings, Galena Biopharma, Dendreon, and Echo Therapeutics",Neutral,-0.0032,154,clinical study update and stock price movement research report merck select medical holding galena biopharma dendreon and echo therapeutic,138,19,0,pharmacy,"['clinical', 'study', 'update', 'and', 'stock', 'price', 'movement', 'research', 'report', 'me', '##rc', '##k', 'select', 'medical', 'holding', 'gal', '##ena', 'bio', '##pha', '##rma', 'den', '##dre', '##on', 'and', 'echo', 'therapeutic']",1
254282,nifty_779,2013-12-16,"Pre-Market Commentary: Health Management Associates, HCA Holdings, Tenet Healthcare, and Universal Health Services",Neutral,-0.0032,114,pre market commentary health management associate hca holding tenet healthcare and universal health service,107,14,0,pharmacy,"['pre', 'market', 'commentary', 'health', 'management', 'associate', 'h', '##ca', 'holding', 'ten', '##et', 'healthcare', 'and', 'universal', 'health', 'service']",1
254293,nifty_779,2013-12-16,Avista Capital Partners Announces a Majority Investment in Vertical Pharmaceuticals and Trigen Laboratories,Neutral,-0.0032,107,avista capital partner announces majority investment vertical pharmaceutical and trigen laboratory,98,11,0,pharmacy,"['a', '##vist', '##a', 'capital', 'partner', 'announces', 'majority', 'investment', 'vertical', 'pharmaceutical', 'and', 't', '##rig', '##en', 'laboratory']",1
254311,nifty_779,2013-12-16,"Results from Clinical Trials, Updated Financial Outlook, New Appointments, and Stock Option Grants - Research Report on Johnson & Johnson, Teva, CytRx, Edwards Lifesciences, and Aegerion",Neutral,-0.0032,186,result from clinical trial updated financial outlook new appointment and stock option grant research report johnson johnson teva cytrx edward lifesciences and aegerion,167,23,0,pharmacy,"['result', 'from', 'clinical', 'trial', 'updated', 'financial', 'outlook', 'new', 'appointment', 'and', 'stock', 'option', 'grant', 'research', 'report', 'j', '##oh', '##nson', 'j', '##oh', '##nson', 'te', '##va', 'c', '##yt', '##r', '##x', 'ed', '##ward', 'life', '##science', '##s', 'and', 'a', '##ege', '##rion']",1
254327,nifty_779,2013-12-16,NW Bio Responds To Shareholder Inquiries Following Immune Therapy Sector's Recent Market Decline,Neutral,-0.0032,96,bio responds shareholder inquiry following immune therapy sector recent market decline,86,11,0,pharmacy,"['bio', 'responds', 'shareholder', 'inquiry', 'following', 'immune', 'therapy', 'sector', 'recent', 'market', 'decline']",1
254349,nifty_779,2013-12-16,Research and Markets: 2014 Analysis of the UK Hospital Cancer Diagnostics Market Gives Sales Forecasts for 40 Cancer Diagnostic Procedures,Neutral,-0.0032,138,research and market analysis the hospital cancer diagnostics market give sale forecast for cancer diagnostic procedure,118,16,0,pharmacy,"['research', 'and', 'market', 'analysis', 'the', 'hospital', 'cancer', 'diagnostic', '##s', 'market', 'give', 'sale', 'forecast', 'for', 'cancer', 'diagnostic', 'procedure']",1
254457,nifty_779,2013-12-16,Research and Markets: Global Glioma Pipeline Highlights: 2014-2017,Neutral,-0.0032,66,research and market global glioma pipeline highlight,52,7,0,pharmacy,"['research', 'and', 'market', 'global', 'g', '##lio', '##ma', 'pipeline', 'highlight']",1
254480,nifty_779,2013-12-16,The Epilepsy Market Will Grow 2 Percent Annually Through 2022 with Expanding Uptake of Third-Generation Brands,Neutral,-0.0032,110,the epilepsy market will grow percent annually through with expanding uptake third generation brand,99,14,0,pharmacy,"['the', 'e', '##pile', '##psy', 'market', 'will', 'grow', 'percent', 'annually', 'through', 'with', 'expanding', 'up', '##take', 'third', 'generation', 'brand']",1
254493,nifty_779,2013-12-16,Research and Markets: Global Insulin Pumps Market 2014-2018: One of the Major Challenges Faced by the Market is the Increase in the Use of CAM,Neutral,-0.0032,142,research and market global insulin pump market one the major challenge faced the market the increase the use cam,112,19,0,pharmacy,"['research', 'and', 'market', 'global', 'insulin', 'pump', 'market', 'one', 'the', 'major', 'challenge', 'faced', 'the', 'market', 'the', 'increase', 'the', 'use', 'ca', '##m']",1
254698,nifty_779,2013-12-16,Digital Assent Joins Greenway Medical Technologies Online Marketplace,Neutral,-0.0032,69,digital assent join greenway medical technology online marketplace,66,8,0,pharmacy,"['digital', 'ass', '##ent', 'join', 'green', '##way', 'medical', 'technology', 'online', 'marketplace']",1
254920,nifty_779,2013-12-16,"Transcept Pharmaceuticals Announces That Largest Stockholder, Roumell Asset Management, Declares Support Of Company Strategies",Neutral,-0.0032,126,transcept pharmaceutical announces that largest stockholder roumell asset management declares support company strategy,118,13,0,pharmacy,"['trans', '##ce', '##pt', 'pharmaceutical', 'announces', 'that', 'largest', 'stock', '##holder', 'r', '##ou', '##mell', 'asset', 'management', 'declares', 'support', 'company', 'strategy']",1
255073,nifty_780,2013-12-17,"Research and Markets: Oligodendroglioma Global Clinical Trials Review, H2, 2013",Rise,0.0171,79,research and market oligodendroglioma global clinical trial review,66,8,0,pharmacy,"['research', 'and', 'market', 'o', '##li', '##go', '##den', '##dr', '##og', '##lio', '##ma', 'global', 'clinical', 'trial', 'review']",1
255113,nifty_780,2013-12-17,Research and Markets: Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market - Pipeline Forecast & Market Forecast in G8 Countries (2011 - 2020),Rise,0.0171,150,research and market acute lymphocytic lymphoblastic leukemia therapeutic market pipeline forecast market forecast country,121,14,0,pharmacy,"['research', 'and', 'market', 'acute', 'l', '##ymph', '##oc', '##ytic', 'l', '##ymph', '##ob', '##lastic', 'le', '##uke', '##mia', 'therapeutic', 'market', 'pipeline', 'forecast', 'market', 'forecast', 'country']",1
255173,nifty_780,2013-12-17,Atara Biotherapeutics Secures $38.5 Million Series B Financing,Rise,0.0171,62,atara biotherapeutics secures million series financing,54,6,0,pharmacy,"['at', '##ara', 'bio', '##ther', '##ap', '##eu', '##tics', 'secure', '##s', 'million', 'series', 'financing']",1
255202,nifty_780,2013-12-17,Research and Markets: Global Microarray Market Report 2013,Rise,0.0171,58,research and market global microarray market report,51,7,0,pharmacy,"['research', 'and', 'market', 'global', 'micro', '##arra', '##y', 'market', 'report']",1
255204,nifty_780,2013-12-17,Research and Markets: Global Stem Cell Market Report 2013,Rise,0.0171,57,research and market global stem cell market report,50,8,0,pharmacy,"['research', 'and', 'market', 'global', 'stem', 'cell', 'market', 'report']",1
255205,nifty_780,2013-12-17,"Pricing of Public Offerings, Agreements, and Stock Movements- Research Report on MiMedx Group, NPS Pharmaceuticals, VIVUS, Merrimack Pharmaceuticals, and GenVec",Rise,0.0171,160,pricing public offering agreement and stock movement research report mimedx group np pharmaceutical vivus merrimack pharmaceutical and genvec,141,18,0,pharmacy,"['pricing', 'public', 'offering', 'agreement', 'and', 'stock', 'movement', 'research', 'report', 'mi', '##med', '##x', 'group', 'n', '##p', 'pharmaceutical', 'v', '##iv', '##us', 'me', '##rri', '##ma', '##ck', 'pharmaceutical', 'and', 'g', '##en', '##ve', '##c']",1
255207,nifty_780,2013-12-17,"Advisory Committee Recommendations, Voting Outcomes, New Appointments, and Stock Price Movements - Research Report on Merck, Bristol-Myers Squibb, Boston Scientific, WellCare, and PAREXEL",Rise,0.0171,187,advisory committee recommendation voting outcome new appointment and stock price movement research report merck bristol myers squibb boston scientific wellcare and parexel,171,22,0,pharmacy,"['advisory', 'committee', 'recommendation', 'voting', 'outcome', 'new', 'appointment', 'and', 'stock', 'price', 'movement', 'research', 'report', 'me', '##rc', '##k', 'br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'b', '##ost', '##on', 'scientific', 'well', '##care', 'and', 'par', '##ex', '##el']",1
255215,nifty_780,2013-12-17,"FDA Approvals, Dividends, Promoting Diversity, Result Publications and Acquisitions - Research Report on Gilead, St. Jude Medical, Cigna, Pharmacyclics, and LifePoint",Rise,0.0171,166,fda approval dividend promoting diversity result publication and acquisition research report gilead jude medical cigna pharmacyclics and lifepoint,146,18,0,pharmacy,"['f', '##da', 'approval', 'divide', '##nd', 'promoting', 'diversity', 'result', 'publication', 'and', 'acquisition', 'research', 'report', 'g', '##ile', '##ad', 'j', '##ude', 'medical', 'c', '##ign', '##a', 'pharmacy', '##c', '##lic', '##s', 'and', 'life', '##point']",1
255219,nifty_780,2013-12-17,"New Leaders, Quarterly Dividends, Positive Clinical Results, and Data Presentations - Research Report on Quintiles, CR Bard, Theravance, Immunomedics and Progenics Pharmaceuticals",Rise,0.0171,179,new leader quarterly dividend positive clinical result and data presentation research report quintiles bard theravance immunomedics and progenics pharmaceutical,160,19,0,pharmacy,"['new', 'leader', 'quarterly', 'divide', '##nd', 'positive', 'clinical', 'result', 'and', 'data', 'presentation', 'research', 'report', 'q', '##uin', '##tile', '##s', 'bar', '##d', 'the', '##ra', '##vance', 'im', '##mu', '##no', '##med', '##ics', 'and', 'pro', '##genic', '##s', 'pharmaceutical']",1
255220,nifty_780,2013-12-17,"Clinical Study Data Presentation, Product Launches, Technology Deployments, and Stock Price Movements - Research Report on Celgene, Mylan, Valeant, Health Management, and CareFusion",Rise,0.0171,181,clinical study data presentation product launch technology deployment and stock price movement research report celgene mylan valeant health management and carefusion,165,21,0,pharmacy,"['clinical', 'study', 'data', 'presentation', 'product', 'launch', 'technology', 'deployment', 'and', 'stock', 'price', 'movement', 'research', 'report', 'c', '##el', '##gene', 'my', '##lan', 'v', '##ale', '##ant', 'health', 'management', 'and', 'care', '##fusion']",1
255254,nifty_780,2013-12-17,"AAAResearchReports.com Pre-Market Technical Analysis: Inovio Pharma, Sequenom, Nektar Therapeutics, and Discovery Laboratories",Rise,0.0171,126,aaaresearchreports com pre market technical analysis inovio pharma sequenom nektar therapeutic and discovery laboratory,119,14,0,pharmacy,"['a', '##aar', '##ese', '##ar', '##ch', '##re', '##ports', 'com', 'pre', 'market', 'technical', 'analysis', 'in', '##ov', '##io', 'p', '##har', '##ma', 'se', '##que', '##no', '##m', 'ne', '##kt', '##ar', 'therapeutic', 'and', 'discovery', 'laboratory']",1
255256,nifty_780,2013-12-17,"Pre-Market Breakdown: Hologic, Navidea Biopharma, St. Jude Medical, and ResMed",Rise,0.0171,78,pre market breakdown hologic navidea biopharma jude medical and resmed,70,10,0,pharmacy,"['pre', 'market', 'breakdown', 'ho', '##log', '##ic', 'na', '##vide', '##a', 'bio', '##pha', '##rma', 'j', '##ude', 'medical', 'and', 're', '##sm', '##ed']",1
255258,nifty_780,2013-12-17,Research and Markets: Global Companion Biomarkers in Drug Development Market Report 2013,Rise,0.0171,88,research and market global companion biomarkers drug development market report,78,10,0,pharmacy,"['research', 'and', 'market', 'global', 'companion', 'bio', '##mark', '##ers', 'drug', 'development', 'market', 'report']",1
255272,nifty_780,2013-12-17,Research and Markets: Global Molecular Diagnostics in Cancer Testing: Market Report 2013,Rise,0.0171,88,research and market global molecular diagnostics cancer testing market report,77,10,0,pharmacy,"['research', 'and', 'market', 'global', 'molecular', 'diagnostic', '##s', 'cancer', 'testing', 'market', 'report']",1
255307,nifty_780,2013-12-17,Research and Markets: Bioseparation Systems for Global Biopharmaceutical Markets: 2013 Report,Rise,0.0171,93,research and market bioseparation system for global biopharmaceutical market report,83,10,0,pharmacy,"['research', 'and', 'market', 'bio', '##se', '##par', '##ation', 'system', 'for', 'global', 'bio', '##pha', '##rma', '##ce', '##utical', 'market', 'report']",1
255363,nifty_780,2013-12-17,"2014 OPEN MINDS Planning & Innovation Institute Zeroes In On Market Positioning - ACOs, Medical Homes, Capitation, & More",Rise,0.0171,121,open mind planning innovation institute zero market positioning acos medical home capitation more,97,13,0,pharmacy,"['open', 'mind', 'planning', 'innovation', 'institute', 'zero', 'market', 'positioning', 'a', '##cos', 'medical', 'home', 'capita', '##tion', 'more']",1
255368,nifty_780,2013-12-17,Forty Blockbuster Drug Brands Will Lose Patent Exclusivity Between 2013 and 2020,Rise,0.0171,80,forty blockbuster drug brand will lose patent exclusivity between and,69,10,0,pharmacy,"['forty', 'block', '##buster', 'drug', 'brand', 'will', 'lose', 'patent', 'ex', '##c', '##lus', '##ivity', 'between', 'and']",1
255385,nifty_780,2013-12-17,Research and Markets: 2013 Report on the North American Home Healthcare Market - Includes Forecasts to 2017,Rise,0.0171,107,research and market report the north american home healthcare market includes forecast,86,12,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'north', 'am', '##eric', '##an', 'home', 'healthcare', 'market', 'includes', 'forecast']",1
255388,nifty_780,2013-12-17,Research and Markets: 2013 Report on the International Healthcare IT Outsourcing Market - Includes Forecast to 2018,Rise,0.0171,115,research and market report the international healthcare outsourcing market includes forecast,92,11,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'healthcare', 'outs', '##our', '##cing', 'market', 'includes', 'forecast']",1
255455,nifty_780,2013-12-17,Research and Markets: Global Medical Device Outsourcing Market Report 2013,Rise,0.0171,74,research and market global medical device outsourcing market report,67,9,0,pharmacy,"['research', 'and', 'market', 'global', 'medical', 'device', 'outs', '##our', '##cing', 'market', 'report']",1
255545,nifty_780,2013-12-17,Research and Markets: EpiCast Report: Breast Cancer - Epidemiology Forecast to 2022,Rise,0.0171,83,research and market epicast report breast cancer epidemiology forecast,70,9,0,pharmacy,"['research', 'and', 'market', 'epic', '##ast', 'report', 'breast', 'cancer', 'e', '##pid', '##em', '##iology', 'forecast']",1
255574,nifty_780,2013-12-17,Research and Markets: EpiCast Report: Bladder Cancer - Epidemiology Forecast to 2022,Rise,0.0171,84,research and market epicast report bladder cancer epidemiology forecast,71,9,0,pharmacy,"['research', 'and', 'market', 'epic', '##ast', 'report', 'bladder', 'cancer', 'e', '##pid', '##em', '##iology', 'forecast']",1
255622,nifty_780,2013-12-17,Research and Markets: Global Orphan Drug Pipeline Analysis Report 2013,Rise,0.0171,70,research and market global orphan drug pipeline analysis report,63,9,0,pharmacy,"['research', 'and', 'market', 'global', 'orphan', 'drug', 'pipeline', 'analysis', 'report']",1
255800,nifty_780,2013-12-17,Drugmakers urge FDA security audit after cyber breach,Rise,0.0171,53,drugmakers urge fda security audit after cyber breach,53,8,0,pharmacy,"['drug', '##makers', 'urge', 'f', '##da', 'security', 'audit', 'after', 'c', '##y', '##ber', 'breach']",1
255846,nifty_780,2013-12-17,"Relationship Cools Between Drug Firms, Doctors",Rise,0.0171,46,relationship cool between drug firm doctor,42,6,0,pharmacy,"['relationship', 'cool', 'between', 'drug', 'firm', 'doctor']",1
255870,nifty_780,2013-12-17,Data Mining to Recruit Sick People,Rise,0.0171,34,data mining recruit sick people,31,5,0,pharmacy,"['data', 'mining', 'recruit', 'sick', 'people']",1
255939,nifty_781,2013-12-18,Bristol-Myers Nears Deal to Sell Stake in Diabetes JV to AstraZeneca,Neutral,-0.0012,68,bristol myers nears deal sell stake diabetes astrazeneca,56,8,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'near', '##s', 'deal', 'sell', 'stake', 'diabetes', 'as', '##tra', '##zen', '##eca']",1
255995,nifty_781,2013-12-18,"Merck, Glaxo to Partner on Renal Cell Cancer Treatment",Neutral,-0.0012,54,merck glaxo partner renal cell cancer treatment,47,7,0,pharmacy,"['me', '##rc', '##k', 'g', '##lax', '##o', 'partner', 're', '##nal', 'cell', 'cancer', 'treatment']",1
256029,nifty_782,2013-12-19,Novartis Recalls Bottles of Sample Drugs,Neutral,0.0004,40,novartis recall bottle sample drug,34,5,0,pharmacy,"['no', '##var', '##tis', 'recall', 'bottle', 'sample', 'drug']",1
256057,nifty_782,2013-12-19,Cholesterol Drug Trial Uses New  Approach to Recruit Patients,Neutral,0.0004,61,cholesterol drug trial us new approach recruit patient,54,8,0,pharmacy,"['ch', '##ole', '##ster', '##ol', 'drug', 'trial', 'us', 'new', 'approach', 'recruit', 'patient']",1
256154,nifty_783,2013-12-23,Research and Markets: Tradjenta (Type 2 Diabetes) - Forecast and Market Analysis to 2022,Neutral,0.0022,88,research and market tradjenta type diabetes forecast and market analysis,72,10,0,pharmacy,"['research', 'and', 'market', 't', '##rad', '##je', '##nta', 'type', 'diabetes', 'forecast', 'and', 'market', 'analysis']",1
256166,nifty_783,2013-12-23,Research and Markets: Tresiba (Type 2 Diabetes) - Forecast and Market Analysis to 2022,Neutral,0.0022,86,research and market tresiba type diabetes forecast and market analysis,70,10,0,pharmacy,"['research', 'and', 'market', 't', '##res', '##iba', 'type', 'diabetes', 'forecast', 'and', 'market', 'analysis']",1
256168,nifty_783,2013-12-23,Research and Markets: Dulaglutide (Type 2 Diabetes) - Forecast and Market Analysis to 2022,Neutral,0.0022,90,research and market dulaglutide type diabetes forecast and market analysis,74,10,0,pharmacy,"['research', 'and', 'market', 'du', '##lag', '##lut', '##ide', 'type', 'diabetes', 'forecast', 'and', 'market', 'analysis']",1
256171,nifty_783,2013-12-23,Research and Markets: 2013 Report on the International Pain Management Therapeutics Market - Includes Forecast to 2018,Neutral,0.0022,118,research and market report the international pain management therapeutic market includes forecast,97,12,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'pain', 'management', 'therapeutic', 'market', 'includes', 'forecast']",1
256184,nifty_783,2013-12-23,Research and Markets: Global Ulcerative Colitis Pipeline Highlights - 2014,Neutral,0.0022,74,research and market global ulcerative colitis pipeline highlight,64,8,0,pharmacy,"['research', 'and', 'market', 'global', 'ul', '##cer', '##ative', 'co', '##lit', '##is', 'pipeline', 'highlight']",1
256203,nifty_783,2013-12-23,Research and Markets: Global Acne Pipeline Highlights - 2014 Research Report,Neutral,0.0022,76,research and market global acne pipeline highlight research report,66,9,0,pharmacy,"['research', 'and', 'market', 'global', 'a', '##c', '##ne', 'pipeline', 'highlight', 'research', 'report']",1
256251,nifty_783,2013-12-23,Research and Markets: Optical Imaging Market Report (2013-2018),Neutral,0.0022,63,research and market optical imaging market report,49,7,0,pharmacy,"['research', 'and', 'market', 'optical', 'imaging', 'market', 'report']",1
256256,nifty_783,2013-12-23,"Research and Markets: Global LBS Market in the Healthcare Industry 2014-2018 with Ekahau Inc., GE Healthcare, and Hewlett-Packard Enterprise Services LLC Dominating",Neutral,0.0022,164,research and market global lb market the healthcare industry with ekahau inc healthcare and hewlett packard enterprise service llc dominating,141,20,0,pharmacy,"['research', 'and', 'market', 'global', 'lb', 'market', 'the', 'healthcare', 'industry', 'with', 'e', '##ka', '##ha', '##u', 'in', '##c', 'healthcare', 'and', 'he', '##wl', '##ett', 'pack', '##ard', 'enterprise', 'service', 'll', '##c', 'dominating']",1
256261,nifty_783,2013-12-23,Research and Markets: 2013 Report on the North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017,Neutral,0.0022,137,research and market report the north american nuclear medicine radiopharmaceutical stable isotope market forecast,113,14,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'north', 'am', '##eric', '##an', 'nuclear', 'medicine', 'radio', '##pha', '##rma', '##ce', '##utical', 'stable', 'is', '##oto', '##pe', 'market', 'forecast']",1
256271,nifty_783,2013-12-23,Infinity Group Invests US$4.2 M in Green BioTech Company BotanoCap,Neutral,0.0022,66,infinity group invests green biotech company botanocap,54,7,0,pharmacy,"['in', '##finity', 'group', 'invest', '##s', 'green', 'bio', '##tech', 'company', 'b', '##ota', '##no', '##cap']",1
256332,nifty_783,2013-12-23,"Clinical Trial Results, Stock Movements, Grants & Donations, and Drug Resubmissions - Research Report on Gilead, WellPoint, Zoetis, Teleflex, and Orexigen",Neutral,0.0022,154,clinical trial result stock movement grant donation and drug resubmissions research report gilead wellpoint zoetis teleflex and orexigen,136,18,0,pharmacy,"['clinical', 'trial', 'result', 'stock', 'movement', 'grant', 'donation', 'and', 'drug', 're', '##su', '##b', '##mission', '##s', 'research', 'report', 'g', '##ile', '##ad', 'well', '##point', 'z', '##oe', '##tis', 'te', '##le', '##fle', '##x', 'and', 'ore', '##xi', '##gen']",1
256336,nifty_783,2013-12-23,"Stock Price Movements of Healthcare Companies- Research Report on LabCorp, Isis Pharmaceuticals, Mindray, Clovis Oncology and Sangamo Biosciences",Neutral,0.0022,145,stock price movement healthcare company research report labcorp isi pharmaceutical mindray clovis oncology and sangamo bioscience,129,16,0,pharmacy,"['stock', 'price', 'movement', 'healthcare', 'company', 'research', 'report', 'lab', '##cor', '##p', 'is', '##i', 'pharmaceutical', 'mind', '##ray', 'c', '##lov', '##is', 'on', '##cology', 'and', 'sang', '##amo', 'bio', '##science']",1
256339,nifty_783,2013-12-23,"Stock Price Updates, Executive Appointments, Acquisitions, Orphan Drug Designations, and Preclinical Developments - Research Report on Ariad, Halozyme, DepoMed, Omeros, and BioCryst",Neutral,0.0022,181,stock price update executive appointment acquisition orphan drug designation and preclinical development research report ariad halozyme depomed omeros and biocryst,163,20,0,pharmacy,"['stock', 'price', 'update', 'executive', 'appointment', 'acquisition', 'orphan', 'drug', 'designation', 'and', 'pre', '##c', '##lini', '##cal', 'development', 'research', 'report', 'a', '##riad', 'ha', '##lo', '##zy', '##me', 'de', '##po', '##med', 'o', '##mer', '##os', 'and', 'bio', '##c', '##ry', '##st']",1
256345,nifty_783,2013-12-23,"Commercial Agreements, Stock Price Updates, Regulatory Approvals, Patent Litigation Settlements, and New Health Plan Strategies - Research Report on Biogen, Express Scripts, GSK, Actavis, and Aetna",Neutral,0.0022,197,commercial agreement stock price update regulatory approval patent litigation settlement and new health plan strategy research report biogen express script gsk actavis and aetna,177,24,0,pharmacy,"['commercial', 'agreement', 'stock', 'price', 'update', 'regulatory', 'approval', 'patent', 'litigation', 'settlement', 'and', 'new', 'health', 'plan', 'strategy', 'research', 'report', 'bio', '##gen', 'express', 'script', 'g', '##sk', 'act', '##avi', '##s', 'and', 'a', '##et', '##na']",1
256356,nifty_783,2013-12-23,"Market Expert Opinion: Baxter Intl., Unilife, CareFusion, and Mindray Medical Intl.",Neutral,0.0022,83,market expert opinion baxter intl unilife carefusion and mindray medical intl,77,11,0,pharmacy,"['market', 'expert', 'opinion', 'b', '##ax', '##ter', 'in', '##tl', 'un', '##ili', '##fe', 'care', '##fusion', 'and', 'mind', '##ray', 'medical', 'in', '##tl']",1
256361,nifty_783,2013-12-23,"Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax",Neutral,0.0022,85,technical research equity ariad pharma mannkind galena biopharma and novavax,76,10,0,pharmacy,"['technical', 'research', 'equity', 'a', '##riad', 'p', '##har', '##ma', 'man', '##nk', '##ind', 'gal', '##ena', 'bio', '##pha', '##rma', 'and', 'no', '##va', '##va', '##x']",1
256363,nifty_783,2013-12-23,"New Clinical Trials, Stock Price Movements, and Completed Acquisitions - Research Report on Merck, Lilly, Allergan, PerkinElmer, and Air Methods",Neutral,0.0022,144,new clinical trial stock price movement and completed acquisition research report merck lilly allergan perkinelmer and air method,129,18,0,pharmacy,"['new', 'clinical', 'trial', 'stock', 'price', 'movement', 'and', 'completed', 'acquisition', 'research', 'report', 'me', '##rc', '##k', 'l', '##ill', '##y', 'all', '##er', '##gan', 'per', '##kin', '##el', '##mer', 'and', 'air', 'method']",1
256367,nifty_783,2013-12-23,"Pre-Market Commentary: Perrigo, Allscripts Healthcare Solutions, Catalyst Pharma Partners, and Ironwood Pharma",Neutral,0.0022,110,pre market commentary perrigo allscripts healthcare solution catalyst pharma partner and ironwood pharma,104,13,0,pharmacy,"['pre', 'market', 'commentary', 'per', '##rig', '##o', 'all', '##s', '##cripts', 'healthcare', 'solution', 'catalyst', 'p', '##har', '##ma', 'partner', 'and', 'iron', '##wood', 'p', '##har', '##ma']",1
256422,nifty_783,2013-12-23,"Taiwan Spends a High Percentage of its Healthcare Budget on Pharmaceuticals, but Second Generation Healthcare Reform is Transforming the Market Landscape",Neutral,0.0022,153,taiwan spends high percentage it healthcare budget pharmaceutical but second generation healthcare reform transforming the market landscape,139,17,0,pharmacy,"['ta', '##i', '##wan', 'spends', 'high', 'percentage', 'it', 'healthcare', 'budget', 'pharmaceutical', 'but', 'second', 'generation', 'healthcare', 'reform', 'transforming', 'the', 'market', 'landscape']",1
256490,nifty_783,2013-12-23,"Research and Markets: Global Epigenetics Market 2014-2018: With Celgene Corp., Eisai Inc. and Merck & Co. Dominating",Neutral,0.0022,116,research and market global epigenetics market with celgene corp eisai inc and merck dominating,94,14,0,pharmacy,"['research', 'and', 'market', 'global', 'e', '##pi', '##gene', '##tics', 'market', 'with', 'c', '##el', '##gene', 'co', '##rp', 'e', '##isa', '##i', 'in', '##c', 'and', 'me', '##rc', '##k', 'dominating']",1
256500,nifty_783,2013-12-23,"Research and Markets: Global RFID Market 2014-2018 with RFID4U, UPM raflatac, and Zebra Technologies Inc. Dominating",Neutral,0.0022,116,research and market global rfid market with rfidu upm raflatac and zebra technology inc dominating,98,15,0,pharmacy,"['research', 'and', 'market', 'global', 'r', '##fi', '##d', 'market', 'with', 'r', '##fi', '##du', 'up', '##m', 'r', '##af', '##lat', '##ac', 'and', 'z', '##eb', '##ra', 'technology', 'in', '##c', 'dominating']",1
256730,nifty_783,2013-12-23,Baxter Recalls Some IV Solutions,Neutral,0.0022,32,baxter recall some solution,27,4,0,pharmacy,"['b', '##ax', '##ter', 'recall', 'some', 'solution']",1
256817,nifty_784,2013-12-26,"Market Technicals on Thursday: Quest Diagnostics, Santarus, Isis Pharma, and Community Health Systems",Neutral,-0.0001,101,market technical thursday quest diagnostics santarus isi pharma and community health system,91,12,0,pharmacy,"['market', 'technical', 'th', '##urs', '##day', 'quest', 'diagnostic', '##s', 'sa', '##nta', '##rus', 'is', '##i', 'p', '##har', '##ma', 'and', 'community', 'health', 'system']",1
256823,nifty_784,2013-12-26,"Technical Briefing on Health Care Sector: Gilead Sciences, Halozyme Therapeutics, NPS Pharma, and InterMune",Neutral,-0.0001,107,technical briefing health care sector gilead science halozyme therapeutic np pharma and intermune,97,13,0,pharmacy,"['technical', 'brief', '##ing', 'health', 'care', 'sector', 'g', '##ile', '##ad', 'science', 'ha', '##lo', '##zy', '##me', 'therapeutic', 'n', '##p', 'p', '##har', '##ma', 'and', 'inter', '##mu', '##ne']",1
257150,nifty_785,2013-12-30,"Conference Schedules, Stock Price Movements, Executive Transitions, and Revenue Outlook - Research Report on Incyte, ViroPharma, Cooper, Varian and PDL BioPharma",Neutral,0.0047,161,conference schedule stock price movement executive transition and revenue outlook research report incyte viropharma cooper varian and pdl biopharma,147,19,0,pharmacy,"['conference', 'schedule', 'stock', 'price', 'movement', 'executive', 'transition', 'and', 'revenue', 'outlook', 'research', 'report', 'in', '##cy', '##te', 'v', '##iro', '##pha', '##rma', 'co', '##oper', 'var', '##ian', 'and', 'p', '##dl', 'bio', '##pha', '##rma']",1
257155,nifty_785,2013-12-30,"Regulatory Filings, Upcoming Healthcare Conferences, Trial Updates, and Innovative Collaborations - Research Report on Novo Nordisk, Hospira, Tesaro, Alnylam, and Sanofi",Neutral,0.0047,169,regulatory filing upcoming healthcare conference trial update and innovative collaboration research report novo nordisk hospira tesaro alnylam and sanofi,153,19,0,pharmacy,"['regulatory', 'filing', 'upcoming', 'healthcare', 'conference', 'trial', 'update', 'and', 'innovative', 'collaboration', 'research', 'report', 'no', '##vo', 'nor', '##dis', '##k', 'ho', '##sp', '##ira', 'te', '##sar', '##o', 'al', '##ny', '##lam', 'and', 'sa', '##no', '##fi']",1
257462,nifty_785,2013-12-30,Sanofi Appeals MS Drug Rejection,Neutral,0.0047,32,sanofi appeal drug rejection,28,4,0,pharmacy,"['sa', '##no', '##fi', 'appeal', 'drug', 'rejection']",1
257610,nifty_787,2014-01-06,"Research and Markets: Minimally Invasive Surgery Market - Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2013 - 2019",Rise,0.0061,135,research and market minimally invasive surgery market global industry analysis size share growth trend forecast,111,15,0,pharmacy,"['research', 'and', 'market', 'minimal', '##ly', 'invasive', 'surgery', 'market', 'global', 'industry', 'analysis', 'size', 'share', 'growth', 'trend', 'forecast']",1
257612,nifty_787,2014-01-06,"Research and Markets: China Medical Monitor Industry Report, 2013-2015",Rise,0.0061,70,research and market china medical monitor industry report,57,8,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'medical', 'monitor', 'industry', 'report']",1
257633,nifty_787,2014-01-06,Research and Markets: EpiCast Report: Ulcerative Colitis - Epidemiology Forecast to 2022,Rise,0.0061,88,research and market epicast report ulcerative colitis epidemiology forecast,75,9,0,pharmacy,"['research', 'and', 'market', 'epic', '##ast', 'report', 'ul', '##cer', '##ative', 'co', '##lit', '##is', 'e', '##pid', '##em', '##iology', 'forecast']",1
257666,nifty_787,2014-01-06,Research and Markets: Global Renal Cell Carcinoma Pipeline Highlights - 2014 Research Report,Rise,0.0061,92,research and market global renal cell carcinoma pipeline highlight research report,82,11,0,pharmacy,"['research', 'and', 'market', 'global', 're', '##nal', 'cell', 'car', '##cin', '##oma', 'pipeline', 'highlight', 'research', 'report']",1
257668,nifty_787,2014-01-06,Research and Markets: Global Bipolar Disorder Pipeline Highlights - 2014 Research Report,Rise,0.0061,88,research and market global bipolar disorder pipeline highlight research report,78,10,0,pharmacy,"['research', 'and', 'market', 'global', 'bi', '##pol', '##ar', 'disorder', 'pipeline', 'highlight', 'research', 'report']",1
257681,nifty_787,2014-01-06,RXi Pharmaceuticals to Present at the Biotech Showcaseâ¢ 2014,Rise,0.0061,62,rxi pharmaceutical present the biotech showcaseâ,48,6,0,pharmacy,"['r', '##xi', 'pharmaceutical', 'present', 'the', 'bio', '##tech', 'showcase', '##â']",1
257720,nifty_787,2014-01-06,"Stock Movements, FDA Clearances, Collaborations, and Agreements - Research Report on CytRx, Quidel, Repligen, Intrexon, and Acacia",Rise,0.0061,130,stock movement fda clearance collaboration and agreement research report cytrx quidel repligen intrexon and acacia,114,15,0,pharmacy,"['stock', 'movement', 'f', '##da', 'clearance', 'collaboration', 'and', 'agreement', 'research', 'report', 'c', '##yt', '##r', '##x', 'q', '##uid', '##el', 're', '##p', '##li', '##gen', 'in', '##tre', '##xon', 'and', 'a', '##cacia']",1
257725,nifty_787,2014-01-06,"Drug Designation, Conference Participations, Induction of Winners, Software Solution Deployment, and Patent Issuance - Research Report on GSK, Centene, WuXi PharmaTech, Allscripts, and Immunomedics",Rise,0.0061,197,drug designation conference participation induction winner software solution deployment and patent issuance research report gsk centene wuxi pharmatech allscripts and immunomedics,179,21,0,pharmacy,"['drug', 'designation', 'conference', 'participation', 'induction', 'winner', 'software', 'solution', 'deployment', 'and', 'patent', 'is', '##su', '##ance', 'research', 'report', 'g', '##sk', 'cent', '##ene', 'w', '##ux', '##i', 'p', '##har', '##mate', '##ch', 'all', '##s', '##cripts', 'and', 'im', '##mu', '##no', '##med', '##ics']",1
257737,nifty_787,2014-01-06,Iroko Pharmaceuticals to Present at 6th Annual Biotech Showcaseâ¢,Rise,0.0061,66,iroko pharmaceutical present annual biotech showcaseâ,53,6,0,pharmacy,"['i', '##rok', '##o', 'pharmaceutical', 'present', 'annual', 'bio', '##tech', 'showcase', '##â']",1
257743,nifty_787,2014-01-06,AdCare Health Systems to Present at Noble Financial Capital Markets' 10th Annual Equity Conference,Rise,0.0061,98,adcare health system present noble financial capital market annual equity conference,84,11,0,pharmacy,"['ad', '##care', 'health', 'system', 'present', 'noble', 'financial', 'capital', 'market', 'annual', 'equity', 'conference']",1
257757,nifty_787,2014-01-06,Research and Markets: 2013 Report on the International Epigenetics Technology Market - World Forecasts to 2017,Rise,0.0061,110,research and market report the international epigenetics technology market world forecast,89,11,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'e', '##pi', '##gene', '##tics', 'technology', 'market', 'world', 'forecast']",1
257767,nifty_787,2014-01-06,Research and Markets: 2013 Report on the International mHealth Market - World Forecasts to 2018,Rise,0.0061,95,research and market report the international mhealth market world forecast,74,10,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'm', '##hea', '##lt', '##h', 'market', 'world', 'forecast']",1
257833,nifty_787,2014-01-06,Research and Markets: 2013 Report on the International Biopsy Devices Market - Global Forecasts to 2018,Rise,0.0061,103,research and market report the international biopsy device market global forecast,81,11,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'bio', '##psy', 'device', 'market', 'global', 'forecast']",1
257837,nifty_787,2014-01-06,"Stellar Biotechnologies, Inc. to Present at Two Investor Conferences in January",Rise,0.0061,79,stellar biotechnology inc present two investor conference january,65,8,0,pharmacy,"['stellar', 'bio', '##tech', '##nology', 'in', '##c', 'present', 'two', 'investor', 'conference', 'j', '##anu', '##ary']",1
257960,nifty_787,2014-01-06,"Research and Markets: Research Report on China Antidiabetic Drug Market, 2014-2018",Rise,0.0061,82,research and market research report china antidiabetic drug market,66,9,0,pharmacy,"['research', 'and', 'market', 'research', 'report', 'chin', '##a', 'anti', '##dia', '##bet', '##ic', 'drug', 'market']",1
257969,nifty_787,2014-01-06,Bio-Path Holdings to Present at the Biotech Showcaseâ¢ 2014 Conference,Rise,0.0061,71,bio path holding present the biotech showcaseâ conference,57,8,0,pharmacy,"['bio', 'path', 'holding', 'present', 'the', 'bio', '##tech', 'showcase', '##â', 'conference']",1
258202,nifty_787,2014-01-06,NPS Pharmaceuticals to Present at J.P. Morgan Healthcare Conference,Rise,0.0061,67,np pharmaceutical present morgan healthcare conference,54,6,0,pharmacy,"['n', '##p', 'pharmaceutical', 'present', 'm', '##or', '##gan', 'healthcare', 'conference']",1
258383,nifty_787,2014-01-06,Royalty Pharma Acquires Drug Stake,Rise,0.0061,34,royalty pharma acquires drug stake,34,5,0,pharmacy,"['royalty', 'p', '##har', '##ma', 'acquire', '##s', 'drug', 'stake']",1
258461,nifty_788,2014-01-07,OraSure Unit to Address FDA Warning Letter,Neutral,0.0002,42,orasure unit address fda warning letter,39,6,0,pharmacy,"['or', '##as', '##ure', 'unit', 'address', 'f', '##da', 'warning', 'letter']",1
258466,nifty_788,2014-01-07,FDA to Decide on Diet Drug by June,Neutral,0.0002,34,fda decide diet drug june,25,5,0,pharmacy,"['f', '##da', 'decide', 'diet', 'drug', 'j', '##une']",1
258494,nifty_789,2014-01-08,Novartis Sued for Alleged Kickbacks,Neutral,0.0007,35,novartis sued for alleged kickback,34,5,0,pharmacy,"['no', '##var', '##tis', 'sued', 'for', 'alleged', 'kick', '##back']",1
258523,nifty_789,2014-01-08,"Quest Diagnostics, University to Develop Diagnostic Tools",Neutral,0.0007,57,quest diagnostics university develop diagnostic tool,52,6,0,pharmacy,"['quest', 'diagnostic', '##s', 'university', 'develop', 'diagnostic', 'tool']",1
258538,nifty_789,2014-01-08,Health Management Shareholders Approve Community Health Deal,Neutral,0.0007,60,health management shareholder approve community health deal,59,7,0,pharmacy,"['health', 'management', 'shareholder', 'approve', 'community', 'health', 'deal']",1
258633,nifty_790,2014-01-09,Biogen Partners with Sangamo on Hemoglobin-Related Therapies,Neutral,0.0027,60,biogen partner with sangamo hemoglobin related therapy,54,7,0,pharmacy,"['bio', '##gen', 'partner', 'with', 'sang', '##amo', 'hem', '##og', '##lo', '##bin', 'related', 'therapy']",1
258635,nifty_790,2014-01-09,Novartis's Blockbuster Drug Hemorrhages Sales,Neutral,0.0027,45,novartis blockbuster drug hemorrhage sale,41,5,0,pharmacy,"['no', '##var', '##tis', 'block', '##buster', 'drug', 'hem', '##or', '##r', '##hage', 'sale']",1
258725,nifty_791,2014-01-13,Merck Filing for Melanoma Treatment,Rise,0.0109,35,merck filing for melanoma treatment,35,5,0,pharmacy,"['me', '##rc', '##k', 'filing', 'for', 'me', '##lan', '##oma', 'treatment']",1
258728,nifty_791,2014-01-13,St. Jude Raises 4th-Quarter Guidance,Rise,0.0109,36,jude raise quarter guidance,27,4,0,pharmacy,"['j', '##ude', 'raise', 'quarter', 'guidance']",1
258764,nifty_792,2014-01-14,New Biotech Knows Roller-Coaster Feeling,Rise,0.0054,40,new biotech know roller coaster feeling,39,6,0,pharmacy,"['new', 'bio', '##tech', 'know', 'roller', 'coaster', 'feeling']",1
258999,nifty_793,2014-01-15,Research and Markets: Global and Chinese Medical MRI Equipment Industry Report 2014,Neutral,-0.0013,83,research and market global and chinese medical mri equipment industry report,76,11,0,pharmacy,"['research', 'and', 'market', 'global', 'and', 'chin', '##ese', 'medical', 'm', '##ri', 'equipment', 'industry', 'report']",1
259015,nifty_793,2014-01-15,Revive Therapeutics Ltd. Announces Initiation of A Phase 2a Study of REV-001 (Tianeptine) for the Prevention of Opioid-Induced Respiratory Depression,Neutral,-0.0013,149,revive therapeutic ltd announces initiation phase study rev tianeptine for the prevention opioid induced respiratory depression,127,16,0,pharmacy,"['revive', 'therapeutic', 'l', '##t', '##d', 'announces', 'initiation', 'phase', 'study', 're', '##v', 't', '##ian', '##ept', '##ine', 'for', 'the', 'prevention', 'op', '##io', '##id', 'induced', 'respiratory', 'depression']",1
259071,nifty_793,2014-01-15,Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference,Neutral,-0.0013,99,echo therapeutic present the noble financial capital market tenth annual equity conference,90,12,0,pharmacy,"['echo', 'therapeutic', 'present', 'the', 'noble', 'financial', 'capital', 'market', 'tenth', 'annual', 'equity', 'conference']",1
259077,nifty_793,2014-01-15,Research and Markets: 2013 Report on the International mHealth Apps & Solutions Market - Global Trends & Forecast to 2018,Neutral,-0.0013,121,research and market report the international mhealth apps solution market global trend forecast,95,13,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'm', '##hea', '##lt', '##h', 'apps', 'solution', 'market', 'global', 'trend', 'forecast']",1
259082,nifty_793,2014-01-15,"Health Care Sector Technical Data: Tenet Healthcare, Community Health Systems, HCA Holdings, and Health Management Associates",Neutral,-0.0013,125,health care sector technical data tenet healthcare community health system hca holding and health management associate,118,16,0,pharmacy,"['health', 'care', 'sector', 'technical', 'data', 'ten', '##et', 'healthcare', 'community', 'health', 'system', 'h', '##ca', 'holding', 'and', 'health', 'management', 'associate']",1
259086,nifty_793,2014-01-15,"Upcoming Earnings Schedule, Supply and Collaboration Agreements, Financial Results, and Stock Options - Research Report on Natus, Haemonetics, AngioDynamics, Horizon Pharma, and ImmunoGen",Neutral,-0.0013,187,upcoming earnings schedule supply and collaboration agreement financial result and stock option research report natus haemonetics angiodynamics horizon pharma and immunogen,172,21,0,pharmacy,"['upcoming', 'earnings', 'schedule', 'supply', 'and', 'collaboration', 'agreement', 'financial', 'result', 'and', 'stock', 'option', 'research', 'report', 'na', '##tus', 'ha', '##emon', '##etics', 'an', '##gio', '##dynamic', '##s', 'horizon', 'p', '##har', '##ma', 'and', 'im', '##mu', '##no', '##gen']",1
259095,nifty_793,2014-01-15,"Multi-Year Contracts, Results Schedules, and Financial Guidance Updates - Research Report on Cigna, PerkinElmer, WuXi PharmaTech, MEDNAX, and WellCare",Neutral,-0.0013,150,multi year contract result schedule and financial guidance update research report cigna perkinelmer wuxi pharmatech mednax and wellcare,135,18,0,pharmacy,"['multi', 'year', 'contract', 'result', 'schedule', 'and', 'financial', 'guidance', 'update', 'research', 'report', 'c', '##ign', '##a', 'per', '##kin', '##el', '##mer', 'w', '##ux', '##i', 'p', '##har', '##mate', '##ch', 'me', '##dn', '##ax', 'and', 'well', '##care']",1
259097,nifty_793,2014-01-15,"Stock Price Movements, Completion of Acquisitions, and Clinical Trial Initiations - Research Report on Endocyte, PharMerica, Synta, AtriCure, and Cytokinetics",Neutral,-0.0013,158,stock price movement completion acquisition and clinical trial initiation research report endocyte pharmerica synta atricure and cytokinetics,141,17,0,pharmacy,"['stock', 'price', 'movement', 'completion', 'acquisition', 'and', 'clinical', 'trial', 'initiation', 'research', 'report', 'end', '##oc', '##yte', 'p', '##har', '##mer', '##ica', 's', '##yn', '##ta', 'at', '##ric', '##ure', 'and', 'c', '##yt', '##oki', '##net', '##ics']",1
259109,nifty_793,2014-01-15,"BrainStorm Hosting a Conference Call with Clinical Trial Advisors in Israel, US and Brazil to Update Shareholders on Current Developments",Neutral,-0.0013,137,brainstorm hosting conference call with clinical trial advisor israel and brazil update shareholder current development,119,15,0,pharmacy,"['brains', '##tor', '##m', 'hosting', 'conference', 'call', 'with', 'clinical', 'trial', 'advisor', 'is', '##rae', '##l', 'and', 'bra', '##zi', '##l', 'update', 'shareholder', 'current', 'development']",1
259417,nifty_793,2014-01-15,"Research and Markets: Global Medical Imaging Equipment Market Report 2013-2019: In-Depth X-ray, Ultrasound, CT, MRI and Nuclear Imaging Analysis",Neutral,-0.0013,144,research and market global medical imaging equipment market report depth ray ultrasound mri and nuclear imaging analysis,120,17,0,pharmacy,"['research', 'and', 'market', 'global', 'medical', 'imaging', 'equipment', 'market', 'report', 'depth', 'ray', 'ultra', '##sound', 'm', '##ri', 'and', 'nuclear', 'imaging', 'analysis']",1
259791,nifty_793,2014-01-15,Chelsea Therapeutics' Northera Gets Strong Support From FDA Panel,Neutral,-0.0013,65,chelsea therapeutic northera get strong support from fda panel,62,9,0,pharmacy,"['ch', '##els', '##ea', 'therapeutic', 'north', '##era', 'get', 'strong', 'support', 'from', 'f', '##da', 'panel']",1
259979,nifty_796,2014-01-22,St. Jude Medical Profit Rises 2.5% on Continued Sales Growth,Fall,-0.0082,60,jude medical profit rise continued sale growth,46,7,0,pharmacy,"['j', '##ude', 'medical', 'profit', 'rise', 'continued', 'sale', 'growth']",1
260024,nifty_796,2014-01-22,FDA Turns Down Application for Amag's Drug,Fall,-0.0082,42,fda turn down application for amag drug,39,7,0,pharmacy,"['f', '##da', 'turn', 'down', 'application', 'for', 'am', '##ag', 'drug']",1
260030,nifty_796,2014-01-22,Quest Diagnostics to Acquire Solstas Lab,Fall,-0.0082,40,quest diagnostics acquire solstas lab,37,5,0,pharmacy,"['quest', 'diagnostic', '##s', 'acquire', 'so', '##ls', '##tas', 'lab']",1
260068,nifty_797,2014-01-23,Positive biotech sector momentum continues - transformational new products the key driver,Fall,-0.0213,89,positive biotech sector momentum continues transformational new product the key driver,86,11,0,pharmacy,"['positive', 'bio', '##tech', 'sector', 'momentum', 'continues', 'transformation', '##al', 'new', 'product', 'the', 'key', 'driver']",1
260164,nifty_797,2014-01-23,Research and Markets: 2013 Report on the International Radiopharmaceuticals Market - Trends And Forecasts to 2018,Fall,-0.0213,113,research and market report the international radiopharmaceutical market trend and forecast,90,11,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'radio', '##pha', '##rma', '##ce', '##utical', 'market', 'trend', 'and', 'forecast']",1
260215,nifty_797,2014-01-23,Research and Markets: Generic Drug Opportunity Assessment - Fingolimod (Gilenya),Fall,-0.0213,80,research and market generic drug opportunity assessment fingolimod gilenya,74,9,0,pharmacy,"['research', 'and', 'market', 'generic', 'drug', 'opportunity', 'assessment', 'fin', '##gol', '##imo', '##d', 'g', '##ile', '##nya']",1
260309,nifty_797,2014-01-23,Research and Markets: 2013 Report on the International North America Injectable Drug Delivery Market - Forecasts to 2017,Fall,-0.0213,120,research and market report the international north america injectable drug delivery market forecast,99,13,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'north', 'am', '##eric', '##a', 'in', '##ject', '##able', 'drug', 'delivery', 'market', 'forecast']",1
260324,nifty_797,2014-01-23,Research and Markets: 2013 Report on the International 3D Imaging Market - Forecasts and Analysis to 2018,Fall,-0.0213,105,research and market report the international imaging market forecast and analysis,81,11,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'imaging', 'market', 'forecast', 'and', 'analysis']",1
260370,nifty_797,2014-01-23,"Alibaba, Yunfeng to invest $170 million in drug data project",Fall,-0.0213,60,alibaba yunfeng invest million drug data project,48,7,0,pharmacy,"['al', '##iba', '##ba', 'y', '##un', '##feng', 'invest', 'million', 'drug', 'data', 'project']",1
260418,nifty_797,2014-01-23,Mintigo Unveils DNA Spotlight Report on the State of the Marketing Technology Industry,Fall,-0.0213,86,mintigo unveils dna spotlight report the state the marketing technology industry,80,11,0,pharmacy,"['mint', '##igo', 'un', '##ve', '##ils', 'd', '##na', 'spotlight', 'report', 'the', 'state', 'the', 'marketing', 'technology', 'industry']",1
260419,nifty_797,2014-01-23,inVentiv Health Leverages Advanced Digital Technology To Slash The Time Required To Conduct Feasibility Studies,Fall,-0.0213,111,inventiv health leverage advanced digital technology slash the time required conduct feasibility study,102,13,0,pharmacy,"['in', '##vent', '##iv', 'health', 'leverage', 'advanced', 'digital', 'technology', 'slash', 'the', 'time', 'required', 'conduct', 'f', '##eas', '##ibility', 'study']",1
260489,nifty_797,2014-01-23,Unprecedented Biotech Showcaseâ¢ 2014 Attendance Reflects Investor Appetite for Biotech Innovation,Fall,-0.0213,99,unprecedented biotech showcaseâ attendance reflects investor appetite for biotech innovation,92,10,0,pharmacy,"['unprecedented', 'bio', '##tech', 'showcase', '##â', 'attendance', 'reflects', 'investor', 'appetite', 'for', 'bio', '##tech', 'innovation']",1
260527,nifty_797,2014-01-23,"Research and Markets: Fragile X Syndrome - Pipeline Review, H2 2013",Fall,-0.0213,67,research and market fragile syndrome pipeline review,52,7,0,pharmacy,"['research', 'and', 'market', 'fragile', 'syndrome', 'pipeline', 'review']",1
260544,nifty_797,2014-01-23,Genome BC Investing in BC Technology and Manufacturing,Fall,-0.0213,54,genome investing technology and manufacturing,45,5,0,pharmacy,"['genome', 'investing', 'technology', 'and', 'manufacturing']",1
260627,nifty_797,2014-01-23,"Research and Markets: Process Validation for Pharmaceutical Products Regulated by EMA & FDA - Balancing Science and Risk During the Product Lifecycle (Seminar, London)",Fall,-0.0213,167,research and market process validation for pharmaceutical product regulated ema fda balancing science and risk during the product lifecycle seminar london,154,21,0,pharmacy,"['research', 'and', 'market', 'process', 'valid', '##ation', 'for', 'pharmaceutical', 'product', 'regulated', 'em', '##a', 'f', '##da', 'balancing', 'science', 'and', 'risk', 'during', 'the', 'product', 'life', '##cycle', 'seminar', 'lo', '##ndon']",1
260686,nifty_797,2014-01-23,"16th Annual BIO CEO & Investor Conference to Highlight 2014 Biotech Outlook, Timely Business Development Issues and Hot Therapeutic Topics",Fall,-0.0213,138,annual bio ceo investor conference highlight biotech outlook timely business development issue and hot therapeutic topic,120,16,0,pharmacy,"['annual', 'bio', 'c', '##eo', 'investor', 'conference', 'highlight', 'bio', '##tech', 'outlook', 'time', '##ly', 'business', 'development', 'issue', 'and', 'hot', 'therapeutic', 'topic']",1
260773,nifty_797,2014-01-23,Tonix Pharmaceuticals Announces Proposed Public Offering of Common Stock,Fall,-0.0213,72,tonix pharmaceutical announces proposed public offering common stock,68,8,0,pharmacy,"['ton', '##ix', 'pharmaceutical', 'announces', 'proposed', 'public', 'offering', 'common', 'stock']",1
260807,nifty_797,2014-01-23,Doctor quizzed about drug info discussions with investors outside of SAC,Fall,-0.0213,72,doctor quizzed about drug info discussion with investor outside sac,67,10,0,pharmacy,"['doctor', 'q', '##uiz', '##zed', 'about', 'drug', 'info', 'discussion', 'with', 'investor', 'outside', 'sa', '##c']",1
260847,nifty_797,2014-01-23,FDA's Thomas Arista and Rick Friedman Confirmed as Keynote Speakers at 23rd Annual ISPE Aseptic Conference,Fall,-0.0213,106,fda thomas arista and rick friedman confirmed keynote speaker annual ispe aseptic conference,92,13,0,pharmacy,"['f', '##da', 'th', '##oma', '##s', 'a', '##rist', '##a', 'and', 'r', '##ick', 'fried', '##man', 'confirmed', 'key', '##note', 'speaker', 'annual', 'is', '##pe', 'as', '##ept', '##ic', 'conference']",1
261212,nifty_799,2014-01-28,"Research and Markets: Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H2 2013 Report",Fall,-0.0096,111,research and market transitional cell carcinoma urothelial cell carcinoma pipeline review report,96,12,0,pharmacy,"['research', 'and', 'market', 'transitional', 'cell', 'car', '##cin', '##oma', 'u', '##roth', '##eli', '##al', 'cell', 'car', '##cin', '##oma', 'pipeline', 'review', 'report']",1
261257,nifty_799,2014-01-28,"Research and Markets: Pharmaceutical Regulatory Affairs in Africa - Including South Africa (Seminar, London) 28th & 29th April 2014",Fall,-0.0096,131,research and market pharmaceutical regulatory affair africa including south africa seminar london april,103,13,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'regulatory', 'affair', 'a', '##f', '##rica', 'including', 'south', 'a', '##f', '##rica', 'seminar', 'lo', '##ndon', 'a', '##p', '##ril']",1
261265,nifty_799,2014-01-28,"Research and Markets: Antibody-Drug Conjugates 2014 - A Business, Technology & Pipeline Analysis",Fall,-0.0096,96,research and market antibody drug conjugate business technology pipeline analysis,81,10,0,pharmacy,"['research', 'and', 'market', 'anti', '##body', 'drug', 'con', '##ju', '##gate', 'business', 'technology', 'pipeline', 'analysis']",1
261309,nifty_799,2014-01-28,"Research and Markets: General Anxiety Disorder - Pipeline Review, H2 2013",Fall,-0.0096,73,research and market general anxiety disorder pipeline review,60,8,0,pharmacy,"['research', 'and', 'market', 'general', 'anxiety', 'disorder', 'pipeline', 'review']",1
261316,nifty_799,2014-01-28,Research and Markets: 2014 Report on the US Predictive Breast Cancer Gene Testing Industry,Fall,-0.0096,90,research and market report the predictive breast cancer gene testing industry,77,11,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'predict', '##ive', 'breast', 'cancer', 'gene', 'testing', 'industry']",1
261365,nifty_799,2014-01-28,Research and Markets: 2014 Analysis on Type 2 Diabetes in the US - Forecasts to 2022,Fall,-0.0096,84,research and market analysis type diabetes the forecast,55,8,0,pharmacy,"['research', 'and', 'market', 'analysis', 'type', 'diabetes', 'the', 'forecast']",1
261373,nifty_799,2014-01-28,Research and Markets: 2014 Report on the International Implantable Drug Delivery Devices Market - Trends and Forecasts to 2018,Fall,-0.0096,126,research and market report the international implantable drug delivery device market trend and forecast,103,14,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'imp', '##lant', '##able', 'drug', 'delivery', 'device', 'market', 'trend', 'and', 'forecast']",1
261393,nifty_799,2014-01-28,Research and Markets: 2014 Report on the International Gynecological Devices Market - Forecasts to 2018,Fall,-0.0096,103,research and market report the international gynecological device market forecast,81,10,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'g', '##yne', '##cological', 'device', 'market', 'forecast']",1
261467,nifty_799,2014-01-28,Research and Markets: 2014 Report on the International Hospital-based EMR Market,Fall,-0.0096,80,research and market report the international hospital based emr market,70,10,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'hospital', 'based', 'em', '##r', 'market']",1
261495,nifty_799,2014-01-28,"New Drug Channels Institute Study Finds Three Companies Dominate Specialty Pharmacy, Identifies Key Trends Affecting Profitability",Fall,-0.0096,130,new drug channel institute study find three company dominate specialty pharmacy identifies key trend affecting profitability,124,16,0,pharmacy,"['new', 'drug', 'channel', 'institute', 'study', 'find', 'three', 'company', 'dominate', 'specialty', 'pharmacy', 'identifies', 'key', 'trend', 'affecting', 'profit', '##ability']",1
261627,nifty_799,2014-01-28,"Hedge Funder, Jeffrey Epstein Funds Groundbreaking Colon Cancer Research at Johns Hopkins University",Fall,-0.0096,100,hedge funder jeffrey epstein fund groundbreaking colon cancer research john hopkins university,94,12,0,pharmacy,"['hedge', 'fund', '##er', 'j', '##ef', '##frey', 'e', '##ps', '##tein', 'fund', 'groundbreaking', 'co', '##lon', 'cancer', 'research', 'j', '##oh', '##n', 'hop', '##kins', 'university']",1
261761,nifty_799,2014-01-28,"The Chronic Kidney Disease (CKD) Drug Market Will Increase to $11.7 Billion in 2022, Driven by the Uptake of Novel Agents",Fall,-0.0096,121,the chronic kidney disease ckd drug market will increase billion driven the uptake novel agent,94,15,0,pharmacy,"['the', 'chronic', 'kidney', 'disease', 'c', '##k', '##d', 'drug', 'market', 'will', 'increase', 'billion', 'driven', 'the', 'up', '##take', 'novel', 'agent']",1
261992,nifty_799,2014-01-28,Amgen profit tops Street expectations; focus on new drugs,Fall,-0.0096,57,amgen profit top street expectation focus new drug,50,8,0,pharmacy,"['am', '##gen', 'profit', 'top', 'street', 'expectation', 'focus', 'new', 'drug']",1
261993,nifty_799,2014-01-28,UPDATE 2-Amgen profit tops Street expectations; focus on new drugs,Fall,-0.0096,66,update amgen profit top street expectation focus new drug,57,9,0,pharmacy,"['update', 'am', '##gen', 'profit', 'top', 'street', 'expectation', 'focus', 'new', 'drug']",1
262071,nifty_799,2014-01-28,Bitter Medicine in Store for Activists,Fall,-0.0096,38,bitter medicine store for activist,34,5,0,pharmacy,"['bitter', 'medicine', 'store', 'for', 'activist']",1
262072,nifty_799,2014-01-28,Bayer's Aleve May Have Lower Cardiac Risk Than Rival Painkillers,Fall,-0.0096,64,bayer aleve may have lower cardiac risk than rival painkiller,61,10,0,pharmacy,"['bay', '##er', 'ale', '##ve', 'may', 'have', 'lower', 'cardiac', 'risk', 'than', 'rival', 'pain', '##kill', '##er']",1
262225,nifty_800,2014-01-29,Biogen Profit Jumps,Rise,0.0106,19,biogen profit jump,18,3,0,pharmacy,"['bio', '##gen', 'profit', 'jump']",1
262364,nifty_801,2014-01-30,J&J to Share Drug Research Data in Pact With Yale,Fall,-0.0059,49,share drug research data pact with yale,39,7,0,pharmacy,"['share', 'drug', 'research', 'data', 'pact', 'with', 'ya', '##le']",1
262434,nifty_802,2014-02-03,FDA Designates GlaxoSmithKline Drug as Breakthrough Therapy,Rise,0.007,59,fda designates glaxosmithkline drug breakthrough therapy,56,6,0,pharmacy,"['f', '##da', 'design', '##ates', 'g', '##lax', '##os', '##mith', '##k', '##line', 'drug', 'breakthrough', 'therapy']",1
262444,nifty_803,2014-02-04,Saudis Push Gene-Sequencing Research,Neutral,-0.0013,36,saudi push gene sequencing research,35,5,0,pharmacy,"['sa', '##udi', 'push', 'gene', 'se', '##quencing', 'research']",1
262453,nifty_803,2014-02-04,Myriad Genetics to Buy Crescendo Bioscience,Neutral,-0.0013,43,myriad genetics buy crescendo bioscience,40,5,0,pharmacy,"['my', '##riad', 'genetics', 'buy', 'c', '##res', '##cend', '##o', 'bio', '##science']",1
262586,nifty_804,2014-02-05,Analysis: Emerging markets buffeted by bipolar world,Rise,0.0132,52,analysis emerging market buffeted bipolar world,47,6,0,pharmacy,"['analysis', 'emerging', 'market', 'b', '##uff', '##eted', 'bi', '##pol', '##ar', 'world']",1
262603,nifty_804,2014-02-05,Cegedim Strategic Data announces the expansion of their EMR-based Real World Patient data and analytics to the US market,Rise,0.0132,120,cegedim strategic data announces the expansion their emr based real world patient data and analytics the market,111,17,0,pharmacy,"['c', '##ege', '##di', '##m', 'strategic', 'data', 'announces', 'the', 'expansion', 'their', 'em', '##r', 'based', 'real', 'world', 'patient', 'data', 'and', 'anal', '##ytic', '##s', 'the', 'market']",1
262678,nifty_804,2014-02-05,Innovus Pharmaceuticals to Present at the 16th Annual BIO CEO & Investor Conference in New York,Rise,0.0132,95,innovus pharmaceutical present the annual bio ceo investor conference new york,78,11,0,pharmacy,"['inn', '##ov', '##us', 'pharmaceutical', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference', 'new', 'yo', '##rk']",1
262680,nifty_804,2014-02-05,Safeguard Scientifics Partner Company Crescendo Bioscience to Be Acquired by Myriad Genetics,Rise,0.0132,92,safeguard scientifics partner company crescendo bioscience acquired myriad genetics,83,9,0,pharmacy,"['safe', '##guard', 'scientific', '##s', 'partner', 'company', 'c', '##res', '##cend', '##o', 'bio', '##science', 'acquired', 'my', '##riad', 'genetics']",1
262747,nifty_804,2014-02-05,Soligenix to Present at the 16th Annual BIO CEO & Investor Conference in New York City,Rise,0.0132,86,soligenix present the annual bio ceo investor conference new york city,70,11,0,pharmacy,"['so', '##li', '##gen', '##ix', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference', 'new', 'yo', '##rk', 'city']",1
262748,nifty_804,2014-02-05,Research and Markets: FDA Regulation and Its Impact on the Pump Market,Rise,0.0132,70,research and market fda regulation and it impact the pump market,64,11,0,pharmacy,"['research', 'and', 'market', 'f', '##da', 'regulation', 'and', 'it', 'impact', 'the', 'pump', 'market']",1
262755,nifty_804,2014-02-05,AcelRx Pharmaceuticals to Participate in Three Upcoming Investor Events,Rise,0.0132,71,acelrx pharmaceutical participate three upcoming investor event,63,7,0,pharmacy,"['ace', '##l', '##r', '##x', 'pharmaceutical', 'participate', 'three', 'upcoming', 'investor', 'event']",1
262763,nifty_804,2014-02-05,"MARKET PULSE-Google, Time Warner, Myriad Genetics, Cognizant, Radian",Rise,0.0132,68,market pulse google time warner myriad genetics cognizant radian,64,9,0,pharmacy,"['market', 'pulse', 'go', '##og', '##le', 'time', 'warn', '##er', 'my', '##riad', 'genetics', 'co', '##gni', '##zan', '##t', 'r', '##adia', '##n']",1
262764,nifty_804,2014-02-05,Research and Markets: Concise Analysis of the International Transdermal Drug Delivery Markets - Updated 2014 Report,Rise,0.0132,115,research and market concise analysis the international transdermal drug delivery market updated report,102,13,0,pharmacy,"['research', 'and', 'market', 'con', '##cise', 'analysis', 'the', 'international', 'trans', '##der', '##mal', 'drug', 'delivery', 'market', 'updated', 'report']",1
262771,nifty_804,2014-02-05,Research and Markets: Concise Analysis on the International Personalized Medicine Market - Updated 2014 Report,Rise,0.0132,110,research and market concise analysis the international personalized medicine market updated report,98,12,0,pharmacy,"['research', 'and', 'market', 'con', '##cise', 'analysis', 'the', 'international', 'personal', '##ized', 'medicine', 'market', 'updated', 'report']",1
262797,nifty_804,2014-02-05,Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences,Rise,0.0132,69,arena pharmaceutical present two upcoming investor conference,61,7,0,pharmacy,"['arena', 'pharmaceutical', 'present', 'two', 'upcoming', 'investor', 'conference']",1
262845,nifty_804,2014-02-05,Aetna Foundation to Give $4 Million in Grants to Support Digital Health Innovations for Underserved Communities,Rise,0.0132,111,aetna foundation give million grant support digital health innovation for underserved community,95,12,0,pharmacy,"['a', '##et', '##na', 'foundation', 'give', 'million', 'grant', 'support', 'digital', 'health', 'innovation', 'for', 'under', '##serve', '##d', 'community']",1
262856,nifty_804,2014-02-05,"KemPharm, Inc. to Present at 16th Annual BIO CEO & Investor Conference",Rise,0.0132,70,kempharm inc present annual bio ceo investor conference,55,8,0,pharmacy,"['k', '##em', '##pha', '##rm', 'in', '##c', 'present', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
262898,nifty_804,2014-02-05,Cerecor to Present at 16th Annual BIO CEO & Investor Conference,Rise,0.0132,63,cerecor present annual bio ceo investor conference,50,7,0,pharmacy,"['c', '##ere', '##cor', 'present', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
262911,nifty_804,2014-02-05,Tetraphase Pharmaceuticals to Present at the 16th Annual BIO CEO & Investor Conference,Rise,0.0132,86,tetraphase pharmaceutical present the annual bio ceo investor conference,72,9,0,pharmacy,"['te', '##tra', '##pha', '##se', 'pharmaceutical', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
262927,nifty_804,2014-02-05,"BRIEF-Merck says still assessing whether to keep, divest non-pharmaceutical units",Rise,0.0132,81,brief merck say still assessing whether keep divest non pharmaceutical unit,75,11,0,pharmacy,"['brief', 'me', '##rc', '##k', 'say', 'still', 'assessing', 'whether', 'keep', 'dive', '##st', 'non', 'pharmaceutical', 'unit']",1
262964,nifty_804,2014-02-05,Research and Markets: EMRs and Clinical Research Report: Current and Potential Impact,Rise,0.0132,85,research and market emrs and clinical research report current and potential impact,82,12,0,pharmacy,"['research', 'and', 'market', 'em', '##rs', 'and', 'clinical', 'research', 'report', 'current', 'and', 'potential', 'impact']",1
263012,nifty_804,2014-02-05,"HealthMedica Inc., launches nationwide network of 75 Longevity Medical Centers across 15 states and 25 major US markets in alliance with $18 billion HCP Inc., (NYSE / S&P; 500), the largest healthcare Real Estate Investment T",Rise,0.0132,225,healthmedica inc launch nationwide network longevity medical center across state and major market alliance with billion hcp inc nyse the largest healthcare real estate investment,178,25,0,pharmacy,"['health', '##med', '##ica', 'in', '##c', 'launch', 'nationwide', 'network', 'long', '##evity', 'medical', 'center', 'across', 'state', 'and', 'major', 'market', 'alliance', 'with', 'billion', 'h', '##c', '##p', 'in', '##c', 'n', '##ys', '##e', 'the', 'largest', 'healthcare', 'real', 'estate', 'investment']",1
263138,nifty_804,2014-02-05,DiaMedica to Present at 16th Annual BIO CEO & Investor Conference,Rise,0.0132,65,diamedica present annual bio ceo investor conference,52,7,0,pharmacy,"['di', '##amed', '##ica', 'present', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
263150,nifty_804,2014-02-05,Research and Markets: Global Biophotonics Market to 2016,Rise,0.0132,56,research and market global biophotonics market,46,6,0,pharmacy,"['research', 'and', 'market', 'global', 'bio', '##ph', '##oto', '##nics', 'market']",1
263204,nifty_804,2014-02-05,Research and Markets: Global Biomaterials Market 2012-2016: High R&D; Costs Could Pose a Challenge to the Growth of the Market,Rise,0.0132,126,research and market global biomaterials market high cost could pose challenge the growth the market,99,15,0,pharmacy,"['research', 'and', 'market', 'global', 'bio', '##mate', '##rial', '##s', 'market', 'high', 'cost', 'could', 'pose', 'challenge', 'the', 'growth', 'the', 'market']",1
263214,nifty_804,2014-02-05,Research and Markets: The RFID Market in India is Forecasted to Grow at the CAGR of Around 25% During 2013-2018,Rise,0.0132,111,research and market the rfid market india forecasted grow the cagr around during,80,13,0,pharmacy,"['research', 'and', 'market', 'the', 'r', '##fi', '##d', 'market', 'in', '##dia', 'forecast', '##ed', 'grow', 'the', 'ca', '##g', '##r', 'around', 'during']",1
263220,nifty_804,2014-02-05,Tekmira to Present at the 16th Annual BIO CEO & Investor Conference,Rise,0.0132,67,tekmira present the annual bio ceo investor conference,54,8,0,pharmacy,"['te', '##k', '##mir', '##a', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
263283,nifty_804,2014-02-05,NPS Pharmaceuticals to Report 2013 Financial Results,Rise,0.0132,52,np pharmaceutical report financial result,41,5,0,pharmacy,"['n', '##p', 'pharmaceutical', 'report', 'financial', 'result']",1
263490,nifty_804,2014-02-05,Allergy-Drug Firm Circassia Seeks U.K. Listing,Rise,0.0132,46,allergy drug firm circassia seek listing,40,6,0,pharmacy,"['all', '##er', '##gy', 'drug', 'firm', 'circa', '##ssi', '##a', 'seek', 'listing']",1
263518,nifty_804,2014-02-05,Merck in Pacts to Study Cancer Treatment,Rise,0.0132,40,merck pact study cancer treatment,33,5,0,pharmacy,"['me', '##rc', '##k', 'pact', 'study', 'cancer', 'treatment']",1
263747,nifty_806,2014-02-10,Research and Markets: Optina (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022 Report,Rise,0.0109,116,research and market optina microvascular complication diabetes forecast and market analysis report,98,12,0,pharmacy,"['research', 'and', 'market', 'op', '##tina', 'micro', '##vas', '##cular', 'com', '##plication', 'diabetes', 'forecast', 'and', 'market', 'analysis', 'report']",1
263770,nifty_806,2014-02-10,"Research and Markets: 2014 Analysis of the World Cancer Diagnostic Testing Market: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities",Rise,0.0109,192,research and market analysis the world cancer diagnostic testing market country segment forecast market share emerging technology competitive strategy growth opportunity,169,21,0,pharmacy,"['research', 'and', 'market', 'analysis', 'the', 'world', 'cancer', 'diagnostic', 'testing', 'market', 'country', 'segment', 'forecast', 'market', 'share', 'emerging', 'technology', 'competitive', 'strategy', 'growth', 'opportunity']",1
263792,nifty_806,2014-02-10,"Research and Markets: 2014 Analysis of the World Clinical Chemistry and Immunodiagnostic Markets: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities",Rise,0.0109,207,research and market analysis the world clinical chemistry and immunodiagnostic market country segment forecast market share emerging technology competitive strategy growth opportunity,183,22,0,pharmacy,"['research', 'and', 'market', 'analysis', 'the', 'world', 'clinical', 'chemistry', 'and', 'im', '##mu', '##no', '##dia', '##gno', '##stic', 'market', 'country', 'segment', 'forecast', 'market', 'share', 'emerging', 'technology', 'competitive', 'strategy', 'growth', 'opportunity']",1
263817,nifty_806,2014-02-10,Research and Markets: Trends and Opportunities in the Diabetes Care Market,Rise,0.0109,74,research and market trend and opportunity the diabetes care market,66,10,0,pharmacy,"['research', 'and', 'market', 'trend', 'and', 'opportunity', 'the', 'diabetes', 'care', 'market']",1
263839,nifty_806,2014-02-10,Research and Markets: Central and Eastern Europe OTC Drugs Industry Outlook to 2017 - Expanding Access to Distribution Channels to Lead Sales Growth,Rise,0.0109,148,research and market central and eastern europe otc drug industry outlook expanding access distribution channel lead sale growth,127,18,0,pharmacy,"['research', 'and', 'market', 'central', 'and', 'eastern', 'euro', '##pe', 'o', '##t', '##c', 'drug', 'industry', 'outlook', 'expanding', 'access', 'distribution', 'channel', 'lead', 'sale', 'growth']",1
263853,nifty_806,2014-02-10,BioDelivery Sciences to Raise $60 Million in Registered Direct Offering From Institutional Investors,Rise,0.0109,100,biodelivery science raise million registered direct offering from institutional investor,88,10,0,pharmacy,"['bio', '##del', '##iver', '##y', 'science', 'raise', 'million', 'registered', 'direct', 'offering', 'from', 'institutional', 'investor']",1
263856,nifty_806,2014-02-10,"Techne Corporation Announces New Trade Name, Bio-Techne",Rise,0.0109,55,techne corporation announces new trade name bio techne,54,8,0,pharmacy,"['tech', '##ne', 'corporation', 'announces', 'new', 'trade', 'name', 'bio', 'tech', '##ne']",1
263905,nifty_806,2014-02-10,WallStAnalyst.com: Generic Drug Makers Focus on Expansion into Biosimilars; US Stocks Edge Higher With Positive Consumer News,Rise,0.0109,125,wallstanalyst com generic drug maker focus expansion into biosimilars stock edge higher with positive consumer news,115,16,0,pharmacy,"['walls', '##tana', '##ly', '##st', 'com', 'generic', 'drug', 'maker', 'focus', 'expansion', 'into', 'bio', '##si', '##mi', '##lars', 'stock', 'edge', 'higher', 'with', 'positive', 'consumer', 'news']",1
263946,nifty_806,2014-02-10,Research and Markets: Australasia Medical Device Market Reports,Rise,0.0109,63,research and market australasia medical device market report,60,8,0,pharmacy,"['research', 'and', 'market', 'au', '##stra', '##lasia', 'medical', 'device', 'market', 'report']",1
263959,nifty_806,2014-02-10,Research and Markets: Concise Analysis of the International Medical Device Connectivity Market - Forecasts to 2019,Rise,0.0109,114,research and market concise analysis the international medical device connectivity market forecast,98,12,0,pharmacy,"['research', 'and', 'market', 'con', '##cise', 'analysis', 'the', 'international', 'medical', 'device', 'connectivity', 'market', 'forecast']",1
263973,nifty_806,2014-02-10,"Strong Q4 Pharmaceutical & Life Sciences M&A; Momentum Expected to Continue into 2014, According to PwC",Rise,0.0109,103,strong pharmaceutical life science momentum expected continue into according pwc,80,10,0,pharmacy,"['strong', 'pharmaceutical', 'life', 'science', 'momentum', 'expected', 'continue', 'into', 'according', 'p', '##w', '##c']",1
264008,nifty_806,2014-02-10,Easton Pharmaceuticals Is in Receipt of Proposal to Increase Current Financing; Provides Other Initiative Updates,Rise,0.0109,113,easton pharmaceutical receipt proposal increase current financing provides other initiative update,98,11,0,pharmacy,"['east', '##on', 'pharmaceutical', 're', '##ceipt', 'proposal', 'increase', 'current', 'financing', 'provides', 'other', 'initiative', 'update']",1
264064,nifty_806,2014-02-10,Broadview Ventures Invests in Novel Stroke Drug Company Remedy Pharmaceuticals,Rise,0.0109,78,broadview venture invests novel stroke drug company remedy pharmaceutical,73,9,0,pharmacy,"['broad', '##view', 'venture', 'invest', '##s', 'novel', 'stroke', 'drug', 'company', 'remedy', 'pharmaceutical']",1
264139,nifty_806,2014-02-10,Research and Markets: The Global Gene Therapy Industry Has the Potential to Become a Multi-Million Dollar Industry by the End of 2017 Says Latest Offering,Rise,0.0109,154,research and market the global gene therapy industry ha the potential become multi million dollar industry the end say latest offering,134,21,0,pharmacy,"['research', 'and', 'market', 'the', 'global', 'gene', 'therapy', 'industry', 'ha', 'the', 'potential', 'become', 'multi', 'million', 'dollar', 'industry', 'the', 'end', 'say', 'latest', 'offering']",1
264199,nifty_806,2014-02-10,"Research and Markets: Molecular Diagnostics - Technologies, Markets and Companies - Updated 2014 Report",Rise,0.0109,103,research and market molecular diagnostics technology market and company updated report,86,11,0,pharmacy,"['research', 'and', 'market', 'molecular', 'diagnostic', '##s', 'technology', 'market', 'and', 'company', 'updated', 'report']",1
264250,nifty_806,2014-02-10,Research and Markets: PharmaPoint: Atopic Dermatitis - Germany Drug Forecast and Market Analysis to 2022,Rise,0.0109,104,research and market pharmapoint atopic dermatitis germany drug forecast and market analysis,91,12,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##point', 'atop', '##ic', 'der', '##mat', '##itis', 'g', '##erman', '##y', 'drug', 'forecast', 'and', 'market', 'analysis']",1
264291,nifty_806,2014-02-10,"Elite Pharmaceuticals, Inc. to Host Third Quarter Business Update Call on February 18, 2014",Rise,0.0109,91,elite pharmaceutical inc host third quarter business update call february,73,10,0,pharmacy,"['elite', 'pharmaceutical', 'in', '##c', 'host', 'third', 'quarter', 'business', 'update', 'call', 'f', '##eb', '##ru', '##ary']",1
264379,nifty_806,2014-02-10,Gilead Sciences to Present at Two Upcoming Investor Conferences,Rise,0.0109,63,gilead science present two upcoming investor conference,55,7,0,pharmacy,"['g', '##ile', '##ad', 'science', 'present', 'two', 'upcoming', 'investor', 'conference']",1
264415,nifty_806,2014-02-10,"Biocept, Inc. Announces Closing of Initial Public Offering",Rise,0.0109,58,biocept inc announces closing initial public offering,53,7,0,pharmacy,"['bio', '##ce', '##pt', 'in', '##c', 'announces', 'closing', 'initial', 'public', 'offering']",1
264482,nifty_806,2014-02-10,Qatar Pushes Diabetes Research,Rise,0.0109,30,qatar push diabetes research,28,4,0,pharmacy,"['q', '##ata', '##r', 'push', 'diabetes', 'research']",1
264483,nifty_806,2014-02-10,Drug Firms Look to Gulf Region as Next Frontier,Rise,0.0109,47,drug firm look gulf region next frontier,40,7,0,pharmacy,"['drug', 'firm', 'look', 'g', '##ulf', 'region', 'next', 'frontier']",1
264493,nifty_806,2014-02-10,FDA Scientist Lays Out Case on Naproxen,Rise,0.0109,39,fda scientist lay out case naproxen,35,6,0,pharmacy,"['f', '##da', 'scientist', 'lay', 'out', 'case', 'nap', '##ro', '##xen']",1
264580,nifty_807,2014-02-11,FDA to Review Clinical Trial Data for AstraZeneca Diabetes Drug,Neutral,0.0005,63,fda review clinical trial data for astrazeneca diabetes drug,60,9,0,pharmacy,"['f', '##da', 'review', 'clinical', 'trial', 'data', 'for', 'as', '##tra', '##zen', '##eca', 'diabetes', 'drug']",1
264601,nifty_807,2014-02-11,Mallinckrodt to Buy Cadence Pharmaceuticals,Neutral,0.0005,43,mallinckrodt buy cadence pharmaceutical,39,4,0,pharmacy,"['mall', '##in', '##ck', '##rod', '##t', 'buy', 'ca', '##dence', 'pharmaceutical']",1
264614,nifty_807,2014-02-11,Nestlé's Galderma Deal Highlights Health-Care Drive,Neutral,0.0005,51,nestlé galderma deal highlight health care drive,48,7,0,pharmacy,"['nest', '##lé', 'gal', '##der', '##ma', 'deal', 'highlight', 'health', 'care', 'drive']",1
264636,nifty_807,2014-02-11,Actelion Profit Lifted by Strong Drug Sales,Neutral,0.0005,43,actelion profit lifted strong drug sale,39,6,0,pharmacy,"['act', '##eli', '##on', 'profit', 'lifted', 'strong', 'drug', 'sale']",1
264728,nifty_808,2014-02-12,Research and Markets: Glucose Monitoring Device Market to 2019 - Technology Adoption and Increasing Health Awareness Serve as Distinct Regional Growth Drivers,Rise,0.0052,158,research and market glucose monitoring device market technology adoption and increasing health awareness serve distinct regional growth driver,142,18,0,pharmacy,"['research', 'and', 'market', 'glucose', 'monitoring', 'device', 'market', 'technology', 'adoption', 'and', 'increasing', 'health', 'awareness', 'serve', 'distinct', 'regional', 'growth', 'driver']",1
264729,nifty_808,2014-02-12,Research and Markets: Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need,Rise,0.0052,164,research and market gastrointestinal therapeutic asia pacific market strong potential for pipeline biologics account high regional unmet need,141,18,0,pharmacy,"['research', 'and', 'market', 'gas', '##tro', '##int', '##est', '##inal', 'therapeutic', 'as', '##ia', 'p', '##ac', '##ific', 'market', 'strong', 'potential', 'for', 'pipeline', 'bio', '##log', '##ics', 'account', 'high', 'regional', 'un', '##met', 'need']",1
264787,nifty_808,2014-02-12,Research and Markets: Systemic Psoriasis Therapeutics: Increased Disease Awareness and Promising Novel Drugs to Drive Market Growth by 2020,Rise,0.0052,139,research and market systemic psoriasis therapeutic increased disease awareness and promising novel drug drive market growth,123,16,0,pharmacy,"['research', 'and', 'market', 'systemic', 'ps', '##oria', '##sis', 'therapeutic', 'increased', 'disease', 'awareness', 'and', 'promising', 'novel', 'drug', 'drive', 'market', 'growth']",1
264804,nifty_808,2014-02-12,Research and Markets: Ranirestat (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022 Research Report,Rise,0.0052,129,research and market ranirestat microvascular complication diabetes forecast and market analysis research report,111,13,0,pharmacy,"['research', 'and', 'market', 'ran', '##ires', '##tat', 'micro', '##vas', '##cular', 'com', '##plication', 'diabetes', 'forecast', 'and', 'market', 'analysis', 'research', 'report']",1
264809,nifty_808,2014-02-12,"Research and Markets: Cardiovascular Inflammation - Pipeline Review, H2 2013 Research Report",Rise,0.0052,92,research and market cardiovascular inflammation pipeline review research report,79,9,0,pharmacy,"['research', 'and', 'market', 'card', '##iovascular', 'inflammation', 'pipeline', 'review', 'research', 'report']",1
264919,nifty_808,2014-02-12,"Precision Medicine, Big Data, Innovative Financing and Emerging Markets Are Focus of MIT Sloan BioInnovations Conference",Rise,0.0052,120,precision medicine big data innovative financing and emerging market are focus mit sloan bioinnovations conference,114,15,0,pharmacy,"['precision', 'medicine', 'big', 'data', 'innovative', 'financing', 'and', 'emerging', 'market', 'are', 'focus', 'mit', 's', '##lo', '##an', 'bio', '##inn', '##ova', '##tions', 'conference']",1
265003,nifty_808,2014-02-12,Research and Markets: Concise Analysis of the International Medical Automation Market - Forecasts to 2018,Rise,0.0052,105,research and market concise analysis the international medical automation market forecast,89,11,0,pharmacy,"['research', 'and', 'market', 'con', '##cise', 'analysis', 'the', 'international', 'medical', 'automation', 'market', 'forecast']",1
265113,nifty_808,2014-02-12,Research and Markets: Global Influence of Antibody Attributes on Clinical Success: Corporate & Technology Breakdown,Rise,0.0052,115,research and market global influence antibody attribute clinical success corporate technology breakdown,103,12,0,pharmacy,"['research', 'and', 'market', 'global', 'influence', 'anti', '##body', 'attribute', 'clinical', 'success', 'corporate', 'technology', 'breakdown']",1
265142,nifty_808,2014-02-12,Research and Markets: 2013-2014 Complete Induced Pluripotent Stem Cell (iPSC) Industry Report - Forecasts to 2018,Rise,0.0052,113,research and market complete induced pluripotent stem cell ipsc industry report forecast,88,12,0,pharmacy,"['research', 'and', 'market', 'complete', 'induced', 'p', '##lu', '##rip', '##ote', '##nt', 'stem', 'cell', 'i', '##ps', '##c', 'industry', 'report', 'forecast']",1
265159,nifty_808,2014-02-12,Research and Markets: Global Portable Medical Devices Market Forecasts & Opportunities to 2018,Rise,0.0052,94,research and market global portable medical device market forecast opportunity,78,10,0,pharmacy,"['research', 'and', 'market', 'global', 'portable', 'medical', 'device', 'market', 'forecast', 'opportunity']",1
265187,nifty_808,2014-02-12,Pharmaceutical Pricing Studies Increasingly Focused on Existing Competitors and Relevant Payers,Rise,0.0052,95,pharmaceutical pricing study increasingly focused existing competitor and relevant payer,88,10,0,pharmacy,"['pharmaceutical', 'pricing', 'study', 'increasingly', 'focused', 'existing', 'competitor', 'and', 'relevant', 'pay', '##er']",1
265218,nifty_808,2014-02-12,Health Savings Accounts Exceed $20 Billion in January,Rise,0.0052,53,health saving account exceed billion january,44,6,0,pharmacy,"['health', 'saving', 'account', 'exceed', 'billion', 'j', '##anu', '##ary']",1
265301,nifty_808,2014-02-12,"McGuireWoods, McGladrey present 11th Annual Healthcare and Life Sciences Private Equity and Finance Conference",Rise,0.0052,110,mcguirewoods mcgladrey present annual healthcare and life science private equity and finance conference,103,13,0,pharmacy,"['m', '##c', '##gu', '##ire', '##woods', 'm', '##c', '##g', '##lad', '##rey', 'present', 'annual', 'healthcare', 'and', 'life', 'science', 'private', 'equity', 'and', 'finance', 'conference']",1
265892,nifty_810,2014-02-18,Research and Markets: Avastin (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022 Research Report,Fall,-0.0066,126,research and market avastin microvascular complication diabetes forecast and market analysis research report,108,13,0,pharmacy,"['research', 'and', 'market', 'a', '##vas', '##tin', 'micro', '##vas', '##cular', 'com', '##plication', 'diabetes', 'forecast', 'and', 'market', 'analysis', 'research', 'report']",1
265952,nifty_810,2014-02-18,Research and Markets: PharmaPoint: Microvascular Complications of Diabetes - Spain Drug Forecast and Market Analysis to 2022,Fall,-0.0066,124,research and market pharmapoint microvascular complication diabetes spain drug forecast and market analysis,107,13,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##point', 'micro', '##vas', '##cular', 'com', '##plication', 'diabetes', 'spa', '##in', 'drug', 'forecast', 'and', 'market', 'analysis']",1
266094,nifty_810,2014-02-18,SurModics to Present at RBC Capital Markets Global Healthcare Conference,Fall,-0.0066,72,surmodics present rbc capital market global healthcare conference,65,8,0,pharmacy,"['sur', '##mo', '##dic', '##s', 'present', 'r', '##b', '##c', 'capital', 'market', 'global', 'healthcare', 'conference']",1
266318,nifty_810,2014-02-18,Cross Country Healthcare to Present at Barclays Global Healthcare Conference and Sidoti & Companyâs Eighteenth Annual Emerging Growth Institutional Investor Forum,Fall,-0.0066,164,cross country healthcare present barclays global healthcare conference and sidoti companyâ eighteenth annual emerging growth institutional investor forum,153,18,0,pharmacy,"['cross', 'country', 'healthcare', 'present', 'bar', '##c', '##lay', '##s', 'global', 'healthcare', 'conference', 'and', 'si', '##do', '##ti', 'company', '##â', 'eighteenth', 'annual', 'emerging', 'growth', 'institutional', 'investor', 'forum']",1
266333,nifty_810,2014-02-18,Research and Markets: 2014 Strategies for the US Therapeutic Drug Monitoring (TDM) Market,Fall,-0.0066,89,research and market strategy for the therapeutic drug monitoring tdm market,75,11,0,pharmacy,"['research', 'and', 'market', 'strategy', 'for', 'the', 'therapeutic', 'drug', 'monitoring', 't', '##d', '##m', 'market']",1
266335,nifty_810,2014-02-18,"MacAulay-Brown, Inc. CEO Shares Insights and Expertise at Health Care Innovation Washington D.C. Conference",Fall,-0.0066,107,macaulay brown inc ceo share insight and expertise health care innovation washington conference,95,13,0,pharmacy,"['mac', '##aul', '##ay', 'brown', 'in', '##c', 'c', '##eo', 'share', 'insight', 'and', 'expertise', 'health', 'care', 'innovation', 'washing', '##ton', 'conference']",1
266356,nifty_810,2014-02-18,Research and Markets: 2014 Strategies for the US Nucleic Acid Testing Market,Fall,-0.0066,76,research and market strategy for the nucleic acid testing market,64,10,0,pharmacy,"['research', 'and', 'market', 'strategy', 'for', 'the', 'nuclei', '##c', 'acid', 'testing', 'market']",1
266440,nifty_810,2014-02-18,Array BioPharma To Present At The RBC Capital Markets Global Healthcare And Cowen Annual Healthcare Conferences,Fall,-0.0066,111,array biopharma present the rbc capital market global healthcare and cowen annual healthcare conference,103,14,0,pharmacy,"['array', 'bio', '##pha', '##rma', 'present', 'the', 'r', '##b', '##c', 'capital', 'market', 'global', 'healthcare', 'and', 'cow', '##en', 'annual', 'healthcare', 'conference']",1
266452,nifty_810,2014-02-18,"Medicaid Expansion, Medicare Reimbursement And The Next Level Of Healthcare Information Technology: U.S. Managed Markets Continue Titanic Shifts In 2014",Fall,-0.0066,152,medicaid expansion medicare reimbursement and the next level healthcare information technology managed market continue titanic shift,132,16,0,pharmacy,"['me', '##dic', '##aid', 'expansion', 'me', '##dic', '##are', 're', '##im', '##bur', '##se', '##ment', 'and', 'the', 'next', 'level', 'healthcare', 'information', 'technology', 'managed', 'market', 'continue', 't', '##ita', '##nic', 'shift']",1
266455,nifty_810,2014-02-18,XenoPort to Present at the RBC Capital Marketsâ Global Healthcare Conference,Fall,-0.0066,78,xenoport present the rbc capital marketsâ global healthcare conference,70,9,0,pharmacy,"['x', '##eno', '##port', 'present', 'the', 'r', '##b', '##c', 'capital', 'markets', '##â', 'global', 'healthcare', 'conference']",1
266488,nifty_810,2014-02-18,Research and Markets: Global Self-Care Medical Devices Market Report 2013 - Forecasts to 2019,Fall,-0.0066,93,research and market global self care medical device market report forecast,74,11,0,pharmacy,"['research', 'and', 'market', 'global', 'self', 'care', 'medical', 'device', 'market', 'report', 'forecast']",1
266603,nifty_810,2014-02-18,NPS Pharmaceuticals Reports Fourth Quarter and Full-Year 2013 Financial Results and Financial Outlook for 2014,Fall,-0.0066,110,np pharmaceutical report fourth quarter and full year financial result and financial outlook for,96,14,0,pharmacy,"['n', '##p', 'pharmaceutical', 'report', 'fourth', 'quarter', 'and', 'full', 'year', 'financial', 'result', 'and', 'financial', 'outlook', 'for']",1
266623,nifty_810,2014-02-18,CryoLife to Present at 2014 RBC Capital Markets' Global Healthcare Conference,Fall,-0.0066,77,cryolife present rbc capital market global healthcare conference,64,8,0,pharmacy,"['cry', '##oli', '##fe', 'present', 'r', '##b', '##c', 'capital', 'market', 'global', 'healthcare', 'conference']",1
266767,nifty_810,2014-02-18,Chelsea Therapeutics' Northera Receives Accelerated FDA Approval,Fall,-0.0066,64,chelsea therapeutic northera receives accelerated fda approval,62,7,0,pharmacy,"['ch', '##els', '##ea', 'therapeutic', 'north', '##era', 'receives', 'accelerated', 'f', '##da', 'approval']",1
266793,nifty_810,2014-02-18,Novo Nordisk Targets Mexico for Anti-Obesity Drug,Fall,-0.0066,49,novo nordisk target mexico for anti obesity drug,48,8,0,pharmacy,"['no', '##vo', 'nor', '##dis', '##k', 'target', 'me', '##xi', '##co', 'for', 'anti', 'o', '##besity', 'drug']",1
266824,nifty_810,2014-02-18,FDA Strengthens Regulatory Presence in India,Fall,-0.0066,44,fda strengthens regulatory presence india,41,5,0,pharmacy,"['f', '##da', 'strengthen', '##s', 'regulatory', 'presence', 'in', '##dia']",1
266947,nifty_812,2014-02-20,BB Biotech's investment success continues - profit of CHF 931.8 mn for 2013,Neutral,-0.0011,75,biotech investment success continues profit chf for,51,7,0,pharmacy,"['bio', '##tech', 'investment', 'success', 'continues', 'profit', 'ch', '##f', 'for']",1
267124,nifty_812,2014-02-20,Research and Markets: Research and Development Trends of China Healthcare Informatization,Neutral,-0.0011,89,research and market research and development trend china healthcare informatization,83,10,0,pharmacy,"['research', 'and', 'market', 'research', 'and', 'development', 'trend', 'chin', '##a', 'healthcare', 'inform', '##ati', '##zation']",1
267125,nifty_812,2014-02-20,"Research and Markets: China Pharmaceutical Equipment Industry Report, 2013-2016",Neutral,-0.0011,79,research and market china pharmaceutical equipment industry report,66,8,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'pharmaceutical', 'equipment', 'industry', 'report']",1
267164,nifty_812,2014-02-20,Threshold Pharmaceuticals Announces Presentations and Webcasts at Three Upcoming Investor Conferences,Neutral,-0.0011,101,threshold pharmaceutical announces presentation and webcasts three upcoming investor conference,95,10,0,pharmacy,"['threshold', 'pharmaceutical', 'announces', 'presentation', 'and', 'web', '##cast', '##s', 'three', 'upcoming', 'investor', 'conference']",1
267170,nifty_812,2014-02-20,Conatus Pharmaceuticals to Participate in Upcoming Investor Events,Neutral,-0.0011,66,conatus pharmaceutical participate upcoming investor event,58,6,0,pharmacy,"['con', '##atus', 'pharmaceutical', 'participate', 'upcoming', 'investor', 'event']",1
267187,nifty_812,2014-02-20,"Research and Markets: Electronic Medical Records Market to Grow Significantly by 2017, Allowing Greater Profitability and Efficiency in the Healthcare Industry",Neutral,-0.0011,159,research and market electronic medical record market grow significantly allowing greater profitability and efficiency the healthcare industry,141,17,0,pharmacy,"['research', 'and', 'market', 'electronic', 'medical', 'record', 'market', 'grow', 'significantly', 'allowing', 'greater', 'profit', '##ability', 'and', 'efficiency', 'the', 'healthcare', 'industry']",1
267192,nifty_812,2014-02-20,BioCryst to Present at Three Upcoming Investor Conferences,Neutral,-0.0011,58,biocryst present three upcoming investor conference,51,6,0,pharmacy,"['bio', '##c', '##ry', '##st', 'present', 'three', 'upcoming', 'investor', 'conference']",1
267219,nifty_812,2014-02-20,"Arena Pharmaceuticals to Provide Corporate Update and Report Financial Results on Thursday, February 27",Neutral,-0.0011,103,arena pharmaceutical provide corporate update and report financial result thursday february,91,11,0,pharmacy,"['arena', 'pharmaceutical', 'provide', 'corporate', 'update', 'and', 'report', 'financial', 'result', 'th', '##urs', '##day', 'f', '##eb', '##ru', '##ary']",1
267261,nifty_812,2014-02-20,Medgenics Reports 2013 Financial Results,Neutral,-0.0011,40,medgenics report financial result,33,4,0,pharmacy,"['me', '##dge', '##nics', 'report', 'financial', 'result']",1
267293,nifty_812,2014-02-20,"Research and Markets: Muckle-Wells Syndrome Global Clinical Trials Review, H1, 2014 Research Report",Neutral,-0.0011,99,research and market muckle well syndrome global clinical trial review research report,85,12,0,pharmacy,"['research', 'and', 'market', 'm', '##uckle', 'well', 'syndrome', 'global', 'clinical', 'trial', 'review', 'research', 'report']",1
267297,nifty_812,2014-02-20,Conversa Health Announces Digital Care Pilot With GreenField Health,Neutral,-0.0011,67,conversa health announces digital care pilot with greenfield health,67,9,0,pharmacy,"['con', '##vers', '##a', 'health', 'announces', 'digital', 'care', 'pilot', 'with', 'green', '##field', 'health']",1
267307,nifty_812,2014-02-20,Announcing MedTech Idol 2014 at Investment In Innovation (IN3) Medical Device 360 Dublin,Neutral,-0.0011,88,announcing medtech idol investment innovation medical device dublin,67,8,0,pharmacy,"['announcing', 'me', '##dt', '##ech', 'idol', 'investment', 'innovation', 'medical', 'device', 'dub', '##lin']",1
267338,nifty_812,2014-02-20,"Alliance Life Sciences Participates as Event Sponsor at 8th Annual Pharma Pricing and Market Access Outlook World Europe Conference, Explores Market Access Transformation",Neutral,-0.0011,170,alliance life science participates event sponsor annual pharma pricing and market access outlook world europe conference explores market access transformation,158,20,0,pharmacy,"['alliance', 'life', 'science', 'participates', 'event', 'sponsor', 'annual', 'p', '##har', '##ma', 'pricing', 'and', 'market', 'access', 'outlook', 'world', 'euro', '##pe', 'conference', 'explores', 'market', 'access', 'transformation']",1
267358,nifty_812,2014-02-20,"The Zacks Analyst Blog Highlights: Regeneron, Gilead, Medicines Co., AbbVie and Cadence",Neutral,-0.0011,87,the zacks analyst blog highlight regeneron gilead medicine abbvie and cadence,77,11,0,pharmacy,"['the', 'z', '##ack', '##s', 'analyst', 'blog', 'highlight', 're', '##gene', '##ron', 'g', '##ile', '##ad', 'medicine', 'a', '##bb', '##vie', 'and', 'ca', '##dence']",1
267494,nifty_812,2014-02-20,Qualtrics Reveals Plans to Launch Qualtrics Innovation Exchange,Neutral,-0.0011,63,qualtrics reveals plan launch qualtrics innovation exchange,59,7,0,pharmacy,"['q', '##ual', '##tric', '##s', 'reveals', 'plan', 'launch', 'q', '##ual', '##tric', '##s', 'innovation', 'exchange']",1
267706,nifty_812,2014-02-20,Alexza Pharmaceuticals' Corporate Presentation to be Webcast from Two Upcoming March Investor Conferences,Neutral,-0.0011,105,alexza pharmaceutical corporate presentation webcast from two upcoming march investor conference,96,11,0,pharmacy,"['ale', '##x', '##za', 'pharmaceutical', 'corporate', 'presentation', 'web', '##cast', 'from', 'two', 'upcoming', 'march', 'investor', 'conference']",1
267714,nifty_812,2014-02-20,Webcast Advisory: Tekmira to Present at the 2014 RBC Capital Markets' Global Healthcare Conference,Neutral,-0.0011,98,webcast advisory tekmira present the rbc capital market global healthcare conference,84,11,0,pharmacy,"['web', '##cast', 'advisory', 'te', '##k', '##mir', '##a', 'present', 'the', 'r', '##b', '##c', 'capital', 'market', 'global', 'healthcare', 'conference']",1
267993,nifty_813,2014-02-24,P&G Seeks to Sell Health-Care Operator,Neutral,-0.0004,38,seek sell health care operator,30,5,0,pharmacy,"['seek', 'sell', 'health', 'care', 'operator']",1
267998,nifty_813,2014-02-24,When a Doctor Eyes Selling the Practice,Neutral,-0.0004,39,when doctor eye selling the practice,36,6,0,pharmacy,"['when', 'doctor', 'eye', 'selling', 'the', 'practice']",1
268131,nifty_814,2014-02-25,Research and Markets: PharmaPoint: Microvascular Complications of Diabetes - UK Drug Forecast and Market Analysis to 2022,Neutral,0.0001,121,research and market pharmapoint microvascular complication diabetes drug forecast and market analysis,101,12,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##point', 'micro', '##vas', '##cular', 'com', '##plication', 'diabetes', 'drug', 'forecast', 'and', 'market', 'analysis']",1
268141,nifty_814,2014-02-25,Research and Markets: PharmaPoint: Microvascular Complications of Diabetes - Italy Drug Forecast and Market Analysis to 2022,Neutral,0.0001,124,research and market pharmapoint microvascular complication diabetes italy drug forecast and market analysis,107,13,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##point', 'micro', '##vas', '##cular', 'com', '##plication', 'diabetes', 'it', '##aly', 'drug', 'forecast', 'and', 'market', 'analysis']",1
268200,nifty_814,2014-02-25,Media Advisory - Oncolytics BiotechÂ® Inc. to Participate in 2014 RBC Capital Markets Global Healthcare Conference,Neutral,0.0001,114,medium advisory oncolytics biotechâ inc participate rbc capital market global healthcare conference,99,12,0,pharmacy,"['medium', 'advisory', 'on', '##co', '##ly', '##tics', 'bio', '##tech', '##â', 'in', '##c', 'participate', 'r', '##b', '##c', 'capital', 'market', 'global', 'healthcare', 'conference']",1
268207,nifty_814,2014-02-25,Research and Markets: Global Medical Imaging Market Report - 2013 Edition,Neutral,0.0001,73,research and market global medical imaging market report edition,64,9,0,pharmacy,"['research', 'and', 'market', 'global', 'medical', 'imaging', 'market', 'report', 'edition']",1
268240,nifty_814,2014-02-25,Health Catalyst Congratulates North Memorial Health Care on Earning a Healthcare Informatics Innovation Award,Neutral,0.0001,109,health catalyst congratulates north memorial health care earning healthcare informatics innovation award,104,12,0,pharmacy,"['health', 'catalyst', 'con', '##gra', '##tu', '##lates', 'north', 'memorial', 'health', 'care', 'earning', 'healthcare', 'inform', '##atic', '##s', 'innovation', 'award']",1
268273,nifty_814,2014-02-25,ADP AdvancedMD Announces General Availability of AdvancedInsight to Deliver Business Intelligence to Private Practices and Optimize Their Financial Health,Neutral,0.0001,154,adp advancedmd announces general availability advancedinsight deliver business intelligence private practice and optimize their financial health,144,16,0,pharmacy,"['ad', '##p', 'advanced', '##m', '##d', 'announces', 'general', 'availability', 'advanced', '##ins', '##ight', 'deliver', 'business', 'intelligence', 'private', 'practice', 'and', 'op', '##ti', '##mize', 'their', 'financial', 'health']",1
268278,nifty_814,2014-02-25,BD to Present at Investor Healthcare Conferences,Neutral,0.0001,48,present investor healthcare conference,38,4,0,pharmacy,"['present', 'investor', 'healthcare', 'conference']",1
268424,nifty_814,2014-02-25,Future of Plandai Biotechnology's Products in Good Hands With Former Microsoft Executive Heading Up Global Marketing,Neutral,0.0001,116,future plandai biotechnology product good hand with former microsoft executive heading global marketing,103,13,0,pharmacy,"['future', 'plan', '##dai', 'bio', '##tech', '##nology', 'product', 'good', 'hand', 'with', 'former', 'micro', '##so', '##ft', 'executive', 'heading', 'global', 'marketing']",1
268434,nifty_814,2014-02-25,Precyse/Jvion ICD-10 Assured Program Puts Healthcare Organizations on Path to Success Beyond ICD-10 Transition,Neutral,0.0001,110,precyse jvion icd assured program put healthcare organization path success beyond icd transition,96,13,0,pharmacy,"['pre', '##cy', '##se', 'j', '##vio', '##n', 'i', '##c', '##d', 'assured', 'program', 'put', 'healthcare', 'organization', 'path', 'success', 'beyond', 'i', '##c', '##d', 'transition']",1
268494,nifty_814,2014-02-25,Merit Medical to Present at Raymond James Institutional Investors Conference,Neutral,0.0001,76,merit medical present raymond james institutional investor conference,69,8,0,pharmacy,"['merit', 'medical', 'present', 'ray', '##mond', 'jam', '##es', 'institutional', 'investor', 'conference']",1
268541,nifty_814,2014-02-25,Medtech Companies Look to Rebound in 2014,Neutral,0.0001,41,medtech company look rebound,28,4,0,pharmacy,"['me', '##dt', '##ech', 'company', 'look', 're', '##bound']",1
268543,nifty_814,2014-02-25,"Brazil, Russia, India and China Markets for Gynecological Devices Will Nearly Double by 2022",Neutral,0.0001,92,brazil russia india and china market for gynecological device will nearly double,80,12,0,pharmacy,"['bra', '##zi', '##l', 'r', '##uss', '##ia', 'in', '##dia', 'and', 'chin', '##a', 'market', 'for', 'g', '##yne', '##cological', 'device', 'will', 'nearly', 'double']",1
268608,nifty_814,2014-02-25,Final High Tide for Healthcare IT Startups Receive Funding From Tallwave Capital at Culmination of Program; Present to Additional Investors,Neutral,0.0001,139,final high tide for healthcare startup receive funding from tallwave capital culmination program present additional investor,124,16,0,pharmacy,"['final', 'high', 'tide', 'for', 'healthcare', 'start', '##up', 'receive', 'funding', 'from', 'tall', '##wave', 'capital', 'cu', '##lm', '##ination', 'program', 'present', 'additional', 'investor']",1
268624,nifty_814,2014-02-25,"INSERTING and REPLACING D&B; to Announce the U.S. Economic Health Tracker Results for February on March 4, 2014",Neutral,0.0001,111,inserting and replacing announce the economic health tracker result for february march,86,12,0,pharmacy,"['insert', '##ing', 'and', 'replacing', 'announce', 'the', 'economic', 'health', 'track', '##er', 'result', 'for', 'f', '##eb', '##ru', '##ary', 'march']",1
268685,nifty_814,2014-02-25,Research and Markets: Concise Analysis of the International and Chinese Medical MRI Equipment Industry,Neutral,0.0001,102,research and market concise analysis the international and chinese medical mri equipment industry,97,13,0,pharmacy,"['research', 'and', 'market', 'con', '##cise', 'analysis', 'the', 'international', 'and', 'chin', '##ese', 'medical', 'm', '##ri', 'equipment', 'industry']",1
268714,nifty_814,2014-02-25,Research and Markets: Concise Analysis of the International and Chinese Medical Flat Panel Detector Industry,Neutral,0.0001,108,research and market concise analysis the international and chinese medical flat panel detector industry,103,14,0,pharmacy,"['research', 'and', 'market', 'con', '##cise', 'analysis', 'the', 'international', 'and', 'chin', '##ese', 'medical', 'flat', 'panel', 'detector', 'industry']",1
268745,nifty_814,2014-02-25,Research and Markets: Global Peptide Therapeutics Market & Pipeline Insights to 2018,Neutral,0.0001,84,research and market global peptide therapeutic market pipeline insight,70,9,0,pharmacy,"['research', 'and', 'market', 'global', 'p', '##eptide', 'therapeutic', 'market', 'pipeline', 'insight']",1
268769,nifty_814,2014-02-25,Research and Markets: pharmahandbook: Three Report Special Offer - BRIC/Asia Pacific/United States,Neutral,0.0001,98,research and market pharmahandbook three report special offer bric asia pacific united state,92,13,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##mah', '##and', '##book', 'three', 'report', 'special', 'offer', 'br', '##ic', 'as', '##ia', 'p', '##ac', '##ific', 'united', 'state']",1
268775,nifty_814,2014-02-25,Research and Markets: PharmaSphere: Pharmaceutical and Healthcare Deal Trends in Latin America: 2008 - 2012,Neutral,0.0001,107,research and market pharmasphere pharmaceutical and healthcare deal trend latin america,87,11,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##mas', '##phere', 'pharmaceutical', 'and', 'healthcare', 'deal', 'trend', 'la', '##tin', 'am', '##eric', '##a']",1
268816,nifty_814,2014-02-25,Research and Markets: The Global EPO Biosimilars Market to Grow at a CAGR of Around 37% During 2013-2018,Neutral,0.0001,104,research and market the global epo biosimilars market grow cagr around during,77,12,0,pharmacy,"['research', 'and', 'market', 'the', 'global', 'e', '##po', 'bio', '##si', '##mi', '##lars', 'market', 'grow', 'ca', '##g', '##r', 'around', 'during']",1
268918,nifty_814,2014-02-25,"Gilead Sciences to Present at the RBC Capital Markets 2014 Global Healthcare Conference on Wednesday, February 26",Neutral,0.0001,113,gilead science present the rbc capital market global healthcare conference wednesday february,93,12,0,pharmacy,"['g', '##ile', '##ad', 'science', 'present', 'the', 'r', '##b', '##c', 'capital', 'market', 'global', 'healthcare', 'conference', 'wed', '##nes', '##day', 'f', '##eb', '##ru', '##ary']",1
268967,nifty_814,2014-02-25,"NABP Moves .Pharmacy Program Closer to Launch, Enters Contracting Phase With ICANN",Neutral,0.0001,82,nabp move pharmacy program closer launch enters contracting phase with icann,76,11,0,pharmacy,"['na', '##b', '##p', 'move', 'pharmacy', 'program', 'closer', 'launch', 'enters', 'contracting', 'phase', 'with', 'i', '##can', '##n']",1
269102,nifty_814,2014-02-25,FDA Approves Myalept for Leptin Deficiency Treatment,Neutral,0.0001,52,fda approves myalept for leptin deficiency treatment,52,7,0,pharmacy,"['f', '##da', 'approve', '##s', 'my', '##ale', '##pt', 'for', 'le', '##pt', '##in', 'deficiency', 'treatment']",1
269104,nifty_814,2014-02-25,InterMune Says Lung Disease Drug Succeeds in Late-Stage Study,Neutral,0.0001,61,intermune say lung disease drug succeeds late stage study,57,9,0,pharmacy,"['inter', '##mu', '##ne', 'say', 'lung', 'disease', 'drug', 'succeeds', 'late', 'stage', 'study']",1
269118,nifty_814,2014-02-25,Lilly Diabetes Drug Comparable to Market Leader,Neutral,0.0001,47,lilly diabetes drug comparable market leader,44,6,0,pharmacy,"['l', '##ill', '##y', 'diabetes', 'drug', 'comparable', 'market', 'leader']",1
269187,nifty_815,2014-02-26,Global Pharma Congress is Coming in May in Shanghai,Rise,0.0052,51,global pharma congress coming may shanghai,42,6,0,pharmacy,"['global', 'p', '##har', '##ma', 'congress', 'coming', 'may', 's', '##hang', '##hai']",1
269256,nifty_815,2014-02-26,Research and Markets: Pharmaceutical Deals and Alliances of 2013 - Research Report,Rise,0.0052,82,research and market pharmaceutical deal and alliance research report,68,9,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'deal', 'and', 'alliance', 'research', 'report']",1
269300,nifty_815,2014-02-26,Research and Markets: Lucentis (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022,Rise,0.0052,111,research and market lucentis microvascular complication diabetes forecast and market analysis,93,11,0,pharmacy,"['research', 'and', 'market', 'l', '##uce', '##nti', '##s', 'micro', '##vas', '##cular', 'com', '##plication', 'diabetes', 'forecast', 'and', 'market', 'analysis']",1
269382,nifty_815,2014-02-26,Foundation Medicine to Present at Upcoming Investor Conferences,Rise,0.0052,63,foundation medicine present upcoming investor conference,56,6,0,pharmacy,"['foundation', 'medicine', 'present', 'upcoming', 'investor', 'conference']",1
269401,nifty_815,2014-02-26,Research and Markets: Medical Electronics Industry in India Research Report,Rise,0.0052,75,research and market medical electronics industry india research report,70,9,0,pharmacy,"['research', 'and', 'market', 'medical', 'electronics', 'industry', 'in', '##dia', 'research', 'report']",1
269489,nifty_815,2014-02-26,Colliers International Reports On Trends Driving Resurgence In Medical Office Investment,Rise,0.0052,88,collier international report trend driving resurgence medical office investment,79,9,0,pharmacy,"['co', '##llie', '##r', 'international', 'report', 'trend', 'driving', 're', '##su', '##rgen', '##ce', 'medical', 'office', 'investment']",1
269553,nifty_815,2014-02-26,"Hero Network, Inc. and DC&R; Unite Forces to Raise Money for Coaches vs. Cancer Through DC&R;'s 'Sixth Man Challenge'",Rise,0.0052,117,hero network inc and unite force raise money for coach cancer through sixth man challenge,89,15,0,pharmacy,"['hero', 'network', 'in', '##c', 'and', 'unite', 'force', 'raise', 'money', 'for', 'coach', 'cancer', 'through', 'sixth', 'man', 'challenge']",1
269567,nifty_815,2014-02-26,"eHealth, Inc. to Present at Upcoming Investor Conferences",Rise,0.0052,57,ehealth inc present upcoming investor conference,48,6,0,pharmacy,"['eh', '##eal', '##th', 'in', '##c', 'present', 'upcoming', 'investor', 'conference']",1
269573,nifty_815,2014-02-26,Arch Therapeutics to Present at The Wall Street Analyst Forum Institutional Investor Conference,Rise,0.0052,95,arch therapeutic present the wall street analyst forum institutional investor conference,88,11,0,pharmacy,"['arch', 'therapeutic', 'present', 'the', 'wall', 'street', 'analyst', 'forum', 'institutional', 'investor', 'conference']",1
269632,nifty_815,2014-02-26,Research and Markets: PharmaPoint: Microvascular Complications of Diabetes - Germany Drug Forecast and Market Analysis to 2022,Rise,0.0052,126,research and market pharmapoint microvascular complication diabetes germany drug forecast and market analysis,109,13,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##point', 'micro', '##vas', '##cular', 'com', '##plication', 'diabetes', 'g', '##erman', '##y', 'drug', 'forecast', 'and', 'market', 'analysis']",1
269649,nifty_815,2014-02-26,The Molecular Diagnostics Market: An In-Depth Analysis of the Main Global Markets With Over 50 Company Profiles Included,Rise,0.0052,120,the molecular diagnostics market depth analysis the main global market with over company profile included,105,15,0,pharmacy,"['the', 'molecular', 'diagnostic', '##s', 'market', 'depth', 'analysis', 'the', 'main', 'global', 'market', 'with', 'over', 'company', 'profile', 'included']",1
269662,nifty_815,2014-02-26,"Companion Diagnostics Report: Market Size, Segmentation, Growth, Competition and Trends",Rise,0.0052,87,companion diagnostics report market size segmentation growth competition and trend,82,10,0,pharmacy,"['companion', 'diagnostic', '##s', 'report', 'market', 'size', 'segment', '##ation', 'growth', 'competition', 'and', 'trend']",1
269676,nifty_815,2014-02-26,Research and Markets: Concise Analysis of International Biochips Market,Rise,0.0052,71,research and market concise analysis international biochip market,65,8,0,pharmacy,"['research', 'and', 'market', 'con', '##cise', 'analysis', 'international', 'bio', '##chi', '##p', 'market']",1
269701,nifty_815,2014-02-26,Research and Markets: Global Biosimilar Market Outlook 2018 Report Discusses Major Trends and Drivers in Detail,Rise,0.0052,111,research and market global biosimilar market outlook report discusses major trend and driver detail,99,14,0,pharmacy,"['research', 'and', 'market', 'global', 'bio', '##si', '##mi', '##lar', 'market', 'outlook', 'report', 'discusses', 'major', 'trend', 'and', 'driver', 'detail']",1
269714,nifty_815,2014-02-26,"Health Insurance Innovations, Inc. to Present at the Raymond James & Associates 35th Annual Institutional Investors Conference",Rise,0.0052,126,health insurance innovation inc present the raymond james associate annual institutional investor conference,108,13,0,pharmacy,"['health', 'insurance', 'innovation', 'in', '##c', 'present', 'the', 'ray', '##mond', 'jam', '##es', 'associate', 'annual', 'institutional', 'investor', 'conference']",1
269730,nifty_815,2014-02-26,Research and Markets: Global Thermal Imaging Market to 2018,Rise,0.0052,59,research and market global thermal imaging market,49,7,0,pharmacy,"['research', 'and', 'market', 'global', 'thermal', 'imaging', 'market']",1
269860,nifty_815,2014-02-26,Research and Markets: The European Injectable Drug Delivery Technologies Expected to Reach $12.4 Billion by 2017 at a CAGR of 12.7% from 2012 To 2017,Rise,0.0052,149,research and market the european injectable drug delivery technology expected reach billion cagr from,101,14,0,pharmacy,"['research', 'and', 'market', 'the', 'euro', '##pe', '##an', 'in', '##ject', '##able', 'drug', 'delivery', 'technology', 'expected', 'reach', 'billion', 'ca', '##g', '##r', 'from']",1
269884,nifty_815,2014-02-26,Research and Markets: The Next Generation Sequencing (NGS) Market is Poised to Reach $2.7 Billion by 2017,Rise,0.0052,105,research and market the next generation sequencing ng market poised reach billion,81,12,0,pharmacy,"['research', 'and', 'market', 'the', 'next', 'generation', 'se', '##quencing', 'ng', 'market', 'poised', 'reach', 'billion']",1
269927,nifty_815,2014-02-26,Research and Markets: Global Hospital Information Systems (HIS) Market 2014-2018: 4 Key Vendors Covered,Rise,0.0052,103,research and market global hospital information system his market key vendor covered,84,12,0,pharmacy,"['research', 'and', 'market', 'global', 'hospital', 'information', 'system', 'his', 'market', 'key', 'vendor', 'covered']",1
269969,nifty_815,2014-02-26,NPS Pharmaceuticals to Present at Barclays Global Healthcare Conference,Rise,0.0052,71,np pharmaceutical present barclays global healthcare conference,63,7,0,pharmacy,"['n', '##p', 'pharmaceutical', 'present', 'bar', '##c', '##lay', '##s', 'global', 'healthcare', 'conference']",1
270001,nifty_815,2014-02-26,"Research and Markets: North America Weight Loss/Obesity Management Market - Forecasts to 2017: Featuring Players such as Atkins Nutritionals, Inc and Johnson & Johnson",Rise,0.0052,167,research and market north america weight loss obesity management market forecast featuring player such atkins nutritionals inc and johnson johnson,146,20,0,pharmacy,"['research', 'and', 'market', 'north', 'am', '##eric', '##a', 'weight', 'loss', 'o', '##besity', 'management', 'market', 'forecast', 'featuring', 'player', 'such', 'at', '##kins', 'nutrition', '##als', 'in', '##c', 'and', 'j', '##oh', '##nson', 'j', '##oh', '##nson']",1
270004,nifty_815,2014-02-26,"Research and Markets: Global Endocrine Testing Market to 2019: E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests",Rise,0.0052,155,research and market global endocrine testing market fsh hcg dheas progesterone testosterone tsh prolactin cortisol insulin test,127,17,0,pharmacy,"['research', 'and', 'market', 'global', 'end', '##oc', '##rine', 'testing', 'market', 'f', '##sh', 'h', '##c', '##g', 'd', '##hea', '##s', 'pro', '##ges', '##tero', '##ne', 'test', '##osterone', 't', '##sh', 'pro', '##la', '##ct', '##in', 'co', '##rt', '##is', '##ol', 'insulin', 'test']",1
270030,nifty_815,2014-02-26,Research and Markets: Medical Gases and Equipment Market Report by Gases & Equipment - Forecasts to 2018,Rise,0.0052,104,research and market medical gas and equipment market report gas equipment forecast,82,12,0,pharmacy,"['research', 'and', 'market', 'medical', 'gas', 'and', 'equipment', 'market', 'report', 'gas', 'equipment', 'forecast']",1
270044,nifty_815,2014-02-26,Prima BioMed to Present at 24th Annual Wall Street Analyst Forum Institutional Investor Conference,Rise,0.0052,98,prima biomed present annual wall street analyst forum institutional investor conference,87,11,0,pharmacy,"['p', '##rima', 'bio', '##med', 'present', 'annual', 'wall', 'street', 'analyst', 'forum', 'institutional', 'investor', 'conference']",1
270060,nifty_815,2014-02-26,Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March,Rise,0.0052,81,jazz pharmaceutical announces participation two investor conference march,73,8,0,pharmacy,"['jazz', 'pharmaceutical', 'announces', 'participation', 'two', 'investor', 'conference', 'march']",1
270070,nifty_815,2014-02-26,"Research and Markets: Global Insulin Pumps Market 2014-2018: Animas, F. Hoffmann La Roche, Insulet & Medtronic Dominate the Industry",Rise,0.0052,132,research and market global insulin pump market anima hoffmann roche insulet medtronic dominate the industry,107,15,0,pharmacy,"['research', 'and', 'market', 'global', 'insulin', 'pump', 'market', 'an', '##ima', 'ho', '##ff', '##mann', 'r', '##och', '##e', 'ins', '##ulet', 'me', '##dt', '##ronic', 'dominate', 'the', 'industry']",1
270088,nifty_815,2014-02-26,Research and Markets: North American Radiopharmaceuticals Market is Poised to Reach $2.7 Billion By 2017 at a CAGR of 7.2%,Rise,0.0052,122,research and market north american radiopharmaceutical market poised reach billion cagr,87,11,0,pharmacy,"['research', 'and', 'market', 'north', 'am', '##eric', '##an', 'radio', '##pha', '##rma', '##ce', '##utical', 'market', 'poised', 'reach', 'billion', 'ca', '##g', '##r']",1
270114,nifty_815,2014-02-26,Research and Markets: China Medical Device Regulatory Update 2014 for the $13 Billion Industry,Rise,0.0052,94,research and market china medical device regulatory update for the billion industry,83,12,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'medical', 'device', 'regulatory', 'update', 'for', 'the', 'billion', 'industry']",1
270558,nifty_819,2014-03-05,Eli Lilly Says Drug Application Rejected on Facility Issues,Neutral,0.0023,59,eli lilly say drug application rejected facility issue,54,8,0,pharmacy,"['el', '##i', 'l', '##ill', '##y', 'say', 'drug', 'application', 'rejected', 'facility', 'issue']",1
270618,nifty_820,2014-03-06,Pharming Reports On Preliminary Financial Results 2013,Neutral,0.0004,54,pharming report preliminary financial result,44,5,0,pharmacy,"['p', '##har', '##ming', 'report', 'preliminary', 'financial', 'result']",1
270759,nifty_820,2014-03-06,US fears for patents on next-generation drugs in India,Neutral,0.0004,54,fear for patent next generation drug india,42,7,0,pharmacy,"['fear', 'for', 'patent', 'next', 'generation', 'drug', 'in', '##dia']",1
270760,nifty_820,2014-03-06,U.S. fears for patents on next-generation drugs in India,Neutral,0.0004,56,fear for patent next generation drug india,42,7,0,pharmacy,"['fear', 'for', 'patent', 'next', 'generation', 'drug', 'in', '##dia']",1
270764,nifty_820,2014-03-06,"Research and Markets: Continuous Glucose Monitoring Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019",Neutral,0.0004,140,research and market continuous glucose monitoring market global industry analysis size share growth trend and forecast,118,16,0,pharmacy,"['research', 'and', 'market', 'continuous', 'glucose', 'monitoring', 'market', 'global', 'industry', 'analysis', 'size', 'share', 'growth', 'trend', 'and', 'forecast']",1
270773,nifty_820,2014-03-06,"Adara Global Announces Liz Coddington as CFO, Melissa Stein as VP of Product",Neutral,0.0004,76,adara global announces liz coddington cfo melissa stein product,63,9,0,pharmacy,"['ad', '##ara', 'global', 'announces', 'l', '##iz', 'co', '##ddington', 'c', '##fo', 'me', '##lis', '##sa', 's', '##tein', 'product']",1
270801,nifty_820,2014-03-06,Research and Markets: Commercial Potential of the Forthcoming US Biosimilars Market,Neutral,0.0004,83,research and market commercial potential the forthcoming biosimilars market,75,9,0,pharmacy,"['research', 'and', 'market', 'commercial', 'potential', 'the', 'forthcoming', 'bio', '##si', '##mi', '##lars', 'market']",1
270873,nifty_820,2014-03-06,Horizon Pharma to Present at the 26th Annual ROTH Conference,Neutral,0.0004,60,horizon pharma present the annual roth conference,49,7,0,pharmacy,"['horizon', 'p', '##har', '##ma', 'present', 'the', 'annual', 'rot', '##h', 'conference']",1
270919,nifty_820,2014-03-06,Catalyst Pharmaceutical Partners to Present at the 26th Annual ROTH Conference,Neutral,0.0004,78,catalyst pharmaceutical partner present the annual roth conference,66,8,0,pharmacy,"['catalyst', 'pharmaceutical', 'partner', 'present', 'the', 'annual', 'rot', '##h', 'conference']",1
270933,nifty_820,2014-03-06,Research and Markets: Concise Analysis of the International and Chinese In-Vitro Diagnostic Reagent Industry,Neutral,0.0004,108,research and market concise analysis the international and chinese vitro diagnostic reagent industry,100,13,0,pharmacy,"['research', 'and', 'market', 'con', '##cise', 'analysis', 'the', 'international', 'and', 'chin', '##ese', 'v', '##it', '##ro', 'diagnostic', 're', '##age', '##nt', 'industry']",1
270934,nifty_820,2014-03-06,Leverage a Mixture of Hard and Soft Metrics to Gauge Pharma Digital Marketing Returns,Neutral,0.0004,85,leverage mixture hard and soft metric gauge pharma digital marketing return,75,11,0,pharmacy,"['leverage', 'mixture', 'hard', 'and', 'soft', 'metric', 'gauge', 'p', '##har', '##ma', 'digital', 'marketing', 'return']",1
270935,nifty_820,2014-03-06,Research and Markets: Concise Analysis of the International and China Monoclonal Antibody Industry,Neutral,0.0004,98,research and market concise analysis the international and china monoclonal antibody industry,93,12,0,pharmacy,"['research', 'and', 'market', 'con', '##cise', 'analysis', 'the', 'international', 'and', 'chin', '##a', 'mon', '##oc', '##lon', '##al', 'anti', '##body', 'industry']",1
270937,nifty_820,2014-03-06,"Patient Support Programs, Financial Results, and Stock Price Movements - Analyst Notes on Gilead, Forest Laboratories, Thermo Fisher Scientific, HCA Holdings, and Nektar",Neutral,0.0004,169,patient support program financial result and stock price movement analyst note gilead forest laboratory thermo fisher scientific hca holding and nektar,151,21,0,pharmacy,"['patient', 'support', 'program', 'financial', 'result', 'and', 'stock', 'price', 'movement', 'analyst', 'note', 'g', '##ile', '##ad', 'forest', 'laboratory', 'the', '##rm', '##o', 'fish', '##er', 'scientific', 'h', '##ca', 'holding', 'and', 'ne', '##kt', '##ar']",1
271050,nifty_820,2014-03-06,"The Zacks Analyst Blog Highlights:Sanofi, Aegerion Pharmaceuticals, Shire, Amgen and Biogen Idec",Neutral,0.0004,96,the zacks analyst blog highlight sanofi aegerion pharmaceutical shire amgen and biogen idec,91,13,0,pharmacy,"['the', 'z', '##ack', '##s', 'analyst', 'blog', 'highlight', 'sa', '##no', '##fi', 'a', '##ege', '##rion', 'pharmaceutical', 's', '##hire', 'am', '##gen', 'and', 'bio', '##gen', 'id', '##ec']",1
271140,nifty_820,2014-03-06,"Research and Markets: Personalized Medicine and Companion Diagnostic Market - 2014 Gives Details of their Operations, Products, Financials and Business Strategy",Neutral,0.0004,160,research and market personalized medicine and companion diagnostic market give detail their operation product financials and business strategy,142,18,0,pharmacy,"['research', 'and', 'market', 'personal', '##ized', 'medicine', 'and', 'companion', 'diagnostic', 'market', 'give', 'detail', 'their', 'operation', 'product', 'financial', '##s', 'and', 'business', 'strategy']",1
271251,nifty_820,2014-03-06,"BioLight Raises NIS 19 Million, Announces China Regulatory Approval for IOPtiMateâ¢ for Glaucoma Surgery",Neutral,0.0004,105,biolight raise ni million announces china regulatory approval for ioptimateâ for glaucoma surgery,97,13,0,pharmacy,"['bio', '##light', 'raise', 'ni', 'million', 'announces', 'chin', '##a', 'regulatory', 'approval', 'for', 'i', '##op', '##ti', '##mate', '##â', 'for', 'g', '##lau', '##com', '##a', 'surgery']",1
271279,nifty_820,2014-03-06,"Research and Markets: Global Clinical Decision Support System (CDSS) Market to 2018: Product, Model, Applications, Delivery Mode, Component",Neutral,0.0004,139,research and market global clinical decision support system cdss market product model application delivery mode component,121,16,0,pharmacy,"['research', 'and', 'market', 'global', 'clinical', 'decision', 'support', 'system', 'c', '##ds', '##s', 'market', 'product', 'model', 'application', 'delivery', 'mode', 'component']",1
271293,nifty_820,2014-03-06,Research and Markets: Nurse Call System Equipment Market in the US 2012-2016 with Jeron Electronic Systems Inc and Stanley Healthcare Solutions Dominating,Neutral,0.0004,154,research and market nurse call system equipment market the with jeron electronic system inc and stanley healthcare solution dominating,134,19,0,pharmacy,"['research', 'and', 'market', 'nurse', 'call', 'system', 'equipment', 'market', 'the', 'with', 'j', '##eron', 'electronic', 'system', 'in', '##c', 'and', 's', '##tan', '##ley', 'healthcare', 'solution', 'dominating']",1
271301,nifty_820,2014-03-06,Global Market Access Complexity Grows As The World's Biggest Pharma Markets React To Reforms And Emerging Markets Turn Their Attention To New Pricing Regulation,Neutral,0.0004,160,global market access complexity grows the world biggest pharma market react reform and emerging market turn their attention new pricing regulation,146,21,0,pharmacy,"['global', 'market', 'access', 'complexity', 'grows', 'the', 'world', 'biggest', 'p', '##har', '##ma', 'market', 'react', 'reform', 'and', 'emerging', 'market', 'turn', 'their', 'attention', 'new', 'pricing', 'regulation']",1
271305,nifty_820,2014-03-06,"Research and Markets: Global Bioinformatics Market 2014-2018 with Accelrys, Affymetrix, Agilent, CLCbio A/S & Illumina Dominating",Neutral,0.0004,129,research and market global bioinformatics market with accelrys affymetrix agilent clcbio illumina dominating,108,13,0,pharmacy,"['research', 'and', 'market', 'global', 'bio', '##in', '##formatics', 'market', 'with', 'a', '##cc', '##el', '##ry', '##s', 'a', '##ffy', '##met', '##rix', 'a', '##gi', '##lent', 'c', '##l', '##c', '##bio', 'ill', '##umi', '##na', 'dominating']",1
271353,nifty_820,2014-03-06,"Research and Markets: Pharmaceutical Industry in China - Cutting-Edge Analysis of Multinational and Chinese Pharma Companies, Industry Trends, Opportunities & Challenges",Neutral,0.0004,169,research and market pharmaceutical industry china cutting edge analysis multinational and chinese pharma company industry trend opportunity challenge,149,18,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'industry', 'chin', '##a', 'cutting', 'edge', 'analysis', 'multinational', 'and', 'chin', '##ese', 'p', '##har', '##ma', 'company', 'industry', 'trend', 'opportunity', 'challenge']",1
271355,nifty_820,2014-03-06,Research and Markets: Investigation Report on China's Insulin Glargine Market to 2018,Neutral,0.0004,85,research and market investigation report china insulin glargine market,70,9,0,pharmacy,"['research', 'and', 'market', 'investigation', 'report', 'chin', '##a', 'insulin', 'g', '##lar', '##gin', '##e', 'market']",1
271528,nifty_820,2014-03-06,Top Maetrics Executive Outlines Potentially Cataclysmic Risk Exposure For Life Sciences Mobile App And Software Developers At ICSQ,Neutral,0.0004,130,top maetrics executive outline potentially cataclysmic risk exposure for life science mobile app and software developer icsq,124,17,0,pharmacy,"['top', 'ma', '##et', '##ric', '##s', 'executive', 'outline', 'potentially', 'cat', '##ac', '##ly', '##smic', 'risk', 'exposure', 'for', 'life', 'science', 'mobile', 'app', 'and', 'software', 'developer', 'i', '##cs', '##q']",1
271744,nifty_821,2014-03-10,Sun Recalls Diabetes Medication,Neutral,-0.0049,31,sun recall diabetes medication,30,4,0,pharmacy,"['sun', 'recall', 'diabetes', 'medication']",1
272056,nifty_824,2014-03-13,"Big Pharma Heads to Big Apple for INTERPHEX 2014 in New York, an Industrial Info News Alert",Neutral,-0.0028,91,big pharma head big apple for interphex new york industrial info news alert,75,13,0,pharmacy,"['big', 'p', '##har', '##ma', 'head', 'big', 'apple', 'for', 'inter', '##phe', '##x', 'new', 'yo', '##rk', 'industrial', 'info', 'news', 'alert']",1
272061,nifty_824,2014-03-13,"FirstBIKE, Knowledge Universe, Nutri Ventures, Sodexo and Four Hospital Systems Join the Partnership for a Healthier America to Offer Healthier Choices",Neutral,-0.0028,151,firstbike knowledge universe nutri venture sodexo and four hospital system join the partnership for healthier america offer healthier choice,140,19,0,pharmacy,"['first', '##bi', '##ke', 'knowledge', 'universe', 'nut', '##ri', 'venture', 'so', '##de', '##x', '##o', 'and', 'four', 'hospital', 'system', 'join', 'the', 'partnership', 'for', 'health', '##ier', 'am', '##eric', '##a', 'offer', 'health', '##ier', 'choice']",1
272063,nifty_824,2014-03-13,Horizon Pharma Reports 2013 Financial Results and Provides Business Update,Neutral,-0.0028,74,horizon pharma report financial result and provides business update,67,9,0,pharmacy,"['horizon', 'p', '##har', '##ma', 'report', 'financial', 'result', 'and', 'provides', 'business', 'update']",1
272073,nifty_824,2014-03-13,Research and Markets: PharmaPoint: Obesity - Italy Drug Forecast and Market Analysis to 2022,Neutral,-0.0028,92,research and market pharmapoint obesity italy drug forecast and market analysis,79,11,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##point', 'o', '##besity', 'it', '##aly', 'drug', 'forecast', 'and', 'market', 'analysis']",1
272075,nifty_824,2014-03-13,"Research and Markets: Pharmacovigilance Market Research Report - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019",Neutral,-0.0028,144,research and market pharmacovigilance market research report global industry analysis size share growth trend and forecast,122,16,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##co', '##vi', '##gi', '##lance', 'market', 'research', 'report', 'global', 'industry', 'analysis', 'size', 'share', 'growth', 'trend', 'and', 'forecast']",1
272112,nifty_824,2014-03-13,"Research and Markets: External Beam Radiation Therapy Devices Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2017",Neutral,-0.0028,176,research and market external beam radiation therapy device market assessment report global size share competitive landscape future prospect and forecast from,157,21,0,pharmacy,"['research', 'and', 'market', 'external', 'beam', 'radiation', 'therapy', 'device', 'market', 'assessment', 'report', 'global', 'size', 'share', 'competitive', 'landscape', 'future', 'prospect', 'and', 'forecast', 'from']",1
272121,nifty_824,2014-03-13,Advaxis to Present at the 2nd Annual Sachs Cancer Bio Partnering & Investment Forum,Neutral,-0.0028,83,advaxis present the annual sachs cancer bio partnering investment forum,71,10,0,pharmacy,"['ad', '##va', '##xi', '##s', 'present', 'the', 'annual', 'sa', '##chs', 'cancer', 'bio', 'partner', '##ing', 'investment', 'forum']",1
272176,nifty_824,2014-03-13,"Pre-Market Health Care Stocks Analysis: Medtronic, Abbott Laboratories, Hologic, and ArthroCare",Neutral,-0.0028,95,pre market health care stock analysis medtronic abbott laboratory hologic and arthrocare,88,12,0,pharmacy,"['pre', 'market', 'health', 'care', 'stock', 'analysis', 'me', '##dt', '##ronic', 'abbot', '##t', 'laboratory', 'ho', '##log', '##ic', 'and', 'art', '##hr', '##oc', '##are']",1
272190,nifty_824,2014-03-13,Dipexium Pharmaceuticals Prices Initial Public Offering of Common Stock,Neutral,-0.0028,71,dipexium pharmaceutical price initial public offering common stock,66,8,0,pharmacy,"['dip', '##ex', '##ium', 'pharmaceutical', 'price', 'initial', 'public', 'offering', 'common', 'stock']",1
272315,nifty_824,2014-03-13,Research and Markets: Concise Analysis of the International Electrophoresis Equipment Market - Forecasts to 2016,Neutral,-0.0028,112,research and market concise analysis the international electrophoresis equipment market forecast,96,11,0,pharmacy,"['research', 'and', 'market', 'con', '##cise', 'analysis', 'the', 'international', 'electro', '##ph', '##ores', '##is', 'equipment', 'market', 'forecast']",1
272368,nifty_824,2014-03-13,Research and Markets: Concise Analysis of the International Orphan Drugs Industry,Neutral,-0.0028,81,research and market concise analysis the international orphan drug industry,75,10,0,pharmacy,"['research', 'and', 'market', 'con', '##cise', 'analysis', 'the', 'international', 'orphan', 'drug', 'industry']",1
272377,nifty_824,2014-03-13,"The Zacks Analyst Blog Highlights: Herbalife, Nu Skin, Avon Products, Bayer and Amgen",Neutral,-0.0028,85,the zacks analyst blog highlight herbalife skin avon product bayer and amgen,76,12,0,pharmacy,"['the', 'z', '##ack', '##s', 'analyst', 'blog', 'highlight', 'herb', '##ali', '##fe', 'skin', 'a', '##von', 'product', 'bay', '##er', 'and', 'am', '##gen']",1
272530,nifty_824,2014-03-13,"Brazil, Russia, India and China Laparoscopic Device Market Will Reach Almost $1.2 Billion by 2022",Neutral,-0.0028,97,brazil russia india and china laparoscopic device market will reach almost billion,82,12,0,pharmacy,"['bra', '##zi', '##l', 'r', '##uss', '##ia', 'in', '##dia', 'and', 'chin', '##a', 'lap', '##aro', '##scopic', 'device', 'market', 'will', 'reach', 'almost', 'billion']",1
272557,nifty_824,2014-03-13,Sagent Pharma wants to spend up to $500 million to boost portfolio: CEO,Neutral,-0.0028,71,sagent pharma want spend million boost portfolio ceo,52,8,0,pharmacy,"['sage', '##nt', 'p', '##har', '##ma', 'want', 'spend', 'million', 'boost', 'portfolio', 'c', '##eo']",1
272658,nifty_824,2014-03-13,"PDL BioPharma to Hold Annual Meeting of Stockholders on May 28, 2014",Neutral,-0.0028,68,pdl biopharma hold annual meeting stockholder may,49,7,0,pharmacy,"['p', '##dl', 'bio', '##pha', '##rma', 'hold', 'annual', 'meeting', 'stock', '##holder', 'may']",1
272672,nifty_824,2014-03-13,BioAmber Reports Fourth Quarter and Full Year 2013 Financial Results,Neutral,-0.0028,68,bioamber report fourth quarter and full year financial result,61,9,0,pharmacy,"['bio', '##am', '##ber', 'report', 'fourth', 'quarter', 'and', 'full', 'year', 'financial', 'result']",1
272676,nifty_824,2014-03-13,"ChemoCentryx Announces Financial Results for the Quarter and Year Ended December 31, 2013",Neutral,-0.0028,89,chemocentryx announces financial result for the quarter and year ended december,79,11,0,pharmacy,"['ch', '##em', '##oc', '##entry', '##x', 'announces', 'financial', 'result', 'for', 'the', 'quarter', 'and', 'year', 'ended', 'de', '##ce', '##mber']",1
272688,nifty_824,2014-03-13,"BioAmber Inc. : Form 8-K for the period ended December 31, 2013",Neutral,-0.0028,63,bioamber inc form for the period ended december,47,8,0,pharmacy,"['bio', '##am', '##ber', 'in', '##c', 'form', 'for', 'the', 'period', 'ended', 'de', '##ce', '##mber']",1
272813,nifty_824,2014-03-13,"Doctors, Device Makers: Close Ties",Neutral,-0.0028,34,doctor device maker close tie,29,5,0,pharmacy,"['doctor', 'device', 'maker', 'close', 'tie']",1
272940,nifty_825,2014-03-17,Amgen Says Cholesterol Drug Study Meets Primary Endpoint,Rise,0.0071,56,amgen say cholesterol drug study meet primary endpoint,54,8,0,pharmacy,"['am', '##gen', 'say', 'ch', '##ole', '##ster', '##ol', 'drug', 'study', 'meet', 'primary', 'end', '##point']",1
272944,nifty_825,2014-03-17,"Bristol-Myers, Five Prime In Cancer Pact",Rise,0.0071,40,bristol myers five prime cancer pact,36,6,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'five', 'prime', 'cancer', 'pact']",1
273100,nifty_827,2014-03-19,Horizon Pharma to Acquire Vidara in $660 Million Deal,Rise,0.0058,53,horizon pharma acquire vidara million deal,42,6,0,pharmacy,"['horizon', 'p', '##har', '##ma', 'acquire', 'v', '##ida', '##ra', 'million', 'deal']",1
273155,nifty_828,2014-03-20,J&J Unit's Test of Schizophrenia Treatment Shows Positive Results,Fall,-0.0083,65,unit test schizophrenia treatment show positive result,54,7,0,pharmacy,"['unit', 'test', 's', '##chi', '##zophrenia', 'treatment', 'show', 'positive', 'result']",1
273169,nifty_828,2014-03-20,J&J Schizophena Drug Has Positive Result,Fall,-0.0083,40,schizophena drug ha positive result,35,5,0,pharmacy,"['s', '##chi', '##zo', '##phe', '##na', 'drug', 'ha', 'positive', 'result']",1
273302,nifty_830,2014-03-25,FDA Staff Recommends Rejection of Novartis Heart-Failure Drug,Fall,-0.0072,61,fda staff recommends rejection novartis heart failure drug,58,8,0,pharmacy,"['f', '##da', 'staff', 'recommend', '##s', 'rejection', 'no', '##var', '##tis', 'heart', 'failure', 'drug']",1
273320,nifty_830,2014-03-25,FDA Warns DexCom Over Deficiencies in Medical Device Reports,Fall,-0.0072,60,fda warns dexcom over deficiency medical device report,54,8,0,pharmacy,"['f', '##da', 'warns', 'de', '##x', '##com', 'over', 'deficiency', 'medical', 'device', 'report']",1
273321,nifty_830,2014-03-25,Pfizer Cancer Drug Xalkori Shows Positive Results as First-Line Remedy,Fall,-0.0072,70,pfizer cancer drug xalkori show positive result first line remedy,65,10,0,pharmacy,"['p', '##fi', '##zer', 'cancer', 'drug', 'x', '##alk', '##ori', 'show', 'positive', 'result', 'first', 'line', 'remedy']",1
273335,nifty_830,2014-03-25,Investors Target China Health Care,Fall,-0.0072,34,investor target china health care,33,5,0,pharmacy,"['investor', 'target', 'chin', '##a', 'health', 'care']",1
273368,nifty_831,2014-03-26,Novartis Drug Shows Promise in Rare Lung Cancer,Neutral,-0.0021,47,novartis drug show promise rare lung cancer,43,7,0,pharmacy,"['no', '##var', '##tis', 'drug', 'show', 'promise', 'rare', 'lung', 'cancer']",1
273381,nifty_831,2014-03-26,"Merck, Glaxo Hold Off on Some Copay Help",Neutral,-0.0021,40,merck glaxo hold off some copay help,36,7,0,pharmacy,"['me', '##rc', '##k', 'g', '##lax', '##o', 'hold', 'off', 'some', 'cop', '##ay', 'help']",1
273420,nifty_831,2014-03-26,Glaxo's Diabetes Drug Eperzan Approved,Neutral,-0.0021,38,glaxo diabetes drug eperzan approved,36,5,0,pharmacy,"['g', '##lax', '##o', 'diabetes', 'drug', 'e', '##per', '##zan', 'approved']",1
273423,nifty_831,2014-03-26,Exelixis Urged to Continue Studying Prostate Cancer Treatment,Neutral,-0.0021,61,exelixis urged continue studying prostate cancer treatment,58,7,0,pharmacy,"['ex', '##eli', '##xi', '##s', 'urged', 'continue', 'studying', 'pro', '##state', 'cancer', 'treatment']",1
273491,nifty_832,2014-03-27,MAINSTAY MEDICAL ANNOUNCES INTENTION TO LAUNCH INITIAL PUBLIC OFFERING AND LIST ON EURONEXT PARIS AND ON THE ENTERPRISE SECURITIES MARKET OF IRISH STOCK EXCHANGE,Neutral,0.0049,161,mainstay medical announces intention launch initial public offering and list euronext paris and the enterprise security market irish stock exchange,147,20,0,pharmacy,"['main', '##sta', '##y', 'medical', 'announces', 'intention', 'launch', 'initial', 'public', 'offering', 'and', 'list', 'euro', '##nex', '##t', 'par', '##is', 'and', 'the', 'enterprise', 'security', 'market', 'i', '##ris', '##h', 'stock', 'exchange']",1
273540,nifty_832,2014-03-27,"Research and Markets: Biotechnology for the Non Biotechnologist Course - France, Nice - 09th-11th April",Neutral,0.0049,103,research and market biotechnology for the non biotechnologist course france nice april,86,12,0,pharmacy,"['research', 'and', 'market', 'bio', '##tech', '##nology', 'for', 'the', 'non', 'bio', '##tech', '##no', '##logist', 'course', 'f', '##rance', 'nice', 'a', '##p', '##ril']",1
273547,nifty_832,2014-03-27,Biotech China to Showcase Industrial Parks,Neutral,0.0049,42,biotech china showcase industrial park,38,5,0,pharmacy,"['bio', '##tech', 'chin', '##a', 'showcase', 'industrial', 'park']",1
273552,nifty_832,2014-03-27,Research and Markets: Global Pharmaceutical and Biotechnology Outlook 2014 - India Pharma,Neutral,0.0049,89,research and market global pharmaceutical and biotechnology outlook india pharma,80,10,0,pharmacy,"['research', 'and', 'market', 'global', 'pharmaceutical', 'and', 'bio', '##tech', '##nology', 'outlook', 'in', '##dia', 'p', '##har', '##ma']",1
273607,nifty_832,2014-03-27,Research and Markets: OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - End of Forecast Surge in Sales for NASH from 2012-2017,Neutral,0.0049,135,research and market opportunityanalyzer nonalcoholic steatohepatitis nash end forecast surge sale for nash from,111,14,0,pharmacy,"['research', 'and', 'market', 'opportunity', '##ana', '##ly', '##zer', 'non', '##al', '##co', '##hol', '##ic', 's', '##te', '##ato', '##he', '##pa', '##titis', 'na', '##sh', 'end', 'forecast', 'surge', 'sale', 'for', 'na', '##sh', 'from']",1
273639,nifty_832,2014-03-27,Exact Sciencesâ Stock Trading Halted Today; FDA Advisory Committee Meeting to Review Premarket Approval Application,Neutral,0.0049,117,exact sciencesâ stock trading halted today fda advisory committee meeting review premarket approval application,111,14,0,pharmacy,"['exact', 'sciences', '##â', 'stock', 'trading', 'halted', 'today', 'f', '##da', 'advisory', 'committee', 'meeting', 'review', 'pre', '##market', 'approval', 'application']",1
273641,nifty_832,2014-03-27,Research and Markets: Global Pharmaceutical and Biotechnology Outlook 2014: Rising Stars,Neutral,0.0049,88,research and market global pharmaceutical and biotechnology outlook rising star,79,10,0,pharmacy,"['research', 'and', 'market', 'global', 'pharmaceutical', 'and', 'bio', '##tech', '##nology', 'outlook', 'rising', 'star']",1
273669,nifty_832,2014-03-27,Research and Markets: Global Pharmaceutical and Biotechnology Outlook 2014 - Japan Pharma,Neutral,0.0049,89,research and market global pharmaceutical and biotechnology outlook japan pharma,80,10,0,pharmacy,"['research', 'and', 'market', 'global', 'pharmaceutical', 'and', 'bio', '##tech', '##nology', 'outlook', 'j', '##apa', '##n', 'p', '##har', '##ma']",1
273680,nifty_832,2014-03-27,"Baxter plans to split into two companies, spin off biotech",Neutral,0.0049,58,baxter plan split into two company spin off biotech,51,9,0,pharmacy,"['b', '##ax', '##ter', 'plan', 'split', 'into', 'two', 'company', 'spin', 'off', 'bio', '##tech']",1
273765,nifty_832,2014-03-27,Research and Markets: Global Pharmaceutical & Biotechnology Outlook 2014: Major US and EU,Neutral,0.0049,89,research and market global pharmaceutical biotechnology outlook major and,73,9,0,pharmacy,"['research', 'and', 'market', 'global', 'pharmaceutical', 'bio', '##tech', '##nology', 'outlook', 'major', 'and']",1
273768,nifty_832,2014-03-27,Research and Markets: Global Pharmaceutical & Biotechnology Outlook 2014: Mature Biotech,Neutral,0.0049,88,research and market global pharmaceutical biotechnology outlook mature biotech,78,9,0,pharmacy,"['research', 'and', 'market', 'global', 'pharmaceutical', 'bio', '##tech', '##nology', 'outlook', 'mature', 'bio', '##tech']",1
273787,nifty_832,2014-03-27,Emergent Health Corp. Announces New Shareholder Update,Neutral,0.0049,54,emergent health corp announces new shareholder update,53,7,0,pharmacy,"['emerge', '##nt', 'health', 'co', '##rp', 'announces', 'new', 'shareholder', 'update']",1
273863,nifty_832,2014-03-27,"Zacks Industry Outlook Highlights: Eli Lilly, AstraZeneca, Shire, Salix and Cubist Pharmaceuticals",Neutral,0.0049,98,zacks industry outlook highlight eli lilly astrazeneca shire salix and cubist pharmaceutical,92,12,0,pharmacy,"['z', '##ack', '##s', 'industry', 'outlook', 'highlight', 'el', '##i', 'l', '##ill', '##y', 'as', '##tra', '##zen', '##eca', 's', '##hire', 'sa', '##lix', 'and', 'cu', '##bis', '##t', 'pharmaceutical']",1
273868,nifty_832,2014-03-27,"The Zacks Analyst Blog Highlights: Gilead, Amgen, Endocyte, Celgene and Biogen",Neutral,0.0049,78,the zacks analyst blog highlight gilead amgen endocyte celgene and biogen,73,11,0,pharmacy,"['the', 'z', '##ack', '##s', 'analyst', 'blog', 'highlight', 'g', '##ile', '##ad', 'am', '##gen', 'end', '##oc', '##yte', 'c', '##el', '##gene', 'and', 'bio', '##gen']",1
273956,nifty_832,2014-03-27,Baxter plans to spin off biotech business in 2015,Neutral,0.0049,49,baxter plan spin off biotech business,37,6,0,pharmacy,"['b', '##ax', '##ter', 'plan', 'spin', 'off', 'bio', '##tech', 'business']",1
274052,nifty_832,2014-03-27,UPDATE 4-Baxter plans to spin off biotech business in 2015,Neutral,0.0049,58,update baxter plan spin off biotech business,44,7,0,pharmacy,"['update', 'b', '##ax', '##ter', 'plan', 'spin', 'off', 'bio', '##tech', 'business']",1
274101,nifty_832,2014-03-27,BioCentury Launches the Third Decade of Future Leaders in the Biotech Industry,Neutral,0.0049,78,biocentury launch the third decade future leader the biotech industry,69,10,0,pharmacy,"['bio', '##cent', '##ury', 'launch', 'the', 'third', 'decade', 'future', 'leader', 'the', 'bio', '##tech', 'industry']",1
274110,nifty_832,2014-03-27,Research and Markets: Analyzing the Global Diabetes Market 2014,Neutral,0.0049,63,research and market analyzing the global diabetes market,56,8,0,pharmacy,"['research', 'and', 'market', 'analyzing', 'the', 'global', 'diabetes', 'market']",1
274195,nifty_832,2014-03-27,Research and Markets: Biomaterials China News Q3 2013,Neutral,0.0049,53,research and market biomaterials china news,43,6,0,pharmacy,"['research', 'and', 'market', 'bio', '##mate', '##rial', '##s', 'chin', '##a', 'news']",1
274312,nifty_832,2014-03-27,"Endocyte, Inc. Prices Public Offering of Common Stock",Neutral,0.0049,53,endocyte inc price public offering common stock,47,7,0,pharmacy,"['end', '##oc', '##yte', 'in', '##c', 'price', 'public', 'offering', 'common', 'stock']",1
274383,nifty_832,2014-03-27,FDA Panel Rejects Novartis Drug for Heart Failure,Neutral,0.0049,49,fda panel reject novartis drug for heart failure,48,8,0,pharmacy,"['f', '##da', 'panel', 'reject', 'no', '##var', '##tis', 'drug', 'for', 'heart', 'failure']",1
274384,nifty_832,2014-03-27,Baxter to Split Into Two Companies,Neutral,0.0049,34,baxter split into two company,29,5,0,pharmacy,"['b', '##ax', '##ter', 'split', 'into', 'two', 'company']",1
274522,nifty_833,2014-03-31,Novartis Boosted by Heart Drug Trials,Rise,0.0066,37,novartis boosted heart drug trial,33,5,0,pharmacy,"['no', '##var', '##tis', 'boost', '##ed', 'heart', 'drug', 'trial']",1
274649,nifty_834,2014-04-01,"Research and Markets: Triple Analysis: Melanoma, Angiogenesis and Cancer Vaccines Reports",Neutral,0.0033,89,research and market triple analysis melanoma angiogenesis and cancer vaccine report,83,11,0,pharmacy,"['research', 'and', 'market', 'triple', 'analysis', 'me', '##lan', '##oma', 'an', '##gio', '##genesis', 'and', 'cancer', 'vaccine', 'report']",1
274651,nifty_834,2014-04-01,Research and Markets: Disease & Therapy Review (DTR) Executive Market Summaries - A Series Including 12 Reports,Neutral,0.0033,111,research and market disease therapy review dtr executive market summary series including report,95,13,0,pharmacy,"['research', 'and', 'market', 'disease', 'therapy', 'review', 'd', '##tr', 'executive', 'market', 'summary', 'series', 'including', 'report']",1
274661,nifty_834,2014-04-01,Research and Markets: Global BioChips & BioMEMS (Bio Microelectromechanical Systems) Report 2012-2018,Neutral,0.0033,101,research and market global biochip biomems bio microelectromechanical system report,83,10,0,pharmacy,"['research', 'and', 'market', 'global', 'bio', '##chi', '##p', 'bio', '##me', '##ms', 'bio', 'micro', '##ele', '##ct', '##rome', '##chan', '##ical', 'system', 'report']",1
274756,nifty_834,2014-04-01,"Clinical Trial Initiation, Executive Appointments, Priced Offering, FDA Clearance, and Upcoming Conferences - Analyst Notes on Cytokinetics, Quintiles, Kindred, Volcano, and Novadaq",Neutral,0.0033,181,clinical trial initiation executive appointment priced offering fda clearance and upcoming conference analyst note cytokinetics quintiles kindred volcano and novadaq,165,20,0,pharmacy,"['clinical', 'trial', 'initiation', 'executive', 'appointment', 'priced', 'offering', 'f', '##da', 'clearance', 'and', 'upcoming', 'conference', 'analyst', 'note', 'c', '##yt', '##oki', '##net', '##ics', 'q', '##uin', '##tile', '##s', 'kind', '##red', 'volcano', 'and', 'no', '##va', '##da', '##q']",1
274758,nifty_834,2014-04-01,"Pending Applications, Closed Public Offering, Joint Venture Formation, Executive Appointment, and Commercial Launch - Analyst Notes on Gilead, Enzymotec, Intrexon, Advaxis, and Repligen",Neutral,0.0033,185,pending application closed public offering joint venture formation executive appointment and commercial launch analyst note gilead enzymotec intrexon advaxis and repligen,170,21,0,pharmacy,"['pending', 'application', 'closed', 'public', 'offering', 'joint', 'venture', 'formation', 'executive', 'appointment', 'and', 'commercial', 'launch', 'analyst', 'note', 'g', '##ile', '##ad', 'en', '##zy', '##mote', '##c', 'in', '##tre', '##xon', 'ad', '##va', '##xi', '##s', 'and', 're', '##p', '##li', '##gen']",1
274765,nifty_834,2014-04-01,"Business Plans, Clinical Trial Results, Meetings, Conferences, and Sponsorships - Analyst Notes on Baxter, Halozyme, WellCare, PDL BioPharma, and Lannett",Neutral,0.0033,153,business plan clinical trial result meeting conference and sponsorship analyst note baxter halozyme wellcare pdl biopharma and lannett,134,18,0,pharmacy,"['business', 'plan', 'clinical', 'trial', 'result', 'meeting', 'conference', 'and', 'sponsorship', 'analyst', 'note', 'b', '##ax', '##ter', 'ha', '##lo', '##zy', '##me', 'well', '##care', 'p', '##dl', 'bio', '##pha', '##rma', 'and', 'la', '##nne', '##tt']",1
274817,nifty_834,2014-04-01,Research and Markets: MicroRNAs in Cancer Drug Pipeline Update 2014,Neutral,0.0033,67,research and market micrornas cancer drug pipeline update,57,8,0,pharmacy,"['research', 'and', 'market', 'micro', '##rna', '##s', 'cancer', 'drug', 'pipeline', 'update']",1
274838,nifty_834,2014-04-01,Research and Markets: South Korea Pharmaceutical Market Outlook 2013-2018,Neutral,0.0033,73,research and market south korea pharmaceutical market outlook,61,8,0,pharmacy,"['research', 'and', 'market', 'south', 'k', '##ore', '##a', 'pharmaceutical', 'market', 'outlook']",1
274905,nifty_834,2014-04-01,Stellar Biotechnologies Presenting Today at 2014 TSX Venture 50(R) Spotlight Event,Neutral,0.0033,82,stellar biotechnology presenting today tsx venture spotlight event,66,8,0,pharmacy,"['stellar', 'bio', '##tech', '##nology', 'presenting', 'today', 't', '##s', '##x', 'venture', 'spotlight', 'event']",1
274981,nifty_834,2014-04-01,Research and Markets: Cancer Molecular Biomarkers 2014: A Global Market Study,Neutral,0.0033,77,research and market cancer molecular biomarkers global market study,67,9,0,pharmacy,"['research', 'and', 'market', 'cancer', 'molecular', 'bio', '##mark', '##ers', 'global', 'market', 'study']",1
275028,nifty_834,2014-04-01,DIA 2014 Annual Meeting to Address Global Debate About Biosimilars,Neutral,0.0033,66,dia annual meeting address global debate about biosimilars,58,8,0,pharmacy,"['di', '##a', 'annual', 'meeting', 'address', 'global', 'debate', 'about', 'bio', '##si', '##mi', '##lars']",1
275043,nifty_834,2014-04-01,Research and Markets: Global RNA Interference (RNAi) Therapy Market Outlook 2018,Neutral,0.0033,80,research and market global rna interference rnai therapy market outlook,71,10,0,pharmacy,"['research', 'and', 'market', 'global', 'r', '##na', 'interference', 'r', '##nai', 'therapy', 'market', 'outlook']",1
275072,nifty_834,2014-04-01,"Research and Markets: Latin American Bioinformatics Market by Sector, Segment & Applications - Forecasts to 2017",Neutral,0.0033,112,research and market latin american bioinformatics market sector segment application forecast,92,11,0,pharmacy,"['research', 'and', 'market', 'la', '##tin', 'am', '##eric', '##an', 'bio', '##in', '##formatics', 'market', 'sector', 'segment', 'application', 'forecast']",1
275080,nifty_834,2014-04-01,Research and Markets: Analysis of the Global Industrial Greases Market and Opportunities for Bio-based Materials,Neutral,0.0033,112,research and market analysis the global industrial grease market and opportunity for bio based material,103,15,0,pharmacy,"['research', 'and', 'market', 'analysis', 'the', 'global', 'industrial', 'g', '##rease', 'market', 'and', 'opportunity', 'for', 'bio', 'based', 'material']",1
275082,nifty_834,2014-04-01,Research and Markets: Dye Sensitized Cell Markets 2014-2022,Neutral,0.0033,59,research and market dye sensitized cell market,46,7,0,pharmacy,"['research', 'and', 'market', 'dye', 'se', '##ns', '##iti', '##zed', 'cell', 'market']",1
275210,nifty_834,2014-04-01,"Research and Markets: China Aged Care Industry Report, 2013-2016",Neutral,0.0033,64,research and market china aged care industry report,51,8,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'aged', 'care', 'industry', 'report']",1
275231,nifty_834,2014-04-01,Research and Markets: Single Cell Omics Trends - Global Market Overivew 2014,Neutral,0.0033,76,research and market single cell omics trend global market overivew,66,10,0,pharmacy,"['research', 'and', 'market', 'single', 'cell', 'o', '##mic', '##s', 'trend', 'global', 'market', 'over', '##ive', '##w']",1
275239,nifty_834,2014-04-01,Research and Markets: Synthetic Cells Trends - Global Market Overview 2014,Neutral,0.0033,74,research and market synthetic cell trend global market overview,63,9,0,pharmacy,"['research', 'and', 'market', 'synthetic', 'cell', 'trend', 'global', 'market', 'overview']",1
275241,nifty_834,2014-04-01,Bio-Path Holdings Reports Fiscal Year 2013 Operational and Financial Results,Neutral,0.0033,76,bio path holding report fiscal year operational and financial result,68,10,0,pharmacy,"['bio', 'path', 'holding', 'report', 'fiscal', 'year', 'operational', 'and', 'financial', 'result']",1
275353,nifty_834,2014-04-01,Healthcare Lobbying Vets Launch New Boutique Firm,Neutral,0.0033,49,healthcare lobbying vet launch new boutique firm,48,7,0,pharmacy,"['healthcare', 'lobbying', 've', '##t', 'launch', 'new', 'bout', '##ique', 'firm']",1
275401,nifty_834,2014-04-01,Intercept Pharmaceuticals Announces Proposed Public Offering of Common Stock,Neutral,0.0033,76,intercept pharmaceutical announces proposed public offering common stock,72,8,0,pharmacy,"['intercept', 'pharmaceutical', 'announces', 'proposed', 'public', 'offering', 'common', 'stock']",1
275550,nifty_834,2014-04-01,Magellan Health to Acquire CDMI for $205 Million,Neutral,0.0033,48,magellan health acquire cdmi for million,40,6,0,pharmacy,"['mage', '##llan', 'health', 'acquire', 'c', '##d', '##mi', 'for', 'million']",1
275608,nifty_835,2014-04-02,Baxter to Acquire Chatham Therapeutics for $70 Million,Neutral,-0.0013,54,baxter acquire chatham therapeutic for million,46,6,0,pharmacy,"['b', '##ax', '##ter', 'acquire', 'chat', '##ham', 'therapeutic', 'for', 'million']",1
275741,nifty_836,2014-04-03,Research and Markets: Re-evaluating the Attractions of Chinese Pharmaceutical Market and Chinese Pharmaceutical Industry,Fall,-0.0118,120,research and market evaluating the attraction chinese pharmaceutical market and chinese pharmaceutical industry,111,13,0,pharmacy,"['research', 'and', 'market', 'evaluating', 'the', 'attraction', 'chin', '##ese', 'pharmaceutical', 'market', 'and', 'chin', '##ese', 'pharmaceutical', 'industry']",1
275747,nifty_836,2014-04-03,"Research and Markets: Deciphering Global Major Pharma Companies' New China Strategies - R&D;, Manufacturing, and Product Marketing",Fall,-0.0118,130,research and market deciphering global major pharma company new china strategy manufacturing and product marketing,114,15,0,pharmacy,"['research', 'and', 'market', 'de', '##ci', '##pher', '##ing', 'global', 'major', 'p', '##har', '##ma', 'company', 'new', 'chin', '##a', 'strategy', 'manufacturing', 'and', 'product', 'marketing']",1
275751,nifty_836,2014-04-03,"Research and Markets: Private Medical Insurance in the UK 2014-2017 with Bupa, Axa, Aviva and Prudential Dominating",Fall,-0.0118,115,research and market private medical insurance the with bupa axa aviva and prudential dominating,95,14,0,pharmacy,"['research', 'and', 'market', 'private', 'medical', 'insurance', 'the', 'with', 'b', '##up', '##a', 'a', '##xa', 'a', '##vi', '##va', 'and', 'p', '##rud', '##ential', 'dominating']",1
275855,nifty_836,2014-04-03,Research and Markets: Victoza (Obesity) - Forecast and Market Analysis to 2022,Fall,-0.0118,78,research and market victoza obesity forecast and market analysis,64,9,0,pharmacy,"['research', 'and', 'market', 'v', '##ict', '##oz', '##a', 'o', '##besity', 'forecast', 'and', 'market', 'analysis']",1
275864,nifty_836,2014-04-03,Research and Markets: Empatic (Obesity) - Forecast and Market Analysis to 2022,Fall,-0.0118,78,research and market empatic obesity forecast and market analysis,64,9,0,pharmacy,"['research', 'and', 'market', 'em', '##pa', '##tic', 'o', '##besity', 'forecast', 'and', 'market', 'analysis']",1
275865,nifty_836,2014-04-03,Research and Markets: Obesity Oblean (cetilistat) - Forecast and Market Analysis to 2022,Fall,-0.0118,88,research and market obesity oblean cetilistat forecast and market analysis,74,10,0,pharmacy,"['research', 'and', 'market', 'o', '##besity', 'o', '##ble', '##an', 'c', '##eti', '##list', '##at', 'forecast', 'and', 'market', 'analysis']",1
275866,nifty_836,2014-04-03,Research and Markets: Obesity Velneperit (S-2367) - Forecast and Market Analysis to 2022,Fall,-0.0118,88,research and market obesity velneperit forecast and market analysis,67,9,0,pharmacy,"['research', 'and', 'market', 'o', '##besity', 've', '##ln', '##eper', '##it', 'forecast', 'and', 'market', 'analysis']",1
275880,nifty_836,2014-04-03,"Financial Results, Launches, Adjusted Conversion Rates, Upcoming Presentations, and Stock Movements - Analyst Notes on AbbVie, Chemed, Antares Pharma, Magellan Health Services, and Natus Medical",Fall,-0.0118,194,financial result launch adjusted conversion rate upcoming presentation and stock movement analyst note abbvie chemed antares pharma magellan health service and natus medical,173,23,0,pharmacy,"['financial', 'result', 'launch', 'adjusted', 'conversion', 'rate', 'upcoming', 'presentation', 'and', 'stock', 'movement', 'analyst', 'note', 'a', '##bb', '##vie', 'ch', '##em', '##ed', 'ant', '##ares', 'p', '##har', '##ma', 'mage', '##llan', 'health', 'service', 'and', 'na', '##tus', 'medical']",1
275893,nifty_836,2014-04-03,"Senior Notes Conversions, FDA Drug Approvals, Acquisitions, Stock Price Updates, and Clinical Trial Studies - Analyst Notes on Gilead, Pfizer, Nordion, Intuitive Surgical, and Novartis",Fall,-0.0118,184,senior note conversion fda drug approval acquisition stock price update and clinical trial study analyst note gilead pfizer nordion intuitive surgical and novartis,163,23,0,pharmacy,"['senior', 'note', 'conversion', 'f', '##da', 'drug', 'approval', 'acquisition', 'stock', 'price', 'update', 'and', 'clinical', 'trial', 'study', 'analyst', 'note', 'g', '##ile', '##ad', 'p', '##fi', '##zer', 'nor', '##dio', '##n', 'in', '##tu', '##itive', 'surgical', 'and', 'no', '##var', '##tis']",1
275930,nifty_836,2014-04-03,"Healthcare Companies Report Transactions, Appeals, New Research Findings and Stock Movements - Analyst Notes on Johnson & Johnson, Teva, Celgene, Cara Therapeutics, and OncoMed Pharmaceuticals",Fall,-0.0118,192,healthcare company report transaction appeal new research finding and stock movement analyst note johnson johnson teva celgene cara therapeutic and oncomed pharmaceutical,170,22,0,pharmacy,"['healthcare', 'company', 'report', 'transaction', 'appeal', 'new', 'research', 'finding', 'and', 'stock', 'movement', 'analyst', 'note', 'j', '##oh', '##nson', 'j', '##oh', '##nson', 'te', '##va', 'c', '##el', '##gene', 'car', '##a', 'therapeutic', 'and', 'on', '##come', '##d', 'pharmaceutical']",1
275960,nifty_836,2014-04-03,"Technical Roundup on Health Care Sector Stocks -- Research on Becton Dickinson and Co., Antares Pharma, Hooper Holmes, and Catamaran",Fall,-0.0118,132,technical roundup health care sector stock research becton dickinson and antares pharma hooper holmes and catamaran,115,16,0,pharmacy,"['technical', 'round', '##up', 'health', 'care', 'sector', 'stock', 'research', 'be', '##cton', 'dick', '##ins', '##on', 'and', 'ant', '##ares', 'p', '##har', '##ma', 'ho', '##oper', 'ho', '##lm', '##es', 'and', 'cat', '##ama', '##ran']",1
275985,nifty_836,2014-04-03,"UNOV Announces Name Change, Symbol and Enters the Fast Growing Health, Nutrition, Wellness and Alternative Medicine Markets",Fall,-0.0118,123,unov announces name change symbol and enters the fast growing health nutrition wellness and alternative medicine market,119,17,0,pharmacy,"['un', '##ov', 'announces', 'name', 'change', 'symbol', 'and', 'enters', 'the', 'fast', 'growing', 'health', 'nutrition', 'well', '##ness', 'and', 'alternative', 'medicine', 'market']",1
276018,nifty_836,2014-04-03,"Catalyst Pharmaceutical Partners, Inc. Prices Public Offering of Common Stock",Fall,-0.0118,77,catalyst pharmaceutical partner inc price public offering common stock,70,9,0,pharmacy,"['catalyst', 'pharmaceutical', 'partner', 'in', '##c', 'price', 'public', 'offering', 'common', 'stock']",1
276106,nifty_836,2014-04-03,"Investment-In-Innovation (IN3) Medical Device 360 Dublin to Feature 30+ Start-Ups Seeking Partnership, and Top-Tier Investors and Industry Leaders",Fall,-0.0118,146,investment innovation medical device dublin feature start ups seeking partnership and top tier investor and industry leader,123,17,0,pharmacy,"['investment', 'innovation', 'medical', 'device', 'dub', '##lin', 'feature', 'start', 'ups', 'seeking', 'partnership', 'and', 'top', 'tier', 'investor', 'and', 'industry', 'leader']",1
276320,nifty_836,2014-04-03,Research and Markets: Full-Body Scanner Trends - Global Market Overview 2014-2017,Fall,-0.0118,81,research and market full body scanner trend global market overview,66,10,0,pharmacy,"['research', 'and', 'market', 'full', 'body', 'scan', '##ner', 'trend', 'global', 'market', 'overview']",1
276325,nifty_836,2014-04-03,Research and Markets: Biosimulation Trends - Global Market Overview 2014-2017,Fall,-0.0118,77,research and market biosimulation trend global market overview,62,8,0,pharmacy,"['research', 'and', 'market', 'bio', '##si', '##mu', '##lation', 'trend', 'global', 'market', 'overview']",1
276557,nifty_836,2014-04-03,FDA Approves Injection to Counteract Painkiller Overdose,Fall,-0.0118,56,fda approves injection counteract painkiller overdose,53,6,0,pharmacy,"['f', '##da', 'approve', '##s', 'injection', 'counter', '##act', 'pain', '##kill', '##er', 'over', '##dos', '##e']",1
276566,nifty_836,2014-04-03,Novartis Shakes Up Japan Ranks,Fall,-0.0118,30,novartis shake japan rank,25,4,0,pharmacy,"['no', '##var', '##tis', 'shake', 'j', '##apa', '##n', 'rank']",1
276568,nifty_836,2014-04-03,"Novo Nordisk Seeks to Boost Sales of Insulin in U.S., Mexico",Fall,-0.0118,60,novo nordisk seek boost sale insulin mexico,43,7,0,pharmacy,"['no', '##vo', 'nor', '##dis', '##k', 'seek', 'boost', 'sale', 'insulin', 'me', '##xi', '##co']",1
276684,nifty_837,2014-04-07,Research and Markets: E.coli Partnering 2009-2014 - Access to the Partnering Deals & Agreement by the Pharma Giants,Neutral,0.0041,115,research and market coli partnering access the partnering deal agreement the pharma giant,89,13,0,pharmacy,"['research', 'and', 'market', 'co', '##li', 'partner', '##ing', 'access', 'the', 'partner', '##ing', 'deal', 'agreement', 'the', 'p', '##har', '##ma', 'giant']",1
276689,nifty_837,2014-04-07,Research and Markets: MRSA Partnering 2009-2014 - Access to the Partnering Deals and Agreements by the Pharma Giants,Neutral,0.0041,116,research and market mrsa partnering access the partnering deal and agreement the pharma giant,93,14,0,pharmacy,"['research', 'and', 'market', 'm', '##rsa', 'partner', '##ing', 'access', 'the', 'partner', '##ing', 'deal', 'and', 'agreement', 'the', 'p', '##har', '##ma', 'giant']",1
276697,nifty_837,2014-04-07,Research and Markets: Sepsis Partnering 2009-2014: Access to the Parterning Deals & Agreements from the World's Pharma Giants,Neutral,0.0041,125,research and market sepsis partnering access the parterning deal agreement from the world pharma giant,102,15,0,pharmacy,"['research', 'and', 'market', 'se', '##psis', 'partner', '##ing', 'access', 'the', 'part', '##ern', '##ing', 'deal', 'agreement', 'from', 'the', 'world', 'p', '##har', '##ma', 'giant']",1
276706,nifty_837,2014-04-07,Research and Markets: Common Cold Partnering 2014 - Access to the Deals & Agreements by the Global Pharma Giants,Neutral,0.0041,112,research and market common cold partnering access the deal agreement the global pharma giant,92,14,0,pharmacy,"['research', 'and', 'market', 'common', 'cold', 'partner', '##ing', 'access', 'the', 'deal', 'agreement', 'the', 'global', 'p', '##har', '##ma', 'giant']",1
276715,nifty_837,2014-04-07,"Research and Markets: Global Genomics Market Forecasts & Opportunities to 2018 - Products, Consumables & Services",Neutral,0.0041,113,research and market global genomics market forecast opportunity product consumables service,91,11,0,pharmacy,"['research', 'and', 'market', 'global', 'g', '##eno', '##mic', '##s', 'market', 'forecast', 'opportunity', 'product', 'con', '##su', '##mable', '##s', 'service']",1
276740,nifty_837,2014-04-07,Research and Markets: Global BiowireleSS Market Opportunities in Wireless Healthcare 2014-2020,Neutral,0.0041,94,research and market global biowireless market opportunity wireless healthcare,77,9,0,pharmacy,"['research', 'and', 'market', 'global', 'bio', '##wire', '##less', 'market', 'opportunity', 'wireless', 'healthcare']",1
276788,nifty_837,2014-04-07,Research and Markets: Global Anthrax Partnering Report 2014: Access to the Deals and Agreements by the Pharma Giants,Neutral,0.0041,116,research and market global anthrax partnering report access the deal and agreement the pharma giant,99,15,0,pharmacy,"['research', 'and', 'market', 'global', 'ant', '##hra', '##x', 'partner', '##ing', 'report', 'access', 'the', 'deal', 'and', 'agreement', 'the', 'p', '##har', '##ma', 'giant']",1
276804,nifty_837,2014-04-07,"Research and Markets: Global Medical Publishing Market 2014-2018 with Informa, John Wiley, Elsevier, Springer Science+Business Media, Truven Health Analytics & Wolters Kluwer N.V. Dominating",Neutral,0.0041,190,research and market global medical publishing market with informa john wiley elsevier springer science business medium truven health analytics wolters kluwer dominating,168,22,0,pharmacy,"['research', 'and', 'market', 'global', 'medical', 'publishing', 'market', 'with', 'inform', '##a', 'j', '##oh', '##n', 'w', '##ile', '##y', 'else', '##vier', 'spring', '##er', 'science', 'business', 'medium', 't', '##ru', '##ven', 'health', 'anal', '##ytic', '##s', 'w', '##olt', '##ers', 'k', '##lu', '##wer', 'dominating']",1
276820,nifty_837,2014-04-07,"Drug Recommendations, Legal Updates, Awards, Stock Price Movements, and Upcoming Results and Conference Call Schedules - Analyst Notes on MannKind, Mylan, WellPoint, Valeant, and Forest Laboratories",Neutral,0.0041,198,drug recommendation legal update award stock price movement and upcoming result and conference call schedule analyst note mannkind mylan wellpoint valeant and forest laboratory,176,24,0,pharmacy,"['drug', 'recommendation', 'legal', 'update', 'award', 'stock', 'price', 'movement', 'and', 'upcoming', 'result', 'and', 'conference', 'call', 'schedule', 'analyst', 'note', 'man', '##nk', '##ind', 'my', '##lan', 'well', '##point', 'v', '##ale', '##ant', 'and', 'forest', 'laboratory']",1
276829,nifty_837,2014-04-07,Alios BioPharma Raises $41 Million in Series B Financing,Neutral,0.0041,56,alios biopharma raise million series financing,46,6,0,pharmacy,"['al', '##ios', 'bio', '##pha', '##rma', 'raise', 'million', 'series', 'financing']",1
276865,nifty_837,2014-04-07,"NDA Filings, FDA Approvals, Executive Appointments, Ceased Clinical Trials, and Public Offerings - Analyst Notes on Johnson & Johnson, Pfizer, Merck, GSK, and Intercept",Neutral,0.0041,168,nda filing fda approval executive appointment ceased clinical trial and public offering analyst note johnson johnson pfizer merck gsk and intercept,147,21,0,pharmacy,"['n', '##da', 'filing', 'f', '##da', 'approval', 'executive', 'appointment', 'ceased', 'clinical', 'trial', 'and', 'public', 'offering', 'analyst', 'note', 'j', '##oh', '##nson', 'j', '##oh', '##nson', 'p', '##fi', '##zer', 'me', '##rc', '##k', 'g', '##sk', 'and', 'intercept']",1
276869,nifty_837,2014-04-07,"Product Launches, Acquisitions, Closed Offerings, Divestitures, and Financial Results - Analyst Notes on Dr. Reddy's, ICON, Endocyte, BioScrip, and DepoMed",Neutral,0.0041,155,product launch acquisition closed offering divestiture and financial result analyst note reddy icon endocyte bioscrip and depomed,129,17,0,pharmacy,"['product', 'launch', 'acquisition', 'closed', 'offering', 'dive', '##st', '##iture', 'and', 'financial', 'result', 'analyst', 'note', 'red', '##dy', 'icon', 'end', '##oc', '##yte', 'bio', '##s', '##c', '##rip', 'and', 'de', '##po', '##med']",1
276892,nifty_837,2014-04-07,"Data Review on Active Stocks -- Research on Procter & Gamble, Halozyme Therapeutics, Symantec, and IsoRay",Neutral,0.0041,105,data review active stock research procter gamble halozyme therapeutic symantec and isoray,89,12,0,pharmacy,"['data', 'review', 'active', 'stock', 'research', 'pro', '##cter', 'g', '##amble', 'ha', '##lo', '##zy', '##me', 'therapeutic', 's', '##yman', '##tec', 'and', 'is', '##ora', '##y']",1
277101,nifty_837,2014-04-07,"Research and Markets: United Kingdom Diagnostic Imaging Market Outlook to 2020 Featuring GE, Philips, Siemens & Toshiba",Neutral,0.0041,119,research and market united kingdom diagnostic imaging market outlook featuring philip siemens toshiba,101,13,0,pharmacy,"['research', 'and', 'market', 'united', 'kingdom', 'diagnostic', 'imaging', 'market', 'outlook', 'featuring', 'p', '##hil', '##ip', 'si', '##em', '##ens', 'to', '##shi', '##ba']",1
277153,nifty_837,2014-04-07,Research and Markets: Asia-Pacific Healthcare Outlook - 2014,Neutral,0.0041,60,research and market asia pacific healthcare outlook,51,7,0,pharmacy,"['research', 'and', 'market', 'as', '##ia', 'p', '##ac', '##ific', 'healthcare', 'outlook']",1
277175,nifty_837,2014-04-07,Research and Markets: Pharma Opportunity/Analyzer Report: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017,Neutral,0.0041,120,research and market pharma opportunity analyzer report pancreatic cancer opportunity analysis and forecast,106,13,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', 'opportunity', 'analyze', '##r', 'report', 'pan', '##cre', '##atic', 'cancer', 'opportunity', 'analysis', 'and', 'forecast']",1
277178,nifty_837,2014-04-07,Research and Markets: DNA Gene Chip Trends - Global Market Overview 2014,Neutral,0.0041,72,research and market dna gene chip trend global market overview,62,10,0,pharmacy,"['research', 'and', 'market', 'd', '##na', 'gene', 'chip', 'trend', 'global', 'market', 'overview']",1
277183,nifty_837,2014-04-07,Research and Markets: Dye Sensitized Cell Trends - Global Market Overview 2014-2017,Neutral,0.0041,83,research and market dye sensitized cell trend global market overview,68,10,0,pharmacy,"['research', 'and', 'market', 'dye', 'se', '##ns', '##iti', '##zed', 'cell', 'trend', 'global', 'market', 'overview']",1
277187,nifty_837,2014-04-07,Research and Markets: Biomimetics Trends - Global Market Overview 2014,Neutral,0.0041,70,research and market biomimetics trend global market overview,60,8,0,pharmacy,"['research', 'and', 'market', 'bio', '##mi', '##met', '##ics', 'trend', 'global', 'market', 'overview']",1
277199,nifty_837,2014-04-07,"Technical Pointers on Pharmaceuticals Equities -- Research on Merck, Bristol-Myers Squibb, Johnson & Johnson, and Eli Lilly",Neutral,0.0041,123,technical pointer pharmaceutical equity research merck bristol myers squibb johnson johnson and eli lilly,105,14,0,pharmacy,"['technical', 'point', '##er', 'pharmaceutical', 'equity', 'research', 'me', '##rc', '##k', 'br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'j', '##oh', '##nson', 'j', '##oh', '##nson', 'and', 'el', '##i', 'l', '##ill', '##y']",1
277201,nifty_837,2014-04-07,Research and Markets: Biosimilar Index 2014: Tracking the Global Biosimilar Pipeline,Neutral,0.0041,84,research and market biosimilar index tracking the global biosimilar pipeline,76,10,0,pharmacy,"['research', 'and', 'market', 'bio', '##si', '##mi', '##lar', 'index', 'tracking', 'the', 'global', 'bio', '##si', '##mi', '##lar', 'pipeline']",1
277254,nifty_837,2014-04-07,Research and Markets: Gene Expression Reagent Trends - Global Market Report 2014,Neutral,0.0041,80,research and market gene expression reagent trend global market report,70,10,0,pharmacy,"['research', 'and', 'market', 'gene', 'expression', 're', '##age', '##nt', 'trend', 'global', 'market', 'report']",1
277302,nifty_837,2014-04-07,Research and Markets: The US Diabetic Devices Industry Outlook to 2018 - Growth to be Led by Next Generation Technology,Neutral,0.0041,119,research and market the diabetic device industry outlook growth led next generation technology,94,13,0,pharmacy,"['research', 'and', 'market', 'the', 'di', '##abe', '##tic', 'device', 'industry', 'outlook', 'growth', 'led', 'next', 'generation', 'technology']",1
277490,nifty_837,2014-04-07,Tracing Source of Fake Cancer Drugs,Neutral,0.0041,35,tracing source fake cancer drug,31,5,0,pharmacy,"['tracing', 'source', 'fake', 'cancer', 'drug']",1
277496,nifty_837,2014-04-07,Zogenix Seeks to Block Massachusetts Ban on Painkiller,Neutral,0.0041,54,zogenix seek block massachusetts ban painkiller,47,6,0,pharmacy,"['z', '##ogen', '##ix', 'seek', 'block', 'mass', '##ach', '##use', '##tts', 'ban', 'pain', '##kill', '##er']",1
277503,nifty_837,2014-04-07,How a Nearly $5 Billion Bet on Generic Drugs Went Awry,Neutral,0.0041,54,how nearly billion bet generic drug went awry,45,8,0,pharmacy,"['how', 'nearly', 'billion', 'bet', 'generic', 'drug', 'went', 'a', '##wry']",1
277535,nifty_837,2014-04-07,Mallinckrodt to Buy Questcor Pharmaceuticals for $5.6 Billion,Neutral,0.0041,61,mallinckrodt buy questcor pharmaceutical for billion,52,6,0,pharmacy,"['mall', '##in', '##ck', '##rod', '##t', 'buy', 'quest', '##cor', 'pharmaceutical', 'for', 'billion']",1
277603,nifty_838,2014-04-08,"Upcoming Events, Shares, Stock Price Updates, Notes Exchange Offer, Clinical Study Results and New Product Launch - Analyst Notes on Salix, Endo, ISIS, IDEXX, and Novo",Rise,0.0108,167,upcoming event share stock price update note exchange offer clinical study result and new product launch analyst note salix endo isi idexx and novo,147,24,0,pharmacy,"['upcoming', 'event', 'share', 'stock', 'price', 'update', 'note', 'exchange', 'offer', 'clinical', 'study', 'result', 'and', 'new', 'product', 'launch', 'analyst', 'note', 'sa', '##lix', 'end', '##o', 'is', '##i', 'id', '##ex', '##x', 'and', 'no', '##vo']",1
277666,nifty_838,2014-04-08,Research and Markets: Global Gastrointestinal Therapeutics in Major Developed Markets to 2019,Rise,0.0108,93,research and market global gastrointestinal therapeutic major developed market,78,9,0,pharmacy,"['research', 'and', 'market', 'global', 'gas', '##tro', '##int', '##est', '##inal', 'therapeutic', 'major', 'developed', 'market']",1
277674,nifty_838,2014-04-08,Research and Markets: Global Multiplexed Diagnostics Market (Technologies & Applications) 2013 - 2019,Rise,0.0108,101,research and market global multiplexed diagnostics market technology application,80,9,0,pharmacy,"['research', 'and', 'market', 'global', 'multiple', '##xed', 'diagnostic', '##s', 'market', 'technology', 'application']",1
277684,nifty_838,2014-04-08,Research and Markets: United States Crohn's Disease Report 2014 - Drug Forecast and Market Analysis to 2022,Rise,0.0108,107,research and market united state crohn disease report drug forecast and market analysis,87,13,0,pharmacy,"['research', 'and', 'market', 'united', 'state', 'c', '##ro', '##hn', 'disease', 'report', 'drug', 'forecast', 'and', 'market', 'analysis']",1
277819,nifty_838,2014-04-08,"Earnings Release Schedules, Product Portfolio Expansion, Initiatives and Stock Price Movements - Analyst Notes on Biogen Idec, Bristol-Myers, Regeneron Pharma, Illumina, West Pharma Services",Rise,0.0108,190,earnings release schedule product portfolio expansion initiative and stock price movement analyst note biogen idec bristol myers regeneron pharma illumina west pharma service,174,23,0,pharmacy,"['earnings', 'release', 'schedule', 'product', 'portfolio', 'expansion', 'initiative', 'and', 'stock', 'price', 'movement', 'analyst', 'note', 'bio', '##gen', 'id', '##ec', 'br', '##ist', '##ol', 'my', '##ers', 're', '##gene', '##ron', 'p', '##har', '##ma', 'ill', '##umi', '##na', 'west', 'p', '##har', '##ma', 'service']",1
277822,nifty_838,2014-04-08,"Healthcare Companies Report Recognitions, Schedules, and Stock Movements - Analyst Notes on WellPoint, Quest Diagnostics, LabCorp, Covance, and Masimo",Rise,0.0108,150,healthcare company report recognition schedule and stock movement analyst note wellpoint quest diagnostics labcorp covance and masimo,133,17,0,pharmacy,"['healthcare', 'company', 'report', 'recognition', 'schedule', 'and', 'stock', 'movement', 'analyst', 'note', 'well', '##point', 'quest', 'diagnostic', '##s', 'lab', '##cor', '##p', 'co', '##vance', 'and', 'ma', '##si', '##mo']",1
277860,nifty_838,2014-04-08,"Divestitures, New Drug Launches, Product Deliveries, Latest News and Stock Updates - Analyst Notes on Encana, Perrigo, Boeing, Genworth, and Itau Unibanco",Rise,0.0108,154,divestiture new drug launch product delivery latest news and stock update analyst note encana perrigo boeing genworth and itau unibanco,135,20,0,pharmacy,"['dive', '##st', '##iture', 'new', 'drug', 'launch', 'product', 'delivery', 'latest', 'news', 'and', 'stock', 'update', 'analyst', 'note', 'en', '##can', '##a', 'per', '##rig', '##o', 'b', '##oe', '##ing', 'g', '##en', '##worth', 'and', 'it', '##au', 'un', '##iba', '##nco']",1
277868,nifty_838,2014-04-08,"Research and Markets: Global Proteomics Market (Technology, Instruments, Reagents & Services) - Global Forecast to 2018",Rise,0.0108,119,research and market global proteomics market technology instrument reagent service global forecast,98,12,0,pharmacy,"['research', 'and', 'market', 'global', 'pro', '##te', '##omi', '##cs', 'market', 'technology', 'instrument', 're', '##age', '##nt', 'service', 'global', 'forecast']",1
277872,nifty_838,2014-04-08,Research and Markets: Singapore Clinical Trial Market Analysis 2014,Rise,0.0108,67,research and market singapore clinical trial market analysis,60,8,0,pharmacy,"['research', 'and', 'market', 'sing', '##ap', '##ore', 'clinical', 'trial', 'market', 'analysis']",1
278004,nifty_838,2014-04-08,ReFlow Medical and MicroPort Scientific Announce Chinese Alliance,Rise,0.0108,65,reflow medical and microport scientific announce chinese alliance,65,8,0,pharmacy,"['re', '##flow', 'medical', 'and', 'micro', '##port', 'scientific', 'announce', 'chin', '##ese', 'alliance']",1
278122,nifty_838,2014-04-08,Research and Markets: Electrodes for Medical Devices - Global Strategic Business Report 2014,Rise,0.0108,92,research and market electrode for medical device global strategic business report,81,11,0,pharmacy,"['research', 'and', 'market', 'electro', '##de', 'for', 'medical', 'device', 'global', 'strategic', 'business', 'report']",1
278142,nifty_838,2014-04-08,"Research and Markets: Innovations in Emerging Africa Economies - Healthcare, Information & Communications, Materials & Coatings, and Automation & Electronics",Rise,0.0108,157,research and market innovation emerging africa economy healthcare information communication material coating and automation electronics,135,15,0,pharmacy,"['research', 'and', 'market', 'innovation', 'emerging', 'a', '##f', '##rica', 'economy', 'healthcare', 'information', 'communication', 'material', 'coating', 'and', 'automation', 'electronics']",1
278184,nifty_838,2014-04-08,"Research and Markets: Global Digital Pathology Market Forecasts & Opportunities, 2020",Rise,0.0108,85,research and market global digital pathology market forecast opportunity,72,9,0,pharmacy,"['research', 'and', 'market', 'global', 'digital', 'path', '##ology', 'market', 'forecast', 'opportunity']",1
278186,nifty_838,2014-04-08,Research and Markets: Japanese Sales Practices at Pharmaceutical Firms,Rise,0.0108,70,research and market japanese sale practice pharmaceutical firm,62,8,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##nese', 'sale', 'practice', 'pharmaceutical', 'firm']",1
278215,nifty_838,2014-04-08,Research and Markets: Top Technologies in Medical Devices - What will Change the Landscape in the Next 3-4 years?,Rise,0.0108,113,research and market top technology medical device what will change the landscape the next year,94,15,0,pharmacy,"['research', 'and', 'market', 'top', 'technology', 'medical', 'device', 'what', 'will', 'change', 'the', 'landscape', 'the', 'next', 'year']",1
278256,nifty_838,2014-04-08,"Active Stocks Coverage -- Research on Mallinckrodt, American Eagle Outfitters, Blackstone, and Inovio Pharma",Rise,0.0108,108,active stock coverage research mallinckrodt american eagle outfitter blackstone and inovio pharma,97,12,0,pharmacy,"['active', 'stock', 'coverage', 'research', 'mall', '##in', '##ck', '##rod', '##t', 'am', '##eric', '##an', 'eagle', 'outfit', '##ter', 'blacks', '##tone', 'and', 'in', '##ov', '##io', 'p', '##har', '##ma']",1
278272,nifty_838,2014-04-08,"Coverage of Biotech Equities -- Research on Arena Pharma, Celgene, PDL BioPharma, and Hemispherx Biopharma",Rise,0.0108,106,coverage biotech equity research arena pharma celgene pdl biopharma and hemispherx biopharma,92,12,0,pharmacy,"['coverage', 'bio', '##tech', 'equity', 'research', 'arena', 'p', '##har', '##ma', 'c', '##el', '##gene', 'p', '##dl', 'bio', '##pha', '##rma', 'and', 'hem', '##is', '##pher', '##x', 'bio', '##pha', '##rma']",1
278273,nifty_838,2014-04-08,"Research and Markets: Global Diagnostic Imaging Market (X-ray, CT, Ultrasound, MRI & Nuclear Imaging) Report 2014- 2018",Rise,0.0108,119,research and market global diagnostic imaging market ray ultrasound mri nuclear imaging report,94,13,0,pharmacy,"['research', 'and', 'market', 'global', 'diagnostic', 'imaging', 'market', 'ray', 'ultra', '##sound', 'm', '##ri', 'nuclear', 'imaging', 'report']",1
278293,nifty_838,2014-04-08,"Research and Markets: Global Breast Imaging (Mammography, MRI, Ultrasound, Tomosynthesis, Nuclear, Thermography & Bioelectric Imaging) Market 2013-2019",Rise,0.0108,151,research and market global breast imaging mammography mri ultrasound tomosynthesis nuclear thermography bioelectric imaging market,130,15,0,pharmacy,"['research', 'and', 'market', 'global', 'breast', 'imaging', 'ma', '##mm', '##ography', 'm', '##ri', 'ultra', '##sound', 'to', '##mos', '##ynth', '##esis', 'nuclear', 'the', '##rm', '##ography', 'bio', '##ele', '##ct', '##ric', 'imaging', 'market']",1
278308,nifty_838,2014-04-08,"Health Care Sector Stocks under Review -- Research on Sanofi, Impax Laboratories, Keryx Biopharma, and Rigel Pharma",Rise,0.0108,115,health care sector stock under review research sanofi impax laboratory keryx biopharma and rigel pharma,103,15,0,pharmacy,"['health', 'care', 'sector', 'stock', 'under', 'review', 'research', 'sa', '##no', '##fi', 'imp', '##ax', 'laboratory', 'k', '##ery', '##x', 'bio', '##pha', '##rma', 'and', 'rig', '##el', 'p', '##har', '##ma']",1
278310,nifty_838,2014-04-08,"Changing Healthcare Marketplace, Accountable Care Organization Implementation Lead Sage Technologies to Rapid Growth, Expanded Leadership Team",Rise,0.0108,142,changing healthcare marketplace accountable care organization implementation lead sage technology rapid growth expanded leadership team,135,15,0,pharmacy,"['changing', 'healthcare', 'marketplace', 'account', '##able', 'care', 'organization', 'implementation', 'lead', 'sage', 'technology', 'rapid', 'growth', 'expanded', 'leadership', 'team']",1
278573,nifty_838,2014-04-08,Alkermes Treatment for Schizophrenia Shows Positive Results,Rise,0.0108,59,alkermes treatment for schizophrenia show positive result,57,7,0,pharmacy,"['al', '##ker', '##mes', 'treatment', 'for', 's', '##chi', '##zophrenia', 'show', 'positive', 'result']",1
278730,nifty_839,2014-04-09,Research and Markets: EMI and RFI Shielding Materials and Technologies - Global Strategic Business Report 2014,Fall,-0.021,110,research and market emi and rfi shielding material and technology global strategic business report,98,14,0,pharmacy,"['research', 'and', 'market', 'em', '##i', 'and', 'r', '##fi', 'shield', '##ing', 'material', 'and', 'technology', 'global', 'strategic', 'business', 'report']",1
278856,nifty_839,2014-04-09,Research and Markets: Top Technologies in Health and Wellness,Fall,-0.021,61,research and market top technology health and wellness,54,8,0,pharmacy,"['research', 'and', 'market', 'top', 'technology', 'health', 'and', 'well', '##ness']",1
278879,nifty_839,2014-04-09,"Healthcare Companies Report Regulatory Affirmations, MPA Inspections, Enrollment in Trials, Stock Movements - Analyst Notes on Halozyme, Align Technology, Cambrex, Receptos, and Anacor Pharmaceuticals",Fall,-0.021,200,healthcare company report regulatory affirmation mpa inspection enrollment trial stock movement analyst note halozyme align technology cambrex receptos and anacor pharmaceutical,177,21,0,pharmacy,"['healthcare', 'company', 'report', 'regulatory', 'a', '##ff', '##ir', '##mation', 'm', '##pa', 'inspection', 'enrollment', 'trial', 'stock', 'movement', 'analyst', 'note', 'ha', '##lo', '##zy', '##me', 'al', '##ign', 'technology', 'ca', '##mbre', '##x', 're', '##ce', '##pt', '##os', 'and', 'an', '##aco', '##r', 'pharmaceutical']",1
278881,nifty_839,2014-04-09,"Upcoming Financial Results, Recent Investments and Agreements, and Expanded Collaborations - Analyst Notes on PerkinElmer, PAREXEL, WuXi, Response Genetics, and Foundation Medicine",Fall,-0.021,180,upcoming financial result recent investment and agreement and expanded collaboration analyst note perkinelmer parexel wuxi response genetics and foundation medicine,164,20,0,pharmacy,"['upcoming', 'financial', 'result', 'recent', 'investment', 'and', 'agreement', 'and', 'expanded', 'collaboration', 'analyst', 'note', 'per', '##kin', '##el', '##mer', 'par', '##ex', '##el', 'w', '##ux', '##i', 'response', 'genetics', 'and', 'foundation', 'medicine']",1
278913,nifty_839,2014-04-09,"Upcoming Results and Conference Call Schedules, New Office Facility, and Stock Price Movements-Analyst Notes on Biogen, Actavis, Bristol-Myers, AbbVie, and Baxter",Fall,-0.021,162,upcoming result and conference call schedule new office facility and stock price movement analyst note biogen actavis bristol myers abbvie and baxter,149,22,0,pharmacy,"['upcoming', 'result', 'and', 'conference', 'call', 'schedule', 'new', 'office', 'facility', 'and', 'stock', 'price', 'movement', 'analyst', 'note', 'bio', '##gen', 'act', '##avi', '##s', 'br', '##ist', '##ol', 'my', '##ers', 'a', '##bb', '##vie', 'and', 'b', '##ax', '##ter']",1
278915,nifty_839,2014-04-09,"Enrollment in Expansion Phase of Trials, Results and Initiation of Phase 2 Studies and Stock Movements - Analyst Notes on Pfizer, Cytokinetics, Portola Pharmaceuticals, Volcano, and Array BioPharma",Fall,-0.021,197,enrollment expansion phase trial result and initiation phase study and stock movement analyst note pfizer cytokinetics portola pharmaceutical volcano and array biopharma,169,22,0,pharmacy,"['enrollment', 'expansion', 'phase', 'trial', 'result', 'and', 'initiation', 'phase', 'study', 'and', 'stock', 'movement', 'analyst', 'note', 'p', '##fi', '##zer', 'c', '##yt', '##oki', '##net', '##ics', 'port', '##ola', 'pharmaceutical', 'volcano', 'and', 'array', 'bio', '##pha', '##rma']",1
278949,nifty_839,2014-04-09,Millennium HealthCare Inc. Continues To Grow Distribution Network With Another New Network Selling Agreement,Fall,-0.021,108,millennium healthcare inc continues grow distribution network with another new network selling agreement,104,13,0,pharmacy,"['millennium', 'healthcare', 'in', '##c', 'continues', 'grow', 'distribution', 'network', 'with', 'another', 'new', 'network', 'selling', 'agreement']",1
278969,nifty_839,2014-04-09,Tonix Pharmaceuticals Spotlighted in April 7 Issue of BioCentury,Fall,-0.021,64,tonix pharmaceutical spotlighted april issue biocentury,55,6,0,pharmacy,"['ton', '##ix', 'pharmaceutical', 'spotlight', '##ed', 'a', '##p', '##ril', 'issue', 'bio', '##cent', '##ury']",1
278970,nifty_839,2014-04-09,"'mHealth: Global Opportunities and Challenges,' Groundbreaking Text Released by Convurgent Publishing",Fall,-0.021,101,mhealth global opportunity and challenge groundbreaking text released convurgent publishing,91,10,0,pharmacy,"['m', '##hea', '##lt', '##h', 'global', 'opportunity', 'and', 'challenge', 'groundbreaking', 'text', 'released', 'con', '##vu', '##rgent', 'publishing']",1
278988,nifty_839,2014-04-09,Research and Markets: Innovations in Bionics (Technical Insights),Fall,-0.021,65,research and market innovation bionics technical insight,56,7,0,pharmacy,"['research', 'and', 'market', 'innovation', 'bio', '##nics', 'technical', 'insight']",1
279031,nifty_839,2014-04-09,"Research and Markets: Global Diabetic Nephropathy Market 2014-2018 with Merck & Co, Mitsubishi Tanabe Pharma, Novartis AG & Sanofi S.A. Dominating",Fall,-0.021,146,research and market global diabetic nephropathy market with merck mitsubishi tanabe pharma novartis sanofi dominating,117,15,0,pharmacy,"['research', 'and', 'market', 'global', 'di', '##abe', '##tic', 'ne', '##ph', '##rop', '##athy', 'market', 'with', 'me', '##rc', '##k', 'mit', '##su', '##bish', '##i', 'tan', '##abe', 'p', '##har', '##ma', 'no', '##var', '##tis', 'sa', '##no', '##fi', 'dominating']",1
279074,nifty_839,2014-04-09,"Equities to Watch in the Health Care Sector -- Research on AbbVie, GlaxoSmithKline, AstraZeneca, and Novartis",Fall,-0.021,109,equity watch the health care sector research abbvie glaxosmithkline astrazeneca and novartis,92,12,0,pharmacy,"['equity', 'watch', 'the', 'health', 'care', 'sector', 'research', 'a', '##bb', '##vie', 'g', '##lax', '##os', '##mith', '##k', '##line', 'as', '##tra', '##zen', '##eca', 'and', 'no', '##var', '##tis']",1
279103,nifty_839,2014-04-09,"Technical Data on Active Equities -- Research on CVS Caremark, Walgreen, Exelon, and Gigamon",Fall,-0.021,92,technical data active equity research cv caremark walgreen exelon and gigamon,77,11,0,pharmacy,"['technical', 'data', 'active', 'equity', 'research', 'c', '##v', 'care', '##mark', 'wa', '##l', '##green', 'ex', '##elo', '##n', 'and', 'gig', '##amon']",1
279109,nifty_839,2014-04-09,"Health Care Sector Stocks under Review -- Research on Endo Intl., Dynavax Technologies, Forest Laboratories, and Orexigen Therapeutics",Fall,-0.021,134,health care sector stock under review research endo intl dynavax technology forest laboratory and orexigen therapeutic,118,16,0,pharmacy,"['health', 'care', 'sector', 'stock', 'under', 'review', 'research', 'end', '##o', 'in', '##tl', 'd', '##yna', '##va', '##x', 'technology', 'forest', 'laboratory', 'and', 'ore', '##xi', '##gen', 'therapeutic']",1
279119,nifty_839,2014-04-09,Research and Markets: The Future of Personalized Genomics,Fall,-0.021,57,research and market the future personalized genomics,52,7,0,pharmacy,"['research', 'and', 'market', 'the', 'future', 'personal', '##ized', 'g', '##eno', '##mic', '##s']",1
279137,nifty_839,2014-04-09,Research and Markets: Global Insulin Delivery Devices Market to 2019,Fall,-0.021,68,research and market global insulin delivery device market,57,8,0,pharmacy,"['research', 'and', 'market', 'global', 'insulin', 'delivery', 'device', 'market']",1
279165,nifty_839,2014-04-09,"Stocks with Approaching Earnings Release -- Research on St Jude Medical, Steel Dynamics, United Rentals, and Advanced Micro Devices",Fall,-0.021,131,stock with approaching earnings release research jude medical steel dynamic united rental and advanced micro device,115,16,0,pharmacy,"['stock', 'with', 'approaching', 'earnings', 'release', 'research', 'j', '##ude', 'medical', 'steel', 'dynamic', 'united', 'rental', 'and', 'advanced', 'micro', 'device']",1
279217,nifty_839,2014-04-09,Biotech Leader Testifies at Congressional Hearing on Legislative Proposals to Enhance Capital Formation for Small and Emerging Growth Companies,Fall,-0.021,143,biotech leader testifies congressional hearing legislative proposal enhance capital formation for small and emerging growth company,131,16,0,pharmacy,"['bio', '##tech', 'leader', 'test', '##ifies', 'congressional', 'hearing', 'legislative', 'proposal', 'enhance', 'capital', 'formation', 'for', 'small', 'and', 'emerging', 'growth', 'company']",1
279271,nifty_839,2014-04-09,U.S. Market for Pain Management Devices Will Reach Nearly $2.7 Billion by 2022,Fall,-0.021,78,market for pain management device will reach nearly billion,59,9,0,pharmacy,"['market', 'for', 'pain', 'management', 'device', 'will', 'reach', 'nearly', 'billion']",1
279304,nifty_839,2014-04-09,Research and Markets: United Kingdom Nuclear Imaging Equipment Market Outlook to 2020,Fall,-0.021,85,research and market united kingdom nuclear imaging equipment market outlook,75,10,0,pharmacy,"['research', 'and', 'market', 'united', 'kingdom', 'nuclear', 'imaging', 'equipment', 'market', 'outlook']",1
279614,nifty_840,2014-04-10,Biotech Stocks' Rout Perplexes Analysts,Fall,-0.009,39,biotech stock rout perplexes analyst,36,5,0,pharmacy,"['bio', '##tech', 'stock', 'r', '##out', 'per', '##plex', '##es', 'analyst']",1
279744,nifty_841,2014-04-14,India's Lupin Recalls Drugs in U.S.,Rise,0.0069,35,india lupin recall drug,23,4,0,pharmacy,"['in', '##dia', 'l', '##up', '##in', 'recall', 'drug']",1
279791,nifty_842,2014-04-15,Glaxo Wins U.S. Approval for Diabetes Treatment Albiglutide,Rise,0.0105,59,glaxo win approval for diabetes treatment albiglutide,53,7,0,pharmacy,"['g', '##lax', '##o', 'win', 'approval', 'for', 'diabetes', 'treatment', 'al', '##bi', '##g', '##lut', '##ide']",1
279909,nifty_843,2014-04-16,FDA Warns Endo Unit Over Minnesota Facility,Neutral,0.0014,43,fda warns endo unit over minnesota facility,43,7,0,pharmacy,"['f', '##da', 'warns', 'end', '##o', 'unit', 'over', 'min', '##nes', '##ota', 'facility']",1
279911,nifty_843,2014-04-16,St. Jude Medical Earnings Rise 12%; Boosts 2014 Outlook,Neutral,0.0014,55,jude medical earnings rise boost outlook,40,6,0,pharmacy,"['j', '##ude', 'medical', 'earnings', 'rise', 'boost', 'outlook']",1
279931,nifty_844,2014-04-21,Activist Aims to Combine Health Giants,Neutral,0.0045,38,activist aim combine health giant,33,5,0,pharmacy,"['activist', 'aim', 'combine', 'health', 'giant']",1
279986,nifty_845,2014-04-22,Drug Companies Back in Deal Mode,Neutral,-0.0023,32,drug company back deal mode,27,5,0,pharmacy,"['drug', 'company', 'back', 'deal', 'mode']",1
280038,nifty_845,2014-04-22,Pharma Shares Rise,Neutral,-0.0023,18,pharma share rise,17,3,0,pharmacy,"['p', '##har', '##ma', 'share', 'rise']",1
280045,nifty_845,2014-04-22,Big Pharma's Deal Frenzy,Neutral,-0.0023,24,big pharma deal frenzy,22,4,0,pharmacy,"['big', 'p', '##har', '##ma', 'deal', 'frenzy']",1
280055,nifty_845,2014-04-22,Glaxo Exits Cancer Drugs,Neutral,-0.0023,24,glaxo exit cancer drug,22,4,0,pharmacy,"['g', '##lax', '##o', 'exit', 'cancer', 'drug']",1
280071,nifty_845,2014-04-22,"Healthscope Draws Interest from China, Malaysia and the U.S.",Neutral,-0.0023,60,healthscope draw interest from china malaysia and the,53,8,0,pharmacy,"['health', '##scope', 'draw', 'interest', 'from', 'chin', '##a', 'ma', '##lay', '##sia', 'and', 'the']",1
280119,nifty_846,2014-04-23,Biogen Idec Profit Rises 12%,Neutral,0.002,28,biogen idec profit rise,23,4,0,pharmacy,"['bio', '##gen', 'id', '##ec', 'profit', 'rise']",1
280221,nifty_847,2014-04-24,Takeda May Not Cover Lilly's Share of Diabetes-Drug Lawsuit,Fall,-0.0082,59,takeda may not cover lilly share diabetes drug lawsuit,54,9,0,pharmacy,"['take', '##da', 'may', 'not', 'cover', 'l', '##ill', '##y', 'share', 'diabetes', 'drug', 'lawsuit']",1
280286,nifty_847,2014-04-24,Novartis Profit Rises,Fall,-0.0082,21,novartis profit rise,20,3,0,pharmacy,"['no', '##var', '##tis', 'profit', 'rise']",1
280350,nifty_848,2014-04-28,Sartorius Stedim Biotech acquires majority stake in U.S. start-up AllPure Technologies,Neutral,0.0047,86,sartorius stedim biotech acquires majority stake start allpure technology,73,9,0,pharmacy,"['sa', '##rt', '##ori', '##us', 's', '##ted', '##im', 'bio', '##tech', 'acquire', '##s', 'majority', 'stake', 'start', 'all', '##pur', '##e', 'technology']",1
280397,nifty_848,2014-04-28,Orca Pharmaceuticals Achieves Development Milestone and Secures Additional Funding,Neutral,0.0047,82,orca pharmaceutical achieves development milestone and secures additional funding,81,9,0,pharmacy,"['or', '##ca', 'pharmaceutical', 'achieve', '##s', 'development', 'milestone', 'and', 'secure', '##s', 'additional', 'funding']",1
280428,nifty_848,2014-04-28,"Research and Markets: BRIC Nuclear Imaging Equipment Market Outlook to 2020 Featuring Key Players, GE Healthcare, Philips Healthcare and Siemens Healthcare",Neutral,0.0047,155,research and market bric nuclear imaging equipment market outlook featuring key player healthcare philip healthcare and siemens healthcare,138,18,0,pharmacy,"['research', 'and', 'market', 'br', '##ic', 'nuclear', 'imaging', 'equipment', 'market', 'outlook', 'featuring', 'key', 'player', 'healthcare', 'p', '##hil', '##ip', 'healthcare', 'and', 'si', '##em', '##ens', 'healthcare']",1
280440,nifty_848,2014-04-28,Research and Markets: PharmaPoint: Migraine - Japan Drug Forecast and Market Analysis to 2023,Neutral,0.0047,93,research and market pharmapoint migraine japan drug forecast and market analysis,80,11,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##point', 'mi', '##gra', '##ine', 'j', '##apa', '##n', 'drug', 'forecast', 'and', 'market', 'analysis']",1
280448,nifty_848,2014-04-28,Research and Markets: Neutropenia Therapeutic Pipeline Review 2014 - Analysis of 16 Companies and 25 Drug Profiles,Neutral,0.0047,114,research and market neutropenia therapeutic pipeline review analysis company and drug profile,93,12,0,pharmacy,"['research', 'and', 'market', 'ne', '##ut', '##rop', '##enia', 'therapeutic', 'pipeline', 'review', 'analysis', 'company', 'and', 'drug', 'profile']",1
280453,nifty_848,2014-04-28,"Research and Markets: BRIC MRI Systems Market Outlook to 2020: High Field MRI Systems, Low Field MRI Systems and Mid Field MRI Systems",Neutral,0.0047,134,research and market bric mri system market outlook high field mri system low field mri system and mid field mri system,118,21,0,pharmacy,"['research', 'and', 'market', 'br', '##ic', 'm', '##ri', 'system', 'market', 'outlook', 'high', 'field', 'm', '##ri', 'system', 'low', 'field', 'm', '##ri', 'system', 'and', 'mid', 'field', 'm', '##ri', 'system']",1
280466,nifty_848,2014-04-28,Research and Markets: Global Polycystic Kidney Disease Therapeutic Pipeline Review 2014,Neutral,0.0047,87,research and market global polycystic kidney disease therapeutic pipeline review,80,10,0,pharmacy,"['research', 'and', 'market', 'global', 'p', '##oly', '##cy', '##stic', 'kidney', 'disease', 'therapeutic', 'pipeline', 'review']",1
280478,nifty_848,2014-04-28,Kraig Biocraft Laboratories Launches New Investor Relations Website,Neutral,0.0047,67,kraig biocraft laboratory launch new investor relation website,62,8,0,pharmacy,"['k', '##rai', '##g', 'bio', '##craft', 'laboratory', 'launch', 'new', 'investor', 'relation', 'website']",1
280487,nifty_848,2014-04-28,Research and Markets: Global Dyskinesia Therapeutic Pipeline Review 2014,Neutral,0.0047,72,research and market global dyskinesia therapeutic pipeline review,65,8,0,pharmacy,"['research', 'and', 'market', 'global', 'd', '##ys', '##kin', '##esi', '##a', 'therapeutic', 'pipeline', 'review']",1
280492,nifty_848,2014-04-28,Research and Markets: Global Hemophilia B Therapeutic Pipeline Review 2014,Neutral,0.0047,74,research and market global hemophilia therapeutic pipeline review,65,8,0,pharmacy,"['research', 'and', 'market', 'global', 'hem', '##op', '##hil', '##ia', 'therapeutic', 'pipeline', 'review']",1
280507,nifty_848,2014-04-28,Research and Markets: Global Bipolar Disorder (Manic Depression) Therapeutic Pipeline Review 2014,Neutral,0.0047,97,research and market global bipolar disorder manic depression therapeutic pipeline review,88,11,0,pharmacy,"['research', 'and', 'market', 'global', 'bi', '##pol', '##ar', 'disorder', 'man', '##ic', 'depression', 'therapeutic', 'pipeline', 'review']",1
280510,nifty_848,2014-04-28,Research and Markets: Thrombocytopenia Therapeutic Pipeline Review 2014 - Analysis of 20 Companies and 25 Drug Profiles,Neutral,0.0047,119,research and market thrombocytopenia therapeutic pipeline review analysis company and drug profile,98,12,0,pharmacy,"['research', 'and', 'market', 'th', '##rom', '##bo', '##cy', '##top', '##enia', 'therapeutic', 'pipeline', 'review', 'analysis', 'company', 'and', 'drug', 'profile']",1
280513,nifty_848,2014-04-28,Research and Markets: Global Neuropathic Pain Therapeutics Pipeline Review 2014,Neutral,0.0047,79,research and market global neuropathic pain therapeutic pipeline review,71,9,0,pharmacy,"['research', 'and', 'market', 'global', 'ne', '##uro', '##pathic', 'pain', 'therapeutic', 'pipeline', 'review']",1
280528,nifty_848,2014-04-28,Research and Markets: Global Urinary Tract Infections Therapeutic Pipeline Review 2014,Neutral,0.0047,86,research and market global urinary tract infection therapeutic pipeline review,78,10,0,pharmacy,"['research', 'and', 'market', 'global', 'u', '##rina', '##ry', 'tract', 'infection', 'therapeutic', 'pipeline', 'review']",1
280536,nifty_848,2014-04-28,Research and Markets: Global Candidiasis Therapeutics Pipeline Review 2014,Neutral,0.0047,74,research and market global candidiasis therapeutic pipeline review,66,8,0,pharmacy,"['research', 'and', 'market', 'global', 'can', '##di', '##dia', '##sis', 'therapeutic', 'pipeline', 'review']",1
280540,nifty_848,2014-04-28,"OncoGenex to Report Financial Results for First Quarter 2014 on April 30, 2014",Neutral,0.0047,78,oncogenex report financial result for first quarter april,57,8,0,pharmacy,"['on', '##co', '##gene', '##x', 'report', 'financial', 'result', 'for', 'first', 'quarter', 'a', '##p', '##ril']",1
280607,nifty_848,2014-04-28,"Strategic Collaborations, Fresh Agreements, and Upcoming Conferences - Analyst Notes on Biogen, Bristol-Myers, AbbVie, Actavis and Bard",Neutral,0.0047,135,strategic collaboration fresh agreement and upcoming conference analyst note biogen bristol myers abbvie actavis and bard,121,16,0,pharmacy,"['strategic', 'collaboration', 'fresh', 'agreement', 'and', 'upcoming', 'conference', 'analyst', 'note', 'bio', '##gen', 'br', '##ist', '##ol', 'my', '##ers', 'a', '##bb', '##vie', 'act', '##avi', '##s', 'and', 'bar', '##d']",1
280681,nifty_848,2014-04-28,Research and Markets: Global Chronic Kidney Disease (Chronic Renal Failure) Therapeutic Pipeline Review 2014,Neutral,0.0047,108,research and market global chronic kidney disease chronic renal failure therapeutic pipeline review,99,13,0,pharmacy,"['research', 'and', 'market', 'global', 'chronic', 'kidney', 'disease', 'chronic', 're', '##nal', 'failure', 'therapeutic', 'pipeline', 'review']",1
280707,nifty_848,2014-04-28,MolecularHealth Continues to Bolster Advisory Board with Industry Experts,Neutral,0.0047,73,molecularhealth continues bolster advisory board with industry expert,69,8,0,pharmacy,"['molecular', '##hea', '##lt', '##h', 'continues', 'b', '##ols', '##ter', 'advisory', 'board', 'with', 'industry', 'expert']",1
280727,nifty_848,2014-04-28,Pharma event risk hits investors,Neutral,0.0047,32,pharma event risk hit investor,30,5,0,pharmacy,"['p', '##har', '##ma', 'event', 'risk', 'hit', 'investor']",1
280758,nifty_848,2014-04-28,Research and Markets: Global Kidney Disease Therapeutics Pipeline Review 2014 - Analysis of 22 Companies & 32 Drug Profiles,Neutral,0.0047,123,research and market global kidney disease therapeutic pipeline review analysis company drug profile,99,13,0,pharmacy,"['research', 'and', 'market', 'global', 'kidney', 'disease', 'therapeutic', 'pipeline', 'review', 'analysis', 'company', 'drug', 'profile']",1
280805,nifty_848,2014-04-28,Research and Markets: Global Acute Respiratory Distress Syndrome Therapeutics Pipeline Review 2014 - Analysis of 9 Companies & 22 Drug Profiles,Neutral,0.0047,143,research and market global acute respiratory distress syndrome therapeutic pipeline review analysis company drug profile,120,15,0,pharmacy,"['research', 'and', 'market', 'global', 'acute', 'respiratory', 'distress', 'syndrome', 'therapeutic', 'pipeline', 'review', 'analysis', 'company', 'drug', 'profile']",1
280889,nifty_848,2014-04-28,Research and Markets: Global Biomarker Partnering Terms and Agreements Deals 2014,Neutral,0.0047,81,research and market global biomarker partnering term and agreement deal,71,10,0,pharmacy,"['research', 'and', 'market', 'global', 'bio', '##mark', '##er', 'partner', '##ing', 'term', 'and', 'agreement', 'deal']",1
280898,nifty_848,2014-04-28,"Research and Markets: Global Pharma, Biotech and Diagnostics Co-promotion and Co-marketing Partnering Terms and Agreements Analysis",Neutral,0.0047,131,research and market global pharma biotech and diagnostics promotion and marketing partnering term and agreement analysis,120,16,0,pharmacy,"['research', 'and', 'market', 'global', 'p', '##har', '##ma', 'bio', '##tech', 'and', 'diagnostic', '##s', 'promotion', 'and', 'marketing', 'partner', '##ing', 'term', 'and', 'agreement', 'analysis']",1
280900,nifty_848,2014-04-28,Research and Markets: Companion Diagnostics Partnering Terms & Agreements Deals Analysis Report 2014,Neutral,0.0047,100,research and market companion diagnostics partnering term agreement deal analysis report,88,11,0,pharmacy,"['research', 'and', 'market', 'companion', 'diagnostic', '##s', 'partner', '##ing', 'term', 'agreement', 'deal', 'analysis', 'report']",1
280921,nifty_848,2014-04-28,Research and Markets: Global Pharma and Biotech Clinical Stage Partnering Terms and Agreements Analysis 2014,Neutral,0.0047,108,research and market global pharma and biotech clinical stage partnering term and agreement analysis,99,14,0,pharmacy,"['research', 'and', 'market', 'global', 'p', '##har', '##ma', 'and', 'bio', '##tech', 'clinical', 'stage', 'partner', '##ing', 'term', 'and', 'agreement', 'analysis']",1
280923,nifty_848,2014-04-28,Research and Markets: Latest Diagnostics Partnering Terms and Agreements Deals Analysis 2014,Neutral,0.0047,92,research and market latest diagnostics partnering term and agreement deal analysis,82,11,0,pharmacy,"['research', 'and', 'market', 'latest', 'diagnostic', '##s', 'partner', '##ing', 'term', 'and', 'agreement', 'deal', 'analysis']",1
280931,nifty_848,2014-04-28,"Research and Markets: Global Pharma, Biotech and Diagnostics Distribution Partnering Terms and Agreements Deals Analysis 2009-2013",Neutral,0.0047,130,research and market global pharma biotech and diagnostics distribution partnering term and agreement deal analysis,114,15,0,pharmacy,"['research', 'and', 'market', 'global', 'p', '##har', '##ma', 'bio', '##tech', 'and', 'diagnostic', '##s', 'distribution', 'partner', '##ing', 'term', 'and', 'agreement', 'deal', 'analysis']",1
280955,nifty_848,2014-04-28,"Research and Markets: Global Pharma, Biotech and Diagnostics Asset Purchase Terms and Agreements Deals Analysis 2009-2014",Neutral,0.0047,121,research and market global pharma biotech and diagnostics asset purchase term and agreement deal analysis,105,15,0,pharmacy,"['research', 'and', 'market', 'global', 'p', '##har', '##ma', 'bio', '##tech', 'and', 'diagnostic', '##s', 'asset', 'purchase', 'term', 'and', 'agreement', 'deal', 'analysis']",1
280959,nifty_848,2014-04-28,"Research and Markets: Global Pharma, Biotech and Diagnostics Royalty Financing Partnering Terms and Agreements Deals Analysis 2007-2014",Neutral,0.0047,135,research and market global pharma biotech and diagnostics royalty financing partnering term and agreement deal analysis,119,16,0,pharmacy,"['research', 'and', 'market', 'global', 'p', '##har', '##ma', 'bio', '##tech', 'and', 'diagnostic', '##s', 'royalty', 'financing', 'partner', '##ing', 'term', 'and', 'agreement', 'deal', 'analysis']",1
280969,nifty_848,2014-04-28,"Research and Markets: Global Pharma, Biotech and Diagnostics Option and Evaluation Partnering Terms and Agreements Deals Report 2014",Neutral,0.0047,132,research and market global pharma biotech and diagnostics option and evaluation partnering term and agreement deal report,121,17,0,pharmacy,"['research', 'and', 'market', 'global', 'p', '##har', '##ma', 'bio', '##tech', 'and', 'diagnostic', '##s', 'option', 'and', 'evaluation', 'partner', '##ing', 'term', 'and', 'agreement', 'deal', 'report']",1
280996,nifty_848,2014-04-28,Research and Markets: Global Metabolic Syndrome Therapeutics Pipeline Review 2014 - Analysis of 14 Companies & 33 Drug Profiles,Neutral,0.0047,127,research and market global metabolic syndrome therapeutic pipeline review analysis company drug profile,103,13,0,pharmacy,"['research', 'and', 'market', 'global', 'metabolic', 'syndrome', 'therapeutic', 'pipeline', 'review', 'analysis', 'company', 'drug', 'profile']",1
281004,nifty_848,2014-04-28,"Research and Markets: Global Orphan Drugs Market Forecasts & Opportunities, 2018",Neutral,0.0047,80,research and market global orphan drug market forecast opportunity,66,9,0,pharmacy,"['research', 'and', 'market', 'global', 'orphan', 'drug', 'market', 'forecast', 'opportunity']",1
281076,nifty_848,2014-04-28,Four U.S. FDA Supply Chain Experts to Answer Industry Questions at PDA Conference,Neutral,0.0047,81,four fda supply chain expert answer industry question pda conference,68,10,0,pharmacy,"['four', 'f', '##da', 'supply', 'chain', 'expert', 'answer', 'industry', 'question', 'p', '##da', 'conference']",1
281101,nifty_848,2014-04-28,Bankers Healthcare Group Joins Forces With National Medical Association To Provide Financing,Neutral,0.0047,92,banker healthcare group join force with national medical association provide financing,86,11,0,pharmacy,"['banker', 'healthcare', 'group', 'join', 'force', 'with', 'national', 'medical', 'association', 'provide', 'financing']",1
281182,nifty_848,2014-04-28,NPS Pharmaceuticals to Present at Bank of America Merrill Lynch Health Care Conference,Neutral,0.0047,86,np pharmaceutical present bank america merrill lynch health care conference,75,10,0,pharmacy,"['n', '##p', 'pharmaceutical', 'present', 'bank', 'am', '##eric', '##a', 'me', '##rri', '##ll', 'l', '##ync', '##h', 'health', 'care', 'conference']",1
281275,nifty_848,2014-04-28,"Research and Markets: Global Hospital Information Systems (HIS) Market 2014-2018 with Cerner, Epic Systems, McKesson & Siemens Healthcare Dominating",Neutral,0.0047,148,research and market global hospital information system his market with cerner epic system mckesson siemens healthcare dominating,128,17,0,pharmacy,"['research', 'and', 'market', 'global', 'hospital', 'information', 'system', 'his', 'market', 'with', 'c', '##erne', '##r', 'epic', 'system', 'm', '##cke', '##sson', 'si', '##em', '##ens', 'healthcare', 'dominating']",1
281365,nifty_848,2014-04-28,"Research and Markets: France Angio Suites Market Outlook to 2020 (GE Healthcare, Philips Healthcare, Siemens Healthcare and Toshiba Medical Systems Corporation dominating)",Neutral,0.0047,171,research and market france angio suite market outlook healthcare philip healthcare siemens healthcare and toshiba medical system corporation dominating,151,19,0,pharmacy,"['research', 'and', 'market', 'f', '##rance', 'an', '##gio', 'suite', 'market', 'outlook', 'healthcare', 'p', '##hil', '##ip', 'healthcare', 'si', '##em', '##ens', 'healthcare', 'and', 'to', '##shi', '##ba', 'medical', 'system', 'corporation', 'dominating']",1
281370,nifty_848,2014-04-28,"Research and Markets: Italy C-Arms Market Outlook to 2020 (GE Healthcare, Philips Healthcare, Ziehm Imaging GmbH, Siemens Healthcare, Toshiba Medical Systems Corporation and Shimadzu Corporation dominating)",Neutral,0.0047,206,research and market italy arm market outlook healthcare philip healthcare ziehm imaging gmbh siemens healthcare toshiba medical system corporation and shimadzu corporation dominating,182,23,0,pharmacy,"['research', 'and', 'market', 'it', '##aly', 'arm', 'market', 'outlook', 'healthcare', 'p', '##hil', '##ip', 'healthcare', 'z', '##ie', '##hm', 'imaging', 'g', '##mb', '##h', 'si', '##em', '##ens', 'healthcare', 'to', '##shi', '##ba', 'medical', 'system', 'corporation', 'and', 's', '##hima', '##d', '##zu', 'corporation', 'dominating']",1
281377,nifty_848,2014-04-28,AstraZeneca Chief Puts Cancer Drugs Ahead of Deals,Neutral,0.0047,50,astrazeneca chief put cancer drug ahead deal,44,7,0,pharmacy,"['as', '##tra', '##zen', '##eca', 'chief', 'put', 'cancer', 'drug', 'ahead', 'deal']",1
281439,nifty_848,2014-04-28,"Teva, OncoGenex Prostate Cancer Therapy Misses Endpoint",Neutral,0.0047,55,teva oncogenex prostate cancer therapy miss endpoint,52,7,0,pharmacy,"['te', '##va', 'on', '##co', '##gene', '##x', 'pro', '##state', 'cancer', 'therapy', 'miss', 'end', '##point']",1
281460,nifty_849,2014-04-29,"In Drug Mergers, There's One Sure Bet: The Layoffs",Neutral,0.003,50,drug merger there one sure bet the layoff,41,8,0,pharmacy,"['drug', 'merger', 'there', 'one', 'sure', 'bet', 'the', 'lay', '##off']",1
281466,nifty_849,2014-04-29,FDA Proposes More Closely Regulating Some Surgical Mesh Kits,Neutral,0.003,60,fda proposes more closely regulating some surgical mesh kit,59,9,0,pharmacy,"['f', '##da', 'proposes', 'more', 'closely', 'regulating', 'some', 'surgical', 'mesh', 'kit']",1
281497,nifty_849,2014-04-29,"Bristol-Myers Reports Higher Earnings, Biotech Buy",Neutral,0.003,50,bristol myers report higher earnings biotech buy,48,7,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'report', 'higher', 'earnings', 'bio', '##tech', 'buy']",1
281535,nifty_849,2014-04-29,Amicus Reports Positive Results for Fabry Treatment,Neutral,0.003,51,amicus report positive result for fabry treatment,49,7,0,pharmacy,"['am', '##icus', 'report', 'positive', 'result', 'for', 'f', '##ab', '##ry', 'treatment']",1
281585,nifty_850,2014-04-30,Addex Therapeutics Reports 2013 Financial Results,Neutral,0.0001,49,addex therapeutic report financial result,41,5,0,pharmacy,"['add', '##ex', 'therapeutic', 'report', 'financial', 'result']",1
281701,nifty_850,2014-04-30,Exclusive: Sanofi explores $7 billion-plus sale of drug portfolio - sources,Neutral,0.0001,75,exclusive sanofi explores billion plus sale drug portfolio source,65,9,0,pharmacy,"['exclusive', 'sa', '##no', '##fi', 'explores', 'billion', 'plus', 'sale', 'drug', 'portfolio', 'source']",1
281705,nifty_850,2014-04-30,"Financial Release Dates -- Research on Acadia Healthcare, Trulia, Grupo Financiero Santander Mexico, and Questar",Neutral,0.0001,112,financial release date research acadia healthcare trulia grupo financiero santander mexico and questar,102,13,0,pharmacy,"['financial', 'release', 'date', 'research', 'a', '##ca', '##dia', 'healthcare', 't', '##ru', '##lia', 'g', '##rup', '##o', 'fin', '##an', '##cier', '##o', 'sa', '##nta', '##nder', 'me', '##xi', '##co', 'and', 'quest', '##ar']",1
281743,nifty_850,2014-04-30,Research and Markets: Global Military Electro-optic Infrared Systems Market 2014-2018: Rising tension across borders has led to an increase in the demand for EO/IR systems globally,Neutral,0.0001,180,research and market global military electro optic infrared system market rising tension across border ha led increase the demand for system globally,148,22,0,pharmacy,"['research', 'and', 'market', 'global', 'military', 'electro', 'op', '##tic', 'infrared', 'system', 'market', 'rising', 'tension', 'across', 'border', 'ha', 'led', 'increase', 'the', 'demand', 'for', 'system', 'globally']",1
281845,nifty_850,2014-04-30,Rich Pharmaceuticals Provides Financing Update,Neutral,0.0001,46,rich pharmaceutical provides financing update,45,5,0,pharmacy,"['rich', 'pharmaceutical', 'provides', 'financing', 'update']",1
281853,nifty_850,2014-04-30,"Research and Markets: Asia-Pacific X-ray Systems Market Outlook to 2020: Key players covered include GE Healthcare, Philips Healthcare and Siemens Healthcare",Neutral,0.0001,157,research and market asia pacific ray system market outlook key player covered include healthcare philip healthcare and siemens healthcare,137,19,0,pharmacy,"['research', 'and', 'market', 'as', '##ia', 'p', '##ac', '##ific', 'ray', 'system', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'healthcare', 'p', '##hil', '##ip', 'healthcare', 'and', 'si', '##em', '##ens', 'healthcare']",1
281869,nifty_850,2014-04-30,"Research and Markets: Russia Nuclear Imaging Equipment Market Outlook to 2020: Key players covered include GE Healthcare, Philips Healthcare and Siemens Healthcare",Neutral,0.0001,163,research and market russia nuclear imaging equipment market outlook key player covered include healthcare philip healthcare and siemens healthcare,146,19,0,pharmacy,"['research', 'and', 'market', 'r', '##uss', '##ia', 'nuclear', 'imaging', 'equipment', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'healthcare', 'p', '##hil', '##ip', 'healthcare', 'and', 'si', '##em', '##ens', 'healthcare']",1
281966,nifty_850,2014-04-30,"Research and Markets: Russia X-ray Systems Market Outlook to 2020: Key players covered include GE Healthcare, Philips Healthcare, Siemens Healthcare, AMICO and Shimadzu Corporation",Neutral,0.0001,180,research and market russia ray system market outlook key player covered include healthcare philip healthcare siemens healthcare amico and shimadzu corporation,158,21,0,pharmacy,"['research', 'and', 'market', 'r', '##uss', '##ia', 'ray', 'system', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'healthcare', 'p', '##hil', '##ip', 'healthcare', 'si', '##em', '##ens', 'healthcare', 'am', '##ico', 'and', 's', '##hima', '##d', '##zu', 'corporation']",1
281975,nifty_850,2014-04-30,"Research and Markets: Brazil MRI Systems Market Outlook to 2020: Key players covered include GE Healthcare, Hitachi Medical Corporation, Philips Healthcare and Siemens Healthcare",Neutral,0.0001,178,research and market brazil mri system market outlook key player covered include healthcare hitachi medical corporation philip healthcare and siemens healthcare,159,21,0,pharmacy,"['research', 'and', 'market', 'bra', '##zi', '##l', 'm', '##ri', 'system', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'healthcare', 'hit', '##achi', 'medical', 'corporation', 'p', '##hil', '##ip', 'healthcare', 'and', 'si', '##em', '##ens', 'healthcare']",1
281979,nifty_850,2014-04-30,"Research and Markets: Italy Diagnostic Imaging Market Outlook to 2020: Key players covered include GE Healthcare, Philips Healthcare, Siemens Healthcare and Toshiba Medical Systems Corporation",Neutral,0.0001,192,research and market italy diagnostic imaging market outlook key player covered include healthcare philip healthcare siemens healthcare and toshiba medical system corporation,173,22,0,pharmacy,"['research', 'and', 'market', 'it', '##aly', 'diagnostic', 'imaging', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'healthcare', 'p', '##hil', '##ip', 'healthcare', 'si', '##em', '##ens', 'healthcare', 'and', 'to', '##shi', '##ba', 'medical', 'system', 'corporation']",1
281996,nifty_850,2014-04-30,Enanta Pharmaceuticals to Present at the 39th Annual Deutsche Bank Securities Healthcare Conference,Neutral,0.0001,99,enanta pharmaceutical present the annual deutsche bank security healthcare conference,85,10,0,pharmacy,"['en', '##ant', '##a', 'pharmaceutical', 'present', 'the', 'annual', 'de', '##uts', '##che', 'bank', 'security', 'healthcare', 'conference']",1
282012,nifty_850,2014-04-30,"Research and Markets: India Diagnostic Imaging Market Outlook to 2020: Key players covered include GE Healthcare, Philips Healthcare, Siemens Healthcare and Toshiba Medical Systems Corporation",Neutral,0.0001,192,research and market india diagnostic imaging market outlook key player covered include healthcare philip healthcare siemens healthcare and toshiba medical system corporation,173,22,0,pharmacy,"['research', 'and', 'market', 'in', '##dia', 'diagnostic', 'imaging', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'healthcare', 'p', '##hil', '##ip', 'healthcare', 'si', '##em', '##ens', 'healthcare', 'and', 'to', '##shi', '##ba', 'medical', 'system', 'corporation']",1
282075,nifty_850,2014-04-30,"Research and Markets: Japan Nuclear Imaging Equipment Market Outlook to 2020: Key players covered include GE Healthcare, Philips Healthcare and Siemens Healthcare",Neutral,0.0001,162,research and market japan nuclear imaging equipment market outlook key player covered include healthcare philip healthcare and siemens healthcare,145,19,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##n', 'nuclear', 'imaging', 'equipment', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'healthcare', 'p', '##hil', '##ip', 'healthcare', 'and', 'si', '##em', '##ens', 'healthcare']",1
282082,nifty_850,2014-04-30,"Research and Markets: Japan X-ray Systems Market Outlook to 2020: Key players covered include GE Healthcare, Philips Healthcare, Siemens Healthcare and Carestream Health",Neutral,0.0001,169,research and market japan ray system market outlook key player covered include healthcare philip healthcare siemens healthcare and carestream health,148,20,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##n', 'ray', 'system', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'healthcare', 'p', '##hil', '##ip', 'healthcare', 'si', '##em', '##ens', 'healthcare', 'and', 'cares', '##tre', '##am', 'health']",1
282125,nifty_850,2014-04-30,"Research and Markets: Global Biopreservation Market 2013-2019 - Regenerative Medicine, Biobanking, and Drug Discovery",Neutral,0.0001,117,research and market global biopreservation market regenerative medicine biobanking and drug discovery,101,12,0,pharmacy,"['research', 'and', 'market', 'global', 'bio', '##p', '##res', '##er', '##vation', 'market', 're', '##gene', '##rative', 'medicine', 'bio', '##bank', '##ing', 'and', 'drug', 'discovery']",1
282191,nifty_850,2014-04-30,Research and Markets: Asia-Pacific MRI Systems Market Outlook to 2020,Neutral,0.0001,69,research and market asia pacific mri system market outlook,58,9,0,pharmacy,"['research', 'and', 'market', 'as', '##ia', 'p', '##ac', '##ific', 'm', '##ri', 'system', 'market', 'outlook']",1
282345,nifty_850,2014-04-30,"Analysts View on Health Care Sector Equities -- Research on Becton Dickinson and Co., Thoratec, Haemonetics, and Antares Pharma",Neutral,0.0001,127,analyst view health care sector equity research becton dickinson and thoratec haemonetics and antares pharma,108,15,0,pharmacy,"['analyst', 'view', 'health', 'care', 'sector', 'equity', 'research', 'be', '##cton', 'dick', '##ins', '##on', 'and', 'th', '##ora', '##tec', 'ha', '##emon', '##etics', 'and', 'ant', '##ares', 'p', '##har', '##ma']",1
282441,nifty_850,2014-04-30,"Research and Markets: Global Radiation Cured Products Market 2013-2019: Ashland Inc., BASF SE, Bayer MaterialScience, Cytech Industries & DIC Corp Dominate this $4.9 Billion Industry",Neutral,0.0001,182,research and market global radiation cured product market ashland inc basf bayer materialscience cytech industry dic corp dominate this billion industry,152,21,0,pharmacy,"['research', 'and', 'market', 'global', 'radiation', 'cured', 'product', 'market', 'ash', '##land', 'in', '##c', 'b', '##as', '##f', 'bay', '##er', 'materials', '##cie', '##nce', 'c', '##yte', '##ch', 'industry', 'di', '##c', 'co', '##rp', 'dominate', 'this', 'billion', 'industry']",1
282494,nifty_850,2014-04-30,Avanir Pharmaceuticals Prevails in NUEDEXTA Patent Trial Resulting in Exclusivity Through 2026,Neutral,0.0001,94,avanir pharmaceutical prevails nuedexta patent trial resulting exclusivity through,82,9,0,pharmacy,"['a', '##vani', '##r', 'pharmaceutical', 'pre', '##va', '##ils', 'n', '##ued', '##ex', '##ta', 'patent', 'trial', 'resulting', 'ex', '##c', '##lus', '##ivity', 'through']",1
282533,nifty_850,2014-04-30,Financial Experts Discuss Trends in Access to Capital for the Health Care Industry,Neutral,0.0001,82,financial expert discus trend access capital for the health care industry,73,11,0,pharmacy,"['financial', 'expert', 'disc', '##us', 'trend', 'access', 'capital', 'for', 'the', 'health', 'care', 'industry']",1
282543,nifty_850,2014-04-30,"OncoGenex Pharmaceuticals, Inc. Reports Financial Results for First Quarter 2014",Neutral,0.0001,80,oncogenex pharmaceutical inc report financial result for first quarter,70,9,0,pharmacy,"['on', '##co', '##gene', '##x', 'pharmaceutical', 'in', '##c', 'report', 'financial', 'result', 'for', 'first', 'quarter']",1
282583,nifty_850,2014-04-30,Momenta Pharmaceuticals to Webcast Presentation at Three Upcoming Investor Conferences,Neutral,0.0001,86,momentum pharmaceutical webcast presentation three upcoming investor conference,79,8,0,pharmacy,"['momentum', 'pharmaceutical', 'web', '##cast', 'presentation', 'three', 'upcoming', 'investor', 'conference']",1
282599,nifty_850,2014-04-30,Merck explores $15 billion-plus drug portfolio sale: sources,Neutral,0.0001,60,merck explores billion plus drug portfolio sale source,54,8,0,pharmacy,"['me', '##rc', '##k', 'explores', 'billion', 'plus', 'drug', 'portfolio', 'sale', 'source']",1
282605,nifty_850,2014-04-30,Aegerion Pharmaceuticals Announces Webcast of Presentations at Upcoming Investor Conferences,Neutral,0.0001,92,aegerion pharmaceutical announces webcast presentation upcoming investor conference,83,8,0,pharmacy,"['a', '##ege', '##rion', 'pharmaceutical', 'announces', 'web', '##cast', 'presentation', 'upcoming', 'investor', 'conference']",1
282609,nifty_850,2014-04-30,Research and Markets: Metastatic Transitional Cell Cancer (Urothelial Cell Cancer) Clinical Trials Review 2014,Neutral,0.0001,110,research and market metastatic transitional cell cancer urothelial cell cancer clinical trial review,100,13,0,pharmacy,"['research', 'and', 'market', 'meta', '##static', 'transitional', 'cell', 'cancer', 'u', '##roth', '##eli', '##al', 'cell', 'cancer', 'clinical', 'trial', 'review']",1
282642,nifty_850,2014-04-30,Scientists urge government to save Britain's pharma industry,Neutral,0.0001,60,scientist urge government save britain pharma industry,54,7,0,pharmacy,"['scientist', 'urge', 'government', 'save', 'br', '##ita', '##in', 'p', '##har', '##ma', 'industry']",1
282657,nifty_850,2014-04-30,Corcept Therapeutics to Announce First Quarter Financial Results and Corporate Update and Host Conference Call,Neutral,0.0001,110,corcept therapeutic announce first quarter financial result and corporate update and host conference call,105,14,0,pharmacy,"['co', '##rc', '##ept', 'therapeutic', 'announce', 'first', 'quarter', 'financial', 'result', 'and', 'corporate', 'update', 'and', 'host', 'conference', 'call']",1
282708,nifty_850,2014-04-30,Research and Markets: Global Population Health Management Market 2014-2018: Market to Reach $26 Billion by 2018 With a CAGR of 26%,Neutral,0.0001,130,research and market global population health management market market reach billion with cagr,93,13,0,pharmacy,"['research', 'and', 'market', 'global', 'population', 'health', 'management', 'market', 'market', 'reach', 'billion', 'with', 'ca', '##g', '##r']",1
282776,nifty_850,2014-04-30,Exclusive: Merck explores $15 billion-plus drug portfolio sale,Neutral,0.0001,62,exclusive merck explores billion plus drug portfolio sale,57,8,0,pharmacy,"['exclusive', 'me', '##rc', '##k', 'explores', 'billion', 'plus', 'drug', 'portfolio', 'sale']",1
283005,nifty_851,2014-05-01,Scientists urge government to save Britain's pharma industry,Neutral,-0.0014,60,scientist urge government save britain pharma industry,54,7,0,pharmacy,"['scientist', 'urge', 'government', 'save', 'br', '##ita', '##in', 'p', '##har', '##ma', 'industry']",1
283006,nifty_851,2014-05-01,Exclusive: Sanofi explores $7 billion-plus sale of drug portfolio - sources,Neutral,-0.0014,75,exclusive sanofi explores billion plus sale drug portfolio source,65,9,0,pharmacy,"['exclusive', 'sa', '##no', '##fi', 'explores', 'billion', 'plus', 'sale', 'drug', 'portfolio', 'source']",1
283101,nifty_851,2014-05-01,"Research and Markets: Global Molecular Diagnostics Market Overivew, Trends & Opportunities, 2019",Neutral,-0.0014,96,research and market global molecular diagnostics market overivew trend opportunity,82,10,0,pharmacy,"['research', 'and', 'market', 'global', 'molecular', 'diagnostic', '##s', 'market', 'over', '##ive', '##w', 'trend', 'opportunity']",1
283134,nifty_851,2014-05-01,"Research and Markets: Global Gene Expression Market Technology, Consumables, Services & Applications Report 2014-2019",Neutral,-0.0014,117,research and market global gene expression market technology consumables service application report,99,12,0,pharmacy,"['research', 'and', 'market', 'global', 'gene', 'expression', 'market', 'technology', 'con', '##su', '##mable', '##s', 'service', 'application', 'report']",1
283156,nifty_851,2014-05-01,"Research and Markets: Global Biochips and Microarrays 2014-218: Technologies, Markets and Companies - Updated 2014 Report",Neutral,-0.0014,121,research and market global biochip and microarrays technology market and company updated report,95,13,0,pharmacy,"['research', 'and', 'market', 'global', 'bio', '##chi', '##p', 'and', 'micro', '##arra', '##ys', 'technology', 'market', 'and', 'company', 'updated', 'report']",1
283159,nifty_851,2014-05-01,RedHill Biopharma to Present at the ChinaBio Partnering Forum 2014,Neutral,-0.0014,66,redhill biopharma present the chinabio partnering forum,55,7,0,pharmacy,"['red', '##hill', 'bio', '##pha', '##rma', 'present', 'the', 'chin', '##abi', '##o', 'partner', '##ing', 'forum']",1
283175,nifty_851,2014-05-01,Threshold Pharmaceuticals Reports First Quarter 2014 Financial and Operational Results,Neutral,-0.0014,86,threshold pharmaceutical report first quarter financial and operational result,78,9,0,pharmacy,"['threshold', 'pharmaceutical', 'report', 'first', 'quarter', 'financial', 'and', 'operational', 'result']",1
283193,nifty_851,2014-05-01,Research and Markets: Global Induced Pluripotent Stem Cell (iPSC) Industry Report 2014-2018,Neutral,-0.0014,91,research and market global induced pluripotent stem cell ipsc industry report,77,11,0,pharmacy,"['research', 'and', 'market', 'global', 'induced', 'p', '##lu', '##rip', '##ote', '##nt', 'stem', 'cell', 'i', '##ps', '##c', 'industry', 'report']",1
283200,nifty_851,2014-05-01,"Research and Markets: Circulating Tumour Cells (CTCs) and Circulating Nucleic Acids (CNAs) in Research, Clinical & Diagnostics and in Drug R&D;: An Integrated Market Study of Developments, Growth Areas and Opportunities",Neutral,-0.0014,219,research and market circulating tumour cell ctc and circulating nucleic acid cnas research clinical diagnostics and drug integrated market study development growth area and opportunity,184,25,0,pharmacy,"['research', 'and', 'market', 'circulating', 't', '##umour', 'cell', 'c', '##t', '##c', 'and', 'circulating', 'nuclei', '##c', 'acid', 'c', '##nas', 'research', 'clinical', 'diagnostic', '##s', 'and', 'drug', 'integrated', 'market', 'study', 'development', 'growth', 'area', 'and', 'opportunity']",1
283204,nifty_851,2014-05-01,Raptor Pharmaceutical to Present at Upcoming Investor Conference,Neutral,-0.0014,64,raptor pharmaceutical present upcoming investor conference,58,6,0,pharmacy,"['rap', '##tor', 'pharmaceutical', 'present', 'upcoming', 'investor', 'conference']",1
283216,nifty_851,2014-05-01,Research and Markets: Clinical Decision Support System (CDSS) Market Forecasts & Opportunities 2014-2018,Neutral,-0.0014,104,research and market clinical decision support system cdss market forecast opportunity,85,11,0,pharmacy,"['research', 'and', 'market', 'clinical', 'decision', 'support', 'system', 'c', '##ds', '##s', 'market', 'forecast', 'opportunity']",1
283235,nifty_851,2014-05-01,"Research and Markets: Malaysia Healthcare, Regulatory and Reimbursement Landscape Report 2014",Neutral,-0.0014,93,research and market malaysia healthcare regulatory and reimbursement landscape report,85,10,0,pharmacy,"['research', 'and', 'market', 'ma', '##lay', '##sia', 'healthcare', 'regulatory', 'and', 're', '##im', '##bur', '##se', '##ment', 'landscape', 'report']",1
283277,nifty_851,2014-05-01,"USARAD Holdings Inc and SecondOpinions.com Partnering with General Hospital of Ningxia Medical University, One of the Largest Hospitals in China and the World",Neutral,-0.0014,158,usarad holding inc and secondopinions com partnering with general hospital ningxia medical university one the largest hospital china and the world,146,21,0,pharmacy,"['us', '##ara', '##d', 'holding', 'in', '##c', 'and', 'second', '##op', '##ini', '##ons', 'com', 'partner', '##ing', 'with', 'general', 'hospital', 'ni', '##ng', '##xia', 'medical', 'university', 'one', 'the', 'largest', 'hospital', 'chin', '##a', 'and', 'the', 'world']",1
283279,nifty_851,2014-05-01,NovaBay Pharmaceuticals Reports First Quarter 2014 Financial Results and a Clinical/Business Update,Neutral,-0.0014,99,novabay pharmaceutical report first quarter financial result and clinical business update,89,11,0,pharmacy,"['no', '##va', '##bay', 'pharmaceutical', 'report', 'first', 'quarter', 'financial', 'result', 'and', 'clinical', 'business', 'update']",1
283295,nifty_851,2014-05-01,"Awards, Stock Price Updates, Quarterly Earnings Releases, and Clinical Study Results - Analyst Notes on Aetna, Regeneron, Questcor, Medtronic and Lilly",Neutral,-0.0014,151,award stock price update quarterly earnings release and clinical study result analyst note aetna regeneron questcor medtronic and lilly,135,19,0,pharmacy,"['award', 'stock', 'price', 'update', 'quarterly', 'earnings', 'release', 'and', 'clinical', 'study', 'result', 'analyst', 'note', 'a', '##et', '##na', 're', '##gene', '##ron', 'quest', '##cor', 'me', '##dt', '##ronic', 'and', 'l', '##ill', '##y']",1
283305,nifty_851,2014-05-01,Research and Markets: Analysis of the Digital Pathology Market in China,Neutral,-0.0014,71,research and market analysis the digital pathology market china,63,9,0,pharmacy,"['research', 'and', 'market', 'analysis', 'the', 'digital', 'path', '##ology', 'market', 'chin', '##a']",1
283310,nifty_851,2014-05-01,Celldex Reports First Quarter 2014 Results,Neutral,-0.0014,42,celldex report first quarter result,35,5,0,pharmacy,"['cell', '##de', '##x', 'report', 'first', 'quarter', 'result']",1
283316,nifty_851,2014-05-01,Research and Markets: Global Regulatory Overview for the 2014 Companion Diagnostics Market,Neutral,-0.0014,90,research and market global regulatory overview for the companion diagnostics market,83,11,0,pharmacy,"['research', 'and', 'market', 'global', 'regulatory', 'overview', 'for', 'the', 'companion', 'diagnostic', '##s', 'market']",1
283391,nifty_851,2014-05-01,FDA Commissioner Among Top Global Regulators Attending DIA Annual Meeting,Neutral,-0.0014,73,fda commissioner among top global regulator attending dia annual meeting,72,10,0,pharmacy,"['f', '##da', 'commissioner', 'among', 'top', 'global', 'regulator', 'attending', 'di', '##a', 'annual', 'meeting']",1
283396,nifty_851,2014-05-01,ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences,Neutral,-0.0014,66,acadia pharmaceutical present upcoming investor conference,58,6,0,pharmacy,"['a', '##ca', '##dia', 'pharmaceutical', 'present', 'upcoming', 'investor', 'conference']",1
283400,nifty_851,2014-05-01,Sovaldi Forecast to be Biggest Selling Drug in 2020 as EvaluatePharma Extends Consensus Sales Forecasts,Neutral,-0.0014,103,sovaldi forecast biggest selling drug evaluatepharma extends consensus sale forecast,84,10,0,pharmacy,"['so', '##val', '##di', 'forecast', 'biggest', 'selling', 'drug', 'evaluate', '##pha', '##rma', 'extends', 'consensus', 'sale', 'forecast']",1
283420,nifty_851,2014-05-01,"Health Care Stocks on our Scanner -- Research on IsoRay, Catamaran, Castlight Health, and Sanofi",Neutral,-0.0014,96,health care stock our scanner research isoray catamaran castlight health and sanofi,83,12,0,pharmacy,"['health', 'care', 'stock', 'our', 'scan', '##ner', 'research', 'is', '##ora', '##y', 'cat', '##ama', '##ran', 'cast', '##light', 'health', 'and', 'sa', '##no', '##fi']",1
283429,nifty_851,2014-05-01,Polydex Pharmaceuticals Provides Year End Financial Report Showing Sales Up 14.8% and Margins Increased to 24%,Neutral,-0.0014,110,polydex pharmaceutical provides year end financial report showing sale and margin increased,91,12,0,pharmacy,"['p', '##oly', '##de', '##x', 'pharmaceutical', 'provides', 'year', 'end', 'financial', 'report', 'showing', 'sale', 'and', 'margin', 'increased']",1
283435,nifty_851,2014-05-01,"Technical Recap on Pharma Equities -- Research on Bristol-Myers Squibb, AstraZeneca, Eli Lilly, and GlaxoSmithKline",Neutral,-0.0014,115,technical recap pharma equity research bristol myers squibb astrazeneca eli lilly and glaxosmithkline,101,13,0,pharmacy,"['technical', 're', '##cap', 'p', '##har', '##ma', 'equity', 'research', 'br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'as', '##tra', '##zen', '##eca', 'el', '##i', 'l', '##ill', '##y', 'and', 'g', '##lax', '##os', '##mith', '##k', '##line']",1
283452,nifty_851,2014-05-01,"The Zacks Analyst Blog Highlights: Celgene, Gilead, Amgen, Biogen and Alexion",Neutral,-0.0014,77,the zacks analyst blog highlight celgene gilead amgen biogen and alexion,72,11,0,pharmacy,"['the', 'z', '##ack', '##s', 'analyst', 'blog', 'highlight', 'c', '##el', '##gene', 'g', '##ile', '##ad', 'am', '##gen', 'bio', '##gen', 'and', 'ale', '##xi', '##on']",1
283511,nifty_851,2014-05-01,Research and Markets: Diagnostic Medical Equipment Markets in China 2014-2018 with a Directory of Producers,Neutral,-0.0014,107,research and market diagnostic medical equipment market china with directory producer,85,11,0,pharmacy,"['research', 'and', 'market', 'diagnostic', 'medical', 'equipment', 'market', 'chin', '##a', 'with', 'directory', 'producer']",1
283560,nifty_851,2014-05-01,"Sterne, Kessler, Goldstein & Fox Announces Digital Healthcare Industry Practice",Neutral,-0.0014,79,sterne kessler goldstein fox announces digital healthcare industry practice,75,9,0,pharmacy,"['stern', '##e', 'k', '##ess', '##ler', 'gold', '##stein', 'fox', 'announces', 'digital', 'healthcare', 'industry', 'practice']",1
283561,nifty_851,2014-05-01,Research and Markets: Global & USA Cancer Biomarker Market Analysis 2014-2018,Neutral,-0.0014,77,research and market global usa cancer biomarker market analysis,63,9,0,pharmacy,"['research', 'and', 'market', 'global', 'us', '##a', 'cancer', 'bio', '##mark', '##er', 'market', 'analysis']",1
283588,nifty_851,2014-05-01,"Research and Markets: China Portable Medical Equipment Industry Report, 2013-2016",Neutral,-0.0014,81,research and market china portable medical equipment industry report,68,9,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'portable', 'medical', 'equipment', 'industry', 'report']",1
283674,nifty_851,2014-05-01,Research and Markets: Global Metastatic Colorectal Cancer Clinical Trials Review 2014: Espy the Commercial Landscape of the Major Institutes & Companies,Neutral,-0.0014,152,research and market global metastatic colorectal cancer clinical trial review espy the commercial landscape the major institute company,135,18,0,pharmacy,"['research', 'and', 'market', 'global', 'meta', '##static', 'color', '##ec', '##tal', 'cancer', 'clinical', 'trial', 'review', 'es', '##py', 'the', 'commercial', 'landscape', 'the', 'major', 'institute', 'company']",1
283779,nifty_851,2014-05-01,Sangamo BioSciences Announces Presentations At Upcoming Investor Conferences,Neutral,-0.0014,76,sangamo bioscience announces presentation upcoming investor conference,70,7,0,pharmacy,"['sang', '##amo', 'bio', '##science', 'announces', 'presentation', 'upcoming', 'investor', 'conference']",1
283791,nifty_851,2014-05-01,Idenix Pharmaceuticals Reports First Quarter 2014 Financial Results and HCV Pipeline Review,Neutral,-0.0014,91,idenix pharmaceutical report first quarter financial result and hcv pipeline review,83,11,0,pharmacy,"['id', '##eni', '##x', 'pharmaceutical', 'report', 'first', 'quarter', 'financial', 'result', 'and', 'h', '##c', '##v', 'pipeline', 'review']",1
283801,nifty_851,2014-05-01,Immunomedics Announces Proposed Public Offering of Common Stock,Neutral,-0.0014,63,immunomedics announces proposed public offering common stock,60,7,0,pharmacy,"['im', '##mu', '##no', '##med', '##ics', 'announces', 'proposed', 'public', 'offering', 'common', 'stock']",1
283892,nifty_851,2014-05-01,New Collaborative Benchmarking Study Is Helping Pharma Leaders Turn the Corner on Digital Marketing: From Showing Promise to Delivering Real Value,Neutral,-0.0014,146,new collaborative benchmarking study helping pharma leader turn the corner digital marketing from showing promise delivering real value,135,18,0,pharmacy,"['new', 'collaborative', 'bench', '##mark', '##ing', 'study', 'helping', 'p', '##har', '##ma', 'leader', 'turn', 'the', 'corner', 'digital', 'marketing', 'from', 'showing', 'promise', 'delivering', 'real', 'value']",1
284002,nifty_851,2014-05-01,Merrimack Pancreatic Cancer Treatment Shows Positive Results in Study,Neutral,-0.0014,69,merrimack pancreatic cancer treatment show positive result study,64,8,0,pharmacy,"['me', '##rri', '##ma', '##ck', 'pan', '##cre', '##atic', 'cancer', 'treatment', 'show', 'positive', 'result', 'study']",1
284315,nifty_855,2014-05-08,Not Feeling Well? Log On. The Doctor Is In,Neutral,0.0015,42,not feeling well log the doctor,31,6,0,pharmacy,"['not', 'feeling', 'well', 'log', 'the', 'doctor']",1
284558,nifty_858,2014-05-14,New Drugs Show Promise Treating More Cancers,Fall,-0.0088,44,new drug show promise treating more cancer,42,7,0,pharmacy,"['new', 'drug', 'show', 'promise', 'treating', 'more', 'cancer']",1
284639,nifty_859,2014-05-15,FDA Cuts Recommended Lunesta Dose,Neutral,0.0035,33,fda cut recommended lunesta dose,32,5,0,pharmacy,"['f', '##da', 'cut', 'recommended', 'l', '##une', '##sta', 'dose']",1
284642,nifty_859,2014-05-15,Novartis Delays Leukemia Drug Competition,Neutral,0.0035,41,novartis delay leukemia drug competition,40,5,0,pharmacy,"['no', '##var', '##tis', 'delay', 'le', '##uke', '##mia', 'drug', 'competition']",1
284806,nifty_860,2014-05-19,Research and Markets: Pneumonia Partnering 2014,Fall,-0.0063,47,research and market pneumonia partnering,40,5,0,pharmacy,"['research', 'and', 'market', 'pneumonia', 'partner', '##ing']",1
284807,nifty_860,2014-05-19,"Research and Markets: Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics: Updated 2014 Report",Fall,-0.0063,128,research and market global merger and acquisition term and agreement pharma biotech and diagnostics updated report,114,16,0,pharmacy,"['research', 'and', 'market', 'global', 'merger', 'and', 'acquisition', 'term', 'and', 'agreement', 'p', '##har', '##ma', 'bio', '##tech', 'and', 'diagnostic', '##s', 'updated', 'report']",1
284816,nifty_860,2014-05-19,Research and Markets: Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech: Updated 2014 Report,Fall,-0.0063,119,research and market global discovery stage partnering term and agreement pharma and biotech updated report,106,15,0,pharmacy,"['research', 'and', 'market', 'global', 'discovery', 'stage', 'partner', '##ing', 'term', 'and', 'agreement', 'p', '##har', '##ma', 'and', 'bio', '##tech', 'updated', 'report']",1
284818,nifty_860,2014-05-19,"Research and Markets: Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics: Updated 2014 Report",Fall,-0.0063,141,research and market global manufacturing and supply partnering term and agreement pharma biotech and diagnostics updated report,127,17,0,pharmacy,"['research', 'and', 'market', 'global', 'manufacturing', 'and', 'supply', 'partner', '##ing', 'term', 'and', 'agreement', 'p', '##har', '##ma', 'bio', '##tech', 'and', 'diagnostic', '##s', 'updated', 'report']",1
284822,nifty_860,2014-05-19,Research and Markets: Circulating Tumor Cells and Cancer Stem Cells Technologies - Global Strategic Business Report 2014,Fall,-0.0063,120,research and market circulating tumor cell and cancer stem cell technology global strategic business report,107,15,0,pharmacy,"['research', 'and', 'market', 'circulating', 'tumor', 'cell', 'and', 'cancer', 'stem', 'cell', 'technology', 'global', 'strategic', 'business', 'report']",1
284825,nifty_860,2014-05-19,Research and Markets: Personalized Medicines - Global Strategic Business Report 2014-2020: Adverse Drug Reactions of Prescription Drugs Drive Personalized Medicine Market,Fall,-0.0063,170,research and market personalized medicine global strategic business report adverse drug reaction prescription drug drive personalized medicine market,149,18,0,pharmacy,"['research', 'and', 'market', 'personal', '##ized', 'medicine', 'global', 'strategic', 'business', 'report', 'adverse', 'drug', 'reaction', 'prescription', 'drug', 'drive', 'personal', '##ized', 'medicine', 'market']",1
284886,nifty_860,2014-05-19,"Business Highlights, Financial Results, and Leadership Appointments - Analyst Notes on PDL BioPharma, bluebird, Osiris, Agios and Ophthotech",Fall,-0.0063,140,business highlight financial result and leadership appointment analyst note pdl biopharma bluebird osiris agio and ophthotech,125,16,0,pharmacy,"['business', 'highlight', 'financial', 'result', 'and', 'leadership', 'appointment', 'analyst', 'note', 'p', '##dl', 'bio', '##pha', '##rma', 'blue', '##bird', 'o', '##sir', '##is', 'a', '##gio', 'and', 'op', '##ht', '##hot', '##ech']",1
284941,nifty_860,2014-05-19,"Recognitions, Agreements, Study Results, Data Presentations, and Financial Results - Analyst Notes on Baxter, Incyte, Isis, Celldex Therapeutics, Inc. and Agilent",Fall,-0.0063,162,recognition agreement study result data presentation and financial result analyst note baxter incyte isi celldex therapeutic inc and agilent,140,19,0,pharmacy,"['recognition', 'agreement', 'study', 'result', 'data', 'presentation', 'and', 'financial', 'result', 'analyst', 'note', 'b', '##ax', '##ter', 'in', '##cy', '##te', 'is', '##i', 'cell', '##de', '##x', 'therapeutic', 'in', '##c', 'and', 'a', '##gi', '##lent']",1
284950,nifty_860,2014-05-19,"Study Results, Analyst Meetings, Upcoming Events, Financial Results, and Welfare Initiatives - Analyst Notes on Pharmacyclics, Thermo Fisher Scientific, Endo, Humana and Aetna",Fall,-0.0063,175,study result analyst meeting upcoming event financial result and welfare initiative analyst note pharmacyclics thermo fisher scientific endo humana and aetna,157,21,0,pharmacy,"['study', 'result', 'analyst', 'meeting', 'upcoming', 'event', 'financial', 'result', 'and', 'welfare', 'initiative', 'analyst', 'note', 'pharmacy', '##c', '##lic', '##s', 'the', '##rm', '##o', 'fish', '##er', 'scientific', 'end', '##o', 'human', '##a', 'and', 'a', '##et', '##na']",1
284958,nifty_860,2014-05-19,"Research and Markets: Philippines Healthcare, Regulatory and Reimbursement Landscape 2014 - New Report on the $4 Billion Market",Fall,-0.0063,127,research and market philippine healthcare regulatory and reimbursement landscape new report the billion market,110,14,0,pharmacy,"['research', 'and', 'market', 'p', '##hil', '##ip', '##pine', 'healthcare', 'regulatory', 'and', 're', '##im', '##bur', '##se', '##ment', 'landscape', 'new', 'report', 'the', 'billion', 'market']",1
285025,nifty_860,2014-05-19,"Research and Markets: Acromegaly Global Clinical Trials Review, H1, 2014",Fall,-0.0063,72,research and market acromegaly global clinical trial review,59,8,0,pharmacy,"['research', 'and', 'market', 'a', '##c', '##rome', '##gal', '##y', 'global', 'clinical', 'trial', 'review']",1
285211,nifty_860,2014-05-19,"Research and Markets: Healthcare IT - Global Strategic Business Report 2014-2020: Third Party Payors, and Healthcare Providers",Fall,-0.0063,126,research and market healthcare global strategic business report third party payors and healthcare provider,106,14,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'global', 'strategic', 'business', 'report', 'third', 'party', 'pay', '##ors', 'and', 'healthcare', 'provider']",1
285212,nifty_860,2014-05-19,Research and Markets: Global Health Information Exchange (HIE) Market - Forecast to 2018: Reliability and flexibility of healthcare data delivery driving the market,Fall,-0.0063,164,research and market global health information exchange hie market forecast reliability and flexibility healthcare data delivery driving the market,146,19,0,pharmacy,"['research', 'and', 'market', 'global', 'health', 'information', 'exchange', 'hi', '##e', 'market', 'forecast', 'reliability', 'and', 'flexibility', 'healthcare', 'data', 'delivery', 'driving', 'the', 'market']",1
285243,nifty_860,2014-05-19,"Technical Summary on Pharma Stocks -- Research on Pacira Pharma, Ventrus Biosciences, Teva Pharma, and Novo Nordisk",Fall,-0.0063,115,technical summary pharma stock research pacira pharma ventrus bioscience teva pharma and novo nordisk,101,14,0,pharmacy,"['technical', 'summary', 'p', '##har', '##ma', 'stock', 'research', 'p', '##ac', '##ira', 'p', '##har', '##ma', 'vent', '##rus', 'bio', '##science', 'te', '##va', 'p', '##har', '##ma', 'and', 'no', '##vo', 'nor', '##dis', '##k']",1
285246,nifty_860,2014-05-19,"Life Sciences Tools & Services Stocks Technical Data -- Research on PerkinElmer, BG Medicine, Covance, and PAREXEL Intl.",Fall,-0.0063,120,life science tool service stock technical data research perkinelmer medicine covance and parexel intl,101,14,0,pharmacy,"['life', 'science', 'tool', 'service', 'stock', 'technical', 'data', 'research', 'per', '##kin', '##el', '##mer', 'medicine', 'co', '##vance', 'and', 'par', '##ex', '##el', 'in', '##tl']",1
285270,nifty_860,2014-05-19,Global Bioenergies Secures a 3 Million Euro Equity Line,Fall,-0.0063,55,global bioenergies secures million euro equity line,51,7,0,pharmacy,"['global', 'bio', '##ener', '##gies', 'secure', '##s', 'million', 'euro', 'equity', 'line']",1
285271,nifty_860,2014-05-19,Research and Markets: NeurogesX's Qutenza (Capsaicin 8% Patch) - Forecast and Market Analysis to 2022,Fall,-0.0063,101,research and market neurogesx qutenza capsaicin patch forecast and market analysis,82,11,0,pharmacy,"['research', 'and', 'market', 'ne', '##uro', '##ges', '##x', 'q', '##ute', '##nza', 'caps', '##aic', '##in', 'patch', 'forecast', 'and', 'market', 'analysis']",1
285338,nifty_860,2014-05-19,Research and Markets: Global Oncology Drug Report 2014: 19 Major Indications & Profiles of 931 Active Cancer Drugs Development Companies,Fall,-0.0063,136,research and market global oncology drug report major indication profile active cancer drug development company,111,15,0,pharmacy,"['research', 'and', 'market', 'global', 'on', '##cology', 'drug', 'report', 'major', 'indication', 'profile', 'active', 'cancer', 'drug', 'development', 'company']",1
285528,nifty_860,2014-05-19,"Merck, Endocyte Withdraw Ovarion Cancer Drug Marketing Applications",Fall,-0.0063,67,merck endocyte withdraw ovarion cancer drug marketing application,65,8,0,pharmacy,"['me', '##rc', '##k', 'end', '##oc', '##yte', 'withdraw', 'o', '##var', '##ion', 'cancer', 'drug', 'marketing', 'application']",1
285530,nifty_860,2014-05-19,"Ophthotech, Novartis in Fovista Drug Pact",Fall,-0.0063,41,ophthotech novartis fovista drug pact,37,5,0,pharmacy,"['op', '##ht', '##hot', '##ech', 'no', '##var', '##tis', 'f', '##ov', '##ista', 'drug', 'pact']",1
285694,nifty_861,2014-05-20,Research and Markets: Global Healthcare IT Integration Market Report 2014-2018: North America Dominates with 69% Market Share,Rise,0.0084,125,research and market global healthcare integration market report north america dominates with market share,105,14,0,pharmacy,"['research', 'and', 'market', 'global', 'healthcare', 'integration', 'market', 'report', 'north', 'am', '##eric', '##a', 'dominate', '##s', 'with', 'market', 'share']",1
285754,nifty_861,2014-05-20,"Company Updates, Takeover Offers, Stock Price Movements, and FDA Approvals - Analyst Notes on Chubb, Valeant, AstraZeneca, Mylan and Perrigo",Rise,0.0084,140,company update takeover offer stock price movement and fda approval analyst note chubb valeant astrazeneca mylan and perrigo,124,18,0,pharmacy,"['company', 'update', 'takeover', 'offer', 'stock', 'price', 'movement', 'and', 'f', '##da', 'approval', 'analyst', 'note', 'ch', '##ub', '##b', 'v', '##ale', '##ant', 'as', '##tra', '##zen', '##eca', 'my', '##lan', 'and', 'per', '##rig', '##o']",1
285761,nifty_861,2014-05-20,"Caribbean International Holdings (CIHN) Releases Update On 22nd Annual World Congress on ANTI-AGING, REGENERATIVE & AESTHETIC MEDICINE, in Orlando, Florida",Rise,0.0084,155,caribbean international holding cihn release update annual world congress anti aging regenerative aesthetic medicine orlando florida,132,16,0,pharmacy,"['car', '##ib', '##be', '##an', 'international', 'holding', 'c', '##ih', '##n', 'release', 'update', 'annual', 'world', 'congress', 'anti', 'aging', 're', '##gene', '##rative', 'aesthetic', 'medicine', 'or', '##land', '##o', 'fl', '##ori', '##da']",1
285766,nifty_861,2014-05-20,BioLineRx Reports First Quarter 2014 Financial Results,Rise,0.0084,54,biolinerx report first quarter financial result,47,6,0,pharmacy,"['bio', '##liner', '##x', 'report', 'first', 'quarter', 'financial', 'result']",1
285791,nifty_861,2014-05-20,"Quarterly Financial Results, Acquisition Proposal, and Financial Outlook - Analyst Notes on Gentiva, Kindred, Envision Healthcare, Emeritus and Amedisys",Rise,0.0084,152,quarterly financial result acquisition proposal and financial outlook analyst note gentiva kindred envision healthcare emeritus and amedisys,140,17,0,pharmacy,"['quarterly', 'financial', 'result', 'acquisition', 'proposal', 'and', 'financial', 'outlook', 'analyst', 'note', 'g', '##ent', '##iva', 'kind', '##red', 'en', '##vision', 'healthcare', 'emeritus', 'and', 'am', '##ed', '##is', '##ys']",1
285958,nifty_861,2014-05-20,Celgene Corporation to Present at Investor Conferences in June,Rise,0.0084,62,celgene corporation present investor conference june,52,6,0,pharmacy,"['c', '##el', '##gene', 'corporation', 'present', 'investor', 'conference', 'j', '##une']",1
286144,nifty_861,2014-05-20,Research and Markets: Asian Medical Tourism Market Outlook 2018,Rise,0.0084,63,research and market asian medical tourism market outlook,56,8,0,pharmacy,"['research', 'and', 'market', 'as', '##ian', 'medical', 'tourism', 'market', 'outlook']",1
286293,nifty_861,2014-05-20,"The 15th Annual BioEquity Europe Conference Features More Than 100 Innovator Companies With Differentiated Products, Upcoming Milestones and Partner-Ready Assets",Rise,0.0084,161,the annual bioequity europe conference feature more than innovator company with differentiated product upcoming milestone and partner ready asset,145,19,0,pharmacy,"['the', 'annual', 'bio', '##e', '##qui', '##ty', 'euro', '##pe', 'conference', 'feature', 'more', 'than', 'inn', '##ova', '##tor', 'company', 'with', 'differentiated', 'product', 'upcoming', 'milestone', 'and', 'partner', 'ready', 'asset']",1
286325,nifty_861,2014-05-20,Research and Markets: Global Point-of-Care Diagnostics Market Outlook 2014-2018 - United States Accounts for Almost 50% of Total Market,Rise,0.0084,135,research and market global point care diagnostics market outlook united state account for almost total market,109,16,0,pharmacy,"['research', 'and', 'market', 'global', 'point', 'care', 'diagnostic', '##s', 'market', 'outlook', 'united', 'state', 'account', 'for', 'almost', 'total', 'market']",1
286336,nifty_861,2014-05-20,Research and Markets: US Proton Therapy Outlook 2014-2018: Market Opportunities for the $1.9 Billion Industry,Rise,0.0084,109,research and market proton therapy outlook market opportunity for the billion industry,86,12,0,pharmacy,"['research', 'and', 'market', 'pro', '##ton', 'therapy', 'outlook', 'market', 'opportunity', 'for', 'the', 'billion', 'industry']",1
286347,nifty_861,2014-05-20,Research and Markets: Global Squamous Cell Carcinoma Therapeutics Pipeline Review 2014,Rise,0.0084,86,research and market global squamous cell carcinoma therapeutic pipeline review,78,10,0,pharmacy,"['research', 'and', 'market', 'global', 'sq', '##ua', '##mous', 'cell', 'car', '##cin', '##oma', 'therapeutic', 'pipeline', 'review']",1
286352,nifty_861,2014-05-20,Research and Markets: Global Eczema Therapeutics Pipeline Report 2014 - 5 Companies & 5 Drug Profiles,Rise,0.0084,101,research and market global eczema therapeutic pipeline report company drug profile,82,11,0,pharmacy,"['research', 'and', 'market', 'global', 'e', '##cz', '##ema', 'therapeutic', 'pipeline', 'report', 'company', 'drug', 'profile']",1
286353,nifty_861,2014-05-20,Research and Markets: Heart Attack Pipeline Therapeutics Review 2014 - 3 Companies & 8 Drug Profiles,Rise,0.0084,100,research and market heart attack pipeline therapeutic review company drug profile,81,11,0,pharmacy,"['research', 'and', 'market', 'heart', 'attack', 'pipeline', 'therapeutic', 'review', 'company', 'drug', 'profile']",1
286367,nifty_861,2014-05-20,Bankers Healthcare Group Executive Educates Physicians on Financial Health,Rise,0.0084,74,banker healthcare group executive educates physician financial health,69,8,0,pharmacy,"['banker', 'healthcare', 'group', 'executive', 'educate', '##s', 'physician', 'financial', 'health']",1
286373,nifty_861,2014-05-20,Research and Markets: Global Pituitary ACTH Hypersecretion (Cushing's Disease) Therapeutics Pipeline Review 2014 - 8 Companies & 11 Drug Profiles,Rise,0.0084,145,research and market global pituitary acth hypersecretion cushing disease therapeutic pipeline review company drug profile,121,15,0,pharmacy,"['research', 'and', 'market', 'global', 'pit', '##uit', '##ary', 'act', '##h', 'h', '##yper', '##se', '##cre', '##tion', 'cu', '##shing', 'disease', 'therapeutic', 'pipeline', 'review', 'company', 'drug', 'profile']",1
286402,nifty_861,2014-05-20,Investment in Innovation (IN3) Medical Device 360 Boston Features Panel on How Investors Pick the Best Medtech Companies,Rise,0.0084,120,investment innovation medical device boston feature panel how investor pick the best medtech company,100,14,0,pharmacy,"['investment', 'innovation', 'medical', 'device', 'b', '##ost', '##on', 'feature', 'panel', 'how', 'investor', 'pick', 'the', 'best', 'me', '##dt', '##ech', 'company']",1
286642,nifty_862,2014-05-21,Intercept Didn't Disclose Cholesterol Data,Neutral,0.0024,42,intercept didn disclose cholesterol data,40,5,0,pharmacy,"['intercept', 'didn', 'disc', '##lose', 'ch', '##ole', '##ster', '##ol', 'data']",1
286937,nifty_864,2014-05-27,Research and Markets: Global Diabetic Food Market Report 2014 - Forecasts to 2018,Neutral,-0.0007,81,research and market global diabetic food market report forecast,63,9,0,pharmacy,"['research', 'and', 'market', 'global', 'di', '##abe', '##tic', 'food', 'market', 'report', 'forecast']",1
286992,nifty_864,2014-05-27,"Pacira Pharmaceuticals, Inc. to Present at June Investor Conferences",Neutral,-0.0007,68,pacira pharmaceutical inc present june investor conference,58,7,0,pharmacy,"['p', '##ac', '##ira', 'pharmaceutical', 'in', '##c', 'present', 'j', '##une', 'investor', 'conference']",1
287020,nifty_864,2014-05-27,"Pharma Stocks Technical Data -- Research on Provectus Biopharma, AstraZeneca, Eli Lilly, and GlaxoSmithKline",Neutral,-0.0007,108,pharma stock technical data research provectus biopharma astrazeneca eli lilly and glaxosmithkline,98,12,0,pharmacy,"['p', '##har', '##ma', 'stock', 'technical', 'data', 'research', 'prove', '##ctus', 'bio', '##pha', '##rma', 'as', '##tra', '##zen', '##eca', 'el', '##i', 'l', '##ill', '##y', 'and', 'g', '##lax', '##os', '##mith', '##k', '##line']",1
287037,nifty_864,2014-05-27,Conatus Pharmaceuticals to Present at Upcoming Investor Conferences,Neutral,-0.0007,67,conatus pharmaceutical present upcoming investor conference,59,6,0,pharmacy,"['con', '##atus', 'pharmaceutical', 'present', 'upcoming', 'investor', 'conference']",1
287042,nifty_864,2014-05-27,RXi Pharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference,Neutral,-0.0007,81,rxi pharmaceutical present the jefferies global healthcare conference,69,8,0,pharmacy,"['r', '##xi', 'pharmaceutical', 'present', 'the', 'j', '##ef', '##fer', '##ies', 'global', 'healthcare', 'conference']",1
287048,nifty_864,2014-05-27,Research and Markets: Global Hypersensitivity Therapeutics Pipeline Review 2014: 4 Companies & 7 Drug Profiles,Neutral,-0.0007,110,research and market global hypersensitivity therapeutic pipeline review company drug profile,92,11,0,pharmacy,"['research', 'and', 'market', 'global', 'h', '##yper', '##sen', '##si', '##ti', '##vity', 'therapeutic', 'pipeline', 'review', 'company', 'drug', 'profile']",1
287064,nifty_864,2014-05-27,"Favorable Support, NDA Submission, Conference Schedule, Acquisition Update, and Executive Appointment - Analyst Notes on Allergan, Pfizer, Eli Lilly, Forest and Pharmacyclics",Neutral,-0.0007,174,favorable support nda submission conference schedule acquisition update and executive appointment analyst note allergan pfizer eli lilly forest and pharmacyclics,161,20,0,pharmacy,"['favorable', 'support', 'n', '##da', 'submission', 'conference', 'schedule', 'acquisition', 'update', 'and', 'executive', 'appointment', 'analyst', 'note', 'all', '##er', '##gan', 'p', '##fi', '##zer', 'el', '##i', 'l', '##ill', '##y', 'forest', 'and', 'pharmacy', '##c', '##lic', '##s']",1
287066,nifty_864,2014-05-27,"Research and Markets: Pharmaceutical Pricing & Distribution in Japan, 2014 Update",Neutral,-0.0007,81,research and market pharmaceutical pricing distribution japan update,68,8,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'pricing', 'distribution', 'j', '##apa', '##n', 'update']",1
287067,nifty_864,2014-05-27,"Research and Markets: Pricing of Medical Devices, Diagnostics & Medical Equipment in Japan 2014: Your Key to Access a $30 Billion Market",Neutral,-0.0007,136,research and market pricing medical device diagnostics medical equipment japan your key access billion market,109,15,0,pharmacy,"['research', 'and', 'market', 'pricing', 'medical', 'device', 'diagnostic', '##s', 'medical', 'equipment', 'j', '##apa', '##n', 'your', 'key', 'access', 'billion', 'market']",1
287076,nifty_864,2014-05-27,Twist Bioscience Secures $31.1 Million,Neutral,-0.0007,38,twist bioscience secures million,32,4,0,pharmacy,"['twist', 'bio', '##science', 'secure', '##s', 'million']",1
287078,nifty_864,2014-05-27,Aerie Pharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference,Neutral,-0.0007,83,aerie pharmaceutical present the jefferies global healthcare conference,71,8,0,pharmacy,"['a', '##erie', 'pharmaceutical', 'present', 'the', 'j', '##ef', '##fer', '##ies', 'global', 'healthcare', 'conference']",1
287092,nifty_864,2014-05-27,Research and Markets: MediPoint: Companion Diagnostic Tests in Oncology - EU Analysis and Market Forecasts 2011-2013 & 2014-2020,Neutral,-0.0007,128,research and market medipoint companion diagnostic test oncology analysis and market forecast,93,12,0,pharmacy,"['research', 'and', 'market', 'me', '##di', '##point', 'companion', 'diagnostic', 'test', 'on', '##cology', 'analysis', 'and', 'market', 'forecast']",1
287285,nifty_864,2014-05-27,Chinese city targets pharma firms in graft crackdown,Neutral,-0.0007,52,chinese city target pharma firm graft crackdown,47,7,0,pharmacy,"['chin', '##ese', 'city', 'target', 'p', '##har', '##ma', 'firm', 'g', '##raft', 'crack', '##down']",1
287446,nifty_864,2014-05-27,Revive Therapeutics Ltd. Provides Statement Regarding Trading Activity,Neutral,-0.0007,70,revive therapeutic ltd provides statement regarding trading activity,68,8,0,pharmacy,"['revive', 'therapeutic', 'l', '##t', '##d', 'provides', 'statement', 'regarding', 'trading', 'activity']",1
287508,nifty_864,2014-05-27,Research and Markets: Monsanto Partnering Deals & Agreements Analysis 2009-2014,Neutral,-0.0007,79,research and market monsanto partnering deal agreement analysis,63,8,0,pharmacy,"['research', 'and', 'market', 'mon', '##san', '##to', 'partner', '##ing', 'deal', 'agreement', 'analysis']",1
287614,nifty_864,2014-05-27,BioCryst Commences Public Offering of Common Stock,Neutral,-0.0007,50,biocryst commences public offering common stock,47,6,0,pharmacy,"['bio', '##c', '##ry', '##st', 'commence', '##s', 'public', 'offering', 'common', 'stock']",1
287761,nifty_864,2014-05-27,SEC sets March 2015 date for new extractives rulesBrazil Drugstore Sector Seen as Attractive for Deals,Neutral,-0.0007,102,sec set march date for new extractives rulesbrazil drugstore sector seen attractive for deal,92,14,0,pharmacy,"['se', '##c', 'set', 'march', 'date', 'for', 'new', 'extract', '##ives', 'rules', '##bra', '##zi', '##l', 'drugs', '##tore', 'sector', 'seen', 'attractive', 'for', 'deal']",1
287779,nifty_864,2014-05-27,Insurers Push to Rein In Spending on Cancer Care,Neutral,-0.0007,48,insurer push rein spending cancer care,38,6,0,pharmacy,"['ins', '##urer', 'push', 're', '##in', 'spending', 'cancer', 'care']",1
287813,nifty_864,2014-05-27,"Bristol-Myers Squibb Partners With CytomX, Incyte in Immunotherapy",Neutral,-0.0007,66,bristol myers squibb partner with cytomx incyte immunotherapy,61,8,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'partner', 'with', 'c', '##yt', '##om', '##x', 'in', '##cy', '##te', 'im', '##mu', '##not', '##her', '##ap', '##y']",1
287833,nifty_865,2014-05-28,Gene Technology Regains Some of Its Luster,Rise,0.0052,42,gene technology regains some it luster,38,6,0,pharmacy,"['gene', 'technology', 'regain', '##s', 'some', 'it', 'lust', '##er']",1
287893,nifty_865,2014-05-28,Lilly Strikes Licensing Deal With Sanofi for Over-the-Counter Cialis,Rise,0.0052,68,lilly strike licensing deal with sanofi for over the counter cialis,67,11,0,pharmacy,"['l', '##ill', '##y', 'strike', 'licensing', 'deal', 'with', 'sa', '##no', '##fi', 'for', 'over', 'the', 'counter', 'c', '##ial', '##is']",1
287956,nifty_866,2014-05-29,Amsurg to Buy Sheridan Healthcare,Neutral,0.0016,33,amsurg buy sheridan healthcare,30,4,0,pharmacy,"['am', '##su', '##rg', 'buy', 'she', '##rida', '##n', 'healthcare']",1
288038,nifty_867,2014-06-02,Nordion Agrees to Sweetened Offer From Sterigenics,Neutral,-0.0005,50,nordion agrees sweetened offer from sterigenics,47,6,0,pharmacy,"['nor', '##dio', '##n', 'agrees', 'sweet', '##ened', 'offer', 'from', 's', '##ter', '##ige', '##nics']",1
288051,nifty_867,2014-06-02,Cancer Drugs Show Promise,Neutral,-0.0005,25,cancer drug show promise,24,4,0,pharmacy,"['cancer', 'drug', 'show', 'promise']",1
288052,nifty_867,2014-06-02,Drug Firms Target Smaller Deals,Neutral,-0.0005,31,drug firm target smaller deal,29,5,0,pharmacy,"['drug', 'firm', 'target', 'smaller', 'deal']",1
288185,nifty_868,2014-06-03,"Research and Markets: Global Molecular Diagnostics Report 2014-2023 - Technologies, Markets and Companies",Neutral,0.002,105,research and market global molecular diagnostics report technology market and company,85,11,0,pharmacy,"['research', 'and', 'market', 'global', 'molecular', 'diagnostic', '##s', 'report', 'technology', 'market', 'and', 'company']",1
288186,nifty_868,2014-06-03,"Research and Markets: Global Cell Therapy Market Report 2014-2023 - Technologies, Markets and Companies",Neutral,0.002,103,research and market global cell therapy market report technology market and company,83,12,0,pharmacy,"['research', 'and', 'market', 'global', 'cell', 'therapy', 'market', 'report', 'technology', 'market', 'and', 'company']",1
288188,nifty_868,2014-06-03,"Acquisitions, FDA Approvals, Appointments, Language Support Programme, and Event Participations - Analyst Notes on Euronet, Qiagen, Aaron's, Barnes & Noble and HSN",Neutral,0.002,163,acquisition fda approval appointment language support programme and event participation analyst note euronet qiagen aaron barnes noble and hsn,142,19,0,pharmacy,"['acquisition', 'f', '##da', 'approval', 'appointment', 'language', 'support', 'programme', 'and', 'event', 'participation', 'analyst', 'note', 'euro', '##net', 'q', '##ia', '##gen', 'a', '##aro', '##n', 'barn', '##es', 'noble', 'and', 'h', '##s', '##n']",1
288191,nifty_868,2014-06-03,"Research and Markets: Global Proteomics Technologies, Markets and Companies Market Report 2014 with Forecasts to 2018 & 2023",Neutral,0.002,124,research and market global proteomics technology market and company market report with forecast,95,13,0,pharmacy,"['research', 'and', 'market', 'global', 'pro', '##te', '##omi', '##cs', 'technology', 'market', 'and', 'company', 'market', 'report', 'with', 'forecast']",1
288198,nifty_868,2014-06-03,Research and Markets: Global Personalized Medicine Market Report 2014 - Scientific and Commercial Aspects to 2023,Neutral,0.002,113,research and market global personalized medicine market report scientific and commercial aspect,95,12,0,pharmacy,"['research', 'and', 'market', 'global', 'personal', '##ized', 'medicine', 'market', 'report', 'scientific', 'and', 'commercial', 'aspect']",1
288204,nifty_868,2014-06-03,"Research and Markets: Global Gene Therapy Market Report 2014 - Technologies, Markets and Companies Forecasts to 2023",Neutral,0.002,116,research and market global gene therapy market report technology market and company forecast,92,13,0,pharmacy,"['research', 'and', 'market', 'global', 'gene', 'therapy', 'market', 'report', 'technology', 'market', 'and', 'company', 'forecast']",1
288209,nifty_868,2014-06-03,"Research and Markets: Global Biomarkers Market Report 2014-2023 - Technologies, Markets and Companies",Neutral,0.002,101,research and market global biomarkers market report technology market and company,81,11,0,pharmacy,"['research', 'and', 'market', 'global', 'bio', '##mark', '##ers', 'market', 'report', 'technology', 'market', 'and', 'company']",1
288224,nifty_868,2014-06-03,Research and Markets: Global Digital Pathology Market Report 2014 - Forecasts to 2020 for the $5.7 Billion Industry,Neutral,0.002,115,research and market global digital pathology market report forecast for the billion industry,92,13,0,pharmacy,"['research', 'and', 'market', 'global', 'digital', 'path', '##ology', 'market', 'report', 'forecast', 'for', 'the', 'billion', 'industry']",1
288226,nifty_868,2014-06-03,"Research and Markets: Global Medical Imaging (X-Ray, CT, MRI, Ultrasound, PET, SPECT, Others) Markets Report Report 2014",Neutral,0.002,120,research and market global medical imaging ray mri ultrasound pet spect others market report report,99,15,0,pharmacy,"['research', 'and', 'market', 'global', 'medical', 'imaging', 'ray', 'm', '##ri', 'ultra', '##sound', 'pet', 's', '##pect', 'others', 'market', 'report', 'report']",1
288256,nifty_868,2014-06-03,"FDA Approvals, Digital Health Guidance, Conference Presentations, and Recognitions - Analyst Notes on Intercept Pharmaceuticals, Cigna, Baxter, Questcor and Mallinckrodt",Neutral,0.002,169,fda approval digital health guidance conference presentation and recognition analyst note intercept pharmaceutical cigna baxter questcor and mallinckrodt,153,18,0,pharmacy,"['f', '##da', 'approval', 'digital', 'health', 'guidance', 'conference', 'presentation', 'and', 'recognition', 'analyst', 'note', 'intercept', 'pharmaceutical', 'c', '##ign', '##a', 'b', '##ax', '##ter', 'quest', '##cor', 'and', 'mall', '##in', '##ck', '##rod', '##t']",1
288258,nifty_868,2014-06-03,"Upcoming Shareholders Meeting, Multi-Choice Medical Plans, FDA Approvals, and Investor Conference Schedules - Analyst Notes on Biogen Idec, UnitedHealth Group, Amgen, WellPoint and Mylan",Neutral,0.002,186,upcoming shareholder meeting multi choice medical plan fda approval and investor conference schedule analyst note biogen idec unitedhealth group amgen wellpoint and mylan,170,23,0,pharmacy,"['upcoming', 'shareholder', 'meeting', 'multi', 'choice', 'medical', 'plan', 'f', '##da', 'approval', 'and', 'investor', 'conference', 'schedule', 'analyst', 'note', 'bio', '##gen', 'id', '##ec', 'united', '##hea', '##lt', '##h', 'group', 'am', '##gen', 'well', '##point', 'and', 'my', '##lan']",1
288263,nifty_868,2014-06-03,Isis Pharmaceuticals to Present a General Corporate Update at its 2014 Annual Meeting of Stockholders and Open House,Neutral,0.002,116,isi pharmaceutical present general corporate update it annual meeting stockholder and open house,96,13,0,pharmacy,"['is', '##i', 'pharmaceutical', 'present', 'general', 'corporate', 'update', 'it', 'annual', 'meeting', 'stock', '##holder', 'and', 'open', 'house']",1
288300,nifty_868,2014-06-03,"Biotech Stocks Technical Data -- Research on Dynavax Technologies, Ironwood Pharma, Rigel Pharma, and Momenta Pharma",Neutral,0.002,116,biotech stock technical data research dynavax technology ironwood pharma rigel pharma and momentum pharma,105,14,0,pharmacy,"['bio', '##tech', 'stock', 'technical', 'data', 'research', 'd', '##yna', '##va', '##x', 'technology', 'iron', '##wood', 'p', '##har', '##ma', 'rig', '##el', 'p', '##har', '##ma', 'and', 'momentum', 'p', '##har', '##ma']",1
288325,nifty_868,2014-06-03,"Health Care Sector Equities Scrutiny -- Research on AVANIR Pharma, Zoetis, Actavis, and Mallinckrodt",Neutral,0.002,100,health care sector equity scrutiny research avanir pharma zoetis actavis and mallinckrodt,89,12,0,pharmacy,"['health', 'care', 'sector', 'equity', 'scrutiny', 'research', 'a', '##vani', '##r', 'p', '##har', '##ma', 'z', '##oe', '##tis', 'act', '##avi', '##s', 'and', 'mall', '##in', '##ck', '##rod', '##t']",1
288366,nifty_868,2014-06-03,Research and Markets: Targeting Natural Killer Cell Mediated Cytotoxicity in Cancer Drug Pipeline Update 2014,Neutral,0.002,109,research and market targeting natural killer cell mediated cytotoxicity cancer drug pipeline update,99,13,0,pharmacy,"['research', 'and', 'market', 'targeting', 'natural', 'killer', 'cell', 'mediated', 'c', '##yt', '##oto', '##xi', '##city', 'cancer', 'drug', 'pipeline', 'update']",1
288369,nifty_868,2014-06-03,Research and Markets: VEGF Signaling Pathway in Cancer Drug Pipeline Update 2014,Neutral,0.002,80,research and market vegf signaling pathway cancer drug pipeline update,70,10,0,pharmacy,"['research', 'and', 'market', 've', '##g', '##f', 'signaling', 'pathway', 'cancer', 'drug', 'pipeline', 'update']",1
288374,nifty_868,2014-06-03,Research and Markets: Viral Carcinogenesis Drug Pipeline Update 2014: 185 companies plus partners developing 243 viral carcinogenesis targeting drugs in 833 developmental projects,Neutral,0.002,179,research and market viral carcinogenesis drug pipeline update company plus partner developing viral carcinogenesis targeting drug developmental project,151,18,0,pharmacy,"['research', 'and', 'market', 'viral', 'car', '##cin', '##ogen', '##esis', 'drug', 'pipeline', 'update', 'company', 'plus', 'partner', 'developing', 'viral', 'car', '##cin', '##ogen', '##esis', 'targeting', 'drug', 'developmental', 'project']",1
288583,nifty_868,2014-06-03,Research and Markets: Japan Glioblastoma Market Analysis Report 2014-2019,Neutral,0.002,73,research and market japan glioblastoma market analysis report,61,8,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##n', 'g', '##lio', '##blast', '##oma', 'market', 'analysis', 'report']",1
288584,nifty_868,2014-06-03,Research and Markets: Japan Type 2 Diabetes Market Report 2014-2019,Neutral,0.002,67,research and market japan type diabetes market report,53,8,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##n', 'type', 'diabetes', 'market', 'report']",1
288594,nifty_868,2014-06-03,"Supreme Pharmaceuticals (CSE:SL) Attending the GreenRush Financial Conference in Toronto, Ontario on June 26, 2014 - Video News Alert on InvestmentPitch.com",Neutral,0.002,156,supreme pharmaceutical cse attending the greenrush financial conference toronto ontario june video news alert investmentpitch com,129,16,0,pharmacy,"['supreme', 'pharmaceutical', 'c', '##se', 'attending', 'the', 'green', '##rush', 'financial', 'conference', 'to', '##ron', '##to', 'on', '##tar', '##io', 'j', '##une', 'video', 'news', 'alert', 'investment', '##pit', '##ch', 'com']",1
288628,nifty_868,2014-06-03,HealthEdge to Present Case Studies on Technology-Enabled Business Transformation at AHIPâs Institute 2014,Neutral,0.002,107,healthedge present case study technology enabled business transformation ahipâ institute,88,10,0,pharmacy,"['health', '##ed', '##ge', 'present', 'case', 'study', 'technology', 'enabled', 'business', 'transformation', 'ah', '##ip', '##â', 'institute']",1
288677,nifty_868,2014-06-03,Research and Markets: The Corporate Reputation of Pharma - The Neurological Patient Perspective on 14 Top Pharma Companies,Neutral,0.002,122,research and market the corporate reputation pharma the neurological patient perspective top pharma company,107,14,0,pharmacy,"['research', 'and', 'market', 'the', 'corporate', 'reputation', 'p', '##har', '##ma', 'the', 'ne', '##uro', '##logical', 'patient', 'perspective', 'top', 'p', '##har', '##ma', 'company']",1
288696,nifty_868,2014-06-03,Research and Markets: The Cancer Patient Perspective - Latest Impressions on the Corporate Reputation of 17 Pharma Companies,Neutral,0.002,124,research and market the cancer patient perspective latest impression the corporate reputation pharma company,108,14,0,pharmacy,"['research', 'and', 'market', 'the', 'cancer', 'patient', 'perspective', 'latest', 'impression', 'the', 'corporate', 'reputation', 'p', '##har', '##ma', 'company']",1
288718,nifty_868,2014-06-03,Research and Markets: 2014 European Bipolar Disorder Market Highlights,Neutral,0.002,70,research and market european bipolar disorder market highlight,62,8,0,pharmacy,"['research', 'and', 'market', 'euro', '##pe', '##an', 'bi', '##pol', '##ar', 'disorder', 'market', 'highlight']",1
288724,nifty_868,2014-06-03,Research and Markets: 2014 Japan Depression Market Highlights,Neutral,0.002,61,research and market japan depression market highlight,53,7,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##n', 'depression', 'market', 'highlight']",1
288747,nifty_868,2014-06-03,Research and Markets: U.S. Market for Uterine Fibroid Embolization Devices Report 2014 with 10 Year Forecasts,Neutral,0.002,109,research and market market for uterine fibroid embolization device report with year forecast,92,13,0,pharmacy,"['research', 'and', 'market', 'market', 'for', 'u', '##ter', '##ine', 'fi', '##bro', '##id', 'em', '##bol', '##ization', 'device', 'report', 'with', 'year', 'forecast']",1
288766,nifty_868,2014-06-03,Research and Markets: Japan Bipolar Disorder Market Highlights - 2014,Neutral,0.002,69,research and market japan bipolar disorder market highlight,59,8,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##n', 'bi', '##pol', '##ar', 'disorder', 'market', 'highlight']",1
288767,nifty_868,2014-06-03,Groundbreaking Documentary on Undiagnosed Diseases Seeks $150K in Crowdfunding to Change the Future of Medicine,Neutral,0.002,111,groundbreaking documentary undiagnosed disease seek crowdfunding change the future medicine,91,10,0,pharmacy,"['groundbreaking', 'documentary', 'und', '##ia', '##gno', '##sed', 'disease', 'seek', 'crowd', '##fu', '##nding', 'change', 'the', 'future', 'medicine']",1
288811,nifty_868,2014-06-03,NPS Pharma to Present at Goldman Sachs Global Healthcare Conference,Neutral,0.002,67,np pharma present goldman sachs global healthcare conference,60,8,0,pharmacy,"['n', '##p', 'p', '##har', '##ma', 'present', 'gold', '##man', 'sa', '##chs', 'global', 'healthcare', 'conference']",1
288900,nifty_868,2014-06-03,REFILE-AstraZeneca fights to regain cancer market prominence,Neutral,0.002,60,refile astrazeneca fight regain cancer market prominence,56,7,0,pharmacy,"['re', '##fi', '##le', 'as', '##tra', '##zen', '##eca', 'fight', 'regain', 'cancer', 'market', 'prominence']",1
288953,nifty_868,2014-06-03,"Sanofi, Merck, Glaxo Considering Deals for Old-Drug Portfolios",Neutral,0.002,62,sanofi merck glaxo considering deal for old drug portfolio,58,9,0,pharmacy,"['sa', '##no', '##fi', 'me', '##rc', '##k', 'g', '##lax', '##o', 'considering', 'deal', 'for', 'old', 'drug', 'portfolio']",1
288954,nifty_868,2014-06-03,"Merck, Sanofi Try to Shed Older Drugs",Neutral,0.002,37,merck sanofi try shed older drug,32,6,0,pharmacy,"['me', '##rc', '##k', 'sa', '##no', '##fi', 'try', 'shed', 'older', 'drug']",1
289004,nifty_868,2014-06-03,Teva Buys Labrys Biologics,Neutral,0.002,26,teva buy labrys biologics,25,4,0,pharmacy,"['te', '##va', 'buy', 'lab', '##ry', '##s', 'bio', '##log', '##ics']",1
289018,nifty_868,2014-06-03,FDA Finds Flaws at Indian Drug Maker's U.S. Plant,Neutral,0.002,49,fda find flaw indian drug maker plant,37,7,0,pharmacy,"['f', '##da', 'find', 'fl', '##aw', 'in', '##dian', 'drug', 'maker', 'plant']",1
289185,nifty_870,2014-06-05,In Vitro Company to Go Public,Neutral,0.0048,29,vitro company public,20,3,0,pharmacy,"['v', '##it', '##ro', 'company', 'public']",1
289212,nifty_871,2014-06-09,Merck to Buy Idenix Pharmaceuticals for $3.85 Billion,Neutral,0.0001,53,merck buy idenix pharmaceutical for billion,43,6,0,pharmacy,"['me', '##rc', '##k', 'buy', 'id', '##eni', '##x', 'pharmaceutical', 'for', 'billion']",1
289344,nifty_872,2014-06-10,"Research and Markets: Respiratory Tract Inflammatory Disorders - Pipeline Review, H1 2014",Neutral,-0.0035,89,research and market respiratory tract inflammatory disorder pipeline review,75,9,0,pharmacy,"['research', 'and', 'market', 'respiratory', 'tract', 'inflammatory', 'disorder', 'pipeline', 'review']",1
289352,nifty_872,2014-06-10,"Earnings Adjustment, Financial Results, Upcoming Conferences, and Product Shipments - Analyst Notes on Agilent, Bio-Reference, RadNet, Foundation Medicine and Fluidigm",Neutral,-0.0035,167,earnings adjustment financial result upcoming conference and product shipment analyst note agilent bio reference radnet foundation medicine and fluidigm,152,19,0,pharmacy,"['earnings', 'adjustment', 'financial', 'result', 'upcoming', 'conference', 'and', 'product', 'shipment', 'analyst', 'note', 'a', '##gi', '##lent', 'bio', 'reference', 'r', '##ad', '##net', 'foundation', 'medicine', 'and', 'fluid', '##ig', '##m']",1
289392,nifty_872,2014-06-10,"Research and Markets: Ischemic Stroke - Pipeline Review, H1 2014",Neutral,-0.0035,64,research and market ischemic stroke pipeline review,51,7,0,pharmacy,"['research', 'and', 'market', 'is', '##che', '##mic', 'stroke', 'pipeline', 'review']",1
289403,nifty_872,2014-06-10,"Research and Markets: Acute Heart Failure - Pipeline Review, H1 2014",Neutral,-0.0035,68,research and market acute heart failure pipeline review,55,8,0,pharmacy,"['research', 'and', 'market', 'acute', 'heart', 'failure', 'pipeline', 'review']",1
289406,nifty_872,2014-06-10,"Strategic Collaborations and Expanded Repurchase Programs - Analyst Notes on Covance, PerkinElmer, PAREXEL, Analogic and Alere",Neutral,-0.0035,126,strategic collaboration and expanded repurchase program analyst note covance perkinelmer parexel analogic and alere,115,14,0,pharmacy,"['strategic', 'collaboration', 'and', 'expanded', 're', '##pur', '##chase', 'program', 'analyst', 'note', 'co', '##vance', 'per', '##kin', '##el', '##mer', 'par', '##ex', '##el', 'analog', '##ic', 'and', 'ale', '##re']",1
289450,nifty_872,2014-06-10,"Health Care Sector Stocks Technical Study -- Research on CR Bard, Quest Diagnostics, Laboratory Corp. of America, and Allscripts Healthcare Solutions",Neutral,-0.0035,149,health care sector stock technical study research bard quest diagnostics laboratory corp america and allscripts healthcare solution,131,17,0,pharmacy,"['health', 'care', 'sector', 'stock', 'technical', 'study', 'research', 'bar', '##d', 'quest', 'diagnostic', '##s', 'laboratory', 'co', '##rp', 'am', '##eric', '##a', 'and', 'all', '##s', '##cripts', 'healthcare', 'solution']",1
289482,nifty_872,2014-06-10,"Biotech Stocks Technical Data -- Research on Navidea Biopharma, Alkermes, Nanosphere, and Organovo Holdings",Neutral,-0.0035,107,biotech stock technical data research navidea biopharma alkermes nanosphere and organovo holding,96,12,0,pharmacy,"['bio', '##tech', 'stock', 'technical', 'data', 'research', 'na', '##vide', '##a', 'bio', '##pha', '##rma', 'al', '##ker', '##mes', 'na', '##nos', '##phere', 'and', 'organ', '##ovo', 'holding']",1
289491,nifty_872,2014-06-10,Raptor Pharmaceutical to Participate in Three Upcoming Investor Conferences in June,Neutral,-0.0035,83,raptor pharmaceutical participate three upcoming investor conference june,73,8,0,pharmacy,"['rap', '##tor', 'pharmaceutical', 'participate', 'three', 'upcoming', 'investor', 'conference', 'j', '##une']",1
289503,nifty_872,2014-06-10,Bioventus Announces U.S. Debut of Feature-Rich New EXOGENÂ® Device,Neutral,-0.0035,66,bioventus announces debut feature rich new exogenâ device,57,8,0,pharmacy,"['bio', '##vent', '##us', 'announces', 'debut', 'feature', 'rich', 'new', 'ex', '##ogen', '##â', 'device']",1
289508,nifty_872,2014-06-10,Celgene Makes Landmark Investment in NantHealth to Advance Groudbreaking Cancer Research for Patients,Neutral,-0.0035,101,celgene make landmark investment nanthealth advance groudbreaking cancer research for patient,93,11,0,pharmacy,"['c', '##el', '##gene', 'make', 'landmark', 'investment', 'na', '##nt', '##hea', '##lt', '##h', 'advance', 'g', '##rou', '##d', '##break', '##ing', 'cancer', 'research', 'for', 'patient']",1
289525,nifty_872,2014-06-10,Research and Markets: Japan Chronic Obstructive Pulmonary Disease Market Highlights - 2014,Neutral,-0.0035,90,research and market japan chronic obstructive pulmonary disease market highlight,80,10,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##n', 'chronic', 'o', '##bs', '##truct', '##ive', 'pulmonary', 'disease', 'market', 'highlight']",1
289596,nifty_872,2014-06-10,Polydex Pharmaceuticals Issues First Quarter Financial Results,Neutral,-0.0035,62,polydex pharmaceutical issue first quarter financial result,59,7,0,pharmacy,"['p', '##oly', '##de', '##x', 'pharmaceutical', 'issue', 'first', 'quarter', 'financial', 'result']",1
289606,nifty_872,2014-06-10,Intel-GE Care Innovationsâ¢ Strengthens Consumer-Engagement Expertise with Leadership Addition,Neutral,-0.0035,95,intel care innovationsâ strengthens consumer engagement expertise with leadership addition,90,10,0,pharmacy,"['in', '##tel', 'care', 'innovations', '##â', 'strengthen', '##s', 'consumer', 'engagement', 'expertise', 'with', 'leadership', 'addition']",1
289632,nifty_872,2014-06-10,Research and Markets: UK Gastro-Esophageal Reflux Disease Market Highlights - 2014,Neutral,-0.0035,82,research and market gastro esophageal reflux disease market highlight,69,9,0,pharmacy,"['research', 'and', 'market', 'gas', '##tro', 'es', '##op', '##hage', '##al', 're', '##f', '##lux', 'disease', 'market', 'highlight']",1
289650,nifty_872,2014-06-10,Research and Markets: Japan Crohn's Disease Market Highlights - 2014,Neutral,-0.0035,68,research and market japan crohn disease market highlight,56,8,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##n', 'c', '##ro', '##hn', 'disease', 'market', 'highlight']",1
289748,nifty_872,2014-06-10,Research and Markets: Europe Sinusitis Market Highlights - 2014 Report Contains Forecasts up to 2019,Neutral,-0.0035,100,research and market europe sinusitis market highlight report contains forecast,78,10,0,pharmacy,"['research', 'and', 'market', 'euro', '##pe', 'sin', '##us', '##itis', 'market', 'highlight', 'report', 'contains', 'forecast']",1
289775,nifty_872,2014-06-10,Tanner Labs Launches Welbe Digital Corporate Wellness Platform,Neutral,-0.0035,62,tanner lab launch welbe digital corporate wellness platform,59,8,0,pharmacy,"['tan', '##ner', 'lab', 'launch', 'we', '##l', '##be', 'digital', 'corporate', 'well', '##ness', 'platform']",1
289799,nifty_872,2014-06-10,Research and Markets: Breast Cancer Pipeline Highlights - 2014 Update Covers Emerging Therapies for Breast Cancer in Active Clinical Development Stages,Neutral,-0.0035,151,research and market breast cancer pipeline highlight update cover emerging therapy for breast cancer active clinical development stage,134,18,0,pharmacy,"['research', 'and', 'market', 'breast', 'cancer', 'pipeline', 'highlight', 'update', 'cover', 'emerging', 'therapy', 'for', 'breast', 'cancer', 'active', 'clinical', 'development', 'stage']",1
289848,nifty_872,2014-06-10,Research and Markets: 2014 Report on the International Pain Management Drugs Market - Forecasts to 2018,Neutral,-0.0035,103,research and market report the international pain management drug market forecast,81,11,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'pain', 'management', 'drug', 'market', 'forecast']",1
289863,nifty_872,2014-06-10,Research and Markets: 2014 Report on the International Remote Patient Monitoring Market - Forecasts to 2018,Neutral,-0.0035,107,research and market report the international remote patient monitoring market forecast,86,11,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'remote', 'patient', 'monitoring', 'market', 'forecast']",1
289874,nifty_872,2014-06-10,Research and Markets: China CRAMS Market Outlook to 2018 - Manufacturing of APIs and Bulk Drugs to Propel Growth,Neutral,-0.0035,112,research and market china crams market outlook manufacturing apis and bulk drug propel growth,93,14,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'c', '##rams', 'market', 'outlook', 'manufacturing', 'a', '##pis', 'and', 'bulk', 'drug', 'prop', '##el', 'growth']",1
289876,nifty_872,2014-06-10,Research and Markets: Germany CRAMS Market Outlook to 2018 - Rising Healthcare Costs to Drive Future Growth,Neutral,-0.0035,107,research and market germany crams market outlook rising healthcare cost drive future growth,91,13,0,pharmacy,"['research', 'and', 'market', 'g', '##erman', '##y', 'c', '##rams', 'market', 'outlook', 'rising', 'healthcare', 'cost', 'drive', 'future', 'growth']",1
289912,nifty_872,2014-06-10,"YOUR MONEY-How to find value, as well as growth, in drug stocks",Neutral,-0.0035,63,your money how find value well growth drug stock,48,9,0,pharmacy,"['your', 'money', 'how', 'find', 'value', 'well', 'growth', 'drug', 'stock']",1
289915,nifty_872,2014-06-10,Research and Markets: India CRAMS Market Outlook to 2018 - Surging Demand for Contract Drug Discovery and Research Services,Neutral,-0.0035,123,research and market india crams market outlook surging demand for contract drug discovery and research service,110,16,0,pharmacy,"['research', 'and', 'market', 'in', '##dia', 'c', '##rams', 'market', 'outlook', 'sur', '##ging', 'demand', 'for', 'contract', 'drug', 'discovery', 'and', 'research', 'service']",1
289937,nifty_872,2014-06-10,"Research and Markets: 2014 Report on the International Proteomics (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) Market - Forecast",Neutral,-0.0035,224,research and market report the international proteomics protein microarray mass spectrometry nmr spectroscopy chromatography electrophoresis surface plasmon resonance ray crystallography market forecast,202,22,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'pro', '##te', '##omi', '##cs', 'protein', 'micro', '##arra', '##y', 'mass', 's', '##pect', '##rome', '##try', 'nm', '##r', 's', '##pect', '##ros', '##copy', 'ch', '##roma', '##tography', 'electro', '##ph', '##ores', '##is', 'surface', 'p', '##las', '##mon', 'resonance', 'ray', 'crystal', '##log', '##raphy', 'market', 'forecast']",1
289942,nifty_872,2014-06-10,Investment in Innovation (IN3) Medical Device 360 Boston Panel Features How Hospitals and Insurers Are Increasingly Emerging as MedTech Investors,Neutral,-0.0035,145,investment innovation medical device boston panel feature how hospital and insurer are increasingly emerging medtech investor,125,16,0,pharmacy,"['investment', 'innovation', 'medical', 'device', 'b', '##ost', '##on', 'panel', 'feature', 'how', 'hospital', 'and', 'ins', '##urer', 'are', 'increasingly', 'emerging', 'me', '##dt', '##ech', 'investor']",1
289984,nifty_872,2014-06-10,Enanta Pharmaceuticals to Present at Two Upcoming Investor Conferences,Neutral,-0.0035,70,enanta pharmaceutical present two upcoming investor conference,62,7,0,pharmacy,"['en', '##ant', '##a', 'pharmaceutical', 'present', 'two', 'upcoming', 'investor', 'conference']",1
290282,nifty_873,2014-06-11,"Stock Option Programs, Proposed Refinancing, FDA Approvals, and Conference Presentations - Analyst Notes on Aegerion, DaVita, DexCom, Impax and Sanofi",Fall,-0.0071,150,stock option program proposed refinancing fda approval and conference presentation analyst note aegerion davita dexcom impax and sanofi,135,18,0,pharmacy,"['stock', 'option', 'program', 'proposed', 're', '##fin', '##an', '##cing', 'f', '##da', 'approval', 'and', 'conference', 'presentation', 'analyst', 'note', 'a', '##ege', '##rion', 'da', '##vi', '##ta', 'de', '##x', '##com', 'imp', '##ax', 'and', 'sa', '##no', '##fi']",1
290288,nifty_873,2014-06-11,"FDA Drug Approvals, Dividends, Fast Track Designation, Event Sponsorship, and Expansion of Role - Analyst Notes on Biogen Idec, UnitedHealth Group, GW Pharmaceuticals, Questcor and Cigna",Fall,-0.0071,186,fda drug approval dividend fast track designation event sponsorship and expansion role analyst note biogen idec unitedhealth group pharmaceutical questcor and cigna,164,22,0,pharmacy,"['f', '##da', 'drug', 'approval', 'divide', '##nd', 'fast', 'track', 'designation', 'event', 'sponsorship', 'and', 'expansion', 'role', 'analyst', 'note', 'bio', '##gen', 'id', '##ec', 'united', '##hea', '##lt', '##h', 'group', 'pharmaceutical', 'quest', '##cor', 'and', 'c', '##ign', '##a']",1
290298,nifty_873,2014-06-11,"Research and Markets: Russia MRI Systems Market Outlook to 2020: Key players covered include GE, Esaote, Hitachi, Philips, Siemens and Toshiba",Fall,-0.0071,142,research and market russia mri system market outlook key player covered include esaote hitachi philip siemens and toshiba,121,18,0,pharmacy,"['research', 'and', 'market', 'r', '##uss', '##ia', 'm', '##ri', 'system', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'es', '##ao', '##te', 'hit', '##achi', 'p', '##hil', '##ip', 'si', '##em', '##ens', 'and', 'to', '##shi', '##ba']",1
290302,nifty_873,2014-06-11,"Research and Markets: Russia Diagnostic Imaging Market Outlook to 2020: Key players covered include GE, Philips, Siemens and Toshiba",Fall,-0.0071,132,research and market russia diagnostic imaging market outlook key player covered include philip siemens and toshiba,114,16,0,pharmacy,"['research', 'and', 'market', 'r', '##uss', '##ia', 'diagnostic', 'imaging', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'p', '##hil', '##ip', 'si', '##em', '##ens', 'and', 'to', '##shi', '##ba']",1
290327,nifty_873,2014-06-11,Research and Markets: Biotechnology and Healthcare Markets in China (9 Full Research Reports Collection),Fall,-0.0071,104,research and market biotechnology and healthcare market china full research report collection,93,12,0,pharmacy,"['research', 'and', 'market', 'bio', '##tech', '##nology', 'and', 'healthcare', 'market', 'chin', '##a', 'full', 'research', 'report', 'collection']",1
290334,nifty_873,2014-06-11,Research and Markets: Common Disease Treatment Drugs Markets in China (13 Full Research Reports Collection),Fall,-0.0071,107,research and market common disease treatment drug market china full research report collection,94,13,0,pharmacy,"['research', 'and', 'market', 'common', 'disease', 'treatment', 'drug', 'market', 'chin', '##a', 'full', 'research', 'report', 'collection']",1
290335,nifty_873,2014-06-11,"Prescription for Profit: Pharma-Biotech Industry Continues Mega-Billion Dollar Merger & Acquisition Binge, an Industrial Info News Alert",Fall,-0.0071,136,prescription for profit pharma biotech industry continues mega billion dollar merger acquisition binge industrial info news alert,129,17,0,pharmacy,"['prescription', 'for', 'profit', 'p', '##har', '##ma', 'bio', '##tech', 'industry', 'continues', 'me', '##ga', 'billion', 'dollar', 'merger', 'acquisition', 'bin', '##ge', 'industrial', 'info', 'news', 'alert']",1
290342,nifty_873,2014-06-11,Research and Markets: Cancer Treatment Drugs Markets in China (12 Full Research Reports Collection),Fall,-0.0071,99,research and market cancer treatment drug market china full research report collection,86,12,0,pharmacy,"['research', 'and', 'market', 'cancer', 'treatment', 'drug', 'market', 'chin', '##a', 'full', 'research', 'report', 'collection']",1
290392,nifty_873,2014-06-11,Isis Pharmaceuticals to Host Investor Event to Discuss ISIS-GCGR Rx Phase 2 Data Presented at the 2014 ADA Scientific Sessions,Fall,-0.0071,126,isi pharmaceutical host investor event discus isi gcgr phase data presented the ada scientific session,102,15,0,pharmacy,"['is', '##i', 'pharmaceutical', 'host', 'investor', 'event', 'disc', '##us', 'is', '##i', 'g', '##c', '##g', '##r', 'phase', 'data', 'presented', 'the', 'ad', '##a', 'scientific', 'session']",1
290399,nifty_873,2014-06-11,Nektar Therapeutics Stock Trading Halted Today; FDA Advisory Committee to Discuss Peripherally-Acting Opioid Receptor Antagonists,Fall,-0.0071,129,nektar therapeutic stock trading halted today fda advisory committee discus peripherally acting opioid receptor antagonist,122,15,0,pharmacy,"['ne', '##kt', '##ar', 'therapeutic', 'stock', 'trading', 'halted', 'today', 'f', '##da', 'advisory', 'committee', 'disc', '##us', 'peripheral', '##ly', 'acting', 'op', '##io', '##id', 'receptor', 'antagonist']",1
290404,nifty_873,2014-06-11,"Stock Watchout on Biotech Industry -- Research on Isis Pharma, Pharmacyclics, Amarin, and Prana Biotechnology",Fall,-0.0071,109,stock watchout biotech industry research isi pharma pharmacyclics amarin and prana biotechnology,96,12,0,pharmacy,"['stock', 'watch', '##out', 'bio', '##tech', 'industry', 'research', 'is', '##i', 'p', '##har', '##ma', 'pharmacy', '##c', '##lic', '##s', 'am', '##ari', '##n', 'and', 'p', '##rana', 'bio', '##tech', '##nology']",1
290407,nifty_873,2014-06-11,"Technical Pulse on Pharma Stocks -- Research on Valeant Pharma Intl., Acura Pharma, Teva Pharma Industries, and Lannett",Fall,-0.0071,119,technical pulse pharma stock research valeant pharma intl acura pharma teva pharma industry and lannett,103,15,0,pharmacy,"['technical', 'pulse', 'p', '##har', '##ma', 'stock', 'research', 'v', '##ale', '##ant', 'p', '##har', '##ma', 'in', '##tl', 'a', '##cu', '##ra', 'p', '##har', '##ma', 'te', '##va', 'p', '##har', '##ma', 'industry', 'and', 'la', '##nne', '##tt']",1
290463,nifty_873,2014-06-11,Three Groundbreaking Biotech Startups Receive Funding from Peter Thielâs Breakout Labs,Fall,-0.0071,88,three groundbreaking biotech startup receive funding from peter thielâ breakout lab,83,11,0,pharmacy,"['three', 'groundbreaking', 'bio', '##tech', 'start', '##up', 'receive', 'funding', 'from', 'pet', '##er', 'th', '##iel', '##â', 'break', '##out', 'lab']",1
290492,nifty_873,2014-06-11,Celator(R) Pharmaceuticals Announces Data and Safety Monitoring Board Recommendation to Continue Phase 3 Study of CPX-351,Fall,-0.0071,121,celator pharmaceutical announces data and safety monitoring board recommendation continue phase study cpx,105,13,0,pharmacy,"['c', '##ela', '##tor', 'pharmaceutical', 'announces', 'data', 'and', 'safety', 'monitoring', 'board', 'recommendation', 'continue', 'phase', 'study', 'c', '##p', '##x']",1
290515,nifty_873,2014-06-11,Research and Markets: UK Bipolar Disorder Market Highlights - 2014,Fall,-0.0071,66,research and market bipolar disorder market highlight,53,7,0,pharmacy,"['research', 'and', 'market', 'bi', '##pol', '##ar', 'disorder', 'market', 'highlight']",1
290524,nifty_873,2014-06-11,Research and Markets: UK Ulcerative Colitis Market Highlights - 2014,Fall,-0.0071,68,research and market ulcerative colitis market highlight,55,7,0,pharmacy,"['research', 'and', 'market', 'ul', '##cer', '##ative', 'co', '##lit', '##is', 'market', 'highlight']",1
290529,nifty_873,2014-06-11,Research and Markets: Germany Ulcerative Colitis Market Highlights - 2014,Fall,-0.0071,73,research and market germany ulcerative colitis market highlight,63,8,0,pharmacy,"['research', 'and', 'market', 'g', '##erman', '##y', 'ul', '##cer', '##ative', 'co', '##lit', '##is', 'market', 'highlight']",1
290561,nifty_873,2014-06-11,Cellnovo Wins BIOVISION Investor Conference Award,Fall,-0.0071,49,cellnovo win biovision investor conference award,48,6,0,pharmacy,"['cell', '##nov', '##o', 'win', 'bio', '##vision', 'investor', 'conference', 'award']",1
290600,nifty_873,2014-06-11,Research and Markets: Chronos Therapeutics Limited - Product Pipeline Review - 2014,Fall,-0.0071,83,research and market chronos therapeutic limited product pipeline review,71,9,0,pharmacy,"['research', 'and', 'market', 'ch', '##ron', '##os', 'therapeutic', 'limited', 'product', 'pipeline', 'review']",1
290611,nifty_873,2014-06-11,"Research and Markets: Sangamo BioSciences, Inc. - Product Pipeline Review - 2014",Fall,-0.0071,80,research and market sangamo bioscience inc product pipeline review,66,9,0,pharmacy,"['research', 'and', 'market', 'sang', '##amo', 'bio', '##science', 'in', '##c', 'product', 'pipeline', 'review']",1
290668,nifty_873,2014-06-11,"Research and Markets: Botulism - Pipeline Review, H1 2014",Fall,-0.0071,57,research and market botulism pipeline review,44,6,0,pharmacy,"['research', 'and', 'market', 'b', '##ot', '##uli', '##sm', 'pipeline', 'review']",1
290670,nifty_873,2014-06-11,Pivotal Therapeutics engages Kilmer Lucas for cross-border investor relations,Fall,-0.0071,77,pivotal therapeutic engages kilmer lucas for cross border investor relation,75,10,0,pharmacy,"['pivotal', 'therapeutic', 'engages', 'k', '##il', '##mer', 'l', '##uca', '##s', 'for', 'cross', 'border', 'investor', 'relation']",1
290709,nifty_873,2014-06-11,"Research and Markets: Skin Inflammation - Pipeline Review, H1 2014",Fall,-0.0071,66,research and market skin inflammation pipeline review,53,7,0,pharmacy,"['research', 'and', 'market', 'skin', 'inflammation', 'pipeline', 'review']",1
290782,nifty_873,2014-06-11,Research and Markets: 2014 Report on the International Molecular Spectroscopy Market - Forecast to 2018,Fall,-0.0071,103,research and market report the international molecular spectroscopy market forecast,83,10,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'molecular', 's', '##pect', '##ros', '##copy', 'market', 'forecast']",1
290790,nifty_873,2014-06-11,"Research and Markets: 2014 Report on the International Infusion Pumps & Accessories (Diabetes, Chemotherapy, Nutrition, Pain Management) Market - Forecasts to 2018",Fall,-0.0071,163,research and market report the international infusion pump accessory diabetes chemotherapy nutrition pain management market forecast,132,16,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'in', '##fusion', 'pump', 'access', '##ory', 'diabetes', 'ch', '##em', '##otherapy', 'nutrition', 'pain', 'management', 'market', 'forecast']",1
290819,nifty_873,2014-06-11,Research and Markets: The Overall Global Market for Minimally Invasive Surgery is Expected to Grow at a CAGR of 10.5% from 2013 to 2019,Fall,-0.0071,135,research and market the overall global market for minimally invasive surgery expected grow cagr from,100,15,0,pharmacy,"['research', 'and', 'market', 'the', 'overall', 'global', 'market', 'for', 'minimal', '##ly', 'invasive', 'surgery', 'expected', 'grow', 'ca', '##g', '##r', 'from']",1
290856,nifty_873,2014-06-11,Research and Markets: Europe In-Vitro Diagnostics Market Outlook to 2018 - Ageing Demographic and Mounting Consolidations to Drive Future Growth,Fall,-0.0071,144,research and market europe vitro diagnostics market outlook ageing demographic and mounting consolidation drive future growth,125,16,0,pharmacy,"['research', 'and', 'market', 'euro', '##pe', 'v', '##it', '##ro', 'diagnostic', '##s', 'market', 'outlook', 'age', '##ing', 'demographic', 'and', 'mounting', 'consolidation', 'drive', 'future', 'growth']",1
290864,nifty_873,2014-06-11,Aduro BioTech Secures $55 Million Series C Financing,Fall,-0.0071,52,aduro biotech secures million series financing,46,6,0,pharmacy,"['ad', '##uro', 'bio', '##tech', 'secure', '##s', 'million', 'series', 'financing']",1
291048,nifty_873,2014-06-11,Lilly's Cyramza Misses Primary Goal,Fall,-0.0071,35,lilly cyramza miss primary goal,31,5,0,pharmacy,"['l', '##ill', '##y', 'c', '##yra', '##m', '##za', 'miss', 'primary', 'goal']",1
291058,nifty_873,2014-06-11,Orexigen Shares Drop as FDA Delays Approval,Fall,-0.0071,43,orexigen share drop fda delay approval,38,6,0,pharmacy,"['ore', '##xi', '##gen', 'share', 'drop', 'f', '##da', 'delay', 'approval']",1
291152,nifty_874,2014-06-12,"Research and Markets: Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2014",Neutral,0.003,103,research and market coronary artery disease cad ischemic heart disease pipeline review,86,12,0,pharmacy,"['research', 'and', 'market', 'co', '##rona', '##ry', 'artery', 'disease', 'ca', '##d', 'is', '##che', '##mic', 'heart', 'disease', 'pipeline', 'review']",1
291201,nifty_874,2014-06-12,Research and Markets: Japan Schizophrenia Market Highlights - 2014,Neutral,0.003,66,research and market japan schizophrenia market highlight,56,7,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##n', 's', '##chi', '##zophrenia', 'market', 'highlight']",1
291208,nifty_874,2014-06-12,"Expansions, New Leadership, Annual Award Winners, FDA Approvals, and Abstracts Presentations - Analyst Notes on AbbVie, Amgen, Regeneron Pharmaceuticals Inc, Valeant Pharmaceuticals and Lilly",Neutral,0.003,191,expansion new leadership annual award winner fda approval and abstract presentation analyst note abbvie amgen regeneron pharmaceutical inc valeant pharmaceutical and lilly,171,22,0,pharmacy,"['expansion', 'new', 'leadership', 'annual', 'award', 'winner', 'f', '##da', 'approval', 'and', 'abstract', 'presentation', 'analyst', 'note', 'a', '##bb', '##vie', 'am', '##gen', 're', '##gene', '##ron', 'pharmaceutical', 'in', '##c', 'v', '##ale', '##ant', 'pharmaceutical', 'and', 'l', '##ill', '##y']",1
291339,nifty_874,2014-06-12,Henry Ford Innovation Institute Announces the Davidson Fellowship for Entrepreneurs in Digital Health,Neutral,0.003,101,henry ford innovation institute announces the davidson fellowship for entrepreneur digital health,97,12,0,pharmacy,"['he', '##n', '##ry', 'for', '##d', 'innovation', 'institute', 'announces', 'the', 'da', '##vid', '##son', 'fellowship', 'for', 'entrepreneur', 'digital', 'health']",1
291403,nifty_874,2014-06-12,"The Zacks Analyst Blog Highlights:Clovis, Biogen, Halozyme, Ariad and Chart Industries",Neutral,0.003,86,the zacks analyst blog highlight clovis biogen halozyme ariad and chart industry,80,12,0,pharmacy,"['the', 'z', '##ack', '##s', 'analyst', 'blog', 'highlight', 'c', '##lov', '##is', 'bio', '##gen', 'ha', '##lo', '##zy', '##me', 'a', '##riad', 'and', 'chart', 'industry']",1
291634,nifty_874,2014-06-12,Pharma Challenged by Increasing Global Market Access Complexity as 2015 Planning Intensifies,Neutral,0.003,92,pharma challenged increasing global market access complexity planning intensifies,81,9,0,pharmacy,"['p', '##har', '##ma', 'challenged', 'increasing', 'global', 'market', 'access', 'complexity', 'planning', 'in', '##tens', '##ifies']",1
291689,nifty_874,2014-06-12,"Research and Markets: Companion Diagnostics Market (2nd Edition), 2014 - 2024",Neutral,0.003,77,research and market companion diagnostics market edition,56,7,0,pharmacy,"['research', 'and', 'market', 'companion', 'diagnostic', '##s', 'market', 'edition']",1
291726,nifty_874,2014-06-12,Canadian Biotech Industry Recognizes Leading Companies,Neutral,0.003,54,canadian biotech industry recognizes leading company,52,6,0,pharmacy,"['can', '##adia', '##n', 'bio', '##tech', 'industry', 'recognizes', 'leading', 'company']",1
291727,nifty_874,2014-06-12,"kloudtrack, Cisco And University Of Maryland Launch Innovation Sandboxâ¢ For Healthcare, Medical And Life Sciences",Neutral,0.003,115,kloudtrack cisco and university maryland launch innovation sandboxâ for healthcare medical and life science,107,14,0,pharmacy,"['k', '##lou', '##dt', '##rack', 'c', '##isco', 'and', 'university', 'ma', '##ryl', '##and', 'launch', 'innovation', 'sand', '##box', '##â', 'for', 'healthcare', 'medical', 'and', 'life', 'science']",1
291892,nifty_874,2014-06-12,"INDIA PRESS-Hoffman La Roche, Cipla in talks with Erlotinib to settle patent row-Economic Times",Neutral,0.003,95,india press hoffman roche cipla talk with erlotinib settle patent row economic time,83,13,0,pharmacy,"['in', '##dia', 'press', 'ho', '##ff', '##man', 'r', '##och', '##e', 'c', '##ip', '##la', 'talk', 'with', 'er', '##lot', '##ini', '##b', 'settle', 'patent', 'row', 'economic', 'time']",1
291911,nifty_874,2014-06-12,Nektar Shares Rise on FDA Panel Recommendation,Neutral,0.003,46,nektar share rise fda panel recommendation,42,6,0,pharmacy,"['ne', '##kt', '##ar', 'share', 'rise', 'f', '##da', 'panel', 'recommendation']",1
292028,nifty_875,2014-06-16,Actelion Shares Surge on Drug Test Result,Neutral,0.0028,41,actelion share surge drug test result,37,6,0,pharmacy,"['act', '##eli', '##on', 'share', 'surge', 'drug', 'test', 'result']",1
292054,nifty_876,2014-06-17,Drug Delays Cost Millions,Rise,0.0073,25,drug delay cost million,23,4,0,pharmacy,"['drug', 'delay', 'cost', 'million']",1
292057,nifty_876,2014-06-17,Endocyte Regains Global Rights to Vintafolide,Rise,0.0073,45,endocyte regains global right vintafolide,41,5,0,pharmacy,"['end', '##oc', '##yte', 'regain', '##s', 'global', 'right', 'v', '##int', '##af', '##oli', '##de']",1
292115,nifty_877,2014-06-18,Novartis emphasizes new focused portfolio at its first Meet Novartis Management investor day,Neutral,0.0011,92,novartis emphasizes new focused portfolio it first meet novartis management investor day,88,12,0,pharmacy,"['no', '##var', '##tis', 'emphasizes', 'new', 'focused', 'portfolio', 'it', 'first', 'meet', 'no', '##var', '##tis', 'management', 'investor', 'day']",1
292116,nifty_877,2014-06-18,REG-Novartis emphasizes new focused portfolio at its first Meet Novartis Management investor day,Neutral,0.0011,96,reg novartis emphasizes new focused portfolio it first meet novartis management investor day,92,13,0,pharmacy,"['re', '##g', 'no', '##var', '##tis', 'emphasizes', 'new', 'focused', 'portfolio', 'it', 'first', 'meet', 'no', '##var', '##tis', 'management', 'investor', 'day']",1
292120,nifty_877,2014-06-18,Novartis says new focus should boost profitability,Neutral,0.0011,50,novartis say new focus should boost profitability,49,7,0,pharmacy,"['no', '##var', '##tis', 'say', 'new', 'focus', 'should', 'boost', 'profit', '##ability']",1
292121,nifty_877,2014-06-18,Novartis says new focus should boost profitability ,Neutral,0.0011,51,novartis say new focus should boost profitability,49,7,0,pharmacy,"['no', '##var', '##tis', 'say', 'new', 'focus', 'should', 'boost', 'profit', '##ability']",1
292263,nifty_877,2014-06-18,"Pharma-Bio Industry to Inject $2 Billion Investment for Capital & Maintenance Project Starts in Third-Quarter 2014, an Industrial Info News Alert",Neutral,0.0011,145,pharma bio industry inject billion investment for capital maintenance project start third quarter industrial info news alert,124,17,0,pharmacy,"['p', '##har', '##ma', 'bio', 'industry', 'in', '##ject', 'billion', 'investment', 'for', 'capital', 'maintenance', 'project', 'start', 'third', 'quarter', 'industrial', 'info', 'news', 'alert']",1
292273,nifty_877,2014-06-18,UPDATE 1-Novartis says slimmer structure to boost profitability,Neutral,0.0011,63,update novartis say slimmer structure boost profitability,57,7,0,pharmacy,"['update', 'no', '##var', '##tis', 'say', 'slim', '##mer', 'structure', 'boost', 'profit', '##ability']",1
292301,nifty_877,2014-06-18,Novartis says slimmer structure to boost profitability,Neutral,0.0011,54,novartis say slimmer structure boost profitability,50,6,0,pharmacy,"['no', '##var', '##tis', 'say', 'slim', '##mer', 'structure', 'boost', 'profit', '##ability']",1
292351,nifty_877,2014-06-18,Research and Markets: UK Private Healthcare Market Report 2014,Neutral,0.0011,62,research and market private healthcare market report,52,7,0,pharmacy,"['research', 'and', 'market', 'private', 'healthcare', 'market', 'report']",1
292353,nifty_877,2014-06-18,Research and Markets: Viibryd (Major Depressive Disorder) - Forecast and Market Analysis to 2023,Neutral,0.0011,96,research and market viibryd major depressive disorder forecast and market analysis,82,11,0,pharmacy,"['research', 'and', 'market', 'v', '##ii', '##b', '##ry', '##d', 'major', 'de', '##pressive', 'disorder', 'forecast', 'and', 'market', 'analysis']",1
292377,nifty_877,2014-06-18,Research and Markets: Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023,Neutral,0.0011,96,research and market effexor major depressive disorder forecast and market analysis,82,11,0,pharmacy,"['research', 'and', 'market', 'e', '##ffe', '##x', '##or', 'major', 'de', '##pressive', 'disorder', 'forecast', 'and', 'market', 'analysis']",1
292438,nifty_877,2014-06-18,Research and Markets: PharmaPoint: Major Depressive Disorder - 5EU Drug Forecast and Market Analysis to 2023,Neutral,0.0011,108,research and market pharmapoint major depressive disorder drug forecast and market analysis,91,12,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##point', 'major', 'de', '##pressive', 'disorder', 'drug', 'forecast', 'and', 'market', 'analysis']",1
292471,nifty_877,2014-06-18,Research and Markets: PharmaPoint: Major Depressive Disorder Report 2014 - Current and Future Players,Neutral,0.0011,101,research and market pharmapoint major depressive disorder report current and future player,90,12,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##point', 'major', 'de', '##pressive', 'disorder', 'report', 'current', 'and', 'future', 'player']",1
292515,nifty_877,2014-06-18,Big Pharma Becomes a Smaller Employer While Biotech Booms,Neutral,0.0011,57,big pharma becomes smaller employer while biotech boom,54,8,0,pharmacy,"['big', 'p', '##har', '##ma', 'becomes', 'smaller', 'employer', 'while', 'bio', '##tech', 'boom']",1
292584,nifty_877,2014-06-18,"Research and Markets: 2014 Report on the International Synthetic Biology (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis) Market - Trends and Forecast to 201",Neutral,0.0011,224,research and market report the international synthetic biology synthetic dna synthetic gene synthetic cell xna chassis organism dna synthesis oligonucleotide synthesis market trend and forecast,193,25,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'synthetic', 'biology', 'synthetic', 'd', '##na', 'synthetic', 'gene', 'synthetic', 'cell', 'x', '##na', 'chassis', 'organism', 'd', '##na', 'synthesis', 'o', '##li', '##gon', '##uc', '##leo', '##tide', 'synthesis', 'market', 'trend', 'and', 'forecast']",1
292590,nifty_877,2014-06-18,Research and Markets: 2014 Report on the International Human Reproductive Technologies Market - Forecast to 2019,Neutral,0.0011,112,research and market report the international human reproductive technology market forecast,90,11,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'human', 'reproductive', 'technology', 'market', 'forecast']",1
292630,nifty_877,2014-06-18,Research and Markets: 2014 Report on the International Clinical Trial Management System Market - Trends and Forecast to 2019,Neutral,0.0011,124,research and market report the international clinical trial management system market trend and forecast,103,14,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'clinical', 'trial', 'management', 'system', 'market', 'trend', 'and', 'forecast']",1
292635,nifty_877,2014-06-18,"Research and Markets: Clinical Data Analytics In Healthcare - Global Growth, Trends And Forecasts 2014 - 2019",Neutral,0.0011,109,research and market clinical data analytics healthcare global growth trend and forecast,87,12,0,pharmacy,"['research', 'and', 'market', 'clinical', 'data', 'anal', '##ytic', '##s', 'healthcare', 'global', 'growth', 'trend', 'and', 'forecast']",1
292691,nifty_877,2014-06-18,Research and Markets: 2014 Report on the International Companion Diagnostics Market - Forecasts to 2018,Neutral,0.0011,103,research and market report the international companion diagnostics market forecast,82,10,0,pharmacy,"['research', 'and', 'market', 'report', 'the', 'international', 'companion', 'diagnostic', '##s', 'market', 'forecast']",1
292705,nifty_877,2014-06-18,"Investment in Innovation (IN3) Medical Device 360 Boston Host Large Company Executives, Investors, and Innovators for Strategic Partnering and M & A Discussions",Neutral,0.0011,160,investment innovation medical device boston host large company executive investor and innovator for strategic partnering and discussion,135,17,0,pharmacy,"['investment', 'innovation', 'medical', 'device', 'b', '##ost', '##on', 'host', 'large', 'company', 'executive', 'investor', 'and', 'inn', '##ova', '##tor', 'for', 'strategic', 'partner', '##ing', 'and', 'discussion']",1
292745,nifty_877,2014-06-18,Research and Markets: Vital Signs - Healthcare News - The Analyst's Perspective - May Issue,Neutral,0.0011,91,research and market vital sign healthcare news the analyst perspective may issue,80,12,0,pharmacy,"['research', 'and', 'market', 'vital', 'sign', 'healthcare', 'news', 'the', 'analyst', 'perspective', 'may', 'issue']",1
292746,nifty_877,2014-06-18,Research and Markets: Vital Signs - Healthcare News - The Analyst's Perspective February 2014 Issue,Neutral,0.0011,99,research and market vital sign healthcare news the analyst perspective february issue,85,12,0,pharmacy,"['research', 'and', 'market', 'vital', 'sign', 'healthcare', 'news', 'the', 'analyst', 'perspective', 'f', '##eb', '##ru', '##ary', 'issue']",1
292759,nifty_877,2014-06-18,"Tragicom Studios Movie Explores Link between the Technology Industry and the Rise in Autism with Futuristic Eugenics Thriller, MindBlinders",Neutral,0.0011,139,tragicom studio movie explores link between the technology industry and the rise autism with futuristic eugenics thriller mindblinders,134,18,0,pharmacy,"['tragic', '##om', 'studio', 'movie', 'explores', 'link', 'between', 'the', 'technology', 'industry', 'and', 'the', 'rise', 'autism', 'with', 'f', '##ut', '##uristic', 'e', '##ugen', '##ics', 'thriller', 'mind', '##blin', '##ders']",1
292774,nifty_877,2014-06-18,Research and Markets: Schizophrenia Drug Market & Pipeline Report 2014,Neutral,0.0011,70,research and market schizophrenia drug market pipeline report,61,8,0,pharmacy,"['research', 'and', 'market', 's', '##chi', '##zophrenia', 'drug', 'market', 'pipeline', 'report']",1
292798,nifty_877,2014-06-18,"Research and Markets: Global Sample Preparation Market 2014-2018 by Product (Instruments, Consumables, Kits), Application (Genomics, Proteomics) & End Users (Molecular Diagnostics)",Neutral,0.0011,180,research and market global sample preparation market product instrument consumables kit application genomics proteomics end user molecular diagnostics,150,18,0,pharmacy,"['research', 'and', 'market', 'global', 'sample', 'preparation', 'market', 'product', 'instrument', 'con', '##su', '##mable', '##s', 'kit', 'application', 'g', '##eno', '##mic', '##s', 'pro', '##te', '##omi', '##cs', 'end', 'user', 'molecular', 'diagnostic', '##s']",1
293067,nifty_877,2014-06-18,Novartis Details Overhaul,Neutral,0.0011,25,novartis detail overhaul,24,3,0,pharmacy,"['no', '##var', '##tis', 'detail', 'overhaul']",1
293165,nifty_879,2014-06-23,Abbott to Acquire Russian Drug Maker Veropharm,Fall,-0.006,46,abbott acquire russian drug maker veropharm,43,6,0,pharmacy,"['abbot', '##t', 'acquire', 'r', '##uss', '##ian', 'drug', 'maker', 've', '##rop', '##har', '##m']",1
293215,nifty_879,2014-06-23,"Bayer, Dimension Therapeutics to Develop Gene Therapy for Hemophilia",Fall,-0.006,68,bayer dimension therapeutic develop gene therapy for hemophilia,63,8,0,pharmacy,"['bay', '##er', 'dimension', 'therapeutic', 'develop', 'gene', 'therapy', 'for', 'hem', '##op', '##hil', '##ia']",1
293227,nifty_880,2014-06-24,Sick Drawn to New Health Plans,Neutral,0.0045,30,sick drawn new health plan,26,5,0,pharmacy,"['sick', 'drawn', 'new', 'health', 'plan']",1
293242,nifty_880,2014-06-24,Bristol-Myers's Melanoma Treatment Compares Favorably,Neutral,0.0045,53,bristol myers melanoma treatment compare favorably,50,6,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'me', '##lan', '##oma', 'treatment', 'compare', 'favor', '##ably']",1
293373,nifty_881,2014-06-25,Elsevier Announces New Reference Module in Biomedical Sciences That Unlocks Current Foundational Content,Neutral,-0.0007,104,elsevier announces new reference module biomedical science that unlocks current foundational content,100,12,0,pharmacy,"['else', '##vier', 'announces', 'new', 'reference', 'module', 'bio', '##medical', 'science', 'that', 'unlock', '##s', 'current', 'foundation', '##al', 'content']",1
293611,nifty_881,2014-06-25,HedgePath Pharmaceuticals Secures Interim Financing To Commence Clinical Trials and Finalizes Key Agreement with Mayne Pharma,Neutral,-0.0007,125,hedgepath pharmaceutical secures interim financing commence clinical trial and finalizes key agreement with mayne pharma,120,15,0,pharmacy,"['hedge', '##path', 'pharmaceutical', 'secure', '##s', 'interim', 'financing', 'commence', 'clinical', 'trial', 'and', 'final', '##izes', 'key', 'agreement', 'with', 'may', '##ne', 'p', '##har', '##ma']",1
293637,nifty_881,2014-06-25,Knight Therapeutics Inc. and Origin Biomed Inc. Sign Secured Debt Financing Agreement,Neutral,-0.0007,85,knight therapeutic inc and origin biomed inc sign secured debt financing agreement,82,12,0,pharmacy,"['knight', 'therapeutic', 'in', '##c', 'and', 'origin', 'bio', '##med', 'in', '##c', 'sign', 'secured', 'debt', 'financing', 'agreement']",1
293822,nifty_881,2014-06-25,"Research and Markets: Neurofibromatoses Type II - Pipeline Review, H1 2014",Neutral,-0.0007,74,research and market neurofibromatoses type pipeline review,58,7,0,pharmacy,"['research', 'and', 'market', 'ne', '##uro', '##fi', '##bro', '##mat', '##ose', '##s', 'type', 'pipeline', 'review']",1
293831,nifty_881,2014-06-25,"Research and Markets: Psychosis - Pipeline Review, H1 2014",Neutral,-0.0007,58,research and market psychosis pipeline review,45,6,0,pharmacy,"['research', 'and', 'market', 'ps', '##ych', '##osis', 'pipeline', 'review']",1
293884,nifty_881,2014-06-25,Research and Markets: Biotech Funding Deals and Partnerships 2014: Analysis of 56 Recent Venture Capital and Corporate Capital Funding and Other Transactions,Neutral,-0.0007,157,research and market biotech funding deal and partnership analysis recent venture capital and corporate capital funding and other transaction,140,19,0,pharmacy,"['research', 'and', 'market', 'bio', '##tech', 'funding', 'deal', 'and', 'partnership', 'analysis', 'recent', 'venture', 'capital', 'and', 'corporate', 'capital', 'funding', 'and', 'other', 'transaction']",1
293980,nifty_881,2014-06-25,"Research and Markets: Global Cell Analysis Market Report 2014-2018: Instruments, Consumables & Applications Analysis",Neutral,-0.0007,116,research and market global cell analysis market report instrument consumables application analysis,98,12,0,pharmacy,"['research', 'and', 'market', 'global', 'cell', 'analysis', 'market', 'report', 'instrument', 'con', '##su', '##mable', '##s', 'application', 'analysis']",1
293994,nifty_881,2014-06-25,NABP Executes Registry Agreement with ICANN for .Pharmacy Domain Consumers Worldwide Will Soon Have New Tool for Finding Safe Internet Pharmacies,Neutral,-0.0007,145,nabp executes registry agreement with icann for pharmacy domain consumer worldwide will soon have new tool for finding safe internet pharmacy,141,21,0,pharmacy,"['na', '##b', '##p', 'execute', '##s', 'registry', 'agreement', 'with', 'i', '##can', '##n', 'for', 'pharmacy', 'domain', 'consumer', 'worldwide', 'will', 'soon', 'have', 'new', 'tool', 'for', 'finding', 'safe', 'internet', 'pharmacy']",1
294015,nifty_881,2014-06-25,Research and Markets: 2014 Worldwide Medical Equipment & Supplies Mfg. Industry-Industry & Market Report,Neutral,-0.0007,104,research and market worldwide medical equipment supply mfg industry industry market report,90,12,0,pharmacy,"['research', 'and', 'market', 'worldwide', 'medical', 'equipment', 'supply', 'm', '##f', '##g', 'industry', 'industry', 'market', 'report']",1
294026,nifty_881,2014-06-25,Research and Markets: Spain Epilepsy Pipeline Market Highlights 2014,Neutral,-0.0007,68,research and market spain epilepsy pipeline market highlight,60,8,0,pharmacy,"['research', 'and', 'market', 'spa', '##in', 'e', '##pile', '##psy', 'pipeline', 'market', 'highlight']",1
294030,nifty_881,2014-06-25,Research and Markets: France Epilepsy Pipeline Market Report 2014,Neutral,-0.0007,65,research and market france epilepsy pipeline market report,58,8,0,pharmacy,"['research', 'and', 'market', 'f', '##rance', 'e', '##pile', '##psy', 'pipeline', 'market', 'report']",1
294031,nifty_881,2014-06-25,Research and Markets: Italy Epilepsy Pipeline Market Highlights 2014,Neutral,-0.0007,68,research and market italy epilepsy pipeline market highlight,60,8,0,pharmacy,"['research', 'and', 'market', 'it', '##aly', 'e', '##pile', '##psy', 'pipeline', 'market', 'highlight']",1
294032,nifty_881,2014-06-25,Research and Markets: Japan Epilepsy Pipeline Market Report 2014,Neutral,-0.0007,64,research and market japan epilepsy pipeline market report,57,8,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##n', 'e', '##pile', '##psy', 'pipeline', 'market', 'report']",1
294149,nifty_881,2014-06-25,Insys: Epilepsy Treatment Gets Orphan Drug Status,Neutral,-0.0007,49,insys epilepsy treatment get orphan drug status,47,7,0,pharmacy,"['ins', '##ys', 'e', '##pile', '##psy', 'treatment', 'get', 'orphan', 'drug', 'status']",1
294212,nifty_882,2014-06-26,Siemens Submits Application to FDA for 3-D Breast Imaging System,Neutral,0.0019,64,siemens submits application fda for breast imaging system,57,8,0,pharmacy,"['si', '##em', '##ens', 'submit', '##s', 'application', 'f', '##da', 'for', 'breast', 'imaging', 'system']",1
294217,nifty_882,2014-06-26,FDA Panel Fails to Fast-Track Astra Cancer Drug,Neutral,0.0019,47,fda panel fails fast track astra cancer drug,44,8,0,pharmacy,"['f', '##da', 'panel', 'fails', 'fast', 'track', 'as', '##tra', 'cancer', 'drug']",1
294241,nifty_882,2014-06-26,Auxilium Pharma to Merge With QLT,Neutral,0.0019,33,auxilium pharma merge with qlt,30,5,0,pharmacy,"['aux', '##ili', '##um', 'p', '##har', '##ma', 'merge', 'with', 'q', '##lt']",1
294318,nifty_883,2014-06-30,Merck Pediatric Anti-Vomiting Drug Effective,Rise,0.0067,44,merck pediatric anti vomiting drug effective,44,6,0,pharmacy,"['me', '##rc', '##k', 'p', '##ediatric', 'anti', 'vomit', '##ing', 'drug', 'effective']",1
294393,nifty_884,2014-07-01,Amgen's Leukemia Drug Gets Breakthrough Designation,Neutral,0.001,51,amgen leukemia drug get breakthrough designation,48,6,0,pharmacy,"['am', '##gen', 'le', '##uke', '##mia', 'drug', 'get', 'breakthrough', 'designation']",1
294438,nifty_885,2014-07-02,What to Know About Throat Cancer,Neutral,0.0049,32,what know about throat cancer,29,5,0,pharmacy,"['what', 'know', 'about', 'throat', 'cancer']",1
294560,nifty_886,2014-07-07,"Research and Markets: Global Analgesic Infusion Pumps Market 2014-2018 with Baxter International, Codman & Shurtleff, Flowonix Medical, Medtronic & Smiths Medical Dominating",Fall,-0.0064,173,research and market global analgesic infusion pump market with baxter international codman shurtleff flowonix medical medtronic smith medical dominating,152,19,0,pharmacy,"['research', 'and', 'market', 'global', 'anal', '##ges', '##ic', 'in', '##fusion', 'pump', 'market', 'with', 'b', '##ax', '##ter', 'international', 'co', '##dman', 's', '##hur', '##tle', '##ff', 'flow', '##oni', '##x', 'medical', 'me', '##dt', '##ronic', 's', '##mith', 'medical', 'dominating']",1
294592,nifty_886,2014-07-07,"Research and Markets: Global Hypercholesterolemia Market 2014-2018 With AbbVie, Astrazeneca, Merck & Co. & Pfizer Dominating",Fall,-0.0064,124,research and market global hypercholesterolemia market with abbvie astrazeneca merck pfizer dominating,102,12,0,pharmacy,"['research', 'and', 'market', 'global', 'h', '##yper', '##cho', '##les', '##tero', '##lem', '##ia', 'market', 'with', 'a', '##bb', '##vie', 'as', '##tra', '##zen', '##eca', 'me', '##rc', '##k', 'p', '##fi', '##zer', 'dominating']",1
294599,nifty_886,2014-07-07,"Research and Markets: Global Breast Cancer Market Forecasts and Opportunities, 2018 Featuring Astrazeneca, Eli Lilly and Co, F. Hoffmann-La Roche, Novartis AG & Sanofi-Aventis",Fall,-0.0064,175,research and market global breast cancer market forecast and opportunity featuring astrazeneca eli lilly and hoffmann roche novartis sanofi aventis,147,20,0,pharmacy,"['research', 'and', 'market', 'global', 'breast', 'cancer', 'market', 'forecast', 'and', 'opportunity', 'featuring', 'as', '##tra', '##zen', '##eca', 'el', '##i', 'l', '##ill', '##y', 'and', 'ho', '##ff', '##mann', 'r', '##och', '##e', 'no', '##var', '##tis', 'sa', '##no', '##fi', 'a', '##vent', '##is']",1
294683,nifty_886,2014-07-07,"Technical Pulse on Pharma Stocks -- Research on Pfizer, Hospira, Endo Intl., and Nektar Therapeutics",Fall,-0.0064,100,technical pulse pharma stock research pfizer hospira endo intl and nektar therapeutic,85,12,0,pharmacy,"['technical', 'pulse', 'p', '##har', '##ma', 'stock', 'research', 'p', '##fi', '##zer', 'ho', '##sp', '##ira', 'end', '##o', 'in', '##tl', 'and', 'ne', '##kt', '##ar', 'therapeutic']",1
294763,nifty_886,2014-07-07,"Lemelson Capital Management Further Increases Short Position in Ligand Pharmaceuticals (NASDAQ: LGND), Appends its LGND Research Report",Fall,-0.0064,135,lemelson capital management further increase short position ligand pharmaceutical nasdaq lgnd appends it lgnd research report,125,16,0,pharmacy,"['le', '##mel', '##son', 'capital', 'management', 'further', 'increase', 'short', 'position', 'l', '##igan', '##d', 'pharmaceutical', 'na', '##s', '##da', '##q', 'l', '##gn', '##d', 'app', '##ends', 'it', 'l', '##gn', '##d', 'research', 'report']",1
294776,nifty_886,2014-07-07,Baxter Names Chief Financial Officers for New Biopharmaceutical Spin-off and Baxter International Inc.,Fall,-0.0064,102,baxter name chief financial officer for new biopharmaceutical spin off and baxter international inc,99,14,0,pharmacy,"['b', '##ax', '##ter', 'name', 'chief', 'financial', 'officer', 'for', 'new', 'bio', '##pha', '##rma', '##ce', '##utical', 'spin', 'off', 'and', 'b', '##ax', '##ter', 'international', 'in', '##c']",1
294792,nifty_886,2014-07-07,Research and Markets: Global Disposable Medical Supplies Markets Report 2014,Fall,-0.0064,76,research and market global disposable medical supply market report,66,9,0,pharmacy,"['research', 'and', 'market', 'global', 'di', '##sp', '##osa', '##ble', 'medical', 'supply', 'market', 'report']",1
294797,nifty_886,2014-07-07,Research and Markets: United States Glucose Testing Markets Report 2014 with Analysis of Almost All Companies Operating in this Market,Fall,-0.0064,134,research and market united state glucose testing market report with analysis almost all company operating this market,117,17,0,pharmacy,"['research', 'and', 'market', 'united', 'state', 'glucose', 'testing', 'market', 'report', 'with', 'analysis', 'almost', 'all', 'company', 'operating', 'this', 'market']",1
294852,nifty_886,2014-07-07,"Research and Markets: Regulatory Affairs for Support Staff Course: An Overview of the Pharmaceutical Regulatory Affairs for Support Staff - 24th-25th September 2014, London UK",Fall,-0.0064,175,research and market regulatory affair for support staff course overview the pharmaceutical regulatory affair for support staff september london,143,19,0,pharmacy,"['research', 'and', 'market', 'regulatory', 'affair', 'for', 'support', 'staff', 'course', 'overview', 'the', 'pharmaceutical', 'regulatory', 'affair', 'for', 'support', 'staff', 'se', '##pt', '##em', '##ber', 'lo', '##ndon']",1
294869,nifty_886,2014-07-07,Highline Research Advisors Initiates on Titan Pharmaceuticals with a Buy Rating,Fall,-0.0064,79,highline research advisor initiate titan pharmaceutical with buy rating,71,9,0,pharmacy,"['high', '##line', 'research', 'advisor', 'initiate', 't', '##ita', '##n', 'pharmaceutical', 'with', 'buy', 'rating']",1
294876,nifty_886,2014-07-07,Research and Markets: Global and US Hypertension Pipeline Report 2014-2017,Fall,-0.0064,74,research and market global and hypertension pipeline report,59,8,0,pharmacy,"['research', 'and', 'market', 'global', 'and', 'h', '##yper', '##tens', '##ion', 'pipeline', 'report']",1
294886,nifty_886,2014-07-07,Research and Markets: Global and US Congestive Heart Failure Pipeline Report 2014-2017,Fall,-0.0064,86,research and market global and congestive heart failure pipeline report,71,10,0,pharmacy,"['research', 'and', 'market', 'global', 'and', 'con', '##ges', '##tive', 'heart', 'failure', 'pipeline', 'report']",1
294890,nifty_886,2014-07-07,"Research and Markets: Biotechnology for the Non Biotechnologist Seminar - 22nd-24th September, London UK",Fall,-0.0064,104,research and market biotechnology for the non biotechnologist seminar september london,86,11,0,pharmacy,"['research', 'and', 'market', 'bio', '##tech', '##nology', 'for', 'the', 'non', 'bio', '##tech', '##no', '##logist', 'seminar', 'se', '##pt', '##em', '##ber', 'lo', '##ndon']",1
294920,nifty_886,2014-07-07,Research and Markets: World Pain Pipeline Report 2014-2017,Fall,-0.0064,58,research and market world pain pipeline report,46,7,0,pharmacy,"['research', 'and', 'market', 'world', 'pain', 'pipeline', 'report']",1
294998,nifty_886,2014-07-07,"Research and Markets: Medical Device Software Seminar: FDA Guidance & Risk Management - 15th October 2014, London, UK",Fall,-0.0064,117,research and market medical device software seminar fda guidance risk management october london,95,13,0,pharmacy,"['research', 'and', 'market', 'medical', 'device', 'software', 'seminar', 'f', '##da', 'guidance', 'risk', 'management', 'o', '##ct', '##obe', '##r', 'lo', '##ndon']",1
295199,nifty_886,2014-07-07,Novartis Leukemia Treatment Gets 'Breakthrough' Status,Fall,-0.0064,54,novartis leukemia treatment get breakthrough status,51,6,0,pharmacy,"['no', '##var', '##tis', 'le', '##uke', '##mia', 'treatment', 'get', 'breakthrough', 'status']",1
295212,nifty_886,2014-07-07,"Endo, BioDelivery Pain Drug Meets Primary Endpoint",Fall,-0.0064,50,endo biodelivery pain drug meet primary endpoint,48,7,0,pharmacy,"['end', '##o', 'bio', '##del', '##iver', '##y', 'pain', 'drug', 'meet', 'primary', 'end', '##point']",1
295242,nifty_887,2014-07-08,Study on Cancer Care Yields Mixed Results,Neutral,0.0045,41,study cancer care yield mixed result,36,6,0,pharmacy,"['study', 'cancer', 'care', 'yield', 'mixed', 'result']",1
295328,nifty_888,2014-07-09,"Regeneron, Sanofi to Begin Eczema Drug Study",Neutral,-0.004,44,regeneron sanofi begin eczema drug study,40,6,0,pharmacy,"['re', '##gene', '##ron', 'sa', '##no', '##fi', 'begin', 'e', '##cz', '##ema', 'drug', 'study']",1
295330,nifty_888,2014-07-09,Study Shows Letrozole's Efficacy in Boosting Pregnancy Odds,Neutral,-0.004,59,study show letrozole efficacy boosting pregnancy odds,53,7,0,pharmacy,"['study', 'show', 'let', '##ro', '##zo', '##le', 'efficacy', 'boost', '##ing', 'pregnancy', 'odds']",1
295345,nifty_888,2014-07-09,EU Fines Drug Producers for Delays,Neutral,-0.004,34,fine drug producer for delay,28,5,0,pharmacy,"['fine', 'drug', 'producer', 'for', 'delay']",1
295366,nifty_888,2014-07-09,Celgene's Phase 3 Study of Arthritis Drug Misses Target,Neutral,-0.004,55,celgene phase study arthritis drug miss target,46,7,0,pharmacy,"['c', '##el', '##gene', 'phase', 'study', 'art', '##hr', '##itis', 'drug', 'miss', 'target']",1
295474,nifty_889,2014-07-10,Research and Markets: Australia Market for Medical Imaging Through 2019,Neutral,0.0014,71,research and market australia market for medical imaging through,64,9,0,pharmacy,"['research', 'and', 'market', 'au', '##stra', '##lia', 'market', 'for', 'medical', 'imaging', 'through']",1
295491,nifty_889,2014-07-10,"Research and Markets: UK Insulin Delivery Devices Market Analysis - Size, Share, Growth, Trends and Forecast Through 2006 - 2019",Neutral,0.0014,128,research and market insulin delivery device market analysis size share growth trend and forecast through,104,15,0,pharmacy,"['research', 'and', 'market', 'insulin', 'delivery', 'device', 'market', 'analysis', 'size', 'share', 'growth', 'trend', 'and', 'forecast', 'through']",1
295492,nifty_889,2014-07-10,Research and Markets: Australia Patient Monitoring and Diagnostic Systems Market Opportunity and Growth Trend Forecast Till 2019,Neutral,0.0014,128,research and market australia patient monitoring and diagnostic system market opportunity and growth trend forecast till,120,16,0,pharmacy,"['research', 'and', 'market', 'au', '##stra', '##lia', 'patient', 'monitoring', 'and', 'diagnostic', 'system', 'market', 'opportunity', 'and', 'growth', 'trend', 'forecast', 'till']",1
295511,nifty_889,2014-07-10,"New Board Director, Clinical Trial Results, New Drug Designations and Marketing Authorizations - Analyst Notes on Johnson & Johnson, Merck, Novartis, GSK and Endo",Neutral,0.0014,162,new board director clinical trial result new drug designation and marketing authorization analyst note johnson johnson merck novartis gsk and endo,146,21,0,pharmacy,"['new', 'board', 'director', 'clinical', 'trial', 'result', 'new', 'drug', 'designation', 'and', 'marketing', 'authorization', 'analyst', 'note', 'j', '##oh', '##nson', 'j', '##oh', '##nson', 'me', '##rc', '##k', 'no', '##var', '##tis', 'g', '##sk', 'and', 'end', '##o']",1
295528,nifty_889,2014-07-10,Research and Markets: UK Market for Patient Monitoring and Diagnostic Systems Through 2019,Neutral,0.0014,90,research and market market for patient monitoring and diagnostic system through,79,11,0,pharmacy,"['research', 'and', 'market', 'market', 'for', 'patient', 'monitoring', 'and', 'diagnostic', 'system', 'through']",1
295533,nifty_889,2014-07-10,Research and Markets: US MRI Systems Market Growth and Forecast To 2019,Neutral,0.0014,71,research and market mri system market growth and forecast,57,9,0,pharmacy,"['research', 'and', 'market', 'm', '##ri', 'system', 'market', 'growth', 'and', 'forecast']",1
295540,nifty_889,2014-07-10,"Research and Markets: France Laryngoscopes Market Outlook to 2020: Key players covered include Olympus Corporation, Hoya Corporation, Fujifilm Holdings Corporation and KARL STORZ GmbH & Co",Neutral,0.0014,188,research and market france laryngoscope market outlook key player covered include olympus corporation hoya corporation fujifilm holding corporation and karl storz gmbh,167,22,0,pharmacy,"['research', 'and', 'market', 'f', '##rance', 'la', '##ryn', '##gos', '##cope', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'o', '##ly', '##mpus', 'corporation', 'ho', '##ya', 'corporation', 'f', '##u', '##ji', '##film', 'holding', 'corporation', 'and', 'ka', '##rl', 's', '##tor', '##z', 'g', '##mb', '##h']",1
295547,nifty_889,2014-07-10,"Research and Markets: Germany Laryngoscopes Market Outlook to 2020: Key players covered include Olympus Corporation, Hoya Corporation, Fujifilm Holdings Corporation and KARL STORZ GmbH & Co",Neutral,0.0014,189,research and market germany laryngoscope market outlook key player covered include olympus corporation hoya corporation fujifilm holding corporation and karl storz gmbh,168,22,0,pharmacy,"['research', 'and', 'market', 'g', '##erman', '##y', 'la', '##ryn', '##gos', '##cope', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'o', '##ly', '##mpus', 'corporation', 'ho', '##ya', 'corporation', 'f', '##u', '##ji', '##film', 'holding', 'corporation', 'and', 'ka', '##rl', 's', '##tor', '##z', 'g', '##mb', '##h']",1
295565,nifty_889,2014-07-10,"Research and Markets: Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2014",Neutral,0.0014,97,research and market bipolar disorder manic depression global clinical trial review,82,11,0,pharmacy,"['research', 'and', 'market', 'bi', '##pol', '##ar', 'disorder', 'man', '##ic', 'depression', 'global', 'clinical', 'trial', 'review']",1
295604,nifty_889,2014-07-10,"Technical Data on Health Care Sector Equities -- Research on Achillion Pharma, Novavax, Dendreon, and Exelixis",Neutral,0.0014,110,technical data health care sector equity research achillion pharma novavax dendreon and exelixis,96,13,0,pharmacy,"['technical', 'data', 'health', 'care', 'sector', 'equity', 'research', 'a', '##chi', '##lli', '##on', 'p', '##har', '##ma', 'no', '##va', '##va', '##x', 'den', '##dre', '##on', 'and', 'ex', '##eli', '##xi', '##s']",1
295626,nifty_889,2014-07-10,"Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma",Neutral,0.0014,125,pre market equity watch biotech industry research halozyme therapeutic xoma amicus therapeutic and arena pharma,111,15,0,pharmacy,"['pre', 'market', 'equity', 'watch', 'bio', '##tech', 'industry', 'research', 'ha', '##lo', '##zy', '##me', 'therapeutic', 'x', '##oma', 'am', '##icus', 'therapeutic', 'and', 'arena', 'p', '##har', '##ma']",1
295686,nifty_889,2014-07-10,Arena Pharmaceuticals Reports that Eisai Completes Planned Increase in Sales Force for BELVIQÂ® (lorcaserin HCl) CIV,Neutral,0.0014,116,arena pharmaceutical report that eisai completes planned increase sale force for belviqâ lorcaserin hcl civ,107,15,0,pharmacy,"['arena', 'pharmaceutical', 'report', 'that', 'e', '##isa', '##i', 'complete', '##s', 'planned', 'increase', 'sale', 'force', 'for', 'be', '##l', '##vi', '##q', '##â', 'lo', '##rca', '##ser', '##in', 'h', '##c', '##l', 'c', '##iv']",1
295711,nifty_889,2014-07-10,"Pre-Market Pulse on Health Care Stocks -- Research on Team Health Holdings, Antares Pharma, Illumina, and Questcor Pharma",Neutral,0.0014,121,pre market pulse health care stock research team health holding antares pharma illumina and questcor pharma,107,16,0,pharmacy,"['pre', 'market', 'pulse', 'health', 'care', 'stock', 'research', 'team', 'health', 'holding', 'ant', '##ares', 'p', '##har', '##ma', 'ill', '##umi', '##na', 'and', 'quest', '##cor', 'p', '##har', '##ma']",1
295728,nifty_889,2014-07-10,Stellar Biotechnologies Reports Third Quarter 2014 Financial Results and Recent Corporate Developments,Neutral,0.0014,102,stellar biotechnology report third quarter financial result and recent corporate development,92,11,0,pharmacy,"['stellar', 'bio', '##tech', '##nology', 'report', 'third', 'quarter', 'financial', 'result', 'and', 'recent', 'corporate', 'development']",1
295766,nifty_889,2014-07-10,"Global RNAi Technologies, Markets and Companies (Updated 2014 Report): Profiles of 161 companies",Neutral,0.0014,96,global rnai technology market and company updated report profile company,72,10,0,pharmacy,"['global', 'r', '##nai', 'technology', 'market', 'and', 'company', 'updated', 'report', 'profile', 'company']",1
295815,nifty_889,2014-07-10,"The Zacks Analyst Blog Highlights:Regado Biosciences, Jazz Pharmaceuticals, Regeneron Pharmaceuticals, Sanofi and Amgen",Neutral,0.0014,119,the zacks analyst blog highlight regado bioscience jazz pharmaceutical regeneron pharmaceutical sanofi and amgen,112,14,0,pharmacy,"['the', 'z', '##ack', '##s', 'analyst', 'blog', 'highlight', 're', '##gado', 'bio', '##science', 'jazz', 'pharmaceutical', 're', '##gene', '##ron', 'pharmaceutical', 'sa', '##no', '##fi', 'and', 'am', '##gen']",1
296031,nifty_889,2014-07-10,"Diagnostic Imaging International Corp., Changes Name to Medical Imaging Corp., and New Stock Symbol MEDD",Neutral,0.0014,104,diagnostic imaging international corp change name medical imaging corp and new stock symbol medd,96,14,0,pharmacy,"['diagnostic', 'imaging', 'international', 'co', '##rp', 'change', 'name', 'medical', 'imaging', 'co', '##rp', 'and', 'new', 'stock', 'symbol', 'me', '##dd']",1
296140,nifty_889,2014-07-10,Arotech Announces Proposed Public Offering of Common Stock,Neutral,0.0014,58,arotech announces proposed public offering common stock,55,7,0,pharmacy,"['a', '##rote', '##ch', 'announces', 'proposed', 'public', 'offering', 'common', 'stock']",1
296380,nifty_890,2014-07-14,Why Pharma Is Flocking to Inversions,Neutral,-0.0019,36,why pharma flocking inversion,29,4,0,pharmacy,"['why', 'p', '##har', '##ma', 'flock', '##ing', 'in', '##version']",1
296401,nifty_890,2014-07-14,St. Jude Medical to Buy NeuroTherm,Neutral,-0.0019,34,jude medical buy neurotherm,27,4,0,pharmacy,"['j', '##ude', 'medical', 'buy', 'ne', '##uro', '##ther', '##m']",1
296541,nifty_892,2014-07-16,Sanofi Looking At Options for Older  Drug Lines,Fall,-0.0114,47,sanofi looking option for older drug line,41,7,0,pharmacy,"['sa', '##no', '##fi', 'looking', 'option', 'for', 'older', 'drug', 'line']",1
296589,nifty_892,2014-07-16,St. Jude Medical Profit More Than Doubles,Fall,-0.0114,41,jude medical profit more than double,36,6,0,pharmacy,"['j', '##ude', 'medical', 'profit', 'more', 'than', 'double']",1
296624,nifty_893,2014-07-17,Amgen Hormone Drug Proves Positive in Study,Rise,0.0102,43,amgen hormone drug prof positive study,38,6,0,pharmacy,"['am', '##gen', 'hormone', 'drug', 'pro', '##f', 'positive', 'study']",1
296678,nifty_893,2014-07-17,Novartis Profit Creeps Higher,Rise,0.0102,29,novartis profit creep higher,28,4,0,pharmacy,"['no', '##var', '##tis', 'profit', 'creep', 'higher']",1
296779,nifty_895,2014-07-22,Turkish Man Admits to Smuggling Fake Cancer Drugs,Neutral,0.0022,49,turkish man admits smuggling fake cancer drug,45,7,0,pharmacy,"['t', '##ur', '##kis', '##h', 'man', 'admits', 'smuggling', 'fake', 'cancer', 'drug']",1
296792,nifty_895,2014-07-22,Puma Shares Soar on Breast-Cancer Therapy Study Results,Neutral,0.0022,55,puma share soar breast cancer therapy study result,50,8,0,pharmacy,"['pu', '##ma', 'share', 'so', '##ar', 'breast', 'cancer', 'therapy', 'study', 'result']",1
296966,nifty_896,2014-07-23,Biogen Idec's Profit Surges,Neutral,0.0001,27,biogen idec profit surge,24,4,0,pharmacy,"['bio', '##gen', 'id', '##ec', 'profit', 'surge']",1
296991,nifty_897,2014-07-24,Chief Scientist Is Out at Biotech,Neutral,-0.0047,33,chief scientist out biotech,27,4,0,pharmacy,"['chief', 'scientist', 'out', 'bio', '##tech']",1
297036,nifty_897,2014-07-24,"Bristol-Myers Posts Lower Profit, Revenue",Neutral,-0.0047,41,bristol myers post lower profit revenue,39,6,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'post', 'lower', 'profit', 'revenue']",1
297150,nifty_898,2014-07-28,Horizon Pharma Shares Fall as Drugs Added to Exclusion List,Neutral,-0.0043,59,horizon pharma share fall drug added exclusion list,51,8,0,pharmacy,"['horizon', 'p', '##har', '##ma', 'share', 'fall', 'drug', 'added', 'exclusion', 'list']",1
297309,nifty_900,2014-07-30,Drug Firms Buy $67.5 Million Voucher to Speed FDA Review,Fall,-0.0197,56,drug firm buy million voucher speed fda review,46,8,0,pharmacy,"['drug', 'firm', 'buy', 'million', 'v', '##ou', '##cher', 'speed', 'f', '##da', 'review']",1
297399,nifty_900,2014-07-30,AstraZeneca in Respiratory-Drugs Deal,Fall,-0.0197,37,astrazeneca respiratory drug deal,33,4,0,pharmacy,"['as', '##tra', '##zen', '##eca', 'respiratory', 'drug', 'deal']",1
297554,nifty_901,2014-07-31,FDA Seeks to Regulate Lab-Developed Tests,Neutral,-0.0031,41,fda seek regulate lab developed test,36,6,0,pharmacy,"['f', '##da', 'seek', 'regulate', 'lab', 'developed', 'test']",1
297614,nifty_902,2014-08-04,Amgen Multiple Myeloma Drug Meets Endpoint,Fall,-0.0097,42,amgen multiple myeloma drug meet endpoint,41,6,0,pharmacy,"['am', '##gen', 'multiple', 'my', '##elo', '##ma', 'drug', 'meet', 'end', '##point']",1
297710,nifty_903,2014-08-05,Research and Markets: India Duodenoscopes Market Outlook to 2020,Neutral,0.0003,64,research and market india duodenoscopes market outlook,54,7,0,pharmacy,"['research', 'and', 'market', 'in', '##dia', 'duo', '##den', '##os', '##cope', '##s', 'market', 'outlook']",1
297740,nifty_903,2014-08-05,"Research and Markets: UK Medical Imaging Market Report, 2006 - 2019",Neutral,0.0003,67,research and market medical imaging market report,49,7,0,pharmacy,"['research', 'and', 'market', 'medical', 'imaging', 'market', 'report']",1
297759,nifty_903,2014-08-05,BioCryst Reports Second Quarter 2014 Financial Results,Neutral,0.0003,54,biocryst report second quarter financial result,47,6,0,pharmacy,"['bio', '##c', '##ry', '##st', 'report', 'second', 'quarter', 'financial', 'result']",1
297769,nifty_903,2014-08-05,"TesoRx Closes $10M in Funding, Secures Key Patent and Hires Renowned Urologist as Chief Medical Officer",Neutral,0.0003,103,tesorx close funding secures key patent and hire renowned urologist chief medical officer,89,13,0,pharmacy,"['te', '##sor', '##x', 'close', 'funding', 'secure', '##s', 'key', 'patent', 'and', 'hire', 'renowned', 'u', '##rol', '##ogist', 'chief', 'medical', 'officer']",1
297772,nifty_903,2014-08-05,Research and Markets: MRI Systems Market Outlook in Spain Through 2019,Neutral,0.0003,70,research and market mri system market outlook spain through,59,9,0,pharmacy,"['research', 'and', 'market', 'm', '##ri', 'system', 'market', 'outlook', 'spa', '##in', 'through']",1
297791,nifty_903,2014-08-05,Research and Markets: Nuclear Imaging Market Outlook in Spain Through 2019,Neutral,0.0003,74,research and market nuclear imaging market outlook spain through,64,9,0,pharmacy,"['research', 'and', 'market', 'nuclear', 'imaging', 'market', 'outlook', 'spa', '##in', 'through']",1
297808,nifty_903,2014-08-05,"Research and Markets: India Patient Monitoring and Diagnostic Systems Market Growth Trends, 2006 - 2019",Neutral,0.0003,103,research and market india patient monitoring and diagnostic system market growth trend,86,12,0,pharmacy,"['research', 'and', 'market', 'in', '##dia', 'patient', 'monitoring', 'and', 'diagnostic', 'system', 'market', 'growth', 'trend']",1
297825,nifty_903,2014-08-05,Hopes build for new Novartis heart failure drug,Neutral,0.0003,47,hope build for new novartis heart failure drug,46,8,0,pharmacy,"['hope', 'build', 'for', 'new', 'no', '##var', '##tis', 'heart', 'failure', 'drug']",1
297866,nifty_903,2014-08-05,"Premier, Inc. Continues Growth Trajectory With Acquisition of Hospira's TheraDoc, Expanding Industry Leading Electronic Clinical Surveillance Solutions to Approximately 1,000 Facilities",Neutral,0.0003,185,premier inc continues growth trajectory with acquisition hospira theradoc expanding industry leading electronic clinical surveillance solution approximately facility,165,18,0,pharmacy,"['premier', 'in', '##c', 'continues', 'growth', 'trajectory', 'with', 'acquisition', 'ho', '##sp', '##ira', 'the', '##rado', '##c', 'expanding', 'industry', 'leading', 'electronic', 'clinical', 'surveillance', 'solution', 'approximately', 'facility']",1
297868,nifty_903,2014-08-05,"PokitDok Expands Executive Team, Ushering New Era of E-commerce into the Business of Healthcare",Neutral,0.0003,95,pokitdok expands executive team ushering new era commerce into the business healthcare,86,12,0,pharmacy,"['p', '##oki', '##t', '##do', '##k', 'expands', 'executive', 'team', 'us', '##hering', 'new', 'era', 'commerce', 'into', 'the', 'business', 'healthcare']",1
298032,nifty_903,2014-08-05,"The Zacks Analyst Blog Highlights:Allergan, Valeant Pharmaceuticals International, AstraZeneca, Salix Pharmaceuticals and Applied Micro Circuits",Neutral,0.0003,144,the zacks analyst blog highlight allergan valeant pharmaceutical international astrazeneca salix pharmaceutical and applied micro circuit,137,16,0,pharmacy,"['the', 'z', '##ack', '##s', 'analyst', 'blog', 'highlight', 'all', '##er', '##gan', 'v', '##ale', '##ant', 'pharmaceutical', 'international', 'as', '##tra', '##zen', '##eca', 'sa', '##lix', 'pharmaceutical', 'and', 'applied', 'micro', 'circuit']",1
298250,nifty_903,2014-08-05,"Cegedim Relationship Management and AHM announce Business Alliance to Provide Unique, End-to-End Disclosure Reporting Solution to Life Sciences Companies Worldwide",Neutral,0.0003,163,cegedim relationship management and ahm announce business alliance provide unique end end disclosure reporting solution life science company worldwide,150,19,0,pharmacy,"['c', '##ege', '##di', '##m', 'relationship', 'management', 'and', 'ah', '##m', 'announce', 'business', 'alliance', 'provide', 'unique', 'end', 'end', 'disclosure', 'reporting', 'solution', 'life', 'science', 'company', 'worldwide']",1
298312,nifty_903,2014-08-05,"Research and Markets: United States Ureteroscopes Market Outlook to 2020: Key players covered include Olympus Corporation, Hoya Corporation, Richard Wolf and KARL STORZ GmbH & Co.",Neutral,0.0003,179,research and market united state ureteroscopes market outlook key player covered include olympus corporation hoya corporation richard wolf and karl storz gmbh,158,22,0,pharmacy,"['research', 'and', 'market', 'united', 'state', 'u', '##ret', '##ero', '##scope', '##s', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'o', '##ly', '##mpus', 'corporation', 'ho', '##ya', 'corporation', 'rich', '##ard', 'wolf', 'and', 'ka', '##rl', 's', '##tor', '##z', 'g', '##mb', '##h']",1
298317,nifty_903,2014-08-05,"Research and Markets: United States Cystoscopes Market Outlook to 2020: Key Players Covered Include Olympus, Hoya, Strykern, Richard Wolf and KARL STORZ GmbH & Co",Neutral,0.0003,162,research and market united state cystoscopes market outlook key player covered include olympus hoya strykern richard wolf and karl storz gmbh,141,21,0,pharmacy,"['research', 'and', 'market', 'united', 'state', 'c', '##ys', '##tos', '##cope', '##s', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'o', '##ly', '##mpus', 'ho', '##ya', 's', '##try', '##ker', '##n', 'rich', '##ard', 'wolf', 'and', 'ka', '##rl', 's', '##tor', '##z', 'g', '##mb', '##h']",1
298318,nifty_903,2014-08-05,"Research and Markets: United Kingdom Laryngoscopes Market Outlook to 2020: Key Players Covered Include Olympus, Hoya, Fujifilm and KARL STORZ GmbH & Co.",Neutral,0.0003,152,research and market united kingdom laryngoscope market outlook key player covered include olympus hoya fujifilm and karl storz gmbh,131,19,0,pharmacy,"['research', 'and', 'market', 'united', 'kingdom', 'la', '##ryn', '##gos', '##cope', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'o', '##ly', '##mpus', 'ho', '##ya', 'f', '##u', '##ji', '##film', 'and', 'ka', '##rl', 's', '##tor', '##z', 'g', '##mb', '##h']",1
298337,nifty_903,2014-08-05,Avanir Pharmaceuticals Reports Fiscal 2014 Third Quarter Financial and Business Update,Neutral,0.0003,86,avanir pharmaceutical report fiscal third quarter financial and business update,79,10,0,pharmacy,"['a', '##vani', '##r', 'pharmaceutical', 'report', 'fiscal', 'third', 'quarter', 'financial', 'and', 'business', 'update']",1
298350,nifty_903,2014-08-05,"ChemoCentryx Announces Financial Results for the Second Quarter Ended June 30, 2014",Neutral,0.0003,83,chemocentryx announces financial result for the second quarter ended june,73,10,0,pharmacy,"['ch', '##em', '##oc', '##entry', '##x', 'announces', 'financial', 'result', 'for', 'the', 'second', 'quarter', 'ended', 'j', '##une']",1
298352,nifty_903,2014-08-05,Cumberland Pharmaceuticals Reports Second Quarter 2014 Financial Results,Neutral,0.0003,72,cumberland pharmaceutical report second quarter financial result,64,7,0,pharmacy,"['cum', '##ber', '##land', 'pharmaceutical', 'report', 'second', 'quarter', 'financial', 'result']",1
298402,nifty_903,2014-08-05,China Biologic Reports Financial Results for the Second Quarter of 2014,Neutral,0.0003,71,china biologic report financial result for the second quarter,61,9,0,pharmacy,"['chin', '##a', 'bio', '##log', '##ic', 'report', 'financial', 'result', 'for', 'the', 'second', 'quarter']",1
298750,nifty_904,2014-08-06,"Research and Markets: Global Life Science Reagents Market 2013-2019: Sigma Aldrich, Abbott Laboratories, Life Technologies, Bio-Rad Dominates the Market",Fall,-0.0054,152,research and market global life science reagent market sigma aldrich abbott laboratory life technology bio rad dominates the market,131,19,0,pharmacy,"['research', 'and', 'market', 'global', 'life', 'science', 're', '##age', '##nt', 'market', 'si', '##gma', 'al', '##dric', '##h', 'abbot', '##t', 'laboratory', 'life', 'technology', 'bio', 'r', '##ad', 'dominate', '##s', 'the', 'market']",1
298814,nifty_904,2014-08-06,BRIEF-China's Yeland Investment in deal with Crimson Capital on elderly caring projects,Fall,-0.0054,87,brief china yeland investment deal with crimson capital elderly caring project,78,11,0,pharmacy,"['brief', 'chin', '##a', 'ye', '##land', 'investment', 'deal', 'with', 'crimson', 'capital', 'elderly', 'caring', 'project']",1
298893,nifty_904,2014-08-06,BioLineRx Reports Second Quarter 2014 Financial Results,Fall,-0.0054,55,biolinerx report second quarter financial result,48,6,0,pharmacy,"['bio', '##liner', '##x', 'report', 'second', 'quarter', 'financial', 'result']",1
298909,nifty_904,2014-08-06,Research and Markets: Global Melatonin Market Report 2014 - 2019,Fall,-0.0054,64,research and market global melatonin market report,50,7,0,pharmacy,"['research', 'and', 'market', 'global', 'me', '##lat', '##oni', '##n', 'market', 'report']",1
298951,nifty_904,2014-08-06,Tonix Pharmaceuticals to Present at Two Investor Conferences in August,Fall,-0.0054,70,tonix pharmaceutical present two investor conference august,59,7,0,pharmacy,"['ton', '##ix', 'pharmaceutical', 'present', 'two', 'investor', 'conference', 'au', '##gus', '##t']",1
298966,nifty_904,2014-08-06,"Biotech Equities Roundup -- Keryx Biopharma, Vertex Pharma, NPS Pharma, Cubist Pharma, and Idera Pharma",Fall,-0.0054,103,biotech equity roundup keryx biopharma vertex pharma np pharma cubist pharma and idera pharma,93,14,0,pharmacy,"['bio', '##tech', 'equity', 'round', '##up', 'k', '##ery', '##x', 'bio', '##pha', '##rma', 'vertex', 'p', '##har', '##ma', 'n', '##p', 'p', '##har', '##ma', 'cu', '##bis', '##t', 'p', '##har', '##ma', 'and', 'id', '##era', 'p', '##har', '##ma']",1
299101,nifty_904,2014-08-06,"Driven By Product Innovations, the U.S. Drug Delivery Device Market Will Reach Over $4.5 Billion by 2022",Fall,-0.0054,104,driven product innovation the drug delivery device market will reach over billion,81,12,0,pharmacy,"['driven', 'product', 'innovation', 'the', 'drug', 'delivery', 'device', 'market', 'will', 'reach', 'over', 'billion']",1
299168,nifty_904,2014-08-06,"CompTIA CEO Says Millennials ""Changing the DNA"" of the IT Industry",Fall,-0.0054,66,comptia ceo say millennials changing the dna the industry,57,9,0,pharmacy,"['com', '##pt', '##ia', 'c', '##eo', 'say', 'mill', '##ennial', '##s', 'changing', 'the', 'd', '##na', 'the', 'industry']",1
299211,nifty_904,2014-08-06,Pivotal Therapeutics To Explore Potential Commercial Partnership Opportunities in China,Fall,-0.0054,87,pivotal therapeutic explore potential commercial partnership opportunity china,78,8,0,pharmacy,"['pivotal', 'therapeutic', 'explore', 'potential', 'commercial', 'partnership', 'opportunity', 'chin', '##a']",1
299294,nifty_904,2014-08-06,Research and Markets: China Medical Device Industry Yearbook 2014,Fall,-0.0054,65,research and market china medical device industry yearbook,58,8,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'medical', 'device', 'industry', 'year', '##book']",1
299343,nifty_904,2014-08-06,Celldex Reports Second Quarter 2014 Results,Fall,-0.0054,43,celldex report second quarter result,36,5,0,pharmacy,"['cell', '##de', '##x', 'report', 'second', 'quarter', 'result']",1
299379,nifty_904,2014-08-06,Aerie Pharmaceuticals Reports Second Quarter 2014 Financial Results and Provides Business and Product Development Update,Fall,-0.0054,120,aerie pharmaceutical report second quarter financial result and provides business and product development update,112,14,0,pharmacy,"['a', '##erie', 'pharmaceutical', 'report', 'second', 'quarter', 'financial', 'result', 'and', 'provides', 'business', 'and', 'product', 'development', 'update']",1
299386,nifty_904,2014-08-06,Raptor Pharmaceutical to Present at Upcoming Investor Conference,Fall,-0.0054,64,raptor pharmaceutical present upcoming investor conference,58,6,0,pharmacy,"['rap', '##tor', 'pharmaceutical', 'present', 'upcoming', 'investor', 'conference']",1
299413,nifty_904,2014-08-06,NPS Pharma Reports Second-Quarter 2014 Financial Results,Fall,-0.0054,56,np pharma report second quarter financial result,48,7,0,pharmacy,"['n', '##p', 'p', '##har', '##ma', 'report', 'second', 'quarter', 'financial', 'result']",1
299416,nifty_904,2014-08-06,Vital Therapies Announces Second Quarter 2014 Financial Results and Provides Update on Operations and Upcoming Conference Presentations,Fall,-0.0054,135,vital therapy announces second quarter financial result and provides update operation and upcoming conference presentation,122,15,0,pharmacy,"['vital', 'therapy', 'announces', 'second', 'quarter', 'financial', 'result', 'and', 'provides', 'update', 'operation', 'and', 'upcoming', 'conference', 'presentation']",1
299449,nifty_904,2014-08-06,Press Release Issued Under the Early Warning System/Sale of Shares of Nymox Pharmaceutical Corporation,Fall,-0.0054,102,press release issued under the early warning system sale share nymox pharmaceutical corporation,95,13,0,pharmacy,"['press', 'release', 'issued', 'under', 'the', 'early', 'warning', 'system', 'sale', 'share', 'n', '##ym', '##ox', 'pharmaceutical', 'corporation']",1
299469,nifty_904,2014-08-06,SANUWAVE Health Reports Second Quarter Financial Results and Provides a Business Update,Fall,-0.0054,87,sanuwave health report second quarter financial result and provides business update,83,11,0,pharmacy,"['sa', '##nu', '##wave', 'health', 'report', 'second', 'quarter', 'financial', 'result', 'and', 'provides', 'business', 'update']",1
299769,nifty_905,2014-08-07,"Research and Markets: Global Human Identification Market Report 2014-2018: Technology, Application, DNA Amplification, Quantification, Extraction, Services, & Software Analysis",Rise,0.0116,176,research and market global human identification market report technology application dna amplification quantification extraction service software analysis,154,17,0,pharmacy,"['research', 'and', 'market', 'global', 'human', 'identification', 'market', 'report', 'technology', 'application', 'd', '##na', 'am', '##p', '##lification', 'q', '##uant', '##ification', 'extraction', 'service', 'software', 'analysis']",1
299848,nifty_905,2014-08-07,Horizon Pharma Reports Second Quarter 2014 Financial Results and Provides Business Update,Rise,0.0116,89,horizon pharma report second quarter financial result and provides business update,82,11,0,pharmacy,"['horizon', 'p', '##har', '##ma', 'report', 'second', 'quarter', 'financial', 'result', 'and', 'provides', 'business', 'update']",1
299851,nifty_905,2014-08-07,Celladon Reports Second Quarter 2014 Financial Results and Recent Highlights,Rise,0.0116,76,celladon report second quarter financial result and recent highlight,68,9,0,pharmacy,"['cell', '##ado', '##n', 'report', 'second', 'quarter', 'financial', 'result', 'and', 'recent', 'highlight']",1
299917,nifty_905,2014-08-07,Sarepta Therapeutics Announces Second Quarter 2014 Financial Results and Recent Corporate Developments,Rise,0.0116,102,sarepta therapeutic announces second quarter financial result and recent corporate development,94,11,0,pharmacy,"['sa', '##re', '##pta', 'therapeutic', 'announces', 'second', 'quarter', 'financial', 'result', 'and', 'recent', 'corporate', 'development']",1
299943,nifty_905,2014-08-07,Bioheart Releases Q2 Financial Information Showing Growth,Rise,0.0116,57,bioheart release financial information showing growth,53,6,0,pharmacy,"['bio', '##heart', 'release', 'financial', 'information', 'showing', 'growth']",1
300023,nifty_905,2014-08-07,Anacor Pharmaceuticals to Present at Upcoming Investor Conferences,Rise,0.0116,66,anacor pharmaceutical present upcoming investor conference,58,6,0,pharmacy,"['an', '##aco', '##r', 'pharmaceutical', 'present', 'upcoming', 'investor', 'conference']",1
300044,nifty_905,2014-08-07,"Biotech Equities Technical Analysis -- BioMarin Pharma, Merrimack Pharma, Sangamo BioSciences, ZIOPHARM Oncology, and Dyax",Rise,0.0116,122,biotech equity technical analysis biomarin pharma merrimack pharma sangamo bioscience ziopharm oncology and dyax,112,14,0,pharmacy,"['bio', '##tech', 'equity', 'technical', 'analysis', 'bio', '##mar', '##in', 'p', '##har', '##ma', 'me', '##rri', '##ma', '##ck', 'p', '##har', '##ma', 'sang', '##amo', 'bio', '##science', 'z', '##io', '##pha', '##rm', 'on', '##cology', 'and', 'd', '##ya', '##x']",1
300113,nifty_905,2014-08-07,"Market Updates on Pharma Stocks -- Theravance, Akorn, Endo Intl., Pernix Therapeutics, and Depomed",Rise,0.0116,98,market update pharma stock theravance akorn endo intl pernix therapeutic and depomed,84,12,0,pharmacy,"['market', 'update', 'p', '##har', '##ma', 'stock', 'the', '##ra', '##vance', 'a', '##kor', '##n', 'end', '##o', 'in', '##tl', 'per', '##ni', '##x', 'therapeutic', 'and', 'de', '##po', '##med']",1
300246,nifty_905,2014-08-07,Fulcrum BioEnergy and Cathay Pacific Announce Strategic Investment,Rise,0.0116,66,fulcrum bioenergy and cathay pacific announce strategic investment,66,8,0,pharmacy,"['f', '##ul', '##c', '##rum', 'bio', '##ener', '##gy', 'and', 'cat', '##hay', 'p', '##ac', '##ific', 'announce', 'strategic', 'investment']",1
300257,nifty_905,2014-08-07,Research and Markets: EpiCast Report: Acute Coronary Syndrome (ACS) - Epidemiology Forecast to 2023,Rise,0.0116,99,research and market epicast report acute coronary syndrome ac epidemiology forecast,83,11,0,pharmacy,"['research', 'and', 'market', 'epic', '##ast', 'report', 'acute', 'co', '##rona', '##ry', 'syndrome', 'a', '##c', 'e', '##pid', '##em', '##iology', 'forecast']",1
300317,nifty_905,2014-08-07,"Research and Markets: Turkey Healthcare, Regulatory and Reimbursement Landscape Report 2014-2020",Rise,0.0116,96,research and market turkey healthcare regulatory and reimbursement landscape report,83,10,0,pharmacy,"['research', 'and', 'market', 'turkey', 'healthcare', 'regulatory', 'and', 're', '##im', '##bur', '##se', '##ment', 'landscape', 'report']",1
300347,nifty_905,2014-08-07,Research and Markets: Circulating Nucleic Acids (CNAs) Based Non-Invasive Cancer Diagnostics: Global Market Report 2014,Rise,0.0116,119,research and market circulating nucleic acid cnas based non invasive cancer diagnostics global market report,108,15,0,pharmacy,"['research', 'and', 'market', 'circulating', 'nuclei', '##c', 'acid', 'c', '##nas', 'based', 'non', 'invasive', 'cancer', 'diagnostic', '##s', 'global', 'market', 'report']",1
300351,nifty_905,2014-08-07,"AVAC Ltd. Announces Investment in eBook Distributor, Enthrill",Rise,0.0116,61,avac ltd announces investment ebook distributor enthrill,56,7,0,pharmacy,"['a', '##va', '##c', 'l', '##t', '##d', 'announces', 'investment', 'e', '##book', 'distributor', 'en', '##th', '##rill']",1
300385,nifty_905,2014-08-07,Janus' Kozlowski seeks stocks immune to market malaise,Rise,0.0116,54,janus kozlowski seek stock immune market malaise,48,7,0,pharmacy,"['j', '##anus', 'k', '##oz', '##lows', '##ki', 'seek', 'stock', 'immune', 'market', 'ma', '##lai', '##se']",1
300406,nifty_905,2014-08-07,Amicus Therapeutics Announces Second Quarter 2014 Financial Results and Corporate Updates,Rise,0.0116,89,amicus therapeutic announces second quarter financial result and corporate update,81,10,0,pharmacy,"['am', '##icus', 'therapeutic', 'announces', 'second', 'quarter', 'financial', 'result', 'and', 'corporate', 'update']",1
300411,nifty_905,2014-08-07,BioAmber Reports Second Quarter 2014 Financial Results,Rise,0.0116,54,bioamber report second quarter financial result,47,6,0,pharmacy,"['bio', '##am', '##ber', 'report', 'second', 'quarter', 'financial', 'result']",1
300417,nifty_905,2014-08-07,"OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Second Quarter 2014",Rise,0.0116,81,oncogenex pharmaceutical inc report financial result for second quarter,71,9,0,pharmacy,"['on', '##co', '##gene', '##x', 'pharmaceutical', 'in', '##c', 'report', 'financial', 'result', 'for', 'second', 'quarter']",1
300428,nifty_905,2014-08-07,Celator(R) Pharmaceuticals Announces Business Update and Second Quarter 2014 Financial Results,Rise,0.0116,94,celator pharmaceutical announces business update and second quarter financial result,84,10,0,pharmacy,"['c', '##ela', '##tor', 'pharmaceutical', 'announces', 'business', 'update', 'and', 'second', 'quarter', 'financial', 'result']",1
300434,nifty_905,2014-08-07,Raptor Pharmaceutical Reports Second Quarter 2014 Financial Results and Provides Corporate Update,Rise,0.0116,97,raptor pharmaceutical report second quarter financial result and provides corporate update,90,11,0,pharmacy,"['rap', '##tor', 'pharmaceutical', 'report', 'second', 'quarter', 'financial', 'result', 'and', 'provides', 'corporate', 'update']",1
300531,nifty_905,2014-08-07,"BioAmber Inc.: 8-K FORM for the three months ended June 30, 2014",Rise,0.0116,64,bioamber inc form for the three month ended june,48,9,0,pharmacy,"['bio', '##am', '##ber', 'in', '##c', 'form', 'for', 'the', 'three', 'month', 'ended', 'j', '##une']",1
300739,nifty_906,2014-08-11,"OXIS International announces plans to Enter the Cannabis Biotech Sector, Completion of Financing, Changes to the Board of Directors",Neutral,-0.0014,131,oxis international announces plan enter the cannabis biotech sector completion financing change the board director,114,15,0,pharmacy,"['o', '##xi', '##s', 'international', 'announces', 'plan', 'enter', 'the', 'cannabis', 'bio', '##tech', 'sector', 'completion', 'financing', 'change', 'the', 'board', 'director']",1
300786,nifty_906,2014-08-11,"Research and Markets: Updated Global Molecular Diagnostics Report 2014: Technologies, Markets and Companies to 2023",Neutral,-0.0014,115,research and market updated global molecular diagnostics report technology market and company,93,12,0,pharmacy,"['research', 'and', 'market', 'updated', 'global', 'molecular', 'diagnostic', '##s', 'report', 'technology', 'market', 'and', 'company']",1
300787,nifty_906,2014-08-11,"Research and Markets: Global Cell Therapy Report 2013-2023 - Updated 2014 Technologies, Markets and Companies Analysis",Neutral,-0.0014,118,research and market global cell therapy report updated technology market and company analysis,93,13,0,pharmacy,"['research', 'and', 'market', 'global', 'cell', 'therapy', 'report', 'updated', 'technology', 'market', 'and', 'company', 'analysis']",1
300789,nifty_906,2014-08-11,"Research and Markets: Global Proteomics Report: Technologies, Markets and Companies 2013-2018 and Long-Term Projections to 2023 (Updated)",Neutral,-0.0014,137,research and market global proteomics report technology market and company and long term projection updated,107,15,0,pharmacy,"['research', 'and', 'market', 'global', 'pro', '##te', '##omi', '##cs', 'report', 'technology', 'market', 'and', 'company', 'and', 'long', 'term', 'projection', 'updated']",1
300790,nifty_906,2014-08-11,"Research and Markets: Transdermal Drug Delivery - Updated Technologies, Markets, and Companies Analysis to 2023",Neutral,-0.0014,111,research and market transdermal drug delivery updated technology market and company analysis,92,12,0,pharmacy,"['research', 'and', 'market', 'trans', '##der', '##mal', 'drug', 'delivery', 'updated', 'technology', 'market', 'and', 'company', 'analysis']",1
300832,nifty_906,2014-08-11,Media Advisory - Oncolytics BiotechÂ® Inc. Announces Participation in Upcoming Conferences,Neutral,-0.0014,90,medium advisory oncolytics biotechâ inc announces participation upcoming conference,83,9,0,pharmacy,"['medium', 'advisory', 'on', '##co', '##ly', '##tics', 'bio', '##tech', '##â', 'in', '##c', 'announces', 'participation', 'upcoming', 'conference']",1
300842,nifty_906,2014-08-11,"Joel Sendek, Leading Wall Street Biotech Analyst, Joins Forward Pharma as Chief Financial Officer",Neutral,-0.0014,97,joel sendek leading wall street biotech analyst join forward pharma chief financial officer,91,13,0,pharmacy,"['j', '##oe', '##l', 'send', '##ek', 'leading', 'wall', 'street', 'bio', '##tech', 'analyst', 'join', 'forward', 'p', '##har', '##ma', 'chief', 'financial', 'officer']",1
300956,nifty_906,2014-08-11,"Biotech Equities Technical Momentum -- InterMune, Biogen Idec, Insmed, Dendreon, and Alexion Pharma",Neutral,-0.0014,99,biotech equity technical momentum intermune biogen idec insmed dendreon and alexion pharma,90,12,0,pharmacy,"['bio', '##tech', 'equity', 'technical', 'momentum', 'inter', '##mu', '##ne', 'bio', '##gen', 'id', '##ec', 'ins', '##med', 'den', '##dre', '##on', 'and', 'ale', '##xi', '##on', 'p', '##har', '##ma']",1
300959,nifty_906,2014-08-11,Tonix Pharmaceuticals Announces Transfer to the NASDAQ Global Market,Neutral,-0.0014,68,tonix pharmaceutical announces transfer the nasdaq global market,64,8,0,pharmacy,"['ton', '##ix', 'pharmaceutical', 'announces', 'transfer', 'the', 'na', '##s', '##da', '##q', 'global', 'market']",1
301006,nifty_906,2014-08-11,"Medical Gases and Equipment (Oxygen, Medical Air, Nitrogen, Nitrous-oxide, Helium, Blood-gas Mixture, Nitrous Oxide-Oxygen Mixture) Market - Global Forecasts to 2018",Neutral,-0.0014,165,medical gas and equipment oxygen medical air nitrogen nitrous oxide helium blood gas mixture nitrous oxide oxygen mixture market global forecast,144,21,0,pharmacy,"['medical', 'gas', 'and', 'equipment', 'oxygen', 'medical', 'air', 'nitrogen', 'ni', '##tro', '##us', 'oxide', 'he', '##lium', 'blood', 'gas', 'mixture', 'ni', '##tro', '##us', 'oxide', 'oxygen', 'mixture', 'market', 'global', 'forecast']",1
301032,nifty_906,2014-08-11,"Product Launch, Technical Updates, Clinical Study Results, Completion of Tender Offer, and Financial Result - Research Reports on Medtronic, Covidien, Johnson & Johnson, Merck and Jazz",Neutral,-0.0014,184,product launch technical update clinical study result completion tender offer and financial result research report medtronic covidien johnson johnson merck and jazz,164,22,0,pharmacy,"['product', 'launch', 'technical', 'update', 'clinical', 'study', 'result', 'completion', 'tender', 'offer', 'and', 'financial', 'result', 'research', 'report', 'me', '##dt', '##ronic', 'co', '##vid', '##ien', 'j', '##oh', '##nson', 'j', '##oh', '##nson', 'me', '##rc', '##k', 'and', 'jazz']",1
301041,nifty_906,2014-08-11,Post-Earnings Review and Highlights - Arena Pharma,Neutral,-0.0014,50,post earnings review and highlight arena pharma,47,7,0,pharmacy,"['post', 'earnings', 'review', 'and', 'highlight', 'arena', 'p', '##har', '##ma']",1
301062,nifty_906,2014-08-11,"Research and Markets: MediPoint: Diagnostic X-ray Imaging - EU Analysis and Market Forecasts 2014: Philips Healthcare, GE Healthcare, and Siemens Healthcare Dominate the Industry with 60% Market Share",Neutral,-0.0014,200,research and market medipoint diagnostic ray imaging analysis and market forecast philip healthcare healthcare and siemens healthcare dominate the industry with market share,173,23,0,pharmacy,"['research', 'and', 'market', 'me', '##di', '##point', 'diagnostic', 'ray', 'imaging', 'analysis', 'and', 'market', 'forecast', 'p', '##hil', '##ip', 'healthcare', 'healthcare', 'and', 'si', '##em', '##ens', 'healthcare', 'dominate', 'the', 'industry', 'with', 'market', 'share']",1
301066,nifty_906,2014-08-11,"Catylix and Aspira Scientific Announce Launch of the ""New Substituent of the Future""",Neutral,-0.0014,84,catylix and aspira scientific announce launch the new substituent the future,76,11,0,pharmacy,"['cat', '##yl', '##ix', 'and', 'as', '##pi', '##ra', 'scientific', 'announce', 'launch', 'the', 'new', 'sub', '##st', '##it', '##uen', '##t', 'the', 'future']",1
301070,nifty_906,2014-08-11,"Global Population Health Management (Provider, Payer, Employer Groups & Government Bodies Analysis) Market - Forecasts to 2018",Neutral,-0.0014,126,global population health management provider payer employer group government body analysis market forecast,106,13,0,pharmacy,"['global', 'population', 'health', 'management', 'provider', 'pay', '##er', 'employer', 'group', 'government', 'body', 'analysis', 'market', 'forecast']",1
301080,nifty_906,2014-08-11,Report: Acquisitions Driving Global Medical Device Market,Neutral,-0.0014,57,report acquisition driving global medical device market,55,7,0,pharmacy,"['report', 'acquisition', 'driving', 'global', 'medical', 'device', 'market']",1
301081,nifty_906,2014-08-11,Research and Markets: EU5 Duodenoscopes Market Outlook to 2020 - Flexible Video Duodenoscopes and Flexible Non-Video (Fibre) Duodenoscopes,Neutral,-0.0014,138,research and market duodenoscopes market outlook flexible video duodenoscopes and flexible non video fibre duodenoscopes,120,15,0,pharmacy,"['research', 'and', 'market', 'duo', '##den', '##os', '##cope', '##s', 'market', 'outlook', 'flexible', 'video', 'duo', '##den', '##os', '##cope', '##s', 'and', 'flexible', 'non', 'video', 'fibre', 'duo', '##den', '##os', '##cope', '##s']",1
301090,nifty_906,2014-08-11,Research and Markets: EU5 Rigid Non-Video Sinuscopes Market Outlook to 2020,Neutral,-0.0014,75,research and market rigid non video sinuscopes market outlook,61,9,0,pharmacy,"['research', 'and', 'market', 'rigid', 'non', 'video', 'sin', '##us', '##cope', '##s', 'market', 'outlook']",1
301098,nifty_906,2014-08-11,Alliance Life Sciences Looks Into the Future of the Insurance Exchange Marketplace and Its Effect on Pharmaceutical Manufacturers,Neutral,-0.0014,129,alliance life science look into the future the insurance exchange marketplace and it effect pharmaceutical manufacturer,119,16,0,pharmacy,"['alliance', 'life', 'science', 'look', 'into', 'the', 'future', 'the', 'insurance', 'exchange', 'marketplace', 'and', 'it', 'effect', 'pharmaceutical', 'manufacturer']",1
301156,nifty_906,2014-08-11,Bestâs Briefing: New U.S. Health Co-ops Fight Through Financial Strains of Launch Phase,Neutral,-0.0014,89,bestâ briefing new health ops fight through financial strain launch phase,73,11,0,pharmacy,"['best', '##â', 'brief', '##ing', 'new', 'health', 'op', '##s', 'fight', 'through', 'financial', 'strain', 'launch', 'phase']",1
301202,nifty_906,2014-08-11,"Investors Applaud Amgen and Novartis for Support of Investor Principles on Biosimilars, Alternatives to Higher Cost Drugs",Neutral,-0.0014,121,investor applaud amgen and novartis for support investor principle biosimilars alternative higher cost drug,107,14,0,pharmacy,"['investor', 'app', '##lau', '##d', 'am', '##gen', 'and', 'no', '##var', '##tis', 'for', 'support', 'investor', 'principle', 'bio', '##si', '##mi', '##lars', 'alternative', 'higher', 'cost', 'drug']",1
301285,nifty_906,2014-08-11,BioSpecifics Technologies Corp. Reports Second Quarter 2014 Financial Results,Neutral,-0.0014,77,biospecifics technology corp report second quarter financial result,67,8,0,pharmacy,"['bio', '##sp', '##ec', '##ific', '##s', 'technology', 'co', '##rp', 'report', 'second', 'quarter', 'financial', 'result']",1
301313,nifty_906,2014-08-11,Intercept Pharmaceuticals Reports Second Quarter 2014 Financial Results and Provides Business Update,Neutral,-0.0014,100,intercept pharmaceutical report second quarter financial result and provides business update,92,11,0,pharmacy,"['intercept', 'pharmaceutical', 'report', 'second', 'quarter', 'financial', 'result', 'and', 'provides', 'business', 'update']",1
301335,nifty_906,2014-08-11,Cellular Dynamics International Reports Second Quarter 2014 Financial Results,Neutral,-0.0014,77,cellular dynamic international report second quarter financial result,69,8,0,pharmacy,"['cellular', 'dynamic', 'international', 'report', 'second', 'quarter', 'financial', 'result']",1
301367,nifty_906,2014-08-11,MEDIA-Care provider NHP tries to avert collapse of HC-One sale - Sky News,Neutral,-0.0014,73,medium care provider nhp try avert collapse one sale sky news,61,11,0,pharmacy,"['medium', 'care', 'provider', 'n', '##hp', 'try', 'a', '##vert', 'collapse', 'one', 'sale', 'sky', 'news']",1
301606,nifty_908,2014-08-13,Amgen Cancer Drug Kyprolis Fails Trial,Neutral,0.0047,38,amgen cancer drug kyprolis fails trial,38,6,0,pharmacy,"['am', '##gen', 'cancer', 'drug', 'k', '##y', '##p', '##rol', '##is', 'fails', 'trial']",1
301612,nifty_908,2014-08-13,Second Turkish Man Pleads Guilty to Smuggling Fake Cancer Drugs,Neutral,0.0047,63,second turkish man pleads guilty smuggling fake cancer drug,59,9,0,pharmacy,"['second', 't', '##ur', '##kis', '##h', 'man', 'plea', '##ds', 'guilty', 'smuggling', 'fake', 'cancer', 'drug']",1
301896,nifty_912,2014-08-20,Mylan Edges Toward Glaxo Drugs,Neutral,0.0029,30,mylan edge toward glaxo drug,28,5,0,pharmacy,"['my', '##lan', 'edge', 'toward', 'g', '##lax', '##o', 'drug']",1
301909,nifty_912,2014-08-20,"Bristol-Myers, Celgene to Collaborate on Cancer-Treatment Study",Neutral,0.0029,63,bristol myers celgene collaborate cancer treatment study,56,7,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'c', '##el', '##gene', 'collaborate', 'cancer', 'treatment', 'study']",1
301917,nifty_912,2014-08-20,Amicus Therapeutics' Fabry Treatment Meets Primary Endpoints,Neutral,0.0029,60,amicus therapeutic fabry treatment meet primary endpoint,56,7,0,pharmacy,"['am', '##icus', 'therapeutic', 'f', '##ab', '##ry', 'treatment', 'meet', 'primary', 'end', '##point']",1
301955,nifty_913,2014-08-21,REG-Aqua Bio Technology: Financial results affected by lawsuit,Neutral,-0.0016,62,reg aqua bio technology financial result affected lawsuit,57,8,0,pharmacy,"['re', '##g', 'a', '##qua', 'bio', 'technology', 'financial', 'result', 'affected', 'lawsuit']",1
302135,nifty_913,2014-08-21,BioLargo to Present at the Rodman & Renshaw 16th Annual Global Investment Conference,Neutral,-0.0016,84,biolargo present the rodman renshaw annual global investment conference,71,9,0,pharmacy,"['bio', '##lar', '##go', 'present', 'the', 'rod', '##man', 're', '##ns', '##haw', 'annual', 'global', 'investment', 'conference']",1
302143,nifty_913,2014-08-21,Health Gorilla Raises $1.2 Million Funding Led by True Ventures to Capitalize on $64 Billion Diagnostic Test Market,Neutral,-0.0016,115,health gorilla raise million funding led true venture capitalize billion diagnostic test market,95,13,0,pharmacy,"['health', 'go', '##rilla', 'raise', 'million', 'funding', 'led', 'true', 'venture', 'capital', '##ize', 'billion', 'diagnostic', 'test', 'market']",1
302165,nifty_913,2014-08-21,Advanced Catheter Therapies Announces Series B Equity Financing,Neutral,-0.0016,63,advanced catheter therapy announces series equity financing,59,7,0,pharmacy,"['advanced', 'cat', '##he', '##ter', 'therapy', 'announces', 'series', 'equity', 'financing']",1
302169,nifty_913,2014-08-21,"Research and Markets: Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk",Neutral,-0.0016,144,research and market global hormone replacement therapy market key vendor are actavis bayer merck novartis and novo nordisk,122,18,0,pharmacy,"['research', 'and', 'market', 'global', 'hormone', 'replacement', 'therapy', 'market', 'key', 'vendor', 'are', 'act', '##avi', '##s', 'bay', '##er', 'me', '##rc', '##k', 'no', '##var', '##tis', 'and', 'no', '##vo', 'nor', '##dis', '##k']",1
302196,nifty_913,2014-08-21,"Research and Markets: FDA's New Import Program Concerning International Consequences: 2-day In-person Seminar - 20th-21st November, Boston, Massachusetts",Neutral,-0.0016,153,research and market fda new import program concerning international consequence day person seminar november boston massachusetts,128,16,0,pharmacy,"['research', 'and', 'market', 'f', '##da', 'new', 'import', 'program', 'concerning', 'international', 'consequence', 'day', 'person', 'seminar', 'no', '##ve', '##mber', 'b', '##ost', '##on', 'mass', '##ach', '##use', '##tts']",1
302199,nifty_913,2014-08-21,"New Drug Launches, Technical Updates, New Facility, Clinical Trials Data, and Dividend Declarations - Research Reports on Covidien, Mylan, Baxter, Achillion and Perrigo",Neutral,-0.0016,168,new drug launch technical update new facility clinical trial data and dividend declaration research report covidien mylan baxter achillion and perrigo,150,21,0,pharmacy,"['new', 'drug', 'launch', 'technical', 'update', 'new', 'facility', 'clinical', 'trial', 'data', 'and', 'divide', '##nd', 'declaration', 'research', 'report', 'co', '##vid', '##ien', 'my', '##lan', 'b', '##ax', '##ter', 'a', '##chi', '##lli', '##on', 'and', 'per', '##rig', '##o']",1
302213,nifty_913,2014-08-21,"Research and Markets: FDA's Refuse to Accept Policy - How to Prepare 510 (K) Submission to Avoid the Pitfalls of the Policy: 2-day In-Person Seminar - 13-14th November, Salt Lake City, UT",Neutral,-0.0016,187,research and market fda refuse accept policy how prepare submission avoid the pitfall the policy day person seminar november salt lake city,139,22,0,pharmacy,"['research', 'and', 'market', 'f', '##da', 'refuse', 'accept', 'policy', 'how', 'prepare', 'submission', 'avoid', 'the', 'pit', '##fall', 'the', 'policy', 'day', 'person', 'seminar', 'no', '##ve', '##mber', 'salt', 'lake', 'city']",1
302245,nifty_913,2014-08-21,Report: Drug Abuse Test Market Will Exceed $3 Billion By 2015,Neutral,-0.0016,61,report drug abuse test market will exceed billion,49,8,0,pharmacy,"['report', 'drug', 'abuse', 'test', 'market', 'will', 'exceed', 'billion']",1
302260,nifty_913,2014-08-21,"Technical Coverage on Pharma Stocks -- Teva Pharmaceutical Industries, AbbVie, Merck, Johnson and Johnson, and Bristol-Myers Squibb",Neutral,-0.0016,131,technical coverage pharma stock teva pharmaceutical industry abbvie merck johnson and johnson and bristol myers squibb,118,16,0,pharmacy,"['technical', 'coverage', 'p', '##har', '##ma', 'stock', 'te', '##va', 'pharmaceutical', 'industry', 'a', '##bb', '##vie', 'me', '##rc', '##k', 'j', '##oh', '##nson', 'and', 'j', '##oh', '##nson', 'and', 'br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb']",1
302341,nifty_913,2014-08-21,Research and Markets: The Emerging Market for Price Transparency in Medical Services: Can Price Transparency be the New Core of Consumer Health Engagement,Neutral,-0.0016,154,research and market the emerging market for price transparency medical service can price transparency the new core consumer health engagement,141,20,0,pharmacy,"['research', 'and', 'market', 'the', 'emerging', 'market', 'for', 'price', 'transparency', 'medical', 'service', 'can', 'price', 'transparency', 'the', 'new', 'core', 'consumer', 'health', 'engagement']",1
302364,nifty_913,2014-08-21,Research and Markets: mHealth Wellness Wearable Devices - 2014 Study,Neutral,-0.0016,68,research and market mhealth wellness wearable device study,58,8,0,pharmacy,"['research', 'and', 'market', 'm', '##hea', '##lt', '##h', 'well', '##ness', 'wear', '##able', 'device', 'study']",1
302401,nifty_913,2014-08-21,Research and Markets: US Orphan Drug Clinical Pipeline Insight 2014 - New Report on the $49 Billion Industry,Neutral,-0.0016,108,research and market orphan drug clinical pipeline insight new report the billion industry,89,13,0,pharmacy,"['research', 'and', 'market', 'orphan', 'drug', 'clinical', 'pipeline', 'insight', 'new', 'report', 'the', 'billion', 'industry']",1
302464,nifty_913,2014-08-21,PerfectServe Doubles Research and Development Funding in Response to Health IT Market Opportunities,Neutral,-0.0016,99,perfectserve double research and development funding response health market opportunity,87,10,0,pharmacy,"['perfect', '##serve', 'double', 'research', 'and', 'development', 'funding', 'response', 'health', 'market', 'opportunity']",1
302472,nifty_913,2014-08-21,"Research and Markets: Why is FDA at My Facility, and What Do I Do During an Inspection?: 2-day In-person Seminar - 16-17th October, Los Angeles, CA",Neutral,-0.0016,147,research and market why fda facility and what during inspection day person seminar october los angeles,102,16,0,pharmacy,"['research', 'and', 'market', 'why', 'f', '##da', 'facility', 'and', 'what', 'during', 'inspection', 'day', 'person', 'seminar', 'o', '##ct', '##obe', '##r', 'los', 'angel', '##es']",1
302579,nifty_913,2014-08-21,Healthcareâs Trillion Dollar Transformation Comes to Life at MediFuture,Neutral,-0.0016,73,healthcareâ trillion dollar transformation come life medifuture,63,7,0,pharmacy,"['healthcare', '##â', 'trillion', 'dollar', 'transformation', 'come', 'life', 'me', '##di', '##fu', '##ture']",1
302631,nifty_913,2014-08-21,Cellectar Biosciences Reports Second Quarter 2014 Financial Results and Recent Highlights,Neutral,-0.0016,89,cellectar bioscience report second quarter financial result and recent highlight,80,10,0,pharmacy,"['cell', '##ec', '##tar', 'bio', '##science', 'report', 'second', 'quarter', 'financial', 'result', 'and', 'recent', 'highlight']",1
302839,nifty_913,2014-08-21,Lilly Psoriasis Treatment Meets Objectives,Neutral,-0.0016,42,lilly psoriasis treatment meet objective,40,5,0,pharmacy,"['l', '##ill', '##y', 'ps', '##oria', '##sis', 'treatment', 'meet', 'objective']",1
302857,nifty_914,2014-08-25,Kite Pharma's Shares Soar After Study Results,Neutral,0.0006,45,kite pharma share soar after study result,41,7,0,pharmacy,"['kit', '##e', 'p', '##har', '##ma', 'share', 'so', '##ar', 'after', 'study', 'result']",1
302978,nifty_915,2014-08-26,"Pfizer, Merck Team Up on Cancer Study",Neutral,-0.0004,37,pfizer merck team cancer study,30,5,0,pharmacy,"['p', '##fi', '##zer', 'me', '##rc', '##k', 'team', 'cancer', 'study']",1
303077,nifty_916,2014-08-27,"Research and Markets: Nitinol Medical Devices Market Forecasts & Opportunities, 2019 - Semi-finished Raw Material & Final Medical Components Analysis",Neutral,-0.0005,149,research and market nitinol medical device market forecast opportunity semi finished raw material final medical component analysis,130,17,0,pharmacy,"['research', 'and', 'market', 'ni', '##tino', '##l', 'medical', 'device', 'market', 'forecast', 'opportunity', 'semi', 'finished', 'raw', 'material', 'final', 'medical', 'component', 'analysis']",1
303203,nifty_916,2014-08-27,"Research and Markets: Medical Imaging Reagents Market Report - Class, Technology & Application Analysis 2014-2019",Neutral,-0.0005,113,research and market medical imaging reagent market report class technology application analysis,95,12,0,pharmacy,"['research', 'and', 'market', 'medical', 'imaging', 're', '##age', '##nt', 'market', 'report', 'class', 'technology', 'application', 'analysis']",1
303227,nifty_916,2014-08-27,New Survey Says Nurses Are Bullish On The Industry Outlook And Encourage People To Enter The Field,Neutral,-0.0005,98,new survey say nurse are bullish the industry outlook and encourage people enter the field,90,15,0,pharmacy,"['new', 'survey', 'say', 'nurse', 'are', 'bull', '##ish', 'the', 'industry', 'outlook', 'and', 'encourage', 'people', 'enter', 'the', 'field']",1
303294,nifty_916,2014-08-27,"Pharma Equities Technical Analysis -- Sanofi, AstraZeneca, Novartis, Salix Pharma, and AcelRx Pharma",Neutral,-0.0005,100,pharma equity technical analysis sanofi astrazeneca novartis salix pharma and acelrx pharma,91,12,0,pharmacy,"['p', '##har', '##ma', 'equity', 'technical', 'analysis', 'sa', '##no', '##fi', 'as', '##tra', '##zen', '##eca', 'no', '##var', '##tis', 'sa', '##lix', 'p', '##har', '##ma', 'and', 'ace', '##l', '##r', '##x', 'p', '##har', '##ma']",1
303318,nifty_916,2014-08-27,GHX Surpasses Important $5 Billion in Healthcare Savings Milestone,Neutral,-0.0005,66,ghx surpasses important billion healthcare saving milestone,59,7,0,pharmacy,"['g', '##h', '##x', 'sur', '##pass', '##es', 'important', 'billion', 'healthcare', 'saving', 'milestone']",1
303382,nifty_916,2014-08-27,Research and Markets: OpportunityAnalyzer: Diabetic Foot Ulcers - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update,Neutral,-0.0005,130,research and market opportunityanalyzer diabetic foot ulcer opportunity analysis and forecast event driven update,113,14,0,pharmacy,"['research', 'and', 'market', 'opportunity', '##ana', '##ly', '##zer', 'di', '##abe', '##tic', 'foot', 'ul', '##cer', 'opportunity', 'analysis', 'and', 'forecast', 'event', 'driven', 'update']",1
303473,nifty_916,2014-08-27,Leading Architectural Design Firm NBBJ Launches Healthcare Practice in China,Neutral,-0.0005,76,leading architectural design firm nbbj launch healthcare practice china,71,9,0,pharmacy,"['leading', 'architectural', 'design', 'firm', 'n', '##bb', '##j', 'launch', 'healthcare', 'practice', 'chin', '##a']",1
303573,nifty_916,2014-08-27,Research and Markets: Biochips Market (Microarrays/Lab on Chip) Report 2014-2019,Neutral,-0.0005,80,research and market biochip market microarrays lab chip report,62,9,0,pharmacy,"['research', 'and', 'market', 'bio', '##chi', '##p', 'market', 'micro', '##arra', '##ys', 'lab', 'chip', 'report']",1
303597,nifty_916,2014-08-27,Research and Markets: Global and Chinese Molecular Diagnostics Equipment Industry Report 2014,Neutral,-0.0005,93,research and market global and chinese molecular diagnostics equipment industry report,86,11,0,pharmacy,"['research', 'and', 'market', 'global', 'and', 'chin', '##ese', 'molecular', 'diagnostic', '##s', 'equipment', 'industry', 'report']",1
303744,nifty_916,2014-08-27,China says to let foreign investors set up hospitals,Neutral,-0.0005,52,china say let foreign investor set hospital,43,7,0,pharmacy,"['chin', '##a', 'say', 'let', 'foreign', 'investor', 'set', 'hospital']",1
303800,nifty_916,2014-08-27,Amgen Heart Drug Gets FDA Priority,Neutral,-0.0005,34,amgen heart drug get fda priority,33,6,0,pharmacy,"['am', '##gen', 'heart', 'drug', 'get', 'f', '##da', 'priority']",1
303998,nifty_918,2014-09-02,Research and Markets: Laparoscopy Devices Market - Global Industry Analysis to 2019,Neutral,-0.0005,83,research and market laparoscopy device market global industry analysis,70,9,0,pharmacy,"['research', 'and', 'market', 'lap', '##aro', '##sco', '##py', 'device', 'market', 'global', 'industry', 'analysis']",1
304001,nifty_918,2014-09-02,"UPDATE 1-""Most exciting ever"" Novartis drug points to huge sales",Neutral,-0.0005,64,update most exciting ever novartis drug point huge sale,55,9,0,pharmacy,"['update', 'most', 'exciting', 'ever', 'no', '##var', '##tis', 'drug', 'point', 'huge', 'sale']",1
304002,nifty_918,2014-09-02,'Most exciting ever' Novartis drug points to huge sales,Neutral,-0.0005,55,most exciting ever novartis drug point huge sale,48,8,0,pharmacy,"['most', 'exciting', 'ever', 'no', '##var', '##tis', 'drug', 'point', 'huge', 'sale']",1
304003,nifty_918,2014-09-02,Research and Markets: Global E-Prescribing Market Analysis Report 2014-2019 - Significant Growth Led by Government Programs,Neutral,-0.0005,123,research and market global prescribing market analysis report significant growth led government program,103,13,0,pharmacy,"['research', 'and', 'market', 'global', 'pre', '##s', '##cribing', 'market', 'analysis', 'report', 'significant', 'growth', 'led', 'government', 'program']",1
304008,nifty_918,2014-09-02,Research and Markets: 2014 Opportunities in the US Cancer Diagnostics Market,Neutral,-0.0005,76,research and market opportunity the cancer diagnostics market,61,8,0,pharmacy,"['research', 'and', 'market', 'opportunity', 'the', 'cancer', 'diagnostic', '##s', 'market']",1
304080,nifty_918,2014-09-02,"Research and Markets: Global RFID Smart Cabinet Market 2014-2018: Key Vendors are LogiTag, Mobile Aspects, TAGSYS RFID Group & WaveMark",Neutral,-0.0005,135,research and market global rfid smart cabinet market key vendor are logitag mobile aspect tagsys rfid group wavemark,116,18,0,pharmacy,"['research', 'and', 'market', 'global', 'r', '##fi', '##d', 'smart', 'cabinet', 'market', 'key', 'vendor', 'are', 'log', '##ita', '##g', 'mobile', 'aspect', 'tags', '##ys', 'r', '##fi', '##d', 'group', 'wave', '##mark']",1
304115,nifty_918,2014-09-02,"Collaboration Results, Litigation Update, Market Activity, Earnings Release, and Clinical Trial Results - Research Reports on Aetna, Allergan, Valeant, Perrigo and Baxter",Neutral,-0.0005,170,collaboration result litigation update market activity earnings release and clinical trial result research report aetna allergan valeant perrigo and baxter,155,20,0,pharmacy,"['collaboration', 'result', 'litigation', 'update', 'market', 'activity', 'earnings', 'release', 'and', 'clinical', 'trial', 'result', 'research', 'report', 'a', '##et', '##na', 'all', '##er', '##gan', 'v', '##ale', '##ant', 'per', '##rig', '##o', 'and', 'b', '##ax', '##ter']",1
304122,nifty_918,2014-09-02,"Clinical Affiliation, Technological Solution Launch, Earnings Release and Upcoming Events - Research Reports on CVS Caremark, TWC, Dollar Tree, Norfolk Southern and Costco",Neutral,-0.0005,171,clinical affiliation technological solution launch earnings release and upcoming event research report cv caremark twc dollar tree norfolk southern and costco,158,21,0,pharmacy,"['clinical', 'affiliation', 'technological', 'solution', 'launch', 'earnings', 'release', 'and', 'upcoming', 'event', 'research', 'report', 'c', '##v', 'care', '##mark', 't', '##w', '##c', 'dollar', 'tree', 'nor', '##fo', '##lk', 'southern', 'and', 'cost', '##co']",1
304197,nifty_918,2014-09-02,"European shares tick higher, drugmakers advance",Neutral,-0.0005,47,european share tick higher drugmakers advance,45,6,0,pharmacy,"['euro', '##pe', '##an', 'share', 't', '##ick', 'higher', 'drug', '##makers', 'advance']",1
304251,nifty_918,2014-09-02,"European shares edge higher, Novartis leads drugmakers",Neutral,-0.0005,54,european share edge higher novartis lead drugmakers,51,7,0,pharmacy,"['euro', '##pe', '##an', 'share', 'edge', 'higher', 'no', '##var', '##tis', 'lead', 'drug', '##makers']",1
304333,nifty_918,2014-09-02,FDA Clears GE 3-D Mammogram,Neutral,-0.0005,27,fda clear mammogram,19,3,0,pharmacy,"['f', '##da', 'clear', 'ma', '##mm', '##ogram']",1
304480,nifty_919,2014-09-03,"Infinity, AbbVie to Develop Cancer Treatment",Neutral,-0.0014,44,infinity abbvie develop cancer treatment,40,5,0,pharmacy,"['in', '##finity', 'a', '##bb', '##vie', 'develop', 'cancer', 'treatment']",1
304504,nifty_920,2014-09-04,New Study for Recro Drug Candidate,Neutral,0.0045,34,new study for recro drug candidate,34,6,0,pharmacy,"['new', 'study', 'for', 're', '##c', '##ro', 'drug', 'candidate']",1
304506,nifty_920,2014-09-04,Merck's Cancer Drug Approved,Neutral,0.0045,28,merck cancer drug approved,26,4,0,pharmacy,"['me', '##rc', '##k', 'cancer', 'drug', 'approved']",1
304519,nifty_920,2014-09-04,"New Cancer Drug Offers Hope, At a High Price Tag",Neutral,0.0045,48,new cancer drug offer hope high price tag,41,8,0,pharmacy,"['new', 'cancer', 'drug', 'offer', 'hope', 'high', 'price', 'tag']",1
304548,nifty_920,2014-09-04,Merck Bacterial Drug Fast-Tracked by FDA,Neutral,0.0045,40,merck bacterial drug fast tracked fda,37,6,0,pharmacy,"['me', '##rc', '##k', 'bacterial', 'drug', 'fast', 'tracked', 'f', '##da']",1
304633,nifty_921,2014-09-08,Hyperion Ends Diabetes Drug Development After Misconduct,Fall,-0.0063,56,hyperion end diabetes drug development after misconduct,55,7,0,pharmacy,"['h', '##yper', '##ion', 'end', 'diabetes', 'drug', 'development', 'after', 'misconduct']",1
304881,nifty_923,2014-09-10,"Neos Therapeutics, Inc. Announces Settlement of Pending Patent Litigation Concerning its Amphetamine Polistirex XR-ODT (NT-0202) with Shire LLC",Neutral,0.0011,143,neos therapeutic inc announces settlement pending patent litigation concerning it amphetamine polistirex odt with shire llc,123,16,0,pharmacy,"['neo', '##s', 'therapeutic', 'in', '##c', 'announces', 'settlement', 'pending', 'patent', 'litigation', 'concerning', 'it', 'am', '##phe', '##tamine', 'p', '##olis', '##ti', '##re', '##x', 'o', '##dt', 'with', 's', '##hire', 'll', '##c']",1
304952,nifty_923,2014-09-10,DNA of an American Entrepreneur: Hiscox study reveals signs of growth and innovation,Neutral,0.0011,84,dna american entrepreneur hiscox study reveals sign growth and innovation,73,10,0,pharmacy,"['d', '##na', 'am', '##eric', '##an', 'entrepreneur', 'his', '##co', '##x', 'study', 'reveals', 'sign', 'growth', 'and', 'innovation']",1
304987,nifty_923,2014-09-10,CEN Biotech Announces Date for Lakeshore Q&A; Open House,Neutral,0.0011,56,cen biotech announces date for lakeshore open house,51,8,0,pharmacy,"['c', '##en', 'bio', '##tech', 'announces', 'date', 'for', 'lakes', '##hore', 'open', 'house']",1
305059,nifty_923,2014-09-10,"Drug Launch, Market Activity, Appointments, and Special Meeting of Shareholders - Research Reports on Teva, Universal Health, Tenet, Allergan and Valeant",Neutral,0.0011,153,drug launch market activity appointment and special meeting shareholder research report teva universal health tenet allergan and valeant,136,18,0,pharmacy,"['drug', 'launch', 'market', 'activity', 'appointment', 'and', 'special', 'meeting', 'shareholder', 'research', 'report', 'te', '##va', 'universal', 'health', 'ten', '##et', 'all', '##er', '##gan', 'and', 'v', '##ale', '##ant']",1
305099,nifty_923,2014-09-10,"Expansion of Pipeline, Launch of New Website, Upcoming Earnings, and Technical Updates - Research Reports on Williams, Apache, FMC Technologies, Freeport and Tesoro",Neutral,0.0011,164,expansion pipeline launch new website upcoming earnings and technical update research report williams apache fmc technology freeport and tesoro,143,19,0,pharmacy,"['expansion', 'pipeline', 'launch', 'new', 'website', 'upcoming', 'earnings', 'and', 'technical', 'update', 'research', 'report', 'will', '##iam', '##s', 'a', '##pa', '##che', 'f', '##m', '##c', 'technology', 'free', '##port', 'and', 'te', '##sor', '##o']",1
305105,nifty_923,2014-09-10,"Biotech Stocks Under Review -- Keryx Biopharma, Sangamo BioSciences, Regeneron Pharma, Sunesis Pharma, and Idera Pharma",Neutral,0.0011,119,biotech stock under review keryx biopharma sangamo bioscience regeneron pharma sunesis pharma and idera pharma,110,15,0,pharmacy,"['bio', '##tech', 'stock', 'under', 'review', 'k', '##ery', '##x', 'bio', '##pha', '##rma', 'sang', '##amo', 'bio', '##science', 're', '##gene', '##ron', 'p', '##har', '##ma', 'sun', '##esis', 'p', '##har', '##ma', 'and', 'id', '##era', 'p', '##har', '##ma']",1
305152,nifty_923,2014-09-10,"Research and Markets: Polycystic Kidney Disease Therapeutics Pipeline Review, H2 2014 - 21 Drug Profiles from 11 Companies",Neutral,0.0011,122,research and market polycystic kidney disease therapeutic pipeline review drug profile from company,99,13,0,pharmacy,"['research', 'and', 'market', 'p', '##oly', '##cy', '##stic', 'kidney', 'disease', 'therapeutic', 'pipeline', 'review', 'drug', 'profile', 'from', 'company']",1
305167,nifty_923,2014-09-10,"Research and Markets: Global Acute Respiratory Distress Syndrome Therapeutics Pipeline Review, H2 2014 - 10 Companies & 24 Drug Profiles",Neutral,0.0011,136,research and market global acute respiratory distress syndrome therapeutic pipeline review company drug profile,111,14,0,pharmacy,"['research', 'and', 'market', 'global', 'acute', 'respiratory', 'distress', 'syndrome', 'therapeutic', 'pipeline', 'review', 'company', 'drug', 'profile']",1
305182,nifty_923,2014-09-10,"International Myeloma Foundation Hosts Congressional Briefing on Environmental Exposures, Such as Toxins at 9/11 World Trade Center Site, and Myeloma",Neutral,0.0011,149,international myeloma foundation host congressional briefing environmental exposure such toxin world trade center site and myeloma,130,16,0,pharmacy,"['international', 'my', '##elo', '##ma', 'foundation', 'host', 'congressional', 'brief', '##ing', 'environmental', 'exposure', 'such', 'to', '##xin', 'world', 'trade', 'center', 'site', 'and', 'my', '##elo', '##ma']",1
305184,nifty_923,2014-09-10,"Research and Markets: Cancer Diagnostics: New Developments, Market Growth and Opportunities in the use of Circulating Tumour Cells and Circulating Nucleic Acids",Neutral,0.0011,160,research and market cancer diagnostics new development market growth and opportunity the use circulating tumour cell and circulating nucleic acid,145,20,0,pharmacy,"['research', 'and', 'market', 'cancer', 'diagnostic', '##s', 'new', 'development', 'market', 'growth', 'and', 'opportunity', 'the', 'use', 'circulating', 't', '##umour', 'cell', 'and', 'circulating', 'nuclei', '##c', 'acid']",1
305213,nifty_923,2014-09-10,Jeff Souza Joins BioBridges as CEO and Partner,Neutral,0.0011,46,jeff souza join biobridges ceo and partner,42,7,0,pharmacy,"['j', '##ef', '##f', 'so', '##uza', 'join', 'bio', '##bridge', '##s', 'c', '##eo', 'and', 'partner']",1
305230,nifty_923,2014-09-10,"Research and Markets: DNA and RNA Sample Preparation Markets 2014: 45 Market Developments, Growth Areas and Opportunities",Neutral,0.0011,121,research and market dna and rna sample preparation market market development growth area and opportunity,104,15,0,pharmacy,"['research', 'and', 'market', 'd', '##na', 'and', 'r', '##na', 'sample', 'preparation', 'market', 'market', 'development', 'growth', 'area', 'and', 'opportunity']",1
305239,nifty_923,2014-09-10,"Research and Markets: Global Nuclear Medicine Market - Growth, Trends & Forecasts 2014-2019",Neutral,0.0011,91,research and market global nuclear medicine market growth trend forecast,72,10,0,pharmacy,"['research', 'and', 'market', 'global', 'nuclear', 'medicine', 'market', 'growth', 'trend', 'forecast']",1
305315,nifty_923,2014-09-10,Evolution1 â a WEX Company Continues Simplifying the Business of Healthcare with New Product Enhancements,Neutral,0.0011,107,evolution wex company continues simplifying the business healthcare with new product enhancement,96,12,0,pharmacy,"['evolution', 'we', '##x', 'company', 'continues', 'si', '##mp', '##lify', '##ing', 'the', 'business', 'healthcare', 'with', 'new', 'product', 'enhance', '##ment']",1
305316,nifty_923,2014-09-10,Research and Markets: Stem Cell Research Market in India 2014: How Stem Cell Research is Gaining Importance as Consumers Realize the Various Benefits,Neutral,0.0011,149,research and market stem cell research market india how stem cell research gaining importance consumer realize the various benefit,130,19,0,pharmacy,"['research', 'and', 'market', 'stem', 'cell', 'research', 'market', 'in', '##dia', 'how', 'stem', 'cell', 'research', 'gaining', 'importance', 'consumer', 'realize', 'the', 'various', 'benefit']",1
305359,nifty_923,2014-09-10,MedPro Billing is Gearing up for the Second Annual Addiction eXecutives Industry Summit with Partner C4 Recovery Solutions,Neutral,0.0011,122,medpro billing gearing for the second annual addiction executive industry summit with partner recovery solution,111,15,0,pharmacy,"['me', '##d', '##p', '##ro', 'bill', '##ing', 'gear', '##ing', 'for', 'the', 'second', 'annual', 'addiction', 'executive', 'industry', 'summit', 'with', 'partner', 'recovery', 'solution']",1
305387,nifty_923,2014-09-10,Akers Biosciences Presenting at US Investor Conferences,Neutral,0.0011,55,akers bioscience presenting investor conference,47,5,0,pharmacy,"['a', '##kers', 'bio', '##science', 'presenting', 'investor', 'conference']",1
305514,nifty_923,2014-09-10,"Auxilium Pharmaceuticals, Inc. Announces Corporate Restructuring Designed To Streamline Operations, Maximize Cash Flow And Drive Sustainable Earnings Growth",Neutral,0.0011,156,auxilium pharmaceutical inc announces corporate restructuring designed streamline operation maximize cash flow and drive sustainable earnings growth,148,17,0,pharmacy,"['aux', '##ili', '##um', 'pharmaceutical', 'in', '##c', 'announces', 'corporate', 'restructuring', 'designed', 'stream', '##line', 'operation', 'ma', '##xi', '##mize', 'cash', 'flow', 'and', 'drive', 'sustainable', 'earnings', 'growth']",1
305563,nifty_923,2014-09-10,DynoSense Debuts World-First Digital Health Innovation at TechCrunch Disrupt SF 2014,Neutral,0.0011,84,dynosense debut world first digital health innovation techcrunch disrupt,72,9,0,pharmacy,"['d', '##yn', '##ose', '##nse', 'debut', 'world', 'first', 'digital', 'health', 'innovation', 'tech', '##c', '##runch', 'disrupt']",1
305684,nifty_924,2014-09-11,Dimon Opens Up on Cancer Treatment,Fall,-0.0058,34,dimon open cancer treatment,27,4,0,pharmacy,"['dim', '##on', 'open', 'cancer', 'treatment']",1
305689,nifty_924,2014-09-11,FDA Panel Recommends Approval of Novo Nordisk Obesity Treatment,Fall,-0.0058,63,fda panel recommends approval novo nordisk obesity treatment,60,8,0,pharmacy,"['f', '##da', 'panel', 'recommend', '##s', 'approval', 'no', '##vo', 'nor', '##dis', '##k', 'o', '##besity', 'treatment']",1
305721,nifty_924,2014-09-11,FDA Approves Weight-Loss Drug,Fall,-0.0058,29,fda approves weight loss drug,29,5,0,pharmacy,"['f', '##da', 'approve', '##s', 'weight', 'loss', 'drug']",1
306048,nifty_926,2014-09-16,Transformational Restructuring Plans to Support Molecular Diagnostics Focus and Finalisation of Financing,Neutral,0.0013,105,transformational restructuring plan support molecular diagnostics focus and finalisation financing,98,10,0,pharmacy,"['transformation', '##al', 'restructuring', 'plan', 'support', 'molecular', 'diagnostic', '##s', 'focus', 'and', 'final', '##isation', 'financing']",1
306085,nifty_926,2014-09-16,"Research and Markets: Global Healthcare Information Systems Market 2014-2018: Leading Vendors are Agfa Gevaert, GE Healthcare, McKesson, Philips Healthcare & Siemens Healthcare",Neutral,0.0013,176,research and market global healthcare information system market leading vendor are agfa gevaert healthcare mckesson philip healthcare siemens healthcare,152,19,0,pharmacy,"['research', 'and', 'market', 'global', 'healthcare', 'information', 'system', 'market', 'leading', 'vendor', 'are', 'a', '##g', '##fa', 'g', '##eva', '##ert', 'healthcare', 'm', '##cke', '##sson', 'p', '##hil', '##ip', 'healthcare', 'si', '##em', '##ens', 'healthcare']",1
306172,nifty_926,2014-09-16,Research and Markets: Bioinformatics Market - Global Strategic Business Report 2014-2020,Neutral,0.0013,88,research and market bioinformatics market global strategic business report,74,9,0,pharmacy,"['research', 'and', 'market', 'bio', '##in', '##formatics', 'market', 'global', 'strategic', 'business', 'report']",1
306224,nifty_926,2014-09-16,"Health Care Sector Stocks Technical Review - Ampio Pharma, InterMune, Biogen Idec, Hologic, and CareFusion Corp.",Neutral,0.0013,112,health care sector stock technical review ampio pharma intermune biogen idec hologic and carefusion corp,104,15,0,pharmacy,"['health', 'care', 'sector', 'stock', 'technical', 'review', 'am', '##pio', 'p', '##har', '##ma', 'inter', '##mu', '##ne', 'bio', '##gen', 'id', '##ec', 'ho', '##log', '##ic', 'and', 'care', '##fusion', 'co', '##rp']",1
306232,nifty_926,2014-09-16,"Event Schedules, Survey Findings, Regulatory Filings, and Market Activity - Research Reports on Amgen, Biogen Idec, Salix, Covidien and Shire",Neutral,0.0013,141,event schedule survey finding regulatory filing and market activity research report amgen biogen idec salix covidien and shire,126,18,0,pharmacy,"['event', 'schedule', 'survey', 'finding', 'regulatory', 'filing', 'and', 'market', 'activity', 'research', 'report', 'am', '##gen', 'bio', '##gen', 'id', '##ec', 'sa', '##lix', 'co', '##vid', '##ien', 'and', 's', '##hire']",1
306238,nifty_926,2014-09-16,Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange,Neutral,0.0013,83,inovio pharmaceutical ino begin trading nasdaq global select market exchange,76,10,0,pharmacy,"['in', '##ov', '##io', 'pharmaceutical', 'in', '##o', 'begin', 'trading', 'na', '##s', '##da', '##q', 'global', 'select', 'market', 'exchange']",1
306282,nifty_926,2014-09-16,"New Product Launch, Accelerated Drug Approvals, Study Initiation, and Market Activity - Research Reports on Johnson & Johnson, Merck, Medtronic, Pharmacyclics and NPS Pharma",Neutral,0.0013,173,new product launch accelerated drug approval study initiation and market activity research report johnson johnson merck medtronic pharmacyclics and np pharma,157,21,0,pharmacy,"['new', 'product', 'launch', 'accelerated', 'drug', 'approval', 'study', 'initiation', 'and', 'market', 'activity', 'research', 'report', 'j', '##oh', '##nson', 'j', '##oh', '##nson', 'me', '##rc', '##k', 'me', '##dt', '##ronic', 'pharmacy', '##c', '##lic', '##s', 'and', 'n', '##p', 'p', '##har', '##ma']",1
306291,nifty_926,2014-09-16,"Expert Briefing on Health Care Sector Stocks - Edwards Lifesciences, Catamaran, Quest Diagnostics, Aetna, and WellPoint",Neutral,0.0013,119,expert briefing health care sector stock edward lifesciences catamaran quest diagnostics aetna and wellpoint,108,14,0,pharmacy,"['expert', 'brief', '##ing', 'health', 'care', 'sector', 'stock', 'ed', '##ward', 'life', '##science', '##s', 'cat', '##ama', '##ran', 'quest', 'diagnostic', '##s', 'a', '##et', '##na', 'and', 'well', '##point']",1
306399,nifty_926,2014-09-16,US STOCKS-Biotechs on track for 3rd straight decline as Gilead drags,Neutral,0.0013,68,stock biotech track for straight decline gilead drag,52,8,0,pharmacy,"['stock', 'bio', '##tech', 'track', 'for', 'straight', 'decline', 'g', '##ile', '##ad', 'drag']",1
306543,nifty_926,2014-09-16,Research and Markets: Brilinta (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023,Neutral,0.0013,95,research and market brilinta acute coronary syndrome forecast and market analysis,81,11,0,pharmacy,"['research', 'and', 'market', 'br', '##ili', '##nta', 'acute', 'co', '##rona', '##ry', 'syndrome', 'forecast', 'and', 'market', 'analysis']",1
306821,nifty_926,2014-09-16,AMA Urges Overhaul of Electronic Records,Neutral,0.0013,40,ama urge overhaul electronic record,35,5,0,pharmacy,"['am', '##a', 'urge', 'overhaul', 'electronic', 'record']",1
306822,nifty_926,2014-09-16,Zara Builds Business Around RFID,Neutral,0.0013,32,zara build business around rfid,31,5,0,pharmacy,"['z', '##ara', 'build', 'business', 'around', 'r', '##fi', '##d']",1
306856,nifty_926,2014-09-16,"Doctors: Skeptical About Health Law, Optimistic About Future of Medicine",Neutral,0.0013,72,doctor skeptical about health law optimistic about future medicine,66,9,0,pharmacy,"['doctor', 'skeptical', 'about', 'health', 'law', 'optimistic', 'about', 'future', 'medicine']",1
306869,nifty_927,2014-09-17,More Study Urged on Testosterone Drugs,Rise,0.0053,38,more study urged testosterone drug,34,5,0,pharmacy,"['more', 'study', 'urged', 'test', '##osterone', 'drug']",1
306944,nifty_928,2014-09-18,FDA Rejects Oral Testosterone-Replacement Drug,Fall,-0.0055,46,fda reject oral testosterone replacement drug,45,6,0,pharmacy,"['f', '##da', 'reject', 'oral', 'test', '##osterone', 'replacement', 'drug']",1
306978,nifty_928,2014-09-18,Stendra Gets FDA Approval as 'On-Demand' Drug,Fall,-0.0055,45,stendra get fda approval demand drug,36,6,0,pharmacy,"['s', '##tend', '##ra', 'get', 'f', '##da', 'approval', 'demand', 'drug']",1
307075,nifty_929,2014-09-22,"FDA Recommendation Doesn't Apply to Androxal, Repros Says",Fall,-0.0057,57,fda recommendation doesn apply androxal repros say,50,7,0,pharmacy,"['f', '##da', 'recommendation', 'doesn', 'apply', 'and', '##ro', '##xa', '##l', 're', '##p', '##ros', 'say']",1
307256,nifty_932,2014-09-25,Aetna International & Starr Companies Launch UltraCare Health Plan Enabling Expatriates and Chinese Nationals to Benefit from Global Health Coverage,Rise,0.0079,148,aetna international starr company launch ultracare health plan enabling expatriate and chinese national benefit from global health coverage,139,18,0,pharmacy,"['a', '##et', '##na', 'international', 'star', '##r', 'company', 'launch', 'ultra', '##care', 'health', 'plan', 'enabling', 'ex', '##pa', '##tri', '##ate', 'and', 'chin', '##ese', 'national', 'benefit', 'from', 'global', 'health', 'coverage']",1
307325,nifty_932,2014-09-25,Research and Markets: PharmaPoint Report: Acute Coronary Syndrome - US Drug Forecast and Market Analysis to 2023,Rise,0.0079,112,research and market pharmapoint report acute coronary syndrome drug forecast and market analysis,96,13,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##point', 'report', 'acute', 'co', '##rona', '##ry', 'syndrome', 'drug', 'forecast', 'and', 'market', 'analysis']",1
307330,nifty_932,2014-09-25,Research and Markets: PharmaPoint: Acute Coronary Syndrome - Japan Drug Forecast and Market Analysis to 2023,Rise,0.0079,108,research and market pharmapoint acute coronary syndrome japan drug forecast and market analysis,95,13,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##point', 'acute', 'co', '##rona', '##ry', 'syndrome', 'j', '##apa', '##n', 'drug', 'forecast', 'and', 'market', 'analysis']",1
307331,nifty_932,2014-09-25,Research and Markets: EpiCast Report: Asthma - Epidemiology Forecast to 2023,Rise,0.0079,76,research and market epicast report asthma epidemiology forecast,63,8,0,pharmacy,"['research', 'and', 'market', 'epic', '##ast', 'report', 'as', '##th', '##ma', 'e', '##pid', '##em', '##iology', 'forecast']",1
307342,nifty_932,2014-09-25,Research and Markets: Angiomax (bivalirudin) for Acute Coronary Syndrome - Forecast and Market Analysis to 2023,Rise,0.0079,111,research and market angiomax bivalirudin for acute coronary syndrome forecast and market analysis,97,13,0,pharmacy,"['research', 'and', 'market', 'an', '##gio', '##max', 'bi', '##val', '##ir', '##udi', '##n', 'for', 'acute', 'co', '##rona', '##ry', 'syndrome', 'forecast', 'and', 'market', 'analysis']",1
307343,nifty_932,2014-09-25,Research and Markets: Crestor (rosuvastatin) for Acute Coronary Syndrome - Forecast and Market Analysis to 2023: Patent Expires in 2016 in the US and 2017 in the EU and Japan,Rise,0.0079,174,research and market crestor rosuvastatin for acute coronary syndrome forecast and market analysis patent expires the and the and japan,134,20,0,pharmacy,"['research', 'and', 'market', 'crest', '##or', 'r', '##os', '##u', '##vas', '##tat', '##in', 'for', 'acute', 'co', '##rona', '##ry', 'syndrome', 'forecast', 'and', 'market', 'analysis', 'patent', 'ex', '##pire', '##s', 'the', 'and', 'the', 'and', 'j', '##apa', '##n']",1
307351,nifty_932,2014-09-25,Research and Markets: Alirocumab for Acute Coronary Syndrome Treatment - Forecast and Market Analysis to 2023,Rise,0.0079,109,research and market alirocumab for acute coronary syndrome treatment forecast and market analysis,97,13,0,pharmacy,"['research', 'and', 'market', 'al', '##iro', '##cum', '##ab', 'for', 'acute', 'co', '##rona', '##ry', 'syndrome', 'treatment', 'forecast', 'and', 'market', 'analysis']",1
307352,nifty_932,2014-09-25,Research and Markets: PCSK9 Evolocumab for Acute Coronary Syndrome Report - Forecast and Market Analysis to 2023,Rise,0.0079,112,research and market pcsk evolocumab for acute coronary syndrome report forecast and market analysis,99,14,0,pharmacy,"['research', 'and', 'market', 'p', '##cs', '##k', 'e', '##vo', '##loc', '##uma', '##b', 'for', 'acute', 'co', '##rona', '##ry', 'syndrome', 'report', 'forecast', 'and', 'market', 'analysis']",1
307372,nifty_932,2014-09-25,Research and Markets: Effient (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023,Rise,0.0079,94,research and market effient acute coronary syndrome forecast and market analysis,80,11,0,pharmacy,"['research', 'and', 'market', 'e', '##ff', '##ient', 'acute', 'co', '##rona', '##ry', 'syndrome', 'forecast', 'and', 'market', 'analysis']",1
307374,nifty_932,2014-09-25,Research and Markets: Xarelto (rivaroxaban) for Acute Coronary Syndrome Report 2014 - Forecast and Market Analysis to 2023,Rise,0.0079,122,research and market xarelto rivaroxaban for acute coronary syndrome report forecast and market analysis,103,14,0,pharmacy,"['research', 'and', 'market', 'x', '##arel', '##to', 'r', '##iva', '##ro', '##xa', '##ban', 'for', 'acute', 'co', '##rona', '##ry', 'syndrome', 'report', 'forecast', 'and', 'market', 'analysis']",1
307376,nifty_932,2014-09-25,"Research and Markets: Global Laparoscopic Devices Market 2014-2018: Key Vendors Are Cardinal Health, Covidien, Ethicon Endo-Surgery, KARL STORZ, Olympus Europa & Stryker",Rise,0.0079,169,research and market global laparoscopic device market key vendor are cardinal health covidien ethicon endo surgery karl storz olympus europa stryker,148,21,0,pharmacy,"['research', 'and', 'market', 'global', 'lap', '##aro', '##scopic', 'device', 'market', 'key', 'vendor', 'are', 'cardinal', 'health', 'co', '##vid', '##ien', 'et', '##hic', '##on', 'end', '##o', 'surgery', 'ka', '##rl', 's', '##tor', '##z', 'o', '##ly', '##mpus', 'euro', '##pa', 's', '##try', '##ker']",1
307394,nifty_932,2014-09-25,"Research and Markets: Global Proteomics Markets for Research and IVD Applications 2014-2018: Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies",Rise,0.0079,190,research and market global proteomics market for research and ivd application mass spectrometry chromatography microarrays electrophoresis immunoassay other technology,167,19,0,pharmacy,"['research', 'and', 'market', 'global', 'pro', '##te', '##omi', '##cs', 'market', 'for', 'research', 'and', 'i', '##v', '##d', 'application', 'mass', 's', '##pect', '##rome', '##try', 'ch', '##roma', '##tography', 'micro', '##arra', '##ys', 'electro', '##ph', '##ores', '##is', 'im', '##mu', '##no', '##ass', '##ay', 'other', 'technology']",1
307398,nifty_932,2014-09-25,Research and Markets: Global Eczema Therapeutics Pipeline Review 2014 - 5 Companies & 6 Drug Profiles,Rise,0.0079,101,research and market global eczema therapeutic pipeline review company drug profile,82,11,0,pharmacy,"['research', 'and', 'market', 'global', 'e', '##cz', '##ema', 'therapeutic', 'pipeline', 'review', 'company', 'drug', 'profile']",1
307402,nifty_932,2014-09-25,Research and Markets: Global Heart Attack Therapeutics Pipeline Review 2014 - 3 Companies & 8 Drug Profiles,Rise,0.0079,107,research and market global heart attack therapeutic pipeline review company drug profile,88,12,0,pharmacy,"['research', 'and', 'market', 'global', 'heart', 'attack', 'therapeutic', 'pipeline', 'review', 'company', 'drug', 'profile']",1
307429,nifty_932,2014-09-25,Qualtrics Raises $150 Million to Continue Aggressive International Growth and New Product Innovation,Rise,0.0079,100,qualtrics raise million continue aggressive international growth and new product innovation,91,11,0,pharmacy,"['q', '##ual', '##tric', '##s', 'raise', 'million', 'continue', 'aggressive', 'international', 'growth', 'and', 'new', 'product', 'innovation']",1
307463,nifty_932,2014-09-25,Research and Markets: New Developments in the Companion Diagnostics Market 2014,Rise,0.0079,79,research and market new development the companion diagnostics market,68,9,0,pharmacy,"['research', 'and', 'market', 'new', 'development', 'the', 'companion', 'diagnostic', '##s', 'market']",1
307475,nifty_932,2014-09-25,"Research and Markets: Medical Diagnostic Devices Research Digest - H1 2014: Latest News for Medical Devices, In-Vitro Diagnostic Devices & Medical Imaging Devices",Rise,0.0079,162,research and market medical diagnostic device research digest latest news for medical device vitro diagnostic device medical imaging device,139,19,0,pharmacy,"['research', 'and', 'market', 'medical', 'diagnostic', 'device', 'research', 'dig', '##est', 'latest', 'news', 'for', 'medical', 'device', 'v', '##it', '##ro', 'diagnostic', 'device', 'medical', 'imaging', 'device']",1
307483,nifty_932,2014-09-25,"Cancer Genetics Inc. to Provide Updates About the Company's Portfolio of Targeted Molecular Diagnostics at Analyst Day on September 25, 2014",Rise,0.0079,140,cancer genetics inc provide update about the company portfolio targeted molecular diagnostics analyst day september,115,15,0,pharmacy,"['cancer', 'genetics', 'in', '##c', 'provide', 'update', 'about', 'the', 'company', 'portfolio', 'targeted', 'molecular', 'diagnostic', '##s', 'analyst', 'day', 'se', '##pt', '##em', '##ber']",1
307492,nifty_932,2014-09-25,Research and Markets: Essential Pharmacovigilance Seminar: Dubai - 30th October 2014,Rise,0.0079,84,research and market essential pharmacovigilance seminar dubai october,69,8,0,pharmacy,"['research', 'and', 'market', 'essential', 'p', '##har', '##ma', '##co', '##vi', '##gi', '##lance', 'seminar', 'dub', '##ai', 'o', '##ct', '##obe', '##r']",1
307509,nifty_932,2014-09-25,"ETST Announces Live CEO Interview and Recent Growth Progress as an Emerging Company Delivering Cutting Edge Nutraceuticals, Bioceuticals and Dietary Supplements for the Health, Wellness, Sports and Alternative Medicine Marke",Rise,0.0079,224,etst announces live ceo interview and recent growth progress emerging company delivering cutting edge nutraceuticals bioceuticals and dietary supplement for the health wellness sport and alternative medicine marke,213,28,0,pharmacy,"['et', '##st', 'announces', 'live', 'c', '##eo', 'interview', 'and', 'recent', 'growth', 'progress', 'emerging', 'company', 'delivering', 'cutting', 'edge', 'nut', '##race', '##utical', '##s', 'bio', '##ce', '##utical', '##s', 'and', 'diet', '##ary', 'supplement', 'for', 'the', 'health', 'well', '##ness', 'sport', 'and', 'alternative', 'medicine', 'mark', '##e']",1
307563,nifty_932,2014-09-25,"Active Equities to Watch in Pharma Industry - Pfizer, BioDelivery Sciences Intl., Repros Therapeutics, Catalent, and Nektar Therapeutics",Rise,0.0079,136,active equity watch pharma industry pfizer biodelivery science intl repros therapeutic catalent and nektar therapeutic,118,15,0,pharmacy,"['active', 'equity', 'watch', 'p', '##har', '##ma', 'industry', 'p', '##fi', '##zer', 'bio', '##del', '##iver', '##y', 'science', 'in', '##tl', 're', '##p', '##ros', 'therapeutic', 'cat', '##ale', '##nt', 'and', 'ne', '##kt', '##ar', 'therapeutic']",1
307588,nifty_932,2014-09-25,"Analysts View on Health Care Equipment and Supplies Equities - Mindray Medical Intl., Alere, Align Technology, Antares Pharma, and Unilife",Rise,0.0079,138,analyst view health care equipment and supply equity mindray medical intl alere align technology antares pharma and unilife,123,18,0,pharmacy,"['analyst', 'view', 'health', 'care', 'equipment', 'and', 'supply', 'equity', 'mind', '##ray', 'medical', 'in', '##tl', 'ale', '##re', 'al', '##ign', 'technology', 'ant', '##ares', 'p', '##har', '##ma', 'and', 'un', '##ili', '##fe']",1
307593,nifty_932,2014-09-25,"""ACT for NIH"" Launches Campaign to Restore U.S. Medical Research Investment",Rise,0.0079,75,act for nih launch campaign restore medical research investment,63,9,0,pharmacy,"['act', 'for', 'ni', '##h', 'launch', 'campaign', 'restore', 'medical', 'research', 'investment']",1
307621,nifty_932,2014-09-25,"Bionym, Makers of the Nymi Band, Closes $14M Series A Financing From Ignition, MasterCard and Relay Ventures",Rise,0.0079,108,bionym maker the nymi band close series financing from ignition mastercard and relay venture,92,14,0,pharmacy,"['bio', '##ny', '##m', 'maker', 'the', 'n', '##ym', '##i', 'band', 'close', 'series', 'financing', 'from', 'ignition', 'master', '##card', 'and', 'relay', 'venture']",1
307638,nifty_932,2014-09-25,North Philadelphia Health System Fuels Financial Future with Enterprise EHR from MEDHOST,Rise,0.0079,88,north philadelphia health system fuel financial future with enterprise ehr from medhost,87,12,0,pharmacy,"['north', 'p', '##hil', '##ade', '##l', '##phi', '##a', 'health', 'system', 'fuel', 'financial', 'future', 'with', 'enterprise', 'eh', '##r', 'from', 'me', '##dh', '##ost']",1
307671,nifty_932,2014-09-25,Vital Capital Announces $10 M Investment in WaterHealth International,Rise,0.0079,69,vital capital announces investment waterhealth international,60,6,0,pharmacy,"['vital', 'capital', 'announces', 'investment', 'water', '##hea', '##lt', '##h', 'international']",1
307704,nifty_932,2014-09-25,Chubb Helps to Advance Sustainability Through New Products and Risk Management Approach for Biorenewable and Industrial Biotech Firms,Rise,0.0079,133,chubb help advance sustainability through new product and risk management approach for biorenewable and industrial biotech firm,127,17,0,pharmacy,"['ch', '##ub', '##b', 'help', 'advance', 'sustainability', 'through', 'new', 'product', 'and', 'risk', 'management', 'approach', 'for', 'bio', '##rene', '##wab', '##le', 'and', 'industrial', 'bio', '##tech', 'firm']",1
307821,nifty_932,2014-09-25,"Research and Markets: Pharmaceutical Regulatory Affairs in Latin America Seminar, London UK - 24th-26th November 2014",Rise,0.0079,117,research and market pharmaceutical regulatory affair latin america seminar london november,90,11,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'regulatory', 'affair', 'la', '##tin', 'am', '##eric', '##a', 'seminar', 'lo', '##ndon', 'no', '##ve', '##mber']",1
307834,nifty_932,2014-09-25,Cellceutix Provides Update to Shareholders,Rise,0.0079,42,cellceutix provides update shareholder,38,4,0,pharmacy,"['cell', '##ce', '##uti', '##x', 'provides', 'update', 'shareholder']",1
307835,nifty_932,2014-09-25,TxCell Financial Results for the First Half of 2014,Rise,0.0079,51,txcell financial result for the first half,42,7,0,pharmacy,"['t', '##x', '##cell', 'financial', 'result', 'for', 'the', 'first', 'half']",1
307886,nifty_932,2014-09-25,Research and Markets: PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update for the $5.35 Billion Potential Market,Rise,0.0079,155,research and market pharmapoint epilepsy global drug forecast and market analysis event driven update for the billion potential market,134,19,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##point', 'e', '##pile', '##psy', 'global', 'drug', 'forecast', 'and', 'market', 'analysis', 'event', 'driven', 'update', 'for', 'the', 'billion', 'potential', 'market']",1
308109,nifty_932,2014-09-25,AbbVie Gets FDA Approval on Humira for Pediatric Crohn's,Rise,0.0079,56,abbvie get fda approval humira for pediatric crohn,50,8,0,pharmacy,"['a', '##bb', '##vie', 'get', 'f', '##da', 'approval', 'hum', '##ira', 'for', 'p', '##ediatric', 'c', '##ro', '##hn']",1
308238,nifty_933,2014-09-29,New Cancer Drugs Get Boost From Latest Trial Results,Neutral,-0.0026,52,new cancer drug get boost from latest trial result,50,9,0,pharmacy,"['new', 'cancer', 'drug', 'get', 'boost', 'from', 'latest', 'trial', 'result']",1
308257,nifty_933,2014-09-29,Daiichi Sankyo to Buy Ambit Biosciences,Neutral,-0.0026,39,daiichi sankyo buy ambit bioscience,35,5,0,pharmacy,"['da', '##ii', '##chi', 'sank', '##yo', 'buy', 'am', '##bit', 'bio', '##science']",1
308285,nifty_934,2014-09-30,Doctors Net Billions From Drug Firms,Fall,-0.0136,36,doctor net billion from drug firm,33,6,0,pharmacy,"['doctor', 'net', 'billion', 'from', 'drug', 'firm']",1
308318,nifty_934,2014-09-30,J&J to Acquire Alios BioPharma for $1.75 Billion,Fall,-0.0136,48,acquire alios biopharma for billion,35,5,0,pharmacy,"['acquire', 'al', '##ios', 'bio', '##pha', '##rma', 'for', 'billion']",1
308558,nifty_935,2014-10-01,Research and Markets: China Insulin Markets Outlook 2023 With a Directory of Leading Producers,Neutral,0.0002,94,research and market china insulin market outlook with directory leading producer,80,11,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'insulin', 'market', 'outlook', 'with', 'directory', 'leading', 'producer']",1
308598,nifty_935,2014-10-01,India's Modi must resist U.S. pressure on drug patents: MSF,Neutral,0.0002,59,india modi must resist pressure drug patent msf,47,8,0,pharmacy,"['in', '##dia', 'm', '##od', '##i', 'must', 'resist', 'pressure', 'drug', 'patent', 'm', '##s', '##f']",1
308642,nifty_935,2014-10-01,"Research and Markets: Global Home Healthcare Market 2014 - 2020: Diagnostics and Monitoring Devices, Therapeutic Home Healthcare Devices & Mobility Assist Devices and Medical Supplies",Neutral,0.0002,183,research and market global home healthcare market diagnostics and monitoring device therapeutic home healthcare device mobility assist device and medical supply,160,21,0,pharmacy,"['research', 'and', 'market', 'global', 'home', 'healthcare', 'market', 'diagnostic', '##s', 'and', 'monitoring', 'device', 'therapeutic', 'home', 'healthcare', 'device', 'mobility', 'assist', 'device', 'and', 'medical', 'supply']",1
308654,nifty_935,2014-10-01,ContraFect Corporation to Present at the 13th Annual BIO Investor Forum,Neutral,0.0002,71,contrafect corporation present the annual bio investor forum,60,8,0,pharmacy,"['con', '##tra', '##fect', 'corporation', 'present', 'the', 'annual', 'bio', 'investor', 'forum']",1
308683,nifty_935,2014-10-01,"Research and Markets: Medical Electronics Market Outlook 2020: Component (Sensor, Battery, Memory Device, Display, & Microprocessor/MCU) & Application (Imaging, Medical Therapeutics, Diagnosis, Monitoring, and Fitness & Well",Neutral,0.0002,224,research and market medical electronics market outlook component sensor battery memory device display microprocessor mcu application imaging medical therapeutic diagnosis monitoring and fitness well,198,24,0,pharmacy,"['research', 'and', 'market', 'medical', 'electronics', 'market', 'outlook', 'component', 'sensor', 'battery', 'memory', 'device', 'display', 'micro', '##p', '##ro', '##cess', '##or', 'm', '##cu', 'application', 'imaging', 'medical', 'therapeutic', 'diagnosis', 'monitoring', 'and', 'fitness', 'well']",1
308731,nifty_935,2014-10-01,Twist Bioscience Secures $10 Million Loan Facility,Neutral,0.0002,50,twist bioscience secures million loan facility,46,6,0,pharmacy,"['twist', 'bio', '##science', 'secure', '##s', 'million', 'loan', 'facility']",1
308740,nifty_935,2014-10-01,Relypsa to Present at the 13th Annual BIO Investor Forum,Neutral,0.0002,56,relypsa present the annual bio investor forum,45,7,0,pharmacy,"['rely', '##ps', '##a', 'present', 'the', 'annual', 'bio', 'investor', 'forum']",1
308789,nifty_935,2014-10-01,"Millennium Healthcare Secures New Sales, Marketing and Distribution Agreement",Neutral,0.0002,77,millennium healthcare secures new sale marketing and distribution agreement,75,9,0,pharmacy,"['millennium', 'healthcare', 'secure', '##s', 'new', 'sale', 'marketing', 'and', 'distribution', 'agreement']",1
308795,nifty_935,2014-10-01,Catabasis Pharmaceuticals Management to Present at October Investor Conferences,Neutral,0.0002,79,catabasis pharmaceutical management present october investor conference,71,7,0,pharmacy,"['cat', '##aba', '##sis', 'pharmaceutical', 'management', 'present', 'o', '##ct', '##obe', '##r', 'investor', 'conference']",1
308802,nifty_935,2014-10-01,Biocept to Present at the 13th Annual BIO Investor Forum,Neutral,0.0002,56,biocept present the annual bio investor forum,45,7,0,pharmacy,"['bio', '##ce', '##pt', 'present', 'the', 'annual', 'bio', 'investor', 'forum']",1
308842,nifty_935,2014-10-01,"Positive Study Results, Acquisitions, Drug Approval, Regulatory Updates, and Collaborations - Research Reports on Gilead, Pfizer, AbbVie, Pacira and Thermo Fisher",Neutral,0.0002,162,positive study result acquisition drug approval regulatory update and collaboration research report gilead pfizer abbvie pacira and thermo fisher,145,19,0,pharmacy,"['positive', 'study', 'result', 'acquisition', 'drug', 'approval', 'regulatory', 'update', 'and', 'collaboration', 'research', 'report', 'g', '##ile', '##ad', 'p', '##fi', '##zer', 'a', '##bb', '##vie', 'p', '##ac', '##ira', 'and', 'the', '##rm', '##o', 'fish', '##er']",1
308923,nifty_935,2014-10-01,Research and Markets: Voice of Customer for Diagnostic Imaging Equipment Market in India,Neutral,0.0002,88,research and market voice customer for diagnostic imaging equipment market india,80,11,0,pharmacy,"['research', 'and', 'market', 'voice', 'customer', 'for', 'diagnostic', 'imaging', 'equipment', 'market', 'in', '##dia']",1
308924,nifty_935,2014-10-01,Report: Race for Proteomics Knowledge Spurs Investment and Partnerships,Neutral,0.0002,71,report race for proteomics knowledge spur investment and partnership,68,9,0,pharmacy,"['report', 'race', 'for', 'pro', '##te', '##omi', '##cs', 'knowledge', 'spur', 'investment', 'and', 'partnership']",1
308999,nifty_935,2014-10-01,Bio-Path Holdings to Present at the 13th Annual BIO Investor Forum,Neutral,0.0002,66,bio path holding present the annual bio investor forum,54,9,0,pharmacy,"['bio', 'path', 'holding', 'present', 'the', 'annual', 'bio', 'investor', 'forum']",1
309060,nifty_935,2014-10-01,"Novantas, Named in IDCâs FinTech Top 100 for the Fourth Consecutive Year, Announces New Pipeline of Solutions Innovations",Neutral,0.0002,123,novantas named idcâ fintech top for the fourth consecutive year announces new pipeline solution innovation,106,15,0,pharmacy,"['no', '##vant', '##as', 'named', 'id', '##c', '##â', 'fin', '##tech', 'top', 'for', 'the', 'fourth', 'consecutive', 'year', 'announces', 'new', 'pipeline', 'solution', 'innovation']",1
309123,nifty_935,2014-10-01,REG-Bellevue Group concludes acquisition of Adamant Biomedical Investments AG from ZÃ¼rcher Kantonalbank,Neutral,0.0002,104,reg bellevue group concludes acquisition adamant biomedical investment from zã¼rcher kantonalbank,97,11,0,pharmacy,"['re', '##g', 'bell', '##ev', '##ue', 'group', 'concludes', 'acquisition', 'ad', '##aman', '##t', 'bio', '##medical', 'investment', 'from', 'z', '##ã', '##¼', '##rch', '##er', 'ka', '##nton', '##al', '##bank']",1
309188,nifty_935,2014-10-01,"Research and Markets: US Diabetes Monitoring, Treatment and Drug Delivery Market 2014-2020",Neutral,0.0002,90,research and market diabetes monitoring treatment and drug delivery market,74,10,0,pharmacy,"['research', 'and', 'market', 'diabetes', 'monitoring', 'treatment', 'and', 'drug', 'delivery', 'market']",1
309318,nifty_935,2014-10-01,"Tasly Pharmaceuticals, Inc. Announces Launch of Deepure",Neutral,0.0002,55,tasly pharmaceutical inc announces launch deepure,49,6,0,pharmacy,"['ta', '##s', '##ly', 'pharmaceutical', 'in', '##c', 'announces', 'launch', 'deep', '##ure']",1
309467,nifty_935,2014-10-01,"Global spa, wellness industry estimated at $3.4 trillion: report",Neutral,0.0002,64,global spa wellness industry estimated trillion report,54,7,0,pharmacy,"['global', 'spa', 'well', '##ness', 'industry', 'estimated', 'trillion', 'report']",1
309500,nifty_935,2014-10-01,New Pump Could Cut Diabetes Treatments,Neutral,0.0002,38,new pump could cut diabetes treatment,37,6,0,pharmacy,"['new', 'pump', 'could', 'cut', 'diabetes', 'treatment']",1
309518,nifty_935,2014-10-01,Maker of Painkiller Tries to Curb Abuse,Neutral,0.0002,39,maker painkiller try curb abuse,31,5,0,pharmacy,"['maker', 'pain', '##kill', '##er', 'try', 'curb', 'abuse']",1
309570,nifty_935,2014-10-01,Hospira Receives FDA Warning Letter,Neutral,0.0002,35,hospira receives fda warning letter,35,5,0,pharmacy,"['ho', '##sp', '##ira', 'receives', 'f', '##da', 'warning', 'letter']",1
309588,nifty_935,2014-10-01,Payments Show Range of Doctors’ Ties With Industry,Neutral,0.0002,50,payment show range doctor tie with industry,43,7,0,pharmacy,"['payment', 'show', 'range', 'doctor', 'tie', 'with', 'industry']",1
309653,nifty_936,2014-10-02,Lilly to Stop Development of Lupus Treatment,Rise,0.011,44,lilly stop development lupus treatment,38,5,0,pharmacy,"['l', '##ill', '##y', 'stop', 'development', 'l', '##up', '##us', 'treatment']",1
309703,nifty_937,2014-10-06,Costly Cancer Treatments Face Hurdles,Fall,-0.0154,37,costly cancer treatment face hurdle,35,5,0,pharmacy,"['costly', 'cancer', 'treatment', 'face', 'h', '##ur', '##dle']",1
309714,nifty_937,2014-10-06,GE Deals Head John Flannery to Lead Health Care,Fall,-0.0154,47,deal head john flannery lead health care,40,7,0,pharmacy,"['deal', 'head', 'j', '##oh', '##n', 'fl', '##anne', '##ry', 'lead', 'health', 'care']",1
309730,nifty_937,2014-10-06,"Teva to End, Divest 14 Pipeline Projects",Fall,-0.0154,40,teva end divest pipeline project,32,5,0,pharmacy,"['te', '##va', 'end', 'dive', '##st', 'pipeline', 'project']",1
309731,nifty_937,2014-10-06,"Bristol-Myers, Novartis to Combine Cancer Treatments in Trials",Fall,-0.0154,62,bristol myers novartis combine cancer treatment trial,53,7,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'no', '##var', '##tis', 'combine', 'cancer', 'treatment', 'trial']",1
309853,nifty_938,2014-10-07,Research and Markets: Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market,Rise,0.0175,162,research and market critical care therapeutic major developed market new and late stage four factor pccs and recombinant product drive market,141,21,0,pharmacy,"['research', 'and', 'market', 'critical', 'care', 'therapeutic', 'major', 'developed', 'market', 'new', 'and', 'late', 'stage', 'four', 'factor', 'p', '##cc', '##s', 'and', 're', '##comb', '##ina', '##nt', 'product', 'drive', 'market']",1
309860,nifty_938,2014-10-07,Research and Markets: France Major Molecular Diagnostic Product Suppliers Sales and Market Shares 2014,Rise,0.0175,102,research and market france major molecular diagnostic product supplier sale and market share,92,13,0,pharmacy,"['research', 'and', 'market', 'f', '##rance', 'major', 'molecular', 'diagnostic', 'product', 'supplier', 'sale', 'and', 'market', 'share']",1
309868,nifty_938,2014-10-07,"BioTime, Inc. and Subsidiaries to Raise $31 Million Through Sales of Common Shares",Rise,0.0175,82,biotime inc and subsidiary raise million through sale common share,66,10,0,pharmacy,"['bio', '##time', 'in', '##c', 'and', 'subsidiary', 'raise', 'million', 'through', 'sale', 'common', 'share']",1
309875,nifty_938,2014-10-07,Research and Markets: European Major Molecular Diagnostic Product Suppliers Sales and Market Shares 2014,Rise,0.0175,104,research and market european major molecular diagnostic product supplier sale and market share,94,13,0,pharmacy,"['research', 'and', 'market', 'euro', '##pe', '##an', 'major', 'molecular', 'diagnostic', 'product', 'supplier', 'sale', 'and', 'market', 'share']",1
309890,nifty_938,2014-10-07,Research and Markets: UK Major Molecular Diagnostic Product Suppliers Sales and Market Shares 2014,Rise,0.0175,98,research and market major molecular diagnostic product supplier sale and market share,85,12,0,pharmacy,"['research', 'and', 'market', 'major', 'molecular', 'diagnostic', 'product', 'supplier', 'sale', 'and', 'market', 'share']",1
309892,nifty_938,2014-10-07,Research and Markets: Italy Major Molecular Diagnostic Product Suppliers Sales and Market Shares 2014,Rise,0.0175,101,research and market italy major molecular diagnostic product supplier sale and market share,91,13,0,pharmacy,"['research', 'and', 'market', 'it', '##aly', 'major', 'molecular', 'diagnostic', 'product', 'supplier', 'sale', 'and', 'market', 'share']",1
309898,nifty_938,2014-10-07,Research and Markets: Germany Major Molecular Diagnostic Product Suppliers Report 2014 - Sales and Market Shares Analysis,Rise,0.0175,121,research and market germany major molecular diagnostic product supplier report sale and market share analysis,109,15,0,pharmacy,"['research', 'and', 'market', 'g', '##erman', '##y', 'major', 'molecular', 'diagnostic', 'product', 'supplier', 'report', 'sale', 'and', 'market', 'share', 'analysis']",1
309899,nifty_938,2014-10-07,Research and Markets: Major Molecular Diagnostic Product Suppliers by Country 2014: Sales and Market Shares Analysis,Rise,0.0175,116,research and market major molecular diagnostic product supplier country sale and market share analysis,102,14,0,pharmacy,"['research', 'and', 'market', 'major', 'molecular', 'diagnostic', 'product', 'supplier', 'country', 'sale', 'and', 'market', 'share', 'analysis']",1
309916,nifty_938,2014-10-07,MetaStat to Present at 13th Annual BIO Investor Forum on October 8 in San Francisco,Rise,0.0175,83,metastat present annual bio investor forum october san francisco,64,9,0,pharmacy,"['meta', '##sta', '##t', 'present', 'annual', 'bio', 'investor', 'forum', 'o', '##ct', '##obe', '##r', 'sa', '##n', 'f', '##ran', '##cis', '##co']",1
310001,nifty_938,2014-10-07,"Critical Outcome Technologies to Present at 13th Annual BIO Investor Forum on Tuesday, October 7, 2014",Rise,0.0175,102,critical outcome technology present annual bio investor forum tuesday october,77,10,0,pharmacy,"['critical', 'outcome', 'technology', 'present', 'annual', 'bio', 'investor', 'forum', 't', '##ues', '##day', 'o', '##ct', '##obe', '##r']",1
310017,nifty_938,2014-10-07,Medtech Market to Achieve Global Sales of $514 Billion by 2020; Megamergers Set to Reshuffle Top Players,Rise,0.0175,104,medtech market achieve global sale billion megamergers set reshuffle top player,79,11,0,pharmacy,"['me', '##dt', '##ech', 'market', 'achieve', 'global', 'sale', 'billion', 'me', '##game', '##rger', '##s', 'set', 're', '##shu', '##ffle', 'top', 'player']",1
310041,nifty_938,2014-10-07,"Technical Updates on Health Care Sector Stocks - AstraZeneca, Novartis, Salix Pharma, Inovio Pharma, and CTI BioPharma",Rise,0.0175,118,technical update health care sector stock astrazeneca novartis salix pharma inovio pharma and cti biopharma,107,15,0,pharmacy,"['technical', 'update', 'health', 'care', 'sector', 'stock', 'as', '##tra', '##zen', '##eca', 'no', '##var', '##tis', 'sa', '##lix', 'p', '##har', '##ma', 'in', '##ov', '##io', 'p', '##har', '##ma', 'and', 'c', '##ti', 'bio', '##pha', '##rma']",1
310102,nifty_938,2014-10-07,The FDA and CMS in Conjunction with Leading Healthcare Stakeholders Tackle Challenges of Drug Pricing & Reimbursement of Specialty Drugs,Rise,0.0175,136,the fda and cm conjunction with leading healthcare stakeholder tackle challenge drug pricing reimbursement specialty drug,121,16,0,pharmacy,"['the', 'f', '##da', 'and', 'cm', 'conjunction', 'with', 'leading', 'healthcare', 'stake', '##holder', 'tackle', 'challenge', 'drug', 'pricing', 're', '##im', '##bur', '##se', '##ment', 'specialty', 'drug']",1
310229,nifty_938,2014-10-07,"Research and Markets: Brain Tumor - Pipeline Review, H2 2014",Rise,0.0175,60,research and market brain tumor pipeline review,47,7,0,pharmacy,"['research', 'and', 'market', 'brain', 'tumor', 'pipeline', 'review']",1
310425,nifty_938,2014-10-07,Dearth of doctors drags on China private healthcare drive,Rise,0.0175,57,dearth doctor drag china private healthcare drive,49,7,0,pharmacy,"['dear', '##th', 'doctor', 'drag', 'chin', '##a', 'private', 'healthcare', 'drive']",1
310552,nifty_938,2014-10-07,AutoGenomics Revives Plans to Go Public,Rise,0.0175,39,autogenomics revives plan public,32,4,0,pharmacy,"['auto', '##gen', '##omi', '##cs', 'revive', '##s', 'plan', 'public']",1
310614,nifty_939,2014-10-08,FDA Panel Recommends Boston Scientific’s Watchman Device,Fall,-0.0198,56,fda panel recommends boston scientific watchman device,54,7,0,pharmacy,"['f', '##da', 'panel', 'recommend', '##s', 'b', '##ost', '##on', 'scientific', 'watch', '##man', 'device']",1
310708,nifty_940,2014-10-09,Swiss-based Molecular Partners sets price range for market debut,Fall,-0.0114,64,swiss based molecular partner set price range for market debut,62,10,0,pharmacy,"['s', '##wi', '##ss', 'based', 'molecular', 'partner', 'set', 'price', 'range', 'for', 'market', 'debut']",1
310764,nifty_940,2014-10-09,"Research and Markets: New Frontiers in the US Clinical Chemistry and Immunodiagnostic Markets 2014: Business Challenges, Emerging Technologies, Competitive Landscape",Fall,-0.0114,165,research and market new frontier the clinical chemistry and immunodiagnostic market business challenge emerging technology competitive landscape,144,17,0,pharmacy,"['research', 'and', 'market', 'new', 'frontier', 'the', 'clinical', 'chemistry', 'and', 'im', '##mu', '##no', '##dia', '##gno', '##stic', 'market', 'business', 'challenge', 'emerging', 'technology', 'competitive', 'landscape']",1
310785,nifty_940,2014-10-09,"Research and Markets: Asia-Pacific Cystoscopes Market Outlook to 2020: Key Players Covered Include Olympus, Hoya, Stryker, Richard Wolf and KARL STORZ GmbH & Co",Fall,-0.0114,160,research and market asia pacific cystoscopes market outlook key player covered include olympus hoya stryker richard wolf and karl storz gmbh,140,21,0,pharmacy,"['research', 'and', 'market', 'as', '##ia', 'p', '##ac', '##ific', 'c', '##ys', '##tos', '##cope', '##s', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'o', '##ly', '##mpus', 'ho', '##ya', 's', '##try', '##ker', 'rich', '##ard', 'wolf', 'and', 'ka', '##rl', 's', '##tor', '##z', 'g', '##mb', '##h']",1
310787,nifty_940,2014-10-09,"Research and Markets: Asia-Pacific Laparoscopes Market Outlook to 2020: Key Players Covered Include Olympus, KARL STORZ GmbH & Co, B. Braun Melsungen and Intuitive Surgical",Fall,-0.0114,172,research and market asia pacific laparoscope market outlook key player covered include olympus karl storz gmbh braun melsungen and intuitive surgical,149,21,0,pharmacy,"['research', 'and', 'market', 'as', '##ia', 'p', '##ac', '##ific', 'lap', '##aro', '##scope', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'o', '##ly', '##mpus', 'ka', '##rl', 's', '##tor', '##z', 'g', '##mb', '##h', 'bra', '##un', 'me', '##ls', '##ungen', 'and', 'in', '##tu', '##itive', 'surgical']",1
310801,nifty_940,2014-10-09,Research and Markets: Global Antibody Drug Conjugates Market Report 2014 - 2024,Fall,-0.0114,79,research and market global antibody drug conjugate market report,64,9,0,pharmacy,"['research', 'and', 'market', 'global', 'anti', '##body', 'drug', 'con', '##ju', '##gate', 'market', 'report']",1
310818,nifty_940,2014-10-09,"Research and Markets: North America Hernia Repair Market Outlook 2020: Key Players are Covidien, Ethicon and C.R. Bard.",Fall,-0.0114,119,research and market north america hernia repair market outlook key player are covidien ethicon and bard,103,16,0,pharmacy,"['research', 'and', 'market', 'north', 'am', '##eric', '##a', 'her', '##nia', 'repair', 'market', 'outlook', 'key', 'player', 'are', 'co', '##vid', '##ien', 'et', '##hic', '##on', 'and', 'bar', '##d']",1
310819,nifty_940,2014-10-09,UPDATE 2-FDA crackdown hurts Gerresheimer's U.S. business,Fall,-0.0114,57,update fda crackdown hurt gerresheimer business,47,6,0,pharmacy,"['update', 'f', '##da', 'crack', '##down', 'hurt', 'g', '##er', '##resh', '##eim', '##er', 'business']",1
310820,nifty_940,2014-10-09,FDA crackdown hurts Gerresheimer's U.S. business,Fall,-0.0114,48,fda crackdown hurt gerresheimer business,40,5,0,pharmacy,"['f', '##da', 'crack', '##down', 'hurt', 'g', '##er', '##resh', '##eim', '##er', 'business']",1
310846,nifty_940,2014-10-09,Neos Therapeutics Announces Issuance of Key Patent Covering its Extended Release Oral Disintegrating Tablet (XR-ODT) Platform Technology,Fall,-0.0114,136,neos therapeutic announces issuance key patent covering it extended release oral disintegrating tablet odt platform technology,126,16,0,pharmacy,"['neo', '##s', 'therapeutic', 'announces', 'is', '##su', '##ance', 'key', 'patent', 'covering', 'it', 'extended', 'release', 'oral', 'di', '##sin', '##te', '##grating', 'tablet', 'o', '##dt', 'platform', 'technology']",1
310862,nifty_940,2014-10-09,New Express Scripts Analysis Reveals Trends Among Health Exchange Members,Fall,-0.0114,73,new express script analysis reveals trend among health exchange member,70,10,0,pharmacy,"['new', 'express', 'script', 'analysis', 'reveals', 'trend', 'among', 'health', 'exchange', 'member']",1
310882,nifty_940,2014-10-09,"Research and Markets: Brain Cancer - Pipeline Review, H2 2014",Fall,-0.0114,61,research and market brain cancer pipeline review,48,7,0,pharmacy,"['research', 'and', 'market', 'brain', 'cancer', 'pipeline', 'review']",1
310963,nifty_940,2014-10-09,"Research and Markets: Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics Analysis 2009-2014",Fall,-0.0114,109,research and market global joint venture partnership pharma biotech and diagnostics analysis,92,12,0,pharmacy,"['research', 'and', 'market', 'global', 'joint', 'venture', 'partnership', 'p', '##har', '##ma', 'bio', '##tech', 'and', 'diagnostic', '##s', 'analysis']",1
310983,nifty_940,2014-10-09,Research and Markets: Molecular Diagnostics Partnering Terms and Agreements Report 2014,Fall,-0.0114,87,research and market molecular diagnostics partnering term and agreement report,78,10,0,pharmacy,"['research', 'and', 'market', 'molecular', 'diagnostic', '##s', 'partner', '##ing', 'term', 'and', 'agreement', 'report']",1
311034,nifty_940,2014-10-09,Research and Markets: Top 50 Big Pharma Partnering and M&A; Deal Trends,Fall,-0.0114,71,research and market top big pharma partnering and deal trend,60,10,0,pharmacy,"['research', 'and', 'market', 'top', 'big', 'p', '##har', '##ma', 'partner', '##ing', 'and', 'deal', 'trend']",1
311041,nifty_940,2014-10-09,Research and Markets: Top 50 Big Biotech Partnering and M&A; Deal Trends,Fall,-0.0114,72,research and market top big biotech partnering and deal trend,61,10,0,pharmacy,"['research', 'and', 'market', 'top', 'big', 'bio', '##tech', 'partner', '##ing', 'and', 'deal', 'trend']",1
311060,nifty_940,2014-10-09,"R&D; Spending Surges in Biotech Industry, BDO USA Analysis Finds",Fall,-0.0114,64,spending surge biotech industry bdo usa analysis find,53,8,0,pharmacy,"['spending', 'surge', 'bio', '##tech', 'industry', 'b', '##do', 'us', '##a', 'analysis', 'find']",1
311071,nifty_940,2014-10-09,Research and Markets: Bioinformatics Partnering Terms and Agreements 2014,Fall,-0.0114,73,research and market bioinformatics partnering term and agreement,64,8,0,pharmacy,"['research', 'and', 'market', 'bio', '##in', '##formatics', 'partner', '##ing', 'term', 'and', 'agreement']",1
311151,nifty_940,2014-10-09,Research and Markets: Global and China Medium-Chain Triglycerides (MCT) Market Outlook 2019,Fall,-0.0114,91,research and market global and china medium chain triglyceride mct market outlook,81,12,0,pharmacy,"['research', 'and', 'market', 'global', 'and', 'chin', '##a', 'medium', 'chain', 't', '##rig', '##ly', '##cer', '##ide', 'm', '##ct', 'market', 'outlook']",1
311191,nifty_940,2014-10-09,"Bourne Partners Releases Video Series Featuring Global Leaders in Private Equity, Healthcare, Pharmaceuticals and Technology",Fall,-0.0114,124,bourne partner release video series featuring global leader private equity healthcare pharmaceutical and technology,115,14,0,pharmacy,"['b', '##our', '##ne', 'partner', 'release', 'video', 'series', 'featuring', 'global', 'leader', 'private', 'equity', 'healthcare', 'pharmaceutical', 'and', 'technology']",1
311278,nifty_940,2014-10-09,Cellectis: Individual Shareholder Meeting,Fall,-0.0114,41,cellectis individual shareholder meeting,40,4,0,pharmacy,"['cell', '##ec', '##tis', 'individual', 'shareholder', 'meeting']",1
311354,nifty_940,2014-10-09,"Avanir Pharmaceuticals to Host Investor Briefing on October 15, 2014",Fall,-0.0114,68,avanir pharmaceutical host investor briefing october,52,6,0,pharmacy,"['a', '##vani', '##r', 'pharmaceutical', 'host', 'investor', 'brief', '##ing', 'o', '##ct', '##obe', '##r']",1
311506,nifty_940,2014-10-09,Kindred Healthcare to Buy Gentiva,Fall,-0.0114,33,kindred healthcare buy gentiva,30,4,0,pharmacy,"['kind', '##red', 'healthcare', 'buy', 'g', '##ent', '##iva']",1
311533,nifty_940,2014-10-09,Impax to Buy Pharmaceutical Companies,Fall,-0.0114,37,impax buy pharmaceutical company,32,4,0,pharmacy,"['imp', '##ax', 'buy', 'pharmaceutical', 'company']",1
311589,nifty_941,2014-10-13,Pfizer Breast Cancer Treatment Gets Priority Review,Neutral,0.0015,51,pfizer breast cancer treatment get priority review,50,7,0,pharmacy,"['p', '##fi', '##zer', 'breast', 'cancer', 'treatment', 'get', 'priority', 'review']",1
311590,nifty_941,2014-10-13,Steris to Buy Synergy Health for $1.9 Billion,Neutral,0.0015,45,steris buy synergy health for billion,37,6,0,pharmacy,"['s', '##ter', '##is', 'buy', 's', '##yne', '##rgy', 'health', 'for', 'billion']",1
311621,nifty_942,2014-10-14,J&J Profit Jumps on Higher Drug Sales,Fall,-0.0068,37,profit jump higher drug sale,28,5,0,pharmacy,"['profit', 'jump', 'higher', 'drug', 'sale']",1
311699,nifty_943,2014-10-15,Panel Backs Requiring Arkansas to Provide Drug,Neutral,-0.0009,46,panel back requiring arkansas provide drug,42,6,0,pharmacy,"['panel', 'back', 'requiring', 'a', '##rka', '##ns', '##as', 'provide', 'drug']",1
311701,nifty_943,2014-10-15,FDA Rejects Insys’s Dronabinol Application,Neutral,-0.0009,42,fda reject insys dronabinol application,39,5,0,pharmacy,"['f', '##da', 'reject', 'ins', '##ys', 'd', '##rona', '##bino', '##l', 'application']",1
311706,nifty_943,2014-10-15,FDA Approves Two Drugs to Treat Lung Disease,Neutral,-0.0009,44,fda approves two drug treat lung disease,40,7,0,pharmacy,"['f', '##da', 'approve', '##s', 'two', 'drug', 'treat', 'lung', 'disease']",1
311757,nifty_943,2014-10-15,St. Jude Cuts Revenue Guidance,Neutral,-0.0009,30,jude cut revenue guidance,25,4,0,pharmacy,"['j', '##ude', 'cut', 'revenue', 'guidance']",1
311825,nifty_944,2014-10-16,Advising Doctors Gets More Complex,Rise,0.0118,34,advising doctor get more complex,32,5,0,pharmacy,"['advising', 'doctor', 'get', 'more', 'complex']",1
311841,nifty_944,2014-10-16,Baxter’s Medical-Products Sales Rise,Rise,0.0118,36,baxter medical product sale rise,32,5,0,pharmacy,"['b', '##ax', '##ter', 'medical', 'product', 'sale', 'rise']",1
311956,nifty_945,2014-10-20,FDA Panel Calls for Psoriasis Drug Approval,Rise,0.0198,43,fda panel call for psoriasis drug approval,42,7,0,pharmacy,"['f', '##da', 'panel', 'call', 'for', 'ps', '##oria', '##sis', 'drug', 'approval']",1
311974,nifty_945,2014-10-20,Dexcom’s Remote Glucose-Monitoring Device Cleared,Rise,0.0198,49,dexcom remote glucose monitoring device cleared,47,6,0,pharmacy,"['de', '##x', '##com', 'remote', 'glucose', 'monitoring', 'device', 'cleared']",1
312038,nifty_946,2014-10-21,Third Point Wants Amgen to Explore Separation,Fall,-0.0071,45,third point want amgen explore separation,41,6,0,pharmacy,"['third', 'point', 'want', 'am', '##gen', 'explore', 'separation']",1
312041,nifty_946,2014-10-21,FDA Panel Recommends Expanded Approval of CF Drug,Fall,-0.0071,49,fda panel recommends expanded approval drug,43,6,0,pharmacy,"['f', '##da', 'panel', 'recommend', '##s', 'expanded', 'approval', 'drug']",1
312108,nifty_946,2014-10-21,Actelion Boosted by New Drug,Fall,-0.0071,28,actelion boosted new drug,25,4,0,pharmacy,"['act', '##eli', '##on', 'boost', '##ed', 'new', 'drug']",1
312161,nifty_947,2014-10-22,Worries Cloud Biogen’s Results,Rise,0.0116,30,worry cloud biogen result,25,4,0,pharmacy,"['worry', 'cloud', 'bio', '##gen', 'result']",1
312237,nifty_948,2014-10-23,Cressey to Sell Home Health Firm,Rise,0.0077,32,cressey sell home health firm,29,5,0,pharmacy,"['c', '##ress', '##ey', 'sell', 'home', 'health', 'firm']",1
312246,nifty_948,2014-10-23,Can Tylenol Ease the Pain of a Home Sale?,Rise,0.0077,41,can tylenol ease the pain home sale,35,7,0,pharmacy,"['can', 't', '##yle', '##no', '##l', 'ease', 'the', 'pain', 'home', 'sale']",1
312319,nifty_949,2014-10-27,Exclusive: Salesforce to make big push into healthcare industry,Rise,0.0115,63,exclusive salesforce make big push into healthcare industry,59,8,0,pharmacy,"['exclusive', 'sales', '##force', 'make', 'big', 'push', 'into', 'healthcare', 'industry']",1
312420,nifty_949,2014-10-27,Higher Drug Sales Buoy Amgen Results,Rise,0.0115,36,higher drug sale buoy amgen result,34,6,0,pharmacy,"['higher', 'drug', 'sale', 'b', '##uo', '##y', 'am', '##gen', 'result']",1
312421,nifty_949,2014-10-27,Receptos Reports Promising Results for Ulcerative Colitis Drug,Rise,0.0115,62,receptos report promising result for ulcerative colitis drug,60,8,0,pharmacy,"['re', '##ce', '##pt', '##os', 'report', 'promising', 'result', 'for', 'ul', '##cer', '##ative', 'co', '##lit', '##is', 'drug']",1
312755,nifty_950,2014-10-28,Ligand Reports Third Quarter 2014 Financial Results,Neutral,-0.0015,51,ligand report third quarter financial result,44,6,0,pharmacy,"['l', '##igan', '##d', 'report', 'third', 'quarter', 'financial', 'result']",1
312768,nifty_950,2014-10-28,"Aegerion Pharmaceuticals to Announce Third-Quarter 2014 Financial Results on Thursday, October 30",Neutral,-0.0015,97,aegerion pharmaceutical announce third quarter financial result thursday october,80,9,0,pharmacy,"['a', '##ege', '##rion', 'pharmaceutical', 'announce', 'third', 'quarter', 'financial', 'result', 'th', '##urs', '##day', 'o', '##ct', '##obe', '##r']",1
312772,nifty_950,2014-10-28,"AMAG Pharmaceuticals, Inc. to Host Conference Call on October 30, 2014 at 8:00 a.m. ET to Discuss Financial Results for the Quarter and Nine Months Ended September 30, 2014",Neutral,-0.0015,172,amag pharmaceutical inc host conference call october discus financial result for the quarter and nine month ended september,123,18,0,pharmacy,"['am', '##ag', 'pharmaceutical', 'in', '##c', 'host', 'conference', 'call', 'o', '##ct', '##obe', '##r', 'disc', '##us', 'financial', 'result', 'for', 'the', 'quarter', 'and', 'nine', 'month', 'ended', 'se', '##pt', '##em', '##ber']",1
312823,nifty_950,2014-10-28,"Assistance Programs, Dividends, Campaigns, Drug Recommendations, and Research Collaborations - Research Reports on Duke Energy, Exelon, Marriott, Vertex and AstraZeneca",Neutral,-0.0015,168,assistance program dividend campaign drug recommendation and research collaboration research report duke energy exelon marriott vertex and astrazeneca,150,18,0,pharmacy,"['assistance', 'program', 'divide', '##nd', 'campaign', 'drug', 'recommendation', 'and', 'research', 'collaboration', 'research', 'report', 'duke', 'energy', 'ex', '##elo', '##n', 'ma', '##rri', '##ott', 'vertex', 'and', 'as', '##tra', '##zen', '##eca']",1
312948,nifty_950,2014-10-28,RSD Selected by Leading Global Biotechnology Company for Information Governance,Neutral,-0.0015,79,rsd selected leading global biotechnology company for information governance,76,9,0,pharmacy,"['r', '##s', '##d', 'selected', 'leading', 'global', 'bio', '##tech', '##nology', 'company', 'for', 'information', 'governance']",1
313061,nifty_950,2014-10-28,Ambu will be distributing Intronix Technologies' Innovative Myoguideâ¢ System Worldwide,Neutral,-0.0015,88,ambu will distributing intronix technology innovative myoguideâ system worldwide,80,9,0,pharmacy,"['am', '##bu', 'will', 'distributing', 'intro', '##ni', '##x', 'technology', 'innovative', 'my', '##og', '##uid', '##e', '##â', 'system', 'worldwide']",1
313113,nifty_950,2014-10-28,"Philadelphia Surging with Digital Health Innovation: EY, Ben Franklin, PACT, Fairmount Partners, CEO Council for Growth Align to Explore; $900M+ invested in sector since 2008",Neutral,-0.0015,174,philadelphia surging with digital health innovation ben franklin pact fairmount partner ceo council for growth align explore invested sector since,146,20,0,pharmacy,"['p', '##hil', '##ade', '##l', '##phi', '##a', 'sur', '##ging', 'with', 'digital', 'health', 'innovation', 'ben', 'f', '##rank', '##lin', 'pact', 'fair', '##mount', 'partner', 'c', '##eo', 'council', 'for', 'growth', 'al', '##ign', 'explore', 'invested', 'sector', 'since']",1
313410,nifty_950,2014-10-28,German Drug Firms Target China,Neutral,-0.0015,30,german drug firm target china,29,5,0,pharmacy,"['g', '##erman', 'drug', 'firm', 'target', 'chin', '##a']",1
313412,nifty_950,2014-10-28,Optum to Buy Alere Health,Neutral,-0.0015,25,optum buy alere health,22,4,0,pharmacy,"['op', '##tum', 'buy', 'ale', '##re', 'health']",1
313439,nifty_950,2014-10-28,Sanofi Shares Fall on Diabetes Warning,Neutral,-0.0015,38,sanofi share fall diabetes warning,34,5,0,pharmacy,"['sa', '##no', '##fi', 'share', 'fall', 'diabetes', 'warning']",1
313462,nifty_950,2014-10-28,Novartis Boosted by Stake Sale,Neutral,-0.0015,30,novartis boosted stake sale,27,4,0,pharmacy,"['no', '##var', '##tis', 'boost', '##ed', 'stake', 'sale']",1
313555,nifty_951,2014-10-29,"Eli Lilly, Boehringer Ingelheim Restructure Diabetes Venture",Rise,0.0064,60,eli lilly boehringer ingelheim restructure diabetes venture,59,7,0,pharmacy,"['el', '##i', 'l', '##ill', '##y', 'b', '##oe', '##hr', '##inger', 'ing', '##el', '##heim', 'rest', '##ru', '##cture', 'diabetes', 'venture']",1
313695,nifty_952,2014-10-30,BRIEF-Neuron Bio share trading suspended - regulator,Rise,0.0114,52,brief neuron bio share trading suspended regulator,50,7,0,pharmacy,"['brief', 'ne', '##uron', 'bio', 'share', 'trading', 'suspended', 'regulator']",1
313829,nifty_952,2014-10-30,Aileron Therapeutics Secures $33 Million in Series E Financing to Advance Its First-In-Class Cancer Drug,Rise,0.0114,104,aileron therapeutic secures million series financing advance it first class cancer drug,87,12,0,pharmacy,"['a', '##iler', '##on', 'therapeutic', 'secure', '##s', 'million', 'series', 'financing', 'advance', 'it', 'first', 'class', 'cancer', 'drug']",1
313859,nifty_952,2014-10-30,Acceleron Pharma to Present at Upcoming Investor Conferences in November,Rise,0.0114,72,acceleron pharma present upcoming investor conference november,62,7,0,pharmacy,"['a', '##cc', '##ele', '##ron', 'p', '##har', '##ma', 'present', 'upcoming', 'investor', 'conference', 'no', '##ve', '##mber']",1
313933,nifty_952,2014-10-30,Report: Urgent Care Center Market in the US Reaches 14 Billion As Hospitals Join Trend,Rise,0.0114,86,report urgent care center market the reach billion hospital join trend,70,11,0,pharmacy,"['report', 'urgent', 'care', 'center', 'market', 'the', 'reach', 'billion', 'hospital', 'join', 'trend']",1
313977,nifty_952,2014-10-30,"Market Movers - Biotech Stocks -- NewLink Genetics, Biogen Idec, United Therapeutics, Dynavax Technologies, and Amarin",Rise,0.0114,118,market mover biotech stock newlink genetics biogen idec united therapeutic dynavax technology and amarin,104,14,0,pharmacy,"['market', 'move', '##r', 'bio', '##tech', 'stock', 'new', '##link', 'genetics', 'bio', '##gen', 'id', '##ec', 'united', 'therapeutic', 'd', '##yna', '##va', '##x', 'technology', 'and', 'am', '##ari', '##n']",1
314004,nifty_952,2014-10-30,Vanda Pharmaceuticals Inc. Prices Public Offering of Common Stock,Rise,0.0114,65,vanda pharmaceutical inc price public offering common stock,59,8,0,pharmacy,"['van', '##da', 'pharmaceutical', 'in', '##c', 'price', 'public', 'offering', 'common', 'stock']",1
314088,nifty_952,2014-10-30,"Quarterly Earnings Releases and Recognitions - Research Reports on GlaxoSmithKline, IDEXX, BioMarin, GE and Lockheed Martin",Rise,0.0114,123,quarterly earnings release and recognition research report glaxosmithkline idexx biomarin and lockheed martin,109,13,0,pharmacy,"['quarterly', 'earnings', 'release', 'and', 'recognition', 'research', 'report', 'g', '##lax', '##os', '##mith', '##k', '##line', 'id', '##ex', '##x', 'bio', '##mar', '##in', 'and', 'lock', '##hee', '##d', 'ma', '##rt', '##in']",1
314202,nifty_952,2014-10-30,"Research and Markets: Retail IT Trends in Brazil - m-commerce, Social Networks, RFID & Analytics",Rise,0.0114,96,research and market retail trend brazil commerce social network rfid analytics,78,11,0,pharmacy,"['research', 'and', 'market', 'retail', 'trend', 'bra', '##zi', '##l', 'commerce', 'social', 'network', 'r', '##fi', '##d', 'anal', '##ytic', '##s']",1
314258,nifty_952,2014-10-30,"The Market for Non-Small-Cell Lung Cancer Will Grow to $8.5 Billion in 2023, Driven by the Entry of Thirteen Novel Drugs",Rise,0.0114,120,the market for non small cell lung cancer will grow billion driven the entry thirteen novel drug,96,17,0,pharmacy,"['the', 'market', 'for', 'non', 'small', 'cell', 'lung', 'cancer', 'will', 'grow', 'billion', 'driven', 'the', 'entry', 'thirteen', 'novel', 'drug']",1
314262,nifty_952,2014-10-30,New Report Shows Orphan Drug Market to Reach $176 Billion by 2020,Rise,0.0114,65,new report show orphan drug market reach billion,48,8,0,pharmacy,"['new', 'report', 'show', 'orphan', 'drug', 'market', 'reach', 'billion']",1
314318,nifty_952,2014-10-30,"Research and Markets: Industrial, Medical and Specialty Gases - A Global Market Overview of the $100+ Billion Industry to 2020",Rise,0.0114,126,research and market industrial medical and specialty gas global market overview the billion industry,100,14,0,pharmacy,"['research', 'and', 'market', 'industrial', 'medical', 'and', 'specialty', 'gas', 'global', 'market', 'overview', 'the', 'billion', 'industry']",1
314409,nifty_952,2014-10-30,The Washington Biotechnology & Biomedical Association Releases Annual Economic Impact of the Life Sciences Report,Rise,0.0114,113,the washington biotechnology biomedical association release annual economic impact the life science report,106,13,0,pharmacy,"['the', 'washing', '##ton', 'bio', '##tech', '##nology', 'bio', '##medical', 'association', 'release', 'annual', 'economic', 'impact', 'the', 'life', 'science', 'report']",1
314477,nifty_952,2014-10-30,CTI BioPharma Reports Third Quarter 2014 Financial Results,Rise,0.0114,58,cti biopharma report third quarter financial result,51,7,0,pharmacy,"['c', '##ti', 'bio', '##pha', '##rma', 'report', 'third', 'quarter', 'financial', 'result']",1
314478,nifty_952,2014-10-30,Qiagen Q3 profit rises on demand for disease diagnostics,Rise,0.0114,56,qiagen profit rise demand for disease diagnostics,49,7,0,pharmacy,"['q', '##ia', '##gen', 'profit', 'rise', 'demand', 'for', 'disease', 'diagnostic', '##s']",1
314691,nifty_952,2014-10-30,INDIA PRESS-Cipla asks government to revoke five patents held by Novartis - Economic Times,Rise,0.0114,90,india press cipla asks government revoke five patent held novartis economic time,80,12,0,pharmacy,"['in', '##dia', 'press', 'c', '##ip', '##la', 'asks', 'government', 're', '##voke', 'five', 'patent', 'held', 'no', '##var', '##tis', 'economic', 'time']",1
314709,nifty_952,2014-10-30,FDA Comments on Sarepta Drug Talks,Rise,0.0114,34,fda comment sarepta drug talk,29,5,0,pharmacy,"['f', '##da', 'comment', 'sa', '##re', '##pta', 'drug', 'talk']",1
314905,nifty_953,2014-11-03,Bristol-Myers Signs Option Agreement to Buy Galecto,Neutral,-0.0035,51,bristol myers sign option agreement buy galecto,47,7,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'sign', 'option', 'agreement', 'buy', 'gal', '##ec', '##to']",1
314995,nifty_954,2014-11-04,Amgen’s Ovarian Cancer Drug Fails To Meet Endpoints,Rise,0.0063,51,amgen ovarian cancer drug fails meet endpoint,45,7,0,pharmacy,"['am', '##gen', 'o', '##var', '##ian', 'cancer', 'drug', 'fails', 'meet', 'end', '##point']",1
315283,nifty_957,2014-11-10,"Trial Results Not Expected to Hurt Merck’s Vytorin, Zetia",Neutral,0.001,57,trial result not expected hurt merck vytorin zetia,50,8,0,pharmacy,"['trial', 'result', 'not', 'expected', 'hurt', 'me', '##rc', '##k', 'v', '##yt', '##ori', '##n', 'z', '##eti', '##a']",1
315474,nifty_959,2014-11-12,French Drug Firm Bets on Tiny Diabetes Device,Neutral,0.0011,45,french drug firm bet tiny diabetes device,41,7,0,pharmacy,"['f', '##rench', 'drug', 'firm', 'bet', 'tiny', 'diabetes', 'device']",1
315623,nifty_960,2014-11-13,"Research and Markets: Global Cell and Tissue Analysis Products Market 2014-2018: Key Vendors are Becton, Dickinson and Company, Danaher, EMD Millipore, GE Healthcare and Thermo Fisher Scientific",Neutral,0.0002,194,research and market global cell and tissue analysis product market key vendor are becton dickinson and company danaher emd millipore healthcare and thermo fisher scientific,172,25,0,pharmacy,"['research', 'and', 'market', 'global', 'cell', 'and', 'tissue', 'analysis', 'product', 'market', 'key', 'vendor', 'are', 'be', '##cton', 'dick', '##ins', '##on', 'and', 'company', 'da', '##nah', '##er', 'em', '##d', 'mill', '##ip', '##ore', 'healthcare', 'and', 'the', '##rm', '##o', 'fish', '##er', 'scientific']",1
315627,nifty_960,2014-11-13,Research and Markets: Novel Drug Delivery System (NDDS) in Cancer Therapy Market - Global Industry Analysis to 2020 for the $15 Billion Market,Neutral,0.0002,142,research and market novel drug delivery system ndds cancer therapy market global industry analysis for the billion market,121,18,0,pharmacy,"['research', 'and', 'market', 'novel', 'drug', 'delivery', 'system', 'n', '##dd', '##s', 'cancer', 'therapy', 'market', 'global', 'industry', 'analysis', 'for', 'the', 'billion', 'market']",1
315684,nifty_960,2014-11-13,Celladon Reports Third Quarter 2014 Financial Results and Recent Highlights,Neutral,0.0002,75,celladon report third quarter financial result and recent highlight,67,9,0,pharmacy,"['cell', '##ado', '##n', 'report', 'third', 'quarter', 'financial', 'result', 'and', 'recent', 'highlight']",1
315731,nifty_960,2014-11-13,Research and Markets: Melanoma Therapeutics Market to 2020: Market is projected to grow from $1.3 billion in 2013 to $3.6 billion in 2020,Neutral,0.0002,137,research and market melanoma therapeutic market market projected grow from billion billion,90,12,0,pharmacy,"['research', 'and', 'market', 'me', '##lan', '##oma', 'therapeutic', 'market', 'market', 'projected', 'grow', 'from', 'billion', 'billion']",1
315750,nifty_960,2014-11-13,Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2014 Global London Healthcare Conference on November 19th,Neutral,0.0002,127,spectrum pharmaceutical present corporate update the jefferies global london healthcare conference november,107,12,0,pharmacy,"['spectrum', 'pharmaceutical', 'present', 'corporate', 'update', 'the', 'j', '##ef', '##fer', '##ies', 'global', 'lo', '##ndon', 'healthcare', 'conference', 'no', '##ve', '##mber']",1
315753,nifty_960,2014-11-13,Tetraphase Pharmaceuticals to Participate in Upcoming Investor Conferences,Neutral,0.0002,74,tetraphase pharmaceutical participate upcoming investor conference,66,6,0,pharmacy,"['te', '##tra', '##pha', '##se', 'pharmaceutical', 'participate', 'upcoming', 'investor', 'conference']",1
315757,nifty_960,2014-11-13,GeneNews Reports Q3-2014 Financial Results,Neutral,0.0002,42,genenews report financial result,32,4,0,pharmacy,"['gene', '##ne', '##ws', 'report', 'financial', 'result']",1
315759,nifty_960,2014-11-13,NovaBay Pharmaceuticals Reports Third Quarter 2014 Financial Results and a Clinical/Business Update,Neutral,0.0002,99,novabay pharmaceutical report third quarter financial result and clinical business update,89,11,0,pharmacy,"['no', '##va', '##bay', 'pharmaceutical', 'report', 'third', 'quarter', 'financial', 'result', 'and', 'clinical', 'business', 'update']",1
315793,nifty_960,2014-11-13,"Research and Markets: North America Compression Therapy Market Outlook to 2020: Key Players are Covidien plc, BSN medical GmbH and SIGVARIS, Inc.",Neutral,0.0002,145,research and market north america compression therapy market outlook key player are covidien plc bsn medical gmbh and sigvaris inc,130,20,0,pharmacy,"['research', 'and', 'market', 'north', 'am', '##eric', '##a', 'compression', 'therapy', 'market', 'outlook', 'key', 'player', 'are', 'co', '##vid', '##ien', 'plc', 'b', '##s', '##n', 'medical', 'g', '##mb', '##h', 'and', 'si', '##g', '##var', '##is', 'in', '##c']",1
315813,nifty_960,2014-11-13,The SEED Partners Launch New Biotech to Revolutionize Research and Diagnostics,Neutral,0.0002,78,the seed partner launch new biotech revolutionize research and diagnostics,74,10,0,pharmacy,"['the', 'seed', 'partner', 'launch', 'new', 'bio', '##tech', 'revolution', '##ize', 'research', 'and', 'diagnostic', '##s']",1
315829,nifty_960,2014-11-13,WuXi AppTec Announces Enhanced Genomics Services for Chinese Researchers,Neutral,0.0002,72,wuxi apptec announces enhanced genomics service for chinese researcher,70,9,0,pharmacy,"['w', '##ux', '##i', 'app', '##tec', 'announces', 'enhanced', 'g', '##eno', '##mic', '##s', 'service', 'for', 'chin', '##ese', 'researcher']",1
315901,nifty_960,2014-11-13,"Wildcard Consulting Tapped by MSA Holding Company, LLC to Design New Proprietary Medical Payments Ecosystem",Neutral,0.0002,107,wildcard consulting tapped msa holding company llc design new proprietary medical payment ecosystem,99,13,0,pharmacy,"['wild', '##card', 'consulting', 'tapped', 'm', '##sa', 'holding', 'company', 'll', '##c', 'design', 'new', 'proprietary', 'medical', 'payment', 'ecosystem']",1
315975,nifty_960,2014-11-13,Dipexium Pharmaceuticals Reports Third Quarter 2014 Financial and Operational Results,Neutral,0.0002,85,dipexium pharmaceutical report third quarter financial and operational result,77,9,0,pharmacy,"['dip', '##ex', '##ium', 'pharmaceutical', 'report', 'third', 'quarter', 'financial', 'and', 'operational', 'result']",1
316040,nifty_960,2014-11-13,LEAGUE Inc. Raises $4M USD Seed Round to Develop New Digital Health & Wellness Platform,Neutral,0.0002,87,league inc raise usd seed round develop new digital health wellness platform,76,12,0,pharmacy,"['league', 'in', '##c', 'raise', 'us', '##d', 'seed', 'round', 'develop', 'new', 'digital', 'health', 'well', '##ness', 'platform']",1
316089,nifty_960,2014-11-13,How to Become a Billionaire Drug Trafficker -- Legally; Kaneh Bosm BioTechnology is Pursuing Near Term Revenues,Neutral,0.0002,111,how become billionaire drug trafficker legally kaneh bosm biotechnology pursuing near term revenue,98,13,0,pharmacy,"['how', 'become', 'billionaire', 'drug', 'traffic', '##ker', 'legally', 'ka', '##ne', '##h', 'b', '##os', '##m', 'bio', '##tech', '##nology', 'pursuing', 'near', 'term', 'revenue']",1
316145,nifty_960,2014-11-13,"Millennium Healthcare Secures Three Additional New Sales, Marketing and Distribution Agreements",Neutral,0.0002,95,millennium healthcare secures three additional new sale marketing and distribution agreement,92,11,0,pharmacy,"['millennium', 'healthcare', 'secure', '##s', 'three', 'additional', 'new', 'sale', 'marketing', 'and', 'distribution', 'agreement']",1
316167,nifty_960,2014-11-13,"Annual Benelux Biotech & Healthcare Conference Organized by KBC Securities, FlandersBio and Flanders Investment & Trade Shows That Benelux Biotech Sector Attracts Strong Interest from Top Segment of US Investors",Neutral,0.0002,211,annual benelux biotech healthcare conference organized kbc security flandersbio and flanders investment trade show that benelux biotech sector attracts strong interest from top segment investor,193,25,0,pharmacy,"['annual', 'ben', '##el', '##ux', 'bio', '##tech', 'healthcare', 'conference', 'organized', 'k', '##b', '##c', 'security', 'fl', '##ander', '##s', '##bio', 'and', 'fl', '##ander', '##s', 'investment', 'trade', 'show', 'that', 'ben', '##el', '##ux', 'bio', '##tech', 'sector', 'attracts', 'strong', 'interest', 'from', 'top', 'segment', 'investor']",1
316174,nifty_960,2014-11-13,Research and Markets: Gastrointestinal Disorders Pipeline Highlights Database 2015,Neutral,0.0002,82,research and market gastrointestinal disorder pipeline highlight database,73,8,0,pharmacy,"['research', 'and', 'market', 'gas', '##tro', '##int', '##est', '##inal', 'disorder', 'pipeline', 'highlight', 'database']",1
316196,nifty_960,2014-11-13,Research and Markets: Respiratory Disorders Pipeline Highlights Database 2015,Neutral,0.0002,77,research and market respiratory disorder pipeline highlight database,68,8,0,pharmacy,"['research', 'and', 'market', 'respiratory', 'disorder', 'pipeline', 'highlight', 'database']",1
316201,nifty_960,2014-11-13,Research and Markets: Blood Disorders Pipeline Highlights Database 2015,Neutral,0.0002,71,research and market blood disorder pipeline highlight database,62,8,0,pharmacy,"['research', 'and', 'market', 'blood', 'disorder', 'pipeline', 'highlight', 'database']",1
316209,nifty_960,2014-11-13,Research and Markets: Central Nervous System Disorders Pipeline Highlights Database 2015,Neutral,0.0002,88,research and market central nervous system disorder pipeline highlight database,79,10,0,pharmacy,"['research', 'and', 'market', 'central', 'nervous', 'system', 'disorder', 'pipeline', 'highlight', 'database']",1
316250,nifty_960,2014-11-13,Research and Markets: Orphan Diseases Pipeline Highlights Database - 2014,Neutral,0.0002,73,research and market orphan disease pipeline highlight database,62,8,0,pharmacy,"['research', 'and', 'market', 'orphan', 'disease', 'pipeline', 'highlight', 'database']",1
316510,nifty_960,2014-11-13,Parnell Pharmaceuticals Holdings Ltd to Present at Upcoming Investor Conferences,Neutral,0.0002,80,parnell pharmaceutical holding ltd present upcoming investor conference,71,8,0,pharmacy,"['par', '##nell', 'pharmaceutical', 'holding', 'l', '##t', '##d', 'present', 'upcoming', 'investor', 'conference']",1
316546,nifty_960,2014-11-13,Future of Merck cholesterol sales could hang on long-awaited study,Neutral,0.0002,66,future merck cholesterol sale could hang long awaited study,59,9,0,pharmacy,"['future', 'me', '##rc', '##k', 'ch', '##ole', '##ster', '##ol', 'sale', 'could', 'hang', 'long', 'awaited', 'study']",1
316548,nifty_960,2014-11-13,BioteQ Reports Q3 2014 Financial and Operating Results,Neutral,0.0002,54,bioteq report financial and operating result,44,6,0,pharmacy,"['bio', '##te', '##q', 'report', 'financial', 'and', 'operating', 'result']",1
316556,nifty_960,2014-11-13,SANUWAVE Health Reports Third Quarter Financial Results and Provides a Business Update,Neutral,0.0002,86,sanuwave health report third quarter financial result and provides business update,82,11,0,pharmacy,"['sa', '##nu', '##wave', 'health', 'report', 'third', 'quarter', 'financial', 'result', 'and', 'provides', 'business', 'update']",1
316593,nifty_960,2014-11-13,"REG-BioAmber Inc : FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2014",Neutral,0.0002,69,reg bioamber inc form for the quarter ended september,53,9,0,pharmacy,"['re', '##g', 'bio', '##am', '##ber', 'in', '##c', 'form', 'for', 'the', 'quarter', 'ended', 'se', '##pt', '##em', '##ber']",1
316833,nifty_961,2014-11-17,"Pfizer, Germany’s Merck to Develop Tumor Treatment",Rise,0.0058,50,pfizer germany merck develop tumor treatment,44,6,0,pharmacy,"['p', '##fi', '##zer', 'g', '##erman', '##y', 'me', '##rc', '##k', 'develop', 'tumor', 'treatment']",1
316916,nifty_962,2014-11-18,AstraZeneca Bets Long Term on Cancer Drugs,Neutral,-0.0016,42,astrazeneca bet long term cancer drug,37,6,0,pharmacy,"['as', '##tra', '##zen', '##eca', 'bet', 'long', 'term', 'cancer', 'drug']",1
317029,nifty_964,2014-11-20,What Does It Cost to Develop a Drug? Latest Study Says $2.6 Billion,Rise,0.0054,67,what doe cost develop drug latest study say billion,51,9,0,pharmacy,"['what', 'do', '##e', 'cost', 'develop', 'drug', 'latest', 'study', 'say', 'billion']",1
317109,nifty_964,2014-11-20,Sanofi Says New Drugs to Boost Sales,Rise,0.0054,36,sanofi say new drug boost sale,30,6,0,pharmacy,"['sa', '##no', '##fi', 'say', 'new', 'drug', 'boost', 'sale']",1
317240,nifty_965,2014-11-24,BioMarin to Pay Up to $840 Million for Prosensa,Neutral,-0.0007,47,biomarin pay million for prosensa,33,5,0,pharmacy,"['bio', '##mar', '##in', 'pay', 'million', 'for', 'prose', '##ns', '##a']",1
317245,nifty_965,2014-11-24,Amgen Ends Trials of Stomach-Cancer Therapy,Neutral,-0.0007,43,amgen end trial stomach cancer therapy,38,6,0,pharmacy,"['am', '##gen', 'end', 'trial', 'stomach', 'cancer', 'therapy']",1
317248,nifty_965,2014-11-24,HealthSouth to Acquire EHHI Holdings for $750 Million,Neutral,-0.0007,53,healthsouth acquire ehhi holding for million,44,6,0,pharmacy,"['health', '##so', '##uth', 'acquire', 'eh', '##hi', 'holding', 'for', 'million']",1
317318,nifty_966,2014-11-25,Parabellum Markets Chooses FlexTrade for White Label FX and Liquidity Aggregation,Neutral,0.0026,81,parabellum market chooses flextrade for white label and liquidity aggregation,77,10,0,pharmacy,"['para', '##bell', '##um', 'market', 'chooses', 'fl', '##ex', '##tra', '##de', 'for', 'white', 'label', 'and', 'liquid', '##ity', 'a', '##gg', '##regation']",1
317341,nifty_966,2014-11-25,"Research and Markets: Global Patient Handling Equipment (Product, Type of Care, Accessories & End User) Market Outlook 2019",Neutral,0.0026,123,research and market global patient handling equipment product type care accessory end user market outlook,105,15,0,pharmacy,"['research', 'and', 'market', 'global', 'patient', 'handling', 'equipment', 'product', 'type', 'care', 'access', '##ory', 'end', 'user', 'market', 'outlook']",1
317364,nifty_966,2014-11-25,"Research and Markets: Global Care Management Solutions Market Outlook 2018 - Component, Delivery Mode & End-user Analysis of the $2.98 Billion Industry",Neutral,0.0026,151,research and market global care management solution market outlook component delivery mode end user analysis the billion industry,129,18,0,pharmacy,"['research', 'and', 'market', 'global', 'care', 'management', 'solution', 'market', 'outlook', 'component', 'delivery', 'mode', 'end', 'user', 'analysis', 'the', 'billion', 'industry']",1
317416,nifty_966,2014-11-25,"Research and Markets: Global Companion Diagnostics Market Outlook, 2019 - Roche Diagnostics, Abbott Labs, Agilent Technologies , QIAGEN N.V. & Thermo Fisher Scientific Dominate the $8.7 Billion Industry",Neutral,0.0026,202,research and market global companion diagnostics market outlook roche diagnostics abbott lab agilent technology qiagen thermo fisher scientific dominate the billion industry,173,22,0,pharmacy,"['research', 'and', 'market', 'global', 'companion', 'diagnostic', '##s', 'market', 'outlook', 'r', '##och', '##e', 'diagnostic', '##s', 'abbot', '##t', 'lab', 'a', '##gi', '##lent', 'technology', 'q', '##ia', '##gen', 'the', '##rm', '##o', 'fish', '##er', 'scientific', 'dominate', 'the', 'billion', 'industry']",1
317431,nifty_966,2014-11-25,Cellceutix: December to Be Momentous Month in Company's History,Neutral,0.0026,63,cellceutix december momentous month company history,51,6,0,pharmacy,"['cell', '##ce', '##uti', '##x', 'de', '##ce', '##mber', 'moment', '##ous', 'month', 'company', 'history']",1
317438,nifty_966,2014-11-25,Conatus Pharmaceuticals to Present at Two December Investor Conferences,Neutral,0.0026,71,conatus pharmaceutical present two december investor conference,63,7,0,pharmacy,"['con', '##atus', 'pharmaceutical', 'present', 'two', 'de', '##ce', '##mber', 'investor', 'conference']",1
317465,nifty_966,2014-11-25,Acceleron Pharma to Present at Upcoming Investor Conferences in December,Neutral,0.0026,72,acceleron pharma present upcoming investor conference december,62,7,0,pharmacy,"['a', '##cc', '##ele', '##ron', 'p', '##har', '##ma', 'present', 'upcoming', 'investor', 'conference', 'de', '##ce', '##mber']",1
317614,nifty_966,2014-11-25,"Biotech Stocks in Motion - Amgen, Merrimack Pharma, NPS Pharma, BioMarin Pharma, and Regeneron Pharma",Neutral,0.0026,101,biotech stock motion amgen merrimack pharma np pharma biomarin pharma and regeneron pharma,90,13,0,pharmacy,"['bio', '##tech', 'stock', 'motion', 'am', '##gen', 'me', '##rri', '##ma', '##ck', 'p', '##har', '##ma', 'n', '##p', 'p', '##har', '##ma', 'bio', '##mar', '##in', 'p', '##har', '##ma', 'and', 're', '##gene', '##ron', 'p', '##har', '##ma']",1
317646,nifty_966,2014-11-25,Healthcare CIOs Highlight Strategies to Address  Emerging Informatics Requirements,Neutral,0.0026,82,healthcare cio highlight strategy address emerging informatics requirement,74,8,0,pharmacy,"['healthcare', 'c', '##io', 'highlight', 'strategy', 'address', 'emerging', 'inform', '##atic', '##s', 'requirement']",1
317752,nifty_966,2014-11-25,"Vendors Expected to Gear Up for Intense Competition in the Global Anti-Obesity Drugs Market, Says TechNavio",Neutral,0.0026,107,vendor expected gear for intense competition the global anti obesity drug market say technavio,94,14,0,pharmacy,"['vendor', 'expected', 'gear', 'for', 'intense', 'competition', 'the', 'global', 'anti', 'o', '##besity', 'drug', 'market', 'say', 'tech', '##na', '##vio']",1
317759,nifty_966,2014-11-25,Research and Markets: Mail Order and Internet Pharmacy in Europe - 2015 Edition - Entering the Digital Battleground,Neutral,0.0026,115,research and market mail order and internet pharmacy europe edition entering the digital battleground,101,14,0,pharmacy,"['research', 'and', 'market', 'mail', 'order', 'and', 'internet', 'pharmacy', 'euro', '##pe', 'edition', 'entering', 'the', 'digital', 'battle', '##ground']",1
317795,nifty_966,2014-11-25,Research and Markets: Global Next Generation Sequencing Technologies Market Analysis - Trends & Forecast to 2020,Neutral,0.0026,112,research and market global next generation sequencing technology market analysis trend forecast,95,12,0,pharmacy,"['research', 'and', 'market', 'global', 'next', 'generation', 'se', '##quencing', 'technology', 'market', 'analysis', 'trend', 'forecast']",1
317834,nifty_966,2014-11-25,Renowned Population Health Experts Make Up Advisory Board for Intel-GE Care Innovationsâ¢ Validation Institute,Neutral,0.0026,111,renowned population health expert make advisory board for intel care innovationsâ validation institute,102,13,0,pharmacy,"['renowned', 'population', 'health', 'expert', 'make', 'advisory', 'board', 'for', 'in', '##tel', 'care', 'innovations', '##â', 'valid', '##ation', 'institute']",1
318326,nifty_967,2014-12-01,Novartis’s MS Treatment Fails in Trial,Rise,0.0065,38,novartis treatment fails trial,30,4,0,pharmacy,"['no', '##var', '##tis', 'treatment', 'fails', 'trial']",1
318354,nifty_968,2014-12-02,"Sanofi, Evotec Discuss Pharmaceutical Research Partnership",Neutral,0.0039,58,sanofi evotec discus pharmaceutical research partnership,56,6,0,pharmacy,"['sa', '##no', '##fi', 'e', '##vo', '##tec', 'disc', '##us', 'pharmaceutical', 'research', 'partnership']",1
318371,nifty_968,2014-12-02,Abilify Maker Otsuka to Buy Avanir,Neutral,0.0039,34,abilify maker otsuka buy avanir,31,5,0,pharmacy,"['a', '##bil', '##ify', 'maker', 'o', '##tsu', '##ka', 'buy', 'a', '##vani', '##r']",1
318657,nifty_971,2014-12-08,Gene Therapy Shows Promise for Lethal Blood Disease,Neutral,-0.0007,51,gene therapy show promise for lethal blood disease,50,8,0,pharmacy,"['gene', 'therapy', 'show', 'promise', 'for', 'lethal', 'blood', 'disease']",1
318795,nifty_972,2014-12-09,"Lilly, Incyte Arthritis Drug Meets Endpoint",Fall,-0.016,43,lilly incyte arthritis drug meet endpoint,41,6,0,pharmacy,"['l', '##ill', '##y', 'in', '##cy', '##te', 'art', '##hr', '##itis', 'drug', 'meet', 'end', '##point']",1
318932,nifty_973,2014-12-10,"Research and Markets: Asia-Pacific Gynecological Devices Market Outlook to 2020: Key players covered include Bayer, Hologic, Boston Scientific, Microsulis Medical, Cook Medical and Merit Medical",Rise,0.0051,194,research and market asia pacific gynecological device market outlook key player covered include bayer hologic boston scientific microsulis medical cook medical and merit medical,177,24,0,pharmacy,"['research', 'and', 'market', 'as', '##ia', 'p', '##ac', '##ific', 'g', '##yne', '##cological', 'device', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'bay', '##er', 'ho', '##log', '##ic', 'b', '##ost', '##on', 'scientific', 'micro', '##sul', '##is', 'medical', 'cook', 'medical', 'and', 'merit', 'medical']",1
318938,nifty_973,2014-12-10,"Research and Markets: BRIC Biopsy Devices Market Outlook to 2020: Key players covered include C.R. Bard, Cook Medical, CareFusion and Hologic",Rise,0.0051,141,research and market bric biopsy device market outlook key player covered include bard cook medical carefusion and hologic,121,18,0,pharmacy,"['research', 'and', 'market', 'br', '##ic', 'bio', '##psy', 'device', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'bar', '##d', 'cook', 'medical', 'care', '##fusion', 'and', 'ho', '##log', '##ic']",1
318943,nifty_973,2014-12-10,"Research and Markets: EU5 Biopsy Devices Market Outlook to 2020: Key players covered include C.R. Bard, Cook Medical, CareFusion and Hologic",Rise,0.0051,140,research and market biopsy device market outlook key player covered include bard cook medical carefusion and hologic,116,17,0,pharmacy,"['research', 'and', 'market', 'bio', '##psy', 'device', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'bar', '##d', 'cook', 'medical', 'care', '##fusion', 'and', 'ho', '##log', '##ic']",1
318945,nifty_973,2014-12-10,"Research and Markets: EU5 Gynecological Devices Market Outlook to 2020: Key players covered include Bayer, Hologic, Boston Scientific, Microsulis, Cook and Merit",Rise,0.0051,161,research and market gynecological device market outlook key player covered include bayer hologic boston scientific microsulis cook and merit,140,19,0,pharmacy,"['research', 'and', 'market', 'g', '##yne', '##cological', 'device', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'bay', '##er', 'ho', '##log', '##ic', 'b', '##ost', '##on', 'scientific', 'micro', '##sul', '##is', 'cook', 'and', 'merit']",1
318946,nifty_973,2014-12-10,"Research and Markets: Asia-Pacific Biopsy Devices Market Outlook to 2020: Key players covered include C.R. Bard, Cook Medical, CareFusion and Hologic",Rise,0.0051,149,research and market asia pacific biopsy device market outlook key player covered include bard cook medical carefusion and hologic,129,19,0,pharmacy,"['research', 'and', 'market', 'as', '##ia', 'p', '##ac', '##ific', 'bio', '##psy', 'device', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'bar', '##d', 'cook', 'medical', 'care', '##fusion', 'and', 'ho', '##log', '##ic']",1
319005,nifty_973,2014-12-10,"Research and Markets: Vitiligo - Pipeline Review, H2 2014",Rise,0.0051,57,research and market vitiligo pipeline review,44,6,0,pharmacy,"['research', 'and', 'market', 'v', '##iti', '##li', '##go', 'pipeline', 'review']",1
319028,nifty_973,2014-12-10,Experts to share healthcare benefits trends to watch in 2015,Rise,0.0051,60,expert share healthcare benefit trend watch,43,6,0,pharmacy,"['expert', 'share', 'healthcare', 'benefit', 'trend', 'watch']",1
319036,nifty_973,2014-12-10,"Research and Markets: Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics (2014 Edition)",Rise,0.0051,107,research and market asset purchase term and agreement pharma biotech and diagnostics edition,92,13,0,pharmacy,"['research', 'and', 'market', 'asset', 'purchase', 'term', 'and', 'agreement', 'p', '##har', '##ma', 'bio', '##tech', 'and', 'diagnostic', '##s', 'edition']",1
319065,nifty_973,2014-12-10,BioMarin to Highlight Breadth of Innovative Development Pipeline at Analyst and Investor Day on December 10th in New York,Rise,0.0051,121,biomarin highlight breadth innovative development pipeline analyst and investor day december new york,101,13,0,pharmacy,"['bio', '##mar', '##in', 'highlight', 'bread', '##th', 'innovative', 'development', 'pipeline', 'analyst', 'and', 'investor', 'day', 'de', '##ce', '##mber', 'new', 'yo', '##rk']",1
319121,nifty_973,2014-12-10,REMINDER: Theravance Biopharma to Host Investor and Analyst Day on December 12th,Rise,0.0051,80,reminder theravance biopharma host investor and analyst day december,68,9,0,pharmacy,"['reminder', 'the', '##ra', '##vance', 'bio', '##pha', '##rma', 'host', 'investor', 'and', 'analyst', 'day', 'de', '##ce', '##mber']",1
319446,nifty_973,2014-12-10,"Investors Applaud Hospira, Walgreens for Support of Principles on Biosimilars, Alternatives to Higher Cost Drugs",Rise,0.0051,112,investor applaud hospira walgreens for support principle biosimilars alternative higher cost drug,97,12,0,pharmacy,"['investor', 'app', '##lau', '##d', 'ho', '##sp', '##ira', 'wa', '##l', '##green', '##s', 'for', 'support', 'principle', 'bio', '##si', '##mi', '##lars', 'alternative', 'higher', 'cost', 'drug']",1
319486,nifty_973,2014-12-10,Research and Markets: Global Nuclear Medicine Radioisotopes Market - Analysis And Forecasts 2014-2019,Rise,0.0051,101,research and market global nuclear medicine radioisotope market analysis and forecast,85,11,0,pharmacy,"['research', 'and', 'market', 'global', 'nuclear', 'medicine', 'radio', '##is', '##oto', '##pe', 'market', 'analysis', 'and', 'forecast']",1
319584,nifty_973,2014-12-10,"Research and Markets: Global Human Growth Hormone Market 2015-2019: Key Vendors are F. Hoffmann-La Roche, Merck Serono, Novo Nordisk and Pfizer",Rise,0.0051,143,research and market global human growth hormone market key vendor are hoffmann roche merck serono novo nordisk and pfizer,121,19,0,pharmacy,"['research', 'and', 'market', 'global', 'human', 'growth', 'hormone', 'market', 'key', 'vendor', 'are', 'ho', '##ff', '##mann', 'r', '##och', '##e', 'me', '##rc', '##k', 'se', '##ron', '##o', 'no', '##vo', 'nor', '##dis', '##k', 'and', 'p', '##fi', '##zer']",1
319587,nifty_973,2014-12-10,"Research and Markets: Global Lung Cancer Therapeutics Market 2015-2019: Key Vendors are AstraZeneca, Celgene, Eli Lilly, F. Hoffmann-La Roche and Pfizer",Rise,0.0051,152,research and market global lung cancer therapeutic market key vendor are astrazeneca celgene eli lilly hoffmann roche and pfizer,128,19,0,pharmacy,"['research', 'and', 'market', 'global', 'lung', 'cancer', 'therapeutic', 'market', 'key', 'vendor', 'are', 'as', '##tra', '##zen', '##eca', 'c', '##el', '##gene', 'el', '##i', 'l', '##ill', '##y', 'ho', '##ff', '##mann', 'r', '##och', '##e', 'and', 'p', '##fi', '##zer']",1
319596,nifty_973,2014-12-10,Bristol-Myers Squibb Announces Dividend,Rise,0.0051,39,bristol myers squibb announces dividend,39,5,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'announces', 'divide', '##nd']",1
319763,nifty_973,2014-12-10,DSI Renal Put Up for Sale,Rise,0.0051,25,dsi renal put for sale,22,5,0,pharmacy,"['d', '##si', 're', '##nal', 'put', 'for', 'sale']",1
319771,nifty_973,2014-12-10,FDA Clears New Version of Merck’s Gardasil,Rise,0.0051,42,fda clear new version merck gardasil,36,6,0,pharmacy,"['f', '##da', 'clear', 'new', 'version', 'me', '##rc', '##k', 'g', '##ard', '##asi', '##l']",1
319819,nifty_973,2014-12-10,Merck Drug Shrank Tumors in Some Breast Cancer Patients,Rise,0.0051,55,merck drug shrank tumor some breast cancer patient,50,8,0,pharmacy,"['me', '##rc', '##k', 'drug', 's', '##hra', '##nk', 'tumor', 'some', 'breast', 'cancer', 'patient']",1
320060,nifty_975,2014-12-15,"Pfizer, OPKO Health Partner on Growth-Hormone Treatment",Fall,-0.008,55,pfizer opko health partner growth hormone treatment,51,7,0,pharmacy,"['p', '##fi', '##zer', 'op', '##ko', 'health', 'partner', 'growth', 'hormone', 'treatment']",1
320090,nifty_975,2014-12-15,UnitedHealthcare Tests a Flat Rate for Cancer Treatment,Fall,-0.008,55,unitedhealthcare test flat rate for cancer treatment,52,7,0,pharmacy,"['united', '##hea', '##lt', '##h', '##care', 'test', 'flat', 'rate', 'for', 'cancer', 'treatment']",1
320154,nifty_976,2014-12-16,Pharma Deal’s Victor Now Must Execute,Rise,0.0196,37,pharma deal victor now must execute,35,6,0,pharmacy,"['p', '##har', '##ma', 'deal', 'v', '##ict', '##or', 'now', 'must', 'execute']",1
320397,nifty_977,2014-12-17,Research and Markets: Asia Pacific Insulin Market Review to 2018 - Transition from Human Insulin to Analog Insulin,Rise,0.0247,114,research and market asia pacific insulin market review transition from human insulin analog insulin,99,14,0,pharmacy,"['research', 'and', 'market', 'as', '##ia', 'p', '##ac', '##ific', 'insulin', 'market', 'review', 'transition', 'from', 'human', 'insulin', 'analog', 'insulin']",1
320403,nifty_977,2014-12-17,"Research and Markets: Small Animal Imaging Market - 2014 Global Industry Analysis: Micro-CT, Micro-MRI, Micro-PET/SPECT, Multimodal, Micro-Ultrasound and Micro-PAT",Rise,0.0247,163,research and market small animal imaging market global industry analysis micro micro mri micro pet spect multimodal micro ultrasound and micro pat,146,22,0,pharmacy,"['research', 'and', 'market', 'small', 'animal', 'imaging', 'market', 'global', 'industry', 'analysis', 'micro', 'micro', 'm', '##ri', 'micro', 'pet', 's', '##pect', 'multi', '##mo', '##dal', 'micro', 'ultra', '##sound', 'and', 'micro', 'pat']",1
320423,nifty_977,2014-12-17,Antibe Therapeutics Announces Appointment of US-Based Investor Relations Consultant,Rise,0.0247,83,antibe therapeutic announces appointment based investor relation consultant,75,8,0,pharmacy,"['anti', '##be', 'therapeutic', 'announces', 'appointment', 'based', 'investor', 'relation', 'consultant']",1
320445,nifty_977,2014-12-17,"ZS Genetics, Inc., Developer of a Unique and Potentially Disruptive âThird-Generationâ DNA Sequencing Technology Platform, Announces Organization Change to Accelerate Strategic Plans",Rise,0.0247,186,genetics inc developer unique and potentially disruptive third generationâ dna sequencing technology platform announces organization change accelerate strategic plan,165,19,0,pharmacy,"['genetics', 'in', '##c', 'developer', 'unique', 'and', 'potentially', 'disrupt', '##ive', 'third', 'generation', '##â', 'd', '##na', 'se', '##quencing', 'technology', 'platform', 'announces', 'organization', 'change', 'accelerate', 'strategic', 'plan']",1
320470,nifty_977,2014-12-17,Research and Markets: Medical Speciality Bags Market - 2014-2020 Global Industry Analysis,Rise,0.0247,89,research and market medical speciality bag market global industry analysis,74,10,0,pharmacy,"['research', 'and', 'market', 'medical', 'special', '##ity', 'bag', 'market', 'global', 'industry', 'analysis']",1
320497,nifty_977,2014-12-17,G. Steven Burrill Issues Annual Predictions for the Biotechnology Industry,Rise,0.0247,74,steven burrill issue annual prediction for the biotechnology industry,69,9,0,pharmacy,"['s', '##te', '##ven', 'b', '##ur', '##rill', 'issue', 'annual', 'prediction', 'for', 'the', 'bio', '##tech', '##nology', 'industry']",1
320583,nifty_977,2014-12-17,Interactive Health Network -- Shareholder Update for Additional Debt Restructure and Statement on the Re-Focus of the Company's Business Activities on the Health and Wellness Market,Rise,0.0247,181,interactive health network shareholder update for additional debt restructure and statement the focus the company business activity the health and wellness market,162,22,0,pharmacy,"['interactive', 'health', 'network', 'shareholder', 'update', 'for', 'additional', 'debt', 'rest', '##ru', '##cture', 'and', 'statement', 'the', 'focus', 'the', 'company', 'business', 'activity', 'the', 'health', 'and', 'well', '##ness', 'market']",1
320636,nifty_977,2014-12-17,Research and Markets: Cervical Cancer Diagnostic Tests Market - 2014 Global Industry Analysis,Rise,0.0247,93,research and market cervical cancer diagnostic test market global industry analysis,83,11,0,pharmacy,"['research', 'and', 'market', 'c', '##er', '##vic', '##al', 'cancer', 'diagnostic', 'test', 'market', 'global', 'industry', 'analysis']",1
320798,nifty_977,2014-12-17,Research and Markets: Australian Diabetes Management Devices Market 2007 - 2020,Rise,0.0247,79,research and market australian diabetes management device market,64,8,0,pharmacy,"['research', 'and', 'market', 'au', '##stra', '##lian', 'diabetes', 'management', 'device', 'market']",1
320808,nifty_977,2014-12-17,"Research and Markets: Global Oncology Market - Trends, Forecast and Pipeline Analysis 2014-2020 - Market is Poised to Grow to $109 Billion by 2020",Rise,0.0247,146,research and market global oncology market trend forecast and pipeline analysis market poised grow billion,106,15,0,pharmacy,"['research', 'and', 'market', 'global', 'on', '##cology', 'market', 'trend', 'forecast', 'and', 'pipeline', 'analysis', 'market', 'poised', 'grow', 'billion']",1
320831,nifty_977,2014-12-17,Research and Markets: China Medical Monitor Industry Report 2014-2017,Rise,0.0247,69,research and market china medical monitor industry report,57,8,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'medical', 'monitor', 'industry', 'report']",1
320840,nifty_977,2014-12-17,"BioMark Diagnostics, Inc. to present at the inaugural equities.com Small-Cap Stars Conference at the NASDAQ MarketSite on December 18, 2014",Rise,0.0247,139,biomark diagnostics inc present the inaugural equity com small cap star conference the nasdaq marketsite december,113,16,0,pharmacy,"['bio', '##mark', 'diagnostic', '##s', 'in', '##c', 'present', 'the', 'inaugural', 'equity', 'com', 'small', 'cap', 'star', 'conference', 'the', 'na', '##s', '##da', '##q', 'markets', '##ite', 'de', '##ce', '##mber']",1
320852,nifty_977,2014-12-17,"Crisis Management Experts Validate BuildingDNA, Accelerate Platform to Market",Rise,0.0247,77,crisis management expert validate buildingdna accelerate platform market,72,8,0,pharmacy,"['crisis', 'management', 'expert', 'valid', '##ate', 'building', '##dn', '##a', 'accelerate', 'platform', 'market']",1
320898,nifty_977,2014-12-17,"Research and Markets: Global Multiple Myeloma Drugs Market 2015-2019 with Celgene, J & J, Novartis, Onyx Pharmaceuticals, Sanofi & Takeda Pharmaceutical Dominating",Rise,0.0247,163,research and market global multiple myeloma drug market with celgene novartis onyx pharmaceutical sanofi takeda pharmaceutical dominating,137,17,0,pharmacy,"['research', 'and', 'market', 'global', 'multiple', 'my', '##elo', '##ma', 'drug', 'market', 'with', 'c', '##el', '##gene', 'no', '##var', '##tis', 'on', '##yx', 'pharmaceutical', 'sa', '##no', '##fi', 'take', '##da', 'pharmaceutical', 'dominating']",1
320904,nifty_977,2014-12-17,"Research and Markets: Global Pharmaceuticals Wholesale and Distribution Market 2015-2019 with Alfresa Holdings, AmerisourceBergen, Cardinal Health, McKesson & PHOENIX Group Dominating",Rise,0.0247,183,research and market global pharmaceutical wholesale and distribution market with alfresa holding amerisourcebergen cardinal health mckesson phoenix group dominating,164,19,0,pharmacy,"['research', 'and', 'market', 'global', 'pharmaceutical', 'wholesale', 'and', 'distribution', 'market', 'with', 'al', '##f', '##res', '##a', 'holding', 'am', '##eri', '##so', '##ur', '##ce', '##berg', '##en', 'cardinal', 'health', 'm', '##cke', '##sson', 'p', '##hoe', '##ni', '##x', 'group', 'dominating']",1
321154,nifty_977,2014-12-17,Philips to Buy U.S. Medical-Imaging Firm,Rise,0.0247,40,philip buy medical imaging firm,31,5,0,pharmacy,"['p', '##hil', '##ip', 'buy', 'medical', 'imaging', 'firm']",1
321306,nifty_978,2014-12-18,"Research and Markets: Biosensors: Medical Biosensors (Glucose Biosensors, & Other Medical Biosensors) & Environmental Biosensors, and Other Biosensors - 2014 Global Strategic Business Report",Neutral,-0.0013,190,research and market biosensors medical biosensors glucose biosensors other medical biosensors environmental biosensors and other biosensors global strategic business report,172,20,0,pharmacy,"['research', 'and', 'market', 'bio', '##sen', '##sors', 'medical', 'bio', '##sen', '##sors', 'glucose', 'bio', '##sen', '##sors', 'other', 'medical', 'bio', '##sen', '##sors', 'environmental', 'bio', '##sen', '##sors', 'and', 'other', 'bio', '##sen', '##sors', 'global', 'strategic', 'business', 'report']",1
321372,nifty_978,2014-12-18,"Research and Markets: India Surgical Sutures Market Outlook to 2020: Key players covered include Johnson & Johnson, Covidien and Sutures India Private",Neutral,-0.0013,150,research and market india surgical suture market outlook key player covered include johnson johnson covidien and suture india private,133,19,0,pharmacy,"['research', 'and', 'market', 'in', '##dia', 'surgical', 'su', '##ture', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'j', '##oh', '##nson', 'j', '##oh', '##nson', 'co', '##vid', '##ien', 'and', 'su', '##ture', 'in', '##dia', 'private']",1
321429,nifty_978,2014-12-18,"Research and Markets: France Compression Therapy Market Outlook to 2020: Key Players Covered Include medi GmbH & Co, Covidien and Laboratoires Innothera",Neutral,-0.0013,152,research and market france compression therapy market outlook key player covered include medi gmbh covidien and laboratoires innothera,134,18,0,pharmacy,"['research', 'and', 'market', 'f', '##rance', 'compression', 'therapy', 'market', 'outlook', 'key', 'player', 'covered', 'include', 'me', '##di', 'g', '##mb', '##h', 'co', '##vid', '##ien', 'and', 'labor', '##ato', '##ires', 'inn', '##oth', '##era']",1
321476,nifty_978,2014-12-18,Nasdaq Lists BioShares(TM) Biotechnology Clinical Trials Fund and BioShares(TM) Biotechnology Products Fund,Neutral,-0.0013,107,nasdaq list bioshares biotechnology clinical trial fund and bioshares biotechnology product fund,96,12,0,pharmacy,"['na', '##s', '##da', '##q', 'list', 'bio', '##sha', '##res', 'bio', '##tech', '##nology', 'clinical', 'trial', 'fund', 'and', 'bio', '##sha', '##res', 'bio', '##tech', '##nology', 'product', 'fund']",1
321520,nifty_978,2014-12-18,VisualDx Launches Open Access Digital Technology to Combat Global Travel-Related Disease Misdiagnosis,Neutral,-0.0013,101,visualdx launch open access digital technology combat global travel related disease misdiagnosis,96,12,0,pharmacy,"['visual', '##d', '##x', 'launch', 'open', 'access', 'digital', 'technology', 'combat', 'global', 'travel', 'related', 'disease', 'mi', '##s', '##dia', '##gno', '##sis']",1
321549,nifty_978,2014-12-18,"Pharma Equities Technical Analysis -- GlaxoSmithKline, Bristol-Myers Squibb, Teva Pharmaceutical Industries, Endo Intl., and Allergan",Neutral,-0.0013,133,pharma equity technical analysis glaxosmithkline bristol myers squibb teva pharmaceutical industry endo intl and allergan,121,15,0,pharmacy,"['p', '##har', '##ma', 'equity', 'technical', 'analysis', 'g', '##lax', '##os', '##mith', '##k', '##line', 'br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'te', '##va', 'pharmaceutical', 'industry', 'end', '##o', 'in', '##tl', 'and', 'all', '##er', '##gan']",1
321581,nifty_978,2014-12-18,"The Zacks Analyst Blog Highlights: Gilead, Biogen, AbbVie and Shire",Neutral,-0.0013,67,the zacks analyst blog highlight gilead biogen abbvie and shire,63,10,0,pharmacy,"['the', 'z', '##ack', '##s', 'analyst', 'blog', 'highlight', 'g', '##ile', '##ad', 'bio', '##gen', 'a', '##bb', '##vie', 'and', 's', '##hire']",1
321605,nifty_978,2014-12-18,"BioShares Launches Two New Biotechnology ETFs (Nasdaq: BBC, BBP)",Neutral,-0.0013,64,bioshares launch two new biotechnology etf nasdaq bbc bbp,57,9,0,pharmacy,"['bio', '##sha', '##res', 'launch', 'two', 'new', 'bio', '##tech', '##nology', 'et', '##f', 'na', '##s', '##da', '##q', 'b', '##b', '##c', 'b', '##b', '##p']",1
321651,nifty_978,2014-12-18,Research and Markets: Global Intraoperative Imaging Report - Micro Market Monitor 2014-2019,Neutral,-0.0013,91,research and market global intraoperative imaging report micro market monitor,77,10,0,pharmacy,"['research', 'and', 'market', 'global', 'in', '##tra', '##oper', '##ative', 'imaging', 'report', 'micro', 'market', 'monitor']",1
321726,nifty_978,2014-12-18,Research and Markets: North American Intrauterine Contraceptive Devices Micro Market Monitor 2014-2019,Neutral,-0.0013,102,research and market north american intrauterine contraceptive device micro market monitor,89,11,0,pharmacy,"['research', 'and', 'market', 'north', 'am', '##eric', '##an', 'in', '##tra', '##uter', '##ine', 'con', '##tra', '##ceptive', 'device', 'micro', 'market', 'monitor']",1
321752,nifty_978,2014-12-18,"HealthPlanOne is the first investment for Peloton Equity, a newly-formed private equity firm focused on investing growth capital in lower middle market healthcare companies",Neutral,-0.0013,172,healthplanone the first investment for peloton equity newly formed private equity firm focused investing growth capital lower middle market healthcare company,158,21,0,pharmacy,"['health', '##p', '##lan', '##one', 'the', 'first', 'investment', 'for', 'p', '##elo', '##ton', 'equity', 'newly', 'formed', 'private', 'equity', 'firm', 'focused', 'investing', 'growth', 'capital', 'lower', 'middle', 'market', 'healthcare', 'company']",1
321810,nifty_978,2014-12-18,Research and Markets: North American Dermatology Diagnostic Devices Market Report 2014,Neutral,-0.0013,86,research and market north american dermatology diagnostic device market report,78,10,0,pharmacy,"['research', 'and', 'market', 'north', 'am', '##eric', '##an', 'der', '##mat', '##ology', 'diagnostic', 'device', 'market', 'report']",1
321812,nifty_978,2014-12-18,Research and Markets: Asia-Pacific Clinical Chemistry Market 2013-2018,Neutral,-0.0013,70,research and market asia pacific clinical chemistry market,58,8,0,pharmacy,"['research', 'and', 'market', 'as', '##ia', 'p', '##ac', '##ific', 'clinical', 'chemistry', 'market']",1
321815,nifty_978,2014-12-18,Research and Markets: Global & USA Transdermal Drug Delivery Market to 2017,Neutral,-0.0013,75,research and market global usa transdermal drug delivery market,63,9,0,pharmacy,"['research', 'and', 'market', 'global', 'us', '##a', 'trans', '##der', '##mal', 'drug', 'delivery', 'market']",1
321853,nifty_978,2014-12-18,"Key Growth Opportunities:Â KSA InterviewsÂ Delmar Pharmaceutical,Â Critical Control Solutions Corp andÂ Cemtrex, Inc.",Neutral,-0.0013,117,key growth opportunity ksa interviewsâ delmar pharmaceutical critical control solution corp andâ cemtrex inc,108,14,0,pharmacy,"['key', 'growth', 'opportunity', 'k', '##sa', 'interviews', '##â', 'del', '##mar', 'pharmaceutical', 'critical', 'control', 'solution', 'co', '##rp', 'and', '##â', 'c', '##em', '##tre', '##x', 'in', '##c']",1
321920,nifty_978,2014-12-18,"CORRECTION -Â Key Growth Opportunities: WSA InterviewsÂ Delmar Pharmaceutical,Â Critical Control Solutions Corp andÂ Cemtrex, Inc.",Neutral,-0.0013,130,correction key growth opportunity wsa interviewsâ delmar pharmaceutical critical control solution corp andâ cemtrex inc,119,15,0,pharmacy,"['correction', 'key', 'growth', 'opportunity', 'w', '##sa', 'interviews', '##â', 'del', '##mar', 'pharmaceutical', 'critical', 'control', 'solution', 'co', '##rp', 'and', '##â', 'c', '##em', '##tre', '##x', 'in', '##c']",1
322058,nifty_978,2014-12-18,Cytori to Provide Corporate Update at 2015 Biotech Showcaseâ¢ in San Francisco,Neutral,-0.0013,79,cytori provide corporate update biotech showcaseâ san francisco,63,8,0,pharmacy,"['c', '##yt', '##ori', 'provide', 'corporate', 'update', 'bio', '##tech', 'showcase', '##â', 'sa', '##n', 'f', '##ran', '##cis', '##co']",1
322160,nifty_978,2014-12-18,Pfizer Reports Statistically Significant Results for Nerve-Pain Treatment,Neutral,-0.0013,73,pfizer report statistically significant result for nerve pain treatment,71,9,0,pharmacy,"['p', '##fi', '##zer', 'report', 'statistical', '##ly', 'significant', 'result', 'for', 'nerve', 'pain', 'treatment']",1
322167,nifty_978,2014-12-18,Merck Acquires OncoEthix for Up to $375 Million,Neutral,-0.0013,47,merck acquires oncoethix for million,36,5,0,pharmacy,"['me', '##rc', '##k', 'acquire', '##s', 'on', '##coe', '##thi', '##x', 'for', 'million']",1
322213,nifty_979,2014-12-22,U.S. Approves Skin Cancer Treatment,Neutral,0.0013,35,approves skin cancer treatment,30,4,0,pharmacy,"['approve', '##s', 'skin', 'cancer', 'treatment']",1
322223,nifty_979,2014-12-22,FTC Puts Conditions on Lilly’s Deal to Buy Novartis Unit,Neutral,0.0013,56,ftc put condition lilly deal buy novartis unit,46,8,0,pharmacy,"['ft', '##c', 'put', 'condition', 'l', '##ill', '##y', 'deal', 'buy', 'no', '##var', '##tis', 'unit']",1
322313,nifty_980,2014-12-23,Novartis Gets European Approval For Glaucoma Treatment,Neutral,0.0001,54,novartis get european approval for glaucoma treatment,53,7,0,pharmacy,"['no', '##var', '##tis', 'get', 'euro', '##pe', '##an', 'approval', 'for', 'g', '##lau', '##com', '##a', 'treatment']",1
322362,nifty_981,2014-12-29,Accenture Wins New HealthCare.gov Contract,Fall,-0.0054,42,accenture win new healthcare gov contract,41,6,0,pharmacy,"['accent', '##ure', 'win', 'new', 'healthcare', 'go', '##v', 'contract']",1
322531,nifty_983,2015-01-05,NPS Pharmaceuticals Seeks Buyer,Fall,-0.0094,31,np pharmaceutical seek buyer,28,4,0,pharmacy,"['n', '##p', 'pharmaceutical', 'seek', 'buyer']",1
322537,nifty_983,2015-01-05,Novartis Wins FDA Staff OK for Neupogen Biosimilar,Fall,-0.0094,50,novartis win fda staff for neupogen biosimilar,46,7,0,pharmacy,"['no', '##var', '##tis', 'win', 'f', '##da', 'staff', 'for', 'ne', '##up', '##ogen', 'bio', '##si', '##mi', '##lar']",1
322544,nifty_983,2015-01-05,"Amgen, Kite Pharma in Immunotherapy Pact",Fall,-0.0094,40,amgen kite pharma immunotherapy pact,36,5,0,pharmacy,"['am', '##gen', 'kit', '##e', 'p', '##har', '##ma', 'im', '##mu', '##not', '##her', '##ap', '##y', 'pact']",1
322625,nifty_984,2015-01-06,Biomet Reports Higher Earnings,Rise,0.0125,30,biomet report higher earnings,29,4,0,pharmacy,"['bio', '##met', 'report', 'higher', 'earnings']",1
322702,nifty_985,2015-01-07,"Research and Markets: Global Surgical Imaging Market to 2019: GE Healthcare, Siemens, Koninklijke Philips,, Ziehm, Toshiba, Shimadzu, Hologic, OrthoScan & Eurocolumbus Dominates the $933 Million Market",Rise,0.0177,201,research and market global surgical imaging market healthcare siemens koninklijke philip ziehm toshiba shimadzu hologic orthoscan eurocolumbus dominates the million market,171,21,0,pharmacy,"['research', 'and', 'market', 'global', 'surgical', 'imaging', 'market', 'healthcare', 'si', '##em', '##ens', 'k', '##oni', '##nk', '##li', '##jk', '##e', 'p', '##hil', '##ip', 'z', '##ie', '##hm', 'to', '##shi', '##ba', 's', '##hima', '##d', '##zu', 'ho', '##log', '##ic', 'or', '##th', '##os', '##can', 'euro', '##co', '##lum', '##bus', 'dominate', '##s', 'the', 'million', 'market']",1
322751,nifty_985,2015-01-07,Research and Markets: Global Non Small Cell Lung Cancer Market & Pipeline Insight 2015 - 268 Drugs With 99 in Phase-II Trials and 30 Marketed NSCLC Drugs,Rise,0.0177,153,research and market global non small cell lung cancer market pipeline insight drug with phase trial and marketed nsclc drug,123,20,0,pharmacy,"['research', 'and', 'market', 'global', 'non', 'small', 'cell', 'lung', 'cancer', 'market', 'pipeline', 'insight', 'drug', 'with', 'phase', 'trial', 'and', 'marketed', 'n', '##s', '##c', '##l', '##c', 'drug']",1
322774,nifty_985,2015-01-07,Research and Markets: Mologen AG's MGN1703 (Colorectal Cancer Pipeline) - Forecast and Market Analysis to 2023,Rise,0.0177,110,research and market mologen mgn colorectal cancer pipeline forecast and market analysis,87,12,0,pharmacy,"['research', 'and', 'market', 'm', '##olo', '##gen', 'mg', '##n', 'color', '##ec', '##tal', 'cancer', 'pipeline', 'forecast', 'and', 'market', 'analysis']",1
322798,nifty_985,2015-01-07,Research and Markets: Biothera's Imprime PGG (Colorectal Cancer Pipeline Report) - Forecast and Market Analysis to 2023,Rise,0.0177,119,research and market biothera imprime pgg colorectal cancer pipeline report forecast and market analysis,103,14,0,pharmacy,"['research', 'and', 'market', 'bio', '##ther', '##a', 'imp', '##rim', '##e', 'p', '##gg', 'color', '##ec', '##tal', 'cancer', 'pipeline', 'report', 'forecast', 'and', 'market', 'analysis']",1
322800,nifty_985,2015-01-07,Research and Markets: PharmaPoint: Colorectal Cancer - US Drug Forecast and Market Analysis to 2023 for the $2.2 Billion Market,Rise,0.0177,127,research and market pharmapoint colorectal cancer drug forecast and market analysis for the billion market,106,15,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##point', 'color', '##ec', '##tal', 'cancer', 'drug', 'forecast', 'and', 'market', 'analysis', 'for', 'the', 'billion', 'market']",1
322801,nifty_985,2015-01-07,Research and Markets: Taiho Pharmaceutical's Lonsurf (Colorectal Cancer Pipeline Report) - Forecast and Market Analysis to 2023,Rise,0.0177,127,research and market taiho pharmaceutical lonsurf colorectal cancer pipeline report forecast and market analysis,111,14,0,pharmacy,"['research', 'and', 'market', 'ta', '##ih', '##o', 'pharmaceutical', 'lo', '##ns', '##ur', '##f', 'color', '##ec', '##tal', 'cancer', 'pipeline', 'report', 'forecast', 'and', 'market', 'analysis']",1
322803,nifty_985,2015-01-07,Research and Markets: Sanofi/Regeneron's Zaltrap (Colorectal Cancer Pipeline Report) - Forecast and Market Analysis to 2023,Rise,0.0177,123,research and market sanofi regeneron zaltrap colorectal cancer pipeline report forecast and market analysis,107,14,0,pharmacy,"['research', 'and', 'market', 'sa', '##no', '##fi', 're', '##gene', '##ron', 'z', '##al', '##tra', '##p', 'color', '##ec', '##tal', 'cancer', 'pipeline', 'report', 'forecast', 'and', 'market', 'analysis']",1
322804,nifty_985,2015-01-07,Research and Markets: Amgen/Takeda's EGFR Antagonist - Vectibix (Colorectal Cancer) - Forecast and Market Analysis to 2023,Rise,0.0177,122,research and market amgen takeda egfr antagonist vectibix colorectal cancer forecast and market analysis,104,14,0,pharmacy,"['research', 'and', 'market', 'am', '##gen', 'take', '##da', 'e', '##g', '##f', '##r', 'antagonist', 've', '##ct', '##ibi', '##x', 'color', '##ec', '##tal', 'cancer', 'forecast', 'and', 'market', 'analysis']",1
322811,nifty_985,2015-01-07,ContraVir Pharmaceuticals to Present at Biotech Showcase 2015,Rise,0.0177,61,contravir pharmaceutical present biotech showcase,49,5,0,pharmacy,"['con', '##tra', '##vir', 'pharmaceutical', 'present', 'bio', '##tech', 'showcase']",1
322823,nifty_985,2015-01-07,Research and Markets: Boehringer Ingelheim's Nintedanib (Colorectal Cancer Drug) - Forecast and Market Analysis to 2023,Rise,0.0177,119,research and market boehringer ingelheim nintedanib colorectal cancer drug forecast and market analysis,103,13,0,pharmacy,"['research', 'and', 'market', 'b', '##oe', '##hr', '##inger', 'ing', '##el', '##heim', 'ni', '##nted', '##ani', '##b', 'color', '##ec', '##tal', 'cancer', 'drug', 'forecast', 'and', 'market', 'analysis']",1
322825,nifty_985,2015-01-07,Research and Markets: Magnetic Resonance Imaging (MRI) Systems - Global Analysis and Market Forecasts 2012-2020 for the $9 Billion Market,Rise,0.0177,137,research and market magnetic resonance imaging mri system global analysis and market forecast for the billion market,116,17,0,pharmacy,"['research', 'and', 'market', 'magnetic', 'resonance', 'imaging', 'm', '##ri', 'system', 'global', 'analysis', 'and', 'market', 'forecast', 'for', 'the', 'billion', 'market']",1
322833,nifty_985,2015-01-07,"cCAM Biotherapeutics Receives FDA Approval to Initiate Phase 1 Trial for CM-24, a Novel Immune Checkpoint Inhibitor for Cancer Immunotherapy",Rise,0.0177,140,ccam biotherapeutics receives fda approval initiate phase trial for novel immune checkpoint inhibitor for cancer immunotherapy,126,16,0,pharmacy,"['cc', '##am', 'bio', '##ther', '##ap', '##eu', '##tics', 'receives', 'f', '##da', 'approval', 'initiate', 'phase', 'trial', 'for', 'novel', 'immune', 'check', '##point', 'inhibitor', 'for', 'cancer', 'im', '##mu', '##not', '##her', '##ap', '##y']",1
322836,nifty_985,2015-01-07,Research and Markets: PharmaPoint: Colorectal Cancer - 5EU Drug Forecast and Market Analysis to 2023,Rise,0.0177,100,research and market pharmapoint colorectal cancer drug forecast and market analysis,83,11,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##point', 'color', '##ec', '##tal', 'cancer', 'drug', 'forecast', 'and', 'market', 'analysis']",1
322838,nifty_985,2015-01-07,Agile Therapeutics to Present at Noble Financial Capital Markets' Eleventh Annual Equity Conference,Rise,0.0177,99,agile therapeutic present noble financial capital market eleventh annual equity conference,90,11,0,pharmacy,"['a', '##gi', '##le', 'therapeutic', 'present', 'noble', 'financial', 'capital', 'market', 'eleventh', 'annual', 'equity', 'conference']",1
322854,nifty_985,2015-01-07,Research and Markets: China Colorectal Cancer Drug Forecast and Market Analysis to 2023 for the $259 Million Market,Rise,0.0177,115,research and market china colorectal cancer drug forecast and market analysis for the million market,100,15,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'color', '##ec', '##tal', 'cancer', 'drug', 'forecast', 'and', 'market', 'analysis', 'for', 'the', 'million', 'market']",1
322857,nifty_985,2015-01-07,Research and Markets: Japan Colorectal Cancer Drug Forecast and Market Analysis to 2023,Rise,0.0177,87,research and market japan colorectal cancer drug forecast and market analysis,77,11,0,pharmacy,"['research', 'and', 'market', 'j', '##apa', '##n', 'color', '##ec', '##tal', 'cancer', 'drug', 'forecast', 'and', 'market', 'analysis']",1
322906,nifty_985,2015-01-07,Coronado Biosciences Reports on Separation of CB Pharma Acquisition Corp. Securities,Rise,0.0177,84,coronado bioscience report separation pharma acquisition corp security,70,8,0,pharmacy,"['co', '##rona', '##do', 'bio', '##science', 'report', 'separation', 'p', '##har', '##ma', 'acquisition', 'co', '##rp', 'security']",1
323068,nifty_985,2015-01-07,Bio-Path Holdings to Present at the Biotech Showcaseâ¢ 2015 Conference,Rise,0.0177,71,bio path holding present the biotech showcaseâ conference,57,8,0,pharmacy,"['bio', 'path', 'holding', 'present', 'the', 'bio', '##tech', 'showcase', '##â', 'conference']",1
323096,nifty_985,2015-01-07,Citeline's ChinatroveÂ® Provides Pharma Industry with Transparency into the Chinese Clinical Trial Market,Rise,0.0177,105,citeline chinatroveâ provides pharma industry with transparency into the chinese clinical trial market,102,13,0,pharmacy,"['c', '##ite', '##line', 'chin', '##at', '##rove', '##â', 'provides', 'p', '##har', '##ma', 'industry', 'with', 'transparency', 'into', 'the', 'chin', '##ese', 'clinical', 'trial', 'market']",1
323110,nifty_985,2015-01-07,Nestle pushes further into health science with Seres investment,Rise,0.0177,63,nestle push further into health science with seres investment,61,9,0,pharmacy,"['nest', '##le', 'push', 'further', 'into', 'health', 'science', 'with', 'se', '##res', 'investment']",1
323291,nifty_985,2015-01-07,SK Capital Makes Strategic Investment in Halo Pharmaceutical,Rise,0.0177,60,capital make strategic investment halo pharmaceutical,53,6,0,pharmacy,"['capital', 'make', 'strategic', 'investment', 'ha', '##lo', 'pharmaceutical']",1
323345,nifty_985,2015-01-07,BioAmber Announces New Chief Financial Officer and Change to the Board,Rise,0.0177,70,bioamber announces new chief financial officer and change the board,67,10,0,pharmacy,"['bio', '##am', '##ber', 'announces', 'new', 'chief', 'financial', 'officer', 'and', 'change', 'the', 'board']",1
323356,nifty_985,2015-01-07,"Venaxis, Inc. to Present at Biotech Showcaseâ¢ 2015",Rise,0.0177,52,venaxis inc present biotech showcaseâ,37,5,0,pharmacy,"['ve', '##na', '##xi', '##s', 'in', '##c', 'present', 'bio', '##tech', 'showcase', '##â']",1
323460,nifty_985,2015-01-07,Five Prime Therapeutics Prices Public Offering of Common Stock,Rise,0.0177,62,five prime therapeutic price public offering common stock,57,8,0,pharmacy,"['five', 'prime', 'therapeutic', 'price', 'public', 'offering', 'common', 'stock']",1
323514,nifty_985,2015-01-07,Alkermes Schizophrenia Drug Shows Less Weight Gain,Rise,0.0177,50,alkermes schizophrenia drug show less weight gain,49,7,0,pharmacy,"['al', '##ker', '##mes', 's', '##chi', '##zophrenia', 'drug', 'show', 'less', 'weight', 'gain']",1
323544,nifty_985,2015-01-07,Small Biotech Gets Rights to Rare Disease Drug,Rise,0.0177,46,small biotech get right rare disease drug,41,7,0,pharmacy,"['small', 'bio', '##tech', 'get', 'right', 'rare', 'disease', 'drug']",1
323611,nifty_986,2015-01-08,"Research and Markets: Global Pharmaceutical Excipients Market Forecasts to 2019 - Products, Functionality, & by Route of Administration",Fall,-0.008,135,research and market global pharmaceutical excipients market forecast product functionality route administration,111,12,0,pharmacy,"['research', 'and', 'market', 'global', 'pharmaceutical', 'ex', '##ci', '##pie', '##nts', 'market', 'forecast', 'product', 'functionality', 'route', 'administration']",1
323638,nifty_986,2015-01-08,Research and Markets: Offices of Optometrists Industry in the U.S. - 2014 Market Research Report,Fall,-0.008,96,research and market office optometrist industry the market research report,74,10,0,pharmacy,"['research', 'and', 'market', 'office', 'op', '##tom', '##et', '##rist', 'industry', 'the', 'market', 'research', 'report']",1
323652,nifty_986,2015-01-08,Research and Markets: Brazil Pharmaceutical Market Outlook 2018,Fall,-0.008,63,research and market brazil pharmaceutical market outlook,56,7,0,pharmacy,"['research', 'and', 'market', 'bra', '##zi', '##l', 'pharmaceutical', 'market', 'outlook']",1
323665,nifty_986,2015-01-08,"Research and Markets: Global X-ray Security Screening Market 2015-2019 with American Science and Engineering, L-3 Communications Holdings, Rapiscan Systems & Smiths Detection Dominating",Fall,-0.008,185,research and market global ray security screening market with american science and engineering communication holding rapiscan system smith detection dominating,159,20,0,pharmacy,"['research', 'and', 'market', 'global', 'ray', 'security', 'screening', 'market', 'with', 'am', '##eric', '##an', 'science', 'and', 'engineering', 'communication', 'holding', 'rap', '##is', '##can', 'system', 's', '##mith', 'detection', 'dominating']",1
323726,nifty_986,2015-01-08,Research and Markets: Oncology Pharmaceuticals Market in India 2014,Fall,-0.008,67,research and market oncology pharmaceutical market india,56,7,0,pharmacy,"['research', 'and', 'market', 'on', '##cology', 'pharmaceutical', 'market', 'in', '##dia']",1
323744,nifty_986,2015-01-08,Research and Markets: Magnetic Resonance Imaging Systems - APAC Analysis and Market Forecasts to 2020,Fall,-0.008,101,research and market magnetic resonance imaging system apac analysis and market forecast,87,12,0,pharmacy,"['research', 'and', 'market', 'magnetic', 'resonance', 'imaging', 'system', 'a', '##pa', '##c', 'analysis', 'and', 'market', 'forecast']",1
323746,nifty_986,2015-01-08,Research and Markets: Magnetic Resonance Imaging Systems 2014-2020 - EU Analysis and Market Forecasts for the $181 Million Market,Fall,-0.008,129,research and market magnetic resonance imaging system analysis and market forecast for the million market,105,15,0,pharmacy,"['research', 'and', 'market', 'magnetic', 'resonance', 'imaging', 'system', 'analysis', 'and', 'market', 'forecast', 'for', 'the', 'million', 'market']",1
323750,nifty_986,2015-01-08,Research and Markets: MediPoint: Magnetic Resonance Imaging Systems - Current and Future Players,Fall,-0.008,96,research and market medipoint magnetic resonance imaging system current and future player,89,12,0,pharmacy,"['research', 'and', 'market', 'me', '##di', '##point', 'magnetic', 'resonance', 'imaging', 'system', 'current', 'and', 'future', 'player']",1
323759,nifty_986,2015-01-08,"ContraFect to Present Company Overview, Including Clinical Plan for CF-301, at the 7th Annual Biotech Showcase",Fall,-0.008,110,contrafect present company overview including clinical plan for the annual biotech showcase,91,12,0,pharmacy,"['con', '##tra', '##fect', 'present', 'company', 'overview', 'including', 'clinical', 'plan', 'for', 'the', 'annual', 'bio', '##tech', 'showcase']",1
323767,nifty_986,2015-01-08,Global X-Ray Market to Be Worth US$9.8 Billion by 2018: Transparency Market Research,Fall,-0.008,84,global ray market worth billion transparency market research,60,8,0,pharmacy,"['global', 'ray', 'market', 'worth', 'billion', 'transparency', 'market', 'research']",1
323779,nifty_986,2015-01-08,DelMar Pharmaceuticals to Present at Biotech Showcaseâ¢ 2015,Fall,-0.008,61,delmar pharmaceutical present biotech showcaseâ,47,5,0,pharmacy,"['del', '##mar', 'pharmaceutical', 'present', 'bio', '##tech', 'showcase', '##â']",1
323798,nifty_986,2015-01-08,Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences,Fall,-0.008,70,corbus pharmaceutical present two upcoming investor conference,62,7,0,pharmacy,"['co', '##rb', '##us', 'pharmaceutical', 'present', 'two', 'upcoming', 'investor', 'conference']",1
323830,nifty_986,2015-01-08,Research and Markets: Medical Diagnostics Market in India 2014,Fall,-0.008,62,research and market medical diagnostics market india,52,7,0,pharmacy,"['research', 'and', 'market', 'medical', 'diagnostic', '##s', 'market', 'in', '##dia']",1
323831,nifty_986,2015-01-08,Research and Markets: Global Nuclear Medicine/Radiopharmaceuticals Market Forecast 2014-2020,Fall,-0.008,92,research and market global nuclear medicine radiopharmaceutical market forecast,79,9,0,pharmacy,"['research', 'and', 'market', 'global', 'nuclear', 'medicine', 'radio', '##pha', '##rma', '##ce', '##utical', 'market', 'forecast']",1
323835,nifty_986,2015-01-08,Research and Markets: India Insulin Market Review to 2018 - Intensifying Strategic Alliances Between Companies,Fall,-0.008,110,research and market india insulin market review intensifying strategic alliance between company,95,12,0,pharmacy,"['research', 'and', 'market', 'in', '##dia', 'insulin', 'market', 'review', 'in', '##tens', '##ifying', 'strategic', 'alliance', 'between', 'company']",1
323839,nifty_986,2015-01-08,Research and Markets: MediPoint: Magnetic Resonance Imaging Systems - South America Analysis and Market Forecasts,Fall,-0.008,113,research and market medipoint magnetic resonance imaging system south america analysis and market forecast,106,14,0,pharmacy,"['research', 'and', 'market', 'me', '##di', '##point', 'magnetic', 'resonance', 'imaging', 'system', 'south', 'am', '##eric', '##a', 'analysis', 'and', 'market', 'forecast']",1
323846,nifty_986,2015-01-08,Research and Markets: Sustained Release Injectables Markets to 2022,Fall,-0.008,67,research and market sustained release injectables market,56,7,0,pharmacy,"['research', 'and', 'market', 'sustained', 'release', 'in', '##ject', '##ables', 'market']",1
323856,nifty_986,2015-01-08,Research and Markets: Injectable Drug Delivery Markets to 2022,Fall,-0.008,62,research and market injectable drug delivery market,51,7,0,pharmacy,"['research', 'and', 'market', 'in', '##ject', '##able', 'drug', 'delivery', 'market']",1
323865,nifty_986,2015-01-08,"Technical Scrutiny on Biotech Stocks - Galena Biopharma, Synta Pharma, Merrimack Pharma, Vertex Pharma, and Spectrum Pharma",Fall,-0.008,123,technical scrutiny biotech stock galena biopharma synta pharma merrimack pharma vertex pharma and spectrum pharma,113,15,0,pharmacy,"['technical', 'scrutiny', 'bio', '##tech', 'stock', 'gal', '##ena', 'bio', '##pha', '##rma', 's', '##yn', '##ta', 'p', '##har', '##ma', 'me', '##rri', '##ma', '##ck', 'p', '##har', '##ma', 'vertex', 'p', '##har', '##ma', 'and', 'spectrum', 'p', '##har', '##ma']",1
323926,nifty_986,2015-01-08,Research and Markets: Drug Self-Administration Market Dynamics and Market Demographics to 2022,Fall,-0.008,94,research and market drug self administration market dynamic and market demographic,82,11,0,pharmacy,"['research', 'and', 'market', 'drug', 'self', 'administration', 'market', 'dynamic', 'and', 'market', 'demographic']",1
323964,nifty_986,2015-01-08,Research and Markets: Impact of Biosensing Technologies (Technical Insights Report),Fall,-0.008,83,research and market impact biosensing technology technical insight report,73,9,0,pharmacy,"['research', 'and', 'market', 'impact', 'bio', '##sen', '##sing', 'technology', 'technical', 'insight', 'report']",1
324035,nifty_986,2015-01-08,"Research and Markets: Global Telehealth Market 2015-2019 with GE Healthcare, McKesson, Philips Healthcare Informatics & Siemens Healthcare Dominating",Fall,-0.008,149,research and market global telehealth market with healthcare mckesson philip healthcare informatics siemens healthcare dominating,129,15,0,pharmacy,"['research', 'and', 'market', 'global', 'te', '##le', '##hea', '##lt', '##h', 'market', 'with', 'healthcare', 'm', '##cke', '##sson', 'p', '##hil', '##ip', 'healthcare', 'inform', '##atic', '##s', 'si', '##em', '##ens', 'healthcare', 'dominating']",1
324042,nifty_986,2015-01-08,"Bloomberg BNA To Host Health Care Outlook Event January 14 In Washington, D.C. -- Experts To Address Key Industry Trends",Fall,-0.008,120,bloomberg bna host health care outlook event january washington expert address key industry trend,97,14,0,pharmacy,"['b', '##loom', '##berg', 'b', '##na', 'host', 'health', 'care', 'outlook', 'event', 'j', '##anu', '##ary', 'washing', '##ton', 'expert', 'address', 'key', 'industry', 'trend']",1
324086,nifty_986,2015-01-08,Increased Need for Bio-security Will Influence the Growth of the Global Bio-Detection Market by 2019: TechNavio,Fall,-0.008,111,increased need for bio security will influence the growth the global bio detection market technavio,99,15,0,pharmacy,"['increased', 'need', 'for', 'bio', 'security', 'will', 'influence', 'the', 'growth', 'the', 'global', 'bio', 'detection', 'market', 'tech', '##na', '##vio']",1
324131,nifty_986,2015-01-08,Dipexium Pharmaceuticals to Present at Biotech Showcaseâ¢ 2015,Fall,-0.008,63,dipexium pharmaceutical present biotech showcaseâ,49,5,0,pharmacy,"['dip', '##ex', '##ium', 'pharmaceutical', 'present', 'bio', '##tech', 'showcase', '##â']",1
324178,nifty_986,2015-01-08,U.S. hedge fund plans to take on big pharma over patents,Fall,-0.008,56,hedge fund plan take big pharma over patent,43,8,0,pharmacy,"['hedge', 'fund', 'plan', 'take', 'big', 'p', '##har', '##ma', 'over', 'patent']",1
324199,nifty_986,2015-01-08,"Research and Markets: Global Cervical Cancer Diagnostic Tests Market 2014-2018 with Abbott Laboratories, Becton Dickinson, Hologic, Qiagen, Quest Diagnostics & Roche Diagnostics Dominating",Fall,-0.008,188,research and market global cervical cancer diagnostic test market with abbott laboratory becton dickinson hologic qiagen quest diagnostics roche diagnostics dominating,167,21,0,pharmacy,"['research', 'and', 'market', 'global', 'c', '##er', '##vic', '##al', 'cancer', 'diagnostic', 'test', 'market', 'with', 'abbot', '##t', 'laboratory', 'be', '##cton', 'dick', '##ins', '##on', 'ho', '##log', '##ic', 'q', '##ia', '##gen', 'quest', 'diagnostic', '##s', 'r', '##och', '##e', 'diagnostic', '##s', 'dominating']",1
324336,nifty_986,2015-01-08,INTERVIEW-Halozyme CEO sees blockbuster potential in its cancer drug,Fall,-0.008,68,interview halozyme ceo see blockbuster potential it cancer drug,63,9,0,pharmacy,"['interview', 'ha', '##lo', '##zy', '##me', 'c', '##eo', 'see', 'block', '##buster', 'potential', 'it', 'cancer', 'drug']",1
324427,nifty_986,2015-01-08,Biogen’s MS Drug Shows Promise Despite Study Failures,Fall,-0.008,53,biogen drug show promise despite study failure,46,7,0,pharmacy,"['bio', '##gen', 'drug', 'show', 'promise', 'despite', 'study', 'failure']",1
324428,nifty_986,2015-01-08,"Pfizer, FDA Continue Talks on Breast-Cancer Drug",Fall,-0.008,48,pfizer fda continue talk breast cancer drug,43,7,0,pharmacy,"['p', '##fi', '##zer', 'f', '##da', 'continue', 'talk', 'breast', 'cancer', 'drug']",1
324447,nifty_986,2015-01-08,"GW Pharmaceuticals, Otsuka Cancer-Pain Drug Misses Primary Endpoint",Fall,-0.008,67,pharmaceutical otsuka cancer pain drug miss primary endpoint,60,8,0,pharmacy,"['pharmaceutical', 'o', '##tsu', '##ka', 'cancer', 'pain', 'drug', 'miss', 'primary', 'end', '##point']",1
324515,nifty_987,2015-01-12,Bristol-Myers’s Lung Cancer Drug Shows Success,Neutral,-0.0028,46,bristol myers lung cancer drug show success,43,7,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'lung', 'cancer', 'drug', 'show', 'success']",1
324526,nifty_987,2015-01-12,Merck to Continue Focus on Cancer Drug Keytruda,Neutral,-0.0028,47,merck continue focus cancer drug keytruda,41,6,0,pharmacy,"['me', '##rc', '##k', 'continue', 'focus', 'cancer', 'drug', 'key', '##tr', '##uda']",1
324584,nifty_988,2015-01-13,Active Biotech to Present at the 33rd Annual J.P. Morgan Healthcare Conference,Fall,-0.006,78,active biotech present the annual morgan healthcare conference,62,8,0,pharmacy,"['active', 'bio', '##tech', 'present', 'the', 'annual', 'm', '##or', '##gan', 'healthcare', 'conference']",1
324736,nifty_988,2015-01-13,"Aegerion Pharmaceuticals Reports Preliminary 2014 Net Product Sales, Its Outlook for 2015 and Other Business Updates",Fall,-0.006,116,aegerion pharmaceutical report preliminary net product sale it outlook for and other business update,100,14,0,pharmacy,"['a', '##ege', '##rion', 'pharmaceutical', 'report', 'preliminary', 'net', 'product', 'sale', 'it', 'outlook', 'for', 'and', 'other', 'business', 'update']",1
324744,nifty_988,2015-01-13,Merck Provides Update on Strategic Actions to Transform the Company and Build a Platform for Sustained Future Growth at the 33rd Annual J.P. Morgan Healthcare Conference,Fall,-0.006,169,merck provides update strategic action transform the company and build platform for sustained future growth the annual morgan healthcare conference,147,20,0,pharmacy,"['me', '##rc', '##k', 'provides', 'update', 'strategic', 'action', 'transform', 'the', 'company', 'and', 'build', 'platform', 'for', 'sustained', 'future', 'growth', 'the', 'annual', 'm', '##or', '##gan', 'healthcare', 'conference']",1
324761,nifty_988,2015-01-13,Amicus Therapeutics Provides Full-Year 2015 Strategic Outlook and Financial Guidance,Fall,-0.006,84,amicus therapeutic provides full year strategic outlook and financial guidance,78,10,0,pharmacy,"['am', '##icus', 'therapeutic', 'provides', 'full', 'year', 'strategic', 'outlook', 'and', 'financial', 'guidance']",1
324789,nifty_988,2015-01-13,"HealthPrize Technologies Adds Leading Healthcare Executives to Board of Directors: Dieter Weinand, President and CEO of Bayer Pharma AG, and Dawn Owens, Former CEO of OptumHealth",Fall,-0.006,178,healthprize technology add leading healthcare executive board director dieter weinand president and ceo bayer pharma and dawn owen former ceo optumhealth,153,21,0,pharmacy,"['health', '##p', '##riz', '##e', 'technology', 'add', 'leading', 'healthcare', 'executive', 'board', 'director', 'diet', '##er', 'we', '##ina', '##nd', 'president', 'and', 'c', '##eo', 'bay', '##er', 'p', '##har', '##ma', 'and', 'dawn', 'owe', '##n', 'former', 'c', '##eo', 'op', '##tum', '##hea', '##lt', '##h']",1
324793,nifty_988,2015-01-13,10X Genomics Closes $55.5 Million Series B Round,Fall,-0.006,48,genomics close million series round,35,5,0,pharmacy,"['g', '##eno', '##mic', '##s', 'close', 'million', 'series', 'round']",1
324979,nifty_988,2015-01-13,"Research and Markets: New Pharmacovigilance Legislation Course: 22nd-23rd April 2015, London UK",Fall,-0.006,95,research and market new pharmacovigilance legislation course april london,73,9,0,pharmacy,"['research', 'and', 'market', 'new', 'p', '##har', '##ma', '##co', '##vi', '##gi', '##lance', 'legislation', 'course', 'a', '##p', '##ril', 'lo', '##ndon']",1
324983,nifty_988,2015-01-13,"Research and Markets: Developing Effective Training Skills in the Pharma Industry Course: 27-28th April 2015, London UK",Fall,-0.006,119,research and market developing effective training skill the pharma industry course april london,95,13,0,pharmacy,"['research', 'and', 'market', 'developing', 'effective', 'training', 'skill', 'the', 'p', '##har', '##ma', 'industry', 'course', 'a', '##p', '##ril', 'lo', '##ndon']",1
325007,nifty_988,2015-01-13,"Research and Markets: Managing Vendor/ CRO Oversight in the Pharm Industry Course: 9th-10th March 2015, London UK",Fall,-0.006,113,research and market managing vendor cro oversight the pharm industry course march london,88,13,0,pharmacy,"['research', 'and', 'market', 'managing', 'vendor', 'c', '##ro', 'oversight', 'the', 'p', '##har', '##m', 'industry', 'course', 'march', 'lo', '##ndon']",1
325051,nifty_988,2015-01-13,"Research and Markets: Behavioral/Mental Health Software Market Report 2014-2019 - Delivery Mode, Functionality & End User Analysis",Fall,-0.006,130,research and market behavioral mental health software market report delivery mode functionality end user analysis,113,15,0,pharmacy,"['research', 'and', 'market', 'behavioral', 'mental', 'health', 'software', 'market', 'report', 'delivery', 'mode', 'functionality', 'end', 'user', 'analysis']",1
325069,nifty_988,2015-01-13,Celgene Corporation Announces 2015 and Long-Term Financial Outlook and Preliminary 2014 Results,Fall,-0.006,95,celgene corporation announces and long term financial outlook and preliminary result,84,11,0,pharmacy,"['c', '##el', '##gene', 'corporation', 'announces', 'and', 'long', 'term', 'financial', 'outlook', 'and', 'preliminary', 'result']",1
325110,nifty_988,2015-01-13,Reformulation of Marketed Drugs Expected to Boost the Epilepsy Market in the US by 2019: TechNavio,Fall,-0.006,98,reformulation marketed drug expected boost the epilepsy market the technavio,76,10,0,pharmacy,"['reform', '##ulation', 'marketed', 'drug', 'expected', 'boost', 'the', 'e', '##pile', '##psy', 'market', 'the', 'tech', '##na', '##vio']",1
325183,nifty_988,2015-01-13,Research and Markets: Global Herbal Medicine Industry Report 2015-2020,Fall,-0.006,70,research and market global herbal medicine industry report,58,8,0,pharmacy,"['research', 'and', 'market', 'global', 'herb', '##al', 'medicine', 'industry', 'report']",1
325243,nifty_988,2015-01-13,Research and Markets: Global Orphan Drug Pipeline & Regulatory Insight 2015,Fall,-0.006,75,research and market global orphan drug pipeline regulatory insight,66,9,0,pharmacy,"['research', 'and', 'market', 'global', 'orphan', 'drug', 'pipeline', 'regulatory', 'insight']",1
325316,nifty_988,2015-01-13,GenMark Announces Completion of ePlexâ¢ Development and Preliminary Q4 Financial Results,Fall,-0.006,89,genmark announces completion eplexâ development and preliminary financial result,80,9,0,pharmacy,"['g', '##en', '##mark', 'announces', 'completion', 'e', '##plex', '##â', 'development', 'and', 'preliminary', 'financial', 'result']",1
325617,nifty_990,2015-01-15,How Far Can a Drug Firm Go in Protecting Its Profits?,Rise,0.0131,53,how far can drug firm protecting it profit,42,8,0,pharmacy,"['how', 'far', 'can', 'drug', 'firm', 'protecting', 'it', 'profit']",1
325954,nifty_992,2015-01-21,"Research and Markets: Emerging Diagnostic Imaging Market 2014-2020: Nuclear Imaging Systems, 3D Imaging, Tactile Imaging, Tomography, Emerging Diagnostic Biomarkers, Wearable Diagnostic Devices",Rise,0.0149,193,research and market emerging diagnostic imaging market nuclear imaging system imaging tactile imaging tomography emerging diagnostic biomarkers wearable diagnostic device,170,20,0,pharmacy,"['research', 'and', 'market', 'emerging', 'diagnostic', 'imaging', 'market', 'nuclear', 'imaging', 'system', 'imaging', 'ta', '##ct', '##ile', 'imaging', 'to', '##mo', '##graphy', 'emerging', 'diagnostic', 'bio', '##mark', '##ers', 'wear', '##able', 'diagnostic', 'device']",1
325971,nifty_992,2015-01-21,"Pharmaceutical-Bio Industry's First-Quarter 2015 Capital and Maintenance Project Starts Near $4 Billion Investment in North America, an Industrial Info News Alert",Rise,0.0149,162,pharmaceutical bio industry first quarter capital and maintenance project start near billion investment north america industrial info news alert,144,19,0,pharmacy,"['pharmaceutical', 'bio', 'industry', 'first', 'quarter', 'capital', 'and', 'maintenance', 'project', 'start', 'near', 'billion', 'investment', 'north', 'am', '##eric', '##a', 'industrial', 'info', 'news', 'alert']",1
326085,nifty_992,2015-01-21,"Research and Markets: Global Breast Imaging Market 2015-2019 with FujiFilms, GE Healthcare, Hologic, Philips Healthcare & Siemens Healthcare Dominating",Rise,0.0149,151,research and market global breast imaging market with fujifilms healthcare hologic philip healthcare siemens healthcare dominating,130,16,0,pharmacy,"['research', 'and', 'market', 'global', 'breast', 'imaging', 'market', 'with', 'f', '##u', '##ji', '##film', '##s', 'healthcare', 'ho', '##log', '##ic', 'p', '##hil', '##ip', 'healthcare', 'si', '##em', '##ens', 'healthcare', 'dominating']",1
326089,nifty_992,2015-01-21,"Research and Markets: Global Anxiety Disorders Market 2015-2019 with Eli Lilly and Company, GlaxoSmithKline & Pfizer Dominating",Rise,0.0149,127,research and market global anxiety disorder market with eli lilly and company glaxosmithkline pfizer dominating,111,15,0,pharmacy,"['research', 'and', 'market', 'global', 'anxiety', 'disorder', 'market', 'with', 'el', '##i', 'l', '##ill', '##y', 'and', 'company', 'g', '##lax', '##os', '##mith', '##k', '##line', 'p', '##fi', '##zer', 'dominating']",1
326130,nifty_992,2015-01-21,Vitae Pharmaceuticals Launches Proposed Follow-on Public Offering of Common Stock,Rise,0.0149,81,vitae pharmaceutical launch proposed follow public offering common stock,72,9,0,pharmacy,"['v', '##ita', '##e', 'pharmaceutical', 'launch', 'proposed', 'follow', 'public', 'offering', 'common', 'stock']",1
326228,nifty_992,2015-01-21,"Morning Analysis on Biotech Stocks -- Novavax, Isis Pharma, OPKO Health, Nanosphere, and NewLink Genetics",Rise,0.0149,105,morning analysis biotech stock novavax isi pharma opko health nanosphere and newlink genetics,93,13,0,pharmacy,"['morning', 'analysis', 'bio', '##tech', 'stock', 'no', '##va', '##va', '##x', 'is', '##i', 'p', '##har', '##ma', 'op', '##ko', 'health', 'na', '##nos', '##phere', 'and', 'new', '##link', 'genetics']",1
326262,nifty_992,2015-01-21,"Research and Markets: United States Healthcare RCM Outsourcing Market 2015-2019 with Conifer Health Solutions, Emdeon, MedAssets, Parallon Business Solutions & The SSI Group Dominating",Rise,0.0149,184,research and market united state healthcare rcm outsourcing market with conifer health solution emdeon medassets parallon business solution the ssi group dominating,164,22,0,pharmacy,"['research', 'and', 'market', 'united', 'state', 'healthcare', 'r', '##c', '##m', 'outs', '##our', '##cing', 'market', 'with', 'con', '##ifer', 'health', 'solution', 'em', '##de', '##on', 'me', '##das', '##sets', 'para', '##llon', 'business', 'solution', 'the', 's', '##si', 'group', 'dominating']",1
326440,nifty_992,2015-01-21,Neovacs to Present at BIO CEO & Investor Conference,Rise,0.0149,51,neovacs present bio ceo investor conference,43,6,0,pharmacy,"['neo', '##va', '##cs', 'present', 'bio', 'c', '##eo', 'investor', 'conference']",1
326517,nifty_992,2015-01-21,Research and Markets: Acute Heart Failure Pipeline Insights Report 2015,Rise,0.0149,71,research and market acute heart failure pipeline insight report,63,9,0,pharmacy,"['research', 'and', 'market', 'acute', 'heart', 'failure', 'pipeline', 'insight', 'report']",1
326534,nifty_992,2015-01-21,Research and Markets: Central Nervous System (CNS) Tumor Pipeline Insights Report 2015,Rise,0.0149,86,research and market central nervous system cns tumor pipeline insight report,76,11,0,pharmacy,"['research', 'and', 'market', 'central', 'nervous', 'system', 'c', '##ns', 'tumor', 'pipeline', 'insight', 'report']",1
326558,nifty_992,2015-01-21,Research and Markets: Fragile X Syndrome Pipeline Insights Report 2015,Rise,0.0149,70,research and market fragile syndrome pipeline insight report,60,8,0,pharmacy,"['research', 'and', 'market', 'fragile', 'syndrome', 'pipeline', 'insight', 'report']",1
326564,nifty_992,2015-01-21,Research and Markets: Fracture Pipeline Insights Report 2015,Rise,0.0149,60,research and market fracture pipeline insight report,52,7,0,pharmacy,"['research', 'and', 'market', 'fracture', 'pipeline', 'insight', 'report']",1
326566,nifty_992,2015-01-21,Research and Markets: Chronic Bronchitis Pipeline Insights Report 2015,Rise,0.0149,70,research and market chronic bronchitis pipeline insight report,62,8,0,pharmacy,"['research', 'and', 'market', 'chronic', 'br', '##on', '##chi', '##tis', 'pipeline', 'insight', 'report']",1
326571,nifty_992,2015-01-21,Research and Markets: Fibromyalgia Pipeline Insights Report 2015,Rise,0.0149,64,research and market fibromyalgia pipeline insight report,56,7,0,pharmacy,"['research', 'and', 'market', 'fi', '##bro', '##my', '##al', '##gia', 'pipeline', 'insight', 'report']",1
326576,nifty_992,2015-01-21,Research and Markets: Fistula Pipeline Insights Report 2015,Rise,0.0149,59,research and market fistula pipeline insight report,51,7,0,pharmacy,"['research', 'and', 'market', 'fist', '##ula', 'pipeline', 'insight', 'report']",1
326726,nifty_992,2015-01-21,biOasis Announces the Release of an Analyst Report,Rise,0.0149,50,bioasis announces the release analyst report,44,6,0,pharmacy,"['bio', '##asis', 'announces', 'the', 'release', 'analyst', 'report']",1
326868,nifty_992,2015-01-21,FDA Approves Novartis Psoriasis Drug,Rise,0.0149,36,fda approves novartis psoriasis drug,36,5,0,pharmacy,"['f', '##da', 'approve', '##s', 'no', '##var', '##tis', 'ps', '##oria', '##sis', 'drug']",1
327153,nifty_995,2015-01-27,Amgen Profit Rises 27% on Higher Sales of Key Drugs,Fall,-0.0128,51,amgen profit rise higher sale key drug,38,7,0,pharmacy,"['am', '##gen', 'profit', 'rise', 'higher', 'sale', 'key', 'drug']",1
327188,nifty_995,2015-01-27,Cancer Drugs Boost Bristol-Myers Sales,Fall,-0.0128,38,cancer drug boost bristol myers sale,36,6,0,pharmacy,"['cancer', 'drug', 'boost', 'br', '##ist', '##ol', 'my', '##ers', 'sale']",1
327214,nifty_995,2015-01-27,Novartis Upbeat Despite Weaker Profit,Fall,-0.0128,37,novartis upbeat despite weaker profit,37,5,0,pharmacy,"['no', '##var', '##tis', 'up', '##beat', 'despite', 'weaker', 'profit']",1
327290,nifty_996,2015-01-28,St. Jude Medical Outlook Hit by Foreign-Exchange Pressures,Rise,0.0092,58,jude medical outlook hit foreign exchange pressure,50,7,0,pharmacy,"['j', '##ude', 'medical', 'outlook', 'hit', 'foreign', 'exchange', 'pressure']",1
327317,nifty_997,2015-01-29,Sharing Some Clinical Trial Data Remains a Problem for Pharma,Fall,-0.0126,61,sharing some clinical trial data remains problem for pharma,59,9,0,pharmacy,"['sharing', 'some', 'clinical', 'trial', 'data', 'remains', 'problem', 'for', 'p', '##har', '##ma']",1
327343,nifty_997,2015-01-29,Biogen’s Profit Nearly Doubles,Fall,-0.0126,30,biogen profit nearly double,27,4,0,pharmacy,"['bio', '##gen', 'profit', 'nearly', 'double']",1
327632,nifty_999,2015-02-03,"Research and Markets: Epigenetics Market by Product, Research Area & by End User - Global Forecast to 2019 with Abcam, Active Motif, Diagenode, EMD Millipore, Illumina, New England Biolabs & QIAGEN Dominating",Neutral,-0.0038,208,research and market epigenetics market product research area end user global forecast with abcam active motif diagenode emd millipore illumina new england biolabs qiagen dominating,180,25,0,pharmacy,"['research', 'and', 'market', 'e', '##pi', '##gene', '##tics', 'market', 'product', 'research', 'area', 'end', 'user', 'global', 'forecast', 'with', 'a', '##b', '##cam', 'active', 'motif', 'di', '##age', '##no', '##de', 'em', '##d', 'mill', '##ip', '##ore', 'ill', '##umi', '##na', 'new', 'en', '##g', '##land', 'bio', '##la', '##bs', 'q', '##ia', '##gen', 'dominating']",1
327635,nifty_999,2015-02-03,Research and Markets: Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Report Featuring 75+ Companies Operating in this Market,Neutral,-0.0038,150,research and market global biomarker technology platform for cancer diagnosis and therapy report featuring company operating this market,136,18,0,pharmacy,"['research', 'and', 'market', 'global', 'bio', '##mark', '##er', 'technology', 'platform', 'for', 'cancer', 'diagnosis', 'and', 'therapy', 'report', 'featuring', 'company', 'operating', 'this', 'market']",1
327638,nifty_999,2015-02-03,"Research and Markets: Global Optical Imaging (Optical Coherence Tomography, Hyperspectral Imaging, Photoacoustic Tomography) Market 2014-2019",Neutral,-0.0038,141,research and market global optical imaging optical coherence tomography hyperspectral imaging photoacoustic tomography market,125,14,0,pharmacy,"['research', 'and', 'market', 'global', 'optical', 'imaging', 'optical', 'co', '##herence', 'to', '##mo', '##graphy', 'h', '##yper', '##spect', '##ral', 'imaging', 'photo', '##aco', '##ustic', 'to', '##mo', '##graphy', 'market']",1
327667,nifty_999,2015-02-03,Research and Markets: Targeting Immune Checkpoints in Cancer Immunotherapy Drug Pipeline Update 2015,Neutral,-0.0038,100,research and market targeting immune checkpoint cancer immunotherapy drug pipeline update,89,11,0,pharmacy,"['research', 'and', 'market', 'targeting', 'immune', 'check', '##point', 'cancer', 'im', '##mu', '##not', '##her', '##ap', '##y', 'drug', 'pipeline', 'update']",1
327699,nifty_999,2015-02-03,CelatorÂ® Pharmaceuticals to Present at BIO CEO and Investor Conference,Neutral,-0.0038,71,celatorâ pharmaceutical present bio ceo and investor conference,63,8,0,pharmacy,"['c', '##ela', '##tor', '##â', 'pharmaceutical', 'present', 'bio', 'c', '##eo', 'and', 'investor', 'conference']",1
327701,nifty_999,2015-02-03,CASI Pharmaceuticals To Present At The 17th Annual BIO CEO & Investor Conference,Neutral,-0.0038,80,casi pharmaceutical present the annual bio ceo investor conference,66,9,0,pharmacy,"['ca', '##si', 'pharmaceutical', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
327715,nifty_999,2015-02-03,RXi Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference,Neutral,-0.0038,79,rxi pharmaceutical present the annual bio ceo investor conference,65,9,0,pharmacy,"['r', '##xi', 'pharmaceutical', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
327723,nifty_999,2015-02-03,REG-Geron to Present at the 17th Annual BIO CEO & Investor Conference,Neutral,-0.0038,69,reg geron present the annual bio ceo investor conference,56,9,0,pharmacy,"['re', '##g', 'g', '##eron', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
327739,nifty_999,2015-02-03,Marinus Pharmaceuticals to Present at BIO CEO & Investor Conference,Neutral,-0.0038,67,marinus pharmaceutical present bio ceo investor conference,58,7,0,pharmacy,"['ma', '##rin', '##us', 'pharmaceutical', 'present', 'bio', 'c', '##eo', 'investor', 'conference']",1
327760,nifty_999,2015-02-03,Research and Markets: Lung Cancer Drug Pathway Analyzer Report 2015,Neutral,-0.0038,67,research and market lung cancer drug pathway analyzer report,60,9,0,pharmacy,"['research', 'and', 'market', 'lung', 'cancer', 'drug', 'pathway', 'analyze', '##r', 'report']",1
327765,nifty_999,2015-02-03,Inovio Pharmaceuticals to Present at Upcoming Investor Conferences,Neutral,-0.0038,66,inovio pharmaceutical present upcoming investor conference,58,6,0,pharmacy,"['in', '##ov', '##io', 'pharmaceutical', 'present', 'upcoming', 'investor', 'conference']",1
327773,nifty_999,2015-02-03,GenVec To Present At The 17th Annual BIO CEO & Investor Conference,Neutral,-0.0038,66,genvec present the annual bio ceo investor conference,53,8,0,pharmacy,"['g', '##en', '##ve', '##c', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
327779,nifty_999,2015-02-03,Arena Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference,Neutral,-0.0038,81,arena pharmaceutical present the annual bio ceo investor conference,67,9,0,pharmacy,"['arena', 'pharmaceutical', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
327782,nifty_999,2015-02-03,"StemCells, Inc. to Participate at the 17th Annual BIO CEO & Investor Conference",Neutral,-0.0038,79,stemcells inc participate the annual bio ceo investor conference,64,9,0,pharmacy,"['stem', '##cell', '##s', 'in', '##c', 'participate', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
327784,nifty_999,2015-02-03,GenSpera Presents at BIO CEO & Investor Conference,Neutral,-0.0038,50,genspera present bio ceo investor conference,44,6,0,pharmacy,"['g', '##ens', '##per', '##a', 'present', 'bio', 'c', '##eo', 'investor', 'conference']",1
327796,nifty_999,2015-02-03,NephroGenex to Present at the 17th Annual BIO CEO & Investor Conference,Neutral,-0.0038,71,nephrogenex present the annual bio ceo investor conference,58,8,0,pharmacy,"['ne', '##ph', '##rogen', '##ex', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
327806,nifty_999,2015-02-03,"Corbus Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference on February 9, 2015",Neutral,-0.0038,102,corbus pharmaceutical present the annual bio ceo investor conference february,77,10,0,pharmacy,"['co', '##rb', '##us', 'pharmaceutical', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference', 'f', '##eb', '##ru', '##ary']",1
327813,nifty_999,2015-02-03,Cortendo AB: Cortendo to Present at the 17th Annual BIO CEO & Investor Conference,Neutral,-0.0038,81,cortendo cortendo present the annual bio ceo investor conference,64,9,0,pharmacy,"['co', '##rten', '##do', 'co', '##rten', '##do', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
327824,nifty_999,2015-02-03,Relypsa to Present at 17th Annual BIO CEO & Investor Conference,Neutral,-0.0038,63,relypsa present annual bio ceo investor conference,50,7,0,pharmacy,"['rely', '##ps', '##a', 'present', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
327830,nifty_999,2015-02-03,Columbia Laboratories to Present at the 17th Annual BIO CEO & Investor Conference,Neutral,-0.0038,81,columbia laboratory present the annual bio ceo investor conference,66,9,0,pharmacy,"['co', '##lum', '##bia', 'laboratory', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
327874,nifty_999,2015-02-03,"CytRx to Present at the 17th Annual BIO CEO & Investor Conference on February 9, 2015 in New York City",Neutral,-0.0038,102,cytrx present the annual bio ceo investor conference february new york city,75,12,0,pharmacy,"['c', '##yt', '##r', '##x', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference', 'f', '##eb', '##ru', '##ary', 'new', 'yo', '##rk', 'city']",1
327903,nifty_999,2015-02-03,"Pharma Equities Under the Scanner - Pfizer, Sanofi, Eli Lilly, AstraZeneca, and Zogenix",Neutral,-0.0038,87,pharma equity under the scanner pfizer sanofi eli lilly astrazeneca and zogenix,79,12,0,pharmacy,"['p', '##har', '##ma', 'equity', 'under', 'the', 'scan', '##ner', 'p', '##fi', '##zer', 'sa', '##no', '##fi', 'el', '##i', 'l', '##ill', '##y', 'as', '##tra', '##zen', '##eca', 'and', 'z', '##ogen', '##ix']",1
327914,nifty_999,2015-02-03,Research and Markets: Cancer Cachexia Pipeline Insights Report 2015,Neutral,-0.0038,67,research and market cancer cachexia pipeline insight report,59,8,0,pharmacy,"['research', 'and', 'market', 'cancer', 'cache', '##xia', 'pipeline', 'insight', 'report']",1
327941,nifty_999,2015-02-03,Research and Markets: Dyskinesia Pipeline Insights Report 2015,Neutral,-0.0038,62,research and market dyskinesia pipeline insight report,54,7,0,pharmacy,"['research', 'and', 'market', 'd', '##ys', '##kin', '##esi', '##a', 'pipeline', 'insight', 'report']",1
327955,nifty_999,2015-02-03,Research and Markets: Cough Pipeline Insights Report 2015,Neutral,-0.0038,57,research and market cough pipeline insight report,49,7,0,pharmacy,"['research', 'and', 'market', 'cough', 'pipeline', 'insight', 'report']",1
327969,nifty_999,2015-02-03,Research and Markets: Coronary Artery Disease (CAD) Pipeline Insights 2015,Neutral,-0.0038,74,research and market coronary artery disease cad pipeline insight,64,9,0,pharmacy,"['research', 'and', 'market', 'co', '##rona', '##ry', 'artery', 'disease', 'ca', '##d', 'pipeline', 'insight']",1
328003,nifty_999,2015-02-03,Research and Markets: Liver Cancer Drug Pathway Analysis 2015,Neutral,-0.0038,61,research and market liver cancer drug pathway analysis,54,8,0,pharmacy,"['research', 'and', 'market', 'liver', 'cancer', 'drug', 'pathway', 'analysis']",1
328006,nifty_999,2015-02-03,HiberGene Diagnostics Secures Series A Funding of â¬2.0 Million,Neutral,-0.0038,64,hibergene diagnostics secures series funding million,52,6,0,pharmacy,"['hi', '##berg', '##ene', 'diagnostic', '##s', 'secure', '##s', 'series', 'funding', 'million']",1
328009,nifty_999,2015-02-03,Research and Markets: Breast Cancer Drug Pathway Analysis 2015: 567 Targeted Molecular Therapies Known to Affect More Than 256 Specific Intracellular Signaling Pathways,Neutral,-0.0038,168,research and market breast cancer drug pathway analysis targeted molecular therapy known affect more than specific intracellular signaling pathway,146,19,0,pharmacy,"['research', 'and', 'market', 'breast', 'cancer', 'drug', 'pathway', 'analysis', 'targeted', 'molecular', 'therapy', 'known', 'affect', 'more', 'than', 'specific', 'in', '##tra', '##cellular', 'signaling', 'pathway']",1
328034,nifty_999,2015-02-03,"With eMindful, companies and consumers may finally have a solution for high health risks, productivity losses, and medical costs.",Neutral,-0.0038,129,with emindful company and consumer may finally have solution for high health risk productivity loss and medical cost,116,18,0,pharmacy,"['with', 'em', '##ind', '##ful', 'company', 'and', 'consumer', 'may', 'finally', 'have', 'solution', 'for', 'high', 'health', 'risk', 'productivity', 'loss', 'and', 'medical', 'cost']",1
328057,nifty_999,2015-02-03,"Succeed In Choosing Your New Or Replacement EHR: OPEN MINDS 20-Year Industry Expert To Deliver Free Executive Web Briefing on February 26, 2015",Neutral,-0.0038,143,succeed choosing your new replacement ehr open mind year industry expert deliver free executive web briefing february,117,17,0,pharmacy,"['succeed', 'choosing', 'your', 'new', 'replacement', 'eh', '##r', 'open', 'mind', 'year', 'industry', 'expert', 'deliver', 'free', 'executive', 'web', 'brief', '##ing', 'f', '##eb', '##ru', '##ary']",1
328085,nifty_999,2015-02-03,Research and Markets: Funded Research in Mental Health 2015-2020,Neutral,-0.0038,64,research and market funded research mental health,49,7,0,pharmacy,"['research', 'and', 'market', 'funded', 'research', 'mental', 'health']",1
328165,nifty_999,2015-02-03,Research and Markets: Calcium Signaling Pathway in Cancer Drug Pipeline Analysis 2015,Neutral,-0.0038,85,research and market calcium signaling pathway cancer drug pipeline analysis,75,10,0,pharmacy,"['research', 'and', 'market', 'calcium', 'signaling', 'pathway', 'cancer', 'drug', 'pipeline', 'analysis']",1
328166,nifty_999,2015-02-03,Research and Markets: Cell Cycle Targeting in Cancer Drug Pipeline Analysis 2015,Neutral,-0.0038,80,research and market cell cycle targeting cancer drug pipeline analysis,70,10,0,pharmacy,"['research', 'and', 'market', 'cell', 'cycle', 'targeting', 'cancer', 'drug', 'pipeline', 'analysis']",1
328167,nifty_999,2015-02-03,Research and Markets: Cancer Stem Cells Drug Pipeline Analysis 2015,Neutral,-0.0038,67,research and market cancer stem cell drug pipeline analysis,59,9,0,pharmacy,"['research', 'and', 'market', 'cancer', 'stem', 'cell', 'drug', 'pipeline', 'analysis']",1
328170,nifty_999,2015-02-03,Research and Markets: Targeting Natural Killer Cell Mediated Cytotoxicity in Cancer Drug Pipeline Analysis 2015,Neutral,-0.0038,111,research and market targeting natural killer cell mediated cytotoxicity cancer drug pipeline analysis,101,13,0,pharmacy,"['research', 'and', 'market', 'targeting', 'natural', 'killer', 'cell', 'mediated', 'c', '##yt', '##oto', '##xi', '##city', 'cancer', 'drug', 'pipeline', 'analysis']",1
328173,nifty_999,2015-02-03,Research and Markets: VEGF Signaling Pathway in Cancer Drug Pipeline Analysis 2015,Neutral,-0.0038,82,research and market vegf signaling pathway cancer drug pipeline analysis,72,10,0,pharmacy,"['research', 'and', 'market', 've', '##g', '##f', 'signaling', 'pathway', 'cancer', 'drug', 'pipeline', 'analysis']",1
328174,nifty_999,2015-02-03,Research and Markets: Fc Epsilon RI Signaling Pathway in Oncology Drug Pipeline Analysis 2015,Neutral,-0.0038,93,research and market epsilon signaling pathway oncology drug pipeline analysis,77,10,0,pharmacy,"['research', 'and', 'market', 'e', '##ps', '##ilon', 'signaling', 'pathway', 'on', '##cology', 'drug', 'pipeline', 'analysis']",1
328185,nifty_999,2015-02-03,Research and Markets: Viral Carcinogenesis Drug Pipeline Analysis 2015,Neutral,-0.0038,70,research and market viral carcinogenesis drug pipeline analysis,63,8,0,pharmacy,"['research', 'and', 'market', 'viral', 'car', '##cin', '##ogen', '##esis', 'drug', 'pipeline', 'analysis']",1
328197,nifty_999,2015-02-03,ECRI Institute Study in Health Affairs Finds 75% Accuracy in Forecasting New Health Technologies,Neutral,-0.0038,96,ecri institute study health affair find accuracy forecasting new health technology,82,11,0,pharmacy,"['e', '##c', '##ri', 'institute', 'study', 'health', 'affair', 'find', 'accuracy', 'forecast', '##ing', 'new', 'health', 'technology']",1
328208,nifty_999,2015-02-03,Navidea to Report Preliminary 2014 Revenue and Present at BIO CEO & Investor Conference February 9,Neutral,-0.0038,98,navidea report preliminary revenue and present bio ceo investor conference february,83,11,0,pharmacy,"['na', '##vide', '##a', 'report', 'preliminary', 'revenue', 'and', 'present', 'bio', 'c', '##eo', 'investor', 'conference', 'f', '##eb', '##ru', '##ary']",1
328236,nifty_999,2015-02-03,Genocea to Present at the 2015 BIO CEO & Investor Conference,Neutral,-0.0038,60,genocea present the bio ceo investor conference,47,7,0,pharmacy,"['g', '##eno', '##cea', 'present', 'the', 'bio', 'c', '##eo', 'investor', 'conference']",1
328256,nifty_999,2015-02-03,Versartis to Present at the 2015 BIO CEO & Investor Conference,Neutral,-0.0038,62,versartis present the bio ceo investor conference,49,7,0,pharmacy,"['versa', '##rt', '##is', 'present', 'the', 'bio', 'c', '##eo', 'investor', 'conference']",1
328289,nifty_999,2015-02-03,Recro Pharma to Present at the 17th Annual BIO CEO & Investor Conference,Neutral,-0.0038,72,recro pharma present the annual bio ceo investor conference,59,9,0,pharmacy,"['re', '##c', '##ro', 'p', '##har', '##ma', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
328290,nifty_999,2015-02-03,Codexis to Present at BIO CEO & Investor Conference,Neutral,-0.0038,51,codexis present bio ceo investor conference,43,6,0,pharmacy,"['code', '##xi', '##s', 'present', 'bio', 'c', '##eo', 'investor', 'conference']",1
328295,nifty_999,2015-02-03,Kite Pharma to Present at the 17th Annual BIO CEO & Investor Conference,Neutral,-0.0038,71,kite pharma present the annual bio ceo investor conference,58,9,0,pharmacy,"['kit', '##e', 'p', '##har', '##ma', 'present', 'the', 'annual', 'bio', 'c', '##eo', 'investor', 'conference']",1
328356,nifty_999,2015-02-03,"Research and Markets: China: Traditional Chinese Medicine - Market Report, Analysis and Forecast to 2020",Neutral,-0.0038,104,research and market china traditional chinese medicine market report analysis and forecast,90,12,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'traditional', 'chin', '##ese', 'medicine', 'market', 'report', 'analysis', 'and', 'forecast']",1
328460,nifty_999,2015-02-03,Pfizer Breast Cancer Drug Ibrance Approved for Sale,Neutral,-0.0038,51,pfizer breast cancer drug ibrance approved for sale,51,8,0,pharmacy,"['p', '##fi', '##zer', 'breast', 'cancer', 'drug', 'i', '##bra', '##nce', 'approved', 'for', 'sale']",1
328484,nifty_999,2015-02-03,Amgen Biosimilar Rheumatoid Arthritis Drug Shows Promise,Neutral,-0.0038,56,amgen biosimilar rheumatoid arthritis drug show promise,55,7,0,pharmacy,"['am', '##gen', 'bio', '##si', '##mi', '##lar', 'r', '##he', '##uma', '##to', '##id', 'art', '##hr', '##itis', 'drug', 'show', 'promise']",1
328541,nifty_999,2015-02-03,J&J Sarcoma Drug Gets Priority Review,Neutral,-0.0038,37,sarcoma drug get priority review,32,5,0,pharmacy,"['sa', '##rc', '##oma', 'drug', 'get', 'priority', 'review']",1
329096,nifty_1005,2015-02-12,A ‘Swear Jar’ for Drug Makers,Neutral,0.0041,29,swear jar for drug maker,24,5,0,pharmacy,"['swear', 'jar', 'for', 'drug', 'maker']",1
329127,nifty_1005,2015-02-12,Painkiller in Short Supply Following Hospira Recall,Neutral,0.0041,51,painkiller short supply following hospira recall,48,6,0,pharmacy,"['pain', '##kill', '##er', 'short', 'supply', 'following', 'ho', '##sp', '##ira', 'recall']",1
329352,nifty_1006,2015-02-17,Research and Markets: Biosensors Market Report - Analysis & Forecast to 2020,Neutral,0.0001,76,research and market biosensors market report analysis forecast,62,8,0,pharmacy,"['research', 'and', 'market', 'bio', '##sen', '##sors', 'market', 'report', 'analysis', 'forecast']",1
329425,nifty_1006,2015-02-17,"Latest Updates on Health Care Sector: Special Research on bluebird bio, Brainstorm, CASI Pharmaceuticals, Celladon, and Cellular Dynamics",Neutral,0.0001,137,latest update health care sector special research bluebird bio brainstorm casi pharmaceutical celladon and cellular dynamic,123,16,0,pharmacy,"['latest', 'update', 'health', 'care', 'sector', 'special', 'research', 'blue', '##bird', 'bio', 'brains', '##tor', '##m', 'ca', '##si', 'pharmaceutical', 'cell', '##ado', '##n', 'and', 'cellular', 'dynamic']",1
329430,nifty_1006,2015-02-17,"A Look at the Latest Occurrences in the Biotechnology Sector: Special Research on China Biologic Products, Compugen, Curis, CytRx, and DBV Technologies",Neutral,0.0001,151,look the latest occurrence the biotechnology sector special research china biologic product compugen curis cytrx and dbv technology,131,18,0,pharmacy,"['look', 'the', 'latest', 'occurrence', 'the', 'bio', '##tech', '##nology', 'sector', 'special', 'research', 'chin', '##a', 'bio', '##log', '##ic', 'product', 'com', '##pu', '##gen', 'cu', '##ris', 'c', '##yt', '##r', '##x', 'and', 'd', '##b', '##v', 'technology']",1
329434,nifty_1006,2015-02-17,"Recent Developments at Pharma Companies: Special Research on Discovery Labs, Enzon, Fate Therapeutics, Genetic Technologies, and Genocea Biosciences",Neutral,0.0001,148,recent development pharma company special research discovery lab enzon fate therapeutic genetic technology and genocea bioscience,129,16,0,pharmacy,"['recent', 'development', 'p', '##har', '##ma', 'company', 'special', 'research', 'discovery', 'lab', 'en', '##zon', 'fate', 'therapeutic', 'genetic', 'technology', 'and', 'g', '##eno', '##cea', 'bio', '##science']",1
329495,nifty_1006,2015-02-17,"Rainbow Medical Raises $25 Million from Chinese Investors, and Sets Up a China Office for Strategic Collaborations",Neutral,0.0001,114,rainbow medical raise million from chinese investor and set china office for strategic collaboration,100,14,0,pharmacy,"['rainbow', 'medical', 'raise', 'million', 'from', 'chin', '##ese', 'investor', 'and', 'set', 'chin', '##a', 'office', 'for', 'strategic', 'collaboration']",1
329516,nifty_1006,2015-02-17,Growing Focus on Stem Cell Research Is Expected to Boost the Global Cell Culture Protein Surface Coating Market through 2019: TechNavio,Neutral,0.0001,135,growing focus stem cell research expected boost the global cell culture protein surface coating market through technavio,120,17,0,pharmacy,"['growing', 'focus', 'stem', 'cell', 'research', 'expected', 'boost', 'the', 'global', 'cell', 'culture', 'protein', 'surface', 'coating', 'market', 'through', 'tech', '##na', '##vio']",1
329572,nifty_1006,2015-02-17,Research and Markets: Diagnostics Partnering Terms and Agreements Report 2015,Neutral,0.0001,77,research and market diagnostics partnering term and agreement report,68,9,0,pharmacy,"['research', 'and', 'market', 'diagnostic', '##s', 'partner', '##ing', 'term', 'and', 'agreement', 'report']",1
329610,nifty_1006,2015-02-17,"Research and Markets: 2015 Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics",Neutral,0.0001,106,research and market distribution partnering term and agreement pharma biotech and diagnostics,93,12,0,pharmacy,"['research', 'and', 'market', 'distribution', 'partner', '##ing', 'term', 'and', 'agreement', 'p', '##har', '##ma', 'bio', '##tech', 'and', 'diagnostic', '##s']",1
329628,nifty_1006,2015-02-17,Research and Markets: Global Serum Industry Report 2015 - Forecasts to 2020,Neutral,0.0001,75,research and market global serum industry report forecast,57,8,0,pharmacy,"['research', 'and', 'market', 'global', 'serum', 'industry', 'report', 'forecast']",1
329928,nifty_1007,2015-02-18,Research and Markets: Global Infrared Sensors Market Analysis and Forecast 2014-2019,Neutral,-0.0007,84,research and market global infrared sensor market analysis and forecast,71,10,0,pharmacy,"['research', 'and', 'market', 'global', 'infrared', 'sensor', 'market', 'analysis', 'and', 'forecast']",1
329991,nifty_1007,2015-02-18,"PDL BioPharma to Announce Fourth Quarter and Full Year 2014 Financial Results on February 23, 2015",Neutral,-0.0007,98,pdl biopharma announce fourth quarter and full year financial result february,77,11,0,pharmacy,"['p', '##dl', 'bio', '##pha', '##rma', 'announce', 'fourth', 'quarter', 'and', 'full', 'year', 'financial', 'result', 'f', '##eb', '##ru', '##ary']",1
330020,nifty_1007,2015-02-18,"Alliqua BioMedical, Inc. to Present at Upcoming Investor Conferences",Neutral,-0.0007,68,alliqua biomedical inc present upcoming investor conference,59,7,0,pharmacy,"['all', '##iq', '##ua', 'bio', '##medical', 'in', '##c', 'present', 'upcoming', 'investor', 'conference']",1
330050,nifty_1007,2015-02-18,Horizon Pharma plc Expands U.S. Headquarters With Opening of Chicago Office,Neutral,-0.0007,75,horizon pharma plc expands headquarters with opening chicago office,67,9,0,pharmacy,"['horizon', 'p', '##har', '##ma', 'plc', 'expands', 'headquarters', 'with', 'opening', 'ch', '##ica', '##go', 'office']",1
330082,nifty_1007,2015-02-18,"Research and Markets: Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market 2015: Strategic Analysis of Industry Trends, Technologies, Participants, and Environment",Neutral,-0.0007,187,research and market personalized medicine targeted therapeutic and companion diagnostic market strategic analysis industry trend technology participant and environment,167,19,0,pharmacy,"['research', 'and', 'market', 'personal', '##ized', 'medicine', 'targeted', 'therapeutic', 'and', 'companion', 'diagnostic', 'market', 'strategic', 'analysis', 'industry', 'trend', 'technology', 'participant', 'and', 'environment']",1
330092,nifty_1007,2015-02-18,Biotech Investor Alex Rabinovich Increases Stake in XTL Biopharmaceuticals,Neutral,-0.0007,74,biotech investor alex rabinovich increase stake xtl biopharmaceuticals,70,8,0,pharmacy,"['bio', '##tech', 'investor', 'ale', '##x', 'r', '##abi', '##nov', '##ich', 'increase', 'stake', 'x', '##tl', 'bio', '##pha', '##rma', '##ce', '##utical', '##s']",1
330093,nifty_1007,2015-02-18,"Regen BioPharma, Inc. Expands Management Team With the Addition of New CFO Todd Caven",Neutral,-0.0007,85,regen biopharma inc expands management team with the addition new cfo todd caven,80,13,0,pharmacy,"['re', '##gen', 'bio', '##pha', '##rma', 'in', '##c', 'expands', 'management', 'team', 'with', 'the', 'addition', 'new', 'c', '##fo', 'to', '##dd', 'cave', '##n']",1
330103,nifty_1007,2015-02-18,Vaxin Enters Definitive Agreement to Acquire Immune Targeting Systems (ITS); Secures $16M in New Financing,Neutral,-0.0007,106,vaxin enters definitive agreement acquire immune targeting system it secures new financing,90,12,0,pharmacy,"['v', '##ax', '##in', 'enters', 'definitive', 'agreement', 'acquire', 'immune', 'targeting', 'system', 'it', 'secure', '##s', 'new', 'financing']",1
330105,nifty_1007,2015-02-18,"ArQule, Inc. to Present at 2015 RBC Capital Marketsâ Global Healthcare Conference",Neutral,-0.0007,83,arqule inc present rbc capital marketsâ global healthcare conference,68,9,0,pharmacy,"['a', '##r', '##q', '##ule', 'in', '##c', 'present', 'r', '##b', '##c', 'capital', 'markets', '##â', 'global', 'healthcare', 'conference']",1
330161,nifty_1007,2015-02-18,HealthEquity to Present at Two Upcoming Investor Conferences,Neutral,-0.0007,60,healthequity present two upcoming investor conference,53,6,0,pharmacy,"['health', '##e', '##qui', '##ty', 'present', 'two', 'upcoming', 'investor', 'conference']",1
330175,nifty_1007,2015-02-18,"Technical Briefing on Biotech Stocks -- Exelixis, Exact Sciences, Idera Pharma, Seattle Genetics, and Ironwood Pharma",Neutral,-0.0007,117,technical briefing biotech stock exelixis exact science idera pharma seattle genetics and ironwood pharma,105,14,0,pharmacy,"['technical', 'brief', '##ing', 'bio', '##tech', 'stock', 'ex', '##eli', '##xi', '##s', 'exact', 'science', 'id', '##era', 'p', '##har', '##ma', 'seat', '##tle', 'genetics', 'and', 'iron', '##wood', 'p', '##har', '##ma']",1
330211,nifty_1007,2015-02-18,"QmedRx, a Nationally Accredited Compound Pharmacy, Discusses the New FDA Proposals That Will Limit Patient Access",Neutral,-0.0007,113,qmedrx nationally accredited compound pharmacy discusses the new fda proposal that will limit patient access,108,15,0,pharmacy,"['q', '##med', '##r', '##x', 'nationally', 'accredited', 'compound', 'pharmacy', 'discusses', 'the', 'new', 'f', '##da', 'proposal', 'that', 'will', 'limit', 'patient', 'access']",1
330282,nifty_1007,2015-02-18,TechNavio Says the Global Transplantation Market Is Expected to See Significant Growth through 2019,Neutral,-0.0007,99,technavio say the global transplantation market expected see significant growth through,87,11,0,pharmacy,"['tech', '##na', '##vio', 'say', 'the', 'global', 'transplant', '##ation', 'market', 'expected', 'see', 'significant', 'growth', 'through']",1
330500,nifty_1007,2015-02-18,Arrowhead to Present at 2015 RBC Capital Markets' Global Healthcare Conference,Neutral,-0.0007,78,arrowhead present rbc capital market global healthcare conference,65,8,0,pharmacy,"['arrow', '##head', 'present', 'r', '##b', '##c', 'capital', 'market', 'global', 'healthcare', 'conference']",1
330564,nifty_1007,2015-02-18,GenMark Diagnostics to Present at Two Upcoming Investor Conferences,Neutral,-0.0007,67,genmark diagnostics present two upcoming investor conference,60,7,0,pharmacy,"['g', '##en', '##mark', 'diagnostic', '##s', 'present', 'two', 'upcoming', 'investor', 'conference']",1
330621,nifty_1007,2015-02-18,"Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2015",Neutral,-0.0007,95,elite pharmaceutical inc report financial result for the third quarter fiscal year,82,12,0,pharmacy,"['elite', 'pharmaceutical', 'in', '##c', 'report', 'financial', 'result', 'for', 'the', 'third', 'quarter', 'fiscal', 'year']",1
330814,nifty_1008,2015-02-19,"Research and Markets: Global Transdermal Drug Delivery Market to 2020: Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and Swot Investigation",Rise,0.006,198,research and market global transdermal drug delivery market strategic analysis technology competitor profile financial evaluation product pipeline assessment and swot investigation,180,21,0,pharmacy,"['research', 'and', 'market', 'global', 'trans', '##der', '##mal', 'drug', 'delivery', 'market', 'strategic', 'analysis', 'technology', 'competitor', 'profile', 'financial', 'evaluation', 'product', 'pipeline', 'assessment', 'and', 's', '##wo', '##t', 'investigation']",1
330834,nifty_1008,2015-02-19,Research and Markets: Global Radiation Hardened Electronic Devices and Components Market Analysis 2013-2019,Rise,0.006,107,research and market global radiation hardened electronic device and component market analysis,93,12,0,pharmacy,"['research', 'and', 'market', 'global', 'radiation', 'hardened', 'electronic', 'device', 'and', 'component', 'market', 'analysis']",1
330866,nifty_1008,2015-02-19,Aerie Pharmaceuticals Announces Potential Breakthroughs with New Preclinical Research,Rise,0.006,85,aerie pharmaceutical announces potential breakthrough with new preclinical research,83,9,0,pharmacy,"['a', '##erie', 'pharmaceutical', 'announces', 'potential', 'breakthrough', 'with', 'new', 'pre', '##c', '##lini', '##cal', 'research']",1
330892,nifty_1008,2015-02-19,Research and Markets: Global Equipments of Traditional Chinese Medicine Industry Report 2015,Rise,0.006,92,research and market global equipment traditional chinese medicine industry report,81,10,0,pharmacy,"['research', 'and', 'market', 'global', 'equipment', 'traditional', 'chin', '##ese', 'medicine', 'industry', 'report']",1
330938,nifty_1008,2015-02-19,Research and Markets: Reverse Costing Analysis of Seek Thermal Infrared Camera & the Raytheon IR Microbolometer,Rise,0.006,111,research and market reverse costing analysis seek thermal infrared camera the raytheon microbolometer,101,13,0,pharmacy,"['research', 'and', 'market', 'reverse', 'costing', 'analysis', 'seek', 'thermal', 'infrared', 'camera', 'the', 'ray', '##theon', 'micro', '##bol', '##ometer']",1
330957,nifty_1008,2015-02-19,Raptor Pharmaceutical to Attend Upcoming Investor Conferences,Rise,0.006,61,raptor pharmaceutical attend upcoming investor conference,57,6,0,pharmacy,"['rap', '##tor', 'pharmaceutical', 'attend', 'upcoming', 'investor', 'conference']",1
330966,nifty_1008,2015-02-19,Arena Pharmaceuticals to Present at the 2015 RBC Capital Markets Healthcare Conference,Rise,0.006,86,arena pharmaceutical present the rbc capital market healthcare conference,73,9,0,pharmacy,"['arena', 'pharmaceutical', 'present', 'the', 'r', '##b', '##c', 'capital', 'market', 'healthcare', 'conference']",1
330975,nifty_1008,2015-02-19,"Biodesix Builds on Investments in Sales, Reimbursement and Government Affairs Growth Strategy",Rise,0.006,93,biodesix build investment sale reimbursement and government affair growth strategy,82,10,0,pharmacy,"['bio', '##des', '##ix', 'build', 'investment', 'sale', 're', '##im', '##bur', '##se', '##ment', 'and', 'government', 'affair', 'growth', 'strategy']",1
330976,nifty_1008,2015-02-19,CEL-SCI to Present at 3rd Annual Sachs Cancer Bio Partnering & Investment Forum,Rise,0.006,79,cel sci present annual sachs cancer bio partnering investment forum,67,10,0,pharmacy,"['c', '##el', 's', '##ci', 'present', 'annual', 'sa', '##chs', 'cancer', 'bio', 'partner', '##ing', 'investment', 'forum']",1
331087,nifty_1008,2015-02-19,"Technical Report on Pharma Stocks -- Novo Nordisk, Theravance, XenoPort, Cempra, and Ampio Pharma",Rise,0.006,97,technical report pharma stock novo nordisk theravance xenoport cempra and ampio pharma,86,12,0,pharmacy,"['technical', 'report', 'p', '##har', '##ma', 'stock', 'no', '##vo', 'nor', '##dis', '##k', 'the', '##ra', '##vance', 'x', '##eno', '##port', 'c', '##em', '##pra', 'and', 'am', '##pio', 'p', '##har', '##ma']",1
331093,nifty_1008,2015-02-19,"Code-N to Provide Secure, Cloud-Based Scientific Intelligence to BioPharma Companies via Exostar's Life Sciences Identity Hub",Rise,0.006,125,code provide secure cloud based scientific intelligence biopharma company via exostar life science identity hub,111,15,0,pharmacy,"['code', 'provide', 'secure', 'cloud', 'based', 'scientific', 'intelligence', 'bio', '##pha', '##rma', 'company', 'via', 'ex', '##ost', '##ar', 'life', 'science', 'identity', 'hub']",1
331104,nifty_1008,2015-02-19,Research and Markets: Global Diabetes Drugs Industry Report 2015-2020 - Development Trends & Competitive Landscape Analysis,Rise,0.006,123,research and market global diabetes drug industry report development trend competitive landscape analysis,105,13,0,pharmacy,"['research', 'and', 'market', 'global', 'diabetes', 'drug', 'industry', 'report', 'development', 'trend', 'competitive', 'landscape', 'analysis']",1
331210,nifty_1008,2015-02-19,Research and Markets: Global Peptide Therapeutics Pipeline Insight 2015,Rise,0.006,71,research and market global peptide therapeutic pipeline insight,63,8,0,pharmacy,"['research', 'and', 'market', 'global', 'p', '##eptide', 'therapeutic', 'pipeline', 'insight']",1
331295,nifty_1008,2015-02-19,"Research and Markets: Global Refurbished Medical Equipment Market 2015-2019 with GE Healthcare, Siemens Healthcare, Philips Healthcare & Toshiba Medical Systems Dominating",Rise,0.006,171,research and market global refurbished medical equipment market with healthcare siemens healthcare philip healthcare toshiba medical system dominating,150,18,0,pharmacy,"['research', 'and', 'market', 'global', 'refurbished', 'medical', 'equipment', 'market', 'with', 'healthcare', 'si', '##em', '##ens', 'healthcare', 'p', '##hil', '##ip', 'healthcare', 'to', '##shi', '##ba', 'medical', 'system', 'dominating']",1
331300,nifty_1008,2015-02-19,HealthSouth To Present At The Raymond James 36th Annual Institutional Investors Conference,Rise,0.006,90,healthsouth present the raymond james annual institutional investor conference,78,9,0,pharmacy,"['health', '##so', '##uth', 'present', 'the', 'ray', '##mond', 'jam', '##es', 'annual', 'institutional', 'investor', 'conference']",1
331446,nifty_1008,2015-02-19,Infinity to Present at the RBC Capital Markets 2015 Healthcare Conference,Rise,0.006,73,infinity present the rbc capital market healthcare conference,61,8,0,pharmacy,"['in', '##finity', 'present', 'the', 'r', '##b', '##c', 'capital', 'market', 'healthcare', 'conference']",1
331506,nifty_1008,2015-02-19,XenoPort to Present at the RBC Capital Marketsâ Global Healthcare Conference,Rise,0.006,78,xenoport present the rbc capital marketsâ global healthcare conference,70,9,0,pharmacy,"['x', '##eno', '##port', 'present', 'the', 'r', '##b', '##c', 'capital', 'markets', '##â', 'global', 'healthcare', 'conference']",1
331806,nifty_1009,2015-02-23,Lilly Delays Diabetes Treatment Submission,Neutral,0.0028,42,lilly delay diabetes treatment submission,41,5,0,pharmacy,"['l', '##ill', '##y', 'delay', 'diabetes', 'treatment', 'submission']",1
331808,nifty_1009,2015-02-23,Bristol-Myers to Acquire Flexus Immunotherapy Pipeline,Neutral,0.0028,54,bristol myers acquire flexus immunotherapy pipeline,51,6,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'acquire', 'fl', '##ex', '##us', 'im', '##mu', '##not', '##her', '##ap', '##y', 'pipeline']",1
331812,nifty_1009,2015-02-23,"Merck to Team With NGM to Develop Diabetes, Obesity Treatments",Neutral,0.0028,62,merck team with ngm develop diabetes obesity treatment,54,8,0,pharmacy,"['me', '##rc', '##k', 'team', 'with', 'ng', '##m', 'develop', 'diabetes', 'o', '##besity', 'treatment']",1
331893,nifty_1010,2015-02-24,Alkermes To Discontinue Development of Pain Treatment,Neutral,-0.0008,53,alkermes discontinue development pain treatment,47,5,0,pharmacy,"['al', '##ker', '##mes', 'disco', '##ntin', '##ue', 'development', 'pain', 'treatment']",1
331918,nifty_1011,2015-02-25,Amgen Drug Shows Positive Results in Late-Phase Study,Neutral,-0.0012,53,amgen drug show positive result late phase study,48,8,0,pharmacy,"['am', '##gen', 'drug', 'show', 'positive', 'result', 'late', 'phase', 'study']",1
332090,nifty_1012,2015-02-26,Independence Holding Company Unveils Technology Platform to Administer Full Spectrum of Health Products on Private and Public Exchanges,Neutral,-0.0034,135,independence holding company unveils technology platform administer full spectrum health product private and public exchange,124,15,0,pharmacy,"['independence', 'holding', 'company', 'un', '##ve', '##ils', 'technology', 'platform', 'administer', 'full', 'spectrum', 'health', 'product', 'private', 'and', 'public', 'exchange']",1
332121,nifty_1012,2015-02-26,Research and Markets: Enzyme-Linked Immunosorbent Assay (ELISA) - Global Strategic Business Report 2015-2020,Neutral,-0.0034,108,research and market enzyme linked immunosorbent assay elisa global strategic business report,92,12,0,pharmacy,"['research', 'and', 'market', 'enzyme', 'linked', 'im', '##mu', '##nos', '##or', '##bent', 'ass', '##ay', 'el', '##isa', 'global', 'strategic', 'business', 'report']",1
332186,nifty_1012,2015-02-26,Research and Markets: Journal of Commercial Biotechnology,Neutral,-0.0034,57,research and market journal commercial biotechnology,52,6,0,pharmacy,"['research', 'and', 'market', 'journal', 'commercial', 'bio', '##tech', '##nology']",1
332212,nifty_1012,2015-02-26,GW Pharmaceuticals to Present at Upcoming Investor Conferences,Neutral,-0.0034,62,pharmaceutical present upcoming investor conference,51,5,0,pharmacy,"['pharmaceutical', 'present', 'upcoming', 'investor', 'conference']",1
332241,nifty_1012,2015-02-26,"Research and Markets: Recurrent Malignant Glioma Therapeutics Pipeline Review, H1 2015 - Analysis of 5 Companies & 12 Drug Profiles",Neutral,-0.0034,131,research and market recurrent malignant glioma therapeutic pipeline review analysis company drug profile,104,13,0,pharmacy,"['research', 'and', 'market', 're', '##current', 'ma', '##li', '##gnant', 'g', '##lio', '##ma', 'therapeutic', 'pipeline', 'review', 'analysis', 'company', 'drug', 'profile']",1
332279,nifty_1012,2015-02-26,Research and Markets: Acute Heart Failure Therapeutics Pipeline Review 2015 - 10 Companies & 13 Drug Profiles,Neutral,-0.0034,109,research and market acute heart failure therapeutic pipeline review company drug profile,88,12,0,pharmacy,"['research', 'and', 'market', 'acute', 'heart', 'failure', 'therapeutic', 'pipeline', 'review', 'company', 'drug', 'profile']",1
332289,nifty_1012,2015-02-26,Research and Markets: Investment Analysis of the European Medical Device Sector 2015,Neutral,-0.0034,84,research and market investment analysis the european medical device sector,74,10,0,pharmacy,"['research', 'and', 'market', 'investment', 'analysis', 'the', 'euro', '##pe', '##an', 'medical', 'device', 'sector']",1
332308,nifty_1012,2015-02-26,QuantRx(R) Biomedical Provides Update on Corporate Developments,Neutral,-0.0034,63,quantrx biomedical provides update corporate development,56,6,0,pharmacy,"['q', '##uant', '##r', '##x', 'bio', '##medical', 'provides', 'update', 'corporate', 'development']",1
332334,nifty_1012,2015-02-26,Research and Markets: Tardive Dyskinesia Therapeutics Pipeline Review 2015 - 5 Companies & 5 Drug Profiles,Neutral,-0.0034,106,research and market tardive dyskinesia therapeutic pipeline review company drug profile,87,11,0,pharmacy,"['research', 'and', 'market', 'ta', '##rdi', '##ve', 'd', '##ys', '##kin', '##esi', '##a', 'therapeutic', 'pipeline', 'review', 'company', 'drug', 'profile']",1
332346,nifty_1012,2015-02-26,"Latest Updates on the Healthcare Sector: Complementary Research on NxStage Medical, PhotoMedex, Rockwell Medical, Semler and Stereotaxis",Neutral,-0.0034,136,latest update the healthcare sector complementary research nxstage medical photomedex rockwell medical semler and stereotaxis,125,15,0,pharmacy,"['latest', 'update', 'the', 'healthcare', 'sector', 'complementary', 'research', 'n', '##x', '##sta', '##ge', 'medical', 'photo', '##med', '##ex', 'rock', '##well', 'medical', 'se', '##mler', 'and', 'stereo', '##ta', '##xi', '##s']",1
332347,nifty_1012,2015-02-26,"Research and Markets: Pyelonephritis - Pipeline Review, H1 2015 - Analysis of 5 Companies",Neutral,-0.0034,89,research and market pyelonephritis pipeline review analysis company,67,8,0,pharmacy,"['research', 'and', 'market', 'p', '##ye', '##lone', '##ph', '##rit', '##is', 'pipeline', 'review', 'analysis', 'company']",1
332364,nifty_1012,2015-02-26,bswift Sustains Its Rapid Growth in an Evolving Health and Benefits Market,Neutral,-0.0034,74,bswift sustains it rapid growth evolving health and benefit market,66,10,0,pharmacy,"['b', '##s', '##wi', '##ft', 'sustain', '##s', 'it', 'rapid', 'growth', 'evolving', 'health', 'and', 'benefit', 'market']",1
332368,nifty_1012,2015-02-26,BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences,Neutral,-0.0034,88,biospecifics technology corp announces presentation upcoming investor conference,80,8,0,pharmacy,"['bio', '##sp', '##ec', '##ific', '##s', 'technology', 'co', '##rp', 'announces', 'presentation', 'upcoming', 'investor', 'conference']",1
332374,nifty_1012,2015-02-26,A.M. Best Special Report: U.S. Health Care Industry Remains Resilient in a Year of Change,Neutral,-0.0034,89,best special report health care industry remains resilient year change,70,10,0,pharmacy,"['best', 'special', 'report', 'health', 'care', 'industry', 'remains', 're', '##si', '##lient', 'year', 'change']",1
332376,nifty_1012,2015-02-26,Marina Biotech Provides 2014 Year-End Financials and Update,Neutral,-0.0034,59,marina biotech provides year end financials and update,54,8,0,pharmacy,"['ma', '##rina', 'bio', '##tech', 'provides', 'year', 'end', 'financial', '##s', 'and', 'update']",1
332394,nifty_1012,2015-02-26,"Research and Markets: Kidney Transplant Market, Numbers & Forecast for United States, Mexico & Canada 2015",Neutral,-0.0034,106,research and market kidney transplant market number forecast for united state mexico canada,91,13,0,pharmacy,"['research', 'and', 'market', 'kidney', 'transplant', 'market', 'number', 'forecast', 'for', 'united', 'state', 'me', '##xi', '##co', 'can', '##ada']",1
332400,nifty_1012,2015-02-26,"Market Updates on Biotech Stocks - Hemispherx Biopharma, Nanosphere, Isis Pharma, Keryx Biopharma, and Spectrum Pharma",Neutral,-0.0034,118,market update biotech stock hemispherx biopharma nanosphere isi pharma keryx biopharma and spectrum pharma,106,14,0,pharmacy,"['market', 'update', 'bio', '##tech', 'stock', 'hem', '##is', '##pher', '##x', 'bio', '##pha', '##rma', 'na', '##nos', '##phere', 'is', '##i', 'p', '##har', '##ma', 'k', '##ery', '##x', 'bio', '##pha', '##rma', 'and', 'spectrum', 'p', '##har', '##ma']",1
332472,nifty_1012,2015-02-26,Study Urges Greater Financial Disclosure by Nonprofit Integrated Health Systems,Neutral,-0.0034,79,study urge greater financial disclosure nonprofit integrated health system,74,9,0,pharmacy,"['study', 'urge', 'greater', 'financial', 'disclosure', 'nonprofit', 'integrated', 'health', 'system']",1
332526,nifty_1012,2015-02-26,Increased Adoption of Corporate Culture in the Healthcare Industry Will Impact the Healthcare IT Market in India through 2019: TechNavio,Neutral,-0.0034,136,increased adoption corporate culture the healthcare industry will impact the healthcare market india through technavio,118,15,0,pharmacy,"['increased', 'adoption', 'corporate', 'culture', 'the', 'healthcare', 'industry', 'will', 'impact', 'the', 'healthcare', 'market', 'in', '##dia', 'through', 'tech', '##na', '##vio']",1
332613,nifty_1012,2015-02-26,Research and Markets: Global Transdermal Patch Market & Pipeline Insight 2015,Neutral,-0.0034,77,research and market global transdermal patch market pipeline insight,68,9,0,pharmacy,"['research', 'and', 'market', 'global', 'trans', '##der', '##mal', 'patch', 'market', 'pipeline', 'insight']",1
332627,nifty_1012,2015-02-26,Research and Markets: Cancer Nanomedicine Market & Pipeline Insight 2015,Neutral,-0.0034,72,research and market cancer nanomedicine market pipeline insight,63,8,0,pharmacy,"['research', 'and', 'market', 'cancer', 'na', '##no', '##med', '##ici', '##ne', 'market', 'pipeline', 'insight']",1
332652,nifty_1012,2015-02-26,"Health Insurance Innovations, Inc. to Present at the Raymond James & Associates 36th Annual Institutional Investors Conference",Neutral,-0.0034,126,health insurance innovation inc present the raymond james associate annual institutional investor conference,108,13,0,pharmacy,"['health', 'insurance', 'innovation', 'in', '##c', 'present', 'the', 'ray', '##mond', 'jam', '##es', 'associate', 'annual', 'institutional', 'investor', 'conference']",1
332654,nifty_1012,2015-02-26,Novacyt Receives Approval in China for NOVAPrepÂ®,Neutral,-0.0034,49,novacyt receives approval china for novaprepâ,45,6,0,pharmacy,"['no', '##va', '##cy', '##t', 'receives', 'approval', 'chin', '##a', 'for', 'no', '##va', '##p', '##re', '##p', '##â']",1
332665,nifty_1012,2015-02-26,BRIEF-Novacyt receives approval in China for NOVAPrep,Neutral,-0.0034,53,brief novacyt receives approval china for novaprep,50,7,0,pharmacy,"['brief', 'no', '##va', '##cy', '##t', 'receives', 'approval', 'chin', '##a', 'for', 'no', '##va', '##p', '##re', '##p']",1
332696,nifty_1012,2015-02-26,"Pharmacyclics mulls selling itself; J&J;, Novartis interested-Bloomberg",Neutral,-0.0034,71,pharmacyclics mull selling itself novartis interested bloomberg,63,7,0,pharmacy,"['pharmacy', '##c', '##lic', '##s', 'm', '##ull', 'selling', 'itself', 'no', '##var', '##tis', 'interested', 'b', '##loom', '##berg']",1
332987,nifty_1012,2015-02-26,Celldex Therapeutics Prices Public Offering of Common Stock,Neutral,-0.0034,59,celldex therapeutic price public offering common stock,54,7,0,pharmacy,"['cell', '##de', '##x', 'therapeutic', 'price', 'public', 'offering', 'common', 'stock']",1
333061,nifty_1012,2015-02-26,Novartis Amends Heart-Drug Trial,Neutral,-0.0034,32,novartis amends heart drug trial,32,5,0,pharmacy,"['no', '##var', '##tis', 'am', '##ends', 'heart', 'drug', 'trial']",1
333104,nifty_1012,2015-02-26,Catamaran to Buy Healthcare Solutions for $405 Million,Neutral,-0.0034,54,catamaran buy healthcare solution for million,45,6,0,pharmacy,"['cat', '##ama', '##ran', 'buy', 'healthcare', 'solution', 'for', 'million']",1
333214,nifty_1013,2015-03-02,Endo to Sell Men’s Health Businesses to Boston Scientific,Neutral,-0.0041,57,endo sell men health business boston scientific,47,7,0,pharmacy,"['end', '##o', 'sell', 'men', 'health', 'business', 'b', '##ost', '##on', 'scientific']",1
333325,nifty_1015,2015-03-04,FDA Approves Bristol-Myers Drug for Lung Cancer,Neutral,0.0011,47,fda approves bristol myers drug for lung cancer,47,8,0,pharmacy,"['f', '##da', 'approve', '##s', 'br', '##ist', '##ol', 'my', '##ers', 'drug', 'for', 'lung', 'cancer']",1
333372,nifty_1015,2015-03-04,Baxter Buys Autoimmune Specialist SuppreMol,Neutral,0.0011,43,baxter buy autoimmune specialist suppremol,42,5,0,pharmacy,"['b', '##ax', '##ter', 'buy', 'auto', '##im', '##mu', '##ne', 'specialist', 'su', '##pp', '##rem', '##ol']",1
333386,nifty_1015,2015-03-04,"Bristol-Myers, Bavarian Nordic Ink Prostate-Cancer Deal",Neutral,0.0011,55,bristol myers bavarian nordic ink prostate cancer deal,54,8,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'b', '##ava', '##rian', 'nor', '##dic', 'ink', 'pro', '##state', 'cancer', 'deal']",1
333443,nifty_1016,2015-03-05,AbbVie in $21 Billion Biotech Deal,Fall,-0.0141,34,abbvie billion biotech deal,27,4,0,pharmacy,"['a', '##bb', '##vie', 'billion', 'bio', '##tech', 'deal']",1
333572,nifty_1017,2015-03-09,FDA Panel Backs Kythera Double-Chin Treatment,Fall,-0.0162,45,fda panel back kythera double chin treatment,44,7,0,pharmacy,"['f', '##da', 'panel', 'back', 'k', '##yt', '##her', '##a', 'double', 'chin', 'treatment']",1
333601,nifty_1017,2015-03-09,AcelRx Says FDA Calls for Additional Trial on Zalviso,Fall,-0.0162,53,acelrx say fda call for additional trial zalviso,48,8,0,pharmacy,"['ace', '##l', '##r', '##x', 'say', 'f', '##da', 'call', 'for', 'additional', 'trial', 'z', '##al', '##vis', '##o']",1
333605,nifty_1017,2015-03-09,Concordia Healthcare to Buy Some Assets of Covis Pharma,Fall,-0.0162,55,concordia healthcare buy some asset covis pharma,48,7,0,pharmacy,"['con', '##cor', '##dia', 'healthcare', 'buy', 'some', 'asset', 'co', '##vis', 'p', '##har', '##ma']",1
333708,nifty_1018,2015-03-10,Research and Markets: Asia Pacific Medical Imaging Market Report 2015 - Analysis and Forecasts 2007-2020,Neutral,-0.0023,104,research and market asia pacific medical imaging market report analysis and forecast,84,12,0,pharmacy,"['research', 'and', 'market', 'as', '##ia', 'p', '##ac', '##ific', 'medical', 'imaging', 'market', 'report', 'analysis', 'and', 'forecast']",1
333715,nifty_1018,2015-03-10,Research and Markets: India Medical Imaging Market Forecasts to 2020,Neutral,-0.0023,68,research and market india medical imaging market forecast,57,8,0,pharmacy,"['research', 'and', 'market', 'in', '##dia', 'medical', 'imaging', 'market', 'forecast']",1
333723,nifty_1018,2015-03-10,Research and Markets: Top 100 India Medical Devices Companies 2015,Neutral,-0.0023,66,research and market top india medical device company,52,8,0,pharmacy,"['research', 'and', 'market', 'top', 'in', '##dia', 'medical', 'device', 'company']",1
333726,nifty_1018,2015-03-10,Research and Markets: Top 100 India Medical Technology Companies,Neutral,-0.0023,64,research and market top india medical technology company,56,8,0,pharmacy,"['research', 'and', 'market', 'top', 'in', '##dia', 'medical', 'technology', 'company']",1
333727,nifty_1018,2015-03-10,Research and Markets: Top 100 India Medical Supplies Companies 2015 - Analysis of the $4.8 Billion Industry,Neutral,-0.0023,107,research and market top india medical supply company analysis the billion industry,82,12,0,pharmacy,"['research', 'and', 'market', 'top', 'in', '##dia', 'medical', 'supply', 'company', 'analysis', 'the', 'billion', 'industry']",1
333730,nifty_1018,2015-03-10,Research and Markets: Top 100 Foreign Medical Devices/Technology/Supplies Companies Active in India: 2015,Neutral,-0.0023,105,research and market top foreign medical device technology supply company active india,85,12,0,pharmacy,"['research', 'and', 'market', 'top', 'foreign', 'medical', 'device', 'technology', 'supply', 'company', 'active', 'in', '##dia']",1
333735,nifty_1018,2015-03-10,Research and Markets: Top 100 Global Medical Devices Not Active in India: 2015 Industry Report,Neutral,-0.0023,94,research and market top global medical device not active india industry report,78,12,0,pharmacy,"['research', 'and', 'market', 'top', 'global', 'medical', 'device', 'not', 'active', 'in', '##dia', 'industry', 'report']",1
333738,nifty_1018,2015-03-10,Research and Markets: Leading 100 Global Medical Technology Companies Currently Not Active in India: 2015 An Industry Report,Neutral,-0.0023,124,research and market leading global medical technology company currently not active india industry report,104,14,0,pharmacy,"['research', 'and', 'market', 'leading', 'global', 'medical', 'technology', 'company', 'currently', 'not', 'active', 'in', '##dia', 'industry', 'report']",1
333739,nifty_1018,2015-03-10,Research and Markets: Global Medical Supplies Not Active in India 100: 2015 Industry Report,Neutral,-0.0023,91,research and market global medical supply not active india industry report,74,11,0,pharmacy,"['research', 'and', 'market', 'global', 'medical', 'supply', 'not', 'active', 'in', '##dia', 'industry', 'report']",1
333741,nifty_1018,2015-03-10,Research and Markets: Top 100 Medical Devices/Technology/Supplies Companies in Australia/New Zealand 2015,Neutral,-0.0023,105,research and market top medical device technology supply company australia new zealand,86,12,0,pharmacy,"['research', 'and', 'market', 'top', 'medical', 'device', 'technology', 'supply', 'company', 'au', '##stra', '##lia', 'new', 'z', '##eal', '##and']",1
333813,nifty_1018,2015-03-10,Catalyst Pharmaceuticals to Present at the 27th Annual ROTH Conference,Neutral,-0.0023,70,catalyst pharmaceutical present the annual roth conference,58,7,0,pharmacy,"['catalyst', 'pharmaceutical', 'present', 'the', 'annual', 'rot', '##h', 'conference']",1
333868,nifty_1018,2015-03-10,Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss 2014 Financial Results and Provide Corporate Update,Neutral,-0.0023,120,xenon pharmaceutical host conference call and webcast discus financial result and provide corporate update,106,14,0,pharmacy,"['x', '##eno', '##n', 'pharmaceutical', 'host', 'conference', 'call', 'and', 'web', '##cast', 'disc', '##us', 'financial', 'result', 'and', 'provide', 'corporate', 'update']",1
333960,nifty_1018,2015-03-10,Research and Markets: Global National eID Industry Report: 2014-2018 - Analysis and Forecasts of the $55 Billion Industry,Neutral,-0.0023,121,research and market global national eid industry report analysis and forecast the billion industry,98,14,0,pharmacy,"['research', 'and', 'market', 'global', 'national', 'e', '##id', 'industry', 'report', 'analysis', 'and', 'forecast', 'the', 'billion', 'industry']",1
333984,nifty_1018,2015-03-10,"Pharma Equities Technical Data - Merck, AbbVie, Bristol-Myers Squibb, Eli Lilly, and Lannett",Neutral,-0.0023,92,pharma equity technical data merck abbvie bristol myers squibb eli lilly and lannett,84,13,0,pharmacy,"['p', '##har', '##ma', 'equity', 'technical', 'data', 'me', '##rc', '##k', 'a', '##bb', '##vie', 'br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'el', '##i', 'l', '##ill', '##y', 'and', 'la', '##nne', '##tt']",1
334062,nifty_1018,2015-03-10,ProtoKinetix Announces Settlement of Debt,Neutral,-0.0023,41,protokinetix announces settlement debt,38,4,0,pharmacy,"['pro', '##tok', '##inet', '##ix', 'announces', 'settlement', 'debt']",1
334112,nifty_1018,2015-03-10,"Research and Markets: North American Healthcare Analytics Market 2015 - Growth, Trends & Forecast To 2020",Neutral,-0.0023,105,research and market north american healthcare analytics market growth trend forecast,84,11,0,pharmacy,"['research', 'and', 'market', 'north', 'am', '##eric', '##an', 'healthcare', 'anal', '##ytic', '##s', 'market', 'growth', 'trend', 'forecast']",1
334114,nifty_1018,2015-03-10,"Research and Markets: Asia-Pacific Healthcare Analytics Market - Growth, Trends & Forecast To 2020",Neutral,-0.0023,98,research and market asia pacific healthcare analytics market growth trend forecast,82,11,0,pharmacy,"['research', 'and', 'market', 'as', '##ia', 'p', '##ac', '##ific', 'healthcare', 'anal', '##ytic', '##s', 'market', 'growth', 'trend', 'forecast']",1
334120,nifty_1018,2015-03-10,"Research and Markets: Global Healthcare Analytics Market - Growth, Trends & Forecast To 2020",Neutral,-0.0023,92,research and market global healthcare analytics market growth trend forecast,76,10,0,pharmacy,"['research', 'and', 'market', 'global', 'healthcare', 'anal', '##ytic', '##s', 'market', 'growth', 'trend', 'forecast']",1
334128,nifty_1018,2015-03-10,"Research and Markets: European Healthcare Analytics Market 2015 - Growth, Trends & Forecast To 2020",Neutral,-0.0023,99,research and market european healthcare analytics market growth trend forecast,78,10,0,pharmacy,"['research', 'and', 'market', 'euro', '##pe', '##an', 'healthcare', 'anal', '##ytic', '##s', 'market', 'growth', 'trend', 'forecast']",1
334171,nifty_1018,2015-03-10,Research and Markets: Global Transplantation Market 2015-2019 - Increased Government and NGO Initiatives,Neutral,-0.0023,104,research and market global transplantation market increased government and ngo initiative,89,11,0,pharmacy,"['research', 'and', 'market', 'global', 'transplant', '##ation', 'market', 'increased', 'government', 'and', 'ng', '##o', 'initiative']",1
334238,nifty_1018,2015-03-10,Takeda Hosts Investor Briefing on its Global Leadership in Gastroenterology,Neutral,-0.0023,75,takeda host investor briefing it global leadership gastroenterology,67,8,0,pharmacy,"['take', '##da', 'host', 'investor', 'brief', '##ing', 'it', 'global', 'leadership', 'gas', '##tro', '##enter', '##ology']",1
334278,nifty_1018,2015-03-10,"Research and Markets: Global Infertility Market 2015-2019: Key Vendors are Bayer Healthcare, CooperSurgical, Ferring Pharmaceuticals & Merck & Co.",Neutral,-0.0023,146,research and market global infertility market key vendor are bayer healthcare coopersurgical ferring pharmaceutical merck,121,15,0,pharmacy,"['research', 'and', 'market', 'global', 'in', '##fer', '##tility', 'market', 'key', 'vendor', 'are', 'bay', '##er', 'healthcare', 'co', '##oper', '##su', '##rg', '##ical', 'f', '##er', '##ring', 'pharmaceutical', 'me', '##rc', '##k']",1
334285,nifty_1018,2015-03-10,Research and Markets: Analysis of the Global Oncology Drug Delivery Market 2015 - Future Impact of Emerging Technologies,Neutral,-0.0023,120,research and market analysis the global oncology drug delivery market future impact emerging technology,103,14,0,pharmacy,"['research', 'and', 'market', 'analysis', 'the', 'global', 'on', '##cology', 'drug', 'delivery', 'market', 'future', 'impact', 'emerging', 'technology']",1
334292,nifty_1018,2015-03-10,Research and Markets: Singapore Private Outpatient Diagnostic Imaging Services Market 2015,Neutral,-0.0023,90,research and market singapore private outpatient diagnostic imaging service market,82,10,0,pharmacy,"['research', 'and', 'market', 'sing', '##ap', '##ore', 'private', 'out', '##patient', 'diagnostic', 'imaging', 'service', 'market']",1
334318,nifty_1018,2015-03-10,Bridging the Confidence Gap: KeyBank and HelloWallet Join Forces to Support Financial Health,Neutral,-0.0023,92,bridging the confidence gap keybank and hellowallet join force support financial health,87,12,0,pharmacy,"['br', '##id', '##ging', 'the', 'confidence', 'gap', 'key', '##bank', 'and', 'hello', '##wall', '##et', 'join', 'force', 'support', 'financial', 'health']",1
334319,nifty_1018,2015-03-10,Precision Advisors Expands Strategic Team to Meet Business Growth in Pharmaceutical and Life Sciences,Neutral,-0.0023,101,precision advisor expands strategic team meet business growth pharmaceutical and life science,93,12,0,pharmacy,"['precision', 'advisor', 'expands', 'strategic', 'team', 'meet', 'business', 'growth', 'pharmaceutical', 'and', 'life', 'science']",1
334354,nifty_1018,2015-03-10,KYTHERA Biopharmaceuticals Announces Proposed Public Offering of Common Stock,Neutral,-0.0023,77,kythera biopharmaceuticals announces proposed public offering common stock,74,8,0,pharmacy,"['k', '##yt', '##her', '##a', 'bio', '##pha', '##rma', '##ce', '##utical', '##s', 'announces', 'proposed', 'public', 'offering', 'common', 'stock']",1
334405,nifty_1018,2015-03-10,Tetraphase Pharmaceuticals Announces Proposed Public Offering of Common Stock,Neutral,-0.0023,77,tetraphase pharmaceutical announces proposed public offering common stock,73,8,0,pharmacy,"['te', '##tra', '##pha', '##se', 'pharmaceutical', 'announces', 'proposed', 'public', 'offering', 'common', 'stock']",1
334699,nifty_1020,2015-03-12,Bristol-Myers’s Andreotti Got $27.1 Million in Compensation in 2014,Fall,-0.0061,67,bristol myers andreotti got million compensation,48,6,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'and', '##re', '##ott', '##i', 'got', 'million', 'compensation']",1
334937,nifty_1022,2015-03-17,Holy Grail: Pain Pills Without the High,Rise,0.012,39,holy grail pain pill without the high,37,7,0,pharmacy,"['holy', 'g', '##rail', 'pain', 'pill', 'without', 'the', 'high']",1
335209,nifty_1023,2015-03-18,Flex Pharma Reports Year End 2014 Financial Results,Neutral,-0.0046,51,flex pharma report year end financial result,44,7,0,pharmacy,"['fl', '##ex', 'p', '##har', '##ma', 'report', 'year', 'end', 'financial', 'result']",1
335317,nifty_1023,2015-03-18,Bio-Path Holdings Reports Fiscal Year 2014 Operational and Financial Results,Neutral,-0.0046,76,bio path holding report fiscal year operational and financial result,68,10,0,pharmacy,"['bio', 'path', 'holding', 'report', 'fiscal', 'year', 'operational', 'and', 'financial', 'result']",1
335493,nifty_1023,2015-03-18,$8 Billion Annual Savings Opportunity for U.S. Healthcare With Adoption of Electronic Business Transactions,Neutral,-0.0046,107,billion annual saving opportunity for healthcare with adoption electronic business transaction,94,11,0,pharmacy,"['billion', 'annual', 'saving', 'opportunity', 'for', 'healthcare', 'with', 'adoption', 'electronic', 'business', 'transaction']",1
335701,nifty_1023,2015-03-18,CelatorÂ® Pharmaceuticals Announces Business Update and Fourth Quarter and Full Year 2014 Financial Results,Neutral,-0.0046,107,celatorâ pharmaceutical announces business update and fourth quarter and full year financial result,99,13,0,pharmacy,"['c', '##ela', '##tor', '##â', 'pharmaceutical', 'announces', 'business', 'update', 'and', 'fourth', 'quarter', 'and', 'full', 'year', 'financial', 'result']",1
335821,nifty_1023,2015-03-18,Vivo Capital Closes Oversubscribed $750 Million 8th Fund to Invest in Healthcare in the U.S. and Greater China,Neutral,-0.0046,110,vivo capital close oversubscribed million fund invest healthcare the and greater china,86,12,0,pharmacy,"['v', '##ivo', 'capital', 'close', 'overs', '##ub', '##scribed', 'million', 'fund', 'invest', 'healthcare', 'the', 'and', 'greater', 'chin', '##a']",1
335959,nifty_1024,2015-03-19,Global Biosensors Market to Grow to US$21.64 Billion in 2020 Due to Rising Chronic Diseases: Transparency Market Research,Neutral,0.0043,121,global biosensors market grow billion due rising chronic disease transparency market research,93,12,0,pharmacy,"['global', 'bio', '##sen', '##sors', 'market', 'grow', 'billion', 'due', 'rising', 'chronic', 'disease', 'transparency', 'market', 'research']",1
336041,nifty_1024,2015-03-19,Boyden Executive Monitor Reveals Healthcare Sector Transformed by Innovation and Consumer Marketing,Neutral,0.0043,99,boyden executive monitor reveals healthcare sector transformed innovation and consumer marketing,96,11,0,pharmacy,"['boy', '##den', 'executive', 'monitor', 'reveals', 'healthcare', 'sector', 'transformed', 'innovation', 'and', 'consumer', 'marketing']",1
336109,nifty_1024,2015-03-19,RestorGenex to Present at the Future Leaders in the Biotech Industry Conference,Neutral,0.0043,79,restorgenex present the future leader the biotech industry conference,69,9,0,pharmacy,"['rest', '##or', '##gene', '##x', 'present', 'the', 'future', 'leader', 'the', 'bio', '##tech', 'industry', 'conference']",1
336153,nifty_1024,2015-03-19,Research and Markets: China Patient Monitoring and Diagnostic Systems Markets 2015-2024,Neutral,0.0043,87,research and market china patient monitoring and diagnostic system market,73,10,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'patient', 'monitoring', 'and', 'diagnostic', 'system', 'market']",1
336159,nifty_1024,2015-03-19,Global Biotechnology Market to Reach US$414.5 Billion by 2017: Transparency Market Research,Neutral,0.0043,91,global biotechnology market reach billion transparency market research,70,8,0,pharmacy,"['global', 'bio', '##tech', '##nology', 'market', 'reach', 'billion', 'transparency', 'market', 'research']",1
336206,nifty_1024,2015-03-19,"Recent Developments at Computer Software Companies: Special Research on Marketo, Materialise, MedAssets, Medical Transcription Billing, and Medidata",Neutral,0.0043,148,recent development computer software company special research marketo materialise medassets medical transcription billing and medidata,134,15,0,pharmacy,"['recent', 'development', 'computer', 'software', 'company', 'special', 'research', 'market', '##o', 'material', '##ise', 'me', '##das', '##sets', 'medical', 'transcription', 'bill', '##ing', 'and', 'me', '##di', '##data']",1
336234,nifty_1024,2015-03-19,"Biotech Stocks Technical Study -- Orexigen Therapeutics, Celgene, PDL BioPharma, Amarin, and Synergy Pharma",Neutral,0.0043,107,biotech stock technical study orexigen therapeutic celgene pdl biopharma amarin and synergy pharma,98,13,0,pharmacy,"['bio', '##tech', 'stock', 'technical', 'study', 'ore', '##xi', '##gen', 'therapeutic', 'c', '##el', '##gene', 'p', '##dl', 'bio', '##pha', '##rma', 'am', '##ari', '##n', 'and', 's', '##yne', '##rgy', 'p', '##har', '##ma']",1
336266,nifty_1024,2015-03-19,Research and Markets: United States Patient Monitoring and Diagnostic Systems Market Assessment and Forecast To 2020,Neutral,0.0043,116,research and market united state patient monitoring and diagnostic system market assessment and forecast,104,14,0,pharmacy,"['research', 'and', 'market', 'united', 'state', 'patient', 'monitoring', 'and', 'diagnostic', 'system', 'market', 'assessment', 'and', 'forecast']",1
336271,nifty_1024,2015-03-19,The Alliance for Regenerative Medicine Releases Agenda for Third Annual Regen Med Investor Day,Neutral,0.0043,94,the alliance for regenerative medicine release agenda for third annual regen med investor day,93,14,0,pharmacy,"['the', 'alliance', 'for', 're', '##gene', '##rative', 'medicine', 'release', 'agenda', 'for', 'third', 'annual', 're', '##gen', 'me', '##d', 'investor', 'day']",1
336292,nifty_1024,2015-03-19,Research and Markets: Medical Devices Markets in China 2015-2024,Neutral,0.0043,64,research and market medical device market china,47,7,0,pharmacy,"['research', 'and', 'market', 'medical', 'device', 'market', 'chin', '##a']",1
336438,nifty_1024,2015-03-19,Research and Markets: Leukodystrophies Therapeutics Pipeline Review 2015 - 6 Companies & 6 Drug Profiles,Neutral,0.0043,104,research and market leukodystrophies therapeutic pipeline review company drug profile,85,10,0,pharmacy,"['research', 'and', 'market', 'le', '##uk', '##ody', '##stro', '##phi', '##es', 'therapeutic', 'pipeline', 'review', 'company', 'drug', 'profile']",1
336506,nifty_1024,2015-03-19,Research and Markets: PharmaPoint: Irritable Bowel Syndrome - 5EU Drug Forecast and Market Analysis to 2023,Neutral,0.0043,107,research and market pharmapoint irritable bowel syndrome drug forecast and market analysis,90,12,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##point', 'i', '##rri', '##table', 'bow', '##el', 'syndrome', 'drug', 'forecast', 'and', 'market', 'analysis']",1
336586,nifty_1024,2015-03-19,Research and Markets: United States Irritable Bowel Syndrome Drug Forecast and Market Analysis to 2023,Neutral,0.0043,102,research and market united state irritable bowel syndrome drug forecast and market analysis,91,13,0,pharmacy,"['research', 'and', 'market', 'united', 'state', 'i', '##rri', '##table', 'bow', '##el', 'syndrome', 'drug', 'forecast', 'and', 'market', 'analysis']",1
336610,nifty_1024,2015-03-19,Research and Markets: United States Lotronex (Irritable Bowel Syndrome) Forecast and Market Analysis to 2023,Neutral,0.0043,108,research and market united state lotronex irritable bowel syndrome forecast and market analysis,95,13,0,pharmacy,"['research', 'and', 'market', 'united', 'state', 'lot', '##rone', '##x', 'i', '##rri', '##table', 'bow', '##el', 'syndrome', 'forecast', 'and', 'market', 'analysis']",1
336613,nifty_1024,2015-03-19,Research and Markets: Amitiza (Irritable Bowel Syndrome) Forecast and Market Analysis to 2023,Neutral,0.0043,93,research and market amitiza irritable bowel syndrome forecast and market analysis,81,11,0,pharmacy,"['research', 'and', 'market', 'am', '##iti', '##za', 'i', '##rri', '##table', 'bow', '##el', 'syndrome', 'forecast', 'and', 'market', 'analysis']",1
336615,nifty_1024,2015-03-19,Research and Markets: Linzess (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023,Neutral,0.0043,95,research and market linzess irritable bowel syndrome forecast and market analysis,81,11,0,pharmacy,"['research', 'and', 'market', 'l', '##in', '##zes', '##s', 'i', '##rri', '##table', 'bow', '##el', 'syndrome', 'forecast', 'and', 'market', 'analysis']",1
336637,nifty_1024,2015-03-19,Research and Markets: UK Multiparameter Patient Monitors Market Growth Trends 2015,Neutral,0.0043,82,research and market multiparameter patient monitor market growth trend,70,9,0,pharmacy,"['research', 'and', 'market', 'multi', '##par', '##ame', '##ter', 'patient', 'monitor', 'market', 'growth', 'trend']",1
336666,nifty_1024,2015-03-19,Research and Markets: Brain Cancer Pipeline Highlights 2014-2017,Neutral,0.0043,64,research and market brain cancer pipeline highlight,51,7,0,pharmacy,"['research', 'and', 'market', 'brain', 'cancer', 'pipeline', 'highlight']",1
336678,nifty_1024,2015-03-19,Research and Markets: Autism Spectrum Disorder Pipeline Highlights 2014-2017,Neutral,0.0043,76,research and market autism spectrum disorder pipeline highlight,63,8,0,pharmacy,"['research', 'and', 'market', 'autism', 'spectrum', 'disorder', 'pipeline', 'highlight']",1
336690,nifty_1024,2015-03-19,Research and Markets: Thrombosis Pipeline Highlights 2014-2017,Neutral,0.0043,62,research and market thrombosis pipeline highlight,49,6,0,pharmacy,"['research', 'and', 'market', 'th', '##rom', '##bos', '##is', 'pipeline', 'highlight']",1
336721,nifty_1024,2015-03-19,Research and Markets: Neuroblastoma Pipeline Highlights 2014-2017,Neutral,0.0043,65,research and market neuroblastoma pipeline highlight,52,6,0,pharmacy,"['research', 'and', 'market', 'ne', '##uro', '##blast', '##oma', 'pipeline', 'highlight']",1
336844,nifty_1024,2015-03-19,Esperion Therapeutics Prices Public Offering of Common Stock,Neutral,0.0043,60,esperion therapeutic price public offering common stock,55,7,0,pharmacy,"['es', '##per', '##ion', 'therapeutic', 'price', 'public', 'offering', 'common', 'stock']",1
336890,nifty_1024,2015-03-19,"Lilly Joins With Chinese Biotech to Develop, Market Cancer Drugs",Neutral,0.0043,64,lilly join with chinese biotech develop market cancer drug,58,9,0,pharmacy,"['l', '##ill', '##y', 'join', 'with', 'chin', '##ese', 'bio', '##tech', 'develop', 'market', 'cancer', 'drug']",1
336905,nifty_1024,2015-03-19,Judge Denies Amgen’s Request to Block Novartis’s Biosimilar of Neupogen,Neutral,0.0043,71,judge denies amgen request block novartis biosimilar neupogen,61,8,0,pharmacy,"['judge', 'denies', 'am', '##gen', 'request', 'block', 'no', '##var', '##tis', 'bio', '##si', '##mi', '##lar', 'ne', '##up', '##ogen']",1
336946,nifty_1024,2015-03-19,"AstraZeneca, Daiichi Sankyo to Sell Constipation Drug in U.S.",Neutral,0.0043,61,astrazeneca daiichi sankyo sell constipation drug,49,6,0,pharmacy,"['as', '##tra', '##zen', '##eca', 'da', '##ii', '##chi', 'sank', '##yo', 'sell', 'con', '##st', '##ip', '##ation', 'drug']",1
336954,nifty_1024,2015-03-19,"Lilly, Hanmi in Autoimmune Treatment Deal",Neutral,0.0043,41,lilly hanmi autoimmune treatment deal,37,5,0,pharmacy,"['l', '##ill', '##y', 'ha', '##n', '##mi', 'auto', '##im', '##mu', '##ne', 'treatment', 'deal']",1
337008,nifty_1025,2015-03-23,"Pfizer, Lilly to Resume Studies of Pain Treatment Tanezumab",Fall,-0.0056,59,pfizer lilly resume study pain treatment tanezumab,50,7,0,pharmacy,"['p', '##fi', '##zer', 'l', '##ill', '##y', 'resume', 'study', 'pain', 'treatment', 'tan', '##ez', '##uma', '##b']",1
337012,nifty_1025,2015-03-23,Biogen Drops Idec From Name,Fall,-0.0056,27,biogen drop idec from name,26,5,0,pharmacy,"['bio', '##gen', 'drop', 'id', '##ec', 'from', 'name']",1
337016,nifty_1025,2015-03-23,Immunogen Reaches Licensing Deal With Takeda,Fall,-0.0056,44,immunogen reach licensing deal with takeda,42,6,0,pharmacy,"['im', '##mu', '##no', '##gen', 'reach', 'licensing', 'deal', 'with', 'take', '##da']",1
337075,nifty_1026,2015-03-24,Merck’s Keytruda Meets Study Goals as Advanced Melanoma Treatment,Fall,-0.0147,65,merck keytruda meet study goal advanced melanoma treatment,58,8,0,pharmacy,"['me', '##rc', '##k', 'key', '##tr', '##uda', 'meet', 'study', 'goal', 'advanced', 'me', '##lan', '##oma', 'treatment']",1
337124,nifty_1027,2015-03-25,FDA Bans Shipments From Indian Drug Maker Aarti,Neutral,-0.0024,47,fda ban shipment from indian drug maker aarti,45,8,0,pharmacy,"['f', '##da', 'ban', 'shipment', 'from', 'in', '##dian', 'drug', 'maker', 'a', '##art', '##i']",1
337317,nifty_1029,2015-03-30,UnitedHealth to Buy Catamaran for $12.8 Billion,Fall,-0.0087,47,unitedhealth buy catamaran for billion,38,5,0,pharmacy,"['united', '##hea', '##lt', '##h', 'buy', 'cat', '##ama', '##ran', 'for', 'billion']",1
337358,nifty_1029,2015-03-30,Amgen Granted FDA Priority Review for Expanded Use of Kyprolis,Fall,-0.0087,62,amgen granted fda priority review for expanded use kyprolis,59,9,0,pharmacy,"['am', '##gen', 'granted', 'f', '##da', 'priority', 'review', 'for', 'expanded', 'use', 'k', '##y', '##p', '##rol', '##is']",1
337371,nifty_1029,2015-03-30,Horizon Pharma to Buy Hyperion Therapeutics,Fall,-0.0087,43,horizon pharma buy hyperion therapeutic,39,5,0,pharmacy,"['horizon', 'p', '##har', '##ma', 'buy', 'h', '##yper', '##ion', 'therapeutic']",1
337566,nifty_1032,2015-04-06,Bristol-Myers Invests in uniQure in Heart-Disease Pact,Neutral,-0.0026,54,bristol myers invests uniqure heart disease pact,48,7,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'invest', '##s', 'un', '##iq', '##ure', 'heart', 'disease', 'pact']",1
337958,nifty_1037,2015-04-14,Telling Doctors What Ails Them,Neutral,0.0045,30,telling doctor what ail them,28,5,0,pharmacy,"['telling', 'doctor', 'what', 'a', '##il', 'them']",1
338006,nifty_1038,2015-04-15,REG-NEOVACS TO PRESENT AT CHINA BIO PARTNERING FORUM,Neutral,-0.0003,52,reg neovacs present china bio partnering forum,46,7,0,pharmacy,"['re', '##g', 'neo', '##va', '##cs', 'present', 'chin', '##a', 'bio', 'partner', '##ing', 'forum']",1
338032,nifty_1038,2015-04-15,BRIEF-Stratec Biomedical says financial forecast confirmed,Neutral,-0.0003,58,brief stratec biomedical say financial forecast confirmed,57,7,0,pharmacy,"['brief', 's', '##trate', '##c', 'bio', '##medical', 'say', 'financial', 'forecast', 'confirmed']",1
338153,nifty_1038,2015-04-15,Research and Markets: Liquid Biopsy: An Emerging Market for Radically Improved Cancer Management,Neutral,-0.0003,96,research and market liquid biopsy emerging market for radically improved cancer management,90,12,0,pharmacy,"['research', 'and', 'market', 'liquid', 'bio', '##psy', 'emerging', 'market', 'for', 'radical', '##ly', 'improved', 'cancer', 'management']",1
338196,nifty_1038,2015-04-15,"Research and Markets: qPCR and dPCR Instrumentation Market: Educational/Research, Testing Laboratories, Pharmaceuticals - Global Strategic Business Report",Neutral,-0.0003,154,research and market qpcr and dpcr instrumentation market educational research testing laboratory pharmaceutical global strategic business report,144,17,0,pharmacy,"['research', 'and', 'market', 'q', '##p', '##c', '##r', 'and', 'd', '##p', '##c', '##r', 'instrumentation', 'market', 'educational', 'research', 'testing', 'laboratory', 'pharmaceutical', 'global', 'strategic', 'business', 'report']",1
338307,nifty_1038,2015-04-15,Research and Markets: Oncogene Inhibitors Therapy Market & Pipeline Insight 2015,Neutral,-0.0003,80,research and market oncogene inhibitor therapy market pipeline insight,70,9,0,pharmacy,"['research', 'and', 'market', 'on', '##co', '##gene', 'inhibitor', 'therapy', 'market', 'pipeline', 'insight']",1
338311,nifty_1038,2015-04-15,Research and Markets: Tyrosine Kinase Inhibitors Market & Pipeline Insight 2015,Neutral,-0.0003,79,research and market tyrosine kinase inhibitor market pipeline insight,69,9,0,pharmacy,"['research', 'and', 'market', 't', '##yr', '##os', '##ine', 'kinase', 'inhibitor', 'market', 'pipeline', 'insight']",1
338318,nifty_1038,2015-04-15,Research and Markets: Global Diabetes Drug Market & Pipeline Insight 2015,Neutral,-0.0003,73,research and market global diabetes drug market pipeline insight,64,9,0,pharmacy,"['research', 'and', 'market', 'global', 'diabetes', 'drug', 'market', 'pipeline', 'insight']",1
338327,nifty_1038,2015-04-15,Research and Markets: Global Nanomedicine Market & Pipeline Insight 2015 - 144 Nanomedicines with 13 Marketed,Neutral,-0.0003,109,research and market global nanomedicine market pipeline insight nanomedicines with marketed,91,11,0,pharmacy,"['research', 'and', 'market', 'global', 'na', '##no', '##med', '##ici', '##ne', 'market', 'pipeline', 'insight', 'na', '##no', '##med', '##ici', '##nes', 'with', 'marketed']",1
338341,nifty_1038,2015-04-15,New Video Documents Plandai Biotechnology's $20 Million Operation at Senteeko Tea Estate,Neutral,-0.0003,88,new video document plandai biotechnology million operation senteeko tea estate,78,10,0,pharmacy,"['new', 'video', 'document', 'plan', '##dai', 'bio', '##tech', '##nology', 'million', 'operation', 'sent', '##eek', '##o', 'tea', 'estate']",1
338358,nifty_1038,2015-04-15,"Updates on Biotech Stocks -- Gilead Sciences, Arena Pharma, ACADIA Pharma, Halozyme Therapeutics, and Anthera Pharma",Neutral,-0.0003,116,update biotech stock gilead science arena pharma acadia pharma halozyme therapeutic and anthera pharma,102,14,0,pharmacy,"['update', 'bio', '##tech', 'stock', 'g', '##ile', '##ad', 'science', 'arena', 'p', '##har', '##ma', 'a', '##ca', '##dia', 'p', '##har', '##ma', 'ha', '##lo', '##zy', '##me', 'therapeutic', 'and', 'ant', '##her', '##a', 'p', '##har', '##ma']",1
338373,nifty_1038,2015-04-15,Millennium Healthcare Engages JP Fortune Group (JPF) to Expand Financial Operations and Investor Awareness,Neutral,-0.0003,106,millennium healthcare engages fortune group jpf expand financial operation and investor awareness,97,12,0,pharmacy,"['millennium', 'healthcare', 'engages', 'fortune', 'group', 'j', '##pf', 'expand', 'financial', 'operation', 'and', 'investor', 'awareness']",1
338598,nifty_1038,2015-04-15,"Research and Markets: Global Medical Practice Management Software Market Outlook, 2020",Neutral,-0.0003,86,research and market global medical practice management software market outlook,78,10,0,pharmacy,"['research', 'and', 'market', 'global', 'medical', 'practice', 'management', 'software', 'market', 'outlook']",1
338690,nifty_1038,2015-04-15,"Transgenomic Announces Business and Financial Update Conference Call on April 15, 2015 at 5:00 PM EDT",Neutral,-0.0003,101,transgenomic announces business and financial update conference call april edt,78,10,0,pharmacy,"['trans', '##gen', '##omi', '##c', 'announces', 'business', 'and', 'financial', 'update', 'conference', 'call', 'a', '##p', '##ril', 'ed', '##t']",1
338691,nifty_1038,2015-04-15,Aptuit LLC and Axxam SpA announce Strategic Alliance for Integrated Drug Discovery Services,Neutral,-0.0003,91,aptuit llc and axxam spa announce strategic alliance for integrated drug discovery service,90,13,0,pharmacy,"['a', '##pt', '##uit', 'll', '##c', 'and', 'a', '##x', '##xa', '##m', 'spa', 'announce', 'strategic', 'alliance', 'for', 'integrated', 'drug', 'discovery', 'service']",1
338772,nifty_1038,2015-04-15,Sartorius Stedim Biotech: Dynamic First Quarter in 2015 | Forecast Revised Upwards,Neutral,-0.0003,82,sartorius stedim biotech dynamic first quarter forecast revised upwards,71,9,0,pharmacy,"['sa', '##rt', '##ori', '##us', 's', '##ted', '##im', 'bio', '##tech', 'dynamic', 'first', 'quarter', 'forecast', 'revised', 'upwards']",1
339037,nifty_1038,2015-04-15,Pfizer Breast-Cancer Study Meets Primary Endpoint,Neutral,-0.0003,49,pfizer breast cancer study meet primary endpoint,48,7,0,pharmacy,"['p', '##fi', '##zer', 'breast', 'cancer', 'study', 'meet', 'primary', 'end', '##point']",1
339075,nifty_1039,2015-04-16,FDA Approves Generic MS Drug by Novartis and Momenta,Fall,-0.0115,52,fda approves generic drug novartis and momentum,47,7,0,pharmacy,"['f', '##da', 'approve', '##s', 'generic', 'drug', 'no', '##var', '##tis', 'and', 'momentum']",1
339088,nifty_1039,2015-04-16,Bristol-Myers to Sell Cancer Drug Rights to Eli Lilly,Fall,-0.0115,53,bristol myers sell cancer drug right eli lilly,46,8,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'sell', 'cancer', 'drug', 'right', 'el', '##i', 'l', '##ill', '##y']",1
339177,nifty_1040,2015-04-20,Ampio Shares Plunge on Disappointing Drug Results,Neutral,-0.0012,49,ampio share plunge disappointing drug result,44,6,0,pharmacy,"['am', '##pio', 'share', 'p', '##lung', '##e', 'disappointing', 'drug', 'result']",1
339190,nifty_1040,2015-04-20,Bristol-Myers Drug Combination Shows Promise,Neutral,-0.0012,44,bristol myers drug combination show promise,43,6,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'drug', 'combination', 'show', 'promise']",1
339225,nifty_1041,2015-04-21,Dollar Wavers as Investors Doubt Health of U.S. Economy,Neutral,0.0049,55,dollar waver investor doubt health economy,42,6,0,pharmacy,"['dollar', 'wave', '##r', 'investor', 'doubt', 'health', 'economy']",1
339260,nifty_1041,2015-04-21,Alnylam Shares Up on Drug Study Results,Neutral,0.0049,39,alnylam share drug study result,31,5,0,pharmacy,"['al', '##ny', '##lam', 'share', 'drug', 'study', 'result']",1
339358,nifty_1042,2015-04-22,St. Jude Medical Cuts Earnings Forecast,Neutral,0.0025,39,jude medical cut earnings forecast,34,5,0,pharmacy,"['j', '##ude', 'medical', 'cut', 'earnings', 'forecast']",1
339479,nifty_1043,2015-04-23,"Jintian Pharmaceutical Has Proposed to Change the Company's Name to Universal Health, Racing into ""Internet + Universal Health""<2211.HK>",Neutral,0.0023,136,jintian pharmaceutical ha proposed change the company name universal health racing into internet universal health,113,15,0,pharmacy,"['ji', '##nti', '##an', 'pharmaceutical', 'ha', 'proposed', 'change', 'the', 'company', 'name', 'universal', 'health', 'racing', 'into', 'internet', 'universal', 'health']",1
339602,nifty_1043,2015-04-23,BRIEF-Mevis Medical Solutions raises forecast for liquidity for current FY 2015,Neutral,0.0023,79,brief mevis medical solution raise forecast for liquidity for current,69,10,0,pharmacy,"['brief', 'me', '##vis', 'medical', 'solution', 'raise', 'forecast', 'for', 'liquid', '##ity', 'for', 'current']",1
339661,nifty_1043,2015-04-23,Growing Cell Culture Protein Surface Coatings Market in North America to Boost Global Growth: Transparency Market Research,Neutral,0.0023,122,growing cell culture protein surface coating market north america boost global growth transparency market research,114,15,0,pharmacy,"['growing', 'cell', 'culture', 'protein', 'surface', 'coating', 'market', 'north', 'am', '##eric', '##a', 'boost', 'global', 'growth', 'transparency', 'market', 'research']",1
339690,nifty_1043,2015-04-23,Research and Markets: China Disposable Medical Supplies Markets Report 2015,Neutral,0.0023,75,research and market china disposable medical supply market report,65,9,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'di', '##sp', '##osa', '##ble', 'medical', 'supply', 'market', 'report']",1
339747,nifty_1043,2015-04-23,Deciphera Pharmaceuticals Presents Data Highlighting Kinase Inhibitor Pipeline including Proprietary and Partnered Programs at AACR 2015 Annual Meeting,Neutral,0.0023,151,deciphera pharmaceutical present data highlighting kinase inhibitor pipeline including proprietary and partnered program aacr annual meeting,140,16,0,pharmacy,"['de', '##ci', '##pher', '##a', 'pharmaceutical', 'present', 'data', 'highlighting', 'kinase', 'inhibitor', 'pipeline', 'including', 'proprietary', 'and', 'partnered', 'program', 'a', '##ac', '##r', 'annual', 'meeting']",1
339891,nifty_1043,2015-04-23,BRIEF-Trading in Guangzhou Boji Medical & Biotechnological shares to debut on Apr 24,Neutral,0.0023,84,brief trading guangzhou boji medical biotechnological share debut apr,69,9,0,pharmacy,"['brief', 'trading', 'g', '##uang', '##zhou', 'b', '##o', '##ji', 'medical', 'bio', '##tech', '##nological', 'share', 'debut', 'a', '##p', '##r']",1
340110,nifty_1043,2015-04-23,"Research and Markets: Global Dermatology Diagnostic Devices Market 2015-2019 - Type (Imaging Techniques, Dermatoscopes, Microscopes) & End-User (Hospitals, Clinics) Analysis",Neutral,0.0023,173,research and market global dermatology diagnostic device market type imaging technique dermatoscopes microscope end user hospital clinic analysis,145,18,0,pharmacy,"['research', 'and', 'market', 'global', 'der', '##mat', '##ology', 'diagnostic', 'device', 'market', 'type', 'imaging', 'technique', 'der', '##mat', '##os', '##cope', '##s', 'micro', '##scope', 'end', 'user', 'hospital', 'clinic', 'analysis']",1
340184,nifty_1043,2015-04-23,"UPDATE 1-DuPont buying microbiome firm, seeks edge in emerging crop products",Neutral,0.0023,76,update dupont buying microbiome firm seek edge emerging crop product,68,10,0,pharmacy,"['update', 'du', '##pont', 'buying', 'micro', '##bio', '##me', 'firm', 'seek', 'edge', 'emerging', 'crop', 'product']",1
340331,nifty_1043,2015-04-23,Agilent Technologies Announces Resolution to U.S. FDA Warning Letter for Dako Denmark,Neutral,0.0023,85,agilent technology announces resolution fda warning letter for dako denmark,75,10,0,pharmacy,"['a', '##gi', '##lent', 'technology', 'announces', 'resolution', 'f', '##da', 'warning', 'letter', 'for', 'da', '##ko', 'den', '##mark']",1
340375,nifty_1043,2015-04-23,"AMAG Pharmaceuticals, Inc. to Host Conference Call on May 5, 2015 at 8:00 a.m. ET to Discuss Financial Results for the Quarter Ended March 31, 2015",Neutral,0.0023,147,amag pharmaceutical inc host conference call may discus financial result for the quarter ended march,100,15,0,pharmacy,"['am', '##ag', 'pharmaceutical', 'in', '##c', 'host', 'conference', 'call', 'may', 'disc', '##us', 'financial', 'result', 'for', 'the', 'quarter', 'ended', 'march']",1
340382,nifty_1043,2015-04-23,Eagle Pharmaceuticals to Present at Deutsche Bank 40th Annual Health Care Conference,Neutral,0.0023,84,eagle pharmaceutical present deutsche bank annual health care conference,72,9,0,pharmacy,"['eagle', 'pharmaceutical', 'present', 'de', '##uts', '##che', 'bank', 'annual', 'health', 'care', 'conference']",1
340572,nifty_1043,2015-04-23,Aerie Pharmaceuticals’ Rhopressa Misses Primary Endpoint in Study,Neutral,0.0023,65,aerie pharmaceutical rhopressa miss primary endpoint study,58,7,0,pharmacy,"['a', '##erie', 'pharmaceutical', 'r', '##hop', '##ress', '##a', 'miss', 'primary', 'end', '##point', 'study']",1
340677,nifty_1044,2015-04-27,Medtronic in FDA Consent Decree Over SynchroMed Infusion Pump,Neutral,0.0032,61,medtronic fda consent decree over synchromed infusion pump,58,8,0,pharmacy,"['me', '##dt', '##ronic', 'f', '##da', 'consent', 'decree', 'over', 's', '##ync', '##hr', '##ome', '##d', 'in', '##fusion', 'pump']",1
340776,nifty_1045,2015-04-28,"R-Tech Ueno: Announcement on Acquisition of the Right to Develop and Commercialize DE-105 from Santen Pharmaceutical Co., Ltd.<4573.T>",Neutral,-0.0041,134,tech ueno announcement acquisition the right develop and commercialize from santen pharmaceutical ltd,101,13,0,pharmacy,"['tech', 'u', '##eno', 'announcement', 'acquisition', 'the', 'right', 'develop', 'and', 'commercial', '##ize', 'from', 'sa', '##nte', '##n', 'pharmaceutical', 'l', '##t', '##d']",1
340856,nifty_1045,2015-04-28,Research and Markets: Global Respiratory Depression Pipeline Review 2015 - 2 Companies & 8 Drug Profiles,Neutral,-0.0041,104,research and market global respiratory depression pipeline review company drug profile,86,11,0,pharmacy,"['research', 'and', 'market', 'global', 'respiratory', 'depression', 'pipeline', 'review', 'company', 'drug', 'profile']",1
340860,nifty_1045,2015-04-28,"Provectus Biopharmaceuticals to Present at Asia Biotech Invest 2015 Conference Wednesday, May 20, 2015, Hong Kong",Neutral,-0.0041,113,provectus biopharmaceuticals present asia biotech invest conference wednesday may hong kong,91,11,0,pharmacy,"['prove', '##ctus', 'bio', '##pha', '##rma', '##ce', '##utical', '##s', 'present', 'as', '##ia', 'bio', '##tech', 'invest', 'conference', 'wed', '##nes', '##day', 'may', 'ho', '##ng', 'k', '##ong']",1
340861,nifty_1045,2015-04-28,Research and Markets: Global Bone Marrow Transplantation Pipeline Review 2015 - 12 Companies & 14 Drug Profiles,Neutral,-0.0041,111,research and market global bone marrow transplantation pipeline review company drug profile,91,12,0,pharmacy,"['research', 'and', 'market', 'global', 'bone', 'ma', '##rrow', 'transplant', '##ation', 'pipeline', 'review', 'company', 'drug', 'profile']",1
340878,nifty_1045,2015-04-28,Research and Markets: Global Anca Vasculitis Pipeline Review 2015 - 4 Companies & 7 Drug Profiles,Neutral,-0.0041,97,research and market global anca vasculitis pipeline review company drug profile,79,11,0,pharmacy,"['research', 'and', 'market', 'global', 'an', '##ca', 'v', '##as', '##cu', '##lit', '##is', 'pipeline', 'review', 'company', 'drug', 'profile']",1
340990,nifty_1045,2015-04-28,Engagement Labs Secures Major Partnership With TOMORRO\\\ To Expand Aggressively The US Market,Neutral,-0.0041,94,engagement lab secures major partnership with tomorro expand aggressively the market,84,11,0,pharmacy,"['engagement', 'lab', 'secure', '##s', 'major', 'partnership', 'with', 'to', '##mor', '##ro', 'expand', 'aggressively', 'the', 'market']",1
341027,nifty_1045,2015-04-28,Research and Markets: Non-Small Cell Lung Cancer Partnering 2010-2015,Neutral,-0.0041,69,research and market non small cell lung cancer partnering,57,9,0,pharmacy,"['research', 'and', 'market', 'non', 'small', 'cell', 'lung', 'cancer', 'partner', '##ing']",1
341070,nifty_1045,2015-04-28,Research and Markets: Thrombus Partnering Deals and Agreements Analysis 2010-2015,Neutral,-0.0041,81,research and market thrombus partnering deal and agreement analysis,67,9,0,pharmacy,"['research', 'and', 'market', 'th', '##rom', '##bus', 'partner', '##ing', 'deal', 'and', 'agreement', 'analysis']",1
341093,nifty_1045,2015-04-28,Research and Markets: Global Radiation Detection Materials Markets: 2015-2022,Neutral,-0.0041,77,research and market global radiation detection material market,62,8,0,pharmacy,"['research', 'and', 'market', 'global', 'radiation', 'detection', 'material', 'market']",1
341102,nifty_1045,2015-04-28,Research and Markets: Epilepsy Partnering Deals and Agreements Analysis 2010-2015,Neutral,-0.0041,81,research and market epilepsy partnering deal and agreement analysis,67,9,0,pharmacy,"['research', 'and', 'market', 'e', '##pile', '##psy', 'partner', '##ing', 'deal', 'and', 'agreement', 'analysis']",1
341112,nifty_1045,2015-04-28,Technavio Publishes New Market Analysis on the Global Biochar Market 2015-2019,Neutral,-0.0041,78,technavio publishes new market analysis the global biochar market,65,9,0,pharmacy,"['tech', '##na', '##vio', 'publishes', 'new', 'market', 'analysis', 'the', 'global', 'bio', '##cha', '##r', 'market']",1
341207,nifty_1045,2015-04-28,Research and Markets: Stroke Partnering 2010-2015,Neutral,-0.0041,49,research and market stroke partnering,37,5,0,pharmacy,"['research', 'and', 'market', 'stroke', 'partner', '##ing']",1
341211,nifty_1045,2015-04-28,Research and Markets: Inflammatory Bowel Disease Partnering 2010-2015,Neutral,-0.0041,69,research and market inflammatory bowel disease partnering,57,7,0,pharmacy,"['research', 'and', 'market', 'inflammatory', 'bow', '##el', 'disease', 'partner', '##ing']",1
341463,nifty_1045,2015-04-28,Major Drug Companies Report Solid Results,Neutral,-0.0041,41,major drug company report solid result,38,6,0,pharmacy,"['major', 'drug', 'company', 'report', 'solid', 'result']",1
341519,nifty_1045,2015-04-28,"Bristol-Myers Reports Higher Sales, Earnings",Neutral,-0.0041,44,bristol myers report higher sale earnings,41,6,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'report', 'higher', 'sale', 'earnings']",1
341558,nifty_1046,2015-04-29,Kythera Wins FDA Approval for Double-Chin Treatment,Fall,-0.01,51,kythera win fda approval for double chin treatment,50,8,0,pharmacy,"['k', '##yt', '##her', '##a', 'win', 'f', '##da', 'approval', 'for', 'double', 'chin', 'treatment']",1
341929,nifty_1050,2015-05-06,Alexion-Synageva Deal Shows Lure of Rare-Disease Drugs,Neutral,0.004,54,alexion synageva deal show lure rare disease drug,49,8,0,pharmacy,"['ale', '##xi', '##on', 's', '##yna', '##ge', '##va', 'deal', 'show', 'lure', 'rare', 'disease', 'drug']",1
342139,nifty_1052,2015-05-11,Former Madoff Aide Frank DiPascali Dies at Age 58 of Lung Cancer,Neutral,-0.003,64,former madoff aide frank dipascali dy age lung cancer,53,9,0,pharmacy,"['former', 'mad', '##off', 'aide', 'f', '##rank', 'dip', '##as', '##cal', '##i', 'd', '##y', 'age', 'lung', 'cancer']",1
342207,nifty_1053,2015-05-12,Orexigen Terminates Required Study for Diet Drug Contrave,Neutral,0.0002,57,orexigen terminates required study for diet drug contrave,57,8,0,pharmacy,"['ore', '##xi', '##gen', 'terminate', '##s', 'required', 'study', 'for', 'diet', 'drug', 'con', '##tra', '##ve']",1
342215,nifty_1053,2015-05-12,Baxter to Buy Leukemia Treatment,Neutral,0.0002,32,baxter buy leukemia treatment,29,4,0,pharmacy,"['b', '##ax', '##ter', 'buy', 'le', '##uke', '##mia', 'treatment']",1
342243,nifty_1054,2015-05-13,Pedialyte Sales Grow—Into an Adult Market,Rise,0.0104,41,pedialyte sale grow into adult market,37,6,0,pharmacy,"['p', '##edia', '##ly', '##te', 'sale', 'grow', 'into', 'adult', 'market']",1
342608,nifty_1057,2015-05-19,Research and Markets: Regulation on In-Vitro Diagnostics (IVDs) Registration in China,Neutral,-0.0007,85,research and market regulation vitro diagnostics ivds registration china,72,9,0,pharmacy,"['research', 'and', 'market', 'regulation', 'v', '##it', '##ro', 'diagnostic', '##s', 'i', '##v', '##ds', 'registration', 'chin', '##a']",1
342612,nifty_1057,2015-05-19,Research and Markets: The 12th Five-Year Plan for China Medical Device Development,Neutral,-0.0007,82,research and market the five year plan for china medical device development,75,12,0,pharmacy,"['research', 'and', 'market', 'the', 'five', 'year', 'plan', 'for', 'chin', '##a', 'medical', 'device', 'development']",1
342617,nifty_1057,2015-05-19,"Global Diabetes Drugs and Devices Market to Be Shaped by Development of New Forms of Insulin, to Grow at 5.9% CAGR: Transparency Market Research",Neutral,-0.0007,144,global diabetes drug and device market shaped development new form insulin grow cagr transparency market research,113,16,0,pharmacy,"['global', 'diabetes', 'drug', 'and', 'device', 'market', 'shaped', 'development', 'new', 'form', 'insulin', 'grow', 'ca', '##g', '##r', 'transparency', 'market', 'research']",1
342650,nifty_1057,2015-05-19,Research and Markets: Global Multiple Myeloma Drug Market & Pipeline Insight 2015,Neutral,-0.0007,81,research and market global multiple myeloma drug market pipeline insight,72,10,0,pharmacy,"['research', 'and', 'market', 'global', 'multiple', 'my', '##elo', '##ma', 'drug', 'market', 'pipeline', 'insight']",1
342661,nifty_1057,2015-05-19,BioLineRx Reports First Quarter 2015 Financial Results,Neutral,-0.0007,54,biolinerx report first quarter financial result,47,6,0,pharmacy,"['bio', '##liner', '##x', 'report', 'first', 'quarter', 'financial', 'result']",1
342681,nifty_1057,2015-05-19,"Research and Markets: Antibody Production Market by Product, Type, Technology & by End-User - Analysis & Global Forecast to 2019",Neutral,-0.0007,128,research and market antibody production market product type technology end user analysis global forecast,104,14,0,pharmacy,"['research', 'and', 'market', 'anti', '##body', 'production', 'market', 'product', 'type', 'technology', 'end', 'user', 'analysis', 'global', 'forecast']",1
342698,nifty_1057,2015-05-19,"Updates From Technology and Utilities Space - Complementary Research on WPCS International, Transgenomic, LookSmart, UTStarcom Holdings and Spark Energy",Neutral,-0.0007,152,update from technology and utility space complementary research wpcs international transgenomic looksmart utstarcom holding and spark energy,140,17,0,pharmacy,"['update', 'from', 'technology', 'and', 'utility', 'space', 'complementary', 'research', 'w', '##p', '##cs', 'international', 'trans', '##gen', '##omi', '##c', 'looks', '##mart', 'u', '##ts', '##tar', '##com', 'holding', 'and', 'spark', 'energy']",1
342741,nifty_1057,2015-05-19,Cantex Pharmaceuticals Announces Efficacy and Safety Data from Study of CX-01 in AML to be Presented at 2015 ASCO Annual Meeting,Neutral,-0.0007,128,cantex pharmaceutical announces efficacy and safety data from study aml presented asco annual meeting,101,14,0,pharmacy,"['can', '##te', '##x', 'pharmaceutical', 'announces', 'efficacy', 'and', 'safety', 'data', 'from', 'study', 'am', '##l', 'presented', 'as', '##co', 'annual', 'meeting']",1
342752,nifty_1057,2015-05-19,"Latest Developments in the Healthcare Sector: Complementary Research on Parnell Pharmaceuticals, Medovex, Cipher Pharmaceuticals, Histogenics, Bio Blast Pharma",Neutral,-0.0007,159,latest development the healthcare sector complementary research parnell pharmaceutical medovex cipher pharmaceutical histogenics bio blast pharma,145,16,0,pharmacy,"['latest', 'development', 'the', 'healthcare', 'sector', 'complementary', 'research', 'par', '##nell', 'pharmaceutical', 'me', '##do', '##ve', '##x', 'c', '##ip', '##her', 'pharmaceutical', 'his', '##to', '##genic', '##s', 'bio', 'blast', 'p', '##har', '##ma']",1
342778,nifty_1057,2015-05-19,"Earnings Update: Complementary Research on Tantech Holdings, Sypris Solutions, Swisher Hygiene, XTL Biopharmaceuticals, ADMA Biologics",Neutral,-0.0007,134,earnings update complementary research tantech holding sypris solution swisher hygiene xtl biopharmaceuticals adma biologics,124,14,0,pharmacy,"['earnings', 'update', 'complementary', 'research', 'tan', '##tech', 'holding', 's', '##y', '##p', '##ris', 'solution', 's', '##wi', '##sher', 'h', '##ygiene', 'x', '##tl', 'bio', '##pha', '##rma', '##ce', '##utical', '##s', 'ad', '##ma', 'bio', '##log', '##ics']",1
342791,nifty_1057,2015-05-19,"Technical Coverage on Biotech Stocks -- Anthera Pharma, RXi Pharma, MiMedx, Sarepta Therapeutics, and Navidea Biopharma",Neutral,-0.0007,119,technical coverage biotech stock anthera pharma rxi pharma mimedx sarepta therapeutic and navidea biopharma,107,14,0,pharmacy,"['technical', 'coverage', 'bio', '##tech', 'stock', 'ant', '##her', '##a', 'p', '##har', '##ma', 'r', '##xi', 'p', '##har', '##ma', 'mi', '##med', '##x', 'sa', '##re', '##pta', 'therapeutic', 'and', 'na', '##vide', '##a', 'bio', '##pha', '##rma']",1
342801,nifty_1057,2015-05-19,HedgePath Pharmaceuticals To Receive $2.5 Million in Funding From Mayne Pharma,Neutral,-0.0007,78,hedgepath pharmaceutical receive million funding from mayne pharma,66,8,0,pharmacy,"['hedge', '##path', 'pharmaceutical', 'receive', 'million', 'funding', 'from', 'may', '##ne', 'p', '##har', '##ma']",1
342828,nifty_1057,2015-05-19,"Biotech Equities Technical Study -- Gilead Sciences, Celgene, Novavax, Arena Pharma, and ACADIA Pharma",Neutral,-0.0007,102,biotech equity technical study gilead science celgene novavax arena pharma and acadia pharma,92,13,0,pharmacy,"['bio', '##tech', 'equity', 'technical', 'study', 'g', '##ile', '##ad', 'science', 'c', '##el', '##gene', 'no', '##va', '##va', '##x', 'arena', 'p', '##har', '##ma', 'and', 'a', '##ca', '##dia', 'p', '##har', '##ma']",1
342857,nifty_1057,2015-05-19,Research and Markets: Thailand Healthcare Market Access Report 2015,Neutral,-0.0007,67,research and market thailand healthcare market access report,60,8,0,pharmacy,"['research', 'and', 'market', 'th', '##ail', '##and', 'healthcare', 'market', 'access', 'report']",1
343011,nifty_1057,2015-05-19,"Peak Pharmaceuticals, Inc. Submits 2015 Q2 Financials With Double Digit Revenue Increase",Neutral,-0.0007,88,peak pharmaceutical inc submits financials with double digit revenue increase,77,10,0,pharmacy,"['peak', 'pharmaceutical', 'in', '##c', 'submit', '##s', 'financial', '##s', 'with', 'double', 'digit', 'revenue', 'increase']",1
343070,nifty_1057,2015-05-19,MOVES-TPG Biotech investing arm hires industry veteran Lukatch,Neutral,-0.0007,62,move tpg biotech investing arm hire industry veteran lukatch,60,9,0,pharmacy,"['move', 't', '##p', '##g', 'bio', '##tech', 'investing', 'arm', 'hire', 'industry', 'veteran', 'l', '##uka', '##tch']",1
343075,nifty_1057,2015-05-19,"Research and Markets: European Molecular Diagnostics Market 2015: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies",Neutral,-0.0007,149,research and market european molecular diagnostics market supplier share country forecast innovative technology competitive strategy,132,15,0,pharmacy,"['research', 'and', 'market', 'euro', '##pe', '##an', 'molecular', 'diagnostic', '##s', 'market', 'supplier', 'share', 'country', 'forecast', 'innovative', 'technology', 'competitive', 'strategy']",1
343083,nifty_1057,2015-05-19,"Research and Markets: 2015 Analysis of Molecular Diagnostic Instrumentation, and Strategic Profiles of Leading Suppliers",Neutral,-0.0007,120,research and market analysis molecular diagnostic instrumentation and strategic profile leading supplier,104,12,0,pharmacy,"['research', 'and', 'market', 'analysis', 'molecular', 'diagnostic', 'instrumentation', 'and', 'strategic', 'profile', 'leading', 'supplier']",1
343084,nifty_1057,2015-05-19,"Research and Markets: United States Molecular Diagnostics Market 2015: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies",Neutral,-0.0007,154,research and market united state molecular diagnostics market supplier share country forecast innovative technology competitive strategy,136,16,0,pharmacy,"['research', 'and', 'market', 'united', 'state', 'molecular', 'diagnostic', '##s', 'market', 'supplier', 'share', 'country', 'forecast', 'innovative', 'technology', 'competitive', 'strategy']",1
343086,nifty_1057,2015-05-19,"Research and Markets: Global Molecular Diagnostics Market 2015: The Next Frontier for Innovation, Competition, and Productivity",Neutral,-0.0007,127,research and market global molecular diagnostics market the next frontier for innovation competition and productivity,117,15,0,pharmacy,"['research', 'and', 'market', 'global', 'molecular', 'diagnostic', '##s', 'market', 'the', 'next', 'frontier', 'for', 'innovation', 'competition', 'and', 'productivity']",1
343158,nifty_1057,2015-05-19,Fate Therapeutics Announces Proposed Public Offering of Common Stock,Neutral,-0.0007,68,fate therapeutic announces proposed public offering common stock,64,8,0,pharmacy,"['fate', 'therapeutic', 'announces', 'proposed', 'public', 'offering', 'common', 'stock']",1
343167,nifty_1057,2015-05-19,Research and Markets: North America Optical Microscopy Market 2015 - Forecasts to 2019,Neutral,-0.0007,86,research and market north america optical microscopy market forecast,68,9,0,pharmacy,"['research', 'and', 'market', 'north', 'am', '##eric', '##a', 'optical', 'micro', '##sco', '##py', 'market', 'forecast']",1
343260,nifty_1057,2015-05-19,Sarepta Shares Surge on Drug Update,Neutral,-0.0007,35,sarepta share surge drug update,31,5,0,pharmacy,"['sa', '##re', '##pta', 'share', 'surge', 'drug', 'update']",1
343290,nifty_1057,2015-05-19,Johnson & Johnson’s Schizophrenia Drug Wins FDA Approval,Neutral,-0.0007,56,johnson johnson schizophrenia drug win fda approval,51,7,0,pharmacy,"['j', '##oh', '##nson', 'j', '##oh', '##nson', 's', '##chi', '##zophrenia', 'drug', 'win', 'f', '##da', 'approval']",1
343377,nifty_1058,2015-05-20,J&J Expects to File at Least 10 New Drugs,Neutral,0.0029,41,expects file least new drug,27,5,0,pharmacy,"['expects', 'file', 'least', 'new', 'drug']",1
343498,nifty_1060,2015-05-26,Big Bets on Proton Therapy Face Uncertain Future,Rise,0.0095,48,big bet proton therapy face uncertain future,44,7,0,pharmacy,"['big', 'bet', 'pro', '##ton', 'therapy', 'face', 'uncertain', 'future']",1
343530,nifty_1061,2015-05-27,Mental-Health Screenings for Pilots Under Review,Neutral,-0.0011,48,mental health screening for pilot under review,46,7,0,pharmacy,"['mental', 'health', 'screening', 'for', 'pilot', 'under', 'review']",1
343552,nifty_1061,2015-05-27,European Biotechs Head to Wall Street,Neutral,-0.0011,37,european biotech head wall street,33,5,0,pharmacy,"['euro', '##pe', '##an', 'bio', '##tech', 'head', 'wall', 'street']",1
343586,nifty_1061,2015-05-27,Retrophin Sells FDA Voucher to Sanofi,Neutral,-0.0011,37,retrophin sell fda voucher sanofi,33,5,0,pharmacy,"['re', '##tro', '##phi', '##n', 'sell', 'f', '##da', 'v', '##ou', '##cher', 'sa', '##no', '##fi']",1
343695,nifty_1062,2015-05-28,Global In Vitro Diagnostics Market to Reach US$74.2 Billion by 2018: Transparency Market Research,Fall,-0.0062,97,global vitro diagnostics market reach billion transparency market research,74,9,0,pharmacy,"['global', 'v', '##it', '##ro', 'diagnostic', '##s', 'market', 'reach', 'billion', 'transparency', 'market', 'research']",1
343759,nifty_1062,2015-05-28,"Research and Markets: Global Cell Therapy Market 2015-2020 - Technologies, Markets and Companies (Updated Edition)",Fall,-0.0062,114,research and market global cell therapy market technology market and company updated edition,92,13,0,pharmacy,"['research', 'and', 'market', 'global', 'cell', 'therapy', 'market', 'technology', 'market', 'and', 'company', 'updated', 'edition']",1
343761,nifty_1062,2015-05-28,"Research and Markets: Global Proteomics Market 2015-2024 - Technologies, Markets and Companies (Updated Edition)",Fall,-0.0062,112,research and market global proteomics market technology market and company updated edition,90,12,0,pharmacy,"['research', 'and', 'market', 'global', 'pro', '##te', '##omi', '##cs', 'market', 'technology', 'market', 'and', 'company', 'updated', 'edition']",1
343791,nifty_1062,2015-05-28,"Research and Markets: Global Transdermal Drug Delivery 2014-2024 - Technologies, Markets, and Companies (Updated Edition)",Fall,-0.0062,121,research and market global transdermal drug delivery technology market and company updated edition,98,13,0,pharmacy,"['research', 'and', 'market', 'global', 'trans', '##der', '##mal', 'drug', 'delivery', 'technology', 'market', 'and', 'company', 'updated', 'edition']",1
343803,nifty_1062,2015-05-28,T2 Biosystems to Present at Upcoming Investor Conferences,Fall,-0.0062,57,biosystems present upcoming investor conference,47,5,0,pharmacy,"['bio', '##sy', '##ste', '##ms', 'present', 'upcoming', 'investor', 'conference']",1
343846,nifty_1062,2015-05-28,DelMar Pharmaceuticals Announces Upcoming Investor and Scientific Conference Presentations,Fall,-0.0062,90,delmar pharmaceutical announces upcoming investor and scientific conference presentation,88,9,0,pharmacy,"['del', '##mar', 'pharmaceutical', 'announces', 'upcoming', 'investor', 'and', 'scientific', 'conference', 'presentation']",1
343867,nifty_1062,2015-05-28,Aerie Pharmaceuticals to Participate in Two Investor Conferences in June,Fall,-0.0062,72,aerie pharmaceutical participate two investor conference june,61,7,0,pharmacy,"['a', '##erie', 'pharmaceutical', 'participate', 'two', 'investor', 'conference', 'j', '##une']",1
343868,nifty_1062,2015-05-28,Acceleron Pharma to Present at Upcoming Investor Conferences in June,Fall,-0.0062,68,acceleron pharma present upcoming investor conference june,58,7,0,pharmacy,"['a', '##cc', '##ele', '##ron', 'p', '##har', '##ma', 'present', 'upcoming', 'investor', 'conference', 'j', '##une']",1
343945,nifty_1062,2015-05-28,Research and Markets: Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects,Fall,-0.0062,103,research and market global personalized medicine report scientific and commercial aspect,88,11,0,pharmacy,"['research', 'and', 'market', 'global', 'personal', '##ized', 'medicine', 'report', 'scientific', 'and', 'commercial', 'aspect']",1
343953,nifty_1062,2015-05-28,"Research and Markets: Global Nitric Oxide Report 2015-2024 - Therapeutics, Markets and Companies",Fall,-0.0062,96,research and market global nitric oxide report therapeutic market and company,77,11,0,pharmacy,"['research', 'and', 'market', 'global', 'ni', '##tric', 'oxide', 'report', 'therapeutic', 'market', 'and', 'company']",1
344030,nifty_1062,2015-05-28,BRIEF-Joincare Pharmaceutical probed by securities regulator for unusual trade,Fall,-0.0062,78,brief joincare pharmaceutical probed security regulator for unusual trade,73,9,0,pharmacy,"['brief', 'join', '##care', 'pharmaceutical', 'probe', '##d', 'security', 'regulator', 'for', 'unusual', 'trade']",1
344113,nifty_1062,2015-05-28,"Research and Markets: Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market 2015: Strategic Analysis of Industry Trends, Technologies, Participants, and Environment",Fall,-0.0062,187,research and market personalized medicine targeted therapeutic and companion diagnostic market strategic analysis industry trend technology participant and environment,167,19,0,pharmacy,"['research', 'and', 'market', 'personal', '##ized', 'medicine', 'targeted', 'therapeutic', 'and', 'companion', 'diagnostic', 'market', 'strategic', 'analysis', 'industry', 'trend', 'technology', 'participant', 'and', 'environment']",1
344251,nifty_1062,2015-05-28,BRIEF-Naturex reorganizes manufacturing operations serving pharmaceutical market,Fall,-0.0062,80,brief naturex reorganizes manufacturing operation serving pharmaceutical market,79,8,0,pharmacy,"['brief', 'nature', '##x', 're', '##or', '##gan', '##izes', 'manufacturing', 'operation', 'serving', 'pharmaceutical', 'market']",1
344319,nifty_1062,2015-05-28,Research and Markets: Closed MRI Systems Market 2015 by Field Strength & by Application - Global Forecast to 2019,Fall,-0.0062,113,research and market closed mri system market field strength application global forecast,87,12,0,pharmacy,"['research', 'and', 'market', 'closed', 'm', '##ri', 'system', 'market', 'field', 'strength', 'application', 'global', 'forecast']",1
344338,nifty_1062,2015-05-28,Research and Markets: Integrated Circuits (ICs) Market in Wireless Portable Medical Devices (WPMDs) 2015 - Global Analysis & Forecast to 2019,Fall,-0.0062,141,research and market integrated circuit ic market wireless portable medical device wpmds global analysis forecast,112,15,0,pharmacy,"['research', 'and', 'market', 'integrated', 'circuit', 'i', '##c', 'market', 'wireless', 'portable', 'medical', 'device', 'w', '##pm', '##ds', 'global', 'analysis', 'forecast']",1
344368,nifty_1062,2015-05-28,Precision Advisors Digital Trends Study: Less Than Half of Managed Care Organizations Have Access to Electronic Medical Records Data,Fall,-0.0062,132,precision advisor digital trend study less than half managed care organization have access electronic medical record data,121,17,0,pharmacy,"['precision', 'advisor', 'digital', 'trend', 'study', 'less', 'than', 'half', 'managed', 'care', 'organization', 'have', 'access', 'electronic', 'medical', 'record', 'data']",1
344393,nifty_1062,2015-05-28,Celldex Therapeutics to Present at the Jefferies 2015 Global Healthcare Conference,Fall,-0.0062,82,celldex therapeutic present the jefferies global healthcare conference,70,8,0,pharmacy,"['cell', '##de', '##x', 'therapeutic', 'present', 'the', 'j', '##ef', '##fer', '##ies', 'global', 'healthcare', 'conference']",1
344397,nifty_1062,2015-05-28,Anacor Pharmaceuticals to Present at Upcoming Investor Conferences,Fall,-0.0062,66,anacor pharmaceutical present upcoming investor conference,58,6,0,pharmacy,"['an', '##aco', '##r', 'pharmaceutical', 'present', 'upcoming', 'investor', 'conference']",1
344416,nifty_1062,2015-05-28,RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants,Fall,-0.0062,83,rxi pharmaceutical announces proposed public offering common stock and warrant,78,10,0,pharmacy,"['r', '##xi', 'pharmaceutical', 'announces', 'proposed', 'public', 'offering', 'common', 'stock', 'and', 'warrant']",1
344451,nifty_1062,2015-05-28,Immune Pharmaceuticals to present at Sachs Immuno-Oncology Business Development (BD&L;) and Investment Forum in Chicago and at Marcum Conference in New York,Fall,-0.0062,156,immune pharmaceutical present sachs immuno oncology business development and investment forum chicago and marcum conference new york,132,17,0,pharmacy,"['immune', 'pharmaceutical', 'present', 'sa', '##chs', 'im', '##mu', '##no', 'on', '##cology', 'business', 'development', 'and', 'investment', 'forum', 'ch', '##ica', '##go', 'and', 'ma', '##rc', '##um', 'conference', 'new', 'yo', '##rk']",1
344515,nifty_1062,2015-05-28,"Research and Markets: Bioinformatics Market by Sector, Segment & Application - Global Forecast to 2020",Fall,-0.0062,102,research and market bioinformatics market sector segment application global forecast,84,10,0,pharmacy,"['research', 'and', 'market', 'bio', '##in', '##formatics', 'market', 'sector', 'segment', 'application', 'global', 'forecast']",1
344523,nifty_1062,2015-05-28,Research and Markets: 2015 Strategies in the US Endocrine Function Testing Market,Fall,-0.0062,81,research and market strategy the endocrine function testing market,66,9,0,pharmacy,"['research', 'and', 'market', 'strategy', 'the', 'end', '##oc', '##rine', 'function', 'testing', 'market']",1
344526,nifty_1062,2015-05-28,"Research and Markets: Global Therapeutic Drug Monitoring Market 2015-2024 - Technologies, Markets, and Companies (Updated Edition)",Fall,-0.0062,130,research and market global therapeutic drug monitoring market technology market and company updated edition,107,14,0,pharmacy,"['research', 'and', 'market', 'global', 'therapeutic', 'drug', 'monitoring', 'market', 'technology', 'market', 'and', 'company', 'updated', 'edition']",1
344527,nifty_1062,2015-05-28,Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs,Fall,-0.0062,72,citizen address recent pbm consolidation and rising pharmacy cost,65,9,0,pharmacy,"['citizen', 'address', 'recent', 'p', '##b', '##m', 'consolidation', 'and', 'rising', 'pharmacy', 'cost']",1
344550,nifty_1062,2015-05-28,"Research and Markets: Global Drug Delivery in Cancer 2015-2024 - Technologies, Markets and Companies",Fall,-0.0062,100,research and market global drug delivery cancer technology market and company,77,11,0,pharmacy,"['research', 'and', 'market', 'global', 'drug', 'delivery', 'cancer', 'technology', 'market', 'and', 'company']",1
344750,nifty_1063,2015-06-01,FDA Grants Priority Review for Merck Lung Cancer Treatment,Neutral,-0.001,58,fda grant priority review for merck lung cancer treatment,57,9,0,pharmacy,"['f', '##da', 'grant', 'priority', 'review', 'for', 'me', '##rc', '##k', 'lung', 'cancer', 'treatment']",1
344930,nifty_1065,2015-06-03,Halozyme Reaches Collaboration Deal With AbbVie,Fall,-0.0084,47,halozyme reach collaboration deal with abbvie,45,6,0,pharmacy,"['ha', '##lo', '##zy', '##me', 'reach', 'collaboration', 'deal', 'with', 'a', '##bb', '##vie']",1
344995,nifty_1066,2015-06-04,Cancer Test Maker Buys Diagnostics Company for $1.47 Billion,Neutral,-0.0017,60,cancer test maker buy diagnostics company for billion,53,8,0,pharmacy,"['cancer', 'test', 'maker', 'buy', 'diagnostic', '##s', 'company', 'for', 'billion']",1
345046,nifty_1067,2015-06-08,Lufthansa CEO: Changing Pilot Mental Health Screening Proving Difficult,Neutral,-0.0001,71,lufthansa ceo changing pilot mental health screening proving difficult,70,9,0,pharmacy,"['l', '##uf', '##than', '##sa', 'c', '##eo', 'changing', 'pilot', 'mental', 'health', 'screening', 'proving', 'difficult']",1
345183,nifty_1068,2015-06-09,"Research and Markets: Brazilian Medical Devices Market: Investment Opportunities, Growth Forecasts by Care Areas and Local Competitive Landscape 2015-2018",Rise,0.012,154,research and market brazilian medical device market investment opportunity growth forecast care area and local competitive landscape,132,17,0,pharmacy,"['research', 'and', 'market', 'bra', '##zi', '##lian', 'medical', 'device', 'market', 'investment', 'opportunity', 'growth', 'forecast', 'care', 'area', 'and', 'local', 'competitive', 'landscape']",1
345184,nifty_1068,2015-06-09,"Research and Markets: Russian Medical Devices Market: Investment Opportunities, Growth Forecasts by Care Areas and Local Competitive Landscape 2015-2018",Rise,0.012,152,research and market russian medical device market investment opportunity growth forecast care area and local competitive landscape,130,17,0,pharmacy,"['research', 'and', 'market', 'r', '##uss', '##ian', 'medical', 'device', 'market', 'investment', 'opportunity', 'growth', 'forecast', 'care', 'area', 'and', 'local', 'competitive', 'landscape']",1
345246,nifty_1068,2015-06-09,Research and Markets: North American Radiotherapy Market Outlook 2015 - Forecasts and Analysis 2014-2020,Rise,0.012,104,research and market north american radiotherapy market outlook forecast and analysis,84,11,0,pharmacy,"['research', 'and', 'market', 'north', 'am', '##eric', '##an', 'radio', '##ther', '##ap', '##y', 'market', 'outlook', 'forecast', 'and', 'analysis']",1
345249,nifty_1068,2015-06-09,Research and Markets: Europe Radiotherapy Market Outlook & Forecasts 2014-2020,Rise,0.012,78,research and market europe radiotherapy market outlook forecast,63,8,0,pharmacy,"['research', 'and', 'market', 'euro', '##pe', 'radio', '##ther', '##ap', '##y', 'market', 'outlook', 'forecast']",1
345251,nifty_1068,2015-06-09,Research and Markets: Asia Pacific Radiotherapy Market Outlook - Forecast (2014-2020),Rise,0.012,85,research and market asia pacific radiotherapy market outlook forecast,69,9,0,pharmacy,"['research', 'and', 'market', 'as', '##ia', 'p', '##ac', '##ific', 'radio', '##ther', '##ap', '##y', 'market', 'outlook', 'forecast']",1
345270,nifty_1068,2015-06-09,Research and Markets: North American Healthcare/Medical Analytics Industry Outlook 2014-2020,Rise,0.012,92,research and market north american healthcare medical analytics industry outlook,80,10,0,pharmacy,"['research', 'and', 'market', 'north', 'am', '##eric', '##an', 'healthcare', 'medical', 'anal', '##ytic', '##s', 'industry', 'outlook']",1
345272,nifty_1068,2015-06-09,Research and Markets: Asia Pacific Healthcare/Medical Analytics Industry Outlook & Forecasts 2012-2020,Rise,0.012,102,research and market asia pacific healthcare medical analytics industry outlook forecast,87,11,0,pharmacy,"['research', 'and', 'market', 'as', '##ia', 'p', '##ac', '##ific', 'healthcare', 'medical', 'anal', '##ytic', '##s', 'industry', 'outlook', 'forecast']",1
345274,nifty_1068,2015-06-09,Research and Markets: Middle East Healthcare/Medical Analytics Industry Outlook & Forecasts 2012-2020,Rise,0.012,101,research and market middle east healthcare medical analytics industry outlook forecast,86,11,0,pharmacy,"['research', 'and', 'market', 'middle', 'east', 'healthcare', 'medical', 'anal', '##ytic', '##s', 'industry', 'outlook', 'forecast']",1
345277,nifty_1068,2015-06-09,Research and Markets: Benchmarking the Pharma Industry's Medical Affairs Functions,Rise,0.012,82,research and market benchmarking the pharma industry medical affair function,76,10,0,pharmacy,"['research', 'and', 'market', 'bench', '##mark', '##ing', 'the', 'p', '##har', '##ma', 'industry', 'medical', 'affair', 'function']",1
345287,nifty_1068,2015-06-09,Research and Markets: Pharmaceutical Detailing: In-person vs. Electronic vs. Phone,Rise,0.012,82,research and market pharmaceutical detailing person electronic phone,68,8,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'detailing', 'person', 'electronic', 'phone']",1
345305,nifty_1068,2015-06-09,Research and Markets: Global Orphan Drug Market Future Outlook 2020 - 697 Orphan Drugs Clinical Pipeline Drugs & 274 Marketed Orphan Drugs,Rise,0.012,138,research and market global orphan drug market future outlook orphan drug clinical pipeline drug marketed orphan drug,116,17,0,pharmacy,"['research', 'and', 'market', 'global', 'orphan', 'drug', 'market', 'future', 'outlook', 'orphan', 'drug', 'clinical', 'pipeline', 'drug', 'marketed', 'orphan', 'drug']",1
345365,nifty_1068,2015-06-09,Cerebain Biotech Receives Financial Commitment of Two Million Dollars,Rise,0.012,69,cerebain biotech receives financial commitment two million dollar,65,8,0,pharmacy,"['c', '##ere', '##ba', '##in', 'bio', '##tech', 'receives', 'financial', 'commitment', 'two', 'million', 'dollar']",1
345374,nifty_1068,2015-06-09,REG-Biotie Increases Proposed U.S. Public Offering of ADSs,Rise,0.012,58,reg biotie increase proposed public offering adss,49,7,0,pharmacy,"['re', '##g', 'bio', '##tie', 'increase', 'proposed', 'public', 'offering', 'ads', '##s']",1
345449,nifty_1068,2015-06-09,"Research and Markets: Global Oncology Partnering 2010-2015: Deal Trends, Players and Financials",Rise,0.012,95,research and market global oncology partnering deal trend player and financials,79,11,0,pharmacy,"['research', 'and', 'market', 'global', 'on', '##cology', 'partner', '##ing', 'deal', 'trend', 'player', 'and', 'financial', '##s']",1
345451,nifty_1068,2015-06-09,"Research and Markets: Global Infectious Diseases Partnering 2010-2015: Deal Trends, Players and Financials",Rise,0.012,106,research and market global infectious disease partnering deal trend player and financials,89,12,0,pharmacy,"['research', 'and', 'market', 'global', 'infectious', 'disease', 'partner', '##ing', 'deal', 'trend', 'player', 'and', 'financial', '##s']",1
345476,nifty_1068,2015-06-09,"Research and Markets: Global Gynecology Partnering 2010-2015: Deal Trends, Players and Financials Analysis",Rise,0.012,106,research and market global gynecology partnering deal trend player and financials analysis,90,12,0,pharmacy,"['research', 'and', 'market', 'global', 'g', '##yne', '##cology', 'partner', '##ing', 'deal', 'trend', 'player', 'and', 'financial', '##s', 'analysis']",1
345484,nifty_1068,2015-06-09,"Research and Markets: Global Cardiovascular Partnering 2010-2015: Deal Trends, Players and Financials",Rise,0.012,101,research and market global cardiovascular partnering deal trend player and financials,85,11,0,pharmacy,"['research', 'and', 'market', 'global', 'card', '##iovascular', 'partner', '##ing', 'deal', 'trend', 'player', 'and', 'financial', '##s']",1
345497,nifty_1068,2015-06-09,"Research and Markets: Global Gastrointestinal Partnering Deals Analysis 2010-2015: Trends, Players and Financials",Rise,0.012,113,research and market global gastrointestinal partnering deal analysis trend player and financials,96,12,0,pharmacy,"['research', 'and', 'market', 'global', 'gas', '##tro', '##int', '##est', '##inal', 'partner', '##ing', 'deal', 'analysis', 'trend', 'player', 'and', 'financial', '##s']",1
345519,nifty_1068,2015-06-09,"TRADE NEWS: Agilent Technologies Launches Updated Gene Expression Microarrays for Human, Mouse and Rat Models",Rise,0.012,109,trade news agilent technology launch updated gene expression microarrays for human mouse and rat model,102,15,0,pharmacy,"['trade', 'news', 'a', '##gi', '##lent', 'technology', 'launch', 'updated', 'gene', 'expression', 'micro', '##arra', '##ys', 'for', 'human', 'mouse', 'and', 'rat', 'model']",1
345546,nifty_1068,2015-06-09,"Research and Markets: Global Immunology Partnering Deals 2010-2015: Trends, Players and Financials for Over 700 Deals",Rise,0.012,117,research and market global immunology partnering deal trend player and financials for over deal,95,14,0,pharmacy,"['research', 'and', 'market', 'global', 'im', '##mu', '##nology', 'partner', '##ing', 'deal', 'trend', 'player', 'and', 'financial', '##s', 'for', 'over', 'deal']",1
345550,nifty_1068,2015-06-09,"Research and Markets: Global Metabolic Partnering Deals Analysis 2010-2015: Trends, Players and Financials for 1,000+ Deals",Rise,0.012,123,research and market global metabolic partnering deal analysis trend player and financials for deal,98,14,0,pharmacy,"['research', 'and', 'market', 'global', 'metabolic', 'partner', '##ing', 'deal', 'analysis', 'trend', 'player', 'and', 'financial', '##s', 'for', 'deal']",1
345556,nifty_1068,2015-06-09,"Research and Markets: Global Respiratory Partnering Deals Analysis 2010-2015: Trends, Players and Financials for 400 Deals",Rise,0.012,122,research and market global respiratory partnering deal analysis trend player and financials for deal,100,14,0,pharmacy,"['research', 'and', 'market', 'global', 'respiratory', 'partner', '##ing', 'deal', 'analysis', 'trend', 'player', 'and', 'financial', '##s', 'for', 'deal']",1
345567,nifty_1068,2015-06-09,"Research and Markets: Global Psychiatry Partnering Deals Analysis 2010-2015: Trends, Players and Financials for 600 Deals",Rise,0.012,121,research and market global psychiatry partnering deal analysis trend player and financials for deal,99,14,0,pharmacy,"['research', 'and', 'market', 'global', 'ps', '##ych', '##ia', '##try', 'partner', '##ing', 'deal', 'analysis', 'trend', 'player', 'and', 'financial', '##s', 'for', 'deal']",1
345611,nifty_1068,2015-06-09,"Research and Markets: Global Pediatrics Partnering Deals 2010-2015: Trends, Players and Financials of Over 200 Deals",Rise,0.012,116,research and market global pediatrics partnering deal trend player and financials over deal,91,13,0,pharmacy,"['research', 'and', 'market', 'global', 'p', '##ediatric', '##s', 'partner', '##ing', 'deal', 'trend', 'player', 'and', 'financial', '##s', 'over', 'deal']",1
345621,nifty_1068,2015-06-09,"Research and Markets: Global Dermatology Partnering Deals Analysis 2010-2015: Trends, Players and Financials",Rise,0.012,108,research and market global dermatology partnering deal analysis trend player and financials,91,12,0,pharmacy,"['research', 'and', 'market', 'global', 'der', '##mat', '##ology', 'partner', '##ing', 'deal', 'analysis', 'trend', 'player', 'and', 'financial', '##s']",1
345632,nifty_1068,2015-06-09,"Research and Markets: Global Orphan Diseases Partnering Deals Analysis 2010-2015: Trends, Players and Financials for 90 Deals",Rise,0.012,125,research and market global orphan disease partnering deal analysis trend player and financials for deal,103,15,0,pharmacy,"['research', 'and', 'market', 'global', 'orphan', 'disease', 'partner', '##ing', 'deal', 'analysis', 'trend', 'player', 'and', 'financial', '##s', 'for', 'deal']",1
345634,nifty_1068,2015-06-09,"Research and Markets: Global Hospital Care Partnering 2010-2015: Deal Trends, Players and Financials of 1500 Deals",Rise,0.012,114,research and market global hospital care partnering deal trend player and financials deal,89,13,0,pharmacy,"['research', 'and', 'market', 'global', 'hospital', 'care', 'partner', '##ing', 'deal', 'trend', 'player', 'and', 'financial', '##s', 'deal']",1
345648,nifty_1068,2015-06-09,"Research and Markets: Global Personalized Medicine Partnering Deals Analysis 2010-2015: Trends, Players, Financials and Forecasts",Rise,0.012,129,research and market global personalized medicine partnering deal analysis trend player financials and forecast,110,14,0,pharmacy,"['research', 'and', 'market', 'global', 'personal', '##ized', 'medicine', 'partner', '##ing', 'deal', 'analysis', 'trend', 'player', 'financial', '##s', 'and', 'forecast']",1
345650,nifty_1068,2015-06-09,"Research and Markets: Global Public Health Partnering Deal Trends, Players and Financials 2010-2015",Rise,0.012,99,research and market global public health partnering deal trend player and financials,84,12,0,pharmacy,"['research', 'and', 'market', 'global', 'public', 'health', 'partner', '##ing', 'deal', 'trend', 'player', 'and', 'financial', '##s']",1
345656,nifty_1068,2015-06-09,"Research and Markets: Global Ophthalmics Partnering Deal Trends, Players and Financials 2010-2015",Rise,0.012,97,research and market global ophthalmics partnering deal trend player and financials,82,11,0,pharmacy,"['research', 'and', 'market', 'global', 'op', '##ht', '##hal', '##mic', '##s', 'partner', '##ing', 'deal', 'trend', 'player', 'and', 'financial', '##s']",1
345659,nifty_1068,2015-06-09,"Research and Markets: Global Anthrax Pipeline Review, H1 2015 - 33 Companies & 29 Drug Profiles",Rise,0.012,95,research and market global anthrax pipeline review company drug profile,71,10,0,pharmacy,"['research', 'and', 'market', 'global', 'ant', '##hra', '##x', 'pipeline', 'review', 'company', 'drug', 'profile']",1
345671,nifty_1068,2015-06-09,"Research and Markets: Global Cachexia Pipeline Review, H1 2015 - 12 Companies & 16 Drug Profiles",Rise,0.012,96,research and market global cachexia pipeline review company drug profile,72,10,0,pharmacy,"['research', 'and', 'market', 'global', 'cache', '##xia', 'pipeline', 'review', 'company', 'drug', 'profile']",1
345676,nifty_1068,2015-06-09,Research and Markets: Hot off the Press: 2015 Diagnostic Imaging Market Consolidation: Who Will Not Survive?,Rise,0.012,108,research and market hot off the press diagnostic imaging market consolidation who will not survive,98,15,0,pharmacy,"['research', 'and', 'market', 'hot', 'off', 'the', 'press', 'diagnostic', 'imaging', 'market', 'consolidation', 'who', 'will', 'not', 'survive']",1
345679,nifty_1068,2015-06-09,"Research and Markets: Global Anxiety Disorders Pipeline Review, H1 2015",Rise,0.012,71,research and market global anxiety disorder pipeline review,59,8,0,pharmacy,"['research', 'and', 'market', 'global', 'anxiety', 'disorder', 'pipeline', 'review']",1
345683,nifty_1068,2015-06-09,"Research and Markets: Global Down Syndrome Pipeline Review, H1 2015 - 5 Companies & 12 Drug Profiles",Rise,0.012,100,research and market global down syndrome pipeline review company drug profile,77,11,0,pharmacy,"['research', 'and', 'market', 'global', 'down', 'syndrome', 'pipeline', 'review', 'company', 'drug', 'profile']",1
345710,nifty_1068,2015-06-09,"Research and Markets: Global Tourette Syndrome Pipeline Review, H1 2015 - 9 Companies & 10 Drug Profiles",Rise,0.012,104,research and market global tourette syndrome pipeline review company drug profile,81,11,0,pharmacy,"['research', 'and', 'market', 'global', 'tour', '##ette', 'syndrome', 'pipeline', 'review', 'company', 'drug', 'profile']",1
345725,nifty_1068,2015-06-09,"Research and Markets: Hepatic Encephalopathy Therapeutics Pipeline Review, H1 2015 - 4 Companies & 5 Drug Profiles",Rise,0.012,114,research and market hepatic encephalopathy therapeutic pipeline review company drug profile,91,11,0,pharmacy,"['research', 'and', 'market', 'he', '##pa', '##tic', 'en', '##ce', '##pha', '##lop', '##athy', 'therapeutic', 'pipeline', 'review', 'company', 'drug', 'profile']",1
345774,nifty_1068,2015-06-09,biOasis Engages Kilmer Lucas for Cross-Border Investor Relations,Rise,0.012,64,bioasis engages kilmer lucas for cross border investor relation,63,9,0,pharmacy,"['bio', '##asis', 'engages', 'k', '##il', '##mer', 'l', '##uca', '##s', 'for', 'cross', 'border', 'investor', 'relation']",1
345777,nifty_1068,2015-06-09,"Gilead Sciences to Present at Two Upcoming Investor Conferences on Tuesday, June 9",Rise,0.012,82,gilead science present two upcoming investor conference tuesday june,68,9,0,pharmacy,"['g', '##ile', '##ad', 'science', 'present', 'two', 'upcoming', 'investor', 'conference', 't', '##ues', '##day', 'j', '##une']",1
345780,nifty_1068,2015-06-09,Research and Markets: Global and Chinese Molecular Biology Analyzer Industry Analysis 2010-2015 & Forecasts 2015-2020,Rise,0.012,117,research and market global and chinese molecular biology analyzer industry analysis forecast,92,12,0,pharmacy,"['research', 'and', 'market', 'global', 'and', 'chin', '##ese', 'molecular', 'biology', 'analyze', '##r', 'industry', 'analysis', 'forecast']",1
345962,nifty_1069,2015-06-10,FDA Panel Recommends Amgen’s Cholesterol-Lowering Drug,Neutral,0.0032,54,fda panel recommends amgen cholesterol lowering drug,52,7,0,pharmacy,"['f', '##da', 'panel', 'recommend', '##s', 'am', '##gen', 'ch', '##ole', '##ster', '##ol', 'lowering', 'drug']",1
346033,nifty_1070,2015-06-11,Pfizer Trial of Antidepressant Fails to Meet Goal,Fall,-0.0077,49,pfizer trial antidepressant fails meet goal,43,6,0,pharmacy,"['p', '##fi', '##zer', 'trial', 'anti', '##de', '##press', '##ant', 'fails', 'meet', 'goal']",1
346170,nifty_1072,2015-06-16,FDA Restricts Trans Fats,Neutral,0.0016,24,fda restricts trans fat,23,4,0,pharmacy,"['f', '##da', 'restrict', '##s', 'trans', 'fat']",1
346509,nifty_1076,2015-06-23,"Research and Markets: Executive Outlook of Health, Wellness, and Wellbeing Technologies in the Global Automotive Industry",Fall,-0.0073,121,research and market executive outlook health wellness and wellbeing technology the global automotive industry,109,14,0,pharmacy,"['research', 'and', 'market', 'executive', 'outlook', 'health', 'well', '##ness', 'and', 'well', '##bei', '##ng', 'technology', 'the', 'global', 'automotive', 'industry']",1
346526,nifty_1076,2015-06-23,Research and Markets: Analysis of the Pharmaceutical Market in Malaysia,Fall,-0.0073,71,research and market analysis the pharmaceutical market malaysia,63,8,0,pharmacy,"['research', 'and', 'market', 'analysis', 'the', 'pharmaceutical', 'market', 'ma', '##lay', '##sia']",1
346801,nifty_1076,2015-06-23,Research and Markets: United States EMR/EHR Market Study 2015-2019 - Growing Global Aging Population,Fall,-0.0073,100,research and market united state emr ehr market study growing global aging population,85,13,0,pharmacy,"['research', 'and', 'market', 'united', 'state', 'em', '##r', 'eh', '##r', 'market', 'study', 'growing', 'global', 'aging', 'population']",1
346830,nifty_1076,2015-06-23,"Research and Markets: Paralysis Therapeutics Pipeline Review, H1 2015 - 4 Companies & 6 Drug Profiles",Fall,-0.0073,101,research and market paralysis therapeutic pipeline review company drug profile,78,10,0,pharmacy,"['research', 'and', 'market', 'para', '##lysis', 'therapeutic', 'pipeline', 'review', 'company', 'drug', 'profile']",1
346890,nifty_1076,2015-06-23,Research and Markets: United States Proton Therapy Market Outlook 2020,Fall,-0.0073,70,research and market united state proton therapy market outlook,62,9,0,pharmacy,"['research', 'and', 'market', 'united', 'state', 'pro', '##ton', 'therapy', 'market', 'outlook']",1
346895,nifty_1076,2015-06-23,Research and Markets: The Market for Patient Registry in the UAE is Projected to Grow at Over 14% Through 2020,Fall,-0.0073,110,research and market the market for patient registry the uae projected grow over through,87,14,0,pharmacy,"['research', 'and', 'market', 'the', 'market', 'for', 'patient', 'registry', 'the', 'u', '##ae', 'projected', 'grow', 'over', 'through']",1
346988,nifty_1076,2015-06-23,"Research and Markets: Genetic Testing Market Outlook 2020: Key Vendors Influencing the Industry Include Abbott, Roche, Siemens, Illumina, Thermo Fisher Scientific, and Myriad Genetics",Fall,-0.0073,183,research and market genetic testing market outlook key vendor influencing the industry include abbott roche siemens illumina thermo fisher scientific and myriad genetics,169,23,0,pharmacy,"['research', 'and', 'market', 'genetic', 'testing', 'market', 'outlook', 'key', 'vendor', 'in', '##f', '##lue', '##ncing', 'the', 'industry', 'include', 'abbot', '##t', 'r', '##och', '##e', 'si', '##em', '##ens', 'ill', '##umi', '##na', 'the', '##rm', '##o', 'fish', '##er', 'scientific', 'and', 'my', '##riad', 'genetics']",1
347049,nifty_1076,2015-06-23,SCILEX Pharmaceuticals Builds Out Market Access Team,Fall,-0.0073,52,scilex pharmaceutical build out market access team,50,7,0,pharmacy,"['s', '##ci', '##lex', 'pharmaceutical', 'build', 'out', 'market', 'access', 'team']",1
347314,nifty_1078,2015-06-25,Jinchi Biotech Ltd is Officially Listed on the National Stock Exchange of Australia,Neutral,-0.0002,83,jinchi biotech ltd officially listed the national stock exchange australia,74,10,0,pharmacy,"['ji', '##nch', '##i', 'bio', '##tech', 'l', '##t', '##d', 'officially', 'listed', 'the', 'national', 'stock', 'exchange', 'au', '##stra', '##lia']",1
347479,nifty_1078,2015-06-25,Research and Markets: Global Endocrine Testing Market 2015-2019,Neutral,-0.0002,63,research and market global endocrine testing market,51,7,0,pharmacy,"['research', 'and', 'market', 'global', 'end', '##oc', '##rine', 'testing', 'market']",1
347498,nifty_1078,2015-06-25,Research and Markets: Global Array Instruments Market 2015-2019 - Growing Importance of Microarrays in Therapeutics,Neutral,-0.0002,115,research and market global array instrument market growing importance microarrays therapeutic,93,11,0,pharmacy,"['research', 'and', 'market', 'global', 'array', 'instrument', 'market', 'growing', 'importance', 'micro', '##arra', '##ys', 'therapeutic']",1
347691,nifty_1078,2015-06-25,BriaCell Therapeutics Begins Trading on the OTCQB (ANCCF) and Presents at a New York Biotech Investor Conference,Neutral,-0.0002,112,briacell therapeutic begin trading the otcqb anccf and present new york biotech investor conference,99,14,0,pharmacy,"['br', '##iac', '##ell', 'therapeutic', 'begin', 'trading', 'the', 'o', '##t', '##c', '##q', '##b', 'an', '##cc', '##f', 'and', 'present', 'new', 'yo', '##rk', 'bio', '##tech', 'investor', 'conference']",1
347728,nifty_1078,2015-06-25,"Research and Markets: Global Restless Legs Syndrome Market 2015-2019 - Key Players Include Boehringer Ingelheim, GlaxoSmithKline, UCB & XenoPort",Neutral,-0.0002,144,research and market global restless leg syndrome market key player include boehringer ingelheim glaxosmithkline ucb xenoport,124,16,0,pharmacy,"['research', 'and', 'market', 'global', 'restless', 'leg', 'syndrome', 'market', 'key', 'player', 'include', 'b', '##oe', '##hr', '##inger', 'ing', '##el', '##heim', 'g', '##lax', '##os', '##mith', '##k', '##line', 'u', '##c', '##b', 'x', '##eno', '##port']",1
347744,nifty_1078,2015-06-25,Technavio Says Growing Popularity of DNA Profiling Will Lead to Widespread Utilization of Forensic Technologies in the Global Market Through 2019,Neutral,-0.0002,145,technavio say growing popularity dna profiling will lead widespread utilization forensic technology the global market through,125,16,0,pharmacy,"['tech', '##na', '##vio', 'say', 'growing', 'popularity', 'd', '##na', 'pro', '##fi', '##ling', 'will', 'lead', 'widespread', 'u', '##til', '##ization', 'forensic', 'technology', 'the', 'global', 'market', 'through']",1
347844,nifty_1078,2015-06-25,Sanomedics and ZenCharts Accelerates Marketing Strategy for its Electronic Health Records Software,Neutral,-0.0002,98,sanomedics and zencharts accelerates marketing strategy for it electronic health record software,96,12,0,pharmacy,"['sa', '##no', '##med', '##ics', 'and', 'z', '##en', '##cha', '##rts', 'accelerate', '##s', 'marketing', 'strategy', 'for', 'it', 'electronic', 'health', 'record', 'software']",1
347886,nifty_1078,2015-06-25,Research and Markets: Global Depression Drugs Market 2015-2019: Antidepressants are Losing Steam in the Face of Alternative Treatment,Neutral,-0.0002,133,research and market global depression drug market antidepressant are losing steam the face alternative treatment,112,15,0,pharmacy,"['research', 'and', 'market', 'global', 'depression', 'drug', 'market', 'anti', '##de', '##press', '##ant', 'are', 'losing', 'steam', 'the', 'face', 'alternative', 'treatment']",1
347945,nifty_1078,2015-06-25,Research and Markets: Binge Eating Disorder Pipeline Review 2015 - 5 Companies & 5 Drug Profiles,Neutral,-0.0002,96,research and market binge eating disorder pipeline review company drug profile,78,11,0,pharmacy,"['research', 'and', 'market', 'bin', '##ge', 'eating', 'disorder', 'pipeline', 'review', 'company', 'drug', 'profile']",1
347961,nifty_1078,2015-06-25,Research and Markets: Narcolepsy Pipeline Review H1 2015 - 7 Companies & 11 Drug Profiles,Neutral,-0.0002,89,research and market narcolepsy pipeline review company drug profile,67,9,0,pharmacy,"['research', 'and', 'market', 'na', '##rc', '##ole', '##psy', 'pipeline', 'review', 'company', 'drug', 'profile']",1
348029,nifty_1078,2015-06-25,"Research and Markets: 2015 New Frontiers in European Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape",Neutral,-0.0002,167,research and market new frontier european clinical chemistry and immunodiagnostic market business challenge emerging technology competitive landscape,149,17,0,pharmacy,"['research', 'and', 'market', 'new', 'frontier', 'euro', '##pe', '##an', 'clinical', 'chemistry', 'and', 'im', '##mu', '##no', '##dia', '##gno', '##stic', 'market', 'business', 'challenge', 'emerging', 'technology', 'competitive', 'landscape']",1
348040,nifty_1078,2015-06-25,"Provectus Biopharmaceuticals, Inc. Announces Closing of Public Offering",Neutral,-0.0002,71,provectus biopharmaceuticals inc announces closing public offering,66,7,0,pharmacy,"['prove', '##ctus', 'bio', '##pha', '##rma', '##ce', '##utical', '##s', 'in', '##c', 'announces', 'closing', 'public', 'offering']",1
348187,nifty_1078,2015-06-25,"Insurance, Hospital Industries Relieved at Subsidy Decision",Neutral,-0.0002,59,insurance hospital industry relieved subsidy decision,53,6,0,pharmacy,"['insurance', 'hospital', 'industry', 'relieved', 'sub', '##si', '##dy', 'decision']",1
348249,nifty_1079,2015-06-29,"Celgene, Juno in 10-Year Collaboration",Neutral,0.0021,38,celgene juno year collaboration,31,4,0,pharmacy,"['c', '##el', '##gene', 'j', '##uno', 'year', 'collaboration']",1
348330,nifty_1080,2015-06-30,"Health Firms Paid $6.49 Billion to Doctors, Hospitals in 2014",Rise,0.008,61,health firm paid billion doctor hospital,40,6,0,pharmacy,"['health', 'firm', 'paid', 'billion', 'doctor', 'hospital']",1
348387,nifty_1080,2015-06-30,United Airlines to Invest $30 Million in Fulcrum BioEnergy,Rise,0.008,58,united airline invest million fulcrum bioenergy,47,6,0,pharmacy,"['united', 'airline', 'invest', 'million', 'f', '##ul', '##c', '##rum', 'bio', '##ener', '##gy']",1
348625,nifty_1083,2015-07-07,Novartis Heart Failure Drug Approved by FDA,Fall,-0.0168,43,novartis heart failure drug approved fda,40,6,0,pharmacy,"['no', '##var', '##tis', 'heart', 'failure', 'drug', 'approved', 'f', '##da']",1
348659,nifty_1083,2015-07-07,Horizon Pharma Offers to Buy Depomed for $1.75 Billion,Fall,-0.0168,54,horizon pharma offer buy depomed for billion,44,7,0,pharmacy,"['horizon', 'p', '##har', '##ma', 'offer', 'buy', 'de', '##po', '##med', 'for', 'billion']",1
348863,nifty_1087,2015-07-14,Celgene to Buy Biotech Receptos for $7.2 Billion,Neutral,-0.0003,48,celgene buy biotech receptos for billion,40,6,0,pharmacy,"['c', '##el', '##gene', 'buy', 'bio', '##tech', 're', '##ce', '##pt', '##os', 'for', 'billion']",1
348925,nifty_1088,2015-07-15,Arivale Launching a New Industry â Scientific Wellness,Rise,0.008,56,arivale launching new industry scientific wellness,50,6,0,pharmacy,"['a', '##ri', '##vale', 'launching', 'new', 'industry', 'scientific', 'well', '##ness']",1
349083,nifty_1088,2015-07-15,"EPIRUS Biopharmaceuticals and Polpharma Group Enter Into a Multi-Product, Multi-Region, Profit-Sharing Collaboration to Advance Biosimilar Portfolio Targeting $6 Billion Addressable Innovator Market",Rise,0.008,198,epirus biopharmaceuticals and polpharma group enter into multi product multi region profit sharing collaboration advance biosimilar portfolio targeting billion addressable innovator market,188,22,0,pharmacy,"['e', '##pi', '##rus', 'bio', '##pha', '##rma', '##ce', '##utical', '##s', 'and', 'p', '##ol', '##pha', '##rma', 'group', 'enter', 'into', 'multi', 'product', 'multi', 'region', 'profit', 'sharing', 'collaboration', 'advance', 'bio', '##si', '##mi', '##lar', 'portfolio', 'targeting', 'billion', 'address', '##able', 'inn', '##ova', '##tor', 'market']",1
349088,nifty_1088,2015-07-15,Research and Markets: Future Horizons and Growth Strategies in the Global Endocrine Function Testing Market 2015: Supplier Shares and Country Forecasts,Rise,0.008,151,research and market future horizon and growth strategy the global endocrine function testing market supplier share and country forecast,135,19,0,pharmacy,"['research', 'and', 'market', 'future', 'horizon', 'and', 'growth', 'strategy', 'the', 'global', 'end', '##oc', '##rine', 'function', 'testing', 'market', 'supplier', 'share', 'and', 'country', 'forecast']",1
349116,nifty_1088,2015-07-15,"Research and Markets: China Biotechnology Markets Report 2015: Historical data (2004, 2009 and 2014) and long-term forecasts through 2019 and 2024",Rise,0.008,146,research and market china biotechnology market report historical data and and long term forecast through and,108,16,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'bio', '##tech', '##nology', 'market', 'report', 'historical', 'data', 'and', 'and', 'long', 'term', 'forecast', 'through', 'and']",1
349150,nifty_1088,2015-07-15,Research and Markets: Cancer Treatment Drugs Markets in China to 2024,Rise,0.008,69,research and market cancer treatment drug market china,54,8,0,pharmacy,"['research', 'and', 'market', 'cancer', 'treatment', 'drug', 'market', 'chin', '##a']",1
349279,nifty_1088,2015-07-15,Tonix Pharmaceuticals Prices Underwritten Public Offering of Common Stock,Rise,0.008,73,tonix pharmaceutical price underwritten public offering common stock,68,8,0,pharmacy,"['ton', '##ix', 'pharmaceutical', 'price', 'under', '##written', 'public', 'offering', 'common', 'stock']",1
349282,nifty_1088,2015-07-15,AppliedMicro's X-Gene(R) Processor Enterprise Software Ecosystem Continues Rapid Growth With SUSE,Rise,0.008,97,appliedmicro gene processor enterprise software ecosystem continues rapid growth with suse,90,11,0,pharmacy,"['applied', '##mic', '##ro', 'gene', 'processor', 'enterprise', 'software', 'ecosystem', 'continues', 'rapid', 'growth', 'with', 'su', '##se']",1
349432,nifty_1088,2015-07-15,"Research and Markets: Medical Device Coatings Market for General Surgery, Cardiovascular, Neurology, Gynecology, Orthopedics, Dentistry and Others End-users - Global Industry Analysis 2014 - 2020",Rise,0.008,195,research and market medical device coating market for general surgery cardiovascular neurology gynecology orthopedics dentistry and others end user global industry analysis,172,22,0,pharmacy,"['research', 'and', 'market', 'medical', 'device', 'coating', 'market', 'for', 'general', 'surgery', 'card', '##iovascular', 'ne', '##uro', '##logy', 'g', '##yne', '##cology', 'or', '##th', '##oped', '##ics', 'den', '##tist', '##ry', 'and', 'others', 'end', 'user', 'global', 'industry', 'analysis']",1
349440,nifty_1088,2015-07-15,"Research and Markets: Global Pulmonary Arterial Hypertension (Prostacyclin and Prostacyclin Analogs, ERAs, PDE-5 Inhibitors, sGC Stimulators and Selexipag) Market 2015-2020",Rise,0.008,172,research and market global pulmonary arterial hypertension prostacyclin and prostacyclin analog era pde inhibitor sgc stimulators and selexipag market,150,19,0,pharmacy,"['research', 'and', 'market', 'global', 'pulmonary', 'art', '##erial', 'h', '##yper', '##tens', '##ion', 'pro', '##sta', '##cy', '##c', '##lin', 'and', 'pro', '##sta', '##cy', '##c', '##lin', 'analog', 'era', 'p', '##de', 'inhibitor', 's', '##g', '##c', 's', '##ti', '##mu', '##lator', '##s', 'and', 'se', '##lex', '##ip', '##ag', 'market']",1
349443,nifty_1088,2015-07-15,Global Cell and Tissue Culture Supplies Market Expected to Hit US$28 Billion by 2020: Persistence Market Research,Rise,0.008,113,global cell and tissue culture supply market expected hit billion persistence market research,93,13,0,pharmacy,"['global', 'cell', 'and', 'tissue', 'culture', 'supply', 'market', 'expected', 'hit', 'billion', 'per', '##sistence', 'market', 'research']",1
349525,nifty_1088,2015-07-15,Research and Markets: Post-Traumatic Stress Disorder (PTSD) - 2015 Pipeline Insights Report,Rise,0.008,91,research and market post traumatic stress disorder ptsd pipeline insight report,79,11,0,pharmacy,"['research', 'and', 'market', 'post', 'traumatic', 'stress', 'disorder', 'p', '##ts', '##d', 'pipeline', 'insight', 'report']",1
349540,nifty_1088,2015-07-15,Research and Markets: USA Directory of 3000+ Medical Devices & Diagnostics Companies 2015,Rise,0.008,89,research and market usa directory medical device diagnostics company,68,9,0,pharmacy,"['research', 'and', 'market', 'us', '##a', 'directory', 'medical', 'device', 'diagnostic', '##s', 'company']",1
349545,nifty_1088,2015-07-15,Research and Markets: China Biotechnology Directory 2015,Rise,0.008,56,research and market china biotechnology directory,49,6,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'bio', '##tech', '##nology', 'directory']",1
349572,nifty_1088,2015-07-15,UL Maintains Global Market Leadership in Medical Device Category for IECEE CB Test Certificates,Rise,0.008,95,maintains global market leadership medical device category for iecee test certificate,85,11,0,pharmacy,"['maintains', 'global', 'market', 'leadership', 'medical', 'device', 'category', 'for', 'i', '##ec', '##ee', 'test', 'certificate']",1
349581,nifty_1088,2015-07-15,Research and Markets: Pouchitis - 2015 Pipeline Insights Report,Rise,0.008,63,research and market pouchitis pipeline insight report,53,7,0,pharmacy,"['research', 'and', 'market', 'pouch', '##itis', 'pipeline', 'insight', 'report']",1
349584,nifty_1088,2015-07-15,Research and Markets: Premature Ejaculation - 2015 Pipeline Insights Study,Rise,0.008,74,research and market premature ejaculation pipeline insight study,64,8,0,pharmacy,"['research', 'and', 'market', 'premature', 'e', '##ja', '##cula', '##tion', 'pipeline', 'insight', 'study']",1
349616,nifty_1088,2015-07-15,Research and Markets: China Medical Devices & Diagnostics Companies 2015,Rise,0.008,72,research and market china medical device diagnostics company,60,8,0,pharmacy,"['research', 'and', 'market', 'chin', '##a', 'medical', 'device', 'diagnostic', '##s', 'company']",1
349620,nifty_1088,2015-07-15,"Nashville Entrepreneurs Launch getRx, New Era in E-prescriptions",Rise,0.008,64,nashville entrepreneur launch getrx new era prescription,56,7,0,pharmacy,"['na', '##sh', '##ville', 'entrepreneur', 'launch', 'get', '##r', '##x', 'new', 'era', 'prescription']",1
349631,nifty_1088,2015-07-15,Research and Markets: Premenstrual Syndrome - 2015 Pipeline Insights,Rise,0.008,68,research and market premenstrual syndrome pipeline insight,58,7,0,pharmacy,"['research', 'and', 'market', 'pre', '##men', '##st', '##ru', '##al', 'syndrome', 'pipeline', 'insight']",1
349637,nifty_1088,2015-07-15,Research and Markets: Global Amenorrhea Pipeline Insights Study 2015,Rise,0.008,68,research and market global amenorrhea pipeline insight study,60,8,0,pharmacy,"['research', 'and', 'market', 'global', 'am', '##eno', '##rr', '##hea', 'pipeline', 'insight', 'study']",1
349639,nifty_1088,2015-07-15,Research and Markets: Global Acute Coronary Syndrome Pipeline Report 2015,Rise,0.008,73,research and market global acute coronary syndrome pipeline report,66,9,0,pharmacy,"['research', 'and', 'market', 'global', 'acute', 'co', '##rona', '##ry', 'syndrome', 'pipeline', 'report']",1
349653,nifty_1088,2015-07-15,Research and Markets: Anal Fistula - 2015 Pipeline Insights Report,Rise,0.008,66,research and market anal fistula pipeline insight report,56,8,0,pharmacy,"['research', 'and', 'market', 'anal', 'fist', '##ula', 'pipeline', 'insight', 'report']",1
349666,nifty_1088,2015-07-15,Research and Markets: Global Mycoses Pipeline Insights Study 2015,Rise,0.008,65,research and market global mycoses pipeline insight study,57,8,0,pharmacy,"['research', 'and', 'market', 'global', 'my', '##cos', '##es', 'pipeline', 'insight', 'study']",1
349669,nifty_1088,2015-07-15,Research and Markets: 2015 Study for the Bladder Cancer Treatment Drugs Markets in China,Rise,0.008,88,research and market study for the bladder cancer treatment drug market china,76,12,0,pharmacy,"['research', 'and', 'market', 'study', 'for', 'the', 'bladder', 'cancer', 'treatment', 'drug', 'market', 'chin', '##a']",1
349683,nifty_1088,2015-07-15,Research and Markets: 2015 Myelofibrosis Pipeline Insights Study,Rise,0.008,64,research and market myelofibrosis pipeline insight study,56,7,0,pharmacy,"['research', 'and', 'market', 'my', '##elo', '##fi', '##bro', '##sis', 'pipeline', 'insight', 'study']",1
349691,nifty_1088,2015-07-15,Research and Markets: Global Myeloid Metaplasia Pipeline Insights 2015,Rise,0.008,70,research and market global myeloid metaplasia pipeline insight,62,8,0,pharmacy,"['research', 'and', 'market', 'global', 'my', '##elo', '##id', 'meta', '##p', '##lasia', 'pipeline', 'insight']",1
349733,nifty_1088,2015-07-15,RedHill Biopharma Announces Proposed Public Offering of Its American Depository Shares,Rise,0.008,86,redhill biopharma announces proposed public offering it american depository share,81,10,0,pharmacy,"['red', '##hill', 'bio', '##pha', '##rma', 'announces', 'proposed', 'public', 'offering', 'it', 'am', '##eric', '##an', 'deposit', '##ory', 'share']",1
349833,nifty_1088,2015-07-15,"Bigger may not be better for China's ""super hospitals""",Rise,0.008,54,bigger may not better for china super hospital,46,8,0,pharmacy,"['bigger', 'may', 'not', 'better', 'for', 'chin', '##a', 'super', 'hospital']",1
350224,nifty_1091,2015-07-21,"Research and Markets: Medical Device Regulation in Asia/Pacific Markets Seminar: London, UK - 21st, 22nd of September 2015",Neutral,-0.0018,122,research and market medical device regulation asia pacific market seminar london september,90,12,0,pharmacy,"['research', 'and', 'market', 'medical', 'device', 'regulation', 'as', '##ia', 'p', '##ac', '##ific', 'market', 'seminar', 'lo', '##ndon', 'se', '##pt', '##em', '##ber']",1
350286,nifty_1091,2015-07-21,Research and Markets: Cardiometabolic Drug News Issue - Afrezza Aggressive Pricing Strategy View Playing Out,Neutral,-0.0018,108,research and market cardiometabolic drug news issue afrezza aggressive pricing strategy view playing out,104,14,0,pharmacy,"['research', 'and', 'market', 'card', '##io', '##met', '##ab', '##olic', 'drug', 'news', 'issue', 'a', '##f', '##rez', '##za', 'aggressive', 'pricing', 'strategy', 'view', 'playing', 'out']",1
350340,nifty_1091,2015-07-21,Progressive Care Enters $10 Billion 340B Market,Neutral,-0.0018,47,progressive care enters billion market,38,5,0,pharmacy,"['progressive', 'care', 'enters', 'billion', 'market']",1
350349,nifty_1091,2015-07-21,"Mapi integrates Epidemiology, HEOR and Strategic Market Access into Real World Strategy and Analytics",Neutral,-0.0018,101,mapi integrates epidemiology heor and strategic market access into real world strategy and analytics,100,14,0,pharmacy,"['map', '##i', 'integrate', '##s', 'e', '##pid', '##em', '##iology', 'he', '##or', 'and', 'strategic', 'market', 'access', 'into', 'real', 'world', 'strategy', 'and', 'anal', '##ytic', '##s']",1
350416,nifty_1091,2015-07-21,Cell MedX Corp. (CMXC) Advances Development Timeline,Neutral,-0.0018,52,cell medx corp cmxc advance development timeline,48,7,0,pharmacy,"['cell', 'me', '##d', '##x', 'co', '##rp', 'cm', '##x', '##c', 'advance', 'development', 'timeline']",1
350465,nifty_1091,2015-07-21,"Watch List for Drug Manufacturers - Major Equities -- Pfizer, Bristol-Myers Squibb, Eli Lilly, Kythera Biopharma, and Impax Laboratories",Neutral,-0.0018,136,watch list for drug manufacturer major equity pfizer bristol myers squibb eli lilly kythera biopharma and impax laboratory,122,18,0,pharmacy,"['watch', 'list', 'for', 'drug', 'manufacturer', 'major', 'equity', 'p', '##fi', '##zer', 'br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'el', '##i', 'l', '##ill', '##y', 'k', '##yt', '##her', '##a', 'bio', '##pha', '##rma', 'and', 'imp', '##ax', 'laboratory']",1
350484,nifty_1091,2015-07-21,"Research and Markets: Global Post-traumatic Stress Disorder Therapeutics Market 2015-2019 - GlaxoSmithKline, Pfizer & Otsuka Pharmaceutical Dominate the Industry",Neutral,-0.0018,161,research and market global post traumatic stress disorder therapeutic market glaxosmithkline pfizer otsuka pharmaceutical dominate the industry,143,17,0,pharmacy,"['research', 'and', 'market', 'global', 'post', 'traumatic', 'stress', 'disorder', 'therapeutic', 'market', 'g', '##lax', '##os', '##mith', '##k', '##line', 'p', '##fi', '##zer', 'o', '##tsu', '##ka', 'pharmaceutical', 'dominate', 'the', 'industry']",1
350545,nifty_1091,2015-07-21,"Research and Markets: US Tumor Marker Testing Market 2015-2019: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies",Neutral,-0.0018,147,research and market tumor marker testing market supplier share country forecast innovative technology competitive strategy,122,15,0,pharmacy,"['research', 'and', 'market', 'tumor', 'marker', 'testing', 'market', 'supplier', 'share', 'country', 'forecast', 'innovative', 'technology', 'competitive', 'strategy']",1
350568,nifty_1091,2015-07-21,"Research and Markets: US Drugs of Abuse Point-of-Care Testing Market 2015-2019: Physician Offices, Emergency Rooms & Ambulatory Care Centers",Neutral,-0.0018,140,research and market drug abuse point care testing market physician office emergency room ambulatory care center,111,16,0,pharmacy,"['research', 'and', 'market', 'drug', 'abuse', 'point', 'care', 'testing', 'market', 'physician', 'office', 'emergency', 'room', 'am', '##bula', '##tory', 'care', 'center']",1
350576,nifty_1091,2015-07-21,Research and Markets: US Molecular Diagnostics Market 2015-2019 - Sales and Market Shares of Major Suppliers,Neutral,-0.0018,108,research and market molecular diagnostics market sale and market share major supplier,85,12,0,pharmacy,"['research', 'and', 'market', 'molecular', 'diagnostic', '##s', 'market', 'sale', 'and', 'market', 'share', 'major', 'supplier']",1
350581,nifty_1091,2015-07-21,"Research and Markets: US Molecular Diagnostics Market 2015-2019 - Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing",Neutral,-0.0018,143,research and market molecular diagnostics market infectious disease genetic disease cancer forensic and paternity testing,121,15,0,pharmacy,"['research', 'and', 'market', 'molecular', 'diagnostic', '##s', 'market', 'infectious', 'disease', 'genetic', 'disease', 'cancer', 'forensic', 'and', 'pat', '##ern', '##ity', 'testing']",1
350582,nifty_1091,2015-07-21,Research and Markets: US Nucleic Acid Testing/NAT Market 2015-2019: Sales and Market Shares of Major Suppliers,Neutral,-0.0018,110,research and market nucleic acid testing nat market sale and market share major supplier,88,14,0,pharmacy,"['research', 'and', 'market', 'nuclei', '##c', 'acid', 'testing', 'na', '##t', 'market', 'sale', 'and', 'market', 'share', 'major', 'supplier']",1
350600,nifty_1091,2015-07-21,Genetic Testing Market â Global Trends & Forecast Unveiled by Technavio,Neutral,-0.0018,73,genetic testing market global trend forecast unveiled technavio,63,8,0,pharmacy,"['genetic', 'testing', 'market', 'global', 'trend', 'forecast', 'unveiled', 'tech', '##na', '##vio']",1
350606,nifty_1091,2015-07-21,Research and Markets: Hyperalgesia Pipeline Insights Study 2015,Neutral,-0.0018,63,research and market hyperalgesia pipeline insight study,55,7,0,pharmacy,"['research', 'and', 'market', 'h', '##yper', '##al', '##ges', '##ia', 'pipeline', 'insight', 'study']",1
350610,nifty_1091,2015-07-21,Research and Markets: Global Hyperammonemia Pipeline Insights Report 2015,Neutral,-0.0018,73,research and market global hyperammonemia pipeline insight report,65,8,0,pharmacy,"['research', 'and', 'market', 'global', 'h', '##yper', '##am', '##mon', '##emia', 'pipeline', 'insight', 'report']",1
350619,nifty_1091,2015-07-21,Research and Markets: Global Hypercalcemia Therapeutics Pipeline Insights Study 2015,Neutral,-0.0018,84,research and market global hypercalcemia therapeutic pipeline insight study,75,9,0,pharmacy,"['research', 'and', 'market', 'global', 'h', '##yper', '##cal', '##ce', '##mia', 'therapeutic', 'pipeline', 'insight', 'study']",1
350625,nifty_1091,2015-07-21,Research and Markets: Global Hyperglycemia Therapeutics Pipeline Insights Study 2015,Neutral,-0.0018,84,research and market global hyperglycemia therapeutic pipeline insight study,75,9,0,pharmacy,"['research', 'and', 'market', 'global', 'h', '##yper', '##gly', '##ce', '##mia', 'therapeutic', 'pipeline', 'insight', 'study']",1
350630,nifty_1091,2015-07-21,Research and Markets: Global Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Therapeutics Pipeline Insights Report 2015,Neutral,-0.0018,129,research and market global mucopolysaccharidosis iii mp iii sanfilippo syndrome therapeutic pipeline insight report,115,14,0,pharmacy,"['research', 'and', 'market', 'global', 'm', '##uc', '##op', '##oly', '##sa', '##cc', '##hari', '##dos', '##is', 'ii', '##i', 'm', '##p', 'ii', '##i', 'sa', '##n', '##fi', '##lip', '##po', 'syndrome', 'therapeutic', 'pipeline', 'insight', 'report']",1
350645,nifty_1091,2015-07-21,Research and Markets: Global Mucositis Pipeline Insights Report 2015,Neutral,-0.0018,68,research and market global mucositis pipeline insight report,60,8,0,pharmacy,"['research', 'and', 'market', 'global', 'm', '##uc', '##os', '##itis', 'pipeline', 'insight', 'report']",1
350656,nifty_1091,2015-07-21,Research and Markets: Mumps - 2015 Pipeline Insights Report,Neutral,-0.0018,59,research and market mumps pipeline insight report,49,7,0,pharmacy,"['research', 'and', 'market', 'mum', '##ps', 'pipeline', 'insight', 'report']",1
350663,nifty_1091,2015-07-21,Research and Markets: Muscle Spasm Pipeline Insights Study 2015,Neutral,-0.0018,63,research and market muscle spasm pipeline insight study,55,8,0,pharmacy,"['research', 'and', 'market', 'muscle', 'spa', '##sm', 'pipeline', 'insight', 'study']",1
350680,nifty_1091,2015-07-21,Research and Markets: Percutaneous Coronary Intervention - 2015 Therapeutics Pipeline Insights,Neutral,-0.0018,94,research and market percutaneous coronary intervention therapeutic pipeline insight,83,9,0,pharmacy,"['research', 'and', 'market', 'per', '##cut', '##aneous', 'co', '##rona', '##ry', 'intervention', 'therapeutic', 'pipeline', 'insight']",1
350689,nifty_1091,2015-07-21,Research and Markets: Global Myalgia Pipeline Insights Report 2015,Neutral,-0.0018,66,research and market global myalgia pipeline insight report,58,8,0,pharmacy,"['research', 'and', 'market', 'global', 'my', '##al', '##gia', 'pipeline', 'insight', 'report']",1
350737,nifty_1091,2015-07-21,Research and Markets: Future Horizons and Growth Strategies in the US Endocrine Function Testing Market 2015: Supplier Shares and Country Forecasts,Neutral,-0.0018,147,research and market future horizon and growth strategy the endocrine function testing market supplier share and country forecast,128,18,0,pharmacy,"['research', 'and', 'market', 'future', 'horizon', 'and', 'growth', 'strategy', 'the', 'end', '##oc', '##rine', 'function', 'testing', 'market', 'supplier', 'share', 'and', 'country', 'forecast']",1
350739,nifty_1091,2015-07-21,Research and Markets: Future Horizons and Growth Strategies in the US Therapeutic Drug Monitoring (TDM) Market 2015: Supplier Shares and Country Forecasts,Neutral,-0.0018,154,research and market future horizon and growth strategy the therapeutic drug monitoring tdm market supplier share and country forecast,133,19,0,pharmacy,"['research', 'and', 'market', 'future', 'horizon', 'and', 'growth', 'strategy', 'the', 'therapeutic', 'drug', 'monitoring', 't', '##d', '##m', 'market', 'supplier', 'share', 'and', 'country', 'forecast']",1
350747,nifty_1091,2015-07-21,Research and Markets: Future Horizons and Growth Strategies in the US Cell Surface Marker Testing Market 2015: Supplier Shares and Country Forecasts,Neutral,-0.0018,148,research and market future horizon and growth strategy the cell surface marker testing market supplier share and country forecast,129,19,0,pharmacy,"['research', 'and', 'market', 'future', 'horizon', 'and', 'growth', 'strategy', 'the', 'cell', 'surface', 'marker', 'testing', 'market', 'supplier', 'share', 'and', 'country', 'forecast']",1
350752,nifty_1091,2015-07-21,Research and Markets: Future Horizons and Growth Strategies in the US Nucleic Acid Testing Market 2015: Supplier Shares and Country Forecasts,Neutral,-0.0018,141,research and market future horizon and growth strategy the nucleic acid testing market supplier share and country forecast,122,18,0,pharmacy,"['research', 'and', 'market', 'future', 'horizon', 'and', 'growth', 'strategy', 'the', 'nuclei', '##c', 'acid', 'testing', 'market', 'supplier', 'share', 'and', 'country', 'forecast']",1
350957,nifty_1091,2015-07-21,Novartis Is Cleared to Sell Biotech Copycat in U.S.,Neutral,-0.0018,51,novartis cleared sell biotech copycat,37,5,0,pharmacy,"['no', '##var', '##tis', 'cleared', 'sell', 'bio', '##tech', 'copy', '##cat']",1
350987,nifty_1091,2015-07-21,Bristol-Myers Squibb Receives Breakthrough Designation for HIV Treatment,Neutral,-0.0018,72,bristol myers squibb receives breakthrough designation for hiv treatment,72,9,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'receives', 'breakthrough', 'designation', 'for', 'hi', '##v', 'treatment']",1
351018,nifty_1092,2015-07-22,"Novartis delivered solid performance in the second quarter, with strong innovation and progress on new launches",Fall,-0.0056,111,novartis delivered solid performance the second quarter with strong innovation and progress new launch,102,14,0,pharmacy,"['no', '##var', '##tis', 'delivered', 'solid', 'performance', 'the', 'second', 'quarter', 'with', 'strong', 'innovation', 'and', 'progress', 'new', 'launch']",1
351042,nifty_1092,2015-07-22,BRIEF-Novartis CEO says no pushback on Entresto drug price in U.S.,Fall,-0.0056,66,brief novartis ceo say pushback entresto drug price,51,8,0,pharmacy,"['brief', 'no', '##var', '##tis', 'c', '##eo', 'say', 'push', '##back', 'en', '##tres', '##to', 'drug', 'price']",1
351101,nifty_1092,2015-07-22,Drugmakers push European shares further away from highs,Fall,-0.0056,55,drugmakers push european share further away from high,53,8,0,pharmacy,"['drug', '##makers', 'push', 'euro', '##pe', '##an', 'share', 'further', 'away', 'from', 'high']",1
351132,nifty_1092,2015-07-22,"Research and Markets: Pharmaceutical Industry in China to 2020: An In Depth Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Cha",Fall,-0.0056,224,research and market pharmaceutical industry china depth analysis multinational and chinese biopharma company industry trend environment regulation market driver restraint opportunity cha,186,22,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'industry', 'chin', '##a', 'depth', 'analysis', 'multinational', 'and', 'chin', '##ese', 'bio', '##pha', '##rma', 'company', 'industry', 'trend', 'environment', 'regulation', 'market', 'driver', 'restraint', 'opportunity', 'ch', '##a']",1
351138,nifty_1092,2015-07-22,"Research and Markets: Bipolar Disorder (Manic Depression) Therapeutics Pipeline Review, H1 2015 - 23 Companies & 29 Drug Profiles",Fall,-0.0056,129,research and market bipolar disorder manic depression therapeutic pipeline review company drug profile,102,13,0,pharmacy,"['research', 'and', 'market', 'bi', '##pol', '##ar', 'disorder', 'man', '##ic', 'depression', 'therapeutic', 'pipeline', 'review', 'company', 'drug', 'profile']",1
351143,nifty_1092,2015-07-22,"Research and Markets: Polycystic Kidney Disease Therapeutics Pipeline Review, H1 2015 - 8 Companies & 17 Drug Profiles",Fall,-0.0056,118,research and market polycystic kidney disease therapeutic pipeline review company drug profile,94,12,0,pharmacy,"['research', 'and', 'market', 'p', '##oly', '##cy', '##stic', 'kidney', 'disease', 'therapeutic', 'pipeline', 'review', 'company', 'drug', 'profile']",1
351179,nifty_1092,2015-07-22,Research and Markets: Cell Culture Market Report - Global Industry Analysis 2015 - 2022,Fall,-0.0056,87,research and market cell culture market report global industry analysis,71,10,0,pharmacy,"['research', 'and', 'market', 'cell', 'culture', 'market', 'report', 'global', 'industry', 'analysis']",1
351225,nifty_1092,2015-07-22,Research and Markets: Acute Coronary Syndrome Therapeutics Pipeline Report 2015 - 15 Companies & 23 Drug Profiles,Fall,-0.0056,113,research and market acute coronary syndrome therapeutic pipeline report company drug profile,92,12,0,pharmacy,"['research', 'and', 'market', 'acute', 'co', '##rona', '##ry', 'syndrome', 'therapeutic', 'pipeline', 'report', 'company', 'drug', 'profile']",1
351245,nifty_1092,2015-07-22,Health Care Microfluidics Market to Grow to Nearly $4 Billion in 2020,Fall,-0.0056,69,health care microfluidics market grow nearly billion,52,7,0,pharmacy,"['health', 'care', 'micro', '##f', '##lu', '##id', '##ics', 'market', 'grow', 'nearly', 'billion']",1
351260,nifty_1092,2015-07-22,"Research and Markets: The US Molecular Diagnostic Testing Market 2015: Test Volume and Sales Forecasts by Application, and Supplier Shares by Test",Fall,-0.0056,146,research and market the molecular diagnostic testing market test volume and sale forecast application and supplier share test,125,18,0,pharmacy,"['research', 'and', 'market', 'the', 'molecular', 'diagnostic', 'testing', 'market', 'test', 'volume', 'and', 'sale', 'forecast', 'application', 'and', 'supplier', 'share', 'test']",1
351316,nifty_1092,2015-07-22,Research and Markets: Aspergillosis Pipeline Review 2015 - 17 Companies & 27 Drug Profiles,Fall,-0.0056,90,research and market aspergillosis pipeline review company drug profile,70,9,0,pharmacy,"['research', 'and', 'market', 'as', '##per', '##gill', '##osis', 'pipeline', 'review', 'company', 'drug', 'profile']",1
351525,nifty_1092,2015-07-22,Research and Markets: The US Cancer Diagnostic Testing Market 2015: Sales Forecasts By Market Segment and Supplier Shares by Test,Fall,-0.0056,129,research and market the cancer diagnostic testing market sale forecast market segment and supplier share test,109,16,0,pharmacy,"['research', 'and', 'market', 'the', 'cancer', 'diagnostic', 'testing', 'market', 'sale', 'forecast', 'market', 'segment', 'and', 'supplier', 'share', 'test']",1
351557,nifty_1092,2015-07-22,Research and Markets: Pharmaceutical Logistics Market in the APAC 2015-2019 - What Are the Market Opportunities and Threats Faced by the Key Vendors?,Fall,-0.0056,149,research and market pharmaceutical logistics market the apac what are the market opportunity and threat faced the key vendor,124,19,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'logistics', 'market', 'the', 'a', '##pa', '##c', 'what', 'are', 'the', 'market', 'opportunity', 'and', 'threat', 'faced', 'the', 'key', 'vendor']",1
351566,nifty_1092,2015-07-22,Research and Markets: Ewing Sarcoma Pipeline Report 2015 - 15 Companies & 23 Drug Profiles,Fall,-0.0056,90,research and market ewing sarcoma pipeline report company drug profile,70,10,0,pharmacy,"['research', 'and', 'market', 'e', '##wing', 'sa', '##rc', '##oma', 'pipeline', 'report', 'company', 'drug', 'profile']",1
351573,nifty_1092,2015-07-22,Research and Markets: Global Inflammatory Bowel Disease Market 2015-2019 - Dominance of Market by Biologics,Fall,-0.0056,107,research and market global inflammatory bowel disease market dominance market biologics,87,11,0,pharmacy,"['research', 'and', 'market', 'global', 'inflammatory', 'bow', '##el', 'disease', 'market', 'dominance', 'market', 'bio', '##log', '##ics']",1
351603,nifty_1092,2015-07-22,"Research and Markets: Major Depressive Disorder Pipeline Review, H1 2015 - 37 Companies & 32 Drug Profiles",Fall,-0.0056,106,research and market major depressive disorder pipeline review company drug profile,82,11,0,pharmacy,"['research', 'and', 'market', 'major', 'de', '##pressive', 'disorder', 'pipeline', 'review', 'company', 'drug', 'profile']",1
351624,nifty_1092,2015-07-22,Research and Markets: Global Fibrosis Therapeutics Pipeline Report 2015 - 32 Companies & 51 Drug Profiles,Fall,-0.0056,105,research and market global fibrosis therapeutic pipeline report company drug profile,84,11,0,pharmacy,"['research', 'and', 'market', 'global', 'fi', '##bro', '##sis', 'therapeutic', 'pipeline', 'report', 'company', 'drug', 'profile']",1
351662,nifty_1092,2015-07-22,Cloud Pharmaceuticals Welcomes Noted Life Sciences Experts to Its Advisory Board,Fall,-0.0056,80,cloud pharmaceutical welcome noted life science expert it advisory board,72,10,0,pharmacy,"['cloud', 'pharmaceutical', 'welcome', 'noted', 'life', 'science', 'expert', 'it', 'advisory', 'board']",1
351682,nifty_1092,2015-07-22,Research and Markets: Global Hypotension Pipeline Insights Report 2015,Fall,-0.0056,70,research and market global hypotension pipeline insight report,62,8,0,pharmacy,"['research', 'and', 'market', 'global', 'h', '##y', '##pot', '##ens', '##ion', 'pipeline', 'insight', 'report']",1
351686,nifty_1092,2015-07-22,Research and Markets: Global Hypoglycemia Pipeline Insights Report 2015,Fall,-0.0056,71,research and market global hypoglycemia pipeline insight report,63,8,0,pharmacy,"['research', 'and', 'market', 'global', 'h', '##y', '##po', '##gly', '##ce', '##mia', 'pipeline', 'insight', 'report']",1
351687,nifty_1092,2015-07-22,Research and Markets: Global Idiopathic (Essential) Hypertension Pipeline Insights Report 2015,Fall,-0.0056,94,research and market global idiopathic essential hypertension pipeline insight report,84,10,0,pharmacy,"['research', 'and', 'market', 'global', 'id', '##io', '##pathic', 'essential', 'h', '##yper', '##tens', '##ion', 'pipeline', 'insight', 'report']",1
351690,nifty_1092,2015-07-22,Research and Markets: Non Muscle Invasive Bladder Cancer (NMIBC) - 2015 Pipeline Insights Study,Fall,-0.0056,95,research and market non muscle invasive bladder cancer nmibc pipeline insight study,83,12,0,pharmacy,"['research', 'and', 'market', 'non', 'muscle', 'invasive', 'bladder', 'cancer', 'nmi', '##b', '##c', 'pipeline', 'insight', 'study']",1
352040,nifty_1093,2015-07-23,Bristol-Myers Gets a Revenue Boost from Opdivo,Fall,-0.0104,46,bristol myers get revenue boost from opdivo,43,7,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'get', 'revenue', 'boost', 'from', 'op', '##di', '##vo']",1
352087,nifty_1093,2015-07-23,Doctors Object to High Cancer-Drug Prices,Fall,-0.0104,41,doctor object high cancer drug price,36,6,0,pharmacy,"['doctor', 'object', 'high', 'cancer', 'drug', 'price']",1
352143,nifty_1094,2015-07-27,Kythera Wins Canadian Approval for Double-Chin Injection,Rise,0.0123,56,kythera win canadian approval for double chin injection,55,8,0,pharmacy,"['k', '##yt', '##her', '##a', 'win', 'can', '##adia', '##n', 'approval', 'for', 'double', 'chin', 'injection']",1
352215,nifty_1095,2015-07-28,Merck Earnings Hurt by Arthritis Drug Knockoffs,Rise,0.0069,47,merck earnings hurt arthritis drug knockoff,43,6,0,pharmacy,"['me', '##rc', '##k', 'earnings', 'hurt', 'art', '##hr', '##itis', 'drug', 'knock', '##off']",1
352367,nifty_1097,2015-07-30,Novartis partners with Phase 4 Partners and institutional investors to help create Mereo BioPharma Group Ltd,Neutral,-0.0015,108,novartis partner with phase partner and institutional investor help create mereo biopharma group ltd,100,14,0,pharmacy,"['no', '##var', '##tis', 'partner', 'with', 'phase', 'partner', 'and', 'institutional', 'investor', 'help', 'create', 'mere', '##o', 'bio', '##pha', '##rma', 'group', 'l', '##t', '##d']",1
352478,nifty_1097,2015-07-30,"Research and Markets: Global Biosimilars Market 2015 - 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others",Neutral,-0.0015,154,research and market global biosimilars market monoclonal antibody mabs insulin interferon csf csf erythropoietin and others,123,16,0,pharmacy,"['research', 'and', 'market', 'global', 'bio', '##si', '##mi', '##lars', 'market', 'mon', '##oc', '##lon', '##al', 'anti', '##body', 'ma', '##bs', 'insulin', 'inter', '##fer', '##on', 'c', '##s', '##f', 'c', '##s', '##f', 'er', '##yt', '##hr', '##op', '##oi', '##eti', '##n', 'and', 'others']",1
352498,nifty_1097,2015-07-30,GE Healthcare to invest in enhanced training for over two million health professionals globally by 2020,Neutral,-0.0015,103,healthcare invest enhanced training for over two million health professional globally,85,11,0,pharmacy,"['healthcare', 'invest', 'enhanced', 'training', 'for', 'over', 'two', 'million', 'health', 'professional', 'globally']",1
352623,nifty_1097,2015-07-30,"RXi Pharmaceuticals to Webcast Second Quarter 2015 Financial Results on Wednesday, August 12, 2015",Neutral,-0.0015,98,rxi pharmaceutical webcast second quarter financial result wednesday august,75,9,0,pharmacy,"['r', '##xi', 'pharmaceutical', 'web', '##cast', 'second', 'quarter', 'financial', 'result', 'wed', '##nes', '##day', 'au', '##gus', '##t']",1
352635,nifty_1097,2015-07-30,Research and Markets: 2015-2019 Growth Strategies for the US Hospital Tumor Marker Testing Market,Neutral,-0.0015,97,research and market growth strategy for the hospital tumor marker testing market,80,12,0,pharmacy,"['research', 'and', 'market', 'growth', 'strategy', 'for', 'the', 'hospital', 'tumor', 'marker', 'testing', 'market']",1
352645,nifty_1097,2015-07-30,"Research and Markets: Global Diagnostic Imaging Market Outlook and Leading Suppliers 2015 - Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba",Neutral,-0.0015,171,research and market global diagnostic imaging market outlook and leading supplier analogic esaote hitachi hologic philip shimadzu siemens and toshiba,149,20,0,pharmacy,"['research', 'and', 'market', 'global', 'diagnostic', 'imaging', 'market', 'outlook', 'and', 'leading', 'supplier', 'analog', '##ic', 'es', '##ao', '##te', 'hit', '##achi', 'ho', '##log', '##ic', 'p', '##hil', '##ip', 's', '##hima', '##d', '##zu', 'si', '##em', '##ens', 'and', 'to', '##shi', '##ba']",1
352656,nifty_1097,2015-07-30,ARIAD to Receive up to $200 Million Through Iclusig Non-Dilutive Synthetic-Royalty Financing with PDL BioPharma,Neutral,-0.0015,111,ariad receive million through iclusig non dilutive synthetic royalty financing with pdl biopharma,97,13,0,pharmacy,"['a', '##riad', 'receive', 'million', 'through', 'i', '##c', '##lus', '##ig', 'non', 'di', '##lut', '##ive', 'synthetic', 'royalty', 'financing', 'with', 'p', '##dl', 'bio', '##pha', '##rma']",1
352668,nifty_1097,2015-07-30,Research and Markets: Global CA Tumor Markers Diagnostics Market 2015-2019 - Opportunities and Business Strategies,Neutral,-0.0015,114,research and market global tumor marker diagnostics market opportunity and business strategy,92,12,0,pharmacy,"['research', 'and', 'market', 'global', 'tumor', 'marker', 'diagnostic', '##s', 'market', 'opportunity', 'and', 'business', 'strategy']",1
352740,nifty_1097,2015-07-30,Top 5 Global Pharma Company Using SHYFT's RWE to Drive Adoption Across Clinical-Commercial Continuum,Neutral,-0.0015,100,top global pharma company using shyft rwe drive adoption across clinical commercial continuum,93,13,0,pharmacy,"['top', 'global', 'p', '##har', '##ma', 'company', 'using', 'shy', '##ft', 'r', '##we', 'drive', 'adoption', 'across', 'clinical', 'commercial', 'con', '##tinuum']",1
352817,nifty_1097,2015-07-30,"Biotechnology Stocks Review -- Juno Therapeutics, Amicus Therapeutics, ImmunoGen, CEL-SCI, and Ignyta",Neutral,-0.0015,101,biotechnology stock review juno therapeutic amicus therapeutic immunogen cel sci and ignyta,91,12,0,pharmacy,"['bio', '##tech', '##nology', 'stock', 'review', 'j', '##uno', 'therapeutic', 'am', '##icus', 'therapeutic', 'im', '##mu', '##no', '##gen', 'c', '##el', 's', '##ci', 'and', 'i', '##gny', '##ta']",1
352821,nifty_1097,2015-07-30,Research and Markets: Biomarkers Market 2015 - Global Forecast to 2020: Market is expected to reach $45.55 Billion by 2020 from $24.10 Billion in 2015,Neutral,-0.0015,150,research and market biomarkers market global forecast market expected reach billion from billion,96,13,0,pharmacy,"['research', 'and', 'market', 'bio', '##mark', '##ers', 'market', 'global', 'forecast', 'market', 'expected', 'reach', 'billion', 'from', 'billion']",1
352914,nifty_1097,2015-07-30,"CORRECTED-BRIEF-Express Scripts says cost of PCSK9 cholesterol drugs could ""wreak financial havoc""",Neutral,-0.0015,98,corrected brief express script say cost pcsk cholesterol drug could wreak financial havoc,89,13,0,pharmacy,"['corrected', 'brief', 'express', 'script', 'say', 'cost', 'p', '##cs', '##k', 'ch', '##ole', '##ster', '##ol', 'drug', 'could', 'w', '##reak', 'financial', 'ha', '##voc']",1
352923,nifty_1097,2015-07-30,New ISR Report Sheds Light on EDC and eCOA/ePRO Usage and Performance; Shifting Market Environment Indicates Rapid Changes for Pharma-Tech Industry,Neutral,-0.0015,147,new isr report shed light edc and ecoa epro usage and performance shifting market environment indicates rapid change for pharma tech industry,141,22,0,pharmacy,"['new', 'is', '##r', 'report', 'shed', 'light', 'ed', '##c', 'and', 'e', '##coa', 'e', '##p', '##ro', 'usage', 'and', 'performance', 'shifting', 'market', 'environment', 'indicates', 'rapid', 'change', 'for', 'p', '##har', '##ma', 'tech', 'industry']",1
353007,nifty_1097,2015-07-30,Research and Markets: Epithelial Tumor - 2015 Pipeline Insights,Neutral,-0.0015,63,research and market epithelial tumor pipeline insight,53,7,0,pharmacy,"['research', 'and', 'market', 'e', '##pit', '##hel', '##ial', 'tumor', 'pipeline', 'insight']",1
353029,nifty_1097,2015-07-30,Research and Markets: Global Pharyngitis Therapeutics Pipeline Insights 2015,Neutral,-0.0015,76,research and market global pharyngitis therapeutic pipeline insight,67,8,0,pharmacy,"['research', 'and', 'market', 'global', 'p', '##har', '##yn', '##git', '##is', 'therapeutic', 'pipeline', 'insight']",1
353047,nifty_1097,2015-07-30,"Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others",Neutral,-0.0015,128,global biosimilars market monoclonal antibody mabs insulin interferon csf csf erythropoietin and others,103,13,0,pharmacy,"['global', 'bio', '##si', '##mi', '##lars', 'market', 'mon', '##oc', '##lon', '##al', 'anti', '##body', 'ma', '##bs', 'insulin', 'inter', '##fer', '##on', 'c', '##s', '##f', 'c', '##s', '##f', 'er', '##yt', '##hr', '##op', '##oi', '##eti', '##n', 'and', 'others']",1
353052,nifty_1097,2015-07-30,Research and Markets: Toxic Shock - Pipeline Insights Report 2015,Neutral,-0.0015,65,research and market toxic shock pipeline insight report,55,8,0,pharmacy,"['research', 'and', 'market', 'toxic', 'shock', 'pipeline', 'insight', 'report']",1
353064,nifty_1097,2015-07-30,Research and Markets: Transitional Cell Carcinoma (Urothelial Cell Carcinoma) Therapeutics - 2015 Pipeline Insights Study,Neutral,-0.0015,121,research and market transitional cell carcinoma urothelial cell carcinoma therapeutic pipeline insight study,108,13,0,pharmacy,"['research', 'and', 'market', 'transitional', 'cell', 'car', '##cin', '##oma', 'u', '##roth', '##eli', '##al', 'cell', 'car', '##cin', '##oma', 'therapeutic', 'pipeline', 'insight', 'study']",1
353066,nifty_1097,2015-07-30,Research and Markets: Global Transitional Cell Cancer (Urothelial Cell Cancer) Therapeutics Report - 2015 Pipeline Insights,Neutral,-0.0015,123,research and market global transitional cell cancer urothelial cell cancer therapeutic report pipeline insight,110,14,0,pharmacy,"['research', 'and', 'market', 'global', 'transitional', 'cell', 'cancer', 'u', '##roth', '##eli', '##al', 'cell', 'cancer', 'therapeutic', 'report', 'pipeline', 'insight']",1
353076,nifty_1097,2015-07-30,Research and Markets: Traveler's Diarrhea - Pipeline Insights 2015,Neutral,-0.0015,66,research and market traveler diarrhea pipeline insight,54,7,0,pharmacy,"['research', 'and', 'market', 'travel', '##er', 'di', '##ar', '##r', '##hea', 'pipeline', 'insight']",1
353085,nifty_1097,2015-07-30,Research and Markets: Global Treatment Resistant Depression Therapeutics Pipeline Insights Report 2015,Neutral,-0.0015,102,research and market global treatment resistant depression therapeutic pipeline insight report,93,11,0,pharmacy,"['research', 'and', 'market', 'global', 'treatment', 'resistant', 'depression', 'therapeutic', 'pipeline', 'insight', 'report']",1
353099,nifty_1097,2015-07-30,Research and Markets: Global Adenomas Therapeutics Pipeline Insights Report 2015,Neutral,-0.0015,80,research and market global adenoma therapeutic pipeline insight report,70,9,0,pharmacy,"['research', 'and', 'market', 'global', 'ad', '##eno', '##ma', 'therapeutic', 'pipeline', 'insight', 'report']",1
353115,nifty_1097,2015-07-30,Research and Markets: Adult Malignant Glioma - Pipeline Insights 2015,Neutral,-0.0015,69,research and market adult malignant glioma pipeline insight,59,8,0,pharmacy,"['research', 'and', 'market', 'adult', 'ma', '##li', '##gnant', 'g', '##lio', '##ma', 'pipeline', 'insight']",1
353120,nifty_1097,2015-07-30,Research and Markets: Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Insights 2015,Neutral,-0.0015,95,research and market adrenocortical carcinoma adrenal cortex cancer pipeline insight,83,10,0,pharmacy,"['research', 'and', 'market', 'ad', '##ren', '##oc', '##ort', '##ical', 'car', '##cin', '##oma', 'ad', '##rena', '##l', 'cortex', 'cancer', 'pipeline', 'insight']",1
353216,nifty_1097,2015-07-30,"Cytokinetics, Inc. Reports Second Quarter 2015 Financial Results",Neutral,-0.0015,64,cytokinetics inc report second quarter financial result,55,7,0,pharmacy,"['c', '##yt', '##oki', '##net', '##ics', 'in', '##c', 'report', 'second', 'quarter', 'financial', 'result']",1
353222,nifty_1097,2015-07-30,Celgene says patent-fighting hedge fund manager wants to short its shares,Neutral,-0.0015,73,celgene say patent fighting hedge fund manager want short it share,66,11,0,pharmacy,"['c', '##el', '##gene', 'say', 'patent', 'fighting', 'hedge', 'fund', 'manager', 'want', 'short', 'it', 'share']",1
353239,nifty_1097,2015-07-30,BioAmber Announces Change in Chief Financial Officer,Neutral,-0.0015,52,bioamber announces change chief financial officer,49,6,0,pharmacy,"['bio', '##am', '##ber', 'announces', 'change', 'chief', 'financial', 'officer']",1
353258,nifty_1097,2015-07-30,Depomed rejects Horizon Pharma's latest bid,Neutral,-0.0015,43,depomed reject horizon pharma latest bid,40,6,0,pharmacy,"['de', '##po', '##med', 'reject', 'horizon', 'p', '##har', '##ma', 'latest', 'bid']",1
353261,nifty_1097,2015-07-30,Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors,Neutral,-0.0015,90,immune pharmaceutical secures funding million from institutional investor,73,8,0,pharmacy,"['immune', 'pharmaceutical', 'secure', '##s', 'funding', 'million', 'from', 'institutional', 'investor']",1
353306,nifty_1097,2015-07-30,Profound Medical Corp. Announces First Quarter 2015 Financial Results of Profound Medical Inc.,Neutral,-0.0015,94,profound medical corp announces first quarter financial result profound medical inc,83,11,0,pharmacy,"['profound', 'medical', 'co', '##rp', 'announces', 'first', 'quarter', 'financial', 'result', 'profound', 'medical', 'in', '##c']",1
353328,nifty_1097,2015-07-30,AMAG Pharmaceuticals Announces Proposed Public Offering of $200 Million of Common Stock,Neutral,-0.0015,87,amag pharmaceutical announces proposed public offering million common stock,75,9,0,pharmacy,"['am', '##ag', 'pharmaceutical', 'announces', 'proposed', 'public', 'offering', 'million', 'common', 'stock']",1
353637,nifty_1099,2015-08-04,Community Health Spinoff to Focus on Smaller Markets,Neutral,0.0033,52,community health spinoff focus smaller market,45,6,0,pharmacy,"['community', 'health', 'spin', '##off', 'focus', 'smaller', 'market']",1
353680,nifty_1099,2015-08-04,Regeneron Pharmaceuticals Profit Doubles,Neutral,0.0033,40,regeneron pharmaceutical profit double,38,4,0,pharmacy,"['re', '##gene', '##ron', 'pharmaceutical', 'profit', 'double']",1
353825,nifty_1101,2015-08-06,BRIEF-Sinclair Pharma sees FY core earnings in line with expectations,Neutral,-0.0019,69,brief sinclair pharma see core earnings line with expectation,61,9,0,pharmacy,"['brief', 'sin', '##c', '##lair', 'p', '##har', '##ma', 'see', 'core', 'earnings', 'line', 'with', 'expectation']",1
353912,nifty_1101,2015-08-06,Research and Markets: Central America Pharmaceutical Market: 2015 Edition,Neutral,-0.0019,73,research and market central america pharmaceutical market edition,65,8,0,pharmacy,"['research', 'and', 'market', 'central', 'am', '##eric', '##a', 'pharmaceutical', 'market', 'edition']",1
353972,nifty_1101,2015-08-06,Illumina Accelerator Invests in Second Class of Genomics Startups from US and Europe,Neutral,-0.0019,84,illumina accelerator invests second class genomics startup from and europe,74,10,0,pharmacy,"['ill', '##umi', '##na', 'a', '##ccelerator', 'invest', '##s', 'second', 'class', 'g', '##eno', '##mic', '##s', 'start', '##up', 'from', 'and', 'euro', '##pe']",1
353985,nifty_1101,2015-08-06,"Endo Divests Non-Core Business Lines from Litha Healthcare Group International Business, Enhancing Focus on Specialty Pharmaceuticals",Neutral,-0.0019,133,endo divests non core business line from litha healthcare group international business enhancing focus specialty pharmaceutical,127,16,0,pharmacy,"['end', '##o', 'dive', '##sts', 'non', 'core', 'business', 'line', 'from', 'lit', '##ha', 'healthcare', 'group', 'international', 'business', 'enhancing', 'focus', 'specialty', 'pharmaceutical']",1
354005,nifty_1101,2015-08-06,Wellness On Wall - Health & Wealth Converge on Wall Street as an all Encompassing Wellness Center Launches - Offering The Latest In Scientific & Medical Breakthroughs,Neutral,-0.0019,166,wellness wall health wealth converge wall street all encompassing wellness center launch offering the latest scientific medical breakthrough,140,18,0,pharmacy,"['well', '##ness', 'wall', 'health', 'wealth', 'con', '##ver', '##ge', 'wall', 'street', 'all', 'encompassing', 'well', '##ness', 'center', 'launch', 'offering', 'the', 'latest', 'scientific', 'medical', 'breakthrough']",1
354017,nifty_1101,2015-08-06,Transparency Life Sciences Announces Start Of Ulcerative Colitis Clinical Trial Assessing Feasibility Of Decentralized Patient Data Collection,Neutral,-0.0019,142,transparency life science announces start ulcerative colitis clinical trial assessing feasibility decentralized patient data collection,135,15,0,pharmacy,"['transparency', 'life', 'science', 'announces', 'start', 'ul', '##cer', '##ative', 'co', '##lit', '##is', 'clinical', 'trial', 'assessing', 'f', '##eas', '##ibility', 'decent', '##ral', '##ized', 'patient', 'data', 'collection']",1
354024,nifty_1101,2015-08-06,Flex Pharma Reports Second Quarter 2015 Financial Results,Neutral,-0.0019,57,flex pharma report second quarter financial result,50,7,0,pharmacy,"['fl', '##ex', 'p', '##har', '##ma', 'report', 'second', 'quarter', 'financial', 'result']",1
354040,nifty_1101,2015-08-06,Research and Markets: Brain Metastasis - 2015 Pipeline Insights,Neutral,-0.0019,63,research and market brain metastasis pipeline insight,53,7,0,pharmacy,"['research', 'and', 'market', 'brain', 'meta', '##sta', '##sis', 'pipeline', 'insight']",1
354044,nifty_1101,2015-08-06,Research and Markets: Global Ischemia Reperfusion Injury Pipeline Insights 2015,Neutral,-0.0019,79,research and market global ischemia reperfusion injury pipeline insight,71,9,0,pharmacy,"['research', 'and', 'market', 'global', 'is', '##che', '##mia', 're', '##per', '##fusion', 'injury', 'pipeline', 'insight']",1
354093,nifty_1101,2015-08-06,Research and Markets: Overview of the Medical Device Market in the United Kingdom 2015,Neutral,-0.0019,86,research and market overview the medical device market the united kingdom,73,11,0,pharmacy,"['research', 'and', 'market', 'overview', 'the', 'medical', 'device', 'market', 'the', 'united', 'kingdom']",1
354094,nifty_1101,2015-08-06,BioHealth Innovation's Relevant Health Accelerator Recognized As One Of The Nation's Leading Startup Accelerators By The U.S. Small Business Administration,Neutral,-0.0019,155,biohealth innovation relevant health accelerator recognized one the nation leading startup accelerator the small business administration,136,16,0,pharmacy,"['bio', '##hea', '##lt', '##h', 'innovation', 'relevant', 'health', 'a', '##ccelerator', 'recognized', 'one', 'the', 'nation', 'leading', 'start', '##up', 'a', '##ccelerator', 'the', 'small', 'business', 'administration']",1
354102,nifty_1101,2015-08-06,Research and Markets: India Medical Device Market: 2015-2018,Neutral,-0.0019,60,research and market india medical device market,47,7,0,pharmacy,"['research', 'and', 'market', 'in', '##dia', 'medical', 'device', 'market']",1
354109,nifty_1101,2015-08-06,Research and Markets: Ireland Medical Device Market Study: 2015-2018,Neutral,-0.0019,68,research and market ireland medical device market study,55,8,0,pharmacy,"['research', 'and', 'market', 'i', '##rel', '##and', 'medical', 'device', 'market', 'study']",1
354111,nifty_1101,2015-08-06,Research and Markets: Russia Medical Device Market Study 2015,Neutral,-0.0019,61,research and market russia medical device market study,54,8,0,pharmacy,"['research', 'and', 'market', 'r', '##uss', '##ia', 'medical', 'device', 'market', 'study']",1
354141,nifty_1101,2015-08-06,Research and Markets: United States Medical Device Market Overview 2015,Neutral,-0.0019,71,research and market united state medical device market overview,63,9,0,pharmacy,"['research', 'and', 'market', 'united', 'state', 'medical', 'device', 'market', 'overview']",1
354215,nifty_1101,2015-08-06,"Biotechnology Stocks Technical Data -- Keryx Biopharma, Idera Pharma, Synthetic Biologics, OvaScience and Infinity Pharma",Neutral,-0.0019,121,biotechnology stock technical data keryx biopharma idera pharma synthetic biologics ovascience and infinity pharma,114,14,0,pharmacy,"['bio', '##tech', '##nology', 'stock', 'technical', 'data', 'k', '##ery', '##x', 'bio', '##pha', '##rma', 'id', '##era', 'p', '##har', '##ma', 'synthetic', 'bio', '##log', '##ics', 'o', '##vas', '##cie', '##nce', 'and', 'in', '##finity', 'p', '##har', '##ma']",1
354270,nifty_1101,2015-08-06,"Research and Markets: Pharmaceuticals Partnerships, Licensing, Investments and M&A; Deals and Trends for 2014",Neutral,-0.0019,109,research and market pharmaceutical partnership licensing investment and deal and trend for,90,12,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'partnership', 'licensing', 'investment', 'and', 'deal', 'and', 'trend', 'for']",1
354275,nifty_1101,2015-08-06,Research and Markets: Global Market for Medical Devices: 2015 Edition with 2014-2019 Analysis & Forecasts,Neutral,-0.0019,105,research and market global market for medical device edition with analysis forecast,83,12,0,pharmacy,"['research', 'and', 'market', 'global', 'market', 'for', 'medical', 'device', 'edition', 'with', 'analysis', 'forecast']",1
354290,nifty_1101,2015-08-06,"Research and Markets: Proteomics Research Markets 2014-2019: Instruments (Mass Spectrometry, Liquid Chromatography, Electrophoresis), Disease Areas (Oncology, Cardio/Blood, Neurology, Other) Market Share and Trends",Neutral,-0.0019,214,research and market proteomics research market instrument mass spectrometry liquid chromatography electrophoresis disease area oncology cardio blood neurology other market share and trend,187,23,0,pharmacy,"['research', 'and', 'market', 'pro', '##te', '##omi', '##cs', 'research', 'market', 'instrument', 'mass', 's', '##pect', '##rome', '##try', 'liquid', 'ch', '##roma', '##tography', 'electro', '##ph', '##ores', '##is', 'disease', 'area', 'on', '##cology', 'card', '##io', 'blood', 'ne', '##uro', '##logy', 'other', 'market', 'share', 'and', 'trend']",1
354306,nifty_1101,2015-08-06,"Research and Markets: An Essential Overview of the Medical Device Industry Seminar: London, United Kingdom - 24th of September 2015",Neutral,-0.0019,131,research and market essential overview the medical device industry seminar london united kingdom september,106,14,0,pharmacy,"['research', 'and', 'market', 'essential', 'overview', 'the', 'medical', 'device', 'industry', 'seminar', 'lo', '##ndon', 'united', 'kingdom', 'se', '##pt', '##em', '##ber']",1
354310,nifty_1101,2015-08-06,"Research and Markets: Drug/Device & Device/Drug Combinations in the EU and USA Seminar: London, United Kingdom - 1st, 2nd of October 2015",Neutral,-0.0019,137,research and market drug device device drug combination the and usa seminar london united kingdom october,105,16,0,pharmacy,"['research', 'and', 'market', 'drug', 'device', 'device', 'drug', 'combination', 'the', 'and', 'us', '##a', 'seminar', 'lo', '##ndon', 'united', 'kingdom', 'o', '##ct', '##obe', '##r']",1
354356,nifty_1101,2015-08-06,"Research and Markets: Global Emesis (Vomiting) Clinical Trials Review, H1, 2015 - Espy the Commercial Landscape of the Major Universities / Institutes / Hospitals or Companies",Neutral,-0.0019,175,research and market global emesis vomiting clinical trial review espy the commercial landscape the major university institute hospital company,142,19,0,pharmacy,"['research', 'and', 'market', 'global', 'em', '##esis', 'vomit', '##ing', 'clinical', 'trial', 'review', 'es', '##py', 'the', 'commercial', 'landscape', 'the', 'major', 'university', 'institute', 'hospital', 'company']",1
354357,nifty_1101,2015-08-06,Technavio Publishes New Market Analysis on Global Plasma Therapeutics Market from 2015-2019,Neutral,-0.0019,91,technavio publishes new market analysis global plasma therapeutic market from,77,10,0,pharmacy,"['tech', '##na', '##vio', 'publishes', 'new', 'market', 'analysis', 'global', 'plasma', 'therapeutic', 'market', 'from']",1
354457,nifty_1101,2015-08-06,"Research and Markets: Pharmaceuticals Partnerships, Licensing, Investments and M&A; Deals and Trends Q1 2015",Neutral,-0.0019,108,research and market pharmaceutical partnership licensing investment and deal and trend,86,11,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'partnership', 'licensing', 'investment', 'and', 'deal', 'and', 'trend']",1
354473,nifty_1101,2015-08-06,Research and Markets: Global Primary Dysmenorrhea Pipeline Insights Study 2015,Neutral,-0.0019,78,research and market global primary dysmenorrhea pipeline insight study,70,9,0,pharmacy,"['research', 'and', 'market', 'global', 'primary', 'd', '##ys', '##men', '##or', '##r', '##hea', 'pipeline', 'insight', 'study']",1
354498,nifty_1101,2015-08-06,"Research and Markets: Global Vasculitis Clinical Trials Review, H1, 2015 - Espy the Commercial Landscape of the Major Universities / Institutes / Hospitals or Companies",Neutral,-0.0019,168,research and market global vasculitis clinical trial review espy the commercial landscape the major university institute hospital company,137,18,0,pharmacy,"['research', 'and', 'market', 'global', 'v', '##as', '##cu', '##lit', '##is', 'clinical', 'trial', 'review', 'es', '##py', 'the', 'commercial', 'landscape', 'the', 'major', 'university', 'institute', 'hospital', 'company']",1
354499,nifty_1101,2015-08-06,"Research and Markets: Global Gall Stone Clinical Trials Review, H1, 2015 - Espy the Commercial Landscape of the Major Universities / Institutes / Hospitals or Companies",Neutral,-0.0019,168,research and market global gall stone clinical trial review espy the commercial landscape the major university institute hospital company,137,19,0,pharmacy,"['research', 'and', 'market', 'global', 'gal', '##l', 'stone', 'clinical', 'trial', 'review', 'es', '##py', 'the', 'commercial', 'landscape', 'the', 'major', 'university', 'institute', 'hospital', 'company']",1
354501,nifty_1101,2015-08-06,Research and Markets: Generalized Seizures-Pipeline Insights - Complete Pipeline Intelligence and Complete Understanding over Therapeutics Development for Generalized Seizures,Neutral,-0.0019,175,research and market generalized seizure pipeline insight complete pipeline intelligence and complete understanding over therapeutic development for generalized seizure,167,19,0,pharmacy,"['research', 'and', 'market', 'generalized', 'seizure', 'pipeline', 'insight', 'complete', 'pipeline', 'intelligence', 'and', 'complete', 'understanding', 'over', 'therapeutic', 'development', 'for', 'generalized', 'seizure']",1
354508,nifty_1101,2015-08-06,"Research and Markets: Diabetic Complications-Pipeline Insights - Strategically Significant Competitor Information, Analysis, and Insights to Formulate Effective R&D; Development Strategies",Neutral,-0.0019,188,research and market diabetic complication pipeline insight strategically significant competitor information analysis and insight formulate effective development strategy,169,18,0,pharmacy,"['research', 'and', 'market', 'di', '##abe', '##tic', 'com', '##plication', 'pipeline', 'insight', 'strategically', 'significant', 'competitor', 'information', 'analysis', 'and', 'insight', 'formula', '##te', 'effective', 'development', 'strategy']",1
354520,nifty_1101,2015-08-06,"Research and Markets: PharmaPoint: Melanoma - Global Drug Forecast and Market Analysis to 2023 Featuring Bristol-Myers Squibb, Novartis, Roche & Merck",Neutral,-0.0019,150,research and market pharmapoint melanoma global drug forecast and market analysis featuring bristol myers squibb novartis roche merck,133,18,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##point', 'me', '##lan', '##oma', 'global', 'drug', 'forecast', 'and', 'market', 'analysis', 'featuring', 'br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'no', '##var', '##tis', 'r', '##och', '##e', 'me', '##rc', '##k']",1
354523,nifty_1101,2015-08-06,Research and Markets: PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2023 for the $8.2 Billion Market,Neutral,-0.0019,129,research and market pharmapoint prostate cancer global drug forecast and market analysis for the billion market,111,16,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##point', 'pro', '##state', 'cancer', 'global', 'drug', 'forecast', 'and', 'market', 'analysis', 'for', 'the', 'billion', 'market']",1
354559,nifty_1101,2015-08-06,Research and Markets: Bleeding and Clotting Disorders-Pipeline Insights -- Developing Strategic Initiatives to Support Your Drug Development Activities,Neutral,-0.0019,151,research and market bleeding and clotting disorder pipeline insight developing strategic initiative support your drug development activity,138,17,0,pharmacy,"['research', 'and', 'market', 'bleeding', 'and', 'c', '##lot', '##ting', 'disorder', 'pipeline', 'insight', 'developing', 'strategic', 'initiative', 'support', 'your', 'drug', 'development', 'activity']",1
354563,nifty_1101,2015-08-06,Research and Markets: Uterine Fibroids - Pipeline Insights 2015,Neutral,-0.0019,63,research and market uterine fibroid pipeline insight,52,7,0,pharmacy,"['research', 'and', 'market', 'u', '##ter', '##ine', 'fi', '##bro', '##id', 'pipeline', 'insight']",1
354570,nifty_1101,2015-08-06,Amicus Therapeutics Announces Second Quarter 2015 Financial Results and Corporate Updates,Neutral,-0.0019,89,amicus therapeutic announces second quarter financial result and corporate update,81,10,0,pharmacy,"['am', '##icus', 'therapeutic', 'announces', 'second', 'quarter', 'financial', 'result', 'and', 'corporate', 'update']",1
354575,nifty_1101,2015-08-06,Tetraphase Pharmaceuticals Reports Second-Quarter 2015 Financial Results,Neutral,-0.0019,72,tetraphase pharmaceutical report second quarter financial result,64,7,0,pharmacy,"['te', '##tra', '##pha', '##se', 'pharmaceutical', 'report', 'second', 'quarter', 'financial', 'result']",1
354581,nifty_1101,2015-08-06,Arena Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Corporate Update,Neutral,-0.0019,97,arena pharmaceutical report second quarter financial result and provides corporate update,89,11,0,pharmacy,"['arena', 'pharmaceutical', 'report', 'second', 'quarter', 'financial', 'result', 'and', 'provides', 'corporate', 'update']",1
354587,nifty_1101,2015-08-06,Aerie Pharmaceuticals and GrayBug Announce Research Collaboration,Neutral,-0.0019,65,aerie pharmaceutical and graybug announce research collaboration,64,7,0,pharmacy,"['a', '##erie', 'pharmaceutical', 'and', 'gray', '##bu', '##g', 'announce', 'research', 'collaboration']",1
354613,nifty_1101,2015-08-06,Aerie Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Business Update,Neutral,-0.0019,96,aerie pharmaceutical report second quarter financial result and provides business update,88,11,0,pharmacy,"['a', '##erie', 'pharmaceutical', 'report', 'second', 'quarter', 'financial', 'result', 'and', 'provides', 'business', 'update']",1
354615,nifty_1101,2015-08-06,Intercept Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Business Update,Neutral,-0.0019,100,intercept pharmaceutical report second quarter financial result and provides business update,92,11,0,pharmacy,"['intercept', 'pharmaceutical', 'report', 'second', 'quarter', 'financial', 'result', 'and', 'provides', 'business', 'update']",1
354622,nifty_1101,2015-08-06,Aegerion Pharmaceuticals Announces Second Quarter 2015 Financial Results,Neutral,-0.0019,72,aegerion pharmaceutical announces second quarter financial result,65,7,0,pharmacy,"['a', '##ege', '##rion', 'pharmaceutical', 'announces', 'second', 'quarter', 'financial', 'result']",1
354624,nifty_1101,2015-08-06,Research and Markets: Global Squamous Non-Small Cell Lung Cancer Pipeline Insights 2015,Neutral,-0.0019,87,research and market global squamous non small cell lung cancer pipeline insight,79,12,0,pharmacy,"['research', 'and', 'market', 'global', 'sq', '##ua', '##mous', 'non', 'small', 'cell', 'lung', 'cancer', 'pipeline', 'insight']",1
354651,nifty_1101,2015-08-06,Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2015 Financial Results and Provide Corporate Update,Neutral,-0.0019,135,xenon pharmaceutical host conference call and webcast discus second quarter financial result and provide corporate update,121,16,0,pharmacy,"['x', '##eno', '##n', 'pharmaceutical', 'host', 'conference', 'call', 'and', 'web', '##cast', 'disc', '##us', 'second', 'quarter', 'financial', 'result', 'and', 'provide', 'corporate', 'update']",1
354671,nifty_1101,2015-08-06,Research and Markets: Artificial Pancreas - Pipeline Review 2015 Featuring Profiles of 35 Key Companies/Institutions,Neutral,-0.0019,116,research and market artificial pancreas pipeline review featuring profile key company institution,97,12,0,pharmacy,"['research', 'and', 'market', 'artificial', 'pan', '##cre', '##as', 'pipeline', 'review', 'featuring', 'profile', 'key', 'company', 'institution']",1
354677,nifty_1101,2015-08-06,China Biologic Reports Financial Results for the Second Quarter of 2015,Neutral,-0.0019,71,china biologic report financial result for the second quarter,61,9,0,pharmacy,"['chin', '##a', 'bio', '##log', '##ic', 'report', 'financial', 'result', 'for', 'the', 'second', 'quarter']",1
354884,nifty_1101,2015-08-06,Chemours to Cut $350 Million in Costs,Neutral,-0.0019,37,chemours cut million cost,25,4,0,pharmacy,"['ch', '##em', '##ours', 'cut', 'million', 'cost']",1
354949,nifty_1102,2015-08-10,Mallinckrodt to Buy Immunotherapy Firm Therakos,Fall,-0.009,47,mallinckrodt buy immunotherapy firm therakos,44,5,0,pharmacy,"['mall', '##in', '##ck', '##rod', '##t', 'buy', 'im', '##mu', '##not', '##her', '##ap', '##y', 'firm', 'the', '##rak', '##os']",1
354976,nifty_1103,2015-08-11,GE to Sell Health-Care Lending Operations to Capital One,Neutral,0.0012,56,sell health care lending operation capital one,46,7,0,pharmacy,"['sell', 'health', 'care', 'lending', 'operation', 'capital', 'one']",1
355401,nifty_1108,2015-08-19,United Therapeutics Sells Priority-Review Voucher to AbbVie,Fall,-0.0209,59,united therapeutic sell priority review voucher abbvie,54,7,0,pharmacy,"['united', 'therapeutic', 'sell', 'priority', 'review', 'v', '##ou', '##cher', 'a', '##bb', '##vie']",1
355464,nifty_1109,2015-08-20,BRIEF-Aqua Bio Technology Q2 EBITDA swings to profit of NOK 4.7 million,Fall,-0.0301,71,brief aqua bio technology ebitda swing profit nok million,57,9,0,pharmacy,"['brief', 'a', '##qua', 'bio', 'technology', 'e', '##bit', '##da', 'swing', 'profit', 'no', '##k', 'million']",1
355483,nifty_1109,2015-08-20,"REG-Interim report January 1-June 30, 2015: Financially stable - new investments in regenerative medicine: CDNF and Lymfactin",Fall,-0.0301,125,reg interim report january june financially stable new investment regenerative medicine cdnf and lymfactin,106,14,0,pharmacy,"['re', '##g', 'interim', 'report', 'j', '##anu', '##ary', 'j', '##une', 'financially', 'stable', 'new', 'investment', 're', '##gene', '##rative', 'medicine', 'c', '##dn', '##f', 'and', 'l', '##ym', '##fa', '##ct', '##in']",1
355535,nifty_1109,2015-08-20,Research and Markets: Global Acne And Related Disorders Pipeline Review 2015,Fall,-0.0301,76,research and market global acne and related disorder pipeline review,68,10,0,pharmacy,"['research', 'and', 'market', 'global', 'a', '##c', '##ne', 'and', 'related', 'disorder', 'pipeline', 'review']",1
355550,nifty_1109,2015-08-20,Research and Markets: Worldwide Breast Disease Pipeline Therapeutics Review 2015,Fall,-0.0301,80,research and market worldwide breast disease pipeline therapeutic review,72,9,0,pharmacy,"['research', 'and', 'market', 'worldwide', 'breast', 'disease', 'pipeline', 'therapeutic', 'review']",1
355553,nifty_1109,2015-08-20,Research and Markets: Thromboembolic Disease Therapeutics Pipeline Insights Report,Fall,-0.0301,82,research and market thromboembolic disease therapeutic pipeline insight report,78,9,0,pharmacy,"['research', 'and', 'market', 'th', '##rom', '##boe', '##mbo', '##lic', 'disease', 'therapeutic', 'pipeline', 'insight', 'report']",1
355582,nifty_1109,2015-08-20,Research and Markets: 2015 Liver Diseases Therapeutics Pipeline Review,Fall,-0.0301,70,research and market liver disease therapeutic pipeline review,61,8,0,pharmacy,"['research', 'and', 'market', 'liver', 'disease', 'therapeutic', 'pipeline', 'review']",1
355586,nifty_1109,2015-08-20,Research and Markets: Polycystic Kidney Disease Pipeline Insights 2015 - The Report Reviews Key Players Involved in the Therapeutics Development for Polycystic Kidney Disease,Fall,-0.0301,174,research and market polycystic kidney disease pipeline insight the report review key player involved the therapeutic development for polycystic kidney disease,158,21,0,pharmacy,"['research', 'and', 'market', 'p', '##oly', '##cy', '##stic', 'kidney', 'disease', 'pipeline', 'insight', 'the', 'report', 'review', 'key', 'player', 'involved', 'the', 'therapeutic', 'development', 'for', 'p', '##oly', '##cy', '##stic', 'kidney', 'disease']",1
355587,nifty_1109,2015-08-20,Research and Markets: Polycythemia Pipeline Insights 2015 - Reviews Key Players Involved in the Therapeutics Development for Polycythemia,Fall,-0.0301,137,research and market polycythemia pipeline insight review key player involved the therapeutic development for polycythemia,121,15,0,pharmacy,"['research', 'and', 'market', 'p', '##oly', '##cy', '##them', '##ia', 'pipeline', 'insight', 'review', 'key', 'player', 'involved', 'the', 'therapeutic', 'development', 'for', 'p', '##oly', '##cy', '##them', '##ia']",1
355627,nifty_1109,2015-08-20,"Research and Markets: Global Contraceptive Devices Market 2015-2019 with Ansell, Actavis, Bayer, Church & Dwight & Merck & Co Dominating",Fall,-0.0301,136,research and market global contraceptive device market with ansell actavis bayer church dwight merck dominating,111,15,0,pharmacy,"['research', 'and', 'market', 'global', 'con', '##tra', '##ceptive', 'device', 'market', 'with', 'an', '##sel', '##l', 'act', '##avi', '##s', 'bay', '##er', 'church', 'd', '##wig', '##ht', 'me', '##rc', '##k', 'dominating']",1
355678,nifty_1109,2015-08-20,Research and Markets: Potassium Channel Openers Therapeutics Pipeline Insights Review 2015,Fall,-0.0301,90,research and market potassium channel opener therapeutic pipeline insight review,80,10,0,pharmacy,"['research', 'and', 'market', 'potassium', 'channel', 'opener', 'therapeutic', 'pipeline', 'insight', 'review']",1
355708,nifty_1109,2015-08-20,Research and Markets: Polo-Like Kinase 2 (PLK2) Inhibitors Pipeline Insights Review 2015,Fall,-0.0301,88,research and market polo like kinase plk inhibitor pipeline insight review,74,11,0,pharmacy,"['research', 'and', 'market', 'polo', 'like', 'kinase', 'p', '##lk', 'inhibitor', 'pipeline', 'insight', 'review']",1
355752,nifty_1109,2015-08-20,Research and Markets: mRNA Guanylyltransferase Inhibitors Therapeutics Pipeline Review 2015,Fall,-0.0301,91,research and market mrna guanylyltransferase inhibitor therapeutic pipeline review,82,9,0,pharmacy,"['research', 'and', 'market', 'm', '##rna', 'g', '##uan', '##yl', '##yl', '##tra', '##ns', '##fer', '##ase', 'inhibitor', 'therapeutic', 'pipeline', 'review']",1
355860,nifty_1109,2015-08-20,Research and Markets: Medical Equipment Quarterly Deals Analysis - M&A; and Investment Trends Q1 2015,Fall,-0.0301,101,research and market medical equipment quarterly deal analysis and investment trend,82,11,0,pharmacy,"['research', 'and', 'market', 'medical', 'equipment', 'quarterly', 'deal', 'analysis', 'and', 'investment', 'trend']",1
355872,nifty_1109,2015-08-20,Research and Markets: Biosensors Market Development and Demand Forecast to 2020 - Provides Information on the Historical and Current Market Size and the Future Potential of the Market,Fall,-0.0301,183,research and market biosensors market development and demand forecast provides information the historical and current market size and the future potential the market,165,23,0,pharmacy,"['research', 'and', 'market', 'bio', '##sen', '##sors', 'market', 'development', 'and', 'demand', 'forecast', 'provides', 'information', 'the', 'historical', 'and', 'current', 'market', 'size', 'and', 'the', 'future', 'potential', 'the', 'market']",1
355873,nifty_1109,2015-08-20,Research and Markets: In Vitro Diagnostics Market 2015 Report With Forecasts to 2020,Fall,-0.0301,84,research and market vitro diagnostics market report with forecast,65,9,0,pharmacy,"['research', 'and', 'market', 'v', '##it', '##ro', 'diagnostic', '##s', 'market', 'report', 'with', 'forecast']",1
355978,nifty_1109,2015-08-20,Research and Markets: Global Sterilization Equipment Market 2015 Report With Forecasts to 2020,Fall,-0.0301,94,research and market global sterilization equipment market report with forecast,78,10,0,pharmacy,"['research', 'and', 'market', 'global', 's', '##ter', '##ilization', 'equipment', 'market', 'report', 'with', 'forecast']",1
355979,nifty_1109,2015-08-20,Research and Markets: Healthcare IT Market in UAE 2015-2019 - The Analysts Forecast the Market in UAE to Grow at a CAGR of 11.12% During 2014-2019,Fall,-0.0301,146,research and market healthcare market uae the analyst forecast the market uae grow cagr during,94,15,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'market', 'u', '##ae', 'the', 'analyst', 'forecast', 'the', 'market', 'u', '##ae', 'grow', 'ca', '##g', '##r', 'during']",1
355980,nifty_1109,2015-08-20,Purchasing Power Adds Financial Wellness Platform,Fall,-0.0301,49,purchasing power add financial wellness platform,48,6,0,pharmacy,"['purchasing', 'power', 'add', 'financial', 'well', '##ness', 'platform']",1
356029,nifty_1109,2015-08-20,Research and Markets: Histone Deacetylase (HDAC) Inhibitors Market & Pipeline Insight 2015 - Marketed Histone Deacetylase (HDAC) Inhibitor Clinical Insight by Company & Indication,Fall,-0.0301,179,research and market histone deacetylase hdac inhibitor market pipeline insight marketed histone deacetylase hdac inhibitor clinical insight company indication,158,19,0,pharmacy,"['research', 'and', 'market', 'his', '##tone', 'de', '##ace', '##ty', '##lase', 'h', '##da', '##c', 'inhibitor', 'market', 'pipeline', 'insight', 'marketed', 'his', '##tone', 'de', '##ace', '##ty', '##lase', 'h', '##da', '##c', 'inhibitor', 'clinical', 'insight', 'company', 'indication']",1
356034,nifty_1109,2015-08-20,"Research and Markets: mHealth: Game Changer for Healthcare - In 2015, 73 Million mHealth Devices will be Shipped Worldwide. Shipments will Keep Increasing at a CAGR of 46%",Fall,-0.0301,171,research and market mhealth game changer for healthcare million mhealth device will shipped worldwide shipment will keep increasing cagr,136,19,0,pharmacy,"['research', 'and', 'market', 'm', '##hea', '##lt', '##h', 'game', 'change', '##r', 'for', 'healthcare', 'million', 'm', '##hea', '##lt', '##h', 'device', 'will', 'shipped', 'worldwide', 'shipment', 'will', 'keep', 'increasing', 'ca', '##g', '##r']",1
356061,nifty_1109,2015-08-20,AGTC Announces Strategic Collaboration With Biogen Effective and Biogen Equity Investment Closed,Fall,-0.0301,96,agtc announces strategic collaboration with biogen effective and biogen equity investment closed,96,12,0,pharmacy,"['a', '##gt', '##c', 'announces', 'strategic', 'collaboration', 'with', 'bio', '##gen', 'effective', 'and', 'bio', '##gen', 'equity', 'investment', 'closed']",1
356351,nifty_1111,2015-08-25,FDA Grants Priority Review to Sarepta Drug,Rise,0.0384,42,fda grant priority review sarepta drug,38,6,0,pharmacy,"['f', '##da', 'grant', 'priority', 'review', 'sa', '##re', '##pta', 'drug']",1
356352,nifty_1111,2015-08-25,Lilly Says Court Ruled in its Favor on Patent,Rise,0.0384,45,lilly say court ruled it favor patent,37,7,0,pharmacy,"['l', '##ill', '##y', 'say', 'court', 'ruled', 'it', 'favor', 'patent']",1
356395,nifty_1111,2015-08-25,Amgen Files for U.S. Approval of Therapy for Dialysis Patients,Rise,0.0384,62,amgen file for approval therapy for dialysis patient,52,8,0,pharmacy,"['am', '##gen', 'file', 'for', 'approval', 'therapy', 'for', 'dial', '##ys', '##is', 'patient']",1
356488,nifty_1113,2015-08-27,FDA Approves Amgen’s Cholesterol Drug,Neutral,0.0001,37,fda approves amgen cholesterol drug,35,5,0,pharmacy,"['f', '##da', 'approve', '##s', 'am', '##gen', 'ch', '##ole', '##ster', '##ol', 'drug']",1
356515,nifty_1113,2015-08-27,Lilly Lung-Cancer Drug Stirs Price Debate,Neutral,0.0001,41,lilly lung cancer drug stir price debate,40,7,0,pharmacy,"['l', '##ill', '##y', 'lung', 'cancer', 'drug', 'stir', 'price', 'debate']",1
356546,nifty_1113,2015-08-27,Medical-Device Company Greatbatch to Buy Lake Region Medical,Neutral,0.0001,60,medical device company greatbatch buy lake region medical,57,8,0,pharmacy,"['medical', 'device', 'company', 'great', '##bat', '##ch', 'buy', 'lake', 'region', 'medical']",1
356592,nifty_1114,2015-08-31,Medicines Shares Surge on Cholesterol-Drug Data,Fall,-0.0298,47,medicine share surge cholesterol drug data,42,6,0,pharmacy,"['medicine', 'share', 'surge', 'ch', '##ole', '##ster', '##ol', 'drug', 'data']",1
356594,nifty_1114,2015-08-31,HealthSouth to Buy CareSouth for $170 Million,Fall,-0.0298,45,healthsouth buy caresouth for million,37,5,0,pharmacy,"['health', '##so', '##uth', 'buy', 'cares', '##outh', 'for', 'million']",1
356596,nifty_1114,2015-08-31,Bristol-Myers Granted Right to Buy Promedior,Fall,-0.0298,44,bristol myers granted right buy promedior,41,6,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'granted', 'right', 'buy', 'pro', '##med', '##ior']",1
356657,nifty_1115,2015-09-01,Amgen Finds Data Falsified in Grizzly Bear Study,Rise,0.019,48,amgen find data falsified grizzly bear study,44,7,0,pharmacy,"['am', '##gen', 'find', 'data', 'f', '##als', '##ified', 'g', '##riz', '##z', '##ly', 'bear', 'study']",1
356665,nifty_1115,2015-09-01,Bristol-Myers Myeloma Drug Accepted for FDA Review,Rise,0.019,50,bristol myers myeloma drug accepted for fda review,50,8,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'my', '##elo', '##ma', 'drug', 'accepted', 'for', 'f', '##da', 'review']",1
356703,nifty_1116,2015-09-02,Novartis Closer to Selling Copy of Amgen’s Neupogen,Neutral,0.0007,51,novartis closer selling copy amgen neupogen,43,6,0,pharmacy,"['no', '##var', '##tis', 'closer', 'selling', 'copy', 'am', '##gen', 'ne', '##up', '##ogen']",1
356772,nifty_1117,2015-09-03,Novartis to Begin Selling Copy of Amgen’s Neupogen in U.S.,Fall,-0.0151,58,novartis begin selling copy amgen neupogen,42,6,0,pharmacy,"['no', '##var', '##tis', 'begin', 'selling', 'copy', 'am', '##gen', 'ne', '##up', '##ogen']",1
356823,nifty_1118,2015-09-08,REG-INNATE PHARMA : Upcoming investor conferences,Fall,-0.0134,49,reg innate pharma upcoming investor conference,46,6,0,pharmacy,"['re', '##g', 'inn', '##ate', 'p', '##har', '##ma', 'upcoming', 'investor', 'conference']",1
356825,nifty_1118,2015-09-08,INNATE PHARMA : Upcoming investor conferences,Fall,-0.0134,45,innate pharma upcoming investor conference,42,5,0,pharmacy,"['inn', '##ate', 'p', '##har', '##ma', 'upcoming', 'investor', 'conference']",1
356873,nifty_1118,2015-09-08,Research and Markets: Telemedicine and Online Healthcare Industry in China 2015,Fall,-0.0134,79,research and market telemedicine and online healthcare industry china,69,9,0,pharmacy,"['research', 'and', 'market', 'te', '##lem', '##edic', '##ine', 'and', 'online', 'healthcare', 'industry', 'chin', '##a']",1
356891,nifty_1118,2015-09-08,"Research and Markets: The New Saudi Arabian Pharmacovigilance Guidelines of June 2015, Dubai (Dubai, UAE - October 20-21 2015)",Fall,-0.0134,126,research and market the new saudi arabian pharmacovigilance guideline june dubai dubai uae october,98,14,0,pharmacy,"['research', 'and', 'market', 'the', 'new', 'sa', '##udi', 'a', '##rab', '##ian', 'p', '##har', '##ma', '##co', '##vi', '##gi', '##lance', 'guide', '##line', 'j', '##une', 'dub', '##ai', 'dub', '##ai', 'u', '##ae', 'o', '##ct', '##obe', '##r']",1
356892,nifty_1118,2015-09-08,"Research and Markets: Successful Pharma Project Management Course, Dubai (Dubai, UAE - October 20-21, 2015)",Fall,-0.0134,107,research and market successful pharma project management course dubai dubai uae october,87,12,0,pharmacy,"['research', 'and', 'market', 'successful', 'p', '##har', '##ma', 'project', 'management', 'course', 'dub', '##ai', 'dub', '##ai', 'u', '##ae', 'o', '##ct', '##obe', '##r']",1
356945,nifty_1118,2015-09-08,Research and Markets: Pharmaceuticals Industry in India 2015-2020,Fall,-0.0134,65,research and market pharmaceutical industry india,49,6,0,pharmacy,"['research', 'and', 'market', 'pharmaceutical', 'industry', 'in', '##dia']",1
356950,nifty_1118,2015-09-08,Research and Markets: Medical Services Industry in India 2015-2020,Fall,-0.0134,66,research and market medical service industry india,50,7,0,pharmacy,"['research', 'and', 'market', 'medical', 'service', 'industry', 'in', '##dia']",1
356952,nifty_1118,2015-09-08,Research and Markets: India Pharmaceuticals Manufacturing Industry 2015 - 2020: Market is Expected to be Worth US$ 41.92 Billion,Fall,-0.0134,128,research and market india pharmaceutical manufacturing industry market expected worth billion,93,11,0,pharmacy,"['research', 'and', 'market', 'in', '##dia', 'pharmaceutical', 'manufacturing', 'industry', 'market', 'expected', 'worth', 'billion']",1
356956,nifty_1118,2015-09-08,Research and Markets: Medical Devices Manufacturing Industry in India 2015 - 2020,Fall,-0.0134,81,research and market medical device manufacturing industry india,63,8,0,pharmacy,"['research', 'and', 'market', 'medical', 'device', 'manufacturing', 'industry', 'in', '##dia']",1
356980,nifty_1118,2015-09-08,Research and Markets: India Pharmaceuticals Retailing Industry 2015-2020 - Analysis and Forecasts for the $32 Billion Industry Featuring Apollo Pharmacy and MedPlus Health Services,Fall,-0.0134,180,research and market india pharmaceutical retailing industry analysis and forecast for the billion industry featuring apollo pharmacy and medplus health service,159,21,0,pharmacy,"['research', 'and', 'market', 'in', '##dia', 'pharmaceutical', 'retail', '##ing', 'industry', 'analysis', 'and', 'forecast', 'for', 'the', 'billion', 'industry', 'featuring', 'a', '##pol', '##lo', 'pharmacy', 'and', 'me', '##d', '##p', '##lus', 'health', 'service']",1
357086,nifty_1118,2015-09-08,Molecular Diagnostics Market to Expand at 11.1% CAGR from 2013 to 2019: Transparency Market Research,Fall,-0.0134,100,molecular diagnostics market expand cagr from transparency market research,74,9,0,pharmacy,"['molecular', 'diagnostic', '##s', 'market', 'expand', 'ca', '##g', '##r', 'from', 'transparency', 'market', 'research']",1
357091,nifty_1118,2015-09-08,"Research and Markets: Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 - F. Hoffmann-La Roche, Novartis & Teva Pharmaceutical Industries Dominate the Market",Fall,-0.0134,173,research and market global chronic lymphocytic leukemia therapeutic market hoffmann roche novartis teva pharmaceutical industry dominate the market,147,18,0,pharmacy,"['research', 'and', 'market', 'global', 'chronic', 'l', '##ymph', '##oc', '##ytic', 'le', '##uke', '##mia', 'therapeutic', 'market', 'ho', '##ff', '##mann', 'r', '##och', '##e', 'no', '##var', '##tis', 'te', '##va', 'pharmaceutical', 'industry', 'dominate', 'the', 'market']",1
357200,nifty_1118,2015-09-08,"Research and Markets: Global Retinoblastoma Treatment Market 2015-2019 with Baxter, Bristol-Myers Squibb, GlaxoSmithKline & Spectrum Pharmaceuticals Dominating",Fall,-0.0134,159,research and market global retinoblastoma treatment market with baxter bristol myers squibb glaxosmithkline spectrum pharmaceutical dominating,142,16,0,pharmacy,"['research', 'and', 'market', 'global', 're', '##tino', '##blast', '##oma', 'treatment', 'market', 'with', 'b', '##ax', '##ter', 'br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'g', '##lax', '##os', '##mith', '##k', '##line', 'spectrum', 'pharmaceutical', 'dominating']",1
357315,nifty_1118,2015-09-08,Canada’s Concordia Healthcare to Buy Amdipharm,Fall,-0.0134,46,canada concordia healthcare buy amdipharm,41,5,0,pharmacy,"['can', '##ada', 'con', '##cor', '##dia', 'healthcare', 'buy', 'am', '##di', '##pha', '##rm']",1
357343,nifty_1119,2015-09-09,Sanders Takes Aim at High Drug Prices,Rise,0.0054,37,sander take aim high drug price,31,6,0,pharmacy,"['sand', '##er', 'take', 'aim', 'high', 'drug', 'price']",1
357521,nifty_1121,2015-09-14,Raptor Pharmaceutical Drug Fails Study,Rise,0.0125,38,raptor pharmaceutical drug fails study,38,5,0,pharmacy,"['rap', '##tor', 'pharmaceutical', 'drug', 'fails', 'study']",1
357647,nifty_1123,2015-09-16,Aerie Pharmaceuticals Shares Rise on Trial Results,Neutral,-0.0022,50,aerie pharmaceutical share rise trial result,44,6,0,pharmacy,"['a', '##erie', 'pharmaceutical', 'share', 'rise', 'trial', 'result']",1
357825,nifty_1124,2015-09-17,"Compression Therapy Market Worth $3.96 Billion by 2022: Grand View Research, Inc.",Fall,-0.0214,81,compression therapy market worth billion grand view research inc,64,9,0,pharmacy,"['compression', 'therapy', 'market', 'worth', 'billion', 'grand', 'view', 'research', 'in', '##c']",1
357961,nifty_1124,2015-09-17,Validic Selected As Digital Health Technology Provider For National On The Move Wellness Challenge,Fall,-0.0214,98,validic selected digital health technology provider for national the move wellness challenge,92,12,0,pharmacy,"['valid', '##ic', 'selected', 'digital', 'health', 'technology', 'provider', 'for', 'national', 'the', 'move', 'well', '##ness', 'challenge']",1
358005,nifty_1124,2015-09-17,"Biotechnology Stocks Technical Data -- Anacor Pharma, CytRx, Cerus, CorMedix, and FibroGen",Fall,-0.0214,90,biotechnology stock technical data anacor pharma cytrx cerus cormedix and fibrogen,82,11,0,pharmacy,"['bio', '##tech', '##nology', 'stock', 'technical', 'data', 'an', '##aco', '##r', 'p', '##har', '##ma', 'c', '##yt', '##r', '##x', 'c', '##erus', 'co', '##rmed', '##ix', 'and', 'fi', '##bro', '##gen']",1
358009,nifty_1124,2015-09-17,Valeant Pharmaceuticals Renews CeraVeÂ® Partnership with USA Swimming as Exclusive Skincare Sponsor,Fall,-0.0214,99,valeant pharmaceutical renews ceraveâ partnership with usa swimming exclusive skincare sponsor,94,11,0,pharmacy,"['v', '##ale', '##ant', 'pharmaceutical', 'renew', '##s', 'c', '##era', '##ve', '##â', 'partnership', 'with', 'us', '##a', 'swimming', 'exclusive', 'skin', '##care', 'sponsor']",1
358096,nifty_1124,2015-09-17,Kalorama: Fast Growth in Medical Apps as Market Nears Half Billion-Dollars,Fall,-0.0214,74,kalorama fast growth medical apps market nears half billion dollar,66,10,0,pharmacy,"['ka', '##lora', '##ma', 'fast', 'growth', 'medical', 'apps', 'market', 'near', '##s', 'half', 'billion', 'dollar']",1
358359,nifty_1124,2015-09-17,World's biggest private biotech Intarcia in no rush to list,Fall,-0.0214,59,world biggest private biotech intarcia rush list,48,7,0,pharmacy,"['world', 'biggest', 'private', 'bio', '##tech', 'in', '##tar', '##cia', 'rush', 'list']",1
358416,nifty_1124,2015-09-17,eCann Media Announces Lineup of Disruptive Companies at the First Ever Cannabis Investor Summit,Fall,-0.0214,95,ecann medium announces lineup disruptive company the first ever cannabis investor summit,88,12,0,pharmacy,"['e', '##can', '##n', 'medium', 'announces', 'lineup', 'disrupt', '##ive', 'company', 'the', 'first', 'ever', 'cannabis', 'investor', 'summit']",1
358622,nifty_1124,2015-09-17,TWi Pharmaceuticals Issues GDR and Raised NT$ 2.83 Billion,Fall,-0.0214,58,twi pharmaceutical issue gdr and raised billion,47,7,0,pharmacy,"['t', '##wi', 'pharmaceutical', 'issue', 'g', '##dr', 'and', 'raised', 'billion']",1
358643,nifty_1124,2015-09-17,New Diabetes Drug Shows Sharply Reduced Risk of Heart-Related Death,Fall,-0.0214,67,new diabetes drug show sharply reduced risk heart related death,63,10,0,pharmacy,"['new', 'diabetes', 'drug', 'show', 'sharply', 'reduced', 'risk', 'heart', 'related', 'death']",1
358721,nifty_1125,2015-09-21,"Biotech Shares Drop, Tempering Market Gains",Fall,-0.013,43,biotech share drop tempering market gain,40,6,0,pharmacy,"['bio', '##tech', 'share', 'drop', 'temper', '##ing', 'market', 'gain']",1
358779,nifty_1126,2015-09-22,Biotech Stocks’ Rout Continues,Neutral,-0.0016,30,biotech stock rout continues,28,4,0,pharmacy,"['bio', '##tech', 'stock', 'r', '##out', 'continues']",1
358934,nifty_1127,2015-09-23,"Research and Markets: Biotechnology Companies in Emerging Markets to 2025: Recent Deals, Partnerships, and Strategic Alliances (China, Singapore, Brazil, South Africa, South Korea, Turkey, India, Russia)",Neutral,-0.0036,203,research and market biotechnology company emerging market recent deal partnership and strategic alliance china singapore brazil south africa south korea turkey india russia,172,23,0,pharmacy,"['research', 'and', 'market', 'bio', '##tech', '##nology', 'company', 'emerging', 'market', 'recent', 'deal', 'partnership', 'and', 'strategic', 'alliance', 'chin', '##a', 'sing', '##ap', '##ore', 'bra', '##zi', '##l', 'south', 'a', '##f', '##rica', 'south', 'k', '##ore', '##a', 'turkey', 'in', '##dia', 'r', '##uss', '##ia']",1
358942,nifty_1127,2015-09-23,"Research and Markets: World Market for Prescription Dermatological Drugs, 2015 Edition (Anti-Acne, Anti-Aging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)",Neutral,-0.0036,191,research and market world market for prescription dermatological drug edition anti acne anti aging dermatitis hair loss psoriasis skin cancer melasma and seborrhea treatment,173,24,0,pharmacy,"['research', 'and', 'market', 'world', 'market', 'for', 'prescription', 'der', '##mat', '##ological', 'drug', 'edition', 'anti', 'a', '##c', '##ne', 'anti', 'aging', 'der', '##mat', '##itis', 'hair', 'loss', 'ps', '##oria', '##sis', 'skin', 'cancer', 'me', '##las', '##ma', 'and', 'se', '##bor', '##r', '##hea', 'treatment']",1
358952,nifty_1127,2015-09-23,"Research and Markets: The Worldwide Market for Bioreactors, 2019",Neutral,-0.0036,64,research and market the worldwide market for bioreactors,56,8,0,pharmacy,"['research', 'and', 'market', 'the', 'worldwide', 'market', 'for', 'bio', '##rea', '##ctors']",1
358965,nifty_1127,2015-09-23,"Research and Markets: In-Situ Hybridization Market by Type (DNA,RNA), Application (Cancer Diagnosis, Cytology, Immunology), End User (Hospitals, Pharma & Biotech, Research Labs) - Analysis and Forecast to 2019",Neutral,-0.0036,209,research and market situ hybridization market type dna rna application cancer diagnosis cytology immunology end user hospital pharma biotech research lab analysis and forecast,175,24,0,pharmacy,"['research', 'and', 'market', 'sit', '##u', 'hybrid', '##ization', 'market', 'type', 'd', '##na', 'r', '##na', 'application', 'cancer', 'diagnosis', 'c', '##yt', '##ology', 'im', '##mu', '##nology', 'end', 'user', 'hospital', 'p', '##har', '##ma', 'bio', '##tech', 'research', 'lab', 'analysis', 'and', 'forecast']",1
359099,nifty_1127,2015-09-23,Flex Pharma to Present at the Ladenburg Thalmann Investment Conference,Neutral,-0.0036,70,flex pharma present the ladenburg thalmann investment conference,64,8,0,pharmacy,"['fl', '##ex', 'p', '##har', '##ma', 'present', 'the', 'laden', '##burg', 'th', '##al', '##mann', 'investment', 'conference']",1
359133,nifty_1127,2015-09-23,"Expert Briefing on Biotechnology Stocks -- Baxalta, Opko Health, Spectrum Pharma, Arrowhead Research, and Oncothyreon",Neutral,-0.0036,117,expert briefing biotechnology stock baxalta opko health spectrum pharma arrowhead research and oncothyreon,106,13,0,pharmacy,"['expert', 'brief', '##ing', 'bio', '##tech', '##nology', 'stock', 'b', '##ax', '##al', '##ta', 'op', '##ko', 'health', 'spectrum', 'p', '##har', '##ma', 'arrow', '##head', 'research', 'and', 'on', '##cot', '##hy', '##re', '##on']",1
359141,nifty_1127,2015-09-23,Research and Markets: Ovarian Cancer Forecast in 17 Major Markets 2015-2025,Neutral,-0.0036,75,research and market ovarian cancer forecast major market,56,8,0,pharmacy,"['research', 'and', 'market', 'o', '##var', '##ian', 'cancer', 'forecast', 'major', 'market']",1
359144,nifty_1127,2015-09-23,"Market Coverage on the Healthcare Sector -- AEterna Zentaris, Great Basin Scientific, Gilead Sciences, WaferGen Bio-systems and Horizon Pharma",Neutral,-0.0036,142,market coverage the healthcare sector aeterna zentaris great basin scientific gilead science wafergen bio system and horizon pharma,131,18,0,pharmacy,"['market', 'coverage', 'the', 'healthcare', 'sector', 'a', '##eter', '##na', 'z', '##ent', '##aris', 'great', 'basin', 'scientific', 'g', '##ile', '##ad', 'science', 'wa', '##fer', '##gen', 'bio', 'system', 'and', 'horizon', 'p', '##har', '##ma']",1
359175,nifty_1127,2015-09-23,"Technical Data on Healthcare Stocks - Infinity Pharmaceuticals, Boston Scientific, Johnson & Johnson, Mallinckrodt and Eli Lilly",Neutral,-0.0036,128,technical data healthcare stock infinity pharmaceutical boston scientific johnson johnson mallinckrodt and eli lilly,116,14,0,pharmacy,"['technical', 'data', 'healthcare', 'stock', 'in', '##finity', 'pharmaceutical', 'b', '##ost', '##on', 'scientific', 'j', '##oh', '##nson', 'j', '##oh', '##nson', 'mall', '##in', '##ck', '##rod', '##t', 'and', 'el', '##i', 'l', '##ill', '##y']",1
359178,nifty_1127,2015-09-23,"Research and Markets: Autism Spectrum Disorders Forecast in 12 Major Markets 2015-2025 - USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Denmark, Sweden and China",Neutral,-0.0036,176,research and market autism spectrum disorder forecast major market usa france germany italy spain brazil japan india denmark sweden and china,141,21,0,pharmacy,"['research', 'and', 'market', 'autism', 'spectrum', 'disorder', 'forecast', 'major', 'market', 'us', '##a', 'f', '##rance', 'g', '##erman', '##y', 'it', '##aly', 'spa', '##in', 'bra', '##zi', '##l', 'j', '##apa', '##n', 'in', '##dia', 'den', '##mark', 's', '##wed', '##en', 'and', 'chin', '##a']",1
359183,nifty_1127,2015-09-23,Research and Markets: Global Pharma and Biotech M&A; Trends 2010-2015: Access to Agreements Entered into by the World's Leading Biopharma Companies,Neutral,-0.0036,147,research and market global pharma and biotech trend access agreement entered into the world leading biopharma company,117,17,0,pharmacy,"['research', 'and', 'market', 'global', 'p', '##har', '##ma', 'and', 'bio', '##tech', 'trend', 'access', 'agreement', 'entered', 'into', 'the', 'world', 'leading', 'bio', '##pha', '##rma', 'company']",1
359196,nifty_1127,2015-09-23,Medical Specialties Distributors Selects Insite Software and NorthPoint Digital to Modernize eCommerce Efforts to Support Growth and Expansion into New Markets,Neutral,-0.0036,159,medical specialty distributor selects insite software and northpoint digital modernize ecommerce effort support growth and expansion into new market,148,19,0,pharmacy,"['medical', 'specialty', 'distributor', 'select', '##s', 'ins', '##ite', 'software', 'and', 'north', '##point', 'digital', 'modern', '##ize', 'e', '##com', '##mer', '##ce', 'effort', 'support', 'growth', 'and', 'expansion', 'into', 'new', 'market']",1
359202,nifty_1127,2015-09-23,"Research and Markets: Global Diagnostics Partnering 2010-2015: Updated Deal Trends, Players, Financials and Forecasts for 150+ Companies",Neutral,-0.0036,136,research and market global diagnostics partnering updated deal trend player financials and forecast for company,111,15,0,pharmacy,"['research', 'and', 'market', 'global', 'diagnostic', '##s', 'partner', '##ing', 'updated', 'deal', 'trend', 'player', 'financial', '##s', 'and', 'forecast', 'for', 'company']",1
359215,nifty_1127,2015-09-23,"Research and Markets: Global Topical Drug Delivery Partnering 2010-2015 - Updated Deals Analysis by Company A-Z, Deal Type, Stage of Development & Therapy Type",Neutral,-0.0036,159,research and market global topical drug delivery partnering updated deal analysis company deal type stage development therapy type,130,18,0,pharmacy,"['research', 'and', 'market', 'global', 'topic', '##al', 'drug', 'delivery', 'partner', '##ing', 'updated', 'deal', 'analysis', 'company', 'deal', 'type', 'stage', 'development', 'therapy', 'type']",1
359219,nifty_1127,2015-09-23,"Healthcare Sector Equities Coverage -- HCA Holdings, Tenet Healthcare, Community Health Systems, BioScrip and DaVita HealthCare Partners",Neutral,-0.0036,136,healthcare sector equity coverage hca holding tenet healthcare community health system bioscrip and davita healthcare partner,125,16,0,pharmacy,"['healthcare', 'sector', 'equity', 'coverage', 'h', '##ca', 'holding', 'ten', '##et', 'healthcare', 'community', 'health', 'system', 'bio', '##s', '##c', '##rip', 'and', 'da', '##vi', '##ta', 'healthcare', 'partner']",1
359244,nifty_1127,2015-09-23,"Research and Markets: Global Collaborative R&D; Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2015",Neutral,-0.0036,109,research and market global collaborative term agreement pharma biotech diagnostics,82,10,0,pharmacy,"['research', 'and', 'market', 'global', 'collaborative', 'term', 'agreement', 'p', '##har', '##ma', 'bio', '##tech', 'diagnostic', '##s']",1
359250,nifty_1127,2015-09-23,"Research and Markets: Global Injectable Drug Delivery Partnering Deal Analysis 2010-2015 - Updated by Company A-Z, Deal Type, Stage of Development & Therapy Type",Neutral,-0.0036,161,research and market global injectable drug delivery partnering deal analysis updated company deal type stage development therapy type,133,18,0,pharmacy,"['research', 'and', 'market', 'global', 'in', '##ject', '##able', 'drug', 'delivery', 'partner', '##ing', 'deal', 'analysis', 'updated', 'company', 'deal', 'type', 'stage', 'development', 'therapy', 'type']",1
359263,nifty_1127,2015-09-23,U.S. Biochar Market is expected to boost up to US$4.94 billion by 2020: Transparency Market Research,Neutral,-0.0036,100,biochar market expected boost billion transparency market research,66,8,0,pharmacy,"['bio', '##cha', '##r', 'market', 'expected', 'boost', 'billion', 'transparency', 'market', 'research']",1
359304,nifty_1127,2015-09-23,Big Data Spending in the Healthcare Industry â Technavio Publishes Global Forecast & Analysis,Neutral,-0.0036,95,big data spending the healthcare industry technavio publishes global forecast analysis,86,11,0,pharmacy,"['big', 'data', 'spending', 'the', 'healthcare', 'industry', 'tech', '##na', '##vio', 'publishes', 'global', 'forecast', 'analysis']",1
359449,nifty_1127,2015-09-23,"Research and Markets: Global Asthma & COPD Market Report: 2015 Edition Featuring Leading Market Players, AstraZeneca, Merck and Co., Roche, Sanofi and Novartis",Neutral,-0.0036,159,research and market global asthma copd market report edition featuring leading market player astrazeneca merck and roche sanofi and novartis,140,20,0,pharmacy,"['research', 'and', 'market', 'global', 'as', '##th', '##ma', 'cop', '##d', 'market', 'report', 'edition', 'featuring', 'leading', 'market', 'player', 'as', '##tra', '##zen', '##eca', 'me', '##rc', '##k', 'and', 'r', '##och', '##e', 'sa', '##no', '##fi', 'and', 'no', '##var', '##tis']",1
359470,nifty_1127,2015-09-23,"Research and Markets: Hidradenitis Suppurativa Pipeline Review, H2 2015 - 5 Companies & 7 Drug Profiles",Neutral,-0.0036,103,research and market hidradenitis suppurativa pipeline review company drug profile,81,10,0,pharmacy,"['research', 'and', 'market', 'hid', '##rade', '##ni', '##tis', 'su', '##pp', '##ura', '##ti', '##va', 'pipeline', 'review', 'company', 'drug', 'profile']",1
359479,nifty_1127,2015-09-23,"Research and Markets: Chronic Bronchitis Pipeline Review, H2 2015 - 4 Companies & Drug Profiles",Neutral,-0.0036,95,research and market chronic bronchitis pipeline review company drug profile,75,10,0,pharmacy,"['research', 'and', 'market', 'chronic', 'br', '##on', '##chi', '##tis', 'pipeline', 'review', 'company', 'drug', 'profile']",1
359486,nifty_1127,2015-09-23,"Research and Markets: Restless Legs Syndrome Pipeline Review, H2 2015 - 8 Companies & 8 Drug Profiles",Neutral,-0.0036,101,research and market restless leg syndrome pipeline review company drug profile,78,11,0,pharmacy,"['research', 'and', 'market', 'restless', 'leg', 'syndrome', 'pipeline', 'review', 'company', 'drug', 'profile']",1
359545,nifty_1127,2015-09-23,Annual Update Shows Floridaâs Biotech Industry is Resilient,Neutral,-0.0036,61,annual update show floridaâ biotech industry resilient,54,7,0,pharmacy,"['annual', 'update', 'show', 'fl', '##ori', '##da', '##â', 'bio', '##tech', 'industry', 're', '##si', '##lient']",1
359712,nifty_1127,2015-09-23,Depomed Says It Receives Favorable Patent Decision,Neutral,-0.0036,50,depomed say receives favorable patent decision,46,6,0,pharmacy,"['de', '##po', '##med', 'say', 'receives', 'favorable', 'patent', 'decision']",1
359916,nifty_1129,2015-09-28,Verastem to Wind Down Mesothelioma Study,Neutral,0.0006,40,verastem wind down mesothelioma study,37,5,0,pharmacy,"['ve', '##ras', '##tem', 'wind', 'down', 'me', '##so', '##the', '##lio', '##ma', 'study']",1
360054,nifty_1131,2015-09-30,e-Therapeutics: Discovery Platform Exceeding Expectations; Company Focus Now on Commercialisation,Neutral,0.0026,97,therapeutic discovery platform exceeding expectation company focus now commercialisation,88,9,0,pharmacy,"['therapeutic', 'discovery', 'platform', 'exceeding', 'expectation', 'company', 'focus', 'now', 'commercial', '##isation']",1
360162,nifty_1131,2015-09-30,Research and Markets: United Kingdom OTC Pharmaceuticals Market Update 2015,Neutral,0.0026,75,research and market united kingdom otc pharmaceutical market update,67,9,0,pharmacy,"['research', 'and', 'market', 'united', 'kingdom', 'o', '##t', '##c', 'pharmaceutical', 'market', 'update']",1
360201,nifty_1131,2015-09-30,MarketResearch.com: Growing In-Vitro Diagnostics Markets in Asia,Neutral,0.0026,64,marketresearch com growing vitro diagnostics market asia,56,7,0,pharmacy,"['market', '##res', '##ear', '##ch', 'com', 'growing', 'v', '##it', '##ro', 'diagnostic', '##s', 'market', 'as', '##ia']",1
360253,nifty_1131,2015-09-30,Research and Markets: Indian Generic Drug Market Outlook 2020 - The Generic Drug Market Anticipated to Grow at a CAGR of 16.3% from 2014-2020,Neutral,0.0026,141,research and market indian generic drug market outlook the generic drug market anticipated grow cagr from,105,16,0,pharmacy,"['research', 'and', 'market', 'in', '##dian', 'generic', 'drug', 'market', 'outlook', 'the', 'generic', 'drug', 'market', 'anticipated', 'grow', 'ca', '##g', '##r', 'from']",1
360264,nifty_1131,2015-09-30,Research and Markets: Global Gene Therapy Market Outlook 2020,Neutral,0.0026,61,research and market global gene therapy market outlook,54,8,0,pharmacy,"['research', 'and', 'market', 'global', 'gene', 'therapy', 'market', 'outlook']",1
360273,nifty_1131,2015-09-30,RXi Pharmaceuticals to Present at Dawson James Securities Growth Stock Conference,Neutral,0.0026,81,rxi pharmaceutical present dawson james security growth stock conference,72,9,0,pharmacy,"['r', '##xi', 'pharmaceutical', 'present', 'da', '##wson', 'jam', '##es', 'security', 'growth', 'stock', 'conference']",1
360317,nifty_1131,2015-09-30,Cloud Pharmaceuticals and THERAMetrics Form Strategic Drug Development Collaboration Targeting Orphan CNS Diseases,Neutral,0.0026,114,cloud pharmaceutical and therametrics form strategic drug development collaboration targeting orphan cns disease,112,13,0,pharmacy,"['cloud', 'pharmaceutical', 'and', 'the', '##ram', '##et', '##ric', '##s', 'form', 'strategic', 'drug', 'development', 'collaboration', 'targeting', 'orphan', 'c', '##ns', 'disease']",1
360336,nifty_1131,2015-09-30,"Oncobiologics Secures Financing from Sabby Management, LLC, to Advance BioSymphonyâ¢ Platform and Monoclonal Antibody Biosimilars Pipeline",Neutral,0.0026,139,oncobiologics secures financing from sabby management llc advance biosymphonyâ platform and monoclonal antibody biosimilars pipeline,132,15,0,pharmacy,"['on', '##co', '##bio', '##log', '##ics', 'secure', '##s', 'financing', 'from', 'sa', '##bby', 'management', 'll', '##c', 'advance', 'bio', '##sy', '##mp', '##hon', '##y', '##â', 'platform', 'and', 'mon', '##oc', '##lon', '##al', 'anti', '##body', 'bio', '##si', '##mi', '##lars', 'pipeline']",1
360363,nifty_1131,2015-09-30,"Premier Biomedical, Inc. Accomplishments and Recent News",Neutral,0.0026,56,premier biomedical inc accomplishment and recent news,53,7,0,pharmacy,"['premier', 'bio', '##medical', 'in', '##c', 'accomplish', '##ment', 'and', 'recent', 'news']",1
360387,nifty_1131,2015-09-30,"Biotechnology Equities Ahead of Market -- Geron, VIVUS, Halozyme Therapeutics, Advaxis, and Progenics Pharma",Neutral,0.0026,108,biotechnology equity ahead market geron vivus halozyme therapeutic advaxis and progenics pharma,95,12,0,pharmacy,"['bio', '##tech', '##nology', 'equity', 'ahead', 'market', 'g', '##eron', 'v', '##iv', '##us', 'ha', '##lo', '##zy', '##me', 'therapeutic', 'ad', '##va', '##xi', '##s', 'and', 'pro', '##genic', '##s', 'p', '##har', '##ma']",1
360479,nifty_1131,2015-09-30,Craneware to Host Industry's First Value Cycle-Focused Healthcare Event,Neutral,0.0026,71,craneware host industry first value cycle focused healthcare event,66,9,0,pharmacy,"['crane', '##ware', 'host', 'industry', 'first', 'value', 'cycle', 'focused', 'healthcare', 'event']",1
360485,nifty_1131,2015-09-30,"Market Updates on the Healthcare Sector - Biogen, Depomed, Arena Pharmaceuticals, Allscripts Healthcare and Amicus Therapeutics",Neutral,0.0026,127,market update the healthcare sector biogen depomed arena pharmaceutical allscripts healthcare and amicus therapeutic,116,14,0,pharmacy,"['market', 'update', 'the', 'healthcare', 'sector', 'bio', '##gen', 'de', '##po', '##med', 'arena', 'pharmaceutical', 'all', '##s', '##cripts', 'healthcare', 'and', 'am', '##icus', 'therapeutic']",1
360496,nifty_1131,2015-09-30,"Market Highlights from the Healthcare Sector - Geron, BioMarin Pharmaceutical, Array BioPharma, Cerner and Arrowhead Research",Neutral,0.0026,125,market highlight from the healthcare sector geron biomarin pharmaceutical array biopharma cerner and arrowhead research,119,15,0,pharmacy,"['market', 'highlight', 'from', 'the', 'healthcare', 'sector', 'g', '##eron', 'bio', '##mar', '##in', 'pharmaceutical', 'array', 'bio', '##pha', '##rma', 'c', '##erne', '##r', 'and', 'arrow', '##head', 'research']",1
360502,nifty_1131,2015-09-30,"Healthcare Sector Stocks under Review - Celldex Therapeutics, Alexion Pharmaceuticals, Advaxis, BioDelivery Sciences and Cytori Therapeutics",Neutral,0.0026,140,healthcare sector stock under review celldex therapeutic alexion pharmaceutical advaxis biodelivery science and cytori therapeutic,130,15,0,pharmacy,"['healthcare', 'sector', 'stock', 'under', 'review', 'cell', '##de', '##x', 'therapeutic', 'ale', '##xi', '##on', 'pharmaceutical', 'ad', '##va', '##xi', '##s', 'bio', '##del', '##iver', '##y', 'science', 'and', 'c', '##yt', '##ori', 'therapeutic']",1
360507,nifty_1131,2015-09-30,"Technical Coverage on Diverse Sectors - American Capital, ARIAD Pharmaceuticals, Endo International, Amgen and Express Scripts",Neutral,0.0026,126,technical coverage diverse sector american capital ariad pharmaceutical endo international amgen and express script,115,14,0,pharmacy,"['technical', 'coverage', 'diverse', 'sector', 'am', '##eric', '##an', 'capital', 'a', '##riad', 'pharmaceutical', 'end', '##o', 'international', 'am', '##gen', 'and', 'express', 'script']",1
360836,nifty_1131,2015-09-30,Pricing fears put drug stocks in sick bay,Neutral,0.0026,41,pricing fear put drug stock sick bay,36,7,0,pharmacy,"['pricing', 'fear', 'put', 'drug', 'stock', 'sick', 'bay']",1
360847,nifty_1131,2015-09-30,"Sangui BioTech: Revenues of USD 127,000 in Financial Year 2015; Net Loss, Cash Burn Reduced; Revenues from Granulox License Fees in EUR Up 34.4%",Neutral,0.0026,144,sangui biotech revenue usd financial year net loss cash burn reduced revenue from granulox license fee eur,106,17,0,pharmacy,"['sang', '##ui', 'bio', '##tech', 'revenue', 'us', '##d', 'financial', 'year', 'net', 'loss', 'cash', 'burn', 'reduced', 'revenue', 'from', 'g', '##ran', '##ulo', '##x', 'license', 'fee', 'e', '##ur']",1
360956,nifty_1131,2015-09-30,U.S. biotech bloodbath hits hedge funds but some bargains emerge,Neutral,0.0026,64,biotech bloodbath hit hedge fund but some bargain emerge,56,9,0,pharmacy,"['bio', '##tech', 'blood', '##bat', '##h', 'hit', 'hedge', 'fund', 'but', 'some', 'bargain', 'emerge']",1
361204,nifty_1132,2015-10-01,BioMarin to Acquire Global Rights to  the Drug Kuvan,Rise,0.0149,52,biomarin acquire global right the drug kuvan,44,7,0,pharmacy,"['bio', '##mar', '##in', 'acquire', 'global', 'right', 'the', 'drug', 'k', '##u', '##van']",1
361304,nifty_1134,2015-10-06,FDA Approves Alkermes’ Schizophrenia Treatment Aristada,Rise,0.0082,55,fda approves alkermes schizophrenia treatment aristada,54,6,0,pharmacy,"['f', '##da', 'approve', '##s', 'al', '##ker', '##mes', 's', '##chi', '##zophrenia', 'treatment', 'a', '##rist', '##ada']",1
361360,nifty_1134,2015-10-06,AmerisourceBergen to Buy PharMEDium Healthcare,Rise,0.0082,46,amerisourcebergen buy pharmedium healthcare,43,4,0,pharmacy,"['am', '##eri', '##so', '##ur', '##ce', '##berg', '##en', 'buy', 'p', '##har', '##med', '##ium', 'healthcare']",1
361492,nifty_1136,2015-10-08,BRIEF-Biotie Therapies issues new treasury shares without consideration,Neutral,0.0006,71,brief biotie therapy issue new treasury share without consideration,67,9,0,pharmacy,"['brief', 'bio', '##tie', 'therapy', 'issue', 'new', 'treasury', 'share', 'without', 'consideration']",1
361568,nifty_1136,2015-10-08,"Research and Markets: Vasculitis Pipeline Review, H2 2015 - 14 Companies & 12 Drug Profiles",Neutral,0.0006,91,research and market vasculitis pipeline review company drug profile,67,9,0,pharmacy,"['research', 'and', 'market', 'v', '##as', '##cu', '##lit', '##is', 'pipeline', 'review', 'company', 'drug', 'profile']",1
361580,nifty_1136,2015-10-08,Research and Markets: UK Retail Pharmacies Market Update 2015,Neutral,0.0006,61,research and market retail pharmacy market update,49,7,0,pharmacy,"['research', 'and', 'market', 'retail', 'pharmacy', 'market', 'update']",1
361606,nifty_1136,2015-10-08,Research and Markets: Global Market Study on 3D Cell Culture 2015: Asia to Witness Highest Growth by 2020,Neutral,0.0006,105,research and market global market study cell culture asia witness highest growth,80,12,0,pharmacy,"['research', 'and', 'market', 'global', 'market', 'study', 'cell', 'culture', 'as', '##ia', 'witness', 'highest', 'growth']",1
361608,nifty_1136,2015-10-08,REG-Bionor to present anticipated next steps to value creation at its Capital Markets Day in Oslo today,Neutral,0.0006,103,reg bionor present anticipated next step value creation it capital market day oslo today,88,14,0,pharmacy,"['re', '##g', 'bio', '##nor', 'present', 'anticipated', 'next', 'step', 'value', 'creation', 'it', 'capital', 'market', 'day', 'o', '##s', '##lo', 'today']",1
361663,nifty_1136,2015-10-08,RXi Pharmaceuticals to Present at 14th Annual BIO Investor Forum,Neutral,0.0006,64,rxi pharmaceutical present annual bio investor forum,52,7,0,pharmacy,"['r', '##xi', 'pharmaceutical', 'present', 'annual', 'bio', 'investor', 'forum']",1
361673,nifty_1136,2015-10-08,Research and Markets: The North American Patient Handling Systems Market - The Base Year is 2014 with Forecasts from 2015 to 2018,Neutral,0.0006,129,research and market the north american patient handling system market the base year with forecast from,102,16,0,pharmacy,"['research', 'and', 'market', 'the', 'north', 'am', '##eric', '##an', 'patient', 'handling', 'system', 'market', 'the', 'base', 'year', 'with', 'forecast', 'from']",1
361707,nifty_1136,2015-10-08,Research and Markets: Global Diabetes Care Devices Market Outlook 2015-2020 - Market is Expected to Grow at a CAGR of 5.2%,Neutral,0.0006,122,research and market global diabetes care device market outlook market expected grow cagr,88,13,0,pharmacy,"['research', 'and', 'market', 'global', 'diabetes', 'care', 'device', 'market', 'outlook', 'market', 'expected', 'grow', 'ca', '##g', '##r']",1
361740,nifty_1136,2015-10-08,"Research and Markets: Global Glioblastoma Multiforme Therapeutics Market 2015-2019 - Key Vendors are Arbor Pharmaceuticals, Bristol-Myers Squibb, Eisai, F. Hoffmann-La Roche & Merck",Neutral,0.0006,181,research and market global glioblastoma multiforme therapeutic market key vendor are arbor pharmaceutical bristol myers squibb eisai hoffmann roche merck,153,20,0,pharmacy,"['research', 'and', 'market', 'global', 'g', '##lio', '##blast', '##oma', 'multi', '##form', '##e', 'therapeutic', 'market', 'key', 'vendor', 'are', 'a', '##rb', '##or', 'pharmaceutical', 'br', '##ist', '##ol', 'my', '##ers', 'sq', '##ui', '##bb', 'e', '##isa', '##i', 'ho', '##ff', '##mann', 'r', '##och', '##e', 'me', '##rc', '##k']",1
361751,nifty_1136,2015-10-08,Evoke Pharma Strengthens Financial Position,Neutral,0.0006,43,evoke pharma strengthens financial position,43,5,0,pharmacy,"['e', '##voke', 'p', '##har', '##ma', 'strengthen', '##s', 'financial', 'position']",1
361806,nifty_1136,2015-10-08,"ContraVir Pharmaceuticals, Inc. Pricing Underwritten Public Offering Of Common Stock",Neutral,0.0006,84,contravir pharmaceutical inc pricing underwritten public offering common stock,78,9,0,pharmacy,"['con', '##tra', '##vir', 'pharmaceutical', 'in', '##c', 'pricing', 'under', '##written', 'public', 'offering', 'common', 'stock']",1
361814,nifty_1136,2015-10-08,Research and Markets: Global 3D Cell Culture Market Outlook: 2015-2020 - Increased use of 3D Cell Culture in Drug Discovery & Toxicology Testing,Neutral,0.0006,144,research and market global cell culture market outlook increased use cell culture drug discovery toxicology testing,115,16,0,pharmacy,"['research', 'and', 'market', 'global', 'cell', 'culture', 'market', 'outlook', 'increased', 'use', 'cell', 'culture', 'drug', 'discovery', 'toxic', '##ology', 'testing']",1
361820,nifty_1136,2015-10-08,Rich Pharmaceuticals Retains Theradex Systems To Finalize Investigational New Drug Application And Initiate Next Phases Of Clinical Trials,Neutral,0.0006,138,rich pharmaceutical retains theradex system finalize investigational new drug application and initiate next phase clinical trial,128,16,0,pharmacy,"['rich', 'pharmaceutical', 'retains', 'the', '##rade', '##x', 'system', 'final', '##ize', 'investigation', '##al', 'new', 'drug', 'application', 'and', 'initiate', 'next', 'phase', 'clinical', 'trial']",1
361830,nifty_1136,2015-10-08,Research and Markets: Remote Diagnostics and its Impact on the Rail Sector - Remote Diagnostics to Generate about $2.80 Billion in Revenue by 2020,Neutral,0.0006,146,research and market remote diagnostics and it impact the rail sector remote diagnostics generate about billion revenue,118,17,0,pharmacy,"['research', 'and', 'market', 'remote', 'diagnostic', '##s', 'and', 'it', 'impact', 'the', 'rail', 'sector', 'remote', 'diagnostic', '##s', 'generate', 'about', 'billion', 'revenue']",1
361877,nifty_1136,2015-10-08,Dyal Capital Partners Acquires Strategic Minority Interest In Chenavari Investment Managers,Neutral,0.0006,91,dyal capital partner acquires strategic minority interest chenavari investment manager,86,10,0,pharmacy,"['d', '##yal', 'capital', 'partner', 'acquire', '##s', 'strategic', 'minority', 'interest', 'ch', '##ena', '##var', '##i', 'investment', 'manager']",1
361984,nifty_1136,2015-10-08,"IDTechEx Show! Coca-Cola, Colgate Palmolive, United Technologies Research, Bayer Healthcare to Present at Printed Electronics USA",Neutral,0.0006,129,idtechex show coca cola colgate palmolive united technology research bayer healthcare present printed electronics usa,117,15,0,pharmacy,"['id', '##tech', '##ex', 'show', 'co', '##ca', 'co', '##la', 'co', '##l', '##gate', 'palm', '##oli', '##ve', 'united', 'technology', 'research', 'bay', '##er', 'healthcare', 'present', 'printed', 'electronics', 'us', '##a']",1
362021,nifty_1136,2015-10-08,"Amicus Therapeutics, Inc. Sued for Securities Fraud After Revealing Its NDA Will Not Be Filed This Year",Neutral,0.0006,103,amicus therapeutic inc sued for security fraud after revealing it nda will not filed this year,94,16,0,pharmacy,"['am', '##icus', 'therapeutic', 'in', '##c', 'sued', 'for', 'security', 'fraud', 'after', 'revealing', 'it', 'n', '##da', 'will', 'not', 'filed', 'this', 'year']",1
362028,nifty_1136,2015-10-08,BRIEF-BB Biotech prelim Q3 profit swings to loss of CHF 575 mln,Neutral,0.0006,63,brief biotech prelim profit swing loss chf mln,46,8,0,pharmacy,"['brief', 'bio', '##tech', 'pre', '##lim', 'profit', 'swing', 'loss', 'ch', '##f', 'm', '##ln']",1
362064,nifty_1136,2015-10-08,bioAffinity Technologies Welcomes New Board Members,Neutral,0.0006,51,bioaffinity technology welcome new board member,47,6,0,pharmacy,"['bio', '##af', '##finity', 'technology', 'welcome', 'new', 'board', 'member']",1
362221,nifty_1136,2015-10-08,Zynerba Pharmaceuticals to Present at  BIO Investor Forum 2015,Neutral,0.0006,62,zynerba pharmaceutical present bio investor forum,49,6,0,pharmacy,"['z', '##yne', '##rb', '##a', 'pharmaceutical', 'present', 'bio', 'investor', 'forum']",1
362385,nifty_1136,2015-10-08,BioCryst Shares Drop Sharply Following Early-Stage Drug Results,Neutral,0.0006,63,biocryst share drop sharply following early stage drug result,61,9,0,pharmacy,"['bio', '##c', '##ry', '##st', 'share', 'drop', 'sharply', 'following', 'early', 'stage', 'drug', 'result']",1
362528,nifty_1138,2015-10-13,Speculative Developers Take Medical Projects Off Back Burner,Neutral,-0.0048,60,speculative developer take medical project off back burner,58,8,0,pharmacy,"['s', '##peculative', 'developer', 'take', 'medical', 'project', 'off', 'back', 'burn', '##er']",1
362579,nifty_1139,2015-10-14,Zafgen Says Patient in Beloranib Study Dies,Rise,0.0154,43,zafgen say patient beloranib study dy,37,6,0,pharmacy,"['z', '##af', '##gen', 'say', 'patient', 'be', '##lora', '##ni', '##b', 'study', 'd', '##y']",1
362843,nifty_1142,2015-10-20,Outsourced-Doctor Provider Seeks Tie-up With Rival,Fall,-0.0062,50,outsourced doctor provider seek tie with rival,46,7,0,pharmacy,"['outs', '##our', '##ced', 'doctor', 'provider', 'seek', 'tie', 'with', 'rival']",1
362853,nifty_1142,2015-10-20,FDA Seeks More Information on Zogenix Trials,Fall,-0.0062,44,fda seek more information zogenix trial,39,6,0,pharmacy,"['f', '##da', 'seek', 'more', 'information', 'z', '##ogen', '##ix', 'trial']",1
362980,nifty_1143,2015-10-21,Research and Markets: Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook,Rise,0.0169,104,research and market gene therapy diverse range technology with promising long term outlook,90,13,0,pharmacy,"['research', 'and', 'market', 'gene', 'therapy', 'diverse', 'range', 'technology', 'with', 'promising', 'long', 'term', 'outlook']",1
363011,nifty_1143,2015-10-21,Research and Markets: United States Molecular Diagnostics Market 2015 - Test Volume and Company Analysis to 2020,Rise,0.0169,112,research and market united state molecular diagnostics market test volume and company analysis,94,13,0,pharmacy,"['research', 'and', 'market', 'united', 'state', 'molecular', 'diagnostic', '##s', 'market', 'test', 'volume', 'and', 'company', 'analysis']",1
363016,nifty_1143,2015-10-21,"Research and Markets: Asia Oncology Drug Market Outlook to 2019 - Driven by Rising Demand and Intensifying Joint Ventures Between Companies With Roche, Novartis, Pfizer Dominating",Rise,0.0169,179,research and market asia oncology drug market outlook driven rising demand and intensifying joint venture between company with roche novartis pfizer dominating,159,22,0,pharmacy,"['research', 'and', 'market', 'as', '##ia', 'on', '##cology', 'drug', 'market', 'outlook', 'driven', 'rising', 'demand', 'and', 'in', '##tens', '##ifying', 'joint', 'venture', 'between', 'company', 'with', 'r', '##och', '##e', 'no', '##var', '##tis', 'p', '##fi', '##zer', 'dominating']",1
363039,nifty_1143,2015-10-21,"Provectus Biopharmaceuticals Will Hold Its 2015 Third Quarter Business Update Conference Call on Thursday, November 5, 2015, at 5 PM Eastern Standard Time",Rise,0.0169,154,provectus biopharmaceuticals will hold it third quarter business update conference call thursday november eastern standard time,127,16,0,pharmacy,"['prove', '##ctus', 'bio', '##pha', '##rma', '##ce', '##utical', '##s', 'will', 'hold', 'it', 'third', 'quarter', 'business', 'update', 'conference', 'call', 'th', '##urs', '##day', 'no', '##ve', '##mber', 'eastern', 'standard', 'time']",1
363069,nifty_1143,2015-10-21,"Research and Markets: Big Data in Global Healthcare Market: Key Trends, Market Opportunities and Industry Forecast 2015-2020 - Market will grow at a CAGR of 45% by 2020.",Rise,0.0169,169,research and market big data global healthcare market key trend market opportunity and industry forecast market will grow cagr,126,19,0,pharmacy,"['research', 'and', 'market', 'big', 'data', 'global', 'healthcare', 'market', 'key', 'trend', 'market', 'opportunity', 'and', 'industry', 'forecast', 'market', 'will', 'grow', 'ca', '##g', '##r']",1
363074,nifty_1143,2015-10-21,Media Advisory - Oncolytics BiotechÂ® Inc. to Participate in the 14th Annual BIO Investor Forum,Rise,0.0169,95,medium advisory oncolytics biotechâ inc participate the annual bio investor forum,81,11,0,pharmacy,"['medium', 'advisory', 'on', '##co', '##ly', '##tics', 'bio', '##tech', '##â', 'in', '##c', 'participate', 'the', 'annual', 'bio', 'investor', 'forum']",1
363157,nifty_1143,2015-10-21,Research and Markets: Global Medical Devices: Quarterly Investments Review Featuring the Most Recent 200 Business Transactions,Rise,0.0169,126,research and market global medical device quarterly investment review featuring the most recent business transaction,116,15,0,pharmacy,"['research', 'and', 'market', 'global', 'medical', 'device', 'quarterly', 'investment', 'review', 'featuring', 'the', 'most', 'recent', 'business', 'transaction']",1
363159,nifty_1143,2015-10-21,Research and Markets: 200 Most Diversified Medical Devices/Technology/Supplies Companies Globally,Rise,0.0169,97,research and market most diversified medical device technology supply company globally,86,11,0,pharmacy,"['research', 'and', 'market', 'most', 'divers', '##ified', 'medical', 'device', 'technology', 'supply', 'company', 'globally']",1
363162,nifty_1143,2015-10-21,Vitae Pharmaceuticals to Host Analyst and Investor Briefing,Rise,0.0169,59,vitae pharmaceutical host analyst and investor briefing,55,7,0,pharmacy,"['v', '##ita', '##e', 'pharmaceutical', 'host', 'analyst', 'and', 'investor', 'brief', '##ing']",1
363166,nifty_1143,2015-10-21,"MabVax Therapeutics to Hold Investor Webcast and Conference Call on Thursday, October 22nd at 11:00 am EDT",Rise,0.0169,106,mabvax therapeutic hold investor webcast and conference call thursday october edt,81,11,0,pharmacy,"['ma', '##b', '##va', '##x', 'therapeutic', 'hold', 'investor', 'web', '##cast', 'and', 'conference', 'call', 'th', '##urs', '##day', 'o', '##ct', '##obe', '##r', 'ed', '##t']",1
363167,nifty_1143,2015-10-21,Science 37 Secures $6.5M Series A Funding To Accelerate Clinical Trial Research,Rise,0.0169,79,science secures series funding accelerate clinical trial research,65,8,0,pharmacy,"['science', 'secure', '##s', 'series', 'funding', 'accelerate', 'clinical', 'trial', 'research']",1
363177,nifty_1143,2015-10-21,Redox Raises $3.5M Series A Funding to Seamlessly Connect the Evolving Healthcare Technology Industry,Rise,0.0169,101,redox raise series funding seamlessly connect the evolving healthcare technology industry,89,11,0,pharmacy,"['red', '##ox', 'raise', 'series', 'funding', 'sea', '##m', '##lessly', 'connect', 'the', 'evolving', 'healthcare', 'technology', 'industry']",1
363210,nifty_1143,2015-10-21,Research and Markets: Global Oncology Molecular Diagnostics Market 2015-2019 - Increase in demand for personalized medicines,Rise,0.0169,124,research and market global oncology molecular diagnostics market increase demand for personalized medicine,106,13,0,pharmacy,"['research', 'and', 'market', 'global', 'on', '##cology', 'molecular', 'diagnostic', '##s', 'market', 'increase', 'demand', 'for', 'personal', '##ized', 'medicine']",1
363225,nifty_1143,2015-10-21,Luminex Corporation and Bio-Techne Corporation Extend and Expand Partnership,Rise,0.0169,76,luminex corporation and bio techne corporation extend and expand partnership,76,10,0,pharmacy,"['l', '##umi', '##nex', 'corporation', 'and', 'bio', 'tech', '##ne', 'corporation', 'extend', 'and', 'expand', 'partnership']",1
363267,nifty_1143,2015-10-21,Forge Launches 'Founders Forum' to Support Digital Health Startups,Rise,0.0169,66,forge launch founder forum support digital health startup,57,8,0,pharmacy,"['forge', 'launch', 'founder', 'forum', 'support', 'digital', 'health', 'start', '##up']",1
363405,nifty_1143,2015-10-21,Covenant Health Selects iVantage Market Analytics Solution to Drive Strategic Planning,Rise,0.0169,86,covenant health selects ivantage market analytics solution drive strategic planning,83,10,0,pharmacy,"['co', '##ven', '##ant', 'health', 'select', '##s', 'i', '##vant', '##age', 'market', 'anal', '##ytic', '##s', 'solution', 'drive', 'strategic', 'planning']",1
363470,nifty_1143,2015-10-21,Research and Markets: 2016 Emerging Strategies for the US Hospital Tumor Marker Testing Market,Rise,0.0169,94,research and market emerging strategy for the hospital tumor marker testing market,82,12,0,pharmacy,"['research', 'and', 'market', 'emerging', 'strategy', 'for', 'the', 'hospital', 'tumor', 'marker', 'testing', 'market']",1
363587,nifty_1143,2015-10-21,"Amino Launches to Empower People to Make Confident Decisions About Their Health Care, Powered by Unprecedented Database and $19.4 Million in Venture Capital Funding",Rise,0.0169,164,amino launch empower people make confident decision about their health care powered unprecedented database and million venture capital funding,142,19,0,pharmacy,"['amino', 'launch', 'em', '##power', 'people', 'make', 'confident', 'decision', 'about', 'their', 'health', 'care', 'powered', 'unprecedented', 'database', 'and', 'million', 'venture', 'capital', 'funding']",1
363595,nifty_1143,2015-10-21,AAAS to Expand the Science Family of Journals by Launching Two New Journals--Science Robotics and Science Immunology,Rise,0.0169,116,aaa expand the science family journal launching two new journal science robotics and science immunology,103,15,0,pharmacy,"['a', '##aa', 'expand', 'the', 'science', 'family', 'journal', 'launching', 'two', 'new', 'journal', 'science', 'robotic', '##s', 'and', 'science', 'im', '##mu', '##nology']",1
363627,nifty_1143,2015-10-21,"Research and Markets: 2016 Emerging US Diagnostics Market: Instrument and Reagent Supplier Shares by Test, Business Environment, Market Structure",Rise,0.0169,145,research and market emerging diagnostics market instrument and reagent supplier share test business environment market structure,128,16,0,pharmacy,"['research', 'and', 'market', 'emerging', 'diagnostic', '##s', 'market', 'instrument', 'and', 're', '##age', '##nt', 'supplier', 'share', 'test', 'business', 'environment', 'market', 'structure']",1
363673,nifty_1143,2015-10-21,"Research and Markets: 2016 Emerging Opportunities in the US Endocrine Function Testing Market: Hospitals, Commercial Labs, Physician Offices",Rise,0.0169,140,research and market emerging opportunity the endocrine function testing market hospital commercial lab physician office,119,15,0,pharmacy,"['research', 'and', 'market', 'emerging', 'opportunity', 'the', 'end', '##oc', '##rine', 'function', 'testing', 'market', 'hospital', 'commercial', 'lab', 'physician', 'office']",1
363934,nifty_1143,2015-10-21,Drug Makers Respond to Concerns Over Specialty-Pharmacy Use,Rise,0.0169,59,drug maker respond concern over specialty pharmacy use,54,8,0,pharmacy,"['drug', 'maker', 'respond', 'concern', 'over', 'specialty', 'pharmacy', 'use']",1
363980,nifty_1143,2015-10-21,"St. Jude Cuts Earnings Forecast as Sales, Profit Slip",Rise,0.0169,53,jude cut earnings forecast sale profit slip,43,7,0,pharmacy,"['j', '##ude', 'cut', 'earnings', 'forecast', 'sale', 'profit', 'slip']",1
363996,nifty_1143,2015-10-21,NeoGenomics to Acquire GE Cancer- Testing Unit,Rise,0.0169,46,neogenomics acquire cancer testing unit,39,5,0,pharmacy,"['neo', '##gen', '##omi', '##cs', 'acquire', 'cancer', 'testing', 'unit']",1
364101,nifty_1144,2015-10-22,Zafgen to Close Portion of Clinical Trial,Rise,0.011,41,zafgen close portion clinical trial,35,5,0,pharmacy,"['z', '##af', '##gen', 'close', 'portion', 'clinical', 'trial']",1
364396,nifty_1146,2015-10-27,BRIEF-Shenzhen Neptunus Bioengineering sees profit surge for 2015 on investment gain,Rise,0.0114,84,brief shenzhen neptunus bioengineering see profit surge for investment gain,75,10,0,pharmacy,"['brief', 'she', '##nz', '##hen', 'ne', '##pt', '##un', '##us', 'bio', '##eng', '##ine', '##ering', 'see', 'profit', 'surge', 'for', 'investment', 'gain']",1
364561,nifty_1146,2015-10-27,"Healthnostics, Inc. Provides Shareholder Update on New Capital Structure and Plans",Rise,0.0114,82,healthnostics inc provides shareholder update new capital structure and plan,76,10,0,pharmacy,"['health', '##nos', '##tics', 'in', '##c', 'provides', 'shareholder', 'update', 'new', 'capital', 'structure', 'and', 'plan']",1
364644,nifty_1146,2015-10-27,Dreamit Showcases Breakthrough Innovations in Digital Health at 10th Philadelphia Demo Day,Rise,0.0114,90,dreamit showcase breakthrough innovation digital health philadelphia demo day,77,9,0,pharmacy,"['dream', '##it', 'showcase', 'breakthrough', 'innovation', 'digital', 'health', 'p', '##hil', '##ade', '##l', '##phi', '##a', 'demo', 'day']",1
364742,nifty_1146,2015-10-27,Regenerative Medicine Market to value US$6.5 billion by 2019: Transparency Market Research,Rise,0.0114,90,regenerative medicine market value billion transparency market research,71,8,0,pharmacy,"['re', '##gene', '##rative', 'medicine', 'market', 'value', 'billion', 'transparency', 'market', 'research']",1
364891,nifty_1146,2015-10-27,BIO-EuropeÂ® 2015 is a virtual barometer of drug development future market,Rise,0.0114,74,bio europeâ virtual barometer drug development future market,60,8,0,pharmacy,"['bio', 'euro', '##pe', '##â', 'virtual', 'bar', '##ometer', 'drug', 'development', 'future', 'market']",1
364927,nifty_1146,2015-10-27,FDA sees no heart risks from Novartis' Parkinson's drug,Rise,0.0114,55,fda see heart risk from novartis parkinson drug,47,8,0,pharmacy,"['f', '##da', 'see', 'heart', 'risk', 'from', 'no', '##var', '##tis', 'park', '##ins', '##on', 'drug']",1
365052,nifty_1146,2015-10-27,Novocure Reports Third Quarter 2015 Operating and Financial Results,Rise,0.0114,67,novocure report third quarter operating and financial result,60,8,0,pharmacy,"['no', '##voc', '##ure', 'report', 'third', 'quarter', 'operating', 'and', 'financial', 'result']",1
365327,nifty_1146,2015-10-27,Bristol-Myers Revenue Rises Above Estimates,Rise,0.0114,43,bristol myers revenue rise above estimate,41,6,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'revenue', 'rise', 'above', 'estimate']",1
365400,nifty_1147,2015-10-28,Rising Fees Pinch Some Pharmacies,Neutral,-0.0006,33,rising fee pinch some pharmacy,30,5,0,pharmacy,"['rising', 'fee', 'pinch', 'some', 'pharmacy']",1
365475,nifty_1148,2015-10-29,Sanofi Recalls Auvi-Q Allergy Injectors,Neutral,-0.0043,39,sanofi recall auvi allergy injector,35,5,0,pharmacy,"['sa', '##no', '##fi', 'recall', 'au', '##vi', 'all', '##er', '##gy', 'in', '##ject', '##or']",1
365579,nifty_1148,2015-10-29,Sanofi Warns of Lower Diabetes Revenue,Neutral,-0.0043,38,sanofi warns lower diabetes revenue,35,5,0,pharmacy,"['sa', '##no', '##fi', 'warns', 'lower', 'diabetes', 'revenue']",1
365745,nifty_1149,2015-11-02,Bristol-Myers to Buy Heart-Drug Maker,Neutral,0.0029,37,bristol myers buy heart drug maker,34,6,0,pharmacy,"['br', '##ist', '##ol', 'my', '##ers', 'buy', 'heart', 'drug', 'maker']",1
365892,nifty_1150,2015-11-03,Research and Markets: Global Medical Nonwoven Disposables Market Analysis 2015 - Forecasts to 2020 for the $10 Billion Industry,Neutral,-0.003,127,research and market global medical nonwoven disposable market analysis forecast for the billion industry,104,14,0,pharmacy,"['research', 'and', 'market', 'global', 'medical', 'non', '##wo', '##ven', 'di', '##sp', '##osa', '##ble', 'market', 'analysis', 'forecast', 'for', 'the', 'billion', 'industry']",1
365895,nifty_1150,2015-11-03,"Research and Markets: Smart Healthcare Market Analysis by Product (RFID Kanban Systems, RFID Smart Cabinets, Electronic Health Records/EHR, Telemedicine, mHealth, Smart Pills, Smart Syringes) and Segment Forecasts to 2022",Neutral,-0.003,221,research and market smart healthcare market analysis product rfid kanban system rfid smart cabinet electronic health record ehr telemedicine mhealth smart pill smart syrinx and segment forecast,193,27,0,pharmacy,"['research', 'and', 'market', 'smart', 'healthcare', 'market', 'analysis', 'product', 'r', '##fi', '##d', 'ka', '##n', '##ban', 'system', 'r', '##fi', '##d', 'smart', 'cabinet', 'electronic', 'health', 'record', 'eh', '##r', 'te', '##lem', '##edic', '##ine', 'm', '##hea', '##lt', '##h', 'smart', 'pill', 'smart', 's', '##yr', '##in', '##x', 'and', 'segment', 'forecast']",1
365904,nifty_1150,2015-11-03,"Research and Markets: Global Carcinoembryonic Antigen (CEA) Market Analysis 2015-2022 - Colorectal, Pancreatic, Ovarian, Breast, Thyroid Cancer Breakdown of the $2.56 Billion Industry",Neutral,-0.003,183,research and market global carcinoembryonic antigen cea market analysis colorectal pancreatic ovarian breast thyroid cancer breakdown the billion industry,154,19,0,pharmacy,"['research', 'and', 'market', 'global', 'car', '##cin', '##oe', '##mb', '##ryo', '##nic', 'anti', '##gen', 'c', '##ea', 'market', 'analysis', 'color', '##ec', '##tal', 'pan', '##cre', '##atic', 'o', '##var', '##ian', 'breast', 'thy', '##roid', 'cancer', 'breakdown', 'the', 'billion', 'industry']",1
365905,nifty_1150,2015-11-03,"Research and Markets: Biosensors Market Analysis 2015 By Application, By Technology And Segment - Forecasts to 2020 for the $21 Billion Industry",Neutral,-0.003,144,research and market biosensors market analysis application technology and segment forecast for the billion industry,115,15,0,pharmacy,"['research', 'and', 'market', 'bio', '##sen', '##sors', 'market', 'analysis', 'application', 'technology', 'and', 'segment', 'forecast', 'for', 'the', 'billion', 'industry']",1
365920,nifty_1150,2015-11-03,Revance Therapeutics Announces Proposed Public Offering of Common Stock,Neutral,-0.003,71,revance therapeutic announces proposed public offering common stock,67,8,0,pharmacy,"['re', '##vance', 'therapeutic', 'announces', 'proposed', 'public', 'offering', 'common', 'stock']",1
365931,nifty_1150,2015-11-03,"Research and Markets: Pharmacovigilance Market Analysis 2015-2020 - Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial), By Type Of Service Providers (In House, Contract Outsourc",Neutral,-0.003,224,research and market pharmacovigilance market analysis clinical trial phase preclinical study phase phase phase iii phase trial type service provider house contract outsourc,172,23,0,pharmacy,"['research', 'and', 'market', 'p', '##har', '##ma', '##co', '##vi', '##gi', '##lance', 'market', 'analysis', 'clinical', 'trial', 'phase', 'pre', '##c', '##lini', '##cal', 'study', 'phase', 'phase', 'phase', 'ii', '##i', 'phase', 'trial', 'type', 'service', 'provider', 'house', 'contract', 'outs', '##our', '##c']",1
365932,nifty_1150,2015-11-03,"Research and Markets: Global Antidiabetics Market Analysis 2015-2020 - Insulin, Biguanides, Thiazolodinediones, GLP-agonists, Sulphonylureas, DPP-4 inhibitors, SGLT-2, Alpha-glucosidase Inhibitors, Meglitinides",Neutral,-0.003,210,research and market global antidiabetic market analysis insulin biguanides thiazolodinediones glp agonist sulphonylureas dpp inhibitor sglt alpha glucosidase inhibitor meglitinides,180,20,0,pharmacy,"['research', 'and', 'market', 'global', 'anti', '##dia', '##bet', '##ic', 'market', 'analysis', 'insulin', 'big', '##uan', '##ides', 'th', '##ia', '##zo', '##lo', '##dine', '##dio', '##nes', 'g', '##l', '##p', 'ago', '##nist', 'su', '##l', '##phony', '##lu', '##rea', '##s', 'd', '##pp', 'inhibitor', 's', '##g', '##lt', 'alpha', 'g', '##lu', '##cos', '##idas', '##e', 'inhibitor', 'me', '##gli', '##tin', '##ides']",1
365976,nifty_1150,2015-11-03,Acceleron Pharma to Present at Upcoming Investor Conferences in November,Neutral,-0.003,72,acceleron pharma present upcoming investor conference november,62,7,0,pharmacy,"['a', '##cc', '##ele', '##ron', 'p', '##har', '##ma', 'present', 'upcoming', 'investor', 'conference', 'no', '##ve', '##mber']",1
366006,nifty_1150,2015-11-03,Research and Markets: Global Healthcare IT Outsourcing Market: Research Analysis 2015-2019 - Adoption of Connected Healthcare Solutions a Major Market Driver,Neutral,-0.003,157,research and market global healthcare outsourcing market research analysis adoption connected healthcare solution major market driver,133,16,0,pharmacy,"['research', 'and', 'market', 'global', 'healthcare', 'outs', '##our', '##cing', 'market', 'research', 'analysis', 'adoption', 'connected', 'healthcare', 'solution', 'major', 'market', 'driver']",1
366015,nifty_1150,2015-11-03,Tetraphase Pharmaceuticals Reports Third-Quarter 2015 Financial Results,Neutral,-0.003,71,tetraphase pharmaceutical report third quarter financial result,63,7,0,pharmacy,"['te', '##tra', '##pha', '##se', 'pharmaceutical', 'report', 'third', 'quarter', 'financial', 'result']",1
366028,nifty_1150,2015-11-03,Cord Blood Banking Services Market to Reach US$15.2 Billion by 2019 Owing to Increasing Applications of Cord Blood Cells: Transparency Market Research,Neutral,-0.003,150,cord blood banking service market reach billion owing increasing application cord blood cell transparency market research,121,16,0,pharmacy,"['cord', 'blood', 'banking', 'service', 'market', 'reach', 'billion', 'owing', 'increasing', 'application', 'cord', 'blood', 'cell', 'transparency', 'market', 'research']",1
366193,nifty_1150,2015-11-03,TriNet Inspire Insights Presents: Find and Fix 7 Common Pitfalls in Biotech Startups,Neutral,-0.003,84,trinet inspire insight present find and fix common pitfall biotech startup,74,11,0,pharmacy,"['t', '##rine', '##t', 'inspire', 'insight', 'present', 'find', 'and', 'fix', 'common', 'pit', '##fall', 'bio', '##tech', 'start', '##up']",1
366313,nifty_1150,2015-11-03,"Research and Markets: Global RNAi Technologies, Markets and Companies 2015 - Profiles of 161 Companies are presented Along with 233 Collaborations",Neutral,-0.003,146,research and market global rnai technology market and company profile company are presented along with collaboration,116,16,0,pharmacy,"['research', 'and', 'market', 'global', 'r', '##nai', 'technology', 'market', 'and', 'company', 'profile', 'company', 'are', 'presented', 'along', 'with', 'collaboration']",1
366632,nifty_1150,2015-11-03,"Vitae Pharmaceuticals to Announce Third Quarter 2015 Financial Results on November 5, 2015",Neutral,-0.003,90,vitae pharmaceutical announce third quarter financial result november,69,8,0,pharmacy,"['v', '##ita', '##e', 'pharmaceutical', 'announce', 'third', 'quarter', 'financial', 'result', 'no', '##ve', '##mber']",1
366662,nifty_1150,2015-11-03,"Research and Markets: Global RFID in Healthcare Market Analysis 2015-2019 - Revenues in Healthcare to Reach $2.3 Billion in 2019, a 2.5-Fold Increase over 2013",Neutral,-0.003,159,research and market global rfid healthcare market analysis revenue healthcare reach billion fold increase over,110,15,0,pharmacy,"['research', 'and', 'market', 'global', 'r', '##fi', '##d', 'healthcare', 'market', 'analysis', 'revenue', 'healthcare', 'reach', 'billion', 'fold', 'increase', 'over']",1
366806,nifty_1150,2015-11-03,Myriad Genetics’ Profit Rises on Higher Sales of DNA Tests,Neutral,-0.003,58,myriad genetics profit rise higher sale dna test,48,8,0,pharmacy,"['my', '##riad', 'genetics', 'profit', 'rise', 'higher', 'sale', 'd', '##na', 'test']",1
366962,nifty_1151,2015-11-04,Portfolio Moves: An Adviser Embraces Beaten-Down Biotech Shares,Neutral,-0.001,63,portfolio move adviser embrace beaten down biotech share,56,8,0,pharmacy,"['portfolio', 'move', 'adviser', 'embrace', 'beaten', 'down', 'bio', '##tech', 'share']",1
367235,nifty_1153,2015-11-09,Horizon Pharma Sees Sharply Higher Sales,Neutral,0.0023,40,horizon pharma see sharply higher sale,38,6,0,pharmacy,"['horizon', 'p', '##har', '##ma', 'see', 'sharply', 'higher', 'sale']",1
367262,nifty_1154,2015-11-10,Express Scripts Cuts Off Pharmacy That Sold Horizon Pharma Drugs,Neutral,-0.0039,64,express script cut off pharmacy that sold horizon pharma drug,61,10,0,pharmacy,"['express', 'script', 'cut', 'off', 'pharmacy', 'that', 'sold', 'horizon', 'p', '##har', '##ma', 'drug']",1
367425,nifty_1155,2015-11-11,Horizon Pharma Responds to Express Scripts,Fall,-0.014,42,horizon pharma responds express script,38,5,0,pharmacy,"['horizon', 'p', '##har', '##ma', 'responds', 'express', 'script']",1
367586,nifty_1157,2015-11-16,New Diagnostic Tools Emerge in War Against Superbugs,Neutral,-0.0007,52,new diagnostic tool emerge war against superbug,47,7,0,pharmacy,"['new', 'diagnostic', 'tool', 'emerge', 'war', 'against', 'superb', '##ug']",1
367917,nifty_1159,2015-11-18,"ARCH Venture Partners, Flagship Ventures and MD Anderson Collaborate to Launch Codiak BioSciences",Neutral,-0.0009,97,arch venture partner flagship venture and anderson collaborate launch codiak bioscience,87,11,0,pharmacy,"['arch', 'venture', 'partner', 'flagship', 'venture', 'and', 'and', '##erson', 'collaborate', 'launch', 'co', '##dia', '##k', 'bio', '##science']",1
367961,nifty_1159,2015-11-18,Research and Markets: EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2024,Neutral,-0.0009,85,research and market epicast report type diabetes epidemiology forecast,70,9,0,pharmacy,"['research', 'and', 'market', 'epic', '##ast', 'report', 'type', 'diabetes', 'e', '##pid', '##em', '##iology', 'forecast']",1
367977,nifty_1159,2015-11-18,BrainStorm Cell Therapeutics Reports Third Quarter 2015 Financial Results And Provides Corporate Update,Neutral,-0.0009,103,brainstorm cell therapeutic report third quarter financial result and provides corporate update,95,12,0,pharmacy,"['brains', '##tor', '##m', 'cell', 'therapeutic', 'report', 'third', 'quarter', 'financial', 'result', 'and', 'provides', 'corporate', 'update']",1
367985,nifty_1159,2015-11-18,Research and Markets: EpiCast Report: Hodgkin's Lymphoma - Epidemiology Forecast to 2024,Neutral,-0.0009,88,research and market epicast report hodgkin lymphoma epidemiology forecast,73,9,0,pharmacy,"['research', 'and', 'market', 'epic', '##ast', 'report', 'ho', '##d', '##g', '##kin', 'l', '##ymph', '##oma', 'e', '##pid', '##em', '##iology', 'forecast']",1
367986,nifty_1159,2015-11-18,Shore Capital Partners Announces Investment in Personalized Medicine Platform,Neutral,-0.0009,77,shore capital partner announces investment personalized medicine platform,73,8,0,pharmacy,"['shore', 'capital', 'partner', 'announces', 'investment', 'personal', '##ized', 'medicine', 'platform']",1
367993,nifty_1159,2015-11-18,Research and Markets: EpiCast Report: Gastric Cancer - Epidemiology Forecast to 2024,Neutral,-0.0009,84,research and market epicast report gastric cancer epidemiology forecast,71,9,0,pharmacy,"['research', 'and', 'market', 'epic', '##ast', 'report', 'gas', '##tric', 'cancer', 'e', '##pid', '##em', '##iology', 'forecast']",1
368066,nifty_1159,2015-11-18,BioBlast Pharma Reports Third Quarter Financial Results,Neutral,-0.0009,55,bioblast pharma report third quarter financial result,53,7,0,pharmacy,"['bio', '##blast', 'p', '##har', '##ma', 'report', 'third', 'quarter', 'financial', 'result']",1
368117,nifty_1159,2015-11-18,Ritter Pharmaceuticals Provides Third Quarter 2015 Financial Results and Business Update,Neutral,-0.0009,88,ritter pharmaceutical provides third quarter financial result and business update,81,10,0,pharmacy,"['r', '##itte', '##r', 'pharmaceutical', 'provides', 'third', 'quarter', 'financial', 'result', 'and', 'business', 'update']",1
368228,nifty_1159,2015-11-18,"Research and Markets: 2015-2019 US Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies",Neutral,-0.0009,145,research and market cancer diagnostics market supplier share country forecast innovative technology competitive strategy,120,14,0,pharmacy,"['research', 'and', 'market', 'cancer', 'diagnostic', '##s', 'market', 'supplier', 'share', 'country', 'forecast', 'innovative', 'technology', 'competitive', 'strategy']",1
368239,nifty_1159,2015-11-18,European biotech gets boost as Genmab market value hits $7 billion,Neutral,-0.0009,66,european biotech get boost genmab market value hit billion,58,9,0,pharmacy,"['euro', '##pe', '##an', 'bio', '##tech', 'get', 'boost', 'g', '##en', '##ma', '##b', 'market', 'value', 'hit', 'billion']",1
368288,nifty_1159,2015-11-18,"Research and Markets: US Clinical Chemistry and Immunodiagnostic Markets 2015-2019: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies",Neutral,-0.0009,167,research and market clinical chemistry and immunodiagnostic market supplier share country forecast innovative technology competitive strategy,141,16,0,pharmacy,"['research', 'and', 'market', 'clinical', 'chemistry', 'and', 'im', '##mu', '##no', '##dia', '##gno', '##stic', 'market', 'supplier', 'share', 'country', 'forecast', 'innovative', 'technology', 'competitive', 'strategy']",1
368368,nifty_1159,2015-11-18,"Research and Markets: 2015-2019 US Cancer Diagnostics Industry: Market Segmentation Analysis - Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains",Neutral,-0.0009,187,research and market cancer diagnostics industry market segmentation analysis oncogene biochemical marker lymphokine gfs csfs hormone immunohistochemical stain,158,18,0,pharmacy,"['research', 'and', 'market', 'cancer', 'diagnostic', '##s', 'industry', 'market', 'segment', '##ation', 'analysis', 'on', '##co', '##gene', 'bio', '##chemical', 'marker', 'l', '##ymph', '##oki', '##ne', 'g', '##fs', 'c', '##s', '##fs', 'hormone', 'im', '##mu', '##no', '##his', '##to', '##chemical', 'stain']",1
368459,nifty_1159,2015-11-18,"McKesson Ventures Invests in Home Care, Adds ClearCare to Portfolio",Neutral,-0.0009,67,mckesson venture invests home care add clearcare portfolio,58,8,0,pharmacy,"['m', '##cke', '##sson', 'venture', 'invest', '##s', 'home', 'care', 'add', 'clear', '##care', 'portfolio']",1
368485,nifty_1159,2015-11-18,"Research and Markets: 2016 US Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices",Neutral,-0.0009,140,research and market cancer diagnostics market segmentation analysis cancer clinic commercial lab hospital physician office,122,15,0,pharmacy,"['research', 'and', 'market', 'cancer', 'diagnostic', '##s', 'market', 'segment', '##ation', 'analysis', 'cancer', 'clinic', 'commercial', 'lab', 'hospital', 'physician', 'office']",1
368506,nifty_1159,2015-11-18,"Research and Markets: 2016 Future Horizons and Growth Strategies in the US Cancer Diagnostics Market: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities",Neutral,-0.0009,201,research and market future horizon and growth strategy the cancer diagnostics market supplier share tumor marker country segment forecast competitive intelligence opportunity,174,22,0,pharmacy,"['research', 'and', 'market', 'future', 'horizon', 'and', 'growth', 'strategy', 'the', 'cancer', 'diagnostic', '##s', 'market', 'supplier', 'share', 'tumor', 'marker', 'country', 'segment', 'forecast', 'competitive', 'intelligence', 'opportunity']",1
368516,nifty_1159,2015-11-18,"Research and Markets: 2016 Future Horizons and Growth Strategies in the US Molecular Diagnostics Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities",Neutral,-0.0009,188,research and market future horizon and growth strategy the molecular diagnostics market supplier share country segment forecast competitive intelligence opportunity,164,20,0,pharmacy,"['research', 'and', 'market', 'future', 'horizon', 'and', 'growth', 'strategy', 'the', 'molecular', 'diagnostic', '##s', 'market', 'supplier', 'share', 'country', 'segment', 'forecast', 'competitive', 'intelligence', 'opportunity']",1
368601,nifty_1159,2015-11-18,"Top healthcare stock fund focuses on costs, orphan drugs in 2016",Neutral,-0.0009,64,top healthcare stock fund focus cost orphan drug,48,8,0,pharmacy,"['top', 'healthcare', 'stock', 'fund', 'focus', 'cost', 'orphan', 'drug']",1
368625,nifty_1159,2015-11-18,Marrone Bio Innovations Reports Third Quarter 2015 Financial Results and Discusses Impact of Financial Restatement and Financial and Business Highlights,Neutral,-0.0009,152,marrone bio innovation report third quarter financial result and discusses impact financial restatement and financial and business highlight,140,18,0,pharmacy,"['ma', '##rro', '##ne', 'bio', 'innovation', 'report', 'third', 'quarter', 'financial', 'result', 'and', 'discusses', 'impact', 'financial', 'rest', '##ate', '##ment', 'and', 'financial', 'and', 'business', 'highlight']",1
368838,nifty_1160,2015-11-19,Global drug spending to hit $1.4 trillion in 2020 - IMS,Neutral,0.0036,55,global drug spending hit trillion ims,37,6,0,pharmacy,"['global', 'drug', 'spending', 'hit', 'trillion', 'im', '##s']",1
368839,nifty_1160,2015-11-19,Global drug spending to hit $1.4 trillion in 2020: IMS,Neutral,0.0036,54,global drug spending hit trillion ims,37,6,0,pharmacy,"['global', 'drug', 'spending', 'hit', 'trillion', 'im', '##s']",1
368955,nifty_1160,2015-11-19,Research and Markets: In Vitro Diagnostic Testing Services Market Forecasts 2015 to 2019 - A Market That Just Keeps on Growing.,Neutral,0.0036,127,research and market vitro diagnostic testing service market forecast market that just keep growing,98,14,0,pharmacy,"['research', 'and', 'market', 'v', '##it', '##ro', 'diagnostic', 'testing', 'service', 'market', 'forecast', 'market', 'that', 'just', 'keep', 'growing']",1
368962,nifty_1160,2015-11-19,Research and Markets: Molecular Diagnostics 2015 to 2019 - Molecular Diagnostics is Positioned to Directly Benefit from the Explosion in Genomics Knowledge,Neutral,0.0036,155,research and market molecular diagnostics molecular diagnostics positioned directly benefit from the explosion genomics knowledge,129,15,0,pharmacy,"['research', 'and', 'market', 'molecular', 'diagnostic', '##s', 'molecular', 'diagnostic', '##s', 'positioned', 'directly', 'benefit', 'from', 'the', 'explosion', 'g', '##eno', '##mic', '##s', 'knowledge']",1
368982,nifty_1160,2015-11-19,Research and Markets: Competitive Intelligence 2015 - Global Diagnostic Imaging Companies Marketing Strategies,Neutral,0.0036,110,research and market competitive intelligence global diagnostic imaging company marketing strategy,97,11,0,pharmacy,"['research', 'and', 'market', 'competitive', 'intelligence', 'global', 'diagnostic', 'imaging', 'company', 'marketing', 'strategy']",1
368983,nifty_1160,2015-11-19,Research and Markets: Competitive Intelligence 2015 - Global Diagnostic Imaging Companies Strategic Directions,Neutral,0.0036,110,research and market competitive intelligence global diagnostic imaging company strategic direction,98,11,0,pharmacy,"['research', 'and', 'market', 'competitive', 'intelligence', 'global', 'diagnostic', 'imaging', 'company', 'strategic', 'direction']",1
369041,nifty_1160,2015-11-19,Research and Markets: Healthcare Payer Services Market - The Market is Expected to Reach USD 21.1 Billion by 2020 from USD 11.8 Billion in 2015,Neutral,0.0036,143,research and market healthcare payer service market the market expected reach usd billion from usd billion,106,16,0,pharmacy,"['research', 'and', 'market', 'healthcare', 'pay', '##er', 'service', 'market', 'the', 'market', 'expected', 'reach', 'us', '##d', 'billion', 'from', 'us', '##d', 'billion']",1
369102,nifty_1160,2015-11-19,Research and Markets: Biophotonics Market To 2020 - The Overall Market for Biophotonics in 2014 was Valued at USD 26.26 Billion,Neutral,0.0036,127,research and market biophotonics market the overall market for biophotonics wa valued usd billion,97,14,0,pharmacy,"['research', 'and', 'market', 'bio', '##ph', '##oto', '##nics', 'market', 'the', 'overall', 'market', 'for', 'bio', '##ph', '##oto', '##nics', 'wa', 'valued', 'us', '##d', 'billion']",1
369106,nifty_1160,2015-11-19,Research and Markets: 2016 Future Horizons and Growth Strategies in the US Cell Surface Marker Testing Market Report,Neutral,0.0036,116,research and market future horizon and growth strategy the cell surface marker testing market report,100,15,0,pharmacy,"['research', 'and', 'market', 'future', 'horizon', 'and', 'growth', 'strategy', 'the', 'cell', 'surface', 'marker', 'testing', 'market', 'report']",1
369145,nifty_1160,2015-11-19,"IMS Health Forecasts Global Drug Spending to Increase 30 Percent by 2020, to $1.4 Trillion, As Medicine Use Gap Narrows",Neutral,0.0036,119,ims health forecast global drug spending increase percent trillion medicine use gap narrow,90,13,0,pharmacy,"['im', '##s', 'health', 'forecast', 'global', 'drug', 'spending', 'increase', 'percent', 'trillion', 'medicine', 'use', 'gap', 'narrow']",1
369160,nifty_1160,2015-11-19,"BioTime, Inc. Announces the Appointment of Life Sciences Industry Veteran Russell Skibsted as Chief Financial Officer",Neutral,0.0036,117,biotime inc announces the appointment life science industry veteran russell skibsted chief financial officer,108,14,0,pharmacy,"['bio', '##time', 'in', '##c', 'announces', 'the', 'appointment', 'life', 'science', 'industry', 'veteran', 'r', '##uss', '##ell', 'ski', '##bs', '##ted', 'chief', 'financial', 'officer']",1
369198,nifty_1160,2015-11-19,"Research and Markets: Global RFID Forecasts, Players and Opportunities 2016-2026",Neutral,0.0036,80,research and market global rfid forecast player and opportunity,63,9,0,pharmacy,"['research', 'and', 'market', 'global', 'r', '##fi', '##d', 'forecast', 'player', 'and', 'opportunity']",1
369210,nifty_1160,2015-11-19,Strongbridge Biopharma plc Provides Update on Corporate Progress,Neutral,0.0036,64,strongbridge biopharma plc provides update corporate progress,61,7,0,pharmacy,"['strong', '##bridge', 'bio', '##pha', '##rma', 'plc', 'provides', 'update', 'corporate', 'progress']",1
369303,nifty_1160,2015-11-19,"Research and Markets: Liquid Biopsy Markets: Global Market Size, Strategies and Forecasts 2015 to 2020 including Potential Market Sizing",Neutral,0.0036,136,research and market liquid biopsy market global market size strategy and forecast including potential market sizing,115,16,0,pharmacy,"['research', 'and', 'market', 'liquid', 'bio', '##psy', 'market', 'global', 'market', 'size', 'strategy', 'and', 'forecast', 'including', 'potential', 'market', 'si', '##zing']",1
369503,nifty_1160,2015-11-19,Research and Markets: Global Big Data Spending in Healthcare Industry 2015-2019 - Increased Complexity and Cost of Big Data Adoption,Neutral,0.0036,132,research and market global big data spending healthcare industry increased complexity and cost big data adoption,112,16,0,pharmacy,"['research', 'and', 'market', 'global', 'big', 'data', 'spending', 'healthcare', 'industry', 'increased', 'complexity', 'and', 'cost', 'big', 'data', 'adoption']",1
369723,nifty_1160,2015-11-19,Ligand Provides Highlights from Todayâs Analyst Day Event,Neutral,0.0036,59,ligand provides highlight from todayâ analyst day event,55,8,0,pharmacy,"['l', '##igan', '##d', 'provides', 'highlight', 'from', 'today', '##â', 'analyst', 'day', 'event']",1
369866,nifty_1160,2015-11-19,Horizon Pharma Withdraws Bid for Depomed,Neutral,0.0036,40,horizon pharma withdraws bid for depomed,40,6,0,pharmacy,"['horizon', 'p', '##har', '##ma', 'withdraw', '##s', 'bid', 'for', 'de', '##po', '##med']",1
370153,nifty_1163,2015-11-30,FDA Approves New Blood-Cancer Drug Empliciti,Rise,0.0095,44,fda approves new blood cancer drug empliciti,44,7,0,pharmacy,"['f', '##da', 'approve', '##s', 'new', 'blood', 'cancer', 'drug', 'em', '##p', '##licit', '##i']",1
370291,nifty_1164,2015-12-01,Beijing stocks up on 'made in China' drugs,Fall,-0.0102,42,beijing stock made china drug,29,5,0,pharmacy,"['be', '##iji', '##ng', 'stock', 'made', 'chin', '##a', 'drug']",1
370298,nifty_1164,2015-12-01,Research and Markets: World Cancer Diagnostics Market 2015-2019,Fall,-0.0102,63,research and market world cancer diagnostics market,51,7,0,pharmacy,"['research', 'and', 'market', 'world', 'cancer', 'diagnostic', '##s', 'market']",1
370329,nifty_1164,2015-12-01,Research and Markets: India Online Healthcare Products Market Outlook to 2020 - Infusion of Online Marketplaces and Healthcare Awareness to Shape Future Growth,Fall,-0.0102,159,research and market india online healthcare product market outlook infusion online marketplace and healthcare awareness shape future growth,139,18,0,pharmacy,"['research', 'and', 'market', 'in', '##dia', 'online', 'healthcare', 'product', 'market', 'outlook', 'in', '##fusion', 'online', 'marketplace', 'and', 'healthcare', 'awareness', 'shape', 'future', 'growth']",1
370350,nifty_1164,2015-12-01,"Research and Markets: Global Clinical Chemistry and Immunodiagnostic Markets Report 2016: Forecasts, Tests, Technologies, Review, & Profiles of Leading Suppliers",Fall,-0.0102,161,research and market global clinical chemistry and immunodiagnostic market report forecast test technology review profile leading supplier,137,17,0,pharmacy,"['research', 'and', 'market', 'global', 'clinical', 'chemistry', 'and', 'im', '##mu', '##no', '##dia', '##gno', '##stic', 'market', 'report', 'forecast', 'test', 'technology', 'review', 'profile', 'leading', 'supplier']",1
370353,nifty_1164,2015-12-01,Research and Markets: Orphan Drugs Market 2015-2019,Fall,-0.0102,51,research and market orphan drug market,38,6,0,pharmacy,"['research', 'and', 'market', 'orphan', 'drug', 'market']",1
370354,nifty_1164,2015-12-01,"Research and Markets: Europe Drugs of Abuse Testing Market Report 2016: Forecasts, Technologies & Strategies - France, Germany, Italy, Spain, UK",Fall,-0.0102,144,research and market europe drug abuse testing market report forecast technology strategy france germany italy spain,115,16,0,pharmacy,"['research', 'and', 'market', 'euro', '##pe', 'drug', 'abuse', 'testing', 'market', 'report', 'forecast', 'technology', 'strategy', 'f', '##rance', 'g', '##erman', '##y', 'it', '##aly', 'spa', '##in']",1
370367,nifty_1164,2015-12-01,"Research and Markets: Europe Therapeutic Drug Monitoring (TDM) Market Report 2016: Forecasts, Technologies & Strategies - France, Germany, Italy, Spain, UK",Fall,-0.0102,155,research and market europe therapeutic drug monitoring tdm market report forecast technology strategy france germany italy spain,128,17,0,pharmacy,"['research', 'and', 'market', 'euro', '##pe', 'therapeutic', 'drug', 'monitoring', 't', '##d', '##m', 'market', 'report', 'forecast', 'technology', 'strategy', 'f', '##rance', 'g', '##erman', '##y', 'it', '##aly', 'spa', '##in']",1
370413,nifty_1164,2015-12-01,"Research and Markets: Europe Endocrine Function Testing Market Report 2016: Forecasts, Technologies, Strategies - France, Germany, Italy, Spain & UK",Fall,-0.0102,148,research and market europe endocrine function testing market report forecast technology strategy france germany italy spain,123,16,0,pharmacy,"['research', 'and', 'market', 'euro', '##pe', 'end', '##oc', '##rine', 'function', 'testing', 'market', 'report', 'forecast', 'technology', 'strategy', 'f', '##rance', 'g', '##erman', '##y', 'it', '##aly', 'spa', '##in']",1
370420,nifty_1164,2015-12-01,Akers Biosciences to Present at 8th Annual LD Micro Investor Conference,Fall,-0.0102,71,akers bioscience present annual micro investor conference,57,7,0,pharmacy,"['a', '##kers', 'bio', '##science', 'present', 'annual', 'micro', 'investor', 'conference']",1
370427,nifty_1164,2015-12-01,"Research and Markets: Global Clinical Chemistry and Immunodiagnostic Markets Report 2016 - Analysis, Trends, Technologies & Forecast",Fall,-0.0102,132,research and market global clinical chemistry and immunodiagnostic market report analysis trend technology forecast,115,14,0,pharmacy,"['research', 'and', 'market', 'global', 'clinical', 'chemistry', 'and', 'im', '##mu', '##no', '##dia', '##gno', '##stic', 'market', 'report', 'analysis', 'trend', 'technology', 'forecast']",1
370539,nifty_1164,2015-12-01,Research and Markets: Latin America Medical Gases & Equipment Market by Product & End User - Forecast to 2020,Fall,-0.0102,109,research and market latin america medical gas equipment market product end user forecast,88,13,0,pharmacy,"['research', 'and', 'market', 'la', '##tin', 'am', '##eric', '##a', 'medical', 'gas', 'equipment', 'market', 'product', 'end', 'user', 'forecast']",1
370600,nifty_1164,2015-12-01,"The Malignant Melanoma Market Will Double to $3 Billion in 2024, Fueled by Uptake of Immune Checkpoint Inhibitors and Combination Therapies",Fall,-0.0102,139,the malignant melanoma market will double billion fueled uptake immune checkpoint inhibitor and combination therapy,115,15,0,pharmacy,"['the', 'ma', '##li', '##gnant', 'me', '##lan', '##oma', 'market', 'will', 'double', 'billion', 'fueled', 'up', '##take', 'immune', 'check', '##point', 'inhibitor', 'and', 'combination', 'therapy']",1
370700,nifty_1164,2015-12-01,"Research and Markets: Global Sepsis Pipeline Therapeutics Review, H2 2015",Fall,-0.0102,73,research and market global sepsis pipeline therapeutic review,61,8,0,pharmacy,"['research', 'and', 'market', 'global', 'se', '##psis', 'pipeline', 'therapeutic', 'review']",1
370850,nifty_1164,2015-12-01,Research and Markets: Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review Report H2 2015,Fall,-0.0102,112,research and market cognitive impairment associated with schizophrenia cia pipeline review report,97,12,0,pharmacy,"['research', 'and', 'market', 'cognitive', 'imp', '##air', '##ment', 'associated', 'with', 's', '##chi', '##zophrenia', 'c', '##ia', 'pipeline', 'review', 'report']",1
370895,nifty_1164,2015-12-01,Champions Oncology to Present at LD MICRO Investor Conference,Fall,-0.0102,61,champion oncology present micro investor conference,51,6,0,pharmacy,"['champion', 'on', '##cology', 'present', 'micro', 'investor', 'conference']",1
370905,nifty_1164,2015-12-01,"Research and Markets: Molecular Diagnostics Market by Application, Technology, End User, Product - Forecast to 2020",Fall,-0.0102,115,research and market molecular diagnostics market application technology end user product forecast,97,12,0,pharmacy,"['research', 'and', 'market', 'molecular', 'diagnostic', '##s', 'market', 'application', 'technology', 'end', 'user', 'product', 'forecast']",1
370976,nifty_1164,2015-12-01,Sysorex Announces Latest in Series of IT Engagements with Fortune 500 Biopharmaceutical Firm,Fall,-0.0102,92,sysorex announces latest series engagement with fortune biopharmaceutical firm,78,9,0,pharmacy,"['s', '##ys', '##ore', '##x', 'announces', 'latest', 'series', 'engagement', 'with', 'fortune', 'bio', '##pha', '##rma', '##ce', '##utical', 'firm']",1
370982,nifty_1164,2015-12-01,Research and Markets: Drug Delivery Technology Market 2015 by Route of Administration & End User - Forecasts to 2020 for the $1.5 Billion Industry,Fall,-0.0102,146,research and market drug delivery technology market route administration end user forecast for the billion industry,115,16,0,pharmacy,"['research', 'and', 'market', 'drug', 'delivery', 'technology', 'market', 'route', 'administration', 'end', 'user', 'forecast', 'for', 'the', 'billion', 'industry']",1
371064,nifty_1164,2015-12-01,"Research and Markets: Europe Cell Surface Markers 2016: Forecasts, Technologies, Strategies & Opportunities - France, Germany, Italy, Spain & UK",Fall,-0.0102,144,research and market europe cell surface marker forecast technology strategy opportunity france germany italy spain,114,15,0,pharmacy,"['research', 'and', 'market', 'euro', '##pe', 'cell', 'surface', 'marker', 'forecast', 'technology', 'strategy', 'opportunity', 'f', '##rance', 'g', '##erman', '##y', 'it', '##aly', 'spa', '##in']",1
371104,nifty_1164,2015-12-01,Research and Markets: Global Laparotomy Sponge Market 2015-2019,Fall,-0.0102,63,research and market global laparotomy sponge market,51,7,0,pharmacy,"['research', 'and', 'market', 'global', 'lap', '##aro', '##tom', '##y', 's', '##po', '##nge', 'market']",1
371171,nifty_1164,2015-12-01,Aptose Biosciences to Participate in Upcoming Investor Conferences,Fall,-0.0102,66,aptose bioscience participate upcoming investor conference,58,6,0,pharmacy,"['a', '##pt', '##ose', 'bio', '##science', 'participate', 'upcoming', 'investor', 'conference']",1
371230,nifty_1164,2015-12-01,"Research and Markets: Actuated Medical, Inc. - Product Pipeline Analysis, 2015 Update",Fall,-0.0102,85,research and market actuated medical inc product pipeline analysis update,73,10,0,pharmacy,"['research', 'and', 'market', 'act', '##uated', 'medical', 'in', '##c', 'product', 'pipeline', 'analysis', 'update']",1
371240,nifty_1164,2015-12-01,Research and Markets: Global Cell-based Assays Market Report 2015 - Forecasts to 2020 for the $18 Billion Industry,Fall,-0.0102,114,research and market global cell based assay market report forecast for the billion industry,91,14,0,pharmacy,"['research', 'and', 'market', 'global', 'cell', 'based', 'ass', '##ay', 'market', 'report', 'forecast', 'for', 'the', 'billion', 'industry']",1
371302,nifty_1164,2015-12-01,Research and Markets: Global Hormone Replacement Therapy Market 2015-2019,Fall,-0.0102,73,research and market global hormone replacement therapy market,61,8,0,pharmacy,"['research', 'and', 'market', 'global', 'hormone', 'replacement', 'therapy', 'market']",1
371388,nifty_1164,2015-12-01,Novo Nordisk Buys Xoma’s Diabetes Treatment,Fall,-0.0102,43,novo nordisk buy xoma diabetes treatment,40,6,0,pharmacy,"['no', '##vo', 'nor', '##dis', '##k', 'buy', 'x', '##oma', 'diabetes', 'treatment']",1
371475,nifty_1165,2015-12-02,Zafgen Says a Second Patient Died in Beloranib Study,Fall,-0.014,52,zafgen say second patient died beloranib study,46,7,0,pharmacy,"['z', '##af', '##gen', 'say', 'second', 'patient', 'died', 'be', '##lora', '##ni', '##b', 'study']",1
371805,nifty_1168,2015-12-08,Northwest Biotherapeutics to Probe CEO Allegations,Fall,-0.0078,50,northwest biotherapeutics probe ceo allegation,46,5,0,pharmacy,"['northwest', 'bio', '##ther', '##ap', '##eu', '##tics', 'probe', 'c', '##eo', 'all', '##egation']",1
372048,nifty_1171,2015-12-14,"Amgen Takes Back Rights to Prolia, Xgeva and Vectibix Drugs",Rise,0.0105,59,amgen take back right prolia xgeva and vectibix drug,52,9,0,pharmacy,"['am', '##gen', 'take', 'back', 'right', 'pro', '##lia', 'x', '##ge', '##va', 'and', 've', '##ct', '##ibi', '##x', 'drug']",1
372105,nifty_1172,2015-12-15,Genetic Testing May Be Coming to Your Office,Rise,0.0146,44,genetic testing may coming your office,38,6,0,pharmacy,"['genetic', 'testing', 'may', 'coming', 'your', 'office']",1
372114,nifty_1172,2015-12-15,Firm Bets on Biotech That Changes How Food Is Produced,Rise,0.0146,54,firm bet biotech that change how food produced,46,8,0,pharmacy,"['firm', 'bet', 'bio', '##tech', 'that', 'change', 'how', 'food', 'produced']",1
372116,nifty_1172,2015-12-15,Millennium Health Wins Approval of Chapter 11 Plan,Rise,0.0146,50,millennium health win approval chapter plan,43,6,0,pharmacy,"['millennium', 'health', 'win', 'approval', 'chapter', 'plan']",1
372128,nifty_1172,2015-12-15,FDA Approves Merck’s Surgery Drug Bridion,Rise,0.0146,41,fda approves merck surgery drug bridion,39,6,0,pharmacy,"['f', '##da', 'approve', '##s', 'me', '##rc', '##k', 'surgery', 'drug', 'br', '##id', '##ion']",1
372240,nifty_1173,2015-12-16,Advaxis Shares Jump After Drug Hold Lifted,Fall,-0.0152,42,advaxis share jump after drug hold lifted,41,7,0,pharmacy,"['ad', '##va', '##xi', '##s', 'share', 'jump', 'after', 'drug', 'hold', 'lifted']",1
372245,nifty_1173,2015-12-16,Array BioPharma Reports Successful Cancer Drug Trial,Fall,-0.0152,52,array biopharma report successful cancer drug trial,51,7,0,pharmacy,"['array', 'bio', '##pha', '##rma', 'report', 'successful', 'cancer', 'drug', 'trial']",1
372336,nifty_1174,2015-12-17,Chemours Says Market Conditions Will Dent Profit,Fall,-0.0236,48,chemours say market condition will dent profit,46,7,0,pharmacy,"['ch', '##em', '##ours', 'say', 'market', 'condition', 'will', 'den', '##t', 'profit']",1
372648,nifty_1179,2015-12-29,The Market’s Latest Comeback Story: Biotech Stocks,Fall,-0.0071,50,the market latest comeback story biotech stock,46,7,0,pharmacy,"['the', 'market', 'latest', 'comeback', 'story', 'bio', '##tech', 'stock']",1
